Citrus Sinensis ID: 047276

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450---
Protein Sequence
MEDKKANIIAASLVLALIIFIIIARVTLKLSKAFFLIVGADIAVVLAVFACVIIRRRYHKRRLLLESKFVTEGRELRIEYSFLRKVAGVPIKFRSKELEEATDNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVDDPPDTQMVIVDWLSIDQDDDAGGDIGRRRLAALASDLGRNLATDSAACSLTMSVLSGR
Secondary Structure (PSIPRED)
cccccccEEHHHHHHHHHHHHHHHHHHHcccccEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccHHHHHHHHHHHcccccccccHHHHHHHHHHHHHHccccccEEEEEEEEccccEEEEEEcccccccHHHHHHHHHHHHHccccccccEEEccccccccEEEEEcccccccHHHHccccccccccccccccccHHHHHHHHHHHHHHHHHHHHcccccEEEEcccccccccccccccccccccccccccccccEEEccccccccccHHHHccccccccccccccHHHHHHHHHccccccccccccccccccccccHHHHHHHHHHcccccccccccccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccEEEEcccccccccHEEEEHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccEEcHHHHHHHHcccHHcccccccccEEEcEcccccEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHHHEEEEcccccEEEEEEEcccccHHHHHcccccHHHcccccccccHHHHHHHHHHHHHHHHHHHHccccEEEEccccHHHEEEcccccccHcHccHHEEccccccEEEEEEEEccccccHHHHHccccccccHHHHHHEEEEEEHccccccccccccccccHHHHHcHHHHHHHHHHccccHHHccccccccccccHHHHHHHHHHHHHHHcccHHccccHHHHHHHHccccccccccccccEEEccccccccccccHHHHHcHHHccccccccccccccccccEEEEEEccc
Coil and Loop (DISEMBL)
MEDKKANIIAASLVLALIIFIIIARVTLKLSKAFFLIVGADIAVVLAVFACVIIRRRYHKRRLLLESKFVTEGRELRIEYSFLRKVAGVPIKFRSKELEEATDNFQAllghgssasVFKGILSDGTSVAVKRingeengekEFRSEVAAIASAQHVNLVRLLGycvvpggprYLVYEFIQngsldhwifptsrrseghysggclsWDLRYRVAIDVAKALSYLHNdcrsrvlhldvkpenilldenyRAVVSDfglsklmsrdqsrcittirgtrgylapewileqgvsekcdiySYGMVLLELtggrrnvsliehgndksknkwQYFPKIVNEKMKEGKLMEIVDQrltdeggidetqVRRLVDVAFWCIQERARLRPSMARVVEMLEgrvavddppdtqMVIVDWLsidqdddaggdIGRRRLAALASDLGrnlatdsaACSLTMSVLSGR
Flexible Loop (DISEMBL)
MEDKKANIIAASLVLALIIFIIIARVTLKLSKAFFLIVGADIAVVLAVFACVIIRRryhkrrllleskfvtegrelrieysflrkvAGVPIKFRSKELEEATDNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLdvkpenilldenyRAVVSDfglsklmsrdqsrcittirgtrgylapewILEQGVSEKCDIYSYGMVLLELTGGRRNVSLiehgndksknkwqYFPKIVnekmkegkLMEIVDQrltdeggidetqvrRLVDVAFWCIqerarlrpsMARVVEMLegrvavddppdTQMVIVDWLSIDQDDDAGGDIGRRRLAALASDlgrnlatdsaacsltmsvlsgr
Low Complexity Region (SEG)
MEDKKaniiaaslvlaliifiiiaRVTLKLSKAFFLIVGADIAVVLAVFACVIIRRRYHKRRLLLESKFVTEGRELRIEYSFLRKVAGVPIKFRSKELEEATDNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVDDPPDTQMVIVDWLSIDQdddaggdigrrrlaalaSDLGRNLATDSAACSLTMSVLSGR
Disordered region (IsUnstruct)
******NIIAASLVLALIIFIIIARVTLKLSKAFFLIVGADIAVVLAVFACVIIRRRYHKRRLLLESKFVTEGRELRIEYSFLRKVAGVPIKFRSKELEEATDNFQALLGHGSSASVFKGILSDGTSVAVKRI***********SEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVDDPPDTQMVIVDWLSIDQDDDAGGDIGRRRLAALASDL*********************
Disordered Region (DISOPRED)
******N*IAASLVLALIIFIIIARVTLKLSKAFFLIVGADIAVVLAVFACVIIRRRYHKRRLLLE************EYSFLRKVAGVPIKFRSKELEEATDNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSE*HYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNV************KWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVDDPPDTQMV*******************************************MSVL***
Disordered Region (DISEMBL)
MEDKKANIIAASLVLALIIFIIIARVTLKLSKAFFLIVGADIAVVLAVFACVIIRRRYHKRRLLLESKFVTEGRELRIEYSFLRKVAGVPIKFRSKELEEATDNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVDDPPDTQMVIVDWLSIDQDDDAGGDIGRRRLAALASDLGRNLATDSAACSLTMSVLSGR
Disordered Region (DISPRO)
******NII*ASLVLALIIFIIIARVTLKLSKAFFLIVGADIAVVLAVFACVIIRRRYHKR**************************GVPIKFRSKELEEATDNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRS**HYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVDDPPDTQ****************************************ACSLTMSVLSGR
Transmembrane Helix (TMHMM)
iiiiiiHHHHHHHHHHHHHHHHHHoooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
iiiiiiiHHHHHHHHHHHHHHHHHooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiHHHHHHHHHHHHHHHHHHHHHHoooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
iiiiiiHHHHHHHHHHHHHHHHHHHHHHoooooHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MEDKKANIIAASLVLALIIFIIIARVTLKLSKAFFLIVGADIAVVLAVFACVIIRRRYHKRRLLLESKFVTEGRELRIEYSFLRKVAGVPIKFRSKELEEATDNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVDDPPDTQMVIVDWLSIDQDDDAGGDIGRRRLAALASDLGRNLATDSAACSLTMSVLSGR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	453	2.2.26 [Sep-21-2011]
Q94C25	452	Probable receptor-like pr	yes	no	0.878	0.880	0.656	1e-146
Q8RWZ5	821	G-type lectin S-receptor-	no	no	0.735	0.405	0.478	8e-91
Q9XID3	829	G-type lectin S-receptor-	no	no	0.679	0.371	0.452	1e-81
Q9FLV4	872	G-type lectin S-receptor-	no	no	0.662	0.344	0.435	4e-74
O64477	828	G-type lectin S-receptor-	no	no	0.664	0.363	0.453	3e-72
O65238	872	G-type lectin S-receptor-	no	no	0.664	0.345	0.423	3e-71
Q39203	797	G-type lectin S-receptor-	no	no	0.633	0.360	0.461	4e-69
Q9SKG5	620	Somatic embryogenesis rec	no	no	0.631	0.461	0.425	2e-55
Q8LPS5	601	Somatic embryogenesis rec	no	no	0.631	0.475	0.422	1e-54
Q39202	832	G-type lectin S-receptor-	no	no	0.629	0.342	0.381	1e-54

>sp|Q94C25|Y5005_ARATH Probable receptor-like protein kinase At5g20050 OS=Arabidopsis thaliana GN=At5g20050 PE=2 SV=1

 Score =  518 bits (1333), Expect = e-146,   Method: Compositional matrix adjust.
 Identities = 264/402 (65%), Positives = 325/402 (80%), Gaps = 4/402 (0%)

Query: 1   MEDKKANIIAASLVLALIIFIIIARVTLKLSKAFFLIVGADIAVVLAVFACVIIRRRYHK 60
           MEDKKANIIA  L+LAL++ II ARV+LKLSK F+LI G DI+++LAV   +IIR RY+K
Sbjct: 1   MEDKKANIIATILILALVVVIIAARVSLKLSKTFYLIAGVDISLILAVICFLIIRSRYNK 60

Query: 61  RRLLLESKFVTEGRELRIEYSFLRKVAGVPIKFRSKELEEATDNFQALLGHGSSASVFKG 120
            R LL S+F +EGRELRIEYSFLRKVAGVP KF+ ++LEEATD F++L+G G S SVFKG
Sbjct: 61  ERKLLVSRFASEGRELRIEYSFLRKVAGVPTKFKLEDLEEATDGFRSLIGKGGSGSVFKG 120

Query: 121 ILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGG--PRYLVYEF 178
           +L DG+ VAVKRI GEE GE+EFRSEVAAIAS QH NLVRL GY        PR+LVY++
Sbjct: 121 VLKDGSQVAVKRIEGEEKGEREFRSEVAAIASVQHKNLVRLYGYSSSTSANRPRFLVYDY 180

Query: 179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKP 238
           I N SLD WIFP    + G   GGCLSW+ RY+VAIDVAKAL+YLH+DCRS++LHLDVKP
Sbjct: 181 IVNSSLDIWIFPDR-GNRGRSGGGCLSWEQRYQVAIDVAKALAYLHHDCRSKILHLDVKP 239

Query: 239 ENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYG 298
           ENILLDEN+RAVV+DFGLSKL++RD+SR +T IRGTRGYLAPEW+LE G+SEK D+YSYG
Sbjct: 240 ENILLDENFRAVVTDFGLSKLIARDESRVLTDIRGTRGYLAPEWLLEHGISEKSDVYSYG 299

Query: 299 MVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDET 358
           +VLLE+ GGRR++S      +  K K +YFP+IVN+KM+E K+MEIVDQRL +   +DE 
Sbjct: 300 IVLLEMIGGRRSISR-VEVKETKKKKLEYFPRIVNQKMRERKIMEIVDQRLIEVNEVDEE 358

Query: 359 QVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVDDPPDT 400
           +V +LV VA WCIQE+++ RP M  V+EMLEGRV V++PPD+
Sbjct: 359 EVMKLVCVALWCIQEKSKKRPDMTMVIEMLEGRVPVNEPPDS 400

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1

 Score =  334 bits (857), Expect = 8e-91,   Method: Compositional matrix adjust.
 Identities = 169/353 (47%), Positives = 235/353 (66%), Gaps = 20/353 (5%)

Query: 52  VIIRRRYHKRR-LLLESKFVTEGRELRIEYSFLRKVAGVPIKFRSKELEEATDNFQALLG 110
           + +  R HKR+ ++LE+      +E   E +FL  ++G+PI+F  K+L+ AT+NF   LG
Sbjct: 446 IFVAFRIHKRKKMILEAP-----QESSEEDNFLENLSGMPIRFAYKDLQSATNNFSVKLG 500

Query: 111 HGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGG 170
            G   SV++G L DG+ +AVK++ G   G+KEFR+EV+ I S  H++LVRL G+C   G 
Sbjct: 501 QGGFGSVYEGTLPDGSRLAVKKLEGIGQGKKEFRAEVSIIGSIHHLHLVRLRGFCA-EGA 559

Query: 171 PRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSR 230
            R L YEF+  GSL+ WIF   R+ +G      L WD R+ +A+  AK L+YLH DC +R
Sbjct: 560 HRLLAYEFLSKGSLERWIF---RKKDGDV---LLDWDTRFNIALGTAKGLAYLHEDCDAR 613

Query: 231 VLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSE 290
           ++H D+KPENILLD+N+ A VSDFGL+KLM+R+QS   TT+RGTRGYLAPEWI    +SE
Sbjct: 614 IVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFTTMRGTRGYLAPEWITNYAISE 673

Query: 291 KCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLT 350
           K D+YSYGMVLLEL GGR+N    E       ++  +FP    +KM+EGKLM+IVD ++ 
Sbjct: 674 KSDVYSYGMVLLELIGGRKNYDPSE------TSEKCHFPSFAFKKMEEGKLMDIVDGKMK 727

Query: 351 DEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVDDPPDTQMV 403
           +    DE +V+R +  A WCIQE  + RPSM++VV+MLEG   V  PP +  +
Sbjct: 728 NVDVTDE-RVQRAMKTALWCIQEDMQTRPSMSKVVQMLEGVFPVVQPPSSSTM 779

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1

 Score =  304 bits (778), Expect = 1e-81,   Method: Compositional matrix adjust.
 Identities = 146/323 (45%), Positives = 216/323 (66%), Gaps = 15/323 (4%)

Query: 76  LRIEYSFLRKVAGVPIKFRSKELEEATDNFQALLGHGSSASVFKGILSDGTSVAVKRING 135
           L   Y+ L   +G P++F  KEL+  T +F+  LG G   +V++G+L++ T VAVK++ G
Sbjct: 457 LSSHYTLLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLEG 516

Query: 136 EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRS 195
            E GEK+FR EVA I+S  H+NLVRL+G+C   G  R LVYEF++NGSLD+++F T    
Sbjct: 517 IEQGEKQFRMEVATISSTHHLNLVRLIGFC-SQGRHRLLVYEFMRNGSLDNFLFTTD--- 572

Query: 196 EGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFG 255
               S   L+W+ R+ +A+  AK ++YLH +CR  ++H D+KPENIL+D+N+ A VSDFG
Sbjct: 573 ----SAKFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFG 628

Query: 256 LSKLMS-RDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLI 314
           L+KL++ +D    ++++RGTRGYLAPEW+    ++ K D+YSYGMVLLEL  G+RN  + 
Sbjct: 629 LAKLLNPKDNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFDVS 688

Query: 315 EHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQER 374
           E  N K  + W Y      E+ ++G    I+D RL+++  +D  QV R+V  +FWCIQE+
Sbjct: 689 EKTNHKKFSIWAY------EEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQ 742

Query: 375 ARLRPSMARVVEMLEGRVAVDDP 397
              RP+M +VV+MLEG   + +P
Sbjct: 743 PLQRPTMGKVVQMLEGITEIKNP 765

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1

 Score =  279 bits (713), Expect = 4e-74,   Method: Compositional matrix adjust.
 Identities = 138/317 (43%), Positives = 202/317 (63%), Gaps = 17/317 (5%)

Query: 90  PIKFRSKELEEATDNFQALLGHGSSASVFKGILSDGTSVAVKRIN-GEENGEKEFRSEVA 148
           P+ F  ++L+  T+NF  LLG G   +V+KG ++  T VAVKR++    +GE+EF +EV 
Sbjct: 517 PVSFTYRDLQNCTNNFSQLLGSGGFGTVYKGTVAGETLVAVKRLDRALSHGEREFITEVN 576

Query: 149 AIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL 208
            I S  H+NLVRL GYC      R LVYE++ NGSLD WIF + +      +   L W  
Sbjct: 577 TIGSMHHMNLVRLCGYCS-EDSHRLLVYEYMINGSLDKWIFSSEQ------TANLLDWRT 629

Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI 268
           R+ +A+  A+ ++Y H  CR+R++H D+KPENILLD+N+   VSDFGL+K+M R+ S  +
Sbjct: 630 RFEIAVATAQGIAYFHEQCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHVV 689

Query: 269 TTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYF 328
           T IRGTRGYLAPEW+  + ++ K D+YSYGM+LLE+ GGRRN+ +     D     W Y 
Sbjct: 690 TMIRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEIVGGRRNLDMSYDAEDFFYPGWAY- 748

Query: 329 PKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEML 388
                +++  G  ++ VD+RL  +G  +E +V + + VAFWCIQ+   +RPSM  VV++L
Sbjct: 749 -----KELTNGTSLKAVDKRL--QGVAEEEEVVKALKVAFWCIQDEVSMRPSMGEVVKLL 801

Query: 389 EGRV-AVDDPPDTQMVI 404
           EG    ++ PP  Q ++
Sbjct: 802 EGTSDEINLPPMPQTIL 818

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1

 Score =  272 bits (696), Expect = 3e-72,   Method: Compositional matrix adjust.
 Identities = 143/315 (45%), Positives = 197/315 (62%), Gaps = 14/315 (4%)

Query: 85  KVAGVPIKFRSKELEEATDNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFR 144
           K  G    F  +EL+ AT NF   LG G   SVFKG L D + +AVKR+ G   GEK+FR
Sbjct: 475 KGDGTLSAFSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGISQGEKQFR 534

Query: 145 SEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCL 204
           +EV  I + QHVNLVRL G+C   G  + LVY+++ NGSLD  +F      +       L
Sbjct: 535 TEVVTIGTIQHVNLVRLRGFCS-EGSKKLLVYDYMPNGSLDSHLFLNQVEEKI-----VL 588

Query: 205 SWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ 264
            W LR+++A+  A+ L+YLH++CR  ++H D+KPENILLD  +   V+DFGL+KL+ RD 
Sbjct: 589 GWKLRFQIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDF 648

Query: 265 SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNK 324
           SR +TT+RGTRGYLAPEWI    ++ K D+YSYGM+L EL  GRRN    E+       K
Sbjct: 649 SRVLTTMRGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTEQSEN------EK 702

Query: 325 WQYFPKIVNEKM-KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMAR 383
            ++FP      + K+G +  +VD RL  +  +D  +V R   VA WCIQ+    RP+M++
Sbjct: 703 VRFFPSWAATILTKDGDIRSLVDPRLEGD-AVDIEEVTRACKVACWCIQDEESHRPAMSQ 761

Query: 384 VVEMLEGRVAVDDPP 398
           VV++LEG + V+ PP
Sbjct: 762 VVQILEGVLEVNPPP 776

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2

 Score =  269 bits (688), Expect = 3e-71,   Method: Compositional matrix adjust.
 Identities = 138/326 (42%), Positives = 202/326 (61%), Gaps = 25/326 (7%)

Query: 86  VAGVPIKFRSKELEEATDNFQALLGHGSSASVFKGILSDGTSVAVKRI-NGEENGEKEFR 144
           + G+P KF  +ELE+AT+NF+  +G G   SV+KG L D T +AVK+I N   +G +EF 
Sbjct: 498 IPGLPQKFEFEELEQATENFKMQIGSGGFGSVYKGTLPDETLIAVKKITNHGLHGRQEFC 557

Query: 145 SEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCL 204
           +E+A I + +H NLV+L G+C   G    LVYE++ +GSL+  +F  +        G  L
Sbjct: 558 TEIAIIGNIRHTNLVKLRGFCAR-GRQLLLVYEYMNHGSLEKTLFSGN--------GPVL 608

Query: 205 SWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ 264
            W  R+ +A+  A+ L+YLH+ C  +++H DVKPENILL ++++  +SDFGLSKL+++++
Sbjct: 609 EWQERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEE 668

Query: 265 SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNK 324
           S   TT+RGTRGYLAPEWI    +SEK D+YSYGMVLLEL  GR+N S     N  +++ 
Sbjct: 669 SSLFTTMRGTRGYLAPEWITNAAISEKADVYSYGMVLLELVSGRKNCSFRSRSNSVTEDN 728

Query: 325 WQ-------------YFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCI 371
            Q             YFP    +  ++G+ ME+ D RL  EG +   +  +LV +A  C+
Sbjct: 729 NQNHSSTTTTSTGLVYFPLYALDMHEQGRYMELADPRL--EGRVTSQEAEKLVRIALCCV 786

Query: 372 QERARLRPSMARVVEMLEGRVAVDDP 397
            E   LRP+MA VV M EG + + +P
Sbjct: 787 HEEPALRPTMAAVVGMFEGSIPLGNP 812

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1

 Score =  262 bits (669), Expect = 4e-69,   Method: Compositional matrix adjust.
 Identities = 139/301 (46%), Positives = 190/301 (63%), Gaps = 14/301 (4%)

Query: 93  FRSKELEEATDNFQALLGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRSEVAAIA 151
           F  KEL+ AT+ F   +GHG   +VFKG L    T VAVKR+    +GE EFR+EV  I 
Sbjct: 451 FSFKELQSATNGFSDKVGHGGFGAVFKGTLPGSSTFVAVKRLERPGSGESEFRAEVCTIG 510

Query: 152 SAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYR 211
           + QHVNLVRL G+C      R LVY+++  GSL  ++  TS +         LSW+ R+R
Sbjct: 511 NIQHVNLVRLRGFCS-ENLHRLLVYDYMPQGSLSSYLSRTSPK--------LLSWETRFR 561

Query: 212 VAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTI 271
           +A+  AK ++YLH  CR  ++H D+KPENILLD +Y A VSDFGL+KL+ RD SR + T+
Sbjct: 562 IALGTAKGIAYLHEGCRDCIIHCDIKPENILLDSDYNAKVSDFGLAKLLGRDFSRVLATM 621

Query: 272 RGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEH--GNDKSKNKWQYFP 329
           RGT GY+APEWI    ++ K D+YS+GM LLEL GGRRNV +     G  +++ +  +FP
Sbjct: 622 RGTWGYVAPEWISGLPITTKADVYSFGMTLLELIGGRRNVIVNSDTLGEKETEPEKWFFP 681

Query: 330 KIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE 389
                ++ +G +  +VD RL  E   +E  V R+  VA WCIQ+   +RP+M  VV+MLE
Sbjct: 682 PWAAREIIQGNVDSVVDSRLNGEYNTEE--VTRMATVAIWCIQDNEEIRPAMGTVVKMLE 739

Query: 390 G 390
           G
Sbjct: 740 G 740

Serine/threonine-protein kinase.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SKG5|SERK4_ARATH Somatic embryogenesis receptor kinase 4 OS=Arabidopsis thaliana GN=SERK4 PE=1 SV=2

 Score =  217 bits (552), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 129/303 (42%), Positives = 180/303 (59%), Gaps = 17/303 (5%)

Query: 92  KFRSKELEEATDNF--QALLGHGSSASVFKGILSDGTSVAVKRINGE--ENGEKEFRSEV 147
           +F  +EL  ATDNF  + +LG G    V+KG L+DG  VAVKR+  E  + GE +F++EV
Sbjct: 281 RFTLRELLVATDNFSNKNVLGRGGFGKVYKGRLADGNLVAVKRLKEERTKGGELQFQTEV 340

Query: 148 AAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWD 207
             I+ A H NL+RL G+C+ P   R LVY ++ NGS+   +     R EG+     L W 
Sbjct: 341 EMISMAVHRNLLRLRGFCMTPT-ERLLVYPYMANGSVASCL---RERPEGN---PALDWP 393

Query: 208 LRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC 267
            R  +A+  A+ L+YLH+ C  +++H DVK  NILLDE + AVV DFGL+KLM+ + S  
Sbjct: 394 KRKHIALGSARGLAYLHDHCDQKIIHRDVKAANILLDEEFEAVVGDFGLAKLMNYNDSHV 453

Query: 268 ITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQY 327
            T +RGT G++APE++     SEK D++ YG++LLEL  G++   L    ND       +
Sbjct: 454 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDDDIMLLDW 513

Query: 328 FPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM 387
               V E +KE KL  +VD  L  EG   ET+V +L+ +A  C Q  A  RP M+ VV M
Sbjct: 514 ----VKEVLKEKKLESLVDAEL--EGKYVETEVEQLIQMALLCTQSSAMERPKMSEVVRM 567

Query: 388 LEG 390
           LEG
Sbjct: 568 LEG 570

Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Positively regulates the BR-dependent plant growth pathway and negatively regulates the BR-independent cell-death pathway.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8LPS5|SERK5_ARATH Somatic embryogenesis receptor kinase 5 OS=Arabidopsis thaliana GN=SERK5 PE=1 SV=2

 Score =  214 bits (545), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 128/303 (42%), Positives = 181/303 (59%), Gaps = 17/303 (5%)

Query: 92  KFRSKELEEATDNF--QALLGHGSSASVFKGILSDGTSVAVKRINGE--ENGEKEFRSEV 147
           +F  +EL  AT+ F  + +LG G    ++KG L+D T VAVKR+N E  + GE +F++EV
Sbjct: 262 RFSLRELLVATEKFSKRNVLGKGRFGILYKGRLADDTLVAVKRLNEERTKGGELQFQTEV 321

Query: 148 AAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWD 207
             I+ A H NL+RL G+C+ P   R LVY ++ NGS+   +     R EG+     L W 
Sbjct: 322 EMISMAVHRNLLRLRGFCMTPT-ERLLVYPYMANGSVASCL---RERPEGN---PALDWP 374

Query: 208 LRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC 267
            R  +A+  A+ L+YLH+ C  +++HLDVK  NILLDE + AVV DFGL+KLM+ + S  
Sbjct: 375 KRKHIALGSARGLAYLHDHCDQKIIHLDVKAANILLDEEFEAVVGDFGLAKLMNYNDSHV 434

Query: 268 ITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQY 327
            T +RGT G++APE++     SEK D++ YG++LLEL  G++   L    ND       +
Sbjct: 435 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDDDIMLLDW 494

Query: 328 FPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM 387
               V E +KE KL  +VD  L  EG   ET+V +L+ +A  C Q  A  RP M+ VV M
Sbjct: 495 ----VKEVLKEKKLESLVDAEL--EGKYVETEVEQLIQMALLCTQSSAMERPKMSEVVRM 548

Query: 388 LEG 390
           LEG
Sbjct: 549 LEG 551

Serine/threonine-kinase of unknown function.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2

 Score =  214 bits (545), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 119/312 (38%), Positives = 182/312 (58%), Gaps = 27/312 (8%)

Query: 93  FRSKELEEATDNFQALLGHGSSASVFKGILS----DGTSVAVKRINGEE-NGEKEFRSEV 147
           F   EL EAT +F   LG G+   V+KG L        +VAVK+++  + + EKEF++EV
Sbjct: 521 FTYGELAEATRDFTEELGRGAFGIVYKGYLEVAGGSEVTVAVKKLDRLDLDNEKEFKNEV 580

Query: 148 AAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWD 207
             I    H NLVRL+G+C   G  + +VYEF+  G+L +++F   R S          W+
Sbjct: 581 KVIGQIHHKNLVRLIGFCN-EGQSQMIVYEFLPQGTLANFLFRRPRPS----------WE 629

Query: 208 LRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC 267
            R  +A+ +A+ + YLH +C  +++H D+KP+NILLDE Y   +SDFGL+KL+  +Q+  
Sbjct: 630 DRKNIAVAIARGILYLHEECSEQIIHCDIKPQNILLDEYYTPRISDFGLAKLLLMNQTYT 689

Query: 268 ITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQY 327
           +T IRGT+GY+APEW     ++ K D+YSYG++LLE+   ++ V L    ++     W Y
Sbjct: 690 LTNIRGTKGYVAPEWFRNSPITSKVDVYSYGVMLLEIVCCKKAVDL---EDNVILINWAY 746

Query: 328 FPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM 387
                 +  ++G+L ++ +     E   D   V R V +A WCIQE   +RP+M  V +M
Sbjct: 747 ------DCFRQGRLEDLTED--DSEAMNDMETVERYVKIAIWCIQEEHGMRPNMRNVTQM 798

Query: 388 LEGRVAVDDPPD 399
           LEG + V DPP+
Sbjct: 799 LEGVIQVFDPPN 810

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	453
255566921	450	BRASSINOSTEROID INSENSITIVE 1-associated	0.993	1.0	0.735	0.0
297738913	450	unnamed protein product [Vitis vinifera]	0.991	0.997	0.733	0.0
359484394	720	PREDICTED: probable receptor-like protei	0.991	0.623	0.733	0.0
357477939	445	Avr9/Cf-9 rapidly elicited protein [Medi	0.973	0.991	0.676	1e-173
356563053	448	PREDICTED: probable receptor-like protei	0.984	0.995	0.668	1e-168
449464588	454	PREDICTED: probable receptor-like protei	1.0	0.997	0.656	1e-167
356510540	434	PREDICTED: probable receptor-like protei	0.955	0.997	0.634	1e-161
15241250	452	putative receptor-like protein kinase [A	0.878	0.880	0.656	1e-144
21554146	452	receptor-like protein kinase-like protei	0.878	0.880	0.656	1e-144
297808069	452	kinase family protein [Arabidopsis lyrat	0.878	0.880	0.651	1e-139

>gi|255566921|ref|XP_002524443.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223536231|gb|EEF37883.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis]

 Score =  688 bits (1776), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 333/453 (73%), Positives = 387/453 (85%), Gaps = 3/453 (0%)

Query: 1   MEDKKANIIAASLVLALIIFIIIARVTLKLSKAFFLIVGADIAVVLAVFACVIIRRRYHK 60
           MEDKKA+I+AAS VL LI  I+IARV+L LSK F+LI+GADIAV+LA+F+CV+IRRRY+ 
Sbjct: 1   MEDKKAHIVAASTVLILIFVIVIARVSLNLSKPFYLILGADIAVILAIFSCVVIRRRYNL 60

Query: 61  RRLLLESKFVTEGRELRIEYSFLRKVAGVPIKFRSKELEEATDNFQALLGHGSSASVFKG 120
           R  LL  +  +EGRELRIEYSFLRKVAGVPIKFR KELEEATDNF ALLG G+SASVFKG
Sbjct: 61  RSKLLVKRLASEGRELRIEYSFLRKVAGVPIKFRYKELEEATDNFDALLGQGASASVFKG 120

Query: 121 ILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ 180
           ILSDGT+VAVKRIN EE GEKEFRSEVAAIAS QH+NLVRLLGYCVV GGPR+LVYEFI 
Sbjct: 121 ILSDGTAVAVKRINREERGEKEFRSEVAAIASVQHINLVRLLGYCVVAGGPRFLVYEFIP 180

Query: 181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPEN 240
           NGSLD WIFP  R +  +  GGCLSW+ RYRVAIDVAKALSYLH+DCRSRVLHLDVKPEN
Sbjct: 181 NGSLDCWIFP-KRGTRNNLPGGCLSWESRYRVAIDVAKALSYLHHDCRSRVLHLDVKPEN 239

Query: 241 ILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMV 300
           IL+DENYRA+VSDFGLSKLM +D+SR IT IRGTRGYLAPEW+LE G+SEKCD+YSYGMV
Sbjct: 240 ILIDENYRAIVSDFGLSKLMGKDESRVITNIRGTRGYLAPEWLLENGISEKCDVYSYGMV 299

Query: 301 LLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQV 360
           LLE+ GG+RNV LI+ GND  + KWQYFPKIVN+K+KEGKLME+VD RL + GGIDE QV
Sbjct: 300 LLEMIGGQRNVCLIQKGNDSIQRKWQYFPKIVNQKLKEGKLMEVVDSRLIESGGIDERQV 359

Query: 361 RRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVDDPPDTQMVIVDWLSIDQDDDAGGDI 420
           RRLV VAFWCIQER RLRP+MAR+V+MLEGRV V++PPDT MV+VD LSID+D   G   
Sbjct: 360 RRLVGVAFWCIQERVRLRPTMARIVDMLEGRVVVEEPPDTHMVVVDMLSIDKDTPEGHK- 418

Query: 421 GRRRLAALASDLGRNLATDSAACSLTMSVLSGR 453
            R ++AALA++   +    +++CS +MS++S R
Sbjct: 419 -RAKVAALAAEQVDSAHPTTSSCSYSMSIISPR 450

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297738913|emb|CBI28158.3| unnamed protein product [Vitis vinifera]

 Score =  675 bits (1742), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 333/454 (73%), Positives = 385/454 (84%), Gaps = 5/454 (1%)

Query: 1   MEDKKANIIAASLVLALIIFIIIARVTLKLSKAFFLIVGADIAVVLAVFACVIIRRRYHK 60
           MEDKKA+IIA S V+ALII II+ARV+LKLS  FFLI+GADIA +LA+F  VIIR R+++
Sbjct: 1   MEDKKASIIAVSSVVALIILIIVARVSLKLSNTFFLILGADIAAILAIFTYVIIRWRFNR 60

Query: 61  RRLLLESKFVTEGRELRIEYSFLRKVAGVPIKFRSKELEEATDNFQALLGHGSSASVFKG 120
           RR LLE++ V+EGRELRIEYSFLRKVAGVP KFR KELEEATDNFQAL+G G+SASVF+G
Sbjct: 61  RRKLLETRLVSEGRELRIEYSFLRKVAGVPTKFRYKELEEATDNFQALIGRGASASVFRG 120

Query: 121 ILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ 180
           IL+DGTSVAVKRI GEE+GEKEF+SEVAAIAS QHVNLVRLLGYC VPGGPR+L+Y+FIQ
Sbjct: 121 ILNDGTSVAVKRIEGEEHGEKEFKSEVAAIASVQHVNLVRLLGYCCVPGGPRFLIYDFIQ 180

Query: 181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPEN 240
           NGSLD WIFP  R S+G    GCLSWD RYRVA+DVAKALSYLH+DCRSRVLHLDVKPEN
Sbjct: 181 NGSLDCWIFP-QRESQGR-PRGCLSWDFRYRVALDVAKALSYLHHDCRSRVLHLDVKPEN 238

Query: 241 ILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMV 300
           ILLDENYRA+VSDFGLSKLM +D+SR +TTIRGTRGYLAPEW+LE GVSEK DIYSYGMV
Sbjct: 239 ILLDENYRALVSDFGLSKLMRKDESRVLTTIRGTRGYLAPEWLLEHGVSEKSDIYSYGMV 298

Query: 301 LLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQV 360
           L E+ GG+RNV LIE+GND+S+ KWQYFPK+V EKM+EGKLME+VD RL + GGIDE +V
Sbjct: 299 LFEMLGGQRNVCLIENGNDRSQRKWQYFPKVVTEKMREGKLMEVVDHRLVEGGGIDEREV 358

Query: 361 RRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVDDPPDTQMVIVDWLSIDQDDDAGGDI 420
           +RLV VA WCIQE+ARLRP+MARVVEMLEG V VD+PP+TQM+IVD L  D+  +     
Sbjct: 359 KRLVYVALWCIQEKARLRPTMARVVEMLEGHVTVDEPPETQMIIVDLLCTDE--EPANAC 416

Query: 421 GRRRLAALASDLGRNLATDSAAC-SLTMSVLSGR 453
            R R+AAL +    N    S +  S  +SVLSGR
Sbjct: 417 NRPRMAALVTPQVDNATLPSTSTYSYALSVLSGR 450

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359484394|ref|XP_002285029.2| PREDICTED: probable receptor-like protein kinase At5g20050 [Vitis vinifera]

 Score =  673 bits (1737), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 333/454 (73%), Positives = 385/454 (84%), Gaps = 5/454 (1%)

Query: 1   MEDKKANIIAASLVLALIIFIIIARVTLKLSKAFFLIVGADIAVVLAVFACVIIRRRYHK 60
           MEDKKA+IIA S V+ALII II+ARV+LKLS  FFLI+GADIA +LA+F  VIIR R+++
Sbjct: 1   MEDKKASIIAVSSVVALIILIIVARVSLKLSNTFFLILGADIAAILAIFTYVIIRWRFNR 60

Query: 61  RRLLLESKFVTEGRELRIEYSFLRKVAGVPIKFRSKELEEATDNFQALLGHGSSASVFKG 120
           RR LLE++ V+EGRELRIEYSFLRKVAGVP KFR KELEEATDNFQAL+G G+SASVF+G
Sbjct: 61  RRKLLETRLVSEGRELRIEYSFLRKVAGVPTKFRYKELEEATDNFQALIGRGASASVFRG 120

Query: 121 ILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ 180
           IL+DGTSVAVKRI GEE+GEKEF+SEVAAIAS QHVNLVRLLGYC VPGGPR+L+Y+FIQ
Sbjct: 121 ILNDGTSVAVKRIEGEEHGEKEFKSEVAAIASVQHVNLVRLLGYCCVPGGPRFLIYDFIQ 180

Query: 181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPEN 240
           NGSLD WIFP  R S+G    GCLSWD RYRVA+DVAKALSYLH+DCRSRVLHLDVKPEN
Sbjct: 181 NGSLDCWIFP-QRESQGR-PRGCLSWDFRYRVALDVAKALSYLHHDCRSRVLHLDVKPEN 238

Query: 241 ILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMV 300
           ILLDENYRA+VSDFGLSKLM +D+SR +TTIRGTRGYLAPEW+LE GVSEK DIYSYGMV
Sbjct: 239 ILLDENYRALVSDFGLSKLMRKDESRVLTTIRGTRGYLAPEWLLEHGVSEKSDIYSYGMV 298

Query: 301 LLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQV 360
           L E+ GG+RNV LIE+GND+S+ KWQYFPK+V EKM+EGKLME+VD RL + GGIDE +V
Sbjct: 299 LFEMLGGQRNVCLIENGNDRSQRKWQYFPKVVTEKMREGKLMEVVDHRLVEGGGIDEREV 358

Query: 361 RRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVDDPPDTQMVIVDWLSIDQDDDAGGDI 420
           +RLV VA WCIQE+ARLRP+MARVVEMLEG V VD+PP+TQM+IVD L  D+  +     
Sbjct: 359 KRLVYVALWCIQEKARLRPTMARVVEMLEGHVTVDEPPETQMIIVDLLCTDE--EPANAC 416

Query: 421 GRRRLAALASDLGRNLATDSAAC-SLTMSVLSGR 453
            R R+AAL +    N    S +  S  +SVLSGR
Sbjct: 417 NRPRMAALVTPQVDNATLPSTSTYSYALSVLSGR 450

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357477939|ref|XP_003609255.1| Avr9/Cf-9 rapidly elicited protein [Medicago truncatula] gi|355510310|gb|AES91452.1| Avr9/Cf-9 rapidly elicited protein [Medicago truncatula]

 Score =  613 bits (1581), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 309/457 (67%), Positives = 374/457 (81%), Gaps = 16/457 (3%)

Query: 1   MEDKKANIIAASLVLALIIFIIIARVTLKLSKAFFLIVGADIAVVLAVFACVIIRRRYHK 60
           MED+K + IAA  V++LII III RV+LKLS+AFFLI GA IAV+LAVF+C++IR+RY+K
Sbjct: 1   MEDRKVHTIAAISVISLIIVIIICRVSLKLSRAFFLICGASIAVILAVFSCILIRQRYNK 60

Query: 61  RRLLLESKFVTEGRELRIEYSFLRKVAGVPIKFRSKELEEATDNFQALLGHGSSASVFKG 120
           RR +LES+  +EGRELRIEYSFLRKVAG+P K+R KELEEATDNFQA++G GSSASVFKG
Sbjct: 61  RRKVLESQLKSEGRELRIEYSFLRKVAGIPTKYRYKELEEATDNFQAIIGKGSSASVFKG 120

Query: 121 ILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ 180
           IL+DGTSVAVKRI+GEE GE+EFRSEV+AIAS QHVNLVRL GYC  P  PRYLVYEFI 
Sbjct: 121 ILNDGTSVAVKRIHGEERGEREFRSEVSAIASVQHVNLVRLFGYCNSPTPPRYLVYEFIP 180

Query: 181 NGSLDHWIFPT----SRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDV 236
           NGSLD WIFP     +RR       GCL W+LRY+VAIDVAKALSYLH+DCRS VLHLDV
Sbjct: 181 NGSLDCWIFPVKETRTRRC------GCLPWNLRYKVAIDVAKALSYLHHDCRSTVLHLDV 234

Query: 237 KPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYS 296
           KPENILLDENY+A+VSDFGLSKL+ +D+S+ +TTIRGTRGYLAPEW+LE+G+SEK DIYS
Sbjct: 235 KPENILLDENYKALVSDFGLSKLVGKDESQVLTTIRGTRGYLAPEWLLERGISEKTDIYS 294

Query: 297 YGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGID 356
           +GMVLLE+ GGRRNVS +E   D +K KWQ+FPKIVNEK++EGKLMEIVDQR+ D GG+D
Sbjct: 295 FGMVLLEIVGGRRNVSKVEDPRDNTKKKWQFFPKIVNEKLREGKLMEIVDQRVVDFGGVD 354

Query: 357 ETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVDDPPDTQMVIVDWLSIDQDDDA 416
           E +V+RLV +A WCIQE+ RLRPSM  VV+MLEGRV V++PP T+M++VD L+ D+D   
Sbjct: 355 ENEVKRLVFIALWCIQEKPRLRPSMVEVVDMLEGRVRVEEPPGTRMILVDLLADDEDPTD 414

Query: 417 GGDIGRRRLAALASDLGRNLATDSAACSLTMSVLSGR 453
             ++ R     L + +  N+   S   SL  ++ SGR
Sbjct: 415 LNNLAR-----LLTPVSSNVECTSTY-SLGSTIFSGR 445

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356563053|ref|XP_003549780.1| PREDICTED: probable receptor-like protein kinase At5g20050-like [Glycine max]

 Score =  599 bits (1544), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 304/455 (66%), Positives = 369/455 (81%), Gaps = 9/455 (1%)

Query: 1   MEDKKANIIAASLVLALIIFIIIARVTLKLSKAFFLIVGADIAVVLAVFACVIIRRRYHK 60
           MED+KAN I+   V+ALII II+ARV+LKLS+AFFLI GA IAV+LAVF+C +IR RY+ 
Sbjct: 1   MEDRKANTISVISVIALIILIIVARVSLKLSRAFFLICGASIAVILAVFSCALIRHRYNH 60

Query: 61  RRLLLESKFVTEGRELRIEYSFLRKVAGVPIKFRSKELEEATDNFQALLGHGSSASVFKG 120
           RR LLES+  TEGRELRIEYSFLRKVAGVP K+R KELEEATD FQALLG GSSASVFKG
Sbjct: 61  RRRLLESQLKTEGRELRIEYSFLRKVAGVPTKYRFKELEEATDGFQALLGKGSSASVFKG 120

Query: 121 ILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ 180
           IL+DGTSVAVKRI+GEE GEKEFRSEVAAIAS  HVNLVR+ GYC  P  PRYLVYE+I 
Sbjct: 121 ILNDGTSVAVKRIDGEERGEKEFRSEVAAIASVHHVNLVRMFGYCNAPTAPRYLVYEYIP 180

Query: 181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPEN 240
           NGSLD WIFP   R      GGCL W+LR +VAIDVA+ LSYLH+DCR RVLHLDVKPEN
Sbjct: 181 NGSLDCWIFPL--RENHTRKGGCLPWNLRQKVAIDVARGLSYLHHDCRRRVLHLDVKPEN 238

Query: 241 ILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMV 300
           ILLDENY+A+V+DFGLS L+ +D S+ +TT+RGTRGYLAPEW+LE+GVSEK D+YSYGMV
Sbjct: 239 ILLDENYKALVADFGLSTLVGKDVSQVMTTMRGTRGYLAPEWLLERGVSEKTDVYSYGMV 298

Query: 301 LLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGG-IDETQ 359
           LLE+ GGRRNVS +E   D++K KW++FPKIVNEK++EGK MEIVD+RL + G  ++E++
Sbjct: 299 LLEIIGGRRNVSRVEDPRDRTKKKWEFFPKIVNEKVREGKFMEIVDRRLVERGSVVEESE 358

Query: 360 VRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVDDPPDTQMVIVDWLSIDQDDDAGGD 419
           V RLV +A WCIQE+ RLRPSMA+VV+MLEGRV VD+PP ++M++VD L++D+D      
Sbjct: 359 VTRLVYIALWCIQEKPRLRPSMAQVVDMLEGRVRVDEPPGSRMILVDLLAVDED-----P 413

Query: 420 IGRRRLAALASDLGRNL-ATDSAACSLTMSVLSGR 453
              R LA L + +  ++  T + +   T ++LSGR
Sbjct: 414 ADHRNLARLLTSVSSHVDCTSTYSLGTTNTILSGR 448

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449464588|ref|XP_004150011.1| PREDICTED: probable receptor-like protein kinase At5g20050-like [Cucumis sativus] gi|449518121|ref|XP_004166092.1| PREDICTED: probable receptor-like protein kinase At5g20050-like [Cucumis sativus]

 Score =  595 bits (1534), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 298/454 (65%), Positives = 365/454 (80%), Gaps = 1/454 (0%)

Query: 1   MEDKKANIIAASLVLALIIFIIIARVTLKLSKAFFLIVGADIAVVLAVFACVIIRRRYHK 60
           MED+KANII+ SL+L LI+ +I+AR+ LK SKAFFLI G D+++ +A+   ++IR R+ +
Sbjct: 1   MEDQKANIISLSLILLLILLLILARIFLKFSKAFFLICGIDVSLTVAILVYMVIRLRFTR 60

Query: 61  RRLLLESKFVTEGRELRIEYSFLRKVAGVPIKFRSKELEEATDNFQALLGHGSSASVFKG 120
           RR  LES+ V+EGRELRIEYSFLRKVAGVP KFR KELEEATD F+AL+G GSS SVFKG
Sbjct: 61  RRKQLESQLVSEGRELRIEYSFLRKVAGVPTKFRYKELEEATDYFRALIGKGSSGSVFKG 120

Query: 121 ILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ 180
           IL DGT+VAVKRI GE  G+KEFR+EV+AIAS QHVNLVRL GY     GPR+LVYEF+ 
Sbjct: 121 ILKDGTAVAVKRIEGENRGDKEFRAEVSAIASVQHVNLVRLFGYSTNSSGPRFLVYEFVP 180

Query: 181 NGSLDHWIFPTSRRSEG-HYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPE 239
           NGSLD WIFP   R +  +  GGCL+WDLRY VAIDVAKAL+YLH+DCRSR+LHLDVKPE
Sbjct: 181 NGSLDCWIFPKKPRHKNRNRPGGCLAWDLRYSVAIDVAKALAYLHHDCRSRILHLDVKPE 240

Query: 240 NILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGM 299
           NILLDENYRA+VSDFGLSKLM +D+SR + ++RGTRGYLAPEW+LE G+SEK D+YSYGM
Sbjct: 241 NILLDENYRAIVSDFGLSKLMGKDESRIMISMRGTRGYLAPEWLLENGISEKSDVYSYGM 300

Query: 300 VLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQ 359
           VLLEL GG+RNVS++E+G  +SK KWQYFP+IV+ KMKEGKLME VDQRL + G IDE +
Sbjct: 301 VLLELVGGQRNVSVVENGEGRSKKKWQYFPRIVSAKMKEGKLMEAVDQRLLETGAIDERE 360

Query: 360 VRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVDDPPDTQMVIVDWLSIDQDDDAGGD 419
           VR+LV V  WCIQE+A+LRP+MA VV+MLEGRVAV++PPDT+M++VD LSID++     +
Sbjct: 361 VRKLVCVGLWCIQEQAKLRPTMAMVVDMLEGRVAVEEPPDTEMLVVDLLSIDEEMMNSQE 420

Query: 420 IGRRRLAALASDLGRNLATDSAACSLTMSVLSGR 453
           I +          G   ++ S  CS   S+LS R
Sbjct: 421 IPKIVPFRERMKDGNVPSSSSTPCSYAFSILSAR 454

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356510540|ref|XP_003523995.1| PREDICTED: probable receptor-like protein kinase At5g20050-like [Glycine max]

 Score =  573 bits (1476), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 288/454 (63%), Positives = 359/454 (79%), Gaps = 21/454 (4%)

Query: 1   MEDKKANIIAASLVLALIIFIIIARVTLKLSKAFFLIVGADIAVVLAVFACVIIRRRYHK 60
           M++++ N IAA  V+ALII I++ARVTLKLSKAFFLI GA   V+LAVFA V++   Y++
Sbjct: 1   MDERRVNTIAAISVIALIILIVVARVTLKLSKAFFLIFGAGDTVILAVFAYVLVSISYNR 60

Query: 61  RRLLLESKFVTEGRELRIEYSFLRKVAGVPIKFRSKELEEATDNFQALLGHGSSASVFKG 120
           RR LLES+  ++G+ELRIEYSFLRKVAGVPIKFR KELEEATD FQAL+G G+SASVFKG
Sbjct: 61  RRRLLESQLKSQGQELRIEYSFLRKVAGVPIKFRYKELEEATDGFQALIGKGASASVFKG 120

Query: 121 ILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ 180
           IL+DGTSVAVK+I+ EE GEK+FRSEVAAIAS  HVNLVRLLGYC  P  PRYLVYE++ 
Sbjct: 121 ILNDGTSVAVKQIDAEERGEKQFRSEVAAIASVHHVNLVRLLGYCNAPTAPRYLVYEYVS 180

Query: 181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPEN 240
           NGSLD WIF   R+ +               VAIDVAK L+YLH+DCRSR+LHLDVKPEN
Sbjct: 181 NGSLDWWIF---RKRD---------------VAIDVAKGLAYLHHDCRSRILHLDVKPEN 222

Query: 241 ILLDENYRAVVSDFGLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGM 299
           ILLDEN+RA+VSDFGL+KL+ +D+S + ++ IRGTRGYLAPEW+LE+G+S+K DIYSYGM
Sbjct: 223 ILLDENFRALVSDFGLAKLIGKDESHKEVSAIRGTRGYLAPEWLLEKGISDKTDIYSYGM 282

Query: 300 VLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQ 359
           VLLE+ GGR+N+  +E  + KSK KWQYFPKIVNEK++EGKLMEI+D RL++ GG+DE Q
Sbjct: 283 VLLEIVGGRKNMCSVEDESAKSKRKWQYFPKIVNEKVREGKLMEIIDHRLSECGGVDERQ 342

Query: 360 VRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVDDPPDTQMVIVDWLSIDQDDDAGGD 419
           VR LV VA W +QE+ RLRPSMA+VV+MLEGRV V+ PPDT+MV+VD+LS+D+       
Sbjct: 343 VRTLVYVALWSVQEKPRLRPSMAQVVDMLEGRVRVETPPDTRMVVVDFLSVDESATDSNT 402

Query: 420 IGRRRLAALASDLGRNLATDSAACSLTMSVLSGR 453
           +   RL  +++   ++    S+  S   +VLSGR
Sbjct: 403 MP--RLDFVSNQRTQSNVECSSTYSYATTVLSGR 434

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15241250|ref|NP_197505.1| putative receptor-like protein kinase [Arabidopsis thaliana] gi|75332090|sp|Q94C25.1|Y5005_ARATH RecName: Full=Probable receptor-like protein kinase At5g20050; Flags: Precursor gi|14335072|gb|AAK59800.1| AT5g20050/F28I16_200 [Arabidopsis thaliana] gi|27363358|gb|AAO11598.1| At5g20050/F28I16_200 [Arabidopsis thaliana] gi|332005403|gb|AED92786.1| putative receptor-like protein kinase [Arabidopsis thaliana]

 Score =  518 bits (1333), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 264/402 (65%), Positives = 325/402 (80%), Gaps = 4/402 (0%)

Query: 1   MEDKKANIIAASLVLALIIFIIIARVTLKLSKAFFLIVGADIAVVLAVFACVIIRRRYHK 60
           MEDKKANIIA  L+LAL++ II ARV+LKLSK F+LI G DI+++LAV   +IIR RY+K
Sbjct: 1   MEDKKANIIATILILALVVVIIAARVSLKLSKTFYLIAGVDISLILAVICFLIIRSRYNK 60

Query: 61  RRLLLESKFVTEGRELRIEYSFLRKVAGVPIKFRSKELEEATDNFQALLGHGSSASVFKG 120
            R LL S+F +EGRELRIEYSFLRKVAGVP KF+ ++LEEATD F++L+G G S SVFKG
Sbjct: 61  ERKLLVSRFASEGRELRIEYSFLRKVAGVPTKFKLEDLEEATDGFRSLIGKGGSGSVFKG 120

Query: 121 ILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGG--PRYLVYEF 178
           +L DG+ VAVKRI GEE GE+EFRSEVAAIAS QH NLVRL GY        PR+LVY++
Sbjct: 121 VLKDGSQVAVKRIEGEEKGEREFRSEVAAIASVQHKNLVRLYGYSSSTSANRPRFLVYDY 180

Query: 179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKP 238
           I N SLD WIFP    + G   GGCLSW+ RY+VAIDVAKAL+YLH+DCRS++LHLDVKP
Sbjct: 181 IVNSSLDIWIFPDR-GNRGRSGGGCLSWEQRYQVAIDVAKALAYLHHDCRSKILHLDVKP 239

Query: 239 ENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYG 298
           ENILLDEN+RAVV+DFGLSKL++RD+SR +T IRGTRGYLAPEW+LE G+SEK D+YSYG
Sbjct: 240 ENILLDENFRAVVTDFGLSKLIARDESRVLTDIRGTRGYLAPEWLLEHGISEKSDVYSYG 299

Query: 299 MVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDET 358
           +VLLE+ GGRR++S      +  K K +YFP+IVN+KM+E K+MEIVDQRL +   +DE 
Sbjct: 300 IVLLEMIGGRRSISR-VEVKETKKKKLEYFPRIVNQKMRERKIMEIVDQRLIEVNEVDEE 358

Query: 359 QVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVDDPPDT 400
           +V +LV VA WCIQE+++ RP M  V+EMLEGRV V++PPD+
Sbjct: 359 EVMKLVCVALWCIQEKSKKRPDMTMVIEMLEGRVPVNEPPDS 400

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|21554146|gb|AAM63226.1| receptor-like protein kinase-like protein [Arabidopsis thaliana]

 Score =  517 bits (1331), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 264/402 (65%), Positives = 325/402 (80%), Gaps = 4/402 (0%)

Query: 1   MEDKKANIIAASLVLALIIFIIIARVTLKLSKAFFLIVGADIAVVLAVFACVIIRRRYHK 60
           MEDKKA IIA  L+LAL++ II ARV+LKLSK F+LI G DI+++LAV   +IIR RY+K
Sbjct: 1   MEDKKAKIIATILILALVVVIIAARVSLKLSKTFYLIAGVDISLILAVICFLIIRSRYNK 60

Query: 61  RRLLLESKFVTEGRELRIEYSFLRKVAGVPIKFRSKELEEATDNFQALLGHGSSASVFKG 120
            R LL S+FV+EGRELRIEYSFLRKVAGVP KF+ ++LEEATD F++L+G G S SVFKG
Sbjct: 61  ERELLVSRFVSEGRELRIEYSFLRKVAGVPTKFKLEDLEEATDGFRSLIGKGGSGSVFKG 120

Query: 121 ILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGG--PRYLVYEF 178
           +L DG+ VAVKRI GEE GE+EFRSEVAAIAS QH NLVRL GY        PR+LVY++
Sbjct: 121 VLKDGSQVAVKRIEGEEKGEREFRSEVAAIASVQHKNLVRLYGYSSSTSANRPRFLVYDY 180

Query: 179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKP 238
           I N SLD WIFP    + G   GGCLSW+ RY+VAIDVAKAL+YLH+DCRS++LHLDVKP
Sbjct: 181 IVNSSLDIWIFPER-GNRGRSGGGCLSWEQRYQVAIDVAKALAYLHHDCRSKILHLDVKP 239

Query: 239 ENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYG 298
           ENILLDEN+RAVV+DFGLSKL++RD+SR +T IRGTRGYLAPEW+LE G+SEK D+YSYG
Sbjct: 240 ENILLDENFRAVVTDFGLSKLIARDESRVLTDIRGTRGYLAPEWLLEHGISEKSDVYSYG 299

Query: 299 MVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDET 358
           +VLLE+ GGRR++S      +  K K +YFP+IVN+KM+E K+MEIVDQRL +   +DE 
Sbjct: 300 IVLLEMIGGRRSISR-VEVKETKKKKLEYFPRIVNQKMRERKIMEIVDQRLIEVNEVDEE 358

Query: 359 QVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVDDPPDT 400
           +V +LV VA WCIQE+++ RP M  V+EMLEGRV V++PPD+
Sbjct: 359 EVMKLVCVALWCIQEKSKKRPDMTMVIEMLEGRVPVNEPPDS 400

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297808069|ref|XP_002871918.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297317755|gb|EFH48177.1| kinase family protein [Arabidopsis lyrata subsp. lyrata]

 Score =  501 bits (1291), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 262/402 (65%), Positives = 327/402 (81%), Gaps = 4/402 (0%)

Query: 1   MEDKKANIIAASLVLALIIFIIIARVTLKLSKAFFLIVGADIAVVLAVFACVIIRRRYHK 60
           MEDKKANIIA  L++AL++ II ARV+LKLSK F+LI G DI+++LAV   +IIR RY+K
Sbjct: 1   MEDKKANIIATILIIALVVVIIAARVSLKLSKTFYLIAGVDISLILAVICFLIIRSRYNK 60

Query: 61  RRLLLESKFVTEGRELRIEYSFLRKVAGVPIKFRSKELEEATDNFQALLGHGSSASVFKG 120
            R LL S+FV+EGRELRIEYSFLRKVAGVP KF+ ++LEEATD F++L+G G S SVFKG
Sbjct: 61  ERKLLVSRFVSEGRELRIEYSFLRKVAGVPTKFKLEDLEEATDGFRSLIGKGGSGSVFKG 120

Query: 121 ILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGY--CVVPGGPRYLVYEF 178
           +L DG+ VAVKRI GEE GE+EFRSEVAAIAS QH NLVRL GY   V    PR+LVY++
Sbjct: 121 VLKDGSQVAVKRIEGEEKGEREFRSEVAAIASVQHKNLVRLYGYSSAVSANRPRFLVYDY 180

Query: 179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKP 238
           I N SLD WIFP    +     GGCLSW+ RY+VAIDVAKAL+YLH+DCRS++LHLDVKP
Sbjct: 181 IVNSSLDIWIFPDR-GNRRRSGGGCLSWEQRYQVAIDVAKALAYLHHDCRSKILHLDVKP 239

Query: 239 ENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYG 298
           ENILLDEN+RAVV+DFGLSKL++RD+SR +T IRGTRGYLAPEW+LE G+SEK D+YS+G
Sbjct: 240 ENILLDENFRAVVTDFGLSKLIARDESRVLTDIRGTRGYLAPEWLLEHGISEKSDVYSFG 299

Query: 299 MVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDET 358
           +VLLE+ GGRR++S +E   +  K K +YFP+IVN+KM+E K+MEIVDQRL +   ++E 
Sbjct: 300 IVLLEMIGGRRSISRVEV-KETKKKKLEYFPRIVNQKMRERKIMEIVDQRLIEANEVNEE 358

Query: 359 QVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVDDPPDT 400
           +V +LV VA WCIQE+++ RP M  V+EM+EGRV V +PPD+
Sbjct: 359 EVMKLVCVALWCIQEKSKNRPDMTMVIEMIEGRVPVKEPPDS 400

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	453
TAIR|locus:2147635	452	AT5G20050 [Arabidopsis thalian	0.993	0.995	0.589	2.2e-137
TAIR|locus:2116525	821	SD2-5 "S-domain-2 5" [Arabidop	0.772	0.426	0.472	4.4e-84
TAIR|locus:2026155	829	AT1G34300 [Arabidopsis thalian	0.679	0.371	0.452	9.3e-75
TAIR|locus:2059103	828	AT2G19130 [Arabidopsis thalian	0.646	0.353	0.462	2.9e-70
TAIR|locus:2182603	872	AT5G35370 [Arabidopsis thalian	0.664	0.345	0.429	2e-65
TAIR|locus:2176737	665	PR5K "PR5-like receptor kinase	0.644	0.439	0.404	7e-54
TAIR|locus:2040461	620	SERK4 "somatic embryogenesis r	0.631	0.461	0.425	1.1e-53
TAIR|locus:2040471	601	SERK5 "somatic embryogenesis r	0.631	0.475	0.422	6.3e-53
TAIR|locus:2204480	666	AT1G66910 [Arabidopsis thalian	0.770	0.524	0.355	5.6e-52
TAIR|locus:2141862	853	AT4G18250 [Arabidopsis thalian	0.668	0.355	0.374	5.7e-52

TAIR|locus:2147635 AT5G20050 [Arabidopsis thaliana (taxid:3702)]

 Score = 1345 (478.5 bits), Expect = 2.2e-137, P = 2.2e-137
 Identities = 268/455 (58%), Positives = 332/455 (72%)

Query:     1 MEDKKXXXXXXXXXXXXXXXXXXXRVTLKLSKAFFLIVGADIAVVLAVFACVIIRRRYHK 60
             MEDKK                   RV+LKLSK F+LI G DI+++LAV   +IIR RY+K
Sbjct:     1 MEDKKANIIATILILALVVVIIAARVSLKLSKTFYLIAGVDISLILAVICFLIIRSRYNK 60

Query:    61 RRLLLESKFVTEGRELRIEYSFLRKVAGVPIKFRSKELEEATDNFQALLGHGSSASVFKG 120
              R LL S+F +EGRELRIEYSFLRKVAGVP KF+ ++LEEATD F++L+G G S SVFKG
Sbjct:    61 ERKLLVSRFASEGRELRIEYSFLRKVAGVPTKFKLEDLEEATDGFRSLIGKGGSGSVFKG 120

Query:   121 ILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGG--PRYLVYEF 178
             +L DG+ VAVKRI GEE GE+EFRSEVAAIAS QH NLVRL GY        PR+LVY++
Sbjct:   121 VLKDGSQVAVKRIEGEEKGEREFRSEVAAIASVQHKNLVRLYGYSSSTSANRPRFLVYDY 180

Query:   179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKP 238
             I N SLD WIFP  R + G   GGCLSW+ RY+VAIDVAKAL+YLH+DCRS++LHLDVKP
Sbjct:   181 IVNSSLDIWIFP-DRGNRGRSGGGCLSWEQRYQVAIDVAKALAYLHHDCRSKILHLDVKP 239

Query:   239 ENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYG 298
             ENILLDEN+RAVV+DFGLSKL++RD+SR +T IRGTRGYLAPEW+LE G+SEK D+YSYG
Sbjct:   240 ENILLDENFRAVVTDFGLSKLIARDESRVLTDIRGTRGYLAPEWLLEHGISEKSDVYSYG 299

Query:   299 MVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDET 358
             +VLLE+ GGRR++S +E    K K K +YFP+IVN+KM+E K+MEIVDQRL +   +DE 
Sbjct:   300 IVLLEMIGGRRSISRVEVKETKKK-KLEYFPRIVNQKMRERKIMEIVDQRLIEVNEVDEE 358

Query:   359 QVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVDDPPDTQMVIVDWLSIDQXXXXXX 418
             +V +LV VA WCIQE+++ RP M  V+EMLEGRV V++PPD+ +V+VD L+ D       
Sbjct:   359 EVMKLVCVALWCIQEKSKKRPDMTMVIEMLEGRVPVNEPPDSDVVVVDLLAADDDDASTG 418

Query:   419 XXXXXXXXXXXSDLGRNLATDSAACSLTMSVLSGR 453
                            RN    S+ CS  +S +S R
Sbjct:   419 VRRVVNIPKLQIHRERNFRL-SSICSSIISPISPR 452

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 842 (301.5 bits), Expect = 4.4e-84, P = 4.4e-84
 Identities = 175/370 (47%), Positives = 242/370 (65%)

Query:    32 KAFFLIVGADIAVVLAVFACVIIRRRYHKRR-LLLESKFVTEGRELRIEYSFLRKVAGVP 90
             K F  +V   +  V  +   + +  R HKR+ ++LE+    E  E   E +FL  ++G+P
Sbjct:   426 KHFPYVVIIVVVTVFIIAVLIFVAFRIHKRKKMILEAP--QESSE---EDNFLENLSGMP 480

Query:    91 IKFRSKELEEATDNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAI 150
             I+F  K+L+ AT+NF   LG G   SV++G L DG+ +AVK++ G   G+KEFR+EV+ I
Sbjct:   481 IRFAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKLEGIGQGKKEFRAEVSII 540

Query:   151 ASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRY 210
              S  H++LVRL G+C   G  R L YEF+  GSL+ WIF   R+ +G      L WD R+
Sbjct:   541 GSIHHLHLVRLRGFCA-EGAHRLLAYEFLSKGSLERWIF---RKKDGDV---LLDWDTRF 593

Query:   211 RVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITT 270
              +A+  AK L+YLH DC +R++H D+KPENILLD+N+ A VSDFGL+KLM+R+QS   TT
Sbjct:   594 NIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFTT 653

Query:   271 IRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPK 330
             +RGTRGYLAPEWI    +SEK D+YSYGMVLLEL GGR+N    E  ++K      +FP 
Sbjct:   654 MRGTRGYLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYDPSET-SEKC-----HFPS 707

Query:   331 IVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEG 390
                +KM+EGKLM+IVD ++ +    DE +V+R +  A WCIQE  + RPSM++VV+MLEG
Sbjct:   708 FAFKKMEEGKLMDIVDGKMKNVDVTDE-RVQRAMKTALWCIQEDMQTRPSMSKVVQMLEG 766

Query:   391 RVAVDDPPDT 400
                V  PP +
Sbjct:   767 VFPVVQPPSS 776

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)]

 Score = 754 (270.5 bits), Expect = 9.3e-75, P = 9.3e-75
 Identities = 146/323 (45%), Positives = 216/323 (66%)

Query:    76 LRIEYSFLRKVAGVPIKFRSKELEEATDNFQALLGHGSSASVFKGILSDGTSVAVKRING 135
             L   Y+ L   +G P++F  KEL+  T +F+  LG G   +V++G+L++ T VAVK++ G
Sbjct:   457 LSSHYTLLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLEG 516

Query:   136 EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRS 195
              E GEK+FR EVA I+S  H+NLVRL+G+C   G  R LVYEF++NGSLD+++F T    
Sbjct:   517 IEQGEKQFRMEVATISSTHHLNLVRLIGFCS-QGRHRLLVYEFMRNGSLDNFLFTTD--- 572

Query:   196 EGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFG 255
                 S   L+W+ R+ +A+  AK ++YLH +CR  ++H D+KPENIL+D+N+ A VSDFG
Sbjct:   573 ----SAKFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFG 628

Query:   256 LSKLMS-RDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLI 314
             L+KL++ +D    ++++RGTRGYLAPEW+    ++ K D+YSYGMVLLEL  G+RN  + 
Sbjct:   629 LAKLLNPKDNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFDVS 688

Query:   315 EHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQER 374
             E  N K  + W Y      E+ ++G    I+D RL+++  +D  QV R+V  +FWCIQE+
Sbjct:   689 EKTNHKKFSIWAY------EEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQ 742

Query:   375 ARLRPSMARVVEMLEGRVAVDDP 397
                RP+M +VV+MLEG   + +P
Sbjct:   743 PLQRPTMGKVVQMLEGITEIKNP 765

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)]

 Score = 688 (247.2 bits), Expect = 2.9e-70, Sum P(2) = 2.9e-70
 Identities = 142/307 (46%), Positives = 196/307 (63%)

Query:    93 FRSKELEEATDNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIAS 152
             F  +EL+ AT NF   LG G   SVFKG L D + +AVKR+ G   GEK+FR+EV  I +
Sbjct:   483 FSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGISQGEKQFRTEVVTIGT 542

Query:   153 AQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRV 212
              QHVNLVRL G+C   G  + LVY+++ NGSLD  +F      +       L W LR+++
Sbjct:   543 IQHVNLVRLRGFCS-EGSKKLLVYDYMPNGSLDSHLFLNQVEEKI-----VLGWKLRFQI 596

Query:   213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR 272
             A+  A+ L+YLH++CR  ++H D+KPENILLD  +   V+DFGL+KL+ RD SR +TT+R
Sbjct:   597 ALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVLTTMR 656

Query:   273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIV 332
             GTRGYLAPEWI    ++ K D+YSYGM+L EL  GRRN    E  N+K +    +FP   
Sbjct:   657 GTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTEQSE--NEKVR----FFPSWA 710

Query:   333 NEKM-KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR 391
                + K+G +  +VD RL  +  +D  +V R   VA WCIQ+    RP+M++VV++LEG 
Sbjct:   711 ATILTKDGDIRSLVDPRLEGDA-VDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEGV 769

Query:   392 VAVDDPP 398
             + V+ PP
Sbjct:   770 LEVNPPP 776

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

TAIR|locus:2182603 AT5G35370 [Arabidopsis thaliana (taxid:3702)]

 Score = 666 (239.5 bits), Expect = 2.0e-65, P = 2.0e-65
 Identities = 140/326 (42%), Positives = 203/326 (62%)

Query:    86 VAGVPIKFRSKELEEATDNFQALLGHGSSASVFKGILSDGTSVAVKRI-NGEENGEKEFR 144
             + G+P KF  +ELE+AT+NF+  +G G   SV+KG L D T +AVK+I N   +G +EF 
Sbjct:   498 IPGLPQKFEFEELEQATENFKMQIGSGGFGSVYKGTLPDETLIAVKKITNHGLHGRQEFC 557

Query:   145 SEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCL 204
             +E+A I + +H NLV+L G+C   G    LVYE++ +GSL+  +F       G+  G  L
Sbjct:   558 TEIAIIGNIRHTNLVKLRGFCA-RGRQLLLVYEYMNHGSLEKTLF------SGN--GPVL 608

Query:   205 SWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ 264
              W  R+ +A+  A+ L+YLH+ C  +++H DVKPENILL ++++  +SDFGLSKL+++++
Sbjct:   609 EWQERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEE 668

Query:   265 SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGN----DK 320
             S   TT+RGTRGYLAPEWI    +SEK D+YSYGMVLLEL  GR+N S     N    D 
Sbjct:   669 SSLFTTMRGTRGYLAPEWITNAAISEKADVYSYGMVLLELVSGRKNCSFRSRSNSVTEDN 728

Query:   321 SKNKWQ---------YFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCI 371
             ++N            YFP    +  ++G+ ME+ D RL  EG +   +  +LV +A  C+
Sbjct:   729 NQNHSSTTTTSTGLVYFPLYALDMHEQGRYMELADPRL--EGRVTSQEAEKLVRIALCCV 786

Query:   372 QERARLRPSMARVVEMLEGRVAVDDP 397
              E   LRP+MA VV M EG + + +P
Sbjct:   787 HEEPALRPTMAAVVGMFEGSIPLGNP 812

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

TAIR|locus:2176737 PR5K "PR5-like receptor kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 557 (201.1 bits), Expect = 7.0e-54, P = 7.0e-54
 Identities = 127/314 (40%), Positives = 192/314 (61%)

Query:    92 KFRSKELEEATDNFQALLGHGSSASVFKGILSD-GTSVAVKRIN-GEENGEKEFRSEVAA 149
             ++    +++ T++F  +LG G   +V+KG L+D G  VAVK +   E NGE EF +EVA+
Sbjct:   320 RYSYTRVKKMTNSFAHVLGKGGFGTVYKGKLADSGRDVAVKILKVSEGNGE-EFINEVAS 378

Query:   150 IASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR 209
             ++   HVN+V LLG+C      R ++YEF+ NGSLD +I  ++  S        + W+  
Sbjct:   379 MSRTSHVNIVSLLGFCYEKN-KRAIIYEFMPNGSLDKYI--SANMSTK------MEWERL 429

Query:   210 YRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC-I 268
             Y VA+ +++ L YLHN C +R++H D+KP+NIL+DEN    +SDFGL+KL    +S   +
Sbjct:   430 YDVAVGISRGLEYLHNRCVTRIVHFDIKPQNILMDENLCPKISDFGLAKLCKNKESIISM 489

Query:   269 TTIRGTRGYLAPEWILEQ--GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQ 326
               +RGT GY+APE   +    VS K D+YSYGMV+LE+ G + N+  +E+    S N   
Sbjct:   490 LHMRGTFGYIAPEMFSKNFGAVSHKSDVYSYGMVVLEMIGAK-NIEKVEYSG--SNNGSM 546

Query:   327 YFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE 386
             YFP+ V +  ++G++  I    +TDE   +E   ++LV VA WCIQ     RP M +V+E
Sbjct:   547 YFPEWVYKDFEKGEITRIFGDSITDE---EEKIAKKLVLVALWCIQMNPSDRPPMIKVIE 603

Query:   387 MLEGRV-AVDDPPD 399
             MLEG + A+  PP+
Sbjct:   604 MLEGNLEALQVPPN 617

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

GO:0009691 "cytokinin biosynthetic process" evidence=RCA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0009620 "response to fungus" evidence=ISS

TAIR|locus:2040461 SERK4 "somatic embryogenesis receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 555 (200.4 bits), Expect = 1.1e-53, P = 1.1e-53
 Identities = 129/303 (42%), Positives = 181/303 (59%)

Query:    92 KFRSKELEEATDNF--QALLGHGSSASVFKGILSDGTSVAVKRINGE--ENGEKEFRSEV 147
             +F  +EL  ATDNF  + +LG G    V+KG L+DG  VAVKR+  E  + GE +F++EV
Sbjct:   281 RFTLRELLVATDNFSNKNVLGRGGFGKVYKGRLADGNLVAVKRLKEERTKGGELQFQTEV 340

Query:   148 AAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWD 207
               I+ A H NL+RL G+C+ P   R LVY ++ NGS+   +     R EG+ +   L W 
Sbjct:   341 EMISMAVHRNLLRLRGFCMTPT-ERLLVYPYMANGSVASCL---RERPEGNPA---LDWP 393

Query:   208 LRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC 267
              R  +A+  A+ L+YLH+ C  +++H DVK  NILLDE + AVV DFGL+KLM+ + S  
Sbjct:   394 KRKHIALGSARGLAYLHDHCDQKIIHRDVKAANILLDEEFEAVVGDFGLAKLMNYNDSHV 453

Query:   268 ITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQY 327
              T +RGT G++APE++     SEK D++ YG++LLEL  G++   L    ND       +
Sbjct:   454 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDDDIMLLDW 513

Query:   328 FPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM 387
                 V E +KE KL  +VD  L  EG   ET+V +L+ +A  C Q  A  RP M+ VV M
Sbjct:   514 ----VKEVLKEKKLESLVDAEL--EGKYVETEVEQLIQMALLCTQSSAMERPKMSEVVRM 567

Query:   388 LEG 390
             LEG
Sbjct:   568 LEG 570

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0060548 "negative regulation of cell death" evidence=IMP

GO:1900140 "regulation of seedling development" evidence=IMP

GO:0010200 "response to chitin" evidence=IEP;RCA

GO:0008219 "cell death" evidence=IGI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IGI

GO:0010150 "leaf senescence" evidence=IGI

GO:0000165 "MAPK cascade" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

TAIR|locus:2040471 SERK5 "somatic embryogenesis receptor-like kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 548 (198.0 bits), Expect = 6.3e-53, P = 6.3e-53
 Identities = 128/303 (42%), Positives = 181/303 (59%)

Query:    92 KFRSKELEEATDNFQA--LLGHGSSASVFKGILSDGTSVAVKRINGE--ENGEKEFRSEV 147
             +F  +EL  AT+ F    +LG G    ++KG L+D T VAVKR+N E  + GE +F++EV
Sbjct:   262 RFSLRELLVATEKFSKRNVLGKGRFGILYKGRLADDTLVAVKRLNEERTKGGELQFQTEV 321

Query:   148 AAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWD 207
               I+ A H NL+RL G+C+ P   R LVY ++ NGS+   +     R EG+ +   L W 
Sbjct:   322 EMISMAVHRNLLRLRGFCMTPT-ERLLVYPYMANGSVASCL---RERPEGNPA---LDWP 374

Query:   208 LRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC 267
              R  +A+  A+ L+YLH+ C  +++HLDVK  NILLDE + AVV DFGL+KLM+ + S  
Sbjct:   375 KRKHIALGSARGLAYLHDHCDQKIIHLDVKAANILLDEEFEAVVGDFGLAKLMNYNDSHV 434

Query:   268 ITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQY 327
              T +RGT G++APE++     SEK D++ YG++LLEL  G++   L    ND       +
Sbjct:   435 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQKAFDLARLANDDDIMLLDW 494

Query:   328 FPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM 387
                 V E +KE KL  +VD  L  EG   ET+V +L+ +A  C Q  A  RP M+ VV M
Sbjct:   495 ----VKEVLKEKKLESLVDAEL--EGKYVETEVEQLIQMALLCTQSSAMERPKMSEVVRM 548

Query:   388 LEG 390
             LEG
Sbjct:   549 LEG 551

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2204480 AT1G66910 [Arabidopsis thaliana (taxid:3702)]

 Score = 539 (194.8 bits), Expect = 5.6e-52, P = 5.6e-52
 Identities = 138/388 (35%), Positives = 223/388 (57%)

Query:    25 RVTLKLSKAFFLIVG---ADIAV--VLAVFACV--IIRRRYHKRRLLLESKFVT--EGRE 75
             +V LKL      ++G   A  A+  V+ V  C+  +IRR+   R+ L + +  T  + R+
Sbjct:   270 KVILKLFFIVIYVLGIGAASFAMMGVILVVTCLNCLIRRQ---RKTLNDPRMRTSDDSRQ 326

Query:    76 LRIEYSFLRKVAGVPIKFRS-KELEEATDNFQALLGHGSSASVFKGILSDGTSVAVKRIN 134
               ++       A +P+K  S  ++   T +F  ++G G   +V++G L DG SVAVK + 
Sbjct:   327 QNLK-------ALIPLKHYSYAQVTSITKSFAEVIGKGGFGTVYRGTLYDGRSVAVKVLK 379

Query:   135 GEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRR 194
               +   ++F +EVA+++   HVN+V LLG+C   G  R ++YEF++NGSLD +I  +S++
Sbjct:   380 ESQGNGEDFINEVASMSQTSHVNIVTLLGFCS-EGYKRAIIYEFMENGSLDKFI--SSKK 436

Query:   195 SEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDF 254
             S        + W   Y +A+ VA+ L YLH+ CR+R++H D+KP+N+LLD+N    VSDF
Sbjct:   437 SS------TMDWRELYGIALGVARGLEYLHHGCRTRIVHFDIKPQNVLLDDNLSPKVSDF 490

Query:   255 GLSKLMSRDQS-RCITTIRGTRGYLAPEWILE-QG-VSEKCDIYSYGMVLLELTGGRRNV 311
             GL+KL  R +S   +   RGT GY+APE      G VS K D+YSYGM++L++ G R   
Sbjct:   491 GLAKLCERKESILSLMDTRGTIGYIAPEVFSRVYGRVSHKSDVYSYGMLVLDIIGARNKT 550

Query:   312 SLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCI 371
             S  +  +  S     YFP+ +   +++    + ++  +++E   DE   +++  V  WCI
Sbjct:   551 STEDTTSSTSS---MYFPEWIYRDLEKAHNGKSIETAISNEE--DEI-AKKMTLVGLWCI 604

Query:   372 QERARLRPSMARVVEMLEGRV-AVDDPP 398
             Q     RP+M RVVEM+EG + A++ PP
Sbjct:   605 QPWPLDRPAMNRVVEMMEGNLDALEVPP 632

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2141862 AT4G18250 [Arabidopsis thaliana (taxid:3702)]

 Score = 544 (196.6 bits), Expect = 5.7e-52, P = 5.7e-52
 Identities = 122/326 (37%), Positives = 191/326 (58%)

Query:    92 KFRSKELEEATDNFQALLGHGSSASVFKGILSD--GTSVAVKRINGEENGEKEFRSEVAA 149
             ++  +++++ T++F  ++G G   +V+KG L D  G  +A+K +   +   +EF +E+ +
Sbjct:   508 RYSFEKVKKMTNSFDHVIGKGGFGTVYKGKLPDASGRDIALKILKESKGNGEEFINELVS 567

Query:   150 IASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR 209
             ++ A HVN+V L G+C   G  R ++YEF+ NGSLD +I      SE   +   + W   
Sbjct:   568 MSRASHVNIVSLFGFCY-EGSQRAIIYEFMPNGSLDKFI------SENMSTK--IEWKTL 618

Query:   210 YRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC-I 268
             Y +A+ VA+ L YLHN C S+++H D+KP+NIL+DE+    +SDFGL+KL  + +S   +
Sbjct:   619 YNIAVGVARGLEYLHNSCVSKIVHFDIKPQNILIDEDLCPKISDFGLAKLCKKKESIISM 678

Query:   269 TTIRGTRGYLAPEWILEQ--GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQ 326
                RGT GY+APE   +   GVS K D+YSYGMV+LE+ G  +   +     DKS     
Sbjct:   679 LDARGTVGYIAPEMFSKNYGGVSHKSDVYSYGMVVLEMIGATKREEVETSATDKSS---M 735

Query:   327 YFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE 386
             YFP  V E ++  + M +++  + +E   +E  V+R+  V  WCIQ     RP M +VVE
Sbjct:   736 YFPDWVYEDLERKETMRLLEDHIIEEEE-EEKIVKRMTLVGLWCIQTNPSDRPPMRKVVE 794

Query:   387 MLEG-RV-AVDDPPDTQM---VIVDW 407
             MLEG R+ A+  PP   +   V+ DW
Sbjct:   795 MLEGSRLEALQVPPKPLLNLHVVTDW 820

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q94C25	Y5005_ARATH	2, ., 7, ., 1, 1, ., 1	0.6567	0.8785	0.8805	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00016845001 SubName- Full=Chromosome chr11 scaffold_13, whole genome shotgun sequence; (450 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	453
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-45
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-45
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-42
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-37
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	7e-37
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-35
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-34
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-34
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-30
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-28
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-26
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-25
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-25
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-23
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-23
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-23
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	8e-23
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-21
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	7e-21
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	9e-21
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-20
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-20
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-20
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-20
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	6e-20
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-19
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-19
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-19
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	9e-19
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-18
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-18
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-18
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-18
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-18
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-18
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-18
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-18
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	5e-18
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	6e-18
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-17
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-17
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-17
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-16
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-16
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-16
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-16
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-16
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-16
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-16
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-16
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-16
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	5e-16
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	7e-16
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-15
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-15
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-15
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-15
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-15
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-15
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-15
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-15
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-15
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-15
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	6e-15
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	7e-15
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	8e-15
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	9e-15
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-14
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-14
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-14
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-14
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-14
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-14
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-14
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-14
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-14
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-14
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-14
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	6e-14
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	8e-14
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	9e-14
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	9e-14
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	9e-14
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-13
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-13
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-13
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-13
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-13
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-13
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-13
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-13
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-13
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-13
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	8e-13
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-12
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-12
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-12
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-12
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-12
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-12
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-12
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	5e-12
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	5e-12
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-12
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-12
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	6e-12
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	6e-12
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	8e-12
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	8e-12
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	8e-12
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	9e-12
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	9e-12
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-11
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-11
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-11
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-11
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-11
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-11
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-11
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-11
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-11
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-11
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-11
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-11
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	5e-11
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	5e-11
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-11
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	6e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	6e-11
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	7e-11
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	7e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	8e-11
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	9e-11
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	9e-11
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-10
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-10
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-10
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-10
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-10
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-10
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-10
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-10
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-10
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-10
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-10
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	7e-10
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	7e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	7e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	8e-10
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-09
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-09
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-09
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-09
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-09
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-09
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-09
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-09
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-09
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-09
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-09
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-09
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-09
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-09
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-09
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-09
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	5e-09
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-09
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-09
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	6e-09
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	7e-09
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-09
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	8e-09
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	9e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-08
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-08
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-08
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-08
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-08
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-08
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-08
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-08
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-08
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-08
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-08
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-08
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-08
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-08
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-08
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-08
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-08
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-08
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	5e-08
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	7e-08
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	7e-08
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	7e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	8e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	8e-08
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	9e-08
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-07
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-07
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-07
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-07
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-07
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-07
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-07
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-07
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-07
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-07
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-07
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-07
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-07
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-07
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-07
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-07
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-07
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	3e-07
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-07
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-07
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-07
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-07
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-07
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-07
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-07
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	5e-07
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	6e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	6e-07
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	7e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	9e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-06
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-06
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-06
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-06
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-06
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-06
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-06
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-06
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-06
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-06
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	5e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-06
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	5e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	6e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	7e-06
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	7e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	7e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	8e-06
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	9e-06
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-05
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-05
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-05
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	3e-05
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-05
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	4e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-05
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	5e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-05
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	6e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	7e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	9e-05
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-04
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	5e-04
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	5e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	8e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	0.002
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	0.002
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	0.003

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  158 bits (401), Expect = 2e-45
 Identities = 71/205 (34%), Positives = 105/205 (51%), Gaps = 20/205 (9%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEF---RSEVAAIASAQHVNLVRLLGY 164
           LG GS  +V+K      G  VAVK +       K+    R E+  +    H N+VRL+  
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66

Query: 165 CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH 224
                   YLV E+ + G L  ++            GG LS D   ++A+ + + L YLH
Sbjct: 67  FEDKDHL-YLVMEYCEGGDLFDYLS----------RGGPLSEDEAKKIALQILRGLEYLH 115

Query: 225 NDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWIL 284
           ++    ++H D+KPENILLDEN    ++DFGL+K + +  S   TT  GT  Y+APE +L
Sbjct: 116 SN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL-TTFVGTPWYMAPEVLL 171

Query: 285 E-QGVSEKCDIYSYGMVLLELTGGR 308
              G   K D++S G++L EL  G+
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  155 bits (395), Expect = 5e-45
 Identities = 71/201 (35%), Positives = 106/201 (52%), Gaps = 19/201 (9%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEENGE--KEFRSEVAAIASAQHVNLVRLLGYC 165
           LG G   +V+       G  VA+K I  E++    +E   E+  +    H N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
                  YLV E+ + GSL   +           + G LS D   R+ + + + L YLH+
Sbjct: 61  EDEN-HLYLVMEYCEGGSLKDLL---------KENEGKLSEDEILRILLQILEGLEYLHS 110

Query: 226 DCRSRVLHLDVKPENILLDE-NYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPE-WI 283
              + ++H D+KPENILLD  N +  ++DFGLSKL++ D+S    TI GT  Y+APE  +
Sbjct: 111 ---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLL-KTIVGTPAYMAPEVLL 166

Query: 284 LEQGVSEKCDIYSYGMVLLEL 304
            +   SEK DI+S G++L EL
Sbjct: 167 GKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  149 bits (378), Expect = 5e-42
 Identities = 63/204 (30%), Positives = 93/204 (45%), Gaps = 19/204 (9%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKRIN--GEENGEKEFRSEVAAIASAQHVNLVRLLGY 164
            LG GS   V+       G  VA+K I     +   +    E+  +   +H N+VRL   
Sbjct: 6   KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65

Query: 165 CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH 224
                   YLV E+ + G L   +    R SE                   +  AL YLH
Sbjct: 66  FEDED-KLYLVMEYCEGGDLFDLLKKRGRLSEDEAR----------FYLRQILSALEYLH 114

Query: 225 NDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWIL 284
                 ++H D+KPENILLDE+    ++DFGL++ +   +    TT  GT  Y+APE +L
Sbjct: 115 ---SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL--TTFVGTPEYMAPEVLL 169

Query: 285 EQGVSEKCDIYSYGMVLLELTGGR 308
            +G  +  DI+S G++L EL  G+
Sbjct: 170 GKGYGKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  136 bits (345), Expect = 3e-37
 Identities = 78/295 (26%), Positives = 124/295 (42%), Gaps = 59/295 (20%)

Query: 109 LGHGSSASVFKGILSDGTS-----VAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRL 161
           LG G+   V+KG L          VAVK +  +  E   +EF  E   +    H N+V+L
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66

Query: 162 LGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALS 221
           LG C     P Y+V E+++ G L  ++    R++        LS       A+ +A+ + 
Sbjct: 67  LGVCTEEE-PLYIVMEYMEGGDLLSYL----RKNRPK-----LSLSDLLSFALQIARGME 116

Query: 222 YLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG---YL 278
           YL        +H D+   N L+ EN    +SDFGLS+ +  D        RG +    ++
Sbjct: 117 YLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD---YYRKRGGKLPIRWM 170

Query: 279 APEWILEQGVSEKCDIYSYGMVLLEL-TGGRRNVSLIEHGNDKSKNKWQYFPKIVN---- 333
           APE + E   + K D++S+G++L E+ T G                  Q +P + N    
Sbjct: 171 APESLKEGKFTSKSDVWSFGVLLWEIFTLGE-----------------QPYPGMSNEEVL 213

Query: 334 EKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEML 388
           E +K G  +         E          L D+   C  E    RP+ + +VE+L
Sbjct: 214 EYLKNGYRLPQPP-NCPPE----------LYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  135 bits (342), Expect = 7e-37
 Identities = 74/295 (25%), Positives = 123/295 (41%), Gaps = 58/295 (19%)

Query: 109 LGHGSSASVFKGILSDG-----TSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRL 161
           LG G+   V+KG L          VAVK +  +  E   +EF  E   +    H N+V+L
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66

Query: 162 LGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALS 221
           LG C     P  +V E++  G L  ++    R++        LS       A+ +A+ + 
Sbjct: 67  LGVCTEEE-PLMIVMEYMPGGDLLDYL----RKNRPKE----LSLSDLLSFALQIARGME 117

Query: 222 YLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG---YL 278
           YL        +H D+   N L+ EN    +SDFGLS+ +  D       ++G +    ++
Sbjct: 118 YLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD---YYKVKGGKLPIRWM 171

Query: 279 APEWILEQGVSEKCDIYSYGMVLLEL-TGGRRNVSLIEHGNDKSKNKWQYFPKIVN---- 333
           APE + E   + K D++S+G++L E+ T G                  + +P + N    
Sbjct: 172 APESLKEGKFTSKSDVWSFGVLLWEIFTLGE-----------------EPYPGMSNAEVL 214

Query: 334 EKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEML 388
           E +K+G  +         E          L  +   C  E    RP+ + +VE+L
Sbjct: 215 EYLKKGYRLPKPP-NCPPE----------LYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  130 bits (330), Expect = 4e-35
 Identities = 83/296 (28%), Positives = 129/296 (43%), Gaps = 51/296 (17%)

Query: 109 LGHGSSASVFKGILSDG----TSVAVKRINGEENGE--KEFRSEVAAIASAQHVNLVRLL 162
           LG G+   V+KG L       T VAVK +  + + E  K+F  E   +    H N+VRLL
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62

Query: 163 GYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY 222
           G C     P YLV E+++ G L  ++   SR          LS       AI +AK + Y
Sbjct: 63  GVCTE-EEPLYLVLEYMEGGDLLDYL-RKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 223 LHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITT-----IRGTRGY 277
           L +    + +H D+   N L+ E+    +SDFGLS+ +  D      T     IR    +
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----W 173

Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLEL-TGGR---RNVSLIEHGNDKSKNKWQYFPKIVN 333
           +APE + +   + K D++S+G++L E+ T G      +S  E                V 
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE----------------VL 217

Query: 334 EKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE 389
           E +++G  +    +   DE          L ++   C Q     RP+ + +VE LE
Sbjct: 218 EYLRKGYRLPK-PEYCPDE----------LYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  128 bits (324), Expect = 3e-34
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 19/208 (9%)

Query: 108 LLGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFRS---EVAAIASAQHVNLVRLLG 163
           LLG GS  SV+  +  D G  +AVK +    + E+E  +   E+  ++S QH N+VR  G
Sbjct: 7   LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66

Query: 164 YCVVPGGPRYLVY-EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY 222
                      ++ E++  GSL   +             G L   +  +    + + L+Y
Sbjct: 67  SERDEEKNTLNIFLEYVSGGSLSSLL----------KKFGKLPEPVIRKYTRQILEGLAY 116

Query: 223 LHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIRGTRGYLAPE 281
           LH    + ++H D+K  NIL+D +    ++DFG +K +   +      ++RGT  ++APE
Sbjct: 117 LH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173

Query: 282 WILEQGVSEKCDIYSYGMVLLELTGGRR 309
            I  +      DI+S G  ++E+  G+ 
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGKP 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  128 bits (324), Expect = 3e-34
 Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 30/217 (13%)

Query: 105 FQALLGHGSSASVFKGIL-----SDGTSVAVK--RINGEENGEKEFRSEVAAIASAQHVN 157
               LG G+   V+KG L        T VAVK  +    E   +EF  E + +    H N
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62

Query: 158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
           +VRLLG C   G P Y+V E++  G L  ++    R+         L+     ++A+ +A
Sbjct: 63  IVRLLGVCT-QGEPLYIVTEYMPGGDLLDFL----RKHGEK-----LTLKDLLQMALQIA 112

Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD-----QSRCITTIR 272
           K + YL        +H D+   N L+ EN    +SDFGLS+ +  D     +      I+
Sbjct: 113 KGMEYLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK 169

Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL-TGGR 308
               ++APE + +   + K D++S+G++L E+ T G 
Sbjct: 170 ----WMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGE 202

Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  118 bits (297), Expect = 2e-30
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 19/203 (9%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEF-RSEVAAIASAQHVNLVRLLGYCV 166
           +G G    V+K      G  VA+K I  E   +KE   +E+  +   +H N+V+  G   
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYG-SY 66

Query: 167 VPGGPRYLVYEFIQNGSLDHWIFPTSRR-SEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
           +     ++V EF   GSL   +  T++  +E   +         Y V  ++ K L YLH+
Sbjct: 67  LKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIA---------Y-VCKELLKGLEYLHS 116

Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILE 285
              + ++H D+K  NILL  +    + DFGLS  +S  ++R   T+ GT  ++APE I  
Sbjct: 117 ---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR--NTMVGTPYWMAPEVING 171

Query: 286 QGVSEKCDIYSYGMVLLELTGGR 308
           +    K DI+S G+  +EL  G+
Sbjct: 172 KPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  115 bits (287), Expect = 2e-28
 Identities = 72/264 (27%), Positives = 107/264 (40%), Gaps = 34/264 (12%)

Query: 104 NFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKE----FRSEVAAIASAQH-VNL 158
                LG GS   V+     D   VA+K +  +   + +    F  E+  +AS  H  N+
Sbjct: 3   RILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60

Query: 159 VRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK 218
           V+L  +    G   YLV E++  GSL+  +       +     G LS      +   +  
Sbjct: 61  VKLYDFFQDEGSL-YLVMEYVDGGSLEDLL-------KKIGRKGPLSESEALFILAQILS 112

Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVV-SDFGLSKLMSRDQSR-----CITTIR 272
           AL YLH      ++H D+KPENILLD + R V   DFGL+KL+    S        +T  
Sbjct: 113 ALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV 169

Query: 273 GTRGYLAPEWIL---EQGVSEKCDIYSYGMVLLELTGGR-------RNVSLIEHGNDKSK 322
           GT GY+APE +L       S   DI+S G+ L EL  G         + +  +      +
Sbjct: 170 GTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE 229

Query: 323 NKWQYFPKIVNEKMKEGKLMEIVD 346
                    ++    E       D
Sbjct: 230 LPTPSLASPLSPSNPELISKAASD 253

Length = 384

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  106 bits (268), Expect = 2e-26
 Identities = 64/207 (30%), Positives = 105/207 (50%), Gaps = 26/207 (12%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKRINGEENGE---KEFRSEVAAIASAQHVNLVRLLG 163
           L+G G+   V+KG+ L  G  VA+K+I+ E+  E   K    E+  + + +H N+V+ +G
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA---KAL 220
             +      Y++ E+ +NGSL   I             G     L   VA+ V    + L
Sbjct: 67  -SIETSDSLYIILEYAENGSLRQIIKKF----------GPFPESL---VAVYVYQVLQGL 112

Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAP 280
           +YLH      V+H D+K  NIL  ++    ++DFG++  ++ D S+   ++ GT  ++AP
Sbjct: 113 AYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLN-DVSKDDASVVGTPYWMAP 168

Query: 281 EWILEQGVSEKCDIYSYGMVLLEL-TG 306
           E I   G S   DI+S G  ++EL TG
Sbjct: 169 EVIEMSGASTASDIWSLGCTVIELLTG 195

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  104 bits (262), Expect = 2e-25
 Identities = 66/213 (30%), Positives = 105/213 (49%), Gaps = 20/213 (9%)

Query: 104 NFQALLGHGSSASVFKGI-LSDGTSVAVKRINGEENGE--KEFRSEVAAIASAQHVNLVR 160
               ++G G++A V+  I L +   VA+KRI+ E+      E R EV A++   H N+V+
Sbjct: 4   ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK 63

Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
                VV G   +LV  ++  GSL   +   S    G      ++  L+     +V K L
Sbjct: 64  YYTSFVV-GDELWLVMPYLSGGSLLDIM--KSSYPRGGLDEAIIATVLK-----EVLKGL 115

Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD---QSRCITTIRGTRGY 277
            YLH    +  +H D+K  NILL E+    ++DFG+S  ++       +   T  GT  +
Sbjct: 116 EYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCW 172

Query: 278 LAPEWILEQ--GVSEKCDIYSYGMVLLELTGGR 308
           +APE ++EQ  G   K DI+S+G+  +EL  G 
Sbjct: 173 MAPE-VMEQVHGYDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  103 bits (260), Expect = 3e-25
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 19/204 (9%)

Query: 109 LGHGSSASVFKGILS-DGTSVAVKRIN--GEENGEKEFRSEVAAIASAQHVNLVRLLG-Y 164
           LG GSS  V+K      G   A+K+I+  G+E   K+   E+  + S +   +V+  G +
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68

Query: 165 CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH 224
                G   +V E++  GSL   +     +  G      L+      +A  + K L YLH
Sbjct: 69  YK--EGEISIVLEYMDGGSLADLL-----KKVGKIPEPVLA-----YIARQILKGLDYLH 116

Query: 225 NDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWIL 284
                 ++H D+KP N+L++      ++DFG+SK++     +C T + GT  Y++PE I 
Sbjct: 117 TK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQ 173

Query: 285 EQGVSEKCDIYSYGMVLLELTGGR 308
            +  S   DI+S G+ LLE   G+
Sbjct: 174 GESYSYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 99.6 bits (249), Expect = 1e-23
 Identities = 66/203 (32%), Positives = 95/203 (46%), Gaps = 14/203 (6%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKE---FRSEVAAIASAQHVNLVRLLGY 164
           +G GS  +V K    SDG  +  K I+     EKE     SEV  +   +H N+VR    
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67

Query: 165 CVVPGGPR-YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL 223
            +       Y+V E+ + G L   I     + E  Y    +  +  +R+   +  AL   
Sbjct: 68  IIDRSNQTLYIVMEYCEGGDLAQLI--QKCKKERKY----IEEEFIWRILTQLLLALYEC 121

Query: 224 HN--DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPE 281
           HN  D  + VLH D+KP NI LD N    + DFGL+K++  D S    T  GT  Y++PE
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA-KTYVGTPYYMSPE 180

Query: 282 WILEQGVSEKCDIYSYGMVLLEL 304
            +      EK DI+S G ++ EL
Sbjct: 181 QLNHMSYDEKSDIWSLGCLIYEL 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 99.6 bits (249), Expect = 1e-23
 Identities = 54/207 (26%), Positives = 104/207 (50%), Gaps = 18/207 (8%)

Query: 103 DNFQALLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRL 161
            N + + G G+S  V+K    + G  VA+K++   +  ++   +E+  +   +H N+V  
Sbjct: 22  KNLEKI-GEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDY 80

Query: 162 LGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRR-SEGHYSGGCLSWDLRYRVAIDVAKAL 220
                + G   ++V E++  GSL   I     R +E   +           V  +V + L
Sbjct: 81  YD-SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIA----------YVCREVLQGL 129

Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAP 280
            YLH+     V+H D+K +NILL ++    ++DFG +  +++++S+   ++ GT  ++AP
Sbjct: 130 EYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK-RNSVVGTPYWMAP 185

Query: 281 EWILEQGVSEKCDIYSYGMVLLELTGG 307
           E I  +    K DI+S G++ +E+  G
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 98.7 bits (247), Expect = 2e-23
 Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 15/206 (7%)

Query: 108 LLGHGSSASVFKG-ILSDGTSVAVKRINGEENGEKEFR---SEVAAIASAQHVNLVRLLG 163
            +G GS   V+     SDG    +K I+     EKE     +EV  +    H N+++   
Sbjct: 7   QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66

Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL 223
                 G   +V E+   G L   I    ++ EG         +      + +  AL YL
Sbjct: 67  -SFEEKGKLCIVMEYADGGDLSQKI--KKQKKEGKP----FPEEQILDWFVQLCLALKYL 119

Query: 224 HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWI 283
           H+    ++LH D+KP+NI L  N    + DFG+SK++S       T + GT  YL+PE  
Sbjct: 120 HSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELC 175

Query: 284 LEQGVSEKCDIYSYGMVLLELTGGRR 309
             +  + K DI+S G VL EL   + 
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKH 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 97.1 bits (242), Expect = 8e-23
 Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 17/200 (8%)

Query: 105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGY 164
             A +G G    V  G    G  VAVK +  +    + F +E + + + +H NLV+LLG 
Sbjct: 10  LGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68

Query: 165 CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH 224
            +  G P Y+V E++  GSL  ++     RS G      ++   +   A+DV + + YL 
Sbjct: 69  VL-QGNPLYIVTEYMAKGSLVDYL-----RSRGR---AVITLAQQLGFALDVCEGMEYLE 119

Query: 225 NDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWIL 284
                  +H D+   N+L+ E+  A VSDFGL+K  S+ Q      ++ T    APE + 
Sbjct: 120 E---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALR 172

Query: 285 EQGVSEKCDIYSYGMVLLEL 304
           E+  S K D++S+G++L E+
Sbjct: 173 EKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 92.2 bits (230), Expect = 3e-21
 Identities = 58/189 (30%), Positives = 91/189 (48%), Gaps = 25/189 (13%)

Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           YLV E+   G L   +       EG +S     +   Y  A ++  AL YLH      ++
Sbjct: 69  YLVLEYAPGGELFSHL-----SKEGRFSEERARF---Y--AAEIVLALEYLH---SLGII 115

Query: 233 HLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKC 292
           + D+KPENILLD +    ++DFGL+K +S + SR   T  GT  YLAPE +L +G  +  
Sbjct: 116 YRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT-NTFCGTPEYLAPEVLLGKGYGKAV 174

Query: 293 DIYSYGMVLLELTGGR-----RNVSLIEHGNDKSKNKWQYFPKIVNEKMK---EGKLMEI 344
           D +S G++L E+  G+      +   I     K   +   FP+ ++ + +    G L + 
Sbjct: 175 DWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLR---FPEFLSPEARDLISGLLQKD 231

Query: 345 VDQRLTDEG 353
             +RL   G
Sbjct: 232 PTKRLGSGG 240

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 91.9 bits (229), Expect = 7e-21
 Identities = 56/257 (21%), Positives = 104/257 (40%), Gaps = 59/257 (22%)

Query: 108 LLGHGSSASVFKGIL-SDGTSVAVKRINGE----ENGEKEFRSEVAAIAS-AQHVNLVRL 161
           ++G GS ++V            A+K ++      E   K  + E   +     H  +++L
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67

Query: 162 LGY-----CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSW-DLRYRVAID 215
                    +      Y V E+  NG L  +I            G  L     R+  A +
Sbjct: 68  YYTFQDEENL------YFVLEYAPNGELLQYI---------RKYG-SLDEKCTRFYAA-E 110

Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQS---------R 266
           +  AL YLH+     ++H D+KPENILLD++    ++DFG +K++  + S          
Sbjct: 111 ILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATN 167

Query: 267 CITTIR----------GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEH 316
             + I           GT  Y++PE + E+   +  D+++ G ++ ++  G+        
Sbjct: 168 IDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF----- 222

Query: 317 GNDKSKNKWQYFPKIVN 333
              +  N++  F KI+ 
Sbjct: 223 ---RGSNEYLTFQKILK 236

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 91.7 bits (228), Expect = 9e-21
 Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 27/217 (12%)

Query: 109 LGHGSSASVFKG---ILSDGTS--VAVKRIN--GEENGEKEFRSEVAAIASAQHVNLVRL 161
           LG G    V       L D T   VAVK +N  GEE    +F  E+  + +  H N+V+ 
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71

Query: 162 LGYCVVPGGPRY-LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
            G C  PGG    L+ E++ +GSL  ++    +R     +   L   L +  +  + K +
Sbjct: 72  KGVCEKPGGRSLRLIMEYLPSGSLRDYL----QRHRDQINLKRL---LLF--SSQICKGM 122

Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG---- 276
            YL +    R +H D+   NIL++      +SDFGL+K++  D+      ++        
Sbjct: 123 DYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKD--YYYVKEPGESPIF 177

Query: 277 YLAPEWILEQGVSEKCDIYSYGMVLLEL-TGGRRNVS 312
           + APE +     S   D++S+G+ L EL T G  + S
Sbjct: 178 WYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS 214

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 91.7 bits (228), Expect = 1e-20
 Identities = 61/204 (29%), Positives = 96/204 (47%), Gaps = 16/204 (7%)

Query: 109 LGHGSSASVFKGIL-SDGTSVAVKRINGEENGE--KEFRSEVAAIASAQHVNLVRLLGYC 165
           LG G+  SV K  L + G   A+K I  + N +  K+   E+    S +   +V+  G  
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68

Query: 166 VVPG-GPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH 224
           +        +  E+ + GSLD  I+   ++  G      L      ++A  V K LSYLH
Sbjct: 69  LDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLG-----KIAESVLKGLSYLH 122

Query: 225 NDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWIL 284
           +    +++H D+KP NILL    +  + DFG+S  +    +    T  GT  Y+APE I 
Sbjct: 123 S---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA---GTFTGTSFYMAPERIQ 176

Query: 285 EQGVSEKCDIYSYGMVLLELTGGR 308
            +  S   D++S G+ LLE+   R
Sbjct: 177 GKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 90.4 bits (225), Expect = 2e-20
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 25/208 (12%)

Query: 106 QALLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEK--EFRSEVAAIASAQHVNLVRLL 162
              +G GS   V+K I       VA+K I+ EE  ++  + + E+  ++  +   + +  
Sbjct: 6   LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYY 65

Query: 163 GYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI---DVAKA 219
           G   + G   +++ E+   GS    + P  +  E +             +A    +V   
Sbjct: 66  G-SFLKGSKLWIIMEYCGGGSCLDLLKP-GKLDETY-------------IAFILREVLLG 110

Query: 220 LSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLA 279
           L YLH +     +H D+K  NILL E     ++DFG+S  ++   S+  T + GT  ++A
Sbjct: 111 LEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMA 166

Query: 280 PEWILEQGVSEKCDIYSYGMVLLELTGG 307
           PE I + G  EK DI+S G+  +EL  G
Sbjct: 167 PEVIKQSGYDEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 93.4 bits (232), Expect = 3e-20
 Identities = 95/361 (26%), Positives = 163/361 (45%), Gaps = 54/361 (14%)

Query: 37  IVGADIAVVLAVFACVIIRRRYHKRRLLLESKFVTEGRELRIEYSFLRKVAGVPIKFRSK 96
            +GA + + L  F  V IR R +     LE K V E  +   E  F          F SK
Sbjct: 635 TLGAFLVLALVAFGFVFIRGRNN-----LELKRV-ENEDGTWELQF----------FDSK 678

Query: 97  ELEEATDNF-------QALLGHGSSASVFKG-ILSDGTSVAVKRINGEENGEKEFRSEVA 148
             +  T N        + ++  G   + +KG  + +G    VK IN + N      SE+A
Sbjct: 679 VSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIN-DVNSIPS--SEIA 735

Query: 149 AIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL 208
            +   QH N+V+L+G C    G  YL++E+I+  +L   +     R+        LSW+ 
Sbjct: 736 DMGKLQHPNIVKLIGLCRSEKGA-YLIHEYIEGKNLSEVL-----RN--------LSWER 781

Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI 268
           R ++AI +AKAL +LH  C   V+  ++ PE I++D      +    L  L+  D    I
Sbjct: 782 RRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFI 840

Query: 269 TTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYF 328
           ++      Y+APE    + ++EK DIY +G++L+EL  G ++ +  E G   S  +W  +
Sbjct: 841 SS-----AYVAPETRETKDITEKSDIYGFGLILIELLTG-KSPADAEFGVHGSIVEWARY 894

Query: 329 PKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEML 388
                    +  L   +D  +  +  +++ ++  ++++A  C       RP    V++ L
Sbjct: 895 ------CYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Query: 389 E 389
           E
Sbjct: 949 E 949

Length = 968

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 89.3 bits (222), Expect = 5e-20
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 30/216 (13%)

Query: 107 ALLGHGSSASVFKGI-LSDGTSVAVKRINGEENGE---KEFRSEVAAIASAQHVNLVRLL 162
             +G G+   V+  + L  G  +AVK I  ++N     KE   E+  +   +H NLV+  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 163 GYCVVPGGPRYLVY---EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKA 219
           G  V     R  VY   E+   G+L           E    G  L   +     + + + 
Sbjct: 66  GVEV----HREKVYIFMEYCSGGTL-------EELLEH---GRILDEHVIRVYTLQLLEG 111

Query: 220 LSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT---TIRGTRG 276
           L+YLH+     ++H D+KP NI LD N    + DFG +  +  + +       ++ GT  
Sbjct: 112 LAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPA 168

Query: 277 YLAPEWILEQGVSEK---CDIYSYGMVLLELTGGRR 309
           Y+APE I            DI+S G V+LE+  G+R
Sbjct: 169 YMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 88.9 bits (220), Expect = 6e-20
 Identities = 64/200 (32%), Positives = 99/200 (49%), Gaps = 17/200 (8%)

Query: 105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGY 164
               +G G    V  G    G  VAVK I  +   +  F +E + +   +H NLV+LLG 
Sbjct: 10  LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA-FLAEASVMTQLRHSNLVQLLGV 67

Query: 165 CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH 224
            V   G  Y+V E++  GSL  ++     RS G      L  D   + ++DV +A+ YL 
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYL-----RSRGR---SVLGGDCLLKFSLDVCEAMEYLE 119

Query: 225 NDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWIL 284
            +     +H D+   N+L+ E+  A VSDFGL+K  S  Q      ++ T    APE + 
Sbjct: 120 AN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALR 172

Query: 285 EQGVSEKCDIYSYGMVLLEL 304
           E+  S K D++S+G++L E+
Sbjct: 173 EKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 16/202 (7%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCV 166
            LG GS  SV+K I    G  VA+K +  EE+ + E   E++ +       +V+  G   
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ-EIIKEISILKQCDSPYIVKYYG-SY 67

Query: 167 VPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHND 226
                 ++V E+   GS+   +  T++          L+ +    +     K L YLH+ 
Sbjct: 68  FKNTDLWIVMEYCGAGSVSDIMKITNKT---------LTEEEIAAILYQTLKGLEYLHS- 117

Query: 227 CRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQ 286
             ++ +H D+K  NILL+E  +A ++DFG+S  ++ D      T+ GT  ++APE I E 
Sbjct: 118 --NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLT-DTMAKRNTVIGTPFWMAPEVIQEI 174

Query: 287 GVSEKCDIYSYGMVLLELTGGR 308
           G + K DI+S G+  +E+  G+
Sbjct: 175 GYNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 87.6 bits (217), Expect = 2e-19
 Identities = 63/221 (28%), Positives = 105/221 (47%), Gaps = 33/221 (14%)

Query: 109 LGHGSSASVFK----GILS--DGTSVAVKRINGEENGE--KEFRSEVAAIASAQHVNLVR 160
           +G G+   VF+    G+L     T VAVK +  E + +   +F+ E A +A   H N+V+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWI---FPTSRRSEGHYSGGCLSWDLRY------- 210
           LLG C V G P  L++E++  G L+ ++    P ++ S  H +       L         
Sbjct: 73  LLGVCAV-GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131

Query: 211 --RVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS-KLMSRDQSRC 267
              +A  VA  ++YL      + +H D+   N L+ EN    ++DFGLS  + S D  + 
Sbjct: 132 QLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188

Query: 268 ----ITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
                  IR    ++ PE I     + + D+++YG+VL E+
Sbjct: 189 SENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 86.9 bits (215), Expect = 2e-19
 Identities = 71/287 (24%), Positives = 122/287 (42%), Gaps = 50/287 (17%)

Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           +G G    V+ G   +   VA+K I      E++F  E   +    H  LV+L G C   
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC-TE 70

Query: 169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCR 228
             P  LV+EF+++G L  ++    R   G +S   L       + +DV + ++YL +   
Sbjct: 71  RSPICLVFEFMEHGCLSDYL----RAQRGKFSQETL-----LGMCLDVCEGMAYLESSN- 120

Query: 229 SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGV 288
             V+H D+   N L+ EN    VSDFG+++ +  DQ    T  +    + +PE       
Sbjct: 121 --VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKY 178

Query: 289 SEKCDIYSYGMVLLELTG-------GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKL 341
           S K D++S+G+++ E+          R N  ++E  N   +    Y P++ ++ + E  L
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFR---LYKPRLASQSVYE--L 233

Query: 342 MEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEML 388
           M+                          C +ER   RPS + ++  L
Sbjct: 234 MQ-------------------------HCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 85.3 bits (211), Expect = 9e-19
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 17/204 (8%)

Query: 109 LGHGSSASVFKGIL-SDGTSVAVKRIN--GEENGEK-EFRSEVAAIASAQHVNLVRLLGY 164
           +G GS   VFK +  +D    A+K+I+       E+ E   E   +A      ++R    
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE- 66

Query: 165 CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH 224
             +  G   +V E+ +NG L   +            G  L  D  +R  I +   L++LH
Sbjct: 67  SFLDKGKLNIVMEYAENGDLHKLL--------KMQRGRPLPEDQVWRFFIQILLGLAHLH 118

Query: 225 NDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWIL 284
           +    ++LH D+K  N+ LD      + D G++KL+S D +    TI GT  YL+PE   
Sbjct: 119 S---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPELCE 174

Query: 285 EQGVSEKCDIYSYGMVLLELTGGR 308
           ++  +EK D+++ G+VL E   G+
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 55/201 (27%), Positives = 89/201 (44%), Gaps = 14/201 (6%)

Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V  G       VA+K I      E +F  E   +    H NLV+L G C   
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC-TK 70

Query: 169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCR 228
             P ++V E++ NG L +++    R  +G      L       +  DV +A+ YL     
Sbjct: 71  QRPIFIVTEYMANGCLLNYL----RERKGKLGTEWL-----LDMCSDVCEAMEYLE---S 118

Query: 229 SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGV 288
           +  +H D+   N L+ E+    VSDFGL++ +  DQ       +    +  PE       
Sbjct: 119 NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRF 178

Query: 289 SEKCDIYSYGMVLLEL-TGGR 308
           S K D++S+G+++ E+ + G+
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 84.8 bits (210), Expect = 2e-18
 Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 20/201 (9%)

Query: 109 LGHGSSASVFKGILSDGTSVAVKRI-NGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVV 167
           LG G    V++G+  +   VA+K + + +   +++F+ EV A+   +H +L+ L   C V
Sbjct: 14  LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73

Query: 168 PGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDC 227
            G P Y++ E ++ GSL  ++    R  EG          L   +A  VA+ ++YL    
Sbjct: 74  -GEPVYIITELMEKGSLLAFL----RSPEGQVLP---VASLID-MACQVAEGMAYLEE-- 122

Query: 228 RSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GYLAPEWIL 284
               +H D+   NIL+ E+    V+DFGL++L+  D    +      +    + APE   
Sbjct: 123 -QNSIHRDLAARNILVGEDLVCKVADFGLARLIKED----VYLSSDKKIPYKWTAPEAAS 177

Query: 285 EQGVSEKCDIYSYGMVLLELT 305
               S K D++S+G++L E+ 
Sbjct: 178 HGTFSTKSDVWSFGILLYEMF 198

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 84.8 bits (210), Expect = 2e-18
 Identities = 63/229 (27%), Positives = 110/229 (48%), Gaps = 33/229 (14%)

Query: 95  SKELEEATDNFQALLGHGSSASVFKGI-LSDGTS----VAVKRINGEENGE--KEFRSEV 147
            + L+E       +LG G+  +V+KG+ + +G      VA+K +  E + +  KE   E 
Sbjct: 1   LRILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEA 60

Query: 148 AAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY-SGGCLSW 206
             +AS  H ++VRLLG C        L+ + +  G L  ++    R  + +  S   L+W
Sbjct: 61  YVMASVDHPHVVRLLGIC--LSSQVQLITQLMPLGCLLDYV----RNHKDNIGSQYLLNW 114

Query: 207 DLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSR 266
                  + +AK +SYL      R++H D+   N+L+       ++DFGL+KL+  D+  
Sbjct: 115 ------CVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE 165

Query: 267 CITT-----IRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL-TGGRR 309
                    I+    ++A E IL +  + K D++SYG+ + EL T G +
Sbjct: 166 YHAEGGKVPIK----WMALESILHRIYTHKSDVWSYGVTVWELMTFGAK 210

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 83.9 bits (207), Expect = 3e-18
 Identities = 61/198 (30%), Positives = 102/198 (51%), Gaps = 19/198 (9%)

Query: 107 ALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCV 166
            ++G G   +V +G  + G  VAVK I  +   +  F  E A +    H NLVRLLG  +
Sbjct: 12  EIIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA-FLEETAVMTKLHHKNLVRLLGVIL 69

Query: 167 VPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHND 226
             G   Y+V E +  G+L +++     R+ G      +S     + ++DVA+ + YL + 
Sbjct: 70  HNG--LYIVMELMSKGNLVNFL-----RTRGRAL---VSVIQLLQFSLDVAEGMEYLES- 118

Query: 227 CRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQ 286
              +++H D+   NIL+ E+  A VSDFGL+++ S         ++ T    APE +  +
Sbjct: 119 --KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHK 172

Query: 287 GVSEKCDIYSYGMVLLEL 304
             S K D++SYG++L E+
Sbjct: 173 KFSSKSDVWSYGVLLWEV 190

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 83.7 bits (207), Expect = 3e-18
 Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 13/209 (6%)

Query: 97  ELEEATDNFQALLGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFRSEVAAIASAQH 155
           E+E      +  LG G    V++G+      +VAVK +  +    +EF  E A +   +H
Sbjct: 2   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 61

Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
            NLV+LLG C     P Y++ EF+  G+L  ++   +R+         ++  +   +A  
Sbjct: 62  PNLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQ 112

Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           ++ A+ YL    +   +H D+   N L+ EN+   V+DFGLS+LM+ D        +   
Sbjct: 113 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 169

Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            + APE +     S K D++++G++L E+
Sbjct: 170 KWTAPESLAYNKFSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 83.8 bits (207), Expect = 3e-18
 Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 26/213 (12%)

Query: 108 LLGHGSSASVFKGILSDGTSVAVKRI----NGEENGEKEFR---SEVAAIASAQHVNLVR 160
           +LG G+  +V+ G+ + G  +AVK++    +     EKE+     EV  + S +HVN+V+
Sbjct: 7   VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
            LG C+       +  EF+  GS+          S      G L   +  +    +   +
Sbjct: 67  YLGTCL-DDNTISIFMEFVPGGSI----------SSILNRFGPLPEPVFCKYTKQILDGV 115

Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM-----SRDQSRCITTIRGTR 275
           +YLHN+C   V+H D+K  N++L  N    + DFG ++ +         S  + ++ GT 
Sbjct: 116 AYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTP 172

Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
            ++APE I E G   K DI+S G  + E+  G+
Sbjct: 173 YWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 83.7 bits (207), Expect = 5e-18
 Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 31/217 (14%)

Query: 109 LGHGSSASVFKGIL------SDGTSVAVKRINGEENG--EKEFRSEVAAIASAQHVNLVR 160
           LG G+   V+KG L         TSVA+K +        ++EFR E   ++  QH N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIF---PTS---RRSEGHYSGGCLSWDLRYRVAI 214
           LLG C     P  +++E++ +G L  ++    P S     S        L       +AI
Sbjct: 73  LLGVC-TKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131

Query: 215 DVAKALSYL--HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM-----SRDQSRC 267
            +A  + YL  H+      +H D+   N L+ E     +SDFGLS+ +      R QS+ 
Sbjct: 132 QIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186

Query: 268 ITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +  +R    ++ PE IL    + + DI+S+G+VL E+
Sbjct: 187 LLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 82.9 bits (205), Expect = 5e-18
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 19/211 (9%)

Query: 104 NFQAL--LGHGSSASVFK-GILSDGTSVAVKRINGEENGEKEFRS---EVAAIASAQHVN 157
           +F+ L  LG GS  SV+K   LSD    A+K ++     +KE      E+  +AS  H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
           ++       + G    +V E+   G L   I      S+       +     +R+ I + 
Sbjct: 61  IISY-KEAFLDGNKLCIVMEYAPFGDLSKAI------SKRKKKRKLIPEQEIWRIFIQLL 113

Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGY 277
           + L  LH     ++LH D+K  NILL  N    + D G+SK++ ++ ++   T  GT  Y
Sbjct: 114 RGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK---TQIGTPHY 167

Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           +APE    +  S K DI+S G +L E+    
Sbjct: 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 83.1 bits (206), Expect = 5e-18
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 29/209 (13%)

Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+ G  +  T VAVK +       + F  E   +   +H  LV+L  Y V  
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQL--YAVCS 71

Query: 169 GG-PRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID----VAKALSYL 223
              P Y+V E++  GSL  ++    +  EG          LR    +D    +A+ ++YL
Sbjct: 72  EEEPIYIVTEYMSKGSLLDFL----KSGEGKK--------LRLPQLVDMAAQIAEGMAYL 119

Query: 224 HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GYLAP 280
                   +H D+   NIL+ EN    ++DFGL++L+  D+    T   G +    + AP
Sbjct: 120 E---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE---YTAREGAKFPIKWTAP 173

Query: 281 EWILEQGVSEKCDIYSYGMVLLEL-TGGR 308
           E       + K D++S+G++L E+ T GR
Sbjct: 174 EAANYGRFTIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 83.1 bits (206), Expect = 6e-18
 Identities = 69/229 (30%), Positives = 102/229 (44%), Gaps = 21/229 (9%)

Query: 109 LGHGSSASVFKG-ILSDGTSVAVKRINGEENGE--KEFRSEVAAIASAQHVNLVRLLGYC 165
           LG G+S  V K      G  +AVK I  E N    K+   E+  +       +V   G  
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
              G    +  E++  GSLD  +    +  +G      L      ++A+ V K L+YLH 
Sbjct: 69  YNNGDI-SICMEYMDGGSLDKIL----KEVQGRIPERILG-----KIAVAVLKGLTYLHE 118

Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILE 285
               +++H DVKP NIL++   +  + DFG+S  +    ++   T  GT  Y+APE I  
Sbjct: 119 K--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK---TFVGTSSYMAPERIQG 173

Query: 286 QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNE 334
              S K DI+S G+ L+EL  GR         ND     ++    IVNE
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGRFPYPPE---NDPPDGIFELLQYIVNE 219

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 82.5 bits (204), Expect = 1e-17
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 15/206 (7%)

Query: 108 LLGHGSSASVF----KGILSDG--TSVAVKRING--EENGEKEFRSEVAAIASAQHVNLV 159
            LG G    VF    KGI  +G  T V VK +    +EN + EFR E+       H N+V
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 160 RLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKA 219
           RLLG C     P Y++ E+   G L  ++  T  + E       LS   +  +   +A  
Sbjct: 72  RLLGLCR-EAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPP-LSTKQKVALCTQIALG 129

Query: 220 LSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYL 278
           + +L N   +R +H D+   N L+       VS   LSK + + +  +    +   R +L
Sbjct: 130 MDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR-WL 185

Query: 279 APEWILEQGVSEKCDIYSYGMVLLEL 304
           APE + E   S K D++S+G+++ E+
Sbjct: 186 APEAVQEDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 81.0 bits (200), Expect = 4e-17
 Identities = 65/222 (29%), Positives = 106/222 (47%), Gaps = 39/222 (17%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKR--INGEENGE---------KEFRSEVAAIASAQH 155
           L+G G+   V+  + ++ G  +AVK+  +     G          K  RSE+  +    H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 156 VNLVRLLGYCVVPGGPRYL--VYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVA 213
           +N+V+ LG+        YL    E++  GS+   +    R  E           L     
Sbjct: 68  LNIVQYLGF---ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE----------QLVRFFT 114

Query: 214 IDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK----LMSRDQSRCIT 269
             V + L+YLH+     +LH D+K +N+L+D +    +SDFG+SK    +   DQ+    
Sbjct: 115 EQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN---M 168

Query: 270 TIRGTRGYLAPEWI--LEQGVSEKCDIYSYGMVLLELTGGRR 309
           +++G+  ++APE I    QG S K DI+S G V+LE+  GRR
Sbjct: 169 SMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 80.2 bits (198), Expect = 5e-17
 Identities = 82/294 (27%), Positives = 126/294 (42%), Gaps = 58/294 (19%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKRINGEENGE------KEFRSEVAAIASAQHVNLVR 160
           LLG GS  SV++G+ L DG   AVK ++  ++G+      K+   E+A ++  QH N+V+
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI----DV 216
            LG         Y+  E +  GSL   +          Y            V       +
Sbjct: 67  YLG-TEREEDNLYIFLELVPGGSLAKLL--------KKYGS------FPEPVIRLYTRQI 111

Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG 276
              L YLH+      +H D+K  NIL+D N    ++DFG++K +   +     + +G+  
Sbjct: 112 LLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVV--EFSFAKSFKGSPY 166

Query: 277 YLAPEWILEQGV-SEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEK 335
           ++APE I +QG      DI+S G  +LE+  G+   S +E              KI   K
Sbjct: 167 WMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE--------GVAAVFKIGRSK 218

Query: 336 MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE 389
               +L  I D  L+DE            D    C+Q    LRP+ A   E+LE
Sbjct: 219 ----ELPPIPDH-LSDEAK----------DFILKCLQRDPSLRPTAA---ELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 27/209 (12%)

Query: 109 LGHGSSASVFK-GILSDGTSVAVKRI---NGEENGEKEFRSEVAAIASAQHVNLVRLLGY 164
           +G G+   VFK      G +VA+K++     E     +   E+ A+ + QH  +V+LL  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD- 66

Query: 165 CVVPGGPR-YLVYEFIQNG---SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
            V P G    LV E++ +     L     P        Y    L             K +
Sbjct: 67  -VFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLL-------------KGV 112

Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAP 280
           +Y+H    + ++H D+KP N+L+  +    ++DFGL++L S ++ R  +    TR Y AP
Sbjct: 113 AYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAP 169

Query: 281 EWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
           E +   +      D+++ G +  EL  G 
Sbjct: 170 ELLYGARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 79.4 bits (196), Expect = 1e-16
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 17/215 (7%)

Query: 97  ELEEATDNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHV 156
           E++  +      LG G    V++G+ ++ T VAVK +       K+F +E   +   +H 
Sbjct: 2   EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHP 61

Query: 157 NLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDV 216
            L++L   C +   P Y+V E ++ GSL  ++           +G  L       +A  V
Sbjct: 62  KLIQLYAVCTL-EEPIYIVTELMKYGSLLEYL--------QGGAGRALKLPQLIDMAAQV 112

Query: 217 AKALSYL--HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGT 274
           A  ++YL   N      +H D+   N+L+ EN    V+DFGL++++  D        +  
Sbjct: 113 ASGMAYLEAQN-----YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFP 167

Query: 275 RGYLAPEWILEQGVSEKCDIYSYGMVLLEL-TGGR 308
             + APE  L    S K D++S+G++L E+ T GR
Sbjct: 168 IKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 79.0 bits (195), Expect = 1e-16
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 24/203 (11%)

Query: 108 LLGHGSSASVFKGILSDGTSVAVK--RINGEENGEKEFRSEVAAIASAQHVNLVRLLGYC 165
            +G G+   V+KG+L   T VAVK  R     + +++F  E   +    H N+V+L+G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
            V   P Y+V E +  GSL  ++    R+ +   +   L      ++++D A  + YL +
Sbjct: 62  -VQKQPIYIVMELVPGGSLLTFL----RKKKNRLTVKKL-----LQMSLDAAAGMEYLES 111

Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG-----YLAP 280
                 +H D+   N L+ EN    +SDFG    MSR++   I T+          + AP
Sbjct: 112 KN---CIHRDLAARNCLVGENNVLKISDFG----MSREEEGGIYTVSDGLKQIPIKWTAP 164

Query: 281 EWILEQGVSEKCDIYSYGMVLLE 303
           E +     + + D++SYG++L E
Sbjct: 165 EALNYGRYTSESDVWSYGILLWE 187

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 57/202 (28%), Positives = 98/202 (48%), Gaps = 21/202 (10%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEENGE-KEFRSEVAAIASAQHVNLVRLLG-YC 165
           +G G+   V+K   ++ G  VA+K I  E   + +  + E++ +   +H N+V   G Y 
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY- 69

Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
            +     ++V E+   GSL   I+          + G LS      V  +  K L+YLH 
Sbjct: 70  -LRRDKLWIVMEYCGGGSLQD-IY--------QVTRGPLSELQIAYVCRETLKGLAYLHE 119

Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILE 285
              +  +H D+K  NILL E+    ++DFG+S  ++   ++  + I GT  ++APE    
Sbjct: 120 ---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAV 175

Query: 286 Q---GVSEKCDIYSYGMVLLEL 304
           +   G   KCDI++ G+  +EL
Sbjct: 176 ERKGGYDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 30/217 (13%)

Query: 106 QALLGHGSSASVFKGILS----DGTSVAVKRING--EENGEKEFRSEVAAIASAQHVNLV 159
           Q ++G G    VF+GIL        +VA+K +     E   ++F SE + +    H N++
Sbjct: 10  QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69

Query: 160 RLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKA 219
           RL G  V    P  ++ E+++NG+LD ++    R  +G +S   L   LR      +A  
Sbjct: 70  RLEG-VVTKFKPAMIITEYMENGALDKYL----RDHDGEFSSYQLVGMLR-----GIAAG 119

Query: 220 LSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITT------IRG 273
           + YL +      +H D+   NIL++ N    VSDFGLS+++  D     TT      IR 
Sbjct: 120 MKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRW 176

Query: 274 TRGYLAPEWILEQGVSEKCDIYSYGMVLLE-LTGGRR 309
           T    APE I  +  +   D++S+G+V+ E ++ G R
Sbjct: 177 T----APEAIAYRKFTSASDVWSFGIVMWEVMSFGER 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 39/117 (33%), Positives = 59/117 (50%), Gaps = 19/117 (16%)

Query: 207 DLRYRV--------------AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVS 252
           DLRY +                ++  AL YLH+     ++H D+KP+NILLDE     ++
Sbjct: 86  DLRYHLSQKVKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHIT 142

Query: 253 DFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRR 309
           DF ++  ++ D     T+  GT GY+APE +  QG S   D +S G+   E   G+R
Sbjct: 143 DFNIATKVTPDTL--TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 78.8 bits (194), Expect = 2e-16
 Identities = 58/201 (28%), Positives = 109/201 (54%), Gaps = 18/201 (8%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFR-SEVAAIASAQHVNLVRLLGYCV 166
           +G G+S +V+  I ++ G  VA+K++N ++  +KE   +E+  +   +H N+V  L   +
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 167 VPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHND 226
           V G   ++V E++  GSL   +  T    EG  +  C           +  +AL +LH++
Sbjct: 87  V-GDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCR----------ECLQALEFLHSN 134

Query: 227 CRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQ 286
              +V+H D+K +NILL  +    ++DFG    ++ +QS+  +T+ GT  ++APE +  +
Sbjct: 135 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRK 190

Query: 287 GVSEKCDIYSYGMVLLELTGG 307
               K DI+S G++ +E+  G
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 78.1 bits (193), Expect = 4e-16
 Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 23/211 (10%)

Query: 105 FQALLGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFRS---EVAAIASAQHVNLVR 160
              ++G G+   V K      G  VA+K+    E+ E   ++   EV  +   +H N+V 
Sbjct: 5   VLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVN 64

Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           L        G  YLV+E+++   L+              S G L  D        + +A+
Sbjct: 65  LKEAFRR-KGRLYLVFEYVERTLLE----------LLEASPGGLPPDAVRSYIWQLLQAI 113

Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAP 280
           +Y H      ++H D+KPENIL+ E+    + DFG ++ +    +  +T    TR Y AP
Sbjct: 114 AYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAP 170

Query: 281 EWIL---EQGVSEKCDIYSYGMVLLELTGGR 308
           E ++     G     D+++ G ++ EL  G 
Sbjct: 171 ELLVGDTNYGKP--VDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 77.8 bits (191), Expect = 5e-16
 Identities = 57/201 (28%), Positives = 109/201 (54%), Gaps = 18/201 (8%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFR-SEVAAIASAQHVNLVRLLGYCV 166
           +G G+S +V+  I ++ G  VA+K++N ++  +KE   +E+  +   ++ N+V  L   +
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86

Query: 167 VPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHND 226
           V G   ++V E++  GSL   +  T    EG  +  C           +  +AL +LH++
Sbjct: 87  V-GDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCR----------ECLQALDFLHSN 134

Query: 227 CRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQ 286
              +V+H D+K +NILL  +    ++DFG    ++ +QS+  +T+ GT  ++APE +  +
Sbjct: 135 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRK 190

Query: 287 GVSEKCDIYSYGMVLLELTGG 307
               K DI+S G++ +E+  G
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 77.2 bits (190), Expect = 5e-16
 Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 14/205 (6%)

Query: 105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGY 164
           F   LG G    V  G       VA+K IN     E++F  E   +    H  LV+L G 
Sbjct: 8   FMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67

Query: 165 CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH 224
           C     P Y+V EF++NG L +++    R+ +G      LS D+   +  DV + + YL 
Sbjct: 68  C-TQQKPLYIVTEFMENGCLLNYL----RQRQGK-----LSKDMLLSMCQDVCEGMEYLE 117

Query: 225 NDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWIL 284
              R+  +H D+   N L+       VSDFG+++ +  D+    +  +    +  PE   
Sbjct: 118 ---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFN 174

Query: 285 EQGVSEKCDIYSYGMVLLEL-TGGR 308
               S K D++S+G+++ E+ T G+
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFTEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 77.4 bits (190), Expect = 7e-16
 Identities = 65/207 (31%), Positives = 107/207 (51%), Gaps = 19/207 (9%)

Query: 103 DNFQALLGHGSSASV-FKGILSDGTSVAVKRINGEENGEKEFR-SEVAAIASAQHVNLVR 160
           DNF  + G GS+  V    + S G  VAVK+++  +   +E   +EV  +   QH N+V 
Sbjct: 23  DNFIKI-GEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81

Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           +    +V G   ++V EF++ G+L   I   +R +E   +  CL+          V KAL
Sbjct: 82  MYNSYLV-GDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLA----------VLKAL 129

Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAP 280
           S LH      V+H D+K ++ILL  + R  +SDFG    +S++  R   ++ GT  ++AP
Sbjct: 130 SVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKSLVGTPYWMAP 185

Query: 281 EWILEQGVSEKCDIYSYGMVLLELTGG 307
           E I       + DI+S G++++E+  G
Sbjct: 186 ELISRLPYGPEVDIWSLGIMVIEMVDG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 76.5 bits (189), Expect = 1e-15
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 24/224 (10%)

Query: 98  LEEATDNFQ--ALLGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFRSEVAAIAS-A 153
           L + T  F+   ++G G+   V+K      G  VA+K ++  E+ E+E + E   +   +
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS 60

Query: 154 QHVNLVRLLG--YCVVPGGPR---YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL 208
            H N+    G      P G     +LV E    GS+   +    R+         +++ L
Sbjct: 61  NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV-KGLRKKGKRLKEEWIAYIL 119

Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI 268
           R     +  + L+YLH    ++V+H D+K +NILL +N    + DFG+S  +     R  
Sbjct: 120 R-----ETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRN 171

Query: 269 TTIRGTRGYLAPEWI-----LEQGVSEKCDIYSYGMVLLELTGG 307
           T I GT  ++APE I      +     + D++S G+  +EL  G
Sbjct: 172 TFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 76.8 bits (190), Expect = 1e-15
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 33/213 (15%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEF-----RSEVAAIASAQHVNLVRLL 162
           +G G+   V+K      G  VA+K+I   EN ++ F     R E+  +   +H N+VRL 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIR-MENEKEGFPITAIR-EIKLLQKLRHPNIVRL- 63

Query: 163 GYCVV---PGGPRYLVYEFIQ---NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDV 216
              +V     G  Y+V+E++     G LD    P  + +E      C    L        
Sbjct: 64  -KEIVTSKGKGSIYMVFEYMDHDLTGLLDS---PEVKFTESQIK--CYMKQL-------- 109

Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG 276
            + L YLH+   + +LH D+K  NIL++ +    ++DFGL++  ++  S   T    T  
Sbjct: 110 LEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLW 166

Query: 277 YLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
           Y  PE +L       + D++S G +L EL  G+
Sbjct: 167 YRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 14/213 (6%)

Query: 97  ELEEATDNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHV 156
           E+   +   +  LG G    V+ G  +  T VA+K +       + F  E   +   +H 
Sbjct: 2   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE 61

Query: 157 NLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDV 216
            LV+L  Y VV   P Y+V E++  GSL  ++       +G   G  L       +A  +
Sbjct: 62  KLVQL--YAVVSEEPIYIVTEYMSKGSLLDFL-------KGEM-GKYLRLPQLVDMAAQI 111

Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG 276
           A  ++Y+    R   +H D++  NIL+ EN    V+DFGL++L+  ++       +    
Sbjct: 112 ASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 168

Query: 277 YLAPEWILEQGVSEKCDIYSYGMVLLEL-TGGR 308
           + APE  L    + K D++S+G++L EL T GR
Sbjct: 169 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 76.3 bits (187), Expect = 2e-15
 Identities = 57/201 (28%), Positives = 107/201 (53%), Gaps = 18/201 (8%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFR-SEVAAIASAQHVNLVRLLGYCV 166
           +G G+S +VF  I ++ G  VA+K+IN ++  +KE   +E+  +   ++ N+V  L   +
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86

Query: 167 VPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHND 226
           V G   ++V E++  GSL   +  T           C+       V  +  +AL +LH +
Sbjct: 87  V-GDELFVVMEYLAGGSLTDVVTET-----------CMDEAQIAAVCRECLQALEFLHAN 134

Query: 227 CRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQ 286
              +V+H D+K +N+LL  +    ++DFG    ++ +QS+  +T+ GT  ++APE +  +
Sbjct: 135 ---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRK 190

Query: 287 GVSEKCDIYSYGMVLLELTGG 307
               K DI+S G++ +E+  G
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 75.7 bits (186), Expect = 2e-15
 Identities = 56/183 (30%), Positives = 93/183 (50%), Gaps = 19/183 (10%)

Query: 127 SVAVKRING--EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL 184
            VA+K +     E   ++F SE + +    H N++ L G  V    P  +V E+++NGSL
Sbjct: 34  PVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEG-VVTKSKPVMIVTEYMENGSL 92

Query: 185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD 244
           D ++    R+ +G ++   L   LR      +A  + YL +      +H D+   NIL++
Sbjct: 93  DAFL----RKHDGQFTVIQLVGMLR-----GIASGMKYLSD---MGYVHRDLAARNILVN 140

Query: 245 ENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GYLAPEWILEQGVSEKCDIYSYGMVL 301
            N    VSDFGLS+++  D     TT RG +    + APE I  +  +   D++SYG+V+
Sbjct: 141 SNLVCKVSDFGLSRVLEDDPEAAYTT-RGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVM 199

Query: 302 LEL 304
            E+
Sbjct: 200 WEV 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 75.3 bits (185), Expect = 2e-15
 Identities = 57/201 (28%), Positives = 101/201 (50%), Gaps = 14/201 (6%)

Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+ G  +  T VA+K +       + F +E   +   QH  LVRL  Y VV 
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRL--YAVVT 71

Query: 169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCR 228
             P Y++ E+++NGSL  ++    +  EG      L+ +    +A  +A+ ++++    R
Sbjct: 72  QEPIYIITEYMENGSLVDFL----KTPEGIK----LTINKLIDMAAQIAEGMAFIE---R 120

Query: 229 SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGV 288
              +H D++  NIL+ E     ++DFGL++L+  ++       +    + APE I     
Sbjct: 121 KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 180

Query: 289 SEKCDIYSYGMVLLEL-TGGR 308
           + K D++S+G++L E+ T GR
Sbjct: 181 TIKSDVWSFGILLTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 75.0 bits (184), Expect = 3e-15
 Identities = 64/202 (31%), Positives = 94/202 (46%), Gaps = 23/202 (11%)

Query: 108 LLGHGSSASVFKGILSDGTSVAVKRINGEENGEKE--FRSEVAAIASAQHVNLVRLLGYC 165
           LLG G+   VFKG L D T VAVK    +   E +  F SE   +    H N+V+L+G C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
                P Y+V E +  G  D   F   ++ E       L      + A+D A  ++YL +
Sbjct: 62  -TQRQPIYIVMELVPGG--DFLSFLRKKKDE-------LKTKQLVKFALDAAAGMAYLES 111

Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR----GYLAPE 281
                 +H D+   N L+ EN    +SDFG    MSR +   I +  G +     + APE
Sbjct: 112 ---KNCIHRDLAARNCLVGENNVLKISDFG----MSRQEDDGIYSSSGLKQIPIKWTAPE 164

Query: 282 WILEQGVSEKCDIYSYGMVLLE 303
            +     S + D++SYG++L E
Sbjct: 165 ALNYGRYSSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 75.6 bits (186), Expect = 3e-15
 Identities = 65/207 (31%), Positives = 107/207 (51%), Gaps = 19/207 (9%)

Query: 103 DNFQALLGHGSSASV-FKGILSDGTSVAVKRINGEENGEKEFR-SEVAAIASAQHVNLVR 160
           DNF  + G GS+  V      S G  VAVK+++  +   +E   +EV  +   QH N+V 
Sbjct: 22  DNFVKI-GEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVE 80

Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           +    +V G   ++V EF++ G+L   I   +R +E   +  CL+          V KAL
Sbjct: 81  MYSSYLV-GDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLA----------VLKAL 128

Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAP 280
           S+LH      V+H D+K ++ILL  + R  +SDFG    +S++  R   ++ GT  ++AP
Sbjct: 129 SFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-RKSLVGTPYWMAP 184

Query: 281 EWILEQGVSEKCDIYSYGMVLLELTGG 307
           E I       + DI+S G++++E+  G
Sbjct: 185 EVISRLPYGTEVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 76.4 bits (188), Expect = 3e-15
 Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 31/210 (14%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRI--NGEENGEKEFRSEVAAIASAQHVNLVRLLGYC 165
           +G G+  +V+K I    G   A+K I  N E+   ++   E+  +    H N+V+     
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDM- 140

Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRY--RVAIDVAKALSYL 223
               G   ++ EF+  GSL           EG +       D ++   VA  +   ++YL
Sbjct: 141 FDHNGEIQVLLEFMDGGSL-----------EGTHI-----ADEQFLADVARQILSGIAYL 184

Query: 224 HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWI 283
           H   R  ++H D+KP N+L++      ++DFG+S+++++    C +++ GT  Y++PE I
Sbjct: 185 H---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERI 240

Query: 284 ---LEQGVSEKC--DIYSYGMVLLELTGGR 308
              L  G  +    DI+S G+ +LE   GR
Sbjct: 241 NTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 74.8 bits (184), Expect = 6e-15
 Identities = 60/232 (25%), Positives = 106/232 (45%), Gaps = 32/232 (13%)

Query: 109 LGHGSSASVFKGILS------DGTSVAVKRING--EENGEKEFRSEVAAIASAQHVNLVR 160
           LG G+   VF G         D   VAVK +      +  K+F  E   + + QH N+V+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIF---PTSRRSEGHYSG-GCLSWDLRYRVAIDV 216
             G C   G P  +V+E++++G L+ ++    P +   +   S  G L+     ++A+ +
Sbjct: 73  FYGVC-TEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131

Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC-ITTIRGTR 275
           A  + YL +      +H D+   N L+  +    + DFG    MSRD        + G  
Sbjct: 132 ASGMVYLAS---QHFVHRDLATRNCLVGYDLVVKIGDFG----MSRDVYTTDYYRVGGHT 184

Query: 276 ----GYLAPEWILEQGVSEKCDIYSYGMVLLEL-TGGRR------NVSLIEH 316
                ++ PE I+ +  + + D++S+G+VL E+ T G++      N  +IE 
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC 236

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 74.3 bits (183), Expect = 6e-15
 Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 31/217 (14%)

Query: 106 QALLGHGSSASVFKGILS----DGTSVAVK--RINGEENGEKEFRSEVAAIASAQHVNLV 159
           + ++G G    V +G L         VA+K  +    +    +F +E + +    H N++
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 160 RLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKA 219
           RL G  V    P  ++ E+++NGSLD ++    R ++G ++ G L   LR      +A  
Sbjct: 69  RLEG-VVTKSRPVMIITEYMENGSLDKFL----RENDGKFTVGQLVGMLR-----GIASG 118

Query: 220 LSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITT------IRG 273
           + YL        +H D+   NIL++ N    VSDFGLS+ +  D     TT      IR 
Sbjct: 119 MKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRL-EDSEATYTTKGGKIPIRW 174

Query: 274 TRGYLAPEWILEQGVSEKCDIYSYGMVLLE-LTGGRR 309
           T    APE I  +  +   D++S+G+V+ E ++ G R
Sbjct: 175 T----APEAIAYRKFTSASDVWSFGIVMWEVMSYGER 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 73.9 bits (181), Expect = 7e-15
 Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 14/201 (6%)

Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG+G    V+ G  +  T VAVK +       + F  E   +   +H  LV+L  Y VV 
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQL--YAVVS 71

Query: 169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCR 228
             P Y+V E++  GSL  ++    +  EG      L       +A  VA  ++Y+    R
Sbjct: 72  EEPIYIVTEYMSKGSLLDFL----KDGEGRA----LKLPNLVDMAAQVAAGMAYIE---R 120

Query: 229 SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGV 288
              +H D++  NIL+ +     ++DFGL++L+  ++       +    + APE  L    
Sbjct: 121 MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 180

Query: 289 SEKCDIYSYGMVLLEL-TGGR 308
           + K D++S+G++L EL T GR
Sbjct: 181 TIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 74.4 bits (182), Expect = 8e-15
 Identities = 55/201 (27%), Positives = 109/201 (54%), Gaps = 18/201 (8%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFR-SEVAAIASAQHVNLVRLLGYCV 166
           +G G+S +V+  + ++ G  VA++++N ++  +KE   +E+  +   ++ N+V  L   +
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 167 VPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHND 226
           V G   ++V E++  GSL   +  T    EG  +  C           +  +AL +LH++
Sbjct: 88  V-GDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCR----------ECLQALEFLHSN 135

Query: 227 CRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQ 286
              +V+H D+K +NILL  +    ++DFG    ++ +QS+  +T+ GT  ++APE +  +
Sbjct: 136 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRK 191

Query: 287 GVSEKCDIYSYGMVLLELTGG 307
               K DI+S G++ +E+  G
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 74.1 bits (182), Expect = 9e-15
 Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 22/211 (10%)

Query: 108 LLGHGSSASVFKGILS--DGTS--VAVK--RINGEENGE-KEFRSEVAAIASAQHVNLVR 160
           +LG G   SV +G LS  DG+   VAVK  +++     E +EF SE A +    H N+++
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 161 LLGYCVV------PGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI 214
           L+G C           P  ++  F+++G L  ++   SR          L      +  +
Sbjct: 66  LIGVCFEASSLQKIPKP-MVILPFMKHGDLHSFLL-YSRLGGLPEK---LPLQTLLKFMV 120

Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS-KLMSRDQSRCITTIRG 273
           D+A  + YL N      +H D+   N +L E+    V+DFGLS K+ S D  R     + 
Sbjct: 121 DIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177

Query: 274 TRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
              ++A E + ++  + K D++++G+ + E+
Sbjct: 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEI 208

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 73.7 bits (181), Expect = 1e-14
 Identities = 53/210 (25%), Positives = 96/210 (45%), Gaps = 31/210 (14%)

Query: 108 LLGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFRSEVAAI-------ASAQHVNLV 159
           LLG G+   V+     D G  +AVK++  + +   E + EV A+        + QH  +V
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPD-SPETKKEVNALECEIQLLKNLQHERIV 67

Query: 160 RLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKA 219
           +  G C+       +  E++  GS+   +           + G L+  +  +    + + 
Sbjct: 68  QYYG-CLRDDETLSIFMEYMPGGSVKDQL----------KAYGALTETVTRKYTRQILEG 116

Query: 220 LSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC-----ITTIRGT 274
           + YLH    + ++H D+K  NIL D      + DFG SK   R Q+ C     + ++ GT
Sbjct: 117 VEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASK---RLQTICSSGTGMKSVTGT 170

Query: 275 RGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
             +++PE I  +G   K D++S G  ++E+
Sbjct: 171 PYWMSPEVISGEGYGRKADVWSVGCTVVEM 200

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 69/232 (29%), Positives = 100/232 (43%), Gaps = 43/232 (18%)

Query: 109 LGHGSSASVFKGI--LSDGTS--VAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLL 162
           LGHG+  SV KG+  +  G    VAVK +  E    G+KEF  E + +A   H  +VRL+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 163 GYCVVPGGPRYLVYEFIQNGSL-----DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
           G C     P  LV E    G L          P S   E               +A  VA
Sbjct: 63  GVCKGE--PLMLVMELAPLGPLLKYLKKRREIPVSDLKE---------------LAHQVA 105

Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQS--RCITTIRGTR 275
             ++YL +      +H D+   N+LL   ++A +SDFG+S+ +       R  T  R   
Sbjct: 106 MGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPL 162

Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLELT-------GGRRN---VSLIEHG 317
            + APE I     S K D++SYG+ L E         G  +    ++++E G
Sbjct: 163 KWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG 214

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 73.4 bits (180), Expect = 1e-14
 Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 31/213 (14%)

Query: 106 QALLGHGSSASVFKGILS----DGTSVAVKRING--EENGEKEFRSEVAAIASAQHVNLV 159
           + ++G G    V +G L         VA+K +     E   ++F SE + +    H N++
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 160 RLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKA 219
            L G  V    P  ++ EF++NG+LD ++    R+++G ++   L   LR      +A  
Sbjct: 69  HLEG-VVTKSRPVMIITEFMENGALDSFL----RQNDGQFTVIQLVGMLR-----GIAAG 118

Query: 220 LSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITT--------I 271
           + YL        +H D+   NIL++ N    VSDFGLS+ +  D S    T        I
Sbjct: 119 MKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPI 175

Query: 272 RGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           R T    APE I  +  +   D++SYG+V+ E+
Sbjct: 176 RWT----APEAIAYRKFTSASDVWSYGIVMWEV 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 78/298 (26%), Positives = 136/298 (45%), Gaps = 52/298 (17%)

Query: 109 LGHGSSASVFKGILSD------GTSVAVKRINGEENGEK--EFRSEVAAIASAQHVNLVR 160
           LG GS   V++G   D       T VAVK +N   +  +  EF +E + +      ++VR
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR--YRVAIDVAK 218
           LLG  V  G P  +V E + +G L  ++   S R E   + G     L+   ++A ++A 
Sbjct: 74  LLG-VVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130

Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            ++YL+     + +H D+   N ++  ++   + DFG    M+RD        +G +G L
Sbjct: 131 GMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFG----MTRDIYETDYYRKGGKGLL 183

Query: 279 APEWI----LEQGV-SEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVN 333
              W+    L+ GV +   D++S+G+VL E+T      SL E          Q +  + N
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEIT------SLAE----------QPYQGLSN 227

Query: 334 EKMKEGKLMEIVDQRLTDEGGID--ETQVRRLVDVAFWCIQERARLRPSMARVVEMLE 389
           E+         V + + D G +D  +    R+ D+   C Q   ++RP+   +V +L+
Sbjct: 228 EQ---------VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 64/210 (30%), Positives = 107/210 (50%), Gaps = 19/210 (9%)

Query: 100 EATDNFQALLGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFR-SEVAAIASAQHVN 157
           E  D+F  + G GS+  V        G  VAVK+++  +   +E   +EV  +    H N
Sbjct: 22  EYLDSFIKI-GEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHEN 80

Query: 158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
           +V +    +V G   ++V EF++ G+L   I   +R +E   +  CLS          V 
Sbjct: 81  VVDMYNSYLV-GDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLS----------VL 128

Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGY 277
           +ALSYLHN     V+H D+K ++ILL  + R  +SDFG    +S++  +   ++ GT  +
Sbjct: 129 RALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKSLVGTPYW 184

Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           +APE I       + DI+S G++++E+  G
Sbjct: 185 MAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 53/143 (37%), Positives = 76/143 (53%), Gaps = 23/143 (16%)

Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL-RYRVAIDVAKALSYLHNDCRSRV 231
           YLV E++  G L   +           + G L  D+ R  +A ++  AL YLH+   + +
Sbjct: 69  YLVMEYLPGGDLASLL----------ENVGSLDEDVARIYIA-EIVLALEYLHS---NGI 114

Query: 232 LHLDVKPENILLDENYRAVVSDFGLSK--LMSR-----DQSRCITTIRGTRGYLAPEWIL 284
           +H D+KP+NIL+D N    ++DFGLSK  L+ R     D  +    I GT  Y+APE IL
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174

Query: 285 EQGVSEKCDIYSYGMVLLE-LTG 306
            QG S+  D +S G +L E L G
Sbjct: 175 GQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 60/222 (27%), Positives = 102/222 (45%), Gaps = 31/222 (13%)

Query: 93  FRSKELEEATDNFQALLGHGSSASVFKGI-LSDGTS----VAVKRINGEENGEKEFRS-- 145
            +  EL +       LLG G   +V KGI + +G S    VA+K I  + +G + F+   
Sbjct: 4   LKETELRKLK-----LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQ-DRSGRQTFQEIT 57

Query: 146 -EVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGG-C 203
             + A+ S  H  +VRLLG C  PG    LV +    GSL   +    R+          
Sbjct: 58  DHMLAMGSLDHAYIVRLLGIC--PGASLQLVTQLSPLGSLLDHV----RQHRDSLDPQRL 111

Query: 204 LSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD 263
           L+W       + +AK + YL       ++H ++   NILL  +    ++DFG++ L+  D
Sbjct: 112 LNW------CVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162

Query: 264 QSRCI-TTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
             +   +  +    ++A E IL    + + D++SYG+ + E+
Sbjct: 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEM 204

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 72.4 bits (177), Expect = 2e-14
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 14/213 (6%)

Query: 97  ELEEATDNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHV 156
           E+   +      LG G    V+ G  +  T VA+K +       + F  E   +   +H 
Sbjct: 2   EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHD 61

Query: 157 NLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDV 216
            LV L  Y VV   P Y+V EF+  GSL  ++    +  +G Y    L       +A  +
Sbjct: 62  KLVPL--YAVVSEEPIYIVTEFMGKGSLLDFL----KEGDGKY----LKLPQLVDMAAQI 111

Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG 276
           A  ++Y+    R   +H D++  NIL+ +N    ++DFGL++L+  ++       +    
Sbjct: 112 ADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIK 168

Query: 277 YLAPEWILEQGVSEKCDIYSYGMVLLEL-TGGR 308
           + APE  L    + K D++S+G++L EL T GR
Sbjct: 169 WTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 72.4 bits (178), Expect = 2e-14
 Identities = 57/206 (27%), Positives = 88/206 (42%), Gaps = 23/206 (11%)

Query: 108 LLGHGSSASVFKG----ILSDGTSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRL 161
            LG GS   V +G           VAVK +  +   +   +F  E A + S  H NL+RL
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 162 LGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSE-GHYSGGCLSWDLRYRVAIDVAKAL 220
             Y VV   P  +V E    GSL        R+   GH+    L  D     A+ +A  +
Sbjct: 62  --YGVVLTHPLMMVTELAPLGSL----LDRLRKDALGHFLISTL-CDY----AVQIANGM 110

Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK--LMSRDQSRCITTIRGTRGYL 278
            YL +    R +H D+   NILL  + +  + DFGL +    + D       ++    + 
Sbjct: 111 RYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWC 167

Query: 279 APEWILEQGVSEKCDIYSYGMVLLEL 304
           APE +  +  S   D++ +G+ L E+
Sbjct: 168 APESLRTRTFSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 50/212 (23%), Positives = 99/212 (46%), Gaps = 27/212 (12%)

Query: 108 LLGHGSSASVFKGILSDG--TSVAVKRIN--------GEENGEKEFRSEVAAIA----SA 153
            LG G+   V+K    +     +A+K IN         +   +K     V+ +       
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 154 QHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL-DHWIFPTSRRSEGHYSGGCLSWDLRYRV 212
           +H N+VR      +     Y+V + I+   L +H  F + +  +  ++      +  + +
Sbjct: 67  RHPNIVRYYK-TFLENDRLYIVMDLIEGAPLGEH--FNSLKEKKQRFTE-----ERIWNI 118

Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR 272
            + +  AL YLH +   R++H D+ P NI+L E+ +  ++DFGL+K    +    +T++ 
Sbjct: 119 FVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK--LTSVV 174

Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           GT  Y  PE +  +   EK D++++G +L ++
Sbjct: 175 GTILYSCPEIVKNEPYGEKADVWAFGCILYQM 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 72.4 bits (178), Expect = 3e-14
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 20/205 (9%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRIN-GEENGEKEFRS--EVAAIASAQHVNLVRLLGY 164
           +G G+   V+K      G  VA+K+I    E+      +  E+  +    H N+++LL  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD- 65

Query: 165 CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH 224
                G  YLV+EF     +D  ++   +  +       L   L       + + L++ H
Sbjct: 66  VFRHKGDLYLVFEF-----MDTDLYKLIKDRQRG-----LPESLIKSYLYQLLQGLAFCH 115

Query: 225 NDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWIL 284
                 +LH D+KPEN+L++      ++DFGL++       R  T    TR Y APE +L
Sbjct: 116 ---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVVTRWYRAPELLL 171

Query: 285 -EQGVSEKCDIYSYGMVLLELTGGR 308
            ++G S   DI+S G +  EL   R
Sbjct: 172 GDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 71.8 bits (176), Expect = 6e-14
 Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 24/207 (11%)

Query: 105 FQALLGHGSSASVFKGI-LSDGTSVAVKRINGEENGE--KEFRSEVAAIASAQHVNLVRL 161
           +Q +LGHG+  +V+K   L     +AVK I  +   E  K+  SE+  +       ++  
Sbjct: 5   YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGF 64

Query: 162 LGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALS 221
            G   V      +  EF+  GSLD +     R+   H  G         R+A+ V K L+
Sbjct: 65  YGAFFVENRIS-ICTEFMDGGSLDVY-----RKIPEHVLG---------RIAVAVVKGLT 109

Query: 222 YLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPE 281
           YL +    ++LH DVKP N+L++   +  + DFG+S  +    +    T  GT  Y+APE
Sbjct: 110 YLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA---KTYVGTNAYMAPE 163

Query: 282 WILEQGVSEKCDIYSYGMVLLELTGGR 308
            I  +      D++S G+  +EL  GR
Sbjct: 164 RISGEQYGIHSDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 71.3 bits (175), Expect = 8e-14
 Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 21/215 (9%)

Query: 99  EEATDNFQALLGHGSSASVFK---GILSDGTS--VAVKRI-NGEENGEKEFRSEVAAIAS 152
           EE    F   LG G+  SV       L D T   VAVK++ +      ++F  E+  + S
Sbjct: 2   EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKS 61

Query: 153 AQHVNLVRLLGYCVVPGGPRY-LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYR 211
            QH N+V+  G C   G     LV E++  GSL  ++     R +           L Y 
Sbjct: 62  LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDH-------RKLLLY- 113

Query: 212 VAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTI 271
            A  + K + YL +    R +H D+   NIL++   R  + DFGL+K++ +D+       
Sbjct: 114 -ASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVRE 169

Query: 272 RGTRG--YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            G     + APE + E   S   D++S+G+VL EL
Sbjct: 170 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 71.2 bits (174), Expect = 9e-14
 Identities = 57/222 (25%), Positives = 106/222 (47%), Gaps = 23/222 (10%)

Query: 92  KFRSKELEEATDNFQALLGHGSSASVFKGILSDGTSVAVK--RINGEENGEKEFRSEVAA 149
           +F    L EA +     LG G+     + +L     VAVK  R +  +    +F  E+  
Sbjct: 17  QFGEVHLCEA-EGLAEFLGEGAPEFDGQPVL-----VAVKMLRADVTKTARNDFLKEIKI 70

Query: 150 IASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGG--CLSWD 207
           ++  ++ N++RLLG CV    P  ++ E+++NG L+ ++      S   ++     +S  
Sbjct: 71  MSRLKNPNIIRLLGVCV-SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIA 129

Query: 208 LRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK-LMSRD--- 263
               +A+ +A  + YL +      +H D+   N L+  +Y   ++DFG+S+ L S D   
Sbjct: 130 NLLYMAVQIASGMKYLAS---LNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYR 186

Query: 264 -QSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            Q R +  IR    ++A E IL    +   D++++G+ L E+
Sbjct: 187 IQGRAVLPIR----WMAWESILLGKFTTASDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 71.3 bits (174), Expect = 9e-14
 Identities = 63/214 (29%), Positives = 107/214 (50%), Gaps = 30/214 (14%)

Query: 108 LLGHGSSASVFKGI-LSDGTSV----AVKRINGEENGEK---EFRSEVAAIASAQHVNLV 159
           +LG G+  +V+KGI + +G +V    A+K +N E  G K   EF  E   +AS  H +LV
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 160 RLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKA 219
           RLLG C+ P     LV + + +G L  ++       +   S   L+W       + +AK 
Sbjct: 73  RLLGVCLSP--TIQLVTQLMPHGCLLDYV---HEHKDNIGSQLLLNW------CVQIAKG 121

Query: 220 LSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---G 276
           + YL      R++H D+   N+L+       ++DFGL++L+  D+        G +    
Sbjct: 122 MMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE--YNADGGKMPIK 176

Query: 277 YLAPEWILEQGVSEKCDIYSYGMVLLELT--GGR 308
           ++A E I  +  + + D++SYG+ + EL   GG+
Sbjct: 177 WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGK 210

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 70.9 bits (174), Expect = 9e-14
 Identities = 55/207 (26%), Positives = 104/207 (50%), Gaps = 23/207 (11%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKRIN--GEENGEKEFRSEVAAIASAQHV---NLVRL 161
           L+G G+  +V++G  +  G  VA+K IN    ++   + + EVA ++  +     N+ + 
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 162 LGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALS 221
            G   + G   +++ E+ + GS+       +    G  +   +S  +R     +V  AL 
Sbjct: 68  YG-SYLKGPRLWIIMEYAEGGSV------RTLMKAGPIAEKYISVIIR-----EVLVALK 115

Query: 222 YLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPE 281
           Y+H   +  V+H D+K  NIL+       + DFG++ L++++ S+  T + GT  ++APE
Sbjct: 116 YIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPE 171

Query: 282 WILE-QGVSEKCDIYSYGMVLLELTGG 307
            I E +    K DI+S G+ + E+  G
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 30/218 (13%)

Query: 105 FQALLGHGSSASVFKG-ILSDG--TSVAVKRIN--GEENGEKEFRSEVAAIAS-AQHVNL 158
           FQ ++G G+   V K  I  DG     A+KR+     ++  ++F  E+  +     H N+
Sbjct: 11  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70

Query: 159 VRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSE-------GHYSGGCLSWDLRYR 211
           + LLG C    G  YL  E+  +G+L  ++   SR  E        + +   LS      
Sbjct: 71  INLLGACE-HRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLH 128

Query: 212 VAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTI 271
            A DVA+ + YL    + + +H D+   NIL+ ENY A ++DFGL    SR Q      +
Sbjct: 129 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGL----SRGQE---VYV 178

Query: 272 RGTRGYLAPEWILEQGV-----SEKCDIYSYGMVLLEL 304
           + T G L   W+  + +     +   D++SYG++L E+
Sbjct: 179 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 216

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 70.7 bits (174), Expect = 1e-13
 Identities = 56/209 (26%), Positives = 103/209 (49%), Gaps = 25/209 (11%)

Query: 107 ALLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAAIA------SAQHVNLV 159
           A +G G+  +V+K   L+ G  VA+K++    + E    S +  IA      S +H N+V
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64

Query: 160 RLLGYCVVPGGPR----YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
           RLL  C  P   R     LV+E +    L  ++             G     ++  +   
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYL-------SKCPKPGLPPETIK-DLMRQ 115

Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + + +LH+    R++H D+KP+NIL+  + +  ++DFGL+++ S + +  +T++  T 
Sbjct: 116 LLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA--LTSVVVTL 170

Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            Y APE +L+   +   D++S G +  EL
Sbjct: 171 WYRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 24/212 (11%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAAIAS-AQHVNLVRLLGYC 165
           ++G+G+   V+KG  +  G   A+K ++  E+ E+E + E+  +   + H N+    G  
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82

Query: 166 VVPGGP-----RYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           +    P      +LV EF   GS+   +  T         G  L  D    +  ++ + L
Sbjct: 83  IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--------GNALKEDWIAYICREILRGL 134

Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAP 280
           ++LH     +V+H D+K +N+LL EN    + DFG+S  + R   R  T I GT  ++AP
Sbjct: 135 AHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAP 190

Query: 281 EWIL-----EQGVSEKCDIYSYGMVLLELTGG 307
           E I      +     + DI+S G+  +E+  G
Sbjct: 191 EVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 56/184 (30%), Positives = 95/184 (51%), Gaps = 17/184 (9%)

Query: 125 GTSVAVKRINGEENGEKEFR-SEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS 183
           G  VAVK ++  +   +E   +EV  +   QH N+V +    +V G   +++ EF+Q G+
Sbjct: 46  GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-GEELWVLMEFLQGGA 104

Query: 184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILL 243
           L   I   +R +E   +  C S          V +AL YLH+     V+H D+K ++ILL
Sbjct: 105 LTD-IVSQTRLNEEQIATVCES----------VLQALCYLHS---QGVIHRDIKSDSILL 150

Query: 244 DENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLE 303
             + R  +SDFG    +S+D  +   ++ GT  ++APE I       + DI+S G++++E
Sbjct: 151 TLDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIE 209

Query: 304 LTGG 307
           +  G
Sbjct: 210 MVDG 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 64/227 (28%), Positives = 105/227 (46%), Gaps = 27/227 (11%)

Query: 97  ELEEATDNFQALLGHGSSASVFKGIL-----SDGTSVAVKRINGEENGEK--EFRSEVAA 149
           EL  +   F   LG  +   ++KG L          VA+K +    N ++  EF+ E + 
Sbjct: 1   ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60

Query: 150 IASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSG---GCLSW 206
           +A   H N+V LLG  V    P  +++E++  G L  ++   S  S+   S    G +  
Sbjct: 61  MAELHHPNIVCLLG-VVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKS 119

Query: 207 DLRY----RVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK-LMS 261
            L +     +AI +A  + YL +      +H D+   NIL+ E     +SD GLS+ + S
Sbjct: 120 SLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYS 176

Query: 262 RD----QSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            D    Q + +  IR    ++ PE I+    S   DI+S+G+VL E+
Sbjct: 177 ADYYRVQPKSLLPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 69.5 bits (170), Expect = 2e-13
 Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 19/199 (9%)

Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V  G       VA+K I      E EF  E   +    H  LV+L G C   
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ 71

Query: 169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCR 228
             P Y+V E++ NG L +++    +R +               +  DV + ++YL +   
Sbjct: 72  R-PIYIVTEYMSNGCLLNYLREHGKRFQPSQ---------LLEMCKDVCEGMAYLES--- 118

Query: 229 SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GYLAPEWILE 285
            + +H D+   N L+D+     VSDFGLS+ +  D+    T+  G++    +  PE +L 
Sbjct: 119 KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLLY 175

Query: 286 QGVSEKCDIYSYGMVLLEL 304
              S K D++++G+++ E+
Sbjct: 176 SKFSSKSDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 69.2 bits (170), Expect = 3e-13
 Identities = 47/137 (34%), Positives = 68/137 (49%), Gaps = 17/137 (12%)

Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y++ E+   G L   +     R  G +      +  R+ +A  V  A  YLHN     ++
Sbjct: 69  YMLMEYCLGGELWTIL-----RDRGLFD----EYTARFYIAC-VVLAFEYLHN---RGII 115

Query: 233 HLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT-TIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+LLD N    + DFG +K +   Q    T T  GT  Y+APE IL +G    
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK---TWTFCGTPEYVAPEIILNKGYDFS 172

Query: 292 CDIYSYGMVLLELTGGR 308
            D +S G++L EL  GR
Sbjct: 173 VDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 60/224 (26%), Positives = 99/224 (44%), Gaps = 34/224 (15%)

Query: 102 TDNFQALLGHGSSASVFKGILSDGTSVAVK--RINGEENGEKEFRSEVAAIASAQHVNLV 159
            D  Q       + +           VAVK  R +  +N  ++F  EV  ++     N+ 
Sbjct: 26  ADGLQDFSEKAFAENDNADA---PVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA 82

Query: 160 RLLGYCVVPGGPRYLVYEFIQNGSLDHW----IFPTSRRSEGHY--SGGCLSWDLRYRVA 213
           RLLG C V   P  ++ E+++NG L+ +    +  TS  +      S   L +     +A
Sbjct: 83  RLLGVCTVD-PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLY-----MA 136

Query: 214 IDVAKALSYL--HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK-LMSRD----QSR 266
             +A  + YL   N      +H D+   N L+ +NY   ++DFG+S+ L S D    Q R
Sbjct: 137 TQIASGMRYLESLN-----FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGR 191

Query: 267 CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLE-LTGGRR 309
               IR    ++A E +L    + K D++++G+ L E LT  R 
Sbjct: 192 APLPIR----WMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 69.5 bits (170), Expect = 3e-13
 Identities = 60/224 (26%), Positives = 105/224 (46%), Gaps = 42/224 (18%)

Query: 107 ALLGHGSSASVFKGI-LSDGTSVAVKRI---NGEENGEKEFRS-------EVAAIASAQH 155
           AL+G GS  SV+ G+  S G  +AVK++   +   + +   RS       E+A +   QH
Sbjct: 6   ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65

Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGS----LDHWIFPTSRRSEGHYSGGCLSWDLRYR 211
            N+V+ LG   +      +  E++  GS    L+++              G     L   
Sbjct: 66  ENIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNY--------------GAFEETLVRN 110

Query: 212 VAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK-------LMSRDQ 264
               + K L+YLHN     ++H D+K  NIL+D      +SDFG+SK           + 
Sbjct: 111 FVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNG 167

Query: 265 SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           +R   +++G+  ++APE + +   + K DI+S G +++E+  G+
Sbjct: 168 AR--PSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 57/172 (33%), Positives = 93/172 (54%), Gaps = 21/172 (12%)

Query: 150 IASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR 209
           +A   H  +V+L  Y     G  YL+ +F++ G L    F T    E  ++      D++
Sbjct: 52  LAEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDL----F-TRLSKEVMFT----EEDVK 101

Query: 210 YRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT 269
           + +A ++A AL +LH+     +++ D+KPENILLDE     ++DFGLSK  S D  +   
Sbjct: 102 FYLA-ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAY 156

Query: 270 TIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLE-LTGGRRNVSLIEHGNDK 320
           +  GT  Y+APE +  +G ++  D +S+G+++ E LTG     SL   G D+
Sbjct: 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG-----SLPFQGKDR 203

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 69.1 bits (169), Expect = 4e-13
 Identities = 64/222 (28%), Positives = 109/222 (49%), Gaps = 31/222 (13%)

Query: 108 LLGHGSSASVFKG----ILSDGTS---VAVKRI-NGEENGEK-EFRSEVAAIASAQHVNL 158
            LG G+   V++G    IL  G+    VAVK +  G  + EK EF  E   +++  H N+
Sbjct: 2   FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61

Query: 159 VRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK 218
           V+LLG C++   P+Y++ E ++ G L  ++     R E          +L   + +DVAK
Sbjct: 62  VKLLGVCLL-NEPQYIIMELMEGGDLLSYL--RDARVERFGPPLLTLKEL-LDICLDVAK 117

Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENY----RAV-VSDFGLSK-LMSRDQSRCITTIR 272
              YL    +   +H D+   N L+ E      R V + DFGL++ +   D  R      
Sbjct: 118 GCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR----KE 170

Query: 273 GTR----GYLAPEWILEQGVSEKCDIYSYGMVLLE-LTGGRR 309
           G       ++APE +L+   + + D++S+G+++ E LT G++
Sbjct: 171 GEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQ 212

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 67.9 bits (166), Expect = 8e-13
 Identities = 36/110 (32%), Positives = 53/110 (48%), Gaps = 12/110 (10%)

Query: 202 GCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK--L 259
           G L  D   +   +V   +  LH      ++H D+KPEN+L+D+     ++DFGLS+  L
Sbjct: 92  GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148

Query: 260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRR 309
            ++          GT  YLAPE IL  G  +  D +S G V+ E   G  
Sbjct: 149 ENKK-------FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYP 191

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 52/197 (26%), Positives = 97/197 (49%), Gaps = 14/197 (7%)

Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+ G  ++ T VAVK +       + F  E   + + QH  LVRL  Y VV 
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRL--YAVVT 71

Query: 169 GG-PRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDC 227
              P Y++ E++  GSL  ++     +S+    GG +        +  +A+ ++Y+    
Sbjct: 72  KEEPIYIITEYMAKGSLLDFL-----KSD---EGGKVLLPKLIDFSAQIAEGMAYIE--- 120

Query: 228 RSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQG 287
           R   +H D++  N+L+ E+    ++DFGL++++  ++       +    + APE I    
Sbjct: 121 RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 180

Query: 288 VSEKCDIYSYGMVLLEL 304
            + K D++S+G++L E+
Sbjct: 181 FTIKSDVWSFGILLYEI 197

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 67.4 bits (164), Expect = 1e-12
 Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 24/212 (11%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAAIAS-AQHVNLVRLLGYC 165
           L+G+G+   V+KG  +  G   A+K ++   + E+E + E+  +   + H N+    G  
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72

Query: 166 VVPGGP-----RYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           +    P      +LV EF   GS+   I  T         G  L  +    +  ++ + L
Sbjct: 73  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--------GNTLKEEWIAYICREILRGL 124

Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAP 280
           S+LH   + +V+H D+K +N+LL EN    + DFG+S  + R   R  T I GT  ++AP
Sbjct: 125 SHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAP 180

Query: 281 EWIL-----EQGVSEKCDIYSYGMVLLELTGG 307
           E I      +     K D++S G+  +E+  G
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 21/206 (10%)

Query: 108 LLGHGSSASVFKGILSDG----TSVAVKRINGEENGEK--EFRSEVAAIASAQHVNLVRL 161
           ++G G    V+ G L D        AVK +N   + E+  +F  E   +    H N++ L
Sbjct: 2   VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61

Query: 162 LGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALS 221
           LG C+   G   +V  ++++G L ++I     RSE H        DL     + VAK + 
Sbjct: 62  LGICLPSEGSPLVVLPYMKHGDLRNFI-----RSETHNP---TVKDL-IGFGLQVAKGME 112

Query: 222 YLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GYL 278
           YL +    + +H D+   N +LDE++   V+DFGL++ +   +   +    G +    ++
Sbjct: 113 YLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWM 169

Query: 279 APEWILEQGVSEKCDIYSYGMVLLEL 304
           A E +  Q  + K D++S+G++L EL
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWEL 195

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 25/203 (12%)

Query: 109 LGHGSSASVFKGIL-SDGTSVAVK--RINGEENGEKEFRSEVAAIASAQHVNLVRLLGYC 165
           +G G+   VF G L +D T VAVK  R     + + +F  E   +    H N+VRL+G C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
                P Y+V E +Q G      F T  R+EG      L      ++  + A  + YL +
Sbjct: 63  T-QKQPIYIVMELVQGGD-----FLTFLRTEGPR----LKVKELIQMVENAAAGMEYLES 112

Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILE 285
                 +H D+   N L+ E     +SDFG    MSR++   +    G    +  +W   
Sbjct: 113 KH---CIHRDLAARNCLVTEKNVLKISDFG----MSREEEDGVYASTGGMKQIPVKWTAP 165

Query: 286 QGV-----SEKCDIYSYGMVLLE 303
           + +     S + D++S+G++L E
Sbjct: 166 EALNYGRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 67.1 bits (164), Expect = 3e-12
 Identities = 38/95 (40%), Positives = 54/95 (56%), Gaps = 4/95 (4%)

Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR 272
           A ++A AL YLH+     +++ D+KPENILLD     V++DFGL K    + S+  +T  
Sbjct: 102 AAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFC 157

Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           GT  YLAPE + +Q      D +  G VL E+  G
Sbjct: 158 GTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 66.4 bits (162), Expect = 3e-12
 Identities = 54/237 (22%), Positives = 101/237 (42%), Gaps = 31/237 (13%)

Query: 107 ALLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKE-------FRSEVAAIASAQHVNL 158
             LG G+ +S ++   +  GT +AVK++    N   E        R E+  +A   H ++
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 159 VRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK 218
           +R+LG          L  E++  GS+ H +             G     +       + +
Sbjct: 66  IRMLG-ATCEDSHFNLFVEWMAGGSVSHLL----------SKYGAFKEAVIINYTEQLLR 114

Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSRDQSRC---ITTIRGT 274
            LSYLH +   +++H DVK  N+L+D   + + ++DFG +  ++   +        + GT
Sbjct: 115 GLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGT 171

Query: 275 RGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKI 331
             ++APE +  +     CD++S G V++E+   +          +K  N      KI
Sbjct: 172 IAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK-----PPWNAEKHSNHLALIFKI 223

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 36/102 (35%), Positives = 61/102 (59%), Gaps = 8/102 (7%)

Query: 211 RVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITT 270
           ++A+ + KAL YLH+  +  V+H DVKP N+L++ N +  + DFG+S  +    ++ I  
Sbjct: 107 KIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA 164

Query: 271 IRGTRGYLAPEWI----LEQGVSEKCDIYSYGMVLLELTGGR 308
             G + Y+APE I     ++G   K D++S G+ ++EL  GR
Sbjct: 165 --GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 68.3 bits (167), Expect = 4e-12
 Identities = 60/198 (30%), Positives = 92/198 (46%), Gaps = 27/198 (13%)

Query: 125 GTSVAVK--RING--EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ 180
           G  VA+K  R +   EE+    FR E A  A   H N+V LL     P G  + V+E++ 
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPEN 240
             +L           E   + G L      R+ + V  AL+  HN     ++H D+KP+N
Sbjct: 63  GRTL----------REVLAADGALPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQN 109

Query: 241 ILL---DENYRAVVSDFGLSKLMSRDQSRCITTIR------GTRGYLAPEWILEQGVSEK 291
           I++        A V DFG+  L+   +   + T+       GT  Y APE +  + V+  
Sbjct: 110 IMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPN 169

Query: 292 CDIYSYGMVLLE-LTGGR 308
            D+Y++G++ LE LTG R
Sbjct: 170 SDLYAWGLIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 66.8 bits (163), Expect = 4e-12
 Identities = 54/189 (28%), Positives = 89/189 (47%), Gaps = 25/189 (13%)

Query: 125 GTSVAVKRI----NGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ 180
           G +VA+K+I    +     ++ +R E+  +   +H N++ L    + P    Y V E + 
Sbjct: 35  GQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHENIISLSDIFISPLEDIYFVTELL- 92

Query: 181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPEN 240
               D     TSR  E  +        ++Y     + + L Y+H+   + V+H D+KP N
Sbjct: 93  --GTDLHRLLTSRPLEKQF--------IQY-FLYQILRGLKYVHS---AGVVHRDLKPSN 138

Query: 241 ILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGM 299
           IL++EN    + DFGL    +R Q   +T    TR Y APE +L  Q    + DI+S G 
Sbjct: 139 ILINENCDLKICDFGL----ARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGC 194

Query: 300 VLLELTGGR 308
           +  E+  G+
Sbjct: 195 IFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 66.0 bits (161), Expect = 5e-12
 Identities = 40/132 (30%), Positives = 71/132 (53%), Gaps = 15/132 (11%)

Query: 177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDV 236
           EF+  GSLD       ++      GG +  ++  ++A+ V + L+YL+N    R++H D+
Sbjct: 83  EFMDCGSLDR----IYKK------GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDI 130

Query: 237 KPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYS 296
           KP NIL++   +  + DFG+S  +    +    T  GT  Y++PE I     + K D++S
Sbjct: 131 KPSNILVNSRGQIKLCDFGVSGELINSIAD---TFVGTSTYMSPERIQGGKYTVKSDVWS 187

Query: 297 YGMVLLELTGGR 308
            G+ ++EL  G+
Sbjct: 188 LGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 65.9 bits (160), Expect = 5e-12
 Identities = 56/211 (26%), Positives = 99/211 (46%), Gaps = 23/211 (10%)

Query: 109 LGHGSSASVFKGIL------SDGTSVAVKRI-NGEENGEKEFRSEVAAIASAQHVNLVRL 161
           LG G+   VF           D   VAVK + +  +N  K+F  E   + + QH ++V+ 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 162 LGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGC---LSWDLRYRVAIDVAK 218
            G C V G P  +V+E++++G L+ ++      +     G     L+      +A  +A 
Sbjct: 73  YGVC-VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131

Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRC----ITTIRG 273
            + YL +      +H D+   N L+ EN    + DFG+S+ + S D  R     +  IR 
Sbjct: 132 GMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR- 187

Query: 274 TRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
              ++ PE I+ +  + + D++S G+VL E+
Sbjct: 188 ---WMPPESIMYRKFTTESDVWSLGVVLWEI 215

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 65.8 bits (161), Expect = 5e-12
 Identities = 73/302 (24%), Positives = 137/302 (45%), Gaps = 60/302 (19%)

Query: 109 LGHGSSASVFKGILSD------GTSVAVKRINGEENGEK--EFRSEVAAIASAQHVN-LV 159
           LG GS   V++G+          T VA+K +N   +  +  EF +E A++    + + +V
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNE-ASVMKEFNCHHVV 72

Query: 160 RLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYS--GGCLSWDLRYRVAIDVA 217
           RLLG  V  G P  +V E +  G L  ++   SRR E   +   G  +     ++A ++A
Sbjct: 73  RLLG-VVSTGQPTLVVMELMAKGDLKSYL--RSRRPEAENNPGLGPPTLQKFIQMAAEIA 129

Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM-SRDQSRCITTIRGTRG 276
             ++YL      + +H D+   N ++ E+    + DFG+++ +   D  R     +G +G
Sbjct: 130 DGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR-----KGGKG 181

Query: 277 YLAPEWI----LEQGV-SEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKI 331
            L   W+    L+ GV + K D++S+G+VL E+       +L E          Q +  +
Sbjct: 182 LLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEM------ATLAE----------QPYQGL 225

Query: 332 VNEK----MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM 387
            NE+    + +G  ++           + E    +L+++   C Q   ++RP+   +V  
Sbjct: 226 SNEEVLKFVIDGGHLD-----------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS 274

Query: 388 LE 389
           L+
Sbjct: 275 LK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 66.1 bits (161), Expect = 5e-12
 Identities = 47/135 (34%), Positives = 66/135 (48%), Gaps = 14/135 (10%)

Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           YLV  FI  G L H +     + EG +           R     A+ L  L N  +  V+
Sbjct: 69  YLVLAFINGGELFHHL-----QREGRFD--------LSRARFYTAELLCALENLHKFNVI 115

Query: 233 HLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKC 292
           + D+KPENILLD      + DFGL KL  +D  +   T  GT  YLAPE +L  G ++  
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK-TNTFCGTPEYLAPELLLGHGYTKAV 174

Query: 293 DIYSYGMVLLELTGG 307
           D ++ G++L E+  G
Sbjct: 175 DWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 65.2 bits (159), Expect = 6e-12
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 23/203 (11%)

Query: 109 LGHGS--SASVFKGILSDGTSVAVKRINGEENGEKEFR---SEVAAIASAQHVNLVRLLG 163
           LG G+   A++++    D + V  K +N     EKE R   +E+  ++  QH N++    
Sbjct: 8   LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66

Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL 223
           +  +      +  E+   G+L   I    R+    +    + W L       +  A+SY+
Sbjct: 67  H-FMDDNTLLIEMEYANGGTLYDKI---VRQKGQLFEEEMVLWYL-----FQIVSAVSYI 117

Query: 224 HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWI 283
           H   ++ +LH D+K  NI L +     + DFG+SK++  + S   T + GT  Y++PE  
Sbjct: 118 H---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPE-- 171

Query: 284 LEQGVS--EKCDIYSYGMVLLEL 304
           L QGV    K DI++ G VL EL
Sbjct: 172 LCQGVKYNFKSDIWALGCVLYEL 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 65.7 bits (161), Expect = 6e-12
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 31/210 (14%)

Query: 107 ALLGHGSSASVFKGI-LSDGTSVAVKRI-NGEENGEKE------FRSEVAAIASAQHVNL 158
             LG G+ A V+K      G  VA+K+I  GE    K+       R E+  +   +H N+
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR-EIKLLQELKHPNI 64

Query: 159 VRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRR-SEGHYSGGCLSWDLRYRVAIDVA 217
           + LL           LV+EF++   L+  I   S   +         S+       +   
Sbjct: 65  IGLLD-VFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIK----SY------MLMTL 112

Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGY 277
           + L YLH    + +LH D+KP N+L+  +    ++DFGL++      +R +T    TR Y
Sbjct: 113 RGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFG-SPNRKMTHQVVTRWY 168

Query: 278 LAPEWIL---EQGVSEKCDIYSYGMVLLEL 304
            APE +      GV    D++S G +  EL
Sbjct: 169 RAPELLFGARHYGVG--VDMWSVGCIFAEL 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 65.7 bits (160), Expect = 8e-12
 Identities = 45/120 (37%), Positives = 68/120 (56%), Gaps = 17/120 (14%)

Query: 200 SGGCLSWDLRY--RVAIDVAK--------ALSYLHNDCRSRVLHLDVKPENILLDENYRA 249
           SGG L W L+   R + D AK        AL +LH   +  +++ D+KPENILLD     
Sbjct: 79  SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHI 135

Query: 250 VVSDFGLSKL-MSRDQSRCITTIRGTRGYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGG 307
            + DFGLSK  ++ +++    T  GT  YLAPE +L E+G ++  D +S G+++ E+  G
Sbjct: 136 ALCDFGLSKANLTDNKT--TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 65.8 bits (160), Expect = 8e-12
 Identities = 58/191 (30%), Positives = 89/191 (46%), Gaps = 22/191 (11%)

Query: 123 SDGTSVAVKRINGEENGEKEFRSEVAA-----IASAQHVNLVRLLGYCVVPGGPRYLVYE 177
           SDG+  AVK +  +   +K+ ++ + A     + + +H  LV L  Y        Y V +
Sbjct: 18  SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL-HYSFQTAEKLYFVLD 76

Query: 178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRV-AIDVAKALSYLHNDCRSRVLHLDV 236
           ++  G L    F   R         C   + R R  A +VA A+ YLH+     +++ D+
Sbjct: 77  YVNGGEL---FFHLQRER-------CFL-EPRARFYAAEVASAIGYLHS---LNIIYRDL 122

Query: 237 KPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYS 296
           KPENILLD     V++DFGL K    +     +T  GT  YLAPE + ++      D + 
Sbjct: 123 KPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWC 181

Query: 297 YGMVLLELTGG 307
            G VL E+  G
Sbjct: 182 LGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 65.8 bits (160), Expect = 8e-12
 Identities = 50/140 (35%), Positives = 65/140 (46%), Gaps = 24/140 (17%)

Query: 173 YLVYEFIQNGSL-----DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDC 227
           Y V +F+  G L         FP  R               R+  A ++A AL YLH+  
Sbjct: 72  YFVLDFVNGGELFFHLQRERSFPEPRA--------------RFYAA-EIASALGYLHS-- 114

Query: 228 RSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQG 287
              +++ D+KPENILLD     V++DFGL K     QS   TT  GT  YLAPE I +Q 
Sbjct: 115 -INIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQP 172

Query: 288 VSEKCDIYSYGMVLLELTGG 307
                D +  G VL E+  G
Sbjct: 173 YDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 65.1 bits (158), Expect = 9e-12
 Identities = 56/202 (27%), Positives = 98/202 (48%), Gaps = 19/202 (9%)

Query: 109 LGHGSSASVFKGILSDGTSV-AVKRINGEENGEK--EFRSEVAAIASAQHVNLVRLLGYC 165
           +G GS   V+KGI +    V A+K I+ EE  ++  + + E+  ++      + R  G  
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG-S 70

Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
            + G   +++ E++  GS    + P      G      ++  LR     ++ K L YLH+
Sbjct: 71  YLKGTKLWIIMEYLGGGSALDLLKP------GPLEETYIATILR-----EILKGLDYLHS 119

Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILE 285
           +   R +H D+K  N+LL E     ++DFG++  ++  Q +   T  GT  ++APE I +
Sbjct: 120 E---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK-RNTFVGTPFWMAPEVIKQ 175

Query: 286 QGVSEKCDIYSYGMVLLELTGG 307
                K DI+S G+  +EL  G
Sbjct: 176 SAYDFKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 65.1 bits (158), Expect = 9e-12
 Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 21/209 (10%)

Query: 109 LGHGSSASVF----KGILSDG--TSVAVKRINGEENGEK--EFRSEVAAIASAQHVNLVR 160
           LG GS   V+    KG++ D   T VA+K +N   +  +  EF +E + +      ++VR
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG  V  G P  ++ E +  G L  ++       E +      S     ++A ++A  +
Sbjct: 74  LLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAP 280
           +YL+ +   + +H D+   N ++ E++   + DFG    M+RD        +G +G L  
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPV 185

Query: 281 EWI----LEQGV-SEKCDIYSYGMVLLEL 304
            W+    L+ GV +   D++S+G+VL E+
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 54/222 (24%), Positives = 101/222 (45%), Gaps = 33/222 (14%)

Query: 109 LGHGSSASVFKGI------LSDGTSVAVKRINGEENGEKEFR---SEVAAIASAQHVNLV 159
           LG G    V K         +  T+VAVK +  E     E R   SE   +    H +++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK-ENASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 160 RLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRY-----RVAI 214
           +L G C    GP  L+ E+ + GSL  ++   SR+    Y G   + +  Y       A+
Sbjct: 67  KLYGACS-QDGPLLLIVEYAKYGSLRSFL-RESRKVGPSYLGSDGNRNSSYLDNPDERAL 124

Query: 215 DVAKALSYLHNDCRS-------RVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC 267
            +   +S+     R        +++H D+   N+L+ E  +  +SDFGLS+ +  + S  
Sbjct: 125 TMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS-- 182

Query: 268 ITTIRGTRG-----YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
              ++ ++G     ++A E + +   + + D++S+G++L E+
Sbjct: 183 --YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 222

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 63/227 (27%), Positives = 104/227 (45%), Gaps = 27/227 (11%)

Query: 96  KELEEATDNFQAL--LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAAIAS 152
           + L + TD ++ +  +G G+   V+K     DG+  AVK ++   + ++E  +E   + S
Sbjct: 15  ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQS 74

Query: 153 -AQHVNLVRLLG------YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLS 205
              H N+V+  G        V  GG  +LV E    GS+   +            G  L 
Sbjct: 75  LPNHPNVVKFYGMFYKADKLV--GGQLWLVLELCNGGSVTELVKGLLIC------GQRLD 126

Query: 206 WDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQS 265
             +   +       L +LHN+   R++H DVK  NILL       + DFG+S  ++  + 
Sbjct: 127 EAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 183

Query: 266 RCITTIRGTRGYLAPEWI-LEQ----GVSEKCDIYSYGMVLLELTGG 307
           R  T++ GT  ++APE I  EQ        +CD++S G+  +EL  G
Sbjct: 184 RRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 64.9 bits (158), Expect = 1e-11
 Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 33/225 (14%)

Query: 97  ELEEATDNFQALLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKE-FRSEVAAIASAQ 154
           E E   +  + +LG G+   V+    LS    +A+K I   ++   +    E+A  +  +
Sbjct: 4   EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLK 63

Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWI------FPTSRRSEGHYSGGCLSWDL 208
           H N+V+ LG      G   +  E +  GSL   +         + ++   Y+   L    
Sbjct: 64  HRNIVQYLG-SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL---- 118

Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVV--SDFGLSKLMSRDQSR 266
                    + L YLH++   +++H D+K +N+L++  Y  VV  SDFG SK ++   + 
Sbjct: 119 ---------EGLKYLHDN---QIVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAG-INP 164

Query: 267 CITTIRGTRGYLAPEWILEQGV---SEKCDIYSYGMVLLELTGGR 308
           C  T  GT  Y+APE ++++G        DI+S G  ++E+  G+
Sbjct: 165 CTETFTGTLQYMAPE-VIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 60/231 (25%), Positives = 93/231 (40%), Gaps = 64/231 (27%)

Query: 108 LLGHGSSASVFKGILSD-GTSVAVKRINGEENG--EKEFRSEVAAIASAQH-VNLVRLLG 163
            +G G+  +V K +    GT +AVKRI    +   +K    ++  +  +     +V+  G
Sbjct: 11  EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70

Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGC-----LSWDLRYR------- 211
                G               D WI              C     +S D  Y+       
Sbjct: 71  ALFREG---------------DCWI--------------CMELMDISLDKFYKYVYEVLK 101

Query: 212 ----------VAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS-KLM 260
                     +A+   KAL+YL  + +  ++H DVKP NILLD N    + DFG+S +L+
Sbjct: 102 SVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159

Query: 261 SRDQSRCITTIRGTRGYLAPEWIL---EQGVSEKCDIYSYGMVLLELTGGR 308
               S   T   G R Y+APE I      G   + D++S G+ L E+  G+
Sbjct: 160 ---DSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 25/213 (11%)

Query: 109 LGHGSSASVFKGILS------DGTSVAVKRI-NGEENGEKEFRSEVAAIASAQHVNLVRL 161
           LG G+   VF           D   VAVK +    E+  ++F+ E   +   QH ++VR 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 162 LGYCVVPGGPRYLVYEFIQNGSLDHWIF---PTSRRSEGHYSGGC--LSWDLRYRVAIDV 216
            G C   G P  +V+E++++G L+ ++    P ++   G        L+      +A  +
Sbjct: 73  YGVCT-EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK-LMSRDQ----SRCITTI 271
           A  + YL +      +H D+   N L+ +     + DFG+S+ + S D      R +  I
Sbjct: 132 ASGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188

Query: 272 RGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           R    ++ PE IL +  + + DI+S+G+VL E+
Sbjct: 189 R----WMPPESILYRKFTTESDIWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 64.1 bits (157), Expect = 2e-11
 Identities = 60/221 (27%), Positives = 90/221 (40%), Gaps = 47/221 (21%)

Query: 104 NFQALLGHGSSASVFKGILSDGTSV-AVKRINGEE----------NGEKEFRSEVAAIAS 152
            F   LG GS   V            A+K ++  +            EK     +     
Sbjct: 4   EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI----- 58

Query: 153 AQHVNLVRLLG------YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSW 206
            +H  LV L G               YLV E++  G L   +     R  G +       
Sbjct: 59  -RHPFLVNLYGSFQDDSNL-------YLVMEYVPGGELFSHL-----RKSGRFP---EPV 102

Query: 207 DLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSR 266
              Y  A  V  AL YLH+     +++ D+KPEN+LLD +    ++DFG +K   R + R
Sbjct: 103 ARFY--AAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK---RVKGR 154

Query: 267 CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
              T+ GT  YLAPE IL +G  +  D ++ G+++ E+  G
Sbjct: 155 T-YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 55/203 (27%), Positives = 99/203 (48%), Gaps = 21/203 (10%)

Query: 109 LGHGSSASVFKGILSDGTSV-AVKRINGEENGEK--EFRSEVAAIASAQHVNLVRLLGYC 165
           +G GS   VFKGI +    V A+K I+ EE  ++  + + E+  ++      + +  G  
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG-S 70

Query: 166 VVPGGPRYLVYEFIQNGS-LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH 224
            + G   +++ E++  GS LD           G +    ++  L+     ++ K L YLH
Sbjct: 71  YLKGTKLWIIMEYLGGGSALD-------LLRAGPFDEFQIATMLK-----EILKGLDYLH 118

Query: 225 NDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWIL 284
           ++   + +H D+K  N+LL E     ++DFG++  ++  Q +   T  GT  ++APE I 
Sbjct: 119 SE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK-RNTFVGTPFWMAPEVIQ 174

Query: 285 EQGVSEKCDIYSYGMVLLELTGG 307
           +     K DI+S G+  +EL  G
Sbjct: 175 QSAYDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 30/209 (14%)

Query: 108 LLGHGSSASVFKGI-LSDGTS----VAVK--RINGEENGEKEFRSEVAAIASAQHVNLVR 160
           +LG G+  +V+KGI + DG +    VA+K  R N      KE   E   +A      + R
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG C+       LV + +  G L  ++     R         L+W       + +AK +
Sbjct: 74  LLGICLT--STVQLVTQLMPYGCLLDYVRENKDRIGSQD---LLNW------CVQIAKGM 122

Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG---- 276
           SYL      R++H D+   N+L+       ++DFGL++L+  D+    T      G    
Sbjct: 123 SYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE----TEYHADGGKVPI 175

Query: 277 -YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            ++A E IL +  + + D++SYG+ + EL
Sbjct: 176 KWMALESILHRRFTHQSDVWSYGVTVWEL 204

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 52/193 (26%), Positives = 93/193 (48%), Gaps = 24/193 (12%)

Query: 128 VAVK--RINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLD 185
           VAVK  R +  +N   +F  EV  ++  +  N++RLLG C V   P  ++ E+++NG L+
Sbjct: 49  VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVC-VDEDPLCMITEYMENGDLN 107

Query: 186 HWIFP------TSRRSEGHYSGGCL---SWDLRYRVAIDVAKALSYLHNDCRSRVLHLDV 236
            ++            ++      CL   S+     VA+ +A  + YL +      +H D+
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDL 164

Query: 237 KPENILLDENYRAVVSDFGLSKLM-----SRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
              N L+ EN    ++DFG+S+ +      R Q R +  IR    ++A E IL    +  
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIR----WMAWECILMGKFTTA 220

Query: 292 CDIYSYGMVLLEL 304
            D++++G+ L E+
Sbjct: 221 SDVWAFGVTLWEI 233

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 55/218 (25%), Positives = 101/218 (46%), Gaps = 30/218 (13%)

Query: 105 FQALLGHGSSASVFKGILS-DGT--SVAVKRIN--GEENGEKEFRSEVAAIAS-AQHVNL 158
           F+ ++G G+   V + ++  DG   + A+K +     EN  ++F  E+  +     H N+
Sbjct: 6   FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65

Query: 159 VRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEG-------HYSGGCLSWDLRYR 211
           + LLG C    G  Y+  E+   G+L  ++   SR  E        H +   L+     +
Sbjct: 66  INLLGACE-NRGYLYIAIEYAPYGNLLDFL-RKSRVLETDPAFAKEHGTASTLTSQQLLQ 123

Query: 212 VAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTI 271
            A DVA  + YL      + +H D+   N+L+ EN  + ++DFGLS+            +
Sbjct: 124 FASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSRGEE-------VYV 173

Query: 272 RGTRGYLAPEWILEQGV-----SEKCDIYSYGMVLLEL 304
           + T G L   W+  + +     + K D++S+G++L E+
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEI 211

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 55/212 (25%), Positives = 94/212 (44%), Gaps = 22/212 (10%)

Query: 102 TDNF--QALLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRS----EVAAIASAQ 154
             NF  +  +G G  + V+K I L DG  VA+K++   E  + + R     E+  +    
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWI--FPTSRRSEGHYSGGCLSWDLRYRV 212
           H N+++ L    +      +V E    G L   I  F   +R     +     W    ++
Sbjct: 61  HPNVIKYLA-SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERT----IWKYFVQL 115

Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR 272
                 AL ++H+    R++H D+KP N+ +       + D GL +  S   +   + + 
Sbjct: 116 C----SALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV- 167

Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           GT  Y++PE I E G + K DI+S G +L E+
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 25/209 (11%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRIN-GEENGEKEFRSEVAAIASAQHVNLVRLLGYCV 166
           LG G+   V+K      G   A K I    E   ++F  E+  ++  +H N+V L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYE-AY 71

Query: 167 VPGGPRYLVYEFIQNGSLDHWIFPTSRR-SEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
                 +++ EF   G+LD  +    R  +E           +RY V   + +AL++LH+
Sbjct: 72  FYENKLWILIEFCDGGALDSIMLELERGLTEPQ---------IRY-VCRQMLEALNFLHS 121

Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLS-KLMSRDQSRCITTIRGTRGYLAPEWIL 284
               +V+H D+K  NILL  +    ++DFG+S K  S  Q R   T  GT  ++APE + 
Sbjct: 122 H---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR--DTFIGTPYWMAPEVVA 176

Query: 285 EQGVSE-----KCDIYSYGMVLLELTGGR 308
            +   +     K DI+S G+ L+EL    
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIELAQME 205

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 50/191 (26%), Positives = 98/191 (51%), Gaps = 18/191 (9%)

Query: 126 TSVAVKRI--NGEENGEKEFRSEVAAIAS-AQHVNLVRLLGYCVVPGGPRYLVYEFIQNG 182
            +VAVK +  +  +    +  SE+  +    +H N++ LLG C    GP Y++ E+   G
Sbjct: 45  VTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT-QDGPLYVLVEYASKG 103

Query: 183 SLDHWIFPTSRRSEG-HYS-GGC------LSWDLRYRVAIDVAKALSYLHNDCRSRVLHL 234
           +L  ++   +RR  G  YS   C      L++      A  VA+ + YL +    + +H 
Sbjct: 104 NLREYL--RARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHR 158

Query: 235 DVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCD 293
           D+   N+L+ E+    ++DFGL++ + + D  +  T  R    ++APE + ++  + + D
Sbjct: 159 DLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 218

Query: 294 IYSYGMVLLEL 304
           ++S+G++L E+
Sbjct: 219 VWSFGVLLWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 52/213 (24%), Positives = 101/213 (47%), Gaps = 14/213 (6%)

Query: 97  ELEEATDNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHV 156
           E+   +   +  LG G    V+    +  T VAVK +       + F +E   + + QH 
Sbjct: 2   EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD 61

Query: 157 NLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDV 216
            LV+L  + VV   P Y++ EF+  GSL  ++    +  EG         D     +  +
Sbjct: 62  KLVKL--HAVVTKEPIYIITEFMAKGSLLDFL----KSDEGSKQPLPKLIDF----SAQI 111

Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG 276
           A+ ++++    +   +H D++  NIL+  +    ++DFGL++++  ++       +    
Sbjct: 112 AEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK 168

Query: 277 YLAPEWILEQGVSEKCDIYSYGMVLLEL-TGGR 308
           + APE I     + K D++S+G++L+E+ T GR
Sbjct: 169 WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 62.6 bits (152), Expect = 5e-11
 Identities = 53/194 (27%), Positives = 93/194 (47%), Gaps = 22/194 (11%)

Query: 122 LSDGTSVAVKRINGEENGEKE---FRSEVAAIASAQHVNLVRLLGY--CVVPGGPRYLVY 176
            +D   V +K+I  E+  + E    ++E   +    H N++    Y    +      +V 
Sbjct: 22  KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNII---EYYENFLEDKALMIVM 78

Query: 177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDV 236
           E+   G+L  +I    R +        L  D      + +  AL ++H      +LH D+
Sbjct: 79  EYAPGGTLAEYI--QKRCNS------LLDEDTILHFFVQILLALHHVHT---KLILHRDL 127

Query: 237 KPENILLDENYRAV-VSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIY 295
           K +NILLD++   V + DFG+SK++S  +S+  T + GT  Y++PE    +  ++K DI+
Sbjct: 128 KTQNILLDKHKMVVKIGDFGISKILS-SKSKAYTVV-GTPCYISPELCEGKPYNQKSDIW 185

Query: 296 SYGMVLLELTGGRR 309
           + G VL EL   +R
Sbjct: 186 ALGCVLYELASLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 63.1 bits (153), Expect = 5e-11
 Identities = 62/259 (23%), Positives = 112/259 (43%), Gaps = 50/259 (19%)

Query: 109 LGHGSSASVFKG------ILSDGTSVAVKRINGEE-NGEKEFRSEVAAIASAQHVNLVRL 161
           LG G+   VF           D   VAVK +        K+F+ E   + + QH ++V+ 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 162 LGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEG-----------HYSGGCLSWDLRY 210
            G C   G P  +V+E++++G L+ ++     R+ G             + G L      
Sbjct: 73  YGVCG-DGDPLIMVFEYMKHGDLNKFL-----RAHGPDAMILVDGQPRQAKGELGLSQML 126

Query: 211 RVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRC-- 267
            +A  +A  + YL +      +H D+   N L+  N    + DFG+S+ + S D  R   
Sbjct: 127 HIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG 183

Query: 268 --ITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKW 325
             +  IR    ++ PE I+ +  + + D++S+G++L E         +  +G    K  W
Sbjct: 184 HTMLPIR----WMPPESIMYRKFTTESDVWSFGVILWE---------IFTYG----KQPW 226

Query: 326 -QYFPKIVNEKMKEGKLME 343
            Q     V E + +G+++E
Sbjct: 227 FQLSNTEVIECITQGRVLE 245

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 62.8 bits (153), Expect = 5e-11
 Identities = 58/220 (26%), Positives = 101/220 (45%), Gaps = 34/220 (15%)

Query: 108 LLGHGSSASVFKGILSD------GTSVAVKRINGEENGEKEFR---SEVAAIAS-AQHVN 157
            LG G+   V K            ++VAVK +  +   EK+     SE+  +    +H N
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKN 77

Query: 158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY--------SGGCLSWDLR 209
           ++ LLG C    GP Y+V E+  +G+L    F  +RR  G Y            L+    
Sbjct: 78  IINLLGVCT-QEGPLYVVVEYAAHGNLRD--FLRARRPPGEYASPDDPRPPEETLTQKDL 134

Query: 210 YRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT 269
              A  VA+ + +L +    + +H D+   N+L+ E++   ++DFGL    +RD      
Sbjct: 135 VSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGL----ARDIHHIDY 187

Query: 270 TIRGTRGYL-----APEWILEQGVSEKCDIYSYGMVLLEL 304
             + T G L     APE + ++  + + D++S+G++L E+
Sbjct: 188 YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 227

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 62.9 bits (153), Expect = 6e-11
 Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 34/216 (15%)

Query: 105 FQALLGHGSSASVFK----GILSDGTS--VAVKRINGEENGEKEFRSEVAAIAS------ 152
           F   LG G+   V +    G+        VAVK +           SE  A+ S      
Sbjct: 39  FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLK-----PTAHSSEREALMSELKIMS 93

Query: 153 --AQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRY 210
               H N+V LLG C + GGP  ++ E+   G L +++    R+ E   +      DL  
Sbjct: 94  HLGNHENIVNLLGACTI-GGPILVITEYCCYGDLLNFL---RRKRESFLT----LEDL-L 144

Query: 211 RVAIDVAKALSYLHN-DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT 269
             +  VAK +++L + +C    +H D+   N+LL       + DFGL++ +  D +  + 
Sbjct: 145 SFSYQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVK 200

Query: 270 -TIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
              R    ++APE I     + + D++SYG++L E+
Sbjct: 201 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 62.7 bits (152), Expect = 6e-11
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 23/211 (10%)

Query: 109 LGHGSSASVFKGILS--DGTSVAVKRINGEENGEKEFRSEVAAI-ASAQHVNLVRLLGYC 165
           +G G+   VFK +L+  +G+  AVK ++   + ++E  +E   + A + H N+V+  G  
Sbjct: 26  IGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84

Query: 166 ----VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALS 221
               V  G   +LV E    GS+   +    +R E       +   +   +  +    L 
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGER------MEEPIIAYILHEALMGLQ 138

Query: 222 YLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPE 281
           +LH +   + +H DVK  NILL       + DFG+S  ++  + R  T++ GT  ++APE
Sbjct: 139 HLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPE 194

Query: 282 WI-----LEQGVSEKCDIYSYGMVLLELTGG 307
            I     L+     +CD++S G+  +EL  G
Sbjct: 195 VIACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 62.7 bits (152), Expect = 7e-11
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)

Query: 108 LLGHGSSASVFKGI-LSDGTS----VAVK--RINGEENGEKEFRSEVAAIASAQHVNLVR 160
           +LG G+  +V+KG+ + +G      VA+K  R        KE   E   +AS  + ++ R
Sbjct: 14  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 73

Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG C+       L+ + +  G L  ++          Y    L+W       + +AK +
Sbjct: 74  LLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQY---LLNW------CVQIAKGM 122

Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GY 277
           +YL      R++H D+   N+L+       ++DFGL+KL+  D+        G +    +
Sbjct: 123 NYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE--YHAEGGKVPIKW 177

Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +A E IL +  + + D++SYG+ + EL
Sbjct: 178 MALESILHRIYTHQSDVWSYGVTVWEL 204

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 61.9 bits (150), Expect = 7e-11
 Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 20/202 (9%)

Query: 109 LGHGSSASVF--KGILSDGTSVAVKRINGEENGEKE---FRSEVAAIASAQHVNLVRLLG 163
           +G GS   ++  K   SD     +K I+  +   KE    + EV  +A  +H N+V    
Sbjct: 8   IGEGSFGKIYLAKA-KSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66

Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL 223
                 G  ++V E+   G L   I    +R         LSW       + ++  L ++
Sbjct: 67  -SFQENGRLFIVMEYCDGGDLMKRI--NRQRGVLFSEDQILSW------FVQISLGLKHI 117

Query: 224 HNDCRSRVLHLDVKPENILLDENYR-AVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEW 282
           H+    ++LH D+K +NI L +N   A + DFG+++ ++ D      T  GT  YL+PE 
Sbjct: 118 HD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTPYYLSPEI 173

Query: 283 ILEQGVSEKCDIYSYGMVLLEL 304
              +  + K DI+S G VL EL
Sbjct: 174 CQNRPYNNKTDIWSLGCVLYEL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 62.7 bits (152), Expect = 8e-11
 Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 37/223 (16%)

Query: 99  EEATDNFQAL--LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHV 156
           E   D+F+ +  LG G+   VFK +    + + + R        K    E+      Q +
Sbjct: 1   ELKDDDFEKISELGAGNGGVVFK-VSHKPSGLIMAR--------KLIHLEIKPAIRNQII 51

Query: 157 NLVRLLGYCVVP-----------GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLS 205
             +++L  C  P            G   +  E +  GSLD  +    R  E         
Sbjct: 52  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--------- 102

Query: 206 WDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQS 265
             +  +V+I V K L+YL    + +++H DVKP NIL++      + DFG+S  +    +
Sbjct: 103 -QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 159

Query: 266 RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
               +  GTR Y++PE +     S + DI+S G+ L+E+  GR
Sbjct: 160 ---NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 62.3 bits (151), Expect = 9e-11
 Identities = 50/192 (26%), Positives = 96/192 (50%), Gaps = 20/192 (10%)

Query: 126 TSVAVKRINGEENGEKEFRSEVAAIAS----AQHVNLVRLLGYCVVPGGPRYLVYEFIQN 181
           T VAVK +  +   EK+    ++ +       +H N++ LLG C    GP Y++ E+   
Sbjct: 51  TKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASK 108

Query: 182 GSLDHWIFPTSRRSEGH---YSGGC-----LSWDLRYRVAIDVAKALSYLHNDCRSRVLH 233
           G+L  ++   +RR  G    Y+        LS+      A  VA+ + YL +    + +H
Sbjct: 109 GNLREYL--RARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIH 163

Query: 234 LDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIRGTRGYLAPEWILEQGVSEKC 292
            D+   N+L+ E+    ++DFGL++ +   D  +  T  R    ++APE + ++  + + 
Sbjct: 164 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 223

Query: 293 DIYSYGMVLLEL 304
           D++S+G++L E+
Sbjct: 224 DVWSFGVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 62.1 bits (152), Expect = 9e-11
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 30/206 (14%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRS----EVAAIASAQHVNLVRLLG 163
           LG G+   V+K      G  VA+K+I  + N E+   S    E++ +   +H N+V+LL 
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLD-NEEEGIPSTALREISLLKELKHPNIVKLL- 64

Query: 164 YCVVPGGPR-YLVYEFIQNGSLDHWIFPTSRRSEGHYSGG---CLSWDLRYRVAIDVAKA 219
             V+    + YLV+E+     L  ++     +  G  S      + + L         + 
Sbjct: 65  -DVIHTERKLYLVFEYCDM-DLKKYL----DKRPGPLSPNLIKSIMYQL--------LRG 110

Query: 220 LSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLA 279
           L+Y H     R+LH D+KP+NIL++ +    ++DFGL++       R  T    T  Y A
Sbjct: 111 LAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP-LRTYTHEVVTLWYRA 166

Query: 280 PEWIL-EQGVSEKCDIYSYGMVLLEL 304
           PE +L  +  S   DI+S G +  E+
Sbjct: 167 PEILLGSKHYSTAVDIWSVGCIFAEM 192

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 19/208 (9%)

Query: 109 LGHGSSASVFKGILSDGTS---VAVK--RINGEENGEKE-FRSEVAAIASAQHVNLVRLL 162
           LG G   SV +G L+   S   VAVK  +I      E E F SE   +    H N++RL+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 163 GYCVV----PGGPRYLV-YEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
           G C+      G P  +V   F+++G L  ++  +       Y    L   +  +   D+A
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQY----LPTQMLVKFMTDIA 122

Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS-KLMSRDQSRCITTIRGTRG 276
             + YL +      +H D+   N +L+EN    V+DFGLS K+ + D  R     +    
Sbjct: 123 SGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179

Query: 277 YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           ++A E + ++  + K D++S+G+ + E+
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEI 207

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 61.8 bits (151), Expect = 1e-10
 Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 44/217 (20%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRS--------EVAAIASAQ-HVNL 158
           LG G+  SV+       G  VA+K++       K+F S        EV ++     H N+
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMK------KKFYSWEECMNLREVKSLRKLNEHPNI 60

Query: 159 VRLL-----GYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVA 213
           V+L         +      Y V+E++  G+L   +    R+      G   S  +   + 
Sbjct: 61  VKLKEVFRENDEL------YFVFEYM-EGNLYQLM--KDRK------GKPFSESVIRSII 105

Query: 214 IDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIR 272
             + + L+++H   +    H D+KPEN+L+       ++DFGL++ + SR      T   
Sbjct: 106 YQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP---YTDYV 159

Query: 273 GTRGYLAPEWILEQGV-SEKCDIYSYGMVLLELTGGR 308
            TR Y APE +L     S   DI++ G ++ EL   R
Sbjct: 160 STRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 27/212 (12%)

Query: 109 LGHGSSASVFKGILS--DGTS----VAVKRI--NGEENGEKEFRSEVAAIASAQHVNLVR 160
           LGHG+   V++G+    DG +    VAVK +  +  E  E +F  E   ++   H N+VR
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73

Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           L+G       PR+++ E +  G L  ++   +R      S   +  DL    A DVAK  
Sbjct: 74  LIGVS-FERLPRFILLELMAGGDLKSFL-RENRPRPERPSSLTMK-DL-LFCARDVAKGC 129

Query: 221 SYLHNDCRSRVLHLDVKPENILLD---ENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGY 277
            YL     +  +H D+   N LL        A ++DFG    M+RD  R     +G R  
Sbjct: 130 KYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFG----MARDIYRASYYRKGGRAM 182

Query: 278 L-----APEWILEQGVSEKCDIYSYGMVLLEL 304
           L      PE  L+   + K D++S+G++L E+
Sbjct: 183 LPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 37/95 (38%), Positives = 54/95 (56%), Gaps = 4/95 (4%)

Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR 272
           A ++A AL YLH+     +++ D+KPENILLD     V++DFGL K  + + +   +T  
Sbjct: 102 AAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFC 157

Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           GT  YLAPE + +Q      D +  G VL E+  G
Sbjct: 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 32/92 (34%), Positives = 54/92 (58%), Gaps = 4/92 (4%)

Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGY 277
           + L YLH+   + +LH D+KP N+L++ N    + DFGL+++   D+S+ +T    T+ Y
Sbjct: 114 RGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170

Query: 278 LAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
            APE ++  +  +   DI+S G +  EL G R
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 34/215 (15%)

Query: 109 LGHGSSASVFKGILSDGTSVA---VKRINGEENGEKE--FRSEVAAIASAQHVNLVRLLG 163
           +G+G    V  G    G S A   VK +      +++  F  EV       H N+++ LG
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL 223
            C +   P  LV EF   G L +++    R + G  +      D+  R+A +VA  L +L
Sbjct: 63  QC-IESIPYLLVLEFCPLGDLKNYL----RSNRGMVAQMAQK-DVLQRMACEVASGLLWL 116

Query: 224 HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITT-------IRGTRG 276
           H   ++  +H D+   N  L  +    + D+GL+  + +       T       +R    
Sbjct: 117 H---QADFIHSDLALRNCQLTADLSVKIGDYGLA--LEQYPEDYYITKDCHAVPLR---- 167

Query: 277 YLAPEWILEQG-------VSEKCDIYSYGMVLLEL 304
           +LAPE +  +G        ++K +I+S G+ + EL
Sbjct: 168 WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 41/132 (31%), Positives = 67/132 (50%), Gaps = 15/132 (11%)

Query: 177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDV 236
           E +  GSLD  +    R  E          ++  +V+I V + L+YL    + +++H DV
Sbjct: 83  EHMDGGSLDQVLKEAKRIPE----------EILGKVSIAVLRGLAYLRE--KHQIMHRDV 130

Query: 237 KPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYS 296
           KP NIL++      + DFG+S  +    +    +  GTR Y++PE +     S + DI+S
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPERLQGTHYSVQSDIWS 187

Query: 297 YGMVLLELTGGR 308
            G+ L+EL  GR
Sbjct: 188 MGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 60.3 bits (146), Expect = 3e-10
 Identities = 49/187 (26%), Positives = 92/187 (49%), Gaps = 21/187 (11%)

Query: 125 GTSVAVKRINGEENGEK--EFRSEVAAIASAQHVNLVRLLGYCVVPGGPRY-LVYEFIQN 181
           G  VAVK +  E  G    + + E+  + +  H N+V+  G C   GG    L+ EF+ +
Sbjct: 33  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92

Query: 182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENI 241
           GSL  ++     R++   +   L   L+Y  A+ + K + YL +    + +H D+   N+
Sbjct: 93  GSLKEYL----PRNKNKIN---LKQQLKY--AVQICKGMDYLGS---RQYVHRDLAARNV 140

Query: 242 LLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG----YLAPEWILEQGVSEKCDIYSY 297
           L++  ++  + DFGL+K +  D+     T++        + APE +++       D++S+
Sbjct: 141 LVESEHQVKIGDFGLTKAIETDKE--YYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSF 198

Query: 298 GMVLLEL 304
           G+ L EL
Sbjct: 199 GVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 60.1 bits (145), Expect = 4e-10
 Identities = 52/202 (25%), Positives = 91/202 (45%), Gaps = 19/202 (9%)

Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEF---RSEVAAIASAQHVNLVRLLGYC 165
           +G GS   VFKGI +    V   +I   E  E E    + E+  ++      + +  G  
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG-S 70

Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
            +     +++ E++  GS    + P           G L       +  ++ K L YLH+
Sbjct: 71  YLKDTKLWIIMEYLGGGSALDLLEP-----------GPLDETQIATILREILKGLDYLHS 119

Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILE 285
           +   + +H D+K  N+LL E+    ++DFG++  ++  Q +   T  GT  ++APE I +
Sbjct: 120 E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNTFVGTPFWMAPEVIKQ 175

Query: 286 QGVSEKCDIYSYGMVLLELTGG 307
                K DI+S G+  +EL  G
Sbjct: 176 SAYDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 60.5 bits (147), Expect = 4e-10
 Identities = 31/98 (31%), Positives = 56/98 (57%), Gaps = 5/98 (5%)

Query: 211 RVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITT 270
           +++I V + L+YL    + +++H DVKP NIL++      + DFG+S  +    +    +
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NS 157

Query: 271 IRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
             GTR Y++PE +     + + DI+S G+ L+E+  GR
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 60.4 bits (147), Expect = 4e-10
 Identities = 34/94 (36%), Positives = 54/94 (57%), Gaps = 6/94 (6%)

Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS--RDQSRCITTIRGTR 275
           + L Y+H+   + VLH D+KP N+LL+ N    + DFGL+++     D +  +T    TR
Sbjct: 117 RGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173

Query: 276 GYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L  +G ++  DI+S G +L E+   R
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 60.4 bits (146), Expect = 4e-10
 Identities = 48/193 (24%), Positives = 97/193 (50%), Gaps = 18/193 (9%)

Query: 124 DGTSVAVKRI--NGEENGEKEFRSEVAAIAS-AQHVNLVRLLGYCVVPGGPRYLVYEFIQ 180
           +  +VAVK +  +  E    +  SE+  +    +H N++ LLG C    GP Y++ E+  
Sbjct: 46  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYAS 104

Query: 181 NGSLDHWIFPTSRRSEG-HYSGGC-------LSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
            G+L  ++   +RR  G  YS          +++         VA+ + YL +    + +
Sbjct: 105 KGNLREYL--RARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCI 159

Query: 233 HLDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           H D+   N+L+ EN    ++DFGL++ ++  D  +  T  R    ++APE + ++  + +
Sbjct: 160 HRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ 219

Query: 292 CDIYSYGMVLLEL 304
            D++S+G+++ E+
Sbjct: 220 SDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 59.8 bits (145), Expect = 5e-10
 Identities = 31/96 (32%), Positives = 50/96 (52%), Gaps = 5/96 (5%)

Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR 272
           A  +   L +LH     R+++ D+KPEN+LLD++    +SD GL+  +   +   I    
Sbjct: 101 AAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRA 155

Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           GT GY+APE +  +      D ++ G  L E+  GR
Sbjct: 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 59.5 bits (144), Expect = 7e-10
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 24/210 (11%)

Query: 109 LGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRS---EVAAIASAQHVNLVRLLGY 164
           LG G+  SV+K +    G ++A+K I  E + E +F     E+  +  A    +V   G 
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELD-ESKFNQIIMELDILHKAVSPYIVDFYGA 67

Query: 165 CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH 224
             + G   Y+  E++  GSLD         + G  + G     LR R+   V K L +L 
Sbjct: 68  FFIEGAV-YMCMEYMDAGSLD------KLYAGGVATEGIPEDVLR-RITYAVVKGLKFLK 119

Query: 225 NDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWIL 284
            +    ++H DVKP N+L++ N +  + DFG+S  +    ++  T I G + Y+APE I 
Sbjct: 120 EE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK--TNI-GCQSYMAPERIK 174

Query: 285 EQGVSE------KCDIYSYGMVLLELTGGR 308
             G ++      + D++S G+ +LE+  GR
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 59.3 bits (144), Expect = 7e-10
 Identities = 72/302 (23%), Positives = 132/302 (43%), Gaps = 50/302 (16%)

Query: 108 LLGHGSSASVFKGILSD-GTSVAVKR-INGEENGE--KEFRSEVAAIASAQHVNLVRLLG 163
           L+G GS   V K    + G  VA+K+ +  E++    K    E+  +   +H NLV L+ 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 164 YCVVPGGPR-----YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK 218
                   R     YLV+EF+ +  LD             Y  G L      +    + +
Sbjct: 68  VF------RRKKRLYLVFEFVDHTVLDDL---------EKYPNG-LDESRVRKYLFQILR 111

Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            + + H+     ++H D+KPENIL+ ++    + DFG ++ ++       T    TR Y 
Sbjct: 112 GIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY-TDYVATRWYR 167

Query: 279 APEWIL-EQGVSEKCDIYSYGMVLLE-LTG-----GRRNVSLIEH-----GN--DKSKNK 324
           APE ++ +       DI++ G ++ E LTG     G  ++  + H     GN   + +  
Sbjct: 168 APELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEI 227

Query: 325 WQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARV 384
           +Q  P     ++ E K +E +++R     G+       ++D+A  C++     RPS +++
Sbjct: 228 FQKNPLFAGMRLPEVKEIEPLEKRFPKLSGL-------VLDLAKQCLRIDPDDRPSSSQL 280

Query: 385 VE 386
           + 
Sbjct: 281 LH 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 60.0 bits (145), Expect = 7e-10
 Identities = 67/265 (25%), Positives = 111/265 (41%), Gaps = 74/265 (27%)

Query: 109 LGHGSSASVFK----GILSDGT--SVAVKRIN-GEENGE-KEFRSEVAA-IASAQHVNLV 159
           LG G+   V +    GI    T  +VAVK +  G  + E +   SE+   I    H+N+V
Sbjct: 15  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74

Query: 160 RLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSE-------------GHYSGGCLSW 206
            LLG C  PGGP  ++ EF + G+L +++   S+R E             G    G +S 
Sbjct: 75  NLLGACTKPGGPLMVIVEFCKFGNLSNYL--RSKRGEFVPYKTKDARFRQGKSGYGDISE 132

Query: 207 DLRYRV----------------------------------------------AIDVAKAL 220
           DL+ R+                                              +  VAK +
Sbjct: 133 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGM 192

Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT-TIRGTRGYLA 279
            +L +    + +H D+   NILL EN    + DFGL++ + +D         R    ++A
Sbjct: 193 EFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 249

Query: 280 PEWILEQGVSEKCDIYSYGMVLLEL 304
           PE I ++  + + D++S+G++L E+
Sbjct: 250 PETIFDRVYTIQSDVWSFGVLLWEI 274

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 59.4 bits (144), Expect = 8e-10
 Identities = 46/143 (32%), Positives = 65/143 (45%), Gaps = 33/143 (23%)

Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK--------ALSYLH 224
           Y + EF+  G L    F T  R  G +               DVAK        A  YLH
Sbjct: 94  YFLLEFVVGGEL----F-THLRKAGRFPN-------------DVAKFYHAELVLAFEYLH 135

Query: 225 NDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWIL 284
           +     +++ D+KPEN+LLD      V+DFG +K   +   R   T+ GT  YLAPE I 
Sbjct: 136 S---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK---KVPDRTF-TLCGTPEYLAPEVIQ 188

Query: 285 EQGVSEKCDIYSYGMVLLELTGG 307
            +G  +  D ++ G++L E   G
Sbjct: 189 SKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 59.2 bits (144), Expect = 1e-09
 Identities = 69/236 (29%), Positives = 96/236 (40%), Gaps = 49/236 (20%)

Query: 108 LLGHGSSASVFKGILSD-GTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLL 162
           LLG G    VF   L   G   A+K ++ +E    N  K   +E   +A+  H  L  L 
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL- 66

Query: 163 GYCVVPGGPR-YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWD-LRYRVAIDVAKAL 220
            Y          LV ++   G L    F   +R      G CLS +  R+  A +V  AL
Sbjct: 67  -YASFQTETYLCLVMDYCPGGEL----FRLLQRQ----PGKCLSEEVARFYAA-EVLLAL 116

Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM--------------SRDQSR 266
            YLH      +++ D+KPENILL E+   ++SDF LSK                SR  S 
Sbjct: 117 EYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSV 173

Query: 267 ---------CITTIR-----GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
                       + R     GT  Y+APE I   G     D ++ G++L E+  G 
Sbjct: 174 NSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 49/203 (24%), Positives = 91/203 (44%), Gaps = 20/203 (9%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRS----EVAAIASAQHVNLVRLLG 163
           +G G  + V++   L D   VA+K++   E  + + R     E+  +    H N+++ L 
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWI--FPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALS 221
              +      +V E    G L   I  F   +R         +     ++  + +  A+ 
Sbjct: 70  -SFIEDNELNIVLELADAGDLSQMIKYFKKQKR--------LIPERTVWKYFVQLCSAVE 120

Query: 222 YLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPE 281
           ++H+    RV+H D+KP N+ +       + D GL +  S  ++    ++ GT  Y++PE
Sbjct: 121 HMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPE 176

Query: 282 WILEQGVSEKCDIYSYGMVLLEL 304
            I E G + K DI+S G +L E+
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 48/203 (23%), Positives = 89/203 (43%), Gaps = 20/203 (9%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRIN----GEENGEKEFRSEVAAIASAQHVNLVRLLG 163
           +G G  + V++   L DG  VA+K++      +     +   E+  +    H N+++   
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69

Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWI--FPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALS 221
              +      +V E    G L   I  F   +R         +     ++  + +  AL 
Sbjct: 70  -SFIEDNELNIVLELADAGDLSRMIKHFKKQKR--------LIPEKTVWKYFVQLCSALE 120

Query: 222 YLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPE 281
           ++H+    RV+H D+KP N+ +       + D GL +  S  ++    ++ GT  Y++PE
Sbjct: 121 HMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPE 176

Query: 282 WILEQGVSEKCDIYSYGMVLLEL 304
            I E G + K DI+S G +L E+
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 48/191 (25%), Positives = 94/191 (49%), Gaps = 18/191 (9%)

Query: 126 TSVAVKRI--NGEENGEKEFRSEVAAIA-SAQHVNLVRLLGYCVVPGGPRYLVYEFIQNG 182
            +VAVK +  N  +    +  SE+  +    +H N++ LLG C    GP Y++ E+   G
Sbjct: 45  VTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT-QEGPLYVIVEYAAKG 103

Query: 183 SLDHWIFPTSRRSEG--------HYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHL 234
           +L  ++   +RR  G              LS+      A  VA+ + YL +    R +H 
Sbjct: 104 NLREFL--RARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHR 158

Query: 235 DVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCD 293
           D+   N+L+ E+    ++DFGL++ +   D  +  +  R    ++APE + ++  + + D
Sbjct: 159 DLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSD 218

Query: 294 IYSYGMVLLEL 304
           ++S+G+++ E+
Sbjct: 219 VWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 23/204 (11%)

Query: 109 LGHGSSASVFKGIL----SDGTSVAVKRINGEENGEKE---FRSEVAAIASAQHVNLVRL 161
           +G GS     K IL     DG    +K IN  +   KE    R EVA +++ +H N+V  
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIV-Q 63

Query: 162 LGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALS 221
                   G  Y+V ++ + G L   I   ++R         L W       + +  AL 
Sbjct: 64  YQESFEENGNLYIVMDYCEGGDLYKKI--NAQRGVLFPEDQILDW------FVQICLALK 115

Query: 222 YLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPE 281
           ++H+    ++LH D+K +NI L ++    + DFG++++++       T I GT  YL+PE
Sbjct: 116 HVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPE 171

Query: 282 WILEQGVSEKCDIYSYGMVLLELT 305
               +  + K DI++ G VL E+ 
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMC 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 27/215 (12%)

Query: 104 NFQAL--LGHGSSASVFKGI-LSDGTSVAVKRIN--GEENGEKEFRSEVAAIASAQHVNL 158
           NF+ L  LG G+ A+V+KG   + G  VA+K I+   EE        E++ +   +H N+
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 159 VRLLGYCVVPGGPRY-LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
           VRL  + V+    +  LV+E++    L  ++       + H   G L  +        + 
Sbjct: 61  VRL--HDVIHTENKLMLVFEYMDK-DLKKYM-------DTHGVRGALDPNTVKSFTYQLL 110

Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRG---T 274
           K +++ H +   RVLH D+KP+N+L+++     ++DFGL    +R     + T      T
Sbjct: 111 KGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGL----ARAFGIPVNTFSNEVVT 163

Query: 275 RGYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
             Y AP+ +L  +  S   DI+S G ++ E+  GR
Sbjct: 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 58.7 bits (143), Expect = 2e-09
 Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 27/213 (12%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKRIN----GEENGEKEFRSEVAAIASAQHVNLVRLL 162
            +G G+   V   +    G  VA+K+I+       + ++  R E+  +   +H N++ LL
Sbjct: 7   PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHENIIGLL 65

Query: 163 GYCVVPGGPR----YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK 218
                P        Y+V E ++   L   I      ++ H          +Y     + +
Sbjct: 66  DILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHI---------QY-FLYQILR 114

Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC--ITTIRGTRG 276
            L YLH    + V+H D+KP NIL++ N    + DFGL++ +  D+     +T    TR 
Sbjct: 115 GLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171

Query: 277 YLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           Y APE +L     ++  DI+S G +  EL   +
Sbjct: 172 YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 37/105 (35%), Positives = 55/105 (52%), Gaps = 14/105 (13%)

Query: 211 RVAIDVAKALSYL---HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC 267
           ++ + + KAL YL   H      V+H DVKP NILLD +    + DFG+S  +   +++ 
Sbjct: 118 KMTVAIVKALHYLKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK- 171

Query: 268 ITTIRGTRGYLAPEWILEQGVSEKCDI----YSYGMVLLELTGGR 308
            T   G   Y+APE I     + K DI    +S G+ L+EL  G+
Sbjct: 172 -TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 54/217 (24%), Positives = 102/217 (47%), Gaps = 40/217 (18%)

Query: 107 ALLGHGSSASVFKG--ILSDGTSVAVKRINGEENGEKEFRSEVAAIA------SAQHVNL 158
           A +G G+   VFK   + + G  VA+KR+  +   E    S +  +A      + +H N+
Sbjct: 7   AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 66

Query: 159 VRLLGYCVVPGGPR----YLVYEFIQ-------NGSLDHWIFPTSRRSEGHYSGGCLSWD 207
           VRL   C V    R     LV+E +        +   +  +   + +            D
Sbjct: 67  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK------------D 114

Query: 208 LRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC 267
           + +++     + L +LH+    RV+H D+KP+NIL+  + +  ++DFGL+++ S   +  
Sbjct: 115 MMFQLL----RGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-- 165

Query: 268 ITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +T++  T  Y APE +L+   +   D++S G +  E+
Sbjct: 166 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 57.8 bits (139), Expect = 2e-09
 Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 32/216 (14%)

Query: 108 LLGHGSSASVFKGILS-DG--TSVAVKRIN--GEENGEKEFRSEVAAIAS-AQHVNLVRL 161
           ++G G+   V K  +  DG     A+KR+     ++  ++F  E+  +     H N++ L
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 162 LGYCVVPGGPRYLVYEFIQNGSLDHWIF--------PTSRRSEGHYSGGCLSWDLRYRVA 213
           LG C    G  YL  E+  +G+L  ++         P    +    +   LS       A
Sbjct: 62  LGACE-HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS--TASTLSSQQLLHFA 118

Query: 214 IDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRG 273
            DVA+ + YL    + + +H D+   NIL+ ENY A ++DFGLS+            ++ 
Sbjct: 119 ADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKK 168

Query: 274 TRGYLAPEWILEQGV-----SEKCDIYSYGMVLLEL 304
           T G L   W+  + +     +   D++SYG++L E+
Sbjct: 169 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 204

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 56/219 (25%), Positives = 102/219 (46%), Gaps = 36/219 (16%)

Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRV-AIDVAKALSYLHNDCRSRV 231
           + V E++  G L   I  + R  E            R R  A ++   L +LH   +  +
Sbjct: 72  FFVMEYLNGGDLMFHIQSSGRFDEA-----------RARFYAAEIICGLQFLH---KKGI 117

Query: 232 LHLDVKPENILLDENYRAVVSDFGLSKL-MSRDQSRCITTIRGTRGYLAPEWILEQGVSE 290
           ++ D+K +N+LLD++    ++DFG+ K  M+ +     +T  GT  Y+APE +  Q  +E
Sbjct: 118 IYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYIAPEILKGQKYNE 175

Query: 291 KCDIYSYGMVLLELTGGRRNVSLIEHGNDKSK------NKWQYFPKIVNEKMKEGKLMEI 344
             D +S+G++L E+  G+       HG D+ +      N   +FP+ +  K  +  L ++
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPF----HGEDEDELFDSILNDRPHFPRWI-SKEAKDCLSKL 230

Query: 345 VDQ----RLTDEGGIDETQVRRLVDVAFWCIQERARLRP 379
            ++    RL  +G I +    R +D   W   E+  + P
Sbjct: 231 FERDPTKRLGVDGDIRQHPFFRGID---WERLEKREIPP 266

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 38/108 (35%), Positives = 53/108 (49%), Gaps = 27/108 (25%)

Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK--LMSR-------------- 262
           AL YLHN     ++H D+KP+N+L+       ++DFGLSK  LMS               
Sbjct: 113 ALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169

Query: 263 ---DQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
              D+  C     GT  Y+APE IL QG  +  D ++ G++L E   G
Sbjct: 170 EFLDKQVC-----GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 58.1 bits (141), Expect = 3e-09
 Identities = 56/227 (24%), Positives = 104/227 (45%), Gaps = 35/227 (15%)

Query: 96  KELEEATDNFQAL--LGHGSSASVFKGILSD-GTSVAVKRIN----GEENGEKEFRSEVA 148
           K + E  D +Q L  +G G+   V     +  G  VA+K+++       + ++ +R E+ 
Sbjct: 8   KTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-ELR 66

Query: 149 AIASAQHVNLVRLLGYCVVPGGPR------YLVYEFIQNGSLDHWIFPTSRRSEGHYSGG 202
            +    H N++ LL     P          YLV   +  G+  + I    + S+ H    
Sbjct: 67  LLKHMDHENVIGLLD-VFTPASSLEDFQDVYLVTHLM--GADLNNIVKCQKLSDDH---- 119

Query: 203 CLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR 262
                +++ V   + + L Y+H+   + ++H D+KP NI ++E+    + DFGL++    
Sbjct: 120 -----IQFLV-YQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170

Query: 263 DQSRCITTIRGTRGYLAPEWILEQG-VSEKCDIYSYGMVLLELTGGR 308
           +    +T    TR Y APE +L     ++  DI+S G ++ EL  G+
Sbjct: 171 E----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 57.6 bits (139), Expect = 3e-09
 Identities = 36/103 (34%), Positives = 59/103 (57%), Gaps = 10/103 (9%)

Query: 207 DLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSR 266
           ++R+  A ++   L ++HN     V++ D+KP NILLDE+    +SD GL+   S+ +  
Sbjct: 98  EMRF-YAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 153

Query: 267 CITTIRGTRGYLAPEWILEQGVS--EKCDIYSYGMVLLELTGG 307
                 GT GY+APE +L++GV+     D +S G +L +L  G
Sbjct: 154 ASV---GTHGYMAPE-VLQKGVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 27/204 (13%)

Query: 109 LGHGSSASV-FKGILSDGTSVAVKRIN--GEENGEK--EFRSEVAAIASAQHVNLVRLLG 163
           +GHGS  +V F   +     VA+K+++  G+++ EK  +   EV  +   +H N +   G
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82

Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL 223
            C +     +LV E+    + D  I    ++         L       +     + L+YL
Sbjct: 83  -CYLREHTAWLVMEYCLGSASD--ILEVHKKP--------LQEVEIAAICHGALQGLAYL 131

Query: 224 HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWI 283
           H+  R   +H D+K  NILL E     ++DFG + L+S   S       GT  ++APE I
Sbjct: 132 HSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS-----FVGTPYWMAPEVI 183

Query: 284 L---EQGVSEKCDIYSYGMVLLEL 304
           L   E     K D++S G+  +EL
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 39/135 (28%), Positives = 65/135 (48%), Gaps = 13/135 (9%)

Query: 174 LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLH 233
           LV   +  G L + I+    R      G  +   + Y   I     + +LH+     +++
Sbjct: 70  LVMSLMNGGDLKYHIYNVGER------GLEMERVIHYSAQI--TCGILHLHS---MDIVY 118

Query: 234 LDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCD 293
            D+KPEN+LLD+     +SD GL+  +   ++  IT   GT GY+APE + E+  S   D
Sbjct: 119 RDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPYSYPVD 176

Query: 294 IYSYGMVLLELTGGR 308
            ++ G  + E+  GR
Sbjct: 177 WFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 42/138 (30%), Positives = 68/138 (49%), Gaps = 17/138 (12%)

Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI-DVAKALSYLHNDCRSRV 231
           +L+ +++  G L    F T      H++      +   RV I ++  AL +LH   +  +
Sbjct: 81  HLILDYVNGGEL----F-THLYQREHFT------ESEVRVYIAEIVLALDHLH---QLGI 126

Query: 232 LHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWIL--EQGVS 289
           ++ D+K ENILLD     V++DFGLSK    ++     +  GT  Y+APE I     G  
Sbjct: 127 IYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHD 186

Query: 290 EKCDIYSYGMVLLELTGG 307
           +  D +S G++  EL  G
Sbjct: 187 KAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 57.9 bits (140), Expect = 4e-09
 Identities = 34/98 (34%), Positives = 53/98 (54%), Gaps = 9/98 (9%)

Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD-QSRCITTIRG 273
           +V  AL  +H+      +H DVKP+N+LLD++    ++DFG    M  +   RC T + G
Sbjct: 150 EVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-G 205

Query: 274 TRGYLAPEWILEQGVS----EKCDIYSYGMVLLELTGG 307
           T  Y++PE +  QG       +CD +S G+ L E+  G
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 56.9 bits (137), Expect = 4e-09
 Identities = 57/219 (26%), Positives = 100/219 (45%), Gaps = 38/219 (17%)

Query: 108 LLGHGSSASVFKGIL--SDGT--SVAVKRINGEENGE---KEFRSEVAAIASAQHVNLVR 160
           +LG G   SV +  L   DG+   VAVK +  +       +EF  E A +    H N+++
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 161 LLGYCV---------VPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYR 211
           L+G  +         +P     ++  F+++G L H     SR  E  ++   L      R
Sbjct: 66  LIGVSLRSRAKGRLPIP----MVILPFMKHGDL-HTFLLMSRIGEEPFT---LPLQTLVR 117

Query: 212 VAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS-KLMSRDQSRCITT 270
             ID+A  + YL +      +H D+   N +L+EN    V+DFGLS K+ S D  R    
Sbjct: 118 FMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYR---- 170

Query: 271 IRGTRGYLAPEWILEQGVSE-----KCDIYSYGMVLLEL 304
            +G    L  +W+  + +++       D++++G+ + E+
Sbjct: 171 -QGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEI 208

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 86/345 (24%), Positives = 144/345 (41%), Gaps = 79/345 (22%)

Query: 92  KFRSKELEEAT----DNFQALLGHGSSA-----SVFKGILSDGTSVAVKRI----NGEEN 138
           +F S ++ ++T      +Q L   GS A     + F  +L  G +VAVK++      + +
Sbjct: 6   QFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTH 63

Query: 139 GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPR---------YLVYEFIQNG------- 182
            ++ +R E+  +    H N++ LL        P+         YLV E +          
Sbjct: 64  AKRAYR-ELVLLKCVNHKNIISLLNVFT----PQKSLEEFQDVYLVMELMDANLCQVIHM 118

Query: 183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENIL 242
            LDH      R S   Y   C                + +LH+   + ++H D+KP NI+
Sbjct: 119 ELDH-----ERMSYLLYQMLC---------------GIKHLHS---AGIIHRDLKPSNIV 155

Query: 243 LDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLL 302
           +  +    + DFGL++    +    +T    TR Y APE IL  G  E  DI+S G ++ 
Sbjct: 156 VKSDCTLKILDFGLARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 213

Query: 303 ELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE--GKLMEIVDQRLTDE---GGIDE 357
           EL  G    S+I  G D   ++W    + +     E   +L   V   + +     GI  
Sbjct: 214 ELVKG----SVIFQGTDHI-DQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISF 268

Query: 358 TQVRRLVDVAFWCIQERARLRPSMAR--VVEML----EGRVAVDD 396
            ++    D  F    ER +L+ S AR  + +ML    + R++VD+
Sbjct: 269 EEL--FPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDE 311

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 57.4 bits (139), Expect = 5e-09
 Identities = 32/94 (34%), Positives = 53/94 (56%), Gaps = 7/94 (7%)

Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD---QSRCITTIRGTR 275
            L Y+H+   + VLH D+KP N+L++ +    + DFGL++  S +    +  +T    TR
Sbjct: 117 GLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173

Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L  Q  ++  D++S G +L EL G +
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 56.5 bits (136), Expect = 5e-09
 Identities = 45/161 (27%), Positives = 72/161 (44%), Gaps = 13/161 (8%)

Query: 144 RSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGC 203
           R E   +A  +H N+V          G  Y+V E+   G L   I    +R +       
Sbjct: 46  RKEAVLLAKMKHPNIVAF-KESFEADGHLYIVMEYCDGGDLMQKI--KLQRGKLFPEDTI 102

Query: 204 LSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD 263
           L W       + +   + ++H     RVLH D+K +NI L +N +  + DFG ++L++  
Sbjct: 103 LQW------FVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153

Query: 264 QSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            +   T + GT  Y+ PE       + K DI+S G +L EL
Sbjct: 154 GAYACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 56.8 bits (137), Expect = 5e-09
 Identities = 48/186 (25%), Positives = 94/186 (50%), Gaps = 18/186 (9%)

Query: 128 VAVK--RINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLD 185
           VAVK  R +  +N   +F  E+  ++  +  N++RLL  C+    P  ++ E+++NG L+
Sbjct: 49  VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCIT-SDPLCMITEYMENGDLN 107

Query: 186 HWIFPTSRRSEGHYSGG-CLSW-DLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILL 243
            ++     +     +    +S+  L + +A  +A  + YL +      +H D+   N L+
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIF-MATQIASGMKYLSS---LNFVHRDLATRNCLV 163

Query: 244 DENYRAVVSDFGLSK-LMSRD----QSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYG 298
            +NY   ++DFG+S+ L S D    Q R +  IR    +++ E IL    +   D++++G
Sbjct: 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR----WMSWESILLGKFTTASDVWAFG 219

Query: 299 MVLLEL 304
           + L E+
Sbjct: 220 VTLWEI 225

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 56.7 bits (137), Expect = 6e-09
 Identities = 45/135 (33%), Positives = 77/135 (57%), Gaps = 17/135 (12%)

Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y++ E++  G L  ++     R+ G +S    S  L Y  A ++  AL YLH+     ++
Sbjct: 77  YMLMEYVPGGELFSYL-----RNSGRFSN---STGLFY--ASEIVCALEYLHS---KEIV 123

Query: 233 HLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKC 292
           + D+KPENILLD+     ++DFG +K + RD++    T+ GT  YLAPE I  +G ++  
Sbjct: 124 YRDLKPENILLDKEGHIKLTDFGFAKKL-RDRT---WTLCGTPEYLAPEVIQSKGHNKAV 179

Query: 293 DIYSYGMVLLELTGG 307
           D ++ G+++ E+  G
Sbjct: 180 DWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 56.5 bits (136), Expect = 7e-09
 Identities = 34/96 (35%), Positives = 55/96 (57%), Gaps = 6/96 (6%)

Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGT 274
           ++  AL +LH   +  +++ D+K ENILLD N   V++DFGLSK    D+     +  GT
Sbjct: 113 EIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGT 169

Query: 275 RGYLAPEWIL--EQGVSEKCDIYSYGMVLLE-LTGG 307
             Y+AP+ +   + G  +  D +S G+++ E LTG 
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGA 205

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 56.8 bits (138), Expect = 7e-09
 Identities = 35/108 (32%), Positives = 54/108 (50%), Gaps = 32/108 (29%)

Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRG---- 273
           KAL Y+H+     V+H D+KP NILL+ + R  ++DFGL        +R ++ +      
Sbjct: 118 KALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGL--------ARSLSELEENPEN 166

Query: 274 --------TRGYLAPEWIL-----EQGVSEKCDIYSYGMVLLELTGGR 308
                   TR Y APE +L      +GV    D++S G +L E+  G+
Sbjct: 167 PVLTDYVATRWYRAPEILLGSTRYTKGV----DMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 56.5 bits (136), Expect = 8e-09
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 19/204 (9%)

Query: 109 LGHGSSASVFKGILS-DGTSVAVKRI--NGEENGEKEFRSEVAAIASAQHVNLVRLLGYC 165
           LG GS A+V+KGI   +G  VA+K I    EE        E + +   +H N+V LL   
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIV-LLHDI 71

Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
           +        V+E++      + I          + GG   +++R      + + L+Y+H 
Sbjct: 72  IHTKETLTFVFEYMHTDLAQYMI---------QHPGGLHPYNVRL-FMFQLLRGLAYIH- 120

Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWIL- 284
                +LH D+KP+N+L+       ++DFGL++  S   S+  ++   T  Y  P+ +L 
Sbjct: 121 --GQHILHRDLKPQNLLISYLGELKLADFGLARAKSI-PSQTYSSEVVTLWYRPPDVLLG 177

Query: 285 EQGVSEKCDIYSYGMVLLELTGGR 308
               S   DI+  G + +E+  G+
Sbjct: 178 ATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 55.7 bits (134), Expect = 9e-09
 Identities = 34/87 (39%), Positives = 51/87 (58%), Gaps = 9/87 (10%)

Query: 220 LSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM--SRDQSRCITTIRGTRGY 277
           + Y+H   + R+LH D+K +NI L  N   +  DFG+S+L+  S D +   TT  GT  Y
Sbjct: 119 VHYMH---QRRILHRDLKAKNIFLKNNLLKI-GDFGVSRLLMGSCDLA---TTFTGTPYY 171

Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLEL 304
           ++PE +  QG   K DI+S G +L E+
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 50/196 (25%), Positives = 85/196 (43%), Gaps = 27/196 (13%)

Query: 125 GTSVAVKRINGEENGEKEFR---SEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN 181
            T VAVK+IN +   +++ +    E+      QH N++  +    +     Y+V   +  
Sbjct: 25  NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV-TSFIVDSELYVVSPLMAY 83

Query: 182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH-NDCRSRVLHLDVKPEN 240
           GS +  +       + H+  G     + + +  DV  AL Y+H        +H  VK  +
Sbjct: 84  GSCEDLL-------KTHFPEGLPELAIAF-ILKDVLNALDYIHSKGF----IHRSVKASH 131

Query: 241 ILLDENYRAVVSDFGLSKLM-SRDQ-SRCI--TTIRGTR--GYLAPEWILEQ---GVSEK 291
           ILL  + + V+S    S  M    +  R +        +   +L+PE +L+Q   G +EK
Sbjct: 132 ILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPE-VLQQNLQGYNEK 190

Query: 292 CDIYSYGMVLLELTGG 307
            DIYS G+   EL  G
Sbjct: 191 SDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 50/165 (30%), Positives = 82/165 (49%), Gaps = 16/165 (9%)

Query: 144 RSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGC 203
           ++E   + + +H  +V L+ Y    GG  YL+ E++  G L    F    R EG +    
Sbjct: 48  KAERNILEAVKHPFIVDLI-YAFQTGGKLYLILEYLSGGEL----FMHLER-EGIFMEDT 101

Query: 204 LSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD 263
             + L      +++ AL +LH   +  +++ D+KPENILLD      ++DFGL K  S  
Sbjct: 102 ACFYLS-----EISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCK-ESIH 152

Query: 264 QSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLE-LTGG 307
           +     T  GT  Y+APE ++  G  +  D +S G ++ + LTG 
Sbjct: 153 EGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGA 197

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 23/203 (11%)

Query: 109 LGHGSSASVFKGILSDGTS---VAVKRINGEENGEK---EFRSEVAAIASAQHVNLVRLL 162
           LG G+  +V KG+     S   VAVK +  + N      E   E   +    +  +VR++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 163 GYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY 222
           G C        LV E  + G L+ ++      +E + +      +L ++V++     + Y
Sbjct: 63  GIC--EAESWMLVMELAELGPLNKFLQKNKHVTEKNIT------ELVHQVSM----GMKY 110

Query: 223 LHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQS--RCITTIRGTRGYLAP 280
           L     +  +H D+   N+LL   + A +SDFGLSK +  D++  +  T  +    + AP
Sbjct: 111 LE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAP 167

Query: 281 EWILEQGVSEKCDIYSYGMVLLE 303
           E +     S K D++S+G+++ E
Sbjct: 168 ECMNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 55/203 (27%), Positives = 96/203 (47%), Gaps = 21/203 (10%)

Query: 109 LGHGSSASVFKGILSD-GTSVAVKRINGEENGEKE-FRSEVAAIASAQHVNLVRLLGYCV 166
           LG G+   V+K    + G   A K I+ +   E E +  E+  +AS  H N+V+LL    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 167 VPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHND 226
                 +++ EF   G++D  +    R          L+      V     +AL+YLH  
Sbjct: 73  YENN-LWILIEFCAGGAVDAVMLELER---------PLTEPQIRVVCKQTLEALNYLHE- 121

Query: 227 CRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWIL-- 284
             ++++H D+K  NIL   +    ++DFG+S   +R   R  + I GT  ++APE ++  
Sbjct: 122 --NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCE 178

Query: 285 ---EQGVSEKCDIYSYGMVLLEL 304
              ++    K D++S G+ L+E+
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 55.3 bits (133), Expect = 1e-08
 Identities = 57/204 (27%), Positives = 91/204 (44%), Gaps = 25/204 (12%)

Query: 109 LGHGSSASVFKGIL---SDGTSVAVKRINGEENGEKEFRSEVAAIASAQHV----NLVRL 161
           LG G+   V KG+         VA+K +  E   EK  R E+   A   H      +VR+
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRM 60

Query: 162 LGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALS 221
           +G C        LV E    G L+   F + ++ E   S      +L ++V++     + 
Sbjct: 61  IGVCEAEA--LMLVMEMASGGPLNK--FLSGKKDEITVSNVV---ELMHQVSM----GMK 109

Query: 222 YLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQS--RCITTIRGTRGYLA 279
           YL        +H D+   N+LL   + A +SDFGLSK +  D S  +  +  +    + A
Sbjct: 110 YLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYA 166

Query: 280 PEWILEQGVSEKCDIYSYGMVLLE 303
           PE I  +  S + D++SYG+ + E
Sbjct: 167 PECINFRKFSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 47/158 (29%), Positives = 79/158 (50%), Gaps = 18/158 (11%)

Query: 207 DLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSR 266
           ++R+  A ++   L ++HN     V++ D+KP NILLDE+    +SD GL+   S+ +  
Sbjct: 98  EMRF-YATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 153

Query: 267 CITTIRGTRGYLAPEWILEQGVS--EKCDIYSYGMVLLELTGG----RRNVSLIEHGNDK 320
                 GT GY+APE +L++G +     D +S G +L +L  G    R++ +  +H  D+
Sbjct: 154 ASV---GTHGYMAPE-VLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 209

Query: 321 SKNKWQY-FPKIVNEKMK---EGKLMEIVDQRLTDEGG 354
                    P   + ++K   EG L   V +RL   G 
Sbjct: 210 MTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGR 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 15/207 (7%)

Query: 108 LLGHGSSASVFKGILSDGTS-----VAVKRI--NGEENGEKEFRSEVAAIASAQHVNLVR 160
           LL  G+   +F GIL D        V VK +  +  E        E   +    H N++ 
Sbjct: 13  LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILP 72

Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           +L  C+  G P +++Y ++  G+L   +F    R     +   LS      +AI +A  +
Sbjct: 73  ILHVCIEDGEPPFVLYPYMNWGNLK--LFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130

Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI--TTIRGTRGYL 278
           SYLH   +  V+H D+   N ++DE  +  ++D  LS+ +      C+     R  + ++
Sbjct: 131 SYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK-WM 186

Query: 279 APEWILEQGVSEKCDIYSYGMVLLELT 305
           A E ++ +  S   D++S+G++L EL 
Sbjct: 187 ALESLVNKEYSSASDVWSFGVLLWELM 213

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 37/109 (33%), Positives = 59/109 (54%), Gaps = 4/109 (3%)

Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGT 274
           ++  AL +LH   +  +++ D+K ENILLD     V++DFGLSK    ++     +  GT
Sbjct: 113 EIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGT 169

Query: 275 RGYLAPEWILEQGVSEKC-DIYSYGMVLLELTGGRRNVSLIEHGNDKSK 322
             Y+APE I  +G   K  D +S G+++ EL  G    +L    N +S+
Sbjct: 170 IEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSE 218

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 41/215 (19%)

Query: 109 LGHGSSASVFKGILS-DGTSVAVK--RINGEENGEKEFRSEVAAIASAQHVNLVRL---- 161
           LG G+ A+VFKG        VA+K  R+  EE        EV+ + + +H N+V L    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 162 -LGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI---DVA 217
               C+       LV+E++ +                 Y   C +    + V I    + 
Sbjct: 73  HTERCLT------LVFEYLDS-------------DLKQYLDNCGNLMSMHNVKIFMFQLL 113

Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS---RDQSRCITTIRGT 274
           + LSY H   + ++LH D+KP+N+L++E     ++DFGL++  S   +  S  + T+   
Sbjct: 114 RGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTL--- 167

Query: 275 RGYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
             Y  P+ +L     S   D++  G +L E+  GR
Sbjct: 168 -WYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 29/93 (31%), Positives = 50/93 (53%), Gaps = 7/93 (7%)

Query: 220 LSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR---DQSRCITTIRGTRG 276
           L Y+H+     V+H D+KP N+L++E+    + DFG+++ +S    +    +T    TR 
Sbjct: 120 LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176

Query: 277 YLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           Y APE +L     +   D++S G +  E+ G R
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRR 209

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 55/220 (25%), Positives = 93/220 (42%), Gaps = 40/220 (18%)

Query: 106 QALLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKE------FRSEVAAIASAQHVNL 158
            A +G G+   VFK         VA+K++  E   EKE       R E+  +   +H N+
Sbjct: 17  LAKIGQGTFGEVFKARHKKTKQIVALKKVLMEN--EKEGFPITALR-EIKILQLLKHENV 73

Query: 159 VRLLGYCVVPGGPR-------YLVYEFIQN---GSLDHWIFPTSRRSEGHYSGGCLSWDL 208
           V L+  C     P        YLV+EF ++   G L +      + +             
Sbjct: 74  VNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSN---KNVKFTLSEIK-------- 122

Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS---RDQS 265
             +V   +   L Y+H   R+++LH D+K  NIL+ ++    ++DFGL++  S     + 
Sbjct: 123 --KVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKP 177

Query: 266 RCITTIRGTRGYLAPEWIL-EQGVSEKCDIYSYGMVLLEL 304
              T    T  Y  PE +L E+      D++  G ++ E+
Sbjct: 178 NRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEM 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 50/184 (27%), Positives = 88/184 (47%), Gaps = 17/184 (9%)

Query: 128 VAVKRI-NGEENGE-KEFR-SEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL 184
           VA+K+  + EEN E KE    E+  + + +  N+V L        G  YLV+E+++   L
Sbjct: 29  VAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVEL-KEAFRRRGKLYLVFEYVEKNML 87

Query: 185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD 244
           +                G     +R  +   + KA+ + H   ++ ++H D+KPEN+L+ 
Sbjct: 88  ELL---------EEMPNGVPPEKVRSYI-YQLIKAIHWCH---KNDIVHRDIKPENLLIS 134

Query: 245 ENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            N    + DFG ++ +S   +   T    TR Y +PE +L     +  D++S G +L EL
Sbjct: 135 HNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGEL 194

Query: 305 TGGR 308
           + G+
Sbjct: 195 SDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 50/203 (24%), Positives = 101/203 (49%), Gaps = 21/203 (10%)

Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEK--EFRSEVAAIASAQHVNLVRLLGYCV 166
           LG G+   V+K    +  ++A  ++   ++ E+  ++  E+  +A+  H  +V+LLG   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLG-AF 78

Query: 167 VPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHND 226
              G  +++ EF   G++D  +    R        G     ++  +   + +AL YLH+ 
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLELDR--------GLTEPQIQV-ICRQMLEALQYLHS- 128

Query: 227 CRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQ 286
              +++H D+K  N+LL  +    ++DFG+S    +   R  + I GT  ++APE ++ +
Sbjct: 129 --MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-GTPYWMAPEVVMCE 185

Query: 287 GVSE-----KCDIYSYGMVLLEL 304
            + +     K DI+S G+ L+E+
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 37/213 (17%)

Query: 109 LGHGSSASVFKG--ILSDGTSVAVK--RINGEENGEKEFRSEVAAIASAQHVNLVRLLGY 164
           LG G+ A+VFKG   L++   VA+K  R+  EE        EV+ +   +H N+V L   
Sbjct: 14  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD- 71

Query: 165 CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI---DVAKALS 221
            V       LV+E++              +    Y   C +    + V I    + + L+
Sbjct: 72  IVHTDKSLTLVFEYLD-------------KDLKQYMDDCGNIMSMHNVKIFLYQILRGLA 118

Query: 222 YLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS---RDQSRCITTIRGTRGYL 278
           Y H   R +VLH D+KP+N+L++E     ++DFGL++  S   +  S  + T+     Y 
Sbjct: 119 YCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTL----WYR 171

Query: 279 APEWILEQGVSE---KCDIYSYGMVLLELTGGR 308
            P+ +L  G SE   + D++  G +  E+  GR
Sbjct: 172 PPDVLL--GSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 32/96 (33%), Positives = 54/96 (56%), Gaps = 5/96 (5%)

Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR 272
           A ++   L  LH   + R+++ D+KPENILLD++    +SD GL+  +   Q+  I    
Sbjct: 108 AAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV 162

Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           GT GY+APE +  +  +   D ++ G +L E+  G+
Sbjct: 163 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 43/206 (20%), Positives = 89/206 (43%), Gaps = 24/206 (11%)

Query: 107 ALLGHGSSASVFKGIL----SDGTSVAVK--RINGEENGEKEFRSEVAAIASAQHVNLVR 160
             +G G    V++G+     ++  +VAVK  +     +  ++F  E   +    H ++V+
Sbjct: 12  RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71

Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRV--AIDVAK 218
           L+G       P ++V E    G L  ++                S DL   +  +  ++ 
Sbjct: 72  LIGVITEN--PVWIVMELAPLGELRSYL---QVNKY--------SLDLASLILYSYQLST 118

Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
           AL+YL +    R +H D+   N+L+       + DFGLS+ +  +     +  +    ++
Sbjct: 119 ALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWM 175

Query: 279 APEWILEQGVSEKCDIYSYGMVLLEL 304
           APE I  +  +   D++ +G+ + E+
Sbjct: 176 APESINFRRFTSASDVWMFGVCMWEI 201

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 3/94 (3%)

Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGT 274
           ++  AL YLH++    V++ D+K EN++LD++    ++DFGL K   +D +  + T  GT
Sbjct: 103 EIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKTFCGT 159

Query: 275 RGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
             YLAPE + +       D +  G+V+ E+  GR
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 53/210 (25%), Positives = 99/210 (47%), Gaps = 29/210 (13%)

Query: 108 LLGHGSSASVFKGILSD-GTSVAVKRIN---GEENGEKEFRS---EVAAIASAQHVNLVR 160
           LLG G+   V+    +D G  +AVK++      +   KE  +   E+  + + +H  +V+
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 161 LLGYCVVPGGPRYLVY-EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKA 219
             G    P   +  ++ E++  GS+   +           + G L+ ++  R    + + 
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQL----------KAYGALTENVTRRYTRQILQG 118

Query: 220 LSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC-----ITTIRGT 274
           +SYLH++    ++H D+K  NIL D      + DFG SK   R Q+ C     I ++ GT
Sbjct: 119 VSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK---RIQTICMSGTGIKSVTGT 172

Query: 275 RGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
             +++PE I  +G   K D++S    ++E+
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSVACTVVEM 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 54.5 bits (131), Expect = 2e-08
 Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 25/217 (11%)

Query: 97  ELEEATDNFQALLGHGSSASVFKGILSDGTS----VAVK--RINGEENGEKEFRSEVAAI 150
           EL+  +   + +LG G    + +G L   +     VA+   R    +   + F +E   +
Sbjct: 1   ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60

Query: 151 ASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRY 210
               H N+VRL G  +  G    +V E++ NG+LD ++    R+ EG    G L   L  
Sbjct: 61  GQFDHSNIVRLEG-VITRGNTMMIVTEYMSNGALDSFL----RKHEGQLVAGQLMGMLP- 114

Query: 211 RVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI-T 269
                +A  + YL        +H  +    +L++ +    +S F     +  D+S  I T
Sbjct: 115 ----GLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRR---LQEDKSEAIYT 164

Query: 270 TIRGTRGYL--APEWILEQGVSEKCDIYSYGMVLLEL 304
           T+ G    L  APE I     S   D++S+G+V+ E+
Sbjct: 165 TMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEV 201

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 54.7 bits (131), Expect = 3e-08
 Identities = 53/211 (25%), Positives = 98/211 (46%), Gaps = 31/211 (14%)

Query: 108 LLGHGSSASVFKGILSD-GTSVAVKRINGEENG---EKEFRS---EVAAIASAQHVNLVR 160
           LLG G+   V+     D G  +A K++  +       KE  +   E+  + + QH  +V+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 161 LLGYCVVPGGPRYLV--YEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK 218
             G C+     + L    E++  GS+   +           + G L+  +  +    + +
Sbjct: 69  YYG-CLRDRAEKTLTIFMEYMPGGSVKDQL----------KAYGALTESVTRKYTRQILE 117

Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT-----TIRG 273
            +SYLH++    ++H D+K  NIL D      + DFG SK   R Q+ C++     ++ G
Sbjct: 118 GMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK---RLQTICMSGTGIRSVTG 171

Query: 274 TRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           T  +++PE I  +G   K D++S G  ++E+
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSLGCTVVEM 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 54.4 bits (131), Expect = 4e-08
 Identities = 38/141 (26%), Positives = 67/141 (47%), Gaps = 24/141 (17%)

Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGH---YSGGCLSWDLRYRVAIDVAKALSYLHNDCRS 229
           Y V E++  G L + I    +  E H   Y             A ++A  L +LH+    
Sbjct: 77  YFVMEYVNGGDLMYHIQQVGKFKEPHAVFY-------------AAEIAIGLFFLHS---K 120

Query: 230 RVLHLDVKPENILLDENYRAVVSDFGLSK--LMSRDQSRCITTIRGTRGYLAPEWILEQG 287
            +++ D+K +N++LD      ++DFG+ K  +     +R   T  GT  Y+APE I  Q 
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR---TFCGTPDYIAPEIIAYQP 177

Query: 288 VSEKCDIYSYGMVLLELTGGR 308
             +  D +++G++L E+  G+
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 54.3 bits (131), Expect = 4e-08
 Identities = 62/216 (28%), Positives = 93/216 (43%), Gaps = 48/216 (22%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRI---NGEENGEKEFRSEVAAIASAQHVNLVRLLGY 164
           +G G+   V+KG     G  VA+K+I   + EE        E++ +   QH N+V L   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD- 66

Query: 165 CVVPGGPR-YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL-RYRVAIDVAKAL-- 220
            V+    R YL++EF                         LS DL +Y  ++   + +  
Sbjct: 67  -VLMQESRLYLIFEF-------------------------LSMDLKKYLDSLPKGQYMDA 100

Query: 221 ----SYLHND------CRS-RVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT 269
               SYL+        C S RVLH D+KP+N+L+D      ++DFGL++       R  T
Sbjct: 101 ELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYT 159

Query: 270 TIRGTRGYLAPEWIL-EQGVSEKCDIYSYGMVLLEL 304
               T  Y APE +L     S   DI+S G +  E+
Sbjct: 160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEM 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 54.3 bits (130), Expect = 5e-08
 Identities = 40/135 (29%), Positives = 64/135 (47%), Gaps = 14/135 (10%)

Query: 174 LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLH 233
            V E++  G L    F  SR           S D       ++  AL YLH+    ++++
Sbjct: 72  FVMEYVNGGEL---FFHLSRER-------VFSEDRTRFYGAEIVSALDYLHS---GKIVY 118

Query: 234 LDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCD 293
            D+K EN++LD++    ++DFGL K    D +  + T  GT  YLAPE + +       D
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMKTFCGTPEYLAPEVLEDNDYGRAVD 177

Query: 294 IYSYGMVLLELTGGR 308
            +  G+V+ E+  GR
Sbjct: 178 WWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 53.8 bits (129), Expect = 5e-08
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 25/209 (11%)

Query: 107 ALLGHGSSASVFKGI-LSDGTSVAVKRI---NGEENGEKEFRSEVAAIASAQ---HVNLV 159
           A +G G+  +V+K      G  VA+K +     E+        EVA +   +   H N+V
Sbjct: 6   AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIV 65

Query: 160 RLLGYCVVPGGPR----YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
           RL+  C      R     LV+E +     D   +       G      L  +    +   
Sbjct: 66  RLMDVCATSRTDRETKVTLVFEHVDQ---DLRTYLDKVPPPG------LPAETIKDLMRQ 116

Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
             + L +LH +C   ++H D+KPENIL+    +  ++DFGL+++ S   +  +T +  T 
Sbjct: 117 FLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA--LTPVVVTL 171

Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            Y APE +L+   +   D++S G +  E+
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 53.5 bits (129), Expect = 5e-08
 Identities = 53/205 (25%), Positives = 96/205 (46%), Gaps = 22/205 (10%)

Query: 109 LGHGSSASVFKGILSD-GTSVAVKR-INGEENG--EKEFRSEVAAIASAQHVNLVRLLGY 164
           +G GS   VFK    + G  VA+K+ +  E++   +K    E+  +   +H NLV L+  
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE- 67

Query: 165 CVVPGGPR-YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL 223
            V     + +LV+E+  +  L+          E +  G  +   L  ++     +A+++ 
Sbjct: 68  -VFRRKRKLHLVFEYCDHTVLNEL--------EKNPRG--VPEHLIKKIIWQTLQAVNFC 116

Query: 224 HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWI 283
           H   +   +H DVKPENIL+ +  +  + DFG +++++       T    TR Y APE +
Sbjct: 117 H---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTG-PGDDYTDYVATRWYRAPELL 172

Query: 284 L-EQGVSEKCDIYSYGMVLLELTGG 307
           + +       D+++ G V  EL  G
Sbjct: 173 VGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 53.1 bits (127), Expect = 7e-08
 Identities = 53/201 (26%), Positives = 96/201 (47%), Gaps = 20/201 (9%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEF-RSEVAAIASAQHVNLVRLLGYCV 166
           +G G+   V+K   ++ G   A+K I  E   +    + E+  +   +H N+V   G   
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFG-SY 75

Query: 167 VPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHND 226
           +     ++  EF   GSL   I+        H +G      + Y V+ +  + L YLH+ 
Sbjct: 76  LRRDKLWICMEFCGGGSLQD-IY--------HVTGPLSESQIAY-VSRETLQGLYYLHSK 125

Query: 227 CRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQ 286
            +   +H D+K  NILL +N    ++DFG+S  ++   ++  + I GT  ++APE    +
Sbjct: 126 GK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVE 181

Query: 287 ---GVSEKCDIYSYGMVLLEL 304
              G ++ CDI++ G+  +EL
Sbjct: 182 RKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 53.1 bits (127), Expect = 7e-08
 Identities = 54/210 (25%), Positives = 98/210 (46%), Gaps = 29/210 (13%)

Query: 108 LLGHGSSASVFKGILSD-GTSVAVKRINGEENG---EKEFRS---EVAAIASAQHVNLVR 160
           LLG G+   V+    +D G  +AVK++  +       KE  +   E+  + +  H  +V+
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 161 LLGYCVVPGGPRYLVY-EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKA 219
             G    P      ++ E +  GS+   +           S G L+ ++  +    + + 
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQL----------KSYGALTENVTRKYTRQILEG 118

Query: 220 LSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT-----TIRGT 274
           +SYLH++    ++H D+K  NIL D      + DFG SK   R Q+ C++     ++ GT
Sbjct: 119 VSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK---RLQTICLSGTGMKSVTGT 172

Query: 275 RGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
             +++PE I  +G   K DI+S G  ++E+
Sbjct: 173 PYWMSPEVISGEGYGRKADIWSVGCTVVEM 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 53.1 bits (127), Expect = 7e-08
 Identities = 52/223 (23%), Positives = 98/223 (43%), Gaps = 30/223 (13%)

Query: 123 SDGTSVAVKRINGEENGEKEFRS---EVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI 179
           +DG    +K++N      +E ++   E   ++  +H N+V          G  Y+V  F 
Sbjct: 23  TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFC 82

Query: 180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPE 239
           + G L H +    ++ +       + W       + +A AL YLH      +LH D+K +
Sbjct: 83  EGGDLYHKL--KEQKGKLLPENQVVEW------FVQIAMALQYLHEK---HILHRDLKTQ 131

Query: 240 NILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGM 299
           N+ L       V D G+++++  +Q    +T+ GT  Y++PE    +  + K D+++ G 
Sbjct: 132 NVFLTRTNIIKVGDLGIARVL-ENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGC 190

Query: 300 VLLELTGGRRNVSLIEHG-NDKSKNKWQYFPKIVNEKMKEGKL 341
            + E+       + ++H  N K  N   Y       ++ EGKL
Sbjct: 191 CVYEM-------ATLKHAFNAKDMNSLVY-------RIIEGKL 219

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 53.5 bits (128), Expect = 8e-08
 Identities = 32/94 (34%), Positives = 52/94 (55%), Gaps = 4/94 (4%)

Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGT 274
           ++  AL YLH+     V++ D+K EN++LD++    ++DFGL K    D +  + T  GT
Sbjct: 103 EIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTFCGT 158

Query: 275 RGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
             YLAPE + +       D +  G+V+ E+  GR
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 53.7 bits (129), Expect = 8e-08
 Identities = 39/97 (40%), Positives = 53/97 (54%), Gaps = 8/97 (8%)

Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS-KL-MSRDQSRCITTIRGTRG 276
           AL+YLH      ++H DVK ENI LDE   AV+ DFG + KL    D  +C     GT  
Sbjct: 197 ALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWS-GTLE 252

Query: 277 YLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSL 313
             +PE +       K DI+S G+VL E++   +NV+L
Sbjct: 253 TNSPELLALDPYCAKTDIWSAGLVLFEMSV--KNVTL 287

Length = 392

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 53.0 bits (128), Expect = 9e-08
 Identities = 30/89 (33%), Positives = 45/89 (50%), Gaps = 7/89 (7%)

Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGY 277
           K+L ++H   R+ + H D+KPENIL+  +    ++DFG  +          T    TR Y
Sbjct: 111 KSLDHMH---RNGIFHRDIKPENILIK-DDILKLADFGSCR--GIYSKPPYTEYISTRWY 164

Query: 278 LAPEWILEQGV-SEKCDIYSYGMVLLELT 305
            APE +L  G    K DI++ G V  E+ 
Sbjct: 165 RAPECLLTDGYYGPKMDIWAVGCVFFEIL 193

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 35/141 (24%), Positives = 62/141 (43%), Gaps = 24/141 (17%)

Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGH---YSGGCLSWDLRYRVAIDVAKALSYLHNDCRS 229
           + V E++  G L   I  + R  E     Y             A ++   L +LH     
Sbjct: 72  FFVMEYVNGGDLMFHIQRSGRFDEPRARFY-------------AAEIVLGLQFLHE---R 115

Query: 230 RVLHLDVKPENILLDENYRAVVSDFGLSK--LMSRDQSRCITTIRGTRGYLAPEWILEQG 287
            +++ D+K +N+LLD      ++DFG+ K  ++    +    T  GT  Y+APE +  Q 
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS---TFCGTPDYIAPEILSYQP 172

Query: 288 VSEKCDIYSYGMVLLELTGGR 308
                D ++ G++L E+  G+
Sbjct: 173 YGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 53.3 bits (128), Expect = 1e-07
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 4/94 (4%)

Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGT 274
           ++  AL YLH      V++ D+K EN++LD++    ++DFGL K    D    + T  GT
Sbjct: 103 EIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCGT 158

Query: 275 RGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
             YLAPE + +       D +  G+V+ E+  GR
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 30/81 (37%), Positives = 48/81 (59%), Gaps = 6/81 (7%)

Query: 232 LHLDVKPENILLDENYRAVVSDFGLSKLMSRD-QSRCITTIRGTRGYLAPEWILEQG--- 287
           +H DVKP+N+LLD++    ++DFG    M+++   RC T + GT  Y++PE +  QG   
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDG 222

Query: 288 -VSEKCDIYSYGMVLLELTGG 307
               +CD +S G+ L E+  G
Sbjct: 223 YYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 25/210 (11%)

Query: 104 NFQAL--LGHGSSASVFKGI-LSDGTSVAVKRINGEENGE----KEFRSEVAAIASAQHV 156
           NFQ +  +G G+   V+K      G  VA+K+I  +   E       R E++ +    H 
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 59

Query: 157 NLVRLLGYCVVPGGPR-YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
           N+V+LL   V+    + YLV+EF+ +  L  ++  +            +   L       
Sbjct: 60  NIVKLLD--VIHTENKLYLVFEFL-HQDLKKFMDASP--------LSGIPLPLIKSYLFQ 108

Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L++ H+    RVLH D+KP+N+L++      ++DFGL++       R  T    T 
Sbjct: 109 LLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTL 164

Query: 276 GYLAPEWIL-EQGVSEKCDIYSYGMVLLEL 304
            Y APE +L  +  S   DI+S G +  E+
Sbjct: 165 WYRAPEILLGCKYYSTAVDIWSLGCIFAEM 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 48/177 (27%), Positives = 85/177 (48%), Gaps = 22/177 (12%)

Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL-MSRDQSRCITTI 271
           A ++   L +LH+     +++ D+K +NILLD +    ++DFG+ K  M  D   C  T 
Sbjct: 102 AAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC--TF 156

Query: 272 RGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKS------KNKW 325
            GT  Y+APE +L Q  +   D +S+G++L E+  G+       HG+D+       +   
Sbjct: 157 CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPF----HGHDEEELFQSIRMDN 212

Query: 326 QYFPKIVNEKMKEGKLMEIV---DQRLTDEGGIDETQVRRLVDVAFWCIQERARLRP 379
             +P+ +  + K+  +   V   ++RL  +G I +    R +D   W   E   + P
Sbjct: 213 PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID---WSALEEREIEP 266

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 40/160 (25%), Positives = 66/160 (41%), Gaps = 43/160 (26%)

Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL-RYRVAIDVAKALSYLHNDCRSRV 231
           YLV E++  G L + +    R+            +  R+ +A ++  AL  +H   +   
Sbjct: 77  YLVMEYMPGGDLMNLL---IRK-------DVFPEETARFYIA-ELVLALDSVH---KLGF 122

Query: 232 LHLDVKPENILLDENYRAVVSDFGLSKLM---------------------------SRDQ 264
           +H D+KP+NIL+D +    ++DFGL K M                              Q
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182

Query: 265 SRCIT-TIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLE 303
            R    +  GT  Y+APE +       +CD +S G++L E
Sbjct: 183 RRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 60/214 (28%), Positives = 88/214 (41%), Gaps = 34/214 (15%)

Query: 105 FQAL--LGHGSSASVFKGILSD-GTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVN 157
           FQ L  +G G    VF     D G  VA+KR+        N  +   +E   + + +   
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62

Query: 158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGH---YSGGCLSWDLRYRVAI 214
           LV+LL Y        YL  E++  G     +      SE H   Y             A+
Sbjct: 63  LVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMF-------EAV 114

Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRG 273
           D    L Y+H D          KPEN L+D +    ++DFGLSK +++   S     + G
Sbjct: 115 DALHELGYIHRDL---------KPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVG 160

Query: 274 TRGYLAPEWILEQGVSEKCDIYSYGMVLLE-LTG 306
           +  Y+APE +  +G     D +S G +L E L G
Sbjct: 161 SPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 53.3 bits (128), Expect = 2e-07
 Identities = 34/97 (35%), Positives = 53/97 (54%), Gaps = 4/97 (4%)

Query: 214 IDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI-TTIR 272
           I V  A+ ++H+     ++H D+K  NILL  N    + DFG SK+ +   S  +  T  
Sbjct: 150 IQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC 206

Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRR 309
           GT  Y+APE    +  S+K D++S G++L EL   +R
Sbjct: 207 GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR 243

Length = 496

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 37/136 (27%), Positives = 63/136 (46%), Gaps = 14/136 (10%)

Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y V E++  G L + I    +  E                A +++  L +LH   R  ++
Sbjct: 77  YFVMEYVNGGDLMYHIQQVGKFKEPQ----------AVFYAAEISVGLFFLH---RRGII 123

Query: 233 HLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKC 292
           + D+K +N++LD      ++DFG+ K    D      T  GT  Y+APE I  Q   +  
Sbjct: 124 YRDLKLDNVMLDSEGHIKIADFGMCKEHMVD-GVTTRTFCGTPDYIAPEIIAYQPYGKSV 182

Query: 293 DIYSYGMVLLELTGGR 308
           D ++YG++L E+  G+
Sbjct: 183 DWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 38/136 (27%), Positives = 64/136 (47%), Gaps = 14/136 (10%)

Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y V E++  G L + I    R  E H              A ++A  L +LH+     ++
Sbjct: 77  YFVMEYVNGGDLMYQIQQVGRFKEPH----------AVFYAAEIAIGLFFLHS---KGII 123

Query: 233 HLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKC 292
           + D+K +N++LD      ++DFG+ K    D      T  GT  Y+APE I  Q   +  
Sbjct: 124 YRDLKLDNVMLDSEGHIKIADFGMCKENMWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSV 182

Query: 293 DIYSYGMVLLELTGGR 308
           D +++G++L E+  G+
Sbjct: 183 DWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 52/215 (24%), Positives = 93/215 (43%), Gaps = 34/215 (15%)

Query: 109 LGHGSSASVFKGILSDG---TSVAVK--RINGEENGEKEFRSEVAAIASAQHVNLVRLLG 163
           +G+G    V  G ++ G     V VK  R++     + +F  E     S QH NL++ LG
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR--YRVAIDVAKALS 221
            C     P  LV EF   G L  ++  + R++E       ++ D     R+A ++A  L 
Sbjct: 63  QC-TEVTPYLLVMEFCPLGDLKGYL-RSCRKAEL------MTPDPTTLQRMACEIALGLL 114

Query: 222 YLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPE 281
           +LH   ++  +H D+   N LL  +    + D+GLS    ++       +   + ++   
Sbjct: 115 HLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED----YYVTPDQLWVPLR 167

Query: 282 WILEQGVSE------------KCDIYSYGMVLLEL 304
           WI  + V E            + +++S G+ + EL
Sbjct: 168 WIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 44/218 (20%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEENGE----KEFRSEVAAIASAQHVNLVRLLG 163
           +G G+  +VFK         VA+KR+  +++ E       R E+  +   +H N+VRL  
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRL-- 64

Query: 164 YCVVPGGPRY-LVYEFIQ----------NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRV 212
           Y V+    +  LV+E+            NG +D  I                S+  +   
Sbjct: 65  YDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEI--------------VKSFMFQ--- 107

Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR 272
              + K L++ H+     VLH D+KP+N+L+++N    ++DFGL++       RC +   
Sbjct: 108 ---LLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGI-PVRCYSAEV 160

Query: 273 GTRGYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGRR 309
            T  Y  P+ +   +  S   D++S G +  EL    R
Sbjct: 161 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 35/100 (35%), Positives = 56/100 (56%), Gaps = 13/100 (13%)

Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQS---RCITTI 271
           +V  AL  +H+     ++H DVKP+N+LLD++    ++DFG    M  D++   RC T +
Sbjct: 150 EVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFG--TCMKMDETGMVRCDTAV 204

Query: 272 RGTRGYLAPEWILEQG----VSEKCDIYSYGMVLLELTGG 307
            GT  Y++PE +  QG       +CD +S G+ L E+  G
Sbjct: 205 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 21/211 (9%)

Query: 103 DNFQAL--LGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRS--EVAAIASAQHVN 157
           D+++ L  LG GS A+V+KG    +G  VA+K I  +E     F +  E + +   +H N
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
           +V LL   +       LV+E++      +            + GG L  +        + 
Sbjct: 65  IV-LLHDIIHTKETLTLVFEYVHTDLCQYM---------DKHPGG-LHPENVKLFLFQLL 113

Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGY 277
           + LSY+H   +  +LH D+KP+N+L+ +     ++DFGL++  S   S   +    T  Y
Sbjct: 114 RGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVVTLWY 169

Query: 278 LAPEWILEQGVSEKC-DIYSYGMVLLELTGG 307
             P+ +L       C D++  G + +E+  G
Sbjct: 170 RPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 33/207 (15%)

Query: 109 LGHGSSASV-FKGILSDGTSVAVKRIN--GEENGEK--EFRSEVAAIASAQHVNLVRLLG 163
           +GHGS  +V F   + +   VA+K+++  G+++ EK  +   EV  +   +H N ++  G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIF---PTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
            C +     +LV E+    + D       P         + G L             + L
Sbjct: 83  -CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGAL-------------QGL 128

Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAP 280
           +YLH+     ++H DVK  NILL E     + DFG + +M+           GT  ++AP
Sbjct: 129 AYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-----FVGTPYWMAP 180

Query: 281 EWIL---EQGVSEKCDIYSYGMVLLEL 304
           E IL   E     K D++S G+  +EL
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 34/142 (23%), Positives = 60/142 (42%), Gaps = 46/142 (32%)

Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL------------ 256
           R+ +A ++  A+  +H       +H D+KP+NIL+D +    ++DFGL            
Sbjct: 104 RFYIA-ELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159

Query: 257 -----------------------------SKLMSRDQSRCIT-TIRGTRGYLAPEWILEQ 286
                                         +   R   RC+  ++ GT  Y+APE +L  
Sbjct: 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT 219

Query: 287 GVSEKCDIYSYGMVLLELTGGR 308
           G ++ CD +S G++L E+  G+
Sbjct: 220 GYTQLCDWWSVGVILYEMLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 53/201 (26%), Positives = 95/201 (47%), Gaps = 20/201 (9%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEF-RSEVAAIASAQHVNLVRLLGYCV 166
           +G G+   V+K   L  G   AVK I  E   +    + E+  +   +H N+V   G   
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFG-SY 75

Query: 167 VPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHND 226
           +     ++  E+   GSL   I+        H +G      + Y V  +  + L+YLH+ 
Sbjct: 76  LSREKLWICMEYCGGGSLQD-IY--------HVTGPLSELQIAY-VCRETLQGLAYLHSK 125

Query: 227 CRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQ 286
            +   +H D+K  NILL +N    ++DFG++  ++   ++  + I GT  ++APE    +
Sbjct: 126 GK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVE 181

Query: 287 ---GVSEKCDIYSYGMVLLEL 304
              G ++ CDI++ G+  +EL
Sbjct: 182 KNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 51.4 bits (123), Expect = 3e-07
 Identities = 29/89 (32%), Positives = 49/89 (55%), Gaps = 4/89 (4%)

Query: 220 LSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLA 279
           L +LH   + R+++ D+KPEN+LLD +    +SD GL+  +   QS+      GT G++A
Sbjct: 110 LEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMA 165

Query: 280 PEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           PE +  +      D ++ G+ L E+   R
Sbjct: 166 PELLQGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 60/220 (27%), Positives = 94/220 (42%), Gaps = 44/220 (20%)

Query: 104 NFQALLGHGSSASVFKGILSDGT--SVAVKRINGEENGEKEFRSEVAAIASAQHVNLVR- 160
           NF   LG GS   V      +     VA+KR           +S++       HV   R 
Sbjct: 33  NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFE---------KSKIIKQKQVDHVFSERK 83

Query: 161 LLGY-----CVVPGGP------RYLVYEFIQNGSLDHWIFPTSRRSEGHYSG-GCLSWDL 208
           +L Y     CV   G        YLV EF+  G      F   RR++   +  GC     
Sbjct: 84  ILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEF----FTFLRRNKRFPNDVGCF---- 135

Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM-SRDQSRC 267
               A  +     YL +     +++ D+KPEN+LLD++    ++DFG +K++ +R  + C
Sbjct: 136 ---YAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC 189

Query: 268 ITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
                GT  Y+APE +L  G  +  D ++ G+ + E+  G
Sbjct: 190 -----GTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 52.0 bits (125), Expect = 3e-07
 Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 5/90 (5%)

Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            + +LH+   + ++H D+KP NI++  +    + DFGL++         +T    TR Y 
Sbjct: 130 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYR 184

Query: 279 APEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           APE IL  G  E  DI+S G ++ E+  G 
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 51.4 bits (123), Expect = 3e-07
 Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 11/99 (11%)

Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR 272
           A ++   L  LH   R R+++ D+KPENILLD+     +SD GL+  +   +     TIR
Sbjct: 108 AAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-----TIR 159

Query: 273 ---GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
              GT GY+APE +  +  +   D +  G ++ E+  G+
Sbjct: 160 GRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 51/170 (30%), Positives = 84/170 (49%), Gaps = 31/170 (18%)

Query: 146 EVAAIAS-AQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCL 204
           E A++ S   H++L  + G CV  G    +V EF+++G LD  +    R+ +G      +
Sbjct: 65  ETASLMSQVSHIHLAFVHGVCV-RGSENIMVEEFVEHGPLDVCL----RKEKGRVP---V 116

Query: 205 SWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENIL-----LDENYRAVV--SDFGLS 257
           +W  +  VA  +A ALSYL +     ++H +V  +NIL     L E     +  SD G+S
Sbjct: 117 AW--KITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS 171

Query: 258 -KLMSRDQSRCITTIRGTR-GYLAPEWILE-QGVSEKCDIYSYGMVLLEL 304
              +SR++       R  R  ++APE +     +S   D +S+G  LLE+
Sbjct: 172 FTALSREE-------RVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 51.0 bits (122), Expect = 3e-07
 Identities = 66/239 (27%), Positives = 109/239 (45%), Gaps = 42/239 (17%)

Query: 109 LGHGSSASVFKGI---LSDG-----TSVAVKRINGEENGEKEFRSEVAAIASA-QHVNLV 159
           LG G+   +FKGI   + D      T V +K ++       E   E A++ S   H +LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 160 RLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKA 219
              G CV  G    +V E+++ GSLD ++     +   +     +SW L   VA  +A A
Sbjct: 63  LNYGVCVC-GDESIMVQEYVKFGSLDTYL-----KKNKNLIN--ISWKL--EVAKQLAWA 112

Query: 220 LSYLHNDCRSRVLHLDVKPENILL-DENYRAV-------VSDFGLSKLMSRDQSRCITTI 271
           L +L +     + H +V  +N+LL  E  R         +SD G+S  +     + I   
Sbjct: 113 LHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV---LPKEILLE 166

Query: 272 RGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLEL-TGGRRNVSLIEHGNDKSKNKWQYF 328
           R    ++ PE I   Q +S   D +S+G  L E+ +GG + +S ++     S+ K Q++
Sbjct: 167 RIP--WVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD-----SQKKLQFY 218

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 53/223 (23%), Positives = 95/223 (42%), Gaps = 19/223 (8%)

Query: 97  ELEEATDNFQALLGHGSSASVFKGILSDGT------SVAVKRINGEENG--EKEFRSEVA 148
           E+  +T  F   LG      V+KG L          +VA+K +  +  G   +EF+ E  
Sbjct: 1   EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60

Query: 149 AIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSE------GHYSGG 202
             +  QH N+V LLG  V    P  +++ +  +  L  ++   S  S+            
Sbjct: 61  MRSRLQHPNIVCLLG-VVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119

Query: 203 CLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL-SKLMS 261
            L       +   +A  + +L +     V+H D+   N+L+ +     +SD GL  ++ +
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176

Query: 262 RDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            D  + +        +++PE I+    S   DI+SYG+VL E+
Sbjct: 177 ADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 51.5 bits (123), Expect = 4e-07
 Identities = 37/134 (27%), Positives = 71/134 (52%), Gaps = 9/134 (6%)

Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           +A+ +  +H+  +   +H D+KP+N+LLD N    ++DFG    M++D +   +   GT 
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTP 167

Query: 276 GYLAPEWI--LEQGVSE---KCDIYSYGMVLLELTGGRRNV---SLIE-HGNDKSKNKWQ 326
            Y++PE +  +E G+ +   +CD +S G+ + E+  G       SL+E +G   +  +  
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF 227

Query: 327 YFPKIVNEKMKEGK 340
            FP  + +  +E K
Sbjct: 228 QFPSHITDVSEEAK 241

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 51.6 bits (123), Expect = 4e-07
 Identities = 39/163 (23%), Positives = 77/163 (47%), Gaps = 14/163 (8%)

Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           + V E++  G L   +    +  E H          R+  A +++ AL+YLH      ++
Sbjct: 72  FFVIEYVNGGDLMFHMQRQRKLPEEH---------ARFYSA-EISLALNYLH---ERGII 118

Query: 233 HLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKC 292
           + D+K +N+LLD      ++D+G+ K   R      +T  GT  Y+APE +  +      
Sbjct: 119 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-PGDTTSTFCGTPNYIAPEILRGEDYGFSV 177

Query: 293 DIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEK 335
           D ++ G+++ E+  GR    ++   ++  +N   Y  +++ EK
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 220

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 57/207 (27%), Positives = 89/207 (42%), Gaps = 33/207 (15%)

Query: 109 LGHGSSASVFKGILSDGTS-VAVKRIN--GEENGEK--EFRSEVAAIASAQHVNLVRLLG 163
           +GHGS  +V+    S     VAVK+++  G++  EK  +   EV  +   +H N +   G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIF---PTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
            C +     +LV E+    + D       P         + G L             + L
Sbjct: 89  -CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGAL-------------QGL 134

Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAP 280
           +YLH+      +H D+K  NILL E  +  ++DFG +   S   S       GT  ++AP
Sbjct: 135 AYLHSHNM---IHRDIKAGNILLTEPGQVKLADFGSASKSSPANS-----FVGTPYWMAP 186

Query: 281 EWIL---EQGVSEKCDIYSYGMVLLEL 304
           E IL   E     K D++S G+  +EL
Sbjct: 187 EVILAMDEGQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 51.2 bits (123), Expect = 4e-07
 Identities = 62/225 (27%), Positives = 93/225 (41%), Gaps = 59/225 (26%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKE------FRSEVAAIASAQHVNLVRL 161
           +G G+   V+K      G  VA+K+I  E   E E       R E++ +    H N+VRL
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLE--TEDEGVPSTAIR-EISLLKELNHPNIVRL 63

Query: 162 LGYCVVPGGPR-YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR------YRVAI 214
               VV    + YLV+EF     LD                     DL+          +
Sbjct: 64  --LDVVHSENKLYLVFEF-----LDL--------------------DLKKYMDSSPLTGL 96

Query: 215 DVAKALSYLHNDCRS-------RVLHLDVKPENILLDENYRAVVSDFGLSKLMS---RDQ 264
           D     SYL+   +        RVLH D+KP+N+L+D      ++DFGL++      R  
Sbjct: 97  DPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY 156

Query: 265 SRCITTIRGTRGYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
           +  + T+     Y APE +L  +  S   DI+S G +  E+   R
Sbjct: 157 THEVVTL----WYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 51.2 bits (123), Expect = 4e-07
 Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 9/94 (9%)

Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGY 277
           + L Y+H+   + VLH D+KP N+LL+ N    + DFGL++  S ++   +T    TR Y
Sbjct: 119 RGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS-EKGDFMTEYVVTRWY 174

Query: 278 LAPEWIL---EQGVSEKCDIYSYGMVLLELTGGR 308
            APE +L   E   +   D++S G +  EL G +
Sbjct: 175 RAPELLLNCSEYTTA--IDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 51.4 bits (123), Expect = 4e-07
 Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 4/96 (4%)

Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR 272
           A +V  AL +LH   R  V++ D+K +NILLD      ++DFG+ K          TT  
Sbjct: 102 AAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFC 157

Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           GT  Y+APE + E       D ++ G+++ E+  G+
Sbjct: 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 51.2 bits (122), Expect = 5e-07
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 33/211 (15%)

Query: 109 LGHGSSASVFKG--ILSDGTSVAVK--RINGEENGEKEFRSEVAAIASAQHVNLVRLLGY 164
           LG G+ A+V+KG   L+D   VA+K  R+  EE        EV+ +   +H N+V L   
Sbjct: 14  LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL--- 69

Query: 165 CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI---DVAKALS 221
                      ++ I        +F    +    Y   C +    + V +    + + L+
Sbjct: 70  -----------HDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLN 118

Query: 222 YLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS---RDQSRCITTIRGTRGYL 278
           Y H   R +VLH D+KP+N+L++E     ++DFGL++  S   +  S  + T+     Y 
Sbjct: 119 YCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTL----WYR 171

Query: 279 APEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
            P+ +L     S + D++  G +  E++ GR
Sbjct: 172 PPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 51.2 bits (123), Expect = 5e-07
 Identities = 36/132 (27%), Positives = 52/132 (39%), Gaps = 46/132 (34%)

Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK-------------- 258
           AID    L Y+H D         +KP+N+LLD      +SDFGL                
Sbjct: 113 AIDSIHKLGYIHRD---------IKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRIL 163

Query: 259 ---LMS---------RDQSRCITTIR-----------GTRGYLAPEWILEQGVSEKCDIY 295
              L S             R   T +           GT  Y+APE  L+ G +++CD +
Sbjct: 164 SHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWW 223

Query: 296 SYGMVLLELTGG 307
           S G+++ E+  G
Sbjct: 224 SLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 50.7 bits (121), Expect = 6e-07
 Identities = 41/153 (26%), Positives = 73/153 (47%), Gaps = 24/153 (15%)

Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRV---AIDVAKALSYLHNDCRS 229
           + V EF+  G L   I    R            +DL YR    A ++   L +LH+    
Sbjct: 72  FFVMEFLNGGDLMFHIQDKGR------------FDL-YRATFYAAEIVCGLQFLHS---K 115

Query: 230 RVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVS 289
            +++ D+K +N++LD +    ++DFG+ K      +R  +T  GT  Y+APE +     +
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA-STFCGTPDYIAPEILQGLKYT 174

Query: 290 EKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSK 322
              D +S+G++L E+  G+       HG+D+ +
Sbjct: 175 FSVDWWSFGVLLYEMLIGQSPF----HGDDEDE 203

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 50.9 bits (122), Expect = 6e-07
 Identities = 51/224 (22%), Positives = 91/224 (40%), Gaps = 44/224 (19%)

Query: 109 LGHGSSASVFKGILSD-GTSVAVKRIN-GEENGEKEFRSEVAAIASAQHVNLVRLLGYCV 166
           LG GS+  VF  + SD    VAVK+I   +    K    E+  I    H N+V+      
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK------ 66

Query: 167 VPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGC-----LSWDLRY-----RVAIDV 216
                   VYE +     D         S    +        +  DL        ++ + 
Sbjct: 67  --------VYEVLGPSGSD---LTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEH 115

Query: 217 AK--------ALSYLHNDCRSRVLHLDVKPENILLD-ENYRAVVSDFGLSKLMSRDQSRC 267
           A+         L Y+H+   + VLH D+KP N+ ++ E+    + DFGL++++    S  
Sbjct: 116 ARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHK 172

Query: 268 --ITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
             ++    T+ Y +P  +L     ++  D+++ G +  E+  G+
Sbjct: 173 GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 50.3 bits (120), Expect = 7e-07
 Identities = 52/190 (27%), Positives = 89/190 (46%), Gaps = 23/190 (12%)

Query: 123 SDGTS--VAVK---RINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRY-LVY 176
           +DGT   VAVK   R  G++N    ++ E+  + +  H N+V+  G C   GG    L+ 
Sbjct: 29  NDGTGEMVAVKTLKRECGQQN-TSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIM 87

Query: 177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDV 236
           E++  GSL  ++ P  + +        L+  L +  A  + + ++YLH+      +H D+
Sbjct: 88  EYVPLGSLRDYL-PKHKLN--------LAQLLLF--AQQICEGMAYLHS---QHYIHRDL 133

Query: 237 KPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG--YLAPEWILEQGVSEKCDI 294
              N+LLD +    + DFGL+K +            G     + A E + E   S   D+
Sbjct: 134 AARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDV 193

Query: 295 YSYGMVLLEL 304
           +S+G+ L EL
Sbjct: 194 WSFGVTLYEL 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 50.3 bits (120), Expect = 9e-07
 Identities = 51/204 (25%), Positives = 92/204 (45%), Gaps = 16/204 (7%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCV 166
            +G G+  SV   I    G  VA+K+++      + F+SE+ A  + + + L++ + +  
Sbjct: 22  QVGSGAYGSVCSAIDKRTGEKVAIKKLS------RPFQSEIFAKRAYRELTLLKHMQHEN 75

Query: 167 VPGGPRYLVYEFIQNGSLDHW-IFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
           V G           +   D + + P  +       G  LS D    +   +   L Y+H 
Sbjct: 76  VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIH- 134

Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILE 285
              + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR Y APE IL 
Sbjct: 135 --SAGIIHRDLKPGNLAVNEDCELKILDFGL----ARHADAEMTGYVVTRWYRAPEVILN 188

Query: 286 -QGVSEKCDIYSYGMVLLELTGGR 308
               ++  DI+S G ++ E+  G+
Sbjct: 189 WMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 25/83 (30%), Positives = 42/83 (50%), Gaps = 6/83 (7%)

Query: 232 LHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           +H D+KPEN+L+D      ++DFG +  ++ ++        GT  Y+APE +       K
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183

Query: 292 ------CDIYSYGMVLLELTGGR 308
                 CD +S G++  E+  GR
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 34/114 (29%), Positives = 56/114 (49%), Gaps = 13/114 (11%)

Query: 228 RSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR---GTRGYLAPEWIL 284
           R R+++ D+KPENILLD+     +SD GL+  +   +     T+R   GT GY+APE I 
Sbjct: 120 RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-----TVRGRVGTVGYMAPEVIN 174

Query: 285 EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE 338
            +  +   D +  G ++ E+  G+           K + K +   + V E  +E
Sbjct: 175 NEKYTFSPDWWGLGCLIYEMIQGQSPFR-----KRKERVKREEVDRRVKEDQEE 223

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 40/163 (24%), Positives = 75/163 (46%), Gaps = 16/163 (9%)

Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           +LV E++  G L   +    +  E H          R+  A ++  AL++LH      ++
Sbjct: 72  FLVIEYVNGGDLMFHMQRQRKLPEEH---------ARFYAA-EICIALNFLH---ERGII 118

Query: 233 HLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKC 292
           + D+K +N+LLD +    ++D+G+ K          +T  GT  Y+APE +  +      
Sbjct: 119 YRDLKLDNVLLDADGHIKLTDYGMCKEGLG-PGDTTSTFCGTPNYIAPEILRGEEYGFSV 177

Query: 293 DIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEK 335
           D ++ G+++ E+  GR    +I    D   N   Y  +++ EK
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPD--MNTEDYLFQVILEK 218

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 47/184 (25%), Positives = 82/184 (44%), Gaps = 25/184 (13%)

Query: 154 QHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRV- 212
            H  L +L   C       + V EF+  G L   I  + R  E            R R  
Sbjct: 54  NHPFLTQLY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA-----------RARFY 101

Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR 272
           A ++  AL +LH+     +++ D+K +N+LLD      ++DFG+ K    +  +  +T  
Sbjct: 102 AAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTSTFC 157

Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIV 332
           GT  Y+APE + E       D ++ G++L E+  G        H   +++N+   F  I+
Sbjct: 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG--------HAPFEAENEDDLFEAIL 209

Query: 333 NEKM 336
           N+++
Sbjct: 210 NDEV 213

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 7/95 (7%)

Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI--TTIRGTR 275
           +AL Y+H    + V H D+KP+NIL + + +  + DFGL+++   D    I  T    TR
Sbjct: 114 RALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 276 GYLAPEWI--LEQGVSEKCDIYSYGMVLLELTGGR 308
            Y APE         +   DI+S G +  E+  G+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)

Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 129 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATR 181

Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 182 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 41/217 (18%)

Query: 109 LGHGSSASVFKGIL---SDG--------TSVAVKRINGEENGEKEFRSEVAAIASAQHVN 157
           LG G+  +++KG+L   SD          SV +K +  +      F    + ++   H +
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
           LV+L G CV       +V E+++ G LD ++     R + + S     W L   VA  +A
Sbjct: 63  LVKLYGVCVRD--ENIMVEEYVKFGPLDVFL----HREKNNVSL---HWKL--DVAKQLA 111

Query: 218 KALSYLHNDCRSRVLHLDVKPENILL-----DENYR--AVVSDFGLSK-LMSRDQSRCIT 269
            AL YL +    +++H +V  +NIL+     +E Y     +SD G+   ++SR++   + 
Sbjct: 112 SALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREE--RVE 166

Query: 270 TIRGTRGYLAPEWI--LEQGVSEKCDIYSYGMVLLEL 304
            I     ++APE I   +  ++   D +S+G  LLE+
Sbjct: 167 RIP----WIAPECIRNGQASLTIAADKWSFGTTLLEI 199

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 31/86 (36%), Positives = 47/86 (54%), Gaps = 4/86 (4%)

Query: 220 LSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLA 279
           L+Y H       LH D+K  NILL+   +  ++DFGL++L + ++SR  T    T  Y  
Sbjct: 129 LNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRP 185

Query: 280 PEWIL-EQGVSEKCDIYSYGMVLLEL 304
           PE +L E+      D++S G +L EL
Sbjct: 186 PELLLGEERYGPAIDVWSCGCILGEL 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 29/86 (33%), Positives = 48/86 (55%), Gaps = 5/86 (5%)

Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            + +LH+   + ++H D+KP NI++  +    + DFGL++  +   S  +T    TR Y 
Sbjct: 131 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 185

Query: 279 APEWILEQGVSEKCDIYSYGMVLLEL 304
           APE IL  G  E  DI+S G ++ E+
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEM 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 49.8 bits (119), Expect = 3e-06
 Identities = 33/112 (29%), Positives = 52/112 (46%), Gaps = 22/112 (19%)

Query: 211 RVAIDVAKALSYLHNDCRSR-VLHLDVKPENILLDENYRAVVSDFG--LSKLMSRDQSRC 267
            +   +   + Y+H    S+ VLH D+KP+NILL      V+ D+G  + K +  +    
Sbjct: 117 SIFHKICATIEYVH----SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172

Query: 268 ITT---------------IRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           I                 I GT  Y+APE +L    SE  DIY+ G++L ++
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQM 224

Length = 932

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 27/204 (13%)

Query: 109 LGHGSSASV-FKGILSDGTSVAVKRIN--GEENGEK--EFRSEVAAIASAQHVNLVRLLG 163
           +GHGS  +V F   +     VA+K+++  G+++ EK  +   EV  +   +H N +   G
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92

Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL 223
            C +     +LV E+    + D          E   +           +     + L+YL
Sbjct: 93  -CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA----------ITHGALQGLAYL 141

Query: 224 HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWI 283
           H+     ++H D+K  NILL E  +  ++DFG + + S   S       GT  ++APE I
Sbjct: 142 HS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS-----FVGTPYWMAPEVI 193

Query: 284 L---EQGVSEKCDIYSYGMVLLEL 304
           L   E     K D++S G+  +EL
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 5/90 (5%)

Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            + +LH+   + ++H D+KP NI++  +    + DFGL++  +   S  +T    TR Y 
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 192

Query: 279 APEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           APE IL  G  E  DI+S G ++ E+  G 
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 48.3 bits (115), Expect = 4e-06
 Identities = 39/166 (23%), Positives = 76/166 (45%), Gaps = 20/166 (12%)

Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGH---YSGGCLSWDLRYRVAIDVAKALSYLHNDCRS 229
           + V EF+  G L   +    +  E H   YS              +++ AL++LH     
Sbjct: 72  FFVIEFVSGGDLMFHMQRQRKLPEEHARFYSA-------------EISLALNFLHE---R 115

Query: 230 RVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVS 289
            +++ D+K +N+LLD      ++D+G+ K   R      +T  GT  Y+APE +  +   
Sbjct: 116 GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTSTFCGTPNYIAPEILRGEDYG 174

Query: 290 EKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEK 335
              D ++ G+++ E+  GR    ++   ++  +N   Y  +++ EK
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK 220

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 49.0 bits (116), Expect = 4e-06
 Identities = 53/203 (26%), Positives = 87/203 (42%), Gaps = 44/203 (21%)

Query: 136 EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPR-YLVYEFIQNGSLDHWIFPTSRR 194
           +E  + +   EV  +   +H N+VR +   +     + Y++ EF   G L       SR 
Sbjct: 52  KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDL-------SRN 104

Query: 195 SEGHYSGGCLSWDLRYRVAIDVAK----ALSYLHN----DCRSRVLHLDVKPENILLDEN 246
            +  Y    +   +     +D+ +    AL+Y HN        RVLH D+KP+NI L   
Sbjct: 105 IQKCYK---MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTG 161

Query: 247 YR-----------------AVVSDFGLSKLMSRDQ--SRCITTIRGTRGYLAPEWILEQG 287
            R                 A + DFGLSK +  +     C+    GT  Y +PE +L + 
Sbjct: 162 IRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCV----GTPYYWSPELLLHET 217

Query: 288 VS--EKCDIYSYGMVLLELTGGR 308
            S  +K D+++ G ++ EL  G+
Sbjct: 218 KSYDDKSDMWALGCIIYELCSGK 240

Length = 1021

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 47.9 bits (114), Expect = 5e-06
 Identities = 58/222 (26%), Positives = 101/222 (45%), Gaps = 37/222 (16%)

Query: 103 DNFQAL--LGHGSSASVFKGI-LSDGTSVAVK--RINGEENG--EKEFRSEVAAIAS-AQ 154
           D ++ L  +G G+   V+K    + G  VA+K  R+  +E G      R E++ +   ++
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR-EISLLQMLSE 59

Query: 155 HVNLVRLLGYCVV-----PGGPR-YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL 208
            + +VRLL   V       G P  YLV+E++ +  L  ++  ++ R  G           
Sbjct: 60  SIYIVRLL--DVEHVEEKNGKPSLYLVFEYL-DSDLKKFM-DSNGRGPGRPLPAKTIKSF 115

Query: 209 RYRVAIDVAKALSYLHNDCRSR-VLHLDVKPENILLDENYRAV-VSDFGLSKLMS---RD 263
            Y++   VA         C    V+H D+KP+N+L+D+    + ++D GL +  S   + 
Sbjct: 116 MYQLLKGVAH--------CHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS 167

Query: 264 QSRCITTIRGTRGYLAPEWIL-EQGVSEKCDIYSYGMVLLEL 304
            +  I T+     Y APE +L     S   DI+S G +  E+
Sbjct: 168 YTHEIVTL----WYRAPEVLLGSTHYSTPVDIWSVGCIFAEM 205

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 48.3 bits (115), Expect = 5e-06
 Identities = 46/183 (25%), Positives = 68/183 (37%), Gaps = 71/183 (38%)

Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEG---HYSGGCLSWDLRYRVAIDVAKALSYLHNDCRS 229
           YL+ EF+  G L   +      SE     Y   C+       +AI+    L ++H D   
Sbjct: 77  YLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECV-------LAIEAVHKLGFIHRD--- 126

Query: 230 RVLHLDVKPENILLDENYRAVVSDFGLS-------------------------------- 257
                 +KP+NIL+D      +SDFGLS                                
Sbjct: 127 ------IKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180

Query: 258 ------KLMSRDQSRCITTIR-----------GTRGYLAPEWILEQGVSEKCDIYSYGMV 300
                  + S+DQ   I T +           GT  Y+APE  L+QG  ++CD +S G +
Sbjct: 181 VDSINLTMSSKDQ---IATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237

Query: 301 LLE 303
           + E
Sbjct: 238 MFE 240

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 47.7 bits (113), Expect = 5e-06
 Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 5/96 (5%)

Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR 272
           A ++   L  LH   R   ++ D+KPENILLD+     +SD GL+  +   +S  I    
Sbjct: 108 AAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV 162

Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           GT GY+APE +  Q  +   D +  G ++ E+  G+
Sbjct: 163 GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 48.1 bits (114), Expect = 6e-06
 Identities = 31/123 (25%), Positives = 54/123 (43%), Gaps = 46/123 (37%)

Query: 232 LHLDVKPENILLDENYRAVVSDFGL----------------------------------- 256
           +H D+KP+NIL+D +    ++DFGL                                   
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 257 ----SKLMSRDQ------SRCIT-TIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELT 305
                +L + +Q       RC+  ++ GT  Y+APE +L +G ++ CD +S G++L E+ 
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242

Query: 306 GGR 308
            G+
Sbjct: 243 VGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 47.7 bits (113), Expect = 7e-06
 Identities = 53/211 (25%), Positives = 100/211 (47%), Gaps = 27/211 (12%)

Query: 108 LLGHGSSASVFKGILSDGTS-VAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCV 166
           ++G+GS   V++ I  D +  VA+K++  +   +     E+  + +  H+N++ L  Y  
Sbjct: 73  IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR---ELLIMKNLNHINIIFLKDY-- 127

Query: 167 VPGGPRYLVYEFIQN------GSLDHWIFPTSRRSEGHYS--GGCLSWDLRYRVAIDVAK 218
                 Y    F +N        +  +I  T  +   HY+     L   L    +  + +
Sbjct: 128 ------YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCR 181

Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSRDQSRCITTIRGTRGY 277
           AL+Y+H+     + H D+KP+N+L+D N   + + DFG +K +   Q R ++ I  +R Y
Sbjct: 182 ALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ-RSVSYI-CSRFY 236

Query: 278 LAPEWIL-EQGVSEKCDIYSYGMVLLELTGG 307
            APE +L     +   D++S G ++ E+  G
Sbjct: 237 RAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 47.1 bits (112), Expect = 7e-06
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 28/210 (13%)

Query: 109 LGHGSSASVFKGILSD---GTSVAVKRINGEENGE----KEFRSEVAAIASAQHVNLVRL 161
           +G G+   V+K    D     ++A+K+I  E+  E       R E++ +   QH N+VRL
Sbjct: 10  IGEGTYGVVYKA--RDRVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEMQHGNIVRL 66

Query: 162 LGYCVVPGGPR-YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
               VV    R YLV+E++ +  L   +  +   ++         +         + + +
Sbjct: 67  --QDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQ--------ILRGI 115

Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSRDQSRCITTIRGTRGYLA 279
           +Y H+    RVLH D+KP+N+L+D    A+ ++DFGL++       R  T    T  Y A
Sbjct: 116 AYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVRTFTHEVVTLWYRA 171

Query: 280 PEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
           PE +L  +  S   DI+S G +  E+   +
Sbjct: 172 PEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 47.4 bits (112), Expect = 7e-06
 Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 14/101 (13%)

Query: 212 VAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTI 271
           +AID    L Y+H D         +KP+NIL+D N    ++DFG    +  D +   +  
Sbjct: 113 IAIDSVHQLHYVHRD---------IKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 163

Query: 272 RGTRGYLAPEWI--LEQG---VSEKCDIYSYGMVLLELTGG 307
            GT  Y++PE +  +E G      +CD +S G+ + E+  G
Sbjct: 164 VGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 47.7 bits (113), Expect = 8e-06
 Identities = 30/123 (24%), Positives = 51/123 (41%), Gaps = 46/123 (37%)

Query: 232 LHLDVKPENILLDENYRAVVSDFGL----------------------------------- 256
           +H D+KP+NIL+D +    ++DFGL                                   
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 257 ----------SKLMSRDQSRCIT-TIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELT 305
                      +  +R   RC+  ++ GT  Y+APE +L  G ++ CD +S G++L E+ 
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 306 GGR 308
            G+
Sbjct: 243 VGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 47.0 bits (112), Expect = 9e-06
 Identities = 46/205 (22%), Positives = 83/205 (40%), Gaps = 27/205 (13%)

Query: 112 GSSASVFKGILSDGTSVAVKRINGEENGEK----EFRSEVAAIASAQHVNLVRLLGYCV- 166
               S++KGI  +   V ++       G K       +E+  +      N++++ G+ + 
Sbjct: 31  NDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIID 89

Query: 167 -VPGGPRY-LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH 224
            V   PR  L+ E+   G L   +               LS+  +  +AID  K L  L+
Sbjct: 90  IVDDLPRLSLILEYCTRGYLREVL----------DKEKDLSFKTKLDMAIDCCKGLYNLY 139

Query: 225 NDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWIL 284
                   +L     + L+ ENY+  +   GL K++S    + +  +     Y + + + 
Sbjct: 140 KYTNKPYKNL--TSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFM----VYFSYKMLN 193

Query: 285 E--QGVSEKCDIYSYGMVLLE-LTG 306
           +     + K DIYS G+VL E  TG
Sbjct: 194 DIFSEYTIKDDIYSLGVVLWEIFTG 218

Length = 283

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 46.8 bits (111), Expect = 1e-05
 Identities = 27/89 (30%), Positives = 45/89 (50%), Gaps = 5/89 (5%)

Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L YLH     R++H DVK ENI +++  +  + D G ++      +     + GT 
Sbjct: 166 ILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA--FLGLAGTV 220

Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
              APE +     + K DI+S G+VL E+
Sbjct: 221 ETNAPEVLARDKYNSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 29/92 (31%), Positives = 50/92 (54%), Gaps = 8/92 (8%)

Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGY 277
           + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR Y
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGL----ARQADDEMTGYVATRWY 181

Query: 278 LAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            APE +L     ++  DI+S G ++ EL  G+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 30/100 (30%), Positives = 45/100 (45%), Gaps = 5/100 (5%)

Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           V +A+ YLH +   R++H D+K ENI ++      + DFG +       +       GT 
Sbjct: 191 VLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTI 247

Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIE 315
              APE +         DI+S G+VL E+       SL E
Sbjct: 248 ATNAPELLARDPYGPAVDIWSAGIVLFEMATCHD--SLFE 285

Length = 391

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 28/92 (30%), Positives = 50/92 (54%), Gaps = 8/92 (8%)

Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGY 277
           K L Y+H    + ++H D+KP N+ ++E+    + DFGL++    + +  +     TR Y
Sbjct: 129 KGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVV----TRWY 181

Query: 278 LAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            APE IL     ++  DI+S G ++ E+  G+
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 45.2 bits (108), Expect = 3e-05
 Identities = 41/157 (26%), Positives = 68/157 (43%), Gaps = 25/157 (15%)

Query: 155 HVNLVRLLGYCVVPGGPR--YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRV 212
           + N ++L  Y V     +   L+ ++I++G L    F   ++       G LS     ++
Sbjct: 68  NPNFIKLY-YSV--TTLKGHVLIMDYIKDGDL----FDLLKKE------GKLSEAEVKKI 114

Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDEN-YRAVVSDFGLSKLMSRDQSRCITTI 271
              + +AL+ LH      ++H D+K EN+L D    R  + D+GL K        C    
Sbjct: 115 IRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCK--IIGTPSC---Y 166

Query: 272 RGTRGYLAPEWILEQGVSEKCDIYSYGMVLLE-LTGG 307
            GT  Y +PE I         D ++ G++  E LTG 
Sbjct: 167 DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 31/87 (35%), Positives = 46/87 (52%), Gaps = 4/87 (4%)

Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI-TTIRGTRGY 277
           AL  +H+     ++H D+K  NI L       + DFG SK  S   S  + ++  GT  Y
Sbjct: 181 ALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYY 237

Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLEL 304
           LAPE    +  S+K D++S G++L EL
Sbjct: 238 LAPELWERKRYSKKADMWSLGVILYEL 264

Length = 478

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 45.7 bits (108), Expect = 3e-05
 Identities = 32/110 (29%), Positives = 51/110 (46%), Gaps = 14/110 (12%)

Query: 211 RVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV--VSDFGLSKLMSR------ 262
           ++      AL Y H +    ++H D+KPENIL++ +   V  V++  L     R      
Sbjct: 235 QIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDL 292

Query: 263 ----DQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
               D+    T I  TR Y +PE +L  G     D++S G ++ EL  G+
Sbjct: 293 GGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 45.4 bits (108), Expect = 3e-05
 Identities = 57/228 (25%), Positives = 97/228 (42%), Gaps = 47/228 (20%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKE------FRSEVAAIASAQHVNLVRL 161
           LG G+   V+K   +  G  VA+K+I    + EK+       R E+  +   +H N+V L
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKIL--MHNEKDGFPITALR-EIKILKKLKHPNVVPL 72

Query: 162 LGYCVVPG-------GPRYLVYEFIQ---NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYR 211
           +   V          G  Y+V  ++    +G L++   P+ + +E       L       
Sbjct: 73  IDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN---PSVKLTESQIKCYMLQ------ 123

Query: 212 VAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ------- 264
               + + ++YLH    + +LH D+K  NIL+D      ++DFGL++             
Sbjct: 124 ----LLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176

Query: 265 ---SRCITTIRGTRGYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
              +R  T +  TR Y  PE +L E+  +   DI+  G V  E+   R
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 45.6 bits (108), Expect = 4e-05
 Identities = 21/50 (42%), Positives = 34/50 (68%), Gaps = 4/50 (8%)

Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL-MSRD 263
           +VA AL YLH   R  ++H D+KP+N+L+       ++DFGLSK+ ++R+
Sbjct: 112 EVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 47/234 (20%), Positives = 94/234 (40%), Gaps = 54/234 (23%)

Query: 212 VAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL--------------- 256
           +AID    L ++H D         +KP+N+LLD      +SDFGL               
Sbjct: 112 LAIDAIHQLGFIHRD---------IKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRN 162

Query: 257 -------------------SKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSY 297
                              ++   +++ +   +  GT  Y+APE  ++ G ++ CD +S 
Sbjct: 163 LTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222

Query: 298 GMVLLE-LTGGRRNVSLIEHGNDKSKNKWQ----YFPKI-VNEKMKEGKLMEIVD-QRLT 350
           G+++ E L G     S       +    W+    + P++ ++EK K+  L    D +   
Sbjct: 223 GVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRI 282

Query: 351 DEGGIDETQVRRLVDVAFWCIQERARLRPSMARV-VEMLEGRVAVDDPPDTQMV 403
              G++E +     +   W      R RP+   + ++ ++     D+ P++ ++
Sbjct: 283 GSNGVEEIKSHPFFEGVDW---GHIRERPAAIPIEIKSIDDTSNFDEFPESDIL 333

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 44.9 bits (106), Expect = 4e-05
 Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 39/217 (17%)

Query: 109 LGHGSSASVFKGILSDGTSVA---VKRI--NGEENGEKEFRSEVAAIASAQHVNLVRLLG 163
           +G+G    V    +   T VA   VK +  N     + EF  +       QH N+++ LG
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL 223
            C V   P  LV+E+ + G L  ++     + + H     L   L  R+A ++A  ++++
Sbjct: 63  QC-VEAIPYLLVFEYCELGDLKSYL----SQEQWHRRNSQLL--LLQRMACEIAAGVTHM 115

Query: 224 HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITT-------IRGTRG 276
           H   +   LH D+   N  L  +    V D+G+    SR +   I T       +R    
Sbjct: 116 H---KHNFLHSDLALRNCFLTSDLTVKVGDYGIG--PSRYKEDYIETEDDKCVPLR---- 166

Query: 277 YLAPEWI---------LEQGVSEKCDIYSYGMVLLEL 304
           +LAPE +          EQ  ++  ++++ G+ L EL
Sbjct: 167 WLAPELVGEFHGGLITAEQ--TKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 45.2 bits (107), Expect = 4e-05
 Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 14/101 (13%)

Query: 212 VAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTI 271
           +AID    L Y+H D         +KP+N+LLD+N    ++DFG    +  D +      
Sbjct: 113 LAIDSVHQLGYVHRD---------IKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA 163

Query: 272 RGTRGYLAPEWI--LEQGVSE---KCDIYSYGMVLLELTGG 307
            GT  Y++PE +  +E G      +CD +S G+ + E+  G
Sbjct: 164 VGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 43.5 bits (103), Expect = 5e-05
 Identities = 26/91 (28%), Positives = 37/91 (40%), Gaps = 9/91 (9%)

Query: 219 ALSYLHNDCRS-RVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGY 277
             +       + R LH   K  NILL  +   ++   G     + +QSR          +
Sbjct: 19  IWAVCLQCLGALRELHRQAKSGNILLTWD--GLLKLDGSVAFKTPEQSR------PDPYF 70

Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           +APE I  Q  +EK DIYS G+ L E     
Sbjct: 71  MAPEVIQGQSYTEKADIYSLGITLYEALDYE 101

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 45.0 bits (106), Expect = 5e-05
 Identities = 27/110 (24%), Positives = 48/110 (43%), Gaps = 34/110 (30%)

Query: 232 LHLDVKPENILLDENYRAVVSDFGL----------------------------------S 257
           +H D+KP+N+LLD      +SDFGL                                  +
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182

Query: 258 KLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           +   R++ +   +  GT  Y+APE  ++ G ++ CD +S G+++ E+  G
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 44.3 bits (105), Expect = 6e-05
 Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 17/156 (10%)

Query: 109 LGHGSSASVFKGILS-DGTSVAVK--RINGEENGEKEFRSEVAAIASAQHVNLVRLLGYC 165
           LG GS A+V+KG     G  VA+K  R+  EE        E + +   +H N+V  L   
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIV-TLHDI 71

Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
           +       LV+E++    L  ++       +    GG LS          + + L+Y H 
Sbjct: 72  IHTKKTLTLVFEYLDT-DLKQYM-------DDC--GGGLSMHNVRLFLFQLLRGLAYCH- 120

Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS 261
             + RVLH D+KP+N+L+ E     ++DFGL++  S
Sbjct: 121 --QRRVLHRDLKPQNLLISERGELKLADFGLARAKS 154

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 44.5 bits (105), Expect = 7e-05
 Identities = 30/101 (29%), Positives = 54/101 (53%), Gaps = 7/101 (6%)

Query: 206 WDLRYRVAIDVAKALSYL-HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ 264
            DL  R +  VA+ + +L   +C    +H DV   N+LL +   A + DFGL++ +  D 
Sbjct: 212 DDL-LRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDS 266

Query: 265 SRCIT-TIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +  +    R    ++APE I +   + + D++SYG++L E+
Sbjct: 267 NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 42.4 bits (100), Expect = 9e-05
 Identities = 36/159 (22%), Positives = 60/159 (37%), Gaps = 24/159 (15%)

Query: 107 ALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLV--RLLGY 164
            LL  G +  V+   L       V +IN       +   EVA +       L   ++L  
Sbjct: 4   KLLKGGLTNRVYL--LGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLAS 61

Query: 165 CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH 224
               G   YL+ E+I+  +LD                  +S + +  +A  +A+ L+ LH
Sbjct: 62  GESDGWS-YLLMEWIEGETLDE-----------------VSEEEKEDIAEQLAELLAKLH 103

Query: 225 NDCRSRVL-HLDVKPENILLDENYRAVVSDFGLSKLMSR 262
                 VL H D+ P NIL+D+     + D+  +     
Sbjct: 104 -QLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGPP 141

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 57/230 (24%), Positives = 102/230 (44%), Gaps = 56/230 (24%)

Query: 104 NFQAL--LGHGSSASVFKGILSDGTS---VAVKRINGEENGEKE------FRSEVAAIAS 152
            F+ L  +G G+   V++    D TS   VA+K++  +   E++       R E+  + +
Sbjct: 8   EFEKLNRIGEGTYGIVYRA--RDTTSGEIVALKKVRMDN--ERDGIPISSLR-EITLLLN 62

Query: 153 AQHVNLVRLLGYCVVPGGPR---YLVYEFIQN--GSL-DHWI--FPTSRRSEGHYSGGCL 204
            +H N+V L    VV G      +LV E+ +    SL D+    F  S+         CL
Sbjct: 63  LRHPNIVELKE--VVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVK-------CL 113

Query: 205 SWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS--- 261
                    + + + L YLH +    ++H D+K  N+LL +     ++DFGL++      
Sbjct: 114 M--------LQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162

Query: 262 RDQSRCITTIRGTRGYLAPEWILEQGVSEK---CDIYSYGMVLLELTGGR 308
           +  +  + T+     Y APE +L  G +      D+++ G +L EL   +
Sbjct: 163 KPMTPKVVTL----WYRAPELLL--GCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 28/91 (30%), Positives = 49/91 (53%), Gaps = 6/91 (6%)

Query: 216 VAKALSYLHN-DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT-TIRG 273
           VAK +S+L + +C    +H D+   NILL       + DFGL++ +  D +  +    R 
Sbjct: 223 VAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL 278

Query: 274 TRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
              ++APE I     + + D++SYG++L E+
Sbjct: 279 PVKWMAPESIFNCVYTFESDVWSYGILLWEI 309

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 26/90 (28%), Positives = 51/90 (56%), Gaps = 4/90 (4%)

Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT-TIRGT 274
           VA+ + +L +    + +H D+   NILL EN    + DFGL++ + +D       + R  
Sbjct: 183 VARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 275 RGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
             ++APE I ++  + + D++S+G++L E+
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEI 269

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 43.9 bits (103), Expect = 1e-04
 Identities = 28/101 (27%), Positives = 52/101 (51%), Gaps = 4/101 (3%)

Query: 204 LSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD 263
           L    R  +   +  A+ Y+H+    +++H D+K ENI L+ + + V+ DFG +    ++
Sbjct: 265 LLKQTR-AIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKE 320

Query: 264 QSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +        GT    +PE +   G  E  DI+S G++LL++
Sbjct: 321 REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361

Length = 501

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 42/161 (26%), Positives = 64/161 (39%), Gaps = 26/161 (16%)

Query: 149 AIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWI----FPTSRRSEGHYSGGCL 204
              S +H  LV L   C         V E+   G L   I    F   R     +   C 
Sbjct: 55  TANSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPR---AVFYAAC- 109

Query: 205 SWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL-MSRD 263
                      V   L YLH +   ++++ D+K +N+LLD      ++DFGL K  M   
Sbjct: 110 -----------VVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155

Query: 264 QSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
                +T  GT  +LAPE + E   +   D +  G+++ E+
Sbjct: 156 DR--TSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEM 194

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 26/90 (28%), Positives = 50/90 (55%), Gaps = 4/90 (4%)

Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT-TIRGT 274
           VA+ + +L +    + +H D+   NILL EN    + DFGL++ + +D         R  
Sbjct: 182 VARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238

Query: 275 RGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
             ++APE I ++  + + D++S+G++L E+
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEI 268

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 42.4 bits (99), Expect = 3e-04
 Identities = 51/208 (24%), Positives = 93/208 (44%), Gaps = 19/208 (9%)

Query: 109 LGHGSSASVFKGILSDGTS---VAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYC 165
           +G G+   V+K    DG      A+K+I G        R E+A +   +H N++ L    
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR-EIALLRELKHPNVISLQKVF 67

Query: 166 VVPGGPR-YLVYEFIQNGSLDHW-IFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL 223
           +     + +L++++ ++   D W I    R S+ +     L   +   +   +   + YL
Sbjct: 68  LSHADRKVWLLFDYAEH---DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124

Query: 224 HNDCRSRVLHLDVKPENILL----DENYRAVVSDFGLSKLMSRDQSRC--ITTIRGTRGY 277
           H +    VLH D+KP NIL+     E  R  ++D G ++L +        +  +  T  Y
Sbjct: 125 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181

Query: 278 LAPEWIL-EQGVSEKCDIYSYGMVLLEL 304
            APE +L  +  ++  DI++ G +  EL
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 42.4 bits (99), Expect = 3e-04
 Identities = 51/208 (24%), Positives = 93/208 (44%), Gaps = 19/208 (9%)

Query: 109 LGHGSSASVFKGILSDGT---SVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYC 165
           +G G+   V+K    DG      A+K+I G        R E+A +   +H N++ L    
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR-EIALLRELKHPNVIALQKVF 67

Query: 166 VVPGGPR-YLVYEFIQNGSLDHW-IFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL 223
           +     + +L++++ ++   D W I    R S+ +     L   +   +   +   + YL
Sbjct: 68  LSHSDRKVWLLFDYAEH---DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124

Query: 224 HNDCRSRVLHLDVKPENILL----DENYRAVVSDFGLSKLMSRDQSRC--ITTIRGTRGY 277
           H +    VLH D+KP NIL+     E  R  ++D G ++L +        +  +  T  Y
Sbjct: 125 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181

Query: 278 LAPEWIL-EQGVSEKCDIYSYGMVLLEL 304
            APE +L  +  ++  DI++ G +  EL
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 41.5 bits (97), Expect = 5e-04
 Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 42/219 (19%)

Query: 109 LGHGSSASVFKGILSD---------GTSVAVKRI-----NGEENGEKEFRSEVAAIASAQ 154
           LG G+   ++ GIL+               +K I         +    F    + +    
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI 214
           H ++V L G CV       +V EF++ G LD ++    R+S+       L+   +++VA 
Sbjct: 63  HKHIVLLYGVCV-RDVENIMVEEFVEFGPLDLFM---HRKSD------VLTTPWKFKVAK 112

Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILL-----DENYRAVV--SDFGLS-KLMSRDQSR 266
            +A ALSYL +     ++H +V  +NILL     D      +  SD G+   ++SR +  
Sbjct: 113 QLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQE-- 167

Query: 267 CITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLEL 304
           C+  I     ++APE + + + +S   D +S+G  L E+
Sbjct: 168 CVERIP----WIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 41.4 bits (98), Expect = 5e-04
 Identities = 26/87 (29%), Positives = 44/87 (50%), Gaps = 5/87 (5%)

Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            +++LH    + +LH D+K  N+LL+      + DFGL++       +  T +  T  Y 
Sbjct: 118 GVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYG-SPLKPYTQLVVTLWYR 173

Query: 279 APEWIL-EQGVSEKCDIYSYGMVLLEL 304
           APE +L  +  S   D++S G +  EL
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAEL 200

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 41.1 bits (96), Expect = 8e-04
 Identities = 17/45 (37%), Positives = 26/45 (57%), Gaps = 3/45 (6%)

Query: 212 VAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL 256
           +  D+   L Y+H    S   H D+KPENI++D N R  + D+G+
Sbjct: 131 IMKDMLTTLEYIHEHGIS---HGDIKPENIMVDGNNRGYIIDYGI 172

Length = 294

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 39.4 bits (92), Expect = 0.002
 Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 11/90 (12%)

Query: 109 LGHGS-----SASVFKGILSDGT--SVAVK--RINGEENGEKEFRSEVAA-IASAQHVNL 158
           LG G+      AS F GI    +  +VAVK  +     +  K   +E+   I    H+N+
Sbjct: 15  LGRGAFGKVIQASAF-GIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNV 73

Query: 159 VRLLGYCVVPGGPRYLVYEFIQNGSLDHWI 188
           V LLG C  PGGP  ++ E+ + G+L +++
Sbjct: 74  VNLLGACTKPGGPLMVIVEYCKFGNLSNYL 103

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 40.1 bits (94), Expect = 0.002
 Identities = 54/248 (21%), Positives = 87/248 (35%), Gaps = 48/248 (19%)

Query: 91  IKFRSKELEEATDNFQALLGHGSSASVFKGI-LSDGTSVAVKR--INGEENGEKEFRS-- 145
           + F   E           LG G+   V K      G  VA+K+  I    N   + R   
Sbjct: 2   MSFSISERYIQKGAH---LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLV 58

Query: 146 -----------EVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRR 194
                      E+  +   +H N++ L+    V G    LV + I    L   +    R 
Sbjct: 59  GMCGIHFTTLRELKIMNEIKHENIMGLVD-VYVEGDFINLVMD-IMASDLKKVVDRKIRL 116

Query: 195 SEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDF 254
           +E      C+   +           L+ LH       +H D+ P NI ++      ++DF
Sbjct: 117 TESQVK--CILLQI--------LNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADF 163

Query: 255 GLSK-----LMSRDQSRCITTIRG--------TRGYLAPEWIL-EQGVSEKCDIYSYGMV 300
           GL++       S   S+  T  R         T  Y APE ++  +      D++S G +
Sbjct: 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCI 223

Query: 301 LLELTGGR 308
             EL  G+
Sbjct: 224 FAELLTGK 231

Length = 335

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 39.6 bits (92), Expect = 0.003
 Identities = 27/90 (30%), Positives = 44/90 (48%), Gaps = 9/90 (10%)

Query: 108 LLGHGS-----SASVF---KGILSDGTSVAVKRINGEENGEKEFRSEVAA-IASAQHVNL 158
           +LGHG+      AS F   K    +  +V + +     +  K   SE+   I    H+N+
Sbjct: 14  VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNV 73

Query: 159 VRLLGYCVVPGGPRYLVYEFIQNGSLDHWI 188
           V LLG C  P GP  ++ EF + G+L +++
Sbjct: 74  VNLLGACTKPNGPLMVIVEFCKYGNLSNFL 103

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	453
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.98
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.98
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.95
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.91
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.89
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.87
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.86
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.86
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.86
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.86
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.86
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.85
PRK12274	218	serine/threonine protein kinase; Provisional	99.84
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.84
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.84
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.81
PRK10345	210	hypothetical protein; Provisional	99.8
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.8
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.79
smart00090	237	RIO RIO-like kinase.	99.77
PRK14879	211	serine/threonine protein kinase; Provisional	99.76
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.76
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.73
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.73
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.72
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.7
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.68
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.65
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.64
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.64
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.56
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.52
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.48
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.39
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.37
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.31
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.26
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.21
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.1
KOG1243	690	consensus Protein kinase [General function predict	99.1
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.07
KOG3087	229	consensus Serine/threonine protein kinase [General	98.96
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.95
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.95
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.92
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.88
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.84
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.76
COG4248	637	Uncharacterized protein with protein kinase and he	98.68
PRK09902	216	hypothetical protein; Provisional	98.65
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.6
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.53
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.43
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.4
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.25
PF01636	239	APH: Phosphotransferase enzyme family This family	98.24
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.2
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.14
PRK10593	297	hypothetical protein; Provisional	98.09
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.09
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.08
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.06
PLN02876	822	acyl-CoA dehydrogenase	98.03
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.92
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.85
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.76
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.66
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.66
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.61
PRK05231	319	homoserine kinase; Provisional	97.54
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.5
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.44
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.29
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.28
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.25
PLN02236	344	choline kinase	96.92
COG2334	331	Putative homoserine kinase type II (protein kinase	96.84
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.7
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.68
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.62
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.5
PRK11768	325	serine/threonine protein kinase; Provisional	96.46
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.43
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.34
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.27
PRK06148	1013	hypothetical protein; Provisional	96.25
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.25
PRK12396	409	5-methylribose kinase; Reviewed	96.14
PLN02756	418	S-methyl-5-thioribose kinase	96.1
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.1
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.68
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.61
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.6
KOG2270	520	consensus Serine/threonine protein kinase involved	95.46
PTZ00384	383	choline kinase; Provisional	94.92
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	94.38
PF01102	122	Glycophorin_A: Glycophorin A; InterPro: IPR001195	94.18

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-61  Score=471.38  Aligned_cols=288  Identities=42%  Similarity=0.748  Sum_probs=249.2

Q ss_pred             CCceecHHHHHHHHHHHh--cccCcCCceEEEEEEeCCCcEEEEEEecCCCcc-HHHHHHHHHHHHhcCCCceeeEeeEE
Q 047276           89 VPIKFRSKELEEATDNFQ--ALLGHGSSASVFKGILSDGTSVAVKRINGEENG-EKEFRSEVAAIASAQHVNLVRLLGYC  165 (453)
Q Consensus        89 ~~~~~~~~el~~~~~~~~--~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~  165 (453)
                      ....|++.||..||++|+  ++||+|+||+||+|.+.+|+.||||++...... .++|.+|+.++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            456799999999999998  699999999999999999999999998875544 67799999999999999999999999


Q ss_pred             EecCCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECC
Q 047276          166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDE  245 (453)
Q Consensus       166 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~  245 (453)
                      .+.+.+.+||||||++|+|.++|+....       . .++|.+|++|+.++|+||+|||+.+.++|+||||||+|||||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~-------~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~  212 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKG-------E-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDE  212 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCC-------C-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECC
Confidence            8544358999999999999999976542       1 5999999999999999999999998889999999999999999


Q ss_pred             CCcEEEeeccccccccC-CCCceeeec-cCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcc
Q 047276          246 NYRAVVSDFGLSKLMSR-DQSRCITTI-RGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKN  323 (453)
Q Consensus       246 ~~~~kl~DfGla~~~~~-~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~  323 (453)
                      ++++||+|||+++..+. ...  .... .||.+|+|||++..+..+.|+|||||||+|+||+||++|.+...+...    
T Consensus       213 ~~~aKlsDFGLa~~~~~~~~~--~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~----  286 (361)
T KOG1187|consen  213 DFNAKLSDFGLAKLGPEGDTS--VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGE----  286 (361)
T ss_pred             CCCEEccCccCcccCCccccc--eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCccc----
Confidence            99999999999976654 222  1222 899999999999999999999999999999999999988764332222    


Q ss_pred             cccchhHHHHHhhhcCcccccccccccCCCCCcH-HHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          324 KWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDE-TQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~-~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                        ..+..|....+.++.+.+++|+++.. ..++. ..+.++..++.+|++.+|..||+|.+|+++|+....
T Consensus       287 --~~l~~w~~~~~~~~~~~eiiD~~l~~-~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  287 --LSLVEWAKPLLEEGKLREIVDPRLKE-GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             --ccHHHHHHHHHHCcchhheeCCCccC-CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence              22667788888899999999999874 33443 688889999999999999999999999999965443

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-52  Score=405.36  Aligned_cols=264  Identities=28%  Similarity=0.413  Sum_probs=224.5

Q ss_pred             cHHHHHHHHHHHhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeE
Q 047276           94 RSKELEEATDNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRY  173 (453)
Q Consensus        94 ~~~el~~~~~~~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~  173 (453)
                      ..+++.....++.+.||+|.||+||.|.+.....||+|.++......+.|.+|+++|++|+|+|||+++|+|. .+++.+
T Consensus       199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~-~~~piy  277 (468)
T KOG0197|consen  199 DPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCT-KQEPIY  277 (468)
T ss_pred             CCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEe-cCCceE
Confidence            4456666777789999999999999999987779999999987777889999999999999999999999997 445899


Q ss_pred             EEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEee
Q 047276          174 LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSD  253 (453)
Q Consensus       174 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~D  253 (453)
                      +|||||+.|+|.+||...        .+..++-.+.+.++.|||+||+||++   +++|||||.++||||+++..+||+|
T Consensus       278 IVtE~m~~GsLl~yLr~~--------~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsD  346 (468)
T KOG0197|consen  278 IVTEYMPKGSLLDYLRTR--------EGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISD  346 (468)
T ss_pred             EEEEecccCcHHHHhhhc--------CCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcc
Confidence            999999999999999752        23448889999999999999999999   8999999999999999999999999


Q ss_pred             ccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHH
Q 047276          254 FGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIV  332 (453)
Q Consensus       254 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  332 (453)
                      ||||+...++.+.......-+..|.|||.+..++|+.|||||||||+||||+| |+.||....             ...+
T Consensus       347 FGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-------------n~ev  413 (468)
T KOG0197|consen  347 FGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-------------NEEV  413 (468)
T ss_pred             cccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-------------HHHH
Confidence            99999666655555555667889999999999999999999999999999999 999985322             1113


Q ss_pred             HHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          333 NEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       333 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                      .+.+..|.       ++    +.|+.++..+.+++..||+.+|++|||++.+...|+....
T Consensus       414 ~~~le~Gy-------Rl----p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  414 LELLERGY-------RL----PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             HHHHhccC-------cC----CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence            33444332       22    2455677789999999999999999999999999887543

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4.4e-52  Score=422.41  Aligned_cols=269  Identities=27%  Similarity=0.435  Sum_probs=224.8

Q ss_pred             HHHHHHHHHHhcccCcCCceEEEEEEeC------CCcEEEEEEecCCCc--cHHHHHHHHHHHHhcCCCceeeEeeEEEe
Q 047276           96 KELEEATDNFQALLGHGSSASVFKGILS------DGTSVAVKRINGEEN--GEKEFRSEVAAIASAQHVNLVRLLGYCVV  167 (453)
Q Consensus        96 ~el~~~~~~~~~~lG~G~fG~Vy~~~~~------~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~  167 (453)
                      .++......|.+.||+|.||+||+|+..      +.+.||||.++....  ...+|++|+++++.++|||||+|+|+|. 
T Consensus       481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~-  559 (774)
T KOG1026|consen  481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR-  559 (774)
T ss_pred             eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc-
Confidence            3444444456789999999999999843      346799999987443  4578999999999999999999999997 


Q ss_pred             cCCCeEEEEEecCCCChhhhhccCCCCCCCCCC----CCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEE
Q 047276          168 PGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYS----GGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILL  243 (453)
Q Consensus       168 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~----~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl  243 (453)
                      .+++.++|+|||..|||.+||..+.........    ..+|+..+.+.||.|||.||+||.+   +.+|||||.++|+||
T Consensus       560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLV  636 (774)
T KOG1026|consen  560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLV  636 (774)
T ss_pred             cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---Ccccccchhhhhcee
Confidence            678999999999999999999877654332222    3349999999999999999999999   899999999999999


Q ss_pred             CCCCcEEEeeccccccccCCCCceee-eccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCC
Q 047276          244 DENYRAVVSDFGLSKLMSRDQSRCIT-TIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKS  321 (453)
Q Consensus       244 ~~~~~~kl~DfGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~  321 (453)
                      .++..+||+||||++.....++.... ...-+.+|||||.+..++|+.+||||||||+|||+++ |+.||....+     
T Consensus       637 ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn-----  711 (774)
T KOG1026|consen  637 GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN-----  711 (774)
T ss_pred             ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch-----
Confidence            99999999999999987655543332 4556789999999999999999999999999999999 9999864332     


Q ss_pred             cccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          322 KNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                              +.+.+.++.|.+.           ..+++++.++.+|+..||+.+|++||+++||-..|+...
T Consensus       712 --------~EVIe~i~~g~lL-----------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~  763 (774)
T KOG1026|consen  712 --------QEVIECIRAGQLL-----------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA  763 (774)
T ss_pred             --------HHHHHHHHcCCcc-----------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence                    2356666666652           356777888999999999999999999999999998754

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-50  Score=391.31  Aligned_cols=254  Identities=30%  Similarity=0.488  Sum_probs=206.5

Q ss_pred             HhcccCcCCceEEEEEEeCCCcEEEEEEecCCCcc---HHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENG---EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      +.+.||+|+||+||+|.+.....||||++......   .++|.+|+.+|.+++|||||+++|+|..+....++|||||++
T Consensus        45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~  124 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG  124 (362)
T ss_pred             hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence            45669999999999999974444999999864322   458999999999999999999999997544468999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCc-eeccCCCCCcEEECCCC-cEEEeecccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSR-VLHLDVKPENILLDENY-RAVVSDFGLSKL  259 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~-ivH~Dlk~~NiLl~~~~-~~kl~DfGla~~  259 (453)
                      |+|.++++...        ...+++..+++++.|||+||.|||+   .+ ||||||||+|||++.++ ++||+|||+++.
T Consensus       125 GsL~~~l~~~~--------~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~  193 (362)
T KOG0192|consen  125 GSLSVLLHKKR--------KRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE  193 (362)
T ss_pred             CcHHHHHhhcc--------cCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence            99999997641        2349999999999999999999999   56 99999999999999997 999999999987


Q ss_pred             ccCCCCceeeeccCCccccchhhhh--cCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhh
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWIL--EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMK  337 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (453)
                      ..... ...+...||+.|||||.+.  ...|+.|+||||||+++|||+||+.||......            ......+.
T Consensus       194 ~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~------------~~~~~v~~  260 (362)
T KOG0192|consen  194 KVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV------------QVASAVVV  260 (362)
T ss_pred             ecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH------------HHHHHHHh
Confidence            65332 2334478999999999999  568999999999999999999999999643321            00111111


Q ss_pred             cCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          338 EGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       338 ~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                      .+..           ...+..+...+..++.+||+.||+.||++.+++..|+....
T Consensus       261 ~~~R-----------p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~  305 (362)
T KOG0192|consen  261 GGLR-----------PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS  305 (362)
T ss_pred             cCCC-----------CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence            1111           11233466678999999999999999999999999987654

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-48  Score=360.07  Aligned_cols=247  Identities=26%  Similarity=0.405  Sum_probs=203.2

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecC--CCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCC
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRING--EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      .+.||+|..|+|||+.++ +++.+|+|++..  +....+++.+|+++++..+||+||.++|.|+.++....++||||++|
T Consensus        84 ~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgG  163 (364)
T KOG0581|consen   84 LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGG  163 (364)
T ss_pred             hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCC
Confidence            468999999999999975 578899999943  45566789999999999999999999999885544589999999999


Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccC
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR  262 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~  262 (453)
                      ||++++...          +.+++...-+|+.++++||.|||+.  ++||||||||+|+|++..|++||||||.++.+..
T Consensus       164 SLd~~~k~~----------g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn  231 (364)
T KOG0581|consen  164 SLDDILKRV----------GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN  231 (364)
T ss_pred             CHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence            999999644          3389999999999999999999964  8999999999999999999999999999987755


Q ss_pred             CCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCccc
Q 047276          263 DQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLM  342 (453)
Q Consensus       263 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (453)
                      .   ...++.||..|||||.+.+..|+.++||||||+.++|+.+|+.||....+       .+...-+.+...+ .+.  
T Consensus       232 S---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~-------~~~~~~~Ll~~Iv-~~p--  298 (364)
T KOG0581|consen  232 S---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP-------PYLDIFELLCAIV-DEP--  298 (364)
T ss_pred             h---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC-------CCCCHHHHHHHHh-cCC--
Confidence            4   34678899999999999999999999999999999999999999853211       1111111111111 111  


Q ss_pred             ccccccccCCCCCcH-HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          343 EIVDQRLTDEGGIDE-TQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       343 ~~~d~~l~~~~~~~~-~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                         -|+      .+. ..+.++.+++..||++||.+||+..|+++
T Consensus       299 ---pP~------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  299 ---PPR------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             ---CCC------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence               122      233 36777999999999999999999999874

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-48  Score=389.94  Aligned_cols=263  Identities=27%  Similarity=0.427  Sum_probs=218.2

Q ss_pred             HHHHHHHHHHhcccCcCCceEEEEEEeCC----CcEEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEecC
Q 047276           96 KELEEATDNFQALLGHGSSASVFKGILSD----GTSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG  169 (453)
Q Consensus        96 ~el~~~~~~~~~~lG~G~fG~Vy~~~~~~----g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~  169 (453)
                      .||..+...++++||.|.||+||+|+++-    ...||||.++..  +....+|+.|+.||.++.||||++|.|+. ...
T Consensus       624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVV-Tks  702 (996)
T KOG0196|consen  624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVV-TKS  702 (996)
T ss_pred             hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEE-ecC
Confidence            35555555566899999999999999752    457999999974  44556899999999999999999999985 477


Q ss_pred             CCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcE
Q 047276          170 GPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRA  249 (453)
Q Consensus       170 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~  249 (453)
                      .+.++|.|||+||+|+.||..++         +.+++.+..-++.+||.||.||.+   .++|||||.++|||++.|..+
T Consensus       703 ~PvMIiTEyMENGsLDsFLR~~D---------GqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvC  770 (996)
T KOG0196|consen  703 KPVMIITEYMENGSLDSFLRQND---------GQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVC  770 (996)
T ss_pred             ceeEEEhhhhhCCcHHHHHhhcC---------CceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEE
Confidence            89999999999999999997654         348999999999999999999999   999999999999999999999


Q ss_pred             EEeeccccccccCCCCceeeec--cCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCccccc
Q 047276          250 VVSDFGLSKLMSRDQSRCITTI--RGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQ  326 (453)
Q Consensus       250 kl~DfGla~~~~~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~  326 (453)
                      |++|||+++.+.++.....+..  .-+.+|.|||.+..++++.+|||||||++|||.++ |.+||-.+.           
T Consensus       771 KVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS-----------  839 (996)
T KOG0196|consen  771 KVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-----------  839 (996)
T ss_pred             EeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc-----------
Confidence            9999999998876553322333  34679999999999999999999999999999887 999984322           


Q ss_pred             chhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccCCC
Q 047276          327 YFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVD  395 (453)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~~~  395 (453)
                        ..-+.+.+.+|       -+|    +.|.+++..|.+|++.|||+|..+||.+.+|+..|.+....+
T Consensus       840 --NQdVIkaIe~g-------yRL----PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  840 --NQDVIKAIEQG-------YRL----PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP  895 (996)
T ss_pred             --hHHHHHHHHhc-------cCC----CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence              12233333332       223    346678888999999999999999999999999999876543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-46  Score=368.54  Aligned_cols=244  Identities=26%  Similarity=0.359  Sum_probs=206.2

Q ss_pred             HHHhcccCcCCceEEEEEEe-CCCcEEEEEEecC----CCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          103 DNFQALLGHGSSASVFKGIL-SDGTSVAVKRING----EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      |...++||+|||..||.++. .+|..||+|++.+    .....+...+|+++.++|+|||||+++++|. +.+..|+|.|
T Consensus        20 Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FE-Ds~nVYivLE   98 (592)
T KOG0575|consen   20 YKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFE-DSNNVYIVLE   98 (592)
T ss_pred             eeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEee-cCCceEEEEE
Confidence            33468999999999999996 8899999999975    4455567889999999999999999999875 6779999999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      +|.+|+|..+++.+          ..+++..+..++.||+.||.|||+   .+|+|||||..|++|+++.++||+|||||
T Consensus        99 LC~~~sL~el~Krr----------k~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLA  165 (592)
T KOG0575|consen   99 LCHRGSLMELLKRR----------KPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLA  165 (592)
T ss_pred             ecCCccHHHHHHhc----------CCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEeccccee
Confidence            99999999998633          349999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhh
Q 047276          258 KLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMK  337 (453)
Q Consensus       258 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (453)
                      ..+..+... ..+.+|||.|+|||++....++..+||||+||++|.|+.|++||....            +.+ .-..++
T Consensus       166 t~le~~~Er-k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~------------vke-ty~~Ik  231 (592)
T KOG0575|consen  166 TQLEYDGER-KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT------------VKE-TYNKIK  231 (592)
T ss_pred             eeecCcccc-cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch------------HHH-HHHHHH
Confidence            988755432 467899999999999999899999999999999999999999996321            000 111111


Q ss_pred             cCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          338 EGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       338 ~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ..            +...|...+.+..+|+..+|+.||.+|||+++|+.
T Consensus       232 ~~------------~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  232 LN------------EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             hc------------CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            11            12344456667889999999999999999999984

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-46  Score=347.36  Aligned_cols=191  Identities=31%  Similarity=0.477  Sum_probs=169.8

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      .+.||.|+||+||+|++ +++..||||.+....   ...+.+..|+.+|+.++|||||.+++++. .++..+||||||.+
T Consensus        15 ~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~-~~~~i~lVMEyC~g   93 (429)
T KOG0595|consen   15 SREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIE-DDDFIYLVMEYCNG   93 (429)
T ss_pred             hhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEe-cCCeEEEEEEeCCC
Confidence            45699999999999996 458999999997642   33455789999999999999999999876 56789999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCC------CcEEEeecc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDEN------YRAVVSDFG  255 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~------~~~kl~DfG  255 (453)
                      |+|.+|++...          .+++.+...++.|+|.||++||+   ++||||||||.||||+.+      -.+||+|||
T Consensus        94 GDLs~yi~~~~----------~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG  160 (429)
T KOG0595|consen   94 GDLSDYIRRRG----------RLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFG  160 (429)
T ss_pred             CCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence            99999997554          39999999999999999999999   899999999999999865      568999999


Q ss_pred             ccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCc
Q 047276          256 LSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVS  312 (453)
Q Consensus       256 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~  312 (453)
                      +|+.+....  ...+.+|++-|||||.+...+|+.|+|+||.|+++|++++|+.||.
T Consensus       161 fAR~L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~  215 (429)
T KOG0595|consen  161 FARFLQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD  215 (429)
T ss_pred             hhhhCCchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence            999886432  2356799999999999999999999999999999999999999996

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-46  Score=393.58  Aligned_cols=269  Identities=25%  Similarity=0.383  Sum_probs=216.2

Q ss_pred             HHHHHHHHhcccCcCCceEEEEEEeCC--Cc----EEEEEEecC--CCccHHHHHHHHHHHHhcCCCceeeEeeEEEecC
Q 047276           98 LEEATDNFQALLGHGSSASVFKGILSD--GT----SVAVKRING--EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG  169 (453)
Q Consensus        98 l~~~~~~~~~~lG~G~fG~Vy~~~~~~--g~----~vavK~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~  169 (453)
                      +....-.+.+.||+|.||.||.|...+  |.    .||||.++.  +.+...+|++|..+|++++|||||+++|+|.+ .
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-~  767 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-S  767 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-C
Confidence            334444556899999999999999643  43    489999976  35566789999999999999999999999986 6


Q ss_pred             CCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcE
Q 047276          170 GPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRA  249 (453)
Q Consensus       170 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~  249 (453)
                      ...++++|||++|+|..||...+....   ....|+....+.++.|||+|+.||++   +++|||||.++|+||+....+
T Consensus       768 ~~~~i~leyM~gGDL~sflr~~r~~~~---~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~V  841 (1025)
T KOG1095|consen  768 GPPLILLEYMEGGDLLSFLRESRPAPF---QPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVV  841 (1025)
T ss_pred             CCcEEEehhcccCcHHHHHHhcccccC---CCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcE
Confidence            788999999999999999976643222   24459999999999999999999999   899999999999999999999


Q ss_pred             EEeeccccccccCCCCceeee-ccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccc
Q 047276          250 VVSDFGLSKLMSRDQSRCITT-IRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQY  327 (453)
Q Consensus       250 kl~DfGla~~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~  327 (453)
                      ||+|||+|+.+....+..... ..-+..|||||.+..+.|+.|+|||||||++||++| |..||.....        +  
T Consensus       842 KIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n--------~--  911 (1025)
T KOG1095|consen  842 KIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN--------F--  911 (1025)
T ss_pred             EEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch--------H--
Confidence            999999999665544433333 355679999999999999999999999999999999 9999843211        1  


Q ss_pred             hhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccCCCCC
Q 047276          328 FPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVDDP  397 (453)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~~~~~  397 (453)
                         .+...+.+|.       +|.    .+..++..+.+++.+||+.+|++||++..+++.+..+.....+
T Consensus       912 ---~v~~~~~~gg-------RL~----~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~  967 (1025)
T KOG1095|consen  912 ---EVLLDVLEGG-------RLD----PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG  967 (1025)
T ss_pred             ---HHHHHHHhCC-------ccC----CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence               1222222222       222    3445666789999999999999999999999988876654433

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.2e-47  Score=338.26  Aligned_cols=257  Identities=24%  Similarity=0.361  Sum_probs=208.9

Q ss_pred             HHHhcccCcCCceEEEEEE-eCCCcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCC-eEEEEE
Q 047276          103 DNFQALLGHGSSASVFKGI-LSDGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGP-RYLVYE  177 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~-~~~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~-~~lv~e  177 (453)
                      +.+.++||.|.||+|||+. +.+|..+|.|.++-.   ....+....|+.+|++|+|||||+.+++....++. .++|||
T Consensus        21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE  100 (375)
T KOG0591|consen   21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVME  100 (375)
T ss_pred             HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHH
Confidence            4556899999999999998 678999999998753   33345688999999999999999999965545555 789999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCC-ceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRS-RVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~-~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||..|+|...++..+.      ....+++.++|+++.|++.||.++|+..++ -|+||||||.||+|+.+|.+||+|||+
T Consensus       101 ~c~~GDLsqmIk~~K~------qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL  174 (375)
T KOG0591|consen  101 LCDAGDLSQMIKHFKK------QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL  174 (375)
T ss_pred             hhcccCHHHHHHHHHh------ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchh
Confidence            9999999998865443      234599999999999999999999984422 399999999999999999999999999


Q ss_pred             cccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhh
Q 047276          257 SKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKM  336 (453)
Q Consensus       257 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (453)
                      ++++..... .....+|||-||+||.+....|+.||||||+||++|||+.-+.||....            + ..+-+.+
T Consensus       175 ~r~l~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------------~-~~L~~KI  240 (375)
T KOG0591|consen  175 GRFLSSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------------L-LSLCKKI  240 (375)
T ss_pred             HhHhcchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------------H-HHHHHHH
Confidence            998865433 3456789999999999999999999999999999999999999996321            1 1133444


Q ss_pred             hcCcccccccccccCCCCCc-HHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 047276          337 KEGKLMEIVDQRLTDEGGID-ETQVRRLVDVAFWCIQERARLRPSMARVVEMLEG  390 (453)
Q Consensus       337 ~~~~~~~~~d~~l~~~~~~~-~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~  390 (453)
                      ..|+..           ..+ .-.+..+.+++..|+..||+.||+...++..+..
T Consensus       241 ~qgd~~-----------~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  241 EQGDYP-----------PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             HcCCCC-----------CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            444321           123 4667789999999999999999997666665554

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.8e-46  Score=348.85  Aligned_cols=246  Identities=26%  Similarity=0.404  Sum_probs=198.3

Q ss_pred             HhcccCcCCceEEEEEE-eCCCcEEEEEEecCCC--------ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEE
Q 047276          105 FQALLGHGSSASVFKGI-LSDGTSVAVKRINGEE--------NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLV  175 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~-~~~g~~vavK~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv  175 (453)
                      ..+.||+|+||.|-+|. -++|+.||||+++...        .......+|+++|++|+|||||++.+++. ..+..|+|
T Consensus       176 i~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~-~~ds~YmV  254 (475)
T KOG0615|consen  176 ISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE-VPDSSYMV  254 (475)
T ss_pred             eeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee-cCCceEEE
Confidence            35789999999999998 4679999999997521        12223569999999999999999999976 55678999


Q ss_pred             EEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCC---CcEEEe
Q 047276          176 YEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDEN---YRAVVS  252 (453)
Q Consensus       176 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~---~~~kl~  252 (453)
                      +|||.+|+|.+++..+..          +.+....-++.|++.|+.|||+   +||+||||||+|||+..+   ..+||+
T Consensus       255 lE~v~GGeLfd~vv~nk~----------l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKIt  321 (475)
T KOG0615|consen  255 LEYVEGGELFDKVVANKY----------LREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKIT  321 (475)
T ss_pred             EEEecCccHHHHHHhccc----------cccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEec
Confidence            999999999999975543          7777778899999999999999   899999999999999766   889999


Q ss_pred             eccccccccCCCCceeeeccCCccccchhhhhcCC---CCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchh
Q 047276          253 DFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQG---VSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFP  329 (453)
Q Consensus       253 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~  329 (453)
                      |||+|+...  ....+.+.+|||.|.|||++....   +..+.|+||+||+||-+++|.+||+....+.           
T Consensus       322 DFGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-----------  388 (475)
T KOG0615|consen  322 DFGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-----------  388 (475)
T ss_pred             ccchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-----------
Confidence            999999865  334567899999999999998654   3348899999999999999999997422111           


Q ss_pred             HHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          330 KIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       330 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                       ...+++..|....-        .........+..+++.++|..||++|||.+|+++
T Consensus       389 -sl~eQI~~G~y~f~--------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  389 -SLKEQILKGRYAFG--------PLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             -cHHHHHhcCccccc--------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence             13344444432111        1123456677999999999999999999999874

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-45  Score=353.81  Aligned_cols=267  Identities=20%  Similarity=0.323  Sum_probs=212.6

Q ss_pred             HHHHHHHHHHhcccCcCCceEEEEEEeCCCcEEEEEEecCCCc--cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeE
Q 047276           96 KELEEATDNFQALLGHGSSASVFKGILSDGTSVAVKRINGEEN--GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRY  173 (453)
Q Consensus        96 ~el~~~~~~~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~  173 (453)
                      .|+......|.++||+|-||+|..+....+..||||.++....  ...+|.+|+++|.+|+|||||.|+|+|. .+++.+
T Consensus       533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~-~DePic  611 (807)
T KOG1094|consen  533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCV-QDDPLC  611 (807)
T ss_pred             hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeee-cCCchH
Confidence            4555555567899999999999999998889999999987433  3468999999999999999999999998 567999


Q ss_pred             EEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEee
Q 047276          174 LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSD  253 (453)
Q Consensus       174 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~D  253 (453)
                      +++|||++|+|..|+..+..        ..+......+|+.||+.||+||.+   .++|||||.++|+|+|.++++||+|
T Consensus       612 mI~EYmEnGDLnqFl~ahea--------pt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiad  680 (807)
T KOG1094|consen  612 MITEYMENGDLNQFLSAHEL--------PTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIAD  680 (807)
T ss_pred             HHHHHHhcCcHHHHHHhccC--------cccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecC
Confidence            99999999999999976532        114555667899999999999999   8999999999999999999999999


Q ss_pred             ccccccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc--CCCCCcccccCCCCCcccccchhH
Q 047276          254 FGLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG--GRRNVSLIEHGNDKSKNKWQYFPK  330 (453)
Q Consensus       254 fGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt--G~~p~~~~~~~~~~~~~~~~~~~~  330 (453)
                      ||+++.+....+ +..+..+-+.+|||||.+..++++.+||||+|||++||+++  ...||+...++...         +
T Consensus       681 fgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv---------e  751 (807)
T KOG1094|consen  681 FGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV---------E  751 (807)
T ss_pred             cccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH---------H
Confidence            999996655443 44455677889999999999999999999999999999764  77888643322110         0


Q ss_pred             HHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 047276          331 IVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR  391 (453)
Q Consensus       331 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~  391 (453)
                      -.......+....        ....|.-+...+.++++.||..+.++||+++++...|++.
T Consensus       752 n~~~~~~~~~~~~--------~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  752 NAGEFFRDQGRQV--------VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             hhhhhcCCCCcce--------eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            0111111111110        0123445566788999999999999999999999998764

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-46  Score=365.56  Aligned_cols=271  Identities=30%  Similarity=0.393  Sum_probs=215.6

Q ss_pred             CceecHHHHHHHHHHHhcccCcCCceEEEEEEeCC--C---cEEEEEEecC----CCccHHHHHHHHHHHHhcCCCceee
Q 047276           90 PIKFRSKELEEATDNFQALLGHGSSASVFKGILSD--G---TSVAVKRING----EENGEKEFRSEVAAIASAQHVNLVR  160 (453)
Q Consensus        90 ~~~~~~~el~~~~~~~~~~lG~G~fG~Vy~~~~~~--g---~~vavK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~  160 (453)
                      |+.-..+||....-.+.++||+|.||.||+|++..  +   ..||||..+.    ......+|++|+++|++++|||||+
T Consensus       146 PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr  225 (474)
T KOG0194|consen  146 PIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVR  225 (474)
T ss_pred             cccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEE
Confidence            44555577776666777999999999999999643  2   2389998874    2345578999999999999999999


Q ss_pred             EeeEEEecCCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCc
Q 047276          161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPEN  240 (453)
Q Consensus       161 l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~N  240 (453)
                      ++|++. ...+.++|||+|+||+|.+||.++..         .++..++++++.+.|+||+|||+   ++++||||.++|
T Consensus       226 ~yGVa~-~~~Pl~ivmEl~~gGsL~~~L~k~~~---------~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARN  292 (474)
T KOG0194|consen  226 FYGVAV-LEEPLMLVMELCNGGSLDDYLKKNKK---------SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARN  292 (474)
T ss_pred             EEEEEc-CCCccEEEEEecCCCcHHHHHHhCCC---------CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHH
Confidence            999987 56799999999999999999976542         39999999999999999999999   899999999999


Q ss_pred             EEECCCCcEEEeeccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCC
Q 047276          241 ILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGND  319 (453)
Q Consensus       241 iLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~  319 (453)
                      +|++.++.+||+|||+++....... ......-+..|+|||.+..+.|+.++|||||||++||+++ |..||......  
T Consensus       293 cL~~~~~~vKISDFGLs~~~~~~~~-~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--  369 (474)
T KOG0194|consen  293 CLYSKKGVVKISDFGLSRAGSQYVM-KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--  369 (474)
T ss_pred             heecCCCeEEeCccccccCCcceee-ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--
Confidence            9999999999999999886541111 1112245679999999999999999999999999999999 88898543211  


Q ss_pred             CCcccccchhHHHHHhh-hcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccCCCCCC
Q 047276          320 KSKNKWQYFPKIVNEKM-KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVDDPP  398 (453)
Q Consensus       320 ~~~~~~~~~~~~~~~~~-~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~~~~~~  398 (453)
                                 .+...+ ..+..       .    ..+...+..+..++.+||..+|++||+|.++.+.|+.......++
T Consensus       370 -----------~v~~kI~~~~~r-------~----~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~  427 (474)
T KOG0194|consen  370 -----------EVKAKIVKNGYR-------M----PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF  427 (474)
T ss_pred             -----------HHHHHHHhcCcc-------C----CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence                       122332 22211       1    122344556778888999999999999999999999876655544

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-46  Score=360.81  Aligned_cols=267  Identities=26%  Similarity=0.382  Sum_probs=225.9

Q ss_pred             CCceecHHHHHHHHHHHhcccCcCCceEEEEEEeCC-CcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEe
Q 047276           89 VPIKFRSKELEEATDNFQALLGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVV  167 (453)
Q Consensus        89 ~~~~~~~~el~~~~~~~~~~lG~G~fG~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~  167 (453)
                      +....+.+|++.......++||.|.||.||.|.|+. .-.||||.++.+....++|++|+.+|+.++|||+|+|+|+|. 
T Consensus       255 vSPn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT-  333 (1157)
T KOG4278|consen  255 VSPNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-  333 (1157)
T ss_pred             ecCCcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhc-
Confidence            334456788887777778999999999999999875 457999999988888899999999999999999999999997 


Q ss_pred             cCCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCC
Q 047276          168 PGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENY  247 (453)
Q Consensus       168 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~  247 (453)
                      ...++|+|+|||.+|+|.+||..+.+.        .++.-..+.++.||+.||+||..   +++|||||.++|+|+.++.
T Consensus       334 ~EpPFYIiTEfM~yGNLLdYLRecnr~--------ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnh  402 (1157)
T KOG4278|consen  334 HEPPFYIITEFMCYGNLLDYLRECNRS--------EVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENH  402 (1157)
T ss_pred             cCCCeEEEEecccCccHHHHHHHhchh--------hcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccc
Confidence            667999999999999999999877653        37777889999999999999998   8999999999999999999


Q ss_pred             cEEEeeccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCccccc
Q 047276          248 RAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQ  326 (453)
Q Consensus       248 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~  326 (453)
                      .+|++||||++++..+.+.......-+..|.|||.+....++.|+|||+|||+|||+.| |..||-..+-          
T Consensus       403 iVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl----------  472 (1157)
T KOG4278|consen  403 IVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----------  472 (1157)
T ss_pred             eEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH----------
Confidence            99999999999998877665556667889999999999999999999999999999998 9888842210          


Q ss_pred             chhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 047276          327 YFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR  391 (453)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~  391 (453)
                         ..+..++..|         .+.  .-++.|+..+.+|++.||+.+|.+||++.|+-+.++..
T Consensus       473 ---SqVY~LLEkg---------yRM--~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  473 ---SQVYGLLEKG---------YRM--DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM  523 (1157)
T ss_pred             ---HHHHHHHhcc---------ccc--cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence               1122222222         111  13456777899999999999999999999999888764

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=6.9e-44  Score=350.67  Aligned_cols=265  Identities=25%  Similarity=0.431  Sum_probs=203.3

Q ss_pred             HHHHhcccCcCCceEEEEEEe------CCCcEEEEEEecCCC--ccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCe
Q 047276          102 TDNFQALLGHGSSASVFKGIL------SDGTSVAVKRINGEE--NGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPR  172 (453)
Q Consensus       102 ~~~~~~~lG~G~fG~Vy~~~~------~~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~  172 (453)
                      .+.+.++||+|+||.||+|..      .+++.||||+++...  .....+.+|+.++..+ +||||++++|+|...+...
T Consensus         8 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~   87 (338)
T cd05102           8 RLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPL   87 (338)
T ss_pred             HceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCce
Confidence            345568999999999999974      235679999987532  2345689999999999 8999999999987666678


Q ss_pred             EEEEEecCCCChhhhhccCCCCCC----------------------------------------------------CCCC
Q 047276          173 YLVYEFIQNGSLDHWIFPTSRRSE----------------------------------------------------GHYS  200 (453)
Q Consensus       173 ~lv~e~~~~gsL~~~l~~~~~~~~----------------------------------------------------~~~~  200 (453)
                      +++|||+++|+|.+++........                                                    ....
T Consensus        88 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (338)
T cd05102          88 MVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLW  167 (338)
T ss_pred             EEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccc
Confidence            999999999999999975421100                                                    0001


Q ss_pred             CCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCCCC-ceeeeccCCccccc
Q 047276          201 GGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQS-RCITTIRGTRGYLA  279 (453)
Q Consensus       201 ~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~a  279 (453)
                      ...+++....+++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++....... .......+++.|+|
T Consensus       168 ~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  244 (338)
T cd05102         168 KSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA  244 (338)
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence            2348899999999999999999999   8999999999999999999999999999986543322 11223456778999


Q ss_pred             hhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHH
Q 047276          280 PEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDET  358 (453)
Q Consensus       280 PE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  358 (453)
                      ||++.+..++.++|||||||++|||++ |..||......            .........+...     .      .+..
T Consensus       245 PE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~------------~~~~~~~~~~~~~-----~------~~~~  301 (338)
T cd05102         245 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN------------EEFCQRLKDGTRM-----R------APEN  301 (338)
T ss_pred             cHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc------------HHHHHHHhcCCCC-----C------CCCC
Confidence            999998899999999999999999997 99998532110            0111122222110     0      1123


Q ss_pred             HHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          359 QVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       359 ~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      ....+.+++.+||+.+|++|||+.++++.|+...
T Consensus       302 ~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~  335 (338)
T cd05102         302 ATPEIYRIMLACWQGDPKERPTFSALVEILGDLL  335 (338)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            3456889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-44  Score=350.25  Aligned_cols=264  Identities=24%  Similarity=0.404  Sum_probs=208.3

Q ss_pred             cHHHHHHHHHHHhcccCcCCceEEEEEEeCCCcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCC
Q 047276           94 RSKELEEATDNFQALLGHGSSASVFKGILSDGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGG  170 (453)
Q Consensus        94 ~~~el~~~~~~~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~  170 (453)
                      .++||...-..+...||+|.||+||+|.|..  .||||+++.+   ....+.|++|+..+++-+|.||+-+.|||..  .
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~--p  460 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN--P  460 (678)
T ss_pred             cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC--C
Confidence            4455655555567899999999999999863  5999999863   3344679999999999999999999999963  3


Q ss_pred             CeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEE
Q 047276          171 PRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV  250 (453)
Q Consensus       171 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~k  250 (453)
                      +..+|+.+|++-+|+.+|+..+.         .++..+.+.|+.|||+||.|||+   ++|||||||..||++.+++.||
T Consensus       461 ~~AIiTqwCeGsSLY~hlHv~et---------kfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVk  528 (678)
T KOG0193|consen  461 PLAIITQWCEGSSLYTHLHVQET---------KFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVK  528 (678)
T ss_pred             ceeeeehhccCchhhhhccchhh---------hhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEE
Confidence            55999999999999999976543         38888999999999999999999   8999999999999999999999


Q ss_pred             EeeccccccccC-CCCceeeeccCCccccchhhhhc---CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCccccc
Q 047276          251 VSDFGLSKLMSR-DQSRCITTIRGTRGYLAPEWILE---QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQ  326 (453)
Q Consensus       251 l~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~  326 (453)
                      |+||||+..-.. ..........|...|||||++..   ..|++.+||||||+++|||+||..||. .+..+..      
T Consensus       529 IgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqI------  601 (678)
T KOG0193|consen  529 IGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQI------  601 (678)
T ss_pred             EecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhhe------
Confidence            999999875332 12222344567889999999974   468999999999999999999999997 2222111      


Q ss_pred             chhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          327 YFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                            .-.+..|.+.    +++   .....++..++.+|+..||..++++||.+.+|+..|+....
T Consensus       602 ------ifmVGrG~l~----pd~---s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  602 ------IFMVGRGYLM----PDL---SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             ------EEEecccccC----ccc---hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence                  1111222211    111   11223556679999999999999999999999998887654

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1e-43  Score=330.83  Aligned_cols=235  Identities=27%  Similarity=0.372  Sum_probs=192.2

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      .++||+|+||+||.++. ++++.+|+|++++.    ....+....|..+|.+++||+||++.--+. +.+.+|+|+||+.
T Consensus        30 lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ-t~~kLylVld~~~  108 (357)
T KOG0598|consen   30 LKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQ-TEEKLYLVLDYLN  108 (357)
T ss_pred             eeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecc-cCCeEEEEEeccC
Confidence            47999999999999995 45889999999763    234567889999999999999999986554 6779999999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      ||.|..+|...          +.+++....-++.+|+.||.|||+   .+||||||||+|||||++|+++|+|||+++..
T Consensus       109 GGeLf~hL~~e----------g~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~  175 (357)
T KOG0598|consen  109 GGELFYHLQRE----------GRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKED  175 (357)
T ss_pred             CccHHHHHHhc----------CCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence            99999999644          348999999999999999999999   89999999999999999999999999999865


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      .... ....+++||+.|||||.+.+..|+..+|.||+|+++|||++|.+||.....            .. ..+.+..+.
T Consensus       176 ~~~~-~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~------------~~-~~~~I~~~k  241 (357)
T KOG0598|consen  176 LKDG-DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV------------KK-MYDKILKGK  241 (357)
T ss_pred             ccCC-CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH------------HH-HHHHHhcCc
Confidence            4332 234568999999999999999999999999999999999999999963211            11 122222222


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCC
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRP  379 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP  379 (453)
                      +           ...+.-......+++...+..+|++|-
T Consensus       242 ~-----------~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  242 L-----------PLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             C-----------CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence            1           011122345588999999999999995

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1e-43  Score=346.94  Aligned_cols=259  Identities=22%  Similarity=0.399  Sum_probs=218.0

Q ss_pred             HHHHHHHHHhcccCcCCceEEEEEEeCC---Cc--EEEEEEecC--CCccHHHHHHHHHHHHhcCCCceeeEeeEEEecC
Q 047276           97 ELEEATDNFQALLGHGSSASVFKGILSD---GT--SVAVKRING--EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG  169 (453)
Q Consensus        97 el~~~~~~~~~~lG~G~fG~Vy~~~~~~---g~--~vavK~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~  169 (453)
                      +|..+.....++||+|-||.||+|.+-+   |.  .||||..+.  +..+.+.|+.|..+|++++|||||+|+|+|.  .
T Consensus       385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~--e  462 (974)
T KOG4257|consen  385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV--E  462 (974)
T ss_pred             eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee--c
Confidence            4555555667899999999999999532   32  589998876  3445678999999999999999999999996  4


Q ss_pred             CCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcE
Q 047276          170 GPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRA  249 (453)
Q Consensus       170 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~  249 (453)
                      .+.++|||.++.|.|..||..++.         .|+..+...++.||+.||+|||+   ..+|||||.++|||+...-.+
T Consensus       463 ~P~WivmEL~~~GELr~yLq~nk~---------sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CV  530 (974)
T KOG4257|consen  463 QPMWIVMELAPLGELREYLQQNKD---------SLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCV  530 (974)
T ss_pred             cceeEEEecccchhHHHHHHhccc---------cchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCccee
Confidence            589999999999999999976543         38889999999999999999999   899999999999999999999


Q ss_pred             EEeeccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccch
Q 047276          250 VVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYF  328 (453)
Q Consensus       250 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~  328 (453)
                      ||+|||+++.+.++.....+...-+..|||||.+...+++.+||||.|||++||++. |..||...+..+...       
T Consensus       531 KLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~-------  603 (974)
T KOG4257|consen  531 KLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG-------  603 (974)
T ss_pred             eecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE-------
Confidence            999999999998877766666667889999999999999999999999999999987 999997554333211       


Q ss_pred             hHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          329 PKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       329 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                            .+..|.       +    .+.|+.++..+..++.+||+.+|.+||.+.++...|+....
T Consensus       604 ------~iEnGe-------R----lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  604 ------HIENGE-------R----LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             ------EecCCC-------C----CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence                  111111       1    34677888889999999999999999999999988876544

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.9e-42  Score=382.50  Aligned_cols=259  Identities=26%  Similarity=0.459  Sum_probs=208.4

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCCh
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL  184 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL  184 (453)
                      .++||+|+||.||+|+. .+|..||||+++.....   ...|++.+++++|||||+++|+|. ..+..++||||+++|+|
T Consensus       695 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~-~~~~~~lv~Ey~~~g~L  770 (968)
T PLN00113        695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCR-SEKGAYLIHEYIEGKNL  770 (968)
T ss_pred             ccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEE-cCCCCEEEEeCCCCCcH
Confidence            46899999999999996 57899999998753322   234688999999999999999997 45678999999999999


Q ss_pred             hhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCCC
Q 047276          185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ  264 (453)
Q Consensus       185 ~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~  264 (453)
                      .++++             .++|..+.+|+.|+++||+|||..+.++++||||||+||+++.++.+++. ||........ 
T Consensus       771 ~~~l~-------------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-  835 (968)
T PLN00113        771 SEVLR-------------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-  835 (968)
T ss_pred             HHHHh-------------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-
Confidence            99983             18999999999999999999997656899999999999999999988875 6665433221 


Q ss_pred             CceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCccccc
Q 047276          265 SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEI  344 (453)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (453)
                          ....+|+.|+|||++.+..++.++|||||||++|||+||+.||...... .      .....|.............
T Consensus       836 ----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~------~~~~~~~~~~~~~~~~~~~  904 (968)
T PLN00113        836 ----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-H------GSIVEWARYCYSDCHLDMW  904 (968)
T ss_pred             ----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-C------CcHHHHHHHhcCccchhhe
Confidence                2236789999999999999999999999999999999999998432111 1      1233334444444445566


Q ss_pred             ccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccCC
Q 047276          345 VDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAV  394 (453)
Q Consensus       345 ~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~~  394 (453)
                      +|+.+......+.+...++.+++.+||+.+|++||+|.+|++.|++....
T Consensus       905 ~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  954 (968)
T PLN00113        905 IDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS  954 (968)
T ss_pred             eCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence            77776554455667788899999999999999999999999999986553

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-43  Score=336.77  Aligned_cols=246  Identities=24%  Similarity=0.354  Sum_probs=202.0

Q ss_pred             HHhcccCcCCceEEEEEE-eCCCcEEEEEEecCC----CccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEEEEE
Q 047276          104 NFQALLGHGSSASVFKGI-LSDGTSVAVKRINGE----ENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~-~~~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      .|.+.||+|+|++|++++ ...++.+|||++.+.    +...+-...|-..|.+| .||.|++|+-.+. +...+|+|+|
T Consensus        76 ~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQ-D~~sLYFvLe  154 (604)
T KOG0592|consen   76 KFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQ-DEESLYFVLE  154 (604)
T ss_pred             chhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEee-cccceEEEEE
Confidence            467899999999999999 456899999999752    33344567788899999 7999999998765 6678999999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |+++|+|.+++++..          .+++.....++.+|+.||+|||+   .|||||||||+|||||.||++||+|||.|
T Consensus       155 ~A~nGdll~~i~K~G----------sfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsA  221 (604)
T KOG0592|consen  155 YAPNGDLLDLIKKYG----------SFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSA  221 (604)
T ss_pred             ecCCCcHHHHHHHhC----------cchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeecccc
Confidence            999999999997553          48999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCc----------ee--eeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccc
Q 047276          258 KLMSRDQSR----------CI--TTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKW  325 (453)
Q Consensus       258 ~~~~~~~~~----------~~--~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~  325 (453)
                      +.+.+....          ..  ..++||-.|.+||.+..+..+..+|+|+|||+||+|+.|++||....        +|
T Consensus       222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N--------ey  293 (604)
T KOG0592|consen  222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN--------EY  293 (604)
T ss_pred             ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc--------HH
Confidence            988542211          11  45889999999999999999999999999999999999999996322        12


Q ss_pred             cchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 047276          326 QYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEML  388 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L  388 (453)
                      ..+..             +++-    +..+++.......+|+.+.|..||.+|++..++-+..
T Consensus       294 liFqk-------------I~~l----~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  294 LIFQK-------------IQAL----DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             HHHHH-------------HHHh----cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence            11111             1111    1234445556688999999999999999999987654

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8e-43  Score=329.95  Aligned_cols=251  Identities=26%  Similarity=0.359  Sum_probs=198.1

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC-ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCC-CeEEEEEecCC
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEE-NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGG-PRYLVYEFIQN  181 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-~~~lv~e~~~~  181 (453)
                      ..+.||+|+||+||++... +|...|||...... ...+.+.+|+.+|.+++|||||+.+|......+ .+++.|||+++
T Consensus        21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~  100 (313)
T KOG0198|consen   21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPG  100 (313)
T ss_pred             hhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCC
Confidence            4679999999999999965 48999999886532 124568999999999999999999997443333 58899999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECC-CCcEEEeeccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDE-NYRAVVSDFGLSKLM  260 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~-~~~~kl~DfGla~~~  260 (453)
                      |+|.+++.+...         .|++..+.++..||++||+|||+   ++++|+||||+|||++. ++.+||+|||+++..
T Consensus       101 GsL~~~~~~~g~---------~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~  168 (313)
T KOG0198|consen  101 GSLSDLIKRYGG---------KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKL  168 (313)
T ss_pred             CcHHHHHHHcCC---------CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence            999999965431         49999999999999999999998   89999999999999999 799999999999876


Q ss_pred             cC--CCCceeeeccCCccccchhhhhcCC-CCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhh
Q 047276          261 SR--DQSRCITTIRGTRGYLAPEWILEQG-VSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMK  337 (453)
Q Consensus       261 ~~--~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (453)
                      ..  ..........||+.|||||++..+. ...++|||||||++.||+||+.||....           ...........
T Consensus       169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~-----------~~~~~~~~ig~  237 (313)
T KOG0198|consen  169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF-----------EEAEALLLIGR  237 (313)
T ss_pred             ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc-----------chHHHHHHHhc
Confidence            53  2222344578999999999999643 3459999999999999999999986320           00011111111


Q ss_pred             cCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 047276          338 EGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE  389 (453)
Q Consensus       338 ~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~  389 (453)
                      .+.     -|      .++...+....+++.+|++.+|+.|||++++++..-
T Consensus       238 ~~~-----~P------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf  278 (313)
T KOG0198|consen  238 EDS-----LP------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF  278 (313)
T ss_pred             cCC-----CC------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence            110     11      234445666889999999999999999999997653

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.7e-42  Score=330.89  Aligned_cols=246  Identities=19%  Similarity=0.266  Sum_probs=196.6

Q ss_pred             cccCcCCceEEEEEEeCCCcEEEEEEecCCCcc----HHHHHHHHHHHHhcCCCceeeEeeEEEe--c-CCCeEEEEEec
Q 047276          107 ALLGHGSSASVFKGILSDGTSVAVKRINGEENG----EKEFRSEVAAIASAQHVNLVRLLGYCVV--P-GGPRYLVYEFI  179 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~g~~~~--~-~~~~~lv~e~~  179 (453)
                      ..||+|++|.||+|.+ +|+.||||+++.....    .+.|.+|+.+|.+++||||++++|++..  . ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            4799999999999998 5889999999764332    3567899999999999999999999865  2 23578999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ++|+|.+++...          ..++|....+++.+++.||.|||+.  .+++||||||+|||+++++.+||+|||+++.
T Consensus       105 ~~g~L~~~l~~~----------~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~  172 (283)
T PHA02988        105 TRGYLREVLDKE----------KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKI  172 (283)
T ss_pred             CCCcHHHHHhhC----------CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhh
Confidence            999999999643          2388999999999999999999973  4788999999999999999999999999986


Q ss_pred             ccCCCCceeeeccCCccccchhhhhc--CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhh
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILE--QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMK  337 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (453)
                      .....    ....|+..|+|||.+.+  ..++.++|||||||++|||++|+.||.....            .........
T Consensus       173 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~------------~~~~~~i~~  236 (283)
T PHA02988        173 LSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT------------KEIYDLIIN  236 (283)
T ss_pred             hcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH------------HHHHHHHHh
Confidence            54322    23457889999999876  6899999999999999999999999953211            011111111


Q ss_pred             cCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          338 EGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       338 ~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      .+.       +.    ..+......+.+++.+||+.||++|||++++++.|+...
T Consensus       237 ~~~-------~~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        237 KNN-------SL----KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             cCC-------CC----CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            111       00    112234556899999999999999999999999998643

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-42  Score=333.90  Aligned_cols=260  Identities=22%  Similarity=0.290  Sum_probs=200.9

Q ss_pred             hcccCcCCceEEEEEE-eCCCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEec-CCCeEEEEEecC
Q 047276          106 QALLGHGSSASVFKGI-LSDGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVP-GGPRYLVYEFIQ  180 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~-~~~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~~lv~e~~~  180 (453)
                      .++||+|.||.||+++ ..+|+.||+|+++.+.   .......+|+.+|++|+||||++|.+...+. ....|||+|||+
T Consensus       122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd  201 (560)
T KOG0600|consen  122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD  201 (560)
T ss_pred             HHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEeccc
Confidence            3689999999999999 5789999999997643   3335567899999999999999999987765 468899999998


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      + ||.-++....         -.++..++..++.|++.||+|+|+   ++|+|||||.+|||||.+|.+||+|||||+++
T Consensus       202 h-DL~GLl~~p~---------vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  202 H-DLSGLLSSPG---------VKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             c-hhhhhhcCCC---------cccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeec
Confidence            8 9988885432         238999999999999999999999   89999999999999999999999999999998


Q ss_pred             cCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCC----------CCccccc--c
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGND----------KSKNKWQ--Y  327 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~----------~~~~~~~--~  327 (453)
                      ........+..+-|.+|.|||.+.+ ..|+...|+||.||||.||++|++.|....+-.+          .....|.  .
T Consensus       269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k  348 (560)
T KOG0600|consen  269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK  348 (560)
T ss_pred             cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence            8776666677788999999999986 4799999999999999999999998864322111          1111121  1


Q ss_pred             hhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          328 FPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      +|...  .   -....-...++.+.   -.......++|+..+|..||.+|.|+.++++
T Consensus       349 LP~~~--~---~kp~~~y~r~l~E~---~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  349 LPHAT--I---FKPQQPYKRRLRET---FKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CCccc--c---cCCCCcccchHHHH---hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            11000  0   00000001111110   1122455788999999999999999999774

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-42  Score=338.06  Aligned_cols=243  Identities=24%  Similarity=0.368  Sum_probs=202.9

Q ss_pred             cccCcCCceEEEEEE-eCCCcEEEEEEecCCCccHH-HHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCCh
Q 047276          107 ALLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEK-EFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL  184 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~-~~~g~~vavK~~~~~~~~~~-~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL  184 (453)
                      .+||+|..|.||.+. ..+++.||||++....+..+ -+.+|+.+|+..+|+|||+++.-+. .++++|+|||||++|+|
T Consensus       279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Syl-v~deLWVVMEym~ggsL  357 (550)
T KOG0578|consen  279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYL-VGDELWVVMEYMEGGSL  357 (550)
T ss_pred             hhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhc-ccceeEEEEeecCCCch
Confidence            579999999999998 56788999999987655544 4789999999999999999999776 45789999999999999


Q ss_pred             hhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCCC
Q 047276          185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ  264 (453)
Q Consensus       185 ~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~  264 (453)
                      .+.+.           ...+++.++..|+.+++.||+|||.   .+|+|||||.+|||++.+|.+||+|||++..+....
T Consensus       358 TDvVt-----------~~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~  423 (550)
T KOG0578|consen  358 TDVVT-----------KTRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ  423 (550)
T ss_pred             hhhhh-----------cccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence            99983           3348999999999999999999999   899999999999999999999999999999887654


Q ss_pred             CceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCccccc
Q 047276          265 SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEI  344 (453)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (453)
                      . .....+|||.|||||......|++|.||||||++++||+-|.+||-...             |-.....+......  
T Consensus       424 ~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~-------------PlrAlyLIa~ng~P--  487 (550)
T KOG0578|consen  424 S-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN-------------PLRALYLIATNGTP--  487 (550)
T ss_pred             C-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC-------------hHHHHHHHhhcCCC--
Confidence            3 3567789999999999999999999999999999999999999994211             11111222222211  


Q ss_pred             ccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          345 VDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       345 ~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                         .+    ..++..+..+.+++.+||+.|+++||++.|+++.
T Consensus       488 ---~l----k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  488 ---KL----KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             ---Cc----CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence               11    1234556679999999999999999999999853

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.8e-42  Score=312.95  Aligned_cols=263  Identities=22%  Similarity=0.254  Sum_probs=194.0

Q ss_pred             cccCcCCceEEEEEEeC-CCcEEEEEEecCCCcc---HHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCC
Q 047276          107 ALLGHGSSASVFKGILS-DGTSVAVKRINGEENG---EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      .++|+|+||+|||++.+ +|+.||||++..++.+   .+-.++|+++|++|+|+|+|.|+.+|. ....++||+|||+..
T Consensus         8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFr-rkrklhLVFE~~dhT   86 (396)
T KOG0593|consen    8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFR-RKRKLHLVFEYCDHT   86 (396)
T ss_pred             hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHH-hcceeEEEeeecchH
Confidence            47999999999999975 5999999999765443   244789999999999999999999986 566889999999884


Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccC
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR  262 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~  262 (453)
                      =|+ -|....         ..++.....+++.|++.|+.|+|+   ++++||||||+||||+.++.+||||||+|+.+..
T Consensus        87 vL~-eLe~~p---------~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~  153 (396)
T KOG0593|consen   87 VLH-ELERYP---------NGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSA  153 (396)
T ss_pred             HHH-HHHhcc---------CCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence            444 443221         128888999999999999999999   8999999999999999999999999999998874


Q ss_pred             CCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcc---cccchhHHHHHhhh-
Q 047276          263 DQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKN---KWQYFPKIVNEKMK-  337 (453)
Q Consensus       263 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~-  337 (453)
                      .. ..-+..+.|.+|.|||.+.+ -+|+...||||+||++.||++|.+-|-...+-+..-..   --...|+. .+... 
T Consensus       154 pg-d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prh-q~iF~~  231 (396)
T KOG0593|consen  154 PG-DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRH-QSIFSS  231 (396)
T ss_pred             Cc-chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHH-HHHhcc
Confidence            22 23456778999999999987 68999999999999999999999877432211100000   00001111 11111 


Q ss_pred             cCcccccccccccCCCC---CcHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 047276          338 EGKLMEIVDQRLTDEGG---IDETQVRRLVDVAFWCIQERARLRPSMARVV  385 (453)
Q Consensus       338 ~~~~~~~~d~~l~~~~~---~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~  385 (453)
                      .+-+..+.-|......+   --+....-+++++..|++.||.+|++.++++
T Consensus       232 N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll  282 (396)
T KOG0593|consen  232 NPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL  282 (396)
T ss_pred             CCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence            11111111111111111   1123345689999999999999999999987

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=6.6e-42  Score=325.16  Aligned_cols=254  Identities=20%  Similarity=0.307  Sum_probs=199.1

Q ss_pred             HHHHHhcccCcCCceEEEEEEeC----CCcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEE
Q 047276          101 ATDNFQALLGHGSSASVFKGILS----DGTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYL  174 (453)
Q Consensus       101 ~~~~~~~~lG~G~fG~Vy~~~~~----~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~l  174 (453)
                      ..+.+.+.||+|+||.||+|.+.    .+..||+|.++...  .....|.+|+..+.+++||||++++|++. .++..++
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~l   83 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT-RGNTMMI   83 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-cCCCcEE
Confidence            34455689999999999999853    35689999987643  23357899999999999999999999976 5668899


Q ss_pred             EEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeec
Q 047276          175 VYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDF  254 (453)
Q Consensus       175 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~Df  254 (453)
                      ||||+++|+|.+++....         ..+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+|++||
T Consensus        84 v~e~~~~~~L~~~l~~~~---------~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~df  151 (266)
T cd05064          84 VTEYMSNGALDSFLRKHE---------GQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGF  151 (266)
T ss_pred             EEEeCCCCcHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCC
Confidence            999999999999985432         248999999999999999999998   89999999999999999999999999


Q ss_pred             cccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHH
Q 047276          255 GLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVN  333 (453)
Q Consensus       255 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  333 (453)
                      |.+...............++..|+|||.+.+..++.++||||||+++||+++ |+.||......             ...
T Consensus       152 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-------------~~~  218 (266)
T cd05064         152 RRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-------------DVI  218 (266)
T ss_pred             cccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-------------HHH
Confidence            9876543222111122345678999999999999999999999999999775 99998532110             011


Q ss_pred             HhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 047276          334 EKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR  391 (453)
Q Consensus       334 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~  391 (453)
                      +...++..       .    ..+...+..+.+++..||+.+|++||+++++.+.|+..
T Consensus       219 ~~~~~~~~-------~----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         219 KAVEDGFR-------L----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             HHHHCCCC-------C----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            11122110       0    11223445688999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-43  Score=338.23  Aligned_cols=239  Identities=26%  Similarity=0.414  Sum_probs=197.8

Q ss_pred             cccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCChhh
Q 047276          107 ALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDH  186 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL~~  186 (453)
                      +-||.|+.|-||+|++. ++.||||+++.-.      ..+++-|++|+|+||+.+.|+|. ....+|+|||||+.|-|..
T Consensus       130 eWlGSGaQGAVF~Grl~-netVAVKKV~elk------ETdIKHLRkLkH~NII~FkGVCt-qsPcyCIiMEfCa~GqL~~  201 (904)
T KOG4721|consen  130 EWLGSGAQGAVFLGRLH-NETVAVKKVRELK------ETDIKHLRKLKHPNIITFKGVCT-QSPCYCIIMEFCAQGQLYE  201 (904)
T ss_pred             hhhccCcccceeeeecc-CceehhHHHhhhh------hhhHHHHHhccCcceeeEeeeec-CCceeEEeeeccccccHHH
Confidence            46999999999999997 6789999886421      24678899999999999999997 5567899999999999999


Q ss_pred             hhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCCCCc
Q 047276          187 WIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSR  266 (453)
Q Consensus       187 ~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~  266 (453)
                      .|+..+          .+.......+..+||.||.|||.   +.|||||||.-||||..+-.+||+|||-++.+.+..  
T Consensus       202 VLka~~----------~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S--  266 (904)
T KOG4721|consen  202 VLKAGR----------PITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS--  266 (904)
T ss_pred             HHhccC----------ccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhhh--
Confidence            996443          48888889999999999999999   899999999999999999999999999998775542  


Q ss_pred             eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCccccccc
Q 047276          267 CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVD  346 (453)
Q Consensus       267 ~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  346 (453)
                      ....+.||..|||||++.+...++|.|||||||+||||+||..||...+...    .-|.         +..+.+ .   
T Consensus       267 TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIwG---------VGsNsL-~---  329 (904)
T KOG4721|consen  267 TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIWG---------VGSNSL-H---  329 (904)
T ss_pred             hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eEEe---------ccCCcc-c---
Confidence            2456889999999999999999999999999999999999999996432211    1111         000111 0   


Q ss_pred             ccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 047276          347 QRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR  391 (453)
Q Consensus       347 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~  391 (453)
                            ...+..++.-+.-|+++||+..|.+||++.+++..|+-+
T Consensus       330 ------LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  330 ------LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             ------ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence                  124455666688999999999999999999999999743

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-42  Score=323.01  Aligned_cols=256  Identities=26%  Similarity=0.365  Sum_probs=200.7

Q ss_pred             HHHhcccCcCCceEEEEEE-eCCCcEEEEEEecCCCc--cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          103 DNFQALLGHGSSASVFKGI-LSDGTSVAVKRINGEEN--GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~-~~~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      |.+.+.||.|..++||+|. .+.+..||||+++.+..  ....+++|+..|+.++||||++.+..|. .+..+|+||.||
T Consensus        28 YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFv-v~~~LWvVmpfM  106 (516)
T KOG0582|consen   28 YELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFV-VDSELWVVMPFM  106 (516)
T ss_pred             eeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEE-ecceeEEeehhh
Confidence            4456899999999999999 56789999999986432  3467999999999999999999998765 667999999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      .+||+.+.++..-.        ..+++..+..|+.++++||.|||.   +|.||||||+.||||+++|.+||+|||.+..
T Consensus       107 a~GS~ldIik~~~~--------~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~  175 (516)
T KOG0582|consen  107 AGGSLLDIIKTYYP--------DGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSAS  175 (516)
T ss_pred             cCCcHHHHHHHHcc--------ccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeee
Confidence            99999999965432        228999999999999999999999   8999999999999999999999999998876


Q ss_pred             ccCCCCce---eeeccCCccccchhhhhc--CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHH
Q 047276          260 MSRDQSRC---ITTIRGTRGYLAPEWILE--QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNE  334 (453)
Q Consensus       260 ~~~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  334 (453)
                      +.......   ...+.||+.|||||.+..  ..|+.|+||||||++..||.+|..||+...+...            +..
T Consensus       176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv------------Ll~  243 (516)
T KOG0582|consen  176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV------------LLL  243 (516)
T ss_pred             ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH------------HHH
Confidence            65443322   255789999999999653  4699999999999999999999999975432110            111


Q ss_pred             hhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 047276          335 KMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVV  385 (453)
Q Consensus       335 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~  385 (453)
                      .+. +......-..+.  .+-.......+.+++..|+++||++|||+++++
T Consensus       244 tLq-n~pp~~~t~~~~--~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLl  291 (516)
T KOG0582|consen  244 TLQ-NDPPTLLTSGLD--KDEDKKFSKSFREMIALCLVKDPSKRPTASKLL  291 (516)
T ss_pred             Hhc-CCCCCcccccCC--hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHh
Confidence            111 111100000000  011123345789999999999999999999988

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=9.7e-42  Score=330.39  Aligned_cols=267  Identities=22%  Similarity=0.343  Sum_probs=198.0

Q ss_pred             HHHhcccCcCCceEEEEEEeCC-----------------CcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEee
Q 047276          103 DNFQALLGHGSSASVFKGILSD-----------------GTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLG  163 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~~-----------------g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g  163 (453)
                      +.+.++||+|+||.||++.+.+                 +..||+|.+....  ....+|.+|+.++.+++||||++++|
T Consensus         7 ~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~   86 (304)
T cd05096           7 LLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLG   86 (304)
T ss_pred             CeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEE
Confidence            3456789999999999998532                 3369999987632  23457999999999999999999999


Q ss_pred             EEEecCCCeEEEEEecCCCChhhhhccCCCCCCC---------CCCCCCCCHHHHHHHHHHHHHHhccccccCCCceecc
Q 047276          164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEG---------HYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHL  234 (453)
Q Consensus       164 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~---------~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~  234 (453)
                      ++. ..+..++||||+++|+|.+++.........         ......++|...++++.|++.||+|||+   .+++||
T Consensus        87 ~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH~  162 (304)
T cd05096          87 VCV-DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHR  162 (304)
T ss_pred             EEe-cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCcccc
Confidence            987 456789999999999999998643211100         1122358999999999999999999999   899999


Q ss_pred             CCCCCcEEECCCCcEEEeeccccccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc--CCCCC
Q 047276          235 DVKPENILLDENYRAVVSDFGLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG--GRRNV  311 (453)
Q Consensus       235 Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt--G~~p~  311 (453)
                      ||||+|||+++++.+||+|||+++....... .......++..|+|||++..+.++.++||||||+++|||++  +..||
T Consensus       163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~  242 (304)
T cd05096         163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY  242 (304)
T ss_pred             CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence            9999999999999999999999986543322 11223455789999999998899999999999999999987  55566


Q ss_pred             cccccCCCCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 047276          312 SLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEG  390 (453)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~  390 (453)
                      ......         ............... ...   .    ..+..++..+.+++.+||+.+|++|||+.+|.+.|++
T Consensus       243 ~~~~~~---------~~~~~~~~~~~~~~~-~~~---~----~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         243 GELTDE---------QVIENAGEFFRDQGR-QVY---L----FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CcCCHH---------HHHHHHHHHhhhccc-ccc---c----cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            422110         000111111111100 000   0    0112334568999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.4e-41  Score=320.81  Aligned_cols=248  Identities=26%  Similarity=0.419  Sum_probs=199.7

Q ss_pred             HhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCCh
Q 047276          105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL  184 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL  184 (453)
                      +.+.||+|+||.||++.++++..+|+|.+.........|.+|+.++++++||||++++++|. .....++||||+++|+|
T Consensus         8 ~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~iv~e~~~~~~L   86 (256)
T cd05114           8 FMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT-QQKPLYIVTEFMENGCL   86 (256)
T ss_pred             EeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEc-cCCCEEEEEEcCCCCcH
Confidence            45789999999999999988889999998766666778999999999999999999999886 56688999999999999


Q ss_pred             hhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCCC
Q 047276          185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ  264 (453)
Q Consensus       185 ~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~  264 (453)
                      .+++....         +.+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++......
T Consensus        87 ~~~~~~~~---------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05114          87 LNYLRQRQ---------GKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE  154 (256)
T ss_pred             HHHHHhCc---------cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence            99985432         238999999999999999999999   899999999999999999999999999988654333


Q ss_pred             CceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcCcccc
Q 047276          265 SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLME  343 (453)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (453)
                      ........++..|+|||.+....++.++||||||+++|||++ |+.||.....            .... .....+..  
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~------------~~~~-~~i~~~~~--  219 (256)
T cd05114         155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN------------YEVV-EMISRGFR--  219 (256)
T ss_pred             eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH------------HHHH-HHHHCCCC--
Confidence            222223345668999999988889999999999999999999 8989853211            1111 11111110  


Q ss_pred             cccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 047276          344 IVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE  389 (453)
Q Consensus       344 ~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~  389 (453)
                      ..         .+......+.+++.+||+.+|++||++.++++.|.
T Consensus       220 ~~---------~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         220 LY---------RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             CC---------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            00         11122346899999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-41  Score=334.15  Aligned_cols=243  Identities=27%  Similarity=0.388  Sum_probs=198.7

Q ss_pred             HHHhcccCcCCceEEEEEEe-CCCcEEEEEEecCC----C--ccHHHHHHHHHHHHhcC-CCceeeEeeEEEecCCCeEE
Q 047276          103 DNFQALLGHGSSASVFKGIL-SDGTSVAVKRINGE----E--NGEKEFRSEVAAIASAQ-HVNLVRLLGYCVVPGGPRYL  174 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~----~--~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~~l  174 (453)
                      +.+.+.||+|+||+|+.|.. .+|..||+|.++..    .  ...+.+.+|+.+++.++ ||||++++.++.. ....++
T Consensus        19 y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t-~~~~~i   97 (370)
T KOG0583|consen   19 YELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT-PTKIYI   97 (370)
T ss_pred             eeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec-CCeEEE
Confidence            44568999999999999984 56899999977542    1  23455778999999999 9999999999764 456999


Q ss_pred             EEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCC-CcEEEee
Q 047276          175 VYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDEN-YRAVVSD  253 (453)
Q Consensus       175 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~-~~~kl~D  253 (453)
                      ||||+.+|+|.+++...          +.+.+....+++.|++.|++|||+   .+|+||||||+|+|+|.+ +++||+|
T Consensus        98 vmEy~~gGdL~~~i~~~----------g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~D  164 (370)
T KOG0583|consen   98 VMEYCSGGDLFDYIVNK----------GRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSD  164 (370)
T ss_pred             EEEecCCccHHHHHHHc----------CCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEec
Confidence            99999999999999753          338889999999999999999999   899999999999999999 9999999


Q ss_pred             ccccccccCCCCceeeeccCCccccchhhhhcCC-CC-ccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHH
Q 047276          254 FGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQG-VS-EKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKI  331 (453)
Q Consensus       254 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~  331 (453)
                      ||++.... .......+.+||+.|+|||.+.+.. |+ .++||||+||+||.|++|+.||+...            .+. 
T Consensus       165 FG~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~------------~~~-  230 (370)
T KOG0583|consen  165 FGLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN------------VPN-  230 (370)
T ss_pred             cccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc------------HHH-
Confidence            99999774 2223457789999999999999876 75 78999999999999999999996411            111 


Q ss_pred             HHHhhhcCcccccccccccCCCCCcHHH-HHHHHHHHHhccccCCCCCCCHHHHH
Q 047276          332 VNEKMKEGKLMEIVDQRLTDEGGIDETQ-VRRLVDVAFWCIQERARLRPSMARVV  385 (453)
Q Consensus       332 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~-~~~l~~l~~~Cl~~~p~~RPs~~~v~  385 (453)
                      ....+..+.            ..++.-. ...+..++.+|++.+|..|+++.+++
T Consensus       231 l~~ki~~~~------------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  231 LYRKIRKGE------------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             HHHHHhcCC------------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            111122221            1223333 66799999999999999999999998

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.8e-41  Score=337.90  Aligned_cols=263  Identities=24%  Similarity=0.368  Sum_probs=200.4

Q ss_pred             HHHHHhcccCcCCceEEEEEEe------CCCcEEEEEEecCCC--ccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCC
Q 047276          101 ATDNFQALLGHGSSASVFKGIL------SDGTSVAVKRINGEE--NGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGP  171 (453)
Q Consensus       101 ~~~~~~~~lG~G~fG~Vy~~~~------~~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~  171 (453)
                      ..+.+.+.||+|+||+||+|+.      .++..||||+++...  ...+.+.+|+.++..+ +||||++++|+|. .++.
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~-~~~~  113 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT-VGGP  113 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec-cCCc
Confidence            3455678999999999999973      235689999987532  2345688999999999 8999999999986 5668


Q ss_pred             eEEEEEecCCCChhhhhccCCCCCCC------------------------------------------------------
Q 047276          172 RYLVYEFIQNGSLDHWIFPTSRRSEG------------------------------------------------------  197 (453)
Q Consensus       172 ~~lv~e~~~~gsL~~~l~~~~~~~~~------------------------------------------------------  197 (453)
                      .++||||+++|+|.+++.........                                                      
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            89999999999999998653210000                                                      


Q ss_pred             -----------CCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCCCCc
Q 047276          198 -----------HYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSR  266 (453)
Q Consensus       198 -----------~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~  266 (453)
                                 ......++|..+++++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                       0012248999999999999999999999   89999999999999999999999999999866433221


Q ss_pred             -eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcCccccc
Q 047276          267 -CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEI  344 (453)
Q Consensus       267 -~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (453)
                       ......++..|+|||.+.+..++.++|||||||++|||++ |..||......            ......+..+.... 
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~------------~~~~~~~~~~~~~~-  337 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD------------SKFYKMIKEGYRML-  337 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch------------HHHHHHHHhCccCC-
Confidence             1222345678999999999899999999999999999998 88888532111            00111122211000 


Q ss_pred             ccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 047276          345 VDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEG  390 (453)
Q Consensus       345 ~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~  390 (453)
                                .+.....++.+++.+||+.+|++||++.+|++.|++
T Consensus       338 ----------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         338 ----------SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             ----------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence                      011123468899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=5.5e-42  Score=324.52  Aligned_cols=247  Identities=32%  Similarity=0.541  Sum_probs=190.9

Q ss_pred             hcccCcCCceEEEEEEeC-----CCcEEEEEEecCCCc--cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEe
Q 047276          106 QALLGHGSSASVFKGILS-----DGTSVAVKRINGEEN--GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-----~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      .+.||.|.||.||+|.+.     .+..|+||.++....  ..+.|.+|++.+++++||||++++|+|. ..+..++|+||
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~-~~~~~~lv~e~   82 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI-ENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE-SSSSEEEEEE-
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccc-ccccccccccc
Confidence            468999999999999976     256899999975332  3578999999999999999999999998 56678999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +++|+|.++|....        ...+++..+++|+.|++.||+|||+   .+++|+||+++||++++++.+||+|||++.
T Consensus        83 ~~~g~L~~~L~~~~--------~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~  151 (259)
T PF07714_consen   83 CPGGSLDDYLKSKN--------KEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSR  151 (259)
T ss_dssp             -TTEBHHHHHHHTC--------TTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGE
T ss_pred             cccccccccccccc--------ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence            99999999997652        2348999999999999999999999   799999999999999999999999999998


Q ss_pred             cccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhh
Q 047276          259 LMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKM  336 (453)
Q Consensus       259 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (453)
                      ....... ...........|+|||.+....++.++||||||+++|||++ |+.||....             .......+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~-------------~~~~~~~~  218 (259)
T PF07714_consen  152 PISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD-------------NEEIIEKL  218 (259)
T ss_dssp             ETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC-------------HHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------------cccccccc
Confidence            7632222 22233456778999999999989999999999999999999 678874221             01112222


Q ss_pred             hcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 047276          337 KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEML  388 (453)
Q Consensus       337 ~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L  388 (453)
                      .++....           .+......+.+++..||+.+|++||++.++++.|
T Consensus       219 ~~~~~~~-----------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  219 KQGQRLP-----------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             HTTEETT-----------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             cccccce-----------eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            2222111           1223345588999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-42  Score=326.60  Aligned_cols=266  Identities=20%  Similarity=0.243  Sum_probs=204.2

Q ss_pred             HHHHHhcccCcCCceEEEEEE-eCCCcEEEEEEecCCCccHH--HHHHHHHHHHhcC-CCceeeEeeEEEecCCCeEEEE
Q 047276          101 ATDNFQALLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEK--EFRSEVAAIASAQ-HVNLVRLLGYCVVPGGPRYLVY  176 (453)
Q Consensus       101 ~~~~~~~~lG~G~fG~Vy~~~-~~~g~~vavK~~~~~~~~~~--~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~~lv~  176 (453)
                      ..|...++||.|.||.||+|+ ..+|..||||+++..-...+  .-++|+..|++|+ |||||+|..++.+.+..+++||
T Consensus        10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf   89 (538)
T KOG0661|consen   10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF   89 (538)
T ss_pred             HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence            456677899999999999999 45788999999986432222  3568999999999 9999999999886666899999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      |||+. +|.++++.++         ..+++..+..|+.||++||+|+|.   +|+.|||+||+|||+..+..+||+|||+
T Consensus        90 E~Md~-NLYqLmK~R~---------r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGL  156 (538)
T KOG0661|consen   90 EFMDC-NLYQLMKDRN---------RLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGL  156 (538)
T ss_pred             Hhhhh-hHHHHHhhcC---------CcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEeccccc
Confidence            99976 9999996553         349999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCceeeeccCCccccchhhhh-cCCCCccccchhHHHHHHHHHcCCCCCcccccCCCC-------Ccccccch
Q 047276          257 SKLMSRDQSRCITTIRGTRGYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDK-------SKNKWQYF  328 (453)
Q Consensus       257 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~-------~~~~~~~~  328 (453)
                      |+.......  .+..+.|.+|.|||++. .+-|+.+.|+||+|||++|+.+-++-|-+..+-++.       ....+..+
T Consensus       157 ARev~SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~  234 (538)
T KOG0661|consen  157 AREVRSKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSW  234 (538)
T ss_pred             ccccccCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccc
Confidence            997755443  35667899999999887 467999999999999999999999888543322110       00111111


Q ss_pred             hHHHHHhhhcCcccccccccccCCC-----CCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 047276          329 PKIVNEKMKEGKLMEIVDQRLTDEG-----GIDETQVRRLVDVAFWCIQERARLRPSMARVVEML  388 (453)
Q Consensus       329 ~~~~~~~~~~~~~~~~~d~~l~~~~-----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L  388 (453)
                      +.-       ..+...+.-+++...     ..-+....++.+++..|++.||.+|||+.+.+++-
T Consensus       235 ~eg-------~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  235 PEG-------YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             hhH-------HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence            110       001111111111111     11123667799999999999999999999998654

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.5e-41  Score=318.91  Aligned_cols=250  Identities=24%  Similarity=0.397  Sum_probs=201.2

Q ss_pred             HhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCCh
Q 047276          105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL  184 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL  184 (453)
                      +.++||+|+||.||+|...++..||+|.+.......+.+.+|+.+++.++|+|++++++++. .++..++++||+++|+|
T Consensus        10 ~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L   88 (261)
T cd05072          10 LVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT-KEEPIYIITEYMAKGSL   88 (261)
T ss_pred             EeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCCcEEEEecCCCCcH
Confidence            45789999999999999888889999998765555678999999999999999999999875 56678999999999999


Q ss_pred             hhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCCC
Q 047276          185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ  264 (453)
Q Consensus       185 ~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~  264 (453)
                      .+++....        ...+++..++.++.|++.||+|||+   .+++|+||||+||++++++.+||+|||++.......
T Consensus        89 ~~~l~~~~--------~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05072          89 LDFLKSDE--------GGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE  157 (261)
T ss_pred             HHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence            99986432        2348899999999999999999999   899999999999999999999999999998764432


Q ss_pred             CceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcCcccc
Q 047276          265 SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLME  343 (453)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (453)
                      ........++..|+|||++..+.++.++||||||+++|||++ |+.||......             .....+..+..  
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-------------~~~~~~~~~~~--  222 (261)
T cd05072         158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS-------------DVMSALQRGYR--  222 (261)
T ss_pred             eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH-------------HHHHHHHcCCC--
Confidence            222223345678999999988889999999999999999998 99998422110             01111111110  


Q ss_pred             cccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 047276          344 IVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEG  390 (453)
Q Consensus       344 ~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~  390 (453)
                           ..    .....+..+.+++.+|++.+|++||+++++.+.|++
T Consensus       223 -----~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         223 -----MP----RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             -----CC----CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                 00    111233458899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-41  Score=318.37  Aligned_cols=255  Identities=26%  Similarity=0.403  Sum_probs=204.6

Q ss_pred             HHHHHHhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          100 EATDNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       100 ~~~~~~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      .....+.+.||+|+||.||+|...+++.||+|.++......+++.+|+.++++++|+|++++++++. ..+..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT-LEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEe-cCCCeeeeeecc
Confidence            3445567899999999999999877889999999876666778999999999999999999999876 566889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ++++|.+++....        ...+++..+.+++.|++.||.|||+   .+++|+||||+||++++++.+||+|||++..
T Consensus        84 ~~~~L~~~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~  152 (261)
T cd05068          84 KYGSLLEYLQGGA--------GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARV  152 (261)
T ss_pred             cCCcHHHHHhccC--------CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEE
Confidence            9999999985432        1248999999999999999999999   8999999999999999999999999999987


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      ..............+..|+|||++.+..++.++||||||+++|||++ |+.||.....             ......+..
T Consensus       153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------------~~~~~~~~~  219 (261)
T cd05068         153 IKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-------------AEVLQQVDQ  219 (261)
T ss_pred             ccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH-------------HHHHHHHHc
Confidence            65332221222233468999999988889999999999999999999 9988853210             001111111


Q ss_pred             CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 047276          339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEG  390 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~  390 (453)
                      +..       +    ..+......+.+++.+|++.+|++||++.++.+.|+.
T Consensus       220 ~~~-------~----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         220 GYR-------M----PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCC-------C----CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            100       0    1122334568999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=4e-41  Score=328.98  Aligned_cols=240  Identities=23%  Similarity=0.277  Sum_probs=191.5

Q ss_pred             cccCcCCceEEEEEEe-CCCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          107 ALLGHGSSASVFKGIL-SDGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      +.||+|+||.||++.. .+|+.||+|+++..    ......+.+|+.+++.++||||+++++++. ..+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~-~~~~~~lv~E~~~~   79 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-THDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEe-cCCEEEEEEeCCCC
Confidence            4699999999999995 46899999998752    223356778999999999999999999876 55688999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      |+|..++...          ..+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++....
T Consensus        80 ~~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~  146 (323)
T cd05595          80 GELFFHLSRE----------RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  146 (323)
T ss_pred             CcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhcccc
Confidence            9999888533          238999999999999999999999   899999999999999999999999999987543


Q ss_pred             CCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcc
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKL  341 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (453)
                      ... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......            . .......+. 
T Consensus       147 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------------~-~~~~~~~~~-  211 (323)
T cd05595         147 SDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------------R-LFELILMEE-  211 (323)
T ss_pred             CCC-CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH------------H-HHHHHhcCC-
Confidence            222 1223457899999999999889999999999999999999999998532110            0 111111110 


Q ss_pred             cccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 047276          342 MEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRP-----SMARVVE  386 (453)
Q Consensus       342 ~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~~v~~  386 (453)
                                 ...+......+.+++.+||+.+|++||     ++.++++
T Consensus       212 -----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         212 -----------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             -----------CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence                       112223345688999999999999998     7888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-41  Score=329.28  Aligned_cols=241  Identities=25%  Similarity=0.286  Sum_probs=191.3

Q ss_pred             cCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCC
Q 047276          109 LGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS  183 (453)
Q Consensus       109 lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gs  183 (453)
                      ||+|+||+||++... +++.||+|.++..    ......+..|+.++.+++||||+++++++. ..+..++||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~g~   79 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQ-SPEKLYLVLAFINGGE   79 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEe-cCCeEEEEEcCCCCCc
Confidence            799999999999964 5789999998642    233456888999999999999999999876 5668899999999999


Q ss_pred             hhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCC
Q 047276          184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD  263 (453)
Q Consensus       184 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~  263 (453)
                      |.+++...          ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        80 L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~  146 (312)
T cd05585          80 LFHHLQRE----------GRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD  146 (312)
T ss_pred             HHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccC
Confidence            99998543          238899999999999999999999   89999999999999999999999999999864322


Q ss_pred             CCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcccc
Q 047276          264 QSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLME  343 (453)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (453)
                      . .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....            ......... .+.   
T Consensus       147 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~------------~~~~~~~~~-~~~---  209 (312)
T cd05585         147 D-DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN------------VNEMYRKIL-QEP---  209 (312)
T ss_pred             C-CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC------------HHHHHHHHH-cCC---
Confidence            2 22344578999999999999899999999999999999999999995321            011111111 110   


Q ss_pred             cccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 047276          344 IVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE  389 (453)
Q Consensus       344 ~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~  389 (453)
                               ..++......+.+++.+||+.+|++||+...+.+.|.
T Consensus       210 ---------~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         210 ---------LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             ---------CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence                     1122234456889999999999999987544444443

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.7e-41  Score=331.60  Aligned_cols=240  Identities=24%  Similarity=0.281  Sum_probs=192.4

Q ss_pred             cccCcCCceEEEEEEe-CCCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          107 ALLGHGSSASVFKGIL-SDGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      +.||+|+||.||++.. .+|+.||+|+++..    ......+.+|+.++.+++||||+++++++. .++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-~~~~~~lv~e~~~~   79 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQ-THDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEE-cCCEEEEEEeCCCC
Confidence            4699999999999986 46899999998752    223356788999999999999999999876 56688999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      |+|.+++...          ..+++.....++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        80 ~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~  146 (323)
T cd05571          80 GELFFHLSRE----------RVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGI  146 (323)
T ss_pred             CcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccc
Confidence            9999998543          238999999999999999999999   899999999999999999999999999987543


Q ss_pred             CCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcc
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKL  341 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (453)
                      ... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......            . .......+. 
T Consensus       147 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------------~-~~~~~~~~~-  211 (323)
T cd05571         147 SDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------------K-LFELILMEE-  211 (323)
T ss_pred             cCC-CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH------------H-HHHHHHcCC-
Confidence            221 2234467999999999999889999999999999999999999999532100            0 111111111 


Q ss_pred             cccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 047276          342 MEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRP-----SMARVVE  386 (453)
Q Consensus       342 ~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~~v~~  386 (453)
                                 ..++......+.+++.+||+.||++||     +..++++
T Consensus       212 -----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         212 -----------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             -----------CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence                       112223345688999999999999999     7888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=4.2e-41  Score=318.92  Aligned_cols=252  Identities=27%  Similarity=0.404  Sum_probs=201.4

Q ss_pred             HHhcccCcCCceEEEEEEeC-CCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCC
Q 047276          104 NFQALLGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      .+.+.||+|+||.||+|... +++.||+|.+..+.....++.+|++++..++|+|+++++++|. .++..+++|||++++
T Consensus         9 ~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~   87 (263)
T cd05052           9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-REPPFYIITEFMTYG   87 (263)
T ss_pred             EEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEc-CCCCcEEEEEeCCCC
Confidence            34678999999999999964 5789999998876556678999999999999999999999986 556889999999999


Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccC
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR  262 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~  262 (453)
                      +|.+++....        ...+++..++.++.|++.||+|||+   .+++||||||+||++++++.+||+|||++.....
T Consensus        88 ~L~~~~~~~~--------~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~  156 (263)
T cd05052          88 NLLDYLRECN--------RQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  156 (263)
T ss_pred             cHHHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence            9999985432        1238999999999999999999998   8999999999999999999999999999987644


Q ss_pred             CCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcCcc
Q 047276          263 DQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKL  341 (453)
Q Consensus       263 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (453)
                      ..........++..|+|||.+.+..++.++||||||+++|||++ |..||.....            .. .......+. 
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~------------~~-~~~~~~~~~-  222 (263)
T cd05052         157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------------SQ-VYELLEKGY-  222 (263)
T ss_pred             ceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH------------HH-HHHHHHCCC-
Confidence            32222222334668999999998899999999999999999998 8888742210            00 111111110 


Q ss_pred             cccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 047276          342 MEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR  391 (453)
Q Consensus       342 ~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~  391 (453)
                          .      ...+...+..+.+++.+|++.+|++||++.+++++|+..
T Consensus       223 ----~------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         223 ----R------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             ----C------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence                0      011223345689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-42  Score=342.86  Aligned_cols=250  Identities=25%  Similarity=0.390  Sum_probs=205.8

Q ss_pred             HhcccCcCCceEEEEEEe-CCCc----EEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          105 FQALLGHGSSASVFKGIL-SDGT----SVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~----~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      -.++||+|+||+||||.+ ..|.    +||+|++...  .....++++|+.+|.+++|||+++|+|+|...  ...||++
T Consensus       700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s--~~qlvtq  777 (1177)
T KOG1025|consen  700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS--TLQLVTQ  777 (1177)
T ss_pred             hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc--hHHHHHH
Confidence            357999999999999996 3443    6999998764  34467899999999999999999999999743  4789999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      ||+.|+|.+|++.++         +.+.-...+.|..|||+||.|||+   ++++||||.++||||..-..+||.|||++
T Consensus       778 ~mP~G~LlDyvr~hr---------~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla  845 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREHR---------DNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLA  845 (1177)
T ss_pred             hcccchHHHHHHHhh---------ccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchh
Confidence            999999999997654         338888999999999999999998   89999999999999999999999999999


Q ss_pred             ccccCCCCc-eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHh
Q 047276          258 KLMSRDQSR-CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEK  335 (453)
Q Consensus       258 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  335 (453)
                      +.+..+... ......-.+.|||-|.+....|+.++|||||||++||++| |..|+....-.             .+...
T Consensus       846 ~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~-------------eI~dl  912 (1177)
T KOG1025|consen  846 KLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE-------------EIPDL  912 (1177)
T ss_pred             hccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH-------------HhhHH
Confidence            988765432 2233345679999999999999999999999999999999 99998643211             12233


Q ss_pred             hhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          336 MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       336 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      ++.|.       +|    .-++.+...+..++.+||..|+..||+++++...+....
T Consensus       913 le~ge-------RL----sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a  958 (1177)
T KOG1025|consen  913 LEKGE-------RL----SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA  958 (1177)
T ss_pred             Hhccc-------cC----CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence            33332       12    235566777999999999999999999999998876543

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=6.2e-41  Score=316.64  Aligned_cols=249  Identities=25%  Similarity=0.410  Sum_probs=199.8

Q ss_pred             HHhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCC
Q 047276          104 NFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS  183 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gs  183 (453)
                      .+.+.||+|+||+||+|...++..+|+|.+........+|.+|+.++.+++||||++++++|. .....+++|||+++|+
T Consensus         7 ~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~   85 (256)
T cd05113           7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT-KQRPIYIVTEYMSNGC   85 (256)
T ss_pred             EEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEc-cCCCcEEEEEcCCCCc
Confidence            356789999999999999877778999998866556778999999999999999999999986 4567899999999999


Q ss_pred             hhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCC
Q 047276          184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD  263 (453)
Q Consensus       184 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~  263 (453)
                      |.+++....         ..+++..+++++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++.....
T Consensus        86 l~~~i~~~~---------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~  153 (256)
T cd05113          86 LLNYLREHG---------KRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD  153 (256)
T ss_pred             HHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence            999985432         238999999999999999999999   89999999999999999999999999998866443


Q ss_pred             CCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcCccc
Q 047276          264 QSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLM  342 (453)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (453)
                      .........++..|++||.+....++.++||||||+++|||++ |+.||......            . .......+...
T Consensus       154 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------------~-~~~~~~~~~~~  220 (256)
T cd05113         154 EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS------------E-TVEKVSQGLRL  220 (256)
T ss_pred             ceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH------------H-HHHHHhcCCCC
Confidence            3222222345678999999988889999999999999999998 99998532110            0 11111111100


Q ss_pred             ccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 047276          343 EIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE  389 (453)
Q Consensus       343 ~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~  389 (453)
                                 ..+......+.+++.+||+.+|++||++.++++.|+
T Consensus       221 -----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         221 -----------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             -----------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                       011122456899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.4e-41  Score=336.86  Aligned_cols=264  Identities=23%  Similarity=0.377  Sum_probs=199.4

Q ss_pred             HHHHHhcccCcCCceEEEEEEe------CCCcEEEEEEecCCC--ccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCC
Q 047276          101 ATDNFQALLGHGSSASVFKGIL------SDGTSVAVKRINGEE--NGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGP  171 (453)
Q Consensus       101 ~~~~~~~~lG~G~fG~Vy~~~~------~~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~  171 (453)
                      ..+.+.+.||+|+||.||++..      .++..||+|+++...  .....+.+|+.+++.+ +|+||++++|+|. ..+.
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~-~~~~  116 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT-HGGP  116 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec-CCCC
Confidence            3445678999999999999874      234579999997532  2235688999999999 8999999999986 5568


Q ss_pred             eEEEEEecCCCChhhhhccCCCCC--------------------------------------------------------
Q 047276          172 RYLVYEFIQNGSLDHWIFPTSRRS--------------------------------------------------------  195 (453)
Q Consensus       172 ~~lv~e~~~~gsL~~~l~~~~~~~--------------------------------------------------------  195 (453)
                      .++||||+++|+|.+++.......                                                        
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            899999999999999986432100                                                        


Q ss_pred             ----CCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCCCCc-eeee
Q 047276          196 ----EGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSR-CITT  270 (453)
Q Consensus       196 ----~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~-~~~~  270 (453)
                          ........+++...++++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++........ ....
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                000012348899999999999999999999   89999999999999999999999999999865433221 1122


Q ss_pred             ccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcCcccccccccc
Q 047276          271 IRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRL  349 (453)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  349 (453)
                      ..++..|+|||++.+..++.++|||||||++|||++ |+.||.......            ........+.     ... 
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~------------~~~~~~~~~~-----~~~-  335 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS------------KFYKMVKRGY-----QMS-  335 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH------------HHHHHHHccc-----Ccc-
Confidence            345678999999988899999999999999999997 999985321110            0111111110     000 


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 047276          350 TDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR  391 (453)
Q Consensus       350 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~  391 (453)
                           .+...+..+.+++.+||+.+|++||++.+|+++|++.
T Consensus       336 -----~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         336 -----RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             -----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                 1111235688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.2e-40  Score=315.15  Aligned_cols=257  Identities=25%  Similarity=0.413  Sum_probs=207.0

Q ss_pred             HHHHHHHHHhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEE
Q 047276           97 ELEEATDNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVY  176 (453)
Q Consensus        97 el~~~~~~~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~  176 (453)
                      ++...++.+.++||+|+||.||+|..++++.||+|.+.........|.+|+.++++++|+|++++++++  ..+..++++
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~~v~   79 (260)
T cd05067           2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV--TQEPIYIIT   79 (260)
T ss_pred             ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEE--ccCCcEEEE
Confidence            344556677889999999999999988899999999987666678899999999999999999999975  345789999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||+++|+|.+++....        ...+++..++.++.|++.||+|||+   .+++|+||||+||++++++.++|+|||+
T Consensus        80 e~~~~~~L~~~~~~~~--------~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~  148 (260)
T cd05067          80 EYMENGSLVDFLKTPE--------GIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGL  148 (260)
T ss_pred             EcCCCCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcc
Confidence            9999999999985432        2348999999999999999999998   8999999999999999999999999999


Q ss_pred             cccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHh
Q 047276          257 SKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEK  335 (453)
Q Consensus       257 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  335 (453)
                      +...............++..|+|||++....++.++||||||+++||+++ |+.||.....            +. ....
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------------~~-~~~~  215 (260)
T cd05067         149 ARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN------------PE-VIQN  215 (260)
T ss_pred             eeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh------------HH-HHHH
Confidence            98765333222233456778999999988889999999999999999999 9999853211            01 1111


Q ss_pred             hhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 047276          336 MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEG  390 (453)
Q Consensus       336 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~  390 (453)
                      +..+..       .    ..+......+.+++.+|++.+|++||++++++..|+.
T Consensus       216 ~~~~~~-------~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         216 LERGYR-------M----PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             HHcCCC-------C----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            111110       0    0112233469999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=4.2e-41  Score=322.96  Aligned_cols=246  Identities=22%  Similarity=0.275  Sum_probs=193.9

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCC----ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      .+.||+|+||+||++.. .+|+.||+|.+....    .....+.+|+.++..++|+|++++.+++. .++..++|+||++
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~-~~~~~~lv~e~~~   83 (285)
T cd05631           5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYE-TKDALCLVLTIMN   83 (285)
T ss_pred             EEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEc-cCCeEEEEEEecC
Confidence            46899999999999995 578999999986422    23346789999999999999999999876 5568899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|.+++....        ...+++..+..++.|++.||+|||+   .+++||||||+|||+++++.+||+|||++...
T Consensus        84 ~g~L~~~~~~~~--------~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~  152 (285)
T cd05631          84 GGDLKFHIYNMG--------NPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQI  152 (285)
T ss_pred             CCcHHHHHHhhC--------CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEc
Confidence            999998875332        1238999999999999999999999   89999999999999999999999999999865


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      ....  ......||..|+|||++.+..++.++|||||||++|||++|+.||.......         .............
T Consensus       153 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---------~~~~~~~~~~~~~  221 (285)
T cd05631         153 PEGE--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV---------KREEVDRRVKEDQ  221 (285)
T ss_pred             CCCC--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch---------hHHHHHHHhhccc
Confidence            4322  2234568999999999999999999999999999999999999996422110         0000111111100


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPS-----MARVVE  386 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~~v~~  386 (453)
                                  ..++......+.+++.+||+.+|++||+     ++++++
T Consensus       222 ------------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         222 ------------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             ------------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence                        1122234456889999999999999997     677764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.1e-41  Score=330.01  Aligned_cols=242  Identities=29%  Similarity=0.412  Sum_probs=202.6

Q ss_pred             HHhcccCcCCceEEEEEEe-CCCcEEEEEEecCCCccH---HHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          104 NFQALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGE---KEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      .+.+.||+|+||+||||+- .+.+.||+|.+.+....+   +.+.+|+++++.++|||||.+++++. ...+.++|.||+
T Consensus         5 hv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfE-t~~~~~vVte~a   83 (808)
T KOG0597|consen    5 HVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFE-TSAHLWVVTEYA   83 (808)
T ss_pred             hHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhc-ccceEEEEehhh
Confidence            3457899999999999995 467899999997644333   45889999999999999999999975 677999999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      .+ +|..+|...          +.++++....|+.+++.||.|||+   .+|.|||+||.|||++.++.+|++|||+|+.
T Consensus        84 ~g-~L~~il~~d----------~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~  149 (808)
T KOG0597|consen   84 VG-DLFTILEQD----------GKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARA  149 (808)
T ss_pred             hh-hHHHHHHhc----------cCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhh
Confidence            77 999999643          349999999999999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      ++.. ....+...|||-|||||...++.|+..+|+||+||++||+.+|++||....            +...+...    
T Consensus       150 m~~~-t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------------i~~Lv~~I----  212 (808)
T KOG0597|consen  150 MSTN-TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------------ITQLVKSI----  212 (808)
T ss_pred             cccC-ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------------HHHHHHHH----
Confidence            7653 334566789999999999999999999999999999999999999995211            11111111    


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                               +.++...+......+..++...+++||..|-+..+++.
T Consensus       213 ---------~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  213 ---------LKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             ---------hcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence                     11122344567778999999999999999999999874

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-40  Score=314.27  Aligned_cols=248  Identities=25%  Similarity=0.408  Sum_probs=199.1

Q ss_pred             HHhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCC
Q 047276          104 NFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS  183 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gs  183 (453)
                      .+.+.||+|+||.||+|.+.++..+|+|.+.........|.+|+.+++.++|+|++++++++. ..+..++|+||+++++
T Consensus         7 ~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~lv~e~~~~~~   85 (256)
T cd05059           7 TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT-KQRPIFIVTEYMANGC   85 (256)
T ss_pred             chhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEc-CCCceEEEEecCCCCC
Confidence            456889999999999999877778999998765556678999999999999999999999876 5568899999999999


Q ss_pred             hhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCC
Q 047276          184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD  263 (453)
Q Consensus       184 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~  263 (453)
                      |.+++....         ..+++..++.++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++.....
T Consensus        86 L~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~  153 (256)
T cd05059          86 LLNYLRERK---------GKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD  153 (256)
T ss_pred             HHHHHHhcc---------cCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccc
Confidence            999986432         248999999999999999999999   89999999999999999999999999999865433


Q ss_pred             CCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcCccc
Q 047276          264 QSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLM  342 (453)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (453)
                      .........++..|+|||.+.+..++.++||||||+++|||++ |+.||.......             .......+.  
T Consensus       154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------------~~~~~~~~~--  218 (256)
T cd05059         154 QYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-------------VVESVSAGY--  218 (256)
T ss_pred             cccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH-------------HHHHHHcCC--
Confidence            2222222234568999999998889999999999999999999 888885321110             111111110  


Q ss_pred             ccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 047276          343 EIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEML  388 (453)
Q Consensus       343 ~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L  388 (453)
                         ..      ..+...+..+.+++.+|++.+|++|||+.++++.|
T Consensus       219 ---~~------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         219 ---RL------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             ---cC------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence               00      11122455699999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.1e-40  Score=313.57  Aligned_cols=252  Identities=24%  Similarity=0.379  Sum_probs=202.7

Q ss_pred             HHHHhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          102 TDNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       102 ~~~~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      .+.+.++||+|+||.||++...++..+|+|.+.......+.|.+|+.++++++|+|++++++++.  ....+++|||+++
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~--~~~~~lv~e~~~~   84 (260)
T cd05070           7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS--EEPIYIVTEYMSK   84 (260)
T ss_pred             HhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC--CCCcEEEEEecCC
Confidence            45567899999999999999888889999999876666678999999999999999999999863  4567999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      ++|.+++....        ...+++..++.++.+++.||+|||+   .+++|+||||+||++++++.++|+|||++....
T Consensus        85 ~~L~~~~~~~~--------~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~  153 (260)
T cd05070          85 GSLLDFLKDGE--------GRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIE  153 (260)
T ss_pred             CcHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeecc
Confidence            99999986432        2348999999999999999999999   899999999999999999999999999998764


Q ss_pred             CCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      ...........++..|+|||.+....++.++|+||||+++|||++ |..||......            . ....+..+.
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------------~-~~~~~~~~~  220 (260)
T cd05070         154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR------------E-VLEQVERGY  220 (260)
T ss_pred             CcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH------------H-HHHHHHcCC
Confidence            433222223345678999999988889999999999999999999 88888532110            0 111111110


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEG  390 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~  390 (453)
                      .           ...+......+.+++.+|++.+|++|||+.++.+.|++
T Consensus       221 ~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         221 R-----------MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             C-----------CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            0           01122344569999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.4e-40  Score=295.98  Aligned_cols=259  Identities=20%  Similarity=0.273  Sum_probs=198.2

Q ss_pred             HhcccCcCCceEEEEEE-eCCCcEEEEEEecCCCcc---HHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          105 FQALLGHGSSASVFKGI-LSDGTSVAVKRINGEENG---EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~-~~~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      -.++||+|.||.||+|+ ..+|+.||||+++..+..   .....+|++.|+.++|+||+.+++++- ..+...+|+|||+
T Consensus         6 ~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~-~~~~l~lVfEfm~   84 (318)
T KOG0659|consen    6 KLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFP-HKSNLSLVFEFMP   84 (318)
T ss_pred             hhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhcc-CCCceEEEEEecc
Confidence            35789999999999999 567999999999864322   356789999999999999999999865 6678899999997


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      . +|+..++...         -.++......++.++.+|++|||+   +.|+||||||.|+|++.+|.+||+|||+++.+
T Consensus        85 t-dLe~vIkd~~---------i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f  151 (318)
T KOG0659|consen   85 T-DLEVVIKDKN---------IILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFF  151 (318)
T ss_pred             c-cHHHHhcccc---------cccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhcc
Confidence            7 9999996543         348899999999999999999999   89999999999999999999999999999998


Q ss_pred             cCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCC----------CCCcccccc--
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGN----------DKSKNKWQY--  327 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~----------~~~~~~~~~--  327 (453)
                      ........ ..+-|.+|.|||.+.+ ..|+...|+||.||++.||+-|.+-|....+-+          .....+|..  
T Consensus       152 ~~p~~~~~-~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~  230 (318)
T KOG0659|consen  152 GSPNRIQT-HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMT  230 (318)
T ss_pred             CCCCcccc-cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccc
Confidence            75543322 2267889999998876 579999999999999999999987664322111          112223322  


Q ss_pred             -hhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 047276          328 -FPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEML  388 (453)
Q Consensus       328 -~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L  388 (453)
                       +|+.+.-..-.       .+.+.   ..-........+++..++..||.+|++++|++++=
T Consensus       231 ~lpdY~~~~~~P-------~~~~~---~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~  282 (318)
T KOG0659|consen  231 SLPDYVKIQQFP-------KPPLN---NLFPAASSDALDLLSKMLTYNPKKRITASQALKHP  282 (318)
T ss_pred             ccccHHHHhcCC-------CCccc---cccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence             22211111000       00000   01122334468999999999999999999988653

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.3e-40  Score=318.83  Aligned_cols=259  Identities=27%  Similarity=0.439  Sum_probs=202.5

Q ss_pred             HHhcccCcCCceEEEEEEeCC------CcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEE
Q 047276          104 NFQALLGHGSSASVFKGILSD------GTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLV  175 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~~------g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv  175 (453)
                      .+.+.||+|+||.||+|....      ...|++|.++...  .....|.+|+.++..++||||+++++++. .....+++
T Consensus         8 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-~~~~~~~~   86 (283)
T cd05048           8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT-KEQPTCML   86 (283)
T ss_pred             chhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc-CCCceEEE
Confidence            356789999999999998542      2579999987532  23456899999999999999999999876 55678999


Q ss_pred             EEecCCCChhhhhccCCCCCCC------CCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcE
Q 047276          176 YEFIQNGSLDHWIFPTSRRSEG------HYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRA  249 (453)
Q Consensus       176 ~e~~~~gsL~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~  249 (453)
                      |||+++|+|.+++.......+.      ......+++...+.++.|++.||+|||+   .+++|+||||+||++++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~  163 (283)
T cd05048          87 FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTV  163 (283)
T ss_pred             EecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCcE
Confidence            9999999999999754322110      1112458999999999999999999999   899999999999999999999


Q ss_pred             EEeeccccccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccc
Q 047276          250 VVSDFGLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQY  327 (453)
Q Consensus       250 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~  327 (453)
                      ||+|||+++....... .......+++.|+|||.+.++.++.++|||||||++|||++ |..||.....           
T Consensus       164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~-----------  232 (283)
T cd05048         164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN-----------  232 (283)
T ss_pred             EECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH-----------
Confidence            9999999986543322 22233456788999999988899999999999999999998 9999853211           


Q ss_pred             hhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 047276          328 FPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEG  390 (453)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~  390 (453)
                        ......+..+...           ..+...+..+.+++.+||+.+|.+||++.+|++.|++
T Consensus       233 --~~~~~~i~~~~~~-----------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         233 --QEVIEMIRSRQLL-----------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             --HHHHHHHHcCCcC-----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence              0111222222111           1233455679999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=317.51  Aligned_cols=271  Identities=23%  Similarity=0.361  Sum_probs=198.8

Q ss_pred             HhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHh--cCCCceeeEeeEEEecCC----CeEEEEEe
Q 047276          105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIAS--AQHVNLVRLLGYCVVPGG----PRYLVYEF  178 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~~~----~~~lv~e~  178 (453)
                      +.++||+|.||.||||++. ++.||||++..  ...+.|.+|-++.+.  ++|+||++++++- ..+.    +++||++|
T Consensus       214 l~eli~~Grfg~V~KaqL~-~~~VAVKifp~--~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~e-kr~t~~~~eywLVt~f  289 (534)
T KOG3653|consen  214 LLELIGRGRFGCVWKAQLD-NRLVAVKIFPE--QEKQSFQNEKNIYSLPGMKHENILQFIGAE-KRGTADRMEYWLVTEF  289 (534)
T ss_pred             hHHHhhcCccceeehhhcc-CceeEEEecCH--HHHHHHHhHHHHHhccCccchhHHHhhchh-ccCCccccceeEEeee
Confidence            4578999999999999996 58999999964  345678888888765  6899999999873 2333    78999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccC------CCceeccCCCCCcEEECCCCcEEEe
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDC------RSRVLHLDVKPENILLDENYRAVVS  252 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~------~~~ivH~Dlk~~NiLl~~~~~~kl~  252 (453)
                      .++|+|.+||..+           .++|....+|+..+++||+|||++.      +++|+|||||++||||..|+++.|+
T Consensus       290 h~kGsL~dyL~~n-----------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa  358 (534)
T KOG3653|consen  290 HPKGSLCDYLKAN-----------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA  358 (534)
T ss_pred             ccCCcHHHHHHhc-----------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence            9999999999543           4999999999999999999999855      4679999999999999999999999


Q ss_pred             eccccccccCCCC-ceeeeccCCccccchhhhhcC-CCC-----ccccchhHHHHHHHHHcCCCCCcccc-cCCCCCcc-
Q 047276          253 DFGLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQ-GVS-----EKCDIYSYGMVLLELTGGRRNVSLIE-HGNDKSKN-  323 (453)
Q Consensus       253 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~-----~~sDV~S~Gvil~elltG~~p~~~~~-~~~~~~~~-  323 (453)
                      |||+|..+..... ......+||.+|||||++.+. .+.     .+.||||+|.+||||++...-+.... +......+ 
T Consensus       359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~  438 (534)
T KOG3653|consen  359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA  438 (534)
T ss_pred             ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence            9999998865432 333457899999999998754 222     36899999999999999876543111 11000000 


Q ss_pred             cccchh--HHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccCCC
Q 047276          324 KWQYFP--KIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVD  395 (453)
Q Consensus       324 ~~~~~~--~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~~~  395 (453)
                      +....|  +.++..+...+    ..|.+++.-. ....+.-+.+.+..||..||+.|-|+.=|.+.+.+.....
T Consensus       439 evG~hPt~e~mq~~VV~kK----~RP~~p~~W~-~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  439 EVGNHPTLEEMQELVVRKK----QRPKIPDAWR-KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             HhcCCCCHHHHHHHHHhhc----cCCCChhhhh-cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence            000000  11112111111    1122221111 1245667899999999999999999999998887765544

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1e-40  Score=327.78  Aligned_cols=266  Identities=24%  Similarity=0.400  Sum_probs=204.0

Q ss_pred             HHHHHhcccCcCCceEEEEEEeC------CCcEEEEEEecCCCc--cHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCC
Q 047276          101 ATDNFQALLGHGSSASVFKGILS------DGTSVAVKRINGEEN--GEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGP  171 (453)
Q Consensus       101 ~~~~~~~~lG~G~fG~Vy~~~~~------~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~  171 (453)
                      ..+.+.+.||+|+||.||+|...      +++.||+|+++....  ..+.+..|+.++.++ +|+||++++++|...+..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            34566789999999999999732      347899999875322  234678899999999 899999999998877778


Q ss_pred             eEEEEEecCCCChhhhhccCCCCCC---------------------------------------------------CCCC
Q 047276          172 RYLVYEFIQNGSLDHWIFPTSRRSE---------------------------------------------------GHYS  200 (453)
Q Consensus       172 ~~lv~e~~~~gsL~~~l~~~~~~~~---------------------------------------------------~~~~  200 (453)
                      .++++||+++|+|.+++........                                                   ....
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            8999999999999999864321100                                                   0001


Q ss_pred             CCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCCCC-ceeeeccCCccccc
Q 047276          201 GGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQS-RCITTIRGTRGYLA  279 (453)
Q Consensus       201 ~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~a  279 (453)
                      ...++|..+.+++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++.+..... .......++..|+|
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence            2358999999999999999999999   8999999999999999999999999999987643322 12233456778999


Q ss_pred             hhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHH
Q 047276          280 PEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDET  358 (453)
Q Consensus       280 PE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  358 (453)
                      ||++.+..++.++|||||||++|||++ |..||......            .........+...           ..+..
T Consensus       244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~------------~~~~~~~~~~~~~-----------~~~~~  300 (337)
T cd05054         244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID------------EEFCRRLKEGTRM-----------RAPEY  300 (337)
T ss_pred             cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc------------HHHHHHHhccCCC-----------CCCcc
Confidence            999999999999999999999999997 99998532111            0011111111110           01122


Q ss_pred             HHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          359 QVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       359 ~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      ....+.+++.+||+.+|++||++.+++++|+...
T Consensus       301 ~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~  334 (337)
T cd05054         301 ATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLL  334 (337)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            3456899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=6.9e-41  Score=327.93  Aligned_cols=241  Identities=23%  Similarity=0.276  Sum_probs=192.6

Q ss_pred             cccCcCCceEEEEEEe-CCCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          107 ALLGHGSSASVFKGIL-SDGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      +.||+|+||.||++.. .+|+.||+|++...    ......+.+|+.+++.++||||+++.+++. .++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~~lv~Ey~~~   79 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQ-TKDRLCFVMEYVNG   79 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE-cCCEEEEEEeCCCC
Confidence            4699999999999995 46899999998752    233456888999999999999999999876 56688999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      |+|.+++...          ..+++.....++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        80 g~L~~~l~~~----------~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~  146 (328)
T cd05593          80 GELFFHLSRE----------RVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGI  146 (328)
T ss_pred             CCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence            9999888533          238999999999999999999999   899999999999999999999999999987543


Q ss_pred             CCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcc
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKL  341 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (453)
                      ... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......            . .......+. 
T Consensus       147 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------------~-~~~~~~~~~-  211 (328)
T cd05593         147 TDA-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------------K-LFELILMED-  211 (328)
T ss_pred             Ccc-cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------------H-HHHHhccCC-
Confidence            222 1233457999999999999889999999999999999999999999532110            0 111111110 


Q ss_pred             cccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 047276          342 MEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRP-----SMARVVEM  387 (453)
Q Consensus       342 ~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~~v~~~  387 (453)
                                 ..++......+.+++.+||+.+|++||     ++.++++.
T Consensus       212 -----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         212 -----------IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             -----------ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence                       112223345688999999999999997     78888754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3.3e-40  Score=312.72  Aligned_cols=254  Identities=25%  Similarity=0.378  Sum_probs=203.0

Q ss_pred             HHHHHhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          101 ATDNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       101 ~~~~~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      ..+.+.++||+|+||.||+|...++..||+|.++......+.|.+|+.+++.++|+|++++++++.  ....++||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~--~~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS--EEPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC--CCCcEEEEEcCC
Confidence            345567899999999999999877778999999875556678999999999999999999999763  456799999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|.+++....        ...+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||.+...
T Consensus        84 ~~~L~~~~~~~~--------~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~  152 (262)
T cd05071          84 KGSLLDFLKGEM--------GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI  152 (262)
T ss_pred             CCcHHHHHhhcc--------ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeec
Confidence            999999995432        1237999999999999999999999   89999999999999999999999999999866


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      ............++..|+|||+..+..++.++||||||+++|||++ |..||.....             .........+
T Consensus       153 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~-------------~~~~~~~~~~  219 (262)
T cd05071         153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------------REVLDQVERG  219 (262)
T ss_pred             cccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh-------------HHHHHHHhcC
Confidence            5433222223446678999999988889999999999999999999 8878742210             0011111111


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR  391 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~  391 (453)
                      ..           ...+.+.+..+.+++.+|++.+|++||++.++.+.|+..
T Consensus       220 ~~-----------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         220 YR-----------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             CC-----------CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            00           011234456689999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=7.3e-41  Score=326.86  Aligned_cols=236  Identities=25%  Similarity=0.324  Sum_probs=184.0

Q ss_pred             cccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHH-HHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          107 ALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVA-AIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      ++||+|+||.||+++.. +|+.||+|++...    ......+..|.. +++.++||||+++++++. ..+..++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~-~~~~~~lv~e~~~   79 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQ-TAEKLYFVLDYVN   79 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEE-cCCEEEEEEcCCC
Confidence            46999999999999964 6889999998642    122334555554 578899999999999875 5668899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|..++...          ..+++.....++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||+++..
T Consensus        80 ~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  146 (321)
T cd05603          80 GGELFFHLQRE----------RCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (321)
T ss_pred             CCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence            99999888532          237888888999999999999998   89999999999999999999999999998753


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      .... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....            .. ....+..+.
T Consensus       147 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------------~~-~~~~i~~~~  212 (321)
T cd05603         147 VEPE-ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV------------SQ-MYDNILHKP  212 (321)
T ss_pred             CCCC-CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH------------HH-HHHHHhcCC
Confidence            2222 223445789999999999988899999999999999999999999953210            00 111111110


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHH
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMA  382 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~  382 (453)
                                  ...+......+.+++.+|++.+|.+||+..
T Consensus       213 ------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         213 ------------LQLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             ------------CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence                        112223345688999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.8e-40  Score=311.80  Aligned_cols=251  Identities=24%  Similarity=0.374  Sum_probs=200.9

Q ss_pred             HHHhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCC
Q 047276          103 DNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      +.+...||+|+||.||++...++..+|+|.+.......+.+.+|+.++++++|+|++++++++.  .+..+++|||+++|
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~v~e~~~~~   85 (260)
T cd05069           8 LRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS--EEPIYIVTEFMGKG   85 (260)
T ss_pred             eeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc--CCCcEEEEEcCCCC
Confidence            4456789999999999999877778999998765556678999999999999999999999863  45679999999999


Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccC
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR  262 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~  262 (453)
                      +|.+++....        ...+++..+..++.|++.||+|||+   .+++|+||||+||++++++.++|+|||++.....
T Consensus        86 ~L~~~~~~~~--------~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05069          86 SLLDFLKEGD--------GKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIED  154 (260)
T ss_pred             CHHHHHhhCC--------CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccC
Confidence            9999996432        2237999999999999999999998   8999999999999999999999999999986643


Q ss_pred             CCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcCcc
Q 047276          263 DQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKL  341 (453)
Q Consensus       263 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (453)
                      ..........++..|+|||......++.++||||||+++|||++ |+.||....+.            . .......+..
T Consensus       155 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------------~-~~~~~~~~~~  221 (260)
T cd05069         155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR------------E-VLEQVERGYR  221 (260)
T ss_pred             CcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH------------H-HHHHHHcCCC
Confidence            32222223345678999999988889999999999999999999 88888532110            0 1111111100


Q ss_pred             cccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 047276          342 MEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEG  390 (453)
Q Consensus       342 ~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~  390 (453)
                                 ...+...+..+.+++.+|++.+|++||++++|++.|++
T Consensus       222 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         222 -----------MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -----------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                       01122345668999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.3e-40  Score=324.34  Aligned_cols=252  Identities=23%  Similarity=0.390  Sum_probs=196.7

Q ss_pred             HHHhcccCcCCceEEEEEEeC-CCc----EEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEE
Q 047276          103 DNFQALLGHGSSASVFKGILS-DGT----SVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLV  175 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~-~g~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv  175 (453)
                      +...+.||+|+||.||+|++. +|.    .||+|.++...  ...+++.+|+.+++.++||||++++|+|..  ...+++
T Consensus         9 f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~--~~~~~v   86 (316)
T cd05108           9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--STVQLI   86 (316)
T ss_pred             ceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC--CCceee
Confidence            334578999999999999853 343    48999987532  334678999999999999999999999863  357899


Q ss_pred             EEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecc
Q 047276          176 YEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFG  255 (453)
Q Consensus       176 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfG  255 (453)
                      +||+++|+|.+++....         ..+++...++++.|++.||+|||+   .+++||||||+|||+++++.+||+|||
T Consensus        87 ~e~~~~g~l~~~l~~~~---------~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG  154 (316)
T cd05108          87 TQLMPFGCLLDYVREHK---------DNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFG  154 (316)
T ss_pred             eecCCCCCHHHHHHhcc---------ccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEcccc
Confidence            99999999999986432         238899999999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCce-eeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHH
Q 047276          256 LSKLMSRDQSRC-ITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVN  333 (453)
Q Consensus       256 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  333 (453)
                      +++......... .....++..|+|||++.+..++.++||||||+++|||++ |+.||......             ...
T Consensus       155 ~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-------------~~~  221 (316)
T cd05108         155 LAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-------------EIS  221 (316)
T ss_pred             ccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-------------HHH
Confidence            998765433221 122334678999999999999999999999999999998 99998532100             011


Q ss_pred             HhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          334 EKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       334 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      .....+.       .+.    .+..+...+.+++.+||+.+|++||++.+++..|....
T Consensus       222 ~~~~~~~-------~~~----~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~  269 (316)
T cd05108         222 SILEKGE-------RLP----QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  269 (316)
T ss_pred             HHHhCCC-------CCC----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            1111111       111    11123345889999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=6e-41  Score=328.53  Aligned_cols=240  Identities=25%  Similarity=0.319  Sum_probs=193.4

Q ss_pred             HHhcccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEe
Q 047276          104 NFQALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      .+.+.||+|+||.||+|+.. +|+.||+|.+...    ....+.+.+|+.++.+++||||+++++++. .++..++||||
T Consensus        21 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~~lv~e~   99 (329)
T PTZ00263         21 EMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ-DENRVYFLLEF   99 (329)
T ss_pred             EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-cCCEEEEEEcC
Confidence            34678999999999999964 5889999998642    223456889999999999999999999876 56688999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +++|+|.+++...          ..+++.....++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       100 ~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~  166 (329)
T PTZ00263        100 VVGGELFTHLRKA----------GRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK  166 (329)
T ss_pred             CCCChHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCce
Confidence            9999999998643          237888999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      ......    ....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....             ....+....
T Consensus       167 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-------------~~~~~~i~~  229 (329)
T PTZ00263        167 KVPDRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-------------FRIYEKILA  229 (329)
T ss_pred             EcCCCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-------------HHHHHHHhc
Confidence            654322    235789999999999988899999999999999999999999953210             011122222


Q ss_pred             CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 047276          339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPS-----MARVVE  386 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~~v~~  386 (453)
                      +..            ..+......+.+++.+||+.||++||+     ++++++
T Consensus       230 ~~~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        230 GRL------------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             CCc------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            211            111122345789999999999999997     577663

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.2e-40  Score=315.51  Aligned_cols=262  Identities=23%  Similarity=0.411  Sum_probs=204.0

Q ss_pred             HHHHHHhcccCcCCceEEEEEEeCC------CcEEEEEEecCCCc--cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCC
Q 047276          100 EATDNFQALLGHGSSASVFKGILSD------GTSVAVKRINGEEN--GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGP  171 (453)
Q Consensus       100 ~~~~~~~~~lG~G~fG~Vy~~~~~~------g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~  171 (453)
                      ..++.+.+.||+|+||.||+|...+      +..||+|.++....  ..+.|.+|++++..++|+|++++++++. .+..
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~   82 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCT-EGDP   82 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEe-cCCC
Confidence            3456677899999999999998643      47899999876433  3467999999999999999999999987 4568


Q ss_pred             eEEEEEecCCCChhhhhccCCCCCC----CCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCC
Q 047276          172 RYLVYEFIQNGSLDHWIFPTSRRSE----GHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENY  247 (453)
Q Consensus       172 ~~lv~e~~~~gsL~~~l~~~~~~~~----~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~  247 (453)
                      .+++|||+++|+|.+++........    .......+++.....++.|++.|++|||+   .+++||||||+||+++.++
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~  159 (280)
T cd05049          83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDL  159 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCC
Confidence            8999999999999999975432110    01123458999999999999999999999   8999999999999999999


Q ss_pred             cEEEeeccccccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccc
Q 047276          248 RAVVSDFGLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKW  325 (453)
Q Consensus       248 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~  325 (453)
                      .+||+|||++........ .......+++.|+|||.+.++.++.++||||||+++|||++ |..||......        
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~--------  231 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE--------  231 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH--------
Confidence            999999999976533221 11223345778999999999999999999999999999998 99998532111        


Q ss_pred             cchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 047276          326 QYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE  389 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~  389 (453)
                          . .......+....           .+......+.+++.+||+.+|++||++.||++.|+
T Consensus       232 ----~-~~~~~~~~~~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         232 ----E-VIECITQGRLLQ-----------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             ----H-HHHHHHcCCcCC-----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence                0 111112221111           11233456899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-40  Score=312.28  Aligned_cols=252  Identities=23%  Similarity=0.386  Sum_probs=198.8

Q ss_pred             HHHhcccCcCCceEEEEEEeCC----CcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEE
Q 047276          103 DNFQALLGHGSSASVFKGILSD----GTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVY  176 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~~----g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~  176 (453)
                      +.+.+.||+|+||+||+|.+..    ...||||.++...  .....|.+|+.++++++||||+++++++. .++..+++|
T Consensus         6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~iv~   84 (266)
T cd05033           6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT-KSRPVMIIT   84 (266)
T ss_pred             ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEe-cCCceEEEE
Confidence            3456899999999999999742    3579999887533  23457899999999999999999999876 566889999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||+++++|.+++....         +.+++..+++++.|++.||+|||+   .+++|+||||+||++++++.++|+|||+
T Consensus        85 e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~  152 (266)
T cd05033          85 EYMENGSLDKFLREND---------GKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGL  152 (266)
T ss_pred             EcCCCCCHHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccch
Confidence            9999999999985432         248999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCc-eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHH
Q 047276          257 SKLMSRDQSR-CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNE  334 (453)
Q Consensus       257 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  334 (453)
                      +......... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.....             .....
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~-------------~~~~~  219 (266)
T cd05033         153 SRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-------------QDVIK  219 (266)
T ss_pred             hhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH-------------HHHHH
Confidence            9877522221 1122345678999999998899999999999999999998 9988842110             00111


Q ss_pred             hhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 047276          335 KMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR  391 (453)
Q Consensus       335 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~  391 (453)
                      ....+...           ..+...+..+.+++.+|++.+|++||++.+|++.|++.
T Consensus       220 ~~~~~~~~-----------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         220 AVEDGYRL-----------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             HHHcCCCC-----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            11111100           01123345688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-41  Score=323.63  Aligned_cols=238  Identities=24%  Similarity=0.274  Sum_probs=191.9

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC----ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      +.+.||+|+||.||++... +|+.||+|++....    ...+.+.+|+.++++++||||+++++++. +++..++||||+
T Consensus         5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~~lv~e~~   83 (291)
T cd05612           5 RIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH-DQRFLYMLMEYV   83 (291)
T ss_pred             eeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc-cCCeEEEEEeCC
Confidence            4578999999999999964 68899999986421    23456889999999999999999999875 556889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ++|+|.+++...          +.+++.....++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++..
T Consensus        84 ~~~~L~~~~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~  150 (291)
T cd05612          84 PGGELFSYLRNS----------GRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKK  150 (291)
T ss_pred             CCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchh
Confidence            999999998543          238899999999999999999999   8999999999999999999999999999986


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      ....    .....|++.|+|||.+.+..++.++|||||||++|||++|+.||.....             .........+
T Consensus       151 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-------------~~~~~~i~~~  213 (291)
T cd05612         151 LRDR----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-------------FGIYEKILAG  213 (291)
T ss_pred             ccCC----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------------HHHHHHHHhC
Confidence            5432    1235689999999999988899999999999999999999999853211             0011111111


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCC-----HHHHH
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPS-----MARVV  385 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~~v~  385 (453)
                      ..            .++......+.+++.+|++.||.+||+     +++++
T Consensus       214 ~~------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l  252 (291)
T cd05612         214 KL------------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVK  252 (291)
T ss_pred             Cc------------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHh
Confidence            10            112223445889999999999999995     77766

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.8e-41  Score=331.44  Aligned_cols=242  Identities=22%  Similarity=0.323  Sum_probs=205.2

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      +++.||.|+.|.|-.|++ .+|+.+|||++...    ......+.+|+.+|+.++|||++++++++. +...+|+|.||+
T Consensus        16 LgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe-~~~~lylvlEyv   94 (786)
T KOG0588|consen   16 LGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWE-NKQHLYLVLEYV   94 (786)
T ss_pred             ccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeec-cCceEEEEEEec
Confidence            367899999999999995 67999999998653    333456889999999999999999999854 777999999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ++|-|.+++...          +.+.+....+++.||+.|+.|+|.   .+|+||||||+|+|||.++++||+|||+|.+
T Consensus        95 ~gGELFdylv~k----------G~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsL  161 (786)
T KOG0588|consen   95 PGGELFDYLVRK----------GPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASL  161 (786)
T ss_pred             CCchhHHHHHhh----------CCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeec
Confidence            999999999644          448999999999999999999999   8999999999999999999999999999986


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcCCC-CccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQGV-SEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      -.++  ....+.+|+|.|.+||.+.+..| +.++||||+|||||.|+||+.||++..             ...+...++.
T Consensus       162 e~~g--klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-------------ir~LLlKV~~  226 (786)
T KOG0588|consen  162 EVPG--KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-------------IRVLLLKVQR  226 (786)
T ss_pred             ccCC--ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-------------HHHHHHHHHc
Confidence            4332  34567899999999999999888 579999999999999999999996211             1123344455


Q ss_pred             CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      |.            .+.|...+.++.+|+.+|+..||+.|-|+.||++.
T Consensus       227 G~------------f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  227 GV------------FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             Cc------------ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence            43            33455666778999999999999999999999975

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.8e-40  Score=314.77  Aligned_cols=260  Identities=22%  Similarity=0.361  Sum_probs=197.7

Q ss_pred             HHHhcccCcCCceEEEEEEeC------CCcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEE
Q 047276          103 DNFQALLGHGSSASVFKGILS------DGTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYL  174 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~------~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~l  174 (453)
                      +.+.+.||+|+||.||+|...      ++..||+|++....  ....+|.+|+.+++.++||||+++++++. .+...++
T Consensus         8 ~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~-~~~~~~l   86 (277)
T cd05062           8 ITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS-QGQPTLV   86 (277)
T ss_pred             ceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCCeEE
Confidence            344688999999999998753      24679999886432  23456889999999999999999999875 5668899


Q ss_pred             EEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeec
Q 047276          175 VYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDF  254 (453)
Q Consensus       175 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~Df  254 (453)
                      |+||+++|+|.+++...............+++..++.++.|++.||+|||+   .+++|+||||+||++++++.++|+||
T Consensus        87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l~df  163 (277)
T cd05062          87 IMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDF  163 (277)
T ss_pred             EEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEECCC
Confidence            999999999999986543221111112347899999999999999999999   89999999999999999999999999


Q ss_pred             cccccccCCCCc-eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHH
Q 047276          255 GLSKLMSRDQSR-CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIV  332 (453)
Q Consensus       255 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  332 (453)
                      |+++........ ......+++.|+|||.+.++.++.++|||||||++|||++ |..||.....             ...
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-------------~~~  230 (277)
T cd05062         164 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-------------EQV  230 (277)
T ss_pred             CCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------------HHH
Confidence            998765432221 1112345778999999998889999999999999999999 6888742210             001


Q ss_pred             HHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 047276          333 NEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEG  390 (453)
Q Consensus       333 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~  390 (453)
                      ......+....           .+......+.+++.+|++.+|++|||+.++++.|++
T Consensus       231 ~~~~~~~~~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         231 LRFVMEGGLLD-----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHHHHcCCcCC-----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            11111111110           112234468999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.1e-40  Score=321.17  Aligned_cols=240  Identities=25%  Similarity=0.353  Sum_probs=190.5

Q ss_pred             cccCcCCceEEEEEEe----CCCcEEEEEEecCC-----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          107 ALLGHGSSASVFKGIL----SDGTSVAVKRINGE-----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~----~~g~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      +.||+|+||.||+++.    .+++.||+|+++..     ......+..|+.+++.++||||+++++++. .++..++|||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-~~~~~~lv~e   80 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQ-TGGKLYLILE   80 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEe-cCCeEEEEEe
Confidence            5799999999999985    35789999998642     223346788999999999999999999876 5568899999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |+++|+|.+++...          +.+.+.....++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++
T Consensus        81 ~~~~~~L~~~~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  147 (323)
T cd05584          81 YLSGGELFMHLERE----------GIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLC  147 (323)
T ss_pred             CCCCchHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCC
Confidence            99999999998533          237888888999999999999999   89999999999999999999999999998


Q ss_pred             ccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhh
Q 047276          258 KLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMK  337 (453)
Q Consensus       258 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (453)
                      +....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....            .. ......
T Consensus       148 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~------------~~-~~~~~~  213 (323)
T cd05584         148 KESIHEGT-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR------------KK-TIDKIL  213 (323)
T ss_pred             eecccCCC-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH------------HH-HHHHHH
Confidence            75432221 22345789999999999988899999999999999999999999953211            00 111111


Q ss_pred             cCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 047276          338 EGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRP-----SMARVVE  386 (453)
Q Consensus       338 ~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~~v~~  386 (453)
                      .+.            ...+......+.+++.+|++.+|++||     ++.++++
T Consensus       214 ~~~------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         214 KGK------------LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             cCC------------CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            111            112223345688999999999999999     7777765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=6.1e-40  Score=309.90  Aligned_cols=244  Identities=24%  Similarity=0.358  Sum_probs=194.1

Q ss_pred             ccCcCCceEEEEEEe---CCCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          108 LLGHGSSASVFKGIL---SDGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       108 ~lG~G~fG~Vy~~~~---~~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      .||+|+||.||+|.+   .++..+|+|+++...   ...+++..|+.+++.++||||++++|++.  ++..++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE--AESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc--CCCcEEEEecCCC
Confidence            689999999999975   357889999986532   23457899999999999999999999874  4577999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      |+|.+++...          ..+++..+.+++.|++.||+|||+   ++++||||||+||+++.++.+||+|||++....
T Consensus        80 ~~L~~~l~~~----------~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~  146 (257)
T cd05116          80 GPLNKFLQKN----------KHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALG  146 (257)
T ss_pred             CcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccC
Confidence            9999998532          238899999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCce--eeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          262 RDQSRC--ITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       262 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      ......  .....++..|+|||.+....++.++|+||||+++|||++ |+.||......             ........
T Consensus       147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------------~~~~~i~~  213 (257)
T cd05116         147 ADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-------------EVTQMIES  213 (257)
T ss_pred             CCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-------------HHHHHHHC
Confidence            433211  122234578999999988889999999999999999998 99998532110             01112222


Q ss_pred             CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 047276          339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEG  390 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~  390 (453)
                      +...           ..+...+..+.+++.+|++.+|++||++++|.+.|++
T Consensus       214 ~~~~-----------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         214 GERM-----------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCC-----------CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            2110           1122334568899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=9.7e-40  Score=306.91  Aligned_cols=246  Identities=26%  Similarity=0.385  Sum_probs=195.9

Q ss_pred             cccCcCCceEEEEEEeCCCcEEEEEEecCCCc--cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCCh
Q 047276          107 ALLGHGSSASVFKGILSDGTSVAVKRINGEEN--GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL  184 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL  184 (453)
                      ++||+|+||.||+|...+++.+|+|.++....  ....|.+|+.+++.++|||+++++++|. ..+..++||||+++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT-QRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEe-cCCccEEEEECCCCCcH
Confidence            36999999999999988899999999875432  2346889999999999999999999986 45678999999999999


Q ss_pred             hhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCCC
Q 047276          185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ  264 (453)
Q Consensus       185 ~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~  264 (453)
                      .+++....         ..+++..++.++.|++.||.|||+   .+++|+||||+||++++++.+||+|||++.......
T Consensus        80 ~~~~~~~~---------~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  147 (250)
T cd05085          80 LSFLRKKK---------DELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI  147 (250)
T ss_pred             HHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccc
Confidence            99985332         237899999999999999999998   899999999999999999999999999987543322


Q ss_pred             CceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcCcccc
Q 047276          265 SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLME  343 (453)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (453)
                      ........++..|+|||++..+.++.++||||||+++||+++ |..||......             ........+..  
T Consensus       148 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-------------~~~~~~~~~~~--  212 (250)
T cd05085         148 YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-------------QAREQVEKGYR--  212 (250)
T ss_pred             cccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-------------HHHHHHHcCCC--
Confidence            222222344678999999998889999999999999999998 99898532110             01111111110  


Q ss_pred             cccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 047276          344 IVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE  389 (453)
Q Consensus       344 ~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~  389 (453)
                           .    ..+......+.+++.+|++.+|++||++.++.+.|.
T Consensus       213 -----~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         213 -----M----SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             -----C----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence                 0    112233456899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=5.2e-40  Score=329.03  Aligned_cols=264  Identities=22%  Similarity=0.367  Sum_probs=200.9

Q ss_pred             HHHHhcccCcCCceEEEEEEeC------CCcEEEEEEecCCC--ccHHHHHHHHHHHHhcC-CCceeeEeeEEEecCCCe
Q 047276          102 TDNFQALLGHGSSASVFKGILS------DGTSVAVKRINGEE--NGEKEFRSEVAAIASAQ-HVNLVRLLGYCVVPGGPR  172 (453)
Q Consensus       102 ~~~~~~~lG~G~fG~Vy~~~~~------~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~  172 (453)
                      .+.+.++||+|+||.||+|+..      .+..||||+++...  ...+.|.+|+.+++++. ||||++++|+|. ..+..
T Consensus        38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~-~~~~~  116 (400)
T cd05105          38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT-KSGPI  116 (400)
T ss_pred             ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc-cCCce
Confidence            3445689999999999999852      13469999997532  23457899999999996 999999999986 56688


Q ss_pred             EEEEEecCCCChhhhhccCCCCCCC-------------------------------------------------------
Q 047276          173 YLVYEFIQNGSLDHWIFPTSRRSEG-------------------------------------------------------  197 (453)
Q Consensus       173 ~lv~e~~~~gsL~~~l~~~~~~~~~-------------------------------------------------------  197 (453)
                      ++||||+++|+|.+++..+......                                                       
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (400)
T cd05105         117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE  196 (400)
T ss_pred             EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence            9999999999999998654210000                                                       


Q ss_pred             -------------------------------CCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCC
Q 047276          198 -------------------------------HYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDEN  246 (453)
Q Consensus       198 -------------------------------~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~  246 (453)
                                                     ......+++..+.+++.|++.||+|||+   .+++||||||+|||++++
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~~  273 (400)
T cd05105         197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQG  273 (400)
T ss_pred             hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeCC
Confidence                                           0011348899999999999999999999   899999999999999999


Q ss_pred             CcEEEeeccccccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCccc
Q 047276          247 YRAVVSDFGLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNK  324 (453)
Q Consensus       247 ~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~  324 (453)
                      +.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.....+       
T Consensus       274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~-------  346 (400)
T cd05105         274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD-------  346 (400)
T ss_pred             CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh-------
Confidence            9999999999986543222 12233456788999999998889999999999999999997 88888532110       


Q ss_pred             ccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          325 WQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                           .........+.       .+    ..+......+.+++.+||+.+|++||++.+|.++|+...
T Consensus       347 -----~~~~~~~~~~~-------~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         347 -----STFYNKIKSGY-------RM----AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             -----HHHHHHHhcCC-------CC----CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence                 00111111111       00    012233456899999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=7.8e-40  Score=309.56  Aligned_cols=251  Identities=25%  Similarity=0.437  Sum_probs=202.6

Q ss_pred             HHHhcccCcCCceEEEEEEeCCCcEEEEEEecCCCc-cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          103 DNFQALLGHGSSASVFKGILSDGTSVAVKRINGEEN-GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      +.+.++||+|+||.||+|...++..+++|.+..... ....+..|+.+++.++|+|++++++++. .....++||||+++
T Consensus         8 y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~lv~e~~~~   86 (261)
T cd05148           8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS-VGEPVYIITELMEK   86 (261)
T ss_pred             HHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe-cCCCeEEEEeeccc
Confidence            455689999999999999988899999999876543 4567899999999999999999999876 55688999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      |+|.+++....        ...+++..+++++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||++....
T Consensus        87 ~~L~~~~~~~~--------~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~  155 (261)
T cd05148          87 GSLLAFLRSPE--------GQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIK  155 (261)
T ss_pred             CCHHHHHhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcC
Confidence            99999996432        2348999999999999999999998   899999999999999999999999999998664


Q ss_pred             CCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      .... ......++..|+|||.+....++.++||||||+++|+|++ |+.||......            . .......+.
T Consensus       156 ~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~------------~-~~~~~~~~~  221 (261)
T cd05148         156 EDVY-LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH------------E-VYDQITAGY  221 (261)
T ss_pred             Cccc-cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH------------H-HHHHHHhCC
Confidence            3322 1223446778999999988889999999999999999998 89998532110            0 111111110


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEG  390 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~  390 (453)
                             +    ...+...+..+.+++.+|++.+|++|||+.++.+.|+.
T Consensus       222 -------~----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         222 -------R----MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             -------c----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence                   0    01122334568899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.4e-40  Score=317.74  Aligned_cols=268  Identities=19%  Similarity=0.232  Sum_probs=194.9

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.+.||+|+||+||+++.. +++.||+|+++..   ....+.+.+|+.+++.++||||+++++++. .++..++||||++
T Consensus         5 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~   83 (287)
T cd07848           5 VLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFR-RRGKLYLVFEYVE   83 (287)
T ss_pred             EEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEe-cCCEEEEEEecCC
Confidence            4578999999999999975 5789999998753   223456889999999999999999999876 5568899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      ++.+..+...          ...+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++...
T Consensus        84 ~~~l~~~~~~----------~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  150 (287)
T cd07848          84 KNMLELLEEM----------PNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNL  150 (287)
T ss_pred             CCHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccc
Confidence            8777655421          1238899999999999999999999   89999999999999999999999999999876


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCccc--ccchhH-HHHHhhh
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNK--WQYFPK-IVNEKMK  337 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~--~~~~~~-~~~~~~~  337 (453)
                      ............|++.|+|||++.+..++.++|||||||++|||++|+.||.............  ...++. .......
T Consensus       151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07848         151 SEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS  230 (287)
T ss_pred             cccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence            5433323344578999999999998889999999999999999999999996422110000000  000000 0000000


Q ss_pred             cCcccccccccccCC----CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          338 EGKLMEIVDQRLTDE----GGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       338 ~~~~~~~~d~~l~~~----~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      .........+.....    .......+..+.+++.+||+.||++|||++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000000000000    0011123456999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=5.1e-40  Score=322.26  Aligned_cols=193  Identities=27%  Similarity=0.394  Sum_probs=166.5

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      ..+.||+|+||.||+++.. +|..+|+|.+....  .....+.+|++++++++||||+++++++. .++..++||||+++
T Consensus         9 ~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~   87 (331)
T cd06649           9 RISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-SDGEISICMEHMDG   87 (331)
T ss_pred             EEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-ECCEEEEEeecCCC
Confidence            3478999999999999965 67889999887532  23457999999999999999999999886 45678999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      |+|.+++....          .+++..+..++.|++.||.|||+.  .+++||||||+|||++.++.+||+|||++....
T Consensus        88 ~~L~~~l~~~~----------~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  155 (331)
T cd06649          88 GSLDQVLKEAK----------RIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (331)
T ss_pred             CcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence            99999985432          388999999999999999999983  469999999999999999999999999987654


Q ss_pred             CCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcc
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSL  313 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~  313 (453)
                      ...   .....|++.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       156 ~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~  204 (331)
T cd06649         156 DSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP  204 (331)
T ss_pred             ccc---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            322   2345689999999999988899999999999999999999999953

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=5.1e-40  Score=314.64  Aligned_cols=246  Identities=20%  Similarity=0.248  Sum_probs=191.1

Q ss_pred             cCcCCceEEEEEEe-CCCcEEEEEEecCCC----ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCC
Q 047276          109 LGHGSSASVFKGIL-SDGTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS  183 (453)
Q Consensus       109 lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gs  183 (453)
                      ||+|+||+||++.. .+|+.+|+|.+....    ...+.+..|+.+++.++|+||+++.+++. .+...++||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-~~~~~~lv~e~~~~g~   79 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQ-TKTDLCLVMTIMNGGD   79 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEc-CCCeEEEEEeCCCCCC
Confidence            79999999999985 468899999986422    22356788999999999999999998875 5567899999999999


Q ss_pred             hhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCC
Q 047276          184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD  263 (453)
Q Consensus       184 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~  263 (453)
                      |.+++.....      ....+++..+..++.|++.||+|||+   .+|+||||||+||++++++.+||+|||++......
T Consensus        80 L~~~~~~~~~------~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  150 (280)
T cd05608          80 LRYHIYNVDE------ENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG  150 (280)
T ss_pred             HHHHHHhccc------cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence            9988754322      22348999999999999999999999   89999999999999999999999999999765433


Q ss_pred             CCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcccc
Q 047276          264 QSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLME  343 (453)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (453)
                      .. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........         .........      
T Consensus       151 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~---------~~~~~~~~~------  214 (280)
T cd05608         151 QS-KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE---------NKELKQRIL------  214 (280)
T ss_pred             Cc-cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh---------HHHHHHhhc------
Confidence            22 22345789999999999999999999999999999999999999953211100         000000000      


Q ss_pred             cccccccCCCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 047276          344 IVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRP-----SMARVVE  386 (453)
Q Consensus       344 ~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~~v~~  386 (453)
                        ..    ....+...+..+.+++.+|++.+|++||     +++++++
T Consensus       215 --~~----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         215 --ND----SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             --cc----CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence              00    0112233455688999999999999999     5566664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=7.7e-40  Score=313.56  Aligned_cols=262  Identities=22%  Similarity=0.339  Sum_probs=201.2

Q ss_pred             HHHHHhcccCcCCceEEEEEEeC------CCcEEEEEEecCCCcc--HHHHHHHHHHHHhcCCCceeeEeeEEEecCCCe
Q 047276          101 ATDNFQALLGHGSSASVFKGILS------DGTSVAVKRINGEENG--EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPR  172 (453)
Q Consensus       101 ~~~~~~~~lG~G~fG~Vy~~~~~------~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  172 (453)
                      ..+.+.+.||+|+||.||+|...      +++.||+|+++.....  ...|..|+.++..++||||+++++++. .....
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-~~~~~   83 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT-KEQPL   83 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCCce
Confidence            34566789999999999999863      2478999999754322  356889999999999999999999986 45578


Q ss_pred             EEEEEecCCCChhhhhccCCCCC------CCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCC
Q 047276          173 YLVYEFIQNGSLDHWIFPTSRRS------EGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDEN  246 (453)
Q Consensus       173 ~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~  246 (453)
                      ++++||+++++|.+++.......      ........+++..+++++.|++.||+|||+   .+++||||||+||+++++
T Consensus        84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCC
Confidence            99999999999999985332110      001112348899999999999999999998   899999999999999999


Q ss_pred             CcEEEeeccccccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCccc
Q 047276          247 YRAVVSDFGLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNK  324 (453)
Q Consensus       247 ~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~  324 (453)
                      +.+||+|||+++....... .......+++.|+|||.+.++.++.++||||||+++|||++ |..||.....        
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------  232 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--------  232 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH--------
Confidence            9999999999886543322 12233456789999999988889999999999999999998 8878753211        


Q ss_pred             ccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 047276          325 WQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEG  390 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~  390 (453)
                           ....+....+...           ..+.+....+.+++..|++.+|++||++++|+..|+.
T Consensus       233 -----~~~~~~i~~~~~~-----------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         233 -----QDVIEMIRNRQVL-----------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             -----HHHHHHHHcCCcC-----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence                 0111222222111           1222345568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.4e-40  Score=322.85  Aligned_cols=247  Identities=23%  Similarity=0.297  Sum_probs=191.7

Q ss_pred             HhcccCcCCceEEEEEEe----CCCcEEEEEEecCC-----CccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEE
Q 047276          105 FQALLGHGSSASVFKGIL----SDGTSVAVKRINGE-----ENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYL  174 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~----~~g~~vavK~~~~~-----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~l  174 (453)
                      +.+.||+|+||+||+++.    .+++.||+|++...     ....+.+..|+.++..+ +|+||+++++++. .++..++
T Consensus         4 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~-~~~~~~l   82 (332)
T cd05614           4 LLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ-TEAKLHL   82 (332)
T ss_pred             EEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEe-cCCEEEE
Confidence            457899999999999885    35789999998642     22335678899999999 5999999998865 5667899


Q ss_pred             EEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeec
Q 047276          175 VYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDF  254 (453)
Q Consensus       175 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~Df  254 (453)
                      ||||+++|+|.+++...          ..+++.....++.|++.||+|||+   .+++||||||+|||++.++.+||+||
T Consensus        83 v~e~~~~g~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Df  149 (332)
T cd05614          83 ILDYVSGGEMFTHLYQR----------DNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDF  149 (332)
T ss_pred             EEeCCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeC
Confidence            99999999999998543          238899999999999999999999   89999999999999999999999999


Q ss_pred             cccccccCCCCceeeeccCCccccchhhhhcC-CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHH
Q 047276          255 GLSKLMSRDQSRCITTIRGTRGYLAPEWILEQ-GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVN  333 (453)
Q Consensus       255 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  333 (453)
                      |+++..............||+.|+|||.+.+. .++.++|||||||++|||++|+.||........         .....
T Consensus       150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---------~~~~~  220 (332)
T cd05614         150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT---------QSEVS  220 (332)
T ss_pred             cCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC---------HHHHH
Confidence            99986544333333456799999999998764 478899999999999999999999953221110         00111


Q ss_pred             HhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 047276          334 EKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRP-----SMARVVE  386 (453)
Q Consensus       334 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~~v~~  386 (453)
                      .....      .++.      .+......+.+++.+|++.+|++||     +++++++
T Consensus       221 ~~~~~------~~~~------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         221 RRILK------CDPP------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             HHHhc------CCCC------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            11111      0111      1223345588999999999999999     6667664

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.2e-40  Score=314.84  Aligned_cols=265  Identities=21%  Similarity=0.310  Sum_probs=198.7

Q ss_pred             HHhcccCcCCceEEEEEEe-----CCCcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecC-CCeEEE
Q 047276          104 NFQALLGHGSSASVFKGIL-----SDGTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG-GPRYLV  175 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~-----~~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~~lv  175 (453)
                      .+.+.||+|+||+||++..     .++..||+|.++...  .....|.+|++++++++||||++++++|.... ...+++
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            3457899999999988653     357889999987543  24567889999999999999999999876543 357899


Q ss_pred             EEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecc
Q 047276          176 YEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFG  255 (453)
Q Consensus       176 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfG  255 (453)
                      |||+++|+|.+++..           ..+++..++.++.|++.||+|||+   .+++||||||+||++++++.+||+|||
T Consensus        87 ~e~~~~~~l~~~~~~-----------~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg  152 (283)
T cd05080          87 MEYVPLGSLRDYLPK-----------HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFG  152 (283)
T ss_pred             ecCCCCCCHHHHHHH-----------cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecc
Confidence            999999999999843           238999999999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCc--eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHH
Q 047276          256 LSKLMSRDQSR--CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVN  333 (453)
Q Consensus       256 la~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  333 (453)
                      +++........  ......++..|+|||.+....++.++||||||+++|||++|+.|+.......... ...      ..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~-~~~------~~  225 (283)
T cd05080         153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEM-IGP------KQ  225 (283)
T ss_pred             cccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhh-hcc------cc
Confidence            99866432211  1122345667999999988889999999999999999999999985322110000 000      00


Q ss_pred             HhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 047276          334 EKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR  391 (453)
Q Consensus       334 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~  391 (453)
                      .......+.+..+....  ...+......+.+++.+|++.+|++|||+++|++.|+..
T Consensus       226 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         226 GQMTVVRLIELLERGMR--LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             cccchhhhhhhhhcCCC--CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            00000011111111111  112233456799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1e-39  Score=318.06  Aligned_cols=237  Identities=21%  Similarity=0.284  Sum_probs=185.7

Q ss_pred             cccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHh-cCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          107 ALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIAS-AQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      ++||+|+||.||+|... +++.||+|.++..    ....+.+..|..++.. .+||||+++++++. .++..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~-~~~~~~lv~e~~~   79 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQ-TKEHLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEE-cCCEEEEEEcCCC
Confidence            46999999999999964 5789999998752    2233445667777765 48999999999876 5568899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|.+++...          ..+++.....++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        80 gg~L~~~~~~~----------~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~  146 (316)
T cd05592          80 GGDLMFHIQSS----------GRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKEN  146 (316)
T ss_pred             CCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence            99999988543          238889999999999999999999   89999999999999999999999999999764


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      .... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......            . ....+....
T Consensus       147 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~------------~-~~~~i~~~~  212 (316)
T cd05592         147 MNGE-GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED------------E-LFDSILNDR  212 (316)
T ss_pred             CCCC-CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH------------H-HHHHHHcCC
Confidence            3322 2234467899999999999888999999999999999999999999532110            0 111111110


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHH
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMAR  383 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~  383 (453)
                                  ...+......+.+++.+||+.+|++||++.+
T Consensus       213 ------------~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~  243 (316)
T cd05592         213 ------------PHFPRWISKEAKDCLSKLFERDPTKRLGVDG  243 (316)
T ss_pred             ------------CCCCCCCCHHHHHHHHHHccCCHHHcCCChH
Confidence                        1112223445789999999999999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=8.1e-40  Score=311.37  Aligned_cols=256  Identities=23%  Similarity=0.380  Sum_probs=196.5

Q ss_pred             HhcccCcCCceEEEEEEeCC-Cc--EEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEecC-----CCeE
Q 047276          105 FQALLGHGSSASVFKGILSD-GT--SVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG-----GPRY  173 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~-g~--~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~~  173 (453)
                      +.++||+|+||.||+|++.+ +.  .+|+|.++..   ....+.+..|+.+++.++|+||++++++|....     ...+
T Consensus         3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   82 (272)
T cd05075           3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV   82 (272)
T ss_pred             cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence            45789999999999999754 33  5899988653   233457889999999999999999999875322     2468


Q ss_pred             EEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEee
Q 047276          174 LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSD  253 (453)
Q Consensus       174 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~D  253 (453)
                      +++||+++|+|.+++.......    ....+++.....++.|++.||+|||+   .+++||||||+|||+++++.+||+|
T Consensus        83 ~v~e~~~~~~l~~~~~~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~D  155 (272)
T cd05075          83 VILPFMKHGDLHSFLLYSRLGD----CPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVAD  155 (272)
T ss_pred             EEEEeCCCCcHHHHHHHhcccC----CcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECC
Confidence            9999999999999885332110    12348999999999999999999999   8999999999999999999999999


Q ss_pred             ccccccccCCCCce-eeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHH
Q 047276          254 FGLSKLMSRDQSRC-ITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKI  331 (453)
Q Consensus       254 fGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  331 (453)
                      ||+++......... .....+++.|++||+.....++.++||||||+++|||++ |+.||......             .
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------------~  222 (272)
T cd05075         156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS-------------E  222 (272)
T ss_pred             CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH-------------H
Confidence            99998764332211 122345678999999998889999999999999999999 78888532110             0


Q ss_pred             HHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 047276          332 VNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR  391 (453)
Q Consensus       332 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~  391 (453)
                      ..+....+....           .+......+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       223 ~~~~~~~~~~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         223 IYDYLRQGNRLK-----------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             HHHHHHcCCCCC-----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            112222221110           1112334588999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=7.2e-40  Score=320.14  Aligned_cols=236  Identities=25%  Similarity=0.302  Sum_probs=184.9

Q ss_pred             cccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHH-HHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          107 ALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVA-AIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.||+|+||+||+|... +|+.||+|++...    .....++..|.. +++.++||||+++++++. ..+..++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~-~~~~~~lv~e~~~   79 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-TADKLYFVLDYVN   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEE-eCCEEEEEEcCCC
Confidence            46999999999999964 6899999998642    122344555555 467899999999999876 5568899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|.+++...          ..+++.....++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++..
T Consensus        80 ~g~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~  146 (323)
T cd05575          80 GGELFFHLQRE----------RSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (323)
T ss_pred             CCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence            99999998543          238899999999999999999999   89999999999999999999999999998754


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      .... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....            .. .......+.
T Consensus       147 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------------~~-~~~~i~~~~  212 (323)
T cd05575         147 IEHS-KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------------AE-MYDNILNKP  212 (323)
T ss_pred             ccCC-CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH------------HH-HHHHHHcCC
Confidence            3222 223445789999999999988999999999999999999999999953210            00 111111111


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHH
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMA  382 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~  382 (453)
                                  ..........+.+++.+|++.+|++||++.
T Consensus       213 ------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         213 ------------LRLKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             ------------CCCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence                        011122345688999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=4e-40  Score=297.10  Aligned_cols=230  Identities=27%  Similarity=0.350  Sum_probs=193.3

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCCC----ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      .+.||.|+||+|...+.+ +|..+|+|+++...    .+.+...+|-.+|+.+.||+++++.+.|. +.+..++||||.+
T Consensus        49 ~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~-d~~~lymvmeyv~  127 (355)
T KOG0616|consen   49 LKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK-DNSNLYMVMEYVP  127 (355)
T ss_pred             eeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeec-cCCeEEEEEeccC
Confidence            478999999999999964 68899999997632    33456788999999999999999999876 5678999999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|-|..+|++.++          +++.....++.||+.||+|||+   .+|++|||||+|||+|.+|.+||+|||.|+..
T Consensus       128 GGElFS~Lrk~~r----------F~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v  194 (355)
T KOG0616|consen  128 GGELFSYLRKSGR----------FSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRV  194 (355)
T ss_pred             CccHHHHHHhcCC----------CCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEe
Confidence            9999999976654          8888999999999999999999   89999999999999999999999999999976


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      ...    +-+.+|||.|+|||.+....+...+|.|||||++|||+.|..||....+             ...-+.+.+++
T Consensus       195 ~~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-------------~~iY~KI~~~~  257 (355)
T KOG0616|consen  195 SGR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-------------IQIYEKILEGK  257 (355)
T ss_pred             cCc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-------------HHHHHHHHhCc
Confidence            543    4678999999999999999999999999999999999999999963221             11223333332


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCC
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLR  378 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~R  378 (453)
                                  ..+|.-....+.+|+...++.|-.+|
T Consensus       258 ------------v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  258 ------------VKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             ------------ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence                        22444445568888888999888888

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.5e-39  Score=307.37  Aligned_cols=246  Identities=24%  Similarity=0.338  Sum_probs=193.8

Q ss_pred             ccCcCCceEEEEEEeC---CCcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCC
Q 047276          108 LLGHGSSASVFKGILS---DGTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       108 ~lG~G~fG~Vy~~~~~---~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      .||+|+||.||+|.+.   ++..||+|++....  ...+.|.+|+.++++++|+||++++++|.  ....++||||+++|
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~--~~~~~lv~e~~~~~   79 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE--AEALMLVMEMASGG   79 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc--CCCeEEEEEeCCCC
Confidence            4899999999999863   35579999987543  22456899999999999999999999874  45789999999999


Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccC
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR  262 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~  262 (453)
                      +|.+++....         ..+++..+++++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.....
T Consensus        80 ~L~~~l~~~~---------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  147 (257)
T cd05115          80 PLNKFLSGKK---------DEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGA  147 (257)
T ss_pred             CHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccC
Confidence            9999985332         238999999999999999999999   8999999999999999999999999999986543


Q ss_pred             CCCce--eeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          263 DQSRC--ITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       263 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      .....  .....+++.|+|||++....++.++||||||+++||+++ |+.||......             .+...+..+
T Consensus       148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------------~~~~~~~~~  214 (257)
T cd05115         148 DDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-------------EVMSFIEQG  214 (257)
T ss_pred             CccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-------------HHHHHHHCC
Confidence            32211  112233578999999988889999999999999999996 99998532110             011222222


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR  391 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~  391 (453)
                      ..           ...+..+...+.+++..||+.+|++||++.+|.+.|+..
T Consensus       215 ~~-----------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         215 KR-----------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CC-----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            11           112223455688999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2e-40  Score=324.36  Aligned_cols=242  Identities=23%  Similarity=0.284  Sum_probs=191.6

Q ss_pred             cccCcCCceEEEEEEe-CCCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          107 ALLGHGSSASVFKGIL-SDGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      +.||+|+||.||++.. .+|+.||+|.+...    ......+..|+.++..++||||+++.+++. ..+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~-~~~~~~lv~E~~~~   79 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ-THDRLCFVMEYANG   79 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEE-cCCEEEEEEeCCCC
Confidence            4699999999999985 46889999998752    223456788999999999999999999875 55688999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      |+|.+++...          ..+++..+..++.|++.||+|||+.  .+|+||||||+|||++.++.+||+|||+++...
T Consensus        80 ~~L~~~l~~~----------~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~  147 (325)
T cd05594          80 GELFFHLSRE----------RVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI  147 (325)
T ss_pred             CcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence            9999988533          2389999999999999999999963  689999999999999999999999999987543


Q ss_pred             CCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcc
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKL  341 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (453)
                      .... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......            . .......+. 
T Consensus       148 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~------------~-~~~~i~~~~-  212 (325)
T cd05594         148 KDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------------K-LFELILMEE-  212 (325)
T ss_pred             CCCc-ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH------------H-HHHHHhcCC-
Confidence            2221 223456999999999999889999999999999999999999999532110            0 111111110 


Q ss_pred             cccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 047276          342 MEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRP-----SMARVVEM  387 (453)
Q Consensus       342 ~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~~v~~~  387 (453)
                                 ..++......+.+++.+|++.||++||     ++.++++.
T Consensus       213 -----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         213 -----------IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             -----------CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence                       011222344588999999999999996     88888754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=9.9e-40  Score=312.91  Aligned_cols=259  Identities=26%  Similarity=0.394  Sum_probs=198.6

Q ss_pred             HHhcccCcCCceEEEEEEe-----CCCcEEEEEEecCCCc--cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEE
Q 047276          104 NFQALLGHGSSASVFKGIL-----SDGTSVAVKRINGEEN--GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVY  176 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~-----~~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~  176 (453)
                      .+.+.||+|+||.||+|.+     .++..+++|.+.....  ....|.+|+.+++.++||||+++++++. .++..+++|
T Consensus         8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~   86 (283)
T cd05090           8 RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVT-QEQPVCMLF   86 (283)
T ss_pred             eeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe-cCCceEEEE
Confidence            4567899999999999984     2467899999875332  2357889999999999999999999876 566889999


Q ss_pred             EecCCCChhhhhccCCCCCC-------CCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcE
Q 047276          177 EFIQNGSLDHWIFPTSRRSE-------GHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRA  249 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~-------~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~  249 (453)
                      ||+++|+|.+++........       .......+++...+.++.|++.||+|||+   .+++||||||+|||+++++.+
T Consensus        87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~~~  163 (283)
T cd05090          87 EYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQLHV  163 (283)
T ss_pred             EcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCCcE
Confidence            99999999999854321110       00112348999999999999999999999   899999999999999999999


Q ss_pred             EEeeccccccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccc
Q 047276          250 VVSDFGLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQY  327 (453)
Q Consensus       250 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~  327 (453)
                      ||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||.....           
T Consensus       164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-----------  232 (283)
T cd05090         164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-----------  232 (283)
T ss_pred             EeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-----------
Confidence            9999999986543221 12233445678999999988889999999999999999998 8888842210           


Q ss_pred             hhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 047276          328 FPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEG  390 (453)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~  390 (453)
                        ....+....+...           ..+......+.+++.+|++.+|++||++.++.+.|..
T Consensus       233 --~~~~~~~~~~~~~-----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         233 --QEVIEMVRKRQLL-----------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             --HHHHHHHHcCCcC-----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence              1111222211110           0112234568899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.9e-40  Score=326.07  Aligned_cols=242  Identities=24%  Similarity=0.310  Sum_probs=193.7

Q ss_pred             HHHhcccCcCCceEEEEEEeCC--CcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEE
Q 047276          103 DNFQALLGHGSSASVFKGILSD--GTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVY  176 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~~--g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~  176 (453)
                      +.+.+.||+|+||.||+|...+  +..||+|++...    ....+.+.+|+.++..++||||+++++++. .++..++||
T Consensus        32 y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~~lv~  110 (340)
T PTZ00426         32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK-DESYLYLVL  110 (340)
T ss_pred             cEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE-eCCEEEEEE
Confidence            4456899999999999998543  368999998642    233456889999999999999999999986 556789999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||+++|+|.+++....          .+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+
T Consensus       111 Ey~~~g~L~~~i~~~~----------~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~  177 (340)
T PTZ00426        111 EFVIGGEFFTFLRRNK----------RFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGF  177 (340)
T ss_pred             eCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCC
Confidence            9999999999996432          38899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhh
Q 047276          257 SKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKM  336 (453)
Q Consensus       257 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (453)
                      +......    .....||+.|+|||++.+..++.++|||||||++|||++|+.||....+             .......
T Consensus       178 a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-------------~~~~~~i  240 (340)
T PTZ00426        178 AKVVDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP-------------LLIYQKI  240 (340)
T ss_pred             CeecCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH-------------HHHHHHH
Confidence            9865432    2345789999999999988899999999999999999999999953211             0111111


Q ss_pred             hcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 047276          337 KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRP-----SMARVVEM  387 (453)
Q Consensus       337 ~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~~v~~~  387 (453)
                      ..+..            .++......+.+++.+|++.+|++|+     +++++.+.
T Consensus       241 ~~~~~------------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        241 LEGII------------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             hcCCC------------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            11110            11222234578999999999999995     78887754

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.8e-40  Score=320.69  Aligned_cols=237  Identities=24%  Similarity=0.295  Sum_probs=189.4

Q ss_pred             cccCcCCceEEEEEEe----CCCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          107 ALLGHGSSASVFKGIL----SDGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~----~~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      +.||+|+||.||++..    .+|+.||+|++....   .....+..|++++++++||||+++++++. .++..++||||+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~   80 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQ-TEGKLYLILDFL   80 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEE-cCCEEEEEEcCC
Confidence            4799999999999874    357899999987522   23345778999999999999999999876 556889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ++|+|.+++...          ..+++..+..++.|++.||+|||+   .+++||||||+|||+++++.+||+|||++..
T Consensus        81 ~~~~L~~~l~~~----------~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  147 (318)
T cd05582          81 RGGDLFTRLSKE----------VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE  147 (318)
T ss_pred             CCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcc
Confidence            999999998533          238999999999999999999999   8999999999999999999999999999876


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      ..... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||......            . ........
T Consensus       148 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~------------~-~~~~i~~~  213 (318)
T cd05582         148 SIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK------------E-TMTMILKA  213 (318)
T ss_pred             cCCCC-CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH------------H-HHHHHHcC
Confidence            54332 2234467899999999999888999999999999999999999999532110            0 11111111


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHH
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMAR  383 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~  383 (453)
                      .            ...+......+.+++.+||+.||++||++.+
T Consensus       214 ~------------~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         214 K------------LGMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             C------------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            1            1122233455889999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=8e-40  Score=321.09  Aligned_cols=197  Identities=28%  Similarity=0.402  Sum_probs=168.2

Q ss_pred             HHHHHhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          101 ATDNFQALLGHGSSASVFKGILS-DGTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       101 ~~~~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      ..+.+.++||+|+||.||++... ++..+|+|.+....  .....+.+|+++++.++|+||++++++|.. ++..++|||
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e   83 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISICME   83 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-CCEEEEEEe
Confidence            34455689999999999999975 57889999887532  234568999999999999999999999874 568899999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |+++|+|.+++...          ..+++.....++.|++.||.|||+.  .+++|+||||+|||++.++.+||+|||++
T Consensus        84 ~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~  151 (333)
T cd06650          84 HMDGGSLDQVLKKA----------GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVS  151 (333)
T ss_pred             cCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcc
Confidence            99999999998533          2388899999999999999999973  47999999999999999999999999998


Q ss_pred             ccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcc
Q 047276          258 KLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSL  313 (453)
Q Consensus       258 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~  313 (453)
                      .......   .....|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       152 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         152 GQLIDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             hhhhhhc---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            7653321   2335688999999999888899999999999999999999999863

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=9.3e-40  Score=309.17  Aligned_cols=255  Identities=22%  Similarity=0.377  Sum_probs=202.8

Q ss_pred             HHHHHHHhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEe
Q 047276           99 EEATDNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus        99 ~~~~~~~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      ....+.+.+.||+|+||.||++...++..+++|.+.........|.+|+.++++++|+|++++.+++..  ...+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~v~e~   81 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK--EPIYIITEF   81 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC--CCeEEEEEe
Confidence            334455678999999999999998778889999887655556779999999999999999999998753  678999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +++|+|.+++....        ...+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||++.
T Consensus        82 ~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~  150 (260)
T cd05073          82 MAKGSLLDFLKSDE--------GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLAR  150 (260)
T ss_pred             CCCCcHHHHHHhCC--------ccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCccee
Confidence            99999999996432        2347899999999999999999998   899999999999999999999999999997


Q ss_pred             cccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhh
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMK  337 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (453)
                      ..............++..|+|||++..+.++.++|+||||+++||+++ |+.||......            . ......
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~------------~-~~~~~~  217 (260)
T cd05073         151 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP------------E-VIRALE  217 (260)
T ss_pred             eccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH------------H-HHHHHh
Confidence            664433222233445678999999988889999999999999999998 89898532110            0 111111


Q ss_pred             cCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 047276          338 EGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEG  390 (453)
Q Consensus       338 ~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~  390 (453)
                      .+..       +    ..+......+.+++.+|++.+|++||++.++.+.|+.
T Consensus       218 ~~~~-------~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         218 RGYR-------M----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CCCC-------C----CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            1110       0    0112234568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-39  Score=305.73  Aligned_cols=246  Identities=29%  Similarity=0.425  Sum_probs=195.3

Q ss_pred             cccCcCCceEEEEEEeC--C--CcEEEEEEecCCCc--cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          107 ALLGHGSSASVFKGILS--D--GTSVAVKRINGEEN--GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~--~--g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      ++||+|+||.||+|.+.  +  +..+|+|.+.....  ..+++.+|+.+++.+.|+|++++++++.  .+..+++|||++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~v~e~~~   78 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK--GEPLMLVMELAP   78 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc--CCceEEEEEeCC
Confidence            47999999999999853  2  26899999876443  4567999999999999999999999864  457899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|.+++....          .+++..++.++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++..
T Consensus        79 ~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~  145 (257)
T cd05060          79 LGPLLKYLKKRR----------EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRAL  145 (257)
T ss_pred             CCcHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEecccccccee
Confidence            999999996432          38999999999999999999998   89999999999999999999999999999876


Q ss_pred             cCCCCcee--eeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhh
Q 047276          261 SRDQSRCI--TTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMK  337 (453)
Q Consensus       261 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (453)
                      ........  ....++..|+|||.+....++.++||||||+++|||++ |+.||......            . ......
T Consensus       146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~------------~-~~~~~~  212 (257)
T cd05060         146 GAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA------------E-VIAMLE  212 (257)
T ss_pred             ecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH------------H-HHHHHH
Confidence            44332211  11223568999999998899999999999999999998 99998532110            0 111111


Q ss_pred             cCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 047276          338 EGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR  391 (453)
Q Consensus       338 ~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~  391 (453)
                      .+..       +    ..+...+..+.+++.+|++.+|++||++.++++.|++.
T Consensus       213 ~~~~-------~----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         213 SGER-------L----PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             cCCc-------C----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            1110       0    11223345688999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=5.6e-40  Score=321.62  Aligned_cols=244  Identities=21%  Similarity=0.293  Sum_probs=188.7

Q ss_pred             cccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          107 ALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.||+|+||.||++... +++.||+|.++..    ......+..|..++.++ +||||+++++++. ..+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~-~~~~~~lv~E~~~   79 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-TESRLFFVIEYVN   79 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEE-eCCEEEEEEeCCC
Confidence            46999999999999964 5789999998752    22334577888888876 7999999999876 5568899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|..++...          ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++..
T Consensus        80 ~~~L~~~~~~~----------~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~  146 (329)
T cd05618          80 GGDLMFHMQRQ----------RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  146 (329)
T ss_pred             CCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence            99999888533          238999999999999999999999   89999999999999999999999999998754


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      .... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........    ....+.......+.
T Consensus       147 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~----~~~~~~~~~i~~~~  221 (329)
T cd05618         147 LRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ----NTEDYLFQVILEKQ  221 (329)
T ss_pred             cCCC-CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCccc----ccHHHHHHHHhcCC
Confidence            3222 122346789999999999999999999999999999999999999963221111100    01111112111111


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCH
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSM  381 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  381 (453)
                                  ...+......+.+++.+||+.+|++||+.
T Consensus       222 ------------~~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         222 ------------IRIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             ------------CCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence                        11223344568899999999999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=7.8e-40  Score=308.04  Aligned_cols=246  Identities=24%  Similarity=0.346  Sum_probs=193.0

Q ss_pred             cccCcCCceEEEEEEe-CCCcEEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCC
Q 047276          107 ALLGHGSSASVFKGIL-SDGTSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS  183 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gs  183 (453)
                      +.||+|+||.||+|.. .+++.+|+|.+...  ......|.+|++++++++||||++++++|. .....++|+||+++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~   79 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-QKQPIYIVMELVQGGD   79 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCCeEEEEeeccCCc
Confidence            4699999999999996 46889999987643  233467899999999999999999999986 4568899999999999


Q ss_pred             hhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCC
Q 047276          184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD  263 (453)
Q Consensus       184 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~  263 (453)
                      |.+++....         ..+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++......
T Consensus        80 L~~~~~~~~---------~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  147 (252)
T cd05084          80 FLTFLRTEG---------PRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDG  147 (252)
T ss_pred             HHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccc
Confidence            999985321         238899999999999999999999   89999999999999999999999999998754322


Q ss_pred             CCce-eeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcCcc
Q 047276          264 QSRC-ITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKL  341 (453)
Q Consensus       264 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (453)
                      .... ......+..|+|||.+..+.++.++||||||+++|||++ |..||......             ........+..
T Consensus       148 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-------------~~~~~~~~~~~  214 (252)
T cd05084         148 VYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-------------QTREAIEQGVR  214 (252)
T ss_pred             cccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-------------HHHHHHHcCCC
Confidence            1111 111123457999999998889999999999999999998 88887432110             01111111100


Q ss_pred             cccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 047276          342 MEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE  389 (453)
Q Consensus       342 ~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~  389 (453)
                                 ...+...+..+.+++.+|++.+|++|||+.+|.++|+
T Consensus       215 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         215 -----------LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             -----------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence                       0122233456899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=5.7e-40  Score=320.56  Aligned_cols=240  Identities=22%  Similarity=0.255  Sum_probs=189.6

Q ss_pred             cccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          107 ALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      ++||+|+||.||+|+.. +++.||+|++...    ......+..|..++..+ +||||+++++++. .++..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~-~~~~~~lv~E~~~   79 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQ-TKDRLFFVMEYVN   79 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-cCCeEEEEEeCCC
Confidence            46999999999999964 5789999998752    23335577889988876 7999999999876 5568899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|..++....          .+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++...
T Consensus        80 ~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~  146 (321)
T cd05591          80 GGDLMFQIQRSR----------KFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEG  146 (321)
T ss_pred             CCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceec
Confidence            999999885432          38899999999999999999999   89999999999999999999999999998754


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      ..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......            . .......+.
T Consensus       147 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~------------~-~~~~i~~~~  212 (321)
T cd05591         147 ILNGV-TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED------------D-LFESILHDD  212 (321)
T ss_pred             ccCCc-cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH------------H-HHHHHHcCC
Confidence            32221 233456899999999999889999999999999999999999999532110            0 111111111


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCC-------CHHHHHH
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRP-------SMARVVE  386 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-------s~~~v~~  386 (453)
                                  ...+......+.+++..|++.+|++||       ++.++++
T Consensus       213 ------------~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         213 ------------VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             ------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence                        011112334588999999999999999       6777664

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.5e-39  Score=311.15  Aligned_cols=250  Identities=24%  Similarity=0.380  Sum_probs=194.4

Q ss_pred             HhcccCcCCceEEEEEEeC-CCc----EEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          105 FQALLGHGSSASVFKGILS-DGT----SVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~----~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      +.+.||+|+||+||+|.+. +|+    .+++|.+....  ....++..|+..+++++||||++++|++.  +...++++|
T Consensus        11 ~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~--~~~~~~i~e   88 (279)
T cd05111          11 KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP--GASLQLVTQ   88 (279)
T ss_pred             eccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC--CCccEEEEE
Confidence            3578999999999999963 444    47788775432  22356778888999999999999999874  456789999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |+++|+|.+++....         ..++|.....++.|++.||+|||+   .+++||||||+|||+++++.+||+|||++
T Consensus        89 ~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~  156 (279)
T cd05111          89 LSPLGSLLDHVRQHR---------DSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVA  156 (279)
T ss_pred             eCCCCcHHHHHHhcc---------cCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccc
Confidence            999999999996432         238999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHh
Q 047276          258 KLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEK  335 (453)
Q Consensus       258 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  335 (453)
                      +....... .......++..|+|||++.++.++.++||||||+++||+++ |+.||.....             ......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-------------~~~~~~  223 (279)
T cd05111         157 DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-------------HEVPDL  223 (279)
T ss_pred             eeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH-------------HHHHHH
Confidence            87643322 12233456779999999998899999999999999999998 9999853211             111122


Q ss_pred             hhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          336 MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       336 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      +..+....  .+         ..+...+.+++.+|++.+|+.|||+.++++.|....
T Consensus       224 ~~~~~~~~--~~---------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~  269 (279)
T cd05111         224 LEKGERLA--QP---------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA  269 (279)
T ss_pred             HHCCCcCC--CC---------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            22221110  01         112335788999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=5e-40  Score=320.76  Aligned_cols=235  Identities=23%  Similarity=0.299  Sum_probs=187.2

Q ss_pred             cccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          107 ALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      ++||+|+||+||+++.. +++.||+|++...    ....+.+..|..++..+ +||||+++++++. ..+..++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~-~~~~~~iv~Ey~~   79 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQ-TPDRLFFVMEFVN   79 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEE-cCCEEEEEEcCCC
Confidence            46999999999999964 5889999998642    23345677888888876 6999999999875 5668899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|.+++....          .+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++..
T Consensus        80 ~g~L~~~i~~~~----------~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~  146 (320)
T cd05590          80 GGDLMFHIQKSR----------RFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  146 (320)
T ss_pred             CchHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence            999999885432          38899999999999999999999   89999999999999999999999999998754


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      .... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......            . ..+.+..+.
T Consensus       147 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------------~-~~~~i~~~~  212 (320)
T cd05590         147 IFNG-KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED------------D-LFEAILNDE  212 (320)
T ss_pred             CcCC-CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------------H-HHHHHhcCC
Confidence            3222 1234457899999999999888999999999999999999999999532110            0 111111111


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCH
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSM  381 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  381 (453)
                      .            ..+......+.+++.+|++.||++||+.
T Consensus       213 ~------------~~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         213 V------------VYPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             C------------CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence            0            1112234458899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.8e-40  Score=322.54  Aligned_cols=268  Identities=21%  Similarity=0.286  Sum_probs=191.7

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEecC----CCeEEEE
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG----GPRYLVY  176 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~~lv~  176 (453)
                      +.++||+|+||.||+|.. .+|+.||||++...   ......+.+|+.++++++||||+++++++....    ...++||
T Consensus         4 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~   83 (338)
T cd07859           4 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF   83 (338)
T ss_pred             EEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEE
Confidence            457899999999999995 46899999998742   233456889999999999999999999876432    2469999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||+. ++|.+++...          ..+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+
T Consensus        84 e~~~-~~L~~~l~~~----------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~  149 (338)
T cd07859          84 ELME-SDLHQVIKAN----------DDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGL  149 (338)
T ss_pred             ecCC-CCHHHHHHhc----------ccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCcc
Confidence            9995 6999988533          238999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCC--ceeeeccCCccccchhhhhc--CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCc-cc-ccchhH
Q 047276          257 SKLMSRDQS--RCITTIRGTRGYLAPEWILE--QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSK-NK-WQYFPK  330 (453)
Q Consensus       257 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~-~~-~~~~~~  330 (453)
                      ++.......  .......||+.|+|||.+.+  ..++.++|||||||++|||++|+.||........... .. ....+.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  229 (338)
T cd07859         150 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSP  229 (338)
T ss_pred             ccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            986533221  11234578999999998865  6789999999999999999999999953221000000 00 000000


Q ss_pred             HHHHhhhcCcccccccccccCCCCCc-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          331 IVNEKMKEGKLMEIVDQRLTDEGGID-----ETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       331 ~~~~~~~~~~~~~~~d~~l~~~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      .....+......+.++. +......+     +.....+.+++.+||+.+|++|||++++++.
T Consensus       230 ~~~~~i~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         230 ETISRVRNEKARRYLSS-MRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHHHHhhhhhHHHHHHh-hcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            00011111111011000 00000000     0123457899999999999999999999853

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=6.8e-40  Score=321.10  Aligned_cols=248  Identities=21%  Similarity=0.289  Sum_probs=191.8

Q ss_pred             cccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          107 ALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.||+|+||.||++... +++.||+|+++..    ......+..|..++..+ +||||+++++++. ..+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~-~~~~~~lv~e~~~   79 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQ-TESRLFFVIEFVS   79 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEE-cCCEEEEEEeCCC
Confidence            46999999999999964 6889999999752    22334578899999988 7999999999876 5568899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|.+++...          ..+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++..
T Consensus        80 ~g~L~~~~~~~----------~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  146 (329)
T cd05588          80 GGDLMFHMQRQ----------RKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  146 (329)
T ss_pred             CCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCcccccc
Confidence            99999888533          238999999999999999999999   89999999999999999999999999998753


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      .... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........    ....+..+....+.
T Consensus       147 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~----~~~~~~~~~~~~~~  221 (329)
T cd05588         147 IRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQ----NTEDYLFQVILEKQ  221 (329)
T ss_pred             ccCC-CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccc----cchHHHHHHHHcCC
Confidence            2221 123346789999999999998999999999999999999999999964322111100    01111112221111


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCC------HHHHH
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPS------MARVV  385 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs------~~~v~  385 (453)
                                  ...+......+.+++.+|++.||.+||+      +.+++
T Consensus       222 ------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~  260 (329)
T cd05588         222 ------------IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK  260 (329)
T ss_pred             ------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence                        1122233456889999999999999998      56665

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-39  Score=307.28  Aligned_cols=252  Identities=26%  Similarity=0.410  Sum_probs=202.7

Q ss_pred             HHHhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCC
Q 047276          103 DNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      +.+.+.||+|+||.||++..++++.+|||.+.......+++.+|+.++++++|+|++++++++. .....+++|||++++
T Consensus         8 ~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~~v~e~~~~~   86 (261)
T cd05034           8 LKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS-EEEPIYIVTEYMSKG   86 (261)
T ss_pred             eeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeee-cCCceEEEEeccCCC
Confidence            3456899999999999999888889999999876667788999999999999999999999875 556889999999999


Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccC
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR  262 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~  262 (453)
                      +|.+++....        ...+++..+..++.+++.|++|||+   .+++|+||||+||++++++.+||+|||++.....
T Consensus        87 ~L~~~i~~~~--------~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~  155 (261)
T cd05034          87 SLLDFLKSGE--------GKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIED  155 (261)
T ss_pred             CHHHHHhccc--------cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccc
Confidence            9999996532        1248999999999999999999999   8999999999999999999999999999886643


Q ss_pred             CCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcCcc
Q 047276          263 DQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKL  341 (453)
Q Consensus       263 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (453)
                      ..........++..|+|||.+.+..++.++||||||+++||+++ |+.||......            . .......+. 
T Consensus       156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~------------~-~~~~~~~~~-  221 (261)
T cd05034         156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR------------E-VLEQVERGY-  221 (261)
T ss_pred             hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------------H-HHHHHHcCC-
Confidence            22222223334668999999998889999999999999999998 99998532110            0 111111110 


Q ss_pred             cccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 047276          342 MEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEG  390 (453)
Q Consensus       342 ~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~  390 (453)
                            ..    ..+...+..+.+++.+|++.+|++||+++++.+.|+.
T Consensus       222 ------~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         222 ------RM----PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ------CC----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                  00    0111224568999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=5.2e-40  Score=321.38  Aligned_cols=239  Identities=26%  Similarity=0.298  Sum_probs=186.3

Q ss_pred             cccCcCCceEEEEEEe-CCCcEEEEEEecCC----CccHHHHHHHHH-HHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          107 ALLGHGSSASVFKGIL-SDGTSVAVKRINGE----ENGEKEFRSEVA-AIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~----~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.||+|+||+||++.. .+|+.+|+|++...    ......+..|.. +++.++||||+++++++. .++..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~-~~~~~~lv~e~~~   79 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-TTEKLYFVLDFVN   79 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEe-cCCEEEEEEcCCC
Confidence            4699999999999995 46899999998642    223345556655 467799999999999876 5668899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|..++...          ..+++.....++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++..
T Consensus        80 ~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~  146 (325)
T cd05604          80 GGELFFHLQRE----------RSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (325)
T ss_pred             CCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence            99999888533          238999999999999999999999   89999999999999999999999999998754


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      .... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....            .. .......+.
T Consensus       147 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~------------~~-~~~~~~~~~  212 (325)
T cd05604         147 IAQS-DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV------------AE-MYDNILHKP  212 (325)
T ss_pred             CCCC-CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH------------HH-HHHHHHcCC
Confidence            3221 123445789999999999998999999999999999999999999953210            01 111111111


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVV  385 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~  385 (453)
                              +    ...+.....+.+++.+|++.+|++||++.+.+
T Consensus       213 --------~----~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         213 --------L----VLRPGASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             --------c----cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence                    0    11112345578999999999999999986433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-41  Score=317.43  Aligned_cols=242  Identities=26%  Similarity=0.386  Sum_probs=199.2

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCC
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      .++||+|.||.||+|.. ..++.||+|++..+  ....+++.+|+.+|..++++||.+.+|.+. .+..++++||||.+|
T Consensus        18 ~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl-~g~~LwiiMey~~gG   96 (467)
T KOG0201|consen   18 LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYL-KGTKLWIIMEYCGGG   96 (467)
T ss_pred             chhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhhee-ecccHHHHHHHhcCc
Confidence            36899999999999994 56889999999763  344578899999999999999999999866 677889999999999


Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccC
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR  262 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~  262 (453)
                      ++.+.|....          .+++....-|+.++..||.|||.   .+.+|||||+.|||+..+|.+|++|||.+..+..
T Consensus        97 sv~~lL~~~~----------~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~  163 (467)
T KOG0201|consen   97 SVLDLLKSGN----------ILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTN  163 (467)
T ss_pred             chhhhhccCC----------CCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeec
Confidence            9999995432          24666666788999999999999   7999999999999999999999999999988866


Q ss_pred             CCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCccc
Q 047276          263 DQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLM  342 (453)
Q Consensus       263 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (453)
                      ..... .+++|||-|||||++....|+.|+||||||++.+||.+|.+|+....+..-             .-.     +.
T Consensus       164 ~~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv-------------lfl-----Ip  224 (467)
T KOG0201|consen  164 TVKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV-------------LFL-----IP  224 (467)
T ss_pred             hhhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE-------------EEe-----cc
Confidence            55443 788999999999999988999999999999999999999999975433110             000     00


Q ss_pred             ccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          343 EIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       343 ~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      +-.-|.+      .......+.+++..||++||+.||++.++++
T Consensus       225 k~~PP~L------~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  225 KSAPPRL------DGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             CCCCCcc------ccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            1111222      2244556899999999999999999999884

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.4e-39  Score=322.12  Aligned_cols=243  Identities=23%  Similarity=0.366  Sum_probs=187.9

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      +.++||+|+||+||+|+.. +|+.||||++....  .....+.+|+++++.++|+||+++++++. .++..++||||+++
T Consensus        78 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~  156 (353)
T PLN00034         78 RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFD-HNGEIQVLLEFMDG  156 (353)
T ss_pred             hhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEec-cCCeEEEEEecCCC
Confidence            4578999999999999964 68999999986532  23457899999999999999999999875 56688999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      |+|.+..              ..++.....++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++...
T Consensus       157 ~~L~~~~--------------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~  219 (353)
T PLN00034        157 GSLEGTH--------------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILA  219 (353)
T ss_pred             Ccccccc--------------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence            9986543              15677788999999999999999   899999999999999999999999999998764


Q ss_pred             CCCCceeeeccCCccccchhhhhc-----CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhh
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILE-----QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKM  336 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (453)
                      .... ......||..|+|||.+..     ...+.++|||||||++|||++|+.||.....      ..|..+   ... .
T Consensus       220 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~------~~~~~~---~~~-~  288 (353)
T PLN00034        220 QTMD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ------GDWASL---MCA-I  288 (353)
T ss_pred             cccc-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC------ccHHHH---HHH-H
Confidence            3221 1234578999999998743     2235689999999999999999999962211      111110   000 0


Q ss_pred             hcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          337 KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       337 ~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      ....           ....+......+.+++.+||+.+|++||++.|+++.
T Consensus       289 ~~~~-----------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        289 CMSQ-----------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             hccC-----------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000           011122344568999999999999999999999864

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-40  Score=321.06  Aligned_cols=247  Identities=25%  Similarity=0.295  Sum_probs=195.3

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      +.+.||+|+||.||+|+.. +++.||+|+++..    ......+..|+.++..++||||+++++++. .++..++||||+
T Consensus         5 ~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-~~~~~~lv~e~~   83 (333)
T cd05600           5 ILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ-DDEYLYLAMEYV   83 (333)
T ss_pred             EEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE-cCCEEEEEEeCC
Confidence            3578999999999999975 5889999998742    223456889999999999999999999876 566889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ++|+|.+++...          ..+++.....++.|++.||.|||+   .+++||||||+|||++.++.+||+|||++..
T Consensus        84 ~g~~L~~~l~~~----------~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~  150 (333)
T cd05600          84 PGGDFRTLLNNL----------GVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKG  150 (333)
T ss_pred             CCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCcc
Confidence            999999999533          238899999999999999999999   8999999999999999999999999999976


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      ...    ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......             ....+...
T Consensus       151 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-------------~~~~i~~~  213 (333)
T cd05600         151 IVT----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-------------TWENLKYW  213 (333)
T ss_pred             ccc----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH-------------HHHHHHhc
Confidence            543    2234568999999999998899999999999999999999999995322110             00111100


Q ss_pred             ccccccc-ccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          340 KLMEIVD-QRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       340 ~~~~~~d-~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      .  .... +...   .........+.+++.+|++.+|.+||++.++++.
T Consensus       214 ~--~~~~~~~~~---~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         214 K--ETLQRPVYD---DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             c--ccccCCCCC---ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            0  0000 0000   0001234568899999999999999999999865

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-39  Score=310.52  Aligned_cols=259  Identities=23%  Similarity=0.386  Sum_probs=200.4

Q ss_pred             HHHhcccCcCCceEEEEEEeCC------CcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEE
Q 047276          103 DNFQALLGHGSSASVFKGILSD------GTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYL  174 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~~------g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~l  174 (453)
                      +.+.+.||+|+||.||+|...+      +..||+|.+....  .....+.+|+.++..++|+|+++++|++. .+...++
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~~~   86 (277)
T cd05032           8 ITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS-TGQPTLV   86 (277)
T ss_pred             eeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc-CCCCcEE
Confidence            3345789999999999998642      3679999986533  23456889999999999999999999976 5568899


Q ss_pred             EEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeec
Q 047276          175 VYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDF  254 (453)
Q Consensus       175 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~Df  254 (453)
                      ||||+++|+|.+++.......+.......++|..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+||
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~df  163 (277)
T cd05032          87 VMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDF  163 (277)
T ss_pred             EEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEECCc
Confidence            999999999999996543221111123458999999999999999999998   89999999999999999999999999


Q ss_pred             cccccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHH
Q 047276          255 GLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIV  332 (453)
Q Consensus       255 Gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  332 (453)
                      |+++....... .......++..|+|||.+.++.++.++||||||+++||+++ |..||.....             ...
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-------------~~~  230 (277)
T cd05032         164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-------------EEV  230 (277)
T ss_pred             ccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH-------------HHH
Confidence            99986543322 12233456789999999988889999999999999999998 8888842111             001


Q ss_pred             HHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 047276          333 NEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE  389 (453)
Q Consensus       333 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~  389 (453)
                      .+....+...           ..+......+.+++.+|++.+|++|||+.++++.|+
T Consensus       231 ~~~~~~~~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         231 LKFVIDGGHL-----------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             HHHHhcCCCC-----------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            1111111111           112223556899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.7e-39  Score=310.74  Aligned_cols=261  Identities=25%  Similarity=0.374  Sum_probs=203.9

Q ss_pred             HHHhcccCcCCceEEEEEEeCC-----CcEEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEE
Q 047276          103 DNFQALLGHGSSASVFKGILSD-----GTSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLV  175 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~~-----g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv  175 (453)
                      +.+.++||+|+||.||+|...+     +..|++|.+...  ......+.+|+.++++++|+|++++++++...+...+++
T Consensus         8 ~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   87 (280)
T cd05043           8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVL   87 (280)
T ss_pred             eEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEE
Confidence            3456899999999999999765     688999988753  233456889999999999999999999988666788999


Q ss_pred             EEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecc
Q 047276          176 YEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFG  255 (453)
Q Consensus       176 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfG  255 (453)
                      +||+++|+|.+++.......  ......+++..++.++.|++.||+|||+   .+++|+||||+||++++++.+||+|||
T Consensus        88 ~~~~~~~~L~~~l~~~~~~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~g  162 (280)
T cd05043          88 YPYMNWGNLKLFLQQCRLGE--ANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNA  162 (280)
T ss_pred             EEcCCCCcHHHHHHhccccc--cccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCCC
Confidence            99999999999986543211  0122458999999999999999999998   899999999999999999999999999


Q ss_pred             ccccccCCCCce-eeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHH
Q 047276          256 LSKLMSRDQSRC-ITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVN  333 (453)
Q Consensus       256 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  333 (453)
                      +++.+....... .....++..|+|||++.+..++.++||||||+++||+++ |+.||......            . ..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------------~-~~  229 (280)
T cd05043         163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF------------E-MA  229 (280)
T ss_pred             CcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH------------H-HH
Confidence            998664433221 122345678999999988889999999999999999999 99998532110            0 11


Q ss_pred             HhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          334 EKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       334 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      .....+.       .+.    .+......+.+++.+|++.+|++|||+.++++.|+...
T Consensus       230 ~~~~~~~-------~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         230 AYLKDGY-------RLA----QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             HHHHcCC-------CCC----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            1111111       000    11123346889999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-40  Score=326.84  Aligned_cols=236  Identities=24%  Similarity=0.311  Sum_probs=200.0

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhcC-CCceeeEeeEEEecCCCeEEEEEe
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASAQ-HVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      |.++||+|+||+|+++..+ +++.+|||+++++    ....+..+.|.+++...+ ||.++++++.+. ..++.++||||
T Consensus       372 ~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQ-T~~~l~fvmey  450 (694)
T KOG0694|consen  372 LLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQ-TKEHLFFVMEY  450 (694)
T ss_pred             EEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccc-cCCeEEEEEEe
Confidence            3479999999999999975 5789999999874    345567888988887775 999999998654 67799999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +.||++..+.+           .+.+++.....++..|+.||+|||+   ++||+||||.+|||||.+|++||+|||+++
T Consensus       451 ~~Ggdm~~~~~-----------~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcK  516 (694)
T KOG0694|consen  451 VAGGDLMHHIH-----------TDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCK  516 (694)
T ss_pred             cCCCcEEEEEe-----------cccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEeccccccc
Confidence            99999655552           2348999999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      ..-... ..+++++|||.|||||.+.+..|+...|.|||||+||||+.|+.||...+                       
T Consensus       517 e~m~~g-~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd-----------------------  572 (694)
T KOG0694|consen  517 EGMGQG-DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD-----------------------  572 (694)
T ss_pred             ccCCCC-CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC-----------------------
Confidence            654222 24678999999999999999999999999999999999999999995322                       


Q ss_pred             CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCH
Q 047276          339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSM  381 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  381 (453)
                        -.+++|.-+.++..+|...+.+.+.++.+.+..+|++|--+
T Consensus       573 --Eee~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  573 --EEEVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             --HHHHHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence              12344444555556777888889999999999999999877

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.5e-39  Score=311.69  Aligned_cols=265  Identities=26%  Similarity=0.350  Sum_probs=196.5

Q ss_pred             HHhcccCcCCceEEEEEEeC-----CCcEEEEEEecCCC-ccHHHHHHHHHHHHhcCCCceeeEeeEEEecC-CCeEEEE
Q 047276          104 NFQALLGHGSSASVFKGILS-----DGTSVAVKRINGEE-NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG-GPRYLVY  176 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~-----~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~~lv~  176 (453)
                      .+.+.||+|+||.||++..+     ++..||+|.+.... ...+.|.+|++++++++|||++++++++...+ ...++|+
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   86 (284)
T cd05081           7 KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVM   86 (284)
T ss_pred             eeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEE
Confidence            34578999999999999843     57899999987543 33467899999999999999999999876433 4578999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||+++|+|.+++....         ..+++..++.++.|++.||+|||+   .+++||||||+||++++++.+||+|||+
T Consensus        87 e~~~~~~L~~~l~~~~---------~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~  154 (284)
T cd05081          87 EYLPYGSLRDYLQKHR---------ERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGL  154 (284)
T ss_pred             EecCCCCHHHHHHhcC---------cCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcc
Confidence            9999999999985432         238999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCce--eeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCC--Ccccc-cchhHH
Q 047276          257 SKLMSRDQSRC--ITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDK--SKNKW-QYFPKI  331 (453)
Q Consensus       257 a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~--~~~~~-~~~~~~  331 (453)
                      +..........  .....++..|+|||++.+..++.++||||||+++|||++|..|+.........  ..... ......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd05081         155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH  234 (284)
T ss_pred             cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHH
Confidence            98765432211  11122345699999998888999999999999999999988765321110000  00000 000000


Q ss_pred             HHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 047276          332 VNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR  391 (453)
Q Consensus       332 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~  391 (453)
                      ..+....+.       .+    ..+......+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus       235 ~~~~~~~~~-------~~----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         235 LIELLKNNG-------RL----PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHHHhcCC-------cC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            011111110       00    11123345689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.3e-39  Score=313.01  Aligned_cols=261  Identities=23%  Similarity=0.318  Sum_probs=189.8

Q ss_pred             HHhcccCcCCceEEEEEEe-C-CCcEEEEEEecCC---CccHHHHHHHHHHHHhc---CCCceeeEeeEEEe----cCCC
Q 047276          104 NFQALLGHGSSASVFKGIL-S-DGTSVAVKRINGE---ENGEKEFRSEVAAIASA---QHVNLVRLLGYCVV----PGGP  171 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~-~-~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~----~~~~  171 (453)
                      .+.+.||+|+||+||+|+. . +|+.||+|.++..   ......+.+|+.+++.+   +||||++++++|..    ....
T Consensus         4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~   83 (290)
T cd07862           4 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK   83 (290)
T ss_pred             ceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCc
Confidence            3467899999999999986 3 4688999988642   22234567788877765   69999999998853    2345


Q ss_pred             eEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEE
Q 047276          172 RYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVV  251 (453)
Q Consensus       172 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl  251 (453)
                      .++|+||++ ++|.+++....        ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||
T Consensus        84 ~~lv~e~~~-~~l~~~~~~~~--------~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl  151 (290)
T cd07862          84 LTLVFEHVD-QDLTTYLDKVP--------EPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKL  151 (290)
T ss_pred             EEEEEccCC-CCHHHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEE
Confidence            789999996 59999985432        2238999999999999999999999   89999999999999999999999


Q ss_pred             eeccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHH
Q 047276          252 SDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKI  331 (453)
Q Consensus       252 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~  331 (453)
                      +|||+++.....  .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........        +...
T Consensus       152 ~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~--------~~~i  221 (290)
T cd07862         152 ADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--------LGKI  221 (290)
T ss_pred             ccccceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH--------HHHH
Confidence            999999865433  223445689999999999888899999999999999999999999964321100        0000


Q ss_pred             HHH-------hhhc-Ccc-cccccccccCC-CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          332 VNE-------KMKE-GKL-MEIVDQRLTDE-GGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       332 ~~~-------~~~~-~~~-~~~~d~~l~~~-~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ...       .+.. ..+ ...+.+.-... ....+.....+.+++.+|++.+|++|||+.++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         222 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             HHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            000       0000 000 00000000000 0001123455789999999999999999999884

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-40  Score=325.98  Aligned_cols=248  Identities=23%  Similarity=0.354  Sum_probs=201.1

Q ss_pred             HHHhcccCcCCceEEEEEEeCC--Cc--EEEEEEecCCCc--cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEE
Q 047276          103 DNFQALLGHGSSASVFKGILSD--GT--SVAVKRINGEEN--GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVY  176 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~~--g~--~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~  176 (453)
                      ....++||+|.||.|++|.|..  |.  .||||.++.+..  ....|++|+.+|.+|+|+|+++|+|+..  +....+|+
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl--~qp~mMV~  189 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVL--DQPAMMVF  189 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeec--cchhhHHh
Confidence            3456899999999999999753  43  589999987543  4578999999999999999999999865  36889999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      |.++.|+|.+.|++..        ...|-......++.|||.||.||.+   +++|||||.++|+||-..-.+||+||||
T Consensus       190 ELaplGSLldrLrka~--------~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGL  258 (1039)
T KOG0199|consen  190 ELAPLGSLLDRLRKAK--------KAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGL  258 (1039)
T ss_pred             hhcccchHHHHHhhcc--------ccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccc
Confidence            9999999999997632        2447888889999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCC-ceeee-ccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHH
Q 047276          257 SKLMSRDQS-RCITT-IRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVN  333 (453)
Q Consensus       257 a~~~~~~~~-~~~~~-~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  333 (453)
                      .+.+..... ..+.. ..-+..|.|||.+..++|+.+||||+|||++|||+| |..||-....             ..+.
T Consensus       259 mRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-------------~qIL  325 (1039)
T KOG0199|consen  259 MRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-------------IQIL  325 (1039)
T ss_pred             eeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-------------HHHH
Confidence            998765433 22222 334668999999999999999999999999999999 8888743211             1122


Q ss_pred             HhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          334 EKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       334 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      +.+.++.       +    ..-+..++..+++++..||..+|++|||+..+.+.
T Consensus       326 ~~iD~~e-------r----LpRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  326 KNIDAGE-------R----LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             Hhccccc-------c----CCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence            2222211       1    23456778889999999999999999999999743

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.1e-39  Score=312.00  Aligned_cols=261  Identities=22%  Similarity=0.401  Sum_probs=202.1

Q ss_pred             HhcccCcCCceEEEEEEeC------CCcEEEEEEecCCCc-cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          105 FQALLGHGSSASVFKGILS------DGTSVAVKRINGEEN-GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      +.+.||+|+||.||+|+..      ++..+++|.+..... ..+.+.+|+.++++++|+||+++++++. .++..++|||
T Consensus         9 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e   87 (291)
T cd05094           9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG-DGDPLIMVFE   87 (291)
T ss_pred             EeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc-cCCceEEEEe
Confidence            3578999999999999842      345689998875433 3457899999999999999999999986 5667899999


Q ss_pred             ecCCCChhhhhccCCCCC------CCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEE
Q 047276          178 FIQNGSLDHWIFPTSRRS------EGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVV  251 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl  251 (453)
                      |+++++|.+++.......      ........+++..+++++.|++.||+|||+   .+++||||||+||++++++.+||
T Consensus        88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~~l  164 (291)
T cd05094          88 YMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKI  164 (291)
T ss_pred             cCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEE
Confidence            999999999996543210      001122358999999999999999999999   89999999999999999999999


Q ss_pred             eeccccccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchh
Q 047276          252 SDFGLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFP  329 (453)
Q Consensus       252 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~  329 (453)
                      +|||++........ .......++..|+|||++.+..++.++||||||+++|||++ |+.||......            
T Consensus       165 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~------------  232 (291)
T cd05094         165 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT------------  232 (291)
T ss_pred             CCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------------
Confidence            99999976543221 11223456788999999998899999999999999999998 99998532110            


Q ss_pred             HHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          330 KIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       330 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                       ...+....+...+.           +...+..+.+++.+|++.+|++||++.+|+++|++...
T Consensus       233 -~~~~~~~~~~~~~~-----------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         233 -EVIECITQGRVLER-----------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             -HHHHHHhCCCCCCC-----------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence             01122222221111           11234468899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.2e-39  Score=334.53  Aligned_cols=249  Identities=22%  Similarity=0.265  Sum_probs=195.8

Q ss_pred             HHhcccCcCCceEEEEEEeC-C-CcEEEEEEecCCC-ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          104 NFQALLGHGSSASVFKGILS-D-GTSVAVKRINGEE-NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~-~-g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      .+.+.||+|+||.||++... + ++.||+|.+.... .....+..|+.+++.++||||++++++|. .++..++||||++
T Consensus        70 ~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-~~~~~~lv~E~~~  148 (478)
T PTZ00267         70 VLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFK-SDDKLLLIMEYGS  148 (478)
T ss_pred             EEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-ECCEEEEEEECCC
Confidence            34678999999999999853 3 5778888765433 33356788999999999999999999986 4568899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|.+++.....      ....+++.....++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       149 gg~L~~~l~~~~~------~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~  219 (478)
T PTZ00267        149 GGDLNKQIKQRLK------EHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY  219 (478)
T ss_pred             CCCHHHHHHHHHh------ccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence            9999998854321      12348899999999999999999999   89999999999999999999999999999876


Q ss_pred             cCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          261 SRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       261 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      ..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....            .... .....+
T Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------------~~~~-~~~~~~  286 (478)
T PTZ00267        220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------------REIM-QQVLYG  286 (478)
T ss_pred             CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------------HHHH-HHHHhC
Confidence            54322 223456799999999999988999999999999999999999999853211            0111 111111


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ...           ..+......+.+++.+||+.+|++||++.+++.
T Consensus       287 ~~~-----------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        287 KYD-----------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCC-----------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            110           112223456899999999999999999999864

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.1e-39  Score=311.59  Aligned_cols=263  Identities=22%  Similarity=0.377  Sum_probs=199.9

Q ss_pred             HHHHhcccCcCCceEEEEEEeC------CCcEEEEEEecCCCc--cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeE
Q 047276          102 TDNFQALLGHGSSASVFKGILS------DGTSVAVKRINGEEN--GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRY  173 (453)
Q Consensus       102 ~~~~~~~lG~G~fG~Vy~~~~~------~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~  173 (453)
                      .+.+.+.||+|+||.||+|...      .+..||+|.++....  ....+.+|+.+++.++||||+++++++. ..+..+
T Consensus         7 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~   85 (288)
T cd05061           7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS-KGQPTL   85 (288)
T ss_pred             HceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCCcE
Confidence            3445689999999999999753      245799998865332  2346888999999999999999999876 556889


Q ss_pred             EEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEee
Q 047276          174 LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSD  253 (453)
Q Consensus       174 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~D  253 (453)
                      +||||+++|+|.+++...............+++....+++.|++.||.|||+   ++++||||||+||++++++.+||+|
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L~D  162 (288)
T cd05061          86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGD  162 (288)
T ss_pred             EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEECc
Confidence            9999999999999996543222111122346788899999999999999999   8999999999999999999999999


Q ss_pred             ccccccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHH
Q 047276          254 FGLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKI  331 (453)
Q Consensus       254 fGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  331 (453)
                      ||+++....... .......++..|+|||.+.++.++.++|||||||++|||++ |..||......            . 
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~------------~-  229 (288)
T cd05061         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------------Q-  229 (288)
T ss_pred             CCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH------------H-
Confidence            999886543221 11122345678999999998889999999999999999998 78787421110            0 


Q ss_pred             HHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          332 VNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       332 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      .......+...           ..+......+.+++.+|++.+|++|||+.++++.|++..
T Consensus       230 ~~~~~~~~~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         230 VLKFVMDGGYL-----------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             HHHHHHcCCCC-----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            11111111110           011223456999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=310.59  Aligned_cols=250  Identities=24%  Similarity=0.266  Sum_probs=192.7

Q ss_pred             HHHhcccCcCCceEEEEEEe-CCCcEEEEEEecCCC---------------ccHHHHHHHHHHHHhcCCCceeeEeeEEE
Q 047276          103 DNFQALLGHGSSASVFKGIL-SDGTSVAVKRINGEE---------------NGEKEFRSEVAAIASAQHVNLVRLLGYCV  166 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~---------------~~~~~~~~E~~~l~~l~h~niv~l~g~~~  166 (453)
                      +.+.+.||+|.||.|-+|.. .+++.||||++.+..               ...+..++|+.+|++++|||||+|+.+..
T Consensus        99 y~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLD  178 (576)
T KOG0585|consen   99 YELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLD  178 (576)
T ss_pred             eehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeec
Confidence            44467899999999999994 568999999996421               11246889999999999999999999754


Q ss_pred             ecC-CCeEEEEEecCCCChhhhhccCCCCCCCCCCCCC-CCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEEC
Q 047276          167 VPG-GPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGC-LSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD  244 (453)
Q Consensus       167 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~-l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~  244 (453)
                      +.. +..|||+|||..|.+..-=           .... |+..+.++++.++..||+|||.   ++|+||||||+|+||+
T Consensus       179 DP~s~~~YlVley~s~G~v~w~p-----------~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~  244 (576)
T KOG0585|consen  179 DPESDKLYLVLEYCSKGEVKWCP-----------PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLS  244 (576)
T ss_pred             CcccCceEEEEEeccCCccccCC-----------CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEc
Confidence            332 4679999999988875432           1223 8999999999999999999999   8999999999999999


Q ss_pred             CCCcEEEeeccccccccCC----CCceeeeccCCccccchhhhhcCC----CCccccchhHHHHHHHHHcCCCCCccccc
Q 047276          245 ENYRAVVSDFGLSKLMSRD----QSRCITTIRGTRGYLAPEWILEQG----VSEKCDIYSYGMVLLELTGGRRNVSLIEH  316 (453)
Q Consensus       245 ~~~~~kl~DfGla~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDV~S~Gvil~elltG~~p~~~~~~  316 (453)
                      ++|++||+|||.+......    .........|||.|+|||...++.    .+.+.||||+||+||.|+.|+.||.... 
T Consensus       245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~-  323 (576)
T KOG0585|consen  245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF-  323 (576)
T ss_pred             CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch-
Confidence            9999999999999866322    112234478999999999988643    3578999999999999999999994210 


Q ss_pred             CCCCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 047276          317 GNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE  389 (453)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~  389 (453)
                                     ..+     ...+++...|.-  ...++....+.+|++++|++||+.|.+..+|....-
T Consensus       324 ---------------~~~-----l~~KIvn~pL~f--P~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw  374 (576)
T KOG0585|consen  324 ---------------ELE-----LFDKIVNDPLEF--PENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW  374 (576)
T ss_pred             ---------------HHH-----HHHHHhcCcccC--CCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence                           000     011222222221  112245677999999999999999999999886653

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2e-39  Score=311.79  Aligned_cols=260  Identities=23%  Similarity=0.415  Sum_probs=200.6

Q ss_pred             HhcccCcCCceEEEEEEeC------CCcEEEEEEecCCC-ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          105 FQALLGHGSSASVFKGILS------DGTSVAVKRINGEE-NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      +.+.||+|+||+||++...      ++..+|+|.+.... .....+.+|+.++.+++|||+++++++|. ..+..++++|
T Consensus         9 ~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e   87 (288)
T cd05093           9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-EGDPLIMVFE   87 (288)
T ss_pred             eccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-cCCccEEEEE
Confidence            4578999999999999842      34568999887533 33457999999999999999999999986 5668899999


Q ss_pred             ecCCCChhhhhccCCCCC---CCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeec
Q 047276          178 FIQNGSLDHWIFPTSRRS---EGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDF  254 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~---~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~Df  254 (453)
                      |+++++|.+++.......   ........+++..+++++.|++.||+|||+   .+++||||||+||++++++.+||+||
T Consensus        88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl~df  164 (288)
T cd05093          88 YMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDF  164 (288)
T ss_pred             cCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEeccC
Confidence            999999999996443110   001122348999999999999999999999   89999999999999999999999999


Q ss_pred             cccccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHH
Q 047276          255 GLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIV  332 (453)
Q Consensus       255 Gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  332 (453)
                      |++........ .......++..|+|||++.+..++.++||||||+++|||++ |..||......             ..
T Consensus       165 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~-------------~~  231 (288)
T cd05093         165 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-------------EV  231 (288)
T ss_pred             CccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------------HH
Confidence            99986543221 11223345778999999998889999999999999999998 88888532110             01


Q ss_pred             HHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          333 NEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       333 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      ......+....           .+......+.+++.+|++.+|.+|||+.+|.+.|++..
T Consensus       232 ~~~i~~~~~~~-----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~  280 (288)
T cd05093         232 IECITQGRVLQ-----------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA  280 (288)
T ss_pred             HHHHHcCCcCC-----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            12222222111           01122345899999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.1e-39  Score=321.60  Aligned_cols=267  Identities=24%  Similarity=0.397  Sum_probs=202.2

Q ss_pred             HHHHHHhcccCcCCceEEEEEEe------CCCcEEEEEEecCCC--ccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCC
Q 047276          100 EATDNFQALLGHGSSASVFKGIL------SDGTSVAVKRINGEE--NGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGG  170 (453)
Q Consensus       100 ~~~~~~~~~lG~G~fG~Vy~~~~------~~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~  170 (453)
                      ...+.+.+.||+|+||.||+|..      .+++.||||+++...  .....+.+|+.++.++ +||||++++++|...+.
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            34456678999999999999973      346889999997532  2335688999999999 68999999999876677


Q ss_pred             CeEEEEEecCCCChhhhhccCCCCCC------------------------------------------------------
Q 047276          171 PRYLVYEFIQNGSLDHWIFPTSRRSE------------------------------------------------------  196 (453)
Q Consensus       171 ~~~lv~e~~~~gsL~~~l~~~~~~~~------------------------------------------------------  196 (453)
                      ..++++||+++|+|.+++........                                                      
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            78999999999999999865321000                                                      


Q ss_pred             ---CCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCCCC-ceeeecc
Q 047276          197 ---GHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQS-RCITTIR  272 (453)
Q Consensus       197 ---~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~  272 (453)
                         .......+++..+.+++.|+++||+|||+   .+++||||||+|||+++++.+||+|||++........ .......
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence               00011347899999999999999999999   8999999999999999999999999999986543222 1122334


Q ss_pred             CCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcCcccccccccccC
Q 047276          273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTD  351 (453)
Q Consensus       273 gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  351 (453)
                      +++.|+|||.+.+..++.++||||||+++|||++ |..||......            .........+....        
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------------~~~~~~~~~~~~~~--------  302 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------------EEFCRRLKEGTRMR--------  302 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc------------HHHHHHHhccCCCC--------
Confidence            5678999999988889999999999999999997 88888532110            00111122221100        


Q ss_pred             CCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          352 EGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       352 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                         .+......+.+++..||+.+|++||++.+|++.|+...
T Consensus       303 ---~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~  340 (343)
T cd05103         303 ---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  340 (343)
T ss_pred             ---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence               01112235889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.4e-39  Score=325.87  Aligned_cols=269  Identities=22%  Similarity=0.371  Sum_probs=203.3

Q ss_pred             HHHHHHHHHHhcccCcCCceEEEEEEeC------CCcEEEEEEecCCC--ccHHHHHHHHHHHHhcC-CCceeeEeeEEE
Q 047276           96 KELEEATDNFQALLGHGSSASVFKGILS------DGTSVAVKRINGEE--NGEKEFRSEVAAIASAQ-HVNLVRLLGYCV  166 (453)
Q Consensus        96 ~el~~~~~~~~~~lG~G~fG~Vy~~~~~------~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~g~~~  166 (453)
                      .++......+.++||+|+||.||+|++.      .+..||+|+++...  ...+.+.+|+.+|.++. ||||++++|+|.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            3444444455789999999999999863      24579999997532  22346889999999997 999999999987


Q ss_pred             ecCCCeEEEEEecCCCChhhhhccCCCCCCC-------------------------------------------------
Q 047276          167 VPGGPRYLVYEFIQNGSLDHWIFPTSRRSEG-------------------------------------------------  197 (453)
Q Consensus       167 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-------------------------------------------------  197 (453)
                       ..+..++|+||+++|+|.++++.+......                                                 
T Consensus       112 -~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (401)
T cd05107         112 -KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV  190 (401)
T ss_pred             -cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence             456889999999999999999754321000                                                 


Q ss_pred             ---------------------------------------CCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCC
Q 047276          198 ---------------------------------------HYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKP  238 (453)
Q Consensus       198 ---------------------------------------~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~  238 (453)
                                                             ......+++...++++.|++.||+|||+   .+++||||||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp  267 (401)
T cd05107         191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAA  267 (401)
T ss_pred             chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCc
Confidence                                                   0012347888999999999999999998   8999999999


Q ss_pred             CcEEECCCCcEEEeeccccccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCccccc
Q 047276          239 ENILLDENYRAVVSDFGLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEH  316 (453)
Q Consensus       239 ~NiLl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~  316 (453)
                      +|||+++++.+||+|||+++....... .......++..|+|||.+....++.++||||||+++|||++ |+.||.....
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~  347 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM  347 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence            999999999999999999986533221 11223456788999999998889999999999999999998 8888843210


Q ss_pred             CCCCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 047276          317 GNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR  391 (453)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~  391 (453)
                                  ..........+.       ++    ..+......+.+++..||+.+|+.||++++|++.|++.
T Consensus       348 ------------~~~~~~~~~~~~-------~~----~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         348 ------------NEQFYNAIKRGY-------RM----AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             ------------hHHHHHHHHcCC-------CC----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                        000111111111       00    01122345689999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=4e-39  Score=309.92  Aligned_cols=260  Identities=23%  Similarity=0.372  Sum_probs=199.7

Q ss_pred             HhcccCcCCceEEEEEEeC------CCcEEEEEEecCCCc--cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEE
Q 047276          105 FQALLGHGSSASVFKGILS------DGTSVAVKRINGEEN--GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVY  176 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~------~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~  176 (453)
                      +.+.||+|+||.||+|...      ....+++|.+.....  ....+.+|+.+++.++||||+++++.|. .++..++++
T Consensus         4 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~   82 (290)
T cd05045           4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS-QDGPLLLIV   82 (290)
T ss_pred             ccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-cCCCcEEEE
Confidence            4578999999999999853      235688888865332  3456889999999999999999999886 556789999


Q ss_pred             EecCCCChhhhhccCCCCCC--------------CCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEE
Q 047276          177 EFIQNGSLDHWIFPTSRRSE--------------GHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENIL  242 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~--------------~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiL  242 (453)
                      ||+++|+|.+++........              .......+++...+.++.|++.||+|||+   .+++||||||+|||
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~nil  159 (290)
T cd05045          83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVL  159 (290)
T ss_pred             EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhheEE
Confidence            99999999999865422110              00122458999999999999999999998   89999999999999


Q ss_pred             ECCCCcEEEeeccccccccCCCCc-eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCC
Q 047276          243 LDENYRAVVSDFGLSKLMSRDQSR-CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDK  320 (453)
Q Consensus       243 l~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~  320 (453)
                      +++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||....     
T Consensus       160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----  234 (290)
T cd05045         160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA-----  234 (290)
T ss_pred             EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC-----
Confidence            999999999999999865433221 1223345678999999988889999999999999999998 998884321     


Q ss_pred             CcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          321 SKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                              +..+.+....+..           ...+......+.+++.+|++.+|++||++.++++.|++..
T Consensus       235 --------~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         235 --------PERLFNLLKTGYR-----------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             --------HHHHHHHHhCCCC-----------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence                    1112222221110           0112233456889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.1e-39  Score=317.72  Aligned_cols=239  Identities=21%  Similarity=0.277  Sum_probs=187.9

Q ss_pred             cccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          107 ALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      ++||+|+||.||+|... +|..||+|.++..    ......+..|..++... +||||+++++++. .++..++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-~~~~~~lv~E~~~   79 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQ-TKEHLFFVMEFLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEE-eCCEEEEEECCCC
Confidence            46999999999999965 5889999998752    23345567788887754 8999999999876 5568899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|.+++...          ..+++.....++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++..
T Consensus        80 ~g~L~~~i~~~----------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05620          80 GGDLMFHIQDK----------GRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKEN  146 (316)
T ss_pred             CCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence            99999988543          238899999999999999999999   89999999999999999999999999998743


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      .... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....             ....+....+.
T Consensus       147 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-------------~~~~~~~~~~~  212 (316)
T cd05620         147 VFGD-NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-------------DELFESIRVDT  212 (316)
T ss_pred             ccCC-CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-------------HHHHHHHHhCC
Confidence            2211 223456789999999999998999999999999999999999999953211             00111111111


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHH-HHH
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMA-RVV  385 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~-~v~  385 (453)
                            +.      .+......+.+++.+|++.||++||++. ++.
T Consensus       213 ------~~------~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         213 ------PH------YPRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             ------CC------CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                  11      1112344588999999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-39  Score=306.23  Aligned_cols=256  Identities=24%  Similarity=0.425  Sum_probs=197.7

Q ss_pred             HhcccCcCCceEEEEEEeCC----CcEEEEEEecCCCc---cHHHHHHHHHHHHhcCCCceeeEeeEEEecCC-----Ce
Q 047276          105 FQALLGHGSSASVFKGILSD----GTSVAVKRINGEEN---GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGG-----PR  172 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~----g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-----~~  172 (453)
                      +.+.||+|+||.||+|....    +..||+|.++....   ....+.+|+..++.++|||++++++++.....     ..
T Consensus         3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   82 (273)
T cd05035           3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP   82 (273)
T ss_pred             cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence            45789999999999998642    36799999875432   23578999999999999999999998764332     36


Q ss_pred             EEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEe
Q 047276          173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVS  252 (453)
Q Consensus       173 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~  252 (453)
                      ++++||+++|+|..++.......    ....+++.....++.|++.||+|||+   .+++||||||+||++++++.+||+
T Consensus        83 ~~v~e~~~~~~l~~~l~~~~~~~----~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~  155 (273)
T cd05035          83 MVILPFMKHGDLHSFLLYSRLGG----LPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVA  155 (273)
T ss_pred             EEEEeccCCCCHHHHHHHhhccC----CcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEEC
Confidence            89999999999999985543211    12348999999999999999999999   899999999999999999999999


Q ss_pred             eccccccccCCCCc-eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhH
Q 047276          253 DFGLSKLMSRDQSR-CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPK  330 (453)
Q Consensus       253 DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  330 (453)
                      |||+++........ ......++..|+|||.+....++.++||||||+++|||++ |..||.....            ..
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~------------~~  223 (273)
T cd05035         156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN------------HE  223 (273)
T ss_pred             CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH------------HH
Confidence            99999876433221 1122335678999999988889999999999999999999 8888843211            01


Q ss_pred             HHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 047276          331 IVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR  391 (453)
Q Consensus       331 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~  391 (453)
                       .......+...           ..+......+.+++.+|++.+|++||++.++++.|++.
T Consensus       224 -~~~~~~~~~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         224 -IYDYLRHGNRL-----------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             -HHHHHHcCCCC-----------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence             11111111110           11223445689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.7e-39  Score=323.48  Aligned_cols=189  Identities=20%  Similarity=0.264  Sum_probs=161.8

Q ss_pred             HHhcccCcCCceEEEEEEe-CCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCC
Q 047276          104 NFQALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      .+.+.||+|+||.||++.. .+++.||+|...     ...+.+|+.++++++||||+++++++. .+...++|+|++. +
T Consensus        95 ~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~-~~~~~~lv~e~~~-~  167 (391)
T PHA03212         95 SILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFT-YNKFTCLILPRYK-T  167 (391)
T ss_pred             EEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEE-ECCeeEEEEecCC-C
Confidence            3447899999999999995 568899999653     234678999999999999999999876 4567899999995 6


Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccC
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR  262 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~  262 (453)
                      +|.+++...          ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       168 ~L~~~l~~~----------~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~  234 (391)
T PHA03212        168 DLYCYLAAK----------RNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVD  234 (391)
T ss_pred             CHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence            898888533          238899999999999999999999   8999999999999999999999999999976433


Q ss_pred             CCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCc
Q 047276          263 DQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVS  312 (453)
Q Consensus       263 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~  312 (453)
                      ..........||+.|+|||++.+..++.++|||||||++|||++|+.|+.
T Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~  284 (391)
T PHA03212        235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF  284 (391)
T ss_pred             ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence            32223345679999999999998899999999999999999999998874

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.9e-39  Score=303.93  Aligned_cols=249  Identities=26%  Similarity=0.443  Sum_probs=199.0

Q ss_pred             HHhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCC
Q 047276          104 NFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS  183 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gs  183 (453)
                      .+.+.||+|+||.||++.+.++..+|+|.+.........|.+|++++++++|||++++++++. .....++++||+++++
T Consensus         7 ~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~~v~e~~~~~~   85 (256)
T cd05112           7 TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT-ERSPICLVFEFMEHGC   85 (256)
T ss_pred             EEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEc-cCCceEEEEEcCCCCc
Confidence            345789999999999999877889999998876666778999999999999999999999875 5568899999999999


Q ss_pred             hhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCC
Q 047276          184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD  263 (453)
Q Consensus       184 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~  263 (453)
                      |.+++....         +.+++..++.++.+++.|++|||+   .+++|+||||+||+++.++.+||+|||++......
T Consensus        86 L~~~~~~~~---------~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  153 (256)
T cd05112          86 LSDYLRAQR---------GKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD  153 (256)
T ss_pred             HHHHHHhCc---------cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccC
Confidence            999985432         238899999999999999999998   89999999999999999999999999998765433


Q ss_pred             CCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcCccc
Q 047276          264 QSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLM  342 (453)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (453)
                      .........++.+|+|||++.++.++.++||||||+++|||++ |+.||......            . ..+....+.  
T Consensus       154 ~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------------~-~~~~~~~~~--  218 (256)
T cd05112         154 QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS------------E-VVETINAGF--  218 (256)
T ss_pred             cccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH------------H-HHHHHhCCC--
Confidence            2222223345678999999988889999999999999999998 99998532110            0 111111110  


Q ss_pred             ccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 047276          343 EIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE  389 (453)
Q Consensus       343 ~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~  389 (453)
                      ....+         ......+.+++.+||+.+|++||++.++++.|.
T Consensus       219 ~~~~~---------~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         219 RLYKP---------RLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             CCCCC---------CCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            00111         112356899999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.7e-39  Score=333.98  Aligned_cols=251  Identities=24%  Similarity=0.327  Sum_probs=196.6

Q ss_pred             HHhcccCcCCceEEEEEEe-CCCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCC-------Ce
Q 047276          104 NFQALLGHGSSASVFKGIL-SDGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGG-------PR  172 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-------~~  172 (453)
                      .+.+.||+|+||+||++.. .+|+.||||++....   .....+.+|+..+..++|+|++++...+.....       ..
T Consensus        35 ~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i  114 (496)
T PTZ00283         35 WISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMI  114 (496)
T ss_pred             EEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEE
Confidence            3467899999999999984 578999999986532   233567889999999999999998876543221       25


Q ss_pred             EEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEe
Q 047276          173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVS  252 (453)
Q Consensus       173 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~  252 (453)
                      ++||||+++|+|.+++.....      ....+++.....++.|++.||+|||+   .+|+||||||+|||++.++.+||+
T Consensus       115 ~lV~Ey~~~gsL~~~l~~~~~------~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~  185 (496)
T PTZ00283        115 ALVLDYANAGDLRQEIKSRAK------TNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLG  185 (496)
T ss_pred             EEEEeCCCCCcHHHHHHHhhc------cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEE
Confidence            799999999999999864432      22458999999999999999999999   899999999999999999999999


Q ss_pred             eccccccccCCC-CceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHH
Q 047276          253 DFGLSKLMSRDQ-SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKI  331 (453)
Q Consensus       253 DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~  331 (453)
                      |||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....            ....
T Consensus       186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~------------~~~~  253 (496)
T PTZ00283        186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN------------MEEV  253 (496)
T ss_pred             ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC------------HHHH
Confidence            999998764322 122344679999999999999899999999999999999999999995321            0111


Q ss_pred             HHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          332 VNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       332 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      .. ....+..    +       ..+......+.+++.+||+.+|.+||++.++++.
T Consensus       254 ~~-~~~~~~~----~-------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        254 MH-KTLAGRY----D-------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HH-HHhcCCC----C-------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            11 1111111    0       1122334568899999999999999999999864

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=9.4e-40  Score=319.43  Aligned_cols=241  Identities=22%  Similarity=0.264  Sum_probs=187.8

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHH---HhcCCCceeeEeeEEEecCCCeEEEE
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAI---ASAQHVNLVRLLGYCVVPGGPRYLVY  176 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l---~~l~h~niv~l~g~~~~~~~~~~lv~  176 (453)
                      +.+.||+|+||.||++... +|+.||||+++..    ....+.+..|..++   +.++||||+++++++. .++..++||
T Consensus         3 i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~-~~~~~~lv~   81 (324)
T cd05589           3 CLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQ-TEDHVCFVM   81 (324)
T ss_pred             EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE-cCCEEEEEE
Confidence            3578999999999999964 6899999999742    22234566776665   4667999999999876 566889999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||+++|+|..++..           ..+++.....++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+
T Consensus        82 E~~~~~~L~~~~~~-----------~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~  147 (324)
T cd05589          82 EYAAGGDLMMHIHT-----------DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGL  147 (324)
T ss_pred             cCCCCCcHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccC
Confidence            99999999988742           248999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhh
Q 047276          257 SKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKM  336 (453)
Q Consensus       257 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (453)
                      +....... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||......            . .....
T Consensus       148 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~------------~-~~~~i  213 (324)
T cd05589         148 CKEGMGFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE------------E-VFDSI  213 (324)
T ss_pred             CccCCCCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH------------H-HHHHH
Confidence            87543222 1234467899999999999889999999999999999999999999532110            0 11111


Q ss_pred             hcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 047276          337 KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPS-----MARVVE  386 (453)
Q Consensus       337 ~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~~v~~  386 (453)
                      ..+.            ...+......+.+++.+||+.+|.+||+     +.++++
T Consensus       214 ~~~~------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         214 VNDE------------VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             HhCC------------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            1111            0112233455889999999999999994     555554

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.6e-40  Score=322.42  Aligned_cols=247  Identities=20%  Similarity=0.241  Sum_probs=193.3

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCCC----ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      +.+.||+|+||+||++.. .+|+.||+|+++...    ...+.+.+|+.+++.++|+||+++++++. ..+..++||||+
T Consensus         5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~-~~~~~~lv~e~~   83 (330)
T cd05601           5 VKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ-DKDNLYLVMEYQ   83 (330)
T ss_pred             EEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe-cCCeEEEEECCC
Confidence            457899999999999996 468899999997532    23456889999999999999999999876 556889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ++|+|.+++....         ..+++.....++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++..
T Consensus        84 ~~~~L~~~l~~~~---------~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~  151 (330)
T cd05601          84 PGGDLLSLLNRYE---------DQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAAR  151 (330)
T ss_pred             CCCCHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeE
Confidence            9999999996442         238999999999999999999999   8999999999999999999999999999987


Q ss_pred             ccCCCCceeeeccCCccccchhhhh------cCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHH
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWIL------EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVN  333 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  333 (453)
                      .............||+.|+|||++.      ...++.++|||||||++|||++|+.||......            ....
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------------~~~~  219 (330)
T cd05601         152 LTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------------KTYN  219 (330)
T ss_pred             CCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------------HHHH
Confidence            6544333334457899999999986      456789999999999999999999999532110            0011


Q ss_pred             HhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          334 EKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       334 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ..........     ..    ........+.+++..|++ +|++||++.++++
T Consensus       220 ~i~~~~~~~~-----~~----~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         220 NIMNFQRFLK-----FP----EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             HHHcCCCccC-----CC----CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            1111111000     00    011234457889999998 9999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-40  Score=307.56  Aligned_cols=257  Identities=22%  Similarity=0.314  Sum_probs=212.4

Q ss_pred             hcccCcCCceEEEEEEeCC------CcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          106 QALLGHGSSASVFKGILSD------GTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~~------g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      ..++-+|.||.||+|.|.+      .+.|.+|.++...  .+...|+.|...+..+.|||+.++.|+|..+....+++|.
T Consensus       289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~  368 (563)
T KOG1024|consen  289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP  368 (563)
T ss_pred             hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence            4679999999999997643      4567888887643  3345688999999999999999999999988888999999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      ++..|+|..||..++...  ......++..+...++.|++.||+|||.   .++||.||.++|++||+..++||+|=.++
T Consensus       369 ~~~~gNLK~FL~~Cr~~~--~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~LqVkltDsaLS  443 (563)
T KOG1024|consen  369 ATGVGNLKSFLQICRGDD--PSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQLQVKLTDSALS  443 (563)
T ss_pred             ccCcchHHHHHHHhccCC--CccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhheeEEeccchhc
Confidence            999999999998665321  1234458888899999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCceeeecc-CCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHh
Q 047276          258 KLMSRDQSRCITTIR-GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEK  335 (453)
Q Consensus       258 ~~~~~~~~~~~~~~~-gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  335 (453)
                      +.+.+.++++.+... .+..||+||.+.+..|+..+|||||||+||||+| |+.||...+             |..+...
T Consensus       444 RDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID-------------PfEm~~y  510 (563)
T KOG1024|consen  444 RDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID-------------PFEMEHY  510 (563)
T ss_pred             cccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC-------------HHHHHHH
Confidence            998888777766543 5669999999999999999999999999999998 999985322             2334445


Q ss_pred             hhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 047276          336 MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR  391 (453)
Q Consensus       336 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~  391 (453)
                      +++|.       ++..    |.+++.+++.++..||...|++||++++++.-|.+.
T Consensus       511 lkdGy-------RlaQ----P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  511 LKDGY-------RLAQ----PFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             Hhccc-------eecC----CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence            55553       2322    335566799999999999999999999999988753

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.7e-39  Score=316.36  Aligned_cols=239  Identities=21%  Similarity=0.275  Sum_probs=187.8

Q ss_pred             cccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHh-cCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          107 ALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIAS-AQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.||+|+||+||+|... +++.||+|.++..    ......+..|..++.. ++||||+++++++. ..+..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~-~~~~~~lv~ey~~   79 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ-TKENLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE-eCCEEEEEEeCCC
Confidence            46999999999999964 5789999998753    2334556678888876 48999999999876 4567899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|.+++...          ..+++.....++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++...
T Consensus        80 ~g~L~~~l~~~----------~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05619          80 GGDLMFHIQSC----------HKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKEN  146 (316)
T ss_pred             CCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence            99999998543          238899999999999999999999   89999999999999999999999999998753


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      .... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......             ........+.
T Consensus       147 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-------------~~~~~i~~~~  212 (316)
T cd05619         147 MLGD-AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-------------ELFQSIRMDN  212 (316)
T ss_pred             CCCC-CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-------------HHHHHHHhCC
Confidence            2221 1234457899999999999888999999999999999999999999532110             0111111111


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHH-HHH
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMA-RVV  385 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~-~v~  385 (453)
                            +.      .+......+.+++.+|++.+|++||++. ++.
T Consensus       213 ------~~------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         213 ------PC------YPRWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             ------CC------CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence                  11      1122334578999999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=7.2e-39  Score=302.30  Aligned_cols=247  Identities=31%  Similarity=0.449  Sum_probs=197.2

Q ss_pred             HHHhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCC
Q 047276          103 DNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      +.+.+.||+|+||.||++... |..+++|.++... ..+.|.+|+.++++++|+|++++++++...++..++++||+++|
T Consensus         8 ~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~   85 (256)
T cd05082           8 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG   85 (256)
T ss_pred             CeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCC
Confidence            344678999999999999875 7789999987543 35678999999999999999999998766666789999999999


Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccC
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR  262 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~  262 (453)
                      +|.+++.....        ..+++..+++++.|++.||+|||+   .+++||||||+||++++++.+||+|||++.....
T Consensus        86 ~L~~~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  154 (256)
T cd05082          86 SLVDYLRSRGR--------SVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  154 (256)
T ss_pred             cHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence            99999864321        238899999999999999999999   8999999999999999999999999999875432


Q ss_pred             CCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcCcc
Q 047276          263 DQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKL  341 (453)
Q Consensus       263 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (453)
                      ..    ....++..|+|||++....++.++||||||+++|||++ |+.||....            ... .......+..
T Consensus       155 ~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~------------~~~-~~~~~~~~~~  217 (256)
T cd05082         155 TQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------------LKD-VVPRVEKGYK  217 (256)
T ss_pred             cC----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC------------HHH-HHHHHhcCCC
Confidence            22    22334568999999988889999999999999999997 998884211            011 1111111110


Q ss_pred             cccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 047276          342 MEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEG  390 (453)
Q Consensus       342 ~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~  390 (453)
                                 ...+...+..+.+++.+|++.+|++|||+.++++.|+.
T Consensus       218 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         218 -----------MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             -----------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence                       01122334568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.7e-39  Score=316.77  Aligned_cols=240  Identities=21%  Similarity=0.263  Sum_probs=190.5

Q ss_pred             cccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          107 ALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.||+|+||+||++... +++.||+|.++..    ......+..|..++..+ +||||+++++++. ..+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~-~~~~~~lv~e~~~   79 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ-TKDRLFFVMEYVN   79 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-cCCEEEEEEcCCC
Confidence            46999999999999965 5789999998742    23345677888998887 6999999999876 5568899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|..++...          ..+++.....++.|++.||.|||+   .+++||||||+|||+++++.+||+|||+++..
T Consensus        80 ~~~L~~~~~~~----------~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  146 (318)
T cd05570          80 GGDLMFHIQRS----------GRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEG  146 (318)
T ss_pred             CCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeec
Confidence            99999988543          238999999999999999999999   89999999999999999999999999998753


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      ..... ......|++.|+|||.+.+..++.++|||||||++|||++|+.||......             ..........
T Consensus       147 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-------------~~~~~i~~~~  212 (318)
T cd05570         147 ILGGV-TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-------------ELFQSILEDE  212 (318)
T ss_pred             CcCCC-cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-------------HHHHHHHcCC
Confidence            22221 223456899999999999999999999999999999999999999532110             0111111111


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSM-----ARVVE  386 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~-----~~v~~  386 (453)
                                  ...+......+.+++.+||+.+|++||++     .++++
T Consensus       213 ------------~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         213 ------------VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             ------------CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence                        01122234568899999999999999999     77764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.5e-39  Score=304.48  Aligned_cols=239  Identities=24%  Similarity=0.380  Sum_probs=184.3

Q ss_pred             cccCcCCceEEEEEEeCC-------------CcEEEEEEecCCC-ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCe
Q 047276          107 ALLGHGSSASVFKGILSD-------------GTSVAVKRINGEE-NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPR  172 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~-------------g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  172 (453)
                      +.||+|+||.||+|++.+             ...|++|.+.... .....|.+|+.++..++||||++++++|. .....
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~-~~~~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCV-RDVEN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCCC
Confidence            368999999999998532             2258899876533 33456888999999999999999999987 45577


Q ss_pred             EEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCc----
Q 047276          173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYR----  248 (453)
Q Consensus       173 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~----  248 (453)
                      +++|||+++|+|..++....         ..+++..+++++.|+++||+|||+   .+++||||||+|||++.++.    
T Consensus        80 ~lv~e~~~~~~l~~~~~~~~---------~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~  147 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRKS---------DVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGEC  147 (262)
T ss_pred             EEEEecccCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCC
Confidence            99999999999999885322         348999999999999999999999   89999999999999987664    


Q ss_pred             ---EEEeeccccccccCCCCceeeeccCCccccchhhhh-cCCCCccccchhHHHHHHHHH-cCCCCCcccccCCCCCcc
Q 047276          249 ---AVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWIL-EQGVSEKCDIYSYGMVLLELT-GGRRNVSLIEHGNDKSKN  323 (453)
Q Consensus       249 ---~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDV~S~Gvil~ell-tG~~p~~~~~~~~~~~~~  323 (453)
                         +|++|||++......     ....++..|+|||++. ...++.++|||||||++|||+ +|+.|+......      
T Consensus       148 ~~~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------  216 (262)
T cd05077         148 GPFIKLSDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA------  216 (262)
T ss_pred             CceeEeCCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh------
Confidence               899999998755322     2345778899999887 466899999999999999998 588777421100      


Q ss_pred             cccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 047276          324 KWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE  389 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~  389 (453)
                            . ..... .+..        .    ........+.+++.+||+.+|++||++.++++.++
T Consensus       217 ------~-~~~~~-~~~~--------~----~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         217 ------E-KERFY-EGQC--------M----LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             ------H-HHHHH-hcCc--------c----CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence                  0 00000 1100        0    01112345889999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=4.7e-39  Score=304.43  Aligned_cols=250  Identities=24%  Similarity=0.389  Sum_probs=191.8

Q ss_pred             cccCcCCceEEEEEEeC----CCcEEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          107 ALLGHGSSASVFKGILS----DGTSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~----~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.||+|+||.||+|.+.    ++..+|+|.+...  ....+.+.+|+.+++.++|||+++++++|...++..++++||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999853    2357999988542  23346788999999999999999999988766667899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|.+++....         ..+++..+..++.|++.||+|||+   .+++||||||+|||+++++.+||+|||+++..
T Consensus        81 ~~~L~~~~~~~~---------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~  148 (262)
T cd05058          81 HGDLRNFIRSET---------HNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDI  148 (262)
T ss_pred             CCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccc
Confidence            999999985432         226788889999999999999998   89999999999999999999999999999765


Q ss_pred             cCCCCc---eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCC-CCCcccccCCCCCcccccchhHHHHHhh
Q 047276          261 SRDQSR---CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR-RNVSLIEHGNDKSKNKWQYFPKIVNEKM  336 (453)
Q Consensus       261 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (453)
                      ......   ......++..|+|||.+....++.++||||||+++|||++|. .||.....            ..... ..
T Consensus       149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------------~~~~~-~~  215 (262)
T cd05058         149 YDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS------------FDITV-YL  215 (262)
T ss_pred             cCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH------------HHHHH-HH
Confidence            432211   112334567899999998888999999999999999999954 45532110            01111 11


Q ss_pred             hcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          337 KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       337 ~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      ..+..       ..    .+...+..+.+++..||+.+|++||++.+|++.|++..
T Consensus       216 ~~~~~-------~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         216 LQGRR-------LL----QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             hcCCC-------CC----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence            11110       00    11122346889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=4.8e-39  Score=307.53  Aligned_cols=251  Identities=23%  Similarity=0.392  Sum_probs=196.4

Q ss_pred             HhcccCcCCceEEEEEEe-CCCc----EEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          105 FQALLGHGSSASVFKGIL-SDGT----SVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~----~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      +.++||+|+||+||+|.+ .+|+    .||+|.++..  .....++.+|+.++..++|+|+++++++|..  ...++++|
T Consensus        11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~l~~~   88 (279)
T cd05109          11 KVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT--STVQLVTQ   88 (279)
T ss_pred             eeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC--CCcEEEEE
Confidence            357899999999999985 3454    4899998753  2334678899999999999999999999863  45789999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |+++|+|.+++....         +.+++..++.++.|++.||+|||+   .+++||||||+|||+++++.+||+|||++
T Consensus        89 ~~~~g~l~~~l~~~~---------~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~  156 (279)
T cd05109          89 LMPYGCLLDYVRENK---------DRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLA  156 (279)
T ss_pred             cCCCCCHHHHHhhcc---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCce
Confidence            999999999986432         238999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCc-eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHh
Q 047276          258 KLMSRDQSR-CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEK  335 (453)
Q Consensus       258 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  335 (453)
                      +........ ......+++.|+|||...+..++.++||||||+++|||++ |..||.....             ......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------------~~~~~~  223 (279)
T cd05109         157 RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-------------REIPDL  223 (279)
T ss_pred             eecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------------HHHHHH
Confidence            876533221 1122334678999999988889999999999999999998 8888853211             001111


Q ss_pred             hhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          336 MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       336 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                      +..+...           ..+......+.+++..||+.+|++||++.++++.|+....
T Consensus       224 ~~~~~~~-----------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         224 LEKGERL-----------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             HHCCCcC-----------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            1111110           0112334568899999999999999999999999986543

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=5.1e-39  Score=305.05  Aligned_cols=255  Identities=20%  Similarity=0.340  Sum_probs=199.7

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      +.+.||+|+||.||+|+. .+++.||||.+...    ......+.+|+.+++.++|||++++++++. ..+..++++||+
T Consensus         6 i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~~v~e~~   84 (267)
T cd08228           6 IEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI-EDNELNIVLELA   84 (267)
T ss_pred             eeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE-ECCeEEEEEEec
Confidence            457899999999999995 46899999987542    223356889999999999999999999876 456889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ++|+|.+++.....      ....+++.....++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++..
T Consensus        85 ~~~~L~~~~~~~~~------~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~  155 (267)
T cd08228          85 DAGDLSQMIKYFKK------QKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRF  155 (267)
T ss_pred             CCCcHHHHHHHhhh------ccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECcccccee
Confidence            99999988853221      12347889999999999999999999   8999999999999999999999999999887


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      ...... ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||......          ... ........
T Consensus       156 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----------~~~-~~~~~~~~  223 (267)
T cd08228         156 FSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----------LFS-LCQKIEQC  223 (267)
T ss_pred             ccchhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----------HHH-HHHHHhcC
Confidence            643321 123346888999999998888999999999999999999999998532110          000 11111111


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR  391 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~  391 (453)
                      ..     +.     .........+.+++.+||+.+|++||++.+|++.|++.
T Consensus       224 ~~-----~~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         224 DY-----PP-----LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             CC-----CC-----CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            10     10     01223446689999999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.8e-39  Score=308.53  Aligned_cols=238  Identities=24%  Similarity=0.372  Sum_probs=183.0

Q ss_pred             ccCcCCceEEEEEEeCC-------------------------CcEEEEEEecCCC-ccHHHHHHHHHHHHhcCCCceeeE
Q 047276          108 LLGHGSSASVFKGILSD-------------------------GTSVAVKRINGEE-NGEKEFRSEVAAIASAQHVNLVRL  161 (453)
Q Consensus       108 ~lG~G~fG~Vy~~~~~~-------------------------g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l  161 (453)
                      +||+|+||.||+|.+..                         ...|++|.+.... .....|.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999998521                         1358899886532 233568889999999999999999


Q ss_pred             eeEEEecCCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcE
Q 047276          162 LGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENI  241 (453)
Q Consensus       162 ~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~Ni  241 (453)
                      +|+|. .+...++||||+++|+|..++....         +.+++..+.+++.|+++||+|||+   .+++||||||+||
T Consensus        82 ~~~~~-~~~~~~lv~ey~~~g~L~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Ni  148 (274)
T cd05076          82 HGVCV-RGSENIMVEEFVEHGPLDVCLRKEK---------GRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNI  148 (274)
T ss_pred             EEEEE-eCCceEEEEecCCCCcHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccE
Confidence            99987 4567899999999999999985422         238899999999999999999998   8999999999999


Q ss_pred             EECCCC-------cEEEeeccccccccCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHH-cCCCCCc
Q 047276          242 LLDENY-------RAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELT-GGRRNVS  312 (453)
Q Consensus       242 Ll~~~~-------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~ell-tG~~p~~  312 (453)
                      |++.++       .+|++|||++......     ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||.
T Consensus       149 ll~~~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~  223 (274)
T cd05076         149 LLARLGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLK  223 (274)
T ss_pred             EEeccCcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcc
Confidence            998644       4899999987644322     12346788999998875 56899999999999999985 7998885


Q ss_pred             ccccCCCCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 047276          313 LIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE  389 (453)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~  389 (453)
                      ......             ........       ..      .+......+.+++.+||+.+|++||++.+|++.|+
T Consensus       224 ~~~~~~-------------~~~~~~~~-------~~------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         224 ERTPSE-------------KERFYEKK-------HR------LPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             ccChHH-------------HHHHHHhc-------cC------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            321110             00110000       00      11112235889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=6.1e-39  Score=306.70  Aligned_cols=247  Identities=21%  Similarity=0.279  Sum_probs=191.1

Q ss_pred             cCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCC
Q 047276          109 LGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS  183 (453)
Q Consensus       109 lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gs  183 (453)
                      ||+|+||+||++..+ +|+.+|+|.+...    ......+..|++++.+++||||+++.+++. .+...++||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~-~~~~~~lv~e~~~g~~   79 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFE-SKTHLCLVMSLMNGGD   79 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEe-cCCeEEEEEecCCCCC
Confidence            799999999999864 5899999998642    122345667999999999999999999875 5668899999999999


Q ss_pred             hhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCC
Q 047276          184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD  263 (453)
Q Consensus       184 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~  263 (453)
                      |.+++.....        ..+++..+..++.|++.||+|||+   .+++||||||+||++++++.++|+|||++......
T Consensus        80 L~~~~~~~~~--------~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~  148 (277)
T cd05607          80 LKYHIYNVGE--------RGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG  148 (277)
T ss_pred             HHHHHHhccc--------cCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence            9988854321        238899999999999999999999   89999999999999999999999999998766432


Q ss_pred             CCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcccc
Q 047276          264 QSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLME  343 (453)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (453)
                      .  ......|+..|+|||++.+..++.++|||||||++|||++|+.||........         ...+........   
T Consensus       149 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~---------~~~~~~~~~~~~---  214 (277)
T cd05607         149 K--TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA---------KEELKRRTLEDE---  214 (277)
T ss_pred             c--eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh---------HHHHHHHhhccc---
Confidence            2  22345689999999999988899999999999999999999999853211100         000111110100   


Q ss_pred             cccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 047276          344 IVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE  389 (453)
Q Consensus       344 ~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~  389 (453)
                       ...       ........+.+++..||+.+|++||++.|+++.+.
T Consensus       215 -~~~-------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~  252 (277)
T cd05607         215 -VKF-------EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR  252 (277)
T ss_pred             -ccc-------ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence             000       00123445899999999999999999987764443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-39  Score=305.78  Aligned_cols=262  Identities=22%  Similarity=0.336  Sum_probs=196.8

Q ss_pred             HhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHh--cCCCceeeEeeEEEecCC---CeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIAS--AQHVNLVRLLGYCVVPGG---PRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~~~---~~~lv~e~~  179 (453)
                      +.+.||+|.||+||+|.|. |..||||++...  +++.+.+|.++...  |+|+||+.+++.-..+.+   .++||.+|.
T Consensus       215 L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr--dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYH  291 (513)
T KOG2052|consen  215 LQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR--DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYH  291 (513)
T ss_pred             EEEEecCccccceeecccc-CCceEEEEeccc--chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecc
Confidence            3478999999999999997 889999999753  34567777777764  799999999986332222   568999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhcccccc-----CCCceeccCCCCCcEEECCCCcEEEeec
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHND-----CRSRVLHLDVKPENILLDENYRAVVSDF  254 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~-----~~~~ivH~Dlk~~NiLl~~~~~~kl~Df  254 (453)
                      ++|||.|||..           ..++....++++..+|.||++||.+     .++.|.|||||+.|||+..|+.+.|+|+
T Consensus       292 e~GSL~DyL~r-----------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL  360 (513)
T KOG2052|consen  292 EHGSLYDYLNR-----------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  360 (513)
T ss_pred             cCCcHHHHHhh-----------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence            99999999943           4499999999999999999999953     3578999999999999999999999999


Q ss_pred             cccccccCCCC---ceeeeccCCccccchhhhhcCC----C--CccccchhHHHHHHHHHcCC----------CCCcccc
Q 047276          255 GLSKLMSRDQS---RCITTIRGTRGYLAPEWILEQG----V--SEKCDIYSYGMVLLELTGGR----------RNVSLIE  315 (453)
Q Consensus       255 Gla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~----~--~~~sDV~S~Gvil~elltG~----------~p~~~~~  315 (453)
                      |||-.......   ...+..+||-+|||||.+....    +  -..+||||||.++||+....          .||...-
T Consensus       361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V  440 (513)
T KOG2052|consen  361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV  440 (513)
T ss_pred             eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence            99987654422   2235578999999999987532    1  13699999999999987532          3443222


Q ss_pred             cCCCCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          316 HGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                      +.+..        -+.+.+.+...++.-.++.++     .+.+.+..+.+++..||..||..|-|+-.+-+.|.+...
T Consensus       441 p~DPs--------~eeMrkVVCv~~~RP~ipnrW-----~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  441 PSDPS--------FEEMRKVVCVQKLRPNIPNRW-----KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CCCCC--------HHHHhcceeecccCCCCCccc-----ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            21111        011112222222222222222     345778889999999999999999999999999987654

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4.8e-39  Score=314.84  Aligned_cols=242  Identities=21%  Similarity=0.279  Sum_probs=189.0

Q ss_pred             cccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          107 ALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      ++||+|+||+||++... +++.||+|+++..    ....+.+..|..++.++ +||||+++++++. ..+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-~~~~~~lv~e~~~   79 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQ-TTSRLFLVIEYVN   79 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEE-eCCEEEEEEeCCC
Confidence            46999999999999964 5789999999753    22334578899999888 6999999999875 5568899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|..++...          ..+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++..
T Consensus        80 ~~~L~~~~~~~----------~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~  146 (327)
T cd05617          80 GGDLMFHMQRQ----------RKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEG  146 (327)
T ss_pred             CCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceec
Confidence            99999888533          238999999999999999999999   89999999999999999999999999998753


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      .... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........      ............
T Consensus       147 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~------~~~~~~~~~~~~  219 (327)
T cd05617         147 LGPG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNT------EDYLFQVILEKP  219 (327)
T ss_pred             cCCC-CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccccc------HHHHHHHHHhCC
Confidence            2221 123456799999999999999999999999999999999999999964332211111      111111111111


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCH
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSM  381 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  381 (453)
                                  ...+......+.+++.+||+.||++||++
T Consensus       220 ------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         220 ------------IRIPRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             ------------CCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence                        11222334557899999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=9.4e-39  Score=303.83  Aligned_cols=254  Identities=23%  Similarity=0.338  Sum_probs=189.1

Q ss_pred             cccCcCCceEEEEEEeCC---CcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          107 ALLGHGSSASVFKGILSD---GTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~---g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      +.||+|+||.||+|...+   +..+|+|.++...  .....+.+|+.++++++||||++++|++. .....++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~   79 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT-EVTPYLLVMEFCPL   79 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-CCCCcEEEEECCCC
Confidence            368999999999998643   3579999887543  23357889999999999999999999876 45678999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      |+|.+++......     ....+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++....
T Consensus        80 g~L~~~l~~~~~~-----~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~  151 (269)
T cd05087          80 GDLKGYLRSCRKA-----ELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKY  151 (269)
T ss_pred             CcHHHHHHHhhhc-----ccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCcccccccc
Confidence            9999999654321     11236788888999999999999999   899999999999999999999999999987543


Q ss_pred             CCCCc-eeeeccCCccccchhhhhcC-------CCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHH
Q 047276          262 RDQSR-CITTIRGTRGYLAPEWILEQ-------GVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIV  332 (453)
Q Consensus       262 ~~~~~-~~~~~~gt~~y~aPE~~~~~-------~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  332 (453)
                      ..... ......++..|+|||.+...       .++.++|+||||+++|||++ |+.||.......            ..
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~------------~~  219 (269)
T cd05087         152 KEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ------------VL  219 (269)
T ss_pred             CcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH------------HH
Confidence            32211 11234567889999988632       35789999999999999996 999985322110            00


Q ss_pred             HHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 047276          333 NEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE  389 (453)
Q Consensus       333 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~  389 (453)
                      ...+. +......++.+.      ......+.+++..|+ .+|++|||+++|++.|+
T Consensus       220 ~~~~~-~~~~~~~~~~~~------~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         220 TYTVR-EQQLKLPKPRLK------LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             HHHhh-cccCCCCCCccC------CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            01111 111112222211      122334778888998 58999999999999886

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=5.5e-39  Score=309.57  Aligned_cols=266  Identities=21%  Similarity=0.342  Sum_probs=198.5

Q ss_pred             HHhcccCcCCceEEEEEEeCC-----------------CcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeE
Q 047276          104 NFQALLGHGSSASVFKGILSD-----------------GTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGY  164 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~~-----------------g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~  164 (453)
                      .+.+.||+|+||.||++...+                 +..||+|.+....  ...+.+.+|++++++++|||+++++++
T Consensus         8 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   87 (296)
T cd05051           8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGV   87 (296)
T ss_pred             cccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            456899999999999988542                 2468999987543  335678999999999999999999999


Q ss_pred             EEecCCCeEEEEEecCCCChhhhhccCCCCCCC-CCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEE
Q 047276          165 CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEG-HYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILL  243 (453)
Q Consensus       165 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl  243 (453)
                      |. .++..++++||+++++|.+++......... ......+++..++.++.|++.||+|||+   .+++|+||||+||++
T Consensus        88 ~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~Nili  163 (296)
T cd05051          88 CT-VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLV  163 (296)
T ss_pred             Ee-cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhceee
Confidence            86 456889999999999999999654321110 1122358999999999999999999998   899999999999999


Q ss_pred             CCCCcEEEeeccccccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc--CCCCCcccccCCCC
Q 047276          244 DENYRAVVSDFGLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG--GRRNVSLIEHGNDK  320 (453)
Q Consensus       244 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt--G~~p~~~~~~~~~~  320 (453)
                      ++++.++|+|||+++....... .......+++.|+|||++..+.++.++||||||+++|||++  |..||.......  
T Consensus       164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~--  241 (296)
T cd05051         164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ--  241 (296)
T ss_pred             cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH--
Confidence            9999999999999876543321 12233456778999999998889999999999999999998  666764221000  


Q ss_pred             CcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 047276          321 SKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEG  390 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~  390 (453)
                             .................        ...+...+..+.+++.+|++.+|++|||+.+|++.|++
T Consensus       242 -------~~~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         242 -------VIENAGHFFRDDGRQIY--------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             -------HHHHHHhcccccccccc--------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence                   00000111111000000        01112233569999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=7.4e-39  Score=320.04  Aligned_cols=247  Identities=21%  Similarity=0.278  Sum_probs=188.0

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      .+.||+|+||+||+|+. .+++.||+|++...    ......+..|+.++..++||||+++++++. ..+..++||||++
T Consensus         6 ~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~-~~~~~~lv~E~~~   84 (381)
T cd05626           6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ-DKDNLYFVMDYIP   84 (381)
T ss_pred             EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe-cCCEEEEEEecCC
Confidence            46899999999999985 46889999999652    223456889999999999999999999876 5668899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|.+++...          ..+++.....++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++..+
T Consensus        85 gg~L~~~l~~~----------~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~  151 (381)
T cd05626          85 GGDMMSLLIRM----------EVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF  151 (381)
T ss_pred             CCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence            99999998643          238888899999999999999999   89999999999999999999999999997643


Q ss_pred             cCCCC----------------------------------------------ceeeeccCCccccchhhhhcCCCCccccc
Q 047276          261 SRDQS----------------------------------------------RCITTIRGTRGYLAPEWILEQGVSEKCDI  294 (453)
Q Consensus       261 ~~~~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV  294 (453)
                      .....                                              .......||+.|+|||.+.+..++.++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di  231 (381)
T cd05626         152 RWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDW  231 (381)
T ss_pred             ccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccce
Confidence            11000                                              00123469999999999998889999999


Q ss_pred             hhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHh--ccc
Q 047276          295 YSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFW--CIQ  372 (453)
Q Consensus       295 ~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~--Cl~  372 (453)
                      |||||++|||++|+.||.......            ...........     ..+....    .....+.+++.+  |+.
T Consensus       232 wSlG~il~elltG~~Pf~~~~~~~------------~~~~i~~~~~~-----~~~~~~~----~~s~~~~dli~~ll~~~  290 (381)
T cd05626         232 WSVGVILFEMLVGQPPFLAPTPTE------------TQLKVINWENT-----LHIPPQV----KLSPEAVDLITKLCCSA  290 (381)
T ss_pred             eehhhHHHHHHhCCCCCcCCCHHH------------HHHHHHccccc-----cCCCCCC----CCCHHHHHHHHHHccCc
Confidence            999999999999999995322110            00011000000     0011111    123346667765  667


Q ss_pred             cCCCCCCCHHHHHHH
Q 047276          373 ERARLRPSMARVVEM  387 (453)
Q Consensus       373 ~~p~~RPs~~~v~~~  387 (453)
                      .+|..||++.++++.
T Consensus       291 ~~~~~R~~~~~~l~h  305 (381)
T cd05626         291 EERLGRNGADDIKAH  305 (381)
T ss_pred             ccccCCCCHHHHhcC
Confidence            777789999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.3e-39  Score=324.06  Aligned_cols=248  Identities=22%  Similarity=0.246  Sum_probs=192.3

Q ss_pred             HHhcccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEe
Q 047276          104 NFQALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      .+.++||+|+||.||+++.. +++.||+|.+...    ....+.+.+|+.+++.++||||+++++++. .++..++||||
T Consensus        46 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~-~~~~~~lv~Ey  124 (370)
T cd05596          46 DVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ-DDKYLYMVMEY  124 (370)
T ss_pred             EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEe-cCCEEEEEEcC
Confidence            34578999999999999964 6889999998642    233455788999999999999999998865 56688999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +++|+|.+++...           .++......++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++.
T Consensus       125 ~~gg~L~~~l~~~-----------~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~  190 (370)
T cd05596         125 MPGGDLVNLMSNY-----------DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (370)
T ss_pred             CCCCcHHHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEecccee
Confidence            9999999998432           27788888999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCceeeeccCCccccchhhhhcC----CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHH
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWILEQ----GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNE  334 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  334 (453)
                      ..............||+.|+|||.+.+.    .++.++|||||||++|||++|+.||.....            .... .
T Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------------~~~~-~  257 (370)
T cd05596         191 KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------------VGTY-S  257 (370)
T ss_pred             eccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH------------HHHH-H
Confidence            7644332223446799999999998643    478999999999999999999999953211            0001 1


Q ss_pred             hhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 047276          335 KMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARL--RPSMARVVEM  387 (453)
Q Consensus       335 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPs~~~v~~~  387 (453)
                      .+..+.. .   ..+..    ....+..+.+++..|++.+|.+  ||++.++++.
T Consensus       258 ~i~~~~~-~---~~~~~----~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         258 KIMDHKN-S---LTFPD----DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             HHHcCCC-c---CCCCC----cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            1111100 0   00110    1123456889999999999988  9999998754

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5e-40  Score=307.09  Aligned_cols=245  Identities=23%  Similarity=0.346  Sum_probs=203.8

Q ss_pred             HHHHHhcccCcCCceEEEEEE-eCCCcEEEEEEecCCC----ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEE
Q 047276          101 ATDNFQALLGHGSSASVFKGI-LSDGTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLV  175 (453)
Q Consensus       101 ~~~~~~~~lG~G~fG~Vy~~~-~~~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv  175 (453)
                      -.+.|.+.||+|.||.|-++. ...|+.||||.++++.    ++.-.+++|+++|+.|+||||+.++.+|. +.+...+|
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFE-NkdKIviv  131 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFE-NKDKIVIV  131 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhc-CCceEEEE
Confidence            455667899999999999998 4789999999997643    33345889999999999999999999875 77788999


Q ss_pred             EEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecc
Q 047276          176 YEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFG  255 (453)
Q Consensus       176 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfG  255 (453)
                      |||..+|.|.+|+..+.          .|++.....|+.||..|+.|+|.   ++++|||||.+|||+|+|+++||+|||
T Consensus       132 MEYaS~GeLYDYiSer~----------~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFG  198 (668)
T KOG0611|consen  132 MEYASGGELYDYISERG----------SLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFG  198 (668)
T ss_pred             EEecCCccHHHHHHHhc----------cccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccc
Confidence            99999999999996543          39999999999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCceeeeccCCccccchhhhhcCCC-CccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHH
Q 047276          256 LSKLMSRDQSRCITTIRGTRGYLAPEWILEQGV-SEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNE  334 (453)
Q Consensus       256 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  334 (453)
                      ++.++....  ...+++|+|-|.+||.+.+..| .+..|-||+||+||.|+.|..||+..+            +.. +-.
T Consensus       199 LSNly~~~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D------------hk~-lvr  263 (668)
T KOG0611|consen  199 LSNLYADKK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD------------HKR-LVR  263 (668)
T ss_pred             hhhhhcccc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch------------HHH-HHH
Confidence            998875433  3577899999999999998887 578999999999999999999996432            111 223


Q ss_pred             hhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          335 KMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       335 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      ++..|...+-             +.+....-|+.|+|-.||++|.|+.+|...
T Consensus       264 QIs~GaYrEP-------------~~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  264 QISRGAYREP-------------ETPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             HhhcccccCC-------------CCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence            3334433221             222335678999999999999999999854

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=7e-39  Score=304.36  Aligned_cols=250  Identities=27%  Similarity=0.439  Sum_probs=196.2

Q ss_pred             HhcccCcCCceEEEEEEeC-CC---cEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEe
Q 047276          105 FQALLGHGSSASVFKGILS-DG---TSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g---~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      ..+.||+|+||.||+|... ++   ..+++|.++...  ...+.+..|++++.+++|+|++++.+++. ..+..++||||
T Consensus         9 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~   87 (268)
T cd05063           9 KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT-KFKPAMIITEY   87 (268)
T ss_pred             EeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc-cCCCcEEEEEc
Confidence            3578999999999999964 33   369999887542  23457899999999999999999999976 55688999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +++++|.+++....         +.+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||++.
T Consensus        88 ~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~  155 (268)
T cd05063          88 MENGALDKYLRDHD---------GEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSR  155 (268)
T ss_pred             CCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccce
Confidence            99999999985432         348999999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCceee--eccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHh
Q 047276          259 LMSRDQSRCIT--TIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEK  335 (453)
Q Consensus       259 ~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  335 (453)
                      ...........  ....+..|+|||++....++.++||||||+++|||++ |+.||.....            .. ....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~------------~~-~~~~  222 (268)
T cd05063         156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN------------HE-VMKA  222 (268)
T ss_pred             ecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH------------HH-HHHH
Confidence            66433221111  1223457999999998889999999999999999997 9999853211            01 1111


Q ss_pred             hhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 047276          336 MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR  391 (453)
Q Consensus       336 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~  391 (453)
                      +..+.       ..    ....+....+.+++.+|++.+|++||++.+|++.|++.
T Consensus       223 i~~~~-------~~----~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         223 INDGF-------RL----PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             HhcCC-------CC----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            11110       00    11123345689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.7e-39  Score=316.38  Aligned_cols=241  Identities=25%  Similarity=0.286  Sum_probs=185.9

Q ss_pred             cccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHH-HHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          107 ALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVA-AIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.||+|+||+||+++.. +++.||+|++...    ......+..|.. +++.++||||+++++++. ..+..++||||++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~-~~~~~~lv~e~~~   79 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-TADKLYFVLDYIN   79 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEE-cCCeEEEEEeCCC
Confidence            46999999999999964 5788999998642    122334455544 467889999999999876 5668899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|.+++...          ..+.+.....++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        80 ~~~L~~~~~~~----------~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~  146 (325)
T cd05602          80 GGELFYHLQRE----------RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKEN  146 (325)
T ss_pred             CCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence            99999998543          237788888899999999999999   89999999999999999999999999998754


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      ..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......            ..... .....
T Consensus       147 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------~~~~~-i~~~~  212 (325)
T cd05602         147 IEHNG-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------------EMYDN-ILNKP  212 (325)
T ss_pred             ccCCC-CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH------------HHHHH-HHhCC
Confidence            32221 234457999999999999989999999999999999999999999532110            00111 11110


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                                  ..........+.+++.+|++.+|.+||+..+.+..
T Consensus       213 ------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~  247 (325)
T cd05602         213 ------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFME  247 (325)
T ss_pred             ------------cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence                        01122334458899999999999999998754433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.1e-38  Score=306.02  Aligned_cols=266  Identities=22%  Similarity=0.306  Sum_probs=198.8

Q ss_pred             HHHhcccCcCCceEEEEEEe-----CCCcEEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEec-CCCeEE
Q 047276          103 DNFQALLGHGSSASVFKGIL-----SDGTSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP-GGPRYL  174 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~-----~~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~~l  174 (453)
                      +...+.||+|+||.||.+..     .++..||+|.++..  ......+.+|+.+++.++|||++++.+++... ....++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (284)
T cd05079           6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL   85 (284)
T ss_pred             hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEE
Confidence            34457899999999999984     34778999998753  23345789999999999999999999998754 246789


Q ss_pred             EEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeec
Q 047276          175 VYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDF  254 (453)
Q Consensus       175 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~Df  254 (453)
                      ||||+++++|.+++....         ..++|..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+||
T Consensus        86 v~e~~~g~~L~~~l~~~~---------~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~df  153 (284)
T cd05079          86 IMEFLPSGSLKEYLPRNK---------NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDF  153 (284)
T ss_pred             EEEccCCCCHHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCC
Confidence            999999999999985332         238999999999999999999999   89999999999999999999999999


Q ss_pred             cccccccCCCC--ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCc--ccccchhH
Q 047276          255 GLSKLMSRDQS--RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSK--NKWQYFPK  330 (453)
Q Consensus       255 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~--~~~~~~~~  330 (453)
                      |+++.......  .......++..|+|||++.+..++.++||||||+++|||++++.|............  ..-.....
T Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd05079         154 GLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVT  233 (284)
T ss_pred             ccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHH
Confidence            99987643322  112234567789999999888899999999999999999998876432110000000  00000000


Q ss_pred             HHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 047276          331 IVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR  391 (453)
Q Consensus       331 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~  391 (453)
                      ........+..       .    +.+...+..+.+++.+|++.+|++||++.++++.|+.+
T Consensus       234 ~~~~~~~~~~~-------~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         234 RLVRVLEEGKR-------L----PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHHHHcCcc-------C----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            01111111110       0    01123345699999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.4e-38  Score=302.77  Aligned_cols=249  Identities=24%  Similarity=0.384  Sum_probs=194.6

Q ss_pred             HHHhcccCcCCceEEEEEEeC-CCcEEEEEEecCCCccHHHHHHHHHHHHhc-CCCceeeEeeEEEecC-----CCeEEE
Q 047276          103 DNFQALLGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPG-----GPRYLV  175 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~-----~~~~lv  175 (453)
                      +.+.+.||+|+||.||+|... +++.||+|.+.........+..|+.++.++ +|+|++++++++....     ...+++
T Consensus         8 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv   87 (272)
T cd06637           8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLV   87 (272)
T ss_pred             hhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEE
Confidence            344578999999999999964 578999999977666667889999999998 6999999999986432     347899


Q ss_pred             EEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecc
Q 047276          176 YEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFG  255 (453)
Q Consensus       176 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfG  255 (453)
                      |||+++|+|.+++....        ...+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+|||
T Consensus        88 ~e~~~~~~L~~~l~~~~--------~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg  156 (272)
T cd06637          88 MEFCGAGSVTDLIKNTK--------GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFG  156 (272)
T ss_pred             EEcCCCCcHHHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCC
Confidence            99999999999986432        1348999999999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCceeeeccCCccccchhhhh-----cCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhH
Q 047276          256 LSKLMSRDQSRCITTIRGTRGYLAPEWIL-----EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPK  330 (453)
Q Consensus       256 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~  330 (453)
                      ++....... .......|++.|+|||++.     ...++.++|||||||++|||++|+.||.......            
T Consensus       157 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~------------  223 (272)
T cd06637         157 VSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR------------  223 (272)
T ss_pred             Cceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH------------
Confidence            988654322 1234456889999999986     3457889999999999999999999985321100            


Q ss_pred             HHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          331 IVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       331 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                       .........     .+.+.     .......+.+++.+||+.+|.+|||+.++++
T Consensus       224 -~~~~~~~~~-----~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         224 -ALFLIPRNP-----APRLK-----SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             -HHHHHhcCC-----CCCCC-----CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence             000000000     01111     1123345889999999999999999999874

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2e-39  Score=311.78  Aligned_cols=268  Identities=21%  Similarity=0.238  Sum_probs=191.2

Q ss_pred             HHhcccCcCCceEEEEEEeC-CCcEEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          104 NFQALLGHGSSASVFKGILS-DGTSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      .+.++||+|+||+||+|... +++.||+|.++..  ......+.+|+.++++++||||+++++++. ..+..++||||++
T Consensus         8 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~   86 (288)
T cd07871           8 VKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIH-TERCLTLVFEYLD   86 (288)
T ss_pred             eEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEc-CCCeEEEEEeCCC
Confidence            34578999999999999964 6889999998643  233456789999999999999999999875 5567899999997


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      + +|.+++....         ..+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++..
T Consensus        87 ~-~l~~~l~~~~---------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~  153 (288)
T cd07871          87 S-DLKQYLDNCG---------NLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAK  153 (288)
T ss_pred             c-CHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeec
Confidence            5 9999885332         237889999999999999999999   89999999999999999999999999999765


Q ss_pred             cCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcc--cccchhHHHHHhh-
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKN--KWQYFPKIVNEKM-  336 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~-  336 (453)
                      .... .......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||............  .....+...+... 
T Consensus       154 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07871         154 SVPT-KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT  232 (288)
T ss_pred             cCCC-ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccc
Confidence            3222 12234567899999998865 56899999999999999999999999532211000000  0000000000000 


Q ss_pred             hcCcccccccccccCCC--CCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          337 KEGKLMEIVDQRLTDEG--GIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       337 ~~~~~~~~~d~~l~~~~--~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ..........+......  .........+.+++.+|++.||.+|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            00000111111100000  000112345789999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.1e-38  Score=302.54  Aligned_cols=256  Identities=22%  Similarity=0.371  Sum_probs=202.2

Q ss_pred             HHhcccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEe
Q 047276          104 NFQALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      .+.+.||+|+||.||+|... +|+.||+|.++..    ....+.+.+|++++++++|+|++++++++. .++..+++|||
T Consensus         5 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~-~~~~~~lv~e~   83 (267)
T cd08224           5 KIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI-ENNELNIVLEL   83 (267)
T ss_pred             eeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee-cCCeEEEEEec
Confidence            45678999999999999976 7899999988631    223567899999999999999999999886 45688999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +++|+|.+++.....      ....+++..++.++.+++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.
T Consensus        84 ~~~~~L~~~l~~~~~------~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~  154 (267)
T cd08224          84 ADAGDLSRMIKHFKK------QKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGR  154 (267)
T ss_pred             CCCCCHHHHHHHhcc------cCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceee
Confidence            999999999854322      22348999999999999999999999   899999999999999999999999999988


Q ss_pred             cccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      ....... ......+++.|+|||.+.+..++.++|||||||++|||++|+.||......          ... ..+....
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------~~~-~~~~~~~  222 (267)
T cd08224         155 FFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----------LYS-LCKKIEK  222 (267)
T ss_pred             eccCCCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----------HHH-HHhhhhc
Confidence            6543322 123346888999999998888999999999999999999999998532100          000 1111111


Q ss_pred             CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 047276          339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR  391 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~  391 (453)
                      +....     .     ........+.+++.+|++.+|++||++.+|+++|++.
T Consensus       223 ~~~~~-----~-----~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         223 CDYPP-----L-----PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             CCCCC-----C-----ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            11100     0     1113445688999999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=7.1e-39  Score=304.04  Aligned_cols=257  Identities=21%  Similarity=0.346  Sum_probs=201.5

Q ss_pred             HHHhcccCcCCceEEEEEEe-CCCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          103 DNFQALLGHGSSASVFKGIL-SDGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      +.+.+.||+|+||.||++.. .+|..++||.+...    .....++.+|+.+++.++|+|++++++++. .++..+++||
T Consensus         4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~~~~v~e   82 (267)
T cd08229           4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-EDNELNIVLE   82 (267)
T ss_pred             hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE-eCCeEEEEEE
Confidence            34568899999999999995 57899999987642    223357889999999999999999999886 4568899999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |+++++|.+++.....      ....+++...+.++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++
T Consensus        83 ~~~~~~L~~~~~~~~~------~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~  153 (267)
T cd08229          83 LADAGDLSRMIKHFKK------QKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             ecCCCCHHHHHHHhhc------cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhh
Confidence            9999999999854221      12348999999999999999999999   89999999999999999999999999998


Q ss_pred             ccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhh
Q 047276          258 KLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMK  337 (453)
Q Consensus       258 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (453)
                      ........ ......++..|+|||++.+..++.++||||||+++|||++|..||.....+.      .    . ......
T Consensus       154 ~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~----~-~~~~~~  221 (267)
T cd08229         154 RFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL------Y----S-LCKKIE  221 (267)
T ss_pred             hccccCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH------H----H-Hhhhhh
Confidence            76643322 1234568889999999988889999999999999999999999985321110      0    0 001111


Q ss_pred             cCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 047276          338 EGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR  391 (453)
Q Consensus       338 ~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~  391 (453)
                      .     ...+.+     ........+.+++.+|++.+|++||||.+|++++++.
T Consensus       222 ~-----~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         222 Q-----CDYPPL-----PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             c-----CCCCCC-----CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            0     001111     1123455689999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-39  Score=311.75  Aligned_cols=267  Identities=20%  Similarity=0.338  Sum_probs=195.6

Q ss_pred             HHHHhcccCcCCceEEEEEEeCC-------------C--cEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeE
Q 047276          102 TDNFQALLGHGSSASVFKGILSD-------------G--TSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGY  164 (453)
Q Consensus       102 ~~~~~~~lG~G~fG~Vy~~~~~~-------------g--~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~  164 (453)
                      .+.+.+.||+|+||.||++...+             +  ..||+|.++...  .....|.+|++++.+++|+|+++++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~   85 (295)
T cd05097           6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGV   85 (295)
T ss_pred             hCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEE
Confidence            34456889999999999987532             2  248999987532  233568999999999999999999999


Q ss_pred             EEecCCCeEEEEEecCCCChhhhhccCCCCCC--CCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEE
Q 047276          165 CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSE--GHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENIL  242 (453)
Q Consensus       165 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiL  242 (453)
                      +. ..+..++||||+++++|.+++........  .......+++..+++++.|++.||+|||+   .+++|+||||+||+
T Consensus        86 ~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil  161 (295)
T cd05097          86 CV-SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCL  161 (295)
T ss_pred             Ec-CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEE
Confidence            86 55688999999999999999854321100  00112347899999999999999999999   89999999999999


Q ss_pred             ECCCCcEEEeeccccccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc--CCCCCcccccCCC
Q 047276          243 LDENYRAVVSDFGLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG--GRRNVSLIEHGND  319 (453)
Q Consensus       243 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt--G~~p~~~~~~~~~  319 (453)
                      +++++.+||+|||++........ .......++..|+|||.+..+.++.++||||||+++|||++  |..||....... 
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~-  240 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ-  240 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence            99999999999999976543221 11223345678999999998889999999999999999998  555664221100 


Q ss_pred             CCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 047276          320 KSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE  389 (453)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~  389 (453)
                              ......+......      ....  ...+...+..+.+++.+|++.+|++||++++|++.|+
T Consensus       241 --------~~~~~~~~~~~~~------~~~~--~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 --------VIENTGEFFRNQG------RQIY--LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             --------HHHHHHHhhhhcc------cccc--CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence                    0000011111000      0000  0011123346999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=7.7e-39  Score=308.22  Aligned_cols=261  Identities=25%  Similarity=0.387  Sum_probs=199.8

Q ss_pred             HHhcccCcCCceEEEEEEeCC------CcEEEEEEecCCC--ccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEE
Q 047276          104 NFQALLGHGSSASVFKGILSD------GTSVAVKRINGEE--NGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYL  174 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~~------g~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~l  174 (453)
                      .+.+.||+|+||.||++...+      ...+|+|.+....  .....+.+|+.++.++ +|+||++++++|. .++..++
T Consensus        15 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~-~~~~~~l   93 (293)
T cd05053          15 TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT-QEGPLYV   93 (293)
T ss_pred             EEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc-CCCCeEE
Confidence            345789999999999998642      3579999887532  2335688999999999 7999999999986 5568899


Q ss_pred             EEEecCCCChhhhhccCCCCCCC------CCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCc
Q 047276          175 VYEFIQNGSLDHWIFPTSRRSEG------HYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYR  248 (453)
Q Consensus       175 v~e~~~~gsL~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~  248 (453)
                      +|||+++|+|.+++.........      ......+++..+++++.|++.||+|||+   .+++||||||+||++++++.
T Consensus        94 i~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~~~~~  170 (293)
T cd05053          94 VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHV  170 (293)
T ss_pred             EEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEcCCCe
Confidence            99999999999999654311100      0123458999999999999999999998   89999999999999999999


Q ss_pred             EEEeeccccccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCccccc
Q 047276          249 AVVSDFGLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQ  326 (453)
Q Consensus       249 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~  326 (453)
                      +||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.....          
T Consensus       171 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----------  240 (293)
T cd05053         171 MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV----------  240 (293)
T ss_pred             EEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH----------
Confidence            99999999987643321 11122345678999999988889999999999999999998 8888742210          


Q ss_pred             chhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          327 YFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                         .........+...           ..+......+.+++.+|++.+|++|||+.++++.|++..
T Consensus       241 ---~~~~~~~~~~~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         241 ---EELFKLLKEGYRM-----------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             ---HHHHHHHHcCCcC-----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence               0011111111100           112233456889999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-38  Score=301.05  Aligned_cols=247  Identities=30%  Similarity=0.455  Sum_probs=199.9

Q ss_pred             HHHhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCC
Q 047276          103 DNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      ..+.+.||+|+||.||+|... |+.||+|.+.......+++.+|+.+++.++|+|++++++++. .....++||||++++
T Consensus         8 ~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~~v~e~~~~~   85 (256)
T cd05039           8 LKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL-QGNPLYIVTEYMAKG   85 (256)
T ss_pred             ccceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEc-CCCCeEEEEEecCCC
Confidence            345689999999999999875 789999999875555678999999999999999999999976 467889999999999


Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccC
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR  262 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~  262 (453)
                      +|.+++.....        ..+++..+..++.|++.||.|||+   .+++|+||||+||++++++.+||+|||.++....
T Consensus        86 ~L~~~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~  154 (256)
T cd05039          86 SLVDYLRSRGR--------AVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ  154 (256)
T ss_pred             cHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEccccccccccc
Confidence            99999864421        248999999999999999999999   8999999999999999999999999999986632


Q ss_pred             CCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcCcc
Q 047276          263 DQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKL  341 (453)
Q Consensus       263 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (453)
                      ..    .....+..|+|||++..+.++.++||||||+++||+++ |+.||.....             .........+..
T Consensus       155 ~~----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------------~~~~~~~~~~~~  217 (256)
T cd05039         155 GQ----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-------------KDVVPHVEKGYR  217 (256)
T ss_pred             cc----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH-------------HHHHHHHhcCCC
Confidence            21    12334668999999988889999999999999999997 9998842210             011111111110


Q ss_pred             cccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 047276          342 MEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEG  390 (453)
Q Consensus       342 ~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~  390 (453)
                      .           ..+...+..+.+++.+|++.+|++||++.+++++|+.
T Consensus       218 ~-----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         218 M-----------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             C-----------CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            0           0112234568899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-39  Score=322.44  Aligned_cols=247  Identities=23%  Similarity=0.297  Sum_probs=195.2

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      +.+.||+|+||+||++... +|+.||+|+++..    ......+..|+.++..++|+||+++++++. .++..++||||+
T Consensus         5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~~lv~e~~   83 (350)
T cd05573           5 VIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ-DEEHLYLVMEYM   83 (350)
T ss_pred             EEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee-cCCeEEEEEcCC
Confidence            4578999999999999964 6899999998752    234467889999999999999999999876 566889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ++|+|.+++...          ..+++.....++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++..
T Consensus        84 ~~~~L~~~l~~~----------~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~  150 (350)
T cd05573          84 PGGDLMNLLIRK----------DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKK  150 (350)
T ss_pred             CCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCcc
Confidence            999999999643          238899999999999999999999   8999999999999999999999999999986


Q ss_pred             ccCCC----------------------------CceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCC
Q 047276          260 MSRDQ----------------------------SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNV  311 (453)
Q Consensus       260 ~~~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~  311 (453)
                      .....                            ........||+.|+|||.+.+..++.++|||||||++|||++|+.||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf  230 (350)
T cd05573         151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF  230 (350)
T ss_pred             CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCC
Confidence            64332                            11223456899999999999999999999999999999999999999


Q ss_pred             cccccCCCCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCC-HHHHHHH
Q 047276          312 SLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPS-MARVVEM  387 (453)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-~~~v~~~  387 (453)
                      ......            . ....+....  +.  ..+..    .......+.+++..|++ +|.+||+ +.++++.
T Consensus       231 ~~~~~~------------~-~~~~i~~~~--~~--~~~p~----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         231 YSDTLQ------------E-TYNKIINWK--ES--LRFPP----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CCCCHH------------H-HHHHHhccC--Cc--ccCCC----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            532210            0 011111000  00  00110    01134568899999997 9999999 9999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.7e-39  Score=316.06  Aligned_cols=237  Identities=22%  Similarity=0.274  Sum_probs=186.8

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEEEEEe
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      +.+.||+|+||.||+|... +++.||+|.+...    ......+..|..++..+ +|++|+++++++. ..+..++||||
T Consensus         4 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-~~~~~~lv~E~   82 (323)
T cd05616           4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ-TMDRLYFVMEY   82 (323)
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe-cCCEEEEEEcC
Confidence            4578999999999999965 5789999998752    22234567788888777 5789999998765 55688999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +++|+|.+++...          ..+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++
T Consensus        83 ~~~g~L~~~~~~~----------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~  149 (323)
T cd05616          83 VNGGDLMYQIQQV----------GRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK  149 (323)
T ss_pred             CCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCce
Confidence            9999999988533          238899999999999999999999   899999999999999999999999999987


Q ss_pred             cccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      ...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......             .....+..
T Consensus       150 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-------------~~~~~i~~  215 (323)
T cd05616         150 ENMWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-------------ELFQSIME  215 (323)
T ss_pred             ecCCCC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH-------------HHHHHHHh
Confidence            543222 1223457899999999999999999999999999999999999999532110             01111111


Q ss_pred             CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCH
Q 047276          339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSM  381 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  381 (453)
                      ..            ..++......+.+++.+|++.+|++|++.
T Consensus       216 ~~------------~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         216 HN------------VAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             CC------------CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence            11            11222344568899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-39  Score=310.03  Aligned_cols=246  Identities=22%  Similarity=0.282  Sum_probs=193.2

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCC----ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      .++||+|+||+||++.. .+++.||+|.+....    .....+.+|+.+++.++||||+++++++. .++..++||||++
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~   83 (285)
T cd05605           5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-TKDALCLVLTLMN   83 (285)
T ss_pred             EEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeec-CCCeEEEEEeccC
Confidence            47899999999999996 468899999986422    22345788999999999999999999876 4568899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|.+++....        ...+++..+..++.|++.||.|||+   .+++||||||+||++++++.++|+|||++...
T Consensus        84 ~~~L~~~~~~~~--------~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~  152 (285)
T cd05605          84 GGDLKFHIYNMG--------NPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEI  152 (285)
T ss_pred             CCcHHHHHHhcC--------cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceec
Confidence            999998885432        1238999999999999999999999   89999999999999999999999999999865


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      .....  .....|++.|+|||.+.+..++.++|||||||++|||++|+.||.......         ...........+.
T Consensus       153 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---------~~~~~~~~~~~~~  221 (285)
T cd05605         153 PEGET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---------KREEVERRVKEDQ  221 (285)
T ss_pred             CCCCc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---------HHHHHHHHhhhcc
Confidence            43221  233468999999999988889999999999999999999999996321100         0000111111100


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRP-----SMARVVE  386 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~~v~~  386 (453)
                                  ..++......+.+++..|++.||++||     ++.++++
T Consensus       222 ------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         222 ------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             ------------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence                        112233455688999999999999999     7777754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-38  Score=302.81  Aligned_cols=256  Identities=26%  Similarity=0.407  Sum_probs=193.6

Q ss_pred             cccCcCCceEEEEEEeCC-Cc--EEEEEEecCC--CccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          107 ALLGHGSSASVFKGILSD-GT--SVAVKRINGE--ENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~-g~--~vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.||+|+||.||+|...+ +.  .+++|.++..  ....+.+.+|+.++.++ +||||++++++|. ..+..+++|||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-~~~~~~lv~e~~~   79 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-HRGYLYLAIEYAP   79 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe-cCCCceEEEEeCC
Confidence            369999999999999753 43  4788888742  23345788999999999 7999999999986 4557899999999


Q ss_pred             CCChhhhhccCCCCCC------CCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeec
Q 047276          181 NGSLDHWIFPTSRRSE------GHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDF  254 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~Df  254 (453)
                      +|+|.+++........      .......+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+||
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~df  156 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADF  156 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCC
Confidence            9999999965432110      00122348999999999999999999998   89999999999999999999999999


Q ss_pred             cccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHH
Q 047276          255 GLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVN  333 (453)
Q Consensus       255 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  333 (453)
                      |++.......  .......+..|+|||++....++.++||||||+++|||++ |..||.....            .. ..
T Consensus       157 gl~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~------------~~-~~  221 (270)
T cd05047         157 GLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------------AE-LY  221 (270)
T ss_pred             CCccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH------------HH-HH
Confidence            9986322111  1111234567999999988889999999999999999997 9999853211            01 11


Q ss_pred             HhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          334 EKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       334 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      .....+..       +    ..+......+.+++.+|++.+|.+|||+.++++.|+.+.
T Consensus       222 ~~~~~~~~-------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         222 EKLPQGYR-------L----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             HHHhCCCC-------C----CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            11111100       0    011123345889999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1e-38  Score=300.78  Aligned_cols=246  Identities=26%  Similarity=0.399  Sum_probs=197.7

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.+.||+|+||.||++... +|+.|++|.+...   ......+.+|+.+++.++|||++++++++. .++..++|+||++
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~   82 (256)
T cd08529           4 ILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL-DKGKLNIVMEYAE   82 (256)
T ss_pred             EeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec-cCCEEEEEEEeCC
Confidence            4578999999999999964 6889999988642   334567889999999999999999999876 4568899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +++|.+++....        ...+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++...
T Consensus        83 ~~~L~~~l~~~~--------~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~  151 (256)
T cd08529          83 NGDLHKLLKMQR--------GRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL  151 (256)
T ss_pred             CCcHHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceec
Confidence            999999996532        2348999999999999999999998   89999999999999999999999999998866


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      ..... ......|++.|+|||+..+..++.++|+||||+++|||++|+.||......             ........+.
T Consensus       152 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------------~~~~~~~~~~  217 (256)
T cd08529         152 SDNTN-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG-------------ALILKIIRGV  217 (256)
T ss_pred             cCccc-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-------------HHHHHHHcCC
Confidence            54322 223456888999999999888999999999999999999999998532210             0111111111


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      .           ...+......+.+++.+|++.+|++||++.++++.
T Consensus       218 ~-----------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         218 F-----------PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             C-----------CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            1           01122344568999999999999999999998853

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.5e-39  Score=315.44  Aligned_cols=237  Identities=21%  Similarity=0.277  Sum_probs=186.5

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCC-ceeeEeeEEEecCCCeEEEEEe
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHV-NLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~-niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      +.+.||+|+||.||+|+.. +++.||+|++...    ....+.+..|..++..++|+ +|+++.+++. ..+..++||||
T Consensus         4 ~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-~~~~~~lv~E~   82 (324)
T cd05587           4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-TMDRLYFVMEY   82 (324)
T ss_pred             EEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE-cCCEEEEEEcC
Confidence            4578999999999999965 5789999998752    23345688899999999765 5777877765 56688999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +++|+|.+++...          ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++.
T Consensus        83 ~~~g~L~~~~~~~----------~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~  149 (324)
T cd05587          83 VNGGDLMYHIQQV----------GKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK  149 (324)
T ss_pred             CCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcce
Confidence            9999999998543          238899999999999999999999   899999999999999999999999999987


Q ss_pred             cccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      ...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......            . .......
T Consensus       150 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~------------~-~~~~i~~  215 (324)
T cd05587         150 ENIFGG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED------------E-LFQSIME  215 (324)
T ss_pred             ecCCCC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------------H-HHHHHHc
Confidence            532221 1234457899999999999988999999999999999999999999532110            0 1111111


Q ss_pred             CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCH
Q 047276          339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSM  381 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  381 (453)
                      ..            ..++......+.+++.+|++.+|++||+.
T Consensus       216 ~~------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         216 HN------------VSYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             CC------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            11            11122334568899999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=8.3e-39  Score=305.62  Aligned_cols=253  Identities=25%  Similarity=0.352  Sum_probs=194.7

Q ss_pred             hcccCcCCceEEEEEEeCC------CcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          106 QALLGHGSSASVFKGILSD------GTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~~------g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      .+.||+|+||.||+|.+.+      +..|++|.+....  .....|..|+.+++.++|+||+++++++. ..+..+++||
T Consensus        11 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~lv~e   89 (277)
T cd05036          11 LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSF-ERLPRFILLE   89 (277)
T ss_pred             eeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-cCCCcEEEEe
Confidence            4789999999999999753      5679999886432  23456899999999999999999999876 4557899999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCC---cEEEeec
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENY---RAVVSDF  254 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~---~~kl~Df  254 (453)
                      |+++++|.+++........   ....++|..+++++.||+.||+|||+   .+++|+||||+||+++.++   .+||+||
T Consensus        90 ~~~g~~L~~~i~~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~df  163 (277)
T cd05036          90 LMAGGDLKSFLRENRPRPE---RPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADF  163 (277)
T ss_pred             cCCCCCHHHHHHHhCCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEeccC
Confidence            9999999999965532111   12358999999999999999999999   8999999999999998764   6999999


Q ss_pred             cccccccCCCCc-eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHH
Q 047276          255 GLSKLMSRDQSR-CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIV  332 (453)
Q Consensus       255 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  332 (453)
                      |+++........ .......+..|+|||++.+..++.++|||||||++|||++ |..||......            . .
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~------------~-~  230 (277)
T cd05036         164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ------------E-V  230 (277)
T ss_pred             ccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------------H-H
Confidence            999876332211 1112233568999999998899999999999999999997 99998532110            0 1


Q ss_pred             HHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 047276          333 NEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE  389 (453)
Q Consensus       333 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~  389 (453)
                      ...+..+..           ...+...+..+.+++.+|++.+|++||++.+|++.|+
T Consensus       231 ~~~~~~~~~-----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         231 MEFVTGGGR-----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHHHHcCCc-----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            111111100           0112233456889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2e-38  Score=299.13  Aligned_cols=254  Identities=30%  Similarity=0.427  Sum_probs=201.3

Q ss_pred             cccCcCCceEEEEEEeCC----CcEEEEEEecCCCcc--HHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          107 ALLGHGSSASVFKGILSD----GTSVAVKRINGEENG--EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~----g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.||+|+||.||++....    +..|++|.+......  .+.+.+|+..+..++|+|++++++++. .+...++++||++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~~lv~e~~~   79 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCT-EEEPLYLVLEYME   79 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeec-CCCceEEEEEecc
Confidence            469999999999999753    788999999864433  578999999999999999999999987 4678899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +++|.+++....... .......+++..++.++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||.+...
T Consensus        80 ~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~  155 (262)
T cd00192          80 GGDLLDYLRKSRPVF-PSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDV  155 (262)
T ss_pred             CCcHHHHHhhccccc-cccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccc
Confidence            999999996542110 00012458999999999999999999999   89999999999999999999999999999876


Q ss_pred             cCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          261 SRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       261 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      ..... .......+++.|+|||.+....++.++||||||+++|||++ |..||.....             .........
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------------~~~~~~~~~  222 (262)
T cd00192         156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-------------EEVLEYLRK  222 (262)
T ss_pred             ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-------------HHHHHHHHc
Confidence            54321 22334567889999999988889999999999999999999 6989854311             111122221


Q ss_pred             CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 047276          339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE  389 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~  389 (453)
                      +..           ...+...+..+.+++.+|++.+|++|||+.++++.|+
T Consensus       223 ~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         223 GYR-----------LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             CCC-----------CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            110           1122233567999999999999999999999998874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.9e-39  Score=312.00  Aligned_cols=195  Identities=26%  Similarity=0.352  Sum_probs=163.0

Q ss_pred             HHhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          104 NFQALLGHGSSASVFKGILS-DGTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      .+.+.||+|+||+||+|... +++.||+|++....  .....+.+|+.+++.++||||+++++++. .....++||||++
T Consensus         8 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~   86 (303)
T cd07869           8 EKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIH-TKETLTLVFEYVH   86 (303)
T ss_pred             eEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEe-cCCeEEEEEECCC
Confidence            34578999999999999965 68899999987532  23346788999999999999999999876 5568899999995


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                       ++|.+++....         ..+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||++...
T Consensus        87 -~~l~~~~~~~~---------~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  153 (303)
T cd07869          87 -TDLCQYMDKHP---------GGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAK  153 (303)
T ss_pred             -cCHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceec
Confidence             68888875432         238888999999999999999999   89999999999999999999999999998754


Q ss_pred             cCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSL  313 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~  313 (453)
                      .... .......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus       154 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  206 (303)
T cd07869         154 SVPS-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG  206 (303)
T ss_pred             cCCC-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            3222 12234567899999998865 4578999999999999999999999964

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=6.5e-39  Score=309.58  Aligned_cols=264  Identities=23%  Similarity=0.379  Sum_probs=198.9

Q ss_pred             HHhcccCcCCceEEEEEEeCC-Cc--EEEEEEecCC--CccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEEEEE
Q 047276          104 NFQALLGHGSSASVFKGILSD-GT--SVAVKRINGE--ENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~~-g~--~vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      .+.+.||+|+||.||+|...+ +.  .+++|.++..  ....+.|.+|+.++.++ +||||+++++++. ..+..++++|
T Consensus         5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-~~~~~~lv~e   83 (297)
T cd05089           5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACE-NRGYLYIAIE   83 (297)
T ss_pred             eeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc-cCCcceEEEE
Confidence            346789999999999998753 33  4788888742  23345789999999999 7999999999876 4557899999


Q ss_pred             ecCCCChhhhhccCCCCCC------CCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEE
Q 047276          178 FIQNGSLDHWIFPTSRRSE------GHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVV  251 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl  251 (453)
                      |+++|+|.+++........      .......+++..++.++.|++.||+|||+   .+++||||||+|||+++++.+||
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl  160 (297)
T cd05089          84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKI  160 (297)
T ss_pred             ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeEEE
Confidence            9999999999965432110      01122358999999999999999999998   89999999999999999999999


Q ss_pred             eeccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhH
Q 047276          252 SDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPK  330 (453)
Q Consensus       252 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  330 (453)
                      +|||++.......  .......+..|+|||++....++.++|||||||++|||++ |..||......            .
T Consensus       161 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~------------~  226 (297)
T cd05089         161 ADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA------------E  226 (297)
T ss_pred             CCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------------H
Confidence            9999986432111  1111223557999999988889999999999999999997 99998532110            0


Q ss_pred             HHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccCCCCC
Q 047276          331 IVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVDDP  397 (453)
Q Consensus       331 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~~~~~  397 (453)
                       .......+..     .      ..+......+.+++.+|++.+|.+||+++++++.|+.......+
T Consensus       227 -~~~~~~~~~~-----~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~  281 (297)
T cd05089         227 -LYEKLPQGYR-----M------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA  281 (297)
T ss_pred             -HHHHHhcCCC-----C------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence             1111111100     0      01122345688999999999999999999999999887655444

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.2e-39  Score=321.03  Aligned_cols=248  Identities=21%  Similarity=0.244  Sum_probs=189.8

Q ss_pred             HHhcccCcCCceEEEEEEeC-CCcEEEEEEecC----CCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEe
Q 047276          104 NFQALLGHGSSASVFKGILS-DGTSVAVKRING----EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      .+.+.||+|+||.||++... +++.+|+|.+..    .......+.+|+.+++.++||||+++++++. .++..++||||
T Consensus        46 ~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~-~~~~~~lv~Ey  124 (370)
T cd05621          46 DVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ-DDKYLYMVMEY  124 (370)
T ss_pred             eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE-cCCEEEEEEcC
Confidence            34578999999999999965 578999999864    2223456889999999999999999999876 56688999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +++|+|.+++...           .+++.....++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||++.
T Consensus       125 ~~gg~L~~~l~~~-----------~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~  190 (370)
T cd05621         125 MPGGDLVNLMSNY-----------DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCM  190 (370)
T ss_pred             CCCCcHHHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccce
Confidence            9999999998422           27888899999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCceeeeccCCccccchhhhhcC----CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHH
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWILEQ----GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNE  334 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  334 (453)
                      ..............||+.|+|||.+...    .++.++|||||||++|||++|+.||.....            ......
T Consensus       191 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------------~~~~~~  258 (370)
T cd05621         191 KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------------VGTYSK  258 (370)
T ss_pred             ecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------------HHHHHH
Confidence            7643332223456799999999998753    378999999999999999999999953211            000111


Q ss_pred             hhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 047276          335 KMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARL--RPSMARVVEM  387 (453)
Q Consensus       335 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPs~~~v~~~  387 (453)
                      .......     ..+.    ........+.+++..|++.++.+  ||++.++++.
T Consensus       259 i~~~~~~-----~~~p----~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         259 IMDHKNS-----LNFP----EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             HHhCCcc-----cCCC----CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            1111000     0011    11123445778888888755543  8899998865

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=9.8e-39  Score=306.78  Aligned_cols=258  Identities=26%  Similarity=0.421  Sum_probs=198.0

Q ss_pred             HhcccCcCCceEEEEEEeC------CCcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEE
Q 047276          105 FQALLGHGSSASVFKGILS------DGTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVY  176 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~------~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~  176 (453)
                      +.+.||+|+||.||++...      ++..||+|.+....  ....+|.+|+.++++++|||+++++++|. .+...++++
T Consensus         9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~-~~~~~~lv~   87 (288)
T cd05050           9 YVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCA-VGKPMCLLF   87 (288)
T ss_pred             ecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEc-CCCccEEEE
Confidence            3578999999999999853      46789999987532  23467999999999999999999999876 556789999


Q ss_pred             EecCCCChhhhhccCCCCCCC------------CCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEEC
Q 047276          177 EFIQNGSLDHWIFPTSRRSEG------------HYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD  244 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~------------~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~  244 (453)
                      ||+++|+|.+++.........            ......+++..++.++.|++.||+|||+   .+++||||||+||+++
T Consensus        88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~nil~~  164 (288)
T cd05050          88 EYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVG  164 (288)
T ss_pred             ecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhheEec
Confidence            999999999999644321110            0112348899999999999999999998   8999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCc
Q 047276          245 ENYRAVVSDFGLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSK  322 (453)
Q Consensus       245 ~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~  322 (453)
                      +++.++|+|||++........ ........+..|+|||.+.+..++.++|||||||++|||++ |..||.....      
T Consensus       165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~------  238 (288)
T cd05050         165 ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH------  238 (288)
T ss_pred             CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH------
Confidence            999999999999876533221 11122334668999999988899999999999999999998 8888742211      


Q ss_pred             ccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 047276          323 NKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEG  390 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~  390 (453)
                            .. .......+...           ..+......+.+++.+|++.+|++|||+.|+++.|++
T Consensus       239 ------~~-~~~~~~~~~~~-----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         239 ------EE-VIYYVRDGNVL-----------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ------HH-HHHHHhcCCCC-----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                  01 11122222211           0122334568999999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=9.2e-39  Score=308.33  Aligned_cols=267  Identities=20%  Similarity=0.318  Sum_probs=197.5

Q ss_pred             HHHhcccCcCCceEEEEEEeC-----------------CCcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEee
Q 047276          103 DNFQALLGHGSSASVFKGILS-----------------DGTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLG  163 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~-----------------~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g  163 (453)
                      +.+.+.||+|+||.||++...                 ++..+|+|.+....  .....|.+|+.+++.++|+||+++++
T Consensus         7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~   86 (296)
T cd05095           7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLA   86 (296)
T ss_pred             ceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            345678999999999998532                 23468999987532  23467999999999999999999999


Q ss_pred             EEEecCCCeEEEEEecCCCChhhhhccCCCCCCC-CCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEE
Q 047276          164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEG-HYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENIL  242 (453)
Q Consensus       164 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiL  242 (453)
                      ++. .++..+++|||+++|+|.+++......... ......+++...++++.|++.||+|||+   .+++|+||||+|||
T Consensus        87 ~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Nil  162 (296)
T cd05095          87 VCI-TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCL  162 (296)
T ss_pred             EEe-cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheEE
Confidence            986 556789999999999999999754322111 1123458899999999999999999999   89999999999999


Q ss_pred             ECCCCcEEEeeccccccccCCCCc-eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc--CCCCCcccccCCC
Q 047276          243 LDENYRAVVSDFGLSKLMSRDQSR-CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG--GRRNVSLIEHGND  319 (453)
Q Consensus       243 l~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt--G~~p~~~~~~~~~  319 (453)
                      +++++.++|+|||+++.+...... ......+++.|++||....+.++.++|||||||++|||++  |..||....... 
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~-  241 (296)
T cd05095         163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ-  241 (296)
T ss_pred             EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH-
Confidence            999999999999999865433221 1222344678999999888889999999999999999998  667774321110 


Q ss_pred             CCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 047276          320 KSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEG  390 (453)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~  390 (453)
                           .   .....+..........    +    ..+..+...+.+++.+||+.+|++||++.+|.+.|++
T Consensus       242 -----~---~~~~~~~~~~~~~~~~----~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         242 -----V---IENTGEFFRDQGRQVY----L----PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             -----H---HHHHHHHHhhcccccc----C----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                 0   0000111110000000    0    0111233568899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=6.6e-39  Score=310.40  Aligned_cols=243  Identities=21%  Similarity=0.281  Sum_probs=190.4

Q ss_pred             cccCcCCceEEEEEEe-CCCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          107 ALLGHGSSASVFKGIL-SDGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      ..||+|+||.||.++- .+|..+|+|+++++    ....+..+.|-.+|....+|+||+|+-.| .+...+||||||++|
T Consensus       147 k~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-QD~~~LYLiMEylPG  225 (550)
T KOG0605|consen  147 KVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-QDKEYLYLIMEYLPG  225 (550)
T ss_pred             eeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-cCCCeeEEEEEecCC
Confidence            6899999999999995 56999999999874    33456688899999999999999999665 467799999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      |++..+|...          +.|++.....++.+++.|++-||+   .|+|||||||+|+|||..|++||+||||+.-+.
T Consensus       226 GD~mTLL~~~----------~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  226 GDMMTLLMRK----------DTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             ccHHHHHHhc----------CcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhh
Confidence            9999999643          459999999999999999999999   899999999999999999999999999985321


Q ss_pred             C----------------------CCCc-----e-------------------eeeccCCccccchhhhhcCCCCccccch
Q 047276          262 R----------------------DQSR-----C-------------------ITTIRGTRGYLAPEWILEQGVSEKCDIY  295 (453)
Q Consensus       262 ~----------------------~~~~-----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~sDV~  295 (453)
                      .                      ....     .                   ....+|||.|||||++.+..|+..+|.|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            1                      0000     0                   1124699999999999999999999999


Q ss_pred             hHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCC
Q 047276          296 SYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERA  375 (453)
Q Consensus       296 S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p  375 (453)
                      |+|||+||||.|-+||....+.     ..|..+..|-.              .|.  .+.......+..+++.+|+. ||
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~-----~T~rkI~nwr~--------------~l~--fP~~~~~s~eA~DLI~rll~-d~  430 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQ-----ETYRKIVNWRE--------------TLK--FPEEVDLSDEAKDLITRLLC-DP  430 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhh--------------hcc--CCCcCcccHHHHHHHHHHhc-CH
Confidence            9999999999999999743322     11211111110              111  01112233668899999999 99


Q ss_pred             CCCCC---HHHHH
Q 047276          376 RLRPS---MARVV  385 (453)
Q Consensus       376 ~~RPs---~~~v~  385 (453)
                      ++|--   ..||-
T Consensus       431 ~~RLG~~G~~EIK  443 (550)
T KOG0605|consen  431 ENRLGSKGAEEIK  443 (550)
T ss_pred             HHhcCcccHHHHh
Confidence            99976   44443

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=9.3e-39  Score=303.77  Aligned_cols=252  Identities=26%  Similarity=0.417  Sum_probs=196.2

Q ss_pred             HHHhcccCcCCceEEEEEEeCC-C---cEEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEE
Q 047276          103 DNFQALLGHGSSASVFKGILSD-G---TSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVY  176 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~~-g---~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~  176 (453)
                      +.+.+.||+|+||.||+|.... +   ..||||.+...  .....+|..|+.+++.++|||++++++++. .+...++|+
T Consensus         6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-~~~~~~lv~   84 (269)
T cd05065           6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-KSRPVMIIT   84 (269)
T ss_pred             eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEEC-CCCceEEEE
Confidence            4567899999999999999642 3   36999998753  233467999999999999999999999875 566889999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||+++|+|.+++....         +.+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+
T Consensus        85 e~~~~~~L~~~l~~~~---------~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~  152 (269)
T cd05065          85 EFMENGALDSFLRQND---------GQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGL  152 (269)
T ss_pred             ecCCCCcHHHHHhhCC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCcc
Confidence            9999999999985432         238999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCce--eeec--cCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHH
Q 047276          257 SKLMSRDQSRC--ITTI--RGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKI  331 (453)
Q Consensus       257 a~~~~~~~~~~--~~~~--~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  331 (453)
                      +..........  ....  ..+..|+|||++....++.++||||||+++||+++ |..||......             .
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-------------~  219 (269)
T cd05065         153 SRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-------------D  219 (269)
T ss_pred             ccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-------------H
Confidence            87654322111  1111  12457999999998899999999999999999886 99998432110             0


Q ss_pred             HHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 047276          332 VNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR  391 (453)
Q Consensus       332 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~  391 (453)
                      ........       ..+    ..+.+.+..+.+++..|++.+|.+||++.+|+..|++.
T Consensus       220 ~~~~i~~~-------~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         220 VINAIEQD-------YRL----PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             HHHHHHcC-------CcC----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            11111111       011    11223345688999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.3e-38  Score=302.51  Aligned_cols=252  Identities=26%  Similarity=0.412  Sum_probs=196.9

Q ss_pred             HHHhcccCcCCceEEEEEEeC-C---CcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEE
Q 047276          103 DNFQALLGHGSSASVFKGILS-D---GTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVY  176 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~-~---g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~  176 (453)
                      +.+.+.||+|+||.||+|... +   +..+|+|.++...  ...+.|..|+.++.+++||||+++++++. .++..++||
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~   84 (267)
T cd05066           6 IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-KSKPVMIVT   84 (267)
T ss_pred             eEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-cCCccEEEE
Confidence            345689999999999999853 2   3479999887532  23457899999999999999999999976 566889999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||+++++|.+++....         ..+++...+.++.|++.||+|||+   .+++||||||+|||++.++.++|+|||+
T Consensus        85 e~~~~~~L~~~~~~~~---------~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~  152 (267)
T cd05066          85 EYMENGSLDAFLRKHD---------GQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGL  152 (267)
T ss_pred             EcCCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCc
Confidence            9999999999995432         248999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCceee--eccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHH
Q 047276          257 SKLMSRDQSRCIT--TIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVN  333 (453)
Q Consensus       257 a~~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  333 (453)
                      +............  ...++..|++||++.+..++.++||||||+++||+++ |..||......            . ..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~------------~-~~  219 (267)
T cd05066         153 SRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ------------D-VI  219 (267)
T ss_pred             ccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH------------H-HH
Confidence            9876543322111  1223568999999998889999999999999999886 99998532110            0 11


Q ss_pred             HhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 047276          334 EKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR  391 (453)
Q Consensus       334 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~  391 (453)
                      ....++.       +..    .+...+..+.+++.+|++.+|++||+|.++++.|+..
T Consensus       220 ~~~~~~~-------~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         220 KAIEEGY-------RLP----APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             HHHhCCC-------cCC----CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            1111110       000    1112345688999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.3e-38  Score=308.44  Aligned_cols=266  Identities=22%  Similarity=0.366  Sum_probs=202.7

Q ss_pred             HHHHHhcccCcCCceEEEEEEeC--------CCcEEEEEEecCC--CccHHHHHHHHHHHHhc-CCCceeeEeeEEEecC
Q 047276          101 ATDNFQALLGHGSSASVFKGILS--------DGTSVAVKRINGE--ENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPG  169 (453)
Q Consensus       101 ~~~~~~~~lG~G~fG~Vy~~~~~--------~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~  169 (453)
                      ..+.+.+.||+|+||.||+++..        ++..||+|.+...  ......+.+|+.++..+ +||||+++++++. ..
T Consensus        15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~-~~   93 (304)
T cd05101          15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT-QD   93 (304)
T ss_pred             HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe-cC
Confidence            33445689999999999999741        2457999988753  23346788999999999 8999999999876 55


Q ss_pred             CCeEEEEEecCCCChhhhhccCCCCCCC------CCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEE
Q 047276          170 GPRYLVYEFIQNGSLDHWIFPTSRRSEG------HYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILL  243 (453)
Q Consensus       170 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl  243 (453)
                      ...+++|||+++|+|.+++.........      ......+++..+..++.|++.||+|||+   .+++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEE
Confidence            6889999999999999999764321100      1123458999999999999999999999   899999999999999


Q ss_pred             CCCCcEEEeeccccccccCCCCc-eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCC
Q 047276          244 DENYRAVVSDFGLSKLMSRDQSR-CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKS  321 (453)
Q Consensus       244 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~  321 (453)
                      ++++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||....      
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------  244 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------  244 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC------
Confidence            99999999999999876433221 1223345678999999988889999999999999999998 777774211      


Q ss_pred             cccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccCC
Q 047276          322 KNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAV  394 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~~  394 (453)
                             .....+....+...           ..+......+.+++.+||+.+|++||++.++++.|+++...
T Consensus       245 -------~~~~~~~~~~~~~~-----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         245 -------VEELFKLLKEGHRM-----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             -------HHHHHHHHHcCCcC-----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence                   00111122211110           01123345688999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=9.4e-39  Score=303.92  Aligned_cols=252  Identities=20%  Similarity=0.343  Sum_probs=197.9

Q ss_pred             HHHhcccCcCCceEEEEEEeCC----CcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEE
Q 047276          103 DNFQALLGHGSSASVFKGILSD----GTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVY  176 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~~----g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~  176 (453)
                      ..+.++||+|+||.||+|...+    ...|+||......  ...+.+.+|+.++++++|||+++++++|.  ....++||
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~lv~   85 (270)
T cd05056           8 ITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT--ENPVWIVM   85 (270)
T ss_pred             ceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEc--CCCcEEEE
Confidence            4456899999999999998643    2468999886533  33457999999999999999999999875  34678999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||+++|+|.+++....         ..+++..++.++.+++.||+|||+   .+++|+||||+||+++.++.+||+|||+
T Consensus        86 e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~  153 (270)
T cd05056          86 ELAPLGELRSYLQVNK---------YSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGL  153 (270)
T ss_pred             EcCCCCcHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCce
Confidence            9999999999995432         238999999999999999999998   8999999999999999999999999999


Q ss_pred             cccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHh
Q 047276          257 SKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEK  335 (453)
Q Consensus       257 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  335 (453)
                      ++..............++..|+|||.+....++.++||||||+++||+++ |..||......            ... ..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------------~~~-~~  220 (270)
T cd05056         154 SRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN------------DVI-GR  220 (270)
T ss_pred             eeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH------------HHH-HH
Confidence            98765443222223334568999999988889999999999999999986 99998532211            001 11


Q ss_pred             hhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          336 MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       336 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      ...+.       .+    ..+...+..+.+++.+|+..+|.+|||+.+++..|++..
T Consensus       221 ~~~~~-------~~----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~  266 (270)
T cd05056         221 IENGE-------RL----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL  266 (270)
T ss_pred             HHcCC-------cC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            11111       00    112233456899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.3e-38  Score=302.27  Aligned_cols=251  Identities=23%  Similarity=0.328  Sum_probs=194.3

Q ss_pred             HHHhcccCcCCceEEEEEEe-CCCcEEEEEEecCCC-ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          103 DNFQALLGHGSSASVFKGIL-SDGTSVAVKRINGEE-NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.+.+.||+|+||.||+|+. .+++.||+|++.... .....+.+|+.++.+++|||++++++++. .++..++|+||++
T Consensus        11 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~-~~~~~~iv~e~~~   89 (267)
T cd06646          11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL-SREKLWICMEYCG   89 (267)
T ss_pred             cchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEE-eCCEEEEEEeCCC
Confidence            34568899999999999995 568899999987532 34456889999999999999999999986 4567899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +++|.+++...          ..+++..+..++.|++.||.|||+   .+++||||+|+||++++++.+||+|||++...
T Consensus        90 ~~~L~~~~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~  156 (267)
T cd06646          90 GGSLQDIYHVT----------GPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKI  156 (267)
T ss_pred             CCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceee
Confidence            99999998532          238899999999999999999999   89999999999999999999999999999866


Q ss_pred             cCCCCceeeeccCCccccchhhhh---cCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhh
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWIL---EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMK  337 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (453)
                      ..... ......+++.|+|||.+.   ...++.++|||||||++|||++|+.||....+.....             .+.
T Consensus       157 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-------------~~~  222 (267)
T cd06646         157 TATIA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-------------LMS  222 (267)
T ss_pred             ccccc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-------------eee
Confidence            43221 123356888999999874   3457889999999999999999999985322111000             000


Q ss_pred             cCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 047276          338 EGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEML  388 (453)
Q Consensus       338 ~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L  388 (453)
                      ...   ...+.+..    .......+.+++.+||+.+|++||+++++++.|
T Consensus       223 ~~~---~~~~~~~~----~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         223 KSN---FQPPKLKD----KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             cCC---CCCCCCcc----ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            000   00011110    112345688999999999999999999998654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.4e-38  Score=310.84  Aligned_cols=272  Identities=23%  Similarity=0.366  Sum_probs=205.5

Q ss_pred             HHHHHHHHHHhcccCcCCceEEEEEEeC--------CCcEEEEEEecCCC--ccHHHHHHHHHHHHhc-CCCceeeEeeE
Q 047276           96 KELEEATDNFQALLGHGSSASVFKGILS--------DGTSVAVKRINGEE--NGEKEFRSEVAAIASA-QHVNLVRLLGY  164 (453)
Q Consensus        96 ~el~~~~~~~~~~lG~G~fG~Vy~~~~~--------~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~  164 (453)
                      +++....+.+.+.||+|+||.||++...        .+..||+|.++...  ...+++.+|+.++.++ +||||++++++
T Consensus         7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (334)
T cd05100           7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA   86 (334)
T ss_pred             cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence            3455556677889999999999999742        12368999887532  2346789999999999 79999999999


Q ss_pred             EEecCCCeEEEEEecCCCChhhhhccCCCCC------CCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCC
Q 047276          165 CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRS------EGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKP  238 (453)
Q Consensus       165 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~  238 (453)
                      |. .++..++++||+++|+|.+++.......      ........++|..++.++.|++.||+|||+   .+++||||||
T Consensus        87 ~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp  162 (334)
T cd05100          87 CT-QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAA  162 (334)
T ss_pred             Ec-cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeecccccc
Confidence            86 4567899999999999999996543110      001133458999999999999999999999   8999999999


Q ss_pred             CcEEECCCCcEEEeeccccccccCCCCc-eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCccccc
Q 047276          239 ENILLDENYRAVVSDFGLSKLMSRDQSR-CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEH  316 (453)
Q Consensus       239 ~NiLl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~  316 (453)
                      +|||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  242 (334)
T cd05100         163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  242 (334)
T ss_pred             ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence            9999999999999999999865432211 1122334568999999998889999999999999999998 8888742210


Q ss_pred             CCCCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccCCC
Q 047276          317 GNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVD  395 (453)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~~~  395 (453)
                                  .. ....+..+...           ..+......+.+++.+|++.+|++||++.++++.|+......
T Consensus       243 ------------~~-~~~~~~~~~~~-----------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         243 ------------EE-LFKLLKEGHRM-----------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             ------------HH-HHHHHHcCCCC-----------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence                        01 11111111110           111233446889999999999999999999999999876443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.7e-38  Score=301.99  Aligned_cols=254  Identities=22%  Similarity=0.343  Sum_probs=187.3

Q ss_pred             cccCcCCceEEEEEEeCC---CcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          107 ALLGHGSSASVFKGILSD---GTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~---g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      +.||+|+||.||+|...+   ...+++|.+....  .....|.+|+.+++.++|+||++++|+|. .....++||||+++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~-~~~~~~lv~e~~~~   79 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI-ESIPYLLVLEFCPL   79 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCceEEEEEeCCC
Confidence            369999999999998543   3468888776432  23456889999999999999999999886 55688999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      |+|.+++......     .....++.....++.|++.||+|||+   .+++||||||+|||+++++.+||+|||++....
T Consensus        80 g~L~~~l~~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  151 (269)
T cd05042          80 GDLKNYLRSNRGM-----VAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQY  151 (269)
T ss_pred             CcHHHHHHhcccc-----ccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccc
Confidence            9999999654321     11235788889999999999999999   899999999999999999999999999987543


Q ss_pred             CCCC-ceeeeccCCccccchhhhhc-------CCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHH
Q 047276          262 RDQS-RCITTIRGTRGYLAPEWILE-------QGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIV  332 (453)
Q Consensus       262 ~~~~-~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  332 (453)
                      .... .......+++.|+|||++..       ..++.++||||||+++|||++ |..||....+.            ...
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------------~~~  219 (269)
T cd05042         152 PEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE------------QVL  219 (269)
T ss_pred             cchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH------------HHH
Confidence            3221 11122345678999998753       356789999999999999999 77787532110            001


Q ss_pred             HHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 047276          333 NEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE  389 (453)
Q Consensus       333 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~  389 (453)
                      ......+ .....++.      .+......+.+++..|+ .+|++||++++|++.|.
T Consensus       220 ~~~~~~~-~~~~~~~~------~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         220 KQVVREQ-DIKLPKPQ------LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             HHHhhcc-CccCCCCc------ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            1111111 11111111      12233455677888888 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.2e-38  Score=300.76  Aligned_cols=247  Identities=27%  Similarity=0.409  Sum_probs=195.7

Q ss_pred             cccCcCCceEEEEEEeCC--C--cEEEEEEecCCCc--cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          107 ALLGHGSSASVFKGILSD--G--TSVAVKRINGEEN--GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~--g--~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      ++||+|++|.||+|.+.+  +  ..||+|.+.....  ..+.|.+|+.++++++||||+++++++..  ...++++||++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~   78 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT--HPLMMVTELAP   78 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC--CeEEEEEEecC
Confidence            468999999999999643  3  3699999976433  45679999999999999999999999864  68899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|.+++.....        ..++|...+.++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||++...
T Consensus        79 ~~~L~~~l~~~~~--------~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~  147 (257)
T cd05040          79 LGSLLDRLRKDAL--------GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRAL  147 (257)
T ss_pred             CCcHHHHHHhccc--------ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccc
Confidence            9999999865421        248999999999999999999999   89999999999999999999999999999876


Q ss_pred             cCCCC--ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhh
Q 047276          261 SRDQS--RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMK  337 (453)
Q Consensus       261 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (453)
                      .....  .......++..|+|||++....++.++||||||+++|||++ |+.||......            ........
T Consensus       148 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------------~~~~~~~~  215 (257)
T cd05040         148 PQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS------------QILKKIDK  215 (257)
T ss_pred             cccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH------------HHHHHHHh
Confidence            54221  11223456789999999998889999999999999999998 99998422110            00111111


Q ss_pred             cCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 047276          338 EGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE  389 (453)
Q Consensus       338 ~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~  389 (453)
                      .+.       .+    ..+...+..+.+++.+|++.+|++||++.++++.|.
T Consensus       216 ~~~-------~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         216 EGE-------RL----ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             cCC-------cC----CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            110       01    111233456889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.7e-38  Score=308.07  Aligned_cols=269  Identities=23%  Similarity=0.352  Sum_probs=203.0

Q ss_pred             HHHHHHHHHhcccCcCCceEEEEEEeC--------CCcEEEEEEecCCC--ccHHHHHHHHHHHHhc-CCCceeeEeeEE
Q 047276           97 ELEEATDNFQALLGHGSSASVFKGILS--------DGTSVAVKRINGEE--NGEKEFRSEVAAIASA-QHVNLVRLLGYC  165 (453)
Q Consensus        97 el~~~~~~~~~~lG~G~fG~Vy~~~~~--------~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~  165 (453)
                      ++....+.+.+.||+|+||.||++...        ++..+|+|.++...  ....++..|+.++..+ +|+||++++++|
T Consensus        14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (307)
T cd05098          14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC   93 (307)
T ss_pred             eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            333444556789999999999999742        23569999987532  2345688899999999 799999999998


Q ss_pred             EecCCCeEEEEEecCCCChhhhhccCCCCCC------CCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCC
Q 047276          166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSE------GHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPE  239 (453)
Q Consensus       166 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~  239 (453)
                      . .++..++|+||+++|+|.+++........      .......++|..+++++.|++.||+|||+   .+++||||||+
T Consensus        94 ~-~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~  169 (307)
T cd05098          94 T-QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAAR  169 (307)
T ss_pred             e-cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHH
Confidence            6 55688999999999999999975432110      01122358999999999999999999998   89999999999


Q ss_pred             cEEECCCCcEEEeeccccccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccC
Q 047276          240 NILLDENYRAVVSDFGLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHG  317 (453)
Q Consensus       240 NiLl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~  317 (453)
                      ||+++.++.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||....  
T Consensus       170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~--  247 (307)
T cd05098         170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--  247 (307)
T ss_pred             heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC--
Confidence            99999999999999999876543221 11122234568999999988889999999999999999998 888874211  


Q ss_pred             CCCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          318 NDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                                 ..........+..           ...+......+.+++.+|++.+|++||++.+|++.|+.+..
T Consensus       248 -----------~~~~~~~~~~~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         248 -----------VEELFKLLKEGHR-----------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             -----------HHHHHHHHHcCCC-----------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence                       0011111111111           01122334568899999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.4e-38  Score=298.23  Aligned_cols=247  Identities=27%  Similarity=0.366  Sum_probs=198.0

Q ss_pred             HHHhcccCcCCceEEEEEEeCC-CcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          103 DNFQALLGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      +.+.+.||+|+||.||+|...+ ++.+++|.+..... .+++.+|++++++++|+|++++++++. .+...++++||+++
T Consensus         5 y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~-~~~~~~l~~e~~~~   82 (256)
T cd06612           5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYF-KNTDLWIVMEYCGA   82 (256)
T ss_pred             chhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeee-cCCcEEEEEecCCC
Confidence            3456789999999999999764 78999999876433 678999999999999999999999887 45688999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      ++|.+++....         ..+++.....++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||++....
T Consensus        83 ~~L~~~l~~~~---------~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~  150 (256)
T cd06612          83 GSVSDIMKITN---------KTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLT  150 (256)
T ss_pred             CcHHHHHHhCc---------cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcc
Confidence            99999985432         348999999999999999999998   899999999999999999999999999998765


Q ss_pred             CCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcc
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKL  341 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (453)
                      .... ......++..|+|||++.+..++.++||||||+++|||++|+.||........             .......  
T Consensus       151 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~-------------~~~~~~~--  214 (256)
T cd06612         151 DTMA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA-------------IFMIPNK--  214 (256)
T ss_pred             cCcc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh-------------hhhhccC--
Confidence            4321 22334578899999999888899999999999999999999999853221110             0000000  


Q ss_pred             cccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          342 MEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       342 ~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                         ..+.    ...+......+.+++.+|++.+|++|||+.+|++
T Consensus       215 ---~~~~----~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         215 ---PPPT----LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             ---CCCC----CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence               0001    1122234456899999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.4e-38  Score=298.77  Aligned_cols=238  Identities=24%  Similarity=0.393  Sum_probs=188.0

Q ss_pred             cccCcCCceEEEEEEeCCCc-----------EEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEE
Q 047276          107 ALLGHGSSASVFKGILSDGT-----------SVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLV  175 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~g~-----------~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv  175 (453)
                      +.||+|+||.||+|...+..           .+++|.+.........|.+|+.+++.++|||+++++|+|..  ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR--DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec--CCcEEE
Confidence            46999999999999975432           57888876544446789999999999999999999999875  567999


Q ss_pred             EEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCC-------c
Q 047276          176 YEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENY-------R  248 (453)
Q Consensus       176 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~-------~  248 (453)
                      +||+++|+|.+++.....         .+++..++.++.|++.||+|||+   .+++||||||+||+++.++       .
T Consensus        79 ~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~  146 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN---------NVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPF  146 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCcee
Confidence            999999999999964321         38999999999999999999998   8999999999999999888       8


Q ss_pred             EEEeeccccccccCCCCceeeeccCCccccchhhhhcC--CCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccc
Q 047276          249 AVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQ--GVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKW  325 (453)
Q Consensus       249 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~  325 (453)
                      +||+|||++.....     .....++..|+|||++...  .++.++||||||+++|||++ |..|+.......       
T Consensus       147 ~kl~Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~-------  214 (259)
T cd05037         147 IKLSDPGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE-------  214 (259)
T ss_pred             EEeCCCCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh-------
Confidence            99999999886543     1223466789999998876  78999999999999999999 566664321100       


Q ss_pred             cchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 047276          326 QYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE  389 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~  389 (453)
                            ....+....       .+      +......+.+++.+|++.+|.+||++.+|++.|+
T Consensus       215 ------~~~~~~~~~-------~~------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         215 ------KERFYQDQH-------RL------PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             ------HHHHHhcCC-------CC------CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                  000111000       00      0011156889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=8.9e-39  Score=318.54  Aligned_cols=265  Identities=23%  Similarity=0.267  Sum_probs=192.2

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEecC----CCeEEEEE
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG----GPRYLVYE  177 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~~lv~e  177 (453)
                      .+.||+|+||.||++.. .+|+.||+|++...   ....+.+.+|+.+++.++|+||+++++++....    ...++|+|
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e   84 (372)
T cd07853           5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTE   84 (372)
T ss_pred             cceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEee
Confidence            47899999999999995 47899999998642   223457889999999999999999999876433    26799999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |+. ++|.+++...          ..+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++
T Consensus        85 ~~~-~~l~~~~~~~----------~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a  150 (372)
T cd07853          85 LMQ-SDLHKIIVSP----------QPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLA  150 (372)
T ss_pred             ccc-cCHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccce
Confidence            996 5888887432          238999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCceeeeccCCccccchhhhhcC-CCCccccchhHHHHHHHHHcCCCCCcccccCCCC----------Cccccc
Q 047276          258 KLMSRDQSRCITTIRGTRGYLAPEWILEQ-GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDK----------SKNKWQ  326 (453)
Q Consensus       258 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~----------~~~~~~  326 (453)
                      +..............+++.|+|||.+.+. .++.++|||||||++|||++|+.||.........          ....+.
T Consensus       151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~  230 (372)
T cd07853         151 RVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMR  230 (372)
T ss_pred             eecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            86644333333445678899999998764 5789999999999999999999999643211000          000000


Q ss_pred             chhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          327 YFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      .........+......   .+...............+.+++.+|++.||++|||+.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         231 SACEGARAHILRGPHK---PPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HhhHHHHHHHHhCCCC---CCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            0000000000000000   000000001112234568899999999999999999999853

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1e-38  Score=309.03  Aligned_cols=254  Identities=24%  Similarity=0.379  Sum_probs=197.6

Q ss_pred             HHHhcccCcCCceEEEEEEeC------CCcEEEEEEecCCC--ccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeE
Q 047276          103 DNFQALLGHGSSASVFKGILS------DGTSVAVKRINGEE--NGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRY  173 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~------~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~  173 (453)
                      ..+.+.||+|+||.||++...      ++..||+|+++...  ...+.+.+|+.+++++ +||||++++++|. ..+..+
T Consensus        37 ~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-~~~~~~  115 (302)
T cd05055          37 LSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT-IGGPIL  115 (302)
T ss_pred             eEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe-cCCceE
Confidence            334689999999999999741      34579999987532  2235689999999999 7999999999886 556889


Q ss_pred             EEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEee
Q 047276          174 LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSD  253 (453)
Q Consensus       174 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~D  253 (453)
                      +++||+++|+|.+++....        ...+++.+...++.|++.||+|||+   .+++|+||||+|||+++++.+||+|
T Consensus       116 lv~e~~~~~~L~~~i~~~~--------~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~d  184 (302)
T cd05055         116 VITEYCCYGDLLNFLRRKR--------ESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICD  184 (302)
T ss_pred             EEEEcCCCCcHHHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECC
Confidence            9999999999999985432        1238999999999999999999999   8999999999999999999999999


Q ss_pred             ccccccccCCCCc-eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHH
Q 047276          254 FGLSKLMSRDQSR-CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKI  331 (453)
Q Consensus       254 fGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  331 (453)
                      ||+++........ ......++..|+|||.+....++.++|||||||++|||++ |..||......            ..
T Consensus       185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~------------~~  252 (302)
T cd05055         185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD------------SK  252 (302)
T ss_pred             CcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch------------HH
Confidence            9999866443221 1222345778999999998889999999999999999998 99998532110            00


Q ss_pred             HHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 047276          332 VNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR  391 (453)
Q Consensus       332 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~  391 (453)
                      .......+...           ..+......+.+++.+|++.+|++||++.++++.|++.
T Consensus       253 ~~~~~~~~~~~-----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         253 FYKLIKEGYRM-----------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             HHHHHHcCCcC-----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            11111111100           01112234689999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.4e-38  Score=304.48  Aligned_cols=257  Identities=23%  Similarity=0.389  Sum_probs=196.8

Q ss_pred             HhcccCcCCceEEEEEEeC------CCcEEEEEEecCC-CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          105 FQALLGHGSSASVFKGILS------DGTSVAVKRINGE-ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      +.++||+|+||.||++...      ++..+++|.+... ......|.+|+++++.++|+||+++++++. .++..++++|
T Consensus         9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e   87 (280)
T cd05092           9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCT-EGRPLLMVFE   87 (280)
T ss_pred             eccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEe-cCCceEEEEe
Confidence            4578999999999999732      3567999988653 333467999999999999999999999876 4567899999


Q ss_pred             ecCCCChhhhhccCCCCC-----CCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEe
Q 047276          178 FIQNGSLDHWIFPTSRRS-----EGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVS  252 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~-----~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~  252 (453)
                      |+++|+|.+++.......     ........+++..++.++.|++.|++|||+   .+++||||||+|||+++++.+||+
T Consensus        88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~kL~  164 (280)
T cd05092          88 YMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIG  164 (280)
T ss_pred             cCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCEEEC
Confidence            999999999996543210     001122358999999999999999999998   899999999999999999999999


Q ss_pred             eccccccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhH
Q 047276          253 DFGLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPK  330 (453)
Q Consensus       253 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  330 (453)
                      |||++........ .......+++.|+|||++.+..++.++|||||||++|||++ |..||......            .
T Consensus       165 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------------~  232 (280)
T cd05092         165 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT------------E  232 (280)
T ss_pred             CCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH------------H
Confidence            9999976543221 11223345678999999998899999999999999999998 89888422110            0


Q ss_pred             HHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 047276          331 IVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE  389 (453)
Q Consensus       331 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~  389 (453)
                       .......+...           ..+...+..+.+++.+||+.+|++||++.+|.+.|+
T Consensus       233 -~~~~~~~~~~~-----------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         233 -AIECITQGREL-----------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             -HHHHHHcCccC-----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence             01111111100           011123345889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.4e-40  Score=286.94  Aligned_cols=243  Identities=26%  Similarity=0.320  Sum_probs=199.0

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      +++.||+|.||.||.|+. +++..||+|++.++    ..-+.++.+|+++-+.|+||||++++||+. +....||++||.
T Consensus        26 igr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh-d~~riyLilEya  104 (281)
T KOG0580|consen   26 IGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFH-DSKRIYLILEYA  104 (281)
T ss_pred             ccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhee-ccceeEEEEEec
Confidence            468999999999999995 46788999998753    344578999999999999999999999987 566889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ++|+|...|....        ...+++.....++.|+|.||.|+|.   ++|+||||||+|+|++.++..||+|||.+-.
T Consensus       105 ~~gel~k~L~~~~--------~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~  173 (281)
T KOG0580|consen  105 PRGELYKDLQEGR--------MKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVH  173 (281)
T ss_pred             CCchHHHHHHhcc--------cccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceee
Confidence            9999999997432        2237777788899999999999999   8999999999999999999999999999875


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      -+   .....+.+||..|.+||...+..++...|+|++|++.||++.|.+||.....+                +..+  
T Consensus       174 ~p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~----------------etYk--  232 (281)
T KOG0580|consen  174 AP---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS----------------ETYK--  232 (281)
T ss_pred             cC---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH----------------HHHH--
Confidence            43   23346789999999999999999999999999999999999999999532211                1111  


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                         ++..-.+    .++........+++.+|+..+|.+|.+..|+++.
T Consensus       233 ---rI~k~~~----~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  233 ---RIRKVDL----KFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             ---HHHHccc----cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence               1111111    1233444558899999999999999999998753

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.6e-38  Score=314.14  Aligned_cols=193  Identities=23%  Similarity=0.367  Sum_probs=165.5

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      .+.||+|+||+||++... +++.||+|++...    ......+..|+.++..++|+||+++++.+. .....++||||++
T Consensus         6 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~-~~~~~~lv~E~~~   84 (363)
T cd05628           6 LKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ-DKLNLYLIMEFLP   84 (363)
T ss_pred             eEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe-cCCeEEEEEcCCC
Confidence            578999999999999854 5889999999752    223356788999999999999999999876 5668899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|.+++...          +.+++.....++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        85 gg~L~~~l~~~----------~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~  151 (363)
T cd05628          85 GGDMMTLLMKK----------DTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL  151 (363)
T ss_pred             CCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence            99999998643          238999999999999999999999   89999999999999999999999999998754


Q ss_pred             cCCCC----------------------------------ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc
Q 047276          261 SRDQS----------------------------------RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG  306 (453)
Q Consensus       261 ~~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt  306 (453)
                      .....                                  .......||+.|+|||.+.+..++.++|||||||++|||++
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~  231 (363)
T cd05628         152 KKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI  231 (363)
T ss_pred             cccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHh
Confidence            32100                                  00123579999999999998899999999999999999999


Q ss_pred             CCCCCc
Q 047276          307 GRRNVS  312 (453)
Q Consensus       307 G~~p~~  312 (453)
                      |+.||.
T Consensus       232 G~~Pf~  237 (363)
T cd05628         232 GYPPFC  237 (363)
T ss_pred             CCCCCC
Confidence            999995

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-39  Score=320.53  Aligned_cols=245  Identities=21%  Similarity=0.283  Sum_probs=188.9

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      .+.||+|+||+||+++.. +|+.||||++...    ......+.+|+.++..++||||+++++++. .++..++||||++
T Consensus         6 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~-~~~~~~lv~E~~~   84 (364)
T cd05599           6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ-DENYLYLIMEYLP   84 (364)
T ss_pred             EEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE-cCCeEEEEECCCC
Confidence            478999999999999964 6899999999642    223356788999999999999999999876 5668899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|.+++...          +.+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++..+
T Consensus        85 ~g~L~~~l~~~----------~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  151 (364)
T cd05599          85 GGDMMTLLMKK----------DTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL  151 (364)
T ss_pred             CcHHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceec
Confidence            99999998543          238999999999999999999999   89999999999999999999999999998754


Q ss_pred             cCCCCc-------------------------------------eeeeccCCccccchhhhhcCCCCccccchhHHHHHHH
Q 047276          261 SRDQSR-------------------------------------CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLE  303 (453)
Q Consensus       261 ~~~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~e  303 (453)
                      ......                                     ......||+.|+|||++....++.++|||||||++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e  231 (364)
T cd05599         152 KKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYE  231 (364)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHH
Confidence            321100                                     0112468999999999998899999999999999999


Q ss_pred             HHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCC---
Q 047276          304 LTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPS---  380 (453)
Q Consensus       304 lltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs---  380 (453)
                      |++|+.||......            ...... .....    ........    .....+.+++.+|+. +|.+|++   
T Consensus       232 l~~G~~Pf~~~~~~------------~~~~~i-~~~~~----~~~~~~~~----~~s~~~~~li~~ll~-~p~~R~~~~~  289 (364)
T cd05599         232 MLVGYPPFCSDNPQ------------ETYRKI-INWKE----TLQFPDEV----PLSPEAKDLIKRLCC-EAERRLGNNG  289 (364)
T ss_pred             hhcCCCCCCCCCHH------------HHHHHH-HcCCC----ccCCCCCC----CCCHHHHHHHHHHcc-CHhhcCCCCC
Confidence            99999999532110            001111 10000    00001001    123457788888886 9999998   


Q ss_pred             HHHHHH
Q 047276          381 MARVVE  386 (453)
Q Consensus       381 ~~~v~~  386 (453)
                      +.++++
T Consensus       290 ~~~ll~  295 (364)
T cd05599         290 VNEIKS  295 (364)
T ss_pred             HHHHhc
Confidence            888765

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-38  Score=317.82  Aligned_cols=247  Identities=22%  Similarity=0.278  Sum_probs=187.3

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      +.++||+|+||+||++.. .+|+.||||++...    ....+.+.+|+.++..++||||+++++++. ..+..++||||+
T Consensus         5 ~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-~~~~~~lv~E~~   83 (377)
T cd05629           5 TVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ-DAQYLYLIMEFL   83 (377)
T ss_pred             EeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE-cCCeeEEEEeCC
Confidence            357899999999999985 46889999998642    223356888999999999999999999876 566889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ++|+|.+++...          ..+++.....++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus        84 ~gg~L~~~l~~~----------~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~  150 (377)
T cd05629          84 PGGDLMTMLIKY----------DTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTG  150 (377)
T ss_pred             CCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeecccccc
Confidence            999999998543          238888999999999999999999   8999999999999999999999999999864


Q ss_pred             ccCCCC-------------c---------------------------------eeeeccCCccccchhhhhcCCCCcccc
Q 047276          260 MSRDQS-------------R---------------------------------CITTIRGTRGYLAPEWILEQGVSEKCD  293 (453)
Q Consensus       260 ~~~~~~-------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sD  293 (453)
                      +.....             .                                 ......||+.|+|||++.+..++.++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  230 (377)
T cd05629         151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECD  230 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCcee
Confidence            321000             0                                 001246899999999999889999999


Q ss_pred             chhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhcccc
Q 047276          294 IYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQE  373 (453)
Q Consensus       294 V~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~  373 (453)
                      ||||||++|||++|+.||......            ............     ..+....    .....+.+++.+|++ 
T Consensus       231 iwSlGvil~elltG~~Pf~~~~~~------------~~~~~i~~~~~~-----~~~p~~~----~~s~~~~dli~~lL~-  288 (377)
T cd05629         231 WWSLGAIMFECLIGWPPFCSENSH------------ETYRKIINWRET-----LYFPDDI----HLSVEAEDLIRRLIT-  288 (377)
T ss_pred             eEecchhhhhhhcCCCCCCCCCHH------------HHHHHHHccCCc-----cCCCCCC----CCCHHHHHHHHHHhc-
Confidence            999999999999999999532110            001111100000     0011101    123457888999997 


Q ss_pred             CCCCC---CCHHHHHHH
Q 047276          374 RARLR---PSMARVVEM  387 (453)
Q Consensus       374 ~p~~R---Ps~~~v~~~  387 (453)
                      +|.+|   |++.++++.
T Consensus       289 ~~~~r~~r~~~~~~l~h  305 (377)
T cd05629         289 NAENRLGRGGAHEIKSH  305 (377)
T ss_pred             CHhhcCCCCCHHHHhcC
Confidence            66665   588888764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.3e-38  Score=308.49  Aligned_cols=261  Identities=27%  Similarity=0.425  Sum_probs=196.4

Q ss_pred             HHhcccCcCCceEEEEEEeC-CCc--EEEEEEecCC--CccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEEEEE
Q 047276          104 NFQALLGHGSSASVFKGILS-DGT--SVAVKRINGE--ENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~-~g~--~vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      .+.+.||+|+||.||+|... ++.  .+++|.+...  ......+.+|+.++.++ +|+||+++++++. .++..++|+|
T Consensus        10 ~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~-~~~~~~lv~e   88 (303)
T cd05088          10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-HRGYLYLAIE   88 (303)
T ss_pred             eeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC-CCCCceEEEE
Confidence            45688999999999999964 454  4677777642  23345788999999999 8999999999976 5567899999


Q ss_pred             ecCCCChhhhhccCCCCCCC------CCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEE
Q 047276          178 FIQNGSLDHWIFPTSRRSEG------HYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVV  251 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl  251 (453)
                      |+++|+|.+++.........      ......+++..++.++.|++.||+|||+   .+++||||||+|||+++++.+||
T Consensus        89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~kl  165 (303)
T cd05088          89 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKI  165 (303)
T ss_pred             eCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcEEe
Confidence            99999999999654321110      0122358999999999999999999998   89999999999999999999999


Q ss_pred             eeccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhH
Q 047276          252 SDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPK  330 (453)
Q Consensus       252 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  330 (453)
                      +|||++.......  ......++..|+|||++....++.++|||||||++|||+| |..||......            .
T Consensus       166 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------------~  231 (303)
T cd05088         166 ADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------------E  231 (303)
T ss_pred             CccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH------------H
Confidence            9999986422111  1112234668999999988889999999999999999998 99998522110            0


Q ss_pred             HHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccCC
Q 047276          331 IVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAV  394 (453)
Q Consensus       331 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~~  394 (453)
                       .......+.       ...    .+......+.+++.+|++.+|++||++.++++.|+.....
T Consensus       232 -~~~~~~~~~-------~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~  283 (303)
T cd05088         232 -LYEKLPQGY-------RLE----KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  283 (303)
T ss_pred             -HHHHHhcCC-------cCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence             011111110       000    1112234588999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.3e-38  Score=300.91  Aligned_cols=253  Identities=25%  Similarity=0.454  Sum_probs=195.5

Q ss_pred             cccCcCCceEEEEEEeCC-------CcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          107 ALLGHGSSASVFKGILSD-------GTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~-------g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      +.||+|+||.||+|+..+       +..+|+|.+....  .....+.+|+.+++.++||||++++++|. .....+++||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~~v~e   79 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL-LNEPQYIIME   79 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeec-CCCCeEEEEe
Confidence            369999999999998643       2579999876532  34567899999999999999999999986 4567899999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCC-----cEEEe
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENY-----RAVVS  252 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~-----~~kl~  252 (453)
                      |+++|+|.+++.......   .....+++..++.++.|++.||+|||+   .+++|+||||+||+++.++     .++|+
T Consensus        80 ~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~  153 (269)
T cd05044          80 LMEGGDLLSYLRDARVER---FGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIG  153 (269)
T ss_pred             ccCCCcHHHHHHHhhhcc---cCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEEC
Confidence            999999999996532211   012348899999999999999999998   8999999999999999887     89999


Q ss_pred             eccccccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhH
Q 047276          253 DFGLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPK  330 (453)
Q Consensus       253 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  330 (453)
                      |||++........ .......++..|+|||++.++.++.++||||||+++|||++ |+.||......            .
T Consensus       154 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~------------~  221 (269)
T cd05044         154 DFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ------------E  221 (269)
T ss_pred             CcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH------------H
Confidence            9999976543221 11223345678999999999999999999999999999998 99998522110            0


Q ss_pred             HHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 047276          331 IVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEG  390 (453)
Q Consensus       331 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~  390 (453)
                       .......+.       .+    ..+...+..+.+++.+||+.+|++||++.+|.+.|++
T Consensus       222 -~~~~~~~~~-------~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         222 -VLQHVTAGG-------RL----QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             -HHHHHhcCC-------cc----CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence             111111111       00    1122334568899999999999999999999999863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-38  Score=296.28  Aligned_cols=246  Identities=25%  Similarity=0.402  Sum_probs=195.0

Q ss_pred             cccCcCCceEEEEEEeCCCcEEEEEEecCCCc--cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCCh
Q 047276          107 ALLGHGSSASVFKGILSDGTSVAVKRINGEEN--GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL  184 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL  184 (453)
                      ++||+|+||.||++...+++.|++|.+.....  ....+.+|++++++++|+||+++++++. .....++|+||+++++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV-QKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEe-cCCCeEEEEEcCCCCcH
Confidence            46999999999999987799999998876433  3467999999999999999999999876 55688999999999999


Q ss_pred             hhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCCC
Q 047276          185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ  264 (453)
Q Consensus       185 ~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~  264 (453)
                      .+++....         ..+++..+..++.+++.||+|||+   .+++||||+|+||+++.++.+||+|||++.......
T Consensus        80 ~~~l~~~~---------~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  147 (251)
T cd05041          80 LTFLRKKK---------NRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGI  147 (251)
T ss_pred             HHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCc
Confidence            99985432         237899999999999999999998   899999999999999999999999999987654222


Q ss_pred             Ccee-eeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcCccc
Q 047276          265 SRCI-TTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLM  342 (453)
Q Consensus       265 ~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (453)
                      .... ....++..|+|||.+.++.++.++|+||||+++|||++ |..||......             ........+.  
T Consensus       148 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~-------------~~~~~~~~~~--  212 (251)
T cd05041         148 YTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ-------------QTRERIESGY--  212 (251)
T ss_pred             ceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH-------------HHHHHHhcCC--
Confidence            1111 12234567999999988889999999999999999999 88887532110             0111111110  


Q ss_pred             ccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 047276          343 EIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE  389 (453)
Q Consensus       343 ~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~  389 (453)
                           .+    ..+...+..+.+++.+|++.+|.+||++.+|++.|+
T Consensus       213 -----~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         213 -----RM----PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             -----CC----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence                 00    112233456999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4.8e-38  Score=308.29  Aligned_cols=195  Identities=23%  Similarity=0.298  Sum_probs=166.2

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      +.+.||+|+||+||+++.. +++.||+|.+...    ......+.+|..++..++|+||+++++++. ..+..++||||+
T Consensus         5 i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~-~~~~~~lv~Ey~   83 (331)
T cd05624           5 IIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ-DENYLYLVMDYY   83 (331)
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-cCCEEEEEEeCC
Confidence            4578999999999999964 5788999998642    222345888999999999999999999876 566889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ++|+|.+++....         ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++..
T Consensus        84 ~gg~L~~~l~~~~---------~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~  151 (331)
T cd05624          84 VGGDLLTLLSKFE---------DRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLK  151 (331)
T ss_pred             CCCcHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceee
Confidence            9999999996422         238899999999999999999999   8999999999999999999999999999987


Q ss_pred             ccCCCCceeeeccCCccccchhhhhc-----CCCCccccchhHHHHHHHHHcCCCCCc
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILE-----QGVSEKCDIYSYGMVLLELTGGRRNVS  312 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDV~S~Gvil~elltG~~p~~  312 (453)
                      .............||+.|+|||++..     +.++.++|||||||++|||++|+.||.
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~  209 (331)
T cd05624         152 MNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY  209 (331)
T ss_pred             ccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCcc
Confidence            65443322334579999999999875     567899999999999999999999995

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-38  Score=323.80  Aligned_cols=256  Identities=21%  Similarity=0.244  Sum_probs=201.7

Q ss_pred             HhcccCcCCceEEEEEEeCCC-cEEEEEEecC-CCccHHHHHHHHHHHHhcC-CCceeeEee-EEEec---C--CCeEEE
Q 047276          105 FQALLGHGSSASVFKGILSDG-TSVAVKRING-EENGEKEFRSEVAAIASAQ-HVNLVRLLG-YCVVP---G--GPRYLV  175 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g-~~vavK~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~g-~~~~~---~--~~~~lv  175 (453)
                      +.++|.+|||+.||.+....+ ..+|+|++-. ++...+...+|+++|++|. |+|||.+++ .....   +  -+.+|.
T Consensus        41 V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllL  120 (738)
T KOG1989|consen   41 VEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLL  120 (738)
T ss_pred             EEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEee
Confidence            357899999999999997655 9999998754 5556677899999999997 999999999 32211   1  256899


Q ss_pred             EEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecc
Q 047276          176 YEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFG  255 (453)
Q Consensus       176 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfG  255 (453)
                      ||||++|+|-+++..+..        ..|++..+++|+.++++|+++||. +.++|||||||-+||||+.+++.||||||
T Consensus       121 mEyC~gg~Lvd~mn~Rlq--------~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFG  191 (738)
T KOG1989|consen  121 MEYCKGGSLVDFMNTRLQ--------TRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFG  191 (738)
T ss_pred             hhhccCCcHHHHHHHHHh--------ccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCccc
Confidence            999999999999965432        229999999999999999999998 45789999999999999999999999999


Q ss_pred             ccccccCCCCc--e------eeeccCCccccchhhhh---cCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCccc
Q 047276          256 LSKLMSRDQSR--C------ITTIRGTRGYLAPEWIL---EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNK  324 (453)
Q Consensus       256 la~~~~~~~~~--~------~~~~~gt~~y~aPE~~~---~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~  324 (453)
                      .+.........  .      .-...-|+.|.+||.+.   +..+++|+|||||||+||-|+....||....         
T Consensus       192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg---------  262 (738)
T KOG1989|consen  192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG---------  262 (738)
T ss_pred             ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc---------
Confidence            98754322211  0      11134688999999986   5578999999999999999999999995210         


Q ss_pred             ccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccCCCC
Q 047276          325 WQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVDD  396 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~~~~  396 (453)
                                      -..+++-...  .+..+.+...+.+|+..||+.||.+||++.+|+..+-.+...+.
T Consensus       263 ----------------~laIlng~Y~--~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~  316 (738)
T KOG1989|consen  263 ----------------KLAILNGNYS--FPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC  316 (738)
T ss_pred             ----------------ceeEEecccc--CCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence                            0111111111  11224788889999999999999999999999998877655443

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=7e-38  Score=305.14  Aligned_cols=203  Identities=23%  Similarity=0.338  Sum_probs=162.2

Q ss_pred             hcccCcCCceEEEEEEeC---CCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEec-CCCeEEEEEecCC
Q 047276          106 QALLGHGSSASVFKGILS---DGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP-GGPRYLVYEFIQN  181 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~~lv~e~~~~  181 (453)
                      ..+||+|+||+||+|...   +++.+|+|.+..... ...+.+|+.++++++||||+++++++... +...++++||+.+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH   84 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence            368999999999999864   467899999875432 34578899999999999999999987543 3456899999964


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEE----CCCCcEEEeecccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILL----DENYRAVVSDFGLS  257 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl----~~~~~~kl~DfGla  257 (453)
                       +|.+++........ ......+++..+..++.|++.||+|||+   .+|+||||||+|||+    +.++.+||+|||++
T Consensus        85 -~l~~~~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          85 -DLWHIIKFHRASKA-NKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CHHHHHHhcccccc-cCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             88888753322110 0122348999999999999999999999   899999999999999    46689999999999


Q ss_pred             ccccCCCC--ceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCccc
Q 047276          258 KLMSRDQS--RCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLI  314 (453)
Q Consensus       258 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~  314 (453)
                      +.......  .......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            87643221  12234578999999999876 45899999999999999999999999643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.8e-38  Score=300.24  Aligned_cols=266  Identities=24%  Similarity=0.354  Sum_probs=201.3

Q ss_pred             HHHhcccCcCCceEEEEEEeC-----CCcEEEEEEecCCCc--cHHHHHHHHHHHHhcCCCceeeEeeEEEec-CCCeEE
Q 047276          103 DNFQALLGHGSSASVFKGILS-----DGTSVAVKRINGEEN--GEKEFRSEVAAIASAQHVNLVRLLGYCVVP-GGPRYL  174 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~-----~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~~l  174 (453)
                      ..+.+.||+|+||.||++.+.     ++..+|||.+.....  ..+.|.+|+++++.++|+|++++++++... +...++
T Consensus         6 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~l   85 (284)
T cd05038           6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRL   85 (284)
T ss_pred             chhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEE
Confidence            345678999999999999853     367899999986544  367899999999999999999999988642 346799


Q ss_pred             EEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeec
Q 047276          175 VYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDF  254 (453)
Q Consensus       175 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~Df  254 (453)
                      ++||+++++|.+++....         ..+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.++|+||
T Consensus        86 v~e~~~~~~l~~~l~~~~---------~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~df  153 (284)
T cd05038          86 IMEYLPSGSLRDYLQRHR---------DQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDF  153 (284)
T ss_pred             EEecCCCCCHHHHHHhCc---------cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccc
Confidence            999999999999996443         138999999999999999999999   89999999999999999999999999


Q ss_pred             cccccccCCCCc--eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCC--cccccchhH
Q 047276          255 GLSKLMSRDQSR--CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKS--KNKWQYFPK  330 (453)
Q Consensus       255 Gla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~--~~~~~~~~~  330 (453)
                      |++.........  ......++..|++||.+....++.++||||||+++|||++|+.|+..........  .........
T Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd05038         154 GLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVT  233 (284)
T ss_pred             ccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHH
Confidence            999876533221  1112344567999999988889999999999999999999999875322111000  000000000


Q ss_pred             HHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 047276          331 IVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR  391 (453)
Q Consensus       331 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~  391 (453)
                      ...+....+.       +.    ..+..+...+.+++.+|++.+|++||++.+|+++|+++
T Consensus       234 ~~~~~~~~~~-------~~----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         234 RLLELLKEGE-------RL----PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHHHcCC-------cC----CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            0111111110       01    11223345689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=5.5e-38  Score=305.59  Aligned_cols=264  Identities=23%  Similarity=0.366  Sum_probs=200.2

Q ss_pred             HHHHhcccCcCCceEEEEEEeC--------CCcEEEEEEecCCC--ccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCC
Q 047276          102 TDNFQALLGHGSSASVFKGILS--------DGTSVAVKRINGEE--NGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGG  170 (453)
Q Consensus       102 ~~~~~~~lG~G~fG~Vy~~~~~--------~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~  170 (453)
                      ...+.+.||+|+||.||+++..        .+..+|+|.++...  .....+..|+.++.++ +||||++++++|. .++
T Consensus        13 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-~~~   91 (314)
T cd05099          13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT-QEG   91 (314)
T ss_pred             HeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc-cCC
Confidence            3445789999999999999742        24569999887532  2345688999999999 6999999999986 456


Q ss_pred             CeEEEEEecCCCChhhhhccCCCCCC------CCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEEC
Q 047276          171 PRYLVYEFIQNGSLDHWIFPTSRRSE------GHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD  244 (453)
Q Consensus       171 ~~~lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~  244 (453)
                      ..++++||+++|+|.+++........      .......++|..+.+++.|++.||.|||+   .+++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEc
Confidence            78999999999999999965432110      01123458999999999999999999998   8999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCc-eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCc
Q 047276          245 ENYRAVVSDFGLSKLMSRDQSR-CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSK  322 (453)
Q Consensus       245 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~  322 (453)
                      +++.+||+|||+++........ ......++..|+|||.+.++.++.++||||||+++|||++ |..||.....      
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~------  242 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV------  242 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH------
Confidence            9999999999999865432211 1122234567999999988889999999999999999999 8888742210      


Q ss_pred             ccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          323 NKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                             .........+...           ..+......+.+++.+|++.+|++||++.++++.|++...
T Consensus       243 -------~~~~~~~~~~~~~-----------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         243 -------EELFKLLREGHRM-----------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             -------HHHHHHHHcCCCC-----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence                   0111111111110           1122334468899999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.8e-38  Score=301.59  Aligned_cols=252  Identities=24%  Similarity=0.355  Sum_probs=193.2

Q ss_pred             HHHHHHHh--cccCcCCceEEEEEEeC-CCcEEEEEEecCCC-ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEE
Q 047276           99 EEATDNFQ--ALLGHGSSASVFKGILS-DGTSVAVKRINGEE-NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYL  174 (453)
Q Consensus        99 ~~~~~~~~--~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~l  174 (453)
                      +.+++++.  ..||+|+||.||+|... ++..|++|.+.... ...+.+.+|+.+++.++|+||++++|++. .++..++
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~l   82 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS-ENGFFKI   82 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec-cCCEEEE
Confidence            33444543  58999999999999954 57889999887543 34567899999999999999999999986 5568899


Q ss_pred             EEEecCCCChhhhhccCCCCCCCCCCCCCC--CHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECC-CCcEEE
Q 047276          175 VYEFIQNGSLDHWIFPTSRRSEGHYSGGCL--SWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDE-NYRAVV  251 (453)
Q Consensus       175 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l--~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~-~~~~kl  251 (453)
                      ++||+++++|.+++....         ..+  ++..+..++.|++.||+|||+   .+++||||||+||+++. ++.++|
T Consensus        83 v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l  150 (268)
T cd06624          83 FMEQVPGGSLSALLRSKW---------GPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKI  150 (268)
T ss_pred             EEecCCCCCHHHHHHHhc---------ccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEE
Confidence            999999999999986432         124  788889999999999999998   89999999999999986 679999


Q ss_pred             eeccccccccCCCCceeeeccCCccccchhhhhcC--CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchh
Q 047276          252 SDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQ--GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFP  329 (453)
Q Consensus       252 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~  329 (453)
                      +|||++........ ......+++.|+|||++...  .++.++||||||+++|||++|+.||.........         
T Consensus       151 ~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---------  220 (268)
T cd06624         151 SDFGTSKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---------  220 (268)
T ss_pred             ecchhheecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---------
Confidence            99999876543221 12234578899999998654  3789999999999999999999998532111000         


Q ss_pred             HHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          330 KIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       330 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                        .   ...+..        ......+......+.+++.+|++.+|++|||+.+++.
T Consensus       221 --~---~~~~~~--------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         221 --M---FKVGMF--------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             --H---hhhhhh--------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence              0   000000        0001122334456889999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=8.9e-38  Score=304.24  Aligned_cols=202  Identities=23%  Similarity=0.339  Sum_probs=161.7

Q ss_pred             cccCcCCceEEEEEEeC---CCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEec-CCCeEEEEEecCCC
Q 047276          107 ALLGHGSSASVFKGILS---DGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP-GGPRYLVYEFIQNG  182 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~~lv~e~~~~g  182 (453)
                      .+||+|+||+||+|+..   ++..||+|.+..... ...+.+|+.+++.++||||+++++++... +...++++||+.+ 
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence            57999999999999965   357899999875432 34678899999999999999999987643 3467899999865 


Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEE----CCCCcEEEeeccccc
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILL----DENYRAVVSDFGLSK  258 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl----~~~~~~kl~DfGla~  258 (453)
                      +|.+++........ ......+++..+..++.|++.||.|||+   .+++||||||+|||+    +.++.+||+|||+++
T Consensus        85 ~l~~~~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 DLWHIIKFHRASKA-NKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             cHHHHHHhhhcccc-CCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence            88887753321110 1122348999999999999999999999   899999999999999    567899999999998


Q ss_pred             cccCCCC--ceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCccc
Q 047276          259 LMSRDQS--RCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLI  314 (453)
Q Consensus       259 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~  314 (453)
                      .......  .......+|+.|+|||.+.+ ..++.++|||||||++|||+||+.||...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            7643321  12234568899999999876 45799999999999999999999999643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.5e-38  Score=301.68  Aligned_cols=260  Identities=24%  Similarity=0.340  Sum_probs=199.5

Q ss_pred             HHHHHhcccCcCCceEEEEEEe-CCCcEEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          101 ATDNFQALLGHGSSASVFKGIL-SDGTSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       101 ~~~~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      ..+.+.+.||+|+||+||++.. ++|+.||+|++...  ....+.+.+|+++++.++||||+++++++. ..+..++|||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e   83 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFL-NENNICMCME   83 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEe-cCCEEEEEEe
Confidence            3445668999999999999996 46889999987643  334567899999999999999999999987 4568899999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |+++++|.+++...          +.+++.....++.+++.||.|||+.  .+++|+||+|+||++++++.++|+|||++
T Consensus        84 ~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~  151 (284)
T cd06620          84 FMDCGSLDRIYKKG----------GPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVS  151 (284)
T ss_pred             cCCCCCHHHHHHhc----------cCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcc
Confidence            99999999988532          2389999999999999999999973  58999999999999999999999999998


Q ss_pred             ccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhh
Q 047276          258 KLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMK  337 (453)
Q Consensus       258 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (453)
                      .......   .....|+..|+|||++.+..++.++|+|||||++||+++|+.||.......+... ..............
T Consensus       152 ~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~  227 (284)
T cd06620         152 GELINSI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD-DPMGILDLLQQIVQ  227 (284)
T ss_pred             cchhhhc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhh-hhhHHHHHHHHHhh
Confidence            7543221   1235688999999999888899999999999999999999999964332211000 00001111111111


Q ss_pred             cCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 047276          338 EGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEML  388 (453)
Q Consensus       338 ~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L  388 (453)
                      . .     .+.+.     .......+.+++.+|++.+|++|||+.|++++.
T Consensus       228 ~-~-----~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         228 E-P-----PPRLP-----SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             c-c-----CCCCC-----chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            0 0     01111     112445688999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=5.5e-38  Score=300.33  Aligned_cols=246  Identities=26%  Similarity=0.411  Sum_probs=191.7

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      +.++||+|+||.||+|.. .+++.||+|.+...  ......+.+|+.++.+++|||++++++++.. .+..++|+||+++
T Consensus         5 ~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~   83 (279)
T cd06619           5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-ENRISICTEFMDG   83 (279)
T ss_pred             heeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-CCEEEEEEecCCC
Confidence            457899999999999985 56889999998653  2334578899999999999999999999874 5678999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      ++|..+.              .+++.....++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++....
T Consensus        84 ~~l~~~~--------------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~  146 (279)
T cd06619          84 GSLDVYR--------------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV  146 (279)
T ss_pred             CChHHhh--------------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceecc
Confidence            9997653              27888899999999999999999   899999999999999999999999999997654


Q ss_pred             CCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcc
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKL  341 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (453)
                      ...   .....++..|+|||++.+..++.++||||||+++|||++|+.||..........      .+........... 
T Consensus       147 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~------~~~~~~~~~~~~~-  216 (279)
T cd06619         147 NSI---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL------MPLQLLQCIVDED-  216 (279)
T ss_pred             ccc---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc------chHHHHHHHhccC-
Confidence            322   234578899999999998889999999999999999999999996422111110      0000011111110 


Q ss_pred             cccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          342 MEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       342 ~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                          .+.+.     .......+.+++.+|++.+|++||++.++++.
T Consensus       217 ----~~~~~-----~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         217 ----PPVLP-----VGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             ----CCCCC-----CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence                01111     11223458899999999999999999998854

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=5.1e-38  Score=300.08  Aligned_cols=245  Identities=25%  Similarity=0.384  Sum_probs=195.4

Q ss_pred             HHHhcccCcCCceEEEEEEe-CCCcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          103 DNFQALLGHGSSASVFKGIL-SDGTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      +...+.||+|+||.||+|.. .+++.||+|.+....  ...+.+.+|+.++++++||||+++++++. .++..++|+||+
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~   84 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYL-KGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccc-cCCceEEEEEcc
Confidence            44457899999999999985 457889999887432  33456889999999999999999999876 566889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ++++|.+++..           ..+++..+..++.|++.|+.|||+   .+++|+||+|+||++++++.++|+|||++..
T Consensus        85 ~~~~L~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~  150 (277)
T cd06642          85 GGGSALDLLKP-----------GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQ  150 (277)
T ss_pred             CCCcHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEcccccccc
Confidence            99999998842           238899999999999999999999   8999999999999999999999999999976


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      ...... ......++..|+|||++.+..++.++||||||+++|||++|+.|+.......             .......+
T Consensus       151 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-------------~~~~~~~~  216 (277)
T cd06642         151 LTDTQI-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-------------VLFLIPKN  216 (277)
T ss_pred             ccCcch-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-------------HHhhhhcC
Confidence            643221 1233467889999999998889999999999999999999999985321110             00011111


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      .     .+      .........+.+++.+|++.+|++||++.++++.
T Consensus       217 ~-----~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         217 S-----PP------TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             C-----CC------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            0     01      1122344568899999999999999999999974

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=9.3e-39  Score=312.24  Aligned_cols=238  Identities=22%  Similarity=0.287  Sum_probs=186.8

Q ss_pred             HHhcccCcCCceEEEEEEe-CCCcEEEEEEecCC----CccHHHHHHHHHHHHhcC-CCceeeEeeEEEecCCCeEEEEE
Q 047276          104 NFQALLGHGSSASVFKGIL-SDGTSVAVKRINGE----ENGEKEFRSEVAAIASAQ-HVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      ++.+.||+|+||+||++.. .+|+.||+|++...    ....+.+..|..++..+. |++|+++.+++. ..+..++|||
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-~~~~~~lv~E   81 (323)
T cd05615           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ-TVDRLYFVME   81 (323)
T ss_pred             eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe-cCCEEEEEEc
Confidence            4567899999999999995 46889999998742    223456778999998886 467777887665 5568899999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |+++|+|.+++...          ..+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++
T Consensus        82 y~~~g~L~~~i~~~----------~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~  148 (323)
T cd05615          82 YVNGGDLMYHIQQV----------GKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMC  148 (323)
T ss_pred             CCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccc
Confidence            99999999998533          238999999999999999999999   89999999999999999999999999998


Q ss_pred             ccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhh
Q 047276          258 KLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMK  337 (453)
Q Consensus       258 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (453)
                      +...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......            . ......
T Consensus       149 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~------------~-~~~~i~  214 (323)
T cd05615         149 KEHMVDG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED------------E-LFQSIM  214 (323)
T ss_pred             cccCCCC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH------------H-HHHHHH
Confidence            7543222 1223456899999999999888999999999999999999999999532110            0 111111


Q ss_pred             cCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCH
Q 047276          338 EGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSM  381 (453)
Q Consensus       338 ~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  381 (453)
                      .+.            ...+......+.+++.+|++.+|.+|++.
T Consensus       215 ~~~------------~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         215 EHN------------VSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             hCC------------CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence            111            11222334568899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-39  Score=285.16  Aligned_cols=261  Identities=23%  Similarity=0.250  Sum_probs=202.4

Q ss_pred             HHHhcccCcCCceEEEEEE-eCCCcEEEEEEecCCC-ccHHHHHHHHHHHHhcCCCceeeEeeEEEecC----CCeEEEE
Q 047276          103 DNFQALLGHGSSASVFKGI-LSDGTSVAVKRINGEE-NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG----GPRYLVY  176 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~-~~~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~~lv~  176 (453)
                      +.+.++||+|||.-||.++ ..++..+|+|++.-.. .+.+..++|++..++++|||++++++++....    ...|+++
T Consensus        23 yri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~  102 (302)
T KOG2345|consen   23 YRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLL  102 (302)
T ss_pred             EEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEe
Confidence            4457899999999999999 6778999999987543 56677899999999999999999999875322    2479999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      +|...|+|.+.+...+.      .+..+++.+.++|+.++++||++||+.. +++.||||||.|||+.+.+.++|.|||.
T Consensus       103 Pyy~~Gsl~d~i~~~k~------kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS  175 (302)
T KOG2345|consen  103 PYYKRGSLLDEIERLKI------KGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGS  175 (302)
T ss_pred             ehhccccHHHHHHHHhh------cCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccC
Confidence            99999999999965543      3345999999999999999999999932 4599999999999999999999999999


Q ss_pred             cccccCCCCc--------eeeeccCCccccchhhhh---cCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccc
Q 047276          257 SKLMSRDQSR--------CITTIRGTRGYLAPEWIL---EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKW  325 (453)
Q Consensus       257 a~~~~~~~~~--------~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~  325 (453)
                      +....-.-..        ......-|..|.|||.+.   +...++++|||||||+||+|+.|..||.......+ +..  
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg-Sla--  252 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG-SLA--  252 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC-eEE--
Confidence            8765321100        011234678999999886   44678999999999999999999999964333111 100  


Q ss_pred             cchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 047276          326 QYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR  391 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~  391 (453)
                                      ..+....+....  ....+..+.+++.+|++.||.+||+..+++..++..
T Consensus       253 ----------------LAv~n~q~s~P~--~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  253 ----------------LAVQNAQISIPN--SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             ----------------EeeeccccccCC--CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                            001111111111  112566799999999999999999999999988764

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5.5e-38  Score=298.53  Aligned_cols=252  Identities=21%  Similarity=0.334  Sum_probs=186.4

Q ss_pred             ccCcCCceEEEEEEeCCC---cEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCC
Q 047276          108 LLGHGSSASVFKGILSDG---TSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       108 ~lG~G~fG~Vy~~~~~~g---~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      .||+|+||+||+|...++   ..+++|.+....  ...+.|.+|+.+++.++|||+++++++|. .....++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~~   80 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV-EAIPYLLVFEYCELG   80 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec-CCCccEEEEecCCCC
Confidence            699999999999985443   346677765432  33467999999999999999999999987 556889999999999


Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccC
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR  262 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~  262 (453)
                      +|.+++......      ...+++.....++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++.....
T Consensus        81 ~L~~~l~~~~~~------~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~  151 (268)
T cd05086          81 DLKSYLSQEQWH------RRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK  151 (268)
T ss_pred             cHHHHHHhhhcc------cccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCc
Confidence            999999654221      1236777888999999999999998   8999999999999999999999999999864322


Q ss_pred             CC-CceeeeccCCccccchhhhhc-------CCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHH
Q 047276          263 DQ-SRCITTIRGTRGYLAPEWILE-------QGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVN  333 (453)
Q Consensus       263 ~~-~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  333 (453)
                      .. ........++..|+|||++..       ..++.++||||||+++|||++ |..||....+            .....
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------------~~~~~  219 (268)
T cd05086         152 EDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------------REVLN  219 (268)
T ss_pred             chhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------------HHHHH
Confidence            11 111234567889999998753       245789999999999999997 5667742211            11111


Q ss_pred             HhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 047276          334 EKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE  389 (453)
Q Consensus       334 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~  389 (453)
                      .... +......++.+..      .....+.+++..|+ .+|.+||++.+|++.|.
T Consensus       220 ~~~~-~~~~~~~~~~~~~------~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         220 HVIK-DQQVKLFKPQLEL------PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             HHHh-hcccccCCCccCC------CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            1111 2222233333321      23345778888899 57999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.5e-38  Score=326.05  Aligned_cols=192  Identities=25%  Similarity=0.365  Sum_probs=159.2

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCCCccHHHHHHHHHHHHhcCC------CceeeEeeEEEecCCCeEEEEE
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRSEVAAIASAQH------VNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      +.++||+|+||+||+|.. .+++.||||+++.......++..|+.++..++|      .+++++++++.......++|||
T Consensus       133 i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~  212 (467)
T PTZ00284        133 ILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMP  212 (467)
T ss_pred             EEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEe
Confidence            347899999999999996 457889999997544444566778888877754      4589999988766667899999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCC----------
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENY----------  247 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~----------  247 (453)
                      ++ +++|.+++...          +.+++..+..|+.||+.||+|||+.  .+|+||||||+|||++.++          
T Consensus       213 ~~-g~~l~~~l~~~----------~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~  279 (467)
T PTZ00284        213 KY-GPCLLDWIMKH----------GPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRA  279 (467)
T ss_pred             cc-CCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccc
Confidence            88 67899888533          2389999999999999999999972  5999999999999998765          


Q ss_pred             ------cEEEeeccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcc
Q 047276          248 ------RAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSL  313 (453)
Q Consensus       248 ------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~  313 (453)
                            .+||+|||.+.....    ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       280 ~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~  347 (467)
T PTZ00284        280 LPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT  347 (467)
T ss_pred             cCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence                  499999998764321    22446789999999999999999999999999999999999999964

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=4.4e-38  Score=303.73  Aligned_cols=243  Identities=23%  Similarity=0.380  Sum_probs=193.7

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCC-CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCC
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGE-ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS  183 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gs  183 (453)
                      .+.||+|+||.||+|.. .+++.|++|.+... ......+.+|+.+++.++|+|++++++++. .+...++||||+++++
T Consensus        25 ~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~-~~~~~~lv~e~~~~~~  103 (296)
T cd06654          25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-VGDELWVVMEYLAGGS  103 (296)
T ss_pred             EEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEE-eCCEEEEeecccCCCC
Confidence            46899999999999985 46889999988753 334567889999999999999999999876 4568899999999999


Q ss_pred             hhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCC
Q 047276          184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD  263 (453)
Q Consensus       184 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~  263 (453)
                      |.+++..           ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++......
T Consensus       104 L~~~~~~-----------~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~  169 (296)
T cd06654         104 LTDVVTE-----------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (296)
T ss_pred             HHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence            9999842           237899999999999999999999   89999999999999999999999999998765432


Q ss_pred             CCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcccc
Q 047276          264 QSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLME  343 (453)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (453)
                      .. ......+++.|+|||.+.+..++.++|||||||++|||++|+.||........            .......+.   
T Consensus       170 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~------------~~~~~~~~~---  233 (296)
T cd06654         170 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------------LYLIATNGT---  233 (296)
T ss_pred             cc-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh------------HHHHhcCCC---
Confidence            21 12334688899999999888899999999999999999999999953221100            000000000   


Q ss_pred             cccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          344 IVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       344 ~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                         +.+    ..+......+.+++.+|++.+|++||++.++++
T Consensus       234 ---~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         234 ---PEL----QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             ---CCC----CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence               001    112233456889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=6.3e-39  Score=320.08  Aligned_cols=195  Identities=24%  Similarity=0.365  Sum_probs=164.7

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      +.+.||+|+||+||+++. .+++.||||.+...    ......+.+|+.+++.++|+||+++++.+. .++..++||||+
T Consensus         5 ~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~-~~~~~~lv~E~~   83 (376)
T cd05598           5 KIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ-DKDNLYFVMDYI   83 (376)
T ss_pred             EEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE-cCCEEEEEEeCC
Confidence            357899999999999995 45889999998642    223456889999999999999999999876 566889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ++|+|.+++...          +.+++.....++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++..
T Consensus        84 ~~g~L~~~i~~~----------~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~  150 (376)
T cd05598          84 PGGDMMSLLIRL----------GIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (376)
T ss_pred             CCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence            999999998543          237888889999999999999999   8999999999999999999999999999753


Q ss_pred             ccCCC------------------------------------------CceeeeccCCccccchhhhhcCCCCccccchhH
Q 047276          260 MSRDQ------------------------------------------SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSY  297 (453)
Q Consensus       260 ~~~~~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~  297 (453)
                      +....                                          ........||+.|+|||++.+..++.++|||||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  230 (376)
T cd05598         151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  230 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeec
Confidence            21000                                          000123469999999999998899999999999


Q ss_pred             HHHHHHHHcCCCCCcc
Q 047276          298 GMVLLELTGGRRNVSL  313 (453)
Q Consensus       298 Gvil~elltG~~p~~~  313 (453)
                      ||++|||++|+.||..
T Consensus       231 Gvilyell~G~~Pf~~  246 (376)
T cd05598         231 GVILYEMLVGQPPFLA  246 (376)
T ss_pred             cceeeehhhCCCCCCC
Confidence            9999999999999953

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.2e-37  Score=296.17  Aligned_cols=251  Identities=24%  Similarity=0.399  Sum_probs=194.7

Q ss_pred             HhcccCcCCceEEEEEEeCC--CcEEEEEEecCC-----------CccHHHHHHHHHHHHh-cCCCceeeEeeEEEecCC
Q 047276          105 FQALLGHGSSASVFKGILSD--GTSVAVKRINGE-----------ENGEKEFRSEVAAIAS-AQHVNLVRLLGYCVVPGG  170 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~--g~~vavK~~~~~-----------~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~~~~  170 (453)
                      +.+.||+|+||.||+|....  ++.+|+|.+...           .....++..|+.++.+ ++|||++++++++. .++
T Consensus         4 ~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-~~~   82 (269)
T cd08528           4 VLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL-END   82 (269)
T ss_pred             hhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-cCC
Confidence            45789999999999999754  678999987531           1122456778888765 79999999999986 566


Q ss_pred             CeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEE
Q 047276          171 PRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV  250 (453)
Q Consensus       171 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~k  250 (453)
                      ..+++|||+++++|.+++.....      ....+++..+++++.|++.||.|||+.  .+++|+||+|+||+++.++.+|
T Consensus        83 ~~~lv~e~~~~~~l~~~l~~~~~------~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~  154 (269)
T cd08528          83 RLYIVMDLIEGAPLGEHFNSLKE------KKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVT  154 (269)
T ss_pred             eEEEEEecCCCCcHHHHHHHHHh------ccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEE
Confidence            88999999999999998853221      123489999999999999999999963  6899999999999999999999


Q ss_pred             EeeccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhH
Q 047276          251 VSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPK  330 (453)
Q Consensus       251 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~  330 (453)
                      |+|||++.......  ......++..|++||.+.++.++.++||||||+++|||++|+.||.....            ..
T Consensus       155 l~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~------------~~  220 (269)
T cd08528         155 ITDFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM------------LS  220 (269)
T ss_pred             Eecccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH------------HH
Confidence            99999998754432  23445688899999999988899999999999999999999999852210            00


Q ss_pred             HHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 047276          331 IVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE  389 (453)
Q Consensus       331 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~  389 (453)
                       .......+.....     .     .......+.+++.+|++.||++||++.||..+++
T Consensus       221 -~~~~~~~~~~~~~-----~-----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         221 -LATKIVEAVYEPL-----P-----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             -HHHHHhhccCCcC-----C-----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence             1111111111100     0     0122345889999999999999999999999886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-37  Score=305.86  Aligned_cols=195  Identities=23%  Similarity=0.318  Sum_probs=165.9

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecC----CCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRING----EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      +.+.||+|+||+||+++.. +++.||+|++..    .....+.+.+|..++..++|+||+++++++. .++..++||||+
T Consensus         5 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~~lv~e~~   83 (331)
T cd05597           5 ILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ-DENNLYLVMDYY   83 (331)
T ss_pred             EEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe-cCCeEEEEEecC
Confidence            4578999999999999964 588999999864    2223456889999999999999999999876 566889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ++|+|.+++....         ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++..
T Consensus        84 ~g~~L~~~l~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  151 (331)
T cd05597          84 VGGDLLTLLSKFE---------DRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLR  151 (331)
T ss_pred             CCCcHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceee
Confidence            9999999985422         238899999999999999999999   8999999999999999999999999999876


Q ss_pred             ccCCCCceeeeccCCccccchhhhhc-----CCCCccccchhHHHHHHHHHcCCCCCc
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILE-----QGVSEKCDIYSYGMVLLELTGGRRNVS  312 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDV~S~Gvil~elltG~~p~~  312 (453)
                      .............||+.|+|||++..     ..++.++|||||||++|||++|+.||.
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~  209 (331)
T cd05597         152 LLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY  209 (331)
T ss_pred             cCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence            65433322334568999999999873     457889999999999999999999995

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.7e-38  Score=317.56  Aligned_cols=194  Identities=25%  Similarity=0.384  Sum_probs=164.1

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCC----ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      .++||+|+||+||+|.. .+++.||+|.+....    .....+.+|+.+++.++|+||+++++.+. .++..++||||++
T Consensus         6 ~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~-~~~~~~lv~E~~~   84 (382)
T cd05625           6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ-DKDNLYFVMDYIP   84 (382)
T ss_pred             EEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE-eCCEEEEEEeCCC
Confidence            47899999999999995 468899999986522    23456889999999999999999999876 5668899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|.+++...          +.+++.....++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++..+
T Consensus        85 gg~L~~~l~~~----------~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~  151 (382)
T cd05625          85 GGDMMSLLIRM----------GIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (382)
T ss_pred             CCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence            99999998543          237888899999999999999999   89999999999999999999999999997533


Q ss_pred             cCCC----------------------------------------------CceeeeccCCccccchhhhhcCCCCccccc
Q 047276          261 SRDQ----------------------------------------------SRCITTIRGTRGYLAPEWILEQGVSEKCDI  294 (453)
Q Consensus       261 ~~~~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV  294 (453)
                      ....                                              ........||+.|+|||.+.+..++.++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di  231 (382)
T cd05625         152 RWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW  231 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeE
Confidence            1000                                              000123468999999999998899999999


Q ss_pred             hhHHHHHHHHHcCCCCCcc
Q 047276          295 YSYGMVLLELTGGRRNVSL  313 (453)
Q Consensus       295 ~S~Gvil~elltG~~p~~~  313 (453)
                      |||||++|||++|+.||..
T Consensus       232 wSlGvil~elltG~~Pf~~  250 (382)
T cd05625         232 WSVGVILYEMLVGQPPFLA  250 (382)
T ss_pred             EechHHHHHHHhCCCCCCC
Confidence            9999999999999999953

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=8.7e-38  Score=299.28  Aligned_cols=248  Identities=22%  Similarity=0.330  Sum_probs=192.5

Q ss_pred             HHhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC-ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          104 NFQALLGHGSSASVFKGILS-DGTSVAVKRINGEE-NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      .+.+.||+|+||.||+|... ++..+++|.+.... ...+.+.+|+.+++.++|||++++++++. .++..++|+||+++
T Consensus         8 ~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-~~~~~~~v~e~~~~   86 (282)
T cd06643           8 EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-YENNLWILIEFCAG   86 (282)
T ss_pred             HHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEe-eCCEEEEEEEecCC
Confidence            44578999999999999965 47788999886533 34567889999999999999999999887 45688999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      ++|..++....         ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++....
T Consensus        87 ~~l~~~~~~~~---------~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  154 (282)
T cd06643          87 GAVDAVMLELE---------RPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT  154 (282)
T ss_pred             CcHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccc
Confidence            99998875321         248999999999999999999999   899999999999999999999999999987653


Q ss_pred             CCCCceeeeccCCccccchhhhh-----cCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhh
Q 047276          262 RDQSRCITTIRGTRGYLAPEWIL-----EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKM  336 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (453)
                      ... .......+++.|+|||++.     +..++.++|||||||++|||++|+.||......            .......
T Consensus       155 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------------~~~~~~~  221 (282)
T cd06643         155 RTI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM------------RVLLKIA  221 (282)
T ss_pred             ccc-cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH------------HHHHHHh
Confidence            322 1223456889999999874     345778999999999999999999998532110            0011111


Q ss_pred             hcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          337 KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       337 ~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                       .+..     +.+.    .+......+.+++.+||+.+|.+||++.++++.
T Consensus       222 -~~~~-----~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         222 -KSEP-----PTLA----QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             -hcCC-----CCCC----CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             1100     0110    112234568899999999999999999998744

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=6.6e-38  Score=295.57  Aligned_cols=248  Identities=23%  Similarity=0.358  Sum_probs=196.2

Q ss_pred             HHhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          104 NFQALLGHGSSASVFKGILS-DGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      .+.+.||+|++|.||++... +++.+|+|.+....   ...+.+.+|+.++++++|+|++++++.+...+...+++|||+
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (257)
T cd08223           3 CFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFC   82 (257)
T ss_pred             eEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEeccc
Confidence            34678999999999999964 57889999986532   234568899999999999999999987654444578999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ++++|.+++....        ...+++.++.+++.+++.|++|||+   .+++|+||||+||+++.++.++|+|||++..
T Consensus        83 ~~~~l~~~l~~~~--------~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~  151 (257)
T cd08223          83 EGGDLYHKLKEQK--------GKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARV  151 (257)
T ss_pred             CCCcHHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEE
Confidence            9999999986432        2348999999999999999999999   8999999999999999999999999999987


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      ..... .......+++.|+|||.+.+..++.++||||||++++||++|+.||...+.            ..... ....+
T Consensus       152 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------------~~~~~-~~~~~  217 (257)
T cd08223         152 LENQC-DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------------NSLVY-RIIEG  217 (257)
T ss_pred             ecccC-CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------------HHHHH-HHHhc
Confidence            64322 223345688899999999988899999999999999999999999852110            00011 11111


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      .+.           ..+......+.+++.+|++.+|++||++.++++.
T Consensus       218 ~~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         218 KLP-----------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             CCC-----------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            110           1223344568999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.3e-38  Score=316.86  Aligned_cols=250  Identities=21%  Similarity=0.241  Sum_probs=190.5

Q ss_pred             HHHhcccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          103 DNFQALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      +.+.+.||+|+||.||++... +++.+|+|++...    ......+.+|..+++.++||||+++++++. .++..++|||
T Consensus        45 y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~-~~~~~~lv~E  123 (371)
T cd05622          45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ-DDRYLYMVME  123 (371)
T ss_pred             cEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-cCCEEEEEEc
Confidence            334588999999999999965 5789999998641    223455788999999999999999999875 5668899999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |+++|+|.+++...           .++...+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus       124 y~~gg~L~~~~~~~-----------~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a  189 (371)
T cd05622         124 YMPGGDLVNLMSNY-----------DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTC  189 (371)
T ss_pred             CCCCCcHHHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence            99999999998432           27888888999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCceeeeccCCccccchhhhhcC----CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHH
Q 047276          258 KLMSRDQSRCITTIRGTRGYLAPEWILEQ----GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVN  333 (453)
Q Consensus       258 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  333 (453)
                      ...............||+.|+|||.+...    .++.++|||||||++|||++|+.||.....            .....
T Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------------~~~~~  257 (371)
T cd05622         190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------------VGTYS  257 (371)
T ss_pred             eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------------HHHHH
Confidence            87654332223456799999999998753    378999999999999999999999953211            00011


Q ss_pred             HhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCC--CCCHHHHHHHh
Q 047276          334 EKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARL--RPSMARVVEML  388 (453)
Q Consensus       334 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPs~~~v~~~L  388 (453)
                      ..........     +.    ........+.+++..|+..++.+  ||++.++.+..
T Consensus       258 ~i~~~~~~~~-----~~----~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         258 KIMNHKNSLT-----FP----DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             HHHcCCCccc-----CC----CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            1111100000     11    11133455788999999844433  78888888654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.3e-38  Score=308.94  Aligned_cols=197  Identities=24%  Similarity=0.280  Sum_probs=161.7

Q ss_pred             HhcccCcC--CceEEEEEEe-CCCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEe
Q 047276          105 FQALLGHG--SSASVFKGIL-SDGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       105 ~~~~lG~G--~fG~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      +.++||+|  +||+||++.. .+|+.||+|+++...   ...+.+.+|+.+++.++||||++++++|. .++..++|+||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-~~~~~~lv~e~   80 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI-ADNELWVVTSF   80 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-ECCEEEEEEec
Confidence            35689999  7899999985 578999999997532   22345778999999999999999999987 45688999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +++|+|.+++..+..        ..+++..+.+++.|++.||+|||+   .+++||||||+|||++.++.++++||+...
T Consensus        81 ~~~~~l~~~~~~~~~--------~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~  149 (327)
T cd08227          81 MAYGSAKDLICTHFM--------DGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNL  149 (327)
T ss_pred             cCCCcHHHHHHhhcc--------CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhh
Confidence            999999999854321        238999999999999999999998   899999999999999999999999998754


Q ss_pred             cccCCCCc------eeeeccCCccccchhhhhc--CCCCccccchhHHHHHHHHHcCCCCCcc
Q 047276          259 LMSRDQSR------CITTIRGTRGYLAPEWILE--QGVSEKCDIYSYGMVLLELTGGRRNVSL  313 (453)
Q Consensus       259 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~--~~~~~~sDV~S~Gvil~elltG~~p~~~  313 (453)
                      ........      ......++..|+|||++.+  ..++.++|||||||++|||++|+.||..
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  212 (327)
T cd08227         150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD  212 (327)
T ss_pred             ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            43211110      0122346778999999876  4589999999999999999999999963

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.5e-38  Score=291.39  Aligned_cols=263  Identities=23%  Similarity=0.292  Sum_probs=194.9

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCCc---cHHHHHHHHHHHHhcCCCc-eeeEeeEEEecCC-----CeEEE
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEEN---GEKEFRSEVAAIASAQHVN-LVRLLGYCVVPGG-----PRYLV  175 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~-----~~~lv  175 (453)
                      -++||+|+||+||+|+. .+|+.||+|+++.+..   -...-.+|+.+++.++|+| ||.|++++.....     ..++|
T Consensus        16 ~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lv   95 (323)
T KOG0594|consen   16 VEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLV   95 (323)
T ss_pred             HHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEE
Confidence            35699999999999994 5789999999976433   2345678999999999999 9999999886553     67899


Q ss_pred             EEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecc
Q 047276          176 YEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFG  255 (453)
Q Consensus       176 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfG  255 (453)
                      +||+.. +|..++.......      ..++...+..++.|++.||+|||+   ++|+||||||.|+||+++|.+||+|||
T Consensus        96 fe~~d~-DL~~ymd~~~~~~------~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   96 FEFLDR-DLKKYMDSLPKKP------QGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             EEeecc-cHHHHHHhccccc------cCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccc
Confidence            999966 9999997654311      236668899999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCceeeeccCCccccchhhhhcC-CCCccccchhHHHHHHHHHcCCCCCcccccCC----------CCCccc
Q 047276          256 LSKLMSRDQSRCITTIRGTRGYLAPEWILEQ-GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGN----------DKSKNK  324 (453)
Q Consensus       256 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~----------~~~~~~  324 (453)
                      +|+...-.. ...+...+|.+|.|||.+.+. .|+...|+||+|||+.||++++.-|.+..+-.          ..+...
T Consensus       166 lAra~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  166 LARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD  244 (323)
T ss_pred             hHHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence            999664222 223455688899999999876 79999999999999999999998885433211          111222


Q ss_pred             ccchhHHHHHhhhcCcccccccccccCCCCCcH---HHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          325 WQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDE---TQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~---~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      |...........   ...+     .........   .......+++.+|++.+|.+|.|+...+++
T Consensus       245 Wp~v~~~~~~k~---~f~~-----~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  245 WPGVSSLPDYKA---PFPK-----WPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCccccccccc---cCcC-----CCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            221110000000   0000     000000000   111368899999999999999999998865

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.9e-38  Score=303.29  Aligned_cols=242  Identities=21%  Similarity=0.263  Sum_probs=188.9

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCC----ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      .+.||+|+||+||++.. .+++.+|+|.+....    .....+.+|+++++.++|+|++++.+++. .++..+++|||++
T Consensus         5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-~~~~~~lv~e~~~   83 (285)
T cd05632           5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYE-TKDALCLVLTIMN   83 (285)
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEe-cCCEEEEEEEecc
Confidence            46799999999999996 468899999986532    22345788999999999999999998875 5668899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +++|.+++....        ...+++..+..++.|++.||.|||+   .+|+||||||+||++++++.+||+|||++...
T Consensus        84 ~~~L~~~~~~~~--------~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~  152 (285)
T cd05632          84 GGDLKFHIYNMG--------NPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKI  152 (285)
T ss_pred             CccHHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceec
Confidence            999998885432        1248999999999999999999999   89999999999999999999999999998765


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      .....  .....|+..|+|||++.+..++.++|+||||+++|||++|+.||.......         ...........+.
T Consensus       153 ~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~---------~~~~~~~~~~~~~  221 (285)
T cd05632         153 PEGES--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV---------KREEVDRRVLETE  221 (285)
T ss_pred             CCCCc--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHHHHhhhccc
Confidence            43221  233468999999999988889999999999999999999999995321110         0000111111110


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHH
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMA  382 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~  382 (453)
                                  ..+.......+.+++..|++.+|++||++.
T Consensus       222 ------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~  251 (285)
T cd05632         222 ------------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQ  251 (285)
T ss_pred             ------------cccCccCCHHHHHHHHHHccCCHhHcCCCc
Confidence                        011222344578999999999999999943

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-38  Score=295.86  Aligned_cols=246  Identities=21%  Similarity=0.302  Sum_probs=193.7

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCCCc------cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGEEN------GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      ..+.||+|+||.||++.. .+++.+|+|.+.....      ....+.+|+.++++++||||+++++++. .+...++++|
T Consensus         6 ~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~~v~e   84 (263)
T cd06625           6 RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR-DDETLSIFME   84 (263)
T ss_pred             ccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc-cCCeEEEEEE
Confidence            357899999999999985 4689999998864221      2246888999999999999999999976 4568899999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |+++++|.+++...          ..+++....+++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++
T Consensus        85 ~~~~~~l~~~~~~~----------~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~  151 (263)
T cd06625          85 YMPGGSVKDQLKAY----------GALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGAS  151 (263)
T ss_pred             ECCCCcHHHHHHHh----------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence            99999999998543          237889999999999999999999   89999999999999999999999999998


Q ss_pred             ccccCCCCcee--eeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHh
Q 047276          258 KLMSRDQSRCI--TTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEK  335 (453)
Q Consensus       258 ~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  335 (453)
                      ...........  ....++..|+|||.+.+..++.++||||||+++|||++|+.||...+..            ......
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------------~~~~~~  219 (263)
T cd06625         152 KRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM------------AAIFKI  219 (263)
T ss_pred             eeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH------------HHHHHH
Confidence            76543221111  3345788999999999888999999999999999999999998532110            000111


Q ss_pred             hhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          336 MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       336 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      ......           ...+......+.+++.+|++.+|.+|||+.++++.
T Consensus       220 ~~~~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         220 ATQPTN-----------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             hccCCC-----------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            000000           11222344568899999999999999999998864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.1e-38  Score=298.69  Aligned_cols=251  Identities=25%  Similarity=0.403  Sum_probs=197.4

Q ss_pred             HHhcccCcCCceEEEEEEeC-CCc----EEEEEEecCCCc--cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEE
Q 047276          104 NFQALLGHGSSASVFKGILS-DGT----SVAVKRINGEEN--GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVY  176 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~-~g~----~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~  176 (453)
                      .+.+.||+|+||+||+|... +|.    .+|+|.+.....  ...++.+|+.++++++|||+++++++|..  ...++++
T Consensus        10 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~v~   87 (279)
T cd05057          10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS--SQVQLIT   87 (279)
T ss_pred             EEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CceEEEE
Confidence            44578999999999999864 333    589998875432  34578899999999999999999999874  6789999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||+++|+|.+++....         ..+++...+.++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+
T Consensus        88 e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~  155 (279)
T cd05057          88 QLMPLGCLLDYVRNHK---------DNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGL  155 (279)
T ss_pred             ecCCCCcHHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcc
Confidence            9999999999986432         238999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCcee-eeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHH
Q 047276          257 SKLMSRDQSRCI-TTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNE  334 (453)
Q Consensus       257 a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  334 (453)
                      ++.......... ....++..|+|||.+....++.++|+||||+++||+++ |+.||.....             .....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------------~~~~~  222 (279)
T cd05057         156 AKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-------------VEIPD  222 (279)
T ss_pred             cccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-------------HHHHH
Confidence            987653322111 12223568999999988889999999999999999998 9999853211             01111


Q ss_pred             hhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          335 KMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       335 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      ....+..       .    ..+..+...+.+++.+||..+|+.||++.++++.|+...
T Consensus       223 ~~~~~~~-------~----~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~  269 (279)
T cd05057         223 LLEKGER-------L----PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA  269 (279)
T ss_pred             HHhCCCC-------C----CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            2211110       0    111123345889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=5.5e-38  Score=311.33  Aligned_cols=265  Identities=22%  Similarity=0.291  Sum_probs=190.1

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEecC-----CCeEEE
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG-----GPRYLV  175 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~~lv  175 (453)
                      +.+.||+|+||.||++.. .+|..||+|.+...   ......+.+|+.+++.++||||+++++++....     ...++|
T Consensus        25 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv  104 (359)
T cd07876          25 QLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLV  104 (359)
T ss_pred             EEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEE
Confidence            357899999999999986 45889999998642   233456889999999999999999999875332     246899


Q ss_pred             EEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecc
Q 047276          176 YEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFG  255 (453)
Q Consensus       176 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfG  255 (453)
                      |||+++ +|.+.+..            .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||
T Consensus       105 ~e~~~~-~l~~~~~~------------~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg  168 (359)
T cd07876         105 MELMDA-NLCQVIHM------------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG  168 (359)
T ss_pred             EeCCCc-CHHHHHhc------------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCC
Confidence            999975 67666521            27888899999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCC---------Ccccc-
Q 047276          256 LSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDK---------SKNKW-  325 (453)
Q Consensus       256 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~---------~~~~~-  325 (453)
                      +++......  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.....         ....+ 
T Consensus       169 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  246 (359)
T cd07876         169 LARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM  246 (359)
T ss_pred             CccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence            997543221  223456899999999999889999999999999999999999999643211000         00000 


Q ss_pred             cchhHHHHHhhhc-C-----cccccccccc-cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          326 QYFPKIVNEKMKE-G-----KLMEIVDQRL-TDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       326 ~~~~~~~~~~~~~-~-----~~~~~~d~~l-~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      ............. .     .+.+...... .............+.+++.+|++.||++|||+.|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0000000000000 0     0000000000 00001111224568899999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.7e-37  Score=304.58  Aligned_cols=195  Identities=23%  Similarity=0.306  Sum_probs=165.4

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      +.++||+|+||+||+++.. +++.+|+|.+...    ......+..|+.++..++|+||+++++++. ..+..++||||+
T Consensus         5 ~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~~lv~ey~   83 (332)
T cd05623           5 ILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ-DENNLYLVMDYY   83 (332)
T ss_pred             EEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe-cCCEEEEEEecc
Confidence            4578999999999999965 4778999998641    222345888999999999999999999876 566889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ++|+|.+++....         ..+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++..
T Consensus        84 ~~g~L~~~l~~~~---------~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~  151 (332)
T cd05623          84 VGGDLLTLLSKFE---------DRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLK  151 (332)
T ss_pred             CCCcHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchhee
Confidence            9999999996432         238899999999999999999999   8999999999999999999999999999876


Q ss_pred             ccCCCCceeeeccCCccccchhhhh-----cCCCCccccchhHHHHHHHHHcCCCCCc
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWIL-----EQGVSEKCDIYSYGMVLLELTGGRRNVS  312 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~S~Gvil~elltG~~p~~  312 (453)
                      .............||+.|+|||++.     ...++.++|||||||++|||++|+.||.
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~  209 (332)
T cd05623         152 LMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY  209 (332)
T ss_pred             cccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCC
Confidence            5443333333457999999999986     3467899999999999999999999995

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=5.4e-38  Score=332.61  Aligned_cols=263  Identities=22%  Similarity=0.267  Sum_probs=197.2

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC----ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      +.++||+|+||.||+|... +|+.||+|++....    ...+.|.+|+.++++++||||+++++++. .++..+++|||+
T Consensus         6 Ii~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~-d~~~lyLVMEY~   84 (932)
T PRK13184          6 IIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS-DGDPVYYTMPYI   84 (932)
T ss_pred             EEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe-eCCEEEEEEEcC
Confidence            3578999999999999964 58999999987532    22456899999999999999999999986 556889999999


Q ss_pred             CCCChhhhhccCCCCC-CCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          180 QNGSLDHWIFPTSRRS-EGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~-~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      ++|+|.+++....... ........+++...++++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        85 eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFGLAk  161 (932)
T PRK13184         85 EGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAI  161 (932)
T ss_pred             CCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecCcce
Confidence            9999999986432111 000112346788899999999999999999   899999999999999999999999999998


Q ss_pred             cccCCC-----------------CceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCC
Q 047276          259 LMSRDQ-----------------SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKS  321 (453)
Q Consensus       259 ~~~~~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~  321 (453)
                      ......                 ........||+.|+|||++.+..++.++|||||||++|||+||+.||......... 
T Consensus       162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~-  240 (932)
T PRK13184        162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS-  240 (932)
T ss_pred             ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh-
Confidence            662110                 00112346899999999999989999999999999999999999999532111000 


Q ss_pred             cccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHhccccC
Q 047276          322 KNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRP-SMARVVEMLEGRVA  393 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-s~~~v~~~L~~~~~  393 (453)
                                ....     .   .++.-   .....+.+..+.+++.+|++.+|++|| +++++.+.|+....
T Consensus       241 ----------~~~~-----i---~~P~~---~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        241 ----------YRDV-----I---LSPIE---VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             ----------hhhh-----c---cChhh---ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                      0000     0   00000   000112334578999999999999995 66777777766543

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.1e-38  Score=301.47  Aligned_cols=239  Identities=25%  Similarity=0.391  Sum_probs=185.0

Q ss_pred             cccCcCCceEEEEEEeCC--------CcEEEEEEecCCC-ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          107 ALLGHGSSASVFKGILSD--------GTSVAVKRINGEE-NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~--------g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      +.||+|+||.||+|....        ...+++|.+.... ...+.+.+|+.+++.++|||++++++++.. +...++|||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-~~~~~lv~e   79 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVC-GDESIMVQE   79 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEe-CCCcEEEEe
Confidence            469999999999998632        2348888876532 334578899999999999999999999874 457899999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCc--------E
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYR--------A  249 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~--------~  249 (453)
                      |+++|+|.+++..+.         ..+++..+++++.|++.||+|||+   .+++||||||+||+++.++.        +
T Consensus        80 ~~~~g~L~~~l~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~  147 (258)
T cd05078          80 YVKFGSLDTYLKKNK---------NLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFI  147 (258)
T ss_pred             cCCCCcHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceE
Confidence            999999999996443         238999999999999999999999   89999999999999987765        6


Q ss_pred             EEeeccccccccCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCC-CCCcccccCCCCCcccccc
Q 047276          250 VVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR-RNVSLIEHGNDKSKNKWQY  327 (453)
Q Consensus       250 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~-~p~~~~~~~~~~~~~~~~~  327 (453)
                      +++|||++......     ....++..|+|||++.+ ..++.++||||||+++|||++|. .|+...+...         
T Consensus       148 ~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~---------  213 (258)
T cd05078         148 KLSDPGISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---------  213 (258)
T ss_pred             EecccccccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH---------
Confidence            99999988654321     23457889999999986 45799999999999999999985 5543211100         


Q ss_pred             hhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 047276          328 FPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE  389 (453)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~  389 (453)
                          ...... .        .    ...+......+.+++.+||+.+|++|||++++++.|+
T Consensus       214 ----~~~~~~-~--------~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         214 ----KLQFYE-D--------R----HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ----HHHHHH-c--------c----ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                000000 0        0    0112222346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.3e-37  Score=296.85  Aligned_cols=256  Identities=27%  Similarity=0.389  Sum_probs=196.1

Q ss_pred             hcccCcCCceEEEEEEeC------CCcEEEEEEecCCCcc--HHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          106 QALLGHGSSASVFKGILS------DGTSVAVKRINGEENG--EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~------~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      ...||+|+||+||+|+.+      +.+.+++|.+......  ...+.+|+.++++++|+|++++++++. .....++|||
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e   88 (275)
T cd05046          10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCR-EAEPHYMILE   88 (275)
T ss_pred             eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEEC-CCCcceEEEE
Confidence            367999999999999964      2467999988654332  467999999999999999999999876 4567899999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |+++|+|.+++......... .....+++..+..++.|++.||+|||+   .+++||||||+||+++.++.++++|||++
T Consensus        89 ~~~~~~L~~~i~~~~~~~~~-~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~~~~  164 (275)
T cd05046          89 YTDLGDLKQFLRATKSKDEK-LKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLS  164 (275)
T ss_pred             ecCCCcHHHHHHhccccccc-ccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEcccccc
Confidence            99999999999654321100 012248999999999999999999998   89999999999999999999999999998


Q ss_pred             ccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhh
Q 047276          258 KLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKM  336 (453)
Q Consensus       258 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (453)
                      ...............++..|+|||.+.+..++.++||||||+++|||++ |..||......            . .....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~------------~-~~~~~  231 (275)
T cd05046         165 KDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE------------E-VLNRL  231 (275)
T ss_pred             cccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH------------H-HHHHH
Confidence            7553322222233345678999999988888999999999999999998 77888422110            0 11111


Q ss_pred             hcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 047276          337 KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE  389 (453)
Q Consensus       337 ~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~  389 (453)
                      ..+.....          .+......+.+++.+|++.+|++||++.+++..|.
T Consensus       232 ~~~~~~~~----------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         232 QAGKLELP----------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             HcCCcCCC----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            11111100          11123346899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=6.4e-38  Score=300.66  Aligned_cols=250  Identities=23%  Similarity=0.345  Sum_probs=192.2

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCCccHHHHHHHHHHHHhc-CCCceeeEeeEEEe----cCCCeEEEEEec
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRSEVAAIASA-QHVNLVRLLGYCVV----PGGPRYLVYEFI  179 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----~~~~~~lv~e~~  179 (453)
                      .+.||+|+||.||++.. .+++.+|+|.+.........+..|+.++.++ +|||+++++++|..    .++..++||||+
T Consensus        23 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~  102 (286)
T cd06638          23 IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELC  102 (286)
T ss_pred             eeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeec
Confidence            47899999999999986 4578999998876444456788999999999 69999999998753    234679999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ++++|.+++.....      ....+++..+..++.|++.||.|||+   .+++||||||+||++++++.+||+|||++..
T Consensus       103 ~~~~L~~~l~~~~~------~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  173 (286)
T cd06638         103 NGGSVTDLVKGFLK------RGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQ  173 (286)
T ss_pred             CCCCHHHHHHHhhc------cCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEccCCceee
Confidence            99999998753221      12348899999999999999999999   8999999999999999999999999999886


Q ss_pred             ccCCCCceeeeccCCccccchhhhhc-----CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHH
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILE-----QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNE  334 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  334 (453)
                      ...... ......|++.|+|||++..     ..++.++|||||||++|||++|+.||........            ...
T Consensus       174 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~------------~~~  240 (286)
T cd06638         174 LTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA------------LFK  240 (286)
T ss_pred             cccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH------------Hhh
Confidence            643221 2233468899999998753     4578899999999999999999999853221100            000


Q ss_pred             hhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          335 KMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       335 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                       ...+.     .+.+.    .+......+.+++.+|++.+|++|||+.++++.
T Consensus       241 -~~~~~-----~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         241 -IPRNP-----PPTLH----QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             -ccccC-----CCccc----CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence             00000     00110    011123458899999999999999999999865

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3e-38  Score=330.79  Aligned_cols=270  Identities=24%  Similarity=0.389  Sum_probs=211.5

Q ss_pred             HHHHHHHHHHHhcccCcCCceEEEEEEeC----C----CcEEEEEEecCC--CccHHHHHHHHHHHHhc-CCCceeeEee
Q 047276           95 SKELEEATDNFQALLGHGSSASVFKGILS----D----GTSVAVKRINGE--ENGEKEFRSEVAAIASA-QHVNLVRLLG  163 (453)
Q Consensus        95 ~~el~~~~~~~~~~lG~G~fG~Vy~~~~~----~----g~~vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g  163 (453)
                      ..|+......+.+.||+|.||.|++|...    .    ...||||.++..  ....+.+..|+++|+.+ +|+|++.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            34555444456679999999999999843    1    356999999863  34457799999999998 5999999999


Q ss_pred             EEEecCCCeEEEEEecCCCChhhhhccCCCCCCCC----CCC--CCCCHHHHHHHHHHHHHHhccccccCCCceeccCCC
Q 047276          164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGH----YSG--GCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVK  237 (453)
Q Consensus       164 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~----~~~--~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk  237 (453)
                      +|.. +++.++|.||+.+|+|.+||..++....-.    ...  ..|+....+.++.|||.||+||++   .+++||||.
T Consensus       370 ~~t~-~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLA  445 (609)
T KOG0200|consen  370 ACTQ-DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLA  445 (609)
T ss_pred             eecc-CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhh
Confidence            9975 778999999999999999998776110000    011  248999999999999999999999   899999999


Q ss_pred             CCcEEECCCCcEEEeeccccccccCCCCceeeecc--CCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCccc
Q 047276          238 PENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR--GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLI  314 (453)
Q Consensus       238 ~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~  314 (453)
                      ++|||+..+..+||+|||+++..............  -+..|||||.+....|+.|||||||||+||||+| |..||...
T Consensus       446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~  525 (609)
T KOG0200|consen  446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI  525 (609)
T ss_pred             hhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence            99999999999999999999976655544323222  3557999999999999999999999999999999 88888421


Q ss_pred             ccCCCCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 047276          315 EHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR  391 (453)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~  391 (453)
                                 ..... +.+.+++|...+           .|..+..++.+++..||+.+|++||++.++++.++..
T Consensus       526 -----------~~~~~-l~~~l~~G~r~~-----------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  526 -----------PPTEE-LLEFLKEGNRME-----------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             -----------CcHHH-HHHHHhcCCCCC-----------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence                       11111 233445544211           2334456688999999999999999999999999873

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.7e-37  Score=293.34  Aligned_cols=249  Identities=23%  Similarity=0.334  Sum_probs=192.9

Q ss_pred             HHHhcccCcCCceEEEEEEe-CCCcEEEEEEecCCC-ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          103 DNFQALLGHGSSASVFKGIL-SDGTSVAVKRINGEE-NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.+.+.||+|+||.||+|.. .+++.||+|.++... .....+.+|+.+++.++|||++++++++. .++..++++||++
T Consensus        11 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~-~~~~~~lv~e~~~   89 (267)
T cd06645          11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL-RRDKLWICMEFCG   89 (267)
T ss_pred             HHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEE-eCCEEEEEEeccC
Confidence            45568899999999999985 468899999987543 23356788999999999999999999876 5568899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +++|.+++...          +.+++...+.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++...
T Consensus        90 ~~~L~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd06645          90 GGSLQDIYHVT----------GPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQI  156 (267)
T ss_pred             CCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEc
Confidence            99999998533          238999999999999999999999   89999999999999999999999999998765


Q ss_pred             cCCCCceeeeccCCccccchhhhh---cCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhh
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWIL---EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMK  337 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (453)
                      .... .......|+..|+|||++.   ...++.++|||||||++|||++|+.||....+...            .. ...
T Consensus       157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~------------~~-~~~  222 (267)
T cd06645         157 TATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------------LF-LMT  222 (267)
T ss_pred             cCcc-cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh------------HH-hhh
Confidence            4322 1223456899999999874   45688999999999999999999999853221100            00 000


Q ss_pred             cCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          338 EGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       338 ~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ....   ..+.+....    .....+.+++.+|++.+|++||+++++++
T Consensus       223 ~~~~---~~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         223 KSNF---QPPKLKDKM----KWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             ccCC---CCCcccccC----CCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            0000   001111101    12335789999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4.1e-38  Score=302.91  Aligned_cols=259  Identities=25%  Similarity=0.370  Sum_probs=197.3

Q ss_pred             HHHHHHHHHH--hcccCcCCceEEEEEEe-CCCcEEEEEEecCCCccHHHHHHHHHHHHhc-CCCceeeEeeEEEecC--
Q 047276           96 KELEEATDNF--QALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPG--  169 (453)
Q Consensus        96 ~el~~~~~~~--~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~--  169 (453)
                      .++..++.+|  .+.||+|+||.||++.. .+++.+|+|.+.........+.+|+.++.++ +|||++++++++...+  
T Consensus        15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~   94 (291)
T cd06639          15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL   94 (291)
T ss_pred             ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence            3444444444  47899999999999996 4688999999876555566788999999998 7999999999987433  


Q ss_pred             --CCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCC
Q 047276          170 --GPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENY  247 (453)
Q Consensus       170 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~  247 (453)
                        ...++|+||+++|+|.+++.....      ....+++..++.++.|++.||+|||+   .+++|+||||+||++++++
T Consensus        95 ~~~~~~lv~ey~~~~sL~~~~~~~~~------~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~  165 (291)
T cd06639          95 VGGQLWLVLELCNGGSVTELVKGLLI------CGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEG  165 (291)
T ss_pred             CCCeeEEEEEECCCCcHHHHHHHhhh------cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCC
Confidence              357999999999999998853221      12348999999999999999999998   8999999999999999999


Q ss_pred             cEEEeeccccccccCCCCceeeeccCCccccchhhhhcC-----CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCc
Q 047276          248 RAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQ-----GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSK  322 (453)
Q Consensus       248 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~  322 (453)
                      .+||+|||++........ ......++..|+|||.+...     .++.++|||||||++|||++|+.||....+.     
T Consensus       166 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-----  239 (291)
T cd06639         166 GVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-----  239 (291)
T ss_pred             CEEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-----
Confidence            999999999886543221 12334678899999987643     3688999999999999999999998532110     


Q ss_pred             ccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          323 NKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                             ..... +..+......         .+......+.+++.+|++.+|++||++.++++
T Consensus       240 -------~~~~~-~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         240 -------KTLFK-IPRNPPPTLL---------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             -------HHHHH-HhcCCCCCCC---------cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                   00111 1111111111         11223346899999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-38  Score=308.97  Aligned_cols=239  Identities=24%  Similarity=0.313  Sum_probs=182.1

Q ss_pred             cCcCCceEEEEEEeC-CCcEEEEEEecCCC----ccHHHHHHHHHHHHhc---CCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          109 LGHGSSASVFKGILS-DGTSVAVKRINGEE----NGEKEFRSEVAAIASA---QHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       109 lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      ||+|+||+||+|+.. +|+.||||++....    .....+..|..++...   +||||+++++++. ..+..++||||++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~-~~~~~~lv~e~~~   79 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQ-TDSDLYLVTDYMS   79 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEe-cCCeEEEEEcCCC
Confidence            799999999999964 58999999986421    1223455677776655   6999999999875 5668899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|.+++...          ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++...
T Consensus        80 ~g~L~~~l~~~----------~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~  146 (330)
T cd05586          80 GGELFWHLQKE----------GRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKAN  146 (330)
T ss_pred             CChHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence            99999988533          238899999999999999999999   89999999999999999999999999998754


Q ss_pred             cCCCCceeeeccCCccccchhhhhcC-CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQ-GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      .... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.....             ......+..+
T Consensus       147 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-------------~~~~~~i~~~  212 (330)
T cd05586         147 LTDN-KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-------------QQMYRNIAFG  212 (330)
T ss_pred             CCCC-CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-------------HHHHHHHHcC
Confidence            3222 123446789999999998754 479999999999999999999999853210             0011111111


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCC----HHHHHH
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPS----MARVVE  386 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs----~~~v~~  386 (453)
                      ..      .+..     ......+.+++.+||+.+|++||+    +.++++
T Consensus       213 ~~------~~~~-----~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         213 KV------RFPK-----NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             CC------CCCC-----ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            11      1110     112345789999999999999995    555543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=6.4e-38  Score=300.91  Aligned_cols=246  Identities=23%  Similarity=0.289  Sum_probs=191.7

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCC----ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      .++||+|+||+||++.. .+++.||+|.+....    .....+..|+.++++++|+|++++++.+. .++..++||||++
T Consensus         5 ~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-~~~~~~lv~e~~~   83 (285)
T cd05630           5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYE-TKDALCLVLTLMN   83 (285)
T ss_pred             eEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEe-cCCEEEEEEEecC
Confidence            46899999999999996 468899999986432    22345788999999999999999999876 4568899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|.+++.....        ..+++..+..++.|++.||.|||+   .+++||||||+||++++++.++|+|||++...
T Consensus        84 g~~L~~~l~~~~~--------~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~  152 (285)
T cd05630          84 GGDLKFHIYHMGE--------AGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHV  152 (285)
T ss_pred             CCcHHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeec
Confidence            9999998854321        238899999999999999999998   89999999999999999999999999998765


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      .....  .....|+..|+|||.+.+..++.++||||||+++|||++|+.||.......     .+    .......... 
T Consensus       153 ~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-----~~----~~~~~~~~~~-  220 (285)
T cd05630         153 PEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-----KR----EEVERLVKEV-  220 (285)
T ss_pred             CCCcc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-----hH----HHHHhhhhhh-
Confidence            43221  233468999999999998899999999999999999999999996322110     00    0001110000 


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPS-----MARVVE  386 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~~v~~  386 (453)
                           ...      .+......+.+++..||+.+|++|||     +.++++
T Consensus       221 -----~~~------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         221 -----QEE------YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             -----hhh------cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence                 000      11223345789999999999999999     677764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.2e-37  Score=293.69  Aligned_cols=246  Identities=23%  Similarity=0.304  Sum_probs=195.5

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      +.+.||+|+||.||++... +++.+|+|.++..  ....+.+..|+.+++.++|+|++++++.+. .++..++++||+++
T Consensus         4 ~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~   82 (255)
T cd08219           4 VLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFE-ADGHLYIVMEYCDG   82 (255)
T ss_pred             EEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEE-ECCEEEEEEeeCCC
Confidence            4578999999999999954 6889999988642  334467889999999999999999999876 56688999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      |+|.+++....        ...+++...+.++.|++.||.|||+   .+++|+||||+||++++++.++|+|||++....
T Consensus        83 ~~l~~~~~~~~--------~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  151 (255)
T cd08219          83 GDLMQKIKLQR--------GKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT  151 (255)
T ss_pred             CcHHHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeec
Confidence            99999885332        2337889999999999999999999   899999999999999999999999999997664


Q ss_pred             CCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcc
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKL  341 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (453)
                      .... ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.....            .. .......+..
T Consensus       152 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------------~~-~~~~~~~~~~  217 (255)
T cd08219         152 SPGA-YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW------------KN-LILKVCQGSY  217 (255)
T ss_pred             cccc-ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH------------HH-HHHHHhcCCC
Confidence            3221 22345688899999999888899999999999999999999999953210            00 1111111111


Q ss_pred             cccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          342 MEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       342 ~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      .           ..+......+.+++.+||+.+|++||++.+++..
T Consensus       218 ~-----------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         218 K-----------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             C-----------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            1           1122234458899999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1e-37  Score=301.27  Aligned_cols=245  Identities=24%  Similarity=0.371  Sum_probs=194.8

Q ss_pred             HHhcccCcCCceEEEEEEe-CCCcEEEEEEecCC-CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          104 NFQALLGHGSSASVFKGIL-SDGTSVAVKRINGE-ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      .+.+.||+|+||.||++.. .+++.||+|.+... ....+.+.+|+.+++.++|+|++++++++. .++..++||||+++
T Consensus        22 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~~~lv~e~~~~  100 (297)
T cd06656          22 TRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-VGDELWVVMEYLAG  100 (297)
T ss_pred             eeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEeecccCC
Confidence            3457899999999999995 57899999998753 334466889999999999999999999886 56688999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      ++|.+++..           ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++....
T Consensus       101 ~~L~~~~~~-----------~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~  166 (297)
T cd06656         101 GSLTDVVTE-----------TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  166 (297)
T ss_pred             CCHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence            999999842           237899999999999999999999   899999999999999999999999999987654


Q ss_pred             CCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcc
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKL  341 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (453)
                      .... ......+++.|+|||.+.+..++.++|||||||++|++++|+.||..........            .....+  
T Consensus       167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------------~~~~~~--  231 (297)
T cd06656         167 PEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------------LIATNG--  231 (297)
T ss_pred             CCcc-CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------------eeccCC--
Confidence            3322 1233468889999999998889999999999999999999999995322111000            000000  


Q ss_pred             cccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          342 MEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       342 ~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                          .+.+    ..+......+.+++.+|++.+|++||++.++++
T Consensus       232 ----~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         232 ----TPEL----QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             ----CCCC----CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                0000    112233445789999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-38  Score=309.03  Aligned_cols=249  Identities=22%  Similarity=0.303  Sum_probs=205.8

Q ss_pred             HHHhcccCcCCceEEEEEEeC-CCcEEEEEEecCCCc---cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEe
Q 047276          103 DNFQALLGHGSSASVFKGILS-DGTSVAVKRINGEEN---GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      |.+.+++|+|+||.++..+.+ ++..+++|.++....   ..+...+|+.++++++|||||.+.+.+..++...++||+|
T Consensus         6 Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y   85 (426)
T KOG0589|consen    6 YEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEY   85 (426)
T ss_pred             hhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEee
Confidence            445679999999999988854 567899999876432   2335788999999999999999999987555448999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      ++||+|.+.+...+.        ..++++...+++.|++.|+.|||+   ..|+|||||+.||+++.++.+||+|||+|+
T Consensus        86 ~eGg~l~~~i~~~k~--------~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK  154 (426)
T KOG0589|consen   86 CEGGDLAQLIKEQKG--------VLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAK  154 (426)
T ss_pred             cCCCCHHHHHHHHhh--------ccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhh
Confidence            999999999976542        338999999999999999999997   899999999999999999999999999999


Q ss_pred             cccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      .+..... ......||+.||.||.+.+..|+.|+|+|||||++|||++-+++|...+            ...++.+....
T Consensus       155 ~l~~~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~------------m~~Li~ki~~~  221 (426)
T KOG0589|consen  155 ILNPEDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN------------MSELILKINRG  221 (426)
T ss_pred             hcCCchh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc------------hHHHHHHHhhc
Confidence            8876542 2356789999999999999999999999999999999999999996322            12222222211


Q ss_pred             CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                       .    .       ...+..++.++..++..|++.+|+.||+..+++.+
T Consensus       222 -~----~-------~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  222 -L----Y-------SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             -c----C-------CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence             1    1       23556777889999999999999999999999865

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.4e-38  Score=300.49  Aligned_cols=249  Identities=29%  Similarity=0.427  Sum_probs=193.6

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCCccHHH---HHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEENGEKE---FRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~~~~~---~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.+.||+|+||+||++... +++.+|+|.+.........   ...|+.++.+++||||+++++++. .....+++|||++
T Consensus         3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-~~~~~~~v~~~~~   81 (260)
T PF00069_consen    3 LVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQ-DDNYLYIVMEYCP   81 (260)
T ss_dssp             EEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEE-ESSEEEEEEEEET
T ss_pred             EeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccc-ccccccccccccc
Confidence            4578999999999999975 4668999999875543332   345999999999999999999976 4668899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +++|.+++...          ..+++..++.++.|+++||+|||+   .+++|+||||+||++++++.++|+|||.+...
T Consensus        82 ~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~  148 (260)
T PF00069_consen   82 GGSLQDYLQKN----------KPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKL  148 (260)
T ss_dssp             TEBHHHHHHHH----------SSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred             ccccccccccc----------cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc
Confidence            99999999622          338999999999999999999999   89999999999999999999999999999764


Q ss_pred             cCCCCceeeeccCCccccchhhhh-cCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      . ..........++..|+|||.+. ...++.++||||+|+++|+|++|..||......         ........... .
T Consensus       149 ~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~---------~~~~~~~~~~~-~  217 (260)
T PF00069_consen  149 S-ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD---------DQLEIIEKILK-R  217 (260)
T ss_dssp             T-STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH---------HHHHHHHHHHH-T
T ss_pred             c-ccccccccccccccccccccccccccccccccccccccccccccccccccccccch---------hhhhhhhhccc-c
Confidence            2 2223345567899999999998 788999999999999999999999998632000         00000000000 0


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                         .. ....    .........+.+++.+||+.+|++||++.++++
T Consensus       218 ---~~-~~~~----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  218 ---PL-PSSS----QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             ---HH-HHHT----TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ---cc-cccc----cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               00 0000    001111267999999999999999999999874

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=6.4e-38  Score=300.97  Aligned_cols=266  Identities=21%  Similarity=0.275  Sum_probs=188.1

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCC---CccHHHHHHHHHHHHhc---CCCceeeEeeEEEec----CCCeE
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGE---ENGEKEFRSEVAAIASA---QHVNLVRLLGYCVVP----GGPRY  173 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~----~~~~~  173 (453)
                      +.+.||+|+||+||+|... +|+.||+|.++..   ......+.+|+.++..+   +||||+++++++...    ....+
T Consensus         4 ~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~   83 (288)
T cd07863           4 PVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVT   83 (288)
T ss_pred             EeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEE
Confidence            3578999999999999964 6889999988742   22234566777777665   699999999987532    23468


Q ss_pred             EEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEee
Q 047276          174 LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSD  253 (453)
Q Consensus       174 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~D  253 (453)
                      +++||+++ +|.+++....        ...+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|
T Consensus        84 lv~e~~~~-~l~~~~~~~~--------~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~d  151 (288)
T cd07863          84 LVFEHVDQ-DLRTYLDKVP--------PPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLAD  151 (288)
T ss_pred             EEEccccc-CHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECc
Confidence            99999975 8988885432        1238999999999999999999999   8999999999999999999999999


Q ss_pred             ccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCc-ccccchhHHH
Q 047276          254 FGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSK-NKWQYFPKIV  332 (453)
Q Consensus       254 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~-~~~~~~~~~~  332 (453)
                      ||++.......  ......+|..|+|||.+.+..++.++|||||||++|||++|+.||........... ......+.  
T Consensus       152 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~--  227 (288)
T cd07863         152 FGLARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP--  227 (288)
T ss_pred             cCccccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCC--
Confidence            99998664322  12335678899999999988899999999999999999999999853221100000 00000000  


Q ss_pred             HHhhhcC-cc-ccccccccc-CCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          333 NEKMKEG-KL-MEIVDQRLT-DEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       333 ~~~~~~~-~~-~~~~d~~l~-~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ...+... .. .....+... ......++....+.+++.+|++.||++|||+.+++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         228 EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             hhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0000000 00 000000000 000011233456889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=9.4e-38  Score=296.34  Aligned_cols=244  Identities=25%  Similarity=0.381  Sum_probs=192.6

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCCCc----------cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeE
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGEEN----------GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRY  173 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~  173 (453)
                      +...||+|+||.||+|.. .+++.+|+|.+.....          ..+.+.+|+.++++++||||+++++++. ..+..+
T Consensus         4 ~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~   82 (267)
T cd06628           4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSL-DADHLN   82 (267)
T ss_pred             ccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-eCCccE
Confidence            457899999999999985 4578999998864221          1145788999999999999999999976 456889


Q ss_pred             EEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEee
Q 047276          174 LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSD  253 (453)
Q Consensus       174 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~D  253 (453)
                      +++||+++++|.+++...          +.+++..+..++.|++.||+|||+   .+++||||+|+||++++++.+||+|
T Consensus        83 lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~d  149 (267)
T cd06628          83 IFLEYVPGGSVAALLNNY----------GAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISD  149 (267)
T ss_pred             EEEEecCCCCHHHHHHhc----------cCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecc
Confidence            999999999999999533          238889999999999999999998   8999999999999999999999999


Q ss_pred             ccccccccCCCC-----ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccch
Q 047276          254 FGLSKLMSRDQS-----RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYF  328 (453)
Q Consensus       254 fGla~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~  328 (453)
                      ||+++.......     .......|+..|+|||.+.+..++.++||||||+++|||++|+.||......           
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----------  218 (267)
T cd06628         150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-----------  218 (267)
T ss_pred             cCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-----------
Confidence            999987653211     1112345788999999998888999999999999999999999999532110           


Q ss_pred             hHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          329 PKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       329 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                       ..... ...     ...+      ..+......+.+++.+||+.+|.+||++.++++
T Consensus       219 -~~~~~-~~~-----~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         219 -QAIFK-IGE-----NASP------EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             -HHHHH-Hhc-----cCCC------cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence             00000 000     0011      122234456889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.5e-39  Score=299.21  Aligned_cols=265  Identities=22%  Similarity=0.267  Sum_probs=187.0

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCC----eEEEEEecC
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGP----RYLVYEFIQ  180 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~----~~lv~e~~~  180 (453)
                      .+++|.|+||.||+|.. .++..||||+.-.+..-   -.+|+.+|+.+.|||||+|.-++....+.    ..+|||||+
T Consensus        29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~---knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP  105 (364)
T KOG0658|consen   29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY---KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP  105 (364)
T ss_pred             eEEEeecccceEEEEEEcCCCceeEEEEecCCCCc---CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch
Confidence            46899999999999995 45789999987643321   13699999999999999999877654333    358999998


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCC-CcEEEeecccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDEN-YRAVVSDFGLSKL  259 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~-~~~kl~DfGla~~  259 (453)
                      . +|.++++....      ....++...+.-+..|+.+||+|||+   .+|+||||||.|+|+|.+ |.+||||||.|+.
T Consensus       106 ~-tL~~~~r~~~~------~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen  106 E-TLYRVIRHYTR------ANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             H-HHHHHHHHHhh------cCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence            8 99999864321      12235666667789999999999999   899999999999999965 9999999999998


Q ss_pred             ccCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      +......  ....-|.-|.|||.+.+ ..|+.+.||||.||++.||+-|++-|.+.+..++.. .-...+.....+.+..
T Consensus       176 L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~-eIik~lG~Pt~e~I~~  252 (364)
T KOG0658|consen  176 LVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLV-EIIKVLGTPTREDIKS  252 (364)
T ss_pred             eccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHH-HHHHHhCCCCHHHHhh
Confidence            8665443  22234667999999986 579999999999999999999999886422211100 0000000000011110


Q ss_pred             --CcccccccccccCCC---CCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          339 --GKLMEIVDQRLTDEG---GIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       339 --~~~~~~~d~~l~~~~---~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                        ....+...+.+....   -.......+.++++.++++.+|.+|.+..|++.
T Consensus       253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence              011122222222111   022233456899999999999999999998874

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-37  Score=295.03  Aligned_cols=244  Identities=25%  Similarity=0.381  Sum_probs=195.7

Q ss_pred             HHhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          104 NFQALLGHGSSASVFKGILS-DGTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      .+.+.||.|+||.||+|... +++.||+|.+....  .....+.+|+.+++.++|+|++++++++. .+...++|+||++
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~~v~e~~~   82 (274)
T cd06609           4 TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL-KGSKLWIIMEYCG   82 (274)
T ss_pred             hhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEE-ECCeEEEEEEeeC
Confidence            45678999999999999964 68899999987532  33456889999999999999999999876 4568899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +++|.+++...           .+++.....++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++...
T Consensus        83 ~~~L~~~~~~~-----------~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~  148 (274)
T cd06609          83 GGSCLDLLKPG-----------KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQL  148 (274)
T ss_pred             CCcHHHHHhhc-----------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceee
Confidence            99999998532           48999999999999999999999   89999999999999999999999999999876


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      .... .......+++.|+|||++.+..++.++||||||+++|||++|+.||....+..             .......+.
T Consensus       149 ~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~-------------~~~~~~~~~  214 (274)
T cd06609         149 TSTM-SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-------------VLFLIPKNN  214 (274)
T ss_pred             cccc-cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH-------------HHHHhhhcC
Confidence            5432 12234567889999999998889999999999999999999999985322100             111111111


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      .     +.+..     ......+.+++.+|++.+|++||+++++++
T Consensus       215 ~-----~~~~~-----~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         215 P-----PSLEG-----NKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             C-----CCCcc-----cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            1     11110     013445889999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.1e-37  Score=301.99  Aligned_cols=249  Identities=25%  Similarity=0.423  Sum_probs=193.4

Q ss_pred             hcccCcCCceEEEEEEe-CCCc----EEEEEEecCCCc--cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEe
Q 047276          106 QALLGHGSSASVFKGIL-SDGT----SVAVKRINGEEN--GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~----~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      .+.||+|+||.||+|.+ .+|.    .+|+|.+.....  ...++.+|+.+++.++||||++++|+|..  ...++++||
T Consensus        12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~~v~e~   89 (303)
T cd05110          12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS--PTIQLVTQL   89 (303)
T ss_pred             ccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC--CCceeeehh
Confidence            46899999999999985 3444    478898875322  23468899999999999999999999863  356799999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +++|+|.+++....         ..+++..++.++.|++.||+|||+   .+++|+||||+||++++++.+||+|||+++
T Consensus        90 ~~~g~l~~~~~~~~---------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~  157 (303)
T cd05110          90 MPHGCLLDYVHEHK---------DNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (303)
T ss_pred             cCCCCHHHHHHhcc---------cCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccc
Confidence            99999999985432         238899999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCc-eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhh
Q 047276          259 LMSRDQSR-CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKM  336 (453)
Q Consensus       259 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (453)
                      ........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||.....             .......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-------------~~~~~~~  224 (303)
T cd05110         158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-------------REIPDLL  224 (303)
T ss_pred             cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-------------HHHHHHH
Confidence            76433221 1122345678999999988889999999999999999997 8888853210             0011111


Q ss_pred             hcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          337 KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       337 ~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      ..+..       +.    .+......+.+++..|+..+|++||++.++++.|+...
T Consensus       225 ~~~~~-------~~----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~  269 (303)
T cd05110         225 EKGER-------LP----QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA  269 (303)
T ss_pred             HCCCC-------CC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            11110       10    11122345889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=8.8e-38  Score=296.31  Aligned_cols=246  Identities=25%  Similarity=0.430  Sum_probs=193.5

Q ss_pred             HhcccCcCCceEEEEEEeCCCcEEEEEEecCCCc-------cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEEN-------GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      ..+.||+|+||+||+|...+|+.+|+|.+.....       ....+.+|+.+++.++|+|+++++++|. ..+..++++|
T Consensus         4 ~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~lv~e   82 (265)
T cd06631           4 KGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL-DDNTISIFME   82 (265)
T ss_pred             ccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee-cCCeEEEEEe
Confidence            3568999999999999988899999998864321       1245888999999999999999999987 4568899999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |+++++|.+++...          ..+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++
T Consensus        83 ~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~  149 (265)
T cd06631          83 FVPGGSISSILNRF----------GPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCA  149 (265)
T ss_pred             cCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhh
Confidence            99999999998533          237899999999999999999998   89999999999999999999999999998


Q ss_pred             ccccCCC-----CceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHH
Q 047276          258 KLMSRDQ-----SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIV  332 (453)
Q Consensus       258 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  332 (453)
                      .......     ........++..|+|||.+.+..++.++||||||+++|||++|+.||...+...           . .
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----------~-~  217 (265)
T cd06631         150 RRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-----------A-M  217 (265)
T ss_pred             HhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-----------H-H
Confidence            7653211     111233468889999999998889999999999999999999999995321100           0 0


Q ss_pred             HHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          333 NEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       333 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      . ......  . ..+.      .+......+.+++.+|++.+|++||++.++++
T Consensus       218 ~-~~~~~~--~-~~~~------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         218 F-YIGAHR--G-LMPR------LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             H-Hhhhcc--C-CCCC------CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0 000000  0 0011      12233456889999999999999999999874

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5.6e-37  Score=292.96  Aligned_cols=245  Identities=23%  Similarity=0.349  Sum_probs=196.7

Q ss_pred             HHHhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          103 DNFQALLGHGSSASVFKGILS-DGTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      +...+.||+|+||.||+|... ++..||+|.+....  .....+.+|+.+++.++|+|++++++++. .++..++||||+
T Consensus         6 y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~   84 (277)
T cd06640           6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-KGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-ECCEEEEEEecC
Confidence            344578999999999999964 58899999887532  33467889999999999999999999886 566889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ++|+|.+++..           ..+++.....++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++..
T Consensus        85 ~~~~L~~~i~~-----------~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~  150 (277)
T cd06640          85 GGGSALDLLRA-----------GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQ  150 (277)
T ss_pred             CCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEccccccee
Confidence            99999999842           237888999999999999999998   8999999999999999999999999999976


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      ...... ......++..|+|||.+.+..++.++||||||+++|||++|+.||....+..             .......+
T Consensus       151 ~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-------------~~~~~~~~  216 (277)
T cd06640         151 LTDTQI-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-------------VLFLIPKN  216 (277)
T ss_pred             ccCCcc-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh-------------HhhhhhcC
Confidence            643321 2233467889999999988889999999999999999999999985322110             00111111


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      ..           ..........+.+++.+||+.+|++||++.++++.
T Consensus       217 ~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         217 NP-----------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CC-----------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            00           11234556778999999999999999999999754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=4.8e-38  Score=305.26  Aligned_cols=267  Identities=21%  Similarity=0.247  Sum_probs=190.1

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      +.+.||+|+||+||+|+.. +++.||+|.++..  ......+.+|+.++++++||||+++++++. .++..++||||+++
T Consensus        10 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~   88 (309)
T cd07872          10 KLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH-TDKSLTLVFEYLDK   88 (309)
T ss_pred             EEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe-eCCeEEEEEeCCCC
Confidence            3578999999999999964 5788999998743  233456788999999999999999999986 45688999999975


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                       +|.+++....         ..+++..+..++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||++....
T Consensus        89 -~l~~~~~~~~---------~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  155 (309)
T cd07872          89 -DLKQYMDDCG---------NIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKS  155 (309)
T ss_pred             -CHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecC
Confidence             8888875332         237889999999999999999999   899999999999999999999999999987643


Q ss_pred             CCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccc--cchhHHHHHhhhc
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKW--QYFPKIVNEKMKE  338 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  338 (453)
                      .... ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||..............  .......+..+..
T Consensus       156 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (309)
T cd07872         156 VPTK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS  234 (309)
T ss_pred             CCcc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcc
Confidence            3221 1233467889999998865 4688999999999999999999999954321110000000  0000000000000


Q ss_pred             C-cccccccccccCC--CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          339 G-KLMEIVDQRLTDE--GGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       339 ~-~~~~~~d~~l~~~--~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      . .....-.+.....  ..........+.+++.+|++.||.+|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            0 0000000000000  0001123445789999999999999999999885

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.6e-37  Score=301.55  Aligned_cols=192  Identities=27%  Similarity=0.416  Sum_probs=164.9

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      +.+.||+|+||.||++... ++..+|+|.+....  ....++.+|++++.+++||||++++++|. .++..++++||+++
T Consensus         5 ~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~ey~~~   83 (308)
T cd06615           5 KLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY-SDGEISICMEHMDG   83 (308)
T ss_pred             EEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-eCCEEEEEeeccCC
Confidence            3578999999999999964 57889999886532  22356889999999999999999999986 56688999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      ++|.+++...          ..+++.....++.|+++||.|||+.  .+++|+||||+|||++.++.+||+|||++....
T Consensus        84 ~~L~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  151 (308)
T cd06615          84 GSLDQVLKKA----------GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  151 (308)
T ss_pred             CcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence            9999999643          2388999999999999999999973  589999999999999999999999999987553


Q ss_pred             CCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCc
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVS  312 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~  312 (453)
                      ...   .....++..|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus       152 ~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~  199 (308)
T cd06615         152 DSM---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIP  199 (308)
T ss_pred             ccc---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence            221   234568899999999888889999999999999999999999985

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=6.3e-38  Score=310.47  Aligned_cols=264  Identities=20%  Similarity=0.239  Sum_probs=190.0

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecC-----CCeEEEE
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG-----GPRYLVY  176 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~~lv~  176 (453)
                      .+.||+|+||.||++.. ..++.||||++....   .....+.+|+.+++.++||||+++++++....     ...++||
T Consensus        22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~  101 (355)
T cd07874          22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM  101 (355)
T ss_pred             EEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEh
Confidence            47899999999999985 458899999987532   23356788999999999999999999875332     2468999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||+++ +|.+++..            .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus       102 e~~~~-~l~~~~~~------------~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874         102 ELMDA-NLCQVIQM------------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             hhhcc-cHHHHHhh------------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcc
Confidence            99965 77776631            27889999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCC----------Cccccc
Q 047276          257 SKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDK----------SKNKWQ  326 (453)
Q Consensus       257 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~----------~~~~~~  326 (453)
                      ++......  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.........          ....+.
T Consensus       166 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (355)
T cd07874         166 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  243 (355)
T ss_pred             cccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            98653321  223456899999999999888999999999999999999999999632211000          000000


Q ss_pred             chhHHHHHhhhc-Ccccccc------cccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          327 YFPKIVNEKMKE-GKLMEIV------DQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       327 ~~~~~~~~~~~~-~~~~~~~------d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      .+.......... .......      +................+.+++.+|++.||++|||+.|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            000000000000 0000000      000000011112234568899999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.9e-38  Score=320.84  Aligned_cols=266  Identities=20%  Similarity=0.276  Sum_probs=185.2

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecC-------CCeEEEE
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG-------GPRYLVY  176 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-------~~~~lv~  176 (453)
                      +.++||+|+||.||+|.. .+++.||||++....   ....+|+.+++.++||||+++++++....       ...++||
T Consensus        70 ~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvm  146 (440)
T PTZ00036         70 LGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVM  146 (440)
T ss_pred             EeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEE
Confidence            457899999999999996 468899999886432   23457999999999999999998764321       1356899


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCC-cEEEeecc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENY-RAVVSDFG  255 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~-~~kl~DfG  255 (453)
                      ||+++ +|.+++.....      ....+++.....++.|++.||+|||+   .+|+||||||+|||++.++ .+||+|||
T Consensus       147 E~~~~-~l~~~~~~~~~------~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        147 EFIPQ-TVHKYMKHYAR------NNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             ecCCc-cHHHHHHHHhh------cCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccc
Confidence            99975 78777643221      22348999999999999999999999   8999999999999999664 79999999


Q ss_pred             ccccccCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHH
Q 047276          256 LSKLMSRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNE  334 (453)
Q Consensus       256 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  334 (453)
                      +++.......  .....||+.|+|||++.+ ..++.++|||||||++|||++|..||............ ...+.....+
T Consensus       217 la~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i-~~~~~~p~~~  293 (440)
T PTZ00036        217 SAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRI-IQVLGTPTED  293 (440)
T ss_pred             cchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-HHHhCCCCHH
Confidence            9986643222  234567999999998875 46899999999999999999999999642211000000 0000000000


Q ss_pred             hhh--cCcccccccccccCC---CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          335 KMK--EGKLMEIVDQRLTDE---GGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       335 ~~~--~~~~~~~~d~~l~~~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      .+.  .....+..-+.....   ..++...+..+.+++.+||+.+|.+|||+.++++
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            000  000000000000000   0011223456889999999999999999999883

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.9e-38  Score=318.08  Aligned_cols=188  Identities=24%  Similarity=0.268  Sum_probs=159.4

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCCh
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL  184 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL  184 (453)
                      .+.||+|+||.||++... +++.||||...     ...+.+|+.++++++|+|||++++++. .++..++|||++. ++|
T Consensus       174 ~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~-~~~~~~lv~e~~~-~~L  246 (461)
T PHA03211        174 HRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRV-VGGLTCLVLPKYR-SDL  246 (461)
T ss_pred             EEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEE-ECCEEEEEEEccC-CCH
Confidence            367999999999999965 47889999643     234678999999999999999999986 4567899999995 699


Q ss_pred             hhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCCC
Q 047276          185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ  264 (453)
Q Consensus       185 ~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~  264 (453)
                      .+++....         ..++|..++.|+.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus       247 ~~~l~~~~---------~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~  314 (461)
T PHA03211        247 YTYLGARL---------RPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW  314 (461)
T ss_pred             HHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence            88885332         248999999999999999999999   899999999999999999999999999998764332


Q ss_pred             C-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCc
Q 047276          265 S-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVS  312 (453)
Q Consensus       265 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~  312 (453)
                      . .......||+.|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus       315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf  363 (461)
T PHA03211        315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF  363 (461)
T ss_pred             ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence            2 12234579999999999999899999999999999999999887653

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.4e-37  Score=300.25  Aligned_cols=243  Identities=24%  Similarity=0.382  Sum_probs=193.9

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCC-CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCC
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGE-ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS  183 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gs  183 (453)
                      .+.||.|+||.||+|.. .+|+.|++|.+... ....+.+.+|+.+++.++|||++++++++. .++..++|+||+++++
T Consensus        24 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~~~  102 (296)
T cd06655          24 YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL-VGDELFVVMEYLAGGS  102 (296)
T ss_pred             EEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe-cCceEEEEEEecCCCc
Confidence            46899999999999985 57899999988653 334567889999999999999999999986 5668899999999999


Q ss_pred             hhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCC
Q 047276          184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD  263 (453)
Q Consensus       184 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~  263 (453)
                      |.+++..           ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++......
T Consensus       103 L~~~~~~-----------~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~  168 (296)
T cd06655         103 LTDVVTE-----------TCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE  168 (296)
T ss_pred             HHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence            9998842           238999999999999999999999   89999999999999999999999999998765433


Q ss_pred             CCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcccc
Q 047276          264 QSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLME  343 (453)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (453)
                      .. ......++..|+|||.+.+..++.++|||||||++|+|++|+.||.......           . . ........  
T Consensus       169 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~-----------~-~-~~~~~~~~--  232 (296)
T cd06655         169 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-----------A-L-YLIATNGT--  232 (296)
T ss_pred             cc-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----------H-H-HHHHhcCC--
Confidence            22 1233468889999999988889999999999999999999999985322110           0 0 00000000  


Q ss_pred             cccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          344 IVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       344 ~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                         +.+    ..+......+.+++.+||+.+|++||++.+++.
T Consensus       233 ---~~~----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         233 ---PEL----QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             ---ccc----CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence               001    112223445889999999999999999999883

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.1e-37  Score=291.94  Aligned_cols=245  Identities=29%  Similarity=0.432  Sum_probs=194.4

Q ss_pred             HHHhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCC
Q 047276          103 DNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      +.+.+.||+|+||.||+|.. +++.||+|.+.... ....+.+|+.++..++|||++++++++..  +..+++|||+++|
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~v~e~~~~~   83 (254)
T cd05083           8 LTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILH--NGLYIVMELMSKG   83 (254)
T ss_pred             ceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcC--CCcEEEEECCCCC
Confidence            44568999999999999975 57889999986543 34678999999999999999999998753  4579999999999


Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccC
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR  262 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~  262 (453)
                      +|.+++....        ...+++..+++++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.....
T Consensus        84 ~L~~~l~~~~--------~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~  152 (254)
T cd05083          84 NLVNFLRTRG--------RALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM  152 (254)
T ss_pred             CHHHHHHhcC--------cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccc
Confidence            9999996432        1238899999999999999999998   8999999999999999999999999999875432


Q ss_pred             CCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcCcc
Q 047276          263 DQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKL  341 (453)
Q Consensus       263 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (453)
                      ..    .....+..|+|||++.++.++.++|+||||+++|||++ |+.||.....            .. .......+..
T Consensus       153 ~~----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------------~~-~~~~~~~~~~  215 (254)
T cd05083         153 GV----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL------------KE-VKECVEKGYR  215 (254)
T ss_pred             cC----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH------------HH-HHHHHhCCCC
Confidence            11    12234568999999988889999999999999999997 9988853211            00 1111111110


Q ss_pred             cccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 047276          342 MEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEG  390 (453)
Q Consensus       342 ~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~  390 (453)
                             .    ..+...+..+.+++.+|++.+|+.||++.++++.|+.
T Consensus       216 -------~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         216 -------M----EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             -------C----CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence                   0    0112334568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.3e-37  Score=283.35  Aligned_cols=262  Identities=20%  Similarity=0.239  Sum_probs=193.7

Q ss_pred             cccCcCCceEEEEEEe-CCCcEEEEEEecCCCccH---HHHHHHHHHHHhcCCCceeeEeeEEEe-cCCCeEEEEEecCC
Q 047276          107 ALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGE---KEFRSEVAAIASAQHVNLVRLLGYCVV-PGGPRYLVYEFIQN  181 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~~lv~e~~~~  181 (453)
                      +.|++|.||.||+|+. ++++.||+|+++.+....   -.-++|+.+|.+.+|||||.+-.+... +-+..|+|||||+.
T Consensus        82 nrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh  161 (419)
T KOG0663|consen   82 NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH  161 (419)
T ss_pred             hhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh
Confidence            6899999999999995 468899999998654322   235789999999999999998876542 22468999999988


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                       +|...+....         ..+.......++.|+++|++|||.   +.|+|||||++|+|+++.|.+||+|||+|+.+.
T Consensus       162 -DLksl~d~m~---------q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  162 -DLKSLMETMK---------QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             -hHHHHHHhcc---------CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhc
Confidence             9999997654         237888889999999999999999   899999999999999999999999999999876


Q ss_pred             CCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCC----------CCcccccchhH
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGND----------KSKNKWQYFPK  330 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~----------~~~~~~~~~~~  330 (453)
                      ... ...+..+-|.+|.|||.+.+ ..|+...|+||+|||+.||+++++-|.....-++          .....|..+..
T Consensus       229 sp~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~  307 (419)
T KOG0663|consen  229 SPL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE  307 (419)
T ss_pred             CCc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence            542 23455677999999999886 5799999999999999999999988854322111          11222222111


Q ss_pred             HHHHhhhcCcccccccccccCCCCCcHH-HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          331 IVNEKMKEGKLMEIVDQRLTDEGGIDET-QVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       331 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~-~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ...  ++.-.+.+.....+...  +... ....-++++...+..||.+|-|+++.++
T Consensus       308 lp~--~k~~~f~~~pyn~lr~k--F~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  308 LPA--VKKMTFSEHPYNNLRKK--FGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             cch--hhccccCCCCchhhhhh--ccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence            100  00000000000111100  1111 3355788999999999999999999764

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3.6e-37  Score=290.51  Aligned_cols=247  Identities=23%  Similarity=0.329  Sum_probs=197.3

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.+.||+|+||.||.++. .+++.+++|.+...   ......+.+|+.++++++|+|++++++++. ..+..+++|||++
T Consensus         4 ~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~~~~~~e~~~   82 (256)
T cd08221           4 PIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFM-DDNTLLIEMEYAN   82 (256)
T ss_pred             EeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEe-cCCeEEEEEEecC
Confidence            457899999999999884 56889999987643   334467889999999999999999999986 4568899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|.+++....        ...+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||++...
T Consensus        83 ~~~L~~~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~  151 (256)
T cd08221          83 GGTLYDKIVRQK--------GQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKIL  151 (256)
T ss_pred             CCcHHHHHHhcc--------ccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEc
Confidence            999999986432        2348999999999999999999998   79999999999999999999999999999876


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      ..... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||.....            ...... ...+.
T Consensus       152 ~~~~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------------~~~~~~-~~~~~  217 (256)
T cd08221         152 GSEYS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP------------LNLVVK-IVQGN  217 (256)
T ss_pred             ccccc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH------------HHHHHH-HHcCC
Confidence            44332 23345689999999999888889999999999999999999999853211            111111 11121


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEML  388 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L  388 (453)
                      ...           .+......+.+++.+|++.+|.+||++.++++.+
T Consensus       218 ~~~-----------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         218 YTP-----------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             CCC-----------CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            111           1123345688999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.9e-37  Score=308.08  Aligned_cols=265  Identities=20%  Similarity=0.252  Sum_probs=190.3

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEecC-----CCeEEE
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG-----GPRYLV  175 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~~lv  175 (453)
                      +.+.||+|+||.||++.. ..++.||||++...   ......+.+|+.+++.++||||+++++++....     ...++|
T Consensus        28 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv  107 (364)
T cd07875          28 NLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV  107 (364)
T ss_pred             EEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEE
Confidence            357899999999999995 45889999998753   233456888999999999999999999865322     346999


Q ss_pred             EEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecc
Q 047276          176 YEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFG  255 (453)
Q Consensus       176 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfG  255 (453)
                      |||+++ +|.+++..            .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||
T Consensus       108 ~e~~~~-~l~~~~~~------------~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG  171 (364)
T cd07875         108 MELMDA-NLCQVIQM------------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG  171 (364)
T ss_pred             EeCCCC-CHHHHHHh------------cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCC
Confidence            999965 77777631            27888999999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCC----------cccc
Q 047276          256 LSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKS----------KNKW  325 (453)
Q Consensus       256 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~----------~~~~  325 (453)
                      +++......  ......+|+.|+|||++.+..++.++|||||||++|||++|+.||..........          ...+
T Consensus       172 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  249 (364)
T cd07875         172 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  249 (364)
T ss_pred             CccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            998653322  2234568999999999999899999999999999999999999996432110000          0000


Q ss_pred             cchhHHHHHhhhc-Ccc-----ccccccc-ccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          326 QYFPKIVNEKMKE-GKL-----MEIVDQR-LTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       326 ~~~~~~~~~~~~~-~~~-----~~~~d~~-l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      ..+.......... ...     .+..... ..............+.+++.+|++.||.+|||+.++++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0000000000000 000     0000000 000001111223568899999999999999999998863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.7e-38  Score=335.16  Aligned_cols=253  Identities=25%  Similarity=0.347  Sum_probs=192.1

Q ss_pred             HHHHhcccCcCCceEEEEEEeC-CCcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEecC-CCeEEEE
Q 047276          102 TDNFQALLGHGSSASVFKGILS-DGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG-GPRYLVY  176 (453)
Q Consensus       102 ~~~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~~lv~  176 (453)
                      .+.+.+.||+|+||+||++... ++..+|+|.+...   ......|..|+.++..++|||||++++++.... ...++||
T Consensus        14 ~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVM   93 (1021)
T PTZ00266         14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILM   93 (1021)
T ss_pred             CEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEE
Confidence            3445689999999999999964 5678999988643   223456889999999999999999999876443 4578999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccC----CCceeccCCCCCcEEECC-------
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDC----RSRVLHLDVKPENILLDE-------  245 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~----~~~ivH~Dlk~~NiLl~~-------  245 (453)
                      ||+++|+|.++|.....      ....+++..++.|+.||+.||+|||+..    ..+|+||||||+||||+.       
T Consensus        94 EY~~gGSL~~lL~k~~~------~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         94 EFCDAGDLSRNIQKCYK------MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             eCCCCCcHHHHHHHHhh------ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            99999999999864322      1234999999999999999999999832    135999999999999964       


Q ss_pred             ----------CCcEEEeeccccccccCCCCceeeeccCCccccchhhhhc--CCCCccccchhHHHHHHHHHcCCCCCcc
Q 047276          246 ----------NYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILE--QGVSEKCDIYSYGMVLLELTGGRRNVSL  313 (453)
Q Consensus       246 ----------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDV~S~Gvil~elltG~~p~~~  313 (453)
                                .+.+||+|||++.......  ......||+.|+|||++..  ..++.++|||||||++|||++|+.||..
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             ccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                      3458999999998654322  1234578999999999864  4588999999999999999999999953


Q ss_pred             cccCCCCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          314 IEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ...           +.. +...+..+       +.+.     .......+.+++..||+.+|.+||++.+++.
T Consensus       246 ~~~-----------~~q-li~~lk~~-------p~lp-----i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        246 ANN-----------FSQ-LISELKRG-------PDLP-----IKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CCc-----------HHH-HHHHHhcC-------CCCC-----cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            211           011 11111111       1110     0122355889999999999999999999983

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=3.4e-37  Score=290.43  Aligned_cols=248  Identities=27%  Similarity=0.440  Sum_probs=196.5

Q ss_pred             HhcccCcCCceEEEEEEeCC-----CcEEEEEEecCCCc--cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          105 FQALLGHGSSASVFKGILSD-----GTSVAVKRINGEEN--GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~-----g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      +.+.||+|+||.||++...+     +..||+|.+.....  ..+.+..|+..+..++|+|++++++++. ..+..+++||
T Consensus         3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~~i~e   81 (258)
T smart00219        3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCT-EEEPLMIVME   81 (258)
T ss_pred             ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEc-CCCeeEEEEe
Confidence            45789999999999999753     37899999976543  4568999999999999999999999986 4468899999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |+++++|.+++.....        ..+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++
T Consensus        82 ~~~~~~l~~~~~~~~~--------~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~  150 (258)
T smart00219       82 YMEGGDLLDYLRKNRP--------KELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLS  150 (258)
T ss_pred             ccCCCCHHHHHHhhhh--------ccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCc
Confidence            9999999999864321        118999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhh
Q 047276          258 KLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKM  336 (453)
Q Consensus       258 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (453)
                      ...............+++.|+|||.+....++.++||||+|++++||++ |+.||.....            .. .....
T Consensus       151 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~------------~~-~~~~~  217 (258)
T smart00219      151 RDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN------------EE-VLEYL  217 (258)
T ss_pred             eecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH------------HH-HHHHH
Confidence            8765442222212346789999999988889999999999999999998 7888743110            00 11111


Q ss_pred             hcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 047276          337 KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEML  388 (453)
Q Consensus       337 ~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L  388 (453)
                      ..+...           ..+...+..+.+++.+|++.+|++|||+.++++.|
T Consensus       218 ~~~~~~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      218 KKGYRL-----------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             hcCCCC-----------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            111110           01122455689999999999999999999998765

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.3e-38  Score=282.43  Aligned_cols=244  Identities=25%  Similarity=0.363  Sum_probs=195.7

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCC-----CccH----HHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEE
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGE-----ENGE----KEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYL  174 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~-----~~~~----~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~l  174 (453)
                      .+.||.|..++|-++.. .+|...|+|++...     ....    +.-.+|+.+|+++ .||||+.+.+++. .+.-.++
T Consensus        22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye-s~sF~Fl  100 (411)
T KOG0599|consen   22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE-SDAFVFL  100 (411)
T ss_pred             HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc-Ccchhhh
Confidence            46799999999988875 46888999998642     1112    2356799999998 5999999999875 5567789


Q ss_pred             EEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeec
Q 047276          175 VYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDF  254 (453)
Q Consensus       175 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~Df  254 (453)
                      |+|.|+.|.|.|+|.+.          -.++++...+|+.|+.+|++|||.   .+||||||||+|||+|+|.++||+||
T Consensus       101 VFdl~prGELFDyLts~----------VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen  101 VFDLMPRGELFDYLTSK----------VTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             hhhhcccchHHHHhhhh----------eeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEecc
Confidence            99999999999999533          348999999999999999999999   89999999999999999999999999


Q ss_pred             cccccccCCCCceeeeccCCccccchhhhhc------CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccch
Q 047276          255 GLSKLMSRDQSRCITTIRGTRGYLAPEWILE------QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYF  328 (453)
Q Consensus       255 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~  328 (453)
                      |++..+.+..  .....+|||+|+|||.+..      ..|+...|.||+||++|.|+.|.+||.             ..-
T Consensus       168 GFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw-------------HRk  232 (411)
T KOG0599|consen  168 GFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW-------------HRK  232 (411)
T ss_pred             ceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh-------------HHH
Confidence            9999876543  3456799999999998853      458889999999999999999999983             211


Q ss_pred             hHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          329 PKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       329 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      .-.+...+.+|... +-.+       -..+......+|+.+|++.||++|-|.+|+++
T Consensus       233 QmlMLR~ImeGkyq-F~sp-------eWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  233 QMLMLRMIMEGKYQ-FRSP-------EWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HHHHHHHHHhcccc-cCCc-------chhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            22233444444421 1111       12355667899999999999999999999884

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.6e-37  Score=293.71  Aligned_cols=252  Identities=28%  Similarity=0.393  Sum_probs=198.1

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEec-CCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVP-GGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~~lv~e~~  179 (453)
                      +.+.||.|+||.||++.. .+|+.+|+|.+....   ...+.+..|+.+++.++|+|++++++++... +...+++|||+
T Consensus         4 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~   83 (265)
T cd08217           4 VLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYC   83 (265)
T ss_pred             eeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhc
Confidence            457899999999999985 467899999986432   2345688899999999999999999987643 34568999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccC--CCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDC--RSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~--~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      ++++|.+++.....      ....+++...+.++.|++.||+|||..+  ..+++|+||+|+||++++++.+||+|||++
T Consensus        84 ~~~~L~~~l~~~~~------~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          84 EGGDLAQLIQKCKK------ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             cCCCHHHHHHHHhh------cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence            99999999865422      1245899999999999999999999321  289999999999999999999999999999


Q ss_pred             ccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhh
Q 047276          258 KLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMK  337 (453)
Q Consensus       258 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (453)
                      ........ ......+++.|+|||.+....++.++||||||+++|+|++|+.||.....             ....+...
T Consensus       158 ~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------------~~~~~~~~  223 (265)
T cd08217         158 KILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-------------LQLASKIK  223 (265)
T ss_pred             ccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-------------HHHHHHHh
Confidence            87654332 12344688999999999988899999999999999999999999863210             00112222


Q ss_pred             cCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          338 EGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       338 ~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      .+..           ...+......+.+++.+|++.+|++||++.+|++.
T Consensus       224 ~~~~-----------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         224 EGKF-----------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             cCCC-----------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            2211           11233445678999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.1e-37  Score=294.98  Aligned_cols=256  Identities=22%  Similarity=0.361  Sum_probs=195.3

Q ss_pred             HhcccCcCCceEEEEEEeC----CCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCC-----Ce
Q 047276          105 FQALLGHGSSASVFKGILS----DGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGG-----PR  172 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~----~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-----~~  172 (453)
                      +.+.||+|+||.||+|.+.    +++.||||++....   ...+++.+|+.+++.++|||++++++++.....     ..
T Consensus         3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   82 (273)
T cd05074           3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP   82 (273)
T ss_pred             chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence            4578999999999999853    36789999987532   334568899999999999999999998764321     23


Q ss_pred             EEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEe
Q 047276          173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVS  252 (453)
Q Consensus       173 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~  252 (453)
                      ++++||+++|+|.+++.......    ....+++...++++.|++.||+|||+   .+++||||||+||+++.++.+||+
T Consensus        83 ~~~~~~~~~~~l~~~~~~~~~~~----~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~  155 (273)
T cd05074          83 MVILPFMKHGDLHTFLLMSRIGE----EPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVA  155 (273)
T ss_pred             EEEEecCCCCcHHHHHHHhcccC----CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEEC
Confidence            78899999999998875332111    11248899999999999999999998   899999999999999999999999


Q ss_pred             eccccccccCCCCc-eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhH
Q 047276          253 DFGLSKLMSRDQSR-CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPK  330 (453)
Q Consensus       253 DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  330 (453)
                      |||+++........ ......+++.|++||.+....++.++||||||+++|||++ |+.||......            .
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~------------~  223 (273)
T cd05074         156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS------------E  223 (273)
T ss_pred             cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH------------H
Confidence            99999866433211 1123345678999999998889999999999999999999 88887522110            0


Q ss_pred             HHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 047276          331 IVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR  391 (453)
Q Consensus       331 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~  391 (453)
                       .......+..       +.    .+......+.+++.+|++.+|++||++.++.+.|+++
T Consensus       224 -~~~~~~~~~~-------~~----~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         224 -IYNYLIKGNR-------LK----QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             -HHHHHHcCCc-------CC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence             1111111110       00    1112345699999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-38  Score=309.26  Aligned_cols=243  Identities=26%  Similarity=0.390  Sum_probs=197.1

Q ss_pred             ccCcCCceEEEEEEeC-CCcEEEEEEecCC-CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCChh
Q 047276          108 LLGHGSSASVFKGILS-DGTSVAVKRINGE-ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLD  185 (453)
Q Consensus       108 ~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL~  185 (453)
                      +||+|.||+||.|+.. +...+|||-+... ....+.+.+|+.+-+.|+|.|||+.+|.|. .++..-+.||.++||+|.
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~s-enGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVS-ENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccC-CCCeEEEEeecCCCCcHH
Confidence            6999999999999964 4557999988653 334456889999999999999999999865 556777999999999999


Q ss_pred             hhhccCCCCCCCCCCCCCC--CHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEEC-CCCcEEEeeccccccccC
Q 047276          186 HWIFPTSRRSEGHYSGGCL--SWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD-ENYRAVVSDFGLSKLMSR  262 (453)
Q Consensus       186 ~~l~~~~~~~~~~~~~~~l--~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~-~~~~~kl~DfGla~~~~~  262 (453)
                      ++|...         .+++  ++.+.-.+..||++||.|||+   +.|||||||-+||||+ -.|.+||+|||-++.+..
T Consensus       661 sLLrsk---------WGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg  728 (1226)
T KOG4279|consen  661 SLLRSK---------WGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG  728 (1226)
T ss_pred             HHHHhc---------cCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhcc
Confidence            999644         3445  677788889999999999999   8999999999999997 578999999999987654


Q ss_pred             CCCceeeeccCCccccchhhhhcC--CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          263 DQSRCITTIRGTRGYLAPEWILEQ--GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       263 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      - +.++.++.||..|||||.+..+  .|+..+|||||||++.||.||++||........              ...+-|-
T Consensus       729 i-nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------------AMFkVGm  793 (1226)
T KOG4279|consen  729 I-NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------------AMFKVGM  793 (1226)
T ss_pred             C-CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------------hhhhhcc
Confidence            3 3456788999999999999865  589999999999999999999999953221110              0001110


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      .        ....++|.+...+...++++|+.++|.+||++.++++
T Consensus       794 y--------KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  794 Y--------KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             e--------ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            0        0113467888999999999999999999999999874

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.9e-37  Score=290.20  Aligned_cols=243  Identities=29%  Similarity=0.430  Sum_probs=193.8

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC------ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEE------NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      ..+.||+|+||.||+|... +++.|++|.+....      ...+.+..|+.+++.++|+|++++++++. .+...++++|
T Consensus         4 ~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~~~lv~e   82 (258)
T cd06632           4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER-EEDNLYIFLE   82 (258)
T ss_pred             ccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEe-cCCeEEEEEE
Confidence            3578999999999999975 78999999886422      23457889999999999999999999876 5568899999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |+++++|.+++...          ..+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||++
T Consensus        83 ~~~~~~L~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~  149 (258)
T cd06632          83 LVPGGSLAKLLKKY----------GSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMA  149 (258)
T ss_pred             ecCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccc
Confidence            99999999998533          238899999999999999999999   89999999999999999999999999998


Q ss_pred             ccccCCCCceeeeccCCccccchhhhhcCC-CCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhh
Q 047276          258 KLMSRDQSRCITTIRGTRGYLAPEWILEQG-VSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKM  336 (453)
Q Consensus       258 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (453)
                      .......  ......++..|++||.+.... ++.++|+||||+++|+|++|+.||......            .......
T Consensus       150 ~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~------------~~~~~~~  215 (258)
T cd06632         150 KQVVEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV------------AAVFKIG  215 (258)
T ss_pred             eeccccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH------------HHHHHHH
Confidence            7654332  223456888999999988766 899999999999999999999998532100            0011110


Q ss_pred             hcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          337 KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       337 ~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      .....           ...+......+.+++.+|++.+|.+||++.+++.
T Consensus       216 ~~~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         216 RSKEL-----------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             hcccC-----------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            00111           1122233456889999999999999999999874

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-37  Score=311.02  Aligned_cols=194  Identities=26%  Similarity=0.306  Sum_probs=163.7

Q ss_pred             HHHHhcccCcCCceEEEEEEeC---CCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEe
Q 047276          102 TDNFQALLGHGSSASVFKGILS---DGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       102 ~~~~~~~lG~G~fG~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      .+.+.+.||+|+||.||++...   .+..|++|.+...    ..+.+|+.++++++||||+++++++. .....+++|||
T Consensus        93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~-~~~~~~lv~e~  167 (392)
T PHA03207         93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYR-WKSTVCMVMPK  167 (392)
T ss_pred             ceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEe-eCCEEEEEehh
Confidence            3455689999999999999753   3578999987643    23567999999999999999999876 45678999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +. ++|.+++...          ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++.
T Consensus       168 ~~-~~l~~~l~~~----------~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~  233 (392)
T PHA03207        168 YK-CDLFTYVDRS----------GPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAAC  233 (392)
T ss_pred             cC-CCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCcccc
Confidence            95 5898888322          348999999999999999999999   899999999999999999999999999997


Q ss_pred             cccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCccc
Q 047276          259 LMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLI  314 (453)
Q Consensus       259 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~  314 (453)
                      ....... .......||+.|+|||++....++.++|||||||++|||++|+.||...
T Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~  290 (392)
T PHA03207        234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK  290 (392)
T ss_pred             ccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            6644322 2223457899999999999889999999999999999999999999643

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.2e-36  Score=290.63  Aligned_cols=246  Identities=24%  Similarity=0.366  Sum_probs=196.0

Q ss_pred             HHHHhcccCcCCceEEEEEEe-CCCcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEe
Q 047276          102 TDNFQALLGHGSSASVFKGIL-SDGTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       102 ~~~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      .+.+.+.||+|+||.||+|.. .++..+|+|.+....  .....+.+|+.++.+++|||++++++++. .++..++||||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~   83 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-KDTKLWIIMEY   83 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE-eCCeEEEEEEe
Confidence            344567899999999999985 468899999876432  23457889999999999999999999886 56688999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +++++|.+++..           ..+++.....++.|++.|+.|||+   .+++|+||+|+||+++.++.++|+|||++.
T Consensus        84 ~~~~~l~~~i~~-----------~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~  149 (277)
T cd06641          84 LGGGSALDLLEP-----------GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAG  149 (277)
T ss_pred             CCCCcHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccce
Confidence            999999999842           238899999999999999999999   899999999999999999999999999987


Q ss_pred             cccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      ....... ......++..|+|||.+.+..++.++|||||||++|||++|..||......             ........
T Consensus       150 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-------------~~~~~~~~  215 (277)
T cd06641         150 QLTDTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-------------KVLFLIPK  215 (277)
T ss_pred             ecccchh-hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-------------HHHHHHhc
Confidence            6543221 123346788999999998888899999999999999999999998532110             01111111


Q ss_pred             CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      +..           ...+......+.+++.+|++.+|.+||++.++++.
T Consensus       216 ~~~-----------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         216 NNP-----------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCC-----------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            110           01122334568899999999999999999999974

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4.6e-37  Score=295.83  Aligned_cols=248  Identities=23%  Similarity=0.344  Sum_probs=192.6

Q ss_pred             HHHhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC-ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          103 DNFQALLGHGSSASVFKGILS-DGTSVAVKRINGEE-NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.+.++||+|+||.||+|+.. ++..+++|.+.... ...+.+.+|+.+++.++|+|++++++++. .++..++||||++
T Consensus        14 y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~   92 (292)
T cd06644          14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY-WDGKLWIMIEFCP   92 (292)
T ss_pred             hhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE-eCCeEEEEEecCC
Confidence            445678999999999999964 58899999987543 33467889999999999999999999876 4568899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +++|..++....         ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++...
T Consensus        93 ~~~l~~~~~~~~---------~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  160 (292)
T cd06644          93 GGAVDAIMLELD---------RGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKN  160 (292)
T ss_pred             CCcHHHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceec
Confidence            999988874332         238999999999999999999999   89999999999999999999999999998754


Q ss_pred             cCCCCceeeeccCCccccchhhhh-----cCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHh
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWIL-----EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEK  335 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  335 (453)
                      .... .......+++.|+|||++.     ...++.++|||||||++|||++|+.||......            ..... 
T Consensus       161 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------------~~~~~-  226 (292)
T cd06644         161 VKTL-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------------RVLLK-  226 (292)
T ss_pred             cccc-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------------HHHHH-
Confidence            3221 1123456788999999885     345678999999999999999999998532110            00111 


Q ss_pred             hhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          336 MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       336 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      .....     .+.+.    .+......+.+++.+||+.+|++||++.++++
T Consensus       227 ~~~~~-----~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         227 IAKSE-----PPTLS----QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             HhcCC-----CccCC----CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            11110     01111    12233446889999999999999999999875

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.3e-37  Score=308.78  Aligned_cols=194  Identities=23%  Similarity=0.366  Sum_probs=165.6

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      .+.||+|+||+||++... +++.||+|+++..    ......+..|+.++..++|+|++++++++. .++..++||||++
T Consensus         6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~-~~~~~~lv~E~~~   84 (360)
T cd05627           6 LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ-DKRNLYLIMEFLP   84 (360)
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE-cCCEEEEEEeCCC
Confidence            478999999999999964 6889999998642    233456888999999999999999999876 5668899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|.+++...          ..+++.....++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++...
T Consensus        85 gg~L~~~l~~~----------~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~  151 (360)
T cd05627          85 GGDMMTLLMKK----------DTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL  151 (360)
T ss_pred             CccHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence            99999998543          238899999999999999999999   89999999999999999999999999998754


Q ss_pred             cCCCC----------------------------------ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc
Q 047276          261 SRDQS----------------------------------RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG  306 (453)
Q Consensus       261 ~~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt  306 (453)
                      .....                                  .......||+.|+|||.+.+..++.++|||||||++|||++
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~t  231 (360)
T cd05627         152 KKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI  231 (360)
T ss_pred             ccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeeccc
Confidence            22100                                  00123469999999999999999999999999999999999


Q ss_pred             CCCCCcc
Q 047276          307 GRRNVSL  313 (453)
Q Consensus       307 G~~p~~~  313 (453)
                      |+.||..
T Consensus       232 G~~Pf~~  238 (360)
T cd05627         232 GYPPFCS  238 (360)
T ss_pred             CCCCCCC
Confidence            9999953

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=4.7e-37  Score=294.10  Aligned_cols=249  Identities=24%  Similarity=0.394  Sum_probs=192.6

Q ss_pred             HHHhcccCcCCceEEEEEEe-CCCcEEEEEEecCCCccHHHHHHHHHHHHhc-CCCceeeEeeEEEec-----CCCeEEE
Q 047276          103 DNFQALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVP-----GGPRYLV  175 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-----~~~~~lv  175 (453)
                      +.+.+.||+|+||.||+|.. .+++.+|+|.+........++..|+.++.++ +|+|++++++++...     ....+++
T Consensus        18 ~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv   97 (282)
T cd06636          18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLV   97 (282)
T ss_pred             hhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEE
Confidence            34457999999999999996 5688999999876555556788999999998 699999999987532     3467999


Q ss_pred             EEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecc
Q 047276          176 YEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFG  255 (453)
Q Consensus       176 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfG  255 (453)
                      |||+++|+|.+++....        ...+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||
T Consensus        98 ~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~dfg  166 (282)
T cd06636          98 MEFCGAGSVTDLVKNTK--------GNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFG  166 (282)
T ss_pred             EEeCCCCcHHHHHHHcc--------CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCc
Confidence            99999999999985432        1237888899999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCceeeeccCCccccchhhhh-----cCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhH
Q 047276          256 LSKLMSRDQSRCITTIRGTRGYLAPEWIL-----EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPK  330 (453)
Q Consensus       256 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~  330 (453)
                      ++........ ......|++.|+|||.+.     ...++.++|||||||++|||++|+.||....+...           
T Consensus       167 ~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~-----------  234 (282)
T cd06636         167 VSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA-----------  234 (282)
T ss_pred             chhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh-----------
Confidence            9876532221 123456888999999875     34678899999999999999999999853221100           


Q ss_pred             HHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          331 IVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       331 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                       ... ....     ..+.+     ........+.+++.+||+.+|.+||++.++++
T Consensus       235 -~~~-~~~~-----~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         235 -LFL-IPRN-----PPPKL-----KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             -hhh-HhhC-----CCCCC-----cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence             000 0000     00111     11123456899999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=5.2e-37  Score=294.05  Aligned_cols=263  Identities=23%  Similarity=0.303  Sum_probs=190.9

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.+.||+|+||.||+|+.. +++.||+|.+...   ......+.+|+.++..++|||++++++++. .++..++|+||++
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~~v~e~~~   82 (285)
T cd07861           4 KIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-QESRLYLIFEFLS   82 (285)
T ss_pred             EeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-eCCeEEEEEecCC
Confidence            3468999999999999964 6889999998643   223467889999999999999999999986 5668899999997


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                       ++|.+++.....       ...+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++...
T Consensus        83 -~~l~~~~~~~~~-------~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  151 (285)
T cd07861          83 -MDLKKYLDSLPK-------GQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAF  151 (285)
T ss_pred             -CCHHHHHhcCCC-------CCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeec
Confidence             689888854321       2348999999999999999999999   89999999999999999999999999998755


Q ss_pred             cCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCC----------CCcccccchh
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGND----------KSKNKWQYFP  329 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~----------~~~~~~~~~~  329 (453)
                      .... .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||........          .....|....
T Consensus       152 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (285)
T cd07861         152 GIPV-RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT  230 (285)
T ss_pred             CCCc-ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcch
Confidence            3221 11223456889999998865 3578999999999999999999999863221000          0000010000


Q ss_pred             HHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          330 KIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       330 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ....  .. ..........+..   .......++.+++.+|++.||++|||+.+|++
T Consensus       231 ~~~~--~~-~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         231 SLPD--YK-NTFPKWKKGSLRS---AVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hhHH--HH-hhccccCcchhHH---hcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            0000  00 0000000000000   01123455789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.8e-37  Score=291.18  Aligned_cols=245  Identities=24%  Similarity=0.346  Sum_probs=195.1

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.+.||+|+||.||++.. .+|+.||+|.+...   ....+++.+|+.++++++|||++++++++. ..+..++|+||++
T Consensus         4 ~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~lv~e~~~   82 (256)
T cd08218           4 KVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFE-ENGNLYIVMDYCE   82 (256)
T ss_pred             EEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeec-CCCeEEEEEecCC
Confidence            457899999999999985 46889999998642   233457899999999999999999999875 5668899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +++|.+++....        ...+++...++++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++...
T Consensus        83 ~~~l~~~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~  151 (256)
T cd08218          83 GGDLYKKINAQR--------GVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVL  151 (256)
T ss_pred             CCcHHHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeec
Confidence            999999985432        1237899999999999999999999   89999999999999999999999999999765


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      ..... ......|++.|+|||++.+..++.++|+||||+++++|++|+.||....            ......... .+.
T Consensus       152 ~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~------------~~~~~~~~~-~~~  217 (256)
T cd08218         152 NSTVE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN------------MKNLVLKII-RGS  217 (256)
T ss_pred             Ccchh-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC------------HHHHHHHHh-cCC
Confidence            43221 1223457889999999988889999999999999999999999985211            111111111 111


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ..           ..+......+.+++.+|++.+|.+||++.+|++
T Consensus       218 ~~-----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         218 YP-----------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             CC-----------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            10           112233456899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-38  Score=306.29  Aligned_cols=238  Identities=23%  Similarity=0.319  Sum_probs=192.0

Q ss_pred             cccCcCCceEEEEEEe-CCCcEEEEEEecCCC----ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          107 ALLGHGSSASVFKGIL-SDGTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      +.||.|+||-||.+.. .+...||||++.-+.    ..-.++.+|+..|.+++|||.+.+-|++. .+...|||||||- 
T Consensus        32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyL-re~TaWLVMEYCl-  109 (948)
T KOG0577|consen   32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYL-REHTAWLVMEYCL-  109 (948)
T ss_pred             HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceee-ccchHHHHHHHHh-
Confidence            4699999999999994 567899999987532    22356899999999999999999999765 6678899999995 


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      ||-.|.+...+         .++.+..+..|+.+.+.||+|||+   .+.||||||+.|||+++.|.+||+|||.|....
T Consensus       110 GSAsDlleVhk---------KplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~  177 (948)
T KOG0577|consen  110 GSASDLLEVHK---------KPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMA  177 (948)
T ss_pred             ccHHHHHHHHh---------ccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcC
Confidence            47777775443         348888899999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCceeeeccCCccccchhhhh---cCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          262 RDQSRCITTIRGTRGYLAPEWIL---EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      +.     ..++|||.|||||++.   .+.|+-|+||||+|++..||...++|+..+...        .     ....+..
T Consensus       178 PA-----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM--------S-----ALYHIAQ  239 (948)
T KOG0577|consen  178 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------S-----ALYHIAQ  239 (948)
T ss_pred             ch-----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH--------H-----HHHHHHh
Confidence            43     4578999999999986   588999999999999999999999997422110        0     1111111


Q ss_pred             CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      +.     .|.|.     ..+-+..+..++..||++-|.+|||.+++++
T Consensus       240 Ne-----sPtLq-----s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  240 NE-----SPTLQ-----SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             cC-----CCCCC-----CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            11     12222     2355677999999999999999999998874

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4e-37  Score=295.20  Aligned_cols=250  Identities=25%  Similarity=0.374  Sum_probs=194.1

Q ss_pred             HHHhcccCcCCceEEEEEEeC-CCcEEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          103 DNFQALLGHGSSASVFKGILS-DGTSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      +.+.+.||+|+||.||++... +|..||+|.+...  ......+.+|+.++.+++|+||+++++++. ..+..++|+||+
T Consensus         3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~~lv~e~~   81 (286)
T cd06622           3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFF-IEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhee-cCCeEEEEEeec
Confidence            345678999999999999975 6899999988653  223457889999999999999999999876 456889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ++++|..++.....       ...+++..+..++.|++.||.|||+.  .+++|+||||+||+++.++.+||+|||++..
T Consensus        82 ~~~~l~~~~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  152 (286)
T cd06622          82 DAGSLDKLYAGGVA-------TEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGN  152 (286)
T ss_pred             CCCCHHHHHHhccc-------cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCccc
Confidence            99999998854311       23489999999999999999999963  5899999999999999999999999999876


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcC------CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHH
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQ------GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVN  333 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  333 (453)
                      .....   .....+++.|+|||.+...      .++.++|+|||||++|||++|+.||.......         ..... 
T Consensus       153 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---------~~~~~-  219 (286)
T cd06622         153 LVASL---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---------IFAQL-  219 (286)
T ss_pred             ccCCc---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---------HHHHH-
Confidence            53221   2234578899999988544      35789999999999999999999985321100         00000 


Q ss_pred             HhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          334 EKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       334 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      .....+..           ...+.+....+.+++.+|++.+|++||++.++++
T Consensus       220 ~~~~~~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         220 SAIVDGDP-----------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             HHHhhcCC-----------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            00111110           1123345566889999999999999999999885

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.4e-37  Score=298.71  Aligned_cols=243  Identities=24%  Similarity=0.344  Sum_probs=192.3

Q ss_pred             cccCcCCceEEEEEEe-CCCcEEEEEEecCC-CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCCh
Q 047276          107 ALLGHGSSASVFKGIL-SDGTSVAVKRINGE-ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL  184 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL  184 (453)
                      ..||+|+||.||++.. .+++.||+|.+... ....+.+.+|+.++..++|||++++++++. .++..++++||+++++|
T Consensus        27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-~~~~~~iv~e~~~~~~L  105 (297)
T cd06659          27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL-VGEELWVLMEFLQGGAL  105 (297)
T ss_pred             hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhee-eCCeEEEEEecCCCCCH
Confidence            4799999999999986 46899999998653 334456889999999999999999999876 56688999999999999


Q ss_pred             hhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCCC
Q 047276          185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ  264 (453)
Q Consensus       185 ~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~  264 (453)
                      .+++..           ..+++..++.++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||++.......
T Consensus       106 ~~~~~~-----------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~  171 (297)
T cd06659         106 TDIVSQ-----------TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV  171 (297)
T ss_pred             HHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence            988732           238999999999999999999999   899999999999999999999999999987654332


Q ss_pred             CceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCccccc
Q 047276          265 SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEI  344 (453)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (453)
                      . ......++..|+|||++.+..++.++||||||+++|||++|+.||.......             ....+.....   
T Consensus       172 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------------~~~~~~~~~~---  234 (297)
T cd06659         172 P-KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-------------AMKRLRDSPP---  234 (297)
T ss_pred             c-cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------------HHHHHhccCC---
Confidence            1 1233568899999999998889999999999999999999999985321100             0011111100   


Q ss_pred             ccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          345 VDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       345 ~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                        +...    ........+.+++.+|++.+|++||++.++++.
T Consensus       235 --~~~~----~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         235 --PKLK----NAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             --CCcc----ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence              0000    011223457899999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-37  Score=293.84  Aligned_cols=249  Identities=24%  Similarity=0.305  Sum_probs=194.5

Q ss_pred             HHHhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC-ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          103 DNFQALLGHGSSASVFKGILS-DGTSVAVKRINGEE-NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.+.+.||+|+||.||++... ++..+|+|.+.... ...+.|..|+.++++++|+|++++++++. .+...++||||++
T Consensus         7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~   85 (280)
T cd06611           7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF-YENKLWILIEFCD   85 (280)
T ss_pred             HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-cCCeEEEEeeccC
Confidence            445678999999999999964 68899999987533 33457889999999999999999999986 5668899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +++|.+++....         ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++...
T Consensus        86 ~~~L~~~~~~~~---------~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~  153 (280)
T cd06611          86 GGALDSIMLELE---------RGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKN  153 (280)
T ss_pred             CCcHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhh
Confidence            999999985432         238999999999999999999999   89999999999999999999999999998765


Q ss_pred             cCCCCceeeeccCCccccchhhhhc-----CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHh
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILE-----QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEK  335 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  335 (453)
                      ..... ......+++.|++||.+..     ..++.++||||||+++|||++|+.||......            . ....
T Consensus       154 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------------~-~~~~  219 (280)
T cd06611         154 KSTLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------------R-VLLK  219 (280)
T ss_pred             ccccc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------------H-HHHH
Confidence            43222 2234568899999998752     34678999999999999999999998532110            0 0111


Q ss_pred             hhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          336 MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       336 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      +..+..     +.+    ..+......+.+++..||+.+|.+||++.++++.
T Consensus       220 ~~~~~~-----~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         220 ILKSEP-----PTL----DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             HhcCCC-----CCc----CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            111110     111    1122334568899999999999999999998753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9e-37  Score=293.12  Aligned_cols=256  Identities=27%  Similarity=0.349  Sum_probs=194.9

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecC-CCeEEEEEecCC
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG-GPRYLVYEFIQN  181 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~~lv~e~~~~  181 (453)
                      .+.||.|++|.||++... +++.+|+|.+....  .....+.+|++++++++||||++++++|.... ...++||||+++
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~   85 (287)
T cd06621           6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEG   85 (287)
T ss_pred             EEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCC
Confidence            468999999999999974 57899999987532  24567899999999999999999999886433 367899999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      ++|.+++.....      ....+++.....++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++....
T Consensus        86 ~~L~~~l~~~~~------~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  156 (287)
T cd06621          86 GSLDSIYKKVKK------RGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV  156 (287)
T ss_pred             CCHHHHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence            999998753221      12348889999999999999999999   899999999999999999999999999987543


Q ss_pred             CCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcc
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKL  341 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (453)
                      ....   ....++..|+|||.+.+..++.++||||||+++|||++|+.||..........       .. ..........
T Consensus       157 ~~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-------~~-~~~~~~~~~~  225 (287)
T cd06621         157 NSLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGP-------IE-LLSYIVNMPN  225 (287)
T ss_pred             cccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCCh-------HH-HHHHHhcCCc
Confidence            2221   23457889999999998899999999999999999999999996432210000       00 1111111010


Q ss_pred             cccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          342 MEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       342 ~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                           +.+.............+.+++.+|++.+|++|||+.|+++
T Consensus       226 -----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         226 -----PELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             -----hhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence                 0111000111123456899999999999999999999886

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-37  Score=289.43  Aligned_cols=248  Identities=25%  Similarity=0.344  Sum_probs=195.2

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCC-CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCC
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGE-ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      +.+.||+|+||.||++... +++.+++|.+... ....+.+.+|+.++++++|||++++++++. .++..+++|||++++
T Consensus         7 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~~~l~~e~~~~~   85 (262)
T cd06613           7 LIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL-RRDKLWIVMEYCGGG   85 (262)
T ss_pred             EEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEE-eCCEEEEEEeCCCCC
Confidence            4578999999999999964 5788999998753 234567899999999999999999999875 566889999999999


Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccC
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR  262 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~  262 (453)
                      +|.+++....         ..+++.....++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||++.....
T Consensus        86 ~l~~~~~~~~---------~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  153 (262)
T cd06613          86 SLQDIYQVTR---------GPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA  153 (262)
T ss_pred             cHHHHHHhhc---------cCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhh
Confidence            9999985431         238899999999999999999998   8999999999999999999999999999876543


Q ss_pred             CCCceeeeccCCccccchhhhhcC---CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          263 DQSRCITTIRGTRGYLAPEWILEQ---GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       263 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      .. .......++..|+|||.+...   .++.++||||||+++|||++|+.||.......             ........
T Consensus       154 ~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~-------------~~~~~~~~  219 (262)
T cd06613         154 TI-AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR-------------ALFLISKS  219 (262)
T ss_pred             hh-hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-------------HHHHHHhc
Confidence            22 122345678899999998776   78999999999999999999999985321100             00001111


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ..   ..+.+    .........+.+++.+|++.+|.+|||+.+|+.
T Consensus       220 ~~---~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         220 NF---PPPKL----KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             cC---CCccc----cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00   00111    112344567899999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=6.4e-37  Score=290.75  Aligned_cols=244  Identities=23%  Similarity=0.338  Sum_probs=187.5

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCC------ccHHHHHHHHHHHHhcCCCceeeEeeEEEec-CCCeEEEEE
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEE------NGEKEFRSEVAAIASAQHVNLVRLLGYCVVP-GGPRYLVYE  177 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~~lv~e  177 (453)
                      .+.||+|+||.||++.. .++..|++|.+....      .....+.+|+.+++.++||||+++++++... +...++++|
T Consensus         7 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e   86 (266)
T cd06651           7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFME   86 (266)
T ss_pred             cceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEe
Confidence            57899999999999986 458899999886421      1234588899999999999999999987643 345689999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |+++++|.+++...          ..+++...+.++.|++.||+|||+   .+++|+||+|+||+++.++.+||+|||++
T Consensus        87 ~~~~~~L~~~l~~~----------~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~  153 (266)
T cd06651          87 YMPGGSVKDQLKAY----------GALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGAS  153 (266)
T ss_pred             CCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCc
Confidence            99999999998533          237889999999999999999998   89999999999999999999999999998


Q ss_pred             ccccCCC--CceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHh
Q 047276          258 KLMSRDQ--SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEK  335 (453)
Q Consensus       258 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  335 (453)
                      .......  ........++..|+|||++.+..++.++||||||+++|||++|+.||......            ......
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~------------~~~~~~  221 (266)
T cd06651         154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM------------AAIFKI  221 (266)
T ss_pred             cccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH------------HHHHHH
Confidence            7654321  11122345788999999999888999999999999999999999998532110            001111


Q ss_pred             hhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          336 MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       336 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ....     ..+      ..+......+.+++ .||..+|++||++++|++
T Consensus       222 ~~~~-----~~~------~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         222 ATQP-----TNP------QLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             hcCC-----CCC------CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            0000     011      12223334455565 788899999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-38  Score=290.79  Aligned_cols=267  Identities=21%  Similarity=0.264  Sum_probs=195.8

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecC---CCccHHHHHHHHHHHHhcCCCceeeEeeEEEe----cCCCeEEEEE
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRING---EENGEKEFRSEVAAIASAQHVNLVRLLGYCVV----PGGPRYLVYE  177 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~~lv~e  177 (453)
                      .+.||+|+||.|+.+.. .+|..||||++..   .....++-.+|+++|+.++|+||+.+.+....    .-+..|+|+|
T Consensus        27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e  106 (359)
T KOG0660|consen   27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE  106 (359)
T ss_pred             cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence            35799999999999995 5789999999873   34455778899999999999999999998764    2346799999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      +|+ .+|...++.++          .|+.....-++.|+++||.|+|+   .+|+||||||+|+|++.+...||+|||+|
T Consensus       107 lMe-tDL~~iik~~~----------~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLA  172 (359)
T KOG0660|consen  107 LME-TDLHQIIKSQQ----------DLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLA  172 (359)
T ss_pred             HHh-hHHHHHHHcCc----------cccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccce
Confidence            994 49999996443          38888999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCC-CceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCccc-c-cchhHHHH
Q 047276          258 KLMSRDQ-SRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNK-W-QYFPKIVN  333 (453)
Q Consensus       258 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~-~-~~~~~~~~  333 (453)
                      +...... ...++..+-|.+|.|||.+.. ..|+...||||.|||+.||++|+.-|-+.+.-.+..... . ..-.+...
T Consensus       173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l  252 (359)
T KOG0660|consen  173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL  252 (359)
T ss_pred             eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence            9876431 223466778999999998764 679999999999999999999999885432211100000 0 00001111


Q ss_pred             HhhhcCcccccccccccCCC--CC---cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          334 EKMKEGKLMEIVDQRLTDEG--GI---DETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       334 ~~~~~~~~~~~~d~~l~~~~--~~---~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      ..+........+.. ++...  ++   -+......++|+.++|..||.+|+|.+|.++.
T Consensus       253 ~~i~s~~ar~yi~s-lp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  253 QKIRSEKARPYIKS-LPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHhccHHHHHHHHh-CCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            11111111111110 00000  00   01234557899999999999999999998754

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.9e-37  Score=298.75  Aligned_cols=243  Identities=24%  Similarity=0.365  Sum_probs=192.0

Q ss_pred             cccCcCCceEEEEEEe-CCCcEEEEEEecCCC-ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCCh
Q 047276          107 ALLGHGSSASVFKGIL-SDGTSVAVKRINGEE-NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL  184 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL  184 (453)
                      ..||+|+||.||++.. .++..||||.+.... ...+.+.+|+.+++.++|+|++++++.+. .++..++||||+++++|
T Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-~~~~~~lv~e~~~~~~L  106 (292)
T cd06658          28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL-VGDELWVVMEFLEGGAL  106 (292)
T ss_pred             hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-cCCeEEEEEeCCCCCcH
Confidence            5699999999999986 458899999986533 33456889999999999999999999876 56688999999999999


Q ss_pred             hhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCCC
Q 047276          185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ  264 (453)
Q Consensus       185 ~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~  264 (453)
                      .+++..           ..+++.....++.|++.||+|||+   .+++||||||+||++++++.++|+|||++.......
T Consensus       107 ~~~~~~-----------~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~  172 (292)
T cd06658         107 TDIVTH-----------TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV  172 (292)
T ss_pred             HHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence            998832           238899999999999999999999   899999999999999999999999999987654322


Q ss_pred             CceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCccccc
Q 047276          265 SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEI  344 (453)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (453)
                      . ......++..|+|||.+.+..++.++||||||+++|||++|+.||......        .     .......     .
T Consensus       173 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--------~-----~~~~~~~-----~  233 (292)
T cd06658         173 P-KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--------Q-----AMRRIRD-----N  233 (292)
T ss_pred             c-cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------H-----HHHHHHh-----c
Confidence            2 123356889999999998888999999999999999999999998532110        0     0001110     1


Q ss_pred             ccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          345 VDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       345 ~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      ..+.+..    .......+.+++.+|++.+|++|||+.++++.
T Consensus       234 ~~~~~~~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         234 LPPRVKD----SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             CCCcccc----ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            1111111    11233457889999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=5.8e-37  Score=290.16  Aligned_cols=247  Identities=26%  Similarity=0.414  Sum_probs=194.4

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCCc---cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEEN---GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      ..+.||+|+||.||+|... +++.|++|.+.....   ..+.+..|+.+++.++|+||+++++++. ..+..++|+||++
T Consensus         4 ~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-~~~~~~lv~e~~~   82 (264)
T cd06626           4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEV-HREKVYIFMEYCS   82 (264)
T ss_pred             eeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEe-cCCEEEEEEecCC
Confidence            3578999999999999964 688999999876433   4567899999999999999999999875 5668899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +++|.+++...          ..+++..+..++.+++.||.|||+   .+++|+||+|+||++++++.+||+|||++...
T Consensus        83 ~~~L~~~~~~~----------~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~  149 (264)
T cd06626          83 GGTLEELLEHG----------RILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKL  149 (264)
T ss_pred             CCcHHHHHhhc----------CCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccccccccc
Confidence            99999998533          237888999999999999999999   89999999999999999999999999999876


Q ss_pred             cCCCCcee---eeccCCccccchhhhhcCC---CCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHH
Q 047276          261 SRDQSRCI---TTIRGTRGYLAPEWILEQG---VSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNE  334 (453)
Q Consensus       261 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~---~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  334 (453)
                      ........   ....+++.|+|||++....   ++.++||||||+++||+++|+.||.....       .+..    .. 
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~-------~~~~----~~-  217 (264)
T cd06626         150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN-------EFQI----MF-  217 (264)
T ss_pred             CCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc-------hHHH----HH-
Confidence            54333221   2356788999999998766   88999999999999999999999953211       0100    00 


Q ss_pred             hhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          335 KMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       335 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ....+.     .+.+..    .......+.+++.+|++.+|.+||++.+++.
T Consensus       218 ~~~~~~-----~~~~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         218 HVGAGH-----KPPIPD----SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             HHhcCC-----CCCCCc----ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000010     111111    1122455789999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.7e-36  Score=290.59  Aligned_cols=267  Identities=21%  Similarity=0.227  Sum_probs=192.1

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.+.||+|+||.||+|... +|+.||+|++....   ...+.+.+|+.++++++|+|++++++++. .+...++||||++
T Consensus         5 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~~~~v~e~~~   83 (286)
T cd07847           5 KLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR-RKRKLHLVFEYCD   83 (286)
T ss_pred             eeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe-eCCEEEEEEeccC
Confidence            4578999999999999975 58999999886422   23456889999999999999999999876 4567899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +++|..++...          ..+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++...
T Consensus        84 ~~~l~~~~~~~----------~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  150 (286)
T cd07847          84 HTVLNELEKNP----------RGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARIL  150 (286)
T ss_pred             ccHHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceec
Confidence            98888876422          238999999999999999999999   89999999999999999999999999999876


Q ss_pred             cCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCccc--ccchhHHHHHhhh
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNK--WQYFPKIVNEKMK  337 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~  337 (453)
                      ..... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.............  ...........+.
T Consensus       151 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07847         151 TGPGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFS  229 (286)
T ss_pred             CCCcc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcc
Confidence            54321 1223457789999999875 457899999999999999999999996332110000000  0000000000000


Q ss_pred             cCcc-cccccccccCCCC---CcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          338 EGKL-MEIVDQRLTDEGG---IDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       338 ~~~~-~~~~d~~l~~~~~---~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      .... .....+.......   ........+.+++.+|++.+|++||++.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            0000 0000000000000   00122456889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.2e-37  Score=290.79  Aligned_cols=249  Identities=25%  Similarity=0.358  Sum_probs=191.5

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCC----c-------cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeE
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEE----N-------GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRY  173 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~----~-------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~  173 (453)
                      .+.||+|+||.||+|.. .+|+.+|+|.++...    .       ..+.+..|+.+++.++|+|++++++++. ..+..+
T Consensus         6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~   84 (272)
T cd06629           6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET-TEEYLS   84 (272)
T ss_pred             cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec-cCCceE
Confidence            46899999999999985 468899999875311    0       1235788999999999999999999876 556889


Q ss_pred             EEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEee
Q 047276          174 LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSD  253 (453)
Q Consensus       174 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~D  253 (453)
                      +|+||+++|+|.+++...          ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|
T Consensus        85 lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d  151 (272)
T cd06629          85 IFLEYVPGGSIGSCLRTY----------GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISD  151 (272)
T ss_pred             EEEecCCCCcHHHHHhhc----------cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEee
Confidence            999999999999998543          238899999999999999999999   8999999999999999999999999


Q ss_pred             ccccccccCCCC-ceeeeccCCccccchhhhhcCC--CCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhH
Q 047276          254 FGLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQG--VSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPK  330 (453)
Q Consensus       254 fGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~  330 (453)
                      ||++........ .......++..|+|||.+....  ++.++||||||+++||+++|..||...+..            .
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------------~  219 (272)
T cd06629         152 FGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------------A  219 (272)
T ss_pred             ccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH------------H
Confidence            999976543221 1223456888999999987654  789999999999999999999998421110            0


Q ss_pred             HHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          331 IVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       331 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      ...+.. .......++.      .........+.+++.+|++.+|++||++.+|++.
T Consensus       220 ~~~~~~-~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         220 AMFKLG-NKRSAPPIPP------DVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             HHHHhh-ccccCCcCCc------cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            000100 0000001111      1112335668999999999999999999998853

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.3e-36  Score=288.06  Aligned_cols=253  Identities=27%  Similarity=0.424  Sum_probs=197.6

Q ss_pred             HHhcccCcCCceEEEEEEe-CCCcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          104 NFQALLGHGSSASVFKGIL-SDGTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      .+.+.||.|+||+||+|.. .++..+++|++....  .....+.+|+..++.++|+|++++++.+. .++..++++||++
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~iv~e~~~   82 (267)
T cd06610           4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFV-VGDELWLVMPYLS   82 (267)
T ss_pred             eeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEe-eCCEEEEEEeccC
Confidence            3467899999999999995 467899999986532  34567899999999999999999999876 5668899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +++|.+++.....       ...+++.....++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++...
T Consensus        83 ~~~l~~~~~~~~~-------~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~  152 (267)
T cd06610          83 GGSLLDIMKSSYP-------RGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASL  152 (267)
T ss_pred             CCcHHHHHHHhcc-------cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHh
Confidence            9999999864321       1348999999999999999999998   89999999999999999999999999999876


Q ss_pred             cCCCCc---eeeeccCCccccchhhhhcC-CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhh
Q 047276          261 SRDQSR---CITTIRGTRGYLAPEWILEQ-GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKM  336 (453)
Q Consensus       261 ~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (453)
                      ......   ......++..|+|||++... .++.++|||||||++|||++|+.||.......            ......
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------------~~~~~~  220 (267)
T cd06610         153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------------VLMLTL  220 (267)
T ss_pred             ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------------hHHHHh
Confidence            543322   22334688999999998876 78999999999999999999999985322110            011111


Q ss_pred             hcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          337 KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       337 ~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ...      .+.+... .........+.+++..|++.+|++||++.++++
T Consensus       221 ~~~------~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         221 QND------PPSLETG-ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             cCC------CCCcCCc-cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            110      0111100 001234566889999999999999999999885

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=5.1e-37  Score=296.24  Aligned_cols=267  Identities=22%  Similarity=0.235  Sum_probs=191.9

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCCc------cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEEN------GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      +.+.||+|+||.||+|... +|+.||||.+.....      ....+..|+.+++.++|+|++++++++.. .+..++|||
T Consensus         4 ~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e   82 (298)
T cd07841           4 KGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-KSNINLVFE   82 (298)
T ss_pred             eeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-CCEEEEEEc
Confidence            4568999999999999964 689999999975322      23457789999999999999999999874 668899999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |+ +|+|.+++....         ..+++..+..++.|+++||+|||+   .+++|+||+|+||+++.++.++|+|||++
T Consensus        83 ~~-~~~L~~~i~~~~---------~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~  149 (298)
T cd07841          83 FM-ETDLEKVIKDKS---------IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLA  149 (298)
T ss_pred             cc-CCCHHHHHhccC---------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceee
Confidence            99 889999985432         248999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhh
Q 047276          258 KLMSRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKM  336 (453)
Q Consensus       258 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (453)
                      ........ ......+++.|+|||.+.+ ..++.++|||||||++|||++|..||....+...... ....+.......+
T Consensus       150 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  227 (298)
T cd07841         150 RSFGSPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGK-IFEALGTPTEENW  227 (298)
T ss_pred             eeccCCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHH-HHHHcCCCchhhh
Confidence            87644321 1223356788999998864 4678999999999999999999777743221000000 0000000000000


Q ss_pred             h-cCcccccccccccCC---CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          337 K-EGKLMEIVDQRLTDE---GGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       337 ~-~~~~~~~~d~~l~~~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      . ...............   ..........+.+++.+|++.+|++|||+.++++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             hhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0 000000000000000   00112235678999999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-36  Score=289.25  Aligned_cols=244  Identities=25%  Similarity=0.411  Sum_probs=193.0

Q ss_pred             HHhcccCcCCceEEEEEEe-CCCcEEEEEEecCC--CccHHHHHHHHHHHHhcC---CCceeeEeeEEEecCCCeEEEEE
Q 047276          104 NFQALLGHGSSASVFKGIL-SDGTSVAVKRINGE--ENGEKEFRSEVAAIASAQ---HVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      .+.+.||+|+||.||+|.. .+++.+|+|.++..  .....++.+|+.+++.++   |||++++++++. .+...+++||
T Consensus         4 ~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-~~~~~~lv~e   82 (277)
T cd06917           4 QRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-KGPRLWIIME   82 (277)
T ss_pred             hhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-eCCEEEEEEe
Confidence            3457899999999999996 56899999998653  334567889999999997   999999999876 5567899999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |+++++|.+++..           ..+++...+.++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++
T Consensus        83 ~~~~~~L~~~~~~-----------~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~  148 (277)
T cd06917          83 YAEGGSVRTLMKA-----------GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVA  148 (277)
T ss_pred             cCCCCcHHHHHHc-----------cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCce
Confidence            9999999999842           248999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCceeeeccCCccccchhhhhcC-CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhh
Q 047276          258 KLMSRDQSRCITTIRGTRGYLAPEWILEQ-GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKM  336 (453)
Q Consensus       258 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (453)
                      ........ ......|+..|+|||.+.++ .++.++|||||||++|+|++|+.||........            . ...
T Consensus       149 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------------~-~~~  214 (277)
T cd06917         149 ALLNQNSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------------M-MLI  214 (277)
T ss_pred             eecCCCcc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------------h-hcc
Confidence            87654332 22344688899999988754 468999999999999999999999953221100            0 000


Q ss_pred             hcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          337 KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       337 ~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ...     ..+.+..     ......+.+++.+|++.+|++||++.++++
T Consensus       215 ~~~-----~~~~~~~-----~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         215 PKS-----KPPRLED-----NGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             ccC-----CCCCCCc-----ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            000     0111111     013456889999999999999999999975

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=299.21  Aligned_cols=247  Identities=26%  Similarity=0.318  Sum_probs=203.9

Q ss_pred             HHHHhcccCcCCceEEEEEEeCC-CcEEEEEEecCCC----ccHHHHHHHHHHHHhcC-CCceeeEeeEEEecCCCeEEE
Q 047276          102 TDNFQALLGHGSSASVFKGILSD-GTSVAVKRINGEE----NGEKEFRSEVAAIASAQ-HVNLVRLLGYCVVPGGPRYLV  175 (453)
Q Consensus       102 ~~~~~~~lG~G~fG~Vy~~~~~~-g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~~lv  175 (453)
                      .+.+.+.||+|.||.||+++.+. |+.+|+|.+.+..    .......+|+.+|+++. |||||.+.+.+. .....++|
T Consensus        36 ~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e-~~~~~~lv  114 (382)
T KOG0032|consen   36 KYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFE-DPDSVYLV  114 (382)
T ss_pred             cEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEE-cCCeEEEE
Confidence            34456899999999999999654 9999999997632    23467899999999998 999999999976 55689999


Q ss_pred             EEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCC----CcEEE
Q 047276          176 YEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDEN----YRAVV  251 (453)
Q Consensus       176 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~----~~~kl  251 (453)
                      ||++.+|.|.+.+...           .+++.....++.|++.++.|||+   .+++||||||+|+|+...    +.+|+
T Consensus       115 mEL~~GGeLfd~i~~~-----------~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~  180 (382)
T KOG0032|consen  115 MELCEGGELFDRIVKK-----------HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKL  180 (382)
T ss_pred             EEecCCchHHHHHHHc-----------cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEE
Confidence            9999999999999543           18899999999999999999999   899999999999999633    57999


Q ss_pred             eeccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHH
Q 047276          252 SDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKI  331 (453)
Q Consensus       252 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~  331 (453)
                      +|||++.....  .......+||+.|+|||.+....|+..+||||.||++|.|++|..||.......             
T Consensus       181 ~DFGla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~-------------  245 (382)
T KOG0032|consen  181 IDFGLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE-------------  245 (382)
T ss_pred             eeCCCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH-------------
Confidence            99999998766  445678899999999999999999999999999999999999999996432111             


Q ss_pred             HHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          332 VNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       332 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ....+..+.+ ++       ..+.-........+++..|+..||..|+|+.++++
T Consensus       246 ~~~~i~~~~~-~f-------~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  246 IFLAILRGDF-DF-------TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             HHHHHHcCCC-CC-------CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            1112223332 11       12233455677899999999999999999999997

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=5.1e-37  Score=296.92  Aligned_cols=267  Identities=20%  Similarity=0.241  Sum_probs=190.2

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      +.+.||+|+||.||+|... +++.||+|.++..  ......+.+|+.+++.++||||+++++++. ..+..++|+||++ 
T Consensus        10 ~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~-~~~~~~lv~e~~~-   87 (301)
T cd07873          10 KLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-TEKSLTLVFEYLD-   87 (301)
T ss_pred             EeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe-cCCeEEEEEeccc-
Confidence            3578999999999999864 5789999998642  233456788999999999999999999976 5568899999997 


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      ++|.+++....         ..+++.....++.|++.||+|||+   .+++|+||||+||++++++.+||+|||++....
T Consensus        88 ~~l~~~l~~~~---------~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  155 (301)
T cd07873          88 KDLKQYLDDCG---------NSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKS  155 (301)
T ss_pred             cCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence            59998885432         237899999999999999999999   899999999999999999999999999987643


Q ss_pred             CCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCc-ccc-cchhHHHHHh-hh
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSK-NKW-QYFPKIVNEK-MK  337 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~-~~~-~~~~~~~~~~-~~  337 (453)
                      .... ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||........... ... .......+.. ..
T Consensus       156 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (301)
T cd07873         156 IPTK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS  234 (301)
T ss_pred             CCCC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc
Confidence            2221 1233456889999998865 3578899999999999999999999964321100000 000 0000000000 00


Q ss_pred             cCcccccccccccCC--CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          338 EGKLMEIVDQRLTDE--GGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       338 ~~~~~~~~d~~l~~~--~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      .......-.+.....  ..........+.+++.+|++.||.+|||++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000000000000000  0001122445789999999999999999999885

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.1e-37  Score=306.88  Aligned_cols=188  Identities=23%  Similarity=0.326  Sum_probs=157.8

Q ss_pred             HHHhcccCcCCceEEEEEEeC-CCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          103 DNFQALLGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      +.+.+.||+|+||.||+|... +++.||+|.....     ....|+.++++++|+||+++++++. .+...++|+||+. 
T Consensus        68 y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~-  140 (357)
T PHA03209         68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLV-SGAITCMVLPHYS-  140 (357)
T ss_pred             cEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEE-eCCeeEEEEEccC-
Confidence            344589999999999999965 4678999975432     2356999999999999999999987 4567899999995 


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      ++|.+++....         ..+++..+..|+.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       141 ~~l~~~l~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  208 (357)
T PHA03209        141 SDLYTYLTKRS---------RPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV  208 (357)
T ss_pred             CcHHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence            68988885432         348999999999999999999999   899999999999999999999999999997543


Q ss_pred             CCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCC
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNV  311 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~  311 (453)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       209 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        209 VAP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             cCc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            221  123456899999999999889999999999999999999866554

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=5.8e-37  Score=294.92  Aligned_cols=238  Identities=27%  Similarity=0.329  Sum_probs=191.8

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      +.+.||+|+||.||++... +++.+|+|.+...    ......+.+|++++++++||||+++++++. .++..++||||+
T Consensus         5 ~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~~v~e~~   83 (290)
T cd05580           5 FIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ-DDSNLYLVMEYV   83 (290)
T ss_pred             EEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE-cCCeEEEEEecC
Confidence            4578999999999999964 5899999998642    223456889999999999999999999876 566889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ++++|.+++...          ..+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||++..
T Consensus        84 ~~~~L~~~~~~~----------~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~  150 (290)
T cd05580          84 PGGELFSHLRKS----------GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKR  150 (290)
T ss_pred             CCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccc
Confidence            999999998543          238899999999999999999999   8999999999999999999999999999987


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      ....    .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||.....             .........+
T Consensus       151 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------------~~~~~~~~~~  213 (290)
T cd05580         151 VKGR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-------------IQIYEKILEG  213 (290)
T ss_pred             cCCC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-------------HHHHHHHhcC
Confidence            6443    2344688999999999888889999999999999999999999853210             0011111111


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHH
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRP-----SMARVV  385 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~~v~  385 (453)
                      .            ...+......+.+++.+||+.+|.+||     +.++++
T Consensus       214 ~------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         214 K------------VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             C------------ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence            1            011222345688999999999999999     556654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.1e-36  Score=286.92  Aligned_cols=244  Identities=22%  Similarity=0.315  Sum_probs=189.0

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCC------ccHHHHHHHHHHHHhcCCCceeeEeeEEEecC-CCeEEEEE
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEE------NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG-GPRYLVYE  177 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~~lv~e  177 (453)
                      .++||+|+||.||+|.. .+|..||+|.+....      ...+.+.+|+.++++++||||+++++++.... ...++++|
T Consensus         7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e   86 (265)
T cd06652           7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME   86 (265)
T ss_pred             eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEE
Confidence            57899999999999996 458899999885321      12346888999999999999999999875432 35679999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |+++++|.+++...          ..+++....+++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++
T Consensus        87 ~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~  153 (265)
T cd06652          87 HMPGGSIKDQLKSY----------GALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGAS  153 (265)
T ss_pred             ecCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccc
Confidence            99999999998533          237888899999999999999999   89999999999999999999999999998


Q ss_pred             ccccCCCC--ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHh
Q 047276          258 KLMSRDQS--RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEK  335 (453)
Q Consensus       258 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  335 (453)
                      ........  .......++..|+|||.+.+..++.++||||||+++|||++|+.||......            ......
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------------~~~~~~  221 (265)
T cd06652         154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM------------AAIFKI  221 (265)
T ss_pred             cccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH------------HHHHHH
Confidence            76532211  1123346888999999998888999999999999999999999998521100            000010


Q ss_pred             hhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          336 MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       336 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ....     ..      ...+......+.+++..|+. +|++||++++|++
T Consensus       222 ~~~~-----~~------~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         222 ATQP-----TN------PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             hcCC-----CC------CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            0000     00      11234455668888889985 8999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=8.8e-37  Score=294.17  Aligned_cols=246  Identities=24%  Similarity=0.376  Sum_probs=195.0

Q ss_pred             HHhcccCcCCceEEEEEEe-CCCcEEEEEEecC-CCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          104 NFQALLGHGSSASVFKGIL-SDGTSVAVKRING-EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      .+.+.||+|+||.||++.. .+++.|++|.+.. .....+.+.+|+.+++.++|||+++++++|. ..+..++|+||+++
T Consensus        22 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-~~~~~~lv~e~~~~  100 (293)
T cd06647          22 TRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL-VGDELWVVMEYLAG  100 (293)
T ss_pred             eeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheee-eCCcEEEEEecCCC
Confidence            3457899999999999985 4678999999864 3334567889999999999999999999986 45688999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      ++|.+++..           ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||++....
T Consensus       101 ~~L~~~~~~-----------~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~  166 (293)
T cd06647         101 GSLTDVVTE-----------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  166 (293)
T ss_pred             CcHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccc
Confidence            999999842           237899999999999999999999   899999999999999999999999999987654


Q ss_pred             CCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcc
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKL  341 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (453)
                      .... ......+++.|++||.+....++.++||||||+++||+++|+.||.........            ......+. 
T Consensus       167 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~------------~~~~~~~~-  232 (293)
T cd06647         167 PEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------------YLIATNGT-  232 (293)
T ss_pred             cccc-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe------------eehhcCCC-
Confidence            3322 223346888999999998888999999999999999999999999532211100            00000000 


Q ss_pred             cccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          342 MEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       342 ~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                           +.+    ..+......+.+++.+||+.+|++||++.+++.+
T Consensus       233 -----~~~----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         233 -----PEL----QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             -----CCC----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 000    1122234568899999999999999999999854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.6e-37  Score=301.70  Aligned_cols=264  Identities=20%  Similarity=0.237  Sum_probs=187.7

Q ss_pred             HHhcccCcCCceEEEEEEe-CCCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecC-----CCeEE
Q 047276          104 NFQALLGHGSSASVFKGIL-SDGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG-----GPRYL  174 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~~l  174 (453)
                      ...+.||+|+||+||++.. .+++.||||++....   .....+.+|+.+++.++||||+++++++....     ...++
T Consensus        18 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~   97 (343)
T cd07878          18 QNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYL   97 (343)
T ss_pred             hhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEE
Confidence            3457899999999999985 567899999987532   23356778999999999999999998765321     34689


Q ss_pred             EEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeec
Q 047276          175 VYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDF  254 (453)
Q Consensus       175 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~Df  254 (453)
                      +++++ +++|.+++..           ..+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+||
T Consensus        98 ~~~~~-~~~l~~~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Df  162 (343)
T cd07878          98 VTNLM-GADLNNIVKC-----------QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDF  162 (343)
T ss_pred             EeecC-CCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCC
Confidence            99988 7799888732           238999999999999999999999   89999999999999999999999999


Q ss_pred             cccccccCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcc-cc-cchhHH
Q 047276          255 GLSKLMSRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKN-KW-QYFPKI  331 (453)
Q Consensus       255 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~-~~-~~~~~~  331 (453)
                      |+++.....    .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||............ .. ......
T Consensus       163 g~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  238 (343)
T cd07878         163 GLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE  238 (343)
T ss_pred             ccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            999865432    234568999999999876 56899999999999999999999998532110000000 00 000000


Q ss_pred             HHHhhhcCcccccccccccCCCC-----CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          332 VNEKMKEGKLMEIVDQRLTDEGG-----IDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       332 ~~~~~~~~~~~~~~d~~l~~~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      ....+.......... .+.....     ........+.+++.+|++.||++|||+.++++.
T Consensus       239 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         239 VLKKISSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHhcchhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000000000000000 0000000     000112347899999999999999999998853

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.3e-36  Score=291.80  Aligned_cols=243  Identities=25%  Similarity=0.354  Sum_probs=193.1

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCC-ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCC
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEE-NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS  183 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gs  183 (453)
                      -+.||+|++|.||++.. .+++.+++|++.... ...+.+.+|+.+++.++|||++++++++. .++..++++||+++++
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~-~~~~~~~v~e~~~~~~  102 (285)
T cd06648          24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL-VGDELWVVMEFLEGGA  102 (285)
T ss_pred             ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEE-cCCeEEEEEeccCCCC
Confidence            36899999999999985 468899999886532 33456889999999999999999999876 5668899999999999


Q ss_pred             hhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCC
Q 047276          184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD  263 (453)
Q Consensus       184 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~  263 (453)
                      |.+++..           ..+++..+..++.|++.||+|||+   .+++||||+|+||+++.++.++|+|||++......
T Consensus       103 L~~~~~~-----------~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~  168 (285)
T cd06648         103 LTDIVTH-----------TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE  168 (285)
T ss_pred             HHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence            9999843           238899999999999999999999   89999999999999999999999999988765433


Q ss_pred             CCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcccc
Q 047276          264 QSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLME  343 (453)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (453)
                      .. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....+.            . .......+.   
T Consensus       169 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------------~-~~~~~~~~~---  231 (285)
T cd06648         169 VP-RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------------Q-AMKRIRDNL---  231 (285)
T ss_pred             Cc-ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------------H-HHHHHHhcC---
Confidence            22 123356889999999998888999999999999999999999998532110            0 111111111   


Q ss_pred             cccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          344 IVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       344 ~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                        .+.+.    .+......+.+++.+|++.+|++||++.++++
T Consensus       232 --~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         232 --PPKLK----NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             --CCCCc----ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence              01111    01123456899999999999999999999884

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-37  Score=295.38  Aligned_cols=246  Identities=26%  Similarity=0.351  Sum_probs=207.1

Q ss_pred             HHHHHhcccCcCCceEEEEEE-eCCCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEE
Q 047276          101 ATDNFQALLGHGSSASVFKGI-LSDGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVY  176 (453)
Q Consensus       101 ~~~~~~~~lG~G~fG~Vy~~~-~~~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~  176 (453)
                      ..|++++.||+|.|..|-.++ .-+|..||||++.+..   .....+.+|++-|+.++|||||+|+.+. +....+|||+
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-DTQTKlyLiL   96 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-DTQTKLYLIL   96 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-cccceEEEEE
Confidence            345667899999999999888 4579999999997643   3446788999999999999999999984 4667889999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEEC-CCCcEEEeecc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD-ENYRAVVSDFG  255 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~-~~~~~kl~DfG  255 (453)
                      |.-++|+|.+|+-++..         .+.++...+++.||+.|+.|+|+   ..+|||||||+||.+- .-|-+||+|||
T Consensus        97 ELGD~GDl~DyImKHe~---------Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFG  164 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEE---------GLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFG  164 (864)
T ss_pred             EecCCchHHHHHHhhhc---------cccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeecc
Confidence            99999999999976543         28999999999999999999999   8999999999999876 56899999999


Q ss_pred             ccccccCCCCceeeeccCCccccchhhhhcCCCC-ccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHH
Q 047276          256 LSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVS-EKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNE  334 (453)
Q Consensus       256 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  334 (453)
                      ++..+.+..  ..++.+|+..|-|||.+.+..|+ ++.||||+|||||.|++|+.||+...+.+                
T Consensus       165 FSNkf~PG~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE----------------  226 (864)
T KOG4717|consen  165 FSNKFQPGK--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE----------------  226 (864)
T ss_pred             ccccCCCcc--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh----------------
Confidence            998775443  45778999999999999998886 67899999999999999999997544322                


Q ss_pred             hhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          335 KMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       335 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                           .+.-++|..    ...|.-...++.+|+..||..||++|.+.++|+.
T Consensus       227 -----TLTmImDCK----YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  227 -----TLTMIMDCK----YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             -----hhhhhhccc----ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence                 233344443    2356677888999999999999999999999883

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=289.76  Aligned_cols=251  Identities=24%  Similarity=0.375  Sum_probs=195.2

Q ss_pred             HHhcccCcCCceEEEEEEeC-CCcEEEEEEecCCCccHHHHHHHHHHHHhc-CCCceeeEeeEEEecC-----CCeEEEE
Q 047276          104 NFQALLGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPG-----GPRYLVY  176 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~-----~~~~lv~  176 (453)
                      .+.+.||+|+||.||+|... +++.+++|.+.........+.+|+.+++++ +|+|++++++++....     ...++||
T Consensus         9 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~   88 (275)
T cd06608           9 ELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVM   88 (275)
T ss_pred             eheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEE
Confidence            34588999999999999974 578999999887666667899999999999 6999999999986432     2478999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||+++++|.+++.....      ....+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||+
T Consensus        89 e~~~~~~L~~~~~~~~~------~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          89 ELCGGGSVTDLVKGLRK------KGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EcCCCCcHHHHHHHHhh------cCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCcc
Confidence            99999999999854321      12348999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCceeeeccCCccccchhhhhc-----CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHH
Q 047276          257 SKLMSRDQSRCITTIRGTRGYLAPEWILE-----QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKI  331 (453)
Q Consensus       257 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~  331 (453)
                      +....... .......++..|+|||.+..     ..++.++||||||+++|||++|+.||.......            .
T Consensus       160 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------------~  226 (275)
T cd06608         160 SAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR------------A  226 (275)
T ss_pred             ceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH------------H
Confidence            87654322 12234568889999998753     346789999999999999999999985321100            0


Q ss_pred             HHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          332 VNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       332 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ... ...+..     +.+    ..+......+.+++.+|+..||++|||+.++++
T Consensus       227 ~~~-~~~~~~-----~~~----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         227 LFK-IPRNPP-----PTL----KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             HHH-hhccCC-----CCC----CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            001 111110     111    112234567889999999999999999999875

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-38  Score=278.58  Aligned_cols=246  Identities=24%  Similarity=0.309  Sum_probs=195.0

Q ss_pred             HHHhcccCcCCceEEEEEEe-CCCcEEEEEEecC---CCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEe
Q 047276          103 DNFQALLGHGSSASVFKGIL-SDGTSVAVKRING---EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      +.+.+.||+|.|+.||++.. .+|+.+|+|.++.   ...+.+++.+|+.+.+.|+||||++|..... .....++|+|+
T Consensus        13 y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~-~~~~~ylvFe~   91 (355)
T KOG0033|consen   13 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-EESFHYLVFDL   91 (355)
T ss_pred             hhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhc-ccceeEEEEec
Confidence            44567899999999999985 5689999998864   3446678899999999999999999998754 55678999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEEC---CCCcEEEeecc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD---ENYRAVVSDFG  255 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~---~~~~~kl~DfG  255 (453)
                      |.+++|..-+..+          ...++...-..+.||+++|.|+|.   ++|||||+||.|+|+-   ...-+||+|||
T Consensus        92 m~G~dl~~eIV~R----------~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FG  158 (355)
T KOG0033|consen   92 VTGGELFEDIVAR----------EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFG  158 (355)
T ss_pred             ccchHHHHHHHHH----------HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccc
Confidence            9999996655332          126777788899999999999999   8999999999999995   33468999999


Q ss_pred             ccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHh
Q 047276          256 LSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEK  335 (453)
Q Consensus       256 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  335 (453)
                      +|....  .......+.|||+|||||.+...+|+..+|||+.||+||-|+.|+.||.....             +.+-+.
T Consensus       159 vAi~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~-------------~rlye~  223 (355)
T KOG0033|consen  159 LAIEVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-------------HRLYEQ  223 (355)
T ss_pred             eEEEeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH-------------HHHHHH
Confidence            999887  33345668899999999999999999999999999999999999999963211             112233


Q ss_pred             hhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 047276          336 MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVV  385 (453)
Q Consensus       336 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~  385 (453)
                      +..|...  +++      ..-.....+..+|+.+||..||++|.|..|.+
T Consensus       224 I~~g~yd--~~~------~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL  265 (355)
T KOG0033|consen  224 IKAGAYD--YPS------PEWDTVTPEAKSLIRRMLTVNPKKRITADEAL  265 (355)
T ss_pred             HhccccC--CCC------cccCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence            3333211  111      11123345578999999999999999999877

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.1e-37  Score=295.80  Aligned_cols=262  Identities=22%  Similarity=0.287  Sum_probs=192.2

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.++||+|+||.||+|... +++.||+|++....   ...+.+.+|+++++.++|||++++++++. .++..++|+||++
T Consensus         5 ~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~   83 (286)
T cd07846           5 NLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFR-RKKRLYLVFEFVD   83 (286)
T ss_pred             EeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcc-cCCeEEEEEecCC
Confidence            3578999999999999975 58899999876422   23456889999999999999999999986 5668899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +++|..+....          ..++|..++.++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++...
T Consensus        84 ~~~l~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~  150 (286)
T cd07846          84 HTVLDDLEKYP----------NGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTL  150 (286)
T ss_pred             ccHHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeec
Confidence            99998876422          238999999999999999999999   89999999999999999999999999998866


Q ss_pred             cCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccch-------hHHH
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYF-------PKIV  332 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~-------~~~~  332 (453)
                      .... .......++..|+|||++.+ ..++.++||||||+++|||++|+.||......     ..+...       ....
T Consensus       151 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~  224 (286)
T cd07846         151 AAPG-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-----DQLYHIIKCLGNLIPRH  224 (286)
T ss_pred             cCCc-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH-----HHHHHHHHHhCCCchhh
Confidence            4332 22233457889999998875 45788999999999999999999888532110     000000       0000


Q ss_pred             HHhhhcCcc-cccccccccCC---CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          333 NEKMKEGKL-MEIVDQRLTDE---GGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       333 ~~~~~~~~~-~~~~d~~l~~~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ......... .....+.....   ....+.....+.+++.+||+.+|++||++.++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         225 QEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             HHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            000000000 00000000000   0001133566899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.3e-36  Score=284.74  Aligned_cols=244  Identities=24%  Similarity=0.369  Sum_probs=192.9

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.+.||+|+||.||++.. .+++.+|+|.+...   ......+.+|+.+++.++|||++++++.+. .++..++|+||++
T Consensus         4 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~~lv~e~~~   82 (256)
T cd08220           4 KIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL-EDKALMIVMEYAP   82 (256)
T ss_pred             EEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEe-cCCEEEEEEecCC
Confidence            357899999999999985 46889999998653   233467889999999999999999999865 5668899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCC-CcEEEeecccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDEN-YRAVVSDFGLSKL  259 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~-~~~kl~DfGla~~  259 (453)
                      +++|.+++....        ...+++..+.+++.+++.||+|||+   .+++|+||+|+||+++++ +.+||+|||++..
T Consensus        83 ~~~L~~~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~  151 (256)
T cd08220          83 GGTLAEYIQKRC--------NSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKI  151 (256)
T ss_pred             CCCHHHHHHHhc--------ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCcee
Confidence            999999996432        2338999999999999999999999   899999999999999855 5689999999987


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      ......  .....++..|+|||.+....++.++||||||+++|+|++|+.||.....            ........ .+
T Consensus       152 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~------------~~~~~~~~-~~  216 (256)
T cd08220         152 LSSKSK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL------------PALVLKIM-SG  216 (256)
T ss_pred             cCCCcc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch------------HHHHHHHH-hc
Confidence            643321  2335678899999999888889999999999999999999999853211            11111111 11


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ..           ...+......+.+++.+||+.+|++|||+.++++
T Consensus       217 ~~-----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         217 TF-----------APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             CC-----------CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            11           0112223455889999999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.2e-36  Score=286.27  Aligned_cols=235  Identities=25%  Similarity=0.287  Sum_probs=188.1

Q ss_pred             cCcCCceEEEEEEeC-CCcEEEEEEecCCC----ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCC
Q 047276          109 LGHGSSASVFKGILS-DGTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS  183 (453)
Q Consensus       109 lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gs  183 (453)
                      ||+|+||.||+++.. +++.+++|.+....    ...+.+.+|+.+++.++|||++++++++. .+...++++||+++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~   79 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK-DKKYIYMLMEYCLGGE   79 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE-cCCccEEEEecCCCCc
Confidence            799999999999964 48899999986532    33467899999999999999999999876 5678899999999999


Q ss_pred             hhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCC
Q 047276          184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD  263 (453)
Q Consensus       184 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~  263 (453)
                      |.+++....          .+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++......
T Consensus        80 L~~~l~~~~----------~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~  146 (262)
T cd05572          80 LWTILRDRG----------LFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG  146 (262)
T ss_pred             HHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence            999995432          38899999999999999999999   89999999999999999999999999999876543


Q ss_pred             CCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcccc
Q 047276          264 QSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLME  343 (453)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (453)
                      .  ......+++.|++||.+....++.++|+||||+++|||++|..||.....+          ......... .+.   
T Consensus       147 ~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----------~~~~~~~~~-~~~---  210 (262)
T cd05572         147 Q--KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----------PMEIYNDIL-KGN---  210 (262)
T ss_pred             c--ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----------HHHHHHHHh-ccC---
Confidence            2  123346788999999998888999999999999999999999999643210          001111111 000   


Q ss_pred             cccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCC
Q 047276          344 IVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPS  380 (453)
Q Consensus       344 ~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs  380 (453)
                         .    ....+......+.+++.+||+.+|++||+
T Consensus       211 ---~----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~  240 (262)
T cd05572         211 ---G----KLEFPNYIDKAAKDLIKQLLRRNPEERLG  240 (262)
T ss_pred             ---C----CCCCCcccCHHHHHHHHHHccCChhhCcC
Confidence               0    01122233567999999999999999999

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.2e-36  Score=290.12  Aligned_cols=246  Identities=24%  Similarity=0.365  Sum_probs=196.6

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCC
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS  183 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gs  183 (453)
                      +.+.||+|+||.||+|... +++.+++|++.......+.+.+|++.++.++|+|++++++++.. .+..++++||+++++
T Consensus        23 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~  101 (286)
T cd06614          23 NLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLV-GDELWVVMEYMDGGS  101 (286)
T ss_pred             HhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEE-CCEEEEEEeccCCCc
Confidence            4578999999999999976 68899999998654456778999999999999999999998874 568899999999999


Q ss_pred             hhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCC
Q 047276          184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD  263 (453)
Q Consensus       184 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~  263 (453)
                      |.+++....         ..+++..+..++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++......
T Consensus       102 L~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614         102 LTDIITQNF---------VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             HHHHHHHhc---------cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            999996432         148999999999999999999999   89999999999999999999999999998765432


Q ss_pred             CCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcccc
Q 047276          264 QSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLME  343 (453)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (453)
                      .. ......++..|++||.+.+..++.++|||||||++|+|++|+.||....+.            . ............
T Consensus       170 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~------------~-~~~~~~~~~~~~  235 (286)
T cd06614         170 KS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL------------R-ALFLITTKGIPP  235 (286)
T ss_pred             hh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH------------H-HHHHHHhcCCCC
Confidence            21 123345788999999998888999999999999999999999998532110            0 000111111100


Q ss_pred             cccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          344 IVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       344 ~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                           +    .........+.+++.+|++.+|..||++.++++
T Consensus       236 -----~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         236 -----L----KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             -----C----cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                 0    011123456889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-37  Score=294.64  Aligned_cols=267  Identities=22%  Similarity=0.307  Sum_probs=194.9

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.+.||+|+||.||+|... +++.|++|.++..   ....+.+.+|++++++++|+||+++++++. .++..++++||++
T Consensus         5 ~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~iv~e~~~   83 (288)
T cd07833           5 VLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFR-RKGRLYLVFEYVE   83 (288)
T ss_pred             EEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEE-ECCEEEEEEecCC
Confidence            4578999999999999965 5789999988753   233467899999999999999999999986 4668899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      ++.+..+....          ..+++.....++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||++...
T Consensus        84 ~~~l~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~  150 (288)
T cd07833          84 RTLLELLEASP----------GGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARAL  150 (288)
T ss_pred             CCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeeccccc
Confidence            87776665322          238999999999999999999999   89999999999999999999999999999876


Q ss_pred             cCCCCceeeeccCCccccchhhhhcC-CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCc--ccccchhHHHHHhhh
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQ-GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSK--NKWQYFPKIVNEKMK  337 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~  337 (453)
                      ............++..|+|||++... .++.++||||||+++|||++|+.||...........  ..+..++......+.
T Consensus       151 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T cd07833         151 RARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS  230 (288)
T ss_pred             CCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc
Confidence            54433223445678899999999887 789999999999999999999999853211100000  000000000000000


Q ss_pred             -cCccc-----ccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          338 -EGKLM-----EIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       338 -~~~~~-----~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                       .....     ...++... ...++......+.+++.+||+.+|++||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         231 SNPRFAGVAFPEPSQPESL-ERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cCccccccccCCCCCcHHH-HHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence             00000     00000000 00111223567999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2e-36  Score=289.66  Aligned_cols=248  Identities=27%  Similarity=0.407  Sum_probs=186.9

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC--ccHHHHHHHHHH-HHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEE--NGEKEFRSEVAA-IASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~-l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.+.||+|+||.||++... +|..||+|+++...  ....++..|+.. ++.++|||++++++++. .++..++++||++
T Consensus         5 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~-~~~~~~lv~e~~~   83 (283)
T cd06617           5 VIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF-REGDVWICMEVMD   83 (283)
T ss_pred             EEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe-cCCcEEEEhhhhc
Confidence            3468999999999999964 68999999987542  234456667765 56678999999999986 5567899999996


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                       |+|.+++.....      ....+++..++.++.|++.||+|||+.  .+++||||||+||+++.++.+||+|||++...
T Consensus        84 -~~l~~~l~~~~~------~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~  154 (283)
T cd06617          84 -TSLDKFYKKVYD------KGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYL  154 (283)
T ss_pred             -ccHHHHHHHhcc------CCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence             689888754322      123489999999999999999999982  38999999999999999999999999999865


Q ss_pred             cCCCCceeeeccCCccccchhhhhc----CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhh
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILE----QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKM  336 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (453)
                      ....  ......++..|+|||.+..    ..++.++|+||||+++|||++|+.||......       +    .......
T Consensus       155 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~----~~~~~~~  221 (283)
T cd06617         155 VDSV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-------F----QQLKQVV  221 (283)
T ss_pred             cccc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-------H----HHHHHHH
Confidence            4322  1223467889999998864    45688999999999999999999998421100       0    0011111


Q ss_pred             hcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          337 KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       337 ~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                       .+.     .+.+.     ....+..+.+++.+|++.+|++||++.++++
T Consensus       222 -~~~-----~~~~~-----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         222 -EEP-----SPQLP-----AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             -hcC-----CCCCC-----ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             111     01111     1123456889999999999999999999885

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.5e-36  Score=288.04  Aligned_cols=247  Identities=24%  Similarity=0.405  Sum_probs=193.8

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCC-------ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEE-------NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      .+.||+|+||.||++.. .+++.+|+|.+....       ...+.+..|+.++++++|+|++++++++. ..+..++|+|
T Consensus         5 ~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~~v~e   83 (268)
T cd06630           5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC-EDSHFNLFVE   83 (268)
T ss_pred             cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceec-cCCeEEEEEe
Confidence            46899999999999985 568899999986422       12356889999999999999999999976 5568899999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCC-cEEEeeccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENY-RAVVSDFGL  256 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~-~~kl~DfGl  256 (453)
                      |+++++|.+++...          ..+++.....++.|++.||.|||+   .+++|+||+|+||+++.++ .+||+|||+
T Consensus        84 ~~~~~~L~~~l~~~----------~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~  150 (268)
T cd06630          84 WMAGGSVSHLLSKY----------GAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGA  150 (268)
T ss_pred             ccCCCcHHHHHHHh----------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccc
Confidence            99999999998533          238899999999999999999999   8999999999999998776 699999999


Q ss_pred             cccccCCCC---ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHH
Q 047276          257 SKLMSRDQS---RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVN  333 (453)
Q Consensus       257 a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  333 (453)
                      +........   .......++..|+|||.+.+..++.++||||+|+++++|++|..||.......         ......
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---------~~~~~~  221 (268)
T cd06630         151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN---------HLALIF  221 (268)
T ss_pred             ccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc---------hHHHHH
Confidence            877653321   11233467889999999988889999999999999999999999985321100         000000


Q ss_pred             HhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          334 EKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       334 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ......           .....+......+.+++.+|++.+|++||++.++++
T Consensus       222 ~~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         222 KIASAT-----------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             HHhccC-----------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            000000           011233445567899999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.5e-36  Score=287.63  Aligned_cols=248  Identities=28%  Similarity=0.411  Sum_probs=195.3

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      +.+.||+|+||.||++... +++.+++|.+...  .....++.+|++++++++||||+++++++. .++..++++||+++
T Consensus         5 ~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~~lv~e~~~~   83 (265)
T cd06605           5 YLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFY-NNGDISICMEYMDG   83 (265)
T ss_pred             HHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeee-cCCEEEEEEEecCC
Confidence            4578999999999999975 6889999998754  234467899999999999999999999887 45688999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      ++|.+++....         ..+++.....++.|++.||+|||+.  .+++|+||||+||++++++.++|+|||.+....
T Consensus        84 ~~L~~~~~~~~---------~~~~~~~~~~~~~~l~~~l~~lH~~--~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~  152 (265)
T cd06605          84 GSLDKILKEVQ---------GRIPERILGKIAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV  152 (265)
T ss_pred             CcHHHHHHHcc---------CCCCHHHHHHHHHHHHHHHHHHcCC--CCeecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence            99999986432         3488899999999999999999983  689999999999999999999999999987654


Q ss_pred             CCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcc
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKL  341 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (453)
                      ....   ....++..|+|||++.+..++.++||||||+++|+|++|+.||.........       ........ ..+..
T Consensus       153 ~~~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-------~~~~~~~~-~~~~~  221 (265)
T cd06605         153 NSLA---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-------IFELLQYI-VNEPP  221 (265)
T ss_pred             HHHh---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-------HHHHHHHH-hcCCC
Confidence            3221   1266888999999998889999999999999999999999998533211000       00111111 11100


Q ss_pred             cccccccccCCCCCcHH-HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          342 MEIVDQRLTDEGGIDET-QVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       342 ~~~~d~~l~~~~~~~~~-~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                           +      ..+.. ....+.+++.+|+..+|++|||+.+++.
T Consensus       222 -----~------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         222 -----P------RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             -----C------CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence                 0      11111 4556889999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=9.2e-37  Score=288.48  Aligned_cols=243  Identities=27%  Similarity=0.361  Sum_probs=193.3

Q ss_pred             cCcCCceEEEEEEeC-CCcEEEEEEecCCC----ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCC
Q 047276          109 LGHGSSASVFKGILS-DGTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS  183 (453)
Q Consensus       109 lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gs  183 (453)
                      ||+|+||.||+++.. +|+.+++|.+....    ...+.+.+|+.++++++|||++++++.+. .+...++++||+++++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~   79 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ-GKKNLYLVMEYLPGGD   79 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhee-cCcEEEEEEecCCCCc
Confidence            699999999999976 48999999986532    23457889999999999999999998865 5668899999999999


Q ss_pred             hhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCC
Q 047276          184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD  263 (453)
Q Consensus       184 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~  263 (453)
                      |.+++...          ..+++..+.+++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++......
T Consensus        80 L~~~l~~~----------~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~  146 (265)
T cd05579          80 LASLLENV----------GSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR  146 (265)
T ss_pred             HHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccC
Confidence            99998543          238999999999999999999998   89999999999999999999999999998765432


Q ss_pred             CC-------ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhh
Q 047276          264 QS-------RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKM  336 (453)
Q Consensus       264 ~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (453)
                      ..       .......++..|++||.......+.++||||||+++|||++|+.||......            . .....
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------------~-~~~~~  213 (265)
T cd05579         147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------------E-IFQNI  213 (265)
T ss_pred             cccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------------H-HHHHH
Confidence            11       1223456788999999998888999999999999999999999998532210            0 11111


Q ss_pred             hcCcccccccccccCCCCCcHH--HHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 047276          337 KEGKLMEIVDQRLTDEGGIDET--QVRRLVDVAFWCIQERARLRPSMARVVEMLEG  390 (453)
Q Consensus       337 ~~~~~~~~~d~~l~~~~~~~~~--~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~  390 (453)
                      ..+..            ..+..  ....+.+++.+|++.+|++|||+.++.+.|+.
T Consensus       214 ~~~~~------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~  257 (265)
T cd05579         214 LNGKI------------EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH  257 (265)
T ss_pred             hcCCc------------CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence            11111            01111  24568999999999999999999777777763

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3.9e-36  Score=291.59  Aligned_cols=243  Identities=23%  Similarity=0.292  Sum_probs=189.7

Q ss_pred             HHHhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC----ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          103 DNFQALLGHGSSASVFKGILS-DGTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      +.+.+.||+|+||+||+|... +|+.||+|.+....    ...+++.+|+.+++.++|||++++.++|. .++..++|+|
T Consensus        17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~-~~~~~~lv~e   95 (307)
T cd06607          17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL-REHTAWLVME   95 (307)
T ss_pred             hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE-eCCeEEEEHH
Confidence            445678999999999999964 68899999886421    22356889999999999999999999987 4567899999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |++ |+|.+++....         ..+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||++
T Consensus        96 ~~~-g~l~~~~~~~~---------~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~  162 (307)
T cd06607          96 YCL-GSASDILEVHK---------KPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSA  162 (307)
T ss_pred             hhC-CCHHHHHHHcc---------cCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcc
Confidence            997 57777764321         238999999999999999999999   89999999999999999999999999998


Q ss_pred             ccccCCCCceeeeccCCccccchhhhh---cCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHH
Q 047276          258 KLMSRDQSRCITTIRGTRGYLAPEWIL---EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNE  334 (453)
Q Consensus       258 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  334 (453)
                      ......     ....+++.|+|||.+.   .+.++.++||||||+++|||++|+.||......            .....
T Consensus       163 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~------------~~~~~  225 (307)
T cd06607         163 SLVSPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------------SALYH  225 (307)
T ss_pred             eecCCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH------------HHHHH
Confidence            765432     2345788999999874   456889999999999999999999998532110            00000


Q ss_pred             hhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          335 KMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       335 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                       ...+..     +.+     ........+.+++.+||+.+|++||++.+++..
T Consensus       226 -~~~~~~-----~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         226 -IAQNDS-----PTL-----SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             -HhcCCC-----CCC-----CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence             000000     111     112344568999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.6e-36  Score=288.36  Aligned_cols=240  Identities=22%  Similarity=0.262  Sum_probs=187.1

Q ss_pred             cCcCCceEEEEEEe-CCCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCC
Q 047276          109 LGHGSSASVFKGIL-SDGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS  183 (453)
Q Consensus       109 lG~G~fG~Vy~~~~-~~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gs  183 (453)
                      ||+|+||+||++.. .+|+.+|+|.+...    ......+..|+++++.++|||++++++++. ..+..++|+||+++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~lv~e~~~~~~   79 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFE-TKDDLCLVMTLMNGGD   79 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEe-cCCeEEEEEecCCCCc
Confidence            79999999999985 46889999988642    223445788999999999999999999875 5568899999999999


Q ss_pred             hhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCC
Q 047276          184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD  263 (453)
Q Consensus       184 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~  263 (453)
                      |.+++.....        ..+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||++......
T Consensus        80 L~~~l~~~~~--------~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~  148 (277)
T cd05577          80 LKYHIYNVGE--------PGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG  148 (277)
T ss_pred             HHHHHHHcCc--------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccC
Confidence            9999864432        248999999999999999999999   89999999999999999999999999998765432


Q ss_pred             CCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcccc
Q 047276          264 QSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLME  343 (453)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (453)
                      .  ......++..|+|||++.++.++.++||||||+++|+|++|+.||........         ......    .... 
T Consensus       149 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---------~~~~~~----~~~~-  212 (277)
T cd05577         149 K--KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE---------KEELKR----RTLE-  212 (277)
T ss_pred             C--ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc---------HHHHHh----cccc-
Confidence            1  22334578899999999888899999999999999999999999853221100         000000    0000 


Q ss_pred             cccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHH
Q 047276          344 IVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMAR  383 (453)
Q Consensus       344 ~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~  383 (453)
                             .....+......+.+++.+||+.+|++||+..+
T Consensus       213 -------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~  245 (277)
T cd05577         213 -------MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRG  245 (277)
T ss_pred             -------ccccCCccCCHHHHHHHHHHccCChhHccCCCc
Confidence                   001122233556889999999999999994444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=3.5e-37  Score=295.24  Aligned_cols=262  Identities=20%  Similarity=0.255  Sum_probs=189.1

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.+.||+|+||.||+|... +|..+|+|.+...   ......+.+|+.++++++|||++++++++. ..+..++++||++
T Consensus         4 ~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~   82 (284)
T cd07839           4 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLH-SDKKLTLVFEYCD   82 (284)
T ss_pred             eEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhc-cCCceEEEEecCC
Confidence            3578999999999999964 6889999998643   222356788999999999999999999876 5668899999997


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                       ++|.+++....         ..+++...+.++.||++||.|||+   .+++||||||+||+++.++.+||+|||++...
T Consensus        83 -~~l~~~~~~~~---------~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~  149 (284)
T cd07839          83 -QDLKKYFDSCN---------GDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAF  149 (284)
T ss_pred             -CCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhcc
Confidence             58888875322         238999999999999999999999   89999999999999999999999999999765


Q ss_pred             cCCCCceeeeccCCccccchhhhhcC-CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccch-------hHHH
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQ-GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYF-------PKIV  332 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~-------~~~~  332 (453)
                      .... .......+++.|+|||.+.+. .++.++|||||||++|||++|+.|+....+...    .....       ....
T Consensus       150 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~----~~~~~~~~~~~~~~~~  224 (284)
T cd07839         150 GIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD----QLKRIFRLLGTPTEES  224 (284)
T ss_pred             CCCC-CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH----HHHHHHHHhCCCChHH
Confidence            3322 122334578899999988764 478999999999999999999988642211100    00000       0000


Q ss_pred             HHhhhc-Ccc--cccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          333 NEKMKE-GKL--MEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       333 ~~~~~~-~~~--~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      +..... ...  .......... ....+.....+.+++.+||+.||.+|||++++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         225 WPGVSKLPDYKPYPMYPATTSL-VNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             hHHhhhcccccccCCCCCcchh-hhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            000000 000  0000000000 0011123456889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.6e-36  Score=288.85  Aligned_cols=241  Identities=22%  Similarity=0.275  Sum_probs=183.2

Q ss_pred             ccCcCCceEEEEEEe-CCCcEEEEEEecCCC----ccHHHHHHHHHHHH---hcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          108 LLGHGSSASVFKGIL-SDGTSVAVKRINGEE----NGEKEFRSEVAAIA---SAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       108 ~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~----~~~~~~~~E~~~l~---~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      +||+|+||.||++.. .+++.+|+|.+....    .....+.+|..++.   ..+|||++.+.+++. .++..++||||+
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~lv~e~~   79 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFH-TPDKLCFILDLM   79 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe-cCCeEEEEEecC
Confidence            489999999999996 458899999886532    12233445554443   347999999998876 456789999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ++|+|.+++...          +.+++.....++.|++.||+|||+   .+++|+||||+|||+++++.++|+|||++..
T Consensus        80 ~~~~L~~~i~~~----------~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~  146 (279)
T cd05633          80 NGGDLHYHLSQH----------GVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACD  146 (279)
T ss_pred             CCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCccee
Confidence            999999988533          238999999999999999999999   8999999999999999999999999999875


Q ss_pred             ccCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      .....   .....|+..|+|||.+.. ..++.++|||||||++|||++|+.||.......      .    .........
T Consensus       147 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------~----~~~~~~~~~  213 (279)
T cd05633         147 FSKKK---PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD------K----HEIDRMTLT  213 (279)
T ss_pred             ccccC---ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC------H----HHHHHHhhc
Confidence            53322   123468999999998864 458899999999999999999999995322110      0    001111000


Q ss_pred             CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 047276          339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRP-----SMARVVEM  387 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~~v~~~  387 (453)
                            ..      ...+......+.+++.+|++.||++||     ++.++++.
T Consensus       214 ------~~------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         214 ------VN------VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             ------CC------cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence                  01      112333455688999999999999999     58888764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.1e-36  Score=295.21  Aligned_cols=251  Identities=22%  Similarity=0.266  Sum_probs=194.1

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC----ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      +.+.||+|+||.||++... +++.|++|.+....    .....+.+|+.+++.++||||+++++.+. .++..++||||+
T Consensus         5 ~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~~lv~e~~   83 (305)
T cd05609           5 TIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE-TKRHLCMVMEYV   83 (305)
T ss_pred             EeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe-cCCEEEEEEecC
Confidence            3478999999999999964 57899999887532    22356889999999999999999999875 556789999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ++++|.+++...          +.+++.....++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++.
T Consensus        84 ~g~~L~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~  150 (305)
T cd05609          84 EGGDCATLLKNI----------GALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKI  150 (305)
T ss_pred             CCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccc
Confidence            999999999533          238999999999999999999999   8999999999999999999999999999864


Q ss_pred             ccCCC--------------CceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccc
Q 047276          260 MSRDQ--------------SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKW  325 (453)
Q Consensus       260 ~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~  325 (453)
                      .....              ........++..|+|||++.+..++.++|+||||+++|||++|+.||.....         
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~---------  221 (305)
T cd05609         151 GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP---------  221 (305)
T ss_pred             cCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------
Confidence            21100              0011224578899999999888899999999999999999999999852110         


Q ss_pred             cchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 047276          326 QYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR  391 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~  391 (453)
                          .........+...   .+..      ....+..+.+++.+|++.+|++||++.++.+.|+..
T Consensus       222 ----~~~~~~~~~~~~~---~~~~------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~  274 (305)
T cd05609         222 ----EELFGQVISDDIE---WPEG------DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR  274 (305)
T ss_pred             ----HHHHHHHHhcccC---CCCc------cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence                0011111111100   0100      012344588999999999999999988888888763

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=292.97  Aligned_cols=194  Identities=28%  Similarity=0.383  Sum_probs=161.5

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      +.+.||+|+||.||+|... +++.||+|.+....  .....+.+|+.++++++|+||+++++++. .++..++||||+++
T Consensus         9 ~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~   87 (291)
T cd07844           9 KLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIH-TKKTLTLVFEYLDT   87 (291)
T ss_pred             EEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEe-cCCeEEEEEecCCC
Confidence            3578999999999999965 68899999986532  22345778999999999999999999976 56688999999985


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                       +|.+++....         ..+++.....++.|+++||.|||+   .+++||||||+||+++.++.+||+|||+++...
T Consensus        88 -~L~~~~~~~~---------~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  154 (291)
T cd07844          88 -DLKQYMDDCG---------GGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKS  154 (291)
T ss_pred             -CHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccC
Confidence             9999885432         238899999999999999999999   899999999999999999999999999987543


Q ss_pred             CCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcc
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSL  313 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~  313 (453)
                      .... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus       155 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~  206 (291)
T cd07844         155 VPSK-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPG  206 (291)
T ss_pred             CCCc-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            2211 1122346788999998875 4588999999999999999999999953

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=6e-38  Score=283.17  Aligned_cols=246  Identities=26%  Similarity=0.347  Sum_probs=203.3

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCC
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS  183 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gs  183 (453)
                      +..+||+|+||.||++.+ ..|+.+|||.+..+ .+.+++.+|+.+|.++..|++|+++|.++ ....+++|||||-.|+
T Consensus        37 i~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-sDLQEIIKEISIMQQC~S~yVVKYYGSYF-K~sDLWIVMEYCGAGS  114 (502)
T KOG0574|consen   37 IVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-TDLQEIIKEISIMQQCKSKYVVKYYGSYF-KHSDLWIVMEYCGAGS  114 (502)
T ss_pred             HHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-chHHHHHHHHHHHHHcCCchhhhhhhhhc-cCCceEeehhhcCCCc
Confidence            457899999999999996 46999999988653 45678999999999999999999999876 5668999999999999


Q ss_pred             hhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCC
Q 047276          184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD  263 (453)
Q Consensus       184 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~  263 (453)
                      ..+.+..++         .+|++..+..++...++||+|||.   ..-+|||||+.|||++.+|.+||+|||.+..+.+.
T Consensus       115 iSDI~R~R~---------K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT  182 (502)
T KOG0574|consen  115 ISDIMRARR---------KPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT  182 (502)
T ss_pred             HHHHHHHhc---------CCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhh
Confidence            999986443         459999999999999999999999   78899999999999999999999999999877543


Q ss_pred             CCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcccc
Q 047276          264 QSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLME  343 (453)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (453)
                      .. ...+..|||-|||||++..-.|+.++||||+|++..||..|++||....+-...-                      
T Consensus       183 MA-KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF----------------------  239 (502)
T KOG0574|consen  183 MA-KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF----------------------  239 (502)
T ss_pred             HH-hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE----------------------
Confidence            22 2356789999999999999999999999999999999999999997443221110                      


Q ss_pred             cccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          344 IVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       344 ~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      ++...-+.....++.-+..+-+++..||-++|++|-|+.++++.
T Consensus       240 MIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  240 MIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             eccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            00000011122356667789999999999999999999888753

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.2e-36  Score=289.71  Aligned_cols=265  Identities=21%  Similarity=0.248  Sum_probs=194.3

Q ss_pred             HHhcccCcCCceEEEEEEe-CCCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          104 NFQALLGHGSSASVFKGIL-SDGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      .+.+.||+|+||.||+|.. .+|+.|++|++....   .....+.+|+.++++++|||++++++++. .+...++|+||+
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~~~v~e~~   81 (286)
T cd07832           3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFP-HGSGFVLVMEYM   81 (286)
T ss_pred             eEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEe-cCCeeEEEeccc
Confidence            3457899999999999996 468999999987532   23467899999999999999999999976 566889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                       +++|.+++....         ..+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++..
T Consensus        82 -~~~L~~~~~~~~---------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~  148 (286)
T cd07832          82 -PSDLSEVLRDEE---------RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARL  148 (286)
T ss_pred             -CCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeeccc
Confidence             999999985432         338999999999999999999999   8999999999999999999999999999987


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcC-CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhH-------H
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQ-GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPK-------I  331 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~-------~  331 (453)
                      .............++..|+|||.+.+. .++.++||||+|++++||++|+.||....+..     .+.....       .
T Consensus       149 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-----~~~~~~~~~~~~~~~  223 (286)
T cd07832         149 FSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE-----QLAIVFRTLGTPNEE  223 (286)
T ss_pred             ccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH-----HHHHHHHHcCCCChH
Confidence            654332223345688899999988654 46899999999999999999987774321100     0000000       0


Q ss_pred             HHHhhhc-CcccccccccccC--CCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          332 VNEKMKE-GKLMEIVDQRLTD--EGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       332 ~~~~~~~-~~~~~~~d~~l~~--~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      .+....+ ........+.-..  .....++....+.+++.+|++.+|++||+++++++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         224 TWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             HHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0000000 0000000000000  000011234678999999999999999999998853

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.7e-36  Score=284.47  Aligned_cols=246  Identities=24%  Similarity=0.349  Sum_probs=194.0

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.+.||+|+||.||+|... +|..+|+|.+...   ....+.+.+|+.+++.++|+|++++++.+. .+...++++||++
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~-~~~~~~lv~e~~~   82 (257)
T cd08225           4 IIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQ-ENGRLFIVMEYCD   82 (257)
T ss_pred             EEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheec-cCCeEEEEEecCC
Confidence            3578999999999999964 5889999998643   234457889999999999999999999876 5668899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCC-cEEEeecccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENY-RAVVSDFGLSKL  259 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~-~~kl~DfGla~~  259 (453)
                      +++|.+++....        ...+++..+..++.|++.||+|||+   .+++|+||+|+||++++++ .+||+|||.+..
T Consensus        83 ~~~L~~~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~  151 (257)
T cd08225          83 GGDLMKRINRQR--------GVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ  151 (257)
T ss_pred             CCcHHHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchh
Confidence            999999985432        1247999999999999999999999   8999999999999999885 569999999886


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      ...... ......|++.|+|||+..+..++.++||||||+++|||++|+.||....            ......... .+
T Consensus       152 ~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------------~~~~~~~~~-~~  217 (257)
T cd08225         152 LNDSME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------------LHQLVLKIC-QG  217 (257)
T ss_pred             ccCCcc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------------HHHHHHHHh-cc
Confidence            643322 2233468889999999988889999999999999999999999985221            011111111 11


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      ....           ........+.+++.+|++.+|++|||+.++++.
T Consensus       218 ~~~~-----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         218 YFAP-----------ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             cCCC-----------CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            1110           111233468899999999999999999999753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-36  Score=293.04  Aligned_cols=248  Identities=26%  Similarity=0.296  Sum_probs=191.4

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCCCc----cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGEEN----GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      .+.||+|+||+||++... +++.+|+|.+.....    ..+.+..|++++..++|+||+++++++. .+...+++|||+.
T Consensus         6 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~lv~e~~~   84 (316)
T cd05574           6 IKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ-TETYLCLVMDYCP   84 (316)
T ss_pred             eeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee-cCCEEEEEEEecC
Confidence            468999999999999965 489999999875332    3356889999999999999999999875 5667899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +++|.+++....        ...+++.....++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++...
T Consensus        85 ~~~L~~~~~~~~--------~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  153 (316)
T cd05574          85 GGELFRLLQRQP--------GKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQS  153 (316)
T ss_pred             CCCHHHHHHhCC--------CCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence            999999985332        2348999999999999999999999   89999999999999999999999999998754


Q ss_pred             cCCCC----------------------------ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCc
Q 047276          261 SRDQS----------------------------RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVS  312 (453)
Q Consensus       261 ~~~~~----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~  312 (453)
                      .....                            .......|+..|+|||++.+..++.++||||||+++|+|++|+.||.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~  233 (316)
T cd05574         154 DVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK  233 (316)
T ss_pred             cccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence            32110                            00112467889999999998889999999999999999999999985


Q ss_pred             ccccCCCCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 047276          313 LIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEML  388 (453)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L  388 (453)
                      ......            ......         +.....  .........+.+++.+|++.+|++||+....++.+
T Consensus       234 ~~~~~~------------~~~~~~---------~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~l  286 (316)
T cd05574         234 GSNRDE------------TFSNIL---------KKEVTF--PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEI  286 (316)
T ss_pred             CCchHH------------HHHHHh---------cCCccC--CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHH
Confidence            322110            001111         111100  00111456699999999999999999943333333

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.1e-35  Score=281.17  Aligned_cols=248  Identities=26%  Similarity=0.403  Sum_probs=198.4

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      +.+.||+|++|.||+++.. +++.|++|++....  .....+.+|+..+.+++|+|++++++++. ..+..++++||+++
T Consensus         5 ~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~lv~e~~~~   83 (264)
T cd06623           5 RVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY-KEGEISIVLEYMDG   83 (264)
T ss_pred             eeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-cCCeEEEEEEecCC
Confidence            3578999999999999975 58999999987643  34567999999999999999999999876 55788999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      ++|.+++...          ..+++..++.++.|+++||+|||+.  .+++|+||+|+||+++.++.++|+|||++....
T Consensus        84 ~~L~~~l~~~----------~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~  151 (264)
T cd06623          84 GSLADLLKKV----------GKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLE  151 (264)
T ss_pred             CcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            9999999543          3489999999999999999999973  599999999999999999999999999998764


Q ss_pred             CCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcc
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKL  341 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (453)
                      ..... .....++..|+|||.+....++.++||||||+++|||++|+.||......      .+   ........ ....
T Consensus       152 ~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~------~~---~~~~~~~~-~~~~  220 (264)
T cd06623         152 NTLDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP------SF---FELMQAIC-DGPP  220 (264)
T ss_pred             cCCCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc------CH---HHHHHHHh-cCCC
Confidence            43322 22445788999999999888999999999999999999999998543220      01   11111111 1111


Q ss_pred             cccccccccCCCCCcHH-HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          342 MEIVDQRLTDEGGIDET-QVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       342 ~~~~d~~l~~~~~~~~~-~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                           +      ..+.. .+..+.+++.+|++.+|++||++.++++.
T Consensus       221 -----~------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         221 -----P------SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             -----C------CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                 1      11222 45679999999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.7e-36  Score=289.69  Aligned_cols=242  Identities=25%  Similarity=0.357  Sum_probs=191.5

Q ss_pred             cccCcCCceEEEEEEe-CCCcEEEEEEecCCC-ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCCh
Q 047276          107 ALLGHGSSASVFKGIL-SDGTSVAVKRINGEE-NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL  184 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL  184 (453)
                      .+||+|+||.||++.. .+|..||+|++.... .....+.+|+.+++.++|+|++++++++. .++..+++|||+++++|
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-VGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEE-eCCEEEEEEecCCCCcH
Confidence            5799999999999986 468899999886432 34456889999999999999999999876 56688999999999999


Q ss_pred             hhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCCC
Q 047276          185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ  264 (453)
Q Consensus       185 ~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~  264 (453)
                      .+++..           ..+++.....++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus       105 ~~~~~~-----------~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~  170 (292)
T cd06657         105 TDIVTH-----------TRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  170 (292)
T ss_pred             HHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccc
Confidence            998732           237899999999999999999999   899999999999999999999999999987654332


Q ss_pred             CceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCccccc
Q 047276          265 SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEI  344 (453)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (453)
                      . ......+++.|+|||.+.+..++.++|+||||+++|||++|..||......            . .......+     
T Consensus       171 ~-~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~------------~-~~~~~~~~-----  231 (292)
T cd06657         171 P-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------------K-AMKMIRDN-----  231 (292)
T ss_pred             c-cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------------H-HHHHHHhh-----
Confidence            1 223456889999999998888899999999999999999999998531110            0 00111110     


Q ss_pred             ccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          345 VDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       345 ~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ..+.+..    .......+.+++.+|++.+|.+||++.++++
T Consensus       232 ~~~~~~~----~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         232 LPPKLKN----LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             CCcccCC----cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            0111111    1122345788999999999999999999886

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=7.3e-36  Score=279.75  Aligned_cols=244  Identities=27%  Similarity=0.392  Sum_probs=196.1

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCCCc-cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCC
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGEEN-GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS  183 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gs  183 (453)
                      .+.||+|++|.||++... ++..+++|++..... ....+.+|+..++.++|+|++++++++. .+...++++||+++++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~l~~e~~~~~~   83 (253)
T cd05122           5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL-KKDELWIVMEFCSGGS   83 (253)
T ss_pred             eeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEe-cCCeEEEEEecCCCCc
Confidence            468999999999999975 688999999976443 5578999999999999999999999876 4568899999999999


Q ss_pred             hhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCC
Q 047276          184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD  263 (453)
Q Consensus       184 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~  263 (453)
                      |.+++....         ..+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||.+......
T Consensus        84 L~~~~~~~~---------~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  151 (253)
T cd05122          84 LKDLLKSTN---------QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT  151 (253)
T ss_pred             HHHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence            999985432         248999999999999999999999   89999999999999999999999999998876543


Q ss_pred             CCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcccc
Q 047276          264 QSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLME  343 (453)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (453)
                      ..  .....++..|++||.+....++.++||||||+++++|++|+.||......            . ............
T Consensus       152 ~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------------~-~~~~~~~~~~~~  216 (253)
T cd05122         152 KA--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM------------K-ALFKIATNGPPG  216 (253)
T ss_pred             cc--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH------------H-HHHHHHhcCCCC
Confidence            32  23456888999999998888999999999999999999999998532110            0 000111111111


Q ss_pred             cccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          344 IVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       344 ~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                           +.    .+......+.+++.+|++.+|++|||+.++++
T Consensus       217 -----~~----~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         217 -----LR----NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             -----cC----cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                 10    11112456899999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.9e-36  Score=288.63  Aligned_cols=253  Identities=25%  Similarity=0.388  Sum_probs=188.6

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCC--CccHHHHHHHHHHHHhcC-CCceeeEeeEEEecCCCeEEEEEecC
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGE--ENGEKEFRSEVAAIASAQ-HVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.+.||+|+||.||++.. .+|+.+|+|.+...  ......+.+|+.++.++. |+||+++++++. ..+..++++||+.
T Consensus         8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~-~~~~~~~~~e~~~   86 (288)
T cd06616           8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALF-REGDCWICMELMD   86 (288)
T ss_pred             HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEe-cCCcEEEEEeccc
Confidence            356899999999999995 45899999998753  233457889999999996 999999999876 4567899999986


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      . +|.++.......     ....+++....+++.+++.||+|||+.  .+++||||||+||+++.++.+||+|||++...
T Consensus        87 ~-~l~~l~~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  158 (288)
T cd06616          87 I-SLDKFYKYVYEV-----LKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQL  158 (288)
T ss_pred             C-CHHHHHHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence            4 665543211000     123489999999999999999999973  58999999999999999999999999999765


Q ss_pred             cCCCCceeeeccCCccccchhhhhcC---CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhh
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQ---GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMK  337 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (453)
                      .....  .....|+..|+|||.+...   .++.++||||||+++|||++|+.||.....           ......... 
T Consensus       159 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----------~~~~~~~~~-  224 (288)
T cd06616         159 VDSIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----------VFDQLTQVV-  224 (288)
T ss_pred             ccCCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----------HHHHHhhhc-
Confidence            43221  1233578899999998765   689999999999999999999999853210           000011110 


Q ss_pred             cCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          338 EGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       338 ~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      .+.     .+.+..  .........+.+++.+|++.+|++|||+.+|++.
T Consensus       225 ~~~-----~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         225 KGD-----PPILSN--SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CCC-----CCcCCC--cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            011     111111  1112345568999999999999999999998853

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.1e-36  Score=289.83  Aligned_cols=193  Identities=26%  Similarity=0.368  Sum_probs=159.7

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCC
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      .+.||+|+||.||+|.. .+|+.||+|.+...  ......+.+|+.+++.++|+||+++.+++. .+...++|+||+. +
T Consensus        10 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-~~~~~~lv~e~~~-~   87 (291)
T cd07870          10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH-TKETLTFVFEYMH-T   87 (291)
T ss_pred             EEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe-cCCeEEEEEeccc-C
Confidence            57899999999999985 46889999998653  223346788999999999999999999876 5567899999996 6


Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccC
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR  262 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~  262 (453)
                      +|.+++....         ..+.+.....++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+++....
T Consensus        88 ~l~~~~~~~~---------~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  155 (291)
T cd07870          88 DLAQYMIQHP---------GGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSI  155 (291)
T ss_pred             CHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence            8877764321         237788888999999999999999   8999999999999999999999999999875432


Q ss_pred             CCCceeeeccCCccccchhhhhcC-CCCccccchhHHHHHHHHHcCCCCCcc
Q 047276          263 DQSRCITTIRGTRGYLAPEWILEQ-GVSEKCDIYSYGMVLLELTGGRRNVSL  313 (453)
Q Consensus       263 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvil~elltG~~p~~~  313 (453)
                      ... ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus       156 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~  206 (291)
T cd07870         156 PSQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPG  206 (291)
T ss_pred             CCC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            221 12234568899999988753 578899999999999999999999964

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.5e-35  Score=287.34  Aligned_cols=247  Identities=22%  Similarity=0.276  Sum_probs=191.4

Q ss_pred             HHHhcccCcCCceEEEEEEe-CCCcEEEEEEecCCC----ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          103 DNFQALLGHGSSASVFKGIL-SDGTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      +...+.||+|+||.||+++. .++..+|+|.+....    .....+.+|+++++.++|||+++++++|. .++..++|||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e  105 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL-REHTAWLVME  105 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-eCCeEEEEEe
Confidence            34467899999999999996 468899999986421    22346889999999999999999999986 4567899999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |++ |+|.+++....         ..++|..+..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||++
T Consensus       106 ~~~-g~l~~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~  172 (317)
T cd06635         106 YCL-GSASDLLEVHK---------KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSA  172 (317)
T ss_pred             CCC-CCHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCc
Confidence            996 58877774322         238999999999999999999999   89999999999999999999999999998


Q ss_pred             ccccCCCCceeeeccCCccccchhhhh---cCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHH
Q 047276          258 KLMSRDQSRCITTIRGTRGYLAPEWIL---EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNE  334 (453)
Q Consensus       258 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  334 (453)
                      ......     ....+++.|+|||++.   .+.++.++|||||||++|||++|+.||......            . ...
T Consensus       173 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------------~-~~~  234 (317)
T cd06635         173 SIASPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------------S-ALY  234 (317)
T ss_pred             cccCCc-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH------------H-HHH
Confidence            754322     2346788999999974   456889999999999999999999998532100            0 001


Q ss_pred             hhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 047276          335 KMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR  391 (453)
Q Consensus       335 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~  391 (453)
                      .+..+..     +..     ........+.+++.+|++.+|.+||++.++++.+-..
T Consensus       235 ~~~~~~~-----~~~-----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~  281 (317)
T cd06635         235 HIAQNES-----PTL-----QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL  281 (317)
T ss_pred             HHHhccC-----CCC-----CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence            1111110     000     1123344588999999999999999999999866543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-36  Score=288.24  Aligned_cols=265  Identities=23%  Similarity=0.274  Sum_probs=192.7

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEec-CCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP-GGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~~lv~e~~  179 (453)
                      +.+.||+|+||.||+|... +|+.+|+|.+...   ......+.+|+.+++.++|+|++++++++... .+..++|+||+
T Consensus         3 ~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~   82 (287)
T cd07840           3 KIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYM   82 (287)
T ss_pred             eeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccc
Confidence            3468999999999999965 5889999999764   23345688999999999999999999998754 26889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ++ +|.+++....         ..+++..++.++.|+++||+|||+   .+++|+||+|+||++++++.+||+|||++..
T Consensus        83 ~~-~l~~~~~~~~---------~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~  149 (287)
T cd07840          83 DH-DLTGLLDSPE---------VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARP  149 (287)
T ss_pred             cc-cHHHHHhccC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceee
Confidence            75 8988885331         248999999999999999999999   8999999999999999999999999999987


Q ss_pred             ccCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCC----------CCcccccch
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGND----------KSKNKWQYF  328 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~----------~~~~~~~~~  328 (453)
                      .............++..|+|||.+.+ ..++.++||||||+++|||++|+.||........          .....|...
T Consensus       150 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07840         150 YTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV  229 (287)
T ss_pred             ccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccc
Confidence            65443222233456788999997764 4578999999999999999999999864321100          000000000


Q ss_pred             hHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          329 PKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       329 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ....  ..............+..  .....+...+.+++.+|++.+|++||++.++++
T Consensus       230 ~~~~--~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         230 SKLP--WFENLKPKKPYKRRLRE--FFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             ccch--hhhhccccccchhHHHH--HhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            0000  00000000000000000  001112567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.7e-36  Score=290.49  Aligned_cols=261  Identities=21%  Similarity=0.280  Sum_probs=189.1

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      .+.||+|+||.||+|+.. +|+.||||.+....   .....+.+|++++++++||||+++++++. .++..++||||+. 
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~~v~e~~~-   82 (284)
T cd07860           5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-TENKLYLVFEFLH-   82 (284)
T ss_pred             eeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcc-cCCcEEEEeeccc-
Confidence            468999999999999864 68899999886532   23357889999999999999999999976 5668899999996 


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      ++|.+++....        ...+++..+..++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||++....
T Consensus        83 ~~l~~~~~~~~--------~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~  151 (284)
T cd07860          83 QDLKKFMDASP--------LSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFG  151 (284)
T ss_pred             cCHHHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence            68998885432        2348999999999999999999999   899999999999999999999999999987653


Q ss_pred             CCCCceeeeccCCccccchhhhhcCC-CCccccchhHHHHHHHHHcCCCCCcccccCCCC----------CcccccchhH
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILEQG-VSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDK----------SKNKWQYFPK  330 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~----------~~~~~~~~~~  330 (453)
                      .... ......++..|+|||.+.+.. ++.++||||||+++|||+||+.||.........          ....|.....
T Consensus       152 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07860         152 VPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  230 (284)
T ss_pred             cCcc-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhH
Confidence            3221 122335678999999876544 688999999999999999999998532211000          0000000000


Q ss_pred             HHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          331 IVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       331 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ..  .. ...........+.   .........+.+++.+|++.||++||++.++++
T Consensus       231 ~~--~~-~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         231 LP--DY-KPSFPKWARQDFS---KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HH--HH-HhhcccccccCHH---HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            00  00 0000000000000   001122345789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=5e-36  Score=294.74  Aligned_cols=270  Identities=24%  Similarity=0.284  Sum_probs=192.2

Q ss_pred             HHHhcccCcCCceEEEEEEeC-CCcEEEEEEecCC---CccHHHHHHHHHHHHhc-CCCceeeEeeEEEecC-CCeEEEE
Q 047276          103 DNFQALLGHGSSASVFKGILS-DGTSVAVKRINGE---ENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPG-GPRYLVY  176 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~-~~~~lv~  176 (453)
                      +.+.+.||+|+||.||+|... +|+.+|+|++...   ......+.+|+.+++++ +||||++++++|...+ ...++|+
T Consensus         9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~   88 (337)
T cd07852           9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVF   88 (337)
T ss_pred             HHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEe
Confidence            445688999999999999965 5789999988542   23345677899999999 9999999999876433 3579999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||++ ++|..++...           .++|..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+
T Consensus        89 e~~~-~~L~~~~~~~-----------~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~  153 (337)
T cd07852          89 EYME-TDLHAVIRAN-----------ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGL  153 (337)
T ss_pred             cccc-cCHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccc
Confidence            9997 5999888432           38899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCC----ceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcc-cc-cchh
Q 047276          257 SKLMSRDQS----RCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKN-KW-QYFP  329 (453)
Q Consensus       257 a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~-~~-~~~~  329 (453)
                      +........    .......|+..|+|||.+.. ..++.++||||||+++|||++|+.||............ .. ....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  233 (337)
T cd07852         154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS  233 (337)
T ss_pred             hhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            986643321    12234568899999998764 46789999999999999999999998532211000000 00 0000


Q ss_pred             HHHHHhhhcCccccccc----ccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          330 KIVNEKMKEGKLMEIVD----QRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       330 ~~~~~~~~~~~~~~~~d----~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      ......+......++++    ................+.+++.+|++.+|++|||+.++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            00000000000000111    00000000111235668999999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-36  Score=290.83  Aligned_cols=202  Identities=23%  Similarity=0.350  Sum_probs=164.0

Q ss_pred             HhcccCcCCceEEEEEEeC---CCcEEEEEEecCCC----ccHHHHHHHHHHHHhcCCCceeeEeeEEEecC-CCeEEEE
Q 047276          105 FQALLGHGSSASVFKGILS---DGTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG-GPRYLVY  176 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~---~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~~lv~  176 (453)
                      +.++||+|+||.||+|...   +++.||+|.+....    .....+.+|+.++..++|||++++++++.... ...++||
T Consensus         4 ~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~   83 (316)
T cd07842           4 IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLF   83 (316)
T ss_pred             EEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEE
Confidence            4578999999999999964   47899999987632    22356788999999999999999999987441 5689999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECC----CCcEEEe
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDE----NYRAVVS  252 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~----~~~~kl~  252 (453)
                      ||+++ +|.+++......     ....+++...+.++.|++.||+|||+   .+++||||||+||+++.    ++.+||+
T Consensus        84 e~~~~-~l~~~~~~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~  154 (316)
T cd07842          84 DYAEH-DLWQIIKFHRQA-----KRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIG  154 (316)
T ss_pred             eCCCc-CHHHHHHhhccC-----CCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEEC
Confidence            99975 777776433221     11358899999999999999999999   89999999999999999    9999999


Q ss_pred             eccccccccCCCC--ceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccc
Q 047276          253 DFGLSKLMSRDQS--RCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIE  315 (453)
Q Consensus       253 DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~  315 (453)
                      |||++........  .......+++.|+|||.+.+ ..++.++||||||++++||++|+.||....
T Consensus       155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  220 (316)
T cd07842         155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE  220 (316)
T ss_pred             CCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence            9999987643322  11233467889999998876 457899999999999999999999996443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-37  Score=290.66  Aligned_cols=240  Identities=25%  Similarity=0.329  Sum_probs=195.7

Q ss_pred             cccCcCCceEEEEEEe-CCCcEEEEEEecC----CCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          107 ALLGHGSSASVFKGIL-SDGTSVAVKRING----EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      ++||+||||.||-++. .+|+-+|.|++.+    ....+..-+.|-.+|.+++.+.||.+- |.+...+.+|+|+..|+|
T Consensus       191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVsla-YAfeTkd~LClVLtlMNG  269 (591)
T KOG0986|consen  191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLA-YAFETKDALCLVLTLMNG  269 (591)
T ss_pred             EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEe-eeecCCCceEEEEEeecC
Confidence            6899999999999986 4688999998864    234556678899999999999999885 445577899999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      |+|.-+|.+...        ..+++.....++.+|+.||++||.   .+||.||+||+|||+|++|+++|+|.|||..++
T Consensus       270 GDLkfHiyn~g~--------~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~  338 (591)
T KOG0986|consen  270 GDLKFHIYNHGN--------PGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIP  338 (591)
T ss_pred             CceeEEeeccCC--------CCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecC
Confidence            999999976542        348999999999999999999999   899999999999999999999999999999876


Q ss_pred             CCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcc
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKL  341 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (453)
                      ....  ....+||.||||||++.++.|+...|.||+||+||||+.|+.||....                  +.++    
T Consensus       339 ~g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K------------------eKvk----  394 (591)
T KOG0986|consen  339 EGKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK------------------EKVK----  394 (591)
T ss_pred             CCCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh------------------hhhh----
Confidence            5543  344589999999999999999999999999999999999999995211                  1111    


Q ss_pred             cccccccc-cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHH
Q 047276          342 MEIVDQRL-TDEGGIDETQVRRLVDVAFWCIQERARLRPSMA  382 (453)
Q Consensus       342 ~~~~d~~l-~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~  382 (453)
                      .+-+|.+. .....++...+.+..++....|+.||++|.-..
T Consensus       395 ~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  395 REEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             HHHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence            11222222 222345666677788899999999999986544

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=7.2e-36  Score=287.58  Aligned_cols=266  Identities=19%  Similarity=0.217  Sum_probs=192.3

Q ss_pred             HHHhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecC-CCeEEEEE
Q 047276          103 DNFQALLGHGSSASVFKGILS-DGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG-GPRYLVYE  177 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~~lv~e  177 (453)
                      +.+.+.||+|+||.||+|... +++.+++|.++...   .....+.+|+.++.+++||||+++++++.... +..++|+|
T Consensus         7 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e   86 (293)
T cd07843           7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVME   86 (293)
T ss_pred             hhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEeh
Confidence            344578999999999999975 58899999987532   22345778999999999999999999876432 68899999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |+++ +|.+++....         ..+++.....++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++
T Consensus        87 ~~~~-~L~~~~~~~~---------~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~  153 (293)
T cd07843          87 YVEH-DLKSLMETMK---------QPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLA  153 (293)
T ss_pred             hcCc-CHHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCce
Confidence            9974 9998885432         238999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCceeeeccCCccccchhhhhcC-CCCccccchhHHHHHHHHHcCCCCCcccccCCCC----------Cccccc
Q 047276          258 KLMSRDQSRCITTIRGTRGYLAPEWILEQ-GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDK----------SKNKWQ  326 (453)
Q Consensus       258 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~----------~~~~~~  326 (453)
                      ........ ......+++.|+|||.+.+. .++.++|+||||+++|||++|+.||.........          ....|.
T Consensus       154 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
T cd07843         154 REYGSPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP  232 (293)
T ss_pred             eeccCCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHH
Confidence            87654321 12334578899999988754 4689999999999999999999998632211000          000000


Q ss_pred             chhHHHHHhhhcCcccccccccccCCCCCcHH-HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          327 YFPKIVNEKMKEGKLMEIVDQRLTDEGGIDET-QVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~-~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      .+...  .........+.....+.  ..++.. ....+.+++.+|++.+|++|||+.|+++
T Consensus       233 ~~~~~--~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         233 GFSEL--PGAKKKTFTKYPYNQLR--KKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             Hhhcc--chhcccccccccchhhh--ccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            00000  00000000011111111  011111 3556889999999999999999999874

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.9e-36  Score=285.98  Aligned_cols=243  Identities=23%  Similarity=0.280  Sum_probs=194.3

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC----ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      +.+.||+|+||.||++... ++..||+|.+....    ...+.+.+|++++++++|||++++++++. .+...++|+||+
T Consensus         4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~   82 (258)
T cd05578           4 LLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQ-DEENMYLVVDLL   82 (258)
T ss_pred             EEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhc-CCCeEEEEEeCC
Confidence            4578999999999999975 58899999986522    34567899999999999999999999875 566889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      .+++|.+++...          ..+++.....++.|+++||.|||+   .+++|+||+|+||++++++.++|+|||++..
T Consensus        83 ~~~~L~~~l~~~----------~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~  149 (258)
T cd05578          83 LGGDLRYHLSQK----------VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATK  149 (258)
T ss_pred             CCCCHHHHHHhc----------CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccc
Confidence            999999998533          248899999999999999999998   8999999999999999999999999999886


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      .....  ......|+..|+|||.+....++.++|+||||+++|+|++|+.||.......          .......... 
T Consensus       150 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----------~~~~~~~~~~-  216 (258)
T cd05578         150 VTPDT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----------RDQIRAKQET-  216 (258)
T ss_pred             cCCCc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----------HHHHHHHhcc-
Confidence            64432  2234567889999999988889999999999999999999999986332110          0111111110 


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCH--HHHH
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSM--ARVV  385 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~--~~v~  385 (453)
                             .    ....+......+.+++.+|++.+|.+||++  +|+.
T Consensus       217 -------~----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         217 -------A----DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             -------c----cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence                   0    011223344678899999999999999999  5543

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=5.6e-36  Score=287.95  Aligned_cols=246  Identities=23%  Similarity=0.269  Sum_probs=188.6

Q ss_pred             HhcccCcCCceEEEEEEe----CCCcEEEEEEecCC-----CccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEE
Q 047276          105 FQALLGHGSSASVFKGIL----SDGTSVAVKRINGE-----ENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYL  174 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~----~~g~~vavK~~~~~-----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~l  174 (453)
                      +.+.||+|+||.||++..    .+|..||+|++...     ....+.+.+|+.++.++ +|+||+++++++. .+...++
T Consensus         4 ~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~-~~~~~~l   82 (290)
T cd05613           4 LLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ-TDTKLHL   82 (290)
T ss_pred             eeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEee-cCCeEEE
Confidence            357899999999999985    36889999998642     12335688899999999 5899999998765 5567899


Q ss_pred             EEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeec
Q 047276          175 VYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDF  254 (453)
Q Consensus       175 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~Df  254 (453)
                      |+||+++++|.+++...          ..+++.....++.|++.||.|||+   .+++||||+|+|||++.++.+||+||
T Consensus        83 v~e~~~~~~L~~~l~~~----------~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~df  149 (290)
T cd05613          83 ILDYINGGELFTHLSQR----------ERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDF  149 (290)
T ss_pred             EEecCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeC
Confidence            99999999999998543          237888999999999999999999   89999999999999999999999999


Q ss_pred             cccccccCCCCceeeeccCCccccchhhhhcC--CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHH
Q 047276          255 GLSKLMSRDQSRCITTIRGTRGYLAPEWILEQ--GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIV  332 (453)
Q Consensus       255 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  332 (453)
                      |++...............|+..|+|||.+...  .++.++||||||+++|+|++|+.||.......        ......
T Consensus       150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--------~~~~~~  221 (290)
T cd05613         150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--------SQAEIS  221 (290)
T ss_pred             ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--------cHHHHH
Confidence            99987644332223345688899999998753  46789999999999999999999985321100        001111


Q ss_pred             HHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHH
Q 047276          333 NEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRP-----SMARVV  385 (453)
Q Consensus       333 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~~v~  385 (453)
                      ......             ....+......+.+++.+|++.+|++||     +..+++
T Consensus       222 ~~~~~~-------------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~  266 (290)
T cd05613         222 RRILKS-------------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIK  266 (290)
T ss_pred             HHhhcc-------------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHH
Confidence            111110             0112223445688999999999999997     555554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.2e-35  Score=277.72  Aligned_cols=246  Identities=24%  Similarity=0.358  Sum_probs=197.6

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecC-CCeEEEEEecC
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG-GPRYLVYEFIQ  180 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~~lv~e~~~  180 (453)
                      .+.||+|++|.||+|... +++.|++|++....   ...+.+.+|+.++++++|+|++++++++.... ...++++||++
T Consensus         5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~   84 (260)
T cd06606           5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVS   84 (260)
T ss_pred             eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecC
Confidence            468999999999999975 68899999987644   34567899999999999999999999876431 57899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +++|.+++....          .+++..++.++.|++.||+|||+   .+++|+||+|+||+++.++.++|+|||.+...
T Consensus        85 ~~~L~~~~~~~~----------~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~  151 (260)
T cd06606          85 GGSLSSLLKKFG----------KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRL  151 (260)
T ss_pred             CCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEec
Confidence            999999985432          48999999999999999999999   89999999999999999999999999999876


Q ss_pred             cCCCCc-eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          261 SRDQSR-CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       261 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      ...... ......++..|++||.+.....+.++||||||+++++|++|+.||.....           ............
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----------~~~~~~~~~~~~  220 (260)
T cd06606         152 GDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----------PMAALYKIGSSG  220 (260)
T ss_pred             ccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----------hHHHHHhccccC
Confidence            544321 12345688899999999888899999999999999999999999863320           000011110000


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ..           ...+......+.+++.+|++.+|++||++.++++
T Consensus       221 ~~-----------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         221 EP-----------PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CC-----------cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            00           1122333567999999999999999999999885

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=3.5e-36  Score=289.08  Aligned_cols=251  Identities=22%  Similarity=0.258  Sum_probs=194.5

Q ss_pred             HhcccCcCCceEEEEEEe----CCCcEEEEEEecCC-----CccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEE
Q 047276          105 FQALLGHGSSASVFKGIL----SDGTSVAVKRINGE-----ENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYL  174 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~----~~g~~vavK~~~~~-----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~l  174 (453)
                      +.+.||+|+||.||+++.    .++..||||.++..     ......+..|+.++.++ +|||++++.+.+. .+...++
T Consensus         4 ~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~-~~~~~~l   82 (288)
T cd05583           4 LLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQ-TDTKLHL   82 (288)
T ss_pred             EEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeee-cCCEEEE
Confidence            357899999999999884    35788999998642     12335688999999999 5999999998765 5667899


Q ss_pred             EEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeec
Q 047276          175 VYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDF  254 (453)
Q Consensus       175 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~Df  254 (453)
                      ||||+++|+|.+++...          ..+++.....++.|+++||.|||+   .+++|+||+|+||+++.++.++|+||
T Consensus        83 v~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df  149 (288)
T cd05583          83 ILDYVNGGELFTHLYQR----------EHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDF  149 (288)
T ss_pred             EEecCCCCcHHHHHhhc----------CCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEEC
Confidence            99999999999998532          238899999999999999999998   89999999999999999999999999


Q ss_pred             cccccccCCCCceeeeccCCccccchhhhhcCC--CCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHH
Q 047276          255 GLSKLMSRDQSRCITTIRGTRGYLAPEWILEQG--VSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIV  332 (453)
Q Consensus       255 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  332 (453)
                      |+++..............|+..|++||...+..  .+.++||||||+++|||++|..||.......        ......
T Consensus       150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------~~~~~~  221 (288)
T cd05583         150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--------SQSEIS  221 (288)
T ss_pred             ccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--------hHHHHH
Confidence            998876544333333456889999999987654  7889999999999999999999985321100        001111


Q ss_pred             HHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 047276          333 NEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEG  390 (453)
Q Consensus       333 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~  390 (453)
                      ..... .      +      ...+......+.+++.+|++.+|++|||+.++.+.|+.
T Consensus       222 ~~~~~-~------~------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         222 RRILK-S------K------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             HHHHc-c------C------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            11110 0      0      11122234458899999999999999999998888775

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9e-37  Score=300.59  Aligned_cols=240  Identities=23%  Similarity=0.409  Sum_probs=190.6

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEec-----CCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCC-CeEEEEE
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRIN-----GEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGG-PRYLVYE  177 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~-----~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-~~~lv~e  177 (453)
                      |..+||+|.|-+||||... +|-.||--.++     ......+.|..|+.+|+.|+||||++++.++.+..+ ...+|+|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            4568999999999999863 46666632221     233344789999999999999999999998765443 4679999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECC-CCcEEEeeccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDE-NYRAVVSDFGL  256 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~-~~~~kl~DfGl  256 (453)
                      .|..|+|..|+.+.++          ++.....+|+.||++||.|||+. .++|+|||||.+||+|+. .|.+||+|+||
T Consensus       124 L~TSGtLr~Y~kk~~~----------vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGL  192 (632)
T KOG0584|consen  124 LFTSGTLREYRKKHRR----------VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGL  192 (632)
T ss_pred             cccCCcHHHHHHHhcc----------CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhH
Confidence            9999999999976654          78889999999999999999995 489999999999999985 48999999999


Q ss_pred             cccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhh
Q 047276          257 SKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKM  336 (453)
Q Consensus       257 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (453)
                      |........   ....|||.|||||... ..|++..||||||++++||+|+..||+--..            +..+-+.+
T Consensus       193 Atl~r~s~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n------------~AQIYKKV  256 (632)
T KOG0584|consen  193 ATLLRKSHA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN------------PAQIYKKV  256 (632)
T ss_pred             HHHhhcccc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC------------HHHHHHHH
Confidence            998765443   2368999999999766 7899999999999999999999999963221            12223333


Q ss_pred             hcCc----ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          337 KEGK----LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       337 ~~~~----~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ..|.    +.++-|              .++.+++.+|+.. .++|||+.|+++
T Consensus       257 ~SGiKP~sl~kV~d--------------Pevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  257 TSGIKPAALSKVKD--------------PEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             HcCCCHHHhhccCC--------------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence            3332    222222              3478999999999 999999999884

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.7e-35  Score=287.86  Aligned_cols=269  Identities=21%  Similarity=0.241  Sum_probs=189.6

Q ss_pred             hcccCcCCceEEEEEEeCCCcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCC
Q 047276          106 QALLGHGSSASVFKGILSDGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      .+.+|.|+++.||++.. +++.||+|+++..   ....+.+.+|+.+++.++|+||+++++++. ..+..+++|||+++|
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~-~~~~~~~~~e~~~~~   84 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI-VDSELYVVSPLMAYG   84 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheee-cCCeEEEEEeccCCC
Confidence            44566667777777666 6899999998753   334467999999999999999999999876 556889999999999


Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccC
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR  262 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~  262 (453)
                      +|.+++.....        ..+++.....++.|++.||+|||+   .+|+||||||+||+++.++.+||+|||.+.....
T Consensus        85 ~l~~~l~~~~~--------~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~  153 (314)
T cd08216          85 SCEDLLKTHFP--------EGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIK  153 (314)
T ss_pred             CHHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecc
Confidence            99999864321        237888999999999999999999   8999999999999999999999999998875532


Q ss_pred             CCC------ceeeeccCCccccchhhhhc--CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHH
Q 047276          263 DQS------RCITTIRGTRGYLAPEWILE--QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNE  334 (453)
Q Consensus       263 ~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  334 (453)
                      ...      .......++..|+|||.+..  ..++.++|||||||++|||++|+.||.................+.+...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (314)
T cd08216         154 HGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDK  233 (314)
T ss_pred             ccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCcccccc
Confidence            211      11223456778999999875  3588999999999999999999999964321100000000000000000


Q ss_pred             ---hhhcCcccc----cccccc--cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          335 ---KMKEGKLME----IVDQRL--TDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       335 ---~~~~~~~~~----~~d~~l--~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                         .........    ..++..  .............+.+++.+||+.+|++|||+.++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             CchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence               000000000    000100  00111233445678899999999999999999998853

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=8.2e-36  Score=285.19  Aligned_cols=266  Identities=20%  Similarity=0.208  Sum_probs=188.6

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCC--CccHHHHHHHHHHHHhcC-CCceeeEeeEEEecC-CCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGE--ENGEKEFRSEVAAIASAQ-HVNLVRLLGYCVVPG-GPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~-~~~~lv~e~~  179 (453)
                      +.+.||+|+||.||+|.. .+++.+|+|.++..  ........+|+.++.++. |+|++++++++.+.. +..++|+||+
T Consensus         3 ~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~   82 (282)
T cd07831           3 ILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM   82 (282)
T ss_pred             eEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecC
Confidence            457899999999999995 46889999998753  222334567899999885 999999999987431 5789999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      + |+|.+++....         ..++|..++.++.|++.||+|||+   .+++||||+|+||+++. +.+||+|||++..
T Consensus        83 ~-~~l~~~l~~~~---------~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~  148 (282)
T cd07831          83 D-MNLYELIKGRK---------RPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRG  148 (282)
T ss_pred             C-ccHHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccc
Confidence            7 58888875432         248999999999999999999999   89999999999999999 9999999999986


Q ss_pred             ccCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCc-cc-ccchhHHHHHhh
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSK-NK-WQYFPKIVNEKM  336 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~-~~-~~~~~~~~~~~~  336 (453)
                      ......  .....++..|+|||.+.. +.++.++|||||||++|||++|..||...+....... .. ....+..+....
T Consensus       149 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (282)
T cd07831         149 IYSKPP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKF  226 (282)
T ss_pred             cccCCC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence            643322  123457889999997654 5578999999999999999999999954321100000 00 000000001111


Q ss_pred             hcCcccccccccccCC--CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          337 KEGKLMEIVDQRLTDE--GGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       337 ~~~~~~~~~d~~l~~~--~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ..........+.....  .......+..+.+++.+||+.+|++||++.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            1110000000000000  0011234577999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=7.7e-36  Score=280.99  Aligned_cols=246  Identities=26%  Similarity=0.348  Sum_probs=196.8

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.++||+|+||.||++.. .+++.+++|.+....   ....++.+|+.+++.++|+||+++.+++. .+...++|+||++
T Consensus         4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~~v~e~~~   82 (256)
T cd08530           4 VLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL-DGNKLCIVMEYAP   82 (256)
T ss_pred             EeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhc-cCCEEEEEehhcC
Confidence            357899999999999985 468899999987532   23456788999999999999999999876 4578899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +++|.+++.....      ....+++...+.++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||++...
T Consensus        83 ~~~L~~~~~~~~~------~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~  153 (256)
T cd08530          83 FGDLSKAISKRKK------KRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVL  153 (256)
T ss_pred             CCCHHHHHHHHHh------hcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhh
Confidence            9999999865321      12348999999999999999999999   89999999999999999999999999999876


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      ....   .....+++.|++||.+.+..++.++|+||||+++|||++|+.||...+..            . .......+.
T Consensus       154 ~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------------~-~~~~~~~~~  217 (256)
T cd08530         154 KKNM---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ------------D-LRYKVQRGK  217 (256)
T ss_pred             ccCC---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------------H-HHHHHhcCC
Confidence            5431   22345788999999999888999999999999999999999998532110            0 111111111


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      .           ...+......+.+++.+|++.+|++||++.++++.
T Consensus       218 ~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         218 Y-----------PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             C-----------CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            1           11223455669999999999999999999998753

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-36  Score=295.97  Aligned_cols=265  Identities=23%  Similarity=0.311  Sum_probs=190.9

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEecC----CCeEEEEE
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG----GPRYLVYE  177 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~~lv~e  177 (453)
                      +.++||+|+||.||+|.. .+|+.||+|.+...  ......+.+|+.++++++|+||+++++++....    ...++++|
T Consensus         9 i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e   88 (336)
T cd07849           9 NLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQE   88 (336)
T ss_pred             EEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEeh
Confidence            357899999999999985 46899999998642  233456888999999999999999999865332    24689999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |+.+ +|.+++..           ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++
T Consensus        89 ~~~~-~l~~~~~~-----------~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~  153 (336)
T cd07849          89 LMET-DLYKLIKT-----------QHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLA  153 (336)
T ss_pred             hccc-CHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccce
Confidence            9965 88887732           238999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCC--ceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccch------
Q 047276          258 KLMSRDQS--RCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYF------  328 (453)
Q Consensus       258 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~------  328 (453)
                      ........  .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.......     .+...      
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~-----~~~~~~~~~~~  228 (336)
T cd07849         154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH-----QLNLILGVLGT  228 (336)
T ss_pred             eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHcCC
Confidence            76543221  11233467889999998754 468999999999999999999999995321100     00000      


Q ss_pred             --hHHHHHhhhcCcccccccccccCCCC-----CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--hccc
Q 047276          329 --PKIVNEKMKEGKLMEIVDQRLTDEGG-----IDETQVRRLVDVAFWCIQERARLRPSMARVVEM--LEGR  391 (453)
Q Consensus       329 --~~~~~~~~~~~~~~~~~d~~l~~~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~--L~~~  391 (453)
                        +..... .......+.. ..+.....     ..+.....+.+++.+||+.+|++|||+.++++.  ++..
T Consensus       229 ~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         229 PSQEDLNC-IISLRARNYI-KSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             CCHHHHHH-hhchhhhhHH-hhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence              000000 0000000000 00000000     011234568999999999999999999999876  5443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-36  Score=286.94  Aligned_cols=265  Identities=23%  Similarity=0.240  Sum_probs=190.6

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.+.||+|++|.||+|.. .+|..||+|++....   .....+.+|+.+++.++|||++++++++. .++..+++|||++
T Consensus         3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-~~~~~~iv~e~~~   81 (283)
T cd07835           3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH-SENKLYLVFEFLD   81 (283)
T ss_pred             hheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec-cCCeEEEEEeccC
Confidence            357899999999999996 478999999986532   23356889999999999999999999986 5578899999995


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                       ++|.+++.....        ..+++..+++++.|+++||+|||+   .+++|+||+|+||+++.++.++|+|||++...
T Consensus        82 -~~l~~~~~~~~~--------~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~  149 (283)
T cd07835          82 -LDLKKYMDSSPL--------TGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAF  149 (283)
T ss_pred             -cCHHHHHhhCCC--------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeeccccccc
Confidence             699999854321        248999999999999999999999   89999999999999999999999999999765


Q ss_pred             cCCCCceeeeccCCccccchhhhhcC-CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCc-cccc-chhHHHHHhhh
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQ-GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSK-NKWQ-YFPKIVNEKMK  337 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~-~~~~-~~~~~~~~~~~  337 (453)
                      ..... ......+++.|+|||++.+. .++.++||||||+++|||++|+.||...+....... .... ......+....
T Consensus       150 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd07835         150 GVPVR-TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVT  228 (283)
T ss_pred             CCCcc-ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhh
Confidence            32211 11223467899999987654 578999999999999999999999853221100000 0000 00000000000


Q ss_pred             -c----CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          338 -E----GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       338 -~----~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                       .    ...........   ..........+.+++.+|++.+|++||++.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         229 SLPDYKPTFPKWARQDL---SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hchhhhhhcccccccch---hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence             0    00000000000   0111223356889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.4e-36  Score=310.23  Aligned_cols=199  Identities=19%  Similarity=0.280  Sum_probs=154.4

Q ss_pred             HHHhcccCcCCceEEEEEEeCC--CcEEEEE------------------EecCCCccHHHHHHHHHHHHhcCCCceeeEe
Q 047276          103 DNFQALLGHGSSASVFKGILSD--GTSVAVK------------------RINGEENGEKEFRSEVAAIASAQHVNLVRLL  162 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~~--g~~vavK------------------~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~  162 (453)
                      +.+.+.||+|+||+||++..+.  +...+.|                  .+.........+.+|+.+|++++||||++++
T Consensus       150 Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~  229 (501)
T PHA03210        150 FRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIE  229 (501)
T ss_pred             cEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEe
Confidence            4445799999999999987532  2222222                  2222222345688999999999999999999


Q ss_pred             eEEEecCCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEE
Q 047276          163 GYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENIL  242 (453)
Q Consensus       163 g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiL  242 (453)
                      +++. ..+..+++++++. ++|.+++.......     ...........++.|++.||+|||+   .+|+||||||+|||
T Consensus       230 ~~~~-~~~~~~lv~e~~~-~~l~~~l~~~~~~~-----~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NIL  299 (501)
T PHA03210        230 EILR-SEANTYMITQKYD-FDLYSFMYDEAFDW-----KDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIF  299 (501)
T ss_pred             EEEE-ECCeeEEEEeccc-cCHHHHHhhccccc-----cccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEE
Confidence            9986 4567899999985 58888775432110     1123455677899999999999999   89999999999999


Q ss_pred             ECCCCcEEEeeccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCC
Q 047276          243 LDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNV  311 (453)
Q Consensus       243 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~  311 (453)
                      ++.++.+||+|||+++.+............||+.|+|||++.+..++.++|||||||++|||++|..++
T Consensus       300 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p  368 (501)
T PHA03210        300 LNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP  368 (501)
T ss_pred             ECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            999999999999999876544333334467999999999999989999999999999999999987543

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.4e-35  Score=281.99  Aligned_cols=240  Identities=21%  Similarity=0.274  Sum_probs=182.7

Q ss_pred             ccCcCCceEEEEEEe-CCCcEEEEEEecCCC----ccHHHHHHHHHH---HHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          108 LLGHGSSASVFKGIL-SDGTSVAVKRINGEE----NGEKEFRSEVAA---IASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       108 ~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~----~~~~~~~~E~~~---l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      .||+|+||.||++.. .+++.||+|.+....    .....+..|..+   +....|||++++.+++. ..+..++|+||+
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~~v~e~~   79 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-TPDKLSFILDLM   79 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeee-cCCEEEEEEecC
Confidence            489999999999985 458899999886532    122234445443   44457999999998876 556889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ++|+|.+++...          ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++..
T Consensus        80 ~g~~L~~~l~~~----------~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~  146 (278)
T cd05606          80 NGGDLHYHLSQH----------GVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACD  146 (278)
T ss_pred             CCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccc
Confidence            999999988532          248999999999999999999999   8999999999999999999999999999875


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcC-CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQ-GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      .....   .....|+..|+|||.+.++ .++.++||||||+++|||++|+.||.........          ........
T Consensus       147 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~----------~~~~~~~~  213 (278)
T cd05606         147 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----------EIDRMTLT  213 (278)
T ss_pred             cCccC---CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH----------HHHHHhhc
Confidence            53322   1234689999999998754 6899999999999999999999999532111100          00010000


Q ss_pred             CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 047276          339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRP-----SMARVVE  386 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~~v~~  386 (453)
                            .+.      ..+...+..+.+++.+|++.+|++||     ++.++++
T Consensus       214 ------~~~------~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         214 ------MAV------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             ------cCC------CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence                  011      12222345689999999999999999     8888874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-35  Score=278.43  Aligned_cols=243  Identities=27%  Similarity=0.415  Sum_probs=195.1

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.+.||+|++|.||++... +++.|++|.+....   .....+.+|++++++++|+|++++++++. .++..++++||++
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~~v~e~~~   82 (254)
T cd06627           4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE-TSDSLYIILEYAE   82 (254)
T ss_pred             eeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE-eCCEEEEEEecCC
Confidence            4578999999999999864 57899999997643   34467899999999999999999999876 4568899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +++|.+++...          ..+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++...
T Consensus        83 ~~~L~~~~~~~----------~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  149 (254)
T cd06627          83 NGSLRQIIKKF----------GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKL  149 (254)
T ss_pred             CCcHHHHHHhc----------cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceec
Confidence            99999998533          238999999999999999999998   89999999999999999999999999999876


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      ...... .....++..|+|||......++.++||||||+++|+|++|+.||.....           ... .... ....
T Consensus       150 ~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----------~~~-~~~~-~~~~  215 (254)
T cd06627         150 NDVSKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----------MAA-LFRI-VQDD  215 (254)
T ss_pred             CCCccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----------HHH-HHHH-hccC
Confidence            543321 2345678899999998877789999999999999999999999853210           000 0010 0000


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      .           ...+......+.+++.+|++.+|++||++.+++.
T Consensus       216 ~-----------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         216 H-----------PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             C-----------CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            0           1112233456889999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.8e-35  Score=285.96  Aligned_cols=258  Identities=22%  Similarity=0.270  Sum_probs=189.4

Q ss_pred             HHhcccCcCCceEEEEEEeC-CCcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEecC---------C
Q 047276          104 NFQALLGHGSSASVFKGILS-DGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG---------G  170 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~---------~  170 (453)
                      .+.+.||+|+||.||+|... +|+.||+|.++..   ......+.+|+.+++.++|||++++++++....         .
T Consensus        10 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   89 (302)
T cd07864          10 DIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKG   89 (302)
T ss_pred             heeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCC
Confidence            34578999999999999975 5889999998653   223356788999999999999999999886432         2


Q ss_pred             CeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEE
Q 047276          171 PRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV  250 (453)
Q Consensus       171 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~k  250 (453)
                      ..++++||+++ +|.+++....         ..+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+|
T Consensus        90 ~~~lv~e~~~~-~l~~~l~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~k  156 (302)
T cd07864          90 AFYLVFEYMDH-DLMGLLESGL---------VHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIK  156 (302)
T ss_pred             cEEEEEcccCc-cHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEE
Confidence            67899999976 7777764321         238999999999999999999999   8999999999999999999999


Q ss_pred             EeeccccccccCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchh
Q 047276          251 VSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFP  329 (453)
Q Consensus       251 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~  329 (453)
                      |+|||++...............++..|+|||.+.. ..++.++|||||||++|||++|+.||...+....        + 
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~--------~-  227 (302)
T cd07864         157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ--------L-  227 (302)
T ss_pred             eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH--------H-
Confidence            99999998765433222223345778999998864 4578999999999999999999999863221100        0 


Q ss_pred             HHHHHhhhcC---ccccc--------cc------ccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          330 KIVNEKMKEG---KLMEI--------VD------QRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       330 ~~~~~~~~~~---~~~~~--------~d------~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ..+.......   ....+        .+      ..+..   .....+..+.+++..||+.+|++||++.+++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         228 ELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLRE---EFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             HHHHHHhCCCChhhcccccccccccccccccccccchhh---hcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0000000000   00000        00      00000   00112456899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-35  Score=281.39  Aligned_cols=243  Identities=23%  Similarity=0.286  Sum_probs=185.9

Q ss_pred             cccCcCCceEEEEEEe-CCCcEEEEEEecCCCc----cHHHHHHHHHHH-HhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          107 ALLGHGSSASVFKGIL-SDGTSVAVKRINGEEN----GEKEFRSEVAAI-ASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~----~~~~~~~E~~~l-~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.||+|+||.||+|.. .+|+.||+|.+.....    ....+..|..++ ...+|+|++++++++. .++..++++||++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-~~~~~~lv~e~~~   80 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ-SKDYLYLVMEYLN   80 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE-cCCeEEEEEeccC
Confidence            4689999999999986 4688999999865321    122344555444 4458999999999876 5668899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +++|.+++...          ..+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||++...
T Consensus        81 ~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  147 (260)
T cd05611          81 GGDCASLIKTL----------GGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG  147 (260)
T ss_pred             CCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceec
Confidence            99999998533          238889999999999999999999   89999999999999999999999999998754


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      ..     .....+++.|++||.+.+..++.++||||||+++|||++|..||......             ........+.
T Consensus       148 ~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------------~~~~~~~~~~  209 (260)
T cd05611         148 LE-----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-------------AVFDNILSRR  209 (260)
T ss_pred             cc-----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-------------HHHHHHHhcc
Confidence            32     12345788999999998888899999999999999999999998532110             0111111111


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE  389 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~  389 (453)
                      ..      .  ...........+.+++.+|++.+|++||++.++.+.|.
T Consensus       210 ~~------~--~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         210 IN------W--PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             cC------C--CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            10      0  00111233456899999999999999998877666554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1e-35  Score=286.96  Aligned_cols=256  Identities=18%  Similarity=0.248  Sum_probs=177.4

Q ss_pred             HHHhcccCcCCceEEEEEEeCC----CcEEEEEEecCCCcc---H---------HHHHHHHHHHHhcCCCceeeEeeEEE
Q 047276          103 DNFQALLGHGSSASVFKGILSD----GTSVAVKRINGEENG---E---------KEFRSEVAAIASAQHVNLVRLLGYCV  166 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~~----g~~vavK~~~~~~~~---~---------~~~~~E~~~l~~l~h~niv~l~g~~~  166 (453)
                      +.+.++||+|+||+||+|...+    +..+|+|........   +         .....+...+..+.|+|++++++++.
T Consensus        14 y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~   93 (294)
T PHA02882         14 WKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGS   93 (294)
T ss_pred             eEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeee
Confidence            3446789999999999999654    345666654322111   0         11122334455678999999999765


Q ss_pred             ecCCC---eEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEE
Q 047276          167 VPGGP---RYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILL  243 (453)
Q Consensus       167 ~~~~~---~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl  243 (453)
                      .....   .++++|++.. ++.+.+...          ...++.....++.|++.||+|||+   .+++||||||+|||+
T Consensus        94 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill  159 (294)
T PHA02882         94 FKRCRMYYRFILLEKLVE-NTKEIFKRI----------KCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMV  159 (294)
T ss_pred             EecCCceEEEEEEehhcc-CHHHHHHhh----------ccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEE
Confidence            43322   2566776643 666655321          125678889999999999999999   899999999999999


Q ss_pred             CCCCcEEEeeccccccccCCCC------ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccC
Q 047276          244 DENYRAVVSDFGLSKLMSRDQS------RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHG  317 (453)
Q Consensus       244 ~~~~~~kl~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~  317 (453)
                      +.++.++|+|||+++.+.....      .......||+.|+|||...+..++.++|||||||++|||++|+.||......
T Consensus       160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~  239 (294)
T PHA02882        160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN  239 (294)
T ss_pred             cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc
Confidence            9999999999999987643211      1122346999999999999999999999999999999999999999643221


Q ss_pred             CCCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 047276          318 NDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE  389 (453)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~  389 (453)
                      ......   .... .......+.        +.     .......+.+++..|++.+|++||++.++.+.++
T Consensus       240 ~~~~~~---~~~~-~~~~~~~~~--------~~-----~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        240 GNLIHA---AKCD-FIKRLHEGK--------IK-----IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             hHHHHH---hHHH-HHHHhhhhh--------hc-----cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            110000   0000 001111111        00     1122456889999999999999999999998763

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.7e-35  Score=278.30  Aligned_cols=246  Identities=25%  Similarity=0.268  Sum_probs=196.0

Q ss_pred             HhcccCcCCceEEEEEEeCC-CcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGILSD-GTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~-g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      +-+.||+|.-|+||++.+.+ +..+|+|++.+.    .....+...|-+||+.+.||.+..|++.+. .++..|++||||
T Consensus        81 llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fe-t~~~~cl~meyC  159 (459)
T KOG0610|consen   81 LLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFE-TDKYSCLVMEYC  159 (459)
T ss_pred             HHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheee-ccceeEEEEecC
Confidence            34789999999999999764 588999999763    233456778999999999999999999875 566889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      +||+|..+++++.        ...+++..+..++.+++.||+|||-   .|||+|||||+||||-++|++-|+||.|+..
T Consensus       160 pGGdL~~LrqkQp--------~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~  228 (459)
T KOG0610|consen  160 PGGDLHSLRQKQP--------GKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLR  228 (459)
T ss_pred             CCccHHHHHhhCC--------CCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeecccccc
Confidence            9999999986553        3559999999999999999999999   8999999999999999999999999998643


Q ss_pred             ccC---------------------------------CCC----------------------ceeeeccCCccccchhhhh
Q 047276          260 MSR---------------------------------DQS----------------------RCITTIRGTRGYLAPEWIL  284 (453)
Q Consensus       260 ~~~---------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~  284 (453)
                      ...                                 ...                      .....++||-.|+|||.+.
T Consensus       229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~  308 (459)
T KOG0610|consen  229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR  308 (459)
T ss_pred             CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence            210                                 000                      0122357999999999999


Q ss_pred             cCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHH
Q 047276          285 EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLV  364 (453)
Q Consensus       285 ~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~  364 (453)
                      +...+.+.|.|+|||++|||+.|..||......                     ..+..++.+.+.-.  -.+..+..+.
T Consensus       309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~---------------------~Tl~NIv~~~l~Fp--~~~~vs~~ak  365 (459)
T KOG0610|consen  309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK---------------------ETLRNIVGQPLKFP--EEPEVSSAAK  365 (459)
T ss_pred             cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCch---------------------hhHHHHhcCCCcCC--CCCcchhHHH
Confidence            999999999999999999999999999643211                     11222222222211  1225567799


Q ss_pred             HHHHhccccCCCCCCC----HHHHH
Q 047276          365 DVAFWCIQERARLRPS----MARVV  385 (453)
Q Consensus       365 ~l~~~Cl~~~p~~RPs----~~~v~  385 (453)
                      +|+.+.|.+||++|--    +.||-
T Consensus       366 DLIr~LLvKdP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  366 DLIRKLLVKDPSKRLGSKRGAAEIK  390 (459)
T ss_pred             HHHHHHhccChhhhhccccchHHhh
Confidence            9999999999999998    66665

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.7e-35  Score=283.44  Aligned_cols=269  Identities=22%  Similarity=0.282  Sum_probs=191.8

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      +.+.||+|++|.||+|+.. +|..||||.++..  ......+.+|+.++++++|+|++++++++. ..+..++||||+++
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~   82 (284)
T cd07836           4 QLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIH-TENKLMLVFEYMDK   82 (284)
T ss_pred             EeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEe-eCCcEEEEEecCCc
Confidence            3578999999999999974 6889999998753  233466788999999999999999999987 45678999999985


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                       +|.+++.....       ...+++..+.+++.|++.||+|||+   .+++|+||+|+||++++++.++|+|||++....
T Consensus        83 -~l~~~~~~~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~  151 (284)
T cd07836          83 -DLKKYMDTHGV-------RGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFG  151 (284)
T ss_pred             -cHHHHHHhcCC-------CCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence             89888854321       2348999999999999999999998   899999999999999999999999999997654


Q ss_pred             CCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcc--cccchhHHHHHhhhc
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKN--KWQYFPKIVNEKMKE  338 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  338 (453)
                      .... ......++..|++||++.+ ..++.++||||||+++|||++|+.||............  .+........+.+..
T Consensus       152 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07836         152 IPVN-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ  230 (284)
T ss_pred             CCcc-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence            3221 1233456889999998865 35788999999999999999999998643211100000  000000000000000


Q ss_pred             -Cccccccccccc-CCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          339 -GKLMEIVDQRLT-DEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       339 -~~~~~~~d~~l~-~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                       ............ ......+.....+.+++.+|++.+|.+||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             000000000000 000011223456889999999999999999999874

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.7e-35  Score=285.19  Aligned_cols=263  Identities=21%  Similarity=0.238  Sum_probs=188.2

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC---ccHHHHHHHHHHHHhcC-CCceeeEeeEEEecCC----CeEEE
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEE---NGEKEFRSEVAAIASAQ-HVNLVRLLGYCVVPGG----PRYLV  175 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~----~~~lv  175 (453)
                      ..+.||+|+||.||+|... +|+.||+|.+....   .....+.+|+.+++.++ |+|++++++++.....    ..+++
T Consensus         5 ~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv   84 (295)
T cd07837           5 KLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLV   84 (295)
T ss_pred             EeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEE
Confidence            3578999999999999964 68999999886532   23356888999999995 6999999998764332    27999


Q ss_pred             EEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECC-CCcEEEeec
Q 047276          176 YEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDE-NYRAVVSDF  254 (453)
Q Consensus       176 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~-~~~~kl~Df  254 (453)
                      |||+++ +|.+++......     ....+++..++.++.||+.||.|||+   .+++||||+|+||+++. ++.+||+||
T Consensus        85 ~e~~~~-~l~~~~~~~~~~-----~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~df  155 (295)
T cd07837          85 FEYLDS-DLKKFMDSNGRG-----PGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADL  155 (295)
T ss_pred             eeccCc-CHHHHHHHhccc-----CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeec
Confidence            999985 898888644321     12348999999999999999999999   89999999999999998 899999999


Q ss_pred             cccccccCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHH
Q 047276          255 GLSKLMSRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVN  333 (453)
Q Consensus       255 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  333 (453)
                      |++......... .....+++.|+|||.+.+ ..++.++||||||+++|||++|..||....+...        ..... 
T Consensus       156 g~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--------~~~~~-  225 (295)
T cd07837         156 GLGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--------LLHIF-  225 (295)
T ss_pred             ccceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--------HHHHH-
Confidence            998765332111 122346788999998865 4578999999999999999999999853221100        00000 


Q ss_pred             HhhhcCc------cccccc----ccccCC--CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          334 EKMKEGK------LMEIVD----QRLTDE--GGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       334 ~~~~~~~------~~~~~d----~~l~~~--~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ..+....      ..+..+    +.....  ....+.....+.+++.+|++.+|++||++.+++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         226 KLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             HHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0000000      000000    000000  0001123456889999999999999999999874

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=8.4e-36  Score=296.22  Aligned_cols=193  Identities=31%  Similarity=0.392  Sum_probs=166.2

Q ss_pred             HHhcccCcCCceEEEEEE-eCCCcEEEEEEecCCCccHHHHHHHHHHHHhcC-C-----CceeeEeeEEEecCCCeEEEE
Q 047276          104 NFQALLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAAIASAQ-H-----VNLVRLLGYCVVPGGPRYLVY  176 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~g~~~~~~~~~~lv~  176 (453)
                      .+.++||+|+||.|-++. .++++.||||+++....-..+-..|+.+|..|+ |     -|+|++++|+. ..++.|+|+
T Consensus       189 ~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~-fr~HlciVf  267 (586)
T KOG0667|consen  189 EVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY-FRNHLCIVF  267 (586)
T ss_pred             EEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc-cccceeeee
Confidence            345789999999999999 467999999999987766677788999999997 4     38999999976 678999999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCC--CcEEEeec
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDEN--YRAVVSDF  254 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~--~~~kl~Df  254 (453)
                      |.+.. +|.++|+.++-        ..++......|+.||+.||.+||+   .+|||+||||+||||.+.  ..+||+||
T Consensus       268 ELL~~-NLYellK~n~f--------~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDF  335 (586)
T KOG0667|consen  268 ELLST-NLYELLKNNKF--------RGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDF  335 (586)
T ss_pred             hhhhh-hHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEec
Confidence            99966 99999987653        238999999999999999999998   899999999999999754  47999999


Q ss_pred             cccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcc
Q 047276          255 GLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSL  313 (453)
Q Consensus       255 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~  313 (453)
                      |.+.......    .....+.-|.|||++.+.+|+.+.||||||||+.||++|.+-|..
T Consensus       336 GSSc~~~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG  390 (586)
T KOG0667|consen  336 GSSCFESQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG  390 (586)
T ss_pred             ccccccCCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence            9998754322    244556789999999999999999999999999999999776643

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=4e-35  Score=287.24  Aligned_cols=266  Identities=21%  Similarity=0.271  Sum_probs=188.5

Q ss_pred             cccCcC--CceEEEEEEe-CCCcEEEEEEecCCCc---cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          107 ALLGHG--SSASVFKGIL-SDGTSVAVKRINGEEN---GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       107 ~~lG~G--~fG~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      ..||+|  +||+||+++. .+|+.||+|.+.....   ..+.+.+|+.+++.++||||+++++++. .++..++|+||++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-~~~~~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFT-TGSWLWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEe-cCCceEEEEeccc
Confidence            356666  9999999996 4789999999875332   2356888999999999999999999986 5567899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|.+++.....        ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.++++||+.+...
T Consensus        83 ~~~l~~~l~~~~~--------~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~  151 (328)
T cd08226          83 YGSANSLLKTYFP--------EGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSL  151 (328)
T ss_pred             CCCHHHHHHhhcc--------cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhh
Confidence            9999999865421        238899999999999999999998   89999999999999999999999999865433


Q ss_pred             cCCCCc--e----eeeccCCccccchhhhhcC--CCCccccchhHHHHHHHHHcCCCCCcccccCCCC-------Ccccc
Q 047276          261 SRDQSR--C----ITTIRGTRGYLAPEWILEQ--GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDK-------SKNKW  325 (453)
Q Consensus       261 ~~~~~~--~----~~~~~gt~~y~aPE~~~~~--~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~-------~~~~~  325 (453)
                      ......  .    .....++..|+|||++.+.  .++.++|||||||++|||++|+.||.........       ....+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  231 (328)
T cd08226         152 VRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPL  231 (328)
T ss_pred             hccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCc
Confidence            221110  0    0112345679999998763  4789999999999999999999999532211000       00000


Q ss_pred             --cchhHHHHH---------------hhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          326 --QYFPKIVNE---------------KMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       326 --~~~~~~~~~---------------~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                        ..++.....               ....+......+..+.  ..........+.+++.+||+.||++|||++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         232 DITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR--TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             cccccchhhhhhccchhhhhcccccchhcccccccccccccc--chhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence              000000000               0000000011111111  1123345678999999999999999999999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.9e-35  Score=276.00  Aligned_cols=246  Identities=26%  Similarity=0.356  Sum_probs=197.0

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      .+.||.|+||.||++... +++.+++|++....   .....+.+|+++++.++|+|++++++.+. .+...++++||+++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~-~~~~~~lv~e~~~~   83 (258)
T cd08215           5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFE-EKGKLCIVMEYADG   83 (258)
T ss_pred             EeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEe-cCCEEEEEEEecCC
Confidence            468999999999999964 68899999987532   34567889999999999999999999876 45788999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      ++|.+++.....      ....+++..+..++.+++.||.|||+   .+++|+||+|+||++++++.++|+|||.+....
T Consensus        84 ~~L~~~l~~~~~------~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~  154 (258)
T cd08215          84 GDLSQKIKKQKK------EGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS  154 (258)
T ss_pred             CcHHHHHHHhhc------cCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecc
Confidence            999999865421      12448999999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcc
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKL  341 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (453)
                      ... .......|++.|+|||......++.++||||+|+++++|++|+.||.....            ....... .....
T Consensus       155 ~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------------~~~~~~~-~~~~~  220 (258)
T cd08215         155 STV-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL------------LELALKI-LKGQY  220 (258)
T ss_pred             cCc-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH------------HHHHHHH-hcCCC
Confidence            433 223345688899999999888899999999999999999999999853211            1111111 11111


Q ss_pred             cccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          342 MEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       342 ~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      .           ..+......+.+++.+|++.+|++||++.++++
T Consensus       221 ~-----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         221 P-----------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             C-----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            1           112233456889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=5.7e-35  Score=283.60  Aligned_cols=245  Identities=23%  Similarity=0.274  Sum_probs=189.4

Q ss_pred             HHHhcccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          103 DNFQALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      +...+.||+|+||.||+|... ++..+++|.+...    .....++.+|+.+++.++|+|++++.+++. .....++|+|
T Consensus        17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e   95 (308)
T cd06634          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-REHTAWLVME   95 (308)
T ss_pred             HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEE-cCCeeEEEEE
Confidence            444578999999999999964 5788999988642    122346888999999999999999999887 4567899999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |+. |+|.+++....         ..+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.+||+|||++
T Consensus        96 ~~~-~~l~~~~~~~~---------~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~  162 (308)
T cd06634          96 YCL-GSASDLLEVHK---------KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSA  162 (308)
T ss_pred             ccC-CCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccc
Confidence            996 68887774322         238899999999999999999998   89999999999999999999999999998


Q ss_pred             ccccCCCCceeeeccCCccccchhhhh---cCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHH
Q 047276          258 KLMSRDQSRCITTIRGTRGYLAPEWIL---EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNE  334 (453)
Q Consensus       258 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  334 (453)
                      ......     ....+++.|+|||.+.   .+.++.++|||||||++|||++|+.||......            . ...
T Consensus       163 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------------~-~~~  224 (308)
T cd06634         163 SIMAPA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------------S-ALY  224 (308)
T ss_pred             eeecCc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH------------H-HHH
Confidence            765432     2345788999999975   356788999999999999999999998432110            0 001


Q ss_pred             hhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 047276          335 KMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE  389 (453)
Q Consensus       335 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~  389 (453)
                      ....+..     +..     ........+.+++.+||+.+|++||++.++++..-
T Consensus       225 ~~~~~~~-----~~~-----~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~  269 (308)
T cd06634         225 HIAQNES-----PAL-----QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  269 (308)
T ss_pred             HHhhcCC-----CCc-----CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence            1111111     100     11234456889999999999999999999986643

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.9e-36  Score=294.03  Aligned_cols=242  Identities=26%  Similarity=0.337  Sum_probs=198.9

Q ss_pred             HHhcccCcCCceEEEEEEe-CCCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          104 NFQALLGHGSSASVFKGIL-SDGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      .+.+.||+|.|++|..|+. .+|..||+|.+.++.   .....+.+|+++|..++|||||+++.+.. ....+++||||+
T Consensus        59 ~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~-t~~~lylV~eya  137 (596)
T KOG0586|consen   59 VIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIE-TEATLYLVMEYA  137 (596)
T ss_pred             eeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeee-ecceeEEEEEec
Confidence            3457899999999999995 468999999997643   22345889999999999999999999865 567899999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      .+|.+++|+.++.+          ........++.|+..|++|||+   +.|+|||||++|+||+.+.++||+|||++.+
T Consensus       138 ~~ge~~~yl~~~gr----------~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~  204 (596)
T KOG0586|consen  138 SGGELFDYLVKHGR----------MKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTF  204 (596)
T ss_pred             cCchhHHHHHhccc----------chhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeecccccee
Confidence            99999999987655          4556778889999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcCCC-CccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQGV-SEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      +...  ....+.+|++.|.|||.+.+..| .+++|+||+|+++|-|++|..||+..                        
T Consensus       205 ~~~~--~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~------------------------  258 (596)
T KOG0586|consen  205 FDYG--LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ------------------------  258 (596)
T ss_pred             eccc--ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc------------------------
Confidence            7633  33567899999999999998766 58999999999999999999999521                        


Q ss_pred             CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                       .+.++-++.+.....++.-...++-+++++.+-.+|.+|++++++.+
T Consensus       259 -~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  259 -NLKELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             -ccccccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence             12222222222222344445556889999999999999999999874

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.7e-35  Score=285.57  Aligned_cols=197  Identities=25%  Similarity=0.338  Sum_probs=160.8

Q ss_pred             HHhcccCcCCceEEEEEEeC-CCcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEecC-------CCe
Q 047276          104 NFQALLGHGSSASVFKGILS-DGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG-------GPR  172 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-------~~~  172 (453)
                      .+.++||+|+||.||++... +++.||||.+...   ......+.+|+.++++++|||+++++++|...+       ...
T Consensus        15 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~   94 (310)
T cd07865          15 EKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSF   94 (310)
T ss_pred             EEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceE
Confidence            34578999999999999964 6889999988642   222345678999999999999999999986443       235


Q ss_pred             EEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEe
Q 047276          173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVS  252 (453)
Q Consensus       173 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~  252 (453)
                      ++||||+.+ +|.+++....         ..+++...+.++.|++.||+|||+   .+++|+||||+||+++.++.+||+
T Consensus        95 ~lv~e~~~~-~l~~~l~~~~---------~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~  161 (310)
T cd07865          95 YLVFEFCEH-DLAGLLSNKN---------VKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLA  161 (310)
T ss_pred             EEEEcCCCc-CHHHHHHhcc---------cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEEC
Confidence            899999965 8888874321         238999999999999999999999   899999999999999999999999


Q ss_pred             eccccccccCCCC---ceeeeccCCccccchhhhhcC-CCCccccchhHHHHHHHHHcCCCCCcc
Q 047276          253 DFGLSKLMSRDQS---RCITTIRGTRGYLAPEWILEQ-GVSEKCDIYSYGMVLLELTGGRRNVSL  313 (453)
Q Consensus       253 DfGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvil~elltG~~p~~~  313 (453)
                      |||++........   .......++..|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~  226 (310)
T cd07865         162 DFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQG  226 (310)
T ss_pred             cCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCC
Confidence            9999986643221   122334578899999988654 478899999999999999999999854

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=7.8e-36  Score=293.01  Aligned_cols=267  Identities=20%  Similarity=0.290  Sum_probs=191.8

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEec---CCCeEEEEEe
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP---GGPRYLVYEF  178 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~---~~~~~lv~e~  178 (453)
                      .+.||+|+||.||+|.. .+|+.||+|++...   ......+.+|+.+++.++||||+++++++...   ....++|+||
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~   89 (334)
T cd07855          10 IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDL   89 (334)
T ss_pred             eeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEeh
Confidence            46899999999999995 46899999998753   23345678899999999999999999876532   2357999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +. |+|.+++...          ..+++.....++.|++.||+|||+   .+++||||||+||++++++.+||+|||++.
T Consensus        90 ~~-~~l~~~~~~~----------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~  155 (334)
T cd07855          90 ME-SDLHHIIHSD----------QPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMAR  155 (334)
T ss_pred             hh-hhHHHHhccC----------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccce
Confidence            95 6999988532          238999999999999999999999   899999999999999999999999999997


Q ss_pred             cccCCCC---ceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCc--ccccchhHHH
Q 047276          259 LMSRDQS---RCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSK--NKWQYFPKIV  332 (453)
Q Consensus       259 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~--~~~~~~~~~~  332 (453)
                      .......   .......++..|+|||.+.. ..++.++||||||+++|||++|+.||...........  ......+...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~  235 (334)
T cd07855         156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV  235 (334)
T ss_pred             eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence            6543221   11233468889999998865 4688999999999999999999999953221100000  0000000000


Q ss_pred             HHhhhcCcccccccccccCCCCC-----cHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          333 NEKMKEGKLMEIVDQRLTDEGGI-----DETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       333 ~~~~~~~~~~~~~d~~l~~~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      .+........+..+. .......     .+.....+.+++.+|++.+|++||++.+++..
T Consensus       236 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         236 LNRIGSDRVRKYIQN-LPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhhhchhhHHHHHhh-cccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            010111111111110 0000001     12235679999999999999999999998863

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-35  Score=288.24  Aligned_cols=248  Identities=25%  Similarity=0.381  Sum_probs=191.6

Q ss_pred             HHHhcccCcCCceEEEEEEeCCCcEEEEEEecC---CCccHHHHHHHHHHHHhcC-CCceeeEeeEEEecCCCeEEEEEe
Q 047276          103 DNFQALLGHGSSASVFKGILSDGTSVAVKRING---EENGEKEFRSEVAAIASAQ-HVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      |...++||+||.+.||++...+.+.+|+|++..   +.+...-|.+|+..|.+|+ |.+||.|++|-. .++.+|+||||
T Consensus       363 Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv-~d~~lYmvmE~  441 (677)
T KOG0596|consen  363 YEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV-TDGYLYMVMEC  441 (677)
T ss_pred             hhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec-cCceEEEEeec
Confidence            344578999999999999988888999998764   3444567999999999996 899999999855 56788999998


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      -+. +|..+|.+....        ..+| .+..+..|++.++.++|.   .+|||.||||.|.|+- .|.+||+|||+|.
T Consensus       442 Gd~-DL~kiL~k~~~~--------~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlV-kG~LKLIDFGIA~  507 (677)
T KOG0596|consen  442 GDI-DLNKILKKKKSI--------DPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLV-KGRLKLIDFGIAN  507 (677)
T ss_pred             ccc-cHHHHHHhccCC--------CchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEE-eeeEEeeeechhc
Confidence            754 999999765432        2445 677889999999999999   8999999999999984 5789999999999


Q ss_pred             cccCCCC-ceeeeccCCccccchhhhhcCC-----------CCccccchhHHHHHHHHHcCCCCCcccccCCCCCccccc
Q 047276          259 LMSRDQS-RCITTIRGTRGYLAPEWILEQG-----------VSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQ  326 (453)
Q Consensus       259 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-----------~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~  326 (453)
                      .+..+.. -.....+||+.||+||.+....           .+.+|||||+|||||+|+.|+.||...            
T Consensus       508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~------------  575 (677)
T KOG0596|consen  508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI------------  575 (677)
T ss_pred             ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH------------
Confidence            8876543 2334568999999999986322           567999999999999999999999521            


Q ss_pred             chhHHHHHhhhcCcccccccccccCCC-CCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          327 YFPKIVNEKMKEGKLMEIVDQRLTDEG-GIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                        ....      ..+..+.||.-.-+. ..+.  ..++++++..||+.||.+||+..++++.
T Consensus       576 --~n~~------aKl~aI~~P~~~Iefp~~~~--~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  576 --INQI------AKLHAITDPNHEIEFPDIPE--NDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             --HHHH------HHHHhhcCCCccccccCCCC--chHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence              1111      112333344211000 1111  1229999999999999999999998853

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-35  Score=276.42  Aligned_cols=245  Identities=21%  Similarity=0.301  Sum_probs=190.5

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCC------CccHHHHHHHHHHHHhcCCCceeeEeeEEEecC-CCeEEEE
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGE------ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG-GPRYLVY  176 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~~lv~  176 (453)
                      +.+.||+|+||.||+|.. .++..||+|.+...      ......+.+|+.++++++|+||+++++++.... ...++++
T Consensus         6 ~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~   85 (264)
T cd06653           6 LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFV   85 (264)
T ss_pred             eeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEE
Confidence            457899999999999995 46899999987532      122356889999999999999999999876433 3578999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||+++++|.+++...          ..+++....+++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||+
T Consensus        86 e~~~~~~L~~~~~~~----------~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~  152 (264)
T cd06653          86 EYMPGGSIKDQLKAY----------GALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGA  152 (264)
T ss_pred             EeCCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccc
Confidence            999999999998532          237888999999999999999998   8999999999999999999999999999


Q ss_pred             cccccCCC--CceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHH
Q 047276          257 SKLMSRDQ--SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNE  334 (453)
Q Consensus       257 a~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  334 (453)
                      ++......  ........++..|+|||++.+..++.++|+|||||++|||++|+.||......            .....
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------------~~~~~  220 (264)
T cd06653         153 SKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM------------AAIFK  220 (264)
T ss_pred             ccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH------------HHHHH
Confidence            98653211  11123356888999999998888999999999999999999999998532100            00111


Q ss_pred             hhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          335 KMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       335 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ....+ ..          ...+......+.+++.+|++ +|..||+..+++.
T Consensus       221 ~~~~~-~~----------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         221 IATQP-TK----------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             HHcCC-CC----------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            11000 00          11233455668999999999 5799999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=4.2e-35  Score=282.40  Aligned_cols=259  Identities=23%  Similarity=0.297  Sum_probs=187.3

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.+.||+|++|+||+|... +|+.||+|.+....   .....+.+|++++++++|+|++++++++. .+...++|+||++
T Consensus         6 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~   84 (294)
T PLN00009          6 KVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-SEKRLYLVFEYLD   84 (294)
T ss_pred             EEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe-cCCeEEEEEeccc
Confidence            3578999999999999964 68899999886432   23356889999999999999999999986 5668899999996


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECC-CCcEEEeecccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDE-NYRAVVSDFGLSKL  259 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~-~~~~kl~DfGla~~  259 (453)
                       ++|.+++....        ...+++.....++.|++.||+|||+   .+++|+||+|+||+++. ++.+||+|||++..
T Consensus        85 -~~l~~~~~~~~--------~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~  152 (294)
T PLN00009         85 -LDLKKHMDSSP--------DFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARA  152 (294)
T ss_pred             -ccHHHHHHhCC--------CCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccc
Confidence             58888874332        1226788888999999999999999   89999999999999985 56799999999976


Q ss_pred             ccCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCC----------Cccccc--
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDK----------SKNKWQ--  326 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~----------~~~~~~--  326 (453)
                      ..... .......+++.|+|||++.+ ..++.++||||||+++|+|+||+.||.........          ....|.  
T Consensus       153 ~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (294)
T PLN00009        153 FGIPV-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGV  231 (294)
T ss_pred             cCCCc-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccc
Confidence            53321 11223456889999998876 45789999999999999999999998532211000          000000  


Q ss_pred             -chhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          327 -YFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       327 -~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                       .++.+..      .........+.   ...+.....+.+++.+|++.+|++||++.++++
T Consensus       232 ~~~~~~~~------~~~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        232 TSLPDYKS------AFPKWPPKDLA---TVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             ccchhhhh------hcccCCCCCHH---HhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence             0000000      00000000000   011223455889999999999999999999885

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.3e-35  Score=288.12  Aligned_cols=264  Identities=22%  Similarity=0.270  Sum_probs=190.9

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEecC----CCeEEEEE
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG----GPRYLVYE  177 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~~lv~e  177 (453)
                      .+.||+|+||+||++.. .+|..||||.+...   ......+.+|+.+++.++|+|++++++++....    ...++++|
T Consensus        10 ~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e   89 (337)
T cd07858          10 IKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE   89 (337)
T ss_pred             EEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEe
Confidence            46899999999999995 46899999998642   233456778999999999999999999876432    24799999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |+. ++|.+++...          ..+++.....++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++
T Consensus        90 ~~~-~~L~~~~~~~----------~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~  155 (337)
T cd07858          90 LMD-TDLHQIIRSS----------QTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLA  155 (337)
T ss_pred             CCC-CCHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccc
Confidence            996 6898888533          238999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCc-cc-ccchhHHHHH
Q 047276          258 KLMSRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSK-NK-WQYFPKIVNE  334 (453)
Q Consensus       258 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~-~~-~~~~~~~~~~  334 (453)
                      ....... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||...+....... .. ....+.....
T Consensus       156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07858         156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG  234 (337)
T ss_pred             cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence            8654332 22233457889999998875 4689999999999999999999999953221000000 00 0000000000


Q ss_pred             hhhcCcccccc-------cccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          335 KMKEGKLMEIV-------DQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       335 ~~~~~~~~~~~-------d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      ....+...+.+       ++.+.   ...+.....+.+++.+|++.+|++|||+.++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         235 FIRNEKARRYIRSLPYTPRQSFA---RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hcCchhhhHHHHhcCcccccCHH---HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            00000000000       00000   0112345668999999999999999999999866

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=6.8e-35  Score=288.53  Aligned_cols=263  Identities=21%  Similarity=0.284  Sum_probs=189.7

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEecC-----CCeEEEE
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG-----GPRYLVY  176 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~~lv~  176 (453)
                      .+.||+|+||.||++.. .+|+.||+|.+...   ......+.+|+.++++++|+|++++++++....     ...++|+
T Consensus        21 ~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~  100 (353)
T cd07850          21 LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVM  100 (353)
T ss_pred             EEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEE
Confidence            47899999999999995 46899999998642   223456778999999999999999999875332     2468999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||+. ++|.+++..            .+++.....++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+
T Consensus       101 e~~~-~~l~~~~~~------------~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850         101 ELMD-ANLCQVIQM------------DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             eccC-CCHHHHHhh------------cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCcc
Confidence            9996 488887731            17888899999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCC---------CCcccc-c
Q 047276          257 SKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGND---------KSKNKW-Q  326 (453)
Q Consensus       257 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~---------~~~~~~-~  326 (453)
                      ++......  ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+....         .....+ .
T Consensus       165 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
T cd07850         165 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS  242 (353)
T ss_pred             ceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            98654322  12334578899999999998999999999999999999999999853321000         000000 0


Q ss_pred             chhHHHHHhhhcC------cccccccccccCC--CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          327 YFPKIVNEKMKEG------KLMEIVDQRLTDE--GGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       327 ~~~~~~~~~~~~~------~~~~~~d~~l~~~--~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      .+...........      .+.+.....+...  ..........+.+++.+|++.||++|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            0000000000000      0001111100000  0001133556889999999999999999999984

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-35  Score=282.80  Aligned_cols=263  Identities=22%  Similarity=0.274  Sum_probs=190.5

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCCc--cHHHHHHHHHHHHhcC-CCceeeEeeEEEecCCCeEEEEEecC
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEEN--GEKEFRSEVAAIASAQ-HVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.+.||+|+||+||+|+.. +++.|+||++.....  ......+|+..+.+++ |+|++++++++. .++..++||||+ 
T Consensus         3 ~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-~~~~~~lv~e~~-   80 (283)
T cd07830           3 VIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFR-ENDELYFVFEYM-   80 (283)
T ss_pred             eheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhh-cCCcEEEEEecC-
Confidence            4578999999999999975 478899999875332  2334567999999999 999999999986 467889999999 


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|.+++....        ...+++..+..++.|++.+|.|||+   .+++|+||+|+||++++++.++|+|||++...
T Consensus        81 ~~~l~~~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~  149 (283)
T cd07830          81 EGNLYQLMKDRK--------GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREI  149 (283)
T ss_pred             CCCHHHHHHhcc--------cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceec
Confidence            889999886442        1248999999999999999999999   89999999999999999999999999999865


Q ss_pred             cCCCCceeeeccCCccccchhhhh-cCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCc-cc-cc--chhHHHHHh
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSK-NK-WQ--YFPKIVNEK  335 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~-~~-~~--~~~~~~~~~  335 (453)
                      .....  .....++..|+|||.+. ...++.++|+||||+++|||++|+.||........... .. ..  ....+....
T Consensus       150 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (283)
T cd07830         150 RSRPP--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGY  227 (283)
T ss_pred             cCCCC--cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHh
Confidence            43221  12345788999999875 45578999999999999999999999853321100000 00 00  000000000


Q ss_pred             hhcCcccccccccccCCC-----CCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          336 MKEGKLMEIVDQRLTDEG-----GIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       336 ~~~~~~~~~~d~~l~~~~-----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      .    +...++..+....     .........+.+++.+|++.+|++||++.|++.
T Consensus       228 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         228 K----LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             h----hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            0    0000111110000     000111456899999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2e-35  Score=285.11  Aligned_cols=248  Identities=23%  Similarity=0.413  Sum_probs=187.2

Q ss_pred             HHhcccCcCCceEEEEEEeCC-CcEEEEEEecCCC--ccHHHHHHHHHHHHhcC-CCceeeEeeEEEecCCCeEEEEEec
Q 047276          104 NFQALLGHGSSASVFKGILSD-GTSVAVKRINGEE--NGEKEFRSEVAAIASAQ-HVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~~-g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      .+.+.||+|+||.||+|...+ ++.||||.++...  ....++..|+.++.+.. |+||++++++|. .+...+++|||+
T Consensus        18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-~~~~~~~v~e~~   96 (296)
T cd06618          18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI-TDSDVFICMELM   96 (296)
T ss_pred             eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee-cCCeEEEEeecc
Confidence            346899999999999999764 8999999987532  23355677887777765 999999999987 556889999998


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      . ++|.+++....         ..+++..+..++.|++.||+|||+.  .+++||||+|+||++++++.+||+|||++..
T Consensus        97 ~-~~l~~l~~~~~---------~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~  164 (296)
T cd06618          97 S-TCLDKLLKRIQ---------GPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGR  164 (296)
T ss_pred             C-cCHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchh
Confidence            5 47777764321         2489999999999999999999973  5899999999999999999999999999876


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcCC----CCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHh
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQG----VSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEK  335 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  335 (453)
                      ......  .....++..|+|||++....    ++.++||||||+++|||++|+.||......       .    ......
T Consensus       165 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~----~~~~~~  231 (296)
T cd06618         165 LVDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-------F----EVLTKI  231 (296)
T ss_pred             ccCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-------H----HHHHHH
Confidence            543222  12335778999999987543    788999999999999999999998532110       0    001111


Q ss_pred             hhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          336 MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       336 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      ... ..     +.+..    .......+.+++.+|++.+|++||++.++++.
T Consensus       232 ~~~-~~-----~~~~~----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         232 LQE-EP-----PSLPP----NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             hcC-CC-----CCCCC----CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            111 10     11110    11234468999999999999999999998854

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1e-35  Score=284.03  Aligned_cols=243  Identities=22%  Similarity=0.329  Sum_probs=193.8

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhcC-CCceeeEeeEEEecCCCeEEEEEe
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASAQ-HVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      +.+.||+|+||.||++... +|+.||+|++...    ....+.+..|..++.+++ |+||+++++++. .++..+++|||
T Consensus         5 ~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-~~~~~~lv~e~   83 (280)
T cd05581           5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQ-DEENLYFVLEY   83 (280)
T ss_pred             EeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhc-CCceEEEEEcC
Confidence            4578999999999999964 6899999998652    233456889999999998 999999999875 56688999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +++++|.+++....          .+++...+.++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++.
T Consensus        84 ~~~~~L~~~l~~~~----------~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~  150 (280)
T cd05581          84 APNGELLQYIRKYG----------SLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAK  150 (280)
T ss_pred             CCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCcccc
Confidence            99999999995432          49999999999999999999998   899999999999999999999999999988


Q ss_pred             cccCCCC-------------------ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCC
Q 047276          259 LMSRDQS-------------------RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGND  319 (453)
Q Consensus       259 ~~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~  319 (453)
                      .......                   .......++..|+|||......++.++||||||++++++++|+.||....    
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----  226 (280)
T cd05581         151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN----  226 (280)
T ss_pred             ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc----
Confidence            6643221                   12233457889999999988889999999999999999999999986322    


Q ss_pred             CCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCH----HHHHH
Q 047276          320 KSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSM----ARVVE  386 (453)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~----~~v~~  386 (453)
                          .+..    .... ...        .    ...+......+.+++.+|++.+|++||++    .++++
T Consensus       227 ----~~~~----~~~~-~~~--------~----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         227 ----EYLT----FQKI-LKL--------E----YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             ----HHHH----HHHH-Hhc--------C----CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence                0100    0111 000        0    11222335568999999999999999999    66653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-34  Score=278.12  Aligned_cols=260  Identities=22%  Similarity=0.284  Sum_probs=189.0

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCCc---cHHHHHHHHHHHHhc---CCCceeeEeeEEEecCC----CeE
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEEN---GEKEFRSEVAAIASA---QHVNLVRLLGYCVVPGG----PRY  173 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~~----~~~  173 (453)
                      +.+.||+|+||.||+|+.. +++.+|+|.++....   ....+.+|+.++.++   +|+|++++++++...+.    ..+
T Consensus         3 ~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~   82 (287)
T cd07838           3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLT   82 (287)
T ss_pred             EEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeE
Confidence            3568999999999999976 489999999974322   234566788777666   59999999999875432    278


Q ss_pred             EEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEee
Q 047276          174 LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSD  253 (453)
Q Consensus       174 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~D  253 (453)
                      ++|||+.+ +|.+++.....        ..+++..++.++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|
T Consensus        83 l~~e~~~~-~l~~~l~~~~~--------~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~d  150 (287)
T cd07838          83 LVFEHVDQ-DLATYLSKCPK--------PGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIAD  150 (287)
T ss_pred             EEehhccc-CHHHHHHHccC--------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEec
Confidence            99999974 89988854321        238999999999999999999999   8999999999999999999999999


Q ss_pred             ccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHH
Q 047276          254 FGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVN  333 (453)
Q Consensus       254 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  333 (453)
                      ||++........  .....++..|+|||.+.+..++.++|+||||+++|||++|+.||........        ......
T Consensus       151 fg~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--------~~~~~~  220 (287)
T cd07838         151 FGLARIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--------LDKIFD  220 (287)
T ss_pred             cCcceeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--------HHHHHH
Confidence            999977643321  1233478899999999988899999999999999999999998863221100        000000


Q ss_pred             HhhhcCcc---------cccccccccC-CCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          334 EKMKEGKL---------MEIVDQRLTD-EGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       334 ~~~~~~~~---------~~~~d~~l~~-~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      .....+..         .......... ......+....+.+++.+||+.+|++||++.+++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         221 VIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             HcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            00000000         0000000000 00112234567889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.4e-35  Score=285.22  Aligned_cols=268  Identities=18%  Similarity=0.191  Sum_probs=188.2

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecC-CCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG-GPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~~lv~e~~  179 (453)
                      +.+.||+|+||.||+|... +|+.||+|.++...   .....+.+|+.++.+++|+|++++++++.... +..++|+||+
T Consensus        11 ~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~   90 (309)
T cd07845          11 KLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYC   90 (309)
T ss_pred             EeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecC
Confidence            3578999999999999964 68999999986432   22335678999999999999999999876433 4579999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      .+ +|.+++....         ..+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+|||++..
T Consensus        91 ~~-~l~~~l~~~~---------~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~  157 (309)
T cd07845          91 EQ-DLASLLDNMP---------TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLART  157 (309)
T ss_pred             CC-CHHHHHHhcc---------cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeee
Confidence            65 8988885432         348999999999999999999999   8999999999999999999999999999987


Q ss_pred             ccCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCc-ccc-cchhHHHHHhh
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSK-NKW-QYFPKIVNEKM  336 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~-~~~-~~~~~~~~~~~  336 (453)
                      ...... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....+...... ... .......+...
T Consensus       158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07845         158 YGLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF  236 (309)
T ss_pred             cCCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence            643321 1222345778999998865 4578999999999999999999999853221100000 000 00000000000


Q ss_pred             hcCcccccc---cccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          337 KEGKLMEIV---DQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       337 ~~~~~~~~~---d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ........+   .................+.+++.+|++.||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            000000000   00000000000112456789999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-36  Score=268.47  Aligned_cols=246  Identities=24%  Similarity=0.382  Sum_probs=190.8

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCCC--ccHHHHHHHHHHHHhcC-CCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGEE--NGEKEFRSEVAAIASAQ-HVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      ...||.|..|.|++.+.. +|...|||.+....  ...+.++..+.++.+-+ .|.||+.+||+.. +...++.||.|..
T Consensus        97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~-n~dV~IcMelMs~  175 (391)
T KOG0983|consen   97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT-NTDVFICMELMST  175 (391)
T ss_pred             HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee-CchHHHHHHHHHH
Confidence            357999999999999964 58899999997643  33456777888877665 8999999999874 4577889999954


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                       .++.+|..-         .+++++...-++...+.+||.||.+.  ++|+|||+||+|||+|+.|++|++|||++..+.
T Consensus       176 -C~ekLlkri---------k~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlv  243 (391)
T KOG0983|consen  176 -CAEKLLKRI---------KGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLV  243 (391)
T ss_pred             -HHHHHHHHh---------cCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceee
Confidence             666666432         23488888899999999999999986  899999999999999999999999999998876


Q ss_pred             CCCCceeeeccCCccccchhhhhc---CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILE---QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      ++..+  +...|-+.|||||.+.-   .+|+.++||||||++++||.||+.||.....       ++..     ...+..
T Consensus       244 dSkAh--trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t-------dFe~-----ltkvln  309 (391)
T KOG0983|consen  244 DSKAH--TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT-------DFEV-----LTKVLN  309 (391)
T ss_pred             ccccc--ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc-------cHHH-----HHHHHh
Confidence            55432  45578899999999863   4788999999999999999999999953221       1111     111111


Q ss_pred             CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      .     ..|.|.....    .+..+.+++..||++|+.+||...++++.
T Consensus       310 ~-----ePP~L~~~~g----FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  310 E-----EPPLLPGHMG----FSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             c-----CCCCCCcccC----cCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            1     1134433222    44558999999999999999999998754

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=5.5e-35  Score=286.17  Aligned_cols=262  Identities=24%  Similarity=0.298  Sum_probs=189.8

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      .+.||+|+||.||++.. .+|+.||+|++...   ....+.+..|+.++..++|||++++++++...+...++++||+ +
T Consensus        15 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~   93 (328)
T cd07856          15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-G   93 (328)
T ss_pred             EEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-c
Confidence            47899999999999985 47899999987542   2334678899999999999999999998876666789999999 5


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      ++|.+++..           ..+++.....++.|+++||+|||+   .+++||||+|+||++++++.+||+|||++....
T Consensus        94 ~~L~~~~~~-----------~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~  159 (328)
T cd07856          94 TDLHRLLTS-----------RPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQD  159 (328)
T ss_pred             cCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence            689888742           237888888999999999999999   899999999999999999999999999987543


Q ss_pred             CCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCC-cccc-cchhHHHHHhhhc
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKS-KNKW-QYFPKIVNEKMKE  338 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~  338 (453)
                      ..    .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......... .... ...+..+.+....
T Consensus       160 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (328)
T cd07856         160 PQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS  235 (328)
T ss_pred             CC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence            21    123456788999998765 568999999999999999999999985322100000 0000 0000000011001


Q ss_pred             CcccccccccccCCCCCc-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          339 GKLMEIVDQRLTDEGGID-----ETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      +...+.+.. +......+     +.....+.+++.+|++.+|++||++.+++..
T Consensus       236 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         236 ENTLRFVQS-LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hhhHHHHhh-ccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            111111100 10000111     1224678999999999999999999998754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-35  Score=279.64  Aligned_cols=261  Identities=23%  Similarity=0.306  Sum_probs=193.6

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCCCc---cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGEEN---GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      .+.||+|++|.||++... +|+.+++|.+.....   ....+..|+.++++++|+|++++++++. .++..++++||+++
T Consensus         4 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~~v~e~~~~   82 (283)
T cd05118           4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR-HKGDLYLVFEFMDT   82 (283)
T ss_pred             ceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhc-cCCCEEEEEeccCC
Confidence            467999999999999964 688999999875332   3467889999999999999999999876 55788999999975


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                       +|.+++....         ..+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||.+....
T Consensus        83 -~l~~~l~~~~---------~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~  149 (283)
T cd05118          83 -DLYKLIKDRQ---------RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFG  149 (283)
T ss_pred             -CHHHHHHhhc---------ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecC
Confidence             8888875432         248999999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCceeeeccCCccccchhhhhcC-CCCccccchhHHHHHHHHHcCCCCCcccccCCC----------CCcccccchhH
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILEQ-GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGND----------KSKNKWQYFPK  330 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~----------~~~~~~~~~~~  330 (453)
                      ... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+....          .....|..+..
T Consensus       150 ~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd05118         150 SPV-RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS  228 (283)
T ss_pred             CCc-ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchh
Confidence            433 112234577889999998876 789999999999999999999999853221100          00000000000


Q ss_pred             HHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          331 IVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       331 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ....    . .....+...........+....+.+++..|++.+|.+||++.+++.
T Consensus       229 ~~~~----~-~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         229 LARN----Y-KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhh----h-hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            0000    0 0000000000000112345677999999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.6e-34  Score=281.04  Aligned_cols=240  Identities=23%  Similarity=0.316  Sum_probs=185.7

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCC----ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      .+.||+|+||+||+|+. .+|+.|++|.+....    .....+.+|+.+++.++|||++++++++. .+...++||||+.
T Consensus        26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~  104 (313)
T cd06633          26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL-KEHTAWLVMEYCL  104 (313)
T ss_pred             ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEE-eCCEEEEEEecCC
Confidence            35799999999999996 468899999986421    22346888999999999999999999986 4567899999996


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                       |+|.+++....         ..+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||++...
T Consensus       105 -~~l~~~l~~~~---------~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~  171 (313)
T cd06633         105 -GSASDLLEVHK---------KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKS  171 (313)
T ss_pred             -CCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCccc
Confidence             58877774322         248999999999999999999998   89999999999999999999999999998643


Q ss_pred             cCCCCceeeeccCCccccchhhhh---cCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhh
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWIL---EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMK  337 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (453)
                      ..     .....|+..|+|||++.   .+.++.++||||||+++|||++|..||...+...            ...... 
T Consensus       172 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~------------~~~~~~-  233 (313)
T cd06633         172 SP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------------ALYHIA-  233 (313)
T ss_pred             CC-----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH------------HHHHHH-
Confidence            22     12346788999999984   4568899999999999999999999985321100            011111 


Q ss_pred             cCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          338 EGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       338 ~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      ....     +..     ........+.+++.+|++.+|.+||++.+++..
T Consensus       234 ~~~~-----~~~-----~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         234 QNDS-----PTL-----QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             hcCC-----CCC-----CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1111     000     011223458899999999999999999998843

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.1e-35  Score=310.34  Aligned_cols=250  Identities=25%  Similarity=0.376  Sum_probs=180.1

Q ss_pred             HHHHh--cccCcCCceEEEEEEeC-CCcEEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEecC-------
Q 047276          102 TDNFQ--ALLGHGSSASVFKGILS-DGTSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG-------  169 (453)
Q Consensus       102 ~~~~~--~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-------  169 (453)
                      ...|+  ++||+||||.|||++.+ ||+.||||++...  ......+.+|+..+++|+|||||+++..+.+..       
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            34455  57999999999999964 8999999999764  333456889999999999999999875432100       


Q ss_pred             --------------------------------------------------------------------------------
Q 047276          170 --------------------------------------------------------------------------------  169 (453)
Q Consensus       170 --------------------------------------------------------------------------------  169 (453)
                                                                                                      
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             -------------------------------CCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHH
Q 047276          170 -------------------------------GPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK  218 (453)
Q Consensus       170 -------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~  218 (453)
                                                     ..+|+-||||+...|.+++..+...         -.-...|+++.+|++
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---------~~~d~~wrLFreIlE  708 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---------SQRDEAWRLFREILE  708 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---------hhhHHHHHHHHHHHH
Confidence                                           0113455666554455544322210         034567899999999


Q ss_pred             HhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc-----------------CCCCceeeeccCCccccchh
Q 047276          219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS-----------------RDQSRCITTIRGTRGYLAPE  281 (453)
Q Consensus       219 ~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~-----------------~~~~~~~~~~~gt~~y~aPE  281 (453)
                      ||+|+|+   .++|||||||.||++|++..+||+|||+|....                 .......+...||.-|+|||
T Consensus       709 GLaYIH~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPE  785 (1351)
T KOG1035|consen  709 GLAYIHD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPE  785 (1351)
T ss_pred             HHHHHHh---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHH
Confidence            9999999   899999999999999999999999999998721                 00111345678999999999


Q ss_pred             hhhcC---CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHH
Q 047276          282 WILEQ---GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDET  358 (453)
Q Consensus       282 ~~~~~---~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  358 (453)
                      .+.+.   .|+.|+|+||+||+++||+.-   |....            -.......++.+.+.+.        ..+..+
T Consensus       786 ll~~~~~~~Yn~KiDmYSLGIVlFEM~yP---F~TsM------------ERa~iL~~LR~g~iP~~--------~~f~~~  842 (1351)
T KOG1035|consen  786 LLSDTSSNKYNSKIDMYSLGIVLFEMLYP---FGTSM------------ERASILTNLRKGSIPEP--------ADFFDP  842 (1351)
T ss_pred             HhcccccccccchhhhHHHHHHHHHHhcc---CCchH------------HHHHHHHhcccCCCCCC--------cccccc
Confidence            99754   599999999999999999953   43110            01112233344443332        223334


Q ss_pred             HHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          359 QVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       359 ~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ....=..++.|++++||.+|||+.|+++
T Consensus       843 ~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  843 EHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             cchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            4455678999999999999999999873

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2e-34  Score=273.99  Aligned_cols=233  Identities=19%  Similarity=0.234  Sum_probs=178.9

Q ss_pred             cCcCCceEEEEEEe-CCCcEEEEEEecCCCccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEEEEEecCCCChhh
Q 047276          109 LGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDH  186 (453)
Q Consensus       109 lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL~~  186 (453)
                      ||+|+||.||++.. .++..+|+|.+........    |+.....+ +|||++++++++. ..+..++||||+++|+|.+
T Consensus        24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~-~~~~~~iv~e~~~~~~L~~   98 (267)
T PHA03390         24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVT-TLKGHVLIMDYIKDGDLFD   98 (267)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEe-cCCeeEEEEEcCCCCcHHH
Confidence            59999999999995 4678899999865322211    22222222 7999999999887 4568899999999999999


Q ss_pred             hhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCC-cEEEeeccccccccCCCC
Q 047276          187 WIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENY-RAVVSDFGLSKLMSRDQS  265 (453)
Q Consensus       187 ~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~-~~kl~DfGla~~~~~~~~  265 (453)
                      ++....          .+++..+..++.|+++||.|||+   .+++||||||+||+++.++ .++|+|||++......  
T Consensus        99 ~l~~~~----------~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--  163 (267)
T PHA03390         99 LLKKEG----------KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--  163 (267)
T ss_pred             HHHhcC----------CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--
Confidence            985432          48999999999999999999999   8999999999999999998 9999999998765432  


Q ss_pred             ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcccccc
Q 047276          266 RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIV  345 (453)
Q Consensus       266 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (453)
                         ....++..|+|||++.+..++.++||||||+++|||++|+.||....... ..      ... ..... .       
T Consensus       164 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~------~~~-~~~~~-~-------  224 (267)
T PHA03390        164 ---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LD------LES-LLKRQ-Q-------  224 (267)
T ss_pred             ---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hh------HHH-HHHhh-c-------
Confidence               22357889999999998889999999999999999999999996322111 00      000 00100 0       


Q ss_pred             cccccCCCCCcHHHHHHHHHHHHhccccCCCCCCC-HHHHH
Q 047276          346 DQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPS-MARVV  385 (453)
Q Consensus       346 d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-~~~v~  385 (453)
                       ..    ..........+.+++.+|++.+|.+||+ +++++
T Consensus       225 -~~----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l  260 (267)
T PHA03390        225 -KK----LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEII  260 (267)
T ss_pred             -cc----CCcccccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence             00    1112234456899999999999999996 58876

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.9e-35  Score=289.04  Aligned_cols=257  Identities=20%  Similarity=0.208  Sum_probs=187.5

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCCCcc---------------HHHHHHHHHHHHhcCCCceeeEeeEEEecC
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGEENG---------------EKEFRSEVAAIASAQHVNLVRLLGYCVVPG  169 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~~---------------~~~~~~E~~~l~~l~h~niv~l~g~~~~~~  169 (453)
                      .+.||+|+||+||+|... +++.||||.+......               ...+.+|+++++.++|+|++++++++. .+
T Consensus        14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~   92 (335)
T PTZ00024         14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYV-EG   92 (335)
T ss_pred             hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEe-cC
Confidence            467999999999999954 6899999988643211               124778999999999999999999976 56


Q ss_pred             CCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcE
Q 047276          170 GPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRA  249 (453)
Q Consensus       170 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~  249 (453)
                      +..+++|||+. |+|.+++...          ..+++.....++.|++.||+|||+   .+++|+||+|+||+++.++.+
T Consensus        93 ~~~~lv~e~~~-~~l~~~l~~~----------~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~  158 (335)
T PTZ00024         93 DFINLVMDIMA-SDLKKVVDRK----------IRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGIC  158 (335)
T ss_pred             CcEEEEEeccc-cCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCE
Confidence            68899999996 6999988532          238899999999999999999999   899999999999999999999


Q ss_pred             EEeeccccccccCCC-------------CceeeeccCCccccchhhhhcC-CCCccccchhHHHHHHHHHcCCCCCcccc
Q 047276          250 VVSDFGLSKLMSRDQ-------------SRCITTIRGTRGYLAPEWILEQ-GVSEKCDIYSYGMVLLELTGGRRNVSLIE  315 (453)
Q Consensus       250 kl~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvil~elltG~~p~~~~~  315 (453)
                      ||+|||++.......             ........++..|+|||.+.+. .++.++||||||+++|||++|+.||....
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~  238 (335)
T PTZ00024        159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN  238 (335)
T ss_pred             EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999997654111             1111223467889999998764 46899999999999999999999986332


Q ss_pred             cCCCCCcccccchhHHHHHhhhcCc---cc--------ccccccccCC-CCCcHHHHHHHHHHHHhccccCCCCCCCHHH
Q 047276          316 HGNDKSKNKWQYFPKIVNEKMKEGK---LM--------EIVDQRLTDE-GGIDETQVRRLVDVAFWCIQERARLRPSMAR  383 (453)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~--------~~~d~~l~~~-~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~  383 (453)
                      +...     .    ...........   ..        .......... ..........+.+++..|++.+|++||++++
T Consensus       239 ~~~~-----~----~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~  309 (335)
T PTZ00024        239 EIDQ-----L----GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKE  309 (335)
T ss_pred             HHHH-----H----HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHH
Confidence            1100     0    00000000000   00        0000000000 0001122456889999999999999999999


Q ss_pred             HHH
Q 047276          384 VVE  386 (453)
Q Consensus       384 v~~  386 (453)
                      ++.
T Consensus       310 ~l~  312 (335)
T PTZ00024        310 ALK  312 (335)
T ss_pred             Hhc
Confidence            985

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=7.1e-35  Score=275.58  Aligned_cols=247  Identities=25%  Similarity=0.352  Sum_probs=189.3

Q ss_pred             HHhcccCcCCceEEEEEEeCC-CcEEEEEEecC------CCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEE
Q 047276          104 NFQALLGHGSSASVFKGILSD-GTSVAVKRING------EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVY  176 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~~-g~~vavK~~~~------~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~  176 (453)
                      .+.+.||+|+||.||++.... +..+++|.++.      ......++..|+.+++.++|||++++++++. .....++|+
T Consensus         3 ~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~   81 (260)
T cd08222           3 ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL-ERDAFCIIT   81 (260)
T ss_pred             eeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHh-cCCceEEEE
Confidence            346789999999999998643 44566666543      1223345778999999999999999999876 456789999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||+++++|.+++.....      ....+++..++.++.|++.||.|||+   .+++|+||+|+||++++ +.+||+|||+
T Consensus        82 e~~~~~~l~~~~~~~~~------~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~  151 (260)
T cd08222          82 EYCEGRDLDCKLEELKH------TGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGV  151 (260)
T ss_pred             EeCCCCCHHHHHHHHhh------cccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCc
Confidence            99999999998864322      22348999999999999999999999   89999999999999976 5699999999


Q ss_pred             cccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhh
Q 047276          257 SKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKM  336 (453)
Q Consensus       257 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (453)
                      +........ ......+++.|+|||...+..++.++|+||||+++|+|++|..||....            ..... ...
T Consensus       152 ~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------------~~~~~-~~~  217 (260)
T cd08222         152 SRLLMGSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------------FLSVV-LRI  217 (260)
T ss_pred             eeecCCCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------------HHHHH-HHH
Confidence            876643322 2234567889999999988888999999999999999999999984211            00001 111


Q ss_pred             hcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          337 KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       337 ~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ..+..           ...+......+.+++.+|++.+|++||++.++++
T Consensus       218 ~~~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         218 VEGPT-----------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             HcCCC-----------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            11110           1123345567899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-35  Score=273.62  Aligned_cols=235  Identities=26%  Similarity=0.316  Sum_probs=189.1

Q ss_pred             cCcCCceEEEEEEeC-CCcEEEEEEecCCC----ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCC
Q 047276          109 LGHGSSASVFKGILS-DGTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS  183 (453)
Q Consensus       109 lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gs  183 (453)
                      ||+|+||.||++... +++.+++|.+....    .....+..|+.++++++|+|++++++.+. .++..+++|||+++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~~v~e~~~~~~   79 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQ-TEEKLYLVLEYAPGGE   79 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHee-cCCeeEEEEecCCCCc
Confidence            799999999999965 58899999987532    23457899999999999999999999875 5668899999999999


Q ss_pred             hhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCC
Q 047276          184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD  263 (453)
Q Consensus       184 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~  263 (453)
                      |.+++....          .+++.....++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++......
T Consensus        80 L~~~l~~~~----------~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~  146 (250)
T cd05123          80 LFSHLSKEG----------RFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSE  146 (250)
T ss_pred             HHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccC
Confidence            999985332          38999999999999999999999   89999999999999999999999999999876443


Q ss_pred             CCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcccc
Q 047276          264 QSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLME  343 (453)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (453)
                      . .......++..|++||...+...+.++|+||||+++||+++|+.||...+.            ...... ...+    
T Consensus       147 ~-~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------------~~~~~~-~~~~----  208 (250)
T cd05123         147 G-SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------------KEIYEK-ILKD----  208 (250)
T ss_pred             C-CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------------HHHHHH-HhcC----
Confidence            2 123445678899999999888889999999999999999999999853211            000111 1111    


Q ss_pred             cccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHH
Q 047276          344 IVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMAR  383 (453)
Q Consensus       344 ~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~  383 (453)
                          .    ...+......+.+++.+|+..+|++||++.+
T Consensus       209 ----~----~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         209 ----P----LRFPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             ----C----CCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence                0    1122223456889999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=5e-35  Score=283.79  Aligned_cols=266  Identities=20%  Similarity=0.207  Sum_probs=186.2

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCC-------CeE
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGG-------PRY  173 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-------~~~  173 (453)
                      +.++||+|+||.||+|... +++.+|+|++....   .....+.+|+++++.++||||+++++++.....       ..+
T Consensus        12 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~   91 (311)
T cd07866          12 ILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVY   91 (311)
T ss_pred             EEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEE
Confidence            3578999999999999964 68899999886422   223457789999999999999999998754332       368


Q ss_pred             EEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEee
Q 047276          174 LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSD  253 (453)
Q Consensus       174 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~D  253 (453)
                      +|+||+.+ +|...+....         ..+++..+..++.|+++||+|||+   .+++|+||||+||++++++.+||+|
T Consensus        92 lv~~~~~~-~l~~~~~~~~---------~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~d  158 (311)
T cd07866          92 MVTPYMDH-DLSGLLENPS---------VKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIAD  158 (311)
T ss_pred             EEEecCCc-CHHHHHhccc---------cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECc
Confidence            99999965 7777764321         248999999999999999999999   8999999999999999999999999


Q ss_pred             ccccccccCCCCc----------eeeeccCCccccchhhhhcC-CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCc
Q 047276          254 FGLSKLMSRDQSR----------CITTIRGTRGYLAPEWILEQ-GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSK  322 (453)
Q Consensus       254 fGla~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~  322 (453)
                      ||++.........          ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||...........
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~  238 (311)
T cd07866         159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL  238 (311)
T ss_pred             CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999865432211          11233567889999987654 578999999999999999999999853221100000


Q ss_pred             --ccccchhHHHHHhhhcCc------ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          323 --NKWQYFPKIVNEKMKEGK------LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       323 --~~~~~~~~~~~~~~~~~~------~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                        ..+.......+..+....      ......+.+..   ........+.+++.+|++.+|++|||+.+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE---RFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHhCCCChhhchhhhhcccccccccCCCCCccHHH---HcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence              000000000000000000      00000000000   00112256889999999999999999999874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-35  Score=294.47  Aligned_cols=196  Identities=27%  Similarity=0.388  Sum_probs=167.0

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEec-----CCCeEEEEE
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP-----GGPRYLVYE  177 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~~lv~e  177 (453)
                      .+.||+|+||.||+|+. .+|+.||||.++..  ....+...+|+++|++++|+|||+++|.=.+.     .....+|||
T Consensus        18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE   97 (732)
T KOG4250|consen   18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME   97 (732)
T ss_pred             hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence            46899999999999994 67999999999863  33456688999999999999999999863211     124589999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEEC--CCC--cEEEee
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD--ENY--RAVVSD  253 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~--~~~--~~kl~D  253 (453)
                      ||++|||...|....+       ...|++...+.++.+++.||.|||+   ++|+||||||.||++-  .+|  .-||+|
T Consensus        98 yC~gGsL~~~L~~PEN-------~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtD  167 (732)
T KOG4250|consen   98 YCSGGSLRKVLNSPEN-------AYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTD  167 (732)
T ss_pred             ecCCCcHHHHhcCccc-------ccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeec
Confidence            9999999999965443       2339999999999999999999998   8999999999999994  333  469999


Q ss_pred             ccccccccCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcc
Q 047276          254 FGLSKLMSRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSL  313 (453)
Q Consensus       254 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~  313 (453)
                      ||.|+.++.+.  ......||..|++||.... +.|+..+|.|||||++||.+||..||..
T Consensus       168 fG~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p  226 (732)
T KOG4250|consen  168 FGAARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP  226 (732)
T ss_pred             ccccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence            99999876554  5677899999999999984 8899999999999999999999999953

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.7e-35  Score=286.25  Aligned_cols=268  Identities=22%  Similarity=0.273  Sum_probs=194.7

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEecC----CCeEEEE
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG----GPRYLVY  176 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~~lv~  176 (453)
                      +.+.||+|+||.||+|+.. +|+.+|+|++...   ....+.+.+|+.+++.++|+||+++.+++....    ...+++|
T Consensus         4 i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~   83 (330)
T cd07834           4 LLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVT   83 (330)
T ss_pred             eeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEe
Confidence            4578999999999999965 4889999998753   334467899999999999999999999876543    3679999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||+++ +|.+++...          ..+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||+
T Consensus        84 e~~~~-~l~~~l~~~----------~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~  149 (330)
T cd07834          84 ELMET-DLHKVIKSP----------QPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGL  149 (330)
T ss_pred             cchhh-hHHHHHhCC----------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCc
Confidence            99974 898888533          248999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCC--ceeeeccCCccccchhhhhcC-CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCc-cc-ccchhHH
Q 047276          257 SKLMSRDQS--RCITTIRGTRGYLAPEWILEQ-GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSK-NK-WQYFPKI  331 (453)
Q Consensus       257 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~-~~-~~~~~~~  331 (453)
                      +........  .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||........... .. ....+..
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  229 (330)
T cd07834         150 ARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEE  229 (330)
T ss_pred             eEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChh
Confidence            987654321  122334578899999999877 789999999999999999999999954321100000 00 0000000


Q ss_pred             HHHhhhcCcccccccccccCC-----CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          332 VNEKMKEGKLMEIVDQRLTDE-----GGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       332 ~~~~~~~~~~~~~~d~~l~~~-----~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      ...........+.+.. ....     .....+....+.+++.+||+.+|++||++.++++.
T Consensus       230 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         230 DLKFITSEKARNYLKS-LPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             HhhhccccchhhHHhh-cccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            0000000000000000 0000     00111234568999999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.1e-35  Score=287.71  Aligned_cols=261  Identities=23%  Similarity=0.280  Sum_probs=186.9

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCCc---cHHHHHHHHHHHHhcCCCceeeEeeEEEecCC-----CeEEEE
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEEN---GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGG-----PRYLVY  176 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-----~~~lv~  176 (453)
                      .+.||+|+||.||++.. .+|..||||++.....   ....+.+|+.+++.++||||+++++++.....     ..++|+
T Consensus        20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~   99 (343)
T cd07880          20 LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVM   99 (343)
T ss_pred             EEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEE
Confidence            46899999999999984 5789999999864322   23468899999999999999999998764332     358999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||+ +++|.+++..           ..+++..+..++.|+++||+|||+   .+++||||||+||+++.++.+||+|||+
T Consensus       100 e~~-~~~l~~~~~~-----------~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880         100 PFM-GTDLGKLMKH-----------EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             ecC-CCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence            999 6799888742           238999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCc-cc-ccchhHHHH
Q 047276          257 SKLMSRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSK-NK-WQYFPKIVN  333 (453)
Q Consensus       257 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~-~~-~~~~~~~~~  333 (453)
                      +......    .....+++.|+|||.+.+ ..++.++|+||||+++|++++|+.||........... .. ....+....
T Consensus       165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  240 (343)
T cd07880         165 ARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV  240 (343)
T ss_pred             ccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            8765322    123457889999999876 4588999999999999999999999963221100000 00 000000001


Q ss_pred             HhhhcCccccccc--ccccCC--CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 047276          334 EKMKEGKLMEIVD--QRLTDE--GGIDETQVRRLVDVAFWCIQERARLRPSMARVV  385 (453)
Q Consensus       334 ~~~~~~~~~~~~d--~~l~~~--~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~  385 (453)
                      ..+..........  +.....  ..........+.+++.+|++.+|++|||+.+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l  296 (343)
T cd07880         241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL  296 (343)
T ss_pred             HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence            1111000000000  000000  001112344588999999999999999999998

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.5e-35  Score=288.57  Aligned_cols=266  Identities=22%  Similarity=0.272  Sum_probs=186.9

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEecC-----CCeEEEE
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG-----GPRYLVY  176 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~~lv~  176 (453)
                      .+.||+|+||.||+|.. .+|+.||+|++...   ......+.+|+.+++.++||||+++++++....     ...++|+
T Consensus        20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~   99 (342)
T cd07879          20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM   99 (342)
T ss_pred             EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEe
Confidence            36899999999999995 46899999998642   222356889999999999999999999876432     2458999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||+.. +|..++.            ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+
T Consensus       100 e~~~~-~l~~~~~------------~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879         100 PYMQT-DLQKIMG------------HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             ccccc-CHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence            99964 7776651            138899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccc--cchhHHHH
Q 047276          257 SKLMSRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKW--QYFPKIVN  333 (453)
Q Consensus       257 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~--~~~~~~~~  333 (453)
                      ++.....    .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..............  ........
T Consensus       164 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (342)
T cd07879         164 ARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV  239 (342)
T ss_pred             CcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            8754322    123456788999999876 4688999999999999999999999963221000000000  00000000


Q ss_pred             HhhhcCccccccc--cccc-CC-CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--hccc
Q 047276          334 EKMKEGKLMEIVD--QRLT-DE-GGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM--LEGR  391 (453)
Q Consensus       334 ~~~~~~~~~~~~d--~~l~-~~-~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~--L~~~  391 (453)
                      +.+.........+  +... .. ....+.....+.+++.+|++.+|++||++.+++..  ++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~  303 (342)
T cd07879         240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF  303 (342)
T ss_pred             HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence            0000000000000  0000 00 00001223458899999999999999999999843  5443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-36  Score=291.41  Aligned_cols=245  Identities=26%  Similarity=0.370  Sum_probs=191.1

Q ss_pred             hcccCcCCceEEEEEEeCC-CcEEEEEEecC-CCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCC
Q 047276          106 QALLGHGSSASVFKGILSD-GTSVAVKRING-EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS  183 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~~-g~~vavK~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gs  183 (453)
                      .-.||.|+||.||++..++ +-..|.|++.. .....+.|+-|++||+.+.||+||+|++.|+ ..+.++++.|||.||.
T Consensus        37 iGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy-~enkLwiliEFC~GGA  115 (1187)
T KOG0579|consen   37 IGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYY-FENKLWILIEFCGGGA  115 (1187)
T ss_pred             HhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHh-ccCceEEEEeecCCch
Confidence            3468999999999999765 33456677765 3344567999999999999999999999776 4568899999999999


Q ss_pred             hhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCC
Q 047276          184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD  263 (453)
Q Consensus       184 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~  263 (453)
                      .+..+..-         +..|.+.++.-++.|++.||.|||+   .+|||||||+.|||++-+|.++|+|||.+......
T Consensus       116 VDaimlEL---------~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t  183 (1187)
T KOG0579|consen  116 VDAIMLEL---------GRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST  183 (1187)
T ss_pred             HhHHHHHh---------ccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchhH
Confidence            98877432         2348999999999999999999999   89999999999999999999999999987543221


Q ss_pred             CCceeeeccCCccccchhhhh-----cCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          264 QSRCITTIRGTRGYLAPEWIL-----EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                       ......+.|||.|||||+..     ...|+.++||||||++|.||..+.+|-+...             |..+.-.+..
T Consensus       184 -~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln-------------pMRVllKiaK  249 (1187)
T KOG0579|consen  184 -RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN-------------PMRVLLKIAK  249 (1187)
T ss_pred             -HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc-------------hHHHHHHHhh
Confidence             12345678999999999876     4578999999999999999999998864221             1111111222


Q ss_pred             CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ....     .|.    -|......+.+++..||.+||..||+.+++++
T Consensus       250 SePP-----TLl----qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  250 SEPP-----TLL----QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             cCCC-----ccc----CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            1111     111    12234556889999999999999999999884

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-34  Score=283.84  Aligned_cols=273  Identities=22%  Similarity=0.274  Sum_probs=190.4

Q ss_pred             HHHHHHHHHHh--cccCcCCceEEEEEEe-CCCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecC
Q 047276           96 KELEEATDNFQ--ALLGHGSSASVFKGIL-SDGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG  169 (453)
Q Consensus        96 ~el~~~~~~~~--~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~  169 (453)
                      .++...+.+|.  +.||+|+||.||+|.. .+|+.||+|++....   ...+.+.+|+.++.+++||||+++++++....
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            34444445553  6899999999999985 568899999987532   22456888999999999999999999875322


Q ss_pred             -----CCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEEC
Q 047276          170 -----GPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD  244 (453)
Q Consensus       170 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~  244 (453)
                           ...+++++++ +++|.+++..           ..+++..+..++.|+++||+|||+   .+++||||||+||+++
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~  154 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVKC-----------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVN  154 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEc
Confidence                 2457888876 7799888742           238999999999999999999999   8999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcc
Q 047276          245 ENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKN  323 (453)
Q Consensus       245 ~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~  323 (453)
                      +++.+||+|||++......    .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||............
T Consensus       155 ~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~  230 (345)
T cd07877         155 EDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI  230 (345)
T ss_pred             CCCCEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            9999999999998754322    233467889999998866 56889999999999999999999998532111000000


Q ss_pred             -cc-cchhHHHHHhhhcCccccc---ccccccCC-CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          324 -KW-QYFPKIVNEKMKEGKLMEI---VDQRLTDE-GGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       324 -~~-~~~~~~~~~~~~~~~~~~~---~d~~l~~~-~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                       .. ...+......+........   .+...... ..........+.+++.+|++.+|.+||++.+++..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence             00 0000000000000000000   00000000 00000124458899999999999999999998854

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-36  Score=316.72  Aligned_cols=244  Identities=27%  Similarity=0.424  Sum_probs=194.2

Q ss_pred             cccCcCCceEEEEEE-eCCCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCC
Q 047276          107 ALLGHGSSASVFKGI-LSDGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~-~~~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      .+||.|.||.||-|. ..+|...|+|-++...   ...+...+|..++..++|||+|+.+|+= .+.+..++.||||++|
T Consensus      1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVE-vHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVE-VHREKVYIFMEYCEGG 1319 (1509)
T ss_pred             cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCcee-ecHHHHHHHHHHhccC
Confidence            589999999999999 5678889999776432   2335678899999999999999999984 4667889999999999


Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccC
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR  262 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~  262 (453)
                      +|.+.+...          +..++.....+..|++.|++|||+   .+||||||||.||+|+.+|.+|++|||.|.....
T Consensus      1320 sLa~ll~~g----------ri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1320 SLASLLEHG----------RIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             cHHHHHHhc----------chhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecC
Confidence            999998432          225666666788999999999999   8999999999999999999999999999988765


Q ss_pred             CCC---ceeeeccCCccccchhhhhcC---CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhh
Q 047276          263 DQS---RCITTIRGTRGYLAPEWILEQ---GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKM  336 (453)
Q Consensus       263 ~~~---~~~~~~~gt~~y~aPE~~~~~---~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (453)
                      +..   .......||+-|||||.+.+.   ....+.||||+||+++||+||++||...+       .+|+..     -.+
T Consensus      1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d-------ne~aIM-----y~V 1454 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD-------NEWAIM-----YHV 1454 (1509)
T ss_pred             chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc-------chhHHH-----hHH
Confidence            431   223456899999999999853   35678999999999999999999996332       223211     112


Q ss_pred             hcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          337 KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       337 ~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      ..|.           ..++|+....+-.+++.+|++.||++|.++.|+++.
T Consensus      1455 ~~gh-----------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1455 AAGH-----------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             hccC-----------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            2222           123556677778899999999999999888876644

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=273.94  Aligned_cols=250  Identities=24%  Similarity=0.359  Sum_probs=193.8

Q ss_pred             hcccCcCCceEEEEEE-eCCCcEEEEEEecCCCccH--------HHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEE
Q 047276          106 QALLGHGSSASVFKGI-LSDGTSVAVKRINGEENGE--------KEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVY  176 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~-~~~g~~vavK~~~~~~~~~--------~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~  176 (453)
                      -++||+|||+.||++. +...+.||||+-.....+.        +...+|..+-+.|.||.||++++|+..+.+.+|-|+
T Consensus       468 LhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVL  547 (775)
T KOG1151|consen  468 LHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVL  547 (775)
T ss_pred             HHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeee
Confidence            3689999999999998 4567889999864332221        335678999999999999999999988888999999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEEC---CCCcEEEee
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD---ENYRAVVSD  253 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~---~~~~~kl~D  253 (453)
                      |||++-+|+-||..++.          +++.....|+.||+.||.||.+. .++|||-||||.|||+-   .-|.+||+|
T Consensus       548 EYceGNDLDFYLKQhkl----------mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD  616 (775)
T KOG1151|consen  548 EYCEGNDLDFYLKQHKL----------MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD  616 (775)
T ss_pred             eecCCCchhHHHHhhhh----------hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence            99999999999975543          89999999999999999999874 58999999999999995   457899999


Q ss_pred             ccccccccCCCCc------eeeeccCCccccchhhhhcC----CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcc
Q 047276          254 FGLSKLMSRDQSR------CITTIRGTRGYLAPEWILEQ----GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKN  323 (453)
Q Consensus       254 fGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~  323 (453)
                      ||+++.+.++...      .+....||.+|++||++.-+    +++.|.||||.|||+|..+.|+.||.......     
T Consensus       617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ-----  691 (775)
T KOG1151|consen  617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ-----  691 (775)
T ss_pred             cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH-----
Confidence            9999998765433      23456899999999998743    57899999999999999999999995322111     


Q ss_pred             cccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 047276          324 KWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVV  385 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~  385 (453)
                                ..+.+..+...-.-.++    ..+....+...++.+||+..-++|-..-++.
T Consensus       692 ----------dILqeNTIlkAtEVqFP----~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  692 ----------DILQENTILKATEVQFP----PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             ----------HHHhhhchhcceeccCC----CCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence                      11112222111111111    1223345577899999999999998766543

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-34  Score=276.20  Aligned_cols=266  Identities=23%  Similarity=0.252  Sum_probs=191.6

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      .+.||+|+||.||+|+.. +++.+|+|.+...   ....+.+..|+.++++++|+|++++++++. ..+..++|+||++ 
T Consensus         4 ~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~~~v~e~~~-   81 (282)
T cd07829           4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH-TERKLYLVFEYCD-   81 (282)
T ss_pred             ehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh-cCCceEEEecCcC-
Confidence            467999999999999965 5899999998763   333467888999999999999999999876 4568899999997 


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      ++|.+++....         ..+++..+.+++.|++.||+|||+   .+++|+||+|+||++++++.+||+|||++....
T Consensus        82 ~~l~~~i~~~~---------~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~  149 (282)
T cd07829          82 MDLKKYLDKRP---------GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFG  149 (282)
T ss_pred             cCHHHHHHhhc---------cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccC
Confidence            59999996432         238999999999999999999999   899999999999999999999999999998664


Q ss_pred             CCCCceeeeccCCccccchhhhhcC-CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcc--cccchhHHHHHhhhc
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILEQ-GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKN--KWQYFPKIVNEKMKE  338 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  338 (453)
                      .... ......++..|+|||.+... .++.++||||||+++|||++|+.||............  .........+..+..
T Consensus       150 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07829         150 IPLR-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK  228 (282)
T ss_pred             CCcc-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcc
Confidence            3321 12233456789999998766 7899999999999999999999998532211000000  000000000000000


Q ss_pred             C-cccccccccccCC-CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          339 G-KLMEIVDQRLTDE-GGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       339 ~-~~~~~~d~~l~~~-~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      - ............. ....+.....+.+++..|++.+|++||++.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            0 0000000000000 0001122456999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2e-34  Score=283.88  Aligned_cols=262  Identities=20%  Similarity=0.266  Sum_probs=185.4

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCC-CccHHHHHHHHHHHHhcCCCceeeEeeEEEecC-------------
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGE-ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG-------------  169 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-------------  169 (453)
                      +.+.||+|+||.||+|.. .+|..||+|.+... ....+.+.+|++++++++||||+++++++...+             
T Consensus         9 ~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~   88 (342)
T cd07854           9 DLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTEL   88 (342)
T ss_pred             EEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccccccc
Confidence            357899999999999996 46889999998653 334567889999999999999999998765332             


Q ss_pred             CCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEEC-CCCc
Q 047276          170 GPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD-ENYR  248 (453)
Q Consensus       170 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~-~~~~  248 (453)
                      ...++|+||++ ++|.+++..           ..+++.....++.|++.||.|||+   .+++||||||+||+++ +++.
T Consensus        89 ~~~~lv~e~~~-~~L~~~~~~-----------~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~  153 (342)
T cd07854          89 NSVYIVQEYME-TDLANVLEQ-----------GPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLV  153 (342)
T ss_pred             ceEEEEeeccc-ccHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCce
Confidence            24689999997 599888732           238899999999999999999998   8999999999999997 5668


Q ss_pred             EEEeeccccccccCCCCc--eeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCC----
Q 047276          249 AVVSDFGLSKLMSRDQSR--CITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKS----  321 (453)
Q Consensus       249 ~kl~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~----  321 (453)
                      +||+|||++.........  ......++..|+|||.+.. ..++.++|||||||++|||++|+.||....+.....    
T Consensus       154 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~  233 (342)
T cd07854         154 LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE  233 (342)
T ss_pred             EEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            899999999765332111  1122357889999998764 467889999999999999999999995332110000    


Q ss_pred             ------cccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          322 ------KNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       322 ------~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                            ...+..+...........    ...+... ...........+.+++.+|++.+|++|||+.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         234 SVPVVREEDRNELLNVIPSFVRND----GGEPRRP-LRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             hcCCCChHHhhhhhhhhhhhhhhc----ccccCCC-HHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence                  000000000000000000    0000000 00001123456889999999999999999999983

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=5.3e-34  Score=279.78  Aligned_cols=267  Identities=21%  Similarity=0.226  Sum_probs=186.0

Q ss_pred             HhcccCcCCceEEEEEEeC-C--CcEEEEEEecCC---CccHHHHHHHHHHHHhc-CCCceeeEeeEEEec---CCCeEE
Q 047276          105 FQALLGHGSSASVFKGILS-D--GTSVAVKRINGE---ENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVP---GGPRYL  174 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~--g~~vavK~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~---~~~~~l  174 (453)
                      +.+.||+|+||.||++... +  +..||+|.+...   ....+.+.+|+.++.++ +||||+++++++...   ....++
T Consensus         4 ~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~   83 (332)
T cd07857           4 LIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYL   83 (332)
T ss_pred             EEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEE
Confidence            4578999999999999964 3  678999988642   22345688899999999 599999999875432   234678


Q ss_pred             EEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeec
Q 047276          175 VYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDF  254 (453)
Q Consensus       175 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~Df  254 (453)
                      ++||+. ++|.+++...          ..+++..+..++.|++.||+|||+   .+++||||||+||++++++.+||+||
T Consensus        84 ~~e~~~-~~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Df  149 (332)
T cd07857          84 YEELME-ADLHQIIRSG----------QPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDF  149 (332)
T ss_pred             EEeccc-CCHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcC
Confidence            888886 5999988533          238999999999999999999999   89999999999999999999999999


Q ss_pred             cccccccCCCC---ceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCc-ccc-cch
Q 047276          255 GLSKLMSRDQS---RCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSK-NKW-QYF  328 (453)
Q Consensus       255 Gla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~-~~~-~~~  328 (453)
                      |++........   .......|++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||........... ... ...
T Consensus       150 g~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  229 (332)
T cd07857         150 GLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTP  229 (332)
T ss_pred             CCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCC
Confidence            99986643221   11233568899999998765 4689999999999999999999999853221000000 000 000


Q ss_pred             hHHHHHhhhcCccccc---ccccccCC-CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 047276          329 PKIVNEKMKEGKLMEI---VDQRLTDE-GGIDETQVRRLVDVAFWCIQERARLRPSMARVV  385 (453)
Q Consensus       329 ~~~~~~~~~~~~~~~~---~d~~l~~~-~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~  385 (453)
                      +......+........   .+..-... ....+.....+.+++.+|++.+|++|||+.+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll  290 (332)
T cd07857         230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL  290 (332)
T ss_pred             CHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence            0000000000000000   00000000 000111245688999999999999999999986

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-35  Score=267.65  Aligned_cols=235  Identities=25%  Similarity=0.332  Sum_probs=187.2

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      |-++||+|.||.|-.++- .+|+.+|+|++++.    ......-+.|-++|...+||.+..|- |.....+.+|+||||.
T Consensus       172 fLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LK-YsFQt~drlCFVMeya  250 (516)
T KOG0690|consen  172 FLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLK-YSFQTQDRLCFVMEYA  250 (516)
T ss_pred             HHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhh-hhhccCceEEEEEEEc
Confidence            568999999999999984 46899999999863    22334567799999999999987765 4445677899999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      .+|.|.-+|...+          .+++.....+..+|+.||.|||+   .+||.||||.+|.|+|.+|++||+|||+++.
T Consensus       251 nGGeLf~HLsrer----------~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE  317 (516)
T KOG0690|consen  251 NGGELFFHLSRER----------VFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKE  317 (516)
T ss_pred             cCceEeeehhhhh----------cccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchh
Confidence            9999999885432          37777778889999999999999   8999999999999999999999999999985


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      .-.. ...+.+++|||.|+|||++....|+...|.|.+||++|||++|+.||...+++                      
T Consensus       318 ~I~~-g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~----------------------  374 (516)
T KOG0690|consen  318 EIKY-GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE----------------------  374 (516)
T ss_pred             cccc-cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh----------------------
Confidence            4322 23467899999999999999999999999999999999999999999632211                      


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCC
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRP  379 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP  379 (453)
                      .+.+++   +.++-.+|.....+...|+...+.++|.+|.
T Consensus       375 kLFeLI---l~ed~kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  375 KLFELI---LMEDLKFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             HHHHHH---HhhhccCCccCCHHHHHHHHHHhhcChHhhc
Confidence            111111   1111224444455567788888899999995

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.8e-34  Score=283.04  Aligned_cols=262  Identities=21%  Similarity=0.276  Sum_probs=187.2

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCC-----CeEEEE
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGG-----PRYLVY  176 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-----~~~lv~  176 (453)
                      .+.||+|+||.||+|... +++.||+|++...   ......+.+|+.+++.++|+|++++++++...+.     ..++|+
T Consensus        20 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~   99 (343)
T cd07851          20 LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVT   99 (343)
T ss_pred             EEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEE
Confidence            478999999999999974 5789999998642   2233567789999999999999999987653321     379999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||+ +++|.+++..           ..+++..+..++.|+++||+|||+   .+++||||+|+||++++++.+||+|||+
T Consensus       100 e~~-~~~L~~~~~~-----------~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851         100 HLM-GADLNNIVKC-----------QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             ecC-CCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEccccc
Confidence            998 5699998842           238999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCc--ccccchhHHHH
Q 047276          257 SKLMSRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSK--NKWQYFPKIVN  333 (453)
Q Consensus       257 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~--~~~~~~~~~~~  333 (453)
                      +......    .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........  ......++...
T Consensus       165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  240 (343)
T cd07851         165 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL  240 (343)
T ss_pred             ccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence            9865432    223457889999998865 3678999999999999999999999853221100000  00000000000


Q ss_pred             HhhhcCcccccccccc-cCCCCC---cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          334 EKMKEGKLMEIVDQRL-TDEGGI---DETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       334 ~~~~~~~~~~~~d~~l-~~~~~~---~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ..+........+.... .....+   .......+.+++.+|++.+|++|||+.+|++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            1110000000000000 000000   0112457899999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-36  Score=268.17  Aligned_cols=252  Identities=24%  Similarity=0.349  Sum_probs=189.3

Q ss_pred             cccCcCCceEEEEEEe-CCCcEEEEEEecCC--CccHHHHHHHHHHHH-hcCCCceeeEeeEEEecCCCeEEEEEecCCC
Q 047276          107 ALLGHGSSASVFKGIL-SDGTSVAVKRINGE--ENGEKEFRSEVAAIA-SAQHVNLVRLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~E~~~l~-~l~h~niv~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      ..||.|.||+|+|-.+ +.|+..|||+++..  ...+++++.|.+... .-+.||||+++|.++. ++..|+.||.|.- 
T Consensus        70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~-EGdcWiCMELMd~-  147 (361)
T KOG1006|consen   70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS-EGDCWICMELMDI-  147 (361)
T ss_pred             HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc-CCceeeeHHHHhh-
Confidence            4699999999999885 46899999999763  345567888888754 4578999999999884 5577999999954 


Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccC
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR  262 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~  262 (453)
                      ||+.+-..--.     .....+++...-.|..-...||.||...  ..|+|||+||+|||+|..|.+||+|||++..+..
T Consensus       148 SlDklYk~vy~-----vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~  220 (361)
T KOG1006|consen  148 SLDKLYKRVYS-----VQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD  220 (361)
T ss_pred             hHHHHHHHHHH-----HHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence            77655321000     0123388888899999999999999986  8999999999999999999999999999987654


Q ss_pred             CCCceeeeccCCccccchhhhhc--CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          263 DQSRCITTIRGTRGYLAPEWILE--QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       263 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      +-.  .+...|-..|||||.+..  ..|+.+|||||+|++|+|+.||+.||..           |...-+.+. .+..|.
T Consensus       221 SiA--kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~-----------w~svfeql~-~Vv~gd  286 (361)
T KOG1006|consen  221 SIA--KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK-----------WDSVFEQLC-QVVIGD  286 (361)
T ss_pred             HHH--hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch-----------HHHHHHHHH-HHHcCC
Confidence            322  234467788999999873  3589999999999999999999999852           322212121 122233


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      ...+..      ..-.......+..++..|+.+|-.+||...++.++
T Consensus       287 pp~l~~------~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  287 PPILLF------DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             CCeecC------cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            221111      11123456779999999999999999999997743

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.2e-33  Score=263.79  Aligned_cols=220  Identities=22%  Similarity=0.210  Sum_probs=173.5

Q ss_pred             CCceEEEEEEe-CCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCChhhhhcc
Q 047276          112 GSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFP  190 (453)
Q Consensus       112 G~fG~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~  190 (453)
                      |.||.||++.. .+++.+|+|.+....    .+..|...+....|||++++++++. ..+..+++|||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIV-SEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhhee-cCCeEEEEEecCCCCCHHHHHHH
Confidence            89999999995 568899999987532    2344555666678999999999876 55688999999999999999853


Q ss_pred             CCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCCCCceeee
Q 047276          191 TSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITT  270 (453)
Q Consensus       191 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~  270 (453)
                      ..          .+++.....++.|++.||+|||+   .+++||||||+||+++.++.++++|||.+......    ...
T Consensus        79 ~~----------~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~  141 (237)
T cd05576          79 FL----------NIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDG  141 (237)
T ss_pred             hc----------CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhccccc----ccc
Confidence            32          38999999999999999999999   89999999999999999999999999987655432    122


Q ss_pred             ccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCccccccccccc
Q 047276          271 IRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLT  350 (453)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  350 (453)
                      ..++..|+|||......++.++||||+|+++|||++|+.|+.......                  ...     ...   
T Consensus       142 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------------~~~-----~~~---  195 (237)
T cd05576         142 EAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------------NTH-----TTL---  195 (237)
T ss_pred             CCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------------ccc-----ccc---
Confidence            345678999999988888999999999999999999998764211000                  000     000   


Q ss_pred             CCCCCcHHHHHHHHHHHHhccccCCCCCCCHH
Q 047276          351 DEGGIDETQVRRLVDVAFWCIQERARLRPSMA  382 (453)
Q Consensus       351 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~  382 (453)
                         ..+......+.+++.+|++.||++||++.
T Consensus       196 ---~~~~~~~~~~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         196 ---NIPEWVSEEARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             ---CCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence               01122344588999999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.7e-34  Score=261.98  Aligned_cols=204  Identities=23%  Similarity=0.352  Sum_probs=167.7

Q ss_pred             HHhcccCcCCceEEEEEEeCC-----CcEEEEEEecCCCc---cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEE
Q 047276          104 NFQALLGHGSSASVFKGILSD-----GTSVAVKRINGEEN---GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLV  175 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~~-----g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv  175 (453)
                      +....||+|.||.||+++-++     ...+|+|+++.+..   -.....+|+.+++.++|||++.|+.++...+...+++
T Consensus        27 e~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~  106 (438)
T KOG0666|consen   27 EGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLL  106 (438)
T ss_pred             hccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEE
Confidence            345789999999999997432     23699999986422   1234678999999999999999999988767788999


Q ss_pred             EEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCC----CcEEE
Q 047276          176 YEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDEN----YRAVV  251 (453)
Q Consensus       176 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~----~~~kl  251 (453)
                      +||.+. +|...++-++..     ....++......|+-||+.|+.|||+   +=|+||||||.|||+..+    |.+||
T Consensus       107 fdYAEh-DL~~II~fHr~~-----~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen  107 FDYAEH-DLWHIIKFHRAS-----KAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             ehhhhh-hHHHHHHHhccc-----hhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEe
Confidence            999988 999888655432     22358999999999999999999999   789999999999999877    99999


Q ss_pred             eeccccccccCCCC--ceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCccccc
Q 047276          252 SDFGLSKLMSRDQS--RCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEH  316 (453)
Q Consensus       252 ~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~  316 (453)
                      +|||+++.+...-.  .....++-|.+|.|||.+.+ ..|+.+.||||.|||+.||+|-.+-|...+.
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~  245 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREE  245 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhh
Confidence            99999998864322  12344567889999999987 4689999999999999999999988865443

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=4.4e-33  Score=295.90  Aligned_cols=140  Identities=26%  Similarity=0.415  Sum_probs=122.5

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC----ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      +.++||+|+||+||+|... +++.||||+++...    .....+..|+.++..++|+||+++++++. .....++||||+
T Consensus         8 i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~~lVmEy~   86 (669)
T cd05610           8 IVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ-SANNVYLVMEYL   86 (669)
T ss_pred             EEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE-ECCEEEEEEeCC
Confidence            3578999999999999965 68899999987532    22356888999999999999999998875 556889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      .+++|.+++...          +.+++...++|+.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        87 ~g~~L~~li~~~----------~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          87 IGGDVKSLLHIY----------GYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999998533          237889999999999999999999   799999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-33  Score=256.06  Aligned_cols=255  Identities=27%  Similarity=0.380  Sum_probs=194.9

Q ss_pred             hcccCcCCceEEEEEE-eCCCcEEEEEEecCCC-ccHHHHHHHHHHHHhcC-CCceeeEeeEEEecCCCeEEEEEecCCC
Q 047276          106 QALLGHGSSASVFKGI-LSDGTSVAVKRINGEE-NGEKEFRSEVAAIASAQ-HVNLVRLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~-~~~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      ++.||+|+|+.|--++ +.+|..+|||++.+.. .......+|++++...+ |+||+.|+.|+. ++..+|||||-|.+|
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFE-dd~~FYLVfEKm~GG  161 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFE-DDTRFYLVFEKMRGG  161 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhc-ccceEEEEEecccCc
Confidence            4689999999998887 6789999999997643 34456889999999985 999999999975 667899999999999


Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCC---cEEEeecccccc
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENY---RAVVSDFGLSKL  259 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~---~~kl~DfGla~~  259 (453)
                      +|..+++++.          .+++....++..+|+.||.|||.   ++|.|||+||+|||-.+..   -+||+||.+..-
T Consensus       162 plLshI~~~~----------~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg  228 (463)
T KOG0607|consen  162 PLLSHIQKRK----------HFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDLGSG  228 (463)
T ss_pred             hHHHHHHHhh----------hccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccccccc
Confidence            9999997554          38899999999999999999999   8999999999999997654   479999988764


Q ss_pred             ccCC------CCceeeeccCCccccchhhhh-----cCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCccccc--
Q 047276          260 MSRD------QSRCITTIRGTRGYLAPEWIL-----EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQ--  326 (453)
Q Consensus       260 ~~~~------~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~--  326 (453)
                      ....      ......+.+|+..|||||+..     ...|+.++|.||+|||+|-|++|..||...-..+    -.|.  
T Consensus       229 ~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d----CGWdrG  304 (463)
T KOG0607|consen  229 IKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD----CGWDRG  304 (463)
T ss_pred             cccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc----CCccCC
Confidence            4211      122234567888999999874     2358899999999999999999999996543321    1221  


Q ss_pred             ----chhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          327 ----YFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       327 ----~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                          .-...+-+.+.+|.. ++-|..+       ...+.+..+++...+..++.+|-++.++++
T Consensus       305 e~Cr~CQ~~LFesIQEGkY-eFPdkdW-------ahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  305 EVCRVCQNKLFESIQEGKY-EFPDKDW-------AHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CccHHHHHHHHHHHhccCC-cCChhhh-------HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence                111222233334332 1212111       133455667778888899999999999886

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1e-32  Score=256.55  Aligned_cols=237  Identities=27%  Similarity=0.348  Sum_probs=188.7

Q ss_pred             CceEEEEEEeC-CCcEEEEEEecCCCcc--HHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCChhhhhc
Q 047276          113 SSASVFKGILS-DGTSVAVKRINGEENG--EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIF  189 (453)
Q Consensus       113 ~fG~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~  189 (453)
                      +||.||+|... +|+.+++|++......  .+.+.+|++.+++++|+|++++++++. .....++++||+++++|.+++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-~~~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFE-DEDKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhhee-eCCEEEEEEeCCCCCCHHHHHH
Confidence            58999999976 4899999999764322  578999999999999999999999986 4567899999999999999985


Q ss_pred             cCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCCCCceee
Q 047276          190 PTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT  269 (453)
Q Consensus       190 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~  269 (453)
                      ...          .+++..++.++.+++.++.|||+   .+++|+||+|+||++++++.++|+|||.+.......  ...
T Consensus        80 ~~~----------~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~  144 (244)
T smart00220       80 KRG----------RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLT  144 (244)
T ss_pred             hcc----------CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccc
Confidence            332          18899999999999999999999   799999999999999999999999999998765432  233


Q ss_pred             eccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcccccccccc
Q 047276          270 TIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRL  349 (453)
Q Consensus       270 ~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  349 (453)
                      ...++..|++||......++.++||||||++++++++|..||......            ....+....+....      
T Consensus       145 ~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~------------~~~~~~~~~~~~~~------  206 (244)
T smart00220      145 TFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL------------LELFKKIGKPKPPF------  206 (244)
T ss_pred             cccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH------------HHHHHHHhccCCCC------
Confidence            456788999999998888999999999999999999999998532100            00111111111100      


Q ss_pred             cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          350 TDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       350 ~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                         ..........+.+++.+|+..+|++||++.++++
T Consensus       207 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      207 ---PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             ---ccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence               0000013456899999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.6e-32  Score=278.40  Aligned_cols=265  Identities=21%  Similarity=0.255  Sum_probs=177.2

Q ss_pred             hcccCcCCceEEEEEEe-----------------CCCcEEEEEEecCCCcc-HHH--------------HHHHHHHHHhc
Q 047276          106 QALLGHGSSASVFKGIL-----------------SDGTSVAVKRINGEENG-EKE--------------FRSEVAAIASA  153 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-----------------~~g~~vavK~~~~~~~~-~~~--------------~~~E~~~l~~l  153 (453)
                      .++||+|+||+||+|..                 .+++.||||+++..... .++              +..|+..+.++
T Consensus       150 ~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l  229 (507)
T PLN03224        150 RDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKI  229 (507)
T ss_pred             eeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHh
Confidence            47999999999999964                 23567999998753221 122              33467777778


Q ss_pred             CCCce-----eeEeeEEEec-------CCCeEEEEEecCCCChhhhhccCCCCC--------------CCCCCCCCCCHH
Q 047276          154 QHVNL-----VRLLGYCVVP-------GGPRYLVYEFIQNGSLDHWIFPTSRRS--------------EGHYSGGCLSWD  207 (453)
Q Consensus       154 ~h~ni-----v~l~g~~~~~-------~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------~~~~~~~~l~~~  207 (453)
                      +|.|+     +++++||...       .+..++||||+++|+|.++++......              ........++|.
T Consensus       230 ~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~  309 (507)
T PLN03224        230 KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDIN  309 (507)
T ss_pred             hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHH
Confidence            76654     6788887532       346799999999999999997532110              011122346889


Q ss_pred             HHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCCCCceeeeccCCccccchhhhhcCC
Q 047276          208 LRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQG  287 (453)
Q Consensus       208 ~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  287 (453)
                      .+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||++...............+++.|+|||.+....
T Consensus       310 ~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~  386 (507)
T PLN03224        310 VIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQ  386 (507)
T ss_pred             HHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCC
Confidence            999999999999999999   89999999999999999999999999999765433222222234578999999875432


Q ss_pred             C----------------------CccccchhHHHHHHHHHcCCC-CCcccccCCCCCccccc-chhHHHHHhhhcCcccc
Q 047276          288 V----------------------SEKCDIYSYGMVLLELTGGRR-NVSLIEHGNDKSKNKWQ-YFPKIVNEKMKEGKLME  343 (453)
Q Consensus       288 ~----------------------~~~sDV~S~Gvil~elltG~~-p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  343 (453)
                      .                      ..+.||||+||+++||++|.. |+.....-... ...+. ....  +..+.....  
T Consensus       387 ~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~-~~~~~~~~~~--~r~~~~~~~--  461 (507)
T PLN03224        387 SCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE-LRQYDNDLNR--WRMYKGQKY--  461 (507)
T ss_pred             CCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH-HhhccchHHH--HHhhcccCC--
Confidence            1                      234799999999999999875 65321110000 00000 0000  111111110  


Q ss_pred             cccccccCCCCCcHHHHHHHHHHHHhccccCC---CCCCCHHHHHH
Q 047276          344 IVDQRLTDEGGIDETQVRRLVDVAFWCIQERA---RLRPSMARVVE  386 (453)
Q Consensus       344 ~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p---~~RPs~~~v~~  386 (453)
                        +  +    ...........+++.+++..+|   .+|+|++|+++
T Consensus       462 --~--~----~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        462 --D--F----SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             --C--c----ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence              0  0    0112234557889999998765   68999999874

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-33  Score=270.56  Aligned_cols=242  Identities=25%  Similarity=0.384  Sum_probs=189.7

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecC---CCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRING---EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      .++||+|.||+||-|+. ++|+.||||++.+   ....+.++++|+.+|.+++||.||.+-.-|. ..+..++|||-+. 
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~E-T~ervFVVMEKl~-  646 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFE-TPERVFVVMEKLH-  646 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeec-CCceEEEEehhhc-
Confidence            37899999999999995 5799999999875   3455678999999999999999999998775 4567899999995 


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCC---CcEEEeeccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDEN---YRAVVSDFGLSK  258 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~---~~~kl~DfGla~  258 (453)
                      |++.+.+.+..        .+.|++.....++.||+.||.|||-   ++|+|+||||+|||+.+.   .++||+|||.|+
T Consensus       647 GDMLEMILSsE--------kgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfAR  715 (888)
T KOG4236|consen  647 GDMLEMILSSE--------KGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFAR  715 (888)
T ss_pred             chHHHHHHHhh--------cccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeecccccee
Confidence            57666654332        2448888888899999999999999   899999999999999643   589999999999


Q ss_pred             cccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      .+....-  ....+|||.|+|||++.++.|...-|+||.|||+|--++|..||...++-.+               ++..
T Consensus       716 iIgEksF--RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd---------------QIQN  778 (888)
T KOG4236|consen  716 IIGEKSF--RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND---------------QIQN  778 (888)
T ss_pred             ecchhhh--hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH---------------Hhhc
Confidence            9875543  2457899999999999999999999999999999999999999964332211               1111


Q ss_pred             CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 047276          339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVV  385 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~  385 (453)
                      ..   ++-|     .+...+.....++++...|+..=.+|-|.++-+
T Consensus       779 Aa---FMyP-----p~PW~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  779 AA---FMYP-----PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             cc---cccC-----CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence            10   0000     111234445577888888888888888776654

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=7e-33  Score=287.68  Aligned_cols=270  Identities=16%  Similarity=0.145  Sum_probs=164.8

Q ss_pred             HhcccCcCCceEEEEEEeC-C----CcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEE-----EecCCCeEE
Q 047276          105 FQALLGHGSSASVFKGILS-D----GTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYC-----VVPGGPRYL  174 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-----~~~~~~~~l  174 (453)
                      +.+.||+|+||.||+|++. +    +..||+|++......+ .+..|  .+....+.+++.++..+     ...+...++
T Consensus       136 l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e-~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~L  212 (566)
T PLN03225        136 LGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE-IWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWL  212 (566)
T ss_pred             EeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH-HHHHH--HHHhhchhhHHHHHHhhhcccccccCCceEE
Confidence            3579999999999999964 4    6899999886432211 11111  11222222222221110     124567899


Q ss_pred             EEEecCCCChhhhhccCCCCC----------CCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEEC
Q 047276          175 VYEFIQNGSLDHWIFPTSRRS----------EGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD  244 (453)
Q Consensus       175 v~e~~~~gsL~~~l~~~~~~~----------~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~  244 (453)
                      |+||+++++|.+++.......          .............+..++.|++.||+|||+   .+|+||||||+|||++
T Consensus       213 V~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP~NILl~  289 (566)
T PLN03225        213 VWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQNIIFS  289 (566)
T ss_pred             EEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCHHHEEEe
Confidence            999999999999986432100          000001112334566899999999999999   8999999999999998


Q ss_pred             C-CCcEEEeeccccccccCCCCceeeeccCCccccchhhhhcC----------------------CCCccccchhHHHHH
Q 047276          245 E-NYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQ----------------------GVSEKCDIYSYGMVL  301 (453)
Q Consensus       245 ~-~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sDV~S~Gvil  301 (453)
                      + ++.+||+|||+++.+............+++.|+|||.+...                      .++.++|||||||++
T Consensus       290 ~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL  369 (566)
T PLN03225        290 EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF  369 (566)
T ss_pred             CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHH
Confidence            5 68999999999987654433334556789999999966422                      234567999999999


Q ss_pred             HHHHcCCCCCcccccCCC--CCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCC
Q 047276          302 LELTGGRRNVSLIEHGND--KSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRP  379 (453)
Q Consensus       302 ~elltG~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP  379 (453)
                      |||+++..|+........  .....+ .+..|... .. ..    ..+.+...............+++.+|++.||++||
T Consensus       370 ~el~~~~~~~~~~~~~~~~~l~~~~~-~~~~~~~~-~~-~~----~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~  442 (566)
T PLN03225        370 LQMAFPNLRSDSNLIQFNRQLKRNDY-DLVAWRKL-VE-PR----ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRI  442 (566)
T ss_pred             HHHHhCcCCCchHHHHHHHHHHhcCC-cHHHHHHh-hc-cc----cchhhhhhhhhccccchHHHHHHHHHccCCcccCC
Confidence            999997765431100000  000000 00010000 00 00    00000000000011123456899999999999999


Q ss_pred             CHHHHHHH
Q 047276          380 SMARVVEM  387 (453)
Q Consensus       380 s~~~v~~~  387 (453)
                      |+.++++.
T Consensus       443 ta~e~L~H  450 (566)
T PLN03225        443 SAKAALAH  450 (566)
T ss_pred             CHHHHhCC
Confidence            99999863

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-32  Score=277.06  Aligned_cols=248  Identities=24%  Similarity=0.378  Sum_probs=202.5

Q ss_pred             HhcccCcCCceEEEEEE-eCCCcEEEEEEecCCCccHHHHHHHHHHHHhc-CCCceeeEeeEEEe----cCCCeEEEEEe
Q 047276          105 FQALLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAAIASA-QHVNLVRLLGYCVV----PGGPRYLVYEF  178 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----~~~~~~lv~e~  178 (453)
                      |.+.||.|.+|.||+++ .++|+..|+|++.......+++..|.++++.+ .|||++.++|++.-    .++.+||||||
T Consensus        23 i~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEf  102 (953)
T KOG0587|consen   23 IIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEF  102 (953)
T ss_pred             EEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeec
Confidence            35799999999999999 56799999999988777788899999999987 59999999999863    24578999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      |.+||..|++++..        +..+.|..+.-|+.+++.|+.+||.   ..++|||||-.|||++.++.+||.|||++.
T Consensus       103 C~gGSVTDLVKn~~--------g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvSa  171 (953)
T KOG0587|consen  103 CGGGSVTDLVKNTK--------GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVSA  171 (953)
T ss_pred             cCCccHHHHHhhhc--------ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeeee
Confidence            99999999996554        3449999999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCceeeeccCCccccchhhhhc-----CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHH
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWILE-----QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVN  333 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  333 (453)
                      .+.... ....+..|||.|||||++..     ..|+..+|+||+|++..||--|.+|+..+.+..             ..
T Consensus       172 QldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr-------------aL  237 (953)
T KOG0587|consen  172 QLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR-------------AL  237 (953)
T ss_pred             eeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh-------------hh
Confidence            775432 23466789999999999864     347789999999999999999999986433211             10


Q ss_pred             HhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          334 EKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       334 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      -.+...-     -|.|    --+..-..++.+++..|+.+|-++||++.++++
T Consensus       238 F~IpRNP-----PPkL----krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  238 FLIPRNP-----PPKL----KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             ccCCCCC-----Cccc----cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            0000000     0111    124566778999999999999999999998874

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.98  E-value=6.5e-33  Score=274.45  Aligned_cols=236  Identities=26%  Similarity=0.310  Sum_probs=186.7

Q ss_pred             HHHhcccCcCCceEEEEEEe-CCCcEEEEEEecCCCccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          103 DNFQALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.|...+|.|+|+.|-++.. .+++..+||++.....   +-.+|+.++... +|||++++.+.+. .+.+.++|||++.
T Consensus       324 y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~---~~~~e~~~~~~~~~h~niv~~~~v~~-~~~~~~~v~e~l~  399 (612)
T KOG0603|consen  324 YEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD---DNQDEIPISLLVRDHPNIVKSHDVYE-DGKEIYLVMELLD  399 (612)
T ss_pred             hccccccCCCCccceeeeeccccccchhheecccccc---ccccccchhhhhcCCCcceeecceec-CCceeeeeehhcc
Confidence            34556799999999988884 5678899999976422   224577666555 6999999999976 6678899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEE-CCCCcEEEeecccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILL-DENYRAVVSDFGLSKL  259 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl-~~~~~~kl~DfGla~~  259 (453)
                      +|-|.+.+....           .....+..|+.+|+.|+.|||+   ++++||||||+|||+ ++.++++|+|||.++.
T Consensus       400 g~ell~ri~~~~-----------~~~~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~  465 (612)
T KOG0603|consen  400 GGELLRRIRSKP-----------EFCSEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSE  465 (612)
T ss_pred             ccHHHHHHHhcc-----------hhHHHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhh
Confidence            998877774332           2226677899999999999999   899999999999999 6999999999999987


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      ...+    ....+-|..|.|||.+....|++++|+||||++||+|++|+.||.....+.            .....+..+
T Consensus       466 ~~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~------------ei~~~i~~~  529 (612)
T KOG0603|consen  466 LERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI------------EIHTRIQMP  529 (612)
T ss_pred             Cchh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH------------HHHHhhcCC
Confidence            6554    223456789999999999999999999999999999999999996443220            012222222


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                                    .+....+....+|+.+||+.+|.+||+|.++..
T Consensus       530 --------------~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  530 --------------KFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             --------------ccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence                          223455666889999999999999999999874

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=2.9e-33  Score=290.37  Aligned_cols=195  Identities=24%  Similarity=0.309  Sum_probs=172.2

Q ss_pred             HHhcccCcCCceEEEEEEeC-CCcEEEEEEecC----CCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEe
Q 047276          104 NFQALLGHGSSASVFKGILS-DGTSVAVKRING----EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      .+.++||+|+||.|...+.+ +++.||.|++++    .......|..|-.+|..-+.+-|+.+.-.| .+.+.+|+||||
T Consensus        78 eilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-QD~~~LYlVMdY  156 (1317)
T KOG0612|consen   78 EILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-QDERYLYLVMDY  156 (1317)
T ss_pred             HHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-cCccceEEEEec
Confidence            34589999999999999974 578899999976    244556799999999999999999987554 467799999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      |+||+|-.++.+..          .++++....++..|+.||.-||+   .|+|||||||+|||||.+|++||+|||.+-
T Consensus       157 ~pGGDlltLlSk~~----------~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsCl  223 (1317)
T KOG0612|consen  157 MPGGDLLTLLSKFD----------RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSCL  223 (1317)
T ss_pred             ccCchHHHHHhhcC----------CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhHH
Confidence            99999999996443          38999999999999999999999   999999999999999999999999999998


Q ss_pred             cccCCCCceeeeccCCccccchhhhh----c-CCCCccccchhHHHHHHHHHcCCCCCc
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWIL----E-QGVSEKCDIYSYGMVLLELTGGRRNVS  312 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDV~S~Gvil~elltG~~p~~  312 (453)
                      .+..+..-.....+|||.|++||.+.    + +.|++.+|.||+||++|||+.|..||.
T Consensus       224 km~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY  282 (1317)
T KOG0612|consen  224 KMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY  282 (1317)
T ss_pred             hcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence            88776666667789999999999986    3 679999999999999999999999995

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-32  Score=247.86  Aligned_cols=246  Identities=20%  Similarity=0.251  Sum_probs=191.6

Q ss_pred             cccCcCCceEEEEEEeC-CCcEEEEEEecCCCccHHHHHHHHHHHHh-cCCCceeeEeeEEEe---cCCCeEEEEEecCC
Q 047276          107 ALLGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRSEVAAIAS-AQHVNLVRLLGYCVV---PGGPRYLVYEFIQN  181 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~---~~~~~~lv~e~~~~  181 (453)
                      ++||-|-.|.|-.+..+ +|+.+|+|++.+...    .++|+++--. -.|||||.+++++..   ....+++|||.|+|
T Consensus        68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~K----ARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meG  143 (400)
T KOG0604|consen   68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDSPK----ARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEG  143 (400)
T ss_pred             hhhccccCCceEEEEeccchhhhHHHHHhcCHH----HHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccc
Confidence            78999999999998854 688999999975433    4568877444 469999999998642   22456899999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEEC---CCCcEEEeeccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD---ENYRAVVSDFGLSK  258 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~---~~~~~kl~DfGla~  258 (453)
                      |.|.+.+..+..        ..+++...-.|+.||+.|+.|||+   .+|.||||||+|+|..   .|..+||+|||+|+
T Consensus       144 GeLfsriq~~g~--------~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK  212 (400)
T KOG0604|consen  144 GELFSRIQDRGD--------QAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAK  212 (400)
T ss_pred             hHHHHHHHHccc--------ccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEeccccccc
Confidence            999999965543        348999999999999999999999   8999999999999997   45679999999998


Q ss_pred             cccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      ....  .....+.+-||-|.|||++...+|+...|+||+||++|-|++|.+||..... ...        ..-....+..
T Consensus       213 ~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg-~ai--------spgMk~rI~~  281 (400)
T KOG0604|consen  213 ETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-LAI--------SPGMKRRIRT  281 (400)
T ss_pred             ccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC-ccC--------ChhHHhHhhc
Confidence            6543  2335667889999999999999999999999999999999999999964322 111        1112333333


Q ss_pred             CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      |.. ++-++.       ....+....++++..|..+|++|-|+.++.+
T Consensus       282 gqy-~FP~pE-------Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  282 GQY-EFPEPE-------WSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             cCc-cCCChh-------HhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            321 111111       1244667789999999999999999999884

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.7e-33  Score=261.00  Aligned_cols=243  Identities=21%  Similarity=0.287  Sum_probs=188.9

Q ss_pred             HHHHHHHHHhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC----ccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCC
Q 047276           97 ELEEATDNFQALLGHGSSASVFKGILS-DGTSVAVKRINGEE----NGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGG  170 (453)
Q Consensus        97 el~~~~~~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~  170 (453)
                      -|..+.-||..+||+|+||.|.++.-+ +...+|||+++++.    .+.+--+.|-++|+.. +-|.++.+..++ ..-+
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF-QTmD  423 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF-QTMD  423 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh-hhhh
Confidence            344455678899999999999999864 35679999998642    2233345677777766 467888888755 4667


Q ss_pred             CeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEE
Q 047276          171 PRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV  250 (453)
Q Consensus       171 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~k  250 (453)
                      .+|+||||+.+|+|--+++...+          +.+..+..++.+||-||-+||+   ++|+.||||.+|||+|.+|++|
T Consensus       424 RLyFVMEyvnGGDLMyhiQQ~Gk----------FKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiK  490 (683)
T KOG0696|consen  424 RLYFVMEYVNGGDLMYHIQQVGK----------FKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIK  490 (683)
T ss_pred             heeeEEEEecCchhhhHHHHhcc----------cCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceE
Confidence            89999999999999888865433          6677788899999999999999   8999999999999999999999


Q ss_pred             EeeccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhH
Q 047276          251 VSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPK  330 (453)
Q Consensus       251 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~  330 (453)
                      |+|||+++.---. ...+.+++|||.|+|||.+....|+...|.|||||+||||+.|+.||+..+.+.            
T Consensus       491 i~DFGmcKEni~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e------------  557 (683)
T KOG0696|consen  491 IADFGMCKENIFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE------------  557 (683)
T ss_pred             eeecccccccccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH------------
Confidence            9999999743222 223567899999999999999999999999999999999999999996432110            


Q ss_pred             HHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCC
Q 047276          331 IVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRP  379 (453)
Q Consensus       331 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP  379 (453)
                       +-..+        .+.    ...++...+.+...+....+.++|.+|.
T Consensus       558 -lF~aI--------~eh----nvsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  558 -LFQAI--------MEH----NVSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             -HHHHH--------HHc----cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence             11111        111    1235566667778888888888888884

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=2.7e-32  Score=229.75  Aligned_cols=191  Identities=26%  Similarity=0.419  Sum_probs=161.2

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCCcc---HHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEENG---EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      -++||+|.||+||+|+. .++..||+|+++.+..+   ....++|+.+++.++|.|||+++++.. .++..-+|+|||..
T Consensus         7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlh-sdkkltlvfe~cdq   85 (292)
T KOG0662|consen    7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-SDKKLTLVFEFCDQ   85 (292)
T ss_pred             HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhc-cCceeEEeHHHhhH
Confidence            36899999999999995 45788999998754322   356789999999999999999999865 55678899999966


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                       +|..|..+..         +.++.+....++.|+.+||.|+|+   +++.|||+||.|.||+.||..|++|||+++.+.
T Consensus        86 -dlkkyfdsln---------g~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafg  152 (292)
T KOG0662|consen   86 -DLKKYFDSLN---------GDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFG  152 (292)
T ss_pred             -HHHHHHHhcC---------CcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcC
Confidence             9998885443         348999999999999999999999   899999999999999999999999999999764


Q ss_pred             CCCCceeeeccCCccccchhhhhcC-CCCccccchhHHHHHHHHHc-CCCCC
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILEQ-GVSEKCDIYSYGMVLLELTG-GRRNV  311 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvil~ellt-G~~p~  311 (453)
                      -. ..+.....-|.+|.+|+++.+. -|+...|+||-||++.|+.. |++-|
T Consensus       153 ip-vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplf  203 (292)
T KOG0662|consen  153 IP-VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF  203 (292)
T ss_pred             Cc-eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCC
Confidence            32 2344555678999999998875 58899999999999999998 55444

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-32  Score=235.09  Aligned_cols=195  Identities=30%  Similarity=0.440  Sum_probs=160.7

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCC--CccHHHHHHHHHHHHh-cCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGE--ENGEKEFRSEVAAIAS-AQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      ...||+|++|.|=+-++ .+|+..|+|++...  .+.+++.+.|+.+..+ ...|.+|.++|... .....++.||.|..
T Consensus        51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~-regdvwIcME~M~t  129 (282)
T KOG0984|consen   51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF-REGDVWICMELMDT  129 (282)
T ss_pred             hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh-ccccEEEeHHHhhh
Confidence            35799999999977774 57999999999763  3445668888888655 47999999999766 55688999999965


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                       ||+.|-...-.      .++.+++...-+|+..+..||.|||+.  ..++|||+||+||||+.+|++||||||++..+.
T Consensus       130 -Sldkfy~~v~~------~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~  200 (282)
T KOG0984|consen  130 -SLDKFYRKVLK------KGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLV  200 (282)
T ss_pred             -hHHHHHHHHHh------cCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence             88777533221      345589999999999999999999996  899999999999999999999999999998775


Q ss_pred             CCCCceeeeccCCccccchhhhhc----CCCCccccchhHHHHHHHHHcCCCCCc
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILE----QGVSEKCDIYSYGMVLLELTGGRRNVS  312 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDV~S~Gvil~elltG~~p~~  312 (453)
                      ++-.  .+...|-..|||||.+..    ..|+.||||||+|+++.||.+++.||.
T Consensus       201 dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~  253 (282)
T KOG0984|consen  201 DSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE  253 (282)
T ss_pred             hhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence            4432  223457778999998863    368999999999999999999999985

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.2e-33  Score=249.75  Aligned_cols=264  Identities=21%  Similarity=0.300  Sum_probs=190.3

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecC---CCccHHHHHHHHHHHHhcCCCceeeEeeEEEecC-------CCeEE
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRING---EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG-------GPRYL  174 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-------~~~~l  174 (453)
                      ..+||+|.||+||+++.+ .|+.||+|+.-.   .+.-...-.+|+.+|..|.|+|++.++..|....       ..+++
T Consensus        22 ~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~yl  101 (376)
T KOG0669|consen   22 LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYL  101 (376)
T ss_pred             HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeee
Confidence            468999999999999964 477889986533   1222234678999999999999999998886432       24799


Q ss_pred             EEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeec
Q 047276          175 VYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDF  254 (453)
Q Consensus       175 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~Df  254 (453)
                      ||++|+. +|.-.|.....         .++...+.+++.++..||.|+|.   ..|+|||+||.|+||+.+|.+||+||
T Consensus       102 Vf~~ceh-DLaGlLsn~~v---------r~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADF  168 (376)
T KOG0669|consen  102 VFDFCEH-DLAGLLSNRKV---------RFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADF  168 (376)
T ss_pred             eHHHhhh-hHHHHhcCccc---------cccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecc
Confidence            9999987 99998854422         38888999999999999999999   89999999999999999999999999


Q ss_pred             cccccccCCCC---ceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCC----------CC
Q 047276          255 GLSKLMSRDQS---RCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGN----------DK  320 (453)
Q Consensus       255 Gla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~----------~~  320 (453)
                      |+++.++....   ...+..+-|.+|.+||.+.+ ..|+++.|||.-||++.||+||.+-++......          ..
T Consensus       169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~  248 (376)
T KOG0669|consen  169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI  248 (376)
T ss_pred             ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence            99987754322   11234556889999999886 579999999999999999999998875432211          11


Q ss_pred             CcccccchhHHH-HHh-----hhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 047276          321 SKNKWQYFPKIV-NEK-----MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEML  388 (453)
Q Consensus       321 ~~~~~~~~~~~~-~~~-----~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L  388 (453)
                      ...-|....... .+.     +.++....+ ..++..   +  .-.....+++..++..||.+||+.++++..-
T Consensus       249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv-~n~~kp---~--~kd~~a~dLle~ll~~DP~kR~~ad~alnh~  316 (376)
T KOG0669|consen  249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKV-KNRLKP---Y--VKDDEALDLLEKLLKLDPTKRIDADQALNHD  316 (376)
T ss_pred             CcccCCCcccchHHHhccCCCCCcchhhhh-hhhccc---c--cCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence            122222111100 000     111111111 111110   0  1122467899999999999999999987654

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.8e-32  Score=254.37  Aligned_cols=278  Identities=21%  Similarity=0.271  Sum_probs=199.5

Q ss_pred             eecHHHHHHHHHHHhcccCcCCceEEEEEEe-CCCcEEEEEEecCCCccHHHHHHHHHHHHhcCC--C----ceeeEeeE
Q 047276           92 KFRSKELEEATDNFQALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRSEVAAIASAQH--V----NLVRLLGY  164 (453)
Q Consensus        92 ~~~~~el~~~~~~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--~----niv~l~g~  164 (453)
                      .|...+.....+.+-+++|+|.||.|-.+.. ..+..||||+++.-..-.+.-+-|+++|.++.+  |    -+|.+.+|
T Consensus        80 v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w  159 (415)
T KOG0671|consen   80 VYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDW  159 (415)
T ss_pred             EEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence            3455555556666678999999999999884 347899999998643333445679999999942  3    37778787


Q ss_pred             EEecCCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEEC
Q 047276          165 CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD  244 (453)
Q Consensus       165 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~  244 (453)
                      +. -.++.|+|+|.+ |-|+.+||..+.-        .+++-..+..|+.|++++++|||+   .+++|.||||+|||+.
T Consensus       160 Fd-yrghiCivfell-G~S~~dFlk~N~y--------~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfv  226 (415)
T KOG0671|consen  160 FD-YRGHICIVFELL-GLSTFDFLKENNY--------IPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFV  226 (415)
T ss_pred             hh-ccCceEEEEecc-ChhHHHHhccCCc--------cccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEe
Confidence            64 567899999998 5599999976532        347888999999999999999999   8999999999999994


Q ss_pred             C--------------------CCcEEEeeccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHH
Q 047276          245 E--------------------NYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL  304 (453)
Q Consensus       245 ~--------------------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~el  304 (453)
                      +                    +..+||+|||.|.+-....    ...+.|..|.|||.+.+-.++.++||||+||||+|+
T Consensus       227 ss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~El  302 (415)
T KOG0671|consen  227 SSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVEL  302 (415)
T ss_pred             ccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEe
Confidence            2                    3468999999998654332    456778899999999999999999999999999999


Q ss_pred             HcCCCCCcccccCCCCCccc--ccchhHHHHH------hhhcCcc-----------cccccccc--cCCCCCcHHHHHHH
Q 047276          305 TGGRRNVSLIEHGNDKSKNK--WQYFPKIVNE------KMKEGKL-----------MEIVDQRL--TDEGGIDETQVRRL  363 (453)
Q Consensus       305 ltG~~p~~~~~~~~~~~~~~--~~~~~~~~~~------~~~~~~~-----------~~~~d~~l--~~~~~~~~~~~~~l  363 (453)
                      .||...|...++.+.....+  ...+|..+..      ....+.+           ..+.++..  ...-.....+...|
T Consensus       303 ytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~L  382 (415)
T KOG0671|consen  303 YTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQL  382 (415)
T ss_pred             eccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHH
Confidence            99999887544221100000  0011111111      1111111           11111110  00011234556779


Q ss_pred             HHHHHhccccCCCCCCCHHHHHH
Q 047276          364 VDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       364 ~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ++|+..+|..||.+|+|+.|++.
T Consensus       383 fDLl~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  383 FDLLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             HHHHHHHHccCccccccHHHHhc
Confidence            99999999999999999999874

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=7.8e-31  Score=257.34  Aligned_cols=198  Identities=25%  Similarity=0.405  Sum_probs=164.7

Q ss_pred             cccCcCCceEEEEEE-eCCCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          107 ALLGHGSSASVFKGI-LSDGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~-~~~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      +.||-|+||+|+++. .++...+|.|.+++.    .........|-.||+.-..+-||+|+--| .+.+.+|+||||++|
T Consensus       635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-QDkdnLYFVMdYIPG  713 (1034)
T KOG0608|consen  635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-QDKDNLYFVMDYIPG  713 (1034)
T ss_pred             eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-ccCCceEEEEeccCC
Confidence            569999999999988 455667999998753    23345577899999999999999999554 577899999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      |++-.+|...          +.+.+.....++.++..|+++.|.   .|+|||||||+|||||.+|++||+||||+.-+.
T Consensus       714 GDmMSLLIrm----------gIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR  780 (1034)
T KOG0608|consen  714 GDMMSLLIRM----------GIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR  780 (1034)
T ss_pred             ccHHHHHHHh----------ccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccce
Confidence            9999998643          447888888899999999999999   999999999999999999999999999986431


Q ss_pred             C--C------CC-----------------ce----------------eeeccCCccccchhhhhcCCCCccccchhHHHH
Q 047276          262 R--D------QS-----------------RC----------------ITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMV  300 (453)
Q Consensus       262 ~--~------~~-----------------~~----------------~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvi  300 (453)
                      -  +      ..                 .+                ....+||+.|+|||++....++..+|.||.|||
T Consensus       781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi  860 (1034)
T KOG0608|consen  781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI  860 (1034)
T ss_pred             eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence            0  0      00                 00                112469999999999999999999999999999


Q ss_pred             HHHHHcCCCCCcccccCC
Q 047276          301 LLELTGGRRNVSLIEHGN  318 (453)
Q Consensus       301 l~elltG~~p~~~~~~~~  318 (453)
                      ||||+.|+.||....+..
T Consensus       861 l~em~~g~~pf~~~tp~~  878 (1034)
T KOG0608|consen  861 LYEMLVGQPPFLADTPGE  878 (1034)
T ss_pred             HHHHhhCCCCccCCCCCc
Confidence            999999999997554443

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=2.4e-29  Score=228.02  Aligned_cols=210  Identities=38%  Similarity=0.579  Sum_probs=180.6

Q ss_pred             cCcCCceEEEEEEeCC-CcEEEEEEecCCCc--cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCChh
Q 047276          109 LGHGSSASVFKGILSD-GTSVAVKRINGEEN--GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLD  185 (453)
Q Consensus       109 lG~G~fG~Vy~~~~~~-g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL~  185 (453)
                      ||+|.+|.||++...+ ++.+++|++.....  ....+.+|+..++.++|++++++++++. .....++++||+++++|.
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-~~~~~~~~~e~~~~~~l~   79 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFE-DENHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeee-cCCeEEEEEecCCCCcHH
Confidence            6899999999999754 88999999986544  3567999999999999999999999976 446789999999999999


Q ss_pred             hhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECC-CCcEEEeeccccccccCCC
Q 047276          186 HWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDE-NYRAVVSDFGLSKLMSRDQ  264 (453)
Q Consensus       186 ~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~-~~~~kl~DfGla~~~~~~~  264 (453)
                      +++....         ..+++..+..++.++++++++||+   .+++|+||+|.||+++. ++.++|+|||.+.......
T Consensus        80 ~~~~~~~---------~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~  147 (215)
T cd00180          80 DLLKENE---------GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK  147 (215)
T ss_pred             HHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCc
Confidence            9985431         238999999999999999999999   79999999999999999 8999999999998665432


Q ss_pred             CceeeeccCCccccchhhhhcC-CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcccc
Q 047276          265 SRCITTIRGTRGYLAPEWILEQ-GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLME  343 (453)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (453)
                      . ......+...|++||..... ..+.++|+|++|+++++|                                       
T Consensus       148 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------  187 (215)
T cd00180         148 S-LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------  187 (215)
T ss_pred             c-hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------
Confidence            1 12334577899999998877 788999999999999999                                       


Q ss_pred             cccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 047276          344 IVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEML  388 (453)
Q Consensus       344 ~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L  388 (453)
                                       ..+.+++..|++.+|++||++.++++.+
T Consensus       188 -----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -----------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -----------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                             2378899999999999999999998653

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5e-32  Score=259.96  Aligned_cols=235  Identities=23%  Similarity=0.269  Sum_probs=190.4

Q ss_pred             cccCcCCceEEEEEEeCCCc-EEEEEEecC----CCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          107 ALLGHGSSASVFKGILSDGT-SVAVKRING----EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~g~-~vavK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      ..||-|+||.|=........ .+|+|.+++    +...++....|-.+|...+.|.||+++-.+. +....|+.||-|-+
T Consensus       426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfr-d~kyvYmLmEaClG  504 (732)
T KOG0614|consen  426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFR-DSKYVYMLMEACLG  504 (732)
T ss_pred             hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhc-cchhhhhhHHhhcC
Confidence            36999999999988875433 378888865    3445567889999999999999999998876 55678999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      |.|...|..+.          .++..+...++..+.+|++|||+   ++||.|||||+|.++|.+|.+||.|||+|+.+.
T Consensus       505 GElWTiLrdRg----------~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~  571 (732)
T KOG0614|consen  505 GELWTILRDRG----------SFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG  571 (732)
T ss_pred             chhhhhhhhcC----------CcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhc
Confidence            99999996443          37778888899999999999999   899999999999999999999999999999875


Q ss_pred             CCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcc
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKL  341 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (453)
                      ...  .+-+++|||.|.|||.+.+...+...|.||+|++++||++|.+||+..++...             -..+-.|  
T Consensus       572 ~g~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt-------------Yn~ILkG--  634 (732)
T KOG0614|consen  572 SGR--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT-------------YNLILKG--  634 (732)
T ss_pred             cCC--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH-------------HHHHHhh--
Confidence            443  35779999999999999999999999999999999999999999975432211             1111111  


Q ss_pred             cccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCC
Q 047276          342 MEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPS  380 (453)
Q Consensus       342 ~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs  380 (453)
                         +|.     -.+|........+++++.+..+|.+|.-
T Consensus       635 ---id~-----i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  635 ---IDK-----IEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             ---hhh-----hhcccccchhHHHHHHHHHhcCcHhhhc
Confidence               111     1234445556788999999999999976

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=1e-30  Score=264.55  Aligned_cols=239  Identities=28%  Similarity=0.383  Sum_probs=178.9

Q ss_pred             cccCcCCceEE-EEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEEEEEecCCCCh
Q 047276          107 ALLGHGSSASV-FKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL  184 (453)
Q Consensus       107 ~~lG~G~fG~V-y~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL  184 (453)
                      +.+|.|+.|+| |+|... |+.||||++-.+.  .....+|+..|+.- +|||||++++. ..+....|+..|.|.. +|
T Consensus       515 eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~-E~d~qF~YIalELC~~-sL  589 (903)
T KOG1027|consen  515 EILGYGSNGTVVFRGVYE-GREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCS-EQDRQFLYIALELCAC-SL  589 (903)
T ss_pred             HHcccCCCCcEEEEEeeC-CceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEee-ccCCceEEEEehHhhh-hH
Confidence            67999999865 999995 8999999885322  23456899999887 59999999864 3345567999999966 99


Q ss_pred             hhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECC---C--CcEEEeecccccc
Q 047276          185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDE---N--YRAVVSDFGLSKL  259 (453)
Q Consensus       185 ~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~---~--~~~kl~DfGla~~  259 (453)
                      .+++.......+   .   ..-...+.++.|++.||++||+   .+||||||||.||||+.   +  ..++|+|||+++.
T Consensus       590 ~dlie~~~~d~~---~---~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk  660 (903)
T KOG1027|consen  590 QDLIESSGLDVE---M---QSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK  660 (903)
T ss_pred             HHHHhccccchh---h---cccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence            999976411100   1   1113346788899999999999   89999999999999975   2  5789999999998


Q ss_pred             ccCCCC--ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcC-CCCCcccccCCCCCcccccchhHHHHHhh
Q 047276          260 MSRDQS--RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG-RRNVSLIEHGNDKSKNKWQYFPKIVNEKM  336 (453)
Q Consensus       260 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (453)
                      +..+..  .......||.||+|||++....-+...|+||+||++|+.++| ..||...-..+.               .+
T Consensus       661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~---------------NI  725 (903)
T KOG1027|consen  661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA---------------NI  725 (903)
T ss_pred             cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh---------------hh
Confidence            875443  224567899999999999988888899999999999999985 899953211100               01


Q ss_pred             hcCc--ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 047276          337 KEGK--LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVV  385 (453)
Q Consensus       337 ~~~~--~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~  385 (453)
                      ..+.  +..+     .   . ..++  ...+|+.+|++++|..||++.+|+
T Consensus       726 l~~~~~L~~L-----~---~-~~d~--eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  726 LTGNYTLVHL-----E---P-LPDC--EAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             hcCccceeee-----c---c-CchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence            1111  1111     1   0 1111  678999999999999999999998

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3e-30  Score=236.54  Aligned_cols=241  Identities=20%  Similarity=0.304  Sum_probs=184.3

Q ss_pred             cccCcCCceEEEEEEe-CCCcEEEEEEecCC----CccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          107 ALLGHGSSASVFKGIL-SDGTSVAVKRINGE----ENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      .+||+|+|..|-.+++ ++.+.+|+|++++.    ..+..-...|-.+..+- +||.+|-+..++. ....+++|.||++
T Consensus       256 ~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfq-tesrlffvieyv~  334 (593)
T KOG0695|consen  256 RVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ-TESRLFFVIEYVN  334 (593)
T ss_pred             eeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhc-ccceEEEEEEEec
Confidence            6899999999999986 45788999998752    22333355566665554 7999999998654 6678899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|--++...+          .|+++....+..+|+.||.|||+   .+|+.||||..|||+|..|++||+|+|+++..
T Consensus       335 ggdlmfhmqrqr----------klpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  335 GGDLMFHMQRQR----------KLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             Ccceeeehhhhh----------cCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcC
Confidence            999977775443          38999999999999999999999   89999999999999999999999999999864


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccC-CCCCcccccchhHHHHHhhhcC
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHG-NDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      -.+. ..+.+++|||.|+|||.+.+..|....|.|++||+++||+.|+.||+....+ .+.+..++  +-    +.+   
T Consensus       402 l~~g-d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedy--lf----qvi---  471 (593)
T KOG0695|consen  402 LGPG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDY--LF----QVI---  471 (593)
T ss_pred             CCCC-cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHH--HH----HHH---
Confidence            4332 3457799999999999999999999999999999999999999999754322 11221111  11    111   


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCC
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPS  380 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs  380 (453)
                           +.+.++    ++...+.+...++..-+++||.+|.-
T Consensus       472 -----lekqir----iprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  472 -----LEKQIR----IPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             -----hhhccc----ccceeehhhHHHHHHhhcCCcHHhcC
Confidence                 111111    23344445667778888999988753

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5e-31  Score=235.58  Aligned_cols=264  Identities=22%  Similarity=0.278  Sum_probs=193.0

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecC---CCccHHHHHHHHHHHHhcCCCceeeEeeEEEecC----CCeEEEEE
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRING---EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG----GPRYLVYE  177 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~~lv~e  177 (453)
                      .+-||-|.||.||..+. .+|+.||.|++..   .-...+.+.+|+++|..++|.|++..++......    .+.|+++|
T Consensus        58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE  137 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE  137 (449)
T ss_pred             CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence            35799999999999985 5799999998864   2234567889999999999999999988754222    14578899


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      .|.. +|...+.+.          ..|+.+...-++.||++||.|||+   .+|.||||||.|.|++.|...||+|||++
T Consensus       138 LmQS-DLHKIIVSP----------Q~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLA  203 (449)
T KOG0664|consen  138 LMQS-DLHKIIVSP----------QALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLA  203 (449)
T ss_pred             HHHh-hhhheeccC----------CCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccc
Confidence            9965 898888543          347778888899999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHH-----
Q 047276          258 KLMSRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKI-----  331 (453)
Q Consensus       258 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~-----  331 (453)
                      +....+....++..+-|..|.|||.+++ ..|+...||||.||++.||+..+.-|....+-..     .+...++     
T Consensus       204 Rvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQ-----L~lItdLLGTPs  278 (449)
T KOG0664|consen  204 RTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQ-----LQMIIDLLGTPS  278 (449)
T ss_pred             cccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHH-----HHHHHHHhCCCc
Confidence            9887766666666777889999999987 5799999999999999999998888754322111     0000000     


Q ss_pred             --HHHhhhcCcccccccccccCC-----C--CCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 047276          332 --VNEKMKEGKLMEIVDQRLTDE-----G--GIDETQVRRLVDVAFWCIQERARLRPSMARVVEML  388 (453)
Q Consensus       332 --~~~~~~~~~~~~~~d~~l~~~-----~--~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L  388 (453)
                        ..+...+|.-..++.......     .  ..+...-.+-.++..+++..+|..|.+.++.+..+
T Consensus       279 ~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  279 QEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             HHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence              011111222111111111100     0  01112233456777788999999999988887655

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=2.9e-28  Score=224.38  Aligned_cols=195  Identities=34%  Similarity=0.503  Sum_probs=167.1

Q ss_pred             HhcccCcCCceEEEEEEeCC-CcEEEEEEecCCCc--cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          105 FQALLGHGSSASVFKGILSD-GTSVAVKRINGEEN--GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~-g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      +.+.||+|++|.||++...+ ++.+++|.+.....  ..+.+.+|++.+.+++|+|++++++++. .....++++||+++
T Consensus         3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~-~~~~~~~v~e~~~~   81 (225)
T smart00221        3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFE-DPEPLYLVMEYCEG   81 (225)
T ss_pred             eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeee-cCCceEEEEeccCC
Confidence            45789999999999999765 88999999986443  4667899999999999999999999876 45688999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      ++|.+++.....         .+++.....++.+++.++.+||+   .+++|+||+|+||+++.++.++|+|||.+....
T Consensus        82 ~~L~~~~~~~~~---------~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~  149 (225)
T smart00221       82 GDLFDYLRKKGG---------KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIH  149 (225)
T ss_pred             CCHHHHHHhccc---------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEec
Confidence            999999854321         17899999999999999999999   799999999999999999999999999998775


Q ss_pred             CCCCceeeeccCCccccchhhh-hcCCCCccccchhHHHHHHHHHcCCCCCc
Q 047276          262 RDQSRCITTIRGTRGYLAPEWI-LEQGVSEKCDIYSYGMVLLELTGGRRNVS  312 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDV~S~Gvil~elltG~~p~~  312 (453)
                      ...........++..|++||.. ....++.++|||+||++++||++|+.||.
T Consensus       150 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      150 RDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             CcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence            4431122345677889999998 66678889999999999999999999995

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=1.3e-28  Score=240.00  Aligned_cols=189  Identities=23%  Similarity=0.270  Sum_probs=159.4

Q ss_pred             cccCcCCceEEEEEEeCC-CcEEEEEEecCCCccH---------HHHHHHHHHHHhcC---CCceeeEeeEEEecCCCeE
Q 047276          107 ALLGHGSSASVFKGILSD-GTSVAVKRINGEENGE---------KEFRSEVAAIASAQ---HVNLVRLLGYCVVPGGPRY  173 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~-g~~vavK~~~~~~~~~---------~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~~  173 (453)
                      +.+|+|+||.|+.+.++. ...|+||.+.+.+.-.         ...-.|+++|+.++   |+||+++++++. +++.+|
T Consensus       567 q~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE-ddd~yy  645 (772)
T KOG1152|consen  567 QPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE-DDDYYY  645 (772)
T ss_pred             eeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee-cCCeeE
Confidence            579999999999999754 5679999887543221         12456999999998   999999999975 667889


Q ss_pred             EEEEecC-CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEe
Q 047276          174 LVYEFIQ-NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVS  252 (453)
Q Consensus       174 lv~e~~~-~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~  252 (453)
                      +++|-.. +.+|.+++....          .+++....-|+.|++.|+++||+   .+|||||||-+||.+|.+|-+||+
T Consensus       646 l~te~hg~gIDLFd~IE~kp----------~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~kli  712 (772)
T KOG1152|consen  646 LETEVHGEGIDLFDFIEFKP----------RMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLI  712 (772)
T ss_pred             EEecCCCCCcchhhhhhccC----------ccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEe
Confidence            9998764 458999985433          38899999999999999999999   899999999999999999999999


Q ss_pred             eccccccccCCCCceeeeccCCccccchhhhhcCCC-CccccchhHHHHHHHHHcCCCCCc
Q 047276          253 DFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGV-SEKCDIYSYGMVLLELTGGRRNVS  312 (453)
Q Consensus       253 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvil~elltG~~p~~  312 (453)
                      |||.+......   ....++||.+|.|||.+.+.+| ...-|||++|++||.++....||.
T Consensus       713 dfgsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  713 DFGSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             eccchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99998765433   3467889999999999998877 566899999999999999999884

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.5e-28  Score=219.59  Aligned_cols=252  Identities=17%  Similarity=0.234  Sum_probs=187.3

Q ss_pred             HHHHhcccCcCCceEEEEEEeC-CCcEEEEEEecCCCccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEEEEEec
Q 047276          102 TDNFQALLGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       102 ~~~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      .+++.+.||+|.||.+-++.++ +.+.+++|-+.......++|.+|...--.| .|.||+.-++......+.+++++||+
T Consensus        25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~a  104 (378)
T KOG1345|consen   25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFA  104 (378)
T ss_pred             hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccC
Confidence            4667889999999999999975 467899998887777788999998764444 58999998887776777888999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEEC--CCCcEEEeecccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD--ENYRAVVSDFGLS  257 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~--~~~~~kl~DfGla  257 (453)
                      +.|+|.+-+..           ..+.+....+++.|++.|+.|+|+   .++||||||.+||||-  +...+||+|||+.
T Consensus       105 P~gdL~snv~~-----------~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t  170 (378)
T KOG1345|consen  105 PRGDLRSNVEA-----------AGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLT  170 (378)
T ss_pred             ccchhhhhcCc-----------ccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccc
Confidence            99999887732           237888889999999999999999   8999999999999994  4458999999998


Q ss_pred             ccccCCCCceeeeccCCccccchhhhhc---C--CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHH
Q 047276          258 KLMSRDQSRCITTIRGTRGYLAPEWILE---Q--GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIV  332 (453)
Q Consensus       258 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  332 (453)
                      +....    .......+..|.+||....   +  ...+.+|+|.||++++.++||+.||+.....+         -+-|-
T Consensus       171 ~k~g~----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d---------~~Y~~  237 (378)
T KOG1345|consen  171 RKVGT----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD---------KPYWE  237 (378)
T ss_pred             cccCc----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC---------chHHH
Confidence            74321    2223344567999997753   2  34678999999999999999999997332111         12223


Q ss_pred             HHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHh
Q 047276          333 NEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEML  388 (453)
Q Consensus       333 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L  388 (453)
                      +..|..+.....     +..  + ......+..+-.+-+.++|++|-...++-++.
T Consensus       238 ~~~w~~rk~~~~-----P~~--F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  238 WEQWLKRKNPAL-----PKK--F-NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             HHHHhcccCccC-----chh--h-cccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence            344444433221     110  1 12233466777788899999997666665554

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=5.2e-28  Score=231.75  Aligned_cols=271  Identities=22%  Similarity=0.285  Sum_probs=193.2

Q ss_pred             HHHHHhcccCcCCceEEEEEEe-CCCcEEEEEEecCCCccHHHHHHHHHHHHhcC-----C---CceeeEeeEEEec---
Q 047276          101 ATDNFQALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRSEVAAIASAQ-----H---VNLVRLLGYCVVP---  168 (453)
Q Consensus       101 ~~~~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~g~~~~~---  168 (453)
                      +.|-+.++||-|.|++||++.. .+.+.||+|+.+....-.+.-+.|+++|++++     |   .+||+|+++|...   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN  157 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN  157 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence            4445568999999999999984 56789999999875555566788999999884     3   3699999998743   


Q ss_pred             CCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCC--
Q 047276          169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDEN--  246 (453)
Q Consensus       169 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~--  246 (453)
                      +.+.|+|+|++ |-+|..++....-        .-++...+.+|+.||+.||.|||.+  .+|||.||||+|||+..+  
T Consensus       158 G~HVCMVfEvL-GdnLLklI~~s~Y--------rGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl~~~e~  226 (590)
T KOG1290|consen  158 GQHVCMVFEVL-GDNLLKLIKYSNY--------RGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLLCSTEI  226 (590)
T ss_pred             CcEEEEEehhh-hhHHHHHHHHhCC--------CCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeeeecccc
Confidence            35789999999 5599999875543        2388999999999999999999997  599999999999999421  


Q ss_pred             --------------------------------------------------------------------------------
Q 047276          247 --------------------------------------------------------------------------------  246 (453)
Q Consensus       247 --------------------------------------------------------------------------------  246 (453)
                                                                                                      
T Consensus       227 ~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~  306 (590)
T KOG1290|consen  227 DPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNE  306 (590)
T ss_pred             chhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------------------------------------------------------------------
Q 047276          247 --------------------------------------------------------------------------------  246 (453)
Q Consensus       247 --------------------------------------------------------------------------------  246 (453)
                                                                                                      
T Consensus       307 ~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~  386 (590)
T KOG1290|consen  307 PRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPL  386 (590)
T ss_pred             cCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCC
Confidence                                                                                            


Q ss_pred             ----CcEEEeeccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCc
Q 047276          247 ----YRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSK  322 (453)
Q Consensus       247 ----~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~  322 (453)
                          ..+||+|||-|......    .+....|..|.|||++.+..|+..+|+|||+|++|||+||...|...+...-...
T Consensus       387 ~~~di~vKIaDlGNACW~~kh----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rD  462 (590)
T KOG1290|consen  387 PECDIRVKIADLGNACWVHKH----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRD  462 (590)
T ss_pred             CccceeEEEeeccchhhhhhh----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCcc
Confidence                00233333333322111    1222356689999999999999999999999999999999988864332211111


Q ss_pred             cc-ccchhHH----HHHhhhcCcc-cccccc-----------------cccCCCCCcHHHHHHHHHHHHhccccCCCCCC
Q 047276          323 NK-WQYFPKI----VNEKMKEGKL-MEIVDQ-----------------RLTDEGGIDETQVRRLVDVAFWCIQERARLRP  379 (453)
Q Consensus       323 ~~-~~~~~~~----~~~~~~~~~~-~~~~d~-----------------~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP  379 (453)
                      .+ .....++    .+.....|.. .++++.                 -|.+...++.+.+..+.+++.-||+.+|++||
T Consensus       463 EDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~  542 (590)
T KOG1290|consen  463 EDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRP  542 (590)
T ss_pred             HHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccc
Confidence            11 1111111    1122222221 222222                 12223467889999999999999999999999


Q ss_pred             CHHHHHH
Q 047276          380 SMARVVE  386 (453)
Q Consensus       380 s~~~v~~  386 (453)
                      |+.+.++
T Consensus       543 tA~~cl~  549 (590)
T KOG1290|consen  543 TAAQCLK  549 (590)
T ss_pred             cHHHHhc
Confidence            9999874

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.95  E-value=7.4e-29  Score=216.56  Aligned_cols=259  Identities=17%  Similarity=0.259  Sum_probs=185.3

Q ss_pred             HHhcccCcCCceEEEEEE-eCCCcEEEEEEecCCCccHHHHHHHHHHHHhcC-CCceeeEeeEEEecC-CCeEEEEEecC
Q 047276          104 NFQALLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAAIASAQ-HVNLVRLLGYCVVPG-GPRYLVYEFIQ  180 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~-~~~~lv~e~~~  180 (453)
                      .+.+++|+|.|++||.|. ..+.+.++||+++.  ...+.+.+|+.+|..|+ ||||++|++...++. ....|++||+.
T Consensus        41 eivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP--VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~  118 (338)
T KOG0668|consen   41 EIVRKVGRGKYSEVFEGINITNNEKCVIKILKP--VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVN  118 (338)
T ss_pred             HHHHHHcCccHhhHhcccccCCCceEEEeeech--HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhc
Confidence            345789999999999998 56778899999974  34567899999999998 999999999866443 35579999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECC-CCcEEEeecccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDE-NYRAVVSDFGLSKL  259 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~-~~~~kl~DfGla~~  259 (453)
                      +.+...+-             ..|+...+...+.+++.||.|+|+   .||+|||+||.|++||. .-..+|+|+|+|.+
T Consensus       119 n~Dfk~ly-------------~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF  182 (338)
T KOG0668|consen  119 NTDFKQLY-------------PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  182 (338)
T ss_pred             cccHHHHh-------------hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhh
Confidence            98776654             236777788899999999999999   99999999999999995 46799999999998


Q ss_pred             ccCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCc-c----cccc------
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSK-N----KWQY------  327 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~-~----~~~~------  327 (453)
                      ..+....  ...+.+.-|-.||.+.. ..|+..-|+|||||++..|+-.+.||....+..+..- .    ....      
T Consensus       183 YHp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~  260 (338)
T KOG0668|consen  183 YHPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN  260 (338)
T ss_pred             cCCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence            7654332  22344556788998865 5688999999999999999999999965443322100 0    0000      


Q ss_pred             -----hhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 047276          328 -----FPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVV  385 (453)
Q Consensus       328 -----~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~  385 (453)
                           ++......+.... .+.+...+..+ + ..-...+.++++...+..|-++|||+.|..
T Consensus       261 KY~i~Ldp~~~~i~~~~~-rk~w~~Fi~~~-n-~hl~~peaiDlldklLrYDHqeRlTakEam  320 (338)
T KOG0668|consen  261 KYQIDLDPQFEDILGRHS-RKPWSRFINSE-N-QHLVSPEAIDLLDKLLRYDHQERLTAKEAM  320 (338)
T ss_pred             HHccCCChhHhhHhhccc-cccHHHhCCcc-c-cccCChHHHHHHHHHHhhccccccchHHHh
Confidence                 0110111000000 00000001100 0 001135688999999999999999999966

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.94  E-value=2.9e-28  Score=234.80  Aligned_cols=208  Identities=27%  Similarity=0.300  Sum_probs=172.7

Q ss_pred             ceecHHHHHHHHHHHhcccCcCCceEEEEEEe-CCCcEEEEEEecCCCccHHHHHHHHHHHHhcCC------CceeeEee
Q 047276           91 IKFRSKELEEATDNFQALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRSEVAAIASAQH------VNLVRLLG  163 (453)
Q Consensus        91 ~~~~~~el~~~~~~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~g  163 (453)
                      .++...|+....|.+.-..|+|-|++|.+|.. ..|+.||||++...+.-.+.=+.|+++|.+|+.      -|+++++-
T Consensus       422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r  501 (752)
T KOG0670|consen  422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFR  501 (752)
T ss_pred             EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence            45667788888888888999999999999985 458899999998766555666789999999962      37888887


Q ss_pred             EEEecCCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEE
Q 047276          164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILL  243 (453)
Q Consensus       164 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl  243 (453)
                      .|. ..+++|||+|-+.- +|.+.|.+.....       .|.......++.|+.-||..|..   .+|+|.||||.|||+
T Consensus       502 ~F~-hknHLClVFE~Lsl-NLRevLKKyG~nv-------GL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLV  569 (752)
T KOG0670|consen  502 HFK-HKNHLCLVFEPLSL-NLREVLKKYGRNV-------GLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILV  569 (752)
T ss_pred             Hhh-hcceeEEEehhhhc-hHHHHHHHhCccc-------ceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEe
Confidence            765 67899999998854 9999998766532       27777888999999999999998   799999999999999


Q ss_pred             CCC-CcEEEeeccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcc
Q 047276          244 DEN-YRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSL  313 (453)
Q Consensus       244 ~~~-~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~  313 (453)
                      ++. ..+||||||.|.....+.   .+...-+--|.|||.+.+-.|+..-|+||.||+||||.||+..|..
T Consensus       570 NE~k~iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG  637 (752)
T KOG0670|consen  570 NESKNILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG  637 (752)
T ss_pred             ccCcceeeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence            965 568999999998765443   2223334469999999999999999999999999999999988853

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=9.9e-28  Score=237.29  Aligned_cols=245  Identities=22%  Similarity=0.322  Sum_probs=191.5

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCC-ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCC
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEE-NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS  183 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gs  183 (453)
                      -..+|.|.||.|||++. ..+...|+|+++... ....-..+|+-+++..+|||||.++|-+. ..+..+++||||.+|+
T Consensus        20 lqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsyl-r~dklwicMEycgggs   98 (829)
T KOG0576|consen   20 LQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYL-RRDKLWICMEYCGGGS   98 (829)
T ss_pred             eeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhh-hhcCcEEEEEecCCCc
Confidence            36899999999999995 568899999998643 33455778999999999999999999865 6678899999999999


Q ss_pred             hhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCC
Q 047276          184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD  263 (453)
Q Consensus       184 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~  263 (453)
                      |.+.-+.          .+.+++.+....+.+..+||+|||+   .+=+|||||-.|||+++.|.+|++|||.+..+...
T Consensus        99 lQdiy~~----------TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitat  165 (829)
T KOG0576|consen   99 LQDIYHV----------TGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT  165 (829)
T ss_pred             ccceeee----------cccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhh
Confidence            9987653          3558898889999999999999999   88899999999999999999999999998766432


Q ss_pred             CCceeeeccCCccccchhhhh---cCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          264 QSRCITTIRGTRGYLAPEWIL---EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      -. ....+.||+.|||||+..   .+.|..++|||+.|+...|+-.-+.|....             .+..+...+....
T Consensus       166 i~-KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl-------------hpmr~l~LmTkS~  231 (829)
T KOG0576|consen  166 IA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL-------------HPMRALFLMTKSG  231 (829)
T ss_pred             hh-hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc-------------chHHHHHHhhccC
Confidence            21 235678999999999875   467899999999999999998888775321             1111222221111


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVV  385 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~  385 (453)
                      .   --+.+.+.    ..-...+-++++.|+-++|++||+.+.++
T Consensus       232 ~---qpp~lkDk----~kws~~fh~fvK~altknpKkRptaeklL  269 (829)
T KOG0576|consen  232 F---QPPTLKDK----TKWSEFFHNFVKGALTKNPKKRPTAEKLL  269 (829)
T ss_pred             C---CCCcccCC----ccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence            0   01122211    12344588999999999999999998765

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=1.3e-27  Score=259.98  Aligned_cols=196  Identities=15%  Similarity=0.193  Sum_probs=136.7

Q ss_pred             hcCC-CceeeEeeEEEe------cCCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhcccc
Q 047276          152 SAQH-VNLVRLLGYCVV------PGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH  224 (453)
Q Consensus       152 ~l~h-~niv~l~g~~~~------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh  224 (453)
                      .++| +||++++++|..      .....++++||+ +++|.++|...         ...+++..++.++.||++||+|||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---------~~~~~~~~~~~i~~qi~~al~~lH   97 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---------DRSVDAFECFHVFRQIVEIVNAAH   97 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---------cccccHHHHHHHHHHHHHHHHHHH
Confidence            4455 578888887621      223567889988 55999999532         133899999999999999999999


Q ss_pred             ccCCCceeccCCCCCcEEECC-------------------CCcEEEeeccccccccCCC---------------Cceeee
Q 047276          225 NDCRSRVLHLDVKPENILLDE-------------------NYRAVVSDFGLSKLMSRDQ---------------SRCITT  270 (453)
Q Consensus       225 ~~~~~~ivH~Dlk~~NiLl~~-------------------~~~~kl~DfGla~~~~~~~---------------~~~~~~  270 (453)
                      +   ++|+||||||+||||+.                   ++.+|++|||+++......               ......
T Consensus        98 ~---~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (793)
T PLN00181         98 S---QGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQIL  174 (793)
T ss_pred             h---CCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccc
Confidence            9   89999999999999965                   4455666666665321100               000112


Q ss_pred             ccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCccccccccccc
Q 047276          271 IRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLT  350 (453)
Q Consensus       271 ~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  350 (453)
                      ..||+.|||||++.+..++.++|||||||+||||++|..|+....          ..    . ..+...    ...+.. 
T Consensus       175 ~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----------~~----~-~~~~~~----~~~~~~-  234 (793)
T PLN00181        175 AMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----------RT----M-SSLRHR----VLPPQI-  234 (793)
T ss_pred             cCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----------HH----H-HHHHHh----hcChhh-
Confidence            357889999999999999999999999999999999988763110          00    0 000000    001100 


Q ss_pred             CCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          351 DEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       351 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                            ........+++.+||+.+|.+||+|.++++
T Consensus       235 ------~~~~~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        235 ------LLNWPKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             ------hhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence                  011233567888999999999999999975

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.94  E-value=3.4e-27  Score=215.77  Aligned_cols=261  Identities=22%  Similarity=0.269  Sum_probs=183.1

Q ss_pred             ccCcCCceEEEEEE-eCCCcEEEEEEecC---CCccHHHHHHHHHHHHhcCCCceeeEeeEEEecC-----CCeEEEEEe
Q 047276          108 LLGHGSSASVFKGI-LSDGTSVAVKRING---EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG-----GPRYLVYEF  178 (453)
Q Consensus       108 ~lG~G~fG~Vy~~~-~~~g~~vavK~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~~lv~e~  178 (453)
                      .+|.|.- .|..+. .-.+++||+|++..   .....+.-.+|...+..++|+|+++++.++....     .+.|+||||
T Consensus        24 p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~  102 (369)
T KOG0665|consen   24 PIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMEL  102 (369)
T ss_pred             ccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHh
Confidence            5777776 454444 22478999998754   2233456678999999999999999999875322     245899999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      |.. +|...+..            .++-.+...|..|++.|+.|||+   .+|+||||||+||++..+...||.|||+++
T Consensus       103 m~~-nl~~vi~~------------elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen  103 MDA-NLCQVILM------------ELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             hhh-HHHHHHHH------------hcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhc
Confidence            955 99888752            17788899999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCC----------CCcccccch
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGND----------KSKNKWQYF  328 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~----------~~~~~~~~~  328 (453)
                      .-...  -..+....|.-|.|||.+.+..+.+.+||||.||++.||++|+.-|.+...-+.          ....-...+
T Consensus       167 ~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL  244 (369)
T KOG0665|consen  167 TEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL  244 (369)
T ss_pred             ccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence            64332  234556677889999999988899999999999999999999987752111000          000000011


Q ss_pred             hHHHHHhhh------cCcccccc-cccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          329 PKIVNEKMK------EGKLMEIV-DQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       329 ~~~~~~~~~------~~~~~~~~-d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      ...+...+.      .-...+.+ |.-+....+.+.-......+++.+||-.+|++|-+.+++++.
T Consensus       245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence            111111111      00111111 111111111222334557899999999999999999998865

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=1.7e-26  Score=205.28  Aligned_cols=166  Identities=22%  Similarity=0.203  Sum_probs=123.4

Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      |+|.+++....         ..++|..++.|+.|++.||+|||+   .+      ||+|||++.++.+|+  ||++....
T Consensus         1 GsL~~~l~~~~---------~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~   60 (176)
T smart00750        1 VSLADILEVRG---------RPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKT   60 (176)
T ss_pred             CcHHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeec
Confidence            68999985432         249999999999999999999998   44      999999999999999  99988654


Q ss_pred             CCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcc
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKL  341 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (453)
                      ...      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||......           ......... +..
T Consensus        61 ~~~------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~-----------~~~~~~~~~-~~~  122 (176)
T smart00750       61 PEQ------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL-----------SAILEILLN-GMP  122 (176)
T ss_pred             ccc------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-----------cHHHHHHHH-Hhc
Confidence            322      25789999999999999999999999999999999999998532110           000111110 000


Q ss_pred             cccccccccCCCCCcHHHHH--HHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 047276          342 MEIVDQRLTDEGGIDETQVR--RLVDVAFWCIQERARLRPSMARVVEMLEG  390 (453)
Q Consensus       342 ~~~~d~~l~~~~~~~~~~~~--~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~  390 (453)
                      ..  ++   ...........  .+.+++.+|++.+|++||++.++++.+..
T Consensus       123 ~~--~~---~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~  168 (176)
T smart00750      123 AD--DP---RDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA  168 (176)
T ss_pred             cC--Cc---cccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence            00  00   00011222222  68999999999999999999999998864

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=3.6e-27  Score=210.87  Aligned_cols=254  Identities=19%  Similarity=0.306  Sum_probs=192.0

Q ss_pred             HHHHHHHHhcccCcCCceEEEEEEeCCCcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEE
Q 047276           98 LEEATDNFQALLGHGSSASVFKGILSDGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYL  174 (453)
Q Consensus        98 l~~~~~~~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~l  174 (453)
                      +.....++..+|.+...|+.|+|+++ |..+++|+++..   ....++|..|.-.|+.+.||||.+++|.|..+ ....+
T Consensus       187 id~~~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-pnlv~  264 (448)
T KOG0195|consen  187 IDVSSLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-PNLVI  264 (448)
T ss_pred             cchhhhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-CCceE
Confidence            33444567778999999999999997 556777887653   33346799999999999999999999999854 57789


Q ss_pred             EEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeec
Q 047276          175 VYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDF  254 (453)
Q Consensus       175 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~Df  254 (453)
                      +..||+.|+|...|+....        -.++..+..+++.++|+||+|||+. ++-|.---|.+..|++|++.+++|+- 
T Consensus       265 isq~mp~gslynvlhe~t~--------vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-  334 (448)
T KOG0195|consen  265 ISQYMPFGSLYNVLHEQTS--------VVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-  334 (448)
T ss_pred             eeeeccchHHHHHHhcCcc--------EEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-
Confidence            9999999999999976532        3367888999999999999999984 34455567999999999999988741 


Q ss_pred             cccccccCCCCceeeeccCCccccchhhhhcCCC---CccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHH
Q 047276          255 GLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGV---SEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKI  331 (453)
Q Consensus       255 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~  331 (453)
                      +-+++..     ........|.||+||.+...+-   -..+|+|||.+++|||.|...||....+.+-.-          
T Consensus       335 ad~kfsf-----qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm----------  399 (448)
T KOG0195|consen  335 ADTKFSF-----QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM----------  399 (448)
T ss_pred             ccceeee-----eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh----------
Confidence            1111110     1122345789999999986543   357999999999999999999996543322111          


Q ss_pred             HHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 047276          332 VNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR  391 (453)
Q Consensus       332 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~  391 (453)
                         .+.-..        ++  ..+++..+..+.+++.-|++.||.+||.++.|+-.||+.
T Consensus       400 ---kialeg--------lr--v~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  400 ---KIALEG--------LR--VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             ---hhhhcc--------cc--ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence               111111        11  235566777799999999999999999999999999864

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.93  E-value=7.6e-26  Score=214.17  Aligned_cols=194  Identities=25%  Similarity=0.328  Sum_probs=158.0

Q ss_pred             hcccCcCCceEEEEEEeC----CCcEEEEEEecCCCccHHHHHHHHHHHHhcC-CCceeeEeeEEEecCCCeEEEEEecC
Q 047276          106 QALLGHGSSASVFKGILS----DGTSVAVKRINGEENGEKEFRSEVAAIASAQ-HVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      .++||+|.|++||++...    ..+.||+|.+..... ...+..|++.|..+. +.||+++.++.. .++..++|+||++
T Consensus        41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-p~ri~~El~~L~~~gG~~ni~~~~~~~r-nnd~v~ivlp~~~  118 (418)
T KOG1167|consen   41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-PSRILNELEMLYRLGGSDNIIKLNGCFR-NNDQVAIVLPYFE  118 (418)
T ss_pred             hccccccchhhhhhhhHhhhccccceEeeeecccccC-chHHHHHHHHHHHhccchhhhcchhhhc-cCCeeEEEecccC
Confidence            478999999999999853    357899999875433 456889999999985 899999998654 7778999999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECC-CCcEEEeecccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDE-NYRAVVSDFGLSKL  259 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~-~~~~kl~DfGla~~  259 (453)
                      .-.-.++..             .++...+..++..+..||+++|.   .|||||||||+|+|.+. .+.-.|.|||+|..
T Consensus       119 H~~f~~l~~-------------~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~  182 (418)
T KOG1167|consen  119 HDRFRDLYR-------------SLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR  182 (418)
T ss_pred             ccCHHHHHh-------------cCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHH
Confidence            998888873             27788888999999999999999   89999999999999984 46778999999872


Q ss_pred             ccC--------C--------------------------CCc---------eeeeccCCccccchhhhhc-CCCCccccch
Q 047276          260 MSR--------D--------------------------QSR---------CITTIRGTRGYLAPEWILE-QGVSEKCDIY  295 (453)
Q Consensus       260 ~~~--------~--------------------------~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~  295 (453)
                      ...        .                          ...         ......||+||.|||++.. +.-+.+.|||
T Consensus       183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw  262 (418)
T KOG1167|consen  183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW  262 (418)
T ss_pred             HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence            100        0                          000         0122469999999999874 5678999999


Q ss_pred             hHHHHHHHHHcCCCCCcccccC
Q 047276          296 SYGMVLLELTGGRRNVSLIEHG  317 (453)
Q Consensus       296 S~Gvil~elltG~~p~~~~~~~  317 (453)
                      |.|||++-+++++.||....++
T Consensus       263 s~GVI~Lslls~~~PFf~a~dd  284 (418)
T KOG1167|consen  263 SAGVILLSLLSRRYPFFKAKDD  284 (418)
T ss_pred             eccceeehhhccccccccCccc
Confidence            9999999999999999655444

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=2.2e-24  Score=210.46  Aligned_cols=160  Identities=23%  Similarity=0.230  Sum_probs=123.8

Q ss_pred             HHHhcccCcCCceEEEEEEeC--CCcEEEEEEecCC------CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEE
Q 047276          103 DNFQALLGHGSSASVFKGILS--DGTSVAVKRINGE------ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYL  174 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~--~g~~vavK~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~l  174 (453)
                      +.+.+.||+|+||+||+|...  +++.||||++...      ....+.|.+|+++|.+++|+|+++.+..    .+..++
T Consensus        20 Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~~~L   95 (365)
T PRK09188         20 FVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TGKDGL   95 (365)
T ss_pred             ceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cCCcEE
Confidence            344678999999999999864  5778899987532      1124568999999999999999864322    135799


Q ss_pred             EEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCC-CCCcEEECCCCcEEEee
Q 047276          175 VYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDV-KPENILLDENYRAVVSD  253 (453)
Q Consensus       175 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dl-k~~NiLl~~~~~~kl~D  253 (453)
                      ||||+++++|....   .           ..   ...++.++++||+|||+   .+|+|||| ||+|||++.++.+||+|
T Consensus        96 VmE~~~G~~L~~~~---~-----------~~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiD  155 (365)
T PRK09188         96 VRGWTEGVPLHLAR---P-----------HG---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVID  155 (365)
T ss_pred             EEEccCCCCHHHhC---c-----------cc---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEE
Confidence            99999999996321   0           00   13578899999999999   89999999 99999999999999999


Q ss_pred             ccccccccCCCCc-------eeeeccCCccccchhhhhcC
Q 047276          254 FGLSKLMSRDQSR-------CITTIRGTRGYLAPEWILEQ  286 (453)
Q Consensus       254 fGla~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~  286 (453)
                      ||+++.+......       ......+++.|+|||.+...
T Consensus       156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            9999977543211       12356788899999988643

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=2.6e-22  Score=195.76  Aligned_cols=259  Identities=20%  Similarity=0.249  Sum_probs=186.5

Q ss_pred             HHHhcccCcCCceEEEEEEeCCC--cEEEEEEecCC-CccHHHHHHHHHHHHhcCC----CceeeEeeEEEecCCCeEEE
Q 047276          103 DNFQALLGHGSSASVFKGILSDG--TSVAVKRINGE-ENGEKEFRSEVAAIASAQH----VNLVRLLGYCVVPGGPRYLV  175 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~~g--~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h----~niv~l~g~~~~~~~~~~lv  175 (453)
                      +.+.++||+|+||.||.+...+.  ..+|+|..... ......+..|..++..+..    +++..+++.....+...++|
T Consensus        20 ~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iV   99 (322)
T KOG1164|consen   20 YKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIV   99 (322)
T ss_pred             eEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEE
Confidence            34468999999999999996543  47888877653 2222267889999988873    57888887653345567899


Q ss_pred             EEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCC-----CcEE
Q 047276          176 YEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDEN-----YRAV  250 (453)
Q Consensus       176 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~-----~~~k  250 (453)
                      |+.+ +.+|.++.....        .+.++..+.++|+.|++.+|++||+   .+++||||||.|+++...     ..+.
T Consensus       100 M~l~-G~sL~dl~~~~~--------~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~  167 (322)
T KOG1164|consen  100 MSLL-GPSLEDLRKRNP--------PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLY  167 (322)
T ss_pred             Eecc-CccHHHHHHhCC--------CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEE
Confidence            9988 679999874332        2348999999999999999999999   899999999999999865     4689


Q ss_pred             Eeeccccc--cccCCCCc------e-eeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCC
Q 047276          251 VSDFGLSK--LMSRDQSR------C-ITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKS  321 (453)
Q Consensus       251 l~DfGla~--~~~~~~~~------~-~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~  321 (453)
                      |.|||+++  .+......      . .....||..|.++....+...+.+.|+||++.++.|++.|..||...+..... 
T Consensus       168 llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~-  246 (322)
T KOG1164|consen  168 LLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK-  246 (322)
T ss_pred             EEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH-
Confidence            99999998  33222111      1 23466999999999999999999999999999999999999998543322110 


Q ss_pred             cccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          322 KNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                                  .............. .   ...   ....+.++...+-..+...+|....+...|++...
T Consensus       247 ------------~~~~~~~~~~~~~~-~---~~~---~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~  299 (322)
T KOG1164|consen  247 ------------SKFEKDPRKLLTDR-F---GDL---KPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD  299 (322)
T ss_pred             ------------HHHHHHhhhhcccc-c---cCC---ChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence                        00000000001000 0   111   22335556666666899999999999999876543

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.87  E-value=6.2e-21  Score=184.33  Aligned_cols=258  Identities=29%  Similarity=0.364  Sum_probs=191.4

Q ss_pred             HhcccCcCCceEEEEEEeCCCcEEEEEEecCCCc----cHHHHHHHHHHHHhcCCC-ceeeEeeEEEecCCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEEN----GEKEFRSEVAAIASAQHV-NLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~-niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      ..+.||.|+||.||++...  ..+++|.+.....    ....|.+|+.++..+.|+ |++++.+++. .....+++++|+
T Consensus         4 ~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~   80 (384)
T COG0515           4 ILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ-DEGSLYLVMEYV   80 (384)
T ss_pred             eEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe-cCCEEEEEEecC
Confidence            3467999999999999986  7899999875322    356799999999999988 7999999874 444579999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCC-cEEEeeccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENY-RAVVSDFGLSK  258 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~-~~kl~DfGla~  258 (453)
                      .+++|.+++......       ..+.......+..|++.++.|+|+   .+++|||+||+||+++..+ .++++|||.++
T Consensus        81 ~~~~l~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~  150 (384)
T COG0515          81 DGGSLEDLLKKIGRK-------GPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAK  150 (384)
T ss_pred             CCCcHHHHHHhcccc-------cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcce
Confidence            999999777433210       248888999999999999999999   7899999999999999988 79999999998


Q ss_pred             cccCCCCc-----eeeeccCCccccchhhhhc---CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhH
Q 047276          259 LMSRDQSR-----CITTIRGTRGYLAPEWILE---QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPK  330 (453)
Q Consensus       259 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~  330 (453)
                      ........     ......|+..|++||.+..   ...+...|+||+|++++++++|..|+......         ....
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---------~~~~  221 (384)
T COG0515         151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---------SATS  221 (384)
T ss_pred             ecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---------ccHH
Confidence            65543321     2456789999999999987   57889999999999999999999996432211         0000


Q ss_pred             HHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          331 IVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       331 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      .....+...... ........  .........+.+++..|+..+|..|.++.+....
T Consensus       222 ~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         222 QTLKIILELPTP-SLASPLSP--SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             HHHHHHHhcCCc-ccccccCc--cccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            011111111100 00000000  0001223568899999999999999999987764

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.86  E-value=9.6e-22  Score=176.47  Aligned_cols=137  Identities=18%  Similarity=0.209  Sum_probs=106.4

Q ss_pred             cccCcCCceEEEEEEeCCCcEEEEEEecCCCc---c-------HHHH-----------------HHHHHHHHhcCCCcee
Q 047276          107 ALLGHGSSASVFKGILSDGTSVAVKRINGEEN---G-------EKEF-----------------RSEVAAIASAQHVNLV  159 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~---~-------~~~~-----------------~~E~~~l~~l~h~niv  159 (453)
                      ..||+|+||.||+|...+|++||||+++....   .       ...|                 ..|+..+.++.++++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~   82 (190)
T cd05147           3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP   82 (190)
T ss_pred             CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence            57999999999999988899999999975321   1       1122                 3499999999877764


Q ss_pred             eEeeEEEecCCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccc-cccCCCceeccCCCC
Q 047276          160 RLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL-HNDCRSRVLHLDVKP  238 (453)
Q Consensus       160 ~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-h~~~~~~ivH~Dlk~  238 (453)
                      ....+..   ...++||||++++++......          ...+++....+++.|++.+|.|+ |+   .+|+||||||
T Consensus        83 ~p~~~~~---~~~~iVmE~i~g~~l~~~~~~----------~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP  146 (190)
T cd05147          83 CPEPILL---KSHVLVMEFIGDDGWAAPRLK----------DAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSE  146 (190)
T ss_pred             CCcEEEe---cCCEEEEEEeCCCCCcchhhh----------cCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCH
Confidence            3333211   233899999998777654321          12388899999999999999999 67   7999999999


Q ss_pred             CcEEECCCCcEEEeeccccccc
Q 047276          239 ENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       239 ~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|||++ ++.++|+|||++...
T Consensus       147 ~NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         147 YNLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             HHEEEE-CCcEEEEEccccccC
Confidence            999998 478999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=1.4e-21  Score=179.91  Aligned_cols=201  Identities=20%  Similarity=0.272  Sum_probs=164.8

Q ss_pred             HHHhcccCcCCceEEEEEE-eCCCcEEEEEEecCCCccHHHHHHHHHHHHhcC-CCceeeEeeEEEecCCCeEEEEEecC
Q 047276          103 DNFQALLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAAIASAQ-HVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.+.++||+|.||+.+.|+ +-++++||||.- .......++..|....+.|. .++|...+-| -..+..-.||+|.+ 
T Consensus        30 yrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfE-PrkS~APQLrdEYr~YKlL~g~~GIP~vYYF-GqeG~~NiLVidLL-  106 (449)
T KOG1165|consen   30 YRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFE-PRKSEAPQLRDEYRTYKLLGGTEGIPQVYYF-GQEGKYNILVIDLL-  106 (449)
T ss_pred             ceeccccccCcceeeecccccccCceEEEEec-cccCCcchHHHHHHHHHHHcCCCCCCceeee-ccccchhhhhhhhh-
Confidence            3457899999999999999 567999999953 34445567888999998886 5777776643 33555668999998 


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCC-----CcEEEeecc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDEN-----YRAVVSDFG  255 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~-----~~~kl~DfG  255 (453)
                      +-||+|++.-+.+         .++.++...||.|++.-++|+|+   +.+|.|||||+|.||...     ..+.|+|||
T Consensus       107 GPSLEDLFD~CgR---------~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG  174 (449)
T KOG1165|consen  107 GPSLEDLFDLCGR---------RFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFG  174 (449)
T ss_pred             CcCHHHHHHHhcC---------cccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEecc
Confidence            6699998865554         38999999999999999999999   899999999999999743     468899999


Q ss_pred             ccccccCCCC------ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCC
Q 047276          256 LSKLMSRDQS------RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGN  318 (453)
Q Consensus       256 la~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~  318 (453)
                      +|+.+.+...      .......||.+||+-....+..-+.+.|+-|+|-+++..+-|..||.....+.
T Consensus       175 mAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t  243 (449)
T KOG1165|consen  175 MAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT  243 (449)
T ss_pred             chhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc
Confidence            9998865432      22345679999999999999999999999999999999999999998665443

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=3.9e-22  Score=175.92  Aligned_cols=279  Identities=20%  Similarity=0.261  Sum_probs=198.2

Q ss_pred             HHHHHhcccCcCCceEEEEEE-eCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCC-ceeeEeeEEEecCCCeEEEEEe
Q 047276          101 ATDNFQALLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHV-NLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       101 ~~~~~~~~lG~G~fG~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      ..+.+.++||+|+||.+|.|. ..+|..||||+-... ....++.-|..+...|++- .|..+.-| ..+.+.-.+|||.
T Consensus        15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-a~hpqL~yEskvY~iL~~g~GiP~i~~y-~~e~~ynvlVMdL   92 (341)
T KOG1163|consen   15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-AKHPQLLYESKVYRILQGGVGIPHIRHY-GTEKDYNVLVMDL   92 (341)
T ss_pred             cceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-CCCcchhHHHHHHHHhccCCCCchhhhh-ccccccceeeeec
Confidence            334556899999999999999 678999999976542 3345678899999999864 44444444 3466677899999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCC---CcEEEeecc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDEN---YRAVVSDFG  255 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~---~~~kl~DfG  255 (453)
                      . +-||++++.-+.+.         ++..+.+-.+.|++.-++|+|.   ++++||||||+|.|..-+   ..+.++|||
T Consensus        93 L-GPsLEdLfnfC~R~---------ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFG  159 (341)
T KOG1163|consen   93 L-GPSLEDLFNFCSRR---------FTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFG  159 (341)
T ss_pred             c-CccHHHHHHHHhhh---------hhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEecc
Confidence            8 66999998766542         8888999999999999999999   899999999999999744   467899999


Q ss_pred             ccccccCCCC------ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchh
Q 047276          256 LSKLMSRDQS------RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFP  329 (453)
Q Consensus       256 la~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~  329 (453)
                      +++.+.+...      .......||.+|.+-....+-..+...|+-|+|.+|....-|..||+.........+.      
T Consensus       160 LaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy------  233 (341)
T KOG1163|consen  160 LAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY------  233 (341)
T ss_pred             chhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH------
Confidence            9997754322      2234457899999888777777789999999999999999999999765443322211      


Q ss_pred             HHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccCCCCCCCCccccccccc
Q 047276          330 KIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVDDPPDTQMVIVDWLS  409 (453)
Q Consensus       330 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~~~~~~~~~~~~~~~~~  409 (453)
                          +.+.+....-.+.       ......+.++.-.+..|-...-++-|.-..+.+.+.-....  -......+.||..
T Consensus       234 ----EkI~EkK~s~~ie-------~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~--ln~~~d~iyDW~~  300 (341)
T KOG1163|consen  234 ----EKISEKKMSTPIE-------VLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRT--LNHQYDYIYDWTM  300 (341)
T ss_pred             ----HHHHHhhcCCCHH-------HHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhh--ccccCCeEeeHHH
Confidence                1111111110000       01122344567777888888888889877766655433221  1223446677765


Q ss_pred             ccCC
Q 047276          410 IDQD  413 (453)
Q Consensus       410 ~~~~  413 (453)
                      ..+.
T Consensus       301 lkqk  304 (341)
T KOG1163|consen  301 LKQK  304 (341)
T ss_pred             HHHH
Confidence            5443

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.86  E-value=1.1e-21  Score=178.55  Aligned_cols=166  Identities=14%  Similarity=0.142  Sum_probs=128.0

Q ss_pred             HHhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHH----------HHHHHHHHHhcCCCceeeEeeEEEecC----
Q 047276          104 NFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKE----------FRSEVAAIASAQHVNLVRLLGYCVVPG----  169 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~----------~~~E~~~l~~l~h~niv~l~g~~~~~~----  169 (453)
                      ...++||.|+||.||.... ++..+|||.++......+.          +.+|+..+.+++|++|..+.+++....    
T Consensus        34 ~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~  112 (232)
T PRK10359         34 KTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTL  112 (232)
T ss_pred             EEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccc
Confidence            3347999999999999655 5778999999753322222          578999999999999999988855332    


Q ss_pred             ---CCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCC
Q 047276          170 ---GPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDEN  246 (453)
Q Consensus       170 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~  246 (453)
                         +..+++|||++|.+|.++..              ++.    ....+++.+|..+|+   .+++|||++|+|++++.+
T Consensus       113 ~~~~~~~lvmEyi~G~tL~~~~~--------------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~  171 (232)
T PRK10359        113 RYAHTYIMLIEYIEGVELNDMPE--------------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKN  171 (232)
T ss_pred             cccCCeEEEEEEECCccHHHhhh--------------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCC
Confidence               35789999999999988741              232    245689999999999   899999999999999998


Q ss_pred             CcEEEeeccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHH
Q 047276          247 YRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELT  305 (453)
Q Consensus       247 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ell  305 (453)
                      + ++|+|||.......+...             ..+.....+..++|+|+||+++.-+.
T Consensus       172 g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        172 G-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             C-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence            8 999999988755322211             11344556778999999999987654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=1.7e-22  Score=209.66  Aligned_cols=250  Identities=20%  Similarity=0.213  Sum_probs=179.2

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEec----CCCcc---HHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRIN----GEENG---EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~----~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      ..++|.|.+|.|+.... ......+.|...    .....   ...+..|+.+-..++|+|++..+..+.. .....-.||
T Consensus       323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~-~~~~~~~mE  401 (601)
T KOG0590|consen  323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQE-IDGILQSME  401 (601)
T ss_pred             cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhh-cccchhhhh
Confidence            46899999997776663 223334444332    21111   1125567777778999999888776553 333344499


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |+++ +|..++...          +.+....+..++.|+..|+.|+|+   .++.|||+|++|++++.+|.+||+|||.+
T Consensus       402 ~~~~-Dlf~~~~~~----------~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~  467 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSN----------GKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAA  467 (601)
T ss_pred             cccH-HHHHHHhcc----------cccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcc
Confidence            9999 999998543          237777888999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCC---ceeeeccCCccccchhhhhcCCCCc-cccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHH
Q 047276          258 KLMSRDQS---RCITTIRGTRGYLAPEWILEQGVSE-KCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVN  333 (453)
Q Consensus       258 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  333 (453)
                      ..+.....   .......|+..|+|||.+....|.+ ..||||.|+++..|++|+.||.......+....          
T Consensus       468 ~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~----------  537 (601)
T KOG0590|consen  468 SVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT----------  537 (601)
T ss_pred             eeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh----------
Confidence            87754332   4456688999999999999988876 589999999999999999999765443322100          


Q ss_pred             HhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          334 EKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       334 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                       ....+.......     ........+.+...++.++++.+|.+|-|+.+|++
T Consensus       538 -~~~~~~~~~~~~-----~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  538 -NNYSDQRNIFEG-----PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             -hccccccccccC-----hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence             000000000000     01122344566788999999999999999999873

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.85  E-value=9.6e-21  Score=170.44  Aligned_cols=140  Identities=16%  Similarity=0.134  Sum_probs=109.1

Q ss_pred             cccCcCCceEEEEEEeCCCcEEEEEEecCCCcc---------------------------HHHHHHHHHHHHhcCCCcee
Q 047276          107 ALLGHGSSASVFKGILSDGTSVAVKRINGEENG---------------------------EKEFRSEVAAIASAQHVNLV  159 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~---------------------------~~~~~~E~~~l~~l~h~niv  159 (453)
                      ..||+|+||.||+|...+|+.||||+++.....                           ...+..|...+.++.|+++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   82 (190)
T cd05145           3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP   82 (190)
T ss_pred             ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence            579999999999999878999999998753210                           11235789999999999875


Q ss_pred             eEeeEEEecCCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCC
Q 047276          160 RLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPE  239 (453)
Q Consensus       160 ~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~  239 (453)
                      ....+.. .  ..++||||++++++......          ...++.....+++.|++.++.++|+.  .+|+||||||+
T Consensus        83 ~p~~~~~-~--~~~lVmE~~~g~~~~~~~l~----------~~~~~~~~~~~i~~~l~~~l~~lH~~--~givHrDlkP~  147 (190)
T cd05145          83 VPEPILL-K--KNVLVMEFIGDDGSPAPRLK----------DVPLEEEEAEELYEQVVEQMRRLYQE--AGLVHGDLSEY  147 (190)
T ss_pred             CceEEEe-c--CCEEEEEEecCCCchhhhhh----------hccCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCChh
Confidence            4444322 2  34899999998855433211          12367788899999999999999984  69999999999


Q ss_pred             cEEECCCCcEEEeeccccccccC
Q 047276          240 NILLDENYRAVVSDFGLSKLMSR  262 (453)
Q Consensus       240 NiLl~~~~~~kl~DfGla~~~~~  262 (453)
                      |||++ ++.++|+|||++.....
T Consensus       148 NIll~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         148 NILYH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             hEEEE-CCCEEEEEcccceecCC
Confidence            99999 88999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.84  E-value=2.4e-20  Score=166.16  Aligned_cols=181  Identities=15%  Similarity=0.052  Sum_probs=138.8

Q ss_pred             hcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHH-----HHHHHHHHHHhcC-CCceeeEeeEEEecCCCeEEEEEec
Q 047276          106 QALLGHGSSASVFKGILSDGTSVAVKRINGEENGEK-----EFRSEVAAIASAQ-HVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~-----~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      ...|++|+||+||.+.- ++.+++.+.+.......+     .|.+|+++|++|. |+++.+++++     +..+++|||+
T Consensus         7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~-----~~~~lvmeyI   80 (218)
T PRK12274          7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW-----DGRHLDRSYL   80 (218)
T ss_pred             ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE-----cCEEEEEeee
Confidence            45799999999997665 678888888876554333     5889999999995 5789999886     2468999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCC-CCCcEEECCCCcEEEeeccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDV-KPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dl-k~~NiLl~~~~~~kl~DfGla~  258 (453)
                      .+.+|...+.           .     . ...++.|++.+|+++|+   .+|+|||| ||.|||++.++.++|+|||++.
T Consensus        81 ~G~~L~~~~~-----------~-----~-~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~  140 (218)
T PRK12274         81 AGAAMYQRPP-----------R-----G-DLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAV  140 (218)
T ss_pred             cCccHHhhhh-----------h-----h-hHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCce
Confidence            9988865431           0     0 13477899999999999   89999999 7999999999999999999998


Q ss_pred             cccCCCCc----e--------eeeccCCccccchhhhhcC-CCC-ccccchhHHHHHHHHHcCCCCCc
Q 047276          259 LMSRDQSR----C--------ITTIRGTRGYLAPEWILEQ-GVS-EKCDIYSYGMVLLELTGGRRNVS  312 (453)
Q Consensus       259 ~~~~~~~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~sDV~S~Gvil~elltG~~p~~  312 (453)
                      ........    .        ..-...++.|+.|+...-- ..+ ...+.++-|.-+|.++|++.+.-
T Consensus       141 ~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        141 RGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             ecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence            65433210    0        1113467888888765422 333 56788999999999999998753

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.84  E-value=1.3e-21  Score=203.60  Aligned_cols=248  Identities=24%  Similarity=0.276  Sum_probs=176.6

Q ss_pred             HhcccCcCCceEEEEEEeCCCcEEEEEEecCC--CccHHHHHHHHHH--HHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          105 FQALLGHGSSASVFKGILSDGTSVAVKRINGE--ENGEKEFRSEVAA--IASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~E~~~--l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.+.||++.|=+|.+++.+.|. |+||++-..  ...-+.|.++++-  ...++|||++++.-+- ..+...|+|-+|..
T Consensus        27 ~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~-~t~kAAylvRqyvk  104 (1431)
T KOG1240|consen   27 YVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVL-VTDKAAYLVRQYVK  104 (1431)
T ss_pred             eecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHH-HhhHHHHHHHHHHh
Confidence            3578999999999999998887 999998542  2333445544433  4556899999987763 34556688889987


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      + +|.|.|.-+          .-|......-|+.|+..||..+|.   .+|+|||||.+||||+.-.-+.|+||...+..
T Consensus       105 h-nLyDRlSTR----------PFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPt  170 (1431)
T KOG1240|consen  105 H-NLYDRLSTR----------PFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPT  170 (1431)
T ss_pred             h-hhhhhhccc----------hHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCc
Confidence            6 999988322          226777788899999999999999   89999999999999999999999999876532


Q ss_pred             --cCCCCceeee----ccCCccccchhhhhcC-----------CCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCc
Q 047276          261 --SRDQSRCITT----IRGTRGYLAPEWILEQ-----------GVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSK  322 (453)
Q Consensus       261 --~~~~~~~~~~----~~gt~~y~aPE~~~~~-----------~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~  322 (453)
                        +.++....+-    ...-.+|+|||.+...           ..+++.||||.||++.||++ |++||....       
T Consensus       171 YLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ-------  243 (1431)
T KOG1240|consen  171 YLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ-------  243 (1431)
T ss_pred             cCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH-------
Confidence              3333222222    2334589999988642           15788999999999999998 788885211       


Q ss_pred             ccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          323 NKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                              +.  .++.|. .......+..      -+...+.++++.|++.||+.|-++++.++.-.+..
T Consensus       244 --------L~--aYr~~~-~~~~e~~Le~------Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~  296 (1431)
T KOG1240|consen  244 --------LL--AYRSGN-ADDPEQLLEK------IEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV  296 (1431)
T ss_pred             --------HH--hHhccC-ccCHHHHHHh------CcCccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence                    00  011111 0000000100      00114789999999999999999999998876654

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.84  E-value=1.1e-20  Score=187.89  Aligned_cols=218  Identities=23%  Similarity=0.313  Sum_probs=159.7

Q ss_pred             HHhcCCCceeeEeeEEEecCCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCC
Q 047276          150 IASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRS  229 (453)
Q Consensus       150 l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~  229 (453)
                      |+.+.|.|+.+++|.|.. +...+.|.+||..|+|.+.+....         ..++|.....+..+++.||+|||..  +
T Consensus         1 l~~l~h~n~~~f~g~~~~-~~~~~~i~~~c~rGsl~D~i~~~~---------~~~d~~F~~s~~rdi~~Gl~ylh~s--~   68 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVD-GPEMIVIWEYCSRGSLLDILSNED---------IKLDYFFILSFIRDISKGLAYLHNS--P   68 (484)
T ss_pred             CcccchhhhhhheeeEec-CCceEEEEeeecCccHHhHHhccc---------cCccHHHHHHHHHHHHHHHHHHhcC--c
Confidence            356889999999999984 578899999999999999996532         2389999999999999999999983  3


Q ss_pred             ceeccCCCCCcEEECCCCcEEEeeccccccccCCC-CceeeeccCCccccchhhhhcC---C----CCccccchhHHHHH
Q 047276          230 RVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ-SRCITTIRGTRGYLAPEWILEQ---G----VSEKCDIYSYGMVL  301 (453)
Q Consensus       230 ~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~---~----~~~~sDV~S~Gvil  301 (453)
                      -..|+.++++|+++|..+.+||+|||+........ ........-..-|.|||.+...   .    .+.+.||||||+++
T Consensus        69 i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~  148 (484)
T KOG1023|consen   69 IGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIM  148 (484)
T ss_pred             ceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHH
Confidence            33999999999999999999999999988764311 1111122234579999988753   1    46789999999999


Q ss_pred             HHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCH
Q 047276          302 LELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSM  381 (453)
Q Consensus       302 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  381 (453)
                      +|+++.+.||.........         ......++. .....+-|.+...    .+....+..++..||..+|++||++
T Consensus       149 ~ei~~r~~~~~~~~~~~~~---------~eii~~~~~-~~~~~~rP~i~~~----~e~~~~l~~l~~~cw~e~P~~rPs~  214 (484)
T KOG1023|consen  149 YEILFRSGPFDLRNLVEDP---------DEIILRVKK-GGSNPFRPSIELL----NELPPELLLLVARCWEEIPEKRPSI  214 (484)
T ss_pred             HHHHhccCccccccccCCh---------HHHHHHHHh-cCCCCcCcchhhh----hhcchHHHHHHHHhcccChhhCccH
Confidence            9999999999643222111         011111222 1111122222111    1233368999999999999999999


Q ss_pred             HHHHHHhccccC
Q 047276          382 ARVVEMLEGRVA  393 (453)
Q Consensus       382 ~~v~~~L~~~~~  393 (453)
                      ++|...++....
T Consensus       215 ~~i~~~~~~~~~  226 (484)
T KOG1023|consen  215 EQIRSKLLTINK  226 (484)
T ss_pred             HHHHhhhhhhcc
Confidence            999998876544

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.81  E-value=1.2e-19  Score=170.11  Aligned_cols=230  Identities=20%  Similarity=0.267  Sum_probs=144.9

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhcCC----------CceeeEeeEEEecCC
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASAQH----------VNLVRLLGYCVVPGG  170 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h----------~niv~l~g~~~~~~~  170 (453)
                      .+.||.|+++.||.++.. +|+++|+|++...    ....+++.+|.-....+.+          -.++--++.....+.
T Consensus        17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~   96 (288)
T PF14531_consen   17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK   96 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred             ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence            468999999999999975 5899999987532    2234566666644444322          111111111111110


Q ss_pred             ----------------CeEEEEEecCCCChhhhhc---cCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCce
Q 047276          171 ----------------PRYLVYEFIQNGSLDHWIF---PTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRV  231 (453)
Q Consensus       171 ----------------~~~lv~e~~~~gsL~~~l~---~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~i  231 (453)
                                      ..+++|+-+ .+||.+++.   .....      ...+....++.+..|+++.+++||+   .|+
T Consensus        97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~------~~~l~~~arl~lT~Q~I~lvA~Lh~---~Gl  166 (288)
T PF14531_consen   97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT------HSPLAFAARLSLTVQMIRLVANLHS---YGL  166 (288)
T ss_dssp             -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT------SHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred             CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc------cchhHHHHHHHHHHHHHHHHHHHhh---cce
Confidence                            336778877 458888753   22111      1225556678888999999999999   899


Q ss_pred             eccCCCCCcEEECCCCcEEEeeccccccccCCCCceeeeccCCccccchhhhhcC--------CCCccccchhHHHHHHH
Q 047276          232 LHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQ--------GVSEKCDIYSYGMVLLE  303 (453)
Q Consensus       232 vH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~sDV~S~Gvil~e  303 (453)
                      +|+||+|+|++++.+|.++|+||+........    ......+..|.+||.....        .++.+.|.|++|+++|.
T Consensus       167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~  242 (288)
T PF14531_consen  167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTR----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS  242 (288)
T ss_dssp             EEST-SGGGEEE-TTS-EEE--GGGEEETTEE----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred             EecccceeeEEEcCCCCEEEcChHHHeecCce----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence            99999999999999999999999876543221    1113455789999977542        47889999999999999


Q ss_pred             HHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCC
Q 047276          304 LTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLR  378 (453)
Q Consensus       304 lltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~R  378 (453)
                      |++|+.||....+.....   |                      .+   ..+. +.+..+..|+...|+.||++|
T Consensus       243 lWC~~lPf~~~~~~~~~~---~----------------------~f---~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  243 LWCGRLPFGLSSPEADPE---W----------------------DF---SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHSS-STCCCGGGSTSG---G----------------------GG---TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHccCCCCCCCcccccc---c----------------------cc---hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            999999997543322111   0                      11   2244 667779999999999999988

>PRK10345 hypothetical protein; Provisional

Probab=99.80  E-value=3.7e-19  Score=161.30  Aligned_cols=134  Identities=23%  Similarity=0.304  Sum_probs=102.4

Q ss_pred             hcccCcCCceEEEEEEeCCCcEEEEEEecCC-CccHHHHHHHHHHHHhc-----CCCceeeEeeEEEecCC--C-eEEEE
Q 047276          106 QALLGHGSSASVFKGILSDGTSVAVKRINGE-ENGEKEFRSEVAAIASA-----QHVNLVRLLGYCVVPGG--P-RYLVY  176 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~-~~~~~~~~~E~~~l~~l-----~h~niv~l~g~~~~~~~--~-~~lv~  176 (453)
                      .++||+|+||.||. .-.++.. +||++... ....+.+.+|+.+++.+     .||||++++|++.++.+  . ..+|+
T Consensus         7 ~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~   84 (210)
T PRK10345          7 QSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA   84 (210)
T ss_pred             cceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence            36899999999996 2234444 79988653 33456799999999999     57999999999876532  2 23789


Q ss_pred             Ee--cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHh-ccccccCCCceeccCCCCCcEEECC----CCcE
Q 047276          177 EF--IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL-SYLHNDCRSRVLHLDVKPENILLDE----NYRA  249 (453)
Q Consensus       177 e~--~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L-~~Lh~~~~~~ivH~Dlk~~NiLl~~----~~~~  249 (453)
                      ||  +++|+|.+++...           .+++.  ..++.+++.++ +|||+   .+|+||||||+|||++.    ++.+
T Consensus        85 e~~G~~~~tL~~~l~~~-----------~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~  148 (210)
T PRK10345         85 DFDGKPSITLTEFAEQC-----------RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIP  148 (210)
T ss_pred             cCCCCcchhHHHHHHcc-----------cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcE
Confidence            99  5679999999432           14444  35577888777 99999   89999999999999974    3489


Q ss_pred             EEeecccc
Q 047276          250 VVSDFGLS  257 (453)
Q Consensus       250 kl~DfGla  257 (453)
                      +|+||+.+
T Consensus       149 ~LiDg~G~  156 (210)
T PRK10345        149 VVCDNIGE  156 (210)
T ss_pred             EEEECCCC
Confidence            99995544

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.80  E-value=1.8e-20  Score=186.34  Aligned_cols=224  Identities=24%  Similarity=0.247  Sum_probs=170.9

Q ss_pred             ccCcCCceEEEEEE----eCCCcEEEEEEecCCC---ccHHHHHHHHHHHHhcC-CCceeeEeeEEEecCCCeEEEEEec
Q 047276          108 LLGHGSSASVFKGI----LSDGTSVAVKRINGEE---NGEKEFRSEVAAIASAQ-HVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       108 ~lG~G~fG~Vy~~~----~~~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      .+|+|.||.|+...    .+.|..+|.|+++...   ........|-.++...+ ||.+|++.- +...+...+++.+|.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhy-afqt~~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHY-AFQTDGKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeee-eeccccchhHhhhhc
Confidence            47999999998765    3346778888876521   11114556788888887 999999874 455677889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      .+|.|...+....          ..++.........++-+++++|+   .+++|||+|++||+++.+|++++.|||+++.
T Consensus        80 rgg~lft~l~~~~----------~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske  146 (612)
T KOG0603|consen   80 RGGDLFTRLSKEV----------MFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKE  146 (612)
T ss_pred             ccchhhhccccCC----------chHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhH
Confidence            9999988885433          26677777788899999999999   8999999999999999999999999999987


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      .-.....     +||..|||||.+.  .....+|-||||++++||+||-.||..                +......+  
T Consensus       147 ~v~~~~~-----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------------~~~~~Il~--  201 (612)
T KOG0603|consen  147 AVKEKIA-----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------------DTMKRILK--  201 (612)
T ss_pred             hHhhhhc-----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------------HHHHHHhh--
Confidence            6443322     8999999999888  467899999999999999999999853                00111111  


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCH
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSM  381 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  381 (453)
                                 .....+.+......++.......+|.+|--.
T Consensus       202 -----------~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  202 -----------AELEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             -----------hccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence                       0123455556666777777777777777654

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.79  E-value=5e-19  Score=187.69  Aligned_cols=188  Identities=20%  Similarity=0.212  Sum_probs=149.4

Q ss_pred             HhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcC---CCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQ---HVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      +.+.||+|+||+||+|...+|+.||+|+-+....++  |.--.+++.+|+   -+-|.++..... -.+.-+||+||.+.
T Consensus       702 I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE--fYI~~q~~~RLk~~~~~~~~~~~~a~~-~~~~S~lv~ey~~~  778 (974)
T KOG1166|consen  702 ISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE--FYICLQVMERLKPQMLPSIMHISSAHV-FQNASVLVSEYSPY  778 (974)
T ss_pred             EEeeeccccceEEEEeecCCCcEEEEEeecCCCcee--eeehHHHHHhhchhhhcchHHHHHHHc-cCCcceeeeecccc
Confidence            357899999999999998889999999987655442  332334444554   122233322222 23466899999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEEC-------CCCcEEEeec
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD-------ENYRAVVSDF  254 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~-------~~~~~kl~Df  254 (453)
                      |+|.+++...          +..+|...+.+..|+++.+++||.   .+|||+||||+|.||.       ++..++|+||
T Consensus       779 Gtlld~~N~~----------~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf  845 (974)
T KOG1166|consen  779 GTLLDLINTN----------KVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLIDF  845 (974)
T ss_pred             ccHHHhhccC----------CCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEEec
Confidence            9999999632          348999999999999999999999   8999999999999994       3457899999


Q ss_pred             cccccccC-CCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCC
Q 047276          255 GLSKLMSR-DQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR  308 (453)
Q Consensus       255 Gla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~  308 (453)
                      |.+-.+.- .........++|-++-.+|...+..++.+.|.|.++.+++-|+-|+
T Consensus       846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence            99977643 2234567788999999999999999999999999999999999997

>smart00090 RIO RIO-like kinase

Probab=99.77  E-value=3.1e-18  Score=159.00  Aligned_cols=139  Identities=17%  Similarity=0.183  Sum_probs=107.3

Q ss_pred             HHHhcccCcCCceEEEEEE--eCCCcEEEEEEecCCCc---c----------------------HHHHHHHHHHHHhcCC
Q 047276          103 DNFQALLGHGSSASVFKGI--LSDGTSVAVKRINGEEN---G----------------------EKEFRSEVAAIASAQH  155 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~--~~~g~~vavK~~~~~~~---~----------------------~~~~~~E~~~l~~l~h  155 (453)
                      +.+.+.||+|+||.||+|.  ..+|+.||+|+++....   .                      ...+..|+..+.++.+
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            3456799999999999998  56899999999874321   0                      1235679999999975


Q ss_pred             C--ceeeEeeEEEecCCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCc-ee
Q 047276          156 V--NLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSR-VL  232 (453)
Q Consensus       156 ~--niv~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~-iv  232 (453)
                      .  .+.+++++     ...++||||+++++|..+....          ..+.......++.|++.++++||+   .+ ++
T Consensus       110 ~~i~~p~~~~~-----~~~~lV~E~~~g~~L~~~~~~~----------~~~~~~~~~~i~~qi~~~l~~LH~---~g~ii  171 (237)
T smart00090      110 AGVPVPKPIAW-----RRNVLVMEFIGGDGLPAPRLKD----------VEPEEEEEFELYDDILEEMRKLYK---EGELV  171 (237)
T ss_pred             cCCCCCeeeEe-----cCceEEEEEecCCccccccccc----------CCcchHHHHHHHHHHHHHHHHHHh---cCCEE
Confidence            3  34444443     1348999999998887654221          124555667899999999999999   78 99


Q ss_pred             ccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          233 HLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       233 H~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      ||||||+||+++ ++.++|+|||.+...
T Consensus       172 H~Dikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      172 HGDLSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             eCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence            999999999999 889999999998754

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.76  E-value=6.2e-18  Score=154.76  Aligned_cols=133  Identities=20%  Similarity=0.319  Sum_probs=110.0

Q ss_pred             cccCcCCceEEEEEEeCCCcEEEEEEecCCCc---------cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          107 ALLGHGSSASVFKGILSDGTSVAVKRINGEEN---------GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      +.||+|++|.||+|.. +|..+++|+......         ....+.+|+.++..++|+|+.....++. ..+..+++||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFV-DPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEE-eCCCCEEEEE
Confidence            4699999999999988 577899998654221         1135778999999999998877666665 3456789999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |+++++|.+++..             ..+ .+..++.+++.+|.++|+   .+++|+|++|.|||++ ++.++|+|||++
T Consensus        80 ~~~G~~L~~~~~~-------------~~~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a  141 (211)
T PRK14879         80 YIEGEPLKDLINS-------------NGM-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLA  141 (211)
T ss_pred             EeCCcCHHHHHHh-------------ccH-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcc
Confidence            9999999998842             122 778999999999999999   8999999999999999 789999999998


Q ss_pred             cc
Q 047276          258 KL  259 (453)
Q Consensus       258 ~~  259 (453)
                      ..
T Consensus       142 ~~  143 (211)
T PRK14879        142 EF  143 (211)
T ss_pred             cC
Confidence            64

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.76  E-value=6e-18  Score=153.33  Aligned_cols=136  Identities=17%  Similarity=0.218  Sum_probs=107.0

Q ss_pred             HHHhcccCcCCceEEEEEEeCCCcEEEEEEecCCCcc-----------------------HHHHHHHHHHHHhcCCCc--
Q 047276          103 DNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENG-----------------------EKEFRSEVAAIASAQHVN--  157 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~-----------------------~~~~~~E~~~l~~l~h~n--  157 (453)
                      +.+.+.||+|+||.||++..++|+.||||++......                       ...+..|..++..+.|++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            4556889999999999999888999999987642210                       113567888899998774  


Q ss_pred             eeeEeeEEEecCCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCC
Q 047276          158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVK  237 (453)
Q Consensus       158 iv~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk  237 (453)
                      +...++.     ...+++|||+++++|......                .....++.+++.++.++|+   .+++|||||
T Consensus        97 v~~~~~~-----~~~~lv~e~~~g~~L~~~~~~----------------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~  152 (198)
T cd05144          97 VPKPIDW-----NRHAVVMEYIDGVELYRVRVL----------------EDPEEVLDEILEEIVKAYK---HGIIHGDLS  152 (198)
T ss_pred             CCceeec-----CCceEEEEEeCCcchhhcccc----------------ccHHHHHHHHHHHHHHHHH---CCCCcCCCC
Confidence            4444432     345899999999999765410                2245788899999999999   899999999


Q ss_pred             CCcEEECCCCcEEEeeccccccccC
Q 047276          238 PENILLDENYRAVVSDFGLSKLMSR  262 (453)
Q Consensus       238 ~~NiLl~~~~~~kl~DfGla~~~~~  262 (453)
                      |+||++++++.++|+|||++.....
T Consensus       153 p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         153 EFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             cccEEEcCCCcEEEEECCccccCCC
Confidence            9999999999999999999965543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.73  E-value=2e-17  Score=149.99  Aligned_cols=129  Identities=21%  Similarity=0.349  Sum_probs=103.3

Q ss_pred             ccCcCCceEEEEEEeCCCcEEEEEEecCCC--c-------cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEe
Q 047276          108 LLGHGSSASVFKGILSDGTSVAVKRINGEE--N-------GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       108 ~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~--~-------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      +||+|+||.||+|.+ +|..+++|......  .       ....+.+|++++..++|+++.....++. ..+..+++|||
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV-DPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEE-ECCCCEEEEEE
Confidence            489999999999996 57889999865321  1       1245778999999999887544444444 34466899999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +++++|.+++....           .      .++.+++.+|.+||+   .+++|+|++|+||+++ ++.++++|||++.
T Consensus        79 ~~g~~l~~~~~~~~-----------~------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~  137 (199)
T TIGR03724        79 IEGKPLKDVIEEGN-----------D------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGK  137 (199)
T ss_pred             ECCccHHHHHhhcH-----------H------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCc
Confidence            99999998873210           0      789999999999999   8999999999999999 8899999999986


Q ss_pred             c
Q 047276          259 L  259 (453)
Q Consensus       259 ~  259 (453)
                      .
T Consensus       138 ~  138 (199)
T TIGR03724       138 Y  138 (199)
T ss_pred             C
Confidence            5

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.73  E-value=1.2e-17  Score=157.30  Aligned_cols=198  Identities=21%  Similarity=0.264  Sum_probs=139.0

Q ss_pred             CCCceeeEeeEEEe--------------------------cCCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHH
Q 047276          154 QHVNLVRLLGYCVV--------------------------PGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWD  207 (453)
Q Consensus       154 ~h~niv~l~g~~~~--------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~  207 (453)
                      +|||||++.+++.+                          .+...|+||.-++. +|..|+..+.           .+..
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-----------~s~r  341 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-----------RSYR  341 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-----------CchH
Confidence            59999999987653                          12345889988866 9999995443           5666


Q ss_pred             HHHHHHHHHHHHhccccccCCCceeccCCCCCcEEE--CCCC--cEEEeeccccccccCCC-----CceeeeccCCcccc
Q 047276          208 LRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILL--DENY--RAVVSDFGLSKLMSRDQ-----SRCITTIRGTRGYL  278 (453)
Q Consensus       208 ~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl--~~~~--~~kl~DfGla~~~~~~~-----~~~~~~~~gt~~y~  278 (453)
                      ...-++.|+++|+.|||.   ++|.|||+|++|||+  |+|+  ...|+|||++---....     ........|.-..|
T Consensus       342 ~~~~~laQlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lm  418 (598)
T KOG4158|consen  342 TGRVILAQLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLM  418 (598)
T ss_pred             HHHHHHHHHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceec
Confidence            777899999999999999   899999999999999  4454  56789999875322110     11123345777899


Q ss_pred             chhhhhcCC------CCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcccccccccccCC
Q 047276          279 APEWILEQG------VSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDE  352 (453)
Q Consensus       279 aPE~~~~~~------~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  352 (453)
                      |||......      --.|+|.|+.|.+.||+++...||.....   ...         -...+++..+     |.    
T Consensus       419 APEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe---m~L---------~~r~Yqe~qL-----Pa----  477 (598)
T KOG4158|consen  419 APEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE---MLL---------DTRTYQESQL-----PA----  477 (598)
T ss_pred             chhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch---hee---------chhhhhhhhC-----CC----
Confidence            999886422      12589999999999999999999964110   000         0001111111     12    


Q ss_pred             CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 047276          353 GGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE  389 (453)
Q Consensus       353 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~  389 (453)
                        .+..+...+.+++...++.||++||+..-..+.|+
T Consensus       478 --lp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  478 --LPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             --CcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence              22334445788888899999999999887777665

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.72  E-value=3.7e-17  Score=170.13  Aligned_cols=131  Identities=21%  Similarity=0.300  Sum_probs=106.1

Q ss_pred             hcccCcCCceEEEEEEeCCCcEEEEEEec-CC-C-------ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEE
Q 047276          106 QALLGHGSSASVFKGILSDGTSVAVKRIN-GE-E-------NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVY  176 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~~g~~vavK~~~-~~-~-------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~  176 (453)
                      .+.||+|+||+||+|.+.+. .+++|+.. .. .       ...+.+.+|++++..++|+|++....++.. ....++||
T Consensus       338 ~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-~~~~~lv~  415 (535)
T PRK09605        338 DHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD-PEEKTIVM  415 (535)
T ss_pred             cceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe-CCCCEEEE
Confidence            57899999999999997644 34444332 11 1       112458899999999999999887777653 45678999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||+++++|.+++.                  ....++.+++++|.|||+   .+++||||||+|||+ +++.++|+|||+
T Consensus       416 E~~~g~~L~~~l~------------------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGl  473 (535)
T PRK09605        416 EYIGGKDLKDVLE------------------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGL  473 (535)
T ss_pred             EecCCCcHHHHHH------------------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCcc
Confidence            9999999998872                  346789999999999999   899999999999999 678999999999


Q ss_pred             cccc
Q 047276          257 SKLM  260 (453)
Q Consensus       257 a~~~  260 (453)
                      ++..
T Consensus       474 a~~~  477 (535)
T PRK09605        474 GKYS  477 (535)
T ss_pred             cccC
Confidence            9753

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.70  E-value=3.9e-18  Score=166.79  Aligned_cols=123  Identities=31%  Similarity=0.499  Sum_probs=106.7

Q ss_pred             CeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEE
Q 047276          171 PRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV  250 (453)
Q Consensus       171 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~k  250 (453)
                      .+++.|++|...+|.+||.....       ....+|.....++.|++.|++|      ++.+|+|+||.||+...+..+|
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~-------~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~k  396 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRT-------GEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLK  396 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCc-------ccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhh
Confidence            46789999999999999964442       2337888899999999999999      3899999999999999999999


Q ss_pred             EeeccccccccCCC-----CceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc
Q 047276          251 VSDFGLSKLMSRDQ-----SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG  306 (453)
Q Consensus       251 l~DfGla~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt  306 (453)
                      |.|||+........     ....+...||..||+||.+.+..|+.|+|+||+|++|+||++
T Consensus       397 IgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  397 IGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             hhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            99999988765443     233456789999999999999999999999999999999997

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.68  E-value=8.8e-17  Score=144.20  Aligned_cols=137  Identities=19%  Similarity=0.240  Sum_probs=97.8

Q ss_pred             hcccCcCCceEEEEEEeCCCcEEEEEEecCCCccH---HHH----------------------HHHHHHHHhcCCCc--e
Q 047276          106 QALLGHGSSASVFKGILSDGTSVAVKRINGEENGE---KEF----------------------RSEVAAIASAQHVN--L  158 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~---~~~----------------------~~E~~~l~~l~h~n--i  158 (453)
                      .+.||+|+||+||+|...+|+.||||+++......   ..+                      ..|...+..+.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            36799999999999998889999999987532111   111                      34556666664432  4


Q ss_pred             eeEeeEEEecCCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCC
Q 047276          159 VRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKP  238 (453)
Q Consensus       159 v~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~  238 (453)
                      .+.+++     ...++||||++++++........          ... .....++.+++.++.++|..  .+++|+||||
T Consensus        82 ~~~~~~-----~~~~lv~e~~~g~~~~~~~l~~~----------~~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p  143 (187)
T cd05119          82 PKPIDL-----NRHVLVMEFIGGDGIPAPRLKDV----------RLL-EDPEELYDQILELMRKLYRE--AGLVHGDLSE  143 (187)
T ss_pred             CceEec-----CCCEEEEEEeCCCCccChhhhhh----------hhc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCCh
Confidence            444432     24589999999965432111000          011 45678999999999999974  6899999999


Q ss_pred             CcEEECCCCcEEEeecccccccc
Q 047276          239 ENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       239 ~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      +||+++ ++.++|+|||.+....
T Consensus       144 ~Nili~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         144 YNILVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             hhEEEE-CCcEEEEECccccccc
Confidence            999999 8999999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.65  E-value=1.4e-15  Score=141.55  Aligned_cols=134  Identities=19%  Similarity=0.209  Sum_probs=104.5

Q ss_pred             cccC-cCCceEEEEEEeCCCcEEEEEEecCC--------------CccHHHHHHHHHHHHhcCCCce--eeEeeEEEecC
Q 047276          107 ALLG-HGSSASVFKGILSDGTSVAVKRINGE--------------ENGEKEFRSEVAAIASAQHVNL--VRLLGYCVVPG  169 (453)
Q Consensus       107 ~~lG-~G~fG~Vy~~~~~~g~~vavK~~~~~--------------~~~~~~~~~E~~~l~~l~h~ni--v~l~g~~~~~~  169 (453)
                      ..|| .|+.|+||+.... +..++||.+...              ......+.+|+.++..++|+++  +..++++....
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            5788 8999999999885 677899877421              1123457889999999998774  67777654333


Q ss_pred             CCe---EEEEEecCC-CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECC
Q 047276          170 GPR---YLVYEFIQN-GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDE  245 (453)
Q Consensus       170 ~~~---~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~  245 (453)
                      ...   ++|+||+++ .+|.+++...           .++..    .+.+++.+|.+||+   .+|+||||||.|||++.
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~~-----------~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~  177 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQEA-----------PLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDP  177 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhcC-----------CCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcC
Confidence            322   499999997 6898887421           24443    35689999999999   89999999999999999


Q ss_pred             CCcEEEeecccccc
Q 047276          246 NYRAVVSDFGLSKL  259 (453)
Q Consensus       246 ~~~~kl~DfGla~~  259 (453)
                      ++.++|+|||.+..
T Consensus       178 ~~~v~LIDfg~~~~  191 (239)
T PRK01723        178 DGKFWLIDFDRGEL  191 (239)
T ss_pred             CCCEEEEECCCccc
Confidence            99999999999875

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.64  E-value=1.4e-16  Score=166.42  Aligned_cols=202  Identities=24%  Similarity=0.336  Sum_probs=133.9

Q ss_pred             cccCcCCceEEEEEEeCC-CcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCChh
Q 047276          107 ALLGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLD  185 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL~  185 (453)
                      ++|..|+||.||..+++. .+.+|.| +++..-          ++     +||..+.      + ..++|      |+-.
T Consensus        89 klisngAygavylvrh~~trqrfa~k-iNkq~l----------il-----Rnilt~a------~-npfvv------gDc~  139 (1205)
T KOG0606|consen   89 KLISNGAYGAVYLVRHKETRQRFAMK-INKQNL----------IL-----RNILTFA------G-NPFVV------GDCA  139 (1205)
T ss_pred             EeeccCCCCceeeeeccccccchhhc-ccccch----------hh-----hcccccc------C-Cccee------chhh
Confidence            689999999999998764 5667773 332111          11     1122211      1 12222      5555


Q ss_pred             hhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCCCC
Q 047276          186 HWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQS  265 (453)
Q Consensus       186 ~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~  265 (453)
                      ..+...          +.++.        +.+.+++|||+   .+|+|||+||+|.+|+.-|++|++|||+.+.......
T Consensus       140 tllk~~----------g~lPv--------dmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  140 TLLKNI----------GPLPV--------DMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             hhcccC----------CCCcc--------hhhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence            555322          22332        23889999999   8999999999999999999999999999875432111


Q ss_pred             --------------ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHH
Q 047276          266 --------------RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKI  331 (453)
Q Consensus       266 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~  331 (453)
                                    -.....+||+.|.|||++....|....|.|++|+|+||.+-|+.||....+..            +
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee------------l  266 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------------L  266 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH------------H
Confidence                          11234689999999999999999999999999999999999999996432211            0


Q ss_pred             HHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCC
Q 047276          332 VNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPS  380 (453)
Q Consensus       332 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs  380 (453)
                      +...+.+..       .+.  . -++....+..+++.+.++.+|..|--
T Consensus       267 fg~visd~i-------~wp--E-~dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  267 FGQVISDDI-------EWP--E-EDEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             Hhhhhhhhc-------ccc--c-cCcCCCHHHHHHHHHHHHhChHhhcc
Confidence            111111100       000  0 02233345778888889999998853

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.64  E-value=2.4e-15  Score=129.17  Aligned_cols=133  Identities=24%  Similarity=0.264  Sum_probs=110.5

Q ss_pred             cccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCC--CceeeEeeEEEecCCCeEEEEEecCCCCh
Q 047276          107 ALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQH--VNLVRLLGYCVVPGGPRYLVYEFIQNGSL  184 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~~lv~e~~~~gsL  184 (453)
                      +.||+|.++.||++...+ ..+++|....... ...+..|+..+..++|  .++.+++++.. ..+..++++||++++++
T Consensus         4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~-~~~~~~~v~e~~~g~~~   80 (155)
T cd05120           4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGE-SDGWSYLLMEWIEGETL   80 (155)
T ss_pred             eecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcC-CCCccEEEEEecCCeec
Confidence            579999999999999864 7899999876443 5678999999999976  58888888754 44678999999988777


Q ss_pred             hhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       185 ~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ..+                 +......++.+++++++++|.....+++|+|++|+||+++.++.+++.|||.+..
T Consensus        81 ~~~-----------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          81 DEV-----------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ccC-----------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            543                 4455677899999999999985445799999999999999999999999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.56  E-value=6.1e-16  Score=160.98  Aligned_cols=248  Identities=23%  Similarity=0.266  Sum_probs=176.6

Q ss_pred             HhcccCcCCceEEEEEEeCC--CcEEEEEEecCCC---ccHHHHHHHHHHHHhcC-CCceeeEeeEEEecCCCeEEEEEe
Q 047276          105 FQALLGHGSSASVFKGILSD--GTSVAVKRINGEE---NGEKEFRSEVAAIASAQ-HVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~--g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      +.+.||+|.|+.|-......  ...+|+|.+....   ........|..+-..+. |+|++.+++... ..+..++..+|
T Consensus        24 ~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~-~~~~~~~~~~~  102 (601)
T KOG0590|consen   24 LSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSS-SPRSYLLSLSY  102 (601)
T ss_pred             ccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccC-CCcccccccCc
Confidence            34569999999998777533  3456666665432   22234445777777776 999999999754 56678899999


Q ss_pred             cCCCChhhhhc-cCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhcccc-ccCCCceeccCCCCCcEEECCCC-cEEEeecc
Q 047276          179 IQNGSLDHWIF-PTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH-NDCRSRVLHLDVKPENILLDENY-RAVVSDFG  255 (453)
Q Consensus       179 ~~~gsL~~~l~-~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh-~~~~~~ivH~Dlk~~NiLl~~~~-~~kl~DfG  255 (453)
                      ..+|++.+-+. ...         ...+....-.+..|+..++.|+| .   .++.|+|+||+|.+++..+ ..+++|||
T Consensus       103 s~g~~~f~~i~~~~~---------~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~  170 (601)
T KOG0590|consen  103 SDGGSLFSKISHPDS---------TGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFG  170 (601)
T ss_pred             ccccccccccccCCc---------cCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCch
Confidence            99999988773 221         01344445678899999999999 6   8999999999999999999 99999999


Q ss_pred             ccccccC-C-CCceeeeccC-CccccchhhhhcC-CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHH
Q 047276          256 LSKLMSR-D-QSRCITTIRG-TRGYLAPEWILEQ-GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKI  331 (453)
Q Consensus       256 la~~~~~-~-~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~  331 (453)
                      +|..+.. . .........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+......... ...|      
T Consensus       171 ~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~------  243 (601)
T KOG0590|consen  171 LATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSW------  243 (601)
T ss_pred             hhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceee------
Confidence            9998876 3 3334455678 9999999988874 4567899999999999999999998644322211 0011      


Q ss_pred             HHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 047276          332 VNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVV  385 (453)
Q Consensus       332 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~  385 (453)
                                   .+..................++...++..+|..|.+.+++.
T Consensus       244 -------------~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  244 -------------KSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             -------------cccccccccCccccCChhhhhcccccccCCchhcccccccc
Confidence                         11100000011122233467788888889999999988865

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.52  E-value=6.2e-14  Score=141.55  Aligned_cols=140  Identities=25%  Similarity=0.274  Sum_probs=100.2

Q ss_pred             cccCcCCceEEEEEEeCCCcEEEEEEecCCCcc-----------------------------------------HHHHHH
Q 047276          107 ALLGHGSSASVFKGILSDGTSVAVKRINGEENG-----------------------------------------EKEFRS  145 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~-----------------------------------------~~~~~~  145 (453)
                      +.||.|++|.||+|++.+|+.||||+.+.....                                         +-+|..
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            469999999999999999999999998653100                                         002445


Q ss_pred             HHHHHHhc----CCCceeeEeeEEEecCCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHH-Hh
Q 047276          146 EVAAIASA----QHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK-AL  220 (453)
Q Consensus       146 E~~~l~~l----~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~-~L  220 (453)
                      |+..+.++    +|.+-+.+-.++.......++||||+++++|.++......         ..+   +.+++..++. .+
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---------~~~---~~~ia~~~~~~~l  270 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---------GLD---RKALAENLARSFL  270 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---------CCC---HHHHHHHHHHHHH
Confidence            55555554    2333344444444344567999999999999887642111         022   3456666665 46


Q ss_pred             ccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       221 ~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      ..+|.   .+++|+|++|.||++++++.++++|||++..+.
T Consensus       271 ~ql~~---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       271 NQVLR---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHh---CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            77887   899999999999999999999999999997664

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.48  E-value=4.4e-14  Score=130.67  Aligned_cols=154  Identities=21%  Similarity=0.305  Sum_probs=115.8

Q ss_pred             HHHHhcCCCceeeEeeEEEecC----CCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccc
Q 047276          148 AAIASAQHVNLVRLLGYCVVPG----GPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL  223 (453)
Q Consensus       148 ~~l~~l~h~niv~l~g~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~L  223 (453)
                      .-|-.+-|.|||++..|+.+..    ....++.|||..|+|..+|+..+.      ....+......+++.||..||.||
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~------~~~a~~~~~wkkw~tqIlsal~yL  192 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK------NQKALFQKAWKKWCTQILSALSYL  192 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH------hhhhhhHHHHHHHHHHHHhhhhhh
Confidence            3455667999999998865322    245789999999999999976543      233467777789999999999999


Q ss_pred             cccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCCC----CceeeeccCCccccchhhhhcCCCCccccchhHHH
Q 047276          224 HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ----SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGM  299 (453)
Q Consensus       224 h~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gv  299 (453)
                      |+ |.++++|+++..+.|++..+|-+||.--. ........    ........+-++|.+||+-..-+.+..+|||+||.
T Consensus       193 hs-~~PpiihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgm  270 (458)
T KOG1266|consen  193 HS-CDPPIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGM  270 (458)
T ss_pred             hc-cCCccccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhH
Confidence            98 67999999999999999999999874221 11111100    01112234678999999877777788999999999


Q ss_pred             HHHHHHcCCC
Q 047276          300 VLLELTGGRR  309 (453)
Q Consensus       300 il~elltG~~  309 (453)
                      ..+||..|..
T Consensus       271 cAlemailEi  280 (458)
T KOG1266|consen  271 CALEMAILEI  280 (458)
T ss_pred             HHHHHHHhee
Confidence            9999988764

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.39  E-value=1.9e-12  Score=113.90  Aligned_cols=130  Identities=20%  Similarity=0.156  Sum_probs=96.0

Q ss_pred             cccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceee-EeeEEEecCCCeEEEEEecCCCChh
Q 047276          107 ALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVR-LLGYCVVPGGPRYLVYEFIQNGSLD  185 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~g~~~~~~~~~~lv~e~~~~gsL~  185 (453)
                      +.|+.|.++.||++... +..+++|...........+..|+..+..+.+.++++ ++++ .  ....++||||+++.++.
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~-~--~~~~~lv~e~i~G~~l~   79 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYF-D--PETGVLITEFIEGSELL   79 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEE-e--CCCCeEEEEecCCCccc
Confidence            45889999999999875 778999987654333345678999999987655544 4433 2  23458999999998875


Q ss_pred             hhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccC--CCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          186 HWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDC--RSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       186 ~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~--~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      +..               ..   ...++.+++++|+.||+..  ...++|+|++|.||+++ ++.++++|||.+..
T Consensus        80 ~~~---------------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          80 TED---------------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccc---------------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            431               00   1245678999999999832  12369999999999999 66899999998763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.37  E-value=2.5e-12  Score=131.54  Aligned_cols=142  Identities=18%  Similarity=0.140  Sum_probs=94.1

Q ss_pred             cccCcCCceEEEEEEeCC-CcEEEEEEecCCCc---------------------------c--------H------HHHH
Q 047276          107 ALLGHGSSASVFKGILSD-GTSVAVKRINGEEN---------------------------G--------E------KEFR  144 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~-g~~vavK~~~~~~~---------------------------~--------~------~~~~  144 (453)
                      +-||+|++|.||+|++++ |+.||||+.+..-.                           .        .      -+|.
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            469999999999999987 99999999974310                           0        0      1244


Q ss_pred             HHHHHHHhcC----CCceeeEeeEEEecCCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHh
Q 047276          145 SEVAAIASAQ----HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL  220 (453)
Q Consensus       145 ~E~~~l~~l~----h~niv~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L  220 (453)
                      +|+..+.+++    +.+.+.+-.++.+-....++||||++|+++.++-.-....    .....+.......++.|+.   
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g----~d~~~la~~~v~~~~~Qif---  277 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG----TDMKLLAERGVEVFFTQVF---  277 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC----CCHHHHHHHHHHHHHHHHH---
Confidence            4555555442    4444444444444445779999999999997752111000    0001133333334444443   


Q ss_pred             ccccccCCCceeccCCCCCcEEECCCC----cEEEeeccccccccC
Q 047276          221 SYLHNDCRSRVLHLDVKPENILLDENY----RAVVSDFGLSKLMSR  262 (453)
Q Consensus       221 ~~Lh~~~~~~ivH~Dlk~~NiLl~~~~----~~kl~DfGla~~~~~  262 (453)
                          .   .+++|+|+||.||+++.++    .+++.|||++..++.
T Consensus       278 ----~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 ----R---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ----h---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                2   6999999999999999888    999999999987654

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.31  E-value=2.7e-12  Score=128.34  Aligned_cols=249  Identities=24%  Similarity=0.245  Sum_probs=172.4

Q ss_pred             HHHHHHHHhcccCc--CCceEEEEEEe---CCCcEEEEEEecCC---CccHHHHHHHHHHHHhcC-CCceeeEeeEEEec
Q 047276           98 LEEATDNFQALLGH--GSSASVFKGIL---SDGTSVAVKRINGE---ENGEKEFRSEVAAIASAQ-HVNLVRLLGYCVVP  168 (453)
Q Consensus        98 l~~~~~~~~~~lG~--G~fG~Vy~~~~---~~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~  168 (453)
                      ...-+-++..-+|.  |.+|.||.+..   .++..+|+|+-+..   ......=.+|+....+++ |+|.++..... ..
T Consensus       111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~-e~  189 (524)
T KOG0601|consen  111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW-EG  189 (524)
T ss_pred             hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc-cc
Confidence            33344445578999  99999999986   45788999974431   122222345666666664 99999977764 46


Q ss_pred             CCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHH----HhccccccCCCceeccCCCCCcEEEC
Q 047276          169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK----ALSYLHNDCRSRVLHLDVKPENILLD  244 (453)
Q Consensus       169 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~----~L~~Lh~~~~~~ivH~Dlk~~NiLl~  244 (453)
                      ++..++-+|++. .+|..+.+....         .++....+.+..+...    |+.++|+   .+++|-|+||.||+..
T Consensus       190 ~~~lfiqtE~~~-~sl~~~~~~~~~---------~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~  256 (524)
T KOG0601|consen  190 SGILFIQTELCG-ESLQSYCHTPCN---------FLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTT  256 (524)
T ss_pred             CCcceeeecccc-chhHHhhhcccc---------cCCchhhhhHHhhhhhcccccccccCC---Ccccccccchhheecc
Confidence            678889999885 588887754322         1444555666666777    9999999   8999999999999999


Q ss_pred             CC-CcEEEeeccccccccCCCC----ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCC
Q 047276          245 EN-YRAVVSDFGLSKLMSRDQS----RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGND  319 (453)
Q Consensus       245 ~~-~~~kl~DfGla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~  319 (453)
                      .+ ..++++|||+...+....-    .+.....|...|++||.. .+.++..+|+|++|-++.+..+|..+.....    
T Consensus       257 ~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~----  331 (524)
T KOG0601|consen  257 SDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGK----  331 (524)
T ss_pred             cccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCC----
Confidence            99 8999999999988765431    222333678899999965 4567899999999999999999876643211    


Q ss_pred             CCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 047276          320 KSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVV  385 (453)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~  385 (453)
                        ...|..++.+.                +.  .++......++.....++++.+|-.|++...+.
T Consensus       332 --~~~W~~~r~~~----------------ip--~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~  377 (524)
T KOG0601|consen  332 --NSSWSQLRQGY----------------IP--LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT  377 (524)
T ss_pred             --CCCcccccccc----------------Cc--hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence              11232221110                00  112222334455688899999999999987755

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.26  E-value=6.1e-11  Score=108.97  Aligned_cols=142  Identities=21%  Similarity=0.283  Sum_probs=104.3

Q ss_pred             cccCcCCceEEEEEEeCCCcEEEEEEecCCCc--cHHHHHHHHHHHHhcCCC--ceeeEeeEEEecC--CCeEEEEEecC
Q 047276          107 ALLGHGSSASVFKGILSDGTSVAVKRINGEEN--GEKEFRSEVAAIASAQHV--NLVRLLGYCVVPG--GPRYLVYEFIQ  180 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~--niv~l~g~~~~~~--~~~~lv~e~~~  180 (453)
                      +.||.|.++.||++...+|..+++|.......  ....+..|.+++..+++.  ++.+++.++....  +..+++|||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            45899999999999987778899998765332  345788999999999763  4566777654221  25589999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhcccccc----------------------------------
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHND----------------------------------  226 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~----------------------------------  226 (453)
                      +.++.+.+..           ..++...+..++.+++++|.+||+.                                  
T Consensus        84 G~~l~~~~~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (223)
T cd05154          84 GRVLRDRLLR-----------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTD  152 (223)
T ss_pred             CEecCCCCCC-----------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccc
Confidence            9888775521           1255555666666666666666631                                  


Q ss_pred             -------------------CCCceeccCCCCCcEEECC--CCcEEEeecccccc
Q 047276          227 -------------------CRSRVLHLDVKPENILLDE--NYRAVVSDFGLSKL  259 (453)
Q Consensus       227 -------------------~~~~ivH~Dlk~~NiLl~~--~~~~kl~DfGla~~  259 (453)
                                         ....++|+|+++.||+++.  ++.+.|+||+.+..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         153 EPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             ccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                               1256899999999999998  66789999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.21  E-value=1.8e-10  Score=102.88  Aligned_cols=135  Identities=17%  Similarity=0.164  Sum_probs=96.4

Q ss_pred             cccCcCCceEEEEEEeCC-------CcEEEEEEecCCC-----------------------ccHHHHH----HHHHHHHh
Q 047276          107 ALLGHGSSASVFKGILSD-------GTSVAVKRINGEE-----------------------NGEKEFR----SEVAAIAS  152 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~-------g~~vavK~~~~~~-----------------------~~~~~~~----~E~~~l~~  152 (453)
                      -.||.|--+.||.|.-.+       +..+|||+.+...                       ...+.+.    +|...|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            368999999999998543       4789999875210                       0012233    78999998


Q ss_pred             cCC--CceeeEeeEEEecCCCeEEEEEecCCCChhh-hhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccc-cccCC
Q 047276          153 AQH--VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDH-WIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL-HNDCR  228 (453)
Q Consensus       153 l~h--~niv~l~g~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-h~~~~  228 (453)
                      +..  -++..++++     ...++||||+.++.+.. .+.           ...++......+..+++.+|..| |.   
T Consensus        83 l~~~Gv~vP~pi~~-----~~~~lvME~Ig~~~~~~~~Lk-----------d~~~~~~~~~~i~~~i~~~l~~l~H~---  143 (197)
T cd05146          83 MQKAGIPCPEVVVL-----KKHVLVMSFIGDDQVPAPKLK-----------DAKLNDEEMKNAYYQVLSMMKQLYKE---  143 (197)
T ss_pred             HHHcCCCCCeEEEe-----cCCEEEEEEcCCCCccchhhh-----------ccccCHHHHHHHHHHHHHHHHHHHHh---
Confidence            853  456666653     24589999997654421 121           11244455667889999999998 77   


Q ss_pred             CceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          229 SRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       229 ~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      .+++|+||++.|||++ ++.+.|+|||.+-...
T Consensus       144 ~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         144 CNLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            7999999999999997 4679999999886543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.10  E-value=1.8e-09  Score=106.33  Aligned_cols=177  Identities=20%  Similarity=0.273  Sum_probs=131.5

Q ss_pred             CceEEEEEEe-CCCcEEEEEEecCCCc-cHHHHHHHHHHHHhcCCCceeeEeeEEEe---cCCCeEEEEEecCC-CChhh
Q 047276          113 SSASVFKGIL-SDGTSVAVKRINGEEN-GEKEFRSEVAAIASAQHVNLVRLLGYCVV---PGGPRYLVYEFIQN-GSLDH  186 (453)
Q Consensus       113 ~fG~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~---~~~~~~lv~e~~~~-gsL~~  186 (453)
                      .-.+.||+.. .||..|++|+++.... .......-++.++++.|.|+|++..++..   .+...++||+|.++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            3457799984 5899999999954321 11123445788999999999999887652   23467899999986 47877


Q ss_pred             hhccCCCCC-----CCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          187 WIFPTSRRS-----EGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       187 ~l~~~~~~~-----~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      +-+......     .....+..+++...|.++.|+..||.++|+   .|+..+-|.+++||++.+..++|+..|......
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            665443322     111233457889999999999999999999   799999999999999999999999999887664


Q ss_pred             CCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCC
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRN  310 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p  310 (453)
                      .+..               |-+..   -.+-|.=.||.+++.|.||...
T Consensus       445 ~d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  445 EDPT---------------EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            4431               11111   2467888999999999999743

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.10  E-value=4.7e-10  Score=113.61  Aligned_cols=165  Identities=20%  Similarity=0.232  Sum_probs=119.4

Q ss_pred             eCCCcEEEEEEecCCCc-cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCChhhhhccCCCCCCCCCC
Q 047276          122 LSDGTSVAVKRINGEEN-GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYS  200 (453)
Q Consensus       122 ~~~g~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~  200 (453)
                      ..++.+|.|...+.... ......+-++.|+.++||||++++.... ..+..|+|+|-+.  .|..++..          
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e-~~~~~ylvTErV~--Pl~~~lk~----------  100 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTE-EEGTLYLVTERVR--PLETVLKE----------  100 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhc-ccCceEEEeeccc--cHHHHHHH----------
Confidence            45788999988876443 2334667788999999999999998654 5668999999874  56666632          


Q ss_pred             CCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCCCCceeeeccCCccccch
Q 047276          201 GGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAP  280 (453)
Q Consensus       201 ~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aP  280 (453)
                         +......-.+.||+.||.|||..  .+++|++|....|+++..|..||++|.++.....-.. .......-..|..|
T Consensus       101 ---l~~~~v~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P  174 (690)
T KOG1243|consen  101 ---LGKEEVCLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDP  174 (690)
T ss_pred             ---hHHHHHHHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccCh
Confidence               33344455688999999999975  7899999999999999999999999998764432111 00011111245566


Q ss_pred             hhhhcCCCCccccchhHHHHHHHHHcC
Q 047276          281 EWILEQGVSEKCDIYSYGMVLLELTGG  307 (453)
Q Consensus       281 E~~~~~~~~~~sDV~S~Gvil~elltG  307 (453)
                      +.+....  -..|.|.||++++|++.|
T Consensus       175 ~~~~~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  175 EEIDPSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             hhcCccc--cchhhhhHHHHHHHHhCc
Confidence            5432211  346999999999999999

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.07  E-value=1.5e-09  Score=93.87  Aligned_cols=128  Identities=21%  Similarity=0.311  Sum_probs=93.5

Q ss_pred             cccCcCCceEEEEEEeCCCcEEEEEEecCCC----c-----cHHHHHHHHHHHHhcCCC--ceeeEeeEEEecCCCeEEE
Q 047276          107 ALLGHGSSASVFKGILSDGTSVAVKRINGEE----N-----GEKEFRSEVAAIASAQHV--NLVRLLGYCVVPGGPRYLV  175 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~----~-----~~~~~~~E~~~l~~l~h~--niv~l~g~~~~~~~~~~lv  175 (453)
                      ..+++|+-..+|.+.+. |.++++|.-....    .     ....-.+|+.++.+++--  +...++++   +.+...++
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv---D~~~~~I~   77 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV---DPDNGLIV   77 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE---cCCCCEEE
Confidence            35789999999999875 4456666432211    1     113456799999887643  33334332   34567899


Q ss_pred             EEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecc
Q 047276          176 YEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFG  255 (453)
Q Consensus       176 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfG  255 (453)
                      |||.++-.|.+++...                 ...++..+-.-+.-||.   .+|+|+||.++|+++..+. +.++|||
T Consensus        78 me~I~G~~lkd~l~~~-----------------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfG  136 (204)
T COG3642          78 MEYIEGELLKDALEEA-----------------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFG  136 (204)
T ss_pred             EEEeCChhHHHHHHhc-----------------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECC
Confidence            9999999999888422                 24567777788888999   8999999999999998765 9999999


Q ss_pred             cccc
Q 047276          256 LSKL  259 (453)
Q Consensus       256 la~~  259 (453)
                      |+..
T Consensus       137 Lg~~  140 (204)
T COG3642         137 LGEF  140 (204)
T ss_pred             cccc
Confidence            9874

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.96  E-value=6.3e-09  Score=89.71  Aligned_cols=140  Identities=21%  Similarity=0.304  Sum_probs=96.7

Q ss_pred             cccCcCCceEEEEEEeCCCcEEEEEEec-CC---C-----ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          107 ALLGHGSSASVFKGILSDGTSVAVKRIN-GE---E-----NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~g~~vavK~~~-~~---~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      .++-+|+-+.|+++.++ |+...||.-. +.   +     -..+...+|++.|.+++--.|.-..-++. +...-.++||
T Consensus        13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~-D~~~~~i~ME   90 (229)
T KOG3087|consen   13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFI-DTYGGQIYME   90 (229)
T ss_pred             eeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEE-ecCCCeEEEE
Confidence            46889999999999985 7777777432 21   1     12345778999999876333222111222 3345579999


Q ss_pred             ecCC-CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCC---cEEEee
Q 047276          178 FIQN-GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENY---RAVVSD  253 (453)
Q Consensus       178 ~~~~-gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~---~~kl~D  253 (453)
                      |.++ .++.+++...-...        ........++..|-+.+.-||.   .+++|+||.++||++..++   .+.++|
T Consensus        91 ~~~g~~~vk~~i~~~~~~~--------~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lId  159 (229)
T KOG3087|consen   91 FIDGASTVKDFILSTMEDE--------SEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILID  159 (229)
T ss_pred             eccchhHHHHHHHHHccCc--------ccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEe
Confidence            9976 37888886543211        1222235788889999999999   8999999999999997554   458999


Q ss_pred             cccccc
Q 047276          254 FGLSKL  259 (453)
Q Consensus       254 fGla~~  259 (453)
                      ||++..
T Consensus       160 fgls~~  165 (229)
T KOG3087|consen  160 FGLSSV  165 (229)
T ss_pred             ecchhc
Confidence            999864

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.95  E-value=6.7e-09  Score=92.39  Aligned_cols=125  Identities=22%  Similarity=0.267  Sum_probs=81.0

Q ss_pred             EEEEEEeCCCcEEEEEEecCCC--------------c---------c----HHHHHHHHHHHHhcCCC--ceeeEeeEEE
Q 047276          116 SVFKGILSDGTSVAVKRINGEE--------------N---------G----EKEFRSEVAAIASAQHV--NLVRLLGYCV  166 (453)
Q Consensus       116 ~Vy~~~~~~g~~vavK~~~~~~--------------~---------~----~~~~~~E~~~l~~l~h~--niv~l~g~~~  166 (453)
                      .||.|...+|..+|||..+...              .         .    .....+|.+.|.++...  ++.+++++ .
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-~   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-N   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-E
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-e
Confidence            4899999899999999875311              0         0    12356799999999765  45666654 1


Q ss_pred             ecCCCeEEEEEecC--CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhcc-ccccCCCceeccCCCCCcEEE
Q 047276          167 VPGGPRYLVYEFIQ--NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY-LHNDCRSRVLHLDVKPENILL  243 (453)
Q Consensus       167 ~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~-Lh~~~~~~ivH~Dlk~~NiLl  243 (453)
                          ..++||||++  +..+..+....            ++......++.+++..+.. +|.   .+++|+||.+.|||+
T Consensus        80 ----~~~ivME~I~~~G~~~~~l~~~~------------~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv  140 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPRLKDVD------------LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILV  140 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGCHHHCG------------GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEE
T ss_pred             ----CCEEEEEecCCCccchhhHHhcc------------ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEe
Confidence                3489999998  54454433111            1123345667777775555 467   899999999999999


Q ss_pred             CCCCcEEEeecccccccc
Q 047276          244 DENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       244 ~~~~~~kl~DfGla~~~~  261 (453)
                      +++ .+.|+|||.+....
T Consensus       141 ~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  141 DDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             ETT-CEEE--GTTEEETT
T ss_pred             ecc-eEEEEecCcceecC
Confidence            988 99999999886543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.95  E-value=4.4e-10  Score=118.53  Aligned_cols=239  Identities=21%  Similarity=0.239  Sum_probs=152.4

Q ss_pred             ccCcCCceEEEEEEe-CCCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCC
Q 047276          108 LLGHGSSASVFKGIL-SDGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       108 ~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      -+-+|.++.++...- ..|...++|.....    ..+.+..+.+-.++-..+||-++...-- .....+..|+++|..++
T Consensus       811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s-~~~rsP~~L~~~~~~~~  889 (1205)
T KOG0606|consen  811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS-FPCRSPLPLVGHYLNGG  889 (1205)
T ss_pred             cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC-CCCCCCcchhhHHhccC
Confidence            566788888877652 22433344433221    1122223333333333445666554322 12456789999999999


Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc-
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS-  261 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~-  261 (453)
                      +|...|+...          +++..-.......+...++|||+   ..+.|+|++|.|.|...++..+++|||...... 
T Consensus       890 ~~~Skl~~~~----------~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~  956 (1205)
T KOG0606|consen  890 DLPSKLHNSG----------CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL  956 (1205)
T ss_pred             CchhhhhcCC----------CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCcccccccccc
Confidence            9999886543          24444444566678899999998   569999999999999999999999998432110 


Q ss_pred             -----CC---------------C---------CceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCc
Q 047276          262 -----RD---------------Q---------SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVS  312 (453)
Q Consensus       262 -----~~---------------~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~  312 (453)
                           ..               .         ........+|+.|.+||...+......+|.|++|++++|.++|..||.
T Consensus       957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen  957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred             ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence                 00               0         011234568999999999999999999999999999999999999996


Q ss_pred             ccccCCCCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHH
Q 047276          313 LIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMA  382 (453)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~  382 (453)
                      ...+...             -+.+..+.      ..+   ...+........++....+..+|.+|-.+.
T Consensus      1037 a~tpq~~-------------f~ni~~~~------~~~---p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQQI-------------FENILNRD------IPW---PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             Ccchhhh-------------hhccccCC------CCC---CCCccccChhhhhhhhhhhccCchhccCcc
Confidence            4332211             01111110      000   112233344566777777788888887665

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.92  E-value=1.2e-09  Score=109.64  Aligned_cols=237  Identities=22%  Similarity=0.204  Sum_probs=159.7

Q ss_pred             cccCcCCceEEEEEEe--CCCcEEEEEEecCCCc---cHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          107 ALLGHGSSASVFKGIL--SDGTSVAVKRINGEEN---GEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~--~~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      ..||.|.|+.|++...  .++..+++|.+.....   +...-..|+.+...+ .|.|++....-+. ..+..++--||++
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~-~~r~~~ip~e~~~  349 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS-QLRQGYIPLEFCE  349 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc-ccccccCchhhhc
Confidence            5799999999998774  3567899997754221   111223566666655 4777777654433 4456678999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCC-CcEEEeecccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDEN-YRAVVSDFGLSKL  259 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~-~~~kl~DfGla~~  259 (453)
                      ++++.....-          ...++...++++..|++.++.++|+   +.++|+|+||+||++..+ +..++.|||++..
T Consensus       350 ~~s~~l~~~~----------~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  350 GGSSSLRSVT----------SQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             CcchhhhhHH----------HHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccccc
Confidence            9988766521          1236777889999999999999998   899999999999999886 8889999999864


Q ss_pred             ccCCCCceeeeccCCcccc--chhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhh
Q 047276          260 MSRDQSRCITTIRGTRGYL--APEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMK  337 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (453)
                      +.-..    .......+++  +++......+..+.|+||||.-+.|.++|..--.        ....|..        +.
T Consensus       417 ~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~--------~~~~~~~--------i~  476 (524)
T KOG0601|consen  417 LAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE--------SGVQSLT--------IR  476 (524)
T ss_pred             cceec----ccccccccccccchhhccccccccccccccccccccccccCcccCc--------cccccee--------ee
Confidence            22111    1222333455  4444456678899999999999999999874321        1111111        11


Q ss_pred             cCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 047276          338 EGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE  389 (453)
Q Consensus       338 ~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~  389 (453)
                      .+..     +.       .......+..++..+...++..||...++..+.+
T Consensus       477 ~~~~-----p~-------~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  477 SGDT-----PN-------LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             cccc-----cC-------CCchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence            1111     11       1111244666777788999999999888765544

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.88  E-value=3.6e-08  Score=92.93  Aligned_cols=140  Identities=16%  Similarity=0.131  Sum_probs=97.9

Q ss_pred             ccCcCCceEEEEEEeCCCcEEEEEEecCCCcc------------HHHHHHHHHHHHhcCC--CceeeEeeEEEec----C
Q 047276          108 LLGHGSSASVFKGILSDGTSVAVKRINGEENG------------EKEFRSEVAAIASAQH--VNLVRLLGYCVVP----G  169 (453)
Q Consensus       108 ~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~------------~~~~~~E~~~l~~l~h--~niv~l~g~~~~~----~  169 (453)
                      .+-.-....|++..+ +|+.+.||........            ...+.+|...+.++..  -...+++++....    .
T Consensus        29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            343334445677766 5788999977542211            1137789888888743  2334455554322    1


Q ss_pred             CCeEEEEEecCCC-ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECC---
Q 047276          170 GPRYLVYEFIQNG-SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDE---  245 (453)
Q Consensus       170 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~---  245 (453)
                      ...++|+|++++. +|.+++.....        ...+...+..++.+++..+.-||.   .||+|+|++++|||++.   
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~~--------~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~  176 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWAT--------NPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFP  176 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhcc--------cCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEecccc
Confidence            2468999999886 89988742111        124556677899999999999999   89999999999999975   


Q ss_pred             ----CCcEEEeecccccc
Q 047276          246 ----NYRAVVSDFGLSKL  259 (453)
Q Consensus       246 ----~~~~kl~DfGla~~  259 (453)
                          ++.+.++||+.+..
T Consensus       177 ~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        177 GREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             CCCCCceEEEEECCcccc
Confidence                46899999998853

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.84  E-value=1.4e-08  Score=93.02  Aligned_cols=133  Identities=19%  Similarity=0.211  Sum_probs=92.9

Q ss_pred             HHHhcccCcCCceEEEEEEeCCCcEEEEEEecCCCc-----------------------cHHHHHHHHHHHHhcCCC--c
Q 047276          103 DNFQALLGHGSSASVFKGILSDGTSVAVKRINGEEN-----------------------GEKEFRSEVAAIASAQHV--N  157 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~-----------------------~~~~~~~E~~~l~~l~h~--n  157 (453)
                      +.+++.||-|--+.||.|..++|.++|||.-+....                       ......+|.+.|.+|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            345689999999999999999999999996532110                       012346788999998755  6


Q ss_pred             eeeEeeEEEecCCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCC
Q 047276          158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVK  237 (453)
Q Consensus       158 iv~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk  237 (453)
                      +.+.+++     +...+||||.++--|...-               ++.+..-.++..|++-+.-+-.   .|+||+|++
T Consensus       173 VP~P~~~-----nRHaVvMe~ieG~eL~~~r---------------~~~en~~~il~~il~~~~~~~~---~GiVHGDlS  229 (304)
T COG0478         173 VPKPIAW-----NRHAVVMEYIEGVELYRLR---------------LDVENPDEILDKILEEVRKAYR---RGIVHGDLS  229 (304)
T ss_pred             CCCcccc-----ccceeeeehcccceeeccc---------------CcccCHHHHHHHHHHHHHHHHH---cCccccCCc
Confidence            7777664     2458999999886664432               1112222333334443333333   699999999


Q ss_pred             CCcEEECCCCcEEEeeccccc
Q 047276          238 PENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       238 ~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +-||++++||.+.++||=-+.
T Consensus       230 efNIlV~~dg~~~vIDwPQ~v  250 (304)
T COG0478         230 EFNILVTEDGDIVVIDWPQAV  250 (304)
T ss_pred             hheEEEecCCCEEEEeCcccc
Confidence            999999999999999996554

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.76  E-value=2.5e-08  Score=101.66  Aligned_cols=145  Identities=23%  Similarity=0.218  Sum_probs=93.4

Q ss_pred             HHh-cccCcCCceEEEEEEeCCCcEEEEEEecCCCcc-----------------------------------------HH
Q 047276          104 NFQ-ALLGHGSSASVFKGILSDGTSVAVKRINGEENG-----------------------------------------EK  141 (453)
Q Consensus       104 ~~~-~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~-----------------------------------------~~  141 (453)
                      .|+ +-|+.++-|.||+|++++|+.||||+.+..-..                                         +-
T Consensus       127 eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~El  206 (517)
T COG0661         127 EFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREEL  206 (517)
T ss_pred             HcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHh
Confidence            344 469999999999999999999999998642110                                         01


Q ss_pred             HHHHHHHHHHhcC----CCceeeEeeEEEecCCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHH
Q 047276          142 EFRSEVAAIASAQ----HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA  217 (453)
Q Consensus       142 ~~~~E~~~l~~l~----h~niv~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia  217 (453)
                      ++..|..-+.+++    ...-+.+=.+|++-.+...|+|||++|..+.+...-.....    ....+...-...++.|+.
T Consensus       207 Dy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~----d~k~ia~~~~~~f~~q~~  282 (517)
T COG0661         207 DYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGI----DRKELAELLVRAFLRQLL  282 (517)
T ss_pred             CHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCC----CHHHHHHHHHHHHHHHHH
Confidence            1344555555442    22223333344544567899999999999988842111100    000122222222233332


Q ss_pred             HHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccC
Q 047276          218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR  262 (453)
Q Consensus       218 ~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~  262 (453)
                      .          .+++|.|.+|.||+++.+|.+.+.|||+...+.+
T Consensus       283 ~----------dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         283 R----------DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             h----------cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            2          5899999999999999999999999999876643

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.68  E-value=4.1e-07  Score=87.87  Aligned_cols=266  Identities=18%  Similarity=0.192  Sum_probs=155.6

Q ss_pred             hcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhc-CCCceeeEeeEE----E-ecCCC-eEEEEEe
Q 047276          106 QALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASA-QHVNLVRLLGYC----V-VPGGP-RYLVYEF  178 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~----~-~~~~~-~~lv~e~  178 (453)
                      +.-||+|+-+.+|-.--- +.. +.|+........+  .+-+..|... .||-+-.-+.|=    + .++.. .-+.|..
T Consensus        16 gr~LgqGgea~ly~l~e~-~d~-VAKIYh~Pppa~~--aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~   91 (637)
T COG4248          16 GRPLGQGGEADLYTLGEV-RDQ-VAKIYHAPPPAAQ--AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPK   91 (637)
T ss_pred             CccccCCccceeeecchh-hch-hheeecCCCchHH--HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEeccc
Confidence            467999999999964321 122 3476665322211  1122333333 344332211110    0 01112 3466666


Q ss_pred             cCCC-ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          179 IQNG-SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       179 ~~~g-sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      +.+. ....++....++    .+....+|...++.+..++.+.+-||+   .|.+-+|+.++|+|+.+++.+.|.|-...
T Consensus        92 v~g~~pI~~~y~p~tRR----qs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          92 VSGKEPIHMIYSPATRR----QSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             CCCccchhhhcCchhhc----ccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccce
Confidence            6554 233333222111    123448999999999999999999999   89999999999999999999999875543


Q ss_pred             ccccCCCCceeeeccCCccccchhhhhcC-----CCCccccchhHHHHHHHHHcC-CCCCcccccCCCCCcccccchhHH
Q 047276          258 KLMSRDQSRCITTIRGTRGYLAPEWILEQ-----GVSEKCDIYSYGMVLLELTGG-RRNVSLIEHGNDKSKNKWQYFPKI  331 (453)
Q Consensus       258 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDV~S~Gvil~elltG-~~p~~~~~~~~~~~~~~~~~~~~~  331 (453)
                      ...  .+.......+|...|.+||.-.-+     .-+...|-|.+||++++++-| ++||+......+....        
T Consensus       165 qi~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p--------  234 (637)
T COG4248         165 QIN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNP--------  234 (637)
T ss_pred             eec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCc--------
Confidence            322  223334556788999999965522     346789999999999998875 9999865433221110        


Q ss_pred             HHHhhhcCcccccccccc---cCCCCCcHHH-HHHHHHHHHhcccc--CCCCCCCHHHHHHHhcccc
Q 047276          332 VNEKMKEGKLMEIVDQRL---TDEGGIDETQ-VRRLVDVAFWCIQE--RARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       332 ~~~~~~~~~~~~~~d~~l---~~~~~~~~~~-~~~l~~l~~~Cl~~--~p~~RPs~~~v~~~L~~~~  392 (453)
                      ....+..|.+...-|.+.   ......+-.. ...+-.+-.+|+..  ++.-|||.+-.+..|....
T Consensus       235 ~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~  301 (637)
T COG4248         235 LETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR  301 (637)
T ss_pred             chhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence            111222233222222211   1111122111 23455666678765  3678999999988886543

>PRK09902 hypothetical protein; Provisional

Probab=98.65  E-value=5.7e-07  Score=80.66  Aligned_cols=138  Identities=20%  Similarity=0.146  Sum_probs=101.9

Q ss_pred             cCcCCceEEEEEEeCCCcEEEEEEecC----C---CccHHHHHHHHHHHHhcCC--CceeeEeeEEEecCC----CeEEE
Q 047276          109 LGHGSSASVFKGILSDGTSVAVKRING----E---ENGEKEFRSEVAAIASAQH--VNLVRLLGYCVVPGG----PRYLV  175 (453)
Q Consensus       109 lG~G~fG~Vy~~~~~~g~~vavK~~~~----~---~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~----~~~lv  175 (453)
                      -|+||.+-|++-.+. |..+-+|+-..    +   +.....|.+|...|.+|..  -++.+.+ ++.....    .-+||
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            467899999998775 55788897652    1   3456789999999998853  2344444 3322221    24799


Q ss_pred             EEecCC-CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCc--EEEe
Q 047276          176 YEFIQN-GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYR--AVVS  252 (453)
Q Consensus       176 ~e~~~~-gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~--~kl~  252 (453)
                      +|-+++ -+|.+++....        ....+...+..+..+++..++-||+   .++.|+|+.+.||+++.++.  ++++
T Consensus       104 Te~L~g~~~L~~~l~~~~--------~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lI  172 (216)
T PRK09902        104 TEDMAGFISIADWYAQHA--------VSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFL  172 (216)
T ss_pred             EEeCCCCccHHHHHhcCC--------cCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEE
Confidence            997763 48999884322        1235677788999999999999999   89999999999999986667  9999


Q ss_pred             ecccccc
Q 047276          253 DFGLSKL  259 (453)
Q Consensus       253 DfGla~~  259 (453)
                      ||.-++.
T Consensus       173 DlEk~r~  179 (216)
T PRK09902        173 DLEKSRR  179 (216)
T ss_pred             Ehhccch
Confidence            9987653

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.60  E-value=1.1e-08  Score=104.40  Aligned_cols=150  Identities=18%  Similarity=0.314  Sum_probs=100.4

Q ss_pred             HHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCCCC-c-------eeeeccCCccccchhhhhc
Q 047276          214 IDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQS-R-------CITTIRGTRGYLAPEWILE  285 (453)
Q Consensus       214 ~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~-~-------~~~~~~gt~~y~aPE~~~~  285 (453)
                      .+++.||.|+|..  .++||++|.|++|.++.++..||+.|+.+-....... .       ..........|.|||++..
T Consensus       106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            3556999999986  8999999999999999999999999998754332111 0       0111234457999999999


Q ss_pred             CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHH
Q 047276          286 QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVD  365 (453)
Q Consensus       286 ~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~  365 (453)
                      ...+.++|+||+||++|-+..|..+............              .++...+   ...   ..+..+.+.++.+
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~--------------~~~~~~~---~~~---~~~s~~~p~el~~  243 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS--------------FSRNLLN---AGA---FGYSNNLPSELRE  243 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhh--------------hhhcccc---ccc---ccccccCcHHHHH
Confidence            8889999999999999999965554322211110000              0000000   000   1122344455777


Q ss_pred             HHHhccccCCCCCCCHHHHH
Q 047276          366 VAFWCIQERARLRPSMARVV  385 (453)
Q Consensus       366 l~~~Cl~~~p~~RPs~~~v~  385 (453)
                      =+.+.+..++.-||++.++.
T Consensus       244 ~l~k~l~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  244 SLKKLLNGDSAVRPTLDLLL  263 (700)
T ss_pred             HHHHHhcCCcccCcchhhhh
Confidence            77888999999999877765

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.53  E-value=6.7e-07  Score=81.36  Aligned_cols=108  Identities=19%  Similarity=0.289  Sum_probs=81.6

Q ss_pred             HHHHHHHHHHHHhcCC--CceeeEeeEEEecCC---CeEEEEEecCCC-ChhhhhccCCCCCCCCCCCCCCCHHHHHHHH
Q 047276          140 EKEFRSEVAAIASAQH--VNLVRLLGYCVVPGG---PRYLVYEFIQNG-SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVA  213 (453)
Q Consensus       140 ~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~---~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~  213 (453)
                      .....+|...+..|..  -...+.+++......   ..++|+|++++. +|.+++.....          ++......++
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----------~~~~~~~~ll  124 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----------LDPSQRRELL  124 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----------cchhhHHHHH
Confidence            3457788888777742  234555665543222   347999999874 89999853211          4556677899


Q ss_pred             HHHHHHhccccccCCCceeccCCCCCcEEECCCC---cEEEeeccccccc
Q 047276          214 IDVAKALSYLHNDCRSRVLHLDVKPENILLDENY---RAVVSDFGLSKLM  260 (453)
Q Consensus       214 ~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~---~~kl~DfGla~~~  260 (453)
                      .+++..++-||+   .+|+|+|++++|||++.+.   .+.++||+-++..
T Consensus       125 ~~l~~~i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  125 RALARLIAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHHHHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999999999999   8999999999999999887   8999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.43  E-value=1.4e-06  Score=88.87  Aligned_cols=142  Identities=20%  Similarity=0.214  Sum_probs=91.1

Q ss_pred             cccCcCCceEEEEEEeCCCcEEEEEEecCCCcc--------------------------------------HHHHHHHHH
Q 047276          107 ALLGHGSSASVFKGILSDGTSVAVKRINGEENG--------------------------------------EKEFRSEVA  148 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~--------------------------------------~~~~~~E~~  148 (453)
                      +-||.-+.|.||++++++|+.||||+-+..-..                                      +-+|.+|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            569999999999999999999999998653111                                      012444544


Q ss_pred             HHHh----cCCCc---eeeEeeEEEecCCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhc
Q 047276          149 AIAS----AQHVN---LVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALS  221 (453)
Q Consensus       149 ~l~~----l~h~n---iv~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~  221 (453)
                      -..+    +.|-+   -|.+=.++++-.....|+||||+|..+.|.-.-.+.         .++......-+.++..-+-
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~---------gi~~~~i~~~l~~~~~~qI  317 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR---------GISPHDILNKLVEAYLEQI  317 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc---------CCCHHHHHHHHHHHHHHHH
Confidence            3333    34555   222333344445678999999999988666422211         1444333322222222111


Q ss_pred             cccccCCCceeccCCCCCcEEECC----CCcEEEeeccccccccC
Q 047276          222 YLHNDCRSRVLHLDVKPENILLDE----NYRAVVSDFGLSKLMSR  262 (453)
Q Consensus       222 ~Lh~~~~~~ivH~Dlk~~NiLl~~----~~~~kl~DfGla~~~~~  262 (453)
                      + +    .|++|.|=+|.||+++.    ++.+.+-|||+....+.
T Consensus       318 f-~----~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  318 F-K----TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             H-h----cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            1 2    58999999999999984    67899999999876654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.40  E-value=3.8e-06  Score=77.47  Aligned_cols=142  Identities=15%  Similarity=0.115  Sum_probs=82.3

Q ss_pred             cccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCc--eeeEeeEEEecCCCeEEEEEecCCCC-
Q 047276          107 ALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVN--LVRLLGYCVVPGGPRYLVYEFIQNGS-  183 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~~~~~~lv~e~~~~gs-  183 (453)
                      ..||+|..+.||+.   .|..+++|...... ......+|.+++..+..-.  +.+.++++. ..+...++||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~-~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVE-DGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEe-cCCeeeeeeeecCCccc
Confidence            46899999999984   24567788776533 3456788999998886433  355566553 4455678999998863 


Q ss_pred             hhhhhccCC---------------CCCCCCCCCCCCC----------------HHHHHHHHHHHHHHhccccccCCCcee
Q 047276          184 LDHWIFPTS---------------RRSEGHYSGGCLS----------------WDLRYRVAIDVAKALSYLHNDCRSRVL  232 (453)
Q Consensus       184 L~~~l~~~~---------------~~~~~~~~~~~l~----------------~~~~~~i~~~ia~~L~~Lh~~~~~~iv  232 (453)
                      +...+....               +-.........+.                .......+......   + . ....++
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~---~-~-~~~~~~  156 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKE---V-P-DTSTCL  156 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHh---C-C-CCCceE
Confidence            221111000               0000000000010                00011111111111   1 1 125679


Q ss_pred             ccCCCCCcEEECCCCcEEEeecccccc
Q 047276          233 HLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       233 H~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      |+|+.|.||++++++ +.|+||+.+..
T Consensus       157 HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       157 HGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             ecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            999999999999988 99999998753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.25  E-value=3.5e-06  Score=75.26  Aligned_cols=105  Identities=24%  Similarity=0.296  Sum_probs=82.4

Q ss_pred             HHHHHHHHhcCC-CceeeEeeEEEecCCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhcc
Q 047276          144 RSEVAAIASAQH-VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY  222 (453)
Q Consensus       144 ~~E~~~l~~l~h-~niv~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~  222 (453)
                      ..|.-++..+++ +++.+++|+|-     .+++.||...+++...-..-.       .....+|..|.+|+.++++.+.+
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG-----~~~v~E~~~~~~~~~~~~~l~-------~~~~~~w~~R~~iA~~lL~~l~~   74 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG-----RFYVVEYVGAGSLYGIYRPLS-------QFLQSPWEQRAKIALQLLELLEE   74 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC-----CEEEEEeecCccccccccccc-------cccccCHHHHHHHHHHHHHHHHH
Confidence            357888889976 69999999992     378999998776642200000       01127999999999999999999


Q ss_pred             ccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          223 LHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       223 Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      |+......+.-.|++++|+-+++++.+|+.|...+...
T Consensus        75 l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   75 LDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             HhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            99865556889999999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.24  E-value=5.6e-06  Score=76.38  Aligned_cols=78  Identities=23%  Similarity=0.328  Sum_probs=56.3

Q ss_pred             cccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCC--ceeeEeeEEEecC--CCeEEEEEecCCC
Q 047276          107 ALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHV--NLVRLLGYCVVPG--GPRYLVYEFIQNG  182 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~g~~~~~~--~~~~lv~e~~~~g  182 (453)
                      +.|+.|..+.||+....+ ..+++|..... .....+..|..++..+...  .+.+++.++....  ...+++|+++++.
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~   80 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR   80 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence            468899999999999877 58999987654 4456788899998888533  3456665443222  2358999999998


Q ss_pred             Chhh
Q 047276          183 SLDH  186 (453)
Q Consensus       183 sL~~  186 (453)
                      .+..
T Consensus        81 ~~~~   84 (239)
T PF01636_consen   81 PLDD   84 (239)
T ss_dssp             EHHH
T ss_pred             cccc
Confidence            8877

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.20  E-value=2.3e-05  Score=71.54  Aligned_cols=135  Identities=21%  Similarity=0.266  Sum_probs=89.0

Q ss_pred             ccCcCCceEEEEEEeCCCcEEEEEEecCCCcc--------------------HHH-----HHHHHHHHHhcC--CCceee
Q 047276          108 LLGHGSSASVFKGILSDGTSVAVKRINGEENG--------------------EKE-----FRSEVAAIASAQ--HVNLVR  160 (453)
Q Consensus       108 ~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~--------------------~~~-----~~~E~~~l~~l~--h~niv~  160 (453)
                      .|..|--..||+|...++..+|||+++.....                    .++     -.+|..-|.++.  +-.+.+
T Consensus        55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~  134 (268)
T COG1718          55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE  134 (268)
T ss_pred             eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence            46678888999999888999999998642211                    111     234666677663  334445


Q ss_pred             EeeEEEecCCCeEEEEEecCCCCh-hhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCC
Q 047276          161 LLGYCVVPGGPRYLVYEFIQNGSL-DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPE  239 (453)
Q Consensus       161 l~g~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~  239 (453)
                      -+++.     .-.|||||+..... .-.|           ..-.+.......+..++++.+.-|-..  .++||+||+.=
T Consensus       135 Pi~~~-----~nVLvMEfIg~~g~pAP~L-----------kDv~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEy  196 (268)
T COG1718         135 PIAFR-----NNVLVMEFIGDDGLPAPRL-----------KDVPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEY  196 (268)
T ss_pred             ceeec-----CCeEEEEeccCCCCCCCCc-----------ccCCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhh
Confidence            55432     34799999965311 1111           111122224555666777777766653  68999999999


Q ss_pred             cEEECCCCcEEEeecccccccc
Q 047276          240 NILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       240 NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      |||+. ++.+.|+|||-+....
T Consensus       197 NiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         197 NILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             heEEE-CCeEEEEECccccccC
Confidence            99999 8899999999886543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.14  E-value=1.1e-06  Score=89.02  Aligned_cols=182  Identities=20%  Similarity=0.113  Sum_probs=127.7

Q ss_pred             cccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCc-eeeEeeEEEecCCCeEEEEEecCCC-Ch
Q 047276          107 ALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVN-LVRLLGYCVVPGGPRYLVYEFIQNG-SL  184 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~~lv~e~~~~g-sL  184 (453)
                      +-+++|+++.+||.+-...+....+.+...    ....-++++|.+++||| .+..++-+. .+...+++++++..+ +-
T Consensus       248 h~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~-~E~~~~i~~~i~s~~rs~  322 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYD-GEDYLWIPMRICSTGRSS  322 (829)
T ss_pred             HHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCC-cccccchhhhhhcCCccc
Confidence            457889999999987433333345544322    45567899999999999 555554432 344667889998776 22


Q ss_pred             hhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCCC
Q 047276          185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ  264 (453)
Q Consensus       185 ~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~  264 (453)
                      ..-..         ...-.+...+...+...-.++++|+|+   ..=+|+|    ||+..+ +..|..||+....+.+..
T Consensus       323 ~~~~~---------~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~  385 (829)
T KOG0576|consen  323 ALEMT---------VSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM  385 (829)
T ss_pred             cccCC---------hhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc
Confidence            11110         011123334445566777889999998   3458998    777655 678999999988765443


Q ss_pred             CceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCc
Q 047276          265 SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVS  312 (453)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~  312 (453)
                        ......+++.|+|||....+.+..+.|+|+.|+-..++.-|-.|-.
T Consensus       386 --~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  386 --KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             --ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence              2355678999999999999999999999999998888888887764

>PRK10593 hypothetical protein; Provisional

Probab=98.09  E-value=6.1e-05  Score=72.55  Aligned_cols=76  Identities=14%  Similarity=0.114  Sum_probs=56.5

Q ss_pred             cccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCC---CceeeEeeEEEec--CCCeEEEEEecCC
Q 047276          107 ALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQH---VNLVRLLGYCVVP--GGPRYLVYEFIQN  181 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~g~~~~~--~~~~~lv~e~~~~  181 (453)
                      +.||+|..+.||+....+++ +++|..+. ......|..|...|+.+.-   -.+.+++++|...  .+..++|||++++
T Consensus        20 ~~i~~G~~~~vy~~~~~~~~-~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G   97 (297)
T PRK10593         20 ECISEQPYAALWALYDSQGN-PMPLMARS-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG   97 (297)
T ss_pred             eecCCccceeEEEEEcCCCC-EEEEEecc-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence            46999999999998776664 66777432 2234678999999998853   3677888877532  3457999999998


Q ss_pred             CCh
Q 047276          182 GSL  184 (453)
Q Consensus       182 gsL  184 (453)
                      +++
T Consensus        98 ~~~  100 (297)
T PRK10593         98 VSV  100 (297)
T ss_pred             Eec
Confidence            765

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.09  E-value=3.6e-05  Score=71.90  Aligned_cols=75  Identities=13%  Similarity=0.165  Sum_probs=51.0

Q ss_pred             cCcCCc-eEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcC-CCceeeEeeEEEecCCCeEEEEEecCCCChhh
Q 047276          109 LGHGSS-ASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQ-HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDH  186 (453)
Q Consensus       109 lG~G~f-G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~~lv~e~~~~gsL~~  186 (453)
                      |-.|.+ ..||+.... +..+.+|......  ...+.+|++++..+. +--+.+++++.. .++..++|||+++|.+|..
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~-~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGS-DDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEe-cCCccEEEEEeeCCccHhH
Confidence            334444 789999765 4678888876432  345678999988874 334556666654 3346789999999987764


Q ss_pred             h
Q 047276          187 W  187 (453)
Q Consensus       187 ~  187 (453)
                      .
T Consensus        82 ~   82 (244)
T cd05150          82 L   82 (244)
T ss_pred             h
Confidence            4

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.08  E-value=4.4e-05  Score=68.95  Aligned_cols=129  Identities=17%  Similarity=0.162  Sum_probs=79.3

Q ss_pred             cccCcCCceEEEEEEeCCCcEEEEEEecCCCc-cHHHH---------HHHHHHHHhcCC---CceeeEeeEEEec----C
Q 047276          107 ALLGHGSSASVFKGILSDGTSVAVKRINGEEN-GEKEF---------RSEVAAIASAQH---VNLVRLLGYCVVP----G  169 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~-~~~~~---------~~E~~~l~~l~h---~niv~l~g~~~~~----~  169 (453)
                      +++-......|.+-.. +|..+.+|..+.... .++.|         .+++..+.+++.   -..+.++.++.-.    .
T Consensus        37 kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~  115 (229)
T PF06176_consen   37 KVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYT  115 (229)
T ss_pred             EeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccce
Confidence            3444444455555545 467888888765322 22222         233333444432   2222322222111    1


Q ss_pred             CCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcE
Q 047276          170 GPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRA  249 (453)
Q Consensus       170 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~  249 (453)
                      ...+++|||++|..|.++..              ++.    .++..+.+++.-||+   .|+.|+|..|+|+++++++ +
T Consensus       116 ~~~~ll~EYIeG~~l~d~~~--------------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~~-i  173 (229)
T PF06176_consen  116 SSYVLLMEYIEGVELNDIED--------------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNNG-I  173 (229)
T ss_pred             eEEEEEEEEecCeecccchh--------------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECCc-E
Confidence            24468999999988876541              332    245667788999999   8999999999999998655 8


Q ss_pred             EEeeccccc
Q 047276          250 VVSDFGLSK  258 (453)
Q Consensus       250 kl~DfGla~  258 (453)
                      ++.||+..+
T Consensus       174 ~iID~~~k~  182 (229)
T PF06176_consen  174 RIIDTQGKR  182 (229)
T ss_pred             EEEECcccc
Confidence            999998765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.06  E-value=3e-05  Score=67.00  Aligned_cols=127  Identities=16%  Similarity=0.280  Sum_probs=87.5

Q ss_pred             HhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceee-EeeEEEecCCCeEEEEEecCCCC
Q 047276          105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVR-LLGYCVVPGGPRYLVYEFIQNGS  183 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~g~~~~~~~~~~lv~e~~~~gs  183 (453)
                      ..+.||+|++|.||+|.+. |..+|+|+-+.+ .....+..|+++|..+.-.++.+ ++.|.     .-++.|||..+-.
T Consensus        26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d-s~r~~l~kEakiLeil~g~~~~p~vy~yg-----~~~i~me~i~G~~   98 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRD-SPRRNLEKEAKILEILAGEGVTPEVYFYG-----EDFIRMEYIDGRP   98 (201)
T ss_pred             hhhhhhcccccEEEEeecc-CceEEEEEecCC-cchhhHHHHHHHHHHhhhcCCCceEEEec-----hhhhhhhhhcCcc
Confidence            3578999999999999997 558999987643 34567899999999998766654 44432     2245599998888


Q ss_pred             hhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCC--CcEEECCCCcEEEeecccccc
Q 047276          184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKP--ENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       184 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~--~NiLl~~~~~~kl~DfGla~~  259 (453)
                      |.++-...             +-.    -...+++. +|.-+.  .+|-|+.|.-  .||++.++ .+.|+||..|+.
T Consensus        99 L~~~~~~~-------------~rk----~l~~vlE~-a~~LD~--~GI~H~El~~~~k~vlv~~~-~~~iIDFd~At~  155 (201)
T COG2112          99 LGKLEIGG-------------DRK----HLLRVLEK-AYKLDR--LGIEHGELSRPWKNVLVNDR-DVYIIDFDSATF  155 (201)
T ss_pred             hhhhhhcc-------------cHH----HHHHHHHH-HHHHHH--hccchhhhcCCceeEEecCC-cEEEEEccchhh
Confidence            87764211             222    22344444 333222  7899999874  56665554 899999998874

>PLN02876 acyl-CoA dehydrogenase

Probab=98.03  E-value=7.4e-05  Score=82.09  Aligned_cols=78  Identities=14%  Similarity=0.370  Sum_probs=56.0

Q ss_pred             cccCcCCceEEEEEEeCCC---cEEEEEEecCCC--ccHHHHHHHHHHHHhcC-CCce--eeEeeEEEecC--CCeEEEE
Q 047276          107 ALLGHGSSASVFKGILSDG---TSVAVKRINGEE--NGEKEFRSEVAAIASAQ-HVNL--VRLLGYCVVPG--GPRYLVY  176 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~g---~~vavK~~~~~~--~~~~~~~~E~~~l~~l~-h~ni--v~l~g~~~~~~--~~~~lv~  176 (453)
                      +.++.|.++.+|+....++   ..+++|+.....  .....+.+|.++|+.+. |.++  .+++++|.+..  +..++||
T Consensus        44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM  123 (822)
T PLN02876         44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM  123 (822)
T ss_pred             EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence            4688999999999887654   367777754322  23457889999999995 6654  77888775321  3568999


Q ss_pred             EecCCCCh
Q 047276          177 EFIQNGSL  184 (453)
Q Consensus       177 e~~~~gsL  184 (453)
                      ||+++..+
T Consensus       124 E~v~G~~~  131 (822)
T PLN02876        124 EYLEGRIF  131 (822)
T ss_pred             EecCCccc
Confidence            99987654

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.92  E-value=9.3e-05  Score=68.76  Aligned_cols=74  Identities=14%  Similarity=0.162  Sum_probs=44.9

Q ss_pred             ccCcCCce-EEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCC---ceeeEeeEEEecC--CCeEEEEEecCC
Q 047276          108 LLGHGSSA-SVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHV---NLVRLLGYCVVPG--GPRYLVYEFIQN  181 (453)
Q Consensus       108 ~lG~G~fG-~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~g~~~~~~--~~~~lv~e~~~~  181 (453)
                      .|+.|+.. .||+.    +..+++|.... ......+..|.+++..+...   .+...++.+...+  ...+++|++++|
T Consensus         4 ~~~~gG~~n~vy~~----~~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G   78 (235)
T cd05155           4 PVDSGGTDNATFRL----GDDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEG   78 (235)
T ss_pred             eccCCCcccceEEc----CCceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecC
Confidence            46666665 58875    23577776554 22345788999999887532   2333443332111  134789999998


Q ss_pred             CChhh
Q 047276          182 GSLDH  186 (453)
Q Consensus       182 gsL~~  186 (453)
                      .++.+
T Consensus        79 ~~l~~   83 (235)
T cd05155          79 ETATA   83 (235)
T ss_pred             CCCCc
Confidence            77743

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.85  E-value=0.00019  Score=66.61  Aligned_cols=74  Identities=18%  Similarity=0.177  Sum_probs=48.1

Q ss_pred             cccCcCCceEEEEEEeCC--CcEEEEEEecCCCccHHHHHHHHHHHHhcCCCce-eeEeeEEEecCCCeEEEEEecCCCC
Q 047276          107 ALLGHGSSASVFKGILSD--GTSVAVKRINGEENGEKEFRSEVAAIASAQHVNL-VRLLGYCVVPGGPRYLVYEFIQNGS  183 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~--g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~~lv~e~~~~gs  183 (453)
                      +.|..|-...+|+....+  +..+++|.........-...+|+.++..+...++ .++++.+  .   ..++|||+++.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~--~---~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF--Q---NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe--C---CcEEEEeeCCCc
Confidence            357788889999998764  6788899775432221233468888888854333 3343332  2   247999999877


Q ss_pred             hh
Q 047276          184 LD  185 (453)
Q Consensus       184 L~  185 (453)
                      +.
T Consensus        79 l~   80 (235)
T cd05157          79 LE   80 (235)
T ss_pred             CC
Confidence            63

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.76  E-value=0.00042  Score=62.26  Aligned_cols=126  Identities=19%  Similarity=0.316  Sum_probs=85.5

Q ss_pred             cccCcCCceEEEEEEeCCCcEEEEEEecCCC-----------------ccHHHHHHHHHHHHhcC------CCceeeEee
Q 047276          107 ALLGHGSSASVFKGILSDGTSVAVKRINGEE-----------------NGEKEFRSEVAAIASAQ------HVNLVRLLG  163 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~-----------------~~~~~~~~E~~~l~~l~------h~niv~l~g  163 (453)
                      ..||+|+.=.||.  +++.....||+.....                 ...+++.+|+.....+.      +.+|.+++|
T Consensus         7 ~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G   84 (199)
T PF10707_consen    7 DLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG   84 (199)
T ss_pred             cccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence            5799999999996  4455567888886543                 23466777877766665      789999999


Q ss_pred             EEEecCCCeEEEEEecCCC------ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCC
Q 047276          164 YCVVPGGPRYLVYEFIQNG------SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVK  237 (453)
Q Consensus       164 ~~~~~~~~~~lv~e~~~~g------sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk  237 (453)
                      +..+ +...-+|+|.+.+.      +|.+++..           +.++. ...+.+.   +-..||-+   ..|+.+|++
T Consensus        85 ~veT-~~G~Glv~e~I~d~dG~~s~TL~~~l~~-----------~~~~~-~~~~~L~---~f~~~l~~---~~Iv~~dl~  145 (199)
T PF10707_consen   85 FVET-NLGLGLVVELIRDADGNISPTLEDYLKE-----------GGLTE-ELRQALD---EFKRYLLD---HHIVIRDLN  145 (199)
T ss_pred             EEec-CCceEEEEEEEECCCCCcCccHHHHHHc-----------CCccH-HHHHHHH---HHHHHHHH---cCCeecCCC
Confidence            9764 44567888887542      57788732           22554 3333333   33445555   689999999


Q ss_pred             CCcEEECCC--C--cEEEee
Q 047276          238 PENILLDEN--Y--RAVVSD  253 (453)
Q Consensus       238 ~~NiLl~~~--~--~~kl~D  253 (453)
                      |+||++..+  +  .+.|+|
T Consensus       146 ~~NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  146 PHNIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             cccEEEEecCCCceEEEEEe
Confidence            999999633  2  466665

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.66  E-value=0.00031  Score=66.14  Aligned_cols=138  Identities=14%  Similarity=0.129  Sum_probs=78.0

Q ss_pred             cCcCCceEEEEEEeCCCcEEEEEEecCCCccH-HHHHHHHHHHHhcCCCcee-eEeeEEEecCCCeEEEEEecCCCChhh
Q 047276          109 LGHGSSASVFKGILSDGTSVAVKRINGEENGE-KEFRSEVAAIASAQHVNLV-RLLGYCVVPGGPRYLVYEFIQNGSLDH  186 (453)
Q Consensus       109 lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~-~~~~~E~~~l~~l~h~niv-~l~g~~~~~~~~~~lv~e~~~~gsL~~  186 (453)
                      +..|-.+.+|+... +|..+++|......... -...+|..+++.+....++ ++++.+  .   .++|+||++|..+..
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~---~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E---HWLLVEWLEGEVITL   77 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C---CEEEEEeccCccccc
Confidence            56688889998874 56778888755422211 1357788888888644333 333332  2   368999999876643


Q ss_pred             h-----------------hccCCCCCCCCCCCCCCCHHHH-HHH------------HHHHHHHhccc--cccCCCceecc
Q 047276          187 W-----------------IFPTSRRSEGHYSGGCLSWDLR-YRV------------AIDVAKALSYL--HNDCRSRVLHL  234 (453)
Q Consensus       187 ~-----------------l~~~~~~~~~~~~~~~l~~~~~-~~i------------~~~ia~~L~~L--h~~~~~~ivH~  234 (453)
                      .                 ||....      ....++.... ...            ...+.+.+...  .......++|+
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~------~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~  151 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPR------FGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHM  151 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCC------CCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecC
Confidence            2                 111110      0111221111 011            11111111111  11112469999


Q ss_pred             CCCCCcEEECCCCcEEEeecccccc
Q 047276          235 DVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       235 Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      |+.|.||++++++ +.|+||..+..
T Consensus       152 Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       152 DVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CCCcCcEEEeCCC-CEEEeccccCc
Confidence            9999999999887 78999998764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.66  E-value=0.00059  Score=67.94  Aligned_cols=74  Identities=22%  Similarity=0.174  Sum_probs=53.2

Q ss_pred             cccCcCCceEEEEEEeCCC-cEEEEEEecC------C--CccHHHHHHHHHHHHhcC---CCceeeEeeEEEecCCCeEE
Q 047276          107 ALLGHGSSASVFKGILSDG-TSVAVKRING------E--ENGEKEFRSEVAAIASAQ---HVNLVRLLGYCVVPGGPRYL  174 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~g-~~vavK~~~~------~--~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~~l  174 (453)
                      +.||.|.+..||+....+| +.++||.-..      .  ....+.+..|.+.|..+.   ..++.+++.+   +....++
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~---D~~~~~l  108 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY---DEELAVT  108 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE---CCCCCEE
Confidence            4689999999999998877 4899997431      1  123456777888888763   3456677765   3345789


Q ss_pred             EEEecCCCC
Q 047276          175 VYEFIQNGS  183 (453)
Q Consensus       175 v~e~~~~gs  183 (453)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998643

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.61  E-value=0.00072  Score=65.03  Aligned_cols=149  Identities=16%  Similarity=0.149  Sum_probs=85.2

Q ss_pred             cccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCc--eeeEeeE-----EEecCCCeEEEEEec
Q 047276          107 ALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVN--LVRLLGY-----CVVPGGPRYLVYEFI  179 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~-----~~~~~~~~~lv~e~~  179 (453)
                      +.|..|....+|+....++ .+++|+...  ........|+.++..+.+.+  +.+++..     ....++..+++++|+
T Consensus        20 ~~i~~G~~n~~y~v~~~~~-~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i   96 (296)
T cd05153          20 EGISAGIENTNYFVTTDSG-RYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL   96 (296)
T ss_pred             ecccCccccceEEEEeCCC-cEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence            4577788889999876544 688898764  33456777888888875332  3444331     111233568999999


Q ss_pred             CCCChhhh--------------hccCCCCCCC-CCCCCCCCHHHHHH----------HHHHHHHHhccccc----cCCCc
Q 047276          180 QNGSLDHW--------------IFPTSRRSEG-HYSGGCLSWDLRYR----------VAIDVAKALSYLHN----DCRSR  230 (453)
Q Consensus       180 ~~gsL~~~--------------l~~~~~~~~~-~~~~~~l~~~~~~~----------i~~~ia~~L~~Lh~----~~~~~  230 (453)
                      +|..+...              +|........ ........|.....          ....+...+.++..    ....+
T Consensus        97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~  176 (296)
T cd05153          97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG  176 (296)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence            98765430              1111000000 00111123322110          11112233333332    12357


Q ss_pred             eeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          231 VLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       231 ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      ++|+|+.|.||++++++.+.|.||+.+.
T Consensus       177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         177 VIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCccCcCcccEEEeCCceEEEeehhhhc
Confidence            9999999999999998778899998875

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=97.54  E-value=0.0037  Score=60.87  Aligned_cols=149  Identities=13%  Similarity=0.119  Sum_probs=78.1

Q ss_pred             cccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCc--eeeEeeE-----EEecCCCeEEEEEec
Q 047276          107 ALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVN--LVRLLGY-----CVVPGGPRYLVYEFI  179 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~-----~~~~~~~~~lv~e~~  179 (453)
                      +.|+.|....+|+....+| .+++|+.+.  ...+....|..++..|...+  +.+.+..     +....+..+++++|+
T Consensus        28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l  104 (319)
T PRK05231         28 KGIAEGIENSNFFLTTTQG-EYVLTLFER--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL  104 (319)
T ss_pred             chhccccccceEEEEeCCC-cEEEEEecc--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence            3466777789999887666 688898762  22344445666666553211  2222211     111234568999999


Q ss_pred             CCCChhh-----------h---hccCCCCCC-CCCCCCCCCH-HHHHH------------HH-HHHHHHhccccc----c
Q 047276          180 QNGSLDH-----------W---IFPTSRRSE-GHYSGGCLSW-DLRYR------------VA-IDVAKALSYLHN----D  226 (453)
Q Consensus       180 ~~gsL~~-----------~---l~~~~~~~~-~~~~~~~l~~-~~~~~------------i~-~~ia~~L~~Lh~----~  226 (453)
                      +|..+..           .   +|....... .......+.| .....            .. ..+...++.+.+    .
T Consensus       105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  184 (319)
T PRK05231        105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA  184 (319)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence            8875421           1   111111000 0000111222 11111            11 111122222221    1


Q ss_pred             CCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          227 CRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       227 ~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      ...+++|+|+.+.||+++++...-|+||+.+.
T Consensus       185 lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        185 LPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             CCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            24689999999999999977666899999875

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.50  E-value=0.0045  Score=59.95  Aligned_cols=150  Identities=17%  Similarity=0.177  Sum_probs=82.3

Q ss_pred             cccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCC--ceeeEeeEE-----EecCCCeEEEEEec
Q 047276          107 ALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHV--NLVRLLGYC-----VVPGGPRYLVYEFI  179 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~g~~-----~~~~~~~~lv~e~~  179 (453)
                      +.++.|....+|+....+| .+++|..+... .......|.+++..|...  ++.+++...     ...++..+++++|+
T Consensus        28 ~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i  105 (307)
T TIGR00938        28 KGIAEGVENSNYLLTTDVG-RYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL  105 (307)
T ss_pred             cccCCccccceEEEEeCCC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence            3577777789999876655 57788765422 234556677777777422  233433311     11234568999999


Q ss_pred             CCCChhhh--------------hccCCCCCCCCCC--CCCCCHHHHH------------HHHHHHHHHhccccc----cC
Q 047276          180 QNGSLDHW--------------IFPTSRRSEGHYS--GGCLSWDLRY------------RVAIDVAKALSYLHN----DC  227 (453)
Q Consensus       180 ~~gsL~~~--------------l~~~~~~~~~~~~--~~~l~~~~~~------------~i~~~ia~~L~~Lh~----~~  227 (453)
                      +|..+...              +|...........  ...-.|....            .....+...++++..    ..
T Consensus       106 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~  185 (307)
T TIGR00938       106 QGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDL  185 (307)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            88654211              1111110000000  0011222110            001122333444422    23


Q ss_pred             CCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          228 RSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       228 ~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      ..+++|+|+++.|+++++++.+.|.||+.+.
T Consensus       186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            4789999999999999998877899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.44  E-value=0.0016  Score=62.84  Aligned_cols=74  Identities=23%  Similarity=0.262  Sum_probs=49.1

Q ss_pred             ccCcCCceEEEEEEeCC-------CcEEEEEEecCCCccHHHHHHHHHHHHhcCCCcee-eEeeEEEecCCCeEEEEEec
Q 047276          108 LLGHGSSASVFKGILSD-------GTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLV-RLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       108 ~lG~G~fG~Vy~~~~~~-------g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~g~~~~~~~~~~lv~e~~  179 (453)
                      .+..|-...+|+....+       ++.+++|..............|..++..+....+. ++++++  .+   ..|+||+
T Consensus         5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~--~~---~~v~e~i   79 (302)
T cd05156           5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIF--PN---GRIEEFI   79 (302)
T ss_pred             EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEe--CC---Cchhhee
Confidence            45667778999988765       47899998765433334567788888887543333 444443  22   3589999


Q ss_pred             CCCChhh
Q 047276          180 QNGSLDH  186 (453)
Q Consensus       180 ~~gsL~~  186 (453)
                      +|..+..
T Consensus        80 ~G~~l~~   86 (302)
T cd05156          80 PSRTLTT   86 (302)
T ss_pred             CCCcCCH
Confidence            9877654

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.29  E-value=0.00082  Score=73.24  Aligned_cols=196  Identities=18%  Similarity=0.182  Sum_probs=130.0

Q ss_pred             HHHHHHHhcCCCceeeEeeEEEecCCC---eEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhc
Q 047276          145 SEVAAIASAQHVNLVRLLGYCVVPGGP---RYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALS  221 (453)
Q Consensus       145 ~E~~~l~~l~h~niv~l~g~~~~~~~~---~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~  221 (453)
                      -|...+.+..|+|++.+++|.......   ..+..+|+..-++...+..          -..++..+.+.+..+..+||+
T Consensus       231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~----------v~~i~~~~~r~~~~~~~~GL~  300 (1351)
T KOG1035|consen  231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS----------VGSIPLETLRILHQKLLEGLA  300 (1351)
T ss_pred             HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh----------ccccCHHHHHHHHHHHhhhHH
Confidence            356667888999999999986543221   1244577777777776642          234788888899999999999


Q ss_pred             cccccCCCceeccCCCCC---cEEECCCCcEEEe--eccccccccCCCCceeeeccCCccccchhhhhcCCCCc--cccc
Q 047276          222 YLHNDCRSRVLHLDVKPE---NILLDENYRAVVS--DFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSE--KCDI  294 (453)
Q Consensus       222 ~Lh~~~~~~ivH~Dlk~~---NiLl~~~~~~kl~--DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~sDV  294 (453)
                      |+|+   ....|.-+..+   +.-.+..+...++  ||+....+......  ....-+..|.+||......++.  ..|+
T Consensus       301 ~~h~---~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~e~~~~~~~~~~r~~dL  375 (1351)
T KOG1035|consen  301 YLHS---LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--FSDLLAEIRNADEDLKENTAKKSRLTDL  375 (1351)
T ss_pred             HHHH---hccceeEEecccccccccCccceeecchhhhcccccCCCcccc--hhhcCccccccccccccccchhhhhhHH
Confidence            9999   55555555555   5555666777777  88887765443221  1222344677888776655444  4799


Q ss_pred             hhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccC
Q 047276          295 YSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQER  374 (453)
Q Consensus       295 ~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~  374 (453)
                      |.+|.....+..|..+-....                        ....+.+.          .......+....|+..+
T Consensus       376 ~~lgll~~~~~~~~~i~~~~~------------------------~~~~~l~~----------~~~~~~~d~~~~~~~~~  421 (1351)
T KOG1035|consen  376 WCLGLLLLQLSQGEDISEKSA------------------------VPVSLLDV----------LSTSELLDALPKCLDED  421 (1351)
T ss_pred             HHHHHHHhhhhhcCccccccc------------------------chhhhhcc----------ccchhhhhhhhhhcchh
Confidence            999999999998875421100                        00011110          00114667788999999


Q ss_pred             CCCCCCHHHHHHHhc
Q 047276          375 ARLRPSMARVVEMLE  389 (453)
Q Consensus       375 p~~RPs~~~v~~~L~  389 (453)
                      +++|++..+++...-
T Consensus       422 ~~~Rl~~~~ll~~~f  436 (1351)
T KOG1035|consen  422 SEERLSALELLTHPF  436 (1351)
T ss_pred             hhhccchhhhhhchh
Confidence            999999999886653

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.28  E-value=0.00017  Score=68.33  Aligned_cols=131  Identities=16%  Similarity=0.166  Sum_probs=87.5

Q ss_pred             HHHhcccCcCCceEEEEEEeCCCcEEEEEEecCCC-------------------ccH----HHHHHHHHHHHhcC-CC-c
Q 047276          103 DNFQALLGHGSSASVFKGILSDGTSVAVKRINGEE-------------------NGE----KEFRSEVAAIASAQ-HV-N  157 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~-------------------~~~----~~~~~E~~~l~~l~-h~-n  157 (453)
                      +.+.+.||-|.-+.+|.+...+|++.++|.-+...                   .+.    -...+|...|+.|. |. -
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            34578999999999999999999999988542211                   000    12346888888885 33 2


Q ss_pred             eeeEeeEEEecCCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCC
Q 047276          158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVK  237 (453)
Q Consensus       158 iv~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk  237 (453)
                      +.+.+++     +..++|||++.+-.|...-+-             .+..+...   .+..-+.-|..   .|+||+|+.
T Consensus       174 VPkpiD~-----~RH~Vvmelv~g~Pl~~v~~v-------------~d~~~ly~---~lm~~Iv~la~---~GlIHgDFN  229 (465)
T KOG2268|consen  174 VPKPIDH-----NRHCVVMELVDGYPLRQVRHV-------------EDPPTLYD---DLMGLIVRLAN---HGLIHGDFN  229 (465)
T ss_pred             CCCcccc-----cceeeHHHhhcccceeeeeec-------------CChHHHHH---HHHHHHHHHHH---cCceecccc
Confidence            3344443     356899999988877654311             22222222   22222233333   799999999


Q ss_pred             CCcEEECCCCcEEEeecccc
Q 047276          238 PENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       238 ~~NiLl~~~~~~kl~DfGla  257 (453)
                      -=||++++++.++++||=-.
T Consensus       230 EFNimv~dd~~i~vIDFPQm  249 (465)
T KOG2268|consen  230 EFNIMVKDDDKIVVIDFPQM  249 (465)
T ss_pred             hheeEEecCCCEEEeechHh
Confidence            99999999999999999544

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.25  E-value=0.0027  Score=56.77  Aligned_cols=122  Identities=29%  Similarity=0.395  Sum_probs=85.1

Q ss_pred             HHhcccCcCCc-eEEEEEEeCCCcEEEEEEecC---C-------C------------ccHHHHHHHHHHHHhcC---CCc
Q 047276          104 NFQALLGHGSS-ASVFKGILSDGTSVAVKRING---E-------E------------NGEKEFRSEVAAIASAQ---HVN  157 (453)
Q Consensus       104 ~~~~~lG~G~f-G~Vy~~~~~~g~~vavK~~~~---~-------~------------~~~~~~~~E~~~l~~l~---h~n  157 (453)
                      .|-+.||.|.- |.||+.+.. |+.+|+|.++.   .       .            .-...|..|.+...+|+   +.+
T Consensus        40 ~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~  118 (207)
T PF13095_consen   40 EFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREG  118 (207)
T ss_pred             eeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccC
Confidence            45589999999 999999995 78999999431   0       0            00124788998888775   446


Q ss_pred             e--eeEeeEEEecC-----------------CCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHH
Q 047276          158 L--VRLLGYCVVPG-----------------GPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK  218 (453)
Q Consensus       158 i--v~l~g~~~~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~  218 (453)
                      +  |+.+||.....                 ..+.+|.||.+...                   .+..    +-+.++.+
T Consensus       119 ~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------------~~~~----~~~~~~~~  175 (207)
T PF13095_consen  119 LWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------------PLQI----RDIPQMLR  175 (207)
T ss_pred             ceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------------ccch----hHHHHHHH
Confidence            6  99999875441                 11246777765532                   0222    23456777


Q ss_pred             HhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       219 ~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      -|..+|.   .+|+-+|+++.|..     .-||+|||.+
T Consensus       176 dl~~~~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  176 DLKILHK---LGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHHH---CCeeeccCcccccc-----CCEEEecccC
Confidence            7788898   89999999999975     3488999864

>PLN02236 choline kinase

Probab=96.92  E-value=0.0082  Score=59.11  Aligned_cols=143  Identities=21%  Similarity=0.244  Sum_probs=79.5

Q ss_pred             ccCcCCceEEEEEEeCC-----CcEEEEEEecCCCccHHHHHHHHHHHHhcCCCcee-eEeeEEEecCCCeEEEEEecCC
Q 047276          108 LLGHGSSASVFKGILSD-----GTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLV-RLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       108 ~lG~G~fG~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      .|-.|-...+|+..+.+     ++.+++|.........-.-.+|..++..+...++. ++++++  .+.   .|++|+++
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~--~~g---~v~efi~g  117 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRF--PNG---RVEEFIHA  117 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEE--CCc---eEEEeeCC
Confidence            35457778899987543     35788998765332222235688888887644443 344543  222   58999987


Q ss_pred             CChhhh-----------------hccCCCCCCCCCCCCCCCHHHHHHHHHHH-----------------HHHhcc----c
Q 047276          182 GSLDHW-----------------IFPTSRRSEGHYSGGCLSWDLRYRVAIDV-----------------AKALSY----L  223 (453)
Q Consensus       182 gsL~~~-----------------l~~~~~~~~~~~~~~~l~~~~~~~i~~~i-----------------a~~L~~----L  223 (453)
                      .+|...                 +|......    ......|....++..++                 ...+..    +
T Consensus       118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~----~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~  193 (344)
T PLN02236        118 RTLSAADLRDPEISALIAAKLREFHSLDMPG----PKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL  193 (344)
T ss_pred             CCCCHHHcCChHHHHHHHHHHHHHhCCCCCC----CCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence            676422                 11111000    00112233322222111                 111111    1


Q ss_pred             cc-cCCCceeccCCCCCcEEECC-CCcEEEeecccccc
Q 047276          224 HN-DCRSRVLHLDVKPENILLDE-NYRAVVSDFGLSKL  259 (453)
Q Consensus       224 h~-~~~~~ivH~Dlk~~NiLl~~-~~~~kl~DfGla~~  259 (453)
                      .. ..+..++|+|+++.|||+++ ++.+.++||..+..
T Consensus       194 ~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        194 SGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             cccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            11 12357999999999999986 57899999988753

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.84  E-value=0.023  Score=55.31  Aligned_cols=148  Identities=20%  Similarity=0.244  Sum_probs=85.6

Q ss_pred             ccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCc---eee---EeeEEE-ecCC--CeEEEEEe
Q 047276          108 LLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVN---LVR---LLGYCV-VPGG--PRYLVYEF  178 (453)
Q Consensus       108 ~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n---iv~---l~g~~~-~~~~--~~~lv~e~  178 (453)
                      .|.+ .-..+|+....+|+. ++|..+.. ....++..|...|..|.-..   .++   +=|-.. .-..  ..+-+++|
T Consensus        33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~  109 (331)
T COG2334          33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY  109 (331)
T ss_pred             cccc-ccCceEEEEecCCCe-EEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence            3444 556789999887776 88888776 56677788888888774211   112   111100 0112  56789999


Q ss_pred             cCCCChhh-h--------------hccCCCCCC--CCCCCCCCCHH-----------------HHHHHHHHHHHHhcccc
Q 047276          179 IQNGSLDH-W--------------IFPTSRRSE--GHYSGGCLSWD-----------------LRYRVAIDVAKALSYLH  224 (453)
Q Consensus       179 ~~~gsL~~-~--------------l~~~~~~~~--~~~~~~~l~~~-----------------~~~~i~~~ia~~L~~Lh  224 (453)
                      ++|..+.. .              |+...+...  .........|.                 .+..+...+..-++.+-
T Consensus       110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~  189 (331)
T COG2334         110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP  189 (331)
T ss_pred             cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence            99988773 1              111111000  00011123333                 33333333433333333


Q ss_pred             ccCCCc---eeccCCCCCcEEECCCCc-EEEeeccccc
Q 047276          225 NDCRSR---VLHLDVKPENILLDENYR-AVVSDFGLSK  258 (453)
Q Consensus       225 ~~~~~~---ivH~Dlk~~NiLl~~~~~-~kl~DfGla~  258 (453)
                      ......   +||+|+.|.||+++++.. +.+.||+-+.
T Consensus       190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            322233   999999999999998875 8899999775

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.70  E-value=0.014  Score=55.51  Aligned_cols=31  Identities=32%  Similarity=0.553  Sum_probs=26.1

Q ss_pred             CceeccCCCCCcEEECCCCc-EEEeecccccc
Q 047276          229 SRVLHLDVKPENILLDENYR-AVVSDFGLSKL  259 (453)
Q Consensus       229 ~~ivH~Dlk~~NiLl~~~~~-~kl~DfGla~~  259 (453)
                      ..++|+|+++.|||+++++. .-|.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            56999999999999997555 46999998864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.68  E-value=0.024  Score=55.53  Aligned_cols=80  Identities=16%  Similarity=0.104  Sum_probs=50.9

Q ss_pred             ccCcCCceEEEEEEeCCC-cEEEEEEecC-----C---CccHHHHHHHHHHHHhcC--CC-ceeeEeeEEEecCCCeEEE
Q 047276          108 LLGHGSSASVFKGILSDG-TSVAVKRING-----E---ENGEKEFRSEVAAIASAQ--HV-NLVRLLGYCVVPGGPRYLV  175 (453)
Q Consensus       108 ~lG~G~fG~Vy~~~~~~g-~~vavK~~~~-----~---~~~~~~~~~E~~~l~~l~--h~-niv~l~g~~~~~~~~~~lv  175 (453)
                      .||.|....||++..++| +.|+||.-..     .   +-...+..-|...|....  -| .+.+++.|   +.....+|
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~---D~e~~~~v   78 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF---DTEMAVTV   78 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE---ccccceeh
Confidence            479999999999998755 5899996431     1   222344456777776653  34 45556544   34466799


Q ss_pred             EEecCCC-Chhhhhcc
Q 047276          176 YEFIQNG-SLDHWIFP  190 (453)
Q Consensus       176 ~e~~~~g-sL~~~l~~  190 (453)
                      ||+++.. .|.+.|..
T Consensus        79 MEdL~~~~ilR~~Li~   94 (370)
T TIGR01767        79 MEDLSHHKIARKGLIE   94 (370)
T ss_pred             HhhCccchHHHHHHHc
Confidence            9999653 34455533

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.62  E-value=0.0068  Score=57.88  Aligned_cols=72  Identities=19%  Similarity=0.368  Sum_probs=46.3

Q ss_pred             cccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcC---CCceeeEeeEEEecCCCeEEEEEecCCC
Q 047276          107 ALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQ---HVNLVRLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      +.++.|....+|+.. .+++.+.||.-.  ......|..|.+-|+.|.   --.+.+++++... .+..+|++||++.+
T Consensus        23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~-~~~~fLlle~l~~~   97 (288)
T PF03881_consen   23 EPVSGGDINEAYRLD-TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEY-DDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEE--SSSSEEEEEE-TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE--SSCCEEEEE-----
T ss_pred             EecCCCChhheEEEE-CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEee-cCCceEEEEeecCC
Confidence            468889999999987 567889999876  333457889999988884   3456778887653 44569999999876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.50  E-value=0.029  Score=54.05  Aligned_cols=145  Identities=20%  Similarity=0.286  Sum_probs=78.6

Q ss_pred             eEEEEEEeCCCcEEEEEEecC---CCccHHHHHHHHHHHHhcCC--CceeeEeeEEEecC-CCeEEEEEecCCCChhhhh
Q 047276          115 ASVFKGILSDGTSVAVKRING---EENGEKEFRSEVAAIASAQH--VNLVRLLGYCVVPG-GPRYLVYEFIQNGSLDHWI  188 (453)
Q Consensus       115 G~Vy~~~~~~g~~vavK~~~~---~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~-~~~~lv~e~~~~gsL~~~l  188 (453)
                      -.+|..... ++.+++. ...   .........+|..+|+.+.-  --+...+++|.... ...+.||+|+++..+.+.+
T Consensus        39 n~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~  116 (321)
T COG3173          39 NDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSAL  116 (321)
T ss_pred             cceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcC
Confidence            344444333 6778877 221   12233456678888887753  33455667776444 4568999999884332222


Q ss_pred             ccC---------------------CCCC---CC---C-CCCCCCCHHHHHHHH--------HHHHHHhccccc-----cC
Q 047276          189 FPT---------------------SRRS---EG---H-YSGGCLSWDLRYRVA--------IDVAKALSYLHN-----DC  227 (453)
Q Consensus       189 ~~~---------------------~~~~---~~---~-~~~~~l~~~~~~~i~--------~~ia~~L~~Lh~-----~~  227 (453)
                      ...                     ....   ..   . ...+.-.|...++.+        -....-..||++     ..
T Consensus       117 ~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~  196 (321)
T COG3173         117 PPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAG  196 (321)
T ss_pred             CcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCC
Confidence            110                     0000   00   0 011112233333111        111222333332     12


Q ss_pred             CCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          228 RSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       228 ~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      ...++|+|+.+.|++++.+.-+=|.||+++....
T Consensus       197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             CceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence            3679999999999999998889999999987653

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.46  E-value=0.046  Score=53.38  Aligned_cols=92  Identities=16%  Similarity=0.106  Sum_probs=54.7

Q ss_pred             ecHHHHHHHHHHHhc------ccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCC--ceeeEe--
Q 047276           93 FRSKELEEATDNFQA------LLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHV--NLVRLL--  162 (453)
Q Consensus        93 ~~~~el~~~~~~~~~------~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~--  162 (453)
                      ++.+.+..+.....=      ..-.+.-..||+....+|..+++|..+.......+...|++.+..|...  .++...  
T Consensus        11 l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~   90 (325)
T PRK11768         11 LTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAF   90 (325)
T ss_pred             CChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccC
Confidence            455566655554421      1112345679999888888899998875555667778888888776421  122211  


Q ss_pred             -e-EEEecCCCeEEEEEecCCCCh
Q 047276          163 -G-YCVVPGGPRYLVYEFIQNGSL  184 (453)
Q Consensus       163 -g-~~~~~~~~~~lv~e~~~~gsL  184 (453)
                       | .....++..+.++++++|...
T Consensus        91 ~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         91 NGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             CCCEEEEECCEEEEEEeeeCCCCC
Confidence             2 001123456789999987643

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.43  E-value=0.00065  Score=75.78  Aligned_cols=162  Identities=13%  Similarity=-0.000  Sum_probs=113.0

Q ss_pred             HHHHHHHHHhcCCCceeeEeeEEE-ecCCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhc
Q 047276          143 FRSEVAAIASAQHVNLVRLLGYCV-VPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALS  221 (453)
Q Consensus       143 ~~~E~~~l~~l~h~niv~l~g~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~  221 (453)
                      ...|...++...|+++.....-.. ....+.+..++|+..|.+.+.+-+....      ...++.........+......
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee------~~~ld~~~v~~~~kvsvl~~~ 1349 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEE------SPDLDRSPVHLRHKVSVLNRN 1349 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhcccc------CCcchhchHHHHHHHHHhccc
Confidence            445555666678988776543211 1223558899999999999998655432      122343333333333344444


Q ss_pred             ccccc--CCCceeccCCCCCcEEECCCCcEEEeeccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHH
Q 047276          222 YLHND--CRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGM  299 (453)
Q Consensus       222 ~Lh~~--~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gv  299 (453)
                      -+|+.  ...-.+|+++|+-|.+|..+.++|++++|+.+...+. ....+...+++-|+.|+....-.++.++|+|..|+
T Consensus      1350 ~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~ 1428 (2724)
T KOG1826|consen 1350 VILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSL 1428 (2724)
T ss_pred             hhhhcccCCccchhhhhhhhccceecCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHH
Confidence            44432  2245799999999999999999999999999833222 22345567788899999888888999999999999


Q ss_pred             HHHHHHcCCCCC
Q 047276          300 VLLELTGGRRNV  311 (453)
Q Consensus       300 il~elltG~~p~  311 (453)
                      -+|+...|..+|
T Consensus      1429 ~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1429 SLYLRSDGNAYF 1440 (2724)
T ss_pred             HHHHHhcccHHH
Confidence            999999898776

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.34  E-value=0.0062  Score=61.30  Aligned_cols=51  Identities=20%  Similarity=0.169  Sum_probs=40.6

Q ss_pred             cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCChhhhhcc
Q 047276          139 GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFP  190 (453)
Q Consensus       139 ~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~  190 (453)
                      ...+++.....++.+.|+|+...+.+.........+|+|++ +.||++.+..
T Consensus        25 ~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~   75 (725)
T KOG1093|consen   25 NSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKT   75 (725)
T ss_pred             cHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHh
Confidence            34567788899999999999999988655445568899999 5599999853

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.27  E-value=0.048  Score=52.69  Aligned_cols=29  Identities=31%  Similarity=0.379  Sum_probs=25.7

Q ss_pred             CceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          229 SRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       229 ~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      .+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            68999999999999988 578899998764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK06148 hypothetical protein; Provisional

Probab=96.25  E-value=0.033  Score=62.64  Aligned_cols=150  Identities=22%  Similarity=0.222  Sum_probs=80.0

Q ss_pred             cccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcC-------CCceeeEe-e----EEEecCC--Ce
Q 047276          107 ALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQ-------HVNLVRLL-G----YCVVPGG--PR  172 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-------h~niv~l~-g----~~~~~~~--~~  172 (453)
                      +.|+ |..-.+|+....+|..+++|+.+... .......|...|..|.       -|.+++-. |    .....++  ..
T Consensus        31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~-~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~  108 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE-PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL  108 (1013)
T ss_pred             eecC-CcCCceEEEEeCCCCeEEEEEcCCcc-chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence            3464 45678899888888899999988643 2334444555665442       23333322 1    1111112  34


Q ss_pred             EEEEEecCCCChhhhhc-----------------cCCCCCCCCCCCCCCCHHH-----------------HHHHHHHHHH
Q 047276          173 YLVYEFIQNGSLDHWIF-----------------PTSRRSEGHYSGGCLSWDL-----------------RYRVAIDVAK  218 (453)
Q Consensus       173 ~lv~e~~~~gsL~~~l~-----------------~~~~~~~~~~~~~~l~~~~-----------------~~~i~~~ia~  218 (453)
                      +-+++|.++..|.+...                 ..-...........+.|..                 ...++.++.+
T Consensus       109 vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~  188 (1013)
T PRK06148        109 LRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLA  188 (1013)
T ss_pred             EEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHH
Confidence            67899999987765211                 0000000000011133321                 1122222222


Q ss_pred             Hhc-----cccccCCCceeccCCCCCcEEECCCC--cEE-Eeecccccc
Q 047276          219 ALS-----YLHNDCRSRVLHLDVKPENILLDENY--RAV-VSDFGLSKL  259 (453)
Q Consensus       219 ~L~-----~Lh~~~~~~ivH~Dlk~~NiLl~~~~--~~k-l~DfGla~~  259 (453)
                      ...     .+. ....++||+|+.+.|||++.++  .+. |+|||-+..
T Consensus       189 ~~~~~v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        189 RFERNVAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            221     121 2346899999999999999875  555 999998753

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.25  E-value=0.029  Score=54.93  Aligned_cols=72  Identities=21%  Similarity=0.287  Sum_probs=44.6

Q ss_pred             ccCcCCceEEEEEEeCC----CcEEEEEEecCCCccHHHHHHHHHHHHhcCCCcee-eEeeEEEecCCCeEEEEEecCCC
Q 047276          108 LLGHGSSASVFKGILSD----GTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLV-RLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       108 ~lG~G~fG~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      .|..|-...+|+....+    +..|++|+........-.-.+|..++..+..-++. ++++++  .++   +|.+|+++.
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~--~~G---~i~~fi~g~   95 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVF--GNG---MIQSFINAR   95 (330)
T ss_pred             EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEe--CCc---EeehhhcCC
Confidence            45557778889887543    23788998765332222235788888888655443 445443  221   589999776


Q ss_pred             Ch
Q 047276          183 SL  184 (453)
Q Consensus       183 sL  184 (453)
                      .|
T Consensus        96 ~l   97 (330)
T PLN02421         96 TL   97 (330)
T ss_pred             CC
Confidence            65

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.14  E-value=0.041  Score=54.57  Aligned_cols=79  Identities=16%  Similarity=0.148  Sum_probs=51.2

Q ss_pred             cccCcCCceEEEEEEeCC-CcEEEEEEecC----C---CccHHHHHHHHHHHHhcC--CC-ceeeEeeEEEecCCCeEEE
Q 047276          107 ALLGHGSSASVFKGILSD-GTSVAVKRING----E---ENGEKEFRSEVAAIASAQ--HV-NLVRLLGYCVVPGGPRYLV  175 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~-g~~vavK~~~~----~---~~~~~~~~~E~~~l~~l~--h~-niv~l~g~~~~~~~~~~lv  175 (453)
                      +.||.|.-.-||++...+ ++.|+||.-..    .   .-...+..-|.+.|+...  -| ++.+++.|   +.....+|
T Consensus        35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~---D~e~~~~v  111 (409)
T PRK12396         35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF---DSVMNCCV  111 (409)
T ss_pred             eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE---CcHHhhHH
Confidence            468999999999999753 56799996431    1   223355566777777653  34 45556654   44466789


Q ss_pred             EEecCCC-Chhhhh
Q 047276          176 YEFIQNG-SLDHWI  188 (453)
Q Consensus       176 ~e~~~~g-sL~~~l  188 (453)
                      ||+++.. .|.+.|
T Consensus       112 MEdL~~~~ilR~~L  125 (409)
T PRK12396        112 MEDLSDHTILRTAL  125 (409)
T ss_pred             HHhCcccHHHHHHH
Confidence            9998643 344444

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.10  E-value=0.15  Score=50.99  Aligned_cols=78  Identities=13%  Similarity=0.088  Sum_probs=51.0

Q ss_pred             cccCcCCceEEEEEEeCCCcEEEEEEecC-----CC---ccHHHHHHHHHHHHhcC---CCceeeEeeEEEecCCCeEEE
Q 047276          107 ALLGHGSSASVFKGILSDGTSVAVKRING-----EE---NGEKEFRSEVAAIASAQ---HVNLVRLLGYCVVPGGPRYLV  175 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~g~~vavK~~~~-----~~---~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~~lv  175 (453)
                      +.||.|....||+.... +..++||.-..     ..   .....-..|...|..+.   ..++.+++.+|.   +..+++
T Consensus        38 ~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de---d~~vlv  113 (418)
T PLN02756         38 KEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR---TMALIG  113 (418)
T ss_pred             EEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC---CCCEEE
Confidence            46899999999998764 55689997541     11   12233344566666553   347778888764   356889


Q ss_pred             EEecCC--CChhhhh
Q 047276          176 YEFIQN--GSLDHWI  188 (453)
Q Consensus       176 ~e~~~~--gsL~~~l  188 (453)
                      |||+++  ..+.+-+
T Consensus       114 ME~L~~~~~ilr~~L  128 (418)
T PLN02756        114 MRYLEPPHIILRKGL  128 (418)
T ss_pred             EeecCCcceehhhhh
Confidence            999977  3455444

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.10  E-value=0.044  Score=53.11  Aligned_cols=32  Identities=19%  Similarity=0.305  Sum_probs=28.5

Q ss_pred             CCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          228 RSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       228 ~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ..+++|+|+.+.|+|+++++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            35899999999999999999999999988763

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.68  E-value=0.031  Score=54.23  Aligned_cols=54  Identities=22%  Similarity=0.234  Sum_probs=48.8

Q ss_pred             CCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          204 LSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       204 l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      -.|++...|+.+.+..++-+...  -++-|||+.-.||||+ +|++.|+||-+++.-
T Consensus       318 ~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfklsRl~  371 (488)
T COG5072         318 DRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             ccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeeeecc
Confidence            57899999999999998888875  7899999999999999 999999999999943

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.61  E-value=0.035  Score=50.43  Aligned_cols=31  Identities=26%  Similarity=0.404  Sum_probs=22.1

Q ss_pred             CceeccCCCCCcEEE-CCCCcEEEeecccccc
Q 047276          229 SRVLHLDVKPENILL-DENYRAVVSDFGLSKL  259 (453)
Q Consensus       229 ~~ivH~Dlk~~NiLl-~~~~~~kl~DfGla~~  259 (453)
                      .-++|.|+.+.|||+ +.++.++++||..+..
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            568999999999999 8899999999988753

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.60  E-value=0.028  Score=55.25  Aligned_cols=62  Identities=21%  Similarity=0.121  Sum_probs=44.0

Q ss_pred             CeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECC
Q 047276          171 PRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDE  245 (453)
Q Consensus       171 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~  245 (453)
                      ...++-+|+.+-++..++...           ..++..+.+++.--+.|+--+--.  .+++|.|+.|.||++--
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~~-----------~~pe~l~kkva~lg~~AllkMl~v--DNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKWK-----------SQPEALVKKVAKLGVNALLKMLIV--DNFVHADLHPGNVLIRF  380 (565)
T ss_pred             cceeeeeccccccHHhhhhcc-----------cChHHHHHHHHHHHHHHHHHHHHh--hcceecccCCCcEEEEe
Confidence            346788888888998888422           245556667776666666544332  58999999999999953

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=95.46  E-value=0.052  Score=52.79  Aligned_cols=137  Identities=18%  Similarity=0.258  Sum_probs=88.3

Q ss_pred             cccCcCCceEEEEEEeCCCcEEEEEEecCC------C----ccH------------H-H----HHHHHHHHHhcCCCcee
Q 047276          107 ALLGHGSSASVFKGILSDGTSVAVKRINGE------E----NGE------------K-E----FRSEVAAIASAQHVNLV  159 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~------~----~~~------------~-~----~~~E~~~l~~l~h~niv  159 (453)
                      -.|..|--..||.+.-.+|..+|||+++.+      .    .++            + .    ...|++-|.+++...|.
T Consensus       150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP  229 (520)
T KOG2270|consen  150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP  229 (520)
T ss_pred             cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            467788889999999999999999987531      0    010            1 1    23466667777644322


Q ss_pred             eEeeEEEecCCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCC
Q 047276          160 RLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPE  239 (453)
Q Consensus       160 ~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~  239 (453)
                      ..--...   ....|||+|+.. +  .|-.       +....-.++...+...-.+++.-|.-|...  .++||.||.-=
T Consensus       230 ~PePIlL---k~hVLVM~FlGr-d--gw~a-------PkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~--c~LVHADLSEf  294 (520)
T KOG2270|consen  230 CPEPILL---KNHVLVMEFLGR-D--GWAA-------PKLKDASLSTSKARELYQQCVRIMRRLYQK--CRLVHADLSEF  294 (520)
T ss_pred             CCCceee---ecceEeeeeccC-C--CCcC-------cccccccCChHHHHHHHHHHHHHHHHHHHH--hceeccchhhh
Confidence            1100001   134799999842 1  1111       011222366666777778888888888776  58999999999


Q ss_pred             cEEECCCCcEEEeecccccc
Q 047276          240 NILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       240 NiLl~~~~~~kl~DfGla~~  259 (453)
                      |+|+- +|.+.|+|-+-+--
T Consensus       295 N~Lyh-dG~lyiIDVSQSVE  313 (520)
T KOG2270|consen  295 NLLYH-DGKLYIIDVSQSVE  313 (520)
T ss_pred             hheEE-CCEEEEEEcccccc
Confidence            99995 56889999886643

>PTZ00384 choline kinase; Provisional

Probab=94.92  E-value=0.18  Score=50.28  Aligned_cols=74  Identities=12%  Similarity=0.163  Sum_probs=44.2

Q ss_pred             ccCcCCceEEEEEEeCCC--cE-----EEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          108 LLGHGSSASVFKGILSDG--TS-----VAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       108 ~lG~G~fG~Vy~~~~~~g--~~-----vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      .|..|-...+|++...++  ..     |.++.........-.-.+|..++..+...++.+-+-.+.    .-.+++||++
T Consensus        57 ~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f----~~g~l~efIe  132 (383)
T PTZ00384         57 KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRF----GDFTIQEWVE  132 (383)
T ss_pred             EeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEec----CCEEEEEEec
Confidence            455688899999986543  22     444432221111112356889999997666655443322    2369999999


Q ss_pred             CCChh
Q 047276          181 NGSLD  185 (453)
Q Consensus       181 ~gsL~  185 (453)
                      +.+|.
T Consensus       133 Gr~l~  137 (383)
T PTZ00384        133 GNTMG  137 (383)
T ss_pred             cccCC
Confidence            87764

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=94.38  E-value=0.43  Score=44.65  Aligned_cols=77  Identities=30%  Similarity=0.228  Sum_probs=54.7

Q ss_pred             ccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec-CCCChhh
Q 047276          108 LLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI-QNGSLDH  186 (453)
Q Consensus       108 ~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~-~~gsL~~  186 (453)
                      .+..|..+.|+.++..+|.+.++|+.........+...+ ..|+..+-...|++++.   +.....+.+|.. ++.+|.+
T Consensus         9 ~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~E~~g~-~~L~~w~G~GaVrll~~---d~~~~AlLLErl~~g~~L~~   84 (253)
T PF04655_consen    9 PPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEHEARGE-AALRWWNGRGAVRLLAA---DPERGALLLERLDPGRSLAS   84 (253)
T ss_pred             CCCCCcceEEEEEEcCCCCeEEEEecCCcccchhhhhHH-hHhheeCCCCceeeecc---ccccchhhhhhccCCCchhh
Confidence            456789999999999999999999887544333322222 44777777888999886   233557888988 5557776


Q ss_pred             hh
Q 047276          187 WI  188 (453)
Q Consensus       187 ~l  188 (453)
                      ..
T Consensus        85 ~~   86 (253)
T PF04655_consen   85 LP   86 (253)
T ss_pred             cc
Confidence            65

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

>PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane

Probab=94.18  E-value=0.071  Score=43.44  Aligned_cols=32  Identities=19%  Similarity=0.209  Sum_probs=19.7

Q ss_pred             chhHHHHHHHHHHHHHHHHHHHHHHHhhhchh
Q 047276           31 SKAFFLIVGADIAVVLAVFACVIIRRRYHKRR   62 (453)
Q Consensus        31 ~~~~~~i~~~~~~~~l~~~~~~~~~~~~~~~~   62 (453)
                      ..++.||+|+++++++++++++++.||++|+.
T Consensus        64 ~~i~~Ii~gv~aGvIg~Illi~y~irR~~Kk~   95 (122)
T PF01102_consen   64 PAIIGIIFGVMAGVIGIILLISYCIRRLRKKS   95 (122)
T ss_dssp             TCHHHHHHHHHHHHHHHHHHHHHHHHHHS---
T ss_pred             cceeehhHHHHHHHHHHHHHHHHHHHHHhccC
Confidence            34667777887777776666666666555543

Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	453
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		6e-54
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-52
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		4e-37
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-36
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-29
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-29
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-28
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-26
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-18
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		7e-18
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		6e-17
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		7e-17
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		8e-17
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-16
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-16
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-16
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-16
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-16
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-16
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-16
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-16
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-16
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-16
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-16
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-16
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-16
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-16
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-16
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-16
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-16
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-16
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-16
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-16
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-16
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-16
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-16
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-16
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-16
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-16
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		5e-16
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-16
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		8e-16
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-15
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-15
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-15
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-15
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-15
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		5e-15
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-15
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-15
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-15
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		6e-15
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		9e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-14
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-14
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-14
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-14
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-14
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-14
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-14
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-14
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-14
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-14
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-14
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-14
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-14
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-14
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-14
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-14
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-14
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-14
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-14
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-14
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-14
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-14
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-14
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-14
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-14
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-14
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-14
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-14
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-14
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-14
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-14
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-14
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-14
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-14
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-14
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		5e-14
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-14
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-14
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		5e-14
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-14
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-14
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-14
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-14
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-14
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		6e-14
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-14
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-14
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		6e-14
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		6e-14
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		6e-14
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		6e-14
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-14
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		7e-14
2pl0_A	289	Lck Bound To Imatinib Length = 289		7e-14
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		7e-14
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		7e-14
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		8e-14
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-14
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		9e-14
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		9e-14
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		9e-14
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-13
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-13
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-13
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-13
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-13
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-13
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-13
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-13
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-13
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-13
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-13
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-13
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-13
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-13
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-13
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		4e-13
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-13
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-13
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-13
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-13
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		6e-13
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		6e-13
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		6e-13
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-13
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		7e-13
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-13
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-13
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		9e-13
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		9e-13
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		9e-13
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		9e-13
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		9e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-12
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-12
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-12
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-12
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-12
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-12
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-12
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-12
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-12
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-12
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-12
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-12
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-12
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-12
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-12
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-12
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-12
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-12
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-12
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-12
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-12
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-12
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-12
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-12
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-12
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-12
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-12
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-12
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-12
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-12
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-12
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-12
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		6e-12
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-12
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-12
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		6e-12
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		6e-12
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		8e-12
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		8e-12
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-12
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		8e-12
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		8e-12
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		9e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		9e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		9e-12
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		9e-12
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		9e-12
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-11
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-11
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-11
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-11
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-11
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-11
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-11
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-11
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-11
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-11
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-11
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-11
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-11
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-11
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-11
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-11
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-11
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-11
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-11
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-11
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-11
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-11
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-11
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-11
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-11
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-11
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-11
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-11
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-11
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-11
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-11
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-11
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		5e-11
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		5e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-11
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		6e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		6e-11
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		6e-11
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-11
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-11
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-11
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		7e-11
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-11
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		7e-11
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		7e-11
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		7e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		7e-11
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		8e-11
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		8e-11
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		8e-11
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		8e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-11
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		8e-11
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		9e-11
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		9e-11
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		9e-11
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		9e-11
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-10
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-10
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-10
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-10
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-10
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-10
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-10
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-10
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-10
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-10
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-10
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-10
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-10
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-10
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-10
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-10
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-10
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-10
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-10
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-10
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-10
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-10
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-10
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-10
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-10
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-10
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		4e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		4e-10
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-10
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-10
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-10
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-10
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-10
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-10
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-10
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-10
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-10
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-10
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		5e-10
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		5e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		5e-10
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		5e-10
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-10
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		5e-10
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		6e-10
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		6e-10
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		6e-10
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		6e-10
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-10
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-10
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		6e-10
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		7e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		7e-10
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		7e-10
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		8e-10
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		9e-10
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		9e-10
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-09
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-09
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-09
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-09
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-09
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-09
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-09
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-09
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-09
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-09
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-09
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-09
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-09
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-09
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-09
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-09
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-09
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-09
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-09
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-09
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-09
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-09
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-09
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-09
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-09
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-09
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-09
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-09
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-09
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-09
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-09
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-09
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-09
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-09
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-09
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-09
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-09
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-09
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-09
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-09
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-09
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-09
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-09
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-09
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-09
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-09
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-09
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-09
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		4e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		4e-09
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-09
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-09
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-09
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-09
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-09
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		5e-09
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-09
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		5e-09
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		5e-09
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		5e-09
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-09
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		5e-09
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-09
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		5e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		5e-09
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-09
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		5e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-09
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-09
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		5e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		5e-09
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-09
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-09
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		5e-09
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		5e-09
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		6e-09
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		6e-09
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		6e-09
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-09
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		6e-09
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		6e-09
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		6e-09
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-09
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		6e-09
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		7e-09
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-09
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		7e-09
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		7e-09
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		7e-09
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		7e-09
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		7e-09
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		8e-09
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		8e-09
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		9e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		9e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		9e-09
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-08
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-08
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-08
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-08
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-08
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-08
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-08
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-08
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-08
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-08
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-08
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-08
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-08
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-08
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-08
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-08
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-08
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-08
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-08
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-08
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-08
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-08
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-08
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-08
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-08
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-08
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-08
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-08
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-08
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-08
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-08
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-08
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-08
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-08
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-08
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-08
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-08
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-08
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-08
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-08
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-08
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-08
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-08
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-08
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-08
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-08
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-08
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-08
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-08
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-08
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-08
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-08
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-08
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-08
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-08
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-08
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-08
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-08
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-08
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-08
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-08
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-08
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-08
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-08
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-08
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-08
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-08
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-08
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-08
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		4e-08
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-08
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-08
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-08
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-08
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-08
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		5e-08
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-08
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		5e-08
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		6e-08
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		6e-08
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		6e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		6e-08
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		6e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-08
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		7e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		7e-08
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		8e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		8e-08
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		8e-08
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		8e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		8e-08
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		8e-08
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		8e-08
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		9e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		9e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		9e-08
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		9e-08
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		9e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-08
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-07
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-07
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-07
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-07
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-07
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-07
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-07
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-07
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-07
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-07
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-07
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-07
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		2e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-07
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-07
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		2e-07
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		2e-07
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-07
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-07
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-07
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		2e-07
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-07
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-07
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-07
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-07
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-07
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-07
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-07
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-07
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-07
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-07
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-07
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-07
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-07
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		3e-07
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		3e-07
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-07
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-07
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-07
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-07
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-07
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-07
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-07
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-07
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-07
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-07
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-07
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-07
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-07
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-07
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-07
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-07
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-07
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		4e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-07
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		4e-07
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-07
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		5e-07
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-07
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-07
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-07
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		5e-07
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		5e-07
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		5e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		5e-07
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-07
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		6e-07
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		6e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		6e-07
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		6e-07
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		6e-07
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		6e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		6e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		6e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		6e-07
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		6e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		7e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		7e-07
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		7e-07
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		7e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		8e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		8e-07
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		8e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		8e-07
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		8e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		9e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		9e-07
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		9e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		9e-07
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-06
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-06
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-06
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-06
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-06
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-06
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-06
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-06
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-06
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-06
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		1e-06
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-06
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-06
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-06
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-06
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-06
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-06
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-06
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		2e-06
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-06
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-06
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-06
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-06
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-06
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-06
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-06
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-06
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-06
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-06
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-06
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-06
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-06
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-06
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-06
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-06
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-06
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-06
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-06
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-06
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-06
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-06
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-06
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-06
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-06
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-06
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-06
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-06
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-06
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-06
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-06
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		4e-06
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-06
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-06
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		4e-06
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-06
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-06
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-06
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-06
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-06
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-06
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-06
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		4e-06
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-06
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-06
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-06
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-06
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		4e-06
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-06
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-06
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-06
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-06
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-06
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-06
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-06
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-06
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-06
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-06
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-06
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-06
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-06
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-06
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-06
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-06
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-06
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-06
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-06
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-06
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-06
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-06
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-06
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-06
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-06
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-06
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-06
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		5e-06
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-06
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		5e-06
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		5e-06
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-06
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-06
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-06
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-06
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-06
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-06
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-06
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-06
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-06
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		5e-06
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		5e-06
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-06
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-06
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-06
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-06
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-06
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-06
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-06
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-06
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		5e-06
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		6e-06
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		6e-06
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		6e-06
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		6e-06
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		6e-06
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		6e-06
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		6e-06
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		6e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		6e-06
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		7e-06
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-06
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		7e-06
2oza_A	356	Structure Of P38alpha Complex Length = 356		7e-06
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-06
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-06
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		7e-06
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		7e-06
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		7e-06
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		7e-06
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		7e-06
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		7e-06
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		8e-06
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		8e-06
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		8e-06
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-06
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		9e-06
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-05
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-05
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-05
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-05
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-05
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-05
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-05
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-05
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-05
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-05
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-05
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-05
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-05
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-05
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-05
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-05
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-05
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-05
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-05
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-05
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-05
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-05
3soa_A	444	Full-Length Human Camkii Length = 444		1e-05
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		1e-05
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-05
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-05
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-05
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-05
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-05
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-05
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-05
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-05
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-05
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-05
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-05
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-05
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-05
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-05
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-05
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-05
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-05
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-05
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-05
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-05
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-05
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-05
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		3e-05
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-05
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-05
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		4e-05
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		4e-05
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		5e-05
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		5e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		5e-05
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		5e-05
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		5e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		6e-05
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		6e-05
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-05
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-05
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		8e-05
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		9e-05
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		9e-05
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		9e-05
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-04
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-04
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-04
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-04
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-04
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-04
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-04
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  208 bits (529), Expect = 6e-54,   Method: Compositional matrix adjust.
 Identities = 124/303 (40%), Positives = 174/303 (57%), Gaps = 17/303 (5%)
Query: 92  KFRSKELEEATDNF--QALLGHGSSASVFKGILSDGTSVAVKRINGE--ENGEKEFRSEV 147
           +F  +EL+ A+DNF  + +LG G    V+KG L+DGT VAVKR+  E  + GE +F++EV
Sbjct: 27  RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEV 86
Query: 148 AAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWD 207
             I+ A H NL+RL G+C+ P   R LVY ++ NGS+       S   E   S   L W 
Sbjct: 87  EMISMAVHRNLLRLRGFCMTPT-ERLLVYPYMANGSV------ASCLRERPESQPPLDWP 139
Query: 208 LRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC 267
            R R+A+  A+ L+YLH+ C  +++H DVK  NILLDE + AVV DFGL+KLM       
Sbjct: 140 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHV 199
Query: 268 ITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQY 327
              +RGT G++APE++     SEK D++ YG++LLEL  G+R   L    ND       +
Sbjct: 200 XXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 259
Query: 328 FPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM 387
              ++ EK    KL  +VD  L  +G   + +V +L+ VA  C Q     RP M+ VV M
Sbjct: 260 VKGLLKEK----KLEALVDVDL--QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 313
Query: 388 LEG 390
           LEG
Sbjct: 314 LEG 316

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  203 bits (517), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 122/303 (40%), Positives = 172/303 (56%), Gaps = 17/303 (5%)
Query: 92  KFRSKELEEATDNF--QALLGHGSSASVFKGILSDGTSVAVKRINGE--ENGEKEFRSEV 147
           +F  +EL+ A+DNF  + +LG G    V+KG L+DG  VAVKR+  E  + GE +F++EV
Sbjct: 19  RFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEV 78
Query: 148 AAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWD 207
             I+ A H NL+RL G+C+ P   R LVY ++ NGS+       S   E   S   L W 
Sbjct: 79  EMISMAVHRNLLRLRGFCMTPT-ERLLVYPYMANGSV------ASCLRERPESQPPLDWP 131
Query: 208 LRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC 267
            R R+A+  A+ L+YLH+ C  +++H DVK  NILLDE + AVV DFGL+KLM       
Sbjct: 132 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHV 191
Query: 268 ITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQY 327
              +RG  G++APE++     SEK D++ YG++LLEL  G+R   L    ND       +
Sbjct: 192 XXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251
Query: 328 FPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM 387
              ++ EK    KL  +VD  L  +G   + +V +L+ VA  C Q     RP M+ VV M
Sbjct: 252 VKGLLKEK----KLEALVDVDL--QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 305
Query: 388 LEG 390
           LEG
Sbjct: 306 LEG 308

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 104/304 (34%), Positives = 166/304 (54%), Gaps = 36/304 (11%)
Query: 97  ELEEATDNF--QALLGHGSSASVFKGILSDGTSVAVKRINGEEN-GEKEFRSEVAAIASA 153
           +LEEAT+NF  + L+GHG    V+KG+L DG  VA+KR   E + G +EF +E+  ++  
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 154 QHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVA 213
           +H +LV L+G+C        L+Y++++NG+L   ++ +   +        +SW+ R  + 
Sbjct: 93  RHPHLVSLIGFCD-ERNEMILIYKYMENGNLKRHLYGSDLPTMS------MSWEQRLEIC 145
Query: 214 IDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIR 272
           I  A+ L YLH      ++H DVK  NILLDEN+   ++DFG+SK  +  DQ+     ++
Sbjct: 146 IGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVK 202
Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPK-I 331
           GT GY+ PE+ ++  ++EK D+YS+G+VL E+   R  +              Q  P+ +
Sbjct: 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV-------------QSLPREM 249
Query: 332 VN------EKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVV 385
           VN      E    G+L +IVD  L D+  I    +R+  D A  C+   +  RPSM  V+
Sbjct: 250 VNLAEWAVESHNNGQLEQIVDPNLADK--IRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307
Query: 386 EMLE 389
             LE
Sbjct: 308 WKLE 311

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 103/304 (33%), Positives = 165/304 (54%), Gaps = 36/304 (11%)
Query: 97  ELEEATDNF--QALLGHGSSASVFKGILSDGTSVAVKRINGEEN-GEKEFRSEVAAIASA 153
           +LEEAT+NF  + L+GHG    V+KG+L DG  VA+KR   E + G +EF +E+  ++  
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 154 QHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVA 213
           +H +LV L+G+C        L+Y++++NG+L   ++ +   +        +SW+ R  + 
Sbjct: 93  RHPHLVSLIGFCD-ERNEMILIYKYMENGNLKRHLYGSDLPTMS------MSWEQRLEIC 145
Query: 214 IDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIR 272
           I  A+ L YLH      ++H DVK  NILLDEN+   ++DFG+SK  +   Q+     ++
Sbjct: 146 IGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVK 202
Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPK-I 331
           GT GY+ PE+ ++  ++EK D+YS+G+VL E+   R  +              Q  P+ +
Sbjct: 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV-------------QSLPREM 249
Query: 332 VN------EKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVV 385
           VN      E    G+L +IVD  L D+  I    +R+  D A  C+   +  RPSM  V+
Sbjct: 250 VNLAEWAVESHNNGQLEQIVDPNLADK--IRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307
Query: 386 EMLE 389
             LE
Sbjct: 308 WKLE 311

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 97/315 (30%), Positives = 155/315 (49%), Gaps = 37/315 (11%)
Query: 93  FRSKELEEATDNFQA--------LLGHGSSASVFKGILSDGTSVAVKRING-----EENG 139
           F   EL+  T+NF           +G G    V+KG +++ T+VAVK++        E  
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 73
Query: 140 EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           +++F  E+  +A  QH NLV LLG+    G    LVY ++ NGSL         R     
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSS-DGDDLCLVYVYMPNGSL-------LDRLSCLD 125
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL 259
               LSW +R ++A   A  +++LH +     +H D+K  NILLDE + A +SDFGL++ 
Sbjct: 126 GTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARA 182
Query: 260 MSR-DQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGN 318
             +  Q+   + I GT  Y+APE  L   ++ K DIYS+G+VLLE+  G   V       
Sbjct: 183 SEKFAQTVMXSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAV------- 234
Query: 319 DKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLR 378
           D+ +            + +E  + + +D+++ D    D T V  +  VA  C+ E+   R
Sbjct: 235 DEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND---ADSTSVEAMYSVASQCLHEKKNKR 291
Query: 379 PSMARVVEMLEGRVA 393
           P + +V ++L+   A
Sbjct: 292 PDIKKVQQLLQEMTA 306

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 97/315 (30%), Positives = 154/315 (48%), Gaps = 37/315 (11%)
Query: 93  FRSKELEEATDNFQA--------LLGHGSSASVFKGILSDGTSVAVKRING-----EENG 139
           F   EL+  T+NF           +G G    V+KG +++ T+VAVK++        E  
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 73
Query: 140 EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           +++F  E+  +A  QH NLV LLG+    G    LVY ++ NGSL         R     
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSS-DGDDLCLVYVYMPNGSL-------LDRLSCLD 125
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL 259
               LSW +R ++A   A  +++LH +     +H D+K  NILLDE + A +SDFGL++ 
Sbjct: 126 GTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARA 182
Query: 260 MSR-DQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGN 318
             +  Q+     I GT  Y+APE  L   ++ K DIYS+G+VLLE+  G   V       
Sbjct: 183 SEKFAQTVMXXRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAV------- 234
Query: 319 DKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLR 378
           D+ +            + +E  + + +D+++ D    D T V  +  VA  C+ E+   R
Sbjct: 235 DEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND---ADSTSVEAMYSVASQCLHEKKNKR 291
Query: 379 PSMARVVEMLEGRVA 393
           P + +V ++L+   A
Sbjct: 292 PDIKKVQQLLQEMTA 306

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 97/315 (30%), Positives = 153/315 (48%), Gaps = 37/315 (11%)
Query: 93  FRSKELEEATDNFQA--------LLGHGSSASVFKGILSDGTSVAVKRING-----EENG 139
           F   EL+  T+NF           +G G    V+KG +++ T+VAVK++        E  
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 67
Query: 140 EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           +++F  E+  +A  QH NLV LLG+    G    LVY ++ NGSL         R     
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSS-DGDDLCLVYVYMPNGSL-------LDRLSCLD 119
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL 259
               LSW +R ++A   A  +++LH +     +H D+K  NILLDE + A +SDFGL++ 
Sbjct: 120 GTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARA 176
Query: 260 MSR-DQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGN 318
             +  Q      I GT  Y+APE  L   ++ K DIYS+G+VLLE+  G   V       
Sbjct: 177 SEKFAQXVMXXRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAV------- 228
Query: 319 DKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLR 378
           D+ +            + +E  + + +D+++ D    D T V  +  VA  C+ E+   R
Sbjct: 229 DEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA---DSTSVEAMYSVASQCLHEKKNKR 285
Query: 379 PSMARVVEMLEGRVA 393
           P + +V ++L+   A
Sbjct: 286 PDIKKVQQLLQEMTA 300

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 97/315 (30%), Positives = 147/315 (46%), Gaps = 37/315 (11%)
Query: 93  FRSKELEEATDNFQA--------LLGHGSSASVFKGILSDGTSVAVKRING-----EENG 139
           F   EL+  T+NF            G G    V+KG +++ T+VAVK++        E  
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 64
Query: 140 EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           +++F  E+   A  QH NLV LLG+    G    LVY +  NGSL         R     
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSS-DGDDLCLVYVYXPNGSL-------LDRLSCLD 116
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL 259
               LSW  R ++A   A  +++LH +     +H D+K  NILLDE + A +SDFGL++ 
Sbjct: 117 GTPPLSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARA 173
Query: 260 MSR-DQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGN 318
             +  Q    + I GT  Y APE  L   ++ K DIYS+G+VLLE+  G   V       
Sbjct: 174 SEKFAQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAV------- 225
Query: 319 DKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLR 378
           D+ +            + +E  + + +D++  D    D T V     VA  C+ E+   R
Sbjct: 226 DEHREPQLLLDIKEEIEDEEKTIEDYIDKKXND---ADSTSVEAXYSVASQCLHEKKNKR 282
Query: 379 PSMARVVEMLEGRVA 393
           P + +V ++L+   A
Sbjct: 283 PDIKKVQQLLQEXTA 297

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 70/209 (33%), Positives = 111/209 (53%), Gaps = 22/209 (10%)
Query: 104 NFQALLGHGSSASVFKGILSDGTSVAVKRINGEE-NGEK--EFRSEVAAIASAQHVNLVR 160
           N +  +G GS  +V +     G+ VAVK +  ++ + E+  EF  EVA +   +H N+V 
Sbjct: 40  NIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRV--AIDVAK 218
            +G    P     +V E++  GSL   +         H SG     D R R+  A DVAK
Sbjct: 99  FMGAVTQPPN-LSIVTEYLSRGSLYRLL---------HKSGAREQLDERRRLSMAYDVAK 148
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITT--IRGTRG 276
            ++YLHN     ++H D+K  N+L+D+ Y   V DFGLS+L +   S  + +    GT  
Sbjct: 149 GMNYLHNR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA---SXFLXSKXAAGTPE 204
Query: 277 YLAPEWILEQGVSEKCDIYSYGMVLLELT 305
           ++APE + ++  +EK D+YS+G++L EL 
Sbjct: 205 WMAPEVLRDEPSNEKSDVYSFGVILWELA 233

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 109/207 (52%), Gaps = 18/207 (8%)
Query: 104 NFQALLGHGSSASVFKGILSDGTSVAVKRINGEE-NGEK--EFRSEVAAIASAQHVNLVR 160
           N +  +G GS  +V +     G+ VAVK +  ++ + E+  EF  EVA +   +H N+V 
Sbjct: 40  NIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL 98
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRV--AIDVAK 218
            +G    P     +V E++  GSL   +         H SG     D R R+  A DVAK
Sbjct: 99  FMGAVTQPPN-LSIVTEYLSRGSLYRLL---------HKSGAREQLDERRRLSMAYDVAK 148
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            ++YLHN     ++H ++K  N+L+D+ Y   V DFGLS+L +        +  GT  ++
Sbjct: 149 GMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA-STFLSSKSAAGTPEWM 206
Query: 279 APEWILEQGVSEKCDIYSYGMVLLELT 305
           APE + ++  +EK D+YS+G++L EL 
Sbjct: 207 APEVLRDEPSNEKSDVYSFGVILWELA 233

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 99/196 (50%), Gaps = 17/196 (8%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           +G G    V  G    G  VAVK I  +   +  F +E + +   +H NLV+LLG  V  
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA-FLAEASVMTQLRHSNLVQLLGVIVEE 71
Query: 169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCR 228
            G  Y+V E++  GSL  ++    R   G   G CL      + ++DV +A+ YL  +  
Sbjct: 72  KGGLYIVTEYMAKGSLVDYLRSRGRSVLG---GDCL-----LKFSLDVCEAMEYLEGN-- 121
Query: 229 SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGV 288
              +H D+   N+L+ E+  A VSDFGL+K  S  Q      ++ T    APE + E+  
Sbjct: 122 -NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKF 176
Query: 289 SEKCDIYSYGMVLLEL 304
           S K D++S+G++L E+
Sbjct: 177 STKSDVWSFGILLWEI 192

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 94/180 (52%), Gaps = 16/180 (8%)
Query: 125 GTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL 184
           G  VAVK I  +   +  F +E + +   +H NLV+LLG  V   G  Y+V E++  GSL
Sbjct: 44  GNKVAVKCIKNDATAQA-FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 102
Query: 185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD 244
             ++    R   G   G CL      + ++DV +A+ YL  +     +H D+   N+L+ 
Sbjct: 103 VDYLRSRGRSVLG---GDCL-----LKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVS 151
Query: 245 ENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           E+  A VSDFGL+K  S  Q      ++ T    APE + E+  S K D++S+G++L E+
Sbjct: 152 EDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTKSDVWSFGILLWEI 207

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 60/180 (33%), Positives = 93/180 (51%), Gaps = 16/180 (8%)
Query: 125 GTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL 184
           G  VAVK I  +   +  F +E + +   +H NLV+LLG  V   G  Y+V E++  GSL
Sbjct: 35  GNKVAVKCIKNDATAQA-FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 93
Query: 185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD 244
             ++    R   G   G CL      + ++DV +A+ YL  +     +H D+   N+L+ 
Sbjct: 94  VDYLRSRGRSVLG---GDCL-----LKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVS 142
Query: 245 ENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           E+  A VSDFGL+K  S  Q      ++ T    APE + E   S K D++S+G++L E+
Sbjct: 143 EDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREAAFSTKSDVWSFGILLWEI 198

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 99/196 (50%), Gaps = 17/196 (8%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           +G G    V  G    G  VAVK I  +   +  F +E + +   +H NLV+LLG  V  
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA-FLAEASVMTQLRHSNLVQLLGVIVEE 258
Query: 169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCR 228
            G  Y+V E++  GSL  ++    R   G   G CL      + ++DV +A+ YL  +  
Sbjct: 259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLG---GDCL-----LKFSLDVCEAMEYLEGN-- 308
Query: 229 SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGV 288
              +H D+   N+L+ E+  A VSDFGL+K  S  Q      ++ T    APE + E+  
Sbjct: 309 -NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKF 363
Query: 289 SEKCDIYSYGMVLLEL 304
           S K D++S+G++L E+
Sbjct: 364 STKSDVWSFGILLWEI 379

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/251 (29%), Positives = 118/251 (47%), Gaps = 36/251 (14%)
Query: 92  KFRSKELEEATDN---FQALLGHGSSASVFKG-ILSDGTSVAVKR-INGEENGE------ 140
           +F    L    DN   ++  +G G    V KG ++ D + VA+K  I G+  GE      
Sbjct: 7   EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK 66
Query: 141 -KEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
            +EF+ EV  +++  H N+V+L G    P  PR +V EF+  G L H +   +       
Sbjct: 67  FQEFQREVFIMSNLNHPNIVKLYGLMHNP--PR-MVMEFVPCGDLYHRLLDKAHP----- 118
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILL---DENYR--AVVSDF 254
               + W ++ R+ +D+A  + Y+ N     ++H D++  NI L   DEN    A V+DF
Sbjct: 119 ----IKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173
Query: 255 GLSKLMSRDQSRCITTIRGTRGYLAPEWI--LEQGVSEKCDIYSYGMVLLELTGGRRNVS 312
           GLS+         ++ + G   ++APE I   E+  +EK D YS+ M+L  +  G     
Sbjct: 174 GLSQ----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229
Query: 313 LIEHGNDKSKN 323
              +G  K  N
Sbjct: 230 EYSYGKIKFIN 240

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 97  ELEEATDNFQALLGHGSSASVFKGILSDGT-SVAVKRINGEENGEKEFRSEVAAIASAQH 155
           E+E      +  LG G    V++G+    + +VAVK +  +    +EF  E A +   +H
Sbjct: 7   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 66
Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
            NLV+LLG C     P Y++ EF+  G+L  ++   +R+         +S  +   +A  
Sbjct: 67  PNLVQLLGVCTREP-PFYIIIEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQ 117
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           ++ A+ YL    +   +H D+   N L+ EN+   V+DFGLS+LM+ D        +   
Sbjct: 118 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI 174
Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            + APE +     S K D++++G++L E+
Sbjct: 175 KWTAPESLAYNKFSIKSDVWAFGVLLWEI 203

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 97  ELEEATDNFQALLGHGSSASVFKGILSDGT-SVAVKRINGEENGEKEFRSEVAAIASAQH 155
           E+E      +  LG G    V++G+    + +VAVK +  +    +EF  E A +   +H
Sbjct: 7   EMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 66
Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
            NLV+LLG C     P Y++ EF+  G+L  ++   +R+         +S  +   +A  
Sbjct: 67  PNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQ 117
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           ++ A+ YL    +   +H D+   N L+ EN+   V+DFGLS+LM+ D        +   
Sbjct: 118 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI 174
Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            + APE +     S K D++++G++L E+
Sbjct: 175 KWTAPESLAYNKFSIKSDVWAFGVLLWEI 203

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 107/218 (49%), Gaps = 13/218 (5%)
Query: 88  GVPIKFRSKELEEATDNFQALLGHGSSASVFKGILSDGT-SVAVKRINGEENGEKEFRSE 146
           G+   +   E+E      +  LG G    V++G+    + +VAVK +  +    +EF  E
Sbjct: 1   GMSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE 60
Query: 147 VAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSW 206
            A +   +H NLV+LLG C     P Y++ EF+  G+L  ++   +R+         ++ 
Sbjct: 61  AAVMKEIKHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQE--------VNA 111
Query: 207 DLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSR 266
            +   +A  ++ A+ YL    +   +H D+   N L+ EN+   V+DFGLS+LM+ D   
Sbjct: 112 VVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 168
Query: 267 CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
                +    + APE +     S K D++++G++L E+
Sbjct: 169 APAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 206

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 97  ELEEATDNFQALLGHGSSASVFKGILSDGT-SVAVKRINGEENGEKEFRSEVAAIASAQH 155
           E+E      +  LG G    V++G+    + +VAVK +  +    +EF  E A +   +H
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 68
Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
            NLV+LLG C     P Y++ EF+  G+L  ++   +R+         +S  +   +A  
Sbjct: 69  PNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQ 119
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           ++ A+ YL    +   +H D+   N L+ EN+   V+DFGLS+LM+ D        +   
Sbjct: 120 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            + APE +     S K D++++G++L E+
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 97  ELEEATDNFQALLGHGSSASVFKGILSDGT-SVAVKRINGEENGEKEFRSEVAAIASAQH 155
           E+E      +  LG G    V++G+    + +VAVK +  +    +EF  E A +   +H
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 68
Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
            NLV+LLG C     P Y++ EF+  G+L  ++   +R+         +S  +   +A  
Sbjct: 69  PNLVQLLGVCTREP-PFYIIIEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQ 119
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           ++ A+ YL    +   +H D+   N L+ EN+   V+DFGLS+LM+ D        +   
Sbjct: 120 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            + APE +     S K D++++G++L E+
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 97  ELEEATDNFQALLGHGSSASVFKGILSDGT-SVAVKRINGEENGEKEFRSEVAAIASAQH 155
           E+E      +  LG G    V++G+    + +VAVK +  +    +EF  E A +   +H
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 68
Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
            NLV+LLG C     P Y++ EF+  G+L  ++   +R+         +S  +   +A  
Sbjct: 69  PNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQ 119
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           ++ A+ YL    +   +H D+   N L+ EN+   V+DFGLS+LM+ D        +   
Sbjct: 120 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            + APE +     S K D++++G++L E+
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 97  ELEEATDNFQALLGHGSSASVFKGILSDGT-SVAVKRINGEENGEKEFRSEVAAIASAQH 155
           E+E      +  LG G    V++G+    + +VAVK +  +    +EF  E A +   +H
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 73
Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
            NLV+LLG C     P Y++ EF+  G+L  ++   +R+         +S  +   +A  
Sbjct: 74  PNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQ 124
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           ++ A+ YL    +   +H D+   N L+ EN+   V+DFGLS+LM+ D        +   
Sbjct: 125 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 181
Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            + APE +     S K D++++G++L E+
Sbjct: 182 KWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 97  ELEEATDNFQALLGHGSSASVFKGILSDGT-SVAVKRINGEENGEKEFRSEVAAIASAQH 155
           E+E      +  LG G    V++G+    + +VAVK +  +    +EF  E A +   +H
Sbjct: 7   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 66
Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
            NLV+LLG C     P Y++ EF+  G+L  ++   +R+         +S  +   +A  
Sbjct: 67  PNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQ 117
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           ++ A+ YL    +   +H D+   N L+ EN+   V+DFGLS+LM+ D        +   
Sbjct: 118 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPI 174
Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            + APE +     S K D++++G++L E+
Sbjct: 175 KWTAPESLAYNKFSIKSDVWAFGVLLWEI 203

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 97  ELEEATDNFQALLGHGSSASVFKGILSDGT-SVAVKRINGEENGEKEFRSEVAAIASAQH 155
           E+E      +  LG G    V++G+    + +VAVK +  +    +EF  E A +   +H
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 68
Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
            NLV+LLG C     P Y++ EF+  G+L  ++   +R+         +S  +   +A  
Sbjct: 69  PNLVQLLGVCTREP-PFYIIIEFMTYGNLLDYLRECNRQE--------VSAVVLLYMATQ 119
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           ++ A+ YL    +   +H D+   N L+ EN+   V+DFGLS+LM+ D        +   
Sbjct: 120 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            + APE +     S K D++++G++L E+
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 97  ELEEATDNFQALLGHGSSASVFKGILSDGT-SVAVKRINGEENGEKEFRSEVAAIASAQH 155
           E+E      +  LG G    V++G+    + +VAVK +  +    +EF  E A +   +H
Sbjct: 11  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 70
Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
            NLV+LLG C     P Y++ EF+  G+L  ++   +R+         ++  +   +A  
Sbjct: 71  PNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQ 121
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           ++ A+ YL    +   +H D+   N L+ EN+   V+DFGLS+LM+ D        +   
Sbjct: 122 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI 178
Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            + APE +     S K D++++G++L E+
Sbjct: 179 KWTAPESLAYNKFSIKSDVWAFGVLLWEI 207

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 97  ELEEATDNFQALLGHGSSASVFKGILSDGT-SVAVKRINGEENGEKEFRSEVAAIASAQH 155
           E+E      +  LG G    V++G+    + +VAVK +  +    +EF  E A +   +H
Sbjct: 10  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 69
Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
            NLV+LLG C     P Y++ EF+  G+L  ++   +R+         ++  +   +A  
Sbjct: 70  PNLVQLLGVCTREP-PFYIIIEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQ 120
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           ++ A+ YL    +   +H D+   N L+ EN+   V+DFGLS+LM+ D        +   
Sbjct: 121 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI 177
Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            + APE +     S K D++++G++L E+
Sbjct: 178 KWTAPESLAYNKFSIKSDVWAFGVLLWEI 206

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 108/220 (49%), Gaps = 13/220 (5%)
Query: 86  VAGVPIKFRSKELEEATDNFQALLGHGSSASVFKGILSDGT-SVAVKRINGEENGEKEFR 144
           + GV   +   E+E      +  LG G    V++G+    + +VAVK +  +    +EF 
Sbjct: 205 IYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL 264
Query: 145 SEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCL 204
            E A +   +H NLV+LLG C     P Y++ EF+  G+L  ++   +R+         +
Sbjct: 265 KEAAVMKEIKHPNLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQE--------V 315
Query: 205 SWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ 264
           S  +   +A  ++ A+ YL    +   +H ++   N L+ EN+   V+DFGLS+LM+ D 
Sbjct: 316 SAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372
Query: 265 SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
                  +    + APE +     S K D++++G++L E+
Sbjct: 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 412

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 97  ELEEATDNFQALLGHGSSASVFKGILSDGT-SVAVKRINGEENGEKEFRSEVAAIASAQH 155
           E+E      +  LG G    V++G+    + +VAVK +  +    +EF  E A +   +H
Sbjct: 11  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 70
Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
            NLV+LLG C     P Y++ EF+  G+L  ++   +R+         ++  +   +A  
Sbjct: 71  PNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQ 121
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           ++ A+ YL    +   +H D+   N L+ EN+   V+DFGLS+LM+ D        +   
Sbjct: 122 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 178
Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            + APE +     S K D++++G++L E+
Sbjct: 179 KWTAPESLAYNKFSIKSDVWAFGVLLWEI 207

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 97  ELEEATDNFQALLGHGSSASVFKGILSDGT-SVAVKRINGEENGEKEFRSEVAAIASAQH 155
           E+E      +  LG G    V++G+    + +VAVK +  +    +EF  E A +   +H
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 73
Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
            NLV+LLG C     P Y++ EF+  G+L  ++   +R+         ++  +   +A  
Sbjct: 74  PNLVQLLGVCTR-EPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQ 124
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           ++ A+ YL    +   +H D+   N L+ EN+   V+DFGLS+LM+ D        +   
Sbjct: 125 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI 181
Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            + APE +     S K D++++G++L E+
Sbjct: 182 KWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 97  ELEEATDNFQALLGHGSSASVFKGILSDGT-SVAVKRINGEENGEKEFRSEVAAIASAQH 155
           E+E      +  LG G    V++G+    + +VAVK +  +    +EF  E A +   +H
Sbjct: 11  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 70
Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
            NLV+LLG C     P Y++ EF+  G+L  ++   +R+         ++  +   +A  
Sbjct: 71  PNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQ 121
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           ++ A+ YL    +   +H D+   N L+ EN+   V+DFGLS+LM+ D        +   
Sbjct: 122 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 178
Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            + APE +     S K D++++G++L E+
Sbjct: 179 KWTAPESLAYNKFSIKSDVWAFGVLLWEI 207

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 117/251 (46%), Gaps = 36/251 (14%)
Query: 92  KFRSKELEEATDN---FQALLGHGSSASVFKG-ILSDGTSVAVKR-INGEENGE------ 140
           +F    L    DN   ++  +G G    V KG ++ D + VA+K  I G+  GE      
Sbjct: 7   EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK 66
Query: 141 -KEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
            +EF+ EV  +++  H N+V+L G    P  PR +V EF+  G L H +   +       
Sbjct: 67  FQEFQREVFIMSNLNHPNIVKLYGLMHNP--PR-MVMEFVPCGDLYHRLLDKAHP----- 118
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILL---DENYR--AVVSDF 254
               + W ++ R+ +D+A  + Y+ N     ++H D++  NI L   DEN    A V+DF
Sbjct: 119 ----IKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173
Query: 255 GLSKLMSRDQSRCITTIRGTRGYLAPEWI--LEQGVSEKCDIYSYGMVLLELTGGRRNVS 312
           G     S+     ++ + G   ++APE I   E+  +EK D YS+ M+L  +  G     
Sbjct: 174 G----TSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229
Query: 313 LIEHGNDKSKN 323
              +G  K  N
Sbjct: 230 EYSYGKIKFIN 240

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 97  ELEEATDNFQALLGHGSSASVFKGILSDGT-SVAVKRINGEENGEKEFRSEVAAIASAQH 155
           E+E      +  LG G    V++G+    + +VAVK +  +    +EF  E A +   +H
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 68
Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
            NLV+LLG C     P Y++ EF+  G+L  ++   +R+         ++  +   +A  
Sbjct: 69  PNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQ 119
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           ++ A+ YL    +   +H D+   N L+ EN+   V+DFGLS+LM+ D        +   
Sbjct: 120 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            + APE +     S K D++++G++L E+
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 97  ELEEATDNFQALLGHGSSASVFKGILSDGT-SVAVKRINGEENGEKEFRSEVAAIASAQH 155
           E+E      +  LG G    V++G+    + +VAVK +  +    +EF  E A +   +H
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 73
Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
            NLV+LLG C     P Y++ EF+  G+L  ++   +R+         ++  +   +A  
Sbjct: 74  PNLVQLLGVCTR-EPPFYIIIEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQ 124
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           ++ A+ YL    +   +H D+   N L+ EN+   V+DFGLS+LM+ D        +   
Sbjct: 125 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 181
Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            + APE +     S K D++++G++L E+
Sbjct: 182 KWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 97  ELEEATDNFQALLGHGSSASVFKGILSDGT-SVAVKRINGEENGEKEFRSEVAAIASAQH 155
           E+E      +  LG G    V++G+    + +VAVK +  +    +EF  E A +   +H
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 73
Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
            NLV+LLG C     P Y++ EF+  G+L  ++   +R+         ++  +   +A  
Sbjct: 74  PNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQ 124
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           ++ A+ YL    +   +H D+   N L+ EN+   V+DFGLS+LM+ D        +   
Sbjct: 125 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 181
Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            + APE +     S K D++++G++L E+
Sbjct: 182 KWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 97  ELEEATDNFQALLGHGSSASVFKGILSDGT-SVAVKRINGEENGEKEFRSEVAAIASAQH 155
           E+E      +  LG G    V++G+    + +VAVK +  +    +EF  E A +   +H
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 73
Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
            NLV+LLG C     P Y++ EF+  G+L  ++   +R+         ++  +   +A  
Sbjct: 74  PNLVQLLGVCTR-EPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQ 124
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           ++ A+ YL    +   +H D+   N L+ EN+   V+DFGLS+LM+ D        +   
Sbjct: 125 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 181
Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            + APE +     S K D++++G++L E+
Sbjct: 182 KWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 97  ELEEATDNFQALLGHGSSASVFKGILSDGT-SVAVKRINGEENGEKEFRSEVAAIASAQH 155
           E+E      +  LG G    V++G+    + +VAVK +  +    +EF  E A +   +H
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 68
Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
            NLV+LLG C     P Y++ EF+  G+L  ++   +R+         ++  +   +A  
Sbjct: 69  PNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQ 119
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           ++ A+ YL    +   +H D+   N L+ EN+   V+DFGLS+LM+ D        +   
Sbjct: 120 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            + APE +     S K D++++G++L E+
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 97  ELEEATDNFQALLGHGSSASVFKGILSDGT-SVAVKRINGEENGEKEFRSEVAAIASAQH 155
           E+E      +  LG G    V++G+    + +VAVK +  +    +EF  E A +   +H
Sbjct: 22  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 81
Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
            NLV+LLG C     P Y++ EF+  G+L  ++   +R+         ++  +   +A  
Sbjct: 82  PNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQ 132
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           ++ A+ YL    +   +H D+   N L+ EN+   V+DFGLS+LM+ D        +   
Sbjct: 133 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 189
Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            + APE +     S K D++++G++L E+
Sbjct: 190 KWTAPESLAYNKFSIKSDVWAFGVLLWEI 218

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 104/209 (49%), Gaps = 13/209 (6%)
Query: 97  ELEEATDNFQALLGHGSSASVFKGILSDGT-SVAVKRINGEENGEKEFRSEVAAIASAQH 155
           E+E      +  LG G    V++G+    + +VAVK +  +    +EF  E A +   +H
Sbjct: 13  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 72
Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
            NLV+LLG C     P Y++ EF+  G+L  ++   +R+         ++  +   +A  
Sbjct: 73  PNLVQLLGVCTR-EPPFYIITEFMTYGNLLDYLRECNRQE--------VNAVVLLYMATQ 123
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           ++ A+ YL    +   +H D+   N L+ EN+   V+DFGLS+LM+ D        +   
Sbjct: 124 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180
Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            + APE +     S K D++++G++L E+
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEI 209

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 117/251 (46%), Gaps = 36/251 (14%)
Query: 92  KFRSKELEEATDN---FQALLGHGSSASVFKG-ILSDGTSVAVKR-INGEENGE------ 140
           +F    L    DN   ++  +G G    V KG ++ D + VA+K  I G+  GE      
Sbjct: 7   EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK 66
Query: 141 -KEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
            +EF+ EV  +++  H N+V+L G    P  PR +V EF+  G L H +   +       
Sbjct: 67  FQEFQREVFIMSNLNHPNIVKLYGLMHNP--PR-MVMEFVPCGDLYHRLLDKAHP----- 118
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILL---DENYR--AVVSDF 254
               + W ++ R+ +D+A  + Y+ N     ++H D++  NI L   DEN    A V+DF
Sbjct: 119 ----IKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173
Query: 255 GLSKLMSRDQSRCITTIRGTRGYLAPEWI--LEQGVSEKCDIYSYGMVLLELTGGRRNVS 312
            LS+         ++ + G   ++APE I   E+  +EK D YS+ M+L  +  G     
Sbjct: 174 SLSQ----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229
Query: 313 LIEHGNDKSKN 323
              +G  K  N
Sbjct: 230 EYSYGKIKFIN 240

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 108/220 (49%), Gaps = 13/220 (5%)
Query: 86  VAGVPIKFRSKELEEATDNFQALLGHGSSASVFKGILSDGT-SVAVKRINGEENGEKEFR 144
           V GV   +   E+E      +  LG G    V++G+    + +VAVK +  +    +EF 
Sbjct: 244 VYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL 303
Query: 145 SEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCL 204
            E A +   +H NLV+LLG C     P Y++ EF+  G+L  ++   +R+         +
Sbjct: 304 KEAAVMKEIKHPNLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQE--------V 354
Query: 205 SWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ 264
           +  +   +A  ++ A+ YL    +   +H ++   N L+ EN+   V+DFGLS+LM+ D 
Sbjct: 355 NAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 411
Query: 265 SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
                  +    + APE +     S K D++++G++L E+
Sbjct: 412 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 451

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 103/209 (49%), Gaps = 13/209 (6%)
Query: 97  ELEEATDNFQALLGHGSSASVFKGILSDGT-SVAVKRINGEENGEKEFRSEVAAIASAQH 155
           E+E      +  LG G    V+ G+    + +VAVK +  +    +EF  E A +   +H
Sbjct: 28  EMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH 87
Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
            NLV+LLG C +   P Y+V E++  G+L  ++   +R          ++  +   +A  
Sbjct: 88  PNLVQLLGVCTLEP-PFYIVTEYMPYGNLLDYLRECNREE--------VTAVVLLYMATQ 138
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           ++ A+ YL    +   +H D+   N L+ EN+   V+DFGLS+LM+ D        +   
Sbjct: 139 ISSAMEYLE---KKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPI 195
Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            + APE +     S K D++++G++L E+
Sbjct: 196 KWTAPESLAYNTFSIKSDVWAFGVLLWEI 224

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 112/225 (49%), Gaps = 30/225 (13%)
Query: 94  RSKELEEATD--NFQALLGHGSSASVFKGILSDGTS----VAVKRINGE--ENGEKEFRS 145
           R K+ E+  D  +F+ +LG G+ + V   IL++       VA+K I  E  E  E    +
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMEN 65
Query: 146 EVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLS 205
           E+A +   +H N+V L       GG  YL+ + +  G L   I      +E   S     
Sbjct: 66  EIAVLHKIKHPNIVAL-DDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS----- 119
Query: 206 WDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENIL---LDENYRAVVSDFGLSKLMSR 262
                R+   V  A+ YLH+     ++H D+KPEN+L   LDE+ + ++SDFGLSK+   
Sbjct: 120 -----RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--E 169
Query: 263 DQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           D    ++T  GT GY+APE + ++  S+  D +S G++   L  G
Sbjct: 170 DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 110/229 (48%), Gaps = 24/229 (10%)
Query: 91  IKFRSKELEEATDNFQALLGHGSSASVFKGILSDGT-----SVAVKRING--EENGEKEF 143
           +KF + E+  +    Q ++G G    V+KG+L   +      VA+K +     E    +F
Sbjct: 35  LKF-TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDF 93
Query: 144 RSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGC 203
             E   +    H N++RL G  +    P  ++ E+++NG+LD ++    R  +G +S   
Sbjct: 94  LGEAGIMGQFSHHNIIRLEG-VISKYKPMMIITEYMENGALDKFL----REKDGEFSVLQ 148
Query: 204 LSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD 263
           L   LR      +A  + YL N      +H D+   NIL++ N    VSDFGLS+++  D
Sbjct: 149 LVGMLR-----GIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200
Query: 264 QSRCITTIRGTRG--YLAPEWILEQGVSEKCDIYSYGMVLLE-LTGGRR 309
                TT  G     + APE I  +  +   D++S+G+V+ E +T G R
Sbjct: 201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 249

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 112/225 (49%), Gaps = 30/225 (13%)
Query: 94  RSKELEEATD--NFQALLGHGSSASVFKGILSDGTS----VAVKRINGE--ENGEKEFRS 145
           R K+ E+  D  +F+ +LG G+ + V   IL++       VA+K I  E  E  E    +
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMEN 65
Query: 146 EVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLS 205
           E+A +   +H N+V L       GG  YL+ + +  G L   I      +E   S     
Sbjct: 66  EIAVLHKIKHPNIVAL-DDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS----- 119
Query: 206 WDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENIL---LDENYRAVVSDFGLSKLMSR 262
                R+   V  A+ YLH+     ++H D+KPEN+L   LDE+ + ++SDFGLSK+   
Sbjct: 120 -----RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--E 169
Query: 263 DQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           D    ++T  GT GY+APE + ++  S+  D +S G++   L  G
Sbjct: 170 DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/225 (31%), Positives = 112/225 (49%), Gaps = 30/225 (13%)
Query: 94  RSKELEEATD--NFQALLGHGSSASVFKGILSDGTS----VAVKRINGE--ENGEKEFRS 145
           R K+ E+  D  +F+ +LG G+ + V   IL++       VA+K I  E  E  E    +
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMEN 65
Query: 146 EVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLS 205
           E+A +   +H N+V L       GG  YL+ + +  G L   I      +E   S     
Sbjct: 66  EIAVLHKIKHPNIVAL-DDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS----- 119
Query: 206 WDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENIL---LDENYRAVVSDFGLSKLMSR 262
                R+   V  A+ YLH+     ++H D+KPEN+L   LDE+ + ++SDFGLSK+   
Sbjct: 120 -----RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--E 169
Query: 263 DQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           D    ++T  GT GY+APE + ++  S+  D +S G++   L  G
Sbjct: 170 DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 13/201 (6%)
Query: 104 NFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLG 163
            F   +G G    V  G   +   VA+K I      E++F  E   +    H  LV+L G
Sbjct: 8   TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 67
Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL 223
            C+    P  LV+EF+++G L  ++    R   G ++   L       + +DV + ++YL
Sbjct: 68  VCL-EQAPICLVFEFMEHGCLSDYL----RTQRGLFAAETL-----LGMCLDVCEGMAYL 117
Query: 224 HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWI 283
              C   V+H D+   N L+ EN    VSDFG+++ +  DQ    T  +    + +PE  
Sbjct: 118 EEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174
Query: 284 LEQGVSEKCDIYSYGMVLLEL 304
                S K D++S+G+++ E+
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEV 195

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 13/201 (6%)
Query: 104 NFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLG 163
            F   +G G    V  G   +   VA+K I      E++F  E   +    H  LV+L G
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL 223
            C+    P  LV+EF+++G L  ++    R   G ++   L       + +DV + ++YL
Sbjct: 70  VCL-EQAPICLVFEFMEHGCLSDYL----RTQRGLFAAETL-----LGMCLDVCEGMAYL 119
Query: 224 HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWI 283
              C   V+H D+   N L+ EN    VSDFG+++ +  DQ    T  +    + +PE  
Sbjct: 120 EEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 176
Query: 284 LEQGVSEKCDIYSYGMVLLEL 304
                S K D++S+G+++ E+
Sbjct: 177 SFSRYSSKSDVWSFGVLMWEV 197

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 13/201 (6%)
Query: 104 NFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLG 163
            F   +G G    V  G   +   VA+K I      E++F  E   +    H  LV+L G
Sbjct: 13  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 72
Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL 223
            C+    P  LV+EF+++G L  ++    R   G ++   L       + +DV + ++YL
Sbjct: 73  VCL-EQAPICLVFEFMEHGCLSDYL----RTQRGLFAAETL-----LGMCLDVCEGMAYL 122
Query: 224 HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWI 283
              C   V+H D+   N L+ EN    VSDFG+++ +  DQ    T  +    + +PE  
Sbjct: 123 EEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 179
Query: 284 LEQGVSEKCDIYSYGMVLLEL 304
                S K D++S+G+++ E+
Sbjct: 180 SFSRYSSKSDVWSFGVLMWEV 200

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 13/201 (6%)
Query: 104 NFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLG 163
            F   +G G    V  G   +   VA+K I      E +F  E   +    H  LV+L G
Sbjct: 30  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYG 89
Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL 223
            C+    P  LV+EF+++G L  ++    R   G ++   L       + +DV + ++YL
Sbjct: 90  VCL-EQAPICLVFEFMEHGCLSDYL----RTQRGLFAAETL-----LGMCLDVCEGMAYL 139
Query: 224 HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWI 283
              C   V+H D+   N L+ EN    VSDFG+++ +  DQ    T  +    + +PE  
Sbjct: 140 EEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 196
Query: 284 LEQGVSEKCDIYSYGMVLLEL 304
                S K D++S+G+++ E+
Sbjct: 197 SFSRYSSKSDVWSFGVLMWEV 217

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 109/201 (54%), Gaps = 18/201 (8%)
Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFR-SEVAAIASAQHVNLVRLLGYCV 166
           +G G+S +V+  + ++ G  VA++++N ++  +KE   +E+  +   ++ N+V  L   +
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 167 VPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHND 226
           V G   ++V E++  GSL   +  T    EG  +  C           +  +AL +LH++
Sbjct: 88  V-GDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCR----------ECLQALEFLHSN 135
Query: 227 CRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQ 286
              +V+H D+K +NILL  +    ++DFG    ++ +QS+  +T+ GT  ++APE +  +
Sbjct: 136 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRK 191
Query: 287 GVSEKCDIYSYGMVLLELTGG 307
               K DI+S G++ +E+  G
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEG 212

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 107/218 (49%), Gaps = 21/218 (9%)
Query: 95  SKELEEATDNFQALLGHGSSASVFKGILS----DGTSVAVK--RINGEENGEKEFRSEVA 148
           +KEL+ +    + ++G G    V  G L        +VA+K  ++   E   ++F  E +
Sbjct: 37  AKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEAS 96
Query: 149 AIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL 208
            +    H N+V L G  V  G P  +V EF++NG+LD ++    R+ +G ++   L   L
Sbjct: 97  IMGQFDHPNVVHLEG-VVTRGKPVMIVIEFMENGALDAFL----RKHDGQFTVIQLVGML 151
Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI 268
           R      +A  + YL +      +H D+   NIL++ N    VSDFGLS+++  D     
Sbjct: 152 R-----GIAAGMRYLAD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVY 203
Query: 269 TTIRGTRG--YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           TT  G     + APE I  +  +   D++SYG+V+ E+
Sbjct: 204 TTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEV 241

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 107/223 (47%), Gaps = 30/223 (13%)
Query: 91  IKFRSKELEEATDNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAI 150
           I ++  E+EE       ++G G+   V K        VA+K+I  E    K F  E+  +
Sbjct: 6   IDYKEIEVEE-------VVGRGAFGVVCKAKWR-AKDVAIKQIESESE-RKAFIVELRQL 56
Query: 151 ASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLD---HWIFPTSRRSEGHYSGGCLSWD 207
           +   H N+V+L G C+    P  LV E+ + GSL    H   P    +  H     +SW 
Sbjct: 57  SRVNHPNIVKLYGACL---NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAH----AMSWC 109
Query: 208 LRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSRDQSR 266
           L+       ++ ++YLH+     ++H D+KP N+LL      + + DFG     + D   
Sbjct: 110 LQ------CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG----TACDIQT 159
Query: 267 CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRR 309
            +T  +G+  ++APE       SEKCD++S+G++L E+   R+
Sbjct: 160 HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK 202

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 104/223 (46%), Gaps = 30/223 (13%)
Query: 91  IKFRSKELEEATDNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAI 150
           I ++  E+EE       ++G G+   V K        VA+K+I  E    K F  E+  +
Sbjct: 5   IDYKEIEVEE-------VVGRGAFGVVCKAKWR-AKDVAIKQIESESE-RKAFIVELRQL 55
Query: 151 ASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLD---HWIFPTSRRSEGHYSGGCLSWD 207
           +   H N+V+L G C+    P  LV E+ + GSL    H   P    +  H    CL   
Sbjct: 56  SRVNHPNIVKLYGACL---NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCL--- 109
Query: 208 LRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSRDQSR 266
                    ++ ++YLH+     ++H D+KP N+LL      + + DFG     + D   
Sbjct: 110 -------QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG----TACDIQT 158
Query: 267 CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRR 309
            +T  +G+  ++APE       SEKCD++S+G++L E+   R+
Sbjct: 159 HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK 201

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 95  SKELEEATDNFQALLGHGSSASVFKGILSDGT----SVAVK--RINGEENGEKEFRSEVA 148
           +KEL+    +   ++G G    V  G L   +    SVA+K  ++   E   ++F  E +
Sbjct: 39  AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 98
Query: 149 AIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL 208
            +    H N++RL G  V    P  +V E+++NGSLD ++    R+ +  ++   L   L
Sbjct: 99  IMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGML 153
Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI 268
           R      +A  + YL +      +H D+   NIL++ N    VSDFGLS+++  D     
Sbjct: 154 R-----GIASGMKYLSD---MGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 269 TTIRGTR---GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           TT RG +    + +PE I  +  +   D++SYG+VL E+
Sbjct: 206 TT-RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 243

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 95  SKELEEATDNFQALLGHGSSASVFKGILSDGT----SVAVK--RINGEENGEKEFRSEVA 148
           +KEL+    +   ++G G    V  G L   +    SVA+K  ++   E   ++F  E +
Sbjct: 27  AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 86
Query: 149 AIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL 208
            +    H N++RL G  V    P  +V E+++NGSLD ++    R+ +  ++   L   L
Sbjct: 87  IMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGML 141
Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI 268
           R      +A  + YL +      +H D+   NIL++ N    VSDFGLS+++  D     
Sbjct: 142 R-----GIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 193
Query: 269 TTIRGTR---GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           TT RG +    + +PE I  +  +   D++SYG+VL E+
Sbjct: 194 TT-RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 231

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 95  SKELEEATDNFQALLGHGSSASVFKGILSDGT----SVAVK--RINGEENGEKEFRSEVA 148
           +KEL+    +   ++G G    V  G L   +    SVA+K  ++   E   ++F  E +
Sbjct: 10  AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 69
Query: 149 AIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL 208
            +    H N++RL G  V    P  +V E+++NGSLD ++    R+ +  ++   L   L
Sbjct: 70  IMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGML 124
Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI 268
           R      +A  + YL +      +H D+   NIL++ N    VSDFGLS+++  D     
Sbjct: 125 R-----GIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 176
Query: 269 TTIRGTR---GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           TT RG +    + +PE I  +  +   D++SYG+VL E+
Sbjct: 177 TT-RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 214

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 95  SKELEEATDNFQALLGHGSSASVFKGILSDGT----SVAVK--RINGEENGEKEFRSEVA 148
           +KEL+    +   ++G G    V  G L   +    SVA+K  ++   E   ++F  E +
Sbjct: 39  AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 98
Query: 149 AIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL 208
            +    H N++RL G  V    P  +V E+++NGSLD ++    R+ +  ++   L   L
Sbjct: 99  IMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGML 153
Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI 268
           R      +A  + YL +      +H D+   NIL++ N    VSDFGLS+++  D     
Sbjct: 154 R-----GIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 269 TTIRGTR---GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           TT RG +    + +PE I  +  +   D++SYG+VL E+
Sbjct: 206 TT-RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 243

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 95  SKELEEATDNFQALLGHGSSASVFKGILSDGT----SVAVK--RINGEENGEKEFRSEVA 148
           +KEL+    +   ++G G    V  G L   +    SVA+K  ++   E   ++F  E +
Sbjct: 39  AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 98
Query: 149 AIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL 208
            +    H N++RL G  V    P  +V E+++NGSLD ++    R+ +  ++   L   L
Sbjct: 99  IMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGML 153
Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI 268
           R      +A  + YL +      +H D+   NIL++ N    VSDFGLS+++  D     
Sbjct: 154 R-----GIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 269 TTIRGTR---GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           TT RG +    + +PE I  +  +   D++SYG+VL E+
Sbjct: 206 TT-RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 243

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 112/225 (49%), Gaps = 30/225 (13%)
Query: 94  RSKELEEATD--NFQALLGHGSSASVFKGILSDGTS----VAVKRINGE--ENGEKEFRS 145
           R K+ E+  D  +F+ +LG G+ + V   IL++       VA+K I  +  E  E    +
Sbjct: 9   RWKQAEDIRDIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKKALEGKEGSMEN 65
Query: 146 EVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLS 205
           E+A +   +H N+V L       GG  YL+ + +  G L   I      +E   S     
Sbjct: 66  EIAVLHKIKHPNIVAL-DDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS----- 119
Query: 206 WDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENIL---LDENYRAVVSDFGLSKLMSR 262
                R+   V  A+ YLH+     ++H D+KPEN+L   LDE+ + ++SDFGLSK+   
Sbjct: 120 -----RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--E 169
Query: 263 DQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           D    ++T  GT GY+APE + ++  S+  D +S G++   L  G
Sbjct: 170 DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 95  SKELEEATDNFQALLGHGSSASVFKGILSDGT----SVAVK--RINGEENGEKEFRSEVA 148
           +KEL+    +   ++G G    V  G L   +    SVA+K  ++   E   ++F  E +
Sbjct: 39  AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 98
Query: 149 AIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL 208
            +    H N++RL G  V    P  +V E+++NGSLD ++    R+ +  ++   L   L
Sbjct: 99  IMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGML 153
Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI 268
           R      +A  + YL +      +H D+   NIL++ N    VSDFGLS+++  D     
Sbjct: 154 R-----GIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 269 TTIRGTR---GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           TT RG +    + +PE I  +  +   D++SYG+VL E+
Sbjct: 206 TT-RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 243

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 95  SKELEEATDNFQALLGHGSSASVFKGILSDGT----SVAVK--RINGEENGEKEFRSEVA 148
           +KEL+    +   ++G G    V  G L   +    SVA+K  ++   E   ++F  E +
Sbjct: 39  AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 98
Query: 149 AIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL 208
            +    H N++RL G  V    P  +V E+++NGSLD ++    R+ +  ++   L   L
Sbjct: 99  IMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGML 153
Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI 268
           R      +A  + YL +      +H D+   NIL++ N    VSDFGLS+++  D     
Sbjct: 154 R-----GIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 269 TTIRGTR---GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           TT RG +    + +PE I  +  +   D++SYG+VL E+
Sbjct: 206 TT-RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 243

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 95  SKELEEATDNFQALLGHGSSASVFKGILSDGT----SVAVK--RINGEENGEKEFRSEVA 148
           +KEL+    +   ++G G    V  G L   +    SVA+K  ++   E   ++F  E +
Sbjct: 37  AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 96
Query: 149 AIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL 208
            +    H N++RL G  V    P  +V E+++NGSLD ++    R+ +  ++   L   L
Sbjct: 97  IMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGML 151
Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI 268
           R      +A  + YL +      +H D+   NIL++ N    VSDFGLS+++  D     
Sbjct: 152 R-----GIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 203
Query: 269 TTIRGTR---GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           TT RG +    + +PE I  +  +   D++SYG+VL E+
Sbjct: 204 TT-RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 241

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 93/201 (46%), Gaps = 13/201 (6%)
Query: 104 NFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLG 163
            F   +G G    V  G   +   VA+K I      E++F  E   +    H  LV+L G
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL 223
            C+    P  LV EF+++G L  ++    R   G ++   L       + +DV + ++YL
Sbjct: 71  VCL-EQAPICLVTEFMEHGCLSDYL----RTQRGLFAAETL-----LGMCLDVCEGMAYL 120
Query: 224 HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWI 283
              C   V+H D+   N L+ EN    VSDFG+++ +  DQ    T  +    + +PE  
Sbjct: 121 EEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 177
Query: 284 LEQGVSEKCDIYSYGMVLLEL 304
                S K D++S+G+++ E+
Sbjct: 178 SFSRYSSKSDVWSFGVLMWEV 198

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 35/213 (16%)
Query: 109 LGHGSSASVFKGILSDGT----SVAVKRI----NGEENGEKEFRSEVAAIASAQHVNLVR 160
           LG G  ++V+   L++ T     VA+K I      +E   K F  EV   +   H N+V 
Sbjct: 19  LGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 161 LLGY-----CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
           ++       C       YLV E+I+  +L  +I       E H   G LS D        
Sbjct: 76  MIDVDEEDDCY------YLVMEYIEGPTLSEYI-------ESH---GPLSVDTAINFTNQ 119
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           +   + + H+    R++H D+KP+NIL+D N    + DFG++K +S         + GT 
Sbjct: 120 ILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTV 176
Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
            Y +PE    +   E  DIYS G+VL E+  G 
Sbjct: 177 QYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 109/201 (54%), Gaps = 18/201 (8%)
Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFR-SEVAAIASAQHVNLVRLLGYCV 166
           +G G+S +V+  + ++ G  VA++++N ++  +KE   +E+  +   ++ N+V  L   +
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 167 VPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHND 226
           V G   ++V E++  GSL   +  T    EG  +  C           +  +AL +LH++
Sbjct: 89  V-GDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCR----------ECLQALEFLHSN 136
Query: 227 CRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQ 286
              +V+H ++K +NILL  +    ++DFG    ++ +QS+  +T+ GT  ++APE +  +
Sbjct: 137 ---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRK 192
Query: 287 GVSEKCDIYSYGMVLLELTGG 307
               K DI+S G++ +E+  G
Sbjct: 193 AYGPKVDIWSLGIMAIEMIEG 213

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 106/218 (48%), Gaps = 21/218 (9%)
Query: 95  SKELEEATDNFQALLGHGSSASVFKGIL----SDGTSVAVKRING--EENGEKEFRSEVA 148
           ++E+E +  + + ++G G S  V  G L         VA+K +     E   ++F SE +
Sbjct: 43  TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEAS 102
Query: 149 AIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL 208
            +    H N++RL G  V  G    +V E+++NGSLD ++    R  +G ++   L   L
Sbjct: 103 IMGQFDHPNIIRLEG-VVTRGRLAMIVTEYMENGSLDTFL----RTHDGQFTIMQLVGML 157
Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI 268
           R      V   + YL +      +H D+   N+L+D N    VSDFGLS+++  D     
Sbjct: 158 R-----GVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAX 209
Query: 269 TTIRGTRG--YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           TT  G     + APE I  +  S   D++S+G+V+ E+
Sbjct: 210 TTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEV 247

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 106/207 (51%), Gaps = 19/207 (9%)
Query: 103 DNFQALLGHGSSASV-FKGILSDGTSVAVKRINGEENGEKEFR-SEVAAIASAQHVNLVR 160
           DNF  + G GS+  V    + S G  VAVK+++  +   +E   +EV  +   QH N+V 
Sbjct: 23  DNFIKI-GEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           +    +V G   ++V EF++ G+L   I   +R +E   +  CL+          V +AL
Sbjct: 82  MYNSYLV-GDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLA----------VLQAL 129
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAP 280
           S LH      V+H D+K ++ILL  + R  +SDFG    +S++  R    + GT  ++AP
Sbjct: 130 SVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAP 185
Query: 281 EWILEQGVSEKCDIYSYGMVLLELTGG 307
           E I       + DI+S G++++E+  G
Sbjct: 186 ELISRLPYGPEVDIWSLGIMVIEMVDG 212

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 106/218 (48%), Gaps = 21/218 (9%)
Query: 95  SKELEEATDNFQALLGHGSSASVFKGIL----SDGTSVAVKRING--EENGEKEFRSEVA 148
           ++E+E +  + + ++G G S  V  G L         VA+K +     E   ++F SE +
Sbjct: 43  TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEAS 102
Query: 149 AIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL 208
            +    H N++RL G  V  G    +V E+++NGSLD ++    R  +G ++   L   L
Sbjct: 103 IMGQFDHPNIIRLEG-VVTRGRLAMIVTEYMENGSLDTFL----RTHDGQFTIMQLVGML 157
Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI 268
           R      V   + YL +      +H D+   N+L+D N    VSDFGLS+++  D     
Sbjct: 158 R-----GVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAY 209
Query: 269 TTIRGTRG--YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           TT  G     + APE I  +  S   D++S+G+V+ E+
Sbjct: 210 TTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEV 247

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 106/207 (51%), Gaps = 19/207 (9%)
Query: 103 DNFQALLGHGSSASV-FKGILSDGTSVAVKRINGEENGEKEFR-SEVAAIASAQHVNLVR 160
           DNF  + G GS+  V    + S G  VAVK+++  +   +E   +EV  +   QH N+V 
Sbjct: 32  DNFIKI-GEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 90
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           +    +V G   ++V EF++ G+L   I   +R +E   +  CL+          V +AL
Sbjct: 91  MYNSYLV-GDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLA----------VLQAL 138
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAP 280
           S LH      V+H D+K ++ILL  + R  +SDFG    +S++  R    + GT  ++AP
Sbjct: 139 SVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAP 194
Query: 281 EWILEQGVSEKCDIYSYGMVLLELTGG 307
           E I       + DI+S G++++E+  G
Sbjct: 195 ELISRLPYGPEVDIWSLGIMVIEMVDG 221

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 108/201 (53%), Gaps = 18/201 (8%)
Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFR-SEVAAIASAQHVNLVRLLGYCV 166
           +G G+S +V+  + ++ G  VA++++N ++  +KE   +E+  +   ++ N+V  L   +
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 167 VPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHND 226
           V G   ++V E++  GSL   +  T    EG  +  C           +  +AL +LH++
Sbjct: 89  V-GDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCR----------ECLQALEFLHSN 136
Query: 227 CRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQ 286
              +V+H D+K +NILL  +    ++DFG    ++ +QS+  + + GT  ++APE +  +
Sbjct: 137 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-SXMVGTPYWMAPEVVTRK 192
Query: 287 GVSEKCDIYSYGMVLLELTGG 307
               K DI+S G++ +E+  G
Sbjct: 193 AYGPKVDIWSLGIMAIEMIEG 213

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 30/215 (13%)
Query: 108 LLGHGSSASVFKGILSDGTSVAVKR--INGEENGEKEFRSEVAAIASAQHVNLVRLLGYC 165
           +LG G      K    +   V V +  I  +E  ++ F  EV  +   +H N+++ +G  
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG-- 74
Query: 166 VVPGGPRY-LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH 224
           V+    R   + E+I+ G+L   I    +  +  Y      W  R   A D+A  ++YLH
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGII----KSMDSQYP-----WSQRVSFAKDIASGMAYLH 125
Query: 225 NDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC-------------ITTI 271
           +     ++H D+   N L+ EN   VV+DFGL++LM  ++++                T+
Sbjct: 126 S---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182
Query: 272 RGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG 306
            G   ++APE I  +   EK D++S+G+VL E+ G
Sbjct: 183 VGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIG 217

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 108/201 (53%), Gaps = 18/201 (8%)
Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFR-SEVAAIASAQHVNLVRLLGYCV 166
           +G G+S +V+  + ++ G  VA++++N ++  +KE   +E+  +   ++ N+V  L   +
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 167 VPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHND 226
           V G   ++V E++  GSL   +  T    EG  +  C           +  +AL +LH++
Sbjct: 88  V-GDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCR----------ECLQALEFLHSN 135
Query: 227 CRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQ 286
              +V+H D+K +NILL  +    ++DFG    ++ +QS+  + + GT  ++APE +  +
Sbjct: 136 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSXMVGTPYWMAPEVVTRK 191
Query: 287 GVSEKCDIYSYGMVLLELTGG 307
               K DI+S G++ +E+  G
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEG 212

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 95  SKELEEATDNFQALLGHGSSASVFKGILSDGT----SVAVK--RINGEENGEKEFRSEVA 148
           +KEL+    +   ++G G    V  G L   +    SVA+K  ++   E   ++F  E +
Sbjct: 39  AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 98
Query: 149 AIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL 208
            +    H N++RL G  V    P  +V E+++NGSLD ++    R+ +  ++   L   L
Sbjct: 99  IMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGML 153
Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI 268
           R      +A  + YL +      +H D+   NIL++ N    VSDFGL++++  D     
Sbjct: 154 R-----GIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAY 205
Query: 269 TTIRGTR---GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           TT RG +    + +PE I  +  +   D++SYG+VL E+
Sbjct: 206 TT-RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 243

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 106/207 (51%), Gaps = 19/207 (9%)
Query: 103 DNFQALLGHGSSASV-FKGILSDGTSVAVKRINGEENGEKEFR-SEVAAIASAQHVNLVR 160
           DNF  + G GS+  V    + S G  VAVK+++  +   +E   +EV  +   QH N+V 
Sbjct: 34  DNFIKI-GEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 92
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           +    +V G   ++V EF++ G+L   I   +R +E   +  CL+          V +AL
Sbjct: 93  MYNSYLV-GDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLA----------VLQAL 140
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAP 280
           S LH      V+H D+K ++ILL  + R  +SDFG    +S++  R    + GT  ++AP
Sbjct: 141 SVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAP 196
Query: 281 EWILEQGVSEKCDIYSYGMVLLELTGG 307
           E I       + DI+S G++++E+  G
Sbjct: 197 ELISRLPYGPEVDIWSLGIMVIEMVDG 223

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 106/207 (51%), Gaps = 19/207 (9%)
Query: 103 DNFQALLGHGSSASV-FKGILSDGTSVAVKRINGEENGEKEFR-SEVAAIASAQHVNLVR 160
           DNF  + G GS+  V    + S G  VAVK+++  +   +E   +EV  +   QH N+V 
Sbjct: 27  DNFIKI-GEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 85
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           +    +V G   ++V EF++ G+L   I   +R +E   +  CL+          V +AL
Sbjct: 86  MYNSYLV-GDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLA----------VLQAL 133
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAP 280
           S LH      V+H D+K ++ILL  + R  +SDFG    +S++  R    + GT  ++AP
Sbjct: 134 SVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAP 189
Query: 281 EWILEQGVSEKCDIYSYGMVLLELTGG 307
           E I       + DI+S G++++E+  G
Sbjct: 190 ELISRLPYGPEVDIWSLGIMVIEMVDG 216

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 108/201 (53%), Gaps = 18/201 (8%)
Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFR-SEVAAIASAQHVNLVRLLGYCV 166
           +G G+S +V+  + ++ G  VA++++N ++  +KE   +E+  +   ++ N+V  L   +
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 167 VPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHND 226
           V G   ++V E++  GSL   +  T    EG  +  C           +  +AL +LH++
Sbjct: 88  V-GDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCR----------ECLQALEFLHSN 135
Query: 227 CRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQ 286
              +V+H D+K +NILL  +    ++DFG    ++ +QS+  + + GT  ++APE +  +
Sbjct: 136 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-SEMVGTPYWMAPEVVTRK 191
Query: 287 GVSEKCDIYSYGMVLLELTGG 307
               K DI+S G++ +E+  G
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEG 212

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 13/201 (6%)
Query: 104 NFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLG 163
            F   +G G    V  G   +   VA+K I      E++F  E   +    H  LV+L G
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL 223
            C+    P  LV+EF+++G L  ++    R   G ++   L       + +DV + ++YL
Sbjct: 70  VCL-EQAPICLVFEFMEHGCLSDYL----RTQRGLFAAETL-----LGMCLDVCEGMAYL 119
Query: 224 HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWI 283
                + V+H D+   N L+ EN    VSDFG+++ +  DQ    T  +    + +PE  
Sbjct: 120 EE---ASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 176
Query: 284 LEQGVSEKCDIYSYGMVLLEL 304
                S K D++S+G+++ E+
Sbjct: 177 SFSRYSSKSDVWSFGVLMWEV 197

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 107/219 (48%), Gaps = 23/219 (10%)
Query: 95  SKELEEATDNFQALLGHGSSASVFKGILSDGT----SVAVK--RINGEENGEKEFRSEVA 148
           +KEL+    +   ++G G    V  G L   +    SVA+K  ++   E   ++F  E +
Sbjct: 39  AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 98
Query: 149 AIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL 208
            +    H N++RL G  V    P  +V E ++NGSLD ++    R+ +  ++   L   L
Sbjct: 99  IMGQFDHPNIIRLEG-VVTKSKPVMIVTEXMENGSLDSFL----RKHDAQFTVIQLVGML 153
Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI 268
           R      +A  + YL +      +H D+   NIL++ N    VSDFGLS+++  D     
Sbjct: 154 R-----GIASGMKYLSD---MGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 269 TTIRGTR---GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           TT RG +    + +PE I  +  +   D++SYG+VL E+
Sbjct: 206 TT-RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 243

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 32/213 (15%)
Query: 108 LLGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLG--- 163
           L+G G    VFK     DG +  +KR+  + N EK  R EV A+A   HVN+V   G   
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKRV--KYNNEKAER-EVKALAKLDHVNIVHYNGCWD 74
Query: 164 -YCVVPGGPR-----------YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYR 211
            +   P               ++  EF   G+L+ WI    RR E       L   L   
Sbjct: 75  GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRGEK------LDKVLALE 126
Query: 212 VAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTI 271
           +   + K + Y+H+    ++++ D+KP NI L +  +  + DFGL   +  D  R  +  
Sbjct: 127 LFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRS-- 181
Query: 272 RGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +GT  Y++PE I  Q   ++ D+Y+ G++L EL
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 214

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+ G  +  T VAVK +         F +E   +   QH  LVRL  Y VV 
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--YAVVT 79
Query: 169 GGPRYLVYEFIQNGSL-DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDC 227
             P Y++ E+++NGSL D    P         SG  L+ +    +A  +A+ ++++    
Sbjct: 80  QEPIYIITEYMENGSLVDFLKTP---------SGIKLTINKLLDMAAQIAEGMAFIE--- 127
Query: 228 RSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQG 287
               +H D++  NIL+ +     ++DFGL++L+  ++       +    + APE I    
Sbjct: 128 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 187
Query: 288 VSEKCDIYSYGMVLLEL-TGGR 308
            + K D++S+G++L E+ T GR
Sbjct: 188 FTIKSDVWSFGILLTEIVTHGR 209

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+ G  +  T VAVK +         F +E   +   QH  LVRL  Y VV 
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--YAVVT 80
Query: 169 GGPRYLVYEFIQNGSL-DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDC 227
             P Y++ E+++NGSL D    P         SG  L+ +    +A  +A+ ++++    
Sbjct: 81  QEPIYIITEYMENGSLVDFLKTP---------SGIKLTINKLLDMAAQIAEGMAFIE--- 128
Query: 228 RSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQG 287
               +H D++  NIL+ +     ++DFGL++L+  ++       +    + APE I    
Sbjct: 129 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 188
Query: 288 VSEKCDIYSYGMVLLEL-TGGR 308
            + K D++S+G++L E+ T GR
Sbjct: 189 FTIKSDVWSFGILLTEIVTHGR 210

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 14/201 (6%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+ G  +  T VAVK +         F +E   +   QH  LVRL  Y VV 
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--YAVVT 87
Query: 169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCR 228
             P Y++ E+++NGSL  ++           SG  L+ +    +A  +A+ ++++     
Sbjct: 88  QEPIYIITEYMENGSLVDFL--------KTPSGIKLTINKLLDMAAQIAEGMAFIE---E 136
Query: 229 SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGV 288
              +H D++  NIL+ +     ++DFGL++L+  ++       +    + APE I     
Sbjct: 137 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTF 196
Query: 289 SEKCDIYSYGMVLLEL-TGGR 308
           + K D++S+G++L E+ T GR
Sbjct: 197 TIKSDVWSFGILLTEIVTHGR 217

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 94/197 (47%), Gaps = 13/197 (6%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+ G  +  T VA+K +       + F  E   +   +H  LV+L  Y VV 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVS 83
Query: 169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCR 228
             P Y+V E++  GSL  ++    +   G Y    L       +A  +A  ++Y+    R
Sbjct: 84  EEPIYIVIEYMSKGSLLDFL----KGEMGKY----LRLPQLVDMAAQIASGMAYVE---R 132
Query: 229 SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGV 288
              +H D++  NIL+ EN    V+DFGL++L+  ++       +    + APE  L    
Sbjct: 133 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRF 192
Query: 289 SEKCDIYSYGMVLLELT 305
           + K D++S+G++L ELT
Sbjct: 193 TIKSDVWSFGILLTELT 209

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 94/197 (47%), Gaps = 13/197 (6%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+ G  +  T VA+K +       + F  E   +   +H  LV+L  Y VV 
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVS 76
Query: 169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCR 228
             P Y+V E++  GSL  ++    +   G Y    L       +A  +A  ++Y+    R
Sbjct: 77  EEPIYIVTEYMSKGSLLDFL----KGETGKY----LRLPQLVDMAAQIASGMAYVE---R 125
Query: 229 SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGV 288
              +H D++  NIL+ EN    V+DFGL++L+  ++       +    + APE  L    
Sbjct: 126 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 185
Query: 289 SEKCDIYSYGMVLLELT 305
           + K D++S+G++L ELT
Sbjct: 186 TIKSDVWSFGILLTELT 202

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+ G  +  T VAVK +         F +E   +   QH  LVRL  Y VV 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--YAVVT 78
Query: 169 GGPRYLVYEFIQNGSL-DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDC 227
             P Y++ E+++NGSL D    P         SG  L+ +    +A  +A+ ++++    
Sbjct: 79  QEPIYIITEYMENGSLVDFLKTP---------SGIKLTINKLLDMAAQIAEGMAFIE--- 126
Query: 228 RSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQG 287
               +H D++  NIL+ +     ++DFGL++L+  ++       +    + APE I    
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 186
Query: 288 VSEKCDIYSYGMVLLEL-TGGR 308
            + K D++S+G++L E+ T GR
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGR 208

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+ G  +  T VAVK +         F +E   +   QH  LVRL  Y VV 
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--YAVVT 73
Query: 169 GGPRYLVYEFIQNGSL-DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDC 227
             P Y++ E+++NGSL D    P         SG  L+ +    +A  +A+ ++++    
Sbjct: 74  QEPIYIITEYMENGSLVDFLKTP---------SGIKLTINKLLDMAAQIAEGMAFIE--- 121
Query: 228 RSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQG 287
               +H D++  NIL+ +     ++DFGL++L+  ++       +    + APE I    
Sbjct: 122 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 181
Query: 288 VSEKCDIYSYGMVLLEL-TGGR 308
            + K D++S+G++L E+ T GR
Sbjct: 182 FTIKSDVWSFGILLTEIVTHGR 203

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+ G  +  T VAVK +         F +E   +   QH  LVRL  Y VV 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--YAVVT 84
Query: 169 GGPRYLVYEFIQNGSL-DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDC 227
             P Y++ E+++NGSL D    P         SG  L+ +    +A  +A+ ++++    
Sbjct: 85  QEPIYIITEYMENGSLVDFLKTP---------SGIKLTINKLLDMAAQIAEGMAFIE--- 132
Query: 228 RSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQG 287
               +H D++  NIL+ +     ++DFGL++L+  ++       +    + APE I    
Sbjct: 133 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 192
Query: 288 VSEKCDIYSYGMVLLEL-TGGR 308
            + K D++S+G++L E+ T GR
Sbjct: 193 FTIKSDVWSFGILLTEIVTHGR 214

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 107/219 (48%), Gaps = 23/219 (10%)
Query: 95  SKELEEATDNFQALLGHGSSASVFKGILSDGT----SVAVK--RINGEENGEKEFRSEVA 148
           +KEL+    +   ++G G    V  G L   +    SVA+K  ++   E   ++F  E +
Sbjct: 10  AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 69
Query: 149 AIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL 208
            +    H N++RL G  V    P  +V E ++NGSLD ++    R+ +  ++   L   L
Sbjct: 70  IMGQFDHPNIIRLEG-VVTKSKPVMIVTEXMENGSLDSFL----RKHDAQFTVIQLVGML 124
Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI 268
           R      +A  + YL +      +H D+   NIL++ N    VSDFGLS+++  D     
Sbjct: 125 R-----GIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 176
Query: 269 TTIRGTR---GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           TT RG +    + +PE I  +  +   D++SYG+VL E+
Sbjct: 177 TT-RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 214

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+ G  +  T VAVK +         F +E   +   QH  LVRL  Y VV 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--YAVVT 78
Query: 169 GGPRYLVYEFIQNGSL-DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDC 227
             P Y++ E+++NGSL D    P         SG  L+ +    +A  +A+ ++++    
Sbjct: 79  QEPIYIITEYMENGSLVDFLKTP---------SGIKLTINKLLDMAAQIAEGMAFIE--- 126
Query: 228 RSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQG 287
               +H D++  NIL+ +     ++DFGL++L+  ++       +    + APE I    
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 186
Query: 288 VSEKCDIYSYGMVLLEL-TGGR 308
            + K D++S+G++L E+ T GR
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGR 208

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 106/207 (51%), Gaps = 19/207 (9%)
Query: 103 DNFQALLGHGSSASV-FKGILSDGTSVAVKRINGEENGEKEFR-SEVAAIASAQHVNLVR 160
           DNF  + G GS+  V    + S G  VAVK+++  +   +E   +EV  +   QH N+V 
Sbjct: 77  DNFIKI-GEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 135
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           +    +V G   ++V EF++ G+L   I   +R +E   +  CL+          V +AL
Sbjct: 136 MYNSYLV-GDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLA----------VLQAL 183
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAP 280
           S LH      V+H D+K ++ILL  + R  +SDFG    +S++  R    + GT  ++AP
Sbjct: 184 SVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAP 239
Query: 281 EWILEQGVSEKCDIYSYGMVLLELTGG 307
           E I       + DI+S G++++E+  G
Sbjct: 240 ELISRLPYGPEVDIWSLGIMVIEMVDG 266

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G +  V+ G  +  T VAVK +         F +E   +   QH  LVRL  Y VV 
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--YAVVT 78
Query: 169 GGPRYLVYEFIQNGSL-DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDC 227
             P Y++ E+++NGSL D    P         SG  L+ +    +A  +A+ ++++    
Sbjct: 79  QEPIYIITEYMENGSLVDFLKTP---------SGIKLTINKLLDMAAQIAEGMAFIE--- 126
Query: 228 RSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQG 287
               +H D++  NIL+ +     ++DFGL++L+   +       +    + APE I    
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGT 186
Query: 288 VSEKCDIYSYGMVLLEL-TGGR 308
            + K D++S+G++L E+ T GR
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGR 208

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 106/207 (51%), Gaps = 19/207 (9%)
Query: 103 DNFQALLGHGSSASV-FKGILSDGTSVAVKRINGEENGEKEFR-SEVAAIASAQHVNLVR 160
           DNF   +G GS+  V    + S G  VAVK+++  +   +E   +EV  +   QH N+V 
Sbjct: 154 DNF-IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 212
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           +    +V G   ++V EF++ G+L   I   +R +E   +  CL+          V +AL
Sbjct: 213 MYNSYLV-GDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLA----------VLQAL 260
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAP 280
           S LH      V+H D+K ++ILL  + R  +SDFG    +S++  R    + GT  ++AP
Sbjct: 261 SVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAP 316
Query: 281 EWILEQGVSEKCDIYSYGMVLLELTGG 307
           E I       + DI+S G++++E+  G
Sbjct: 317 ELISRLPYGPEVDIWSLGIMVIEMVDG 343

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+ G  +  T VAVK +         F +E   +   QH  LVRL  Y VV 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--YAVVT 84
Query: 169 GGPRYLVYEFIQNGSL-DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDC 227
             P Y++ E+++NGSL D    P         SG  L+ +    +A  +A+ ++++    
Sbjct: 85  QEPIYIITEYMENGSLVDFLKTP---------SGIKLTINKLLDMAAQIAEGMAFIE--- 132
Query: 228 RSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQG 287
               +H D++  NIL+ +     ++DFGL++L+  ++       +    + APE I    
Sbjct: 133 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 192
Query: 288 VSEKCDIYSYGMVLLEL-TGGR 308
            + K D++S+G++L E+ T GR
Sbjct: 193 FTIKSDVWSFGILLTEIVTHGR 214

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+ G  +  T VAVK +         F +E   +   QH  LVRL  Y VV 
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--YAVVT 83
Query: 169 GGPRYLVYEFIQNGSL-DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDC 227
             P Y++ E+++NGSL D    P         SG  L+ +    +A  +A+ ++++    
Sbjct: 84  QEPIYIITEYMENGSLVDFLKTP---------SGIKLTINKLLDMAAQIAEGMAFIE--- 131
Query: 228 RSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQG 287
               +H D++  NIL+ +     ++DFGL++L+  ++       +    + APE I    
Sbjct: 132 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 191
Query: 288 VSEKCDIYSYGMVLLEL-TGGR 308
            + K D++S+G++L E+ T GR
Sbjct: 192 FTIKSDVWSFGILLTEIVTHGR 213

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 107/219 (48%), Gaps = 23/219 (10%)
Query: 95  SKELEEATDNFQALLGHGSSASVFKGILSDGT----SVAVK--RINGEENGEKEFRSEVA 148
           +KEL+    +   ++G G    V  G L   +    SVA+K  ++   E   ++F  E +
Sbjct: 39  AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 98
Query: 149 AIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL 208
            +    H N++RL G  V    P  +V E+++NGSLD ++    R+ +  ++   L   L
Sbjct: 99  IMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGML 153
Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI 268
           R      +A  + YL +      +H D+   NIL++ N    VSDFGL +++  D     
Sbjct: 154 R-----GIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAY 205
Query: 269 TTIRGTR---GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           TT RG +    + +PE I  +  +   D++SYG+VL E+
Sbjct: 206 TT-RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 243

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+ G  +  T VAVK +         F +E   +   QH  LVRL  Y VV 
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--YAVVT 86
Query: 169 GGPRYLVYEFIQNGSL-DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDC 227
             P Y++ E+++NGSL D    P         SG  L+ +    +A  +A+ ++++    
Sbjct: 87  QEPIYIITEYMENGSLVDFLKTP---------SGIKLTINKLLDMAAQIAEGMAFIE--- 134
Query: 228 RSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQG 287
               +H D++  NIL+ +     ++DFGL++L+  ++       +    + APE I    
Sbjct: 135 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 194
Query: 288 VSEKCDIYSYGMVLLEL-TGGR 308
            + K D++S+G++L E+ T GR
Sbjct: 195 FTIKSDVWSFGILLTEIVTHGR 216

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+ G  +  T VAVK +         F +E   +   QH  LVRL  Y VV 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--YAVVT 78
Query: 169 GGPRYLVYEFIQNGSL-DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDC 227
             P Y++ E+++NGSL D    P         SG  L+ +    +A  +A+ ++++    
Sbjct: 79  QEPIYIITEYMENGSLVDFLKTP---------SGIKLTINKLLDMAAQIAEGMAFIE--- 126
Query: 228 RSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQG 287
               +H D++  NIL+ +     ++DFGL++L+  ++       +    + APE I    
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 288 VSEKCDIYSYGMVLLEL-TGGR 308
            + K D++S+G++L E+ T GR
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGR 208

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 94/197 (47%), Gaps = 13/197 (6%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+ G  +  T VA+K +       + F  E   +   +H  LV+L  Y VV 
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVS 74
Query: 169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCR 228
             P Y+V E++  GSL  ++    +   G Y    L       +A  +A  ++Y+    R
Sbjct: 75  EEPIYIVTEYMSKGSLLDFL----KGEMGKY----LRLPQLVDMAAQIASGMAYVE---R 123
Query: 229 SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGV 288
              +H D++  NIL+ EN    V+DFGL++L+  ++       +    + APE  L    
Sbjct: 124 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 183
Query: 289 SEKCDIYSYGMVLLELT 305
           + K D++S+G++L ELT
Sbjct: 184 TIKSDVWSFGILLTELT 200

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 128/288 (44%), Gaps = 42/288 (14%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKE---FRSEVAAIASAQHVNLVRLLGYC 165
           +G GS  +V+KG       VAVK +N      ++   F++EV  +   +HVN++  +GY 
Sbjct: 20  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
             P     +V ++ +  SL H +         H S           +A   A+ + YLH 
Sbjct: 78  TKP--QLAIVTQWCEGSSLYHHL---------HASETKFEMKKLIDIARQTARGMDYLHA 126
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIRGTRGYLAPEWIL 284
                ++H D+K  NI L E+    + DFGL+ + SR   S     + G+  ++APE I 
Sbjct: 127 KS---IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 183
Query: 285 EQG---VSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKL 341
            Q     S + D+Y++G+VL EL  G+   S I   N++ +         + E +  G L
Sbjct: 184 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI---NNRDQ---------IIEMVGRGSL 231
Query: 342 MEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE 389
                    D   +     +R+  +   C++++   RPS  R++  +E
Sbjct: 232 S-------PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 272

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 94/197 (47%), Gaps = 13/197 (6%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+ G  +  T VA+K +       + F  E   +   +H  LV+L  Y VV 
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVS 72
Query: 169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCR 228
             P Y+V E++  GSL  ++    +   G Y    L       +A  +A  ++Y+    R
Sbjct: 73  EEPIYIVTEYMSKGSLLDFL----KGEMGKY----LRLPQLVDMAAQIASGMAYVE---R 121
Query: 229 SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGV 288
              +H D++  NIL+ EN    V+DFGL++L+  ++       +    + APE  L    
Sbjct: 122 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 181
Query: 289 SEKCDIYSYGMVLLELT 305
           + K D++S+G++L ELT
Sbjct: 182 TIKSDVWSFGILLTELT 198

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 107/219 (48%), Gaps = 23/219 (10%)
Query: 95  SKELEEATDNFQALLGHGSSASVFKGILSDGT----SVAVK--RINGEENGEKEFRSEVA 148
           +KEL+    +   ++G G    V  G L   +    SVA+K  ++   E   ++F  E +
Sbjct: 39  AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 98
Query: 149 AIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL 208
            +    H N++RL G  V    P  +V E ++NGSLD ++    R+ +  ++   L   L
Sbjct: 99  IMGQFDHPNIIRLEG-VVTKSKPVMIVTEXMENGSLDSFL----RKHDAQFTVIQLVGML 153
Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI 268
           R      +A  + YL +      +H D+   NIL++ N    VSDFGLS+++  D     
Sbjct: 154 R-----GIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 269 TTIRGTR---GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           TT RG +    + +PE I  +  +   D++SYG+VL E+
Sbjct: 206 TT-RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV 243

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 94/197 (47%), Gaps = 13/197 (6%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+ G  +  T VA+K +       + F  E   +   +H  LV+L  Y VV 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVS 83
Query: 169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCR 228
             P Y+V E++  GSL  ++    +   G Y    L       +A  +A  ++Y+    R
Sbjct: 84  EEPIYIVIEYMSKGSLLDFL----KGEMGKY----LRLPQLVDMAAQIASGMAYVE---R 132
Query: 229 SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGV 288
              +H D++  NIL+ EN    V+DFGL++L+  ++       +    + APE  L    
Sbjct: 133 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 192
Query: 289 SEKCDIYSYGMVLLELT 305
           + K D++S+G++L ELT
Sbjct: 193 TIKSDVWSFGILLTELT 209

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 94/197 (47%), Gaps = 13/197 (6%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+ G  +  T VA+K +       + F  E   +   +H  LV+L  Y VV 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQL--YAVVS 83
Query: 169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCR 228
             P Y+V E++  GSL  ++    +   G Y    L       +A  +A  ++Y+    R
Sbjct: 84  EEPIYIVTEYMSKGSLLDFL----KGEMGKY----LRLPQLVDMAAQIASGMAYVE---R 132
Query: 229 SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGV 288
              +H D++  NIL+ EN    V+DFGL++L+  ++       +    + APE  L    
Sbjct: 133 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 192
Query: 289 SEKCDIYSYGMVLLELT 305
           + K D++S+G++L ELT
Sbjct: 193 TIKSDVWSFGILLTELT 209

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 94/197 (47%), Gaps = 13/197 (6%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+ G  +  T VA+K +       + F  E   +   +H  LV+L  Y VV 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVS 83
Query: 169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCR 228
             P Y+V E++  GSL  ++    +   G Y    L       +A  +A  ++Y+    R
Sbjct: 84  EEPIYIVTEYMSKGSLLDFL----KGEMGKY----LRLPQLVDMAAQIASGMAYVE---R 132
Query: 229 SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGV 288
              +H D++  NIL+ EN    V+DFGL++L+  ++       +    + APE  L    
Sbjct: 133 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 192
Query: 289 SEKCDIYSYGMVLLELT 305
           + K D++S+G++L ELT
Sbjct: 193 TIKSDVWSFGILLTELT 209

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 95/197 (48%), Gaps = 13/197 (6%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+ G  +  T VA+K +       + F  E   +   +H  LV+L  Y VV 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVS 249
Query: 169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCR 228
             P Y+V E++  GSL  ++     + E   +G  L       +A  +A  ++Y+    R
Sbjct: 250 EEPIYIVTEYMSKGSLLDFL-----KGE---TGKYLRLPQLVDMAAQIASGMAYVE---R 298
Query: 229 SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGV 288
              +H D++  NIL+ EN    V+DFGL++L+  ++       +    + APE  L    
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 358
Query: 289 SEKCDIYSYGMVLLELT 305
           + K D++S+G++L ELT
Sbjct: 359 TIKSDVWSFGILLTELT 375

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+ G  +  T VAVK +         F +E   +   QH  LVRL  Y VV 
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--YAVVT 88
Query: 169 GGPRYLVYEFIQNGSL-DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDC 227
             P Y++ E+++NGSL D    P         SG  L+ +    +A  +A+ ++++    
Sbjct: 89  QEPIYIITEYMENGSLVDFLKTP---------SGIKLTINKLLDMAAQIAEGMAFIE--- 136
Query: 228 RSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQG 287
               +H D++  NIL+ +     ++DFGL++L+  ++       +    + APE I    
Sbjct: 137 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 196
Query: 288 VSEKCDIYSYGMVLLEL-TGGR 308
            + K D++S+G++L E+ T GR
Sbjct: 197 FTIKSDVWSFGILLTEIVTHGR 218

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 94/197 (47%), Gaps = 13/197 (6%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+ G  +  T VA+K +       + F  E   +   +H  LV+L  Y VV 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVS 83
Query: 169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCR 228
             P Y+V E++  GSL  ++    +   G Y    L       +A  +A  ++Y+    R
Sbjct: 84  EEPIYIVCEYMSKGSLLDFL----KGEMGKY----LRLPQLVDMAAQIASGMAYVE---R 132
Query: 229 SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGV 288
              +H D++  NIL+ EN    V+DFGL++L+  ++       +    + APE  L    
Sbjct: 133 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 192
Query: 289 SEKCDIYSYGMVLLELT 305
           + K D++S+G++L ELT
Sbjct: 193 TIKSDVWSFGILLTELT 209

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 95/197 (48%), Gaps = 13/197 (6%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+ G  +  T VA+K +       + F  E   +   +H  LV+L  Y VV 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVS 249
Query: 169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCR 228
             P Y+V E++  GSL  ++     + E   +G  L       +A  +A  ++Y+    R
Sbjct: 250 EEPIYIVTEYMSKGSLLDFL-----KGE---TGKYLRLPQLVDMAAQIASGMAYVE---R 298
Query: 229 SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGV 288
              +H D++  NIL+ EN    V+DFGL++L+  ++       +    + APE  L    
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 358
Query: 289 SEKCDIYSYGMVLLELT 305
           + K D++S+G++L ELT
Sbjct: 359 TIKSDVWSFGILLTELT 375

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 21/201 (10%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+ G  +  T VA+K +       + F  E   +   +H  LV+L  Y VV 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVS 80
Query: 169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID----VAKALSYLH 224
             P Y+V E++  GSL  ++    +   G Y        LR    +D    +A  ++Y+ 
Sbjct: 81  EEPIYIVTEYMNKGSLLDFL----KGETGKY--------LRLPQLVDMSAQIASGMAYVE 128
Query: 225 NDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWIL 284
              R   +H D++  NIL+ EN    V+DFGL++L+  ++       +    + APE  L
Sbjct: 129 ---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 185
Query: 285 EQGVSEKCDIYSYGMVLLELT 305
               + K D++S+G++L ELT
Sbjct: 186 YGRFTIKSDVWSFGILLTELT 206

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 127/288 (44%), Gaps = 42/288 (14%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKE---FRSEVAAIASAQHVNLVRLLGYC 165
           +G GS  +V+KG       VAVK +N      ++   F++EV  +   +HVN++  +GY 
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
             P     +V ++ +  SL H +         H S           +A   A+ + YLH 
Sbjct: 90  TAP--QLAIVTQWCEGSSLYHHL---------HASETKFEMKKLIDIARQTARGMDYLHA 138
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIRGTRGYLAPEWIL 284
                ++H D+K  NI L E+    + DFGL+   SR   S     + G+  ++APE I 
Sbjct: 139 KS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 285 EQG---VSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKL 341
            Q     S + D+Y++G+VL EL  G+   S I   N++ +         + E +  G L
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI---NNRDQ---------IIEMVGRGSL 243
Query: 342 MEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE 389
                    D   +     +R+  +   C++++   RPS  R++  +E
Sbjct: 244 S-------PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 21/201 (10%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+ G  +  T VA+K +       + F  E   +   +H  LV+L  Y VV 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVS 80
Query: 169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID----VAKALSYLH 224
             P Y+V E++  GSL  ++    +   G Y        LR    +D    +A  ++Y+ 
Sbjct: 81  EEPIYIVTEYMNKGSLLDFL----KGETGKY--------LRLPQLVDMSAQIASGMAYVE 128
Query: 225 NDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWIL 284
              R   +H D++  NIL+ EN    V+DFGL++L+  ++       +    + APE  L
Sbjct: 129 ---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAAL 185
Query: 285 EQGVSEKCDIYSYGMVLLELT 305
               + K D++S+G++L ELT
Sbjct: 186 YGRFTIKSDVWSFGILLTELT 206

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 137/304 (45%), Gaps = 46/304 (15%)
Query: 95  SKELEEATDNFQALLGHGSSASVFKGILS----DGTSVAVK--RINGEENGEKEFRSEVA 148
           +KE+E +    + ++G G    V  G L         VA+K  ++   E   ++F  E +
Sbjct: 16  AKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEAS 75
Query: 149 AIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL 208
            +    H N++ L G  V    P  +V E+++NGSLD ++    ++++G ++   L   L
Sbjct: 76  IMGQFDHPNIIHLEG-VVTKSKPVMIVTEYMENGSLDTFL----KKNDGQFTVIQLVGML 130
Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI 268
           R      ++  + YL +      +H D+   NIL++ N    VSDFGLS+++  D     
Sbjct: 131 R-----GISAGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 182
Query: 269 TTIRGTR---GYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKW 325
           TT RG +    + APE I  +  +   D++SYG+V+ E         ++ +G    +  W
Sbjct: 183 TT-RGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWE---------VVSYG---ERPYW 229
Query: 326 QYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVV 385
           +   + V + ++EG        RL           + ++D    C Q+    RP    +V
Sbjct: 230 EMTNQDVIKAVEEG-------YRLPSPMDCPAALYQLMLD----CWQKERNSRPKFDEIV 278
Query: 386 EMLE 389
            ML+
Sbjct: 279 NMLD 282

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 100/227 (44%), Gaps = 47/227 (20%)
Query: 108 LLGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYC- 165
           L+G G    VFK     DG +  ++R+  + N EK  R EV A+A   HVN+V   G C 
Sbjct: 19  LIGSGGFGQVFKAKHRIDGKTYVIRRV--KYNNEKAER-EVKALAKLDHVNIVHYNG-CW 74
Query: 166 ------------------VVPGGPR----------YLVYEFIQNGSLDHWIFPTSRRSEG 197
                               P   +          ++  EF   G+L+ WI    RR E 
Sbjct: 75  DGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRGEK 132
Query: 198 HYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS 257
                 L   L   +   + K + Y+H+    +++H D+KP NI L +  +  + DFGL 
Sbjct: 133 ------LDKVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFGLV 183
Query: 258 KLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
             +  D  R  T  +GT  Y++PE I  Q   ++ D+Y+ G++L EL
Sbjct: 184 TSLKNDGKR--TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 228

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 23/220 (10%)
Query: 95  SKELEEATDNFQALLGHGSSASVFKGILSDG----TSVAVKRING--EENGEKEFRSEVA 148
           +KE++ +    + ++G G    V +G L       + VA+K + G   E   +EF SE +
Sbjct: 8   AKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEAS 67
Query: 149 AIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL 208
            +   +H N++RL G  V    P  ++ EF++NG+LD ++    R ++G ++   L   L
Sbjct: 68  IMGQFEHPNIIRLEG-VVTNSMPVMILTEFMENGALDSFL----RLNDGQFTVIQLVGML 122
Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQS-RC 267
           R      +A  + YL        +H D+   NIL++ N    VSDFGLS+ +  + S   
Sbjct: 123 R-----GIASGMRYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPT 174
Query: 268 ITTIRGTR---GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            T+  G +    + APE I  +  +   D +SYG+V+ E+
Sbjct: 175 YTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEV 214

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 93/197 (47%), Gaps = 13/197 (6%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+ G  +  T VA+K +       + F  E   +   +H  LV+L  Y VV 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVS 83
Query: 169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCR 228
             P Y+V E++  GSL  ++    +   G Y    L       +A  +A  ++Y+    R
Sbjct: 84  EEPIYIVTEYMSKGSLLDFL----KGEMGKY----LRLPQLVDMAAQIASGMAYVE---R 132
Query: 229 SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGV 288
              +H D+   NIL+ EN    V+DFGL++L+  ++       +    + APE  L    
Sbjct: 133 MNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 192
Query: 289 SEKCDIYSYGMVLLELT 305
           + K D++S+G++L ELT
Sbjct: 193 TIKSDVWSFGILLTELT 209

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 94/197 (47%), Gaps = 13/197 (6%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+ G  +  T VA+K +       + F  E   +   +H  LV+L  Y VV 
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVS 249
Query: 169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCR 228
             P Y+V E++  GSL  ++    +   G Y    L       +A  +A  ++Y+    R
Sbjct: 250 EEPIYIVGEYMSKGSLLDFL----KGETGKY----LRLPQLVDMAAQIASGMAYVE---R 298
Query: 229 SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGV 288
              +H D++  NIL+ EN    V+DFGL++L+  ++       +    + APE  L    
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 358
Query: 289 SEKCDIYSYGMVLLELT 305
           + K D++S+G++L ELT
Sbjct: 359 TIKSDVWSFGILLTELT 375

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 108/224 (48%), Gaps = 31/224 (13%)
Query: 95  SKELEEATDNFQALLGHGSSASVFKGILSDG----TSVAVKRING--EENGEKEFRSEVA 148
           +KE++ +    + ++G G    V +G L       + VA+K + G   E   +EF SE +
Sbjct: 10  AKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEAS 69
Query: 149 AIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL 208
            +   +H N++RL G  V    P  ++ EF++NG+LD ++    R ++G ++   L   L
Sbjct: 70  IMGQFEHPNIIRLEG-VVTNSMPVMILTEFMENGALDSFL----RLNDGQFTVIQLVGML 124
Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI 268
           R      +A  + YL        +H D+   NIL++ N    VSDFGLS+ +  + S   
Sbjct: 125 R-----GIASGMRYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPT 176
Query: 269 TT--------IRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            T        IR T    APE I  +  +   D +SYG+V+ E+
Sbjct: 177 ETSSLGGKIPIRWT----APEAIAFRKFTSASDAWSYGIVMWEV 216

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 94/197 (47%), Gaps = 13/197 (6%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+ G  +  T VA+K +       + F  E   +   +H  LV+L  Y VV 
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVS 332
Query: 169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCR 228
             P Y+V E++  GSL  ++    +   G Y    L       +A  +A  ++Y+    R
Sbjct: 333 EEPIYIVTEYMSKGSLLDFL----KGETGKY----LRLPQLVDMAAQIASGMAYVE---R 381
Query: 229 SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGV 288
              +H D++  NIL+ EN    V+DFGL++L+  ++       +    + APE  L    
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 441
Query: 289 SEKCDIYSYGMVLLELT 305
           + K D++S+G++L ELT
Sbjct: 442 TIKSDVWSFGILLTELT 458

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 93/197 (47%), Gaps = 13/197 (6%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+ G  +  T VA+K +       + F  E   +   +H  LV+L  Y VV 
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQEAQVMKKLRHEKLVQL--YAVVS 250
Query: 169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCR 228
             P Y+V E++  GSL  ++    +   G Y    L       +A  +A  ++Y+    R
Sbjct: 251 EEPIYIVTEYMSKGSLLDFL----KGEMGKY----LRLPQLVDMAAQIASGMAYVE---R 299
Query: 229 SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGV 288
              +H D++  NIL+ EN    V+DFGL +L+  ++       +    + APE  L    
Sbjct: 300 MNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRF 359
Query: 289 SEKCDIYSYGMVLLELT 305
           + K D++S+G++L ELT
Sbjct: 360 TIKSDVWSFGILLTELT 376

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 105/216 (48%), Gaps = 24/216 (11%)
Query: 105 FQALLGHGSSASVFKGILSDGTS-VAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRL 161
            Q ++G G++A V     +     VA+KRIN E  +    E   E+ A++   H N+V  
Sbjct: 19  LQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSY 78
Query: 162 LGYCVVPGGPRYLVYEFIQNGS----LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
               VV     +LV + +  GS    + H +      ++G +  G L       +  +V 
Sbjct: 79  YTSFVV-KDELWLVMKLLSGGSVLDIIKHIV------AKGEHKSGVLDESTIATILREVL 131
Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR----DQSRCITTIRG 273
           + L YLH + +   +H DVK  NILL E+    ++DFG+S  ++      +++   T  G
Sbjct: 132 EGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 274 TRGYLAPEWILEQ--GVSEKCDIYSYGMVLLELTGG 307
           T  ++APE ++EQ  G   K DI+S+G+  +EL  G
Sbjct: 189 TPCWMAPE-VMEQVRGYDFKADIWSFGITAIELATG 223

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+ G  +  T VAVK +         F +E   +   QH  LVRL  Y VV 
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--YAVVT 74
Query: 169 GGPRYLVYEFIQNGSL-DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDC 227
             P Y++ E+++NGSL D    P         SG  L+ +    +A  +A+ ++++    
Sbjct: 75  QEPIYIITEYMENGSLVDFLKTP---------SGIKLTINKLLDMAAQIAEGMAFIE--- 122
Query: 228 RSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQG 287
               +H +++  NIL+ +     ++DFGL++L+  ++       +    + APE I    
Sbjct: 123 ERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 182
Query: 288 VSEKCDIYSYGMVLLEL-TGGR 308
            + K D++S+G++L E+ T GR
Sbjct: 183 FTIKSDVWSFGILLTEIVTHGR 204

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 127/288 (44%), Gaps = 42/288 (14%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKE---FRSEVAAIASAQHVNLVRLLGYC 165
           +G GS  +V+KG       VAVK +N      ++   F++EV  +   +HVN++  +GY 
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
             P     +V ++ +  SL H +         H S           +A   A+ + YLH 
Sbjct: 90  TKP--QLAIVTQWCEGSSLYHHL---------HASETKFEMKKLIDIARQTARGMDYLHA 138
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIRGTRGYLAPEWIL 284
                ++H D+K  NI L E+    + DFGL+   SR   S     + G+  ++APE I 
Sbjct: 139 KS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 285 EQG---VSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKL 341
            Q     S + D+Y++G+VL EL  G+   S I   N++ +         + E +  G L
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI---NNRDQ---------IIEMVGRGSL 243
Query: 342 MEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE 389
                    D   +     +R+  +   C++++   RPS  R++  +E
Sbjct: 244 S-------PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 13/197 (6%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+ G  +  T VA+K +       + F  E   +   +H  LV+L  Y VV 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVS 83
Query: 169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCR 228
             P Y+V E++  G L  ++    +   G Y    L       +A  +A  ++Y+    R
Sbjct: 84  EEPIYIVMEYMSKGCLLDFL----KGEMGKY----LRLPQLVDMAAQIASGMAYVE---R 132
Query: 229 SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGV 288
              +H D++  NIL+ EN    V+DFGL++L+  ++       +    + APE  L    
Sbjct: 133 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 192
Query: 289 SEKCDIYSYGMVLLELT 305
           + K D++S+G++L ELT
Sbjct: 193 TIKSDVWSFGILLTELT 209

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 105/216 (48%), Gaps = 24/216 (11%)
Query: 105 FQALLGHGSSASVFKGILSDGT-SVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRL 161
            Q ++G G++A V     +     VA+KRIN E  +    E   E+ A++   H N+V  
Sbjct: 14  LQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSY 73
Query: 162 LGYCVVPGGPRYLVYEFIQNGS----LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
               VV     +LV + +  GS    + H +      ++G +  G L       +  +V 
Sbjct: 74  YTSFVV-KDELWLVMKLLSGGSVLDIIKHIV------AKGEHKSGVLDESTIATILREVL 126
Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR----DQSRCITTIRG 273
           + L YLH + +   +H DVK  NILL E+    ++DFG+S  ++      +++   T  G
Sbjct: 127 EGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 183
Query: 274 TRGYLAPEWILEQ--GVSEKCDIYSYGMVLLELTGG 307
           T  ++APE ++EQ  G   K DI+S+G+  +EL  G
Sbjct: 184 TPCWMAPE-VMEQVRGYDFKADIWSFGITAIELATG 218

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 13/197 (6%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+ G  +  T VA+K +       + F  E   +   +H  LV+L  Y VV 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVS 83
Query: 169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCR 228
             P Y+V E++  G L  ++    +   G Y    L       +A  +A  ++Y+    R
Sbjct: 84  EEPIYIVTEYMSKGCLLDFL----KGEMGKY----LRLPQLVDMAAQIASGMAYVE---R 132
Query: 229 SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGV 288
              +H D++  NIL+ EN    V+DFGL++L+  ++       +    + APE  L    
Sbjct: 133 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 192
Query: 289 SEKCDIYSYGMVLLELT 305
           + K D++S+G++L ELT
Sbjct: 193 TIKSDVWSFGILLTELT 209

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 105/213 (49%), Gaps = 28/213 (13%)
Query: 108 LLGHGSSASVFKGI-LSDGTSVAVK---RINGEENGEK---EFRSEVAAIASAQHVNLVR 160
           +LG G+  +V+KGI + +G +V +    +I  E  G K   EF  E   +AS  H +LVR
Sbjct: 22  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 81
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG C+ P     LV + + +G L  ++       +   S   L+W       + +AK +
Sbjct: 82  LLGVCLSPT--IQLVTQLMPHGCLLEYV---HEHKDNIGSQLLLNW------CVQIAKGM 130
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GY 277
            YL      R++H D+   N+L+       ++DFGL++L+  D+        G +    +
Sbjct: 131 MYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE--YNADGGKMPIKW 185
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLELT--GGR 308
           +A E I  +  + + D++SYG+ + EL   GG+
Sbjct: 186 MALECIHYRKFTHQSDVWSYGVTIWELMTFGGK 218

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 13/197 (6%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+ G  +  T VA+K +       + F  E   +   +H  LV+L  Y VV 
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVVS 73
Query: 169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCR 228
             P  +V E++  GSL  ++    +   G Y    L       +A  +A  ++Y+    R
Sbjct: 74  EEPIXIVTEYMSKGSLLDFL----KGETGKY----LRLPQLVDMAAQIASGMAYVE---R 122
Query: 229 SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGV 288
              +H D++  NIL+ EN    V+DFGL++L+  ++       +    + APE  L    
Sbjct: 123 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRF 182
Query: 289 SEKCDIYSYGMVLLELT 305
           + K D++S+G++L ELT
Sbjct: 183 TIKSDVWSFGILLTELT 199

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 107/219 (48%), Gaps = 23/219 (10%)
Query: 95  SKELEEATDNFQALLGHGSSASVFKGILS----DGTSVAVKRING--EENGEKEFRSEVA 148
           +KE++ +    + ++G G    V  G L         VA+K +     +   ++F SE +
Sbjct: 23  AKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEAS 82
Query: 149 AIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL 208
            +    H N++ L G  V    P  ++ E+++NGSLD ++    R+++G ++   L   L
Sbjct: 83  IMGQFDHPNIIHLEG-VVTKCKPVMIITEYMENGSLDAFL----RKNDGRFTVIQLVGML 137
Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI 268
           R      +   + YL +      +H D+   NIL++ N    VSDFG+S+++  D     
Sbjct: 138 R-----GIGSGMKYLSD---MSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAY 189
Query: 269 TTIRGTR---GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           TT RG +    + APE I  +  +   D++SYG+V+ E+
Sbjct: 190 TT-RGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 227

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 23/215 (10%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKE---FRSEVAAIASAQHVNLVRLLGYC 165
           +G GS  +V+KG       VAVK +N      ++   F++EV  +   +HVN++  +GY 
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
             P     +V ++ +  SL H +     + E               +A   A+ + YLH 
Sbjct: 74  TAPQ--LAIVTQWCEGSSLYHHLHIIETKFE---------MIKLIDIARQTAQGMDYLHA 122
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIRGTRGYLAPEWIL 284
                ++H D+K  NI L E+    + DFGL+ + SR   S     + G+  ++APE I 
Sbjct: 123 KS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 285 EQ---GVSEKCDIYSYGMVLLELTGGRRNVSLIEH 316
            Q     S + D+Y++G+VL EL  G+   S I +
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 107/220 (48%), Gaps = 23/220 (10%)
Query: 95  SKELEEATDNFQALLGHGSSASVFKGILSDGTS----VAVKRING--EENGEKEFRSEVA 148
           +KE++ +    + ++G G    V  G L         VA+K +     E   ++F SE +
Sbjct: 27  AKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEAS 86
Query: 149 AIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL 208
            +    H N++ L G  V    P  ++ EF++NGSLD ++    R+++G ++   L   L
Sbjct: 87  IMGQFDHPNVIHLEG-VVTKSTPVMIITEFMENGSLDSFL----RQNDGQFTVIQLVGML 141
Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQS-RC 267
           R      +A  + YL +      +H D+   NIL++ N    VSDFGLS+ +  D S   
Sbjct: 142 R-----GIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 193
Query: 268 ITTIRGTR---GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            T+  G +    + APE I  +  +   D++SYG+V+ E+
Sbjct: 194 YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEV 233

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 105/213 (49%), Gaps = 28/213 (13%)
Query: 108 LLGHGSSASVFKGI-LSDGTSVAVK---RINGEENGEK---EFRSEVAAIASAQHVNLVR 160
           +LG G+  +V+KGI + +G +V +    +I  E  G K   EF  E   +AS  H +LVR
Sbjct: 45  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 104
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG C+ P     LV + + +G L  ++       +   S   L+W       + +AK +
Sbjct: 105 LLGVCLSPT--IQLVTQLMPHGCLLEYV---HEHKDNIGSQLLLNW------CVQIAKGM 153
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GY 277
            YL      R++H D+   N+L+       ++DFGL++L+  D+        G +    +
Sbjct: 154 MYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE--YNADGGKMPIKW 208
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLELT--GGR 308
           +A E I  +  + + D++SYG+ + EL   GG+
Sbjct: 209 MALECIHYRKFTHQSDVWSYGVTIWELMTFGGK 241

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 99/224 (44%), Gaps = 35/224 (15%)
Query: 97  ELEEATDNFQALLGHGSSASVFK---GILSDGTS--VAVKRI-NGEENGEKEFRSEVAAI 150
           + EE    F   LG G+  SV       L D T   VAVK++ +  E   ++F  E+  +
Sbjct: 9   QFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 68
Query: 151 ASAQHVNLVRLLGYCVVPGGPRY-LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR 209
            S QH N+V+  G C   G     L+ EF+  GSL  ++                    +
Sbjct: 69  KSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYL-------------------QK 109
Query: 210 YRVAIDVAKALSYLHNDCR-------SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR 262
           ++  ID  K L Y    C+        R +H D+   NIL++   R  + DFGL+K++ +
Sbjct: 110 HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 169
Query: 263 DQSRCITTIRGTRG--YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           D+        G     + APE + E   S   D++S+G+VL EL
Sbjct: 170 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 213

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 97/225 (43%), Gaps = 19/225 (8%)
Query: 97  ELEEATDNFQALLGHGSSASVFKGILSDGTSVAV-KRINGEENGEKEFRSEVAAIASAQH 155
           E+E +       +G GS  +V+KG      +V + K ++      + FR+EVA +   +H
Sbjct: 32  EIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRH 91
Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
           VN++  +GY                   +  W   +S     H             +A  
Sbjct: 92  VNILLFMGYMTKDNL-----------AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQ 140
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIRGT 274
            A+ + YLH      ++H D+K  NI L E     + DFGL+ + SR   S+ +    G+
Sbjct: 141 TAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGS 197
Query: 275 RGYLAPEWILEQ---GVSEKCDIYSYGMVLLELTGGRRNVSLIEH 316
             ++APE I  Q     S + D+YSYG+VL EL  G    S I +
Sbjct: 198 VLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN 242

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 107/219 (48%), Gaps = 23/219 (10%)
Query: 95  SKELEEATDNFQALLGHGSSASVFKGILS----DGTSVAVKRING--EENGEKEFRSEVA 148
           +KE++ +    + ++G G    V  G L         VA+K +     +   ++F SE +
Sbjct: 8   AKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEAS 67
Query: 149 AIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL 208
            +    H N++ L G  V    P  ++ E+++NGSLD ++    R+++G ++   L   L
Sbjct: 68  IMGQFDHPNIIHLEG-VVTKCKPVMIITEYMENGSLDAFL----RKNDGRFTVIQLVGML 122
Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI 268
           R      +   + YL +      +H D+   NIL++ N    VSDFG+S+++  D     
Sbjct: 123 R-----GIGSGMKYLSD---MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAY 174
Query: 269 TTIRGTR---GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           TT RG +    + APE I  +  +   D++SYG+V+ E+
Sbjct: 175 TT-RGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 212

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 19/210 (9%)
Query: 108 LLGHGSSASVFKGILS--DGTS--VAVKRI---NGEENGEKEFRSEVAAIASAQHVNLVR 160
           +LG G   SV +G L   DGTS  VAVK +   N  +   +EF SE A +    H N++R
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 161 LLGYCV---VPGGPRYLV-YEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDV 216
           LLG C+     G P+ +V   F++ G L  ++   SR   G      +      +  +D+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLL-YSRLETGPKH---IPLQTLLKFMVDI 156
Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS-KLMSRDQSRCITTIRGTR 275
           A  + YL N      LH D+   N +L ++    V+DFGLS K+ S D  R     +   
Sbjct: 157 ALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 213
Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLELT 305
            ++A E + ++  + K D++++G+ + E+ 
Sbjct: 214 KWIAIESLADRVYTSKSDVWAFGVTMWEIA 243

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG+G    V+ G  +  T VA+K +       + F  E   +   +H  LV+L  Y VV 
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHDKLVQL--YAVVS 74
Query: 169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCR 228
             P Y+V E++  GSL  ++    +  EG      L       +A  VA  ++Y+    R
Sbjct: 75  EEPIYIVTEYMNKGSLLDFL----KDGEGR----ALKLPNLVDMAAQVAAGMAYIE---R 123
Query: 229 SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGV 288
              +H D++  NIL+       ++DFGL++L+  ++       +    + APE  L    
Sbjct: 124 MNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRF 183
Query: 289 SEKCDIYSYGMVLLEL-TGGR 308
           + K D++S+G++L EL T GR
Sbjct: 184 TIKSDVWSFGILLTELVTKGR 204

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 107/219 (48%), Gaps = 23/219 (10%)
Query: 95  SKELEEATDNFQALLGHGSSASVFKGILS----DGTSVAVKRING--EENGEKEFRSEVA 148
           +KE++ +    + ++G G    V  G L         VA+K +     +   ++F SE +
Sbjct: 2   AKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEAS 61
Query: 149 AIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL 208
            +    H N++ L G  V    P  ++ E+++NGSLD ++    R+++G ++   L   L
Sbjct: 62  IMGQFDHPNIIHLEG-VVTKCKPVMIITEYMENGSLDAFL----RKNDGRFTVIQLVGML 116
Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI 268
           R      +   + YL +      +H D+   NIL++ N    VSDFG+S+++  D     
Sbjct: 117 R-----GIGSGMKYLSD---MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAY 168
Query: 269 TTIRGTR---GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           TT RG +    + APE I  +  +   D++SYG+V+ E+
Sbjct: 169 TT-RGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 206

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 23/215 (10%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKE---FRSEVAAIASAQHVNLVRLLGYC 165
           +G GS  +V+KG       VAVK +N      ++   F++EV  +   +HVN++  +GY 
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
             P     +V ++ +  SL H +     + E               +A   A+ + YLH 
Sbjct: 74  TKPQ--LAIVTQWCEGSSLYHHLHIIETKFE---------MIKLIDIARQTAQGMDYLHA 122
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIRGTRGYLAPEWIL 284
                ++H D+K  NI L E+    + DFGL+ + SR   S     + G+  ++APE I 
Sbjct: 123 KS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 285 EQ---GVSEKCDIYSYGMVLLELTGGRRNVSLIEH 316
            Q     S + D+Y++G+VL EL  G+   S I +
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 23/215 (10%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKE---FRSEVAAIASAQHVNLVRLLGYC 165
           +G GS  +V+KG       VAVK +N      ++   F++EV  +   +HVN++  +GY 
Sbjct: 43  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
             P     +V ++ +  SL H +     + E               +A   A+ + YLH 
Sbjct: 101 TKP--QLAIVTQWCEGSSLYHHLHIIETKFE---------MIKLIDIARQTAQGMDYLHA 149
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIRGTRGYLAPEWIL 284
                ++H D+K  NI L E+    + DFGL+ + SR   S     + G+  ++APE I 
Sbjct: 150 KS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 206
Query: 285 EQG---VSEKCDIYSYGMVLLELTGGRRNVSLIEH 316
            Q     S + D+Y++G+VL EL  G+   S I +
Sbjct: 207 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 241

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 23/215 (10%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKE---FRSEVAAIASAQHVNLVRLLGYC 165
           +G GS  +V+KG       VAVK +N      ++   F++EV  +   +HVN++  +GY 
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
             P     +V ++ +  SL H +     + E               +A   A+ + YLH 
Sbjct: 102 TKP--QLAIVTQWCEGSSLYHHLHIIETKFE---------MIKLIDIARQTAQGMDYLHA 150
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIRGTRGYLAPEWIL 284
                ++H D+K  NI L E+    + DFGL+ + SR   S     + G+  ++APE I 
Sbjct: 151 KS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 207
Query: 285 EQG---VSEKCDIYSYGMVLLELTGGRRNVSLIEH 316
            Q     S + D+Y++G+VL EL  G+   S I +
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 242

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 23/215 (10%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKE---FRSEVAAIASAQHVNLVRLLGYC 165
           +G GS  +V+KG       VAVK +N      ++   F++EV  +   +HVN++  +GY 
Sbjct: 21  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
             P     +V ++ +  SL H +     + E               +A   A+ + YLH 
Sbjct: 79  TKPQ--LAIVTQWCEGSSLYHHLHIIETKFE---------MIKLIDIARQTAQGMDYLHA 127
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIRGTRGYLAPEWIL 284
                ++H D+K  NI L E+    + DFGL+ + SR   S     + G+  ++APE I 
Sbjct: 128 KS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 184
Query: 285 EQ---GVSEKCDIYSYGMVLLELTGGRRNVSLIEH 316
            Q     S + D+Y++G+VL EL  G+   S I +
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 219

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 96/184 (52%), Gaps = 17/184 (9%)
Query: 125 GTSVAVKRINGEENGEKEFR-SEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS 183
           G  VAVK+++  +   +E   +EV  +    H N+V +    +V G   ++V EF++ G+
Sbjct: 70  GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLV-GDELWVVMEFLEGGA 128
Query: 184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILL 243
           L   I   +R +E   +  CLS          V +ALSYLHN     V+H D+K ++ILL
Sbjct: 129 LTD-IVTHTRMNEEQIATVCLS----------VLRALSYLHNQG---VIHRDIKSDSILL 174
Query: 244 DENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLE 303
             + R  +SDFG    +S++  +    + GT  ++APE I       + DI+S G++++E
Sbjct: 175 TSDGRIKLSDFGFCAQVSKEVPKRKXLV-GTPYWMAPEVISRLPYGTEVDIWSLGIMVIE 233
Query: 304 LTGG 307
           +  G
Sbjct: 234 MIDG 237

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 23/215 (10%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKE---FRSEVAAIASAQHVNLVRLLGYC 165
           +G GS  +V+KG       VAVK +N      ++   F++EV  +   +HVN++  +GY 
Sbjct: 21  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
             P     +V ++ +  SL H +     + E               +A   A+ + YLH 
Sbjct: 79  TKPQ--LAIVTQWCEGSSLYHHLHIIETKFE---------MIKLIDIARQTAQGMDYLHA 127
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIRGTRGYLAPEWIL 284
                ++H D+K  NI L E+    + DFGL+ + SR   S     + G+  ++APE I 
Sbjct: 128 KS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 184
Query: 285 EQ---GVSEKCDIYSYGMVLLELTGGRRNVSLIEH 316
            Q     S + D+Y++G+VL EL  G+   S I +
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 219

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 23/215 (10%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKE---FRSEVAAIASAQHVNLVRLLGYC 165
           +G GS  +V+KG       VAVK +N      ++   F++EV  +   +HVN++  +GY 
Sbjct: 18  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
             P     +V ++ +  SL H +     + E               +A   A+ + YLH 
Sbjct: 76  TKPQ--LAIVTQWCEGSSLYHHLHIIETKFE---------MIKLIDIARQTAQGMDYLHA 124
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIRGTRGYLAPEWIL 284
                ++H D+K  NI L E+    + DFGL+ + SR   S     + G+  ++APE I 
Sbjct: 125 KS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 181
Query: 285 EQ---GVSEKCDIYSYGMVLLELTGGRRNVSLIEH 316
            Q     S + D+Y++G+VL EL  G+   S I +
Sbjct: 182 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 216

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 136/298 (45%), Gaps = 52/298 (17%)
Query: 109 LGHGSSASVFKGILSD------GTSVAVKRINGEENGEK--EFRSEVAAIASAQHVNLVR 160
           LG GS   V++G   D       T VAVK +N   +  +  EF +E + +      ++VR
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR--YRVAIDVAK 218
           LLG  V  G P  +V E + +G L  ++   S R E   + G     L+   ++A ++A 
Sbjct: 82  LLG-VVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAEIAD 138
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            ++YL+     + +H D+   N ++  ++   + DFG    M+RD        +G +G L
Sbjct: 139 GMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFG----MTRDIXETDXXRKGGKGLL 191
Query: 279 APEWI----LEQGV-SEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVN 333
              W+    L+ GV +   D++S+G+VL E+T      SL E          Q +  + N
Sbjct: 192 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEIT------SLAE----------QPYQGLSN 235
Query: 334 EKMKEGKLMEIVDQRLTDEGGIDETQ--VRRLVDVAFWCIQERARLRPSMARVVEMLE 389
           E+         V + + D G +D+      R+ D+   C Q   ++RP+   +V +L+
Sbjct: 236 EQ---------VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 284

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 136/298 (45%), Gaps = 52/298 (17%)
Query: 109 LGHGSSASVFKGILSD------GTSVAVKRINGEENGEK--EFRSEVAAIASAQHVNLVR 160
           LG GS   V++G   D       T VAVK +N   +  +  EF +E + +      ++VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR--YRVAIDVAK 218
           LLG  V  G P  +V E + +G L  ++   S R E   + G     L+   ++A ++A 
Sbjct: 85  LLG-VVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            ++YL+     + +H D+   N ++  ++   + DFG    M+RD        +G +G L
Sbjct: 142 GMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFG----MTRDIXETDXXRKGGKGLL 194
Query: 279 APEWI----LEQGV-SEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVN 333
              W+    L+ GV +   D++S+G+VL E+T      SL E          Q +  + N
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEIT------SLAE----------QPYQGLSN 238
Query: 334 EKMKEGKLMEIVDQRLTDEGGIDETQ--VRRLVDVAFWCIQERARLRPSMARVVEMLE 389
           E+         V + + D G +D+      R+ D+   C Q   ++RP+   +V +L+
Sbjct: 239 EQ---------VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 99/224 (44%), Gaps = 35/224 (15%)
Query: 97  ELEEATDNFQALLGHGSSASVFK---GILSDGTS--VAVKRI-NGEENGEKEFRSEVAAI 150
           + EE    F   LG G+  SV       L D T   VAVK++ +  E   ++F  E+  +
Sbjct: 10  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 69
Query: 151 ASAQHVNLVRLLGYCVVPGGPRY-LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR 209
            S QH N+V+  G C   G     L+ E++  GSL  ++                    +
Sbjct: 70  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-------------------QK 110
Query: 210 YRVAIDVAKALSYLHNDCR-------SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR 262
           ++  ID  K L Y    C+        R +H D+   NIL++   R  + DFGL+K++ +
Sbjct: 111 HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 170
Query: 263 DQSRCITTIRGTRG--YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           D+        G     + APE + E   S   D++S+G+VL EL
Sbjct: 171 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 214

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 102/231 (44%), Gaps = 40/231 (17%)
Query: 90  PIKFRSKELEEATDNFQALLGHGSSASVFK---GILSDGTS--VAVKRI-NGEENGEKEF 143
           P +F  + L+     F   LG G+  SV       L D T   VAVK++ +  E   ++F
Sbjct: 7   PTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 61
Query: 144 RSEVAAIASAQHVNLVRLLGYCVVPGGPRY-LVYEFIQNGSLDHWIFPTSRRSEGHYSGG 202
             E+  + S QH N+V+  G C   G     L+ E++  GSL  ++              
Sbjct: 62  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-------------- 107
Query: 203 CLSWDLRYRVAIDVAKALSYLHNDCR-------SRVLHLDVKPENILLDENYRAVVSDFG 255
                 +++  ID  K L Y    C+        R +H D+   NIL++   R  + DFG
Sbjct: 108 -----QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 162
Query: 256 LSKLMSRDQSRCITTIRGTRG--YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           L+K++ +D+        G     + APE + E   S   D++S+G+VL EL
Sbjct: 163 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 213

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 102/231 (44%), Gaps = 40/231 (17%)
Query: 90  PIKFRSKELEEATDNFQALLGHGSSASVFK---GILSDGTS--VAVKRI-NGEENGEKEF 143
           P +F  + L+     F   LG G+  SV       L D T   VAVK++ +  E   ++F
Sbjct: 4   PTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 58
Query: 144 RSEVAAIASAQHVNLVRLLGYCVVPGGPRY-LVYEFIQNGSLDHWIFPTSRRSEGHYSGG 202
             E+  + S QH N+V+  G C   G     L+ E++  GSL  ++              
Sbjct: 59  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-------------- 104
Query: 203 CLSWDLRYRVAIDVAKALSYLHNDCR-------SRVLHLDVKPENILLDENYRAVVSDFG 255
                 +++  ID  K L Y    C+        R +H D+   NIL++   R  + DFG
Sbjct: 105 -----QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 159
Query: 256 LSKLMSRDQSRCITTIRGTRG--YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           L+K++ +D+        G     + APE + E   S   D++S+G+VL EL
Sbjct: 160 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 210

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 102/231 (44%), Gaps = 40/231 (17%)
Query: 90  PIKFRSKELEEATDNFQALLGHGSSASVFK---GILSDGTS--VAVKRI-NGEENGEKEF 143
           P +F  + L+     F   LG G+  SV       L D T   VAVK++ +  E   ++F
Sbjct: 2   PTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 56
Query: 144 RSEVAAIASAQHVNLVRLLGYCVVPGGPRY-LVYEFIQNGSLDHWIFPTSRRSEGHYSGG 202
             E+  + S QH N+V+  G C   G     L+ E++  GSL  ++              
Sbjct: 57  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-------------- 102
Query: 203 CLSWDLRYRVAIDVAKALSYLHNDCR-------SRVLHLDVKPENILLDENYRAVVSDFG 255
                 +++  ID  K L Y    C+        R +H D+   NIL++   R  + DFG
Sbjct: 103 -----QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 157
Query: 256 LSKLMSRDQSRCITTIRGTRG--YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           L+K++ +D+        G     + APE + E   S   D++S+G+VL EL
Sbjct: 158 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 208

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 102/231 (44%), Gaps = 40/231 (17%)
Query: 90  PIKFRSKELEEATDNFQALLGHGSSASVFK---GILSDGTS--VAVKRI-NGEENGEKEF 143
           P +F  + L+     F   LG G+  SV       L D T   VAVK++ +  E   ++F
Sbjct: 3   PTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 57
Query: 144 RSEVAAIASAQHVNLVRLLGYCVVPGGPRY-LVYEFIQNGSLDHWIFPTSRRSEGHYSGG 202
             E+  + S QH N+V+  G C   G     L+ E++  GSL  ++              
Sbjct: 58  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-------------- 103
Query: 203 CLSWDLRYRVAIDVAKALSYLHNDCR-------SRVLHLDVKPENILLDENYRAVVSDFG 255
                 +++  ID  K L Y    C+        R +H D+   NIL++   R  + DFG
Sbjct: 104 -----QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 158
Query: 256 LSKLMSRDQSRCITTIRGTRG--YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           L+K++ +D+        G     + APE + E   S   D++S+G+VL EL
Sbjct: 159 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 209

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 102/231 (44%), Gaps = 40/231 (17%)
Query: 90  PIKFRSKELEEATDNFQALLGHGSSASVFK---GILSDGTS--VAVKRI-NGEENGEKEF 143
           P +F  + L+     F   LG G+  SV       L D T   VAVK++ +  E   ++F
Sbjct: 10  PTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 64
Query: 144 RSEVAAIASAQHVNLVRLLGYCVVPGGPRY-LVYEFIQNGSLDHWIFPTSRRSEGHYSGG 202
             E+  + S QH N+V+  G C   G     L+ E++  GSL  ++              
Sbjct: 65  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-------------- 110
Query: 203 CLSWDLRYRVAIDVAKALSYLHNDCR-------SRVLHLDVKPENILLDENYRAVVSDFG 255
                 +++  ID  K L Y    C+        R +H D+   NIL++   R  + DFG
Sbjct: 111 -----QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 165
Query: 256 LSKLMSRDQSRCITTIRGTRG--YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           L+K++ +D+        G     + APE + E   S   D++S+G+VL EL
Sbjct: 166 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 216

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 102/231 (44%), Gaps = 40/231 (17%)
Query: 90  PIKFRSKELEEATDNFQALLGHGSSASVFK---GILSDGTS--VAVKRI-NGEENGEKEF 143
           P +F  + L+     F   LG G+  SV       L D T   VAVK++ +  E   ++F
Sbjct: 35  PTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 89
Query: 144 RSEVAAIASAQHVNLVRLLGYCVVPGGPRY-LVYEFIQNGSLDHWIFPTSRRSEGHYSGG 202
             E+  + S QH N+V+  G C   G     L+ E++  GSL  ++              
Sbjct: 90  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-------------- 135
Query: 203 CLSWDLRYRVAIDVAKALSYLHNDCR-------SRVLHLDVKPENILLDENYRAVVSDFG 255
                 +++  ID  K L Y    C+        R +H D+   NIL++   R  + DFG
Sbjct: 136 -----QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 190
Query: 256 LSKLMSRDQSRCITTIRGTRG--YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           L+K++ +D+        G     + APE + E   S   D++S+G+VL EL
Sbjct: 191 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 241

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 102/231 (44%), Gaps = 40/231 (17%)
Query: 90  PIKFRSKELEEATDNFQALLGHGSSASVFK---GILSDGTS--VAVKRI-NGEENGEKEF 143
           P +F  + L+     F   LG G+  SV       L D T   VAVK++ +  E   ++F
Sbjct: 9   PTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 63
Query: 144 RSEVAAIASAQHVNLVRLLGYCVVPGGPRY-LVYEFIQNGSLDHWIFPTSRRSEGHYSGG 202
             E+  + S QH N+V+  G C   G     L+ E++  GSL  ++              
Sbjct: 64  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-------------- 109
Query: 203 CLSWDLRYRVAIDVAKALSYLHNDCR-------SRVLHLDVKPENILLDENYRAVVSDFG 255
                 +++  ID  K L Y    C+        R +H D+   NIL++   R  + DFG
Sbjct: 110 -----QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 164
Query: 256 LSKLMSRDQSRCITTIRGTRG--YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           L+K++ +D+        G     + APE + E   S   D++S+G+VL EL
Sbjct: 165 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 215

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 102/231 (44%), Gaps = 40/231 (17%)
Query: 90  PIKFRSKELEEATDNFQALLGHGSSASVFK---GILSDGTS--VAVKRI-NGEENGEKEF 143
           P +F  + L+     F   LG G+  SV       L D T   VAVK++ +  E   ++F
Sbjct: 4   PTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 58
Query: 144 RSEVAAIASAQHVNLVRLLGYCVVPGGPRY-LVYEFIQNGSLDHWIFPTSRRSEGHYSGG 202
             E+  + S QH N+V+  G C   G     L+ E++  GSL  ++              
Sbjct: 59  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-------------- 104
Query: 203 CLSWDLRYRVAIDVAKALSYLHNDCR-------SRVLHLDVKPENILLDENYRAVVSDFG 255
                 +++  ID  K L Y    C+        R +H D+   NIL++   R  + DFG
Sbjct: 105 -----QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 159
Query: 256 LSKLMSRDQSRCITTIRGTRG--YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           L+K++ +D+        G     + APE + E   S   D++S+G+VL EL
Sbjct: 160 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 210

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 101/231 (43%), Gaps = 40/231 (17%)
Query: 90  PIKFRSKELEEATDNFQALLGHGSSASVFK---GILSDGTS--VAVKRI-NGEENGEKEF 143
           P +F  + L+     F   LG G+  SV       L D T   VAVK++ +  E   ++F
Sbjct: 7   PTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 61
Query: 144 RSEVAAIASAQHVNLVRLLGYCVVPGGPRY-LVYEFIQNGSLDHWIFPTSRRSEGHYSGG 202
             E+  + S QH N+V+  G C   G     L+ E++  GSL  ++   + R        
Sbjct: 62  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAER-------- 113
Query: 203 CLSWDLRYRVAIDVAKALSYLHNDCR-------SRVLHLDVKPENILLDENYRAVVSDFG 255
                      ID  K L Y    C+        R +H D+   NIL++   R  + DFG
Sbjct: 114 -----------IDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 162
Query: 256 LSKLMSRDQSRCITTIRGTRG--YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           L+K++ +D+        G     + APE + E   S   D++S+G+VL EL
Sbjct: 163 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 213

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 99/224 (44%), Gaps = 35/224 (15%)
Query: 97  ELEEATDNFQALLGHGSSASVFK---GILSDGTS--VAVKRI-NGEENGEKEFRSEVAAI 150
           + EE    F   LG G+  SV       L D T   VAVK++ +  E   ++F  E+  +
Sbjct: 24  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 83
Query: 151 ASAQHVNLVRLLGYCVVPGGPRY-LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR 209
            S QH N+V+  G C   G     L+ E++  GSL  ++                    +
Sbjct: 84  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-------------------QK 124
Query: 210 YRVAIDVAKALSYLHNDCR-------SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR 262
           ++  ID  K L Y    C+        R +H D+   NIL++   R  + DFGL+K++ +
Sbjct: 125 HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 184
Query: 263 DQSRCITTIRGTRG--YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           D+        G     + APE + E   S   D++S+G+VL EL
Sbjct: 185 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 228

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 102/231 (44%), Gaps = 40/231 (17%)
Query: 90  PIKFRSKELEEATDNFQALLGHGSSASVFK---GILSDGTS--VAVKRI-NGEENGEKEF 143
           P +F  + L+     F   LG G+  SV       L D T   VAVK++ +  E   ++F
Sbjct: 11  PTQFEERHLK-----FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 65
Query: 144 RSEVAAIASAQHVNLVRLLGYCVVPGGPRY-LVYEFIQNGSLDHWIFPTSRRSEGHYSGG 202
             E+  + S QH N+V+  G C   G     L+ E++  GSL  ++              
Sbjct: 66  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-------------- 111
Query: 203 CLSWDLRYRVAIDVAKALSYLHNDCR-------SRVLHLDVKPENILLDENYRAVVSDFG 255
                 +++  ID  K L Y    C+        R +H D+   NIL++   R  + DFG
Sbjct: 112 -----QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 166
Query: 256 LSKLMSRDQSRCITTIRGTRG--YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           L+K++ +D+        G     + APE + E   S   D++S+G+VL EL
Sbjct: 167 LTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 217

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 104 NFQALLGHGSSASVFKGIL--SDGTSV--AVKRING-EENGE-KEFRSEVAAIASAQHVN 157
           +F  ++G G    V+ G L  +DG  +  AVK +N   + GE  +F +E   +    H N
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
           ++ LLG C+   G   +V  ++++G L ++I     R+E H        DL     + VA
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-----RNETH---NPTVKDL-IGFGLQVA 142
Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR-- 275
           K + YL      + +H D+   N +LDE +   V+DFGL++ M   +   +    G +  
Sbjct: 143 KGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLP 199
Query: 276 -GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
             ++A E +  Q  + K D++S+G++L EL
Sbjct: 200 VKWMALESLQTQKFTTKSDVWSFGVLLWEL 229

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 23/220 (10%)
Query: 95  SKELEEATDNFQALLGHGSSASVFKGILSDGTS----VAVKRING--EENGEKEFRSEVA 148
           SKE++ +    + ++G G    V  G L         VA+K +     E   ++F SE +
Sbjct: 1   SKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEAS 60
Query: 149 AIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL 208
            +    H N++ L G  V    P  ++ EF++NGSLD ++    R+++G ++   L   L
Sbjct: 61  IMGQFDHPNVIHLEG-VVTKSTPVMIITEFMENGSLDSFL----RQNDGQFTVIQLVGML 115
Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQS-RC 267
           R      +A  + YL +      +H  +   NIL++ N    VSDFGLS+ +  D S   
Sbjct: 116 R-----GIAAGMKYLAD---MNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 167
Query: 268 ITTIRGTR---GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            T+  G +    + APE I  +  +   D++SYG+V+ E+
Sbjct: 168 YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEV 207

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 136/298 (45%), Gaps = 52/298 (17%)
Query: 109 LGHGSSASVFKGILSD------GTSVAVKRINGEENGEK--EFRSEVAAIASAQHVNLVR 160
           LG GS   V++G   D       T VAVK +N   +  +  EF +E + +      ++VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR--YRVAIDVAK 218
           LLG  V  G P  +V E + +G L  ++   S R E   + G     L+   ++A ++A 
Sbjct: 85  LLG-VVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            ++YL+     + +H D+   N ++  ++   + DFG    M+RD        +G +G L
Sbjct: 142 GMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFG----MTRDIYETAYYRKGGKGLL 194
Query: 279 APEWI----LEQGV-SEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVN 333
              W+    L+ GV +   D++S+G+VL E+T      SL E          Q +  + N
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEIT------SLAE----------QPYQGLSN 238
Query: 334 EKMKEGKLMEIVDQRLTDEGGIDETQ--VRRLVDVAFWCIQERARLRPSMARVVEMLE 389
           E+         V + + D G +D+      R+ D+   C Q   ++RP+   +V +L+
Sbjct: 239 EQ---------VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 104 NFQALLGHGS-SASVFKGILSDGTSVAVKRING----EENGEKEFRSEVAAIASAQHVNL 158
            F  +LG GS S  V    L+     A+K +      +EN       E   ++   H   
Sbjct: 40  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 99
Query: 159 VRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK 218
           V+L  +C       Y    + +NG L  +I     R  G +   C     R+  A ++  
Sbjct: 100 VKLY-FCFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCT----RFYTA-EIVS 148
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC-ITTIRGTRGY 277
           AL YLH      ++H D+KPENILL+E+    ++DFG +K++S +  +       GT  Y
Sbjct: 149 ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 205
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           ++PE + E+   +  D+++ G ++ +L  G
Sbjct: 206 VSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 99/224 (44%), Gaps = 35/224 (15%)
Query: 97  ELEEATDNFQALLGHGSSASVFK---GILSDGTS--VAVKRI-NGEENGEKEFRSEVAAI 150
           + EE    F   LG G+  SV       L D T   VAVK++ +  E   ++F  E+  +
Sbjct: 24  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 83
Query: 151 ASAQHVNLVRLLGYCVVPGGPRY-LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR 209
            S QH N+V+  G C   G     L+ E++  GSL  ++                    +
Sbjct: 84  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-------------------QK 124
Query: 210 YRVAIDVAKALSYLHNDCR-------SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR 262
           ++  ID  K L Y    C+        R +H D+   NIL++   R  + DFGL+K++ +
Sbjct: 125 HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 184
Query: 263 DQSRCITTIRGTRG--YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           D+        G     + APE + E   S   D++S+G+VL EL
Sbjct: 185 DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 228

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 23/215 (10%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKE---FRSEVAAIASAQHVNLVRLLGYC 165
           +G GS  +V+KG       VAVK +N      ++   F++EV  +   +HVN++  +GY 
Sbjct: 16  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
             P     +V ++ +  SL H +     + E               +A   A+ + YLH 
Sbjct: 74  TKPQ--LAIVTQWCEGSSLYHHLHIIETKFE---------MIKLIDIARQTAQGMDYLHA 122
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIRGTRGYLAPEWIL 284
                ++H D+K  NI L E+    + DFGL+   SR   S     + G+  ++APE I 
Sbjct: 123 KS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 285 EQ---GVSEKCDIYSYGMVLLELTGGRRNVSLIEH 316
            Q     S + D+Y++G+VL EL  G+   S I +
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 135/298 (45%), Gaps = 52/298 (17%)
Query: 109 LGHGSSASVFKGILSD------GTSVAVKRINGEENGEK--EFRSEVAAIASAQHVNLVR 160
           LG GS   V++G   D       T VAVK +N   +  +  EF +E + +      ++VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR--YRVAIDVAK 218
           LLG  V  G P  +V E + +G L  ++   S R E   + G     L+   ++A ++A 
Sbjct: 85  LLG-VVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            ++YL+     + +H D+   N ++  ++   + DFG    M+RD        +G +G L
Sbjct: 142 GMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFG----MTRDIXETDXXRKGGKGLL 194
Query: 279 APEWI----LEQGV-SEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVN 333
              W+    L+ GV +   D++S+G+VL E+T      SL E          Q +  + N
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEIT------SLAE----------QPYQGLSN 238
Query: 334 EKMKEGKLMEIVDQRLTDEGGIDETQ--VRRLVDVAFWCIQERARLRPSMARVVEMLE 389
           E+         V + + D G +D+      R+ D+   C Q    +RP+   +V +L+
Sbjct: 239 EQ---------VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 104/224 (46%), Gaps = 29/224 (12%)
Query: 97  ELEEATDNFQALLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEF---RSEVAAIAS 152
           E++ A    + ++G G    V++   + D  +V   R + +E+  +     R E    A 
Sbjct: 3   EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAM 62
Query: 153 AQHVNLVRLLGYCVVPGGPRY-LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYR 211
            +H N++ L G C+    P   LV EF + G L+  +           SG  +  D+   
Sbjct: 63  LKHPNIIALRGVCL--KEPNLCLVMEFARGGPLNRVL-----------SGKRIPPDILVN 109
Query: 212 VAIDVAKALSYLHNDCRSRVLHLDVKPENILLDE--------NYRAVVSDFGLSKLMSRD 263
            A+ +A+ ++YLH++    ++H D+K  NIL+ +        N    ++DFGL++   R 
Sbjct: 110 WAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT 169
Query: 264 QSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
                 +  G   ++APE I     S+  D++SYG++L EL  G
Sbjct: 170 TK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG 210

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 23/215 (10%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKE---FRSEVAAIASAQHVNLVRLLGYC 165
           +G GS  +V+KG       VAVK +N      ++   F++EV  +   +HVN++  +GY 
Sbjct: 44  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
             P     +V ++ +  SL H +     + E               +A   A+ + YLH 
Sbjct: 102 TKP--QLAIVTQWCEGSSLYHHLHIIETKFE---------MIKLIDIARQTAQGMDYLHA 150
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIRGTRGYLAPEWIL 284
                ++H D+K  NI L E+    + DFGL+   SR   S     + G+  ++APE I 
Sbjct: 151 KS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 207
Query: 285 EQG---VSEKCDIYSYGMVLLELTGGRRNVSLIEH 316
            Q     S + D+Y++G+VL EL  G+   S I +
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 242

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 23/215 (10%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKE---FRSEVAAIASAQHVNLVRLLGYC 165
           +G GS  +V+KG       VAVK +N      ++   F++EV  +   +HVN++  +GY 
Sbjct: 36  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
             P     +V ++ +  SL H +     + E               +A   A+ + YLH 
Sbjct: 94  TKPQ--LAIVTQWCEGSSLYHHLHIIETKFE---------MIKLIDIARQTAQGMDYLHA 142
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIRGTRGYLAPEWIL 284
                ++H D+K  NI L E+    + DFGL+   SR   S     + G+  ++APE I 
Sbjct: 143 KS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 199
Query: 285 EQ---GVSEKCDIYSYGMVLLELTGGRRNVSLIEH 316
            Q     S + D+Y++G+VL EL  G+   S I +
Sbjct: 200 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 234

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 99/224 (44%), Gaps = 35/224 (15%)
Query: 97  ELEEATDNFQALLGHGSSASVFK---GILSDGTS--VAVKRI-NGEENGEKEFRSEVAAI 150
           + EE    F   LG G+  SV       L D T   VAVK++ +  E   ++F  E+  +
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 151 ASAQHVNLVRLLGYCVVPGGPRY-LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR 209
            S QH N+V+  G C   G     L+ E++  GSL  ++                    +
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-------------------QK 106
Query: 210 YRVAIDVAKALSYLHNDCR-------SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR 262
           ++  ID  K L Y    C+        R +H D+   NIL++   R  + DFGL+K++ +
Sbjct: 107 HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166
Query: 263 DQSRCITTIRGTRG--YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           D+        G     + APE + E   S   D++S+G+VL EL
Sbjct: 167 DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 210

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 104 NFQALLGHGSSASVFKGIL--SDGTSV--AVKRING-EENGE-KEFRSEVAAIASAQHVN 157
           +F  ++G G    V+ G L  +DG  +  AVK +N   + GE  +F +E   +    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
           ++ LLG C+   G   +V  ++++G L ++I     R+E H        DL     + VA
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-----RNETH---NPTVKDL-IGFGLQVA 143
Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR-- 275
           K + YL      + +H D+   N +LDE +   V+DFGL++ M   +   +    G +  
Sbjct: 144 KGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 200
Query: 276 -GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
             ++A E +  Q  + K D++S+G++L EL
Sbjct: 201 VKWMALESLQTQKFTTKSDVWSFGVLLWEL 230

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/174 (31%), Positives = 90/174 (51%), Gaps = 19/174 (10%)
Query: 150 IASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR 209
           +A   H  +V+L  Y     G  YL+ +F++ G L      T    E  ++      D++
Sbjct: 84  LADVNHPFVVKL-HYAFQTEGKLYLILDFLRGGDLF-----TRLSKEVMFT----EEDVK 133
Query: 210 YRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT 269
           + +A ++A  L +LH+     +++ D+KPENILLDE     ++DFGLSK  + D  +   
Sbjct: 134 FYLA-ELALGLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK-EAIDHEKKAY 188
Query: 270 TIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKN 323
           +  GT  Y+APE +  QG S   D +SYG+++ E+  G    SL   G D+ + 
Sbjct: 189 SFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTG----SLPFQGKDRKET 238

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 104 NFQALLGHGSSASVFKGIL--SDGTSV--AVKRING-EENGE-KEFRSEVAAIASAQHVN 157
           +F  ++G G    V+ G L  +DG  +  AVK +N   + GE  +F +E   +    H N
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
           ++ LLG C+   G   +V  ++++G L ++I     R+E H        DL     + VA
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-----RNETH---NPTVKDL-IGFGLQVA 140
Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR-- 275
           K + YL      + +H D+   N +LDE +   V+DFGL++ M   +   +    G +  
Sbjct: 141 KGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 197
Query: 276 -GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
             ++A E +  Q  + K D++S+G++L EL
Sbjct: 198 VKWMALESLQTQKFTTKSDVWSFGVLLWEL 227

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 136/298 (45%), Gaps = 52/298 (17%)
Query: 109 LGHGSSASVFKGILSD------GTSVAVKRINGEENGEK--EFRSEVAAIASAQHVNLVR 160
           LG GS   V++G   D       T VAVK +N   +  +  EF +E + +      ++VR
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR--YRVAIDVAK 218
           LLG  V  G P  +V E + +G L  ++   S R E   + G     L+   ++A ++A 
Sbjct: 84  LLG-VVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAEIAD 140
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            ++YL+     + +H D+   N ++  ++   + DFG    M+RD        +G +G L
Sbjct: 141 GMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFG----MTRDIYETDYYRKGGKGLL 193
Query: 279 APEWI----LEQGV-SEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVN 333
              W+    L+ GV +   D++S+G+VL E+T      SL E          Q +  + N
Sbjct: 194 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEIT------SLAE----------QPYQGLSN 237
Query: 334 EKMKEGKLMEIVDQRLTDEGGIDETQ--VRRLVDVAFWCIQERARLRPSMARVVEMLE 389
           E+         V + + D G +D+      R+ D+   C Q   ++RP+   +V +L+
Sbjct: 238 EQ---------VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 286

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 104 NFQALLGHGSSASVFKGIL--SDGTSV--AVKRING-EENGE-KEFRSEVAAIASAQHVN 157
           +F  ++G G    V+ G L  +DG  +  AVK +N   + GE  +F +E   +    H N
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
           ++ LLG C+   G   +V  ++++G L ++I     R+E H        DL     + VA
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-----RNETH---NPTVKDL-IGFGLQVA 142
Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR-- 275
           K + YL      + +H D+   N +LDE +   V+DFGL++ M   +   +    G +  
Sbjct: 143 KGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 199
Query: 276 -GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
             ++A E +  Q  + K D++S+G++L EL
Sbjct: 200 VKWMALESLQTQKFTTKSDVWSFGVLLWEL 229

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 104 NFQALLGHGSSASVFKGIL--SDGTSV--AVKRING-EENGE-KEFRSEVAAIASAQHVN 157
           +F  ++G G    V+ G L  +DG  +  AVK +N   + GE  +F +E   +    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
           ++ LLG C+   G   +V  ++++G L ++I     R+E H        DL     + VA
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-----RNETH---NPTVKDL-IGFGLQVA 143
Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR-- 275
           K + YL      + +H D+   N +LDE +   V+DFGL++ M   +   +    G +  
Sbjct: 144 KGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 200
Query: 276 -GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
             ++A E +  Q  + K D++S+G++L EL
Sbjct: 201 VKWMALESLQTQKFTTKSDVWSFGVLLWEL 230

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 104 NFQALLGHGSSASVFKGIL--SDGTSV--AVKRING-EENGE-KEFRSEVAAIASAQHVN 157
           +F  ++G G    V+ G L  +DG  +  AVK +N   + GE  +F +E   +    H N
Sbjct: 51  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 110
Query: 158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
           ++ LLG C+   G   +V  ++++G L ++I     R+E H        DL     + VA
Sbjct: 111 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-----RNETH---NPTVKDL-IGFGLQVA 161
Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR-- 275
           K + YL      + +H D+   N +LDE +   V+DFGL++ M   +   +    G +  
Sbjct: 162 KGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 218
Query: 276 -GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
             ++A E +  Q  + K D++S+G++L EL
Sbjct: 219 VKWMALESLQTQKFTTKSDVWSFGVLLWEL 248

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 104 NFQALLGHGSSASVFKGIL--SDGTSV--AVKRING-EENGE-KEFRSEVAAIASAQHVN 157
           +F  ++G G    V+ G L  +DG  +  AVK +N   + GE  +F +E   +    H N
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
           ++ LLG C+   G   +V  ++++G L ++I     R+E H        DL     + VA
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-----RNETH---NPTVKDL-IGFGLQVA 141
Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR-- 275
           K + YL      + +H D+   N +LDE +   V+DFGL++ M   +   +    G +  
Sbjct: 142 KGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 198
Query: 276 -GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
             ++A E +  Q  + K D++S+G++L EL
Sbjct: 199 VKWMALESLQTQKFTTKSDVWSFGVLLWEL 228

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 104 NFQALLGHGSSASVFKGIL--SDGTSV--AVKRING-EENGE-KEFRSEVAAIASAQHVN 157
           +F  ++G G    V+ G L  +DG  +  AVK +N   + GE  +F +E   +    H N
Sbjct: 25  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 84
Query: 158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
           ++ LLG C+   G   +V  ++++G L ++I     R+E H        DL     + VA
Sbjct: 85  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-----RNETH---NPTVKDL-IGFGLQVA 135
Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR-- 275
           K + YL      + +H D+   N +LDE +   V+DFGL++ M   +   +    G +  
Sbjct: 136 KGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 192
Query: 276 -GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
             ++A E +  Q  + K D++S+G++L EL
Sbjct: 193 VKWMALESLQTQKFTTKSDVWSFGVLLWEL 222

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 104 NFQALLGHGSSASVFKGIL--SDGTSV--AVKRING-EENGE-KEFRSEVAAIASAQHVN 157
           +F  ++G G    V+ G L  +DG  +  AVK +N   + GE  +F +E   +    H N
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
           ++ LLG C+   G   +V  ++++G L ++I     R+E H        DL     + VA
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-----RNETH---NPTVKDL-IGFGLQVA 138
Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR-- 275
           K + YL      + +H D+   N +LDE +   V+DFGL++ M   +   +    G +  
Sbjct: 139 KGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 195
Query: 276 -GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
             ++A E +  Q  + K D++S+G++L EL
Sbjct: 196 VKWMALESLQTQKFTTKSDVWSFGVLLWEL 225

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 136/298 (45%), Gaps = 52/298 (17%)
Query: 109 LGHGSSASVFKGILSD------GTSVAVKRINGEENGEK--EFRSEVAAIASAQHVNLVR 160
           LG GS   V++G   D       T VAVK +N   +  +  EF +E + +      ++VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR--YRVAIDVAK 218
           LLG  V  G P  +V E + +G L  ++   S R E   + G     L+   ++A ++A 
Sbjct: 85  LLG-VVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            ++YL+     + +H D+   N ++  ++   + DFG    M+RD        +G +G L
Sbjct: 142 GMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFG----MTRDIYETDYYRKGGKGLL 194
Query: 279 APEWI----LEQGV-SEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVN 333
              W+    L+ GV +   D++S+G+VL E+T      SL E          Q +  + N
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEIT------SLAE----------QPYQGLSN 238
Query: 334 EKMKEGKLMEIVDQRLTDEGGIDETQ--VRRLVDVAFWCIQERARLRPSMARVVEMLE 389
           E+         V + + D G +D+      R+ D+   C Q   ++RP+   +V +L+
Sbjct: 239 EQ---------VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 104 NFQALLGHGSSASVFKGIL--SDGTSV--AVKRING-EENGE-KEFRSEVAAIASAQHVN 157
           +F  ++G G    V+ G L  +DG  +  AVK +N   + GE  +F +E   +    H N
Sbjct: 52  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 111
Query: 158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
           ++ LLG C+   G   +V  ++++G L ++I     R+E H        DL     + VA
Sbjct: 112 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-----RNETH---NPTVKDL-IGFGLQVA 162
Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR-- 275
           K + YL      + +H D+   N +LDE +   V+DFGL++ M   +   +    G +  
Sbjct: 163 KGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 219
Query: 276 -GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
             ++A E +  Q  + K D++S+G++L EL
Sbjct: 220 VKWMALESLQTQKFTTKSDVWSFGVLLWEL 249

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 72/136 (52%), Gaps = 14/136 (10%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y    + +NG L  +I     R  G +   C     R+  A ++  AL YLH      ++
Sbjct: 108 YFGLSYAKNGCLLKYI-----RKIGSFDETCT----RFYTA-EIVSALEYLHGKG---II 154
Query: 233 HLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC-ITTIRGTRGYLAPEWILEQGVSEK 291
           H D+KPENILL+E+    ++DFG +K++S +  +    +  GT  Y++PE + E+  S+ 
Sbjct: 155 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSASKS 214
Query: 292 CDIYSYGMVLLELTGG 307
            D+++ G ++ +L  G
Sbjct: 215 SDLWALGCIIYQLVAG 230

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 89/175 (50%), Gaps = 22/175 (12%)
Query: 137 ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSE 196
           E   +E  +E++ + S  H N+++L           YLV EF + G L   I    +  E
Sbjct: 87  EKFHEEIYNEISLLKSLDHPNIIKLFD-VFEDKKYFYLVTEFYEGGELFEQIINRHKFDE 145
Query: 197 GHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVS---- 252
                 C + ++  ++       + YLH   +  ++H D+KPENILL EN  ++++    
Sbjct: 146 ------CDAANIMKQIL----SGICYLH---KHNIVHRDIKPENILL-ENKNSLLNIKIV 191
Query: 253 DFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           DFGLS   S+D    +    GT  Y+APE +L++  +EKCD++S G+++  L  G
Sbjct: 192 DFGLSSFFSKDYK--LRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 20/217 (9%)
Query: 104 NFQALLGHGSSASVFK----GILSDGT--SVAVKRIN-GEENGE-KEFRSEVAA-IASAQ 154
           N    LG G+   V +    GI    T  +VAVK +  G  + E +   SE+   I    
Sbjct: 31  NLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 90
Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWI------FPTSRRSEGHYSGGCLSWDL 208
           H+N+V LLG C  PGGP  ++ EF + G+L  ++      F   +  E  Y    L+ + 
Sbjct: 91  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYK-DFLTLEH 149
Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI 268
               +  VAK + +L +    + +H D+   NILL E     + DFGL++ + +D     
Sbjct: 150 LICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 206
Query: 269 T-TIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
               R    ++APE I ++  + + D++S+G++L E+
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 19/215 (8%)
Query: 104 NFQALLGHGSSASVFK----GILSDGT--SVAVKRIN-GEENGE-KEFRSEVAA-IASAQ 154
           N    LG G+   V +    GI    T  +VAVK +  G  + E +   SE+   I    
Sbjct: 30  NLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSE----GHYSGGCLSWDLRY 210
           H+N+V LLG C  PGGP  ++ EF + G+L  ++   S+R+E           L+ +   
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKDLYKDFLTLEHLI 147
Query: 211 RVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT- 269
             +  VAK + +L      + +H D+   NILL E     + DFGL++ + +D       
Sbjct: 148 XYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKG 204
Query: 270 TIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
             R    ++APE I ++  + + D++S+G++L E+
Sbjct: 205 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 239

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 99/224 (44%), Gaps = 35/224 (15%)
Query: 97  ELEEATDNFQALLGHGSSASVFK---GILSDGTS--VAVKRI-NGEENGEKEFRSEVAAI 150
           + EE    F   LG G+  SV       L D T   VAVK++ +  E   ++F  E+  +
Sbjct: 7   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 66
Query: 151 ASAQHVNLVRLLGYCVVPGGPRY-LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR 209
            S QH N+V+  G C   G     L+ E++  GSL  ++                    +
Sbjct: 67  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-------------------QK 107
Query: 210 YRVAIDVAKALSYLHNDCR-------SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR 262
           ++  ID  K L Y    C+        R +H ++   NIL++   R  + DFGL+K++ +
Sbjct: 108 HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQ 167
Query: 263 DQSRCITTIRGTRG--YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           D+        G     + APE + E   S   D++S+G+VL EL
Sbjct: 168 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 211

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 104 NFQALLGHGSSASVFKGIL--SDGTSV--AVKRING-EENGE-KEFRSEVAAIASAQHVN 157
           +F  ++G G    V+ G L  +DG  +  AVK +N   + GE  +F +E   +    H N
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
           ++ LLG C+   G   +V  ++++G L ++I     R+E H        DL     + VA
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-----RNETH---NPTVKDL-IGFGLQVA 141
Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR-- 275
           K + +L      + +H D+   N +LDE +   V+DFGL++ M   +   +    G +  
Sbjct: 142 KGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 198
Query: 276 -GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
             ++A E +  Q  + K D++S+G++L EL
Sbjct: 199 VKWMALESLQTQKFTTKSDVWSFGVLLWEL 228

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 104 NFQALLGHGSSASVFKGIL--SDGTSV--AVKRING-EENGE-KEFRSEVAAIASAQHVN 157
           +F  ++G G    V+ G L  +DG  +  AVK +N   + GE  +F +E   +    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
           ++ LLG C+   G   +V  ++++G L ++I     R+E H        DL     + VA
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-----RNETH---NPTVKDL-IGFGLQVA 143
Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR-- 275
           K + +L      + +H D+   N +LDE +   V+DFGL++ M   +   +    G +  
Sbjct: 144 KGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 200
Query: 276 -GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
             ++A E +  Q  + K D++S+G++L EL
Sbjct: 201 VKWMALESLQTQKFTTKSDVWSFGVLLWEL 230

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 104 NFQALLGHGSSASVFKGIL--SDGTSV--AVKRING-EENGE-KEFRSEVAAIASAQHVN 157
           +F  ++G G    V+ G L  +DG  +  AVK +N   + GE  +F +E   +    H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
           ++ LLG C+   G   +V  ++++G L ++I     R+E H        DL     + VA
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-----RNETH---NPTVKDL-IGFGLQVA 143
Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR-- 275
           K + +L      + +H D+   N +LDE +   V+DFGL++ M   +   +    G +  
Sbjct: 144 KGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 200
Query: 276 -GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
             ++A E +  Q  + K D++S+G++L EL
Sbjct: 201 VKWMALESLQTQKFTTKSDVWSFGVLLWEL 230

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 104 NFQALLGHGS-SASVFKGILSDGTSVAVKRING----EENGEKEFRSEVAAIASAQHVNL 158
            F  +LG GS S +V    L+     A+K +      +EN       E   ++   H   
Sbjct: 33  KFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 159 VRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK 218
           V+L  +        Y    + +NG L  +I     R  G +   C     R+  A ++  
Sbjct: 93  VKLY-FTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCT----RFYTA-EIVS 141
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC-ITTIRGTRGY 277
           AL YLH      ++H D+KPENILL+E+    ++DFG +K++S +  +       GT  Y
Sbjct: 142 ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           ++PE + E+   +  D+++ G ++ +L  G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 104 NFQALLGHGSSASVFKGIL--SDGTSV--AVKRING-EENGE-KEFRSEVAAIASAQHVN 157
           +F  ++G G    V+ G L  +DG  +  AVK +N   + GE  +F +E   +    H N
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
           ++ LLG C+   G   +V  ++++G L ++I     R+E H        DL     + VA
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-----RNETH---NPTVKDL-IGFGLQVA 144
Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR-- 275
           K + +L      + +H D+   N +LDE +   V+DFGL++ M   +   +    G +  
Sbjct: 145 KGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 201
Query: 276 -GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
             ++A E +  Q  + K D++S+G++L EL
Sbjct: 202 VKWMALESLQTQKFTTKSDVWSFGVLLWEL 231

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 104 NFQALLGHGSSASVFKGIL--SDGTSV--AVKRING-EENGE-KEFRSEVAAIASAQHVN 157
           +F  ++G G    V+ G L  +DG  +  AVK +N   + GE  +F +E   +    H N
Sbjct: 38  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 97
Query: 158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
           ++ LLG C+   G   +V  ++++G L ++I     R+E H        DL     + VA
Sbjct: 98  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-----RNETH---NPTVKDL-IGFGLQVA 148
Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR-- 275
           K + +L      + +H D+   N +LDE +   V+DFGL++ M   +   +    G +  
Sbjct: 149 KGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 205
Query: 276 -GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
             ++A E +  Q  + K D++S+G++L EL
Sbjct: 206 VKWMALESLQTQKFTTKSDVWSFGVLLWEL 235

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 104 NFQALLGHGSSASVFKGIL--SDGTSV--AVKRING-EENGE-KEFRSEVAAIASAQHVN 157
           +F  ++G G    V+ G L  +DG  +  AVK +N   + GE  +F +E   +    H N
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
           ++ LLG C+   G   +V  ++++G L ++I     R+E H        DL     + VA
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-----RNETH---NPTVKDL-IGFGLQVA 144
Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR-- 275
           K + +L      + +H D+   N +LDE +   V+DFGL++ M   +   +    G +  
Sbjct: 145 KGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLP 201
Query: 276 -GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
             ++A E +  Q  + K D++S+G++L EL
Sbjct: 202 VKWMALESLQTQKFTTKSDVWSFGVLLWEL 231

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 43/122 (35%), Positives = 65/122 (53%), Gaps = 18/122 (14%)
Query: 201 GGCLSWDLRYRVAI----------DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV 250
           GG L + L+  V            ++  AL YL N    R++H D+KP+NILLDE+    
Sbjct: 99  GGDLRYHLQQNVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVH 155
Query: 251 VSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQ---GVSEKCDIYSYGMVLLELTGG 307
           ++DF ++ ++ R+    ITT+ GT+ Y+APE    +   G S   D +S G+   EL  G
Sbjct: 156 ITDFNIAAMLPRETQ--ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRG 213
Query: 308 RR 309
           RR
Sbjct: 214 RR 215

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 104 NFQALLGHGSSASVFKGIL--SDGTSV--AVKRING-EENGE-KEFRSEVAAIASAQHVN 157
           +F  ++G G    V+ G L  +DG  +  AVK +N   + GE  +F +E   +    H N
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
           ++ LLG C+   G   +V  ++++G L ++I     R+E H        DL     + VA
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-----RNETH---NPTVKDL-IGFGLQVA 202
Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR-- 275
           K + +L      + +H D+   N +LDE +   V+DFGL++ M   +   +    G +  
Sbjct: 203 KGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 259
Query: 276 -GYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
             ++A E +  Q  + K D++S+G++L EL
Sbjct: 260 VKWMALESLQTQKFTTKSDVWSFGVLLWEL 289

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 104/225 (46%), Gaps = 24/225 (10%)
Query: 90  PIKFRSKELEEATDNFQALLGHGS-SASVFKGILSDGTSVAVKRING----EENGEKEFR 144
           P + R K  E+    F  +LG GS S  V    L+     A+K +      +EN      
Sbjct: 1   PPQPRKKRPEDF--KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT 58
Query: 145 SEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCL 204
            E   ++   H   V+L  +        Y    + +NG L  +I     R  G +   C 
Sbjct: 59  RERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCT 112
Query: 205 SWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD- 263
               R+  A ++  AL YLH      ++H D+KPENILL+E+    ++DFG +K++S + 
Sbjct: 113 ----RFYTA-EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 164
Query: 264 -QSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
            Q+R    + GT  Y++PE + E+   +  D+++ G ++ +L  G
Sbjct: 165 KQARANXFV-GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 82/168 (48%), Gaps = 17/168 (10%)
Query: 140 EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           E + R EV   +  +H N++RL GY        YL+ E+   G++   +   SR  E   
Sbjct: 56  EHQLRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSRFDEQRT 114
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL 259
           +              ++A ALSY H+    RV+H D+KPEN+LL  N    ++DFG S  
Sbjct: 115 AT----------YITELANALSYCHS---KRVIHRDIKPENLLLGSNGELKIADFGWS-- 159
Query: 260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           +    SR  TT+ GT  YL PE I  +   EK D++S G++  E   G
Sbjct: 160 VHAPSSRR-TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 95  SKELEEATDNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQ 154
           S E++     F   LG G    V  G       VA+K I      E EF  E   + +  
Sbjct: 3   SWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS 62
Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI 214
           H  LV+L G C     P +++ E++ NG L +++     R +               +  
Sbjct: 63  HEKLVQLYGVC-TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQ---------LLEMCK 112
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGT 274
           DV +A+ YL +    + LH D+   N L+++     VSDFGLS+ +  D+    T+ RG+
Sbjct: 113 DVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSRGS 166
Query: 275 RG---YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +    +  PE ++    S K DI+++G+++ E+
Sbjct: 167 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEI 199

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 92/187 (49%), Gaps = 21/187 (11%)
Query: 125 GTSVAVKRINGEENGEK--EFRSEVAAIASAQHVNLVRLLGYCVVPGGPRY-LVYEFIQN 181
           G  VAVK +  E  G    + + E+  + +  H N+V+  G C   GG    L+ EF+ +
Sbjct: 50  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 109
Query: 182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENI 241
           GSL  ++ P ++          L   L+Y  A+ + K + YL +    + +H D+   N+
Sbjct: 110 GSLKEYL-PKNKNKIN------LKQQLKY--AVQICKGMDYLGS---RQYVHRDLAARNV 157
Query: 242 LLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG----YLAPEWILEQGVSEKCDIYSY 297
           L++  ++  + DFGL+K +  D+     T++  R     + APE +++       D++S+
Sbjct: 158 LVESEHQVKIGDFGLTKAIETDKEX--XTVKDDRDSPVFWYAPECLMQSKFYIASDVWSF 215
Query: 298 GMVLLEL 304
           G+ L EL
Sbjct: 216 GVTLHEL 222

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 108 LLGHGSSASVFKG-ILSDGTSVAVKRINGEENGEKEFRSEVAAIAS-AQHVNLVRLLGYC 165
           L+G+G+   V+KG  +  G   A+K ++   + E+E + E+  +   + H N+    G  
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 166 VVPGGPR-----YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           +    P      +LV EF   GS+   I  T         G  L  +    +  ++ + L
Sbjct: 91  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--------GNTLKEEWIAYICREILRGL 142
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAP 280
           S+LH   + +V+H D+K +N+LL EN    + DFG+S  + R   R  T I GT  ++AP
Sbjct: 143 SHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAP 198
Query: 281 EWIL-----EQGVSEKCDIYSYGMVLLELTGG 307
           E I      +     K D++S G+  +E+  G
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 104 NFQALLGHGS-SASVFKGILSDGTSVAVKRING----EENGEKEFRSEVAAIASAQHVNL 158
            F  +LG GS S  V    L+     A+K +      +EN       E   ++   H   
Sbjct: 10  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 69
Query: 159 VRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK 218
           V+L  +        Y    + +NG L  +I     R  G +   C     R+  A ++  
Sbjct: 70  VKLY-FTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCT----RFYTA-EIVS 118
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD--QSRCITTIRGTRG 276
           AL YLH      ++H D+KPENILL+E+    ++DFG +K++S +  Q+R    + GT  
Sbjct: 119 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQ 174
Query: 277 YLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           Y++PE + E+   +  D+++ G ++ +L  G
Sbjct: 175 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/188 (31%), Positives = 88/188 (46%), Gaps = 13/188 (6%)
Query: 123 SDGTSVAVKRINGEENGEKEFR---SEVAAIASAQHVNLVRLLGYCV-VPGGPRYLVYEF 178
           SDG  +  K ++     E E +   SEV  +   +H N+VR     +       Y+V E+
Sbjct: 29  SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY 88
Query: 179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH--NDCRSRVLHLDV 236
            + G L   I  T    E  Y    L  +   RV   +  AL   H  +D    VLH D+
Sbjct: 89  CEGGDLASVI--TKGTKERQY----LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDL 142
Query: 237 KPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYS 296
           KP N+ LD      + DFGL+++++ D S   T + GT  Y++PE +     +EK DI+S
Sbjct: 143 KPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNRMSYNEKSDIWS 201
Query: 297 YGMVLLEL 304
            G +L EL
Sbjct: 202 LGCLLYEL 209

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 104 NFQALLGHGS-SASVFKGILSDGTSVAVKRING----EENGEKEFRSEVAAIASAQHVNL 158
            F  +LG GS S  V    L+     A+K +      +EN       E   ++   H   
Sbjct: 11  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 70
Query: 159 VRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK 218
           V+L  +        Y    + +NG L  +I     R  G +   C     R+  A ++  
Sbjct: 71  VKLY-FTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCT----RFYTA-EIVS 119
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD--QSRCITTIRGTRG 276
           AL YLH      ++H D+KPENILL+E+    ++DFG +K++S +  Q+R    + GT  
Sbjct: 120 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQ 175
Query: 277 YLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           Y++PE + E+   +  D+++ G ++ +L  G
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 95/196 (48%), Gaps = 12/196 (6%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+ G  ++ T VAVK +       + F  E   + + QH  LVRL    V  
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYA-VVTK 78
Query: 169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCR 228
             P Y++ EF+  GSL  ++     +S+    GG +        +  +A+ ++Y+    R
Sbjct: 79  EEPIYIITEFMAKGSLLDFL-----KSD---EGGKVLLPKLIDFSAQIAEGMAYIE---R 127
Query: 229 SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGV 288
              +H D++  N+L+ E+    ++DFGL++++  ++       +    + APE I     
Sbjct: 128 KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCF 187
Query: 289 SEKCDIYSYGMVLLEL 304
           + K +++S+G++L E+
Sbjct: 188 TIKSNVWSFGILLYEI 203

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 104 NFQALLGHGS-SASVFKGILSDGTSVAVKRING----EENGEKEFRSEVAAIASAQHVNL 158
            F  +LG GS S  V    L+     A+K +      +EN       E   ++   H   
Sbjct: 32  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 91
Query: 159 VRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK 218
           V+L  +        Y    + +NG L  +I     R  G +   C     R+  A ++  
Sbjct: 92  VKLY-FTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCT----RFYTA-EIVS 140
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC-ITTIRGTRGY 277
           AL YLH      ++H D+KPENILL+E+    ++DFG +K++S +  +    +  GT  Y
Sbjct: 141 ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 197
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           ++PE + E+   +  D+++ G ++ +L  G
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 100/209 (47%), Gaps = 22/209 (10%)
Query: 105 FQALLGHGS-SASVFKGILSDGTSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRL 161
           F+  LG G+ S  V     + G   AVK I  +  +  E    +E+A +   +H N+V L
Sbjct: 26  FKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVAL 85
Query: 162 LGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALS 221
                 P    YLV + +  G L   I       +G Y+    S  +R      V  A+ 
Sbjct: 86  EDIYESPNH-LYLVMQLVSGGELFDRIV-----EKGFYTEKDASTLIR-----QVLDAVY 134
Query: 222 YLHNDCRSRVLHLDVKPENILL---DENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
           YLH   R  ++H D+KPEN+L    DE  + ++SDFGLSK+  +     ++T  GT GY+
Sbjct: 135 YLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD--VMSTACGTPGYV 189
Query: 279 APEWILEQGVSEKCDIYSYGMVLLELTGG 307
           APE + ++  S+  D +S G++   L  G
Sbjct: 190 APEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 85/158 (53%), Gaps = 15/158 (9%)
Query: 150 IASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR 209
           +    H  +V+L  Y     G  YL+ +F++ G L      T    E  ++      D++
Sbjct: 80  LVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLF-----TRLSKEVMFT----EEDVK 129
Query: 210 YRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT 269
           + +A ++A AL +LH+     +++ D+KPENILLDE     ++DFGLSK  S D  +   
Sbjct: 130 FYLA-ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAY 184
Query: 270 TIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           +  GT  Y+APE +  +G ++  D +S+G+++ E+  G
Sbjct: 185 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 92/187 (49%), Gaps = 21/187 (11%)
Query: 125 GTSVAVKRINGEENGEK--EFRSEVAAIASAQHVNLVRLLGYCVVPGGPRY-LVYEFIQN 181
           G  VAVK +  E  G    + + E+  + +  H N+V+  G C   GG    L+ EF+ +
Sbjct: 38  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 97
Query: 182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENI 241
           GSL  ++ P ++          L   L+Y  A+ + K + YL +    + +H D+   N+
Sbjct: 98  GSLKEYL-PKNKNKIN------LKQQLKY--AVQICKGMDYLGS---RQYVHRDLAARNV 145
Query: 242 LLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG----YLAPEWILEQGVSEKCDIYSY 297
           L++  ++  + DFGL+K +  D+     T++  R     + APE +++       D++S+
Sbjct: 146 LVESEHQVKIGDFGLTKAIETDKEX--XTVKDDRDSPVFWYAPECLMQSKFYIASDVWSF 203
Query: 298 GMVLLEL 304
           G+ L EL
Sbjct: 204 GVTLHEL 210

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 19/215 (8%)
Query: 104 NFQALLGHGSSASVFK----GILSDGT--SVAVKRIN-GEENGE-KEFRSEVAA-IASAQ 154
           N    LG G+   V +    GI    T  +VAVK +  G  + E +   SE+   I    
Sbjct: 30  NLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSE----GHYSGGCLSWDLRY 210
           H+N+V LLG C  PGGP  ++ EF + G+L  ++   S+R+E           L+ +   
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKDLYKDFLTLEHLI 147
Query: 211 RVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT- 269
             +  VAK + +L +    + +H D+   NILL E     + DFGL++ + +D       
Sbjct: 148 CYSFQVAKGMEFLAS---RKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 204
Query: 270 TIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
             R    ++APE I ++  + + D++S+G++L E+
Sbjct: 205 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 239

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 71/136 (52%), Gaps = 14/136 (10%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y    + +NG L  +I     R  G +   C     R+  A ++  AL YLH      ++
Sbjct: 109 YFGLSYAKNGELLKYI-----RKIGSFDETCT----RFYTA-EIVSALEYLHG---KGII 155
Query: 233 HLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC-ITTIRGTRGYLAPEWILEQGVSEK 291
           H D+KPENILL+E+    ++DFG +K++S +  +    +  GT  Y++PE + E+   + 
Sbjct: 156 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKS 215
Query: 292 CDIYSYGMVLLELTGG 307
            D+++ G ++ +L  G
Sbjct: 216 SDLWALGCIIYQLVAG 231

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 104 NFQALLGHGS-SASVFKGILSDGTSVAVKRING----EENGEKEFRSEVAAIASAQHVNL 158
            F  +LG GS S  V    L+     A+K +      +EN       E   ++   H   
Sbjct: 12  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 71
Query: 159 VRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK 218
           V+L  +        Y    + +NG L  +I     R  G +   C     R+  A ++  
Sbjct: 72  VKLY-FTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCT----RFYTA-EIVS 120
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD--QSRCITTIRGTRG 276
           AL YLH      ++H D+KPENILL+E+    ++DFG +K++S +  Q+R    + GT  
Sbjct: 121 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV-GTAQ 176
Query: 277 YLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           Y++PE + E+   +  D+++ G ++ +L  G
Sbjct: 177 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 109 LGHGSSASVFK----GILSDGT--SVAVKRIN-GEENGE-KEFRSEVAA-IASAQHVNLV 159
           LG G+   V +    GI    T  +VAVK +  G  + E +   SE+   I    H+N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 160 RLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSE------GHYSGGCLSWDLRYRVA 213
            LLG C  PGGP  ++ EF + G+L  ++   S+R+E             L+ +     +
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKPEDLYKDFLTLEHLIXYS 154
Query: 214 IDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT-TIR 272
             VAK + +L      + +H D+   NILL E     + DFGL++ + +D         R
Sbjct: 155 FQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
               ++APE I ++  + + D++S+G++L E+
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 91/174 (52%), Gaps = 19/174 (10%)
Query: 150 IASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR 209
           +    H  +V+L  Y     G  YL+ +F++ G L      T    E  ++      D++
Sbjct: 80  LVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLF-----TRLSKEVMFT----EEDVK 129
Query: 210 YRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT 269
           + +A ++A AL +LH+     +++ D+KPENILLDE     ++DFGLSK  S D  +   
Sbjct: 130 FYLA-ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAY 184
Query: 270 TIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKN 323
           +  GT  Y+APE +  +G ++  D +S+G+++ E+  G    +L   G D+ + 
Sbjct: 185 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG----TLPFQGKDRKET 234

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 85/158 (53%), Gaps = 15/158 (9%)
Query: 150 IASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR 209
           +    H  +V+L  Y     G  YL+ +F++ G L      T    E  ++      D++
Sbjct: 81  LVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLF-----TRLSKEVMFT----EEDVK 130
Query: 210 YRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT 269
           + +A ++A AL +LH+     +++ D+KPENILLDE     ++DFGLSK  S D  +   
Sbjct: 131 FYLA-ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAY 185
Query: 270 TIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           +  GT  Y+APE +  +G ++  D +S+G+++ E+  G
Sbjct: 186 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+ G  ++ T VAVK +       + F  E   + + QH  LVRL  Y VV 
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRL--YAVVT 78
Query: 169 -GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDC 227
              P Y++ E++  GSL  ++     +S+    GG +        +  +A+ ++Y+    
Sbjct: 79  REEPIYIITEYMAKGSLLDFL-----KSD---EGGKVLLPKLIDFSAQIAEGMAYIE--- 127
Query: 228 RSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQG 287
           R   +H D++  N+L+ E+    ++DFGL++++  ++       +    + APE I    
Sbjct: 128 RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGC 187
Query: 288 VSEKCDIYSYGMVLLEL 304
            + K D++S+G++L E+
Sbjct: 188 FTIKSDVWSFGILLYEI 204

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 102/218 (46%), Gaps = 25/218 (11%)
Query: 109 LGHGSSASVFK----GILS--DGTSVAVKRINGEENG--EKEFRSEVAAIASAQHVNLVR 160
           +G G+   VF+    G+L     T VAVK +  E +   + +F+ E A +A   + N+V+
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG C V G P  L++E++  G L+ ++   S  +    S   LS   R RV+      L
Sbjct: 115 LLGVCAV-GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS--TRARVSSPGPPPL 171
Query: 221 SYLHNDCRSR-------------VLHLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSR 266
           S     C +R              +H D+   N L+ EN    ++DFGLS+ + S D  +
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 267 CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
                     ++ PE I     + + D+++YG+VL E+
Sbjct: 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 269

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 135/298 (45%), Gaps = 52/298 (17%)
Query: 109 LGHGSSASVFKGILSD------GTSVAVKRINGEENGEK--EFRSEVAAIASAQHVNLVR 160
           LG GS   V++G   D       T VAVK +N   +  +  EF +E + +      ++VR
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR--YRVAIDVAK 218
           LLG  V  G P  +V E + +G L  ++   S R E   + G     L+   ++A ++A 
Sbjct: 85  LLG-VVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            ++YL+     + +H ++   N ++  ++   + DFG    M+RD        +G +G L
Sbjct: 142 GMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFG----MTRDIYETDYYRKGGKGLL 194
Query: 279 APEWI----LEQGV-SEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVN 333
              W+    L+ GV +   D++S+G+VL E+T      SL E          Q +  + N
Sbjct: 195 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEIT------SLAE----------QPYQGLSN 238
Query: 334 EKMKEGKLMEIVDQRLTDEGGIDETQ--VRRLVDVAFWCIQERARLRPSMARVVEMLE 389
           E+         V + + D G +D+      R+ D+   C Q    +RP+   +V +L+
Sbjct: 239 EQ---------VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 77/298 (25%), Positives = 135/298 (45%), Gaps = 52/298 (17%)
Query: 109 LGHGSSASVFKGILSD------GTSVAVKRINGEENGEK--EFRSEVAAIASAQHVNLVR 160
           LG GS   V++G   D       T VAVK +N   +  +  EF +E + +      ++VR
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR--YRVAIDVAK 218
           LLG  V  G P  +V E + +G L  ++   S R E   + G     L+   ++A ++A 
Sbjct: 86  LLG-VVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAEIAD 142
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            ++YL+     + +H ++   N ++  ++   + DFG    M+RD        +G +G L
Sbjct: 143 GMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFG----MTRDIYETDYYRKGGKGLL 195
Query: 279 APEWI----LEQGV-SEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVN 333
              W+    L+ GV +   D++S+G+VL E+T      SL E          Q +  + N
Sbjct: 196 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEIT------SLAE----------QPYQGLSN 239
Query: 334 EKMKEGKLMEIVDQRLTDEGGIDETQ--VRRLVDVAFWCIQERARLRPSMARVVEMLE 389
           E+         V + + D G +D+      R+ D+   C Q    +RP+   +V +L+
Sbjct: 240 EQ---------VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 288

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 70/136 (51%), Gaps = 14/136 (10%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y    + +NG L  +I     R  G +   C     R+  A ++  AL YLH      ++
Sbjct: 108 YFGLSYAKNGELLKYI-----RKIGSFDETCT----RFYTA-EIVSALEYLHGKG---II 154
Query: 233 HLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC-ITTIRGTRGYLAPEWILEQGVSEK 291
           H D+KPENILL+E+    ++DFG +K++S +  +       GT  Y++PE + E+   + 
Sbjct: 155 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAXKS 214
Query: 292 CDIYSYGMVLLELTGG 307
            D+++ G ++ +L  G
Sbjct: 215 SDLWALGCIIYQLVAG 230

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 104 NFQALLGHGS-SASVFKGILSDGTSVAVKRING----EENGEKEFRSEVAAIASAQHVNL 158
            F  +LG GS S  V    L+     A+K +      +EN       E   ++   H   
Sbjct: 17  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 76
Query: 159 VRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK 218
           V+L  +        Y    + +NG L  +I     R  G +   C     R+  A ++  
Sbjct: 77  VKLY-FTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCT----RFYTA-EIVS 125
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD--QSRCITTIRGTRG 276
           AL YLH      ++H D+KPENILL+E+    ++DFG +K++S +  Q+R      GT  
Sbjct: 126 ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NXFVGTAQ 181
Query: 277 YLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           Y++PE + E+   +  D+++ G ++ +L  G
Sbjct: 182 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 103/206 (50%), Gaps = 24/206 (11%)
Query: 108 LLGHGSSASVFKGI-LSDGTSVAVK---RINGEENGEKEFRS---EVAAIASAQHVNLVR 160
           +LG G   +V KG+ + +G S+ +    ++  +++G + F++    + AI S  H ++VR
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSL-DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKA 219
           LLG C  PG    LV +++  GSL DH      R+  G      L   L     + +AK 
Sbjct: 80  LLGLC--PGSSLQLVTQYLPLGSLLDH-----VRQHRG-----ALGPQLLLNWGVQIAKG 127
Query: 220 LSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR-GYL 278
           + YL       ++H ++   N+LL    +  V+DFG++ L+  D  + + +   T   ++
Sbjct: 128 MYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM 184
Query: 279 APEWILEQGVSEKCDIYSYGMVLLEL 304
           A E I     + + D++SYG+ + EL
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWEL 210

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 103/206 (50%), Gaps = 24/206 (11%)
Query: 108 LLGHGSSASVFKGI-LSDGTSVAVK---RINGEENGEKEFRS---EVAAIASAQHVNLVR 160
           +LG G   +V KG+ + +G S+ +    ++  +++G + F++    + AI S  H ++VR
Sbjct: 38  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 97
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSL-DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKA 219
           LLG C  PG    LV +++  GSL DH      R+  G      L   L     + +AK 
Sbjct: 98  LLGLC--PGSSLQLVTQYLPLGSLLDH-----VRQHRG-----ALGPQLLLNWGVQIAKG 145
Query: 220 LSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR-GYL 278
           + YL       ++H ++   N+LL    +  V+DFG++ L+  D  + + +   T   ++
Sbjct: 146 MYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM 202
Query: 279 APEWILEQGVSEKCDIYSYGMVLLEL 304
           A E I     + + D++SYG+ + EL
Sbjct: 203 ALESIHFGKYTHQSDVWSYGVTVWEL 228

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 70/136 (51%), Gaps = 14/136 (10%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y    + +NG L  +I     R  G +   C     R+  A ++  AL YLH      ++
Sbjct: 106 YFGLSYAKNGELLKYI-----RKIGSFDETCT----RFYTA-EIVSALEYLHG---KGII 152
Query: 233 HLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC-ITTIRGTRGYLAPEWILEQGVSEK 291
           H D+KPENILL+E+    ++DFG +K++S +  +       GT  Y++PE + E+   + 
Sbjct: 153 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSACKS 212
Query: 292 CDIYSYGMVLLELTGG 307
            D+++ G ++ +L  G
Sbjct: 213 SDLWALGCIIYQLVAG 228

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 20/210 (9%)
Query: 104 NFQALLGHGS-SASVFKGILSDGTSVAVKRING----EENGEKEFRSEVAAIASAQHVNL 158
            F  +LG GS S  V    L+     A+K +      +EN       E   ++   H   
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 159 VRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK 218
           V+L  +        Y    + +NG L  +I     R  G +   C     R+  A ++  
Sbjct: 93  VKLY-FTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCT----RFYTA-EIVS 141
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC-ITTIRGTRGY 277
           AL YLH      ++H D+KPENILL+E+    ++DFG +K++S +  +       GT  Y
Sbjct: 142 ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           ++PE + E+   +  D+++ G ++ +L  G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 20/210 (9%)
Query: 104 NFQALLGHGS-SASVFKGILSDGTSVAVKRING----EENGEKEFRSEVAAIASAQHVNL 158
            F  +LG GS S  V    L+     A+K +      +EN       E   ++   H   
Sbjct: 33  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 159 VRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK 218
           V+L  +        Y    + +NG L  +I     R  G +   C     R+  A ++  
Sbjct: 93  VKLY-FTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCT----RFYTA-EIVS 141
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC-ITTIRGTRGY 277
           AL YLH      ++H D+KPENILL+E+    ++DFG +K++S +  +       GT  Y
Sbjct: 142 ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           ++PE + E+   +  D+++ G ++ +L  G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 70/136 (51%), Gaps = 14/136 (10%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y    + +NG L  +I     R  G +   C     R+  A ++  AL YLH      ++
Sbjct: 108 YFGLSYAKNGELLKYI-----RKIGSFDETCT----RFYTA-EIVSALEYLHG---KGII 154
Query: 233 HLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC-ITTIRGTRGYLAPEWILEQGVSEK 291
           H D+KPENILL+E+    ++DFG +K++S +  +       GT  Y++PE + E+   + 
Sbjct: 155 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKS 214
Query: 292 CDIYSYGMVLLELTGG 307
            D+++ G ++ +L  G
Sbjct: 215 SDLWALGCIIYQLVAG 230

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 21/213 (9%)
Query: 109 LGHGSSASVFK----GILSDGT--SVAVKRIN-GEENGE-KEFRSEVAA-IASAQHVNLV 159
           LG G+   V +    GI    T  +VAVK +  G  + E +   SE+   I    H+N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 160 RLLGYCVVPGGPRYLVYEFIQNGSLDHWI-------FPTSRRSEGHYSGGCLSWDLRYRV 212
            LLG C  PGGP  ++ EF + G+L  ++        P     E  Y    L+ +     
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK-DFLTLEHLICY 144
Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT-TI 271
           +  VAK + +L +    + +H D+   NILL E     + DFGL++ + +D         
Sbjct: 145 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 201
Query: 272 RGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           R    ++APE I ++  + + D++S+G++L E+
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 94/184 (51%), Gaps = 17/184 (9%)
Query: 125 GTSVAVKRINGEENGEKEFR-SEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS 183
           G  VAVK ++  +   +E   +EV  +   QH N+V +    +V G   +++ EF+Q G+
Sbjct: 70  GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLV-GEELWVLMEFLQGGA 128
Query: 184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILL 243
           L   I    R +E   +  C +          V +AL+YLH      V+H D+K ++ILL
Sbjct: 129 LTD-IVSQVRLNEEQIATVCEA----------VLQALAYLHAQG---VIHRDIKSDSILL 174
Query: 244 DENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLE 303
             + R  +SDFG    +S+D  +    + GT  ++APE I     + + DI+S G++++E
Sbjct: 175 TLDGRVKLSDFGFCAQISKDVPKRKXLV-GTPYWMAPEVISRSLYATEVDIWSLGIMVIE 233
Query: 304 LTGG 307
           +  G
Sbjct: 234 MVDG 237

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 21/213 (9%)
Query: 109 LGHGSSASVFK----GILSDGT--SVAVKRIN-GEENGE-KEFRSEVAA-IASAQHVNLV 159
           LG G+   V +    GI    T  +VAVK +  G  + E +   SE+   I    H+N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 160 RLLGYCVVPGGPRYLVYEFIQNGSLDHWI-------FPTSRRSEGHYSGGCLSWDLRYRV 212
            LLG C  PGGP  ++ EF + G+L  ++        P     E  Y    L+ +     
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK-DFLTLEHLICY 144
Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT-TI 271
           +  VAK + +L +    + +H D+   NILL E     + DFGL++ + +D         
Sbjct: 145 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 201
Query: 272 RGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           R    ++APE I ++  + + D++S+G++L E+
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 21/213 (9%)
Query: 109 LGHGSSASVFK----GILSDGT--SVAVKRIN-GEENGE-KEFRSEVAA-IASAQHVNLV 159
           LG G+   V +    GI    T  +VAVK +  G  + E +   SE+   I    H+N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 160 RLLGYCVVPGGPRYLVYEFIQNGSLDHWI-------FPTSRRSEGHYSGGCLSWDLRYRV 212
            LLG C  PGGP  ++ EF + G+L  ++        P     E  Y    L+ +     
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK-DFLTLEHLICY 153
Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT-TI 271
           +  VAK + +L +    + +H D+   NILL E     + DFGL++ + +D         
Sbjct: 154 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 272 RGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           R    ++APE I ++  + + D++S+G++L E+
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 104 NFQALLGHGS-SASVFKGILSDGTSVAVKRING----EENGEKEFRSEVAAIASAQHVNL 158
            F  +LG GS S  V    L+     A+K +      +EN       E   ++   H   
Sbjct: 32  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 91
Query: 159 VRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK 218
           V+L  +        Y    + +NG L  +I     R  G +   C     R+  A ++  
Sbjct: 92  VKLY-FTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCT----RFYTA-EIVS 140
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD--QSRCITTIRGTRG 276
           AL YLH      ++H D+KPENILL+E+    ++DFG +K++S +  Q+R      GT  
Sbjct: 141 ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA-NXFVGTAQ 196
Query: 277 YLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           Y++PE + E+   +  D+++ G ++ +L  G
Sbjct: 197 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 21/213 (9%)
Query: 109 LGHGSSASVFK----GILSDGT--SVAVKRIN-GEENGE-KEFRSEVAA-IASAQHVNLV 159
           LG G+   V +    GI    T  +VAVK +  G  + E +   SE+   I    H+N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 160 RLLGYCVVPGGPRYLVYEFIQNGSLDHWI-------FPTSRRSEGHYSGGCLSWDLRYRV 212
            LLG C  PGGP  ++ EF + G+L  ++        P     E  Y    L+ +     
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYK-DFLTLEHLICY 155
Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT-TI 271
           +  VAK + +L +    + +H D+   NILL E     + DFGL++ + +D         
Sbjct: 156 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 212
Query: 272 RGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           R    ++APE I ++  + + D++S+G++L E+
Sbjct: 213 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 245

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 20/210 (9%)
Query: 104 NFQALLGHGS-SASVFKGILSDGTSVAVKRING----EENGEKEFRSEVAAIASAQHVNL 158
            F  +LG GS S  V    L+     A+K +      +EN       E   ++   H   
Sbjct: 35  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 94
Query: 159 VRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK 218
           V+L  +        Y    + +NG L  +I     R  G +   C     R+  A ++  
Sbjct: 95  VKLY-FTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCT----RFYTA-EIVS 143
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC-ITTIRGTRGY 277
           AL YLH      ++H D+KPENILL+E+    ++DFG +K++S +  +       GT  Y
Sbjct: 144 ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           ++PE + E+   +  D+++ G ++ +L  G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 70/136 (51%), Gaps = 14/136 (10%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y    + +NG L  +I     R  G +   C     R+  A ++  AL YLH      ++
Sbjct: 108 YFGLSYAKNGELLKYI-----RKIGSFDETCT----RFYTA-EIVSALEYLHG---KGII 154
Query: 233 HLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC-ITTIRGTRGYLAPEWILEQGVSEK 291
           H D+KPENILL+E+    ++DFG +K++S +  +       GT  Y++PE + E+   + 
Sbjct: 155 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKS 214
Query: 292 CDIYSYGMVLLELTGG 307
            D+++ G ++ +L  G
Sbjct: 215 SDLWALGCIIYQLVAG 230

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 70/136 (51%), Gaps = 14/136 (10%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y    + +NG L  +I     R  G +   C     R+  A ++  AL YLH      ++
Sbjct: 109 YFGLSYAKNGELLKYI-----RKIGSFDETCT----RFYTA-EIVSALEYLHG---KGII 155
Query: 233 HLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC-ITTIRGTRGYLAPEWILEQGVSEK 291
           H D+KPENILL+E+    ++DFG +K++S +  +       GT  Y++PE + E+   + 
Sbjct: 156 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKS 215
Query: 292 CDIYSYGMVLLELTGG 307
            D+++ G ++ +L  G
Sbjct: 216 SDLWALGCIIYQLVAG 231

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 70/136 (51%), Gaps = 14/136 (10%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y    + +NG L  +I     R  G +   C     R+  A ++  AL YLH      ++
Sbjct: 108 YFGLSYAKNGELLKYI-----RKIGSFDETCT----RFYTA-EIVSALEYLHG---KGII 154
Query: 233 HLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC-ITTIRGTRGYLAPEWILEQGVSEK 291
           H D+KPENILL+E+    ++DFG +K++S +  +       GT  Y++PE + E+   + 
Sbjct: 155 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKS 214
Query: 292 CDIYSYGMVLLELTGG 307
            D+++ G ++ +L  G
Sbjct: 215 SDLWALGCIIYQLVAG 230

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 70/136 (51%), Gaps = 14/136 (10%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y    + +NG L  +I     R  G +   C     R+  A ++  AL YLH      ++
Sbjct: 111 YFGLSYAKNGELLKYI-----RKIGSFDETCT----RFYTA-EIVSALEYLHGKG---II 157
Query: 233 HLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC-ITTIRGTRGYLAPEWILEQGVSEK 291
           H D+KPENILL+E+    ++DFG +K++S +  +       GT  Y++PE + E+   + 
Sbjct: 158 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKS 217
Query: 292 CDIYSYGMVLLELTGG 307
            D+++ G ++ +L  G
Sbjct: 218 SDLWALGCIIYQLVAG 233

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 102/228 (44%), Gaps = 30/228 (13%)
Query: 109 LGHGSSASVFKGILSDGT----SVAVKRINGEENGEKE----FRSEVAAIASAQHVNLVR 160
           LG GS   V +G     +    SVAVK +  +   + E    F  EV A+ S  H NL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           L G  + P  P  +V E    GSL        R+ +GH+  G LS     R A+ VA+ +
Sbjct: 76  LYGVVLTP--PMKMVTELAPLGSL----LDRLRKHQGHFLLGTLS-----RYAVQVAEGM 124
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTI--RGTRGYL 278
            YL +    R +H D+   N+LL       + DFGL + + ++    +     +    + 
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWC 181
Query: 279 APEWILEQGVSEKCDIYSYGMVLLEL-TGGRR-----NVSLIEHGNDK 320
           APE +  +  S   D + +G+ L E+ T G+      N S I H  DK
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 79/171 (46%), Gaps = 20/171 (11%)
Query: 143 FRSEVAAIASAQHVNLVRL--LGYCVVPGGP-RYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           FR E    A+  H  +V +   G    P GP  Y+V E++   +L   +          +
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----------H 108
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL 259
           + G ++      V  D  +AL++ H +    ++H DVKP NI++       V DFG+++ 
Sbjct: 109 TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA 165
Query: 260 MSRDQSRCIT---TIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           ++ D    +T    + GT  YL+PE      V  + D+YS G VL E+  G
Sbjct: 166 IA-DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 79/171 (46%), Gaps = 20/171 (11%)
Query: 143 FRSEVAAIASAQHVNLVRL--LGYCVVPGGP-RYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           FR E    A+  H  +V +   G    P GP  Y+V E++   +L   +          +
Sbjct: 59  FRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIV----------H 108
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL 259
           + G ++      V  D  +AL++ H +    ++H DVKP NI++       V DFG+++ 
Sbjct: 109 TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA 165
Query: 260 MSRDQSRCIT---TIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           ++ D    +T    + GT  YL+PE      V  + D+YS G VL E+  G
Sbjct: 166 IA-DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 109 LGHGSSASVFKGILSDGT----SVAVKRINGEENGEKE----FRSEVAAIASAQHVNLVR 160
           LG GS   V +G     +    SVAVK +  +   + E    F  EV A+ S  H NL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           L G  + P  P  +V E    GSL        R+ +GH+  G LS     R A+ VA+ +
Sbjct: 76  LYGVVLTP--PMKMVTELAPLGSL----LDRLRKHQGHFLLGTLS-----RYAVQVAEGM 124
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTI--RGTRGYL 278
            YL +    R +H D+   N+LL       + DFGL + + ++    +     +    + 
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 279 APEWILEQGVSEKCDIYSYGMVLLEL-TGGRR-----NVSLIEHGNDKSKNK 324
           APE +  +  S   D + +G+ L E+ T G+      N S I H  DK   +
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER 233

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 102/228 (44%), Gaps = 30/228 (13%)
Query: 109 LGHGSSASVFKGILSDGT----SVAVKRINGEENGEKE----FRSEVAAIASAQHVNLVR 160
           LG GS   V +G     +    SVAVK +  +   + E    F  EV A+ S  H NL+R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           L G  + P  P  +V E    GSL        R+ +GH+  G LS     R A+ VA+ +
Sbjct: 76  LYGVVLTP--PMKMVTELAPLGSL----LDRLRKHQGHFLLGTLS-----RYAVQVAEGM 124
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTI--RGTRGYL 278
            YL +    R +H D+   N+LL       + DFGL + + ++    +     +    + 
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 279 APEWILEQGVSEKCDIYSYGMVLLEL-TGGRR-----NVSLIEHGNDK 320
           APE +  +  S   D + +G+ L E+ T G+      N S I H  DK
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 94/214 (43%), Gaps = 13/214 (6%)
Query: 91  IKFRSKELEEATDNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAI 150
           + + S E++     F   LG G    V  G       VA+K I      E EF  E   +
Sbjct: 14  LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVM 73
Query: 151 ASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRY 210
            +  H  LV+L G C     P +++ E++ NG L +++     R +              
Sbjct: 74  MNLSHEKLVQLYGVC-TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQ---------LL 123
Query: 211 RVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITT 270
            +  DV +A+ YL +    + LH D+   N L+++     VSDFGLS+ +  D+      
Sbjct: 124 EMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVG 180
Query: 271 IRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            +    +  PE ++    S K DI+++G+++ E+
Sbjct: 181 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEI 214

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 102/228 (44%), Gaps = 30/228 (13%)
Query: 109 LGHGSSASVFKGILSDGT----SVAVKRINGEENGEKE----FRSEVAAIASAQHVNLVR 160
           LG GS   V +G     +    SVAVK +  +   + E    F  EV A+ S  H NL+R
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           L G  + P  P  +V E    GSL        R+ +GH+  G LS     R A+ VA+ +
Sbjct: 80  LYGVVLTP--PMKMVTELAPLGSL----LDRLRKHQGHFLLGTLS-----RYAVQVAEGM 128
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTI--RGTRGYL 278
            YL +    R +H D+   N+LL       + DFGL + + ++    +     +    + 
Sbjct: 129 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 185
Query: 279 APEWILEQGVSEKCDIYSYGMVLLEL-TGGRR-----NVSLIEHGNDK 320
           APE +  +  S   D + +G+ L E+ T G+      N S I H  DK
Sbjct: 186 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 233

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 97/225 (43%), Gaps = 39/225 (17%)
Query: 107 ALLGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLG-- 163
           A+LG G+   V K   + D    A+K+I   E       SEV  +AS  H  +VR     
Sbjct: 12  AVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 164 ----------YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVA 213
                       V      ++  E+ +NG+L   I         H        D  +R+ 
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI---------HSENLNQQRDEYWRLF 122
Query: 214 IDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD---------- 263
             + +ALSY+H+     ++H D+KP NI +DE+    + DFGL+K + R           
Sbjct: 123 RQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 264 ---QSRCITTIRGTRGYLAPEWILEQG-VSEKCDIYSYGMVLLEL 304
               S  +T+  GT  Y+A E +   G  +EK D+YS G++  E+
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 79/171 (46%), Gaps = 20/171 (11%)
Query: 143 FRSEVAAIASAQHVNLVRL--LGYCVVPGGP-RYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           FR E    A+  H  +V +   G    P GP  Y+V E++   +L   +          +
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----------H 108
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL 259
           + G ++      V  D  +AL++ H +    ++H DVKP NI++       V DFG+++ 
Sbjct: 109 TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA 165
Query: 260 MSRDQSRCIT---TIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           ++ D    +T    + GT  YL+PE      V  + D+YS G VL E+  G
Sbjct: 166 IA-DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 30/218 (13%)
Query: 105 FQALLGHGSSASVFKG-ILSDG--TSVAVKRIN--GEENGEKEFRSEVAAIAS-AQHVNL 158
           FQ ++G G+   V K  I  DG     A+KR+     ++  ++F  E+  +     H N+
Sbjct: 29  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 159 VRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSE-------GHYSGGCLSWDLRYR 211
           + LLG C    G  YL  E+  +G+L  ++   SR  E        + +   LS      
Sbjct: 89  INLLGACE-HRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 212 VAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTI 271
            A DVA+ + YL    + + +H D+   NIL+ ENY A ++DFGL    SR Q      +
Sbjct: 147 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGL----SRGQE---VYV 196
Query: 272 RGTRGYLAPEWILEQGV-----SEKCDIYSYGMVLLEL 304
           + T G L   W+  + +     +   D++SYG++L E+
Sbjct: 197 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 234

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 79/171 (46%), Gaps = 20/171 (11%)
Query: 143 FRSEVAAIASAQHVNLVRL--LGYCVVPGGP-RYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           FR E    A+  H  +V +   G    P GP  Y+V E++   +L   +          +
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----------H 108
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL 259
           + G ++      V  D  +AL++ H +    ++H DVKP NI++       V DFG+++ 
Sbjct: 109 TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA 165
Query: 260 MSRDQSRCIT---TIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           ++ D    +T    + GT  YL+PE      V  + D+YS G VL E+  G
Sbjct: 166 IA-DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 21/213 (9%)
Query: 109 LGHGSSASVFK----GILSDGT--SVAVKRIN-GEENGE-KEFRSEVAA-IASAQHVNLV 159
           LG G+   V +    GI    T  +VAVK +  G  + E +   SE+   I    H+N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 160 RLLGYCVVPGGPRYLVYEFIQNGSLDHWI-------FPTSRRSEGHYSGGCLSWDLRYRV 212
            LLG C  PGGP  ++ EF + G+L  ++        P     E  Y    L+ +     
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK-DFLTLEHLICY 153
Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT-TI 271
           +  VAK + +L +    + +H D+   NILL E     + DFGL++ + +D         
Sbjct: 154 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDA 210
Query: 272 RGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           R    ++APE I ++  + + D++S+G++L E+
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 109 LGHGSSASVFKGILSDGT----SVAVKRINGEENGEKE----FRSEVAAIASAQHVNLVR 160
           LG GS   V +G     +    SVAVK +  +   + E    F  EV A+ S  H NL+R
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           L G  + P  P  +V E    GSL        R+ +GH+  G LS     R A+ VA+ +
Sbjct: 86  LYGVVLTP--PMKMVTELAPLGSL----LDRLRKHQGHFLLGTLS-----RYAVQVAEGM 134
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTI--RGTRGYL 278
            YL +    R +H D+   N+LL       + DFGL + + ++    +     +    + 
Sbjct: 135 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWC 191
Query: 279 APEWILEQGVSEKCDIYSYGMVLLEL-TGGRR-----NVSLIEHGNDKSKNK 324
           APE +  +  S   D + +G+ L E+ T G+      N S I H  DK   +
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER 243

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 21/213 (9%)
Query: 109 LGHGSSASVFK----GILSDGT--SVAVKRIN-GEENGE-KEFRSEVAA-IASAQHVNLV 159
           LG G+   V +    GI    T  +VAVK +  G  + E +   SE+   I    H+N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 160 RLLGYCVVPGGPRYLVYEFIQNGSLDHWI-------FPTSRRSEGHYSGGCLSWDLRYRV 212
            LLG C  PGGP  ++ EF + G+L  ++        P     E  Y    L+ +     
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK-DFLTLEHLICY 153
Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT-TI 271
           +  VAK + +L +    + +H D+   NILL E     + DFGL++ + +D         
Sbjct: 154 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 210
Query: 272 RGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           R    ++APE I ++  + + D++S+G++L E+
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 94/214 (43%), Gaps = 13/214 (6%)
Query: 91  IKFRSKELEEATDNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAI 150
           + + S E++     F   LG G    V  G       VA+K I      E EF  E   +
Sbjct: 5   LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVM 64
Query: 151 ASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRY 210
            +  H  LV+L G C     P +++ E++ NG L +++     R +              
Sbjct: 65  MNLSHEKLVQLYGVC-TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQ---------LL 114
Query: 211 RVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITT 270
            +  DV +A+ YL +    + LH D+   N L+++     VSDFGLS+ +  D+      
Sbjct: 115 EMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 171
Query: 271 IRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            +    +  PE ++    S K DI+++G+++ E+
Sbjct: 172 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEI 205

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 13/210 (6%)
Query: 95  SKELEEATDNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQ 154
           S E++     F   LG G    V  G       VA+K I      E EF  E   + +  
Sbjct: 2   SWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS 61
Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI 214
           H  LV+L G C     P +++ E++ NG L +++     R +               +  
Sbjct: 62  HEKLVQLYGVC-TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQ---------LLEMCK 111
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGT 274
           DV +A+ YL +    + LH D+   N L+++     VSDFGLS+ +  D+       +  
Sbjct: 112 DVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP 168
Query: 275 RGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
             +  PE ++    S K DI+++G+++ E+
Sbjct: 169 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEI 198

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 102/228 (44%), Gaps = 30/228 (13%)
Query: 109 LGHGSSASVFKGILSDGT----SVAVKRINGEENGEKE----FRSEVAAIASAQHVNLVR 160
           LG GS   V +G     +    SVAVK +  +   + E    F  EV A+ S  H NL+R
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           L G  + P  P  +V E    GSL        R+ +GH+  G LS     R A+ VA+ +
Sbjct: 80  LYGVVLTP--PMKMVTELAPLGSL----LDRLRKHQGHFLLGTLS-----RYAVQVAEGM 128
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTI--RGTRGYL 278
            YL +    R +H D+   N+LL       + DFGL + + ++    +     +    + 
Sbjct: 129 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 185
Query: 279 APEWILEQGVSEKCDIYSYGMVLLEL-TGGRR-----NVSLIEHGNDK 320
           APE +  +  S   D + +G+ L E+ T G+      N S I H  DK
Sbjct: 186 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 233

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 21/213 (9%)
Query: 109 LGHGSSASVFK----GILSDGT--SVAVKRIN-GEENGE-KEFRSEVAA-IASAQHVNLV 159
           LG G+   V +    GI    T  +VAVK +  G  + E +   SE+   I    H+N+V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 160 RLLGYCVVPGGPRYLVYEFIQNGSLDHWI-------FPTSRRSEGHYSGGCLSWDLRYRV 212
            LLG C  PGGP  ++ EF + G+L  ++        P     E  Y    L+ +     
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK-DFLTLEHLICY 190
Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT-TI 271
           +  VAK + +L +    + +H D+   NILL E     + DFGL++ + +D         
Sbjct: 191 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 247
Query: 272 RGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           R    ++APE I ++  + + D++S+G++L E+
Sbjct: 248 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 280

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 78/170 (45%), Gaps = 18/170 (10%)
Query: 143 FRSEVAAIASAQHVNLVRL--LGYCVVPGGP-RYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           FR E    A+  H  +V +   G    P GP  Y+V E++   +L   +          +
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----------H 108
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL 259
           + G ++      V  D  +AL++ H +    ++H DVKP NIL+       V DFG+++ 
Sbjct: 109 TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARA 165
Query: 260 MSRDQSRCITT--IRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           ++   +    T  + GT  YL+PE      V  + D+YS G VL E+  G
Sbjct: 166 IADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/170 (32%), Positives = 80/170 (47%), Gaps = 21/170 (12%)
Query: 140 EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           E + R EV   +  +H N++RL GY        YL+ E+   G++   +   SR  E   
Sbjct: 56  EHQLRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSRFDEQRT 114
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS-- 257
           +              ++A ALSY H+    RV+H D+KPEN+LL  N    ++DFG S  
Sbjct: 115 AT----------YITELANALSYCHS---KRVIHRDIKPENLLLGSNGELKIADFGWSVH 161
Query: 258 KLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
              SR  + C     GT  YL PE I  +   EK D++S G++  E   G
Sbjct: 162 APSSRRDTLC-----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 13/210 (6%)
Query: 95  SKELEEATDNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQ 154
           S E++     F   LG G    V  G       VA+K I      E EF  E   + +  
Sbjct: 3   SWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS 62
Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI 214
           H  LV+L G C     P +++ E++ NG L +++     R +               +  
Sbjct: 63  HEKLVQLYGVC-TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQ---------LLEMCK 112
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGT 274
           DV +A+ YL +    + LH D+   N L+++     VSDFGLS+ +  D+       +  
Sbjct: 113 DVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP 169
Query: 275 RGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
             +  PE ++    S K DI+++G+++ E+
Sbjct: 170 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEI 199

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 25/203 (12%)
Query: 109 LGHGSSASVFKGIL-SDGTSVAVK--RINGEENGEKEFRSEVAAIASAQHVNLVRLLGYC 165
           +G G+   VF G L +D T VAVK  R     + + +F  E   +    H N+VRL+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
                P Y+V E +Q G      F T  R+EG      L      ++  D A  + YL +
Sbjct: 182 TQ-KQPIYIVMELVQGGD-----FLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLES 231
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILE 285
            C    +H D+   N L+ E     +SDFG    MSR+++  +    G    +  +W   
Sbjct: 232 KC---CIHRDLAARNCLVTEKNVLKISDFG----MSREEADGVXAASGGLRQVPVKWTAP 284
Query: 286 QGV-----SEKCDIYSYGMVLLE 303
           + +     S + D++S+G++L E
Sbjct: 285 EALNYGRYSSESDVWSFGILLWE 307

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 30/218 (13%)
Query: 105 FQALLGHGSSASVFKG-ILSDG--TSVAVKRIN--GEENGEKEFRSEVAAIAS-AQHVNL 158
           FQ ++G G+   V K  I  DG     A+KR+     ++  ++F  E+  +     H N+
Sbjct: 19  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 78
Query: 159 VRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSE-------GHYSGGCLSWDLRYR 211
           + LLG C    G  YL  E+  +G+L  ++   SR  E        + +   LS      
Sbjct: 79  INLLGACE-HRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLH 136
Query: 212 VAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTI 271
            A DVA+ + YL    + + +H D+   NIL+ ENY A ++DFGL    SR Q      +
Sbjct: 137 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGL----SRGQE---VYV 186
Query: 272 RGTRGYLAPEWILEQGV-----SEKCDIYSYGMVLLEL 304
           + T G L   W+  + +     +   D++SYG++L E+
Sbjct: 187 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 224

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 21/213 (9%)
Query: 109 LGHGSSASVFK----GILSDGT--SVAVKRIN-GEENGE-KEFRSEVAA-IASAQHVNLV 159
           LG G+   V +    GI    T  +VAVK +  G  + E +   SE+   I    H+N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 160 RLLGYCVVPGGPRYLVYEFIQNGSLDHWI-------FPTSRRSEGHYSGGCLSWDLRYRV 212
            LLG C  PGGP  ++ EF + G+L  ++        P     E  Y    L+ +     
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK-DFLTLEHLICY 144
Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT-TI 271
           +  VAK + +L +    + +H D+   NILL E     + DFGL++ + +D         
Sbjct: 145 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 201
Query: 272 RGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           R    ++APE I ++  + + D++S+G++L E+
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 103/232 (44%), Gaps = 30/232 (12%)
Query: 109 LGHGSSASVFKGILSDGT----SVAVKRINGEENGEKE----FRSEVAAIASAQHVNLVR 160
           LG GS   V +G     +    SVAVK +  +   + E    F  EV A+ S  H NL+R
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           L G  + P  P  +V E    GSL        R+ +GH+  G LS     R A+ VA+ +
Sbjct: 86  LYGVVLTP--PMKMVTELAPLGSL----LDRLRKHQGHFLLGTLS-----RYAVQVAEGM 134
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTI--RGTRGYL 278
            YL +    R +H D+   N+LL       + DFGL + + ++    +     +    + 
Sbjct: 135 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 191
Query: 279 APEWILEQGVSEKCDIYSYGMVLLEL-TGGRR-----NVSLIEHGNDKSKNK 324
           APE +  +  S   D + +G+ L E+ T G+      N S I H  DK   +
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER 243

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 109 LGHGSSASVFKGIL------SDGTSVAVKRI-NGEENGEKEFRSEVAAIASAQHVNLVRL 161
           LG G+   VF           D   VAVK + +  +N  K+F  E   + + QH ++V+ 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 162 LGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGC---LSWDLRYRVAIDVAK 218
            G C V G P  +V+E++++G L+ ++      +     G     L+      +A  +A 
Sbjct: 81  YGVC-VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAA 139
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGY 277
            + YL        +H D+   N L+ EN    + DFG+S+ + S D  R          +
Sbjct: 140 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 196
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLEL 304
           + PE I+ +  + + D++S G+VL E+
Sbjct: 197 MPPESIMYRKFTTESDVWSLGVVLWEI 223

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 94/214 (43%), Gaps = 13/214 (6%)
Query: 91  IKFRSKELEEATDNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAI 150
           + + S E++     F   LG G    V  G       VA+K I      E EF  E   +
Sbjct: 14  LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVM 73
Query: 151 ASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRY 210
            +  H  LV+L G C     P +++ E++ NG L +++     R +              
Sbjct: 74  MNLSHEKLVQLYGVC-TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQ---------LL 123
Query: 211 RVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITT 270
            +  DV +A+ YL +    + LH D+   N L+++     VSDFGLS+ +  D+      
Sbjct: 124 EMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 180
Query: 271 IRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            +    +  PE ++    S K DI+++G+++ E+
Sbjct: 181 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEI 214

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 21/213 (9%)
Query: 109 LGHGSSASVFK----GILSDGT--SVAVKRIN-GEENGE-KEFRSEVAA-IASAQHVNLV 159
           LG G+   V +    GI    T  +VAVK +  G  + E +   SE+   I    H+N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 160 RLLGYCVVPGGPRYLVYEFIQNGSLDHWI-------FPTSRRSEGHYSGGCLSWDLRYRV 212
            LLG C  PGGP  ++ EF + G+L  ++        P     E  Y    L+ +     
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK-DFLTLEHLICY 144
Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT-TI 271
           +  VAK + +L +    + +H D+   NILL E     + DFGL++ + +D         
Sbjct: 145 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 201
Query: 272 RGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           R    ++APE I ++  + + D++S+G++L E+
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 79/171 (46%), Gaps = 20/171 (11%)
Query: 143 FRSEVAAIASAQHVNLVRL--LGYCVVPGGP-RYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           FR E    A+  H  +V +   G    P GP  Y+V E++   +L   +          +
Sbjct: 76  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----------H 125
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL 259
           + G ++      V  D  +AL++ H +    ++H DVKP NI++       V DFG+++ 
Sbjct: 126 TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA 182
Query: 260 MSRDQSRCIT---TIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           ++ D    +T    + GT  YL+PE      V  + D+YS G VL E+  G
Sbjct: 183 IA-DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 232

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 87/188 (46%), Gaps = 13/188 (6%)
Query: 123 SDGTSVAVKRINGEENGEKEFR---SEVAAIASAQHVNLVRLLGYCV-VPGGPRYLVYEF 178
           SDG  +  K ++     E E +   SEV  +   +H N+VR     +       Y+V E+
Sbjct: 29  SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY 88
Query: 179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH--NDCRSRVLHLDV 236
            + G L   I  T    E  Y    L  +   RV   +  AL   H  +D    VLH D+
Sbjct: 89  CEGGDLASVI--TKGTKERQY----LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDL 142
Query: 237 KPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYS 296
           KP N+ LD      + DFGL+++++ D S     + GT  Y++PE +     +EK DI+S
Sbjct: 143 KPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV-GTPYYMSPEQMNRMSYNEKSDIWS 201
Query: 297 YGMVLLEL 304
            G +L EL
Sbjct: 202 LGCLLYEL 209

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 80/169 (47%), Gaps = 17/169 (10%)
Query: 140 EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           E + R EV   +  +H N++RL GY        YL+ E+   G++   +   S+  E   
Sbjct: 53  EHQLRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT 111
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL 259
           +              ++A ALSY H+    RV+H D+KPEN+LL       ++DFG S  
Sbjct: 112 AT----------YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-- 156
Query: 260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
                S   TT+ GT  YL PE I  +   EK D++S G++  E   G+
Sbjct: 157 -CHAPSSRRTTLSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 98/222 (44%), Gaps = 37/222 (16%)
Query: 109 LGHGSSASVFKGILS-DGTSVAVKRI---NGEENGEKEFRSEVAAIASAQHVNLVRLLGY 164
           LG G    VF+     D  + A+KRI   N E   EK  R EV A+A  +H  +VR    
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMR-EVKALAKLEHPGIVRYFNA 71
Query: 165 CV--------VPGGPRYLVY---EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVA 213
            +         P  P+  +Y   +  +  +L  W+       E   S  CL       + 
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV-CL------HIF 124
Query: 214 IDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSR--CITTI 271
           + +A+A+ +LH+     ++H D+KP NI    +    V DFGL   M +D+     +T +
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 272 R---------GTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
                     GT+ Y++PE I     S K DI+S G++L EL
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 25/203 (12%)
Query: 109 LGHGSSASVFKGIL-SDGTSVAVK--RINGEENGEKEFRSEVAAIASAQHVNLVRLLGYC 165
           +G G+   VF G L +D T VAVK  R     + + +F  E   +    H N+VRL+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
                P Y+V E +Q G      F T  R+EG      L      ++  D A  + YL +
Sbjct: 182 TQ-KQPIYIVMELVQGGD-----FLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLES 231
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILE 285
            C    +H D+   N L+ E     +SDFG    MSR+++  +    G    +  +W   
Sbjct: 232 KC---CIHRDLAARNCLVTEKNVLKISDFG----MSREEADGVYAASGGLRQVPVKWTAP 284
Query: 286 QGV-----SEKCDIYSYGMVLLE 303
           + +     S + D++S+G++L E
Sbjct: 285 EALNYGRYSSESDVWSFGILLWE 307

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 89/190 (46%), Gaps = 18/190 (9%)
Query: 123 SDGTSVAVKRINGEEN--GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ 180
           S G    +K IN + +    ++  +E+  + S  H N++++           Y+V E  +
Sbjct: 45  SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE-VFEDYHNMYIVMETCE 103
Query: 181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPEN 240
            G L   I     R      G  LS      +   +  AL+Y H+     V+H D+KPEN
Sbjct: 104 GGELLERIVSAQAR------GKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPEN 154
Query: 241 ILLDE---NYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSY 297
           IL  +   +    + DFGL++L   D+    T   GT  Y+APE + ++ V+ KCDI+S 
Sbjct: 155 ILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAAGTALYMAPE-VFKRDVTFKCDIWSA 211
Query: 298 GMVLLELTGG 307
           G+V+  L  G
Sbjct: 212 GVVMYFLLTG 221

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 13/201 (6%)
Query: 104 NFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLG 163
            F   LG G    V  G       VA+K I      E EF  E   + +  H  LV+L G
Sbjct: 7   TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66
Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL 223
            C     P +++ E++ NG L +++     R +               +  DV +A+ YL
Sbjct: 67  VC-TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQ---------LLEMCKDVCEAMEYL 116
Query: 224 HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWI 283
            +    + LH D+   N L+++     VSDFGLS+ +  D+       +    +  PE +
Sbjct: 117 ES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173
Query: 284 LEQGVSEKCDIYSYGMVLLEL 304
           +    S K DI+++G+++ E+
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEI 194

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 103/212 (48%), Gaps = 32/212 (15%)
Query: 112 GSSASVFKG-ILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGY---CVV 167
           G    V+K  +L++  +V +  I  +++ + E+  EV ++   +H N+++ +G       
Sbjct: 35  GRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEY--EVYSLPGMKHENILQFIGAEKRGTS 92
Query: 168 PGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDC 227
                +L+  F + GSL  ++               +SW+    +A  +A+ L+YLH D 
Sbjct: 93  VDVDLWLITAFHEKGSLSDFL-----------KANVVSWNELCHIAETMARGLAYLHEDI 141
Query: 228 -------RSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR-GTRGYLA 279
                  +  + H D+K +N+LL  N  A ++DFGL+      +S   T  + GTR Y+A
Sbjct: 142 PGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMA 201
Query: 280 PEWILEQGVS------EKCDIYSYGMVLLELT 305
           PE +LE  ++       + D+Y+ G+VL EL 
Sbjct: 202 PE-VLEGAINFQRDAFLRIDMYAMGLVLWELA 232

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 100/213 (46%), Gaps = 31/213 (14%)
Query: 106 QALLGHGSSASVF--KGILSDGTSVAVKRINGEENGEKEFRS----EVAAIASAQHVNLV 159
           Q +LG GS   V   K  ++ G   AVK I+  +  +K  +     EV  +    H N++
Sbjct: 31  QRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIM 89
Query: 160 RLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKA 219
           +L  +     G  YLV E    G L   I    R SE   +          R+   V   
Sbjct: 90  KLYEF-FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA----------RIIRQVLSG 138
Query: 220 LSYLHNDCRSRVLHLDVKPENILL-----DENYRAVVSDFGLSKLMSRDQSRCITTIRGT 274
           ++Y+H   +++++H D+KPEN+LL     D N R +  DFGLS     + S+ +    GT
Sbjct: 139 ITYMH---KNKIVHRDLKPENLLLESKSKDANIRII--DFGLSTHF--EASKKMKDKIGT 191
Query: 275 RGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
             Y+APE +L     EKCD++S G++L  L  G
Sbjct: 192 AYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 140 EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           E + R EV   +  +H N++RL GY        YL+ E+   G +   +   S+  E   
Sbjct: 57  EHQLRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPRGEVYKELQKLSKFDEQRT 115
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL 259
           +              ++A ALSY H+    RV+H D+KPEN+LL       ++DFG S  
Sbjct: 116 AT----------YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-- 160
Query: 260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           +    SR  TT+ GT  YL PE I  +   EK D++S G++  E   G+
Sbjct: 161 VHAPSSR-RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 34/211 (16%)
Query: 108 LLGHGSSASVFKGI-LSDGTSVAVK------RINGEENGEKEFRSEVAAIASAQHVNLVR 160
           +LG G+  +V+KGI + DG +V +       R N      KE   E   +A      + R
Sbjct: 24  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSR 83
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSL-DHWIFPTSRRSEGHY-SGGCLSWDLRYRVAIDVAK 218
           LLG C+       LV + +  G L DH      R + G   S   L+W       + +AK
Sbjct: 84  LLGICLT--STVQLVTQLMPYGCLLDH-----VRENRGRLGSQDLLNW------CMQIAK 130
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            +SYL +    R++H D+   N+L+       ++DFGL++L+  D+    T      G +
Sbjct: 131 GMSYLED---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE----TEYHADGGKV 183
Query: 279 APEW-----ILEQGVSEKCDIYSYGMVLLEL 304
             +W     IL +  + + D++SYG+ + EL
Sbjct: 184 PIKWMALESILRRRFTHQSDVWSYGVTVWEL 214

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 109/239 (45%), Gaps = 30/239 (12%)
Query: 84  RKVAGVPIKFRSKELEEATDNFQALLGHGSSASVFKG-ILSDG--TSVAVKRIN--GEEN 138
           RKV   P       L+     FQ ++G G+   V K  I  DG     A+KR+     ++
Sbjct: 5   RKVKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD 64
Query: 139 GEKEFRSEVAAIAS-AQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSE- 196
             ++F  E+  +     H N++ LLG C    G  YL  E+  +G+L  ++   SR  E 
Sbjct: 65  DHRDFAGELEVLCKLGHHPNIINLLGACE-HRGYLYLAIEYAPHGNLLDFL-RKSRVLET 122
Query: 197 ------GHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV 250
                  + +   LS       A DVA+ + YL    + + +H ++   NIL+ ENY A 
Sbjct: 123 DPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAK 179
Query: 251 VSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGV-----SEKCDIYSYGMVLLEL 304
           ++DFGL    SR Q      ++ T G L   W+  + +     +   D++SYG++L E+
Sbjct: 180 IADFGL----SRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 231

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 105/210 (50%), Gaps = 26/210 (12%)
Query: 107 ALLGHGSSASVFKG--ILSDGTSVAVKRI---NGEENGEKEFRSEVAAI---ASAQHVNL 158
           A +G G+   VFK   + + G  VA+KR+    GEE        EVA +    + +H N+
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 159 VRLLGYCVVPGGPR----YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI 214
           VRL   C V    R     LV+E + +  L  ++    +  E       +  D+ +++  
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL---DKVPEPGVPTETIK-DMMFQLL- 130
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGT 274
              + L +LH+    RV+H D+KP+NIL+  + +  ++DFGL+++ S   +  +T++  T
Sbjct: 131 ---RGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVT 182
Query: 275 RGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
             Y APE +L+   +   D++S G +  E+
Sbjct: 183 LWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 105 FQALLGHGSSASVF--KGILSDGTSVAVKRINGEENG-EKEFRSEVAAIASAQHVNLVRL 161
           F  +LG G+ + VF  K  L+ G   A+K I       +    +E+A +   +H N+V L
Sbjct: 13  FMEVLGSGAFSEVFLVKQRLT-GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71
Query: 162 LGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALS 221
                      YLV + +  G L   I      +E   S           V   V  A+ 
Sbjct: 72  ED-IYESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS----------LVIQQVLSAVK 120
Query: 222 YLHNDCRSRVLHLDVKPENILL---DENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
           YLH +    ++H D+KPEN+L    +EN + +++DFGLSK+   +Q+  ++T  GT GY+
Sbjct: 121 YLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMSTACGTPGYV 174
Query: 279 APEWILEQGVSEKCDIYSYGMVLLELTGG 307
           APE + ++  S+  D +S G++   L  G
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVITYILLCG 203

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 87/188 (46%), Gaps = 13/188 (6%)
Query: 123 SDGTSVAVKRINGEENGEKEFR---SEVAAIASAQHVNLVRLLGYCV-VPGGPRYLVYEF 178
           SDG  +  K ++     E E +   SEV  +   +H N+VR     +       Y+V E+
Sbjct: 29  SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEY 88
Query: 179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH--NDCRSRVLHLDV 236
            + G L   I  T    E  Y    L  +   RV   +  AL   H  +D    VLH D+
Sbjct: 89  CEGGDLASVI--TKGTKERQY----LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDL 142
Query: 237 KPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYS 296
           KP N+ LD      + DFGL+++++ D+      + GT  Y++PE +     +EK DI+S
Sbjct: 143 KPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFV-GTPYYMSPEQMNRMSYNEKSDIWS 201
Query: 297 YGMVLLEL 304
            G +L EL
Sbjct: 202 LGCLLYEL 209

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 105/210 (50%), Gaps = 26/210 (12%)
Query: 107 ALLGHGSSASVFKG--ILSDGTSVAVKRI---NGEENGEKEFRSEVAAI---ASAQHVNL 158
           A +G G+   VFK   + + G  VA+KR+    GEE        EVA +    + +H N+
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 159 VRLLGYCVVPGGPR----YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI 214
           VRL   C V    R     LV+E + +  L  ++    +  E       +  D+ +++  
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL---DKVPEPGVPTETIK-DMMFQLL- 130
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGT 274
              + L +LH+    RV+H D+KP+NIL+  + +  ++DFGL+++ S   +  +T++  T
Sbjct: 131 ---RGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVT 182
Query: 275 RGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
             Y APE +L+   +   D++S G +  E+
Sbjct: 183 LWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 140 EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           E + R EV   +  +H N++RL GY        YL+ E+   G++   +   S+  E   
Sbjct: 57  EHQLRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT 115
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL 259
           +              ++A ALSY H+    RV+H D+KPEN+LL       ++DFG S  
Sbjct: 116 AT----------YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-- 160
Query: 260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           +    SR  TT+ GT  YL PE I  +   EK D++S G++  E   G+
Sbjct: 161 VHAPSSR-RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 140 EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           E + R EV   +  +H N++RL GY        YL+ E+   G++   +   S+  E   
Sbjct: 57  EHQLRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT 115
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL 259
           +              ++A ALSY H+    RV+H D+KPEN+LL       ++DFG S  
Sbjct: 116 AT----------YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-- 160
Query: 260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           +    SR  TT+ GT  YL PE I  +   EK D++S G++  E   G+
Sbjct: 161 VHAPSSR-RTTLCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 86/196 (43%), Gaps = 13/196 (6%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V  G       VAVK I      E EF  E   +    H  LV+  G C   
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC-SK 74
Query: 169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCR 228
             P Y+V E+I NG L +++     RS     G  L       +  DV + +++L +   
Sbjct: 75  EYPIYIVTEYISNGCLLNYL-----RSH----GKGLEPSQLLEMCYDVCEGMAFLES--- 122
Query: 229 SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGV 288
            + +H D+   N L+D +    VSDFG+++ +  DQ       +    + APE       
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKY 182
Query: 289 SEKCDIYSYGMVLLEL 304
           S K D++++G+++ E+
Sbjct: 183 SSKSDVWAFGILMWEV 198

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 140 EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           E + R EV   +  +H N++RL GY        YL+ E+   G++   +   S+  E   
Sbjct: 55  EHQLRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT 113
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL 259
           +              ++A ALSY H+    RV+H D+KPEN+LL       ++DFG S  
Sbjct: 114 AT----------YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-- 158
Query: 260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           +    SR  TT+ GT  YL PE I  +   EK D++S G++  E   G+
Sbjct: 159 VHAPSSR-RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 99/214 (46%), Gaps = 33/214 (15%)
Query: 106 QALLGHGSSASVFKGILSD---GTSVAVKRINGEENGEKEFRS----EVAAIASAQHVNL 158
           Q +LG GS   V   +  D   G   AVK I+  +  +K  +     EV  +    H N+
Sbjct: 37  QRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 94
Query: 159 VRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK 218
           ++L  +     G  YLV E    G L   I    R SE   +          R+   V  
Sbjct: 95  MKLYEF-FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA----------RIIRQVLS 143
Query: 219 ALSYLHNDCRSRVLHLDVKPENILL-----DENYRAVVSDFGLSKLMSRDQSRCITTIRG 273
            ++Y+H   +++++H D+KPEN+LL     D N R +  DFGLS     + S+ +    G
Sbjct: 144 GITYMH---KNKIVHRDLKPENLLLESKSKDANIRII--DFGLSTHF--EASKKMKDKIG 196
Query: 274 TRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           T  Y+APE +L     EKCD++S G++L  L  G
Sbjct: 197 TAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 140 EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           E + R EV   +  +H N++RL GY        YL+ E+   G++   +   S+  E   
Sbjct: 55  EHQLRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT 113
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL 259
           +              ++A ALSY H+    RV+H D+KPEN+LL       ++DFG S  
Sbjct: 114 AT----------YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-- 158
Query: 260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           +    SR  TT+ GT  YL PE I  +   EK D++S G++  E   G+
Sbjct: 159 VHAPSSRR-TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 140 EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           E + R EV   +  +H N++RL GY        YL+ E+   G++   +   S+  E   
Sbjct: 69  EHQLRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT 127
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL 259
           +              ++A ALSY H+    RV+H D+KPEN+LL       ++DFG S  
Sbjct: 128 AT----------YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-- 172
Query: 260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           +    SR  TT+ GT  YL PE I  +   EK D++S G++  E   G+
Sbjct: 173 VHAPSSR-RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 97/201 (48%), Gaps = 14/201 (6%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+    +  T VAVK +       + F +E   + + QH  LV+L  + VV 
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL--HAVVT 80
Query: 169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCR 228
             P Y++ EF+  GSL  ++    +  EG         D     +  +A+ ++++    +
Sbjct: 81  KEPIYIITEFMAKGSLLDFL----KSDEGSKQPLPKLIDF----SAQIAEGMAFIE---Q 129
Query: 229 SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGV 288
              +H D++  NIL+  +    ++DFGL++++  ++       +    + APE I     
Sbjct: 130 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 189
Query: 289 SEKCDIYSYGMVLLEL-TGGR 308
           + K D++S+G++L+E+ T GR
Sbjct: 190 TIKSDVWSFGILLMEIVTYGR 210

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 140 EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           E + R EV   +  +H N++RL GY        YL+ E+   G++   +   S+  E   
Sbjct: 49  EHQLRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT 107
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL 259
           +              ++A ALSY H+    RV+H D+KPEN+LL       ++DFG S  
Sbjct: 108 AT----------YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-- 152
Query: 260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           +    SR  TT+ GT  YL PE I  +   EK D++S G++  E   G+
Sbjct: 153 VHAPSSRR-TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 93/192 (48%), Gaps = 20/192 (10%)
Query: 126 TSVAVKRINGEENGEKEFRSEVAAIAS----AQHVNLVRLLGYCVVPGGPRYLVYEFIQN 181
           T VAVK +  +   EK+    ++ +       +H N++ LLG C    GP Y++ E+   
Sbjct: 61  TKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASK 118
Query: 182 GSLDHWIFPTSRRSEG--------HYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLH 233
           G+L  ++   +RR  G        H     LS       A  VA+ + YL      + +H
Sbjct: 119 GNLREYL--QARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIH 173
Query: 234 LDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIRGTRGYLAPEWILEQGVSEKC 292
            D+   N+L+ E+    ++DFGL++ +   D  +  T  R    ++APE + ++  + + 
Sbjct: 174 RDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQS 233
Query: 293 DIYSYGMVLLEL 304
           D++S+G++L E+
Sbjct: 234 DVWSFGVLLWEI 245

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 105/210 (50%), Gaps = 26/210 (12%)
Query: 107 ALLGHGSSASVFKG--ILSDGTSVAVKRI---NGEENGEKEFRSEVAAI---ASAQHVNL 158
           A +G G+   VFK   + + G  VA+KR+    GEE        EVA +    + +H N+
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 159 VRLLGYCVVPGGPR----YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI 214
           VRL   C V    R     LV+E + +  L  ++    +  E       +  D+ +++  
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL---DKVPEPGVPTETIK-DMMFQLL- 130
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGT 274
              + L +LH+    RV+H D+KP+NIL+  + +  ++DFGL+++ S   +  +T++  T
Sbjct: 131 ---RGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVT 182
Query: 275 RGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
             Y APE +L+   +   D++S G +  E+
Sbjct: 183 LWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 140 EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           E + R EV   +  +H N++RL GY        YL+ E+   G++   +   S+  E   
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT 110
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL 259
           +              ++A ALSY H+    RV+H D+KPEN+LL       ++DFG S  
Sbjct: 111 AT----------YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-- 155
Query: 260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           +    SR  TT+ GT  YL PE I  +   EK D++S G++  E   G+
Sbjct: 156 VHAPSSR-RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 140 EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           E + R EV   +  +H N++RL GY        YL+ E+   G++   +   S+  E   
Sbjct: 51  EHQLRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT 109
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL 259
           +              ++A ALSY H+    RV+H D+KPEN+LL       ++DFG S  
Sbjct: 110 AT----------YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-- 154
Query: 260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           +    SR  TT+ GT  YL PE I  +   EK D++S G++  E   G+
Sbjct: 155 VHAPSSRR-TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 140 EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           E + R EV   +  +H N++RL GY        YL+ E+   G++   +   S+  E   
Sbjct: 56  EHQLRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT 114
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL 259
           +              ++A ALSY H+    RV+H D+KPEN+LL       ++DFG S  
Sbjct: 115 AT----------YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-- 159
Query: 260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           +    SR  TT+ GT  YL PE I  +   EK D++S G++  E   G+
Sbjct: 160 VHAPSSRR-TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 47/190 (24%), Positives = 93/190 (48%), Gaps = 30/190 (15%)
Query: 201 GGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM 260
           G  +  D+  ++A+ + KAL +LH+  +  V+H DVKP N+L++   +  + DFG+S  +
Sbjct: 103 GQTIPEDILGKIAVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160
Query: 261 SRDQSRCITTIRGTRGYLAPEWI----LEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEH 316
             D ++ I    G + Y+APE I     ++G S K DI+S G+ ++EL       +++  
Sbjct: 161 VDDVAKDIDA--GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL-------AILRF 211
Query: 317 GNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERAR 376
             D     +Q   ++V E        ++   + + E           VD    C+++ ++
Sbjct: 212 PYDSWGTPFQQLKQVVEEPSP-----QLPADKFSAE----------FVDFTSQCLKKNSK 256
Query: 377 LRPSMARVVE 386
            RP+   +++
Sbjct: 257 ERPTYPELMQ 266

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 130/293 (44%), Gaps = 50/293 (17%)
Query: 109 LGHGSSASVF----KGILSDG--TSVAVKRINGEENGEK--EFRSEVAAIASAQHVNLVR 160
           LG GS   V+    KG++ D   T VA+K +N   +  +  EF +E + +      ++VR
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG  V  G P  ++ E +  G L  ++       E +      S     ++A ++A  +
Sbjct: 78  LLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 136
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAP 280
           +YL+ +   + +H D+   N ++ E++   + DFG    M+RD        +G +G L  
Sbjct: 137 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFG----MTRDIXETDXXRKGGKGLLPV 189
Query: 281 EWI----LEQGV-SEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEK 335
            W+    L+ GV +   D++S+G+VL E+       +L E          Q +  + NE+
Sbjct: 190 RWMSPESLKDGVFTTYSDVWSFGVVLWEIA------TLAE----------QPYQGLSNEQ 233
Query: 336 MKEGKLMEIVDQRLTDEGGI---DETQVRRLVDVAFWCIQERARLRPSMARVV 385
           +           R   EGG+    +     L+++   C Q   ++RPS   ++
Sbjct: 234 V----------LRFVMEGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEII 276

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 99/214 (46%), Gaps = 33/214 (15%)
Query: 106 QALLGHGSSASVFKGILSD---GTSVAVKRINGEENGEKEFRS----EVAAIASAQHVNL 158
           Q +LG GS   V   +  D   G   AVK I+  +  +K  +     EV  +    H N+
Sbjct: 55  QRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 112
Query: 159 VRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK 218
           ++L  +     G  YLV E    G L   I    R SE   +          R+   V  
Sbjct: 113 MKLYEF-FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA----------RIIRQVLS 161
Query: 219 ALSYLHNDCRSRVLHLDVKPENILL-----DENYRAVVSDFGLSKLMSRDQSRCITTIRG 273
            ++Y+H   +++++H D+KPEN+LL     D N R +  DFGLS     + S+ +    G
Sbjct: 162 GITYMH---KNKIVHRDLKPENLLLESKSKDANIRII--DFGLSTHF--EASKKMKDKIG 214
Query: 274 TRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           T  Y+APE +L     EKCD++S G++L  L  G
Sbjct: 215 TAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 99/214 (46%), Gaps = 33/214 (15%)
Query: 106 QALLGHGSSASVFKGILSD---GTSVAVKRINGEENGEKEFRS----EVAAIASAQHVNL 158
           Q +LG GS   V   +  D   G   AVK I+  +  +K  +     EV  +    H N+
Sbjct: 54  QRVLGKGSFGEVI--LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 111
Query: 159 VRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK 218
           ++L  +     G  YLV E    G L   I    R SE   +          R+   V  
Sbjct: 112 MKLYEF-FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA----------RIIRQVLS 160
Query: 219 ALSYLHNDCRSRVLHLDVKPENILL-----DENYRAVVSDFGLSKLMSRDQSRCITTIRG 273
            ++Y+H   +++++H D+KPEN+LL     D N R +  DFGLS     + S+ +    G
Sbjct: 161 GITYMH---KNKIVHRDLKPENLLLESKSKDANIRII--DFGLSTHF--EASKKMKDKIG 213
Query: 274 TRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           T  Y+APE +L     EKCD++S G++L  L  G
Sbjct: 214 TAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 140 EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           E + R EV   +  +H N++RL GY        YL+ E+   G++   +   S+  E   
Sbjct: 78  EHQLRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT 136
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL 259
           +              ++A ALSY H+    RV+H D+KPEN+LL       ++DFG S  
Sbjct: 137 AT----------YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-- 181
Query: 260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           +    SR  TT+ GT  YL PE I  +   EK D++S G++  E   G+
Sbjct: 182 VHAPSSR-RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 101/210 (48%), Gaps = 21/210 (10%)
Query: 109 LGHGSSASVF----KGILSDG--TSVAVKRINGEENGEK--EFRSEVAAIASAQHVNLVR 160
           LG GS   V+    KG++ D   T VA+K +N   +  +  EF +E + +      ++VR
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG  V  G P  ++ E +  G L  ++       E +      S     ++A ++A  +
Sbjct: 87  LLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 145
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAP 280
           +YL+ +   + +H D+   N ++ E++   + DFG    M+RD        +G +G L  
Sbjct: 146 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFG----MTRDIXETDXXRKGGKGLLPV 198
Query: 281 EWI----LEQGV-SEKCDIYSYGMVLLELT 305
            W+    L+ GV +   D++S+G+VL E+ 
Sbjct: 199 RWMSPESLKDGVFTTYSDVWSFGVVLWEIA 228

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 25/213 (11%)
Query: 109 LGHGSSASVF----KGILS--DGTSVAVKRIN-GEENGEKEFRSEVAAIASAQHVNLVRL 161
           LG G+   VF      +L   D   VAVK +    E+  ++F+ E   +   QH ++VR 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 162 LGYCVVPGGPRYLVYEFIQNGSLDHWI---FPTSRRSEG--HYSGGCLSWDLRYRVAIDV 216
            G C   G P  +V+E++++G L+ ++    P ++   G    + G L       VA  V
Sbjct: 86  FGVC-TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK-LMSRDQ----SRCITTI 271
           A  + YL        +H D+   N L+ +     + DFG+S+ + S D      R +  I
Sbjct: 145 AAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 272 RGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           R    ++ PE IL +  + + D++S+G+VL E+
Sbjct: 202 R----WMPPESILYRKFTTESDVWSFGVVLWEI 230

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 25/213 (11%)
Query: 109 LGHGSSASVF----KGILS--DGTSVAVKRIN-GEENGEKEFRSEVAAIASAQHVNLVRL 161
           LG G+   VF      +L   D   VAVK +    E+  ++F+ E   +   QH ++VR 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 162 LGYCVVPGGPRYLVYEFIQNGSLDHWI---FPTSRRSEG--HYSGGCLSWDLRYRVAIDV 216
            G C   G P  +V+E++++G L+ ++    P ++   G    + G L       VA  V
Sbjct: 80  FGVC-TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK-LMSRDQ----SRCITTI 271
           A  + YL        +H D+   N L+ +     + DFG+S+ + S D      R +  I
Sbjct: 139 AAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 272 RGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           R    ++ PE IL +  + + D++S+G+VL E+
Sbjct: 196 R----WMPPESILYRKFTTESDVWSFGVVLWEI 224

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/190 (24%), Positives = 92/190 (48%), Gaps = 30/190 (15%)
Query: 201 GGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM 260
           G  +  D+  ++A+ + KAL +LH+  +  V+H DVKP N+L++   +  + DFG+S  +
Sbjct: 147 GQTIPEDILGKIAVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 204
Query: 261 SRDQSRCITTIRGTRGYLAPEWI----LEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEH 316
               ++ I    G + Y+APE I     ++G S K DI+S G+ ++EL       +++  
Sbjct: 205 VDSVAKTIDA--GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL-------AILRF 255
Query: 317 GNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERAR 376
             D     +Q   ++V E        ++   + + E           VD    C+++ ++
Sbjct: 256 PYDSWGTPFQQLKQVVEEPSP-----QLPADKFSAE----------FVDFTSQCLKKNSK 300
Query: 377 LRPSMARVVE 386
            RP+   +++
Sbjct: 301 ERPTYPELMQ 310

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 93/192 (48%), Gaps = 20/192 (10%)
Query: 126 TSVAVKRINGEENGEKEFRSEVAAIAS----AQHVNLVRLLGYCVVPGGPRYLVYEFIQN 181
           T VAVK +  +   EK+    ++ +       +H N++ LLG C    GP Y++ E+   
Sbjct: 46  TKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASK 103
Query: 182 GSLDHWIFPTSRRSEG--------HYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLH 233
           G+L  ++   +RR  G        H     LS       A  VA+ + YL      + +H
Sbjct: 104 GNLREYL--QARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIH 158
Query: 234 LDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIRGTRGYLAPEWILEQGVSEKC 292
            D+   N+L+ E+    ++DFGL++ +   D  +  T  R    ++APE + ++  + + 
Sbjct: 159 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 218
Query: 293 DIYSYGMVLLEL 304
           D++S+G++L E+
Sbjct: 219 DVWSFGVLLWEI 230

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 96/225 (42%), Gaps = 39/225 (17%)
Query: 107 ALLGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLG-- 163
           A+LG G+   V K   + D    A+K+I   E       SEV  +AS  H  +VR     
Sbjct: 12  AVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 164 ----------YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVA 213
                       V      ++  E+ +N +L   I         H        D  +R+ 
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLI---------HSENLNQQRDEYWRLF 122
Query: 214 IDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD---------- 263
             + +ALSY+H+     ++H D+KP NI +DE+    + DFGL+K + R           
Sbjct: 123 RQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 264 ---QSRCITTIRGTRGYLAPEWILEQG-VSEKCDIYSYGMVLLEL 304
               S  +T+  GT  Y+A E +   G  +EK D+YS G++  E+
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 93/192 (48%), Gaps = 20/192 (10%)
Query: 126 TSVAVKRINGEENGEKEFRSEVAAIAS----AQHVNLVRLLGYCVVPGGPRYLVYEFIQN 181
           T VAVK +  +   EK+    ++ +       +H N++ LLG C    GP Y++ E+   
Sbjct: 61  TKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASK 118
Query: 182 GSLDHWIFPTSRRSEG--------HYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLH 233
           G+L  ++   +RR  G        H     LS       A  VA+ + YL      + +H
Sbjct: 119 GNLREYL--QARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIH 173
Query: 234 LDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIRGTRGYLAPEWILEQGVSEKC 292
            D+   N+L+ E+    ++DFGL++ +   D  +  T  R    ++APE + ++  + + 
Sbjct: 174 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 233
Query: 293 DIYSYGMVLLEL 304
           D++S+G++L E+
Sbjct: 234 DVWSFGVLLWEI 245

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 93/192 (48%), Gaps = 20/192 (10%)
Query: 126 TSVAVKRINGEENGEKEFRSEVAAIAS----AQHVNLVRLLGYCVVPGGPRYLVYEFIQN 181
           T VAVK +  +   EK+    ++ +       +H N++ LLG C    GP Y++ E+   
Sbjct: 54  TKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASK 111
Query: 182 GSLDHWIFPTSRRSEG--------HYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLH 233
           G+L  ++   +RR  G        H     LS       A  VA+ + YL      + +H
Sbjct: 112 GNLREYL--QARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIH 166
Query: 234 LDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIRGTRGYLAPEWILEQGVSEKC 292
            D+   N+L+ E+    ++DFGL++ +   D  +  T  R    ++APE + ++  + + 
Sbjct: 167 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 226
Query: 293 DIYSYGMVLLEL 304
           D++S+G++L E+
Sbjct: 227 DVWSFGVLLWEI 238

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 93/192 (48%), Gaps = 20/192 (10%)
Query: 126 TSVAVKRINGEENGEKEFRSEVAAIAS----AQHVNLVRLLGYCVVPGGPRYLVYEFIQN 181
           T VAVK +  +   EK+    ++ +       +H N++ LLG C    GP Y++ E+   
Sbjct: 50  TKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASK 107
Query: 182 GSLDHWIFPTSRRSEG--------HYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLH 233
           G+L  ++   +RR  G        H     LS       A  VA+ + YL      + +H
Sbjct: 108 GNLREYL--QARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIH 162
Query: 234 LDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIRGTRGYLAPEWILEQGVSEKC 292
            D+   N+L+ E+    ++DFGL++ +   D  +  T  R    ++APE + ++  + + 
Sbjct: 163 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 222
Query: 293 DIYSYGMVLLEL 304
           D++S+G++L E+
Sbjct: 223 DVWSFGVLLWEI 234

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 97/201 (48%), Gaps = 14/201 (6%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+    +  T VAVK +       + F +E   + + QH  LV+L  + VV 
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL--HAVVT 253
Query: 169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCR 228
             P Y++ EF+  GSL  ++    +  EG         D     +  +A+ ++++    +
Sbjct: 254 KEPIYIITEFMAKGSLLDFL----KSDEGSKQPLPKLIDF----SAQIAEGMAFIE---Q 302
Query: 229 SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGV 288
              +H D++  NIL+  +    ++DFGL++++  ++       +    + APE I     
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 362
Query: 289 SEKCDIYSYGMVLLEL-TGGR 308
           + K D++S+G++L+E+ T GR
Sbjct: 363 TIKSDVWSFGILLMEIVTYGR 383

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 93/192 (48%), Gaps = 20/192 (10%)
Query: 126 TSVAVKRINGEENGEKEFRSEVAAIAS----AQHVNLVRLLGYCVVPGGPRYLVYEFIQN 181
           T VAVK +  +   EK+    ++ +       +H N++ LLG C    GP Y++ E+   
Sbjct: 61  TKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASK 118
Query: 182 GSLDHWIFPTSRRSEG--------HYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLH 233
           G+L  ++   +RR  G        H     LS       A  VA+ + YL      + +H
Sbjct: 119 GNLREYL--QARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIH 173
Query: 234 LDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIRGTRGYLAPEWILEQGVSEKC 292
            D+   N+L+ E+    ++DFGL++ +   D  +  T  R    ++APE + ++  + + 
Sbjct: 174 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 233
Query: 293 DIYSYGMVLLEL 304
           D++S+G++L E+
Sbjct: 234 DVWSFGVLLWEI 245

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 92/190 (48%), Gaps = 25/190 (13%)
Query: 125 GTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ 180
           G  VAVK +N ++    +   + + E+  +   +H ++++L      P    ++V E++ 
Sbjct: 36  GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD-FFMVMEYVS 94
Query: 181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPEN 240
            G L  +I    R  E          + R R+   +  A+ Y H   R  V+H D+KPEN
Sbjct: 95  GGELFDYICKHGRVEE---------MEAR-RLFQQILSAVDYCH---RHMVVHRDLKPEN 141
Query: 241 ILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWI---LEQGVSEKCDIYSY 297
           +LLD +  A ++DFGLS +MS      + T  G+  Y APE I   L  G   + DI+S 
Sbjct: 142 VLLDAHMNAKIADFGLSNMMS--DGEFLRTSCGSPNYAAPEVISGRLYAG--PEVDIWSC 197
Query: 298 GMVLLELTGG 307
           G++L  L  G
Sbjct: 198 GVILYALLCG 207

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 93/213 (43%), Gaps = 28/213 (13%)
Query: 104 NFQALLGHGSSASVFKGILSDGTS---VAVKRINGEENGEKEFRS---EVAAIASAQHVN 157
           N   +LG GS   V K    D  +    AVK IN      K+  +   EV  +    H N
Sbjct: 25  NIVCMLGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82
Query: 158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
           +++L    +      Y+V E    G L   I    R SE   +          R+   V 
Sbjct: 83  IMKLFE-ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA----------RIIKQVF 131
Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAV---VSDFGLSKLMSRDQSRCITTIRGT 274
             ++Y+H   +  ++H D+KPENILL+   +     + DFGLS      Q+  +    GT
Sbjct: 132 SGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRIGT 186
Query: 275 RGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
             Y+APE +L     EKCD++S G++L  L  G
Sbjct: 187 AYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 140 EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           E + R EV   +  +H N++RL GY        YL+ E+   G++   +   S+  E   
Sbjct: 54  EHQLRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT 112
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL 259
           +              ++A ALSY H+    RV+H D+KPEN+LL       +++FG S  
Sbjct: 113 AT----------YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWS-- 157
Query: 260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           +    SR  TT+ GT  YL PE I  +   EK D++S G++  E   G+
Sbjct: 158 VHAPSSR-RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 93/192 (48%), Gaps = 20/192 (10%)
Query: 126 TSVAVKRINGEENGEKEFRSEVAAIAS----AQHVNLVRLLGYCVVPGGPRYLVYEFIQN 181
           T VAVK +  +   EK+    ++ +       +H N++ LLG C    GP Y++ E+   
Sbjct: 53  TKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASK 110
Query: 182 GSLDHWIFPTSRRSEG--------HYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLH 233
           G+L  ++   +RR  G        H     LS       A  VA+ + YL      + +H
Sbjct: 111 GNLREYL--QARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIH 165
Query: 234 LDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIRGTRGYLAPEWILEQGVSEKC 292
            D+   N+L+ E+    ++DFGL++ +   D  +  T  R    ++APE + ++  + + 
Sbjct: 166 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 225
Query: 293 DIYSYGMVLLEL 304
           D++S+G++L E+
Sbjct: 226 DVWSFGVLLWEI 237

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 17/215 (7%)
Query: 95  SKELEEATDNFQALLGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFRSEVAAIASA 153
           +K+ EE  D  + L G GS  SV+K I  + G  VA+K++  E + + E   E++ +   
Sbjct: 24  TKQPEEVFDVLEKL-GEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ-EIIKEISIMQQC 81
Query: 154 QHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVA 213
              ++V+  G         ++V E+   GS+   I               L+ D    + 
Sbjct: 82  DSPHVVKYYG-SYFKNTDLWIVMEYCGAGSVSDII---------RLRNKTLTEDEIATIL 131
Query: 214 IDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRG 273
               K L YLH     R +H D+K  NILL+    A ++DFG++  ++   ++    I G
Sbjct: 132 QSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVI-G 187
Query: 274 TRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           T  ++APE I E G +   DI+S G+  +E+  G+
Sbjct: 188 TPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 80/171 (46%), Gaps = 21/171 (12%)
Query: 140 EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           E + R EV   +  +H N++RL GY        YL+ E+   G++   +   S+  E   
Sbjct: 53  EHQLRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT 111
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS-- 257
           +              ++A ALSY H+    RV+H D+KPEN+LL       ++DFG S  
Sbjct: 112 AT----------YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVH 158
Query: 258 KLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
              SR  + C     GT  YL PE I  +   EK D++S G++  E   G+
Sbjct: 159 APSSRRDTLC-----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 93/213 (43%), Gaps = 28/213 (13%)
Query: 104 NFQALLGHGSSASVFKGILSDGTS---VAVKRINGEENGEKEFRS---EVAAIASAQHVN 157
           N   +LG GS   V K    D  +    AVK IN      K+  +   EV  +    H N
Sbjct: 25  NIVCMLGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82
Query: 158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
           +++L    +      Y+V E    G L   I    R SE   +          R+   V 
Sbjct: 83  IMKLFE-ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA----------RIIKQVF 131
Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAV---VSDFGLSKLMSRDQSRCITTIRGT 274
             ++Y+H   +  ++H D+KPENILL+   +     + DFGLS      Q+  +    GT
Sbjct: 132 SGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRIGT 186
Query: 275 RGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
             Y+APE +L     EKCD++S G++L  L  G
Sbjct: 187 AYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 140 EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           E + R EV   +  +H N++RL GY        YL+ E+   G++   +   S+  E   
Sbjct: 55  EHQLRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT 113
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL 259
           +              ++A ALSY H+    RV+H D+KPEN+LL       +++FG S  
Sbjct: 114 AT----------YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWS-- 158
Query: 260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           +    SR  TT+ GT  YL PE I  +   EK D++S G++  E   G+
Sbjct: 159 VHAPSSRR-TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 25/213 (11%)
Query: 109 LGHGSSASVF----KGILS--DGTSVAVKRIN-GEENGEKEFRSEVAAIASAQHVNLVRL 161
           LG G+   VF      +L   D   VAVK +    E+  ++F+ E   +   QH ++VR 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 162 LGYCVVPGGPRYLVYEFIQNGSLDHWI---FPTSRRSEG--HYSGGCLSWDLRYRVAIDV 216
            G C   G P  +V+E++++G L+ ++    P ++   G    + G L       VA  V
Sbjct: 109 FGVC-TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK-LMSRDQ----SRCITTI 271
           A  + YL        +H D+   N L+ +     + DFG+S+ + S D      R +  I
Sbjct: 168 AAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 272 RGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           R    ++ PE IL +  + + D++S+G+VL E+
Sbjct: 225 R----WMPPESILYRKFTTESDVWSFGVVLWEI 253

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 93/192 (48%), Gaps = 20/192 (10%)
Query: 126 TSVAVKRINGEENGEKEFRSEVAAIAS----AQHVNLVRLLGYCVVPGGPRYLVYEFIQN 181
           T VAVK +  +   EK+    ++ +       +H N++ LLG C    GP Y++ E+   
Sbjct: 102 TKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASK 159
Query: 182 GSLDHWIFPTSRRSEG--------HYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLH 233
           G+L  ++   +RR  G        H     LS       A  VA+ + YL      + +H
Sbjct: 160 GNLREYL--QARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIH 214
Query: 234 LDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIRGTRGYLAPEWILEQGVSEKC 292
            D+   N+L+ E+    ++DFGL++ +   D  +  T  R    ++APE + ++  + + 
Sbjct: 215 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 274
Query: 293 DIYSYGMVLLEL 304
           D++S+G++L E+
Sbjct: 275 DVWSFGVLLWEI 286

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 93/213 (43%), Gaps = 28/213 (13%)
Query: 104 NFQALLGHGSSASVFKGILSDGTS---VAVKRINGEENGEKEFRS---EVAAIASAQHVN 157
           N   +LG GS   V K    D  +    AVK IN      K+  +   EV  +    H N
Sbjct: 25  NIVCMLGKGSFGEVLK--CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82
Query: 158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
           +++L    +      Y+V E    G L   I    R SE   +          R+   V 
Sbjct: 83  IMKLFE-ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA----------RIIKQVF 131
Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAV---VSDFGLSKLMSRDQSRCITTIRGT 274
             ++Y+H   +  ++H D+KPENILL+   +     + DFGLS      Q+  +    GT
Sbjct: 132 SGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--QNTKMKDRIGT 186
Query: 275 RGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
             Y+APE +L     EKCD++S G++L  L  G
Sbjct: 187 AYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 140 EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           E + R EV   +  +H N++RL GY        YL+ E+   G++   +   S+  E   
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT 110
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL 259
           +              ++A ALSY H+    RV+H D+KPEN+LL       ++DFG S  
Sbjct: 111 AT----------YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-- 155
Query: 260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           +    SR  T + GT  YL PE I  +   EK D++S G++  E   G+
Sbjct: 156 VHAPSSR-RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 140 EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           E + R EV   +  +H N++RL GY        YL+ E+   G++   +   S+  E   
Sbjct: 53  EHQLRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT 111
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL 259
           +              ++A ALSY H+    RV+H D+KPEN+LL       ++DFG S  
Sbjct: 112 AT----------YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-- 156
Query: 260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           +    SR  T + GT  YL PE I  +   EK D++S G++  E   G+
Sbjct: 157 VHAPSSR-RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 27/223 (12%)
Query: 105 FQALLGHGSSASVFK----GILSDGTS--VAVKRINGE-ENGEKE-FRSEVAAIAS-AQH 155
           F  +LG G+   V      GI   G S  VAVK +  + ++ E+E   SE+  +     H
Sbjct: 49  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWI-------------FPTSRRSEGHYSGG 202
            N+V LLG C +  GP YL++E+   G L +++             +   +R E      
Sbjct: 109 ENIVNLLGACTL-SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 203 CLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR 262
            L+++     A  VAK + +L        +H D+   N+L+       + DFGL++ +  
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 263 DQSRCI-TTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           D +  +    R    ++APE + E   + K D++SYG++L E+
Sbjct: 225 DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 129/293 (44%), Gaps = 50/293 (17%)
Query: 109 LGHGSSASVF----KGILSDG--TSVAVKRINGEENGEK--EFRSEVAAIASAQHVNLVR 160
           LG GS   V+    KG++ D   T VA+K +N   +  +  EF +E + +      ++VR
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 83
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG  V  G P  ++ E +  G L  ++       E +      S     ++A ++A  +
Sbjct: 84  LLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 142
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAP 280
           +YL+ +   + +H D+   N ++ E++   + DFG    M+RD        +G +G L  
Sbjct: 143 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPV 195
Query: 281 EWI----LEQGV-SEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEK 335
            W+    L+ GV +   D++S+G+VL E+       +L E          Q +  + NE+
Sbjct: 196 RWMSPESLKDGVFTTYSDVWSFGVVLWEIA------TLAE----------QPYQGLSNEQ 239
Query: 336 MKEGKLMEIVDQRLTDEGGI---DETQVRRLVDVAFWCIQERARLRPSMARVV 385
           +           R   EGG+    +     L ++   C Q   ++RPS   ++
Sbjct: 240 V----------LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 282

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 88/190 (46%), Gaps = 25/190 (13%)
Query: 125 GTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ 180
           G  VAVK +N ++    +   + R E+  +   +H ++++L      P    ++V E++ 
Sbjct: 41  GHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSD-IFMVMEYVS 99
Query: 181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPEN 240
            G L  +I    R  E              R+   +   + Y H   R  V+H D+KPEN
Sbjct: 100 GGELFDYICKNGRLDEKESR----------RLFQQILSGVDYCH---RHMVVHRDLKPEN 146
Query: 241 ILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWI---LEQGVSEKCDIYSY 297
           +LLD +  A ++DFGLS +MS      +    G+  Y APE I   L  G   + DI+S 
Sbjct: 147 VLLDAHMNAKIADFGLSNMMS--DGEFLRXSCGSPNYAAPEVISGRLYAG--PEVDIWSS 202
Query: 298 GMVLLELTGG 307
           G++L  L  G
Sbjct: 203 GVILYALLCG 212

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 120/231 (51%), Gaps = 21/231 (9%)
Query: 101 ATDNFQAL--LGHGSSASVFKGI-LSDGTSVAVK--RINGEENGEKEFRSEVAAIASAQH 155
           ++  F+ L  LG+G+ A+V+KG+  + G  VA+K  +++ EE        E++ +   +H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 156 VNLVRLLGYCVVPGGPRY-LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI 214
            N+VRL  Y V+    +  LV+EF+ N  L  ++     R+ G+   G L  +L      
Sbjct: 63  ENIVRL--YDVIHTENKLTLVFEFMDN-DLKKYM---DSRTVGNTPRG-LELNLVKYFQW 115
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGT 274
            + + L++ H +   ++LH D+KP+N+L+++  +  + DFGL++      +   + +  T
Sbjct: 116 QLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-T 171
Query: 275 RGYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNK 324
             Y AP+ ++  +  S   DI+S G +L E+  G+    L    ND+ + K
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK---PLFPGTNDEEQLK 219

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 140 EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           E + R EV   +  +H N++RL GY        YL+ E+   G++   +   S+  E   
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT 110
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL 259
           +              ++A ALSY H+    RV+H D+KPEN+LL       ++DFG S  
Sbjct: 111 AT----------YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-- 155
Query: 260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           +    SR  T + GT  YL PE I  +   EK D++S G++  E   G+
Sbjct: 156 VHAPSSR-RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 80/171 (46%), Gaps = 21/171 (12%)
Query: 140 EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           E + R EV   +  +H N++RL GY        YL+ E+   G++   +   S+  E   
Sbjct: 55  EHQLRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT 113
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS-- 257
           +              ++A ALSY H+    RV+H D+KPEN+LL       ++DFG S  
Sbjct: 114 AT----------YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVH 160
Query: 258 KLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
              SR  + C     GT  YL PE I  +   EK D++S G++  E   G+
Sbjct: 161 APSSRRAALC-----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 80/171 (46%), Gaps = 21/171 (12%)
Query: 140 EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           E + R EV   +  +H N++RL GY        YL+ E+   G++   +   S+  E   
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT 110
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS-- 257
           +              ++A ALSY H+    RV+H D+KPEN+LL       ++DFG S  
Sbjct: 111 AT----------YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVH 157
Query: 258 KLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
              SR  + C     GT  YL PE I  +   EK D++S G++  E   G+
Sbjct: 158 APSSRRAALC-----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 101/210 (48%), Gaps = 21/210 (10%)
Query: 109 LGHGSSASVF----KGILSDG--TSVAVKRINGEENGEK--EFRSEVAAIASAQHVNLVR 160
           LG GS   V+    KG++ D   T VA+K +N   +  +  EF +E + +      ++VR
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG  V  G P  ++ E +  G L  ++       E +      S     ++A ++A  +
Sbjct: 86  LLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 144
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAP 280
           +YL+ +   + +H D+   N ++ E++   + DFG    M+RD        +G +G L  
Sbjct: 145 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPV 197
Query: 281 EWI----LEQGV-SEKCDIYSYGMVLLELT 305
            W+    L+ GV +   D++S+G+VL E+ 
Sbjct: 198 RWMSPESLKDGVFTTYSDVWSFGVVLWEIA 227

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 140 EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           E + R EV   +  +H N++RL GY        YL+ E+   G++   +   S+  E   
Sbjct: 57  EHQLRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT 115
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL 259
           +              ++A ALSY H+    RV+H D+KPEN+LL       ++DFG S  
Sbjct: 116 AT----------YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-- 160
Query: 260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           +    SR  T + GT  YL PE I  +   EK D++S G++  E   G+
Sbjct: 161 VHAPSSR-RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 129/293 (44%), Gaps = 50/293 (17%)
Query: 109 LGHGSSASVF----KGILSDG--TSVAVKRINGEENGEK--EFRSEVAAIASAQHVNLVR 160
           LG GS   V+    KG++ D   T VA+K +N   +  +  EF +E + +      ++VR
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG  V  G P  ++ E +  G L  ++       E +      S     ++A ++A  +
Sbjct: 86  LLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 144
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAP 280
           +YL+ +   + +H D+   N ++ E++   + DFG    M+RD        +G +G L  
Sbjct: 145 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPV 197
Query: 281 EWI----LEQGV-SEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEK 335
            W+    L+ GV +   D++S+G+VL E+       +L E          Q +  + NE+
Sbjct: 198 RWMSPESLKDGVFTTYSDVWSFGVVLWEIA------TLAE----------QPYQGLSNEQ 241
Query: 336 MKEGKLMEIVDQRLTDEGGI---DETQVRRLVDVAFWCIQERARLRPSMARVV 385
           +           R   EGG+    +     L ++   C Q   ++RPS   ++
Sbjct: 242 V----------LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 284

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 140 EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           E + R EV   +  +H N++RL GY        YL+ E+   G++   +   S+  E   
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT 110
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL 259
           +              ++A ALSY H+    RV+H D+KPEN+LL       ++DFG S  
Sbjct: 111 AT----------YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-- 155
Query: 260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           +    SR  T + GT  YL PE I  +   EK D++S G++  E   G+
Sbjct: 156 VHAPSSR-RTELCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 81/169 (47%), Gaps = 17/169 (10%)
Query: 140 EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           E + R EV   +  +H N++RL GY        YL+ E+   G++   +   S+  E   
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT 110
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL 259
           +              ++A ALSY H+    RV+H D+KPEN+LL       ++DFG S  
Sbjct: 111 AT----------YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-- 155
Query: 260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           +    SR  T + GT  YL PE I  +   EK D++S G++  E   G+
Sbjct: 156 VHAPSSRR-TXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 129/293 (44%), Gaps = 50/293 (17%)
Query: 109 LGHGSSASVF----KGILSDG--TSVAVKRINGEENGEK--EFRSEVAAIASAQHVNLVR 160
           LG GS   V+    KG++ D   T VA+K +N   +  +  EF +E + +      ++VR
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG  V  G P  ++ E +  G L  ++       E +      S     ++A ++A  +
Sbjct: 87  LLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 145
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAP 280
           +YL+ +   + +H D+   N ++ E++   + DFG    M+RD        +G +G L  
Sbjct: 146 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPV 198
Query: 281 EWI----LEQGV-SEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEK 335
            W+    L+ GV +   D++S+G+VL E+       +L E          Q +  + NE+
Sbjct: 199 RWMSPESLKDGVFTTYSDVWSFGVVLWEIA------TLAE----------QPYQGLSNEQ 242
Query: 336 MKEGKLMEIVDQRLTDEGGI---DETQVRRLVDVAFWCIQERARLRPSMARVV 385
           +           R   EGG+    +     L ++   C Q   ++RPS   ++
Sbjct: 243 V----------LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 285

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 101/210 (48%), Gaps = 21/210 (10%)
Query: 109 LGHGSSASVF----KGILSDG--TSVAVKRINGEENGEK--EFRSEVAAIASAQHVNLVR 160
           LG GS   V+    KG++ D   T VA+K +N   +  +  EF +E + +      ++VR
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG  V  G P  ++ E +  G L  ++       E +      S     ++A ++A  +
Sbjct: 93  LLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 151
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAP 280
           +YL+ +   + +H D+   N ++ E++   + DFG    M+RD        +G +G L  
Sbjct: 152 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPV 204
Query: 281 EWI----LEQGV-SEKCDIYSYGMVLLELT 305
            W+    L+ GV +   D++S+G+VL E+ 
Sbjct: 205 RWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 101/210 (48%), Gaps = 21/210 (10%)
Query: 109 LGHGSSASVF----KGILSDG--TSVAVKRINGEENGEK--EFRSEVAAIASAQHVNLVR 160
           LG GS   V+    KG++ D   T VA+K +N   +  +  EF +E + +      ++VR
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG  V  G P  ++ E +  G L  ++       E +      S     ++A ++A  +
Sbjct: 80  LLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 138
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAP 280
           +YL+ +   + +H D+   N ++ E++   + DFG    M+RD        +G +G L  
Sbjct: 139 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPV 191
Query: 281 EWI----LEQGV-SEKCDIYSYGMVLLELT 305
            W+    L+ GV +   D++S+G+VL E+ 
Sbjct: 192 RWMSPESLKDGVFTTYSDVWSFGVVLWEIA 221

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 37/95 (38%), Positives = 54/95 (56%), Gaps = 4/95 (4%)
Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR 272
           A ++A AL YLH+     +++ D+KPENILLD     V++DFGL K  + + +   +T  
Sbjct: 145 AAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFC 200
Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           GT  YLAPE + +Q      D +  G VL E+  G
Sbjct: 201 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 129/293 (44%), Gaps = 50/293 (17%)
Query: 109 LGHGSSASVF----KGILSDG--TSVAVKRINGEENGEK--EFRSEVAAIASAQHVNLVR 160
           LG GS   V+    KG++ D   T VA+K +N   +  +  EF +E + +      ++VR
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG  V  G P  ++ E +  G L  ++       E +      S     ++A ++A  +
Sbjct: 115 LLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 173
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAP 280
           +YL+ +   + +H D+   N ++ E++   + DFG    M+RD        +G +G L  
Sbjct: 174 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPV 226
Query: 281 EWI----LEQGV-SEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEK 335
            W+    L+ GV +   D++S+G+VL E+       +L E          Q +  + NE+
Sbjct: 227 RWMSPESLKDGVFTTYSDVWSFGVVLWEIA------TLAE----------QPYQGLSNEQ 270
Query: 336 MKEGKLMEIVDQRLTDEGGI---DETQVRRLVDVAFWCIQERARLRPSMARVV 385
           +           R   EGG+    +     L ++   C Q   ++RPS   ++
Sbjct: 271 V----------LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 313

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 79/171 (46%), Gaps = 21/171 (12%)
Query: 140 EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           E + R EV   +  +H N++RL GY        YL+ E+   G++   +   S+  E   
Sbjct: 54  EHQLRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT 112
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS-- 257
           +              ++A ALSY H+    RV+H D+KPEN+LL       ++DFG S  
Sbjct: 113 AT----------YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVH 159
Query: 258 KLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
              SR    C     GT  YL PE I  +   EK D++S G++  E   G+
Sbjct: 160 APSSRRXXLC-----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 79/171 (46%), Gaps = 21/171 (12%)
Query: 140 EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           E + R EV   +  +H N++RL GY        YL+ E+   G++   +   S+  E   
Sbjct: 55  EHQLRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT 113
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS-- 257
           +              ++A ALSY H+    RV+H D+KPEN+LL       ++DFG S  
Sbjct: 114 AT----------YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVH 160
Query: 258 KLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
              SR    C     GT  YL PE I  +   EK D++S G++  E   G+
Sbjct: 161 APSSRRXXLC-----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 79/169 (46%), Gaps = 17/169 (10%)
Query: 140 EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           E + R EV   +  +H N++RL GY        YL+ E+   G +   +   S+  E   
Sbjct: 57  EHQLRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPRGEVYKELQKLSKFDEQRT 115
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL 259
           +              ++A ALSY H+    RV+H D+KPEN+LL       ++DFG S  
Sbjct: 116 AT----------YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS-- 160
Query: 260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           +    SR    + GT  YL PE I  +   EK D++S G++  E   G+
Sbjct: 161 VHAPSSRR-XXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 97/213 (45%), Gaps = 31/213 (14%)
Query: 106 QALLGHGSSASVF--KGILSDGTSVAVKRINGEENGEKEFRS----EVAAIASAQHVNLV 159
           Q +LG GS   V   K  ++ G   AVK I+  +  +K  +     EV  +    H N+ 
Sbjct: 31  QRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIX 89
Query: 160 RLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKA 219
           +L  +     G  YLV E    G L   I    R SE   +          R+   V   
Sbjct: 90  KLYEF-FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA----------RIIRQVLSG 138
Query: 220 LSYLHNDCRSRVLHLDVKPENILL-----DENYRAVVSDFGLSKLMSRDQSRCITTIRGT 274
           ++Y H   +++++H D+KPEN+LL     D N R +  DFGLS     + S+      GT
Sbjct: 139 ITYXH---KNKIVHRDLKPENLLLESKSKDANIRII--DFGLSTHF--EASKKXKDKIGT 191
Query: 275 RGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
             Y+APE +L     EKCD++S G++L  L  G
Sbjct: 192 AYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 35/223 (15%)
Query: 98  LEEATDNFQALLGHGSSASV---FKGILSDGTS--VAVKRI-NGEENGEKEFRSEVAAIA 151
            EE    + + LG G+  SV       L D T   VAVK++ +   + +++F+ E+  + 
Sbjct: 4   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 63
Query: 152 SAQHVNLVRLLGYCVVPGGPRY-LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRY 210
           +     +V+  G    PG P   LV E++ +G L  ++                    R+
Sbjct: 64  ALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFL-------------------QRH 104
Query: 211 RVAIDVAKALSYLHNDCRS-------RVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD 263
           R  +D ++ L Y    C+        R +H D+   NIL++      ++DFGL+KL+  D
Sbjct: 105 RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 164
Query: 264 QSRCITTIRGTRG--YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +   +    G     + APE + +   S + D++S+G+VL EL
Sbjct: 165 KDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 207

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 25/213 (11%)
Query: 109 LGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFR--SEVAAIASAQHVNLVRLLGYC 165
           LG G    V + I  D G  VA+K+   E + +   R   E+  +    H N+V      
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 166 -----VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI-DVAKA 219
                + P     L  E+ + G L        R+    +   C   +   R  + D++ A
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDL--------RKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 220 LSYLHNDCRSRVLHLDVKPENILLDENYRAVVS---DFGLSKLMSRDQSRCITTIRGTRG 276
           L YLH +   R++H D+KPENI+L    + ++    D G +K +  DQ    T   GT  
Sbjct: 134 LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQ 188
Query: 277 YLAPEWILEQGVSEKCDIYSYGMVLLELTGGRR 309
           YLAPE + ++  +   D +S+G +  E   G R
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 25/213 (11%)
Query: 109 LGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFR--SEVAAIASAQHVNLVRLLGYC 165
           LG G    V + I  D G  VA+K+   E + +   R   E+  +    H N+V      
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 82
Query: 166 -----VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI-DVAKA 219
                + P     L  E+ + G L        R+    +   C   +   R  + D++ A
Sbjct: 83  DGLQKLAPNDLPLLAMEYCEGGDL--------RKYLNQFENCCGLKEGPIRTLLSDISSA 134
Query: 220 LSYLHNDCRSRVLHLDVKPENILLDENYRAVVS---DFGLSKLMSRDQSRCITTIRGTRG 276
           L YLH +   R++H D+KPENI+L    + ++    D G +K +  DQ    T   GT  
Sbjct: 135 LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQ 189
Query: 277 YLAPEWILEQGVSEKCDIYSYGMVLLELTGGRR 309
           YLAPE + ++  +   D +S+G +  E   G R
Sbjct: 190 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 222

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 79/171 (46%), Gaps = 21/171 (12%)
Query: 140 EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           E + R EV   +  +H N++RL GY        YL+ E+   G++   +   S+  E   
Sbjct: 78  EHQLRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT 136
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS-- 257
           +              ++A ALSY H+    RV+H D+KPEN+LL       ++DFG S  
Sbjct: 137 AT----------YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVH 183
Query: 258 KLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
              SR    C     GT  YL PE I  +   EK D++S G++  E   G+
Sbjct: 184 APSSRRDDLC-----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 79/171 (46%), Gaps = 21/171 (12%)
Query: 140 EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           E + R EV   +  +H N++RL GY        YL+ E+   G++   +   S+  E   
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT 110
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS-- 257
           +              ++A ALSY H+    RV+H D+KPEN+LL       ++DFG S  
Sbjct: 111 AT----------YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVH 157
Query: 258 KLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
              SR    C     GT  YL PE I  +   EK D++S G++  E   G+
Sbjct: 158 APSSRRXXLC-----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 79/171 (46%), Gaps = 21/171 (12%)
Query: 140 EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           E + R EV   +  +H N++RL GY        YL+ E+   G++   +   S+  E   
Sbjct: 55  EHQLRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT 113
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS-- 257
           +              ++A ALSY H+    RV+H D+KPEN+LL       ++DFG S  
Sbjct: 114 AT----------YITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVH 160
Query: 258 KLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
              SR    C     GT  YL PE I  +   EK D++S G++  E   G+
Sbjct: 161 APSSRRDDLC-----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 17/200 (8%)
Query: 109 LGHGS-SASVFKGILSDGTSVAVKRINGEENGEKE---FRSEVAAIASAQHVNLVRLLGY 164
           +G GS   ++      DG    +K IN      KE    R EVA +A+ +H N+V+    
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE- 90
Query: 165 CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH 224
                G  Y+V ++ + G L   I   +++         L W       + +  AL ++H
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRI--NAQKGVLFQEDQILDW------FVQICLALKHVH 142
Query: 225 NDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWIL 284
           +    ++LH D+K +NI L ++    + DFG++++++         I GT  YL+PE   
Sbjct: 143 D---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICE 198
Query: 285 EQGVSEKCDIYSYGMVLLEL 304
            +  + K DI++ G VL EL
Sbjct: 199 NKPYNNKSDIWALGCVLYEL 218

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 80/171 (46%), Gaps = 28/171 (16%)
Query: 142 EFRSEVAAIASAQHVNLVRLLGYCVVPGG------PRYLVYEFIQNGSL---DHWIFPTS 192
           +F++E+  I   ++        YC+   G        Y++YE+++N S+   D + F   
Sbjct: 89  DFKNELQIITDIKN-------EYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLD 141
Query: 193 RRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVS 252
           +          +   ++      V  + SY+HN+    + H DVKP NIL+D+N R  +S
Sbjct: 142 KNYTCFIPIQVIKCIIK-----SVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLS 194
Query: 253 DFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSE--KCDIYSYGMVL 301
           DFG S+ M     + I   RGT  ++ PE+   +      K DI+S G+ L
Sbjct: 195 DFGESEYMV---DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 97/194 (50%), Gaps = 20/194 (10%)
Query: 124 DGTSVAVKRINGEENGEKEFRSEVAAIAS----AQHVNLVRLLGYCVVPGGPRYLVYEFI 179
           +  +VAVK +  ++  EK+    V+ +       +H N++ LLG C    GP Y++ E+ 
Sbjct: 66  EAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYA 123
Query: 180 QNGSLDHWIFPTSRRSEG-HYSGGC-------LSWDLRYRVAIDVAKALSYLHNDCRSRV 231
             G+L  ++   +RR  G  YS          +++         +A+ + YL      + 
Sbjct: 124 SKGNLREYL--RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKC 178
Query: 232 LHLDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIRGTRGYLAPEWILEQGVSE 290
           +H D+   N+L+ EN    ++DFGL++ ++  D  +  T  R    ++APE + ++  + 
Sbjct: 179 IHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTH 238
Query: 291 KCDIYSYGMVLLEL 304
           + D++S+G+++ E+
Sbjct: 239 QSDVWSFGVLMWEI 252

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 92/185 (49%), Gaps = 12/185 (6%)
Query: 128 VAVKRINGEENG-EKE-FRSEVAAIAS-AQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL 184
           VAVK +    +  EKE   SE+  ++   QH N+V LLG C   GGP  ++ E+   G L
Sbjct: 79  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT-HGGPVLVITEYCCYGDL 137
Query: 185 DHWIFPTSRRSEGHYSGGCLSWDLRYR----VAIDVAKALSYLHNDCRSRVLHLDVKPEN 240
            +++   SR  E   +    +  L  R     +  VA+ +++L        +H DV   N
Sbjct: 138 LNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARN 194
Query: 241 ILLDENYRAVVSDFGLSKLMSRDQSRCIT-TIRGTRGYLAPEWILEQGVSEKCDIYSYGM 299
           +LL   + A + DFGL++ +  D +  +    R    ++APE I +   + + D++SYG+
Sbjct: 195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 254
Query: 300 VLLEL 304
           +L E+
Sbjct: 255 LLWEI 259

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 129/293 (44%), Gaps = 50/293 (17%)
Query: 109 LGHGSSASVF----KGILSDG--TSVAVKRINGEENGEK--EFRSEVAAIASAQHVNLVR 160
           LG GS   V+    KG++ D   T VA+K +N   +  +  EF +E + +      ++VR
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG  V  G P  ++ E +  G L  ++       E +      S     ++A ++A  +
Sbjct: 80  LLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 138
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAP 280
           +YL+ +   + +H D+   N  + E++   + DFG    M+RD        +G +G L  
Sbjct: 139 AYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPV 191
Query: 281 EWI----LEQGV-SEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEK 335
            W+    L+ GV +   D++S+G+VL E+       +L E          Q +  + NE+
Sbjct: 192 RWMSPESLKDGVFTTYSDVWSFGVVLWEIA------TLAE----------QPYQGLSNEQ 235
Query: 336 MKEGKLMEIVDQRLTDEGGI---DETQVRRLVDVAFWCIQERARLRPSMARVV 385
           +           R   EGG+    +     L+++   C Q   ++RPS   ++
Sbjct: 236 V----------LRFVMEGGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEII 278

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 40/128 (31%), Positives = 66/128 (51%), Gaps = 9/128 (7%)
Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR 272
           A +V  AL YLH+     +++ D+KPENILLD+N    ++DFG +K +          + 
Sbjct: 112 AAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYXLC 164
Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNV--SLIEHGNDKSKNKWQYFPK 330
           GT  Y+APE +  +  ++  D +S+G+++ E+  G      S      +K  N    FP 
Sbjct: 165 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP 224
Query: 331 IVNEKMKE 338
             NE +K+
Sbjct: 225 FFNEDVKD 232

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 92/192 (47%), Gaps = 20/192 (10%)
Query: 126 TSVAVKRINGEENGEKEFRSEVAAIAS----AQHVNLVRLLGYCVVPGGPRYLVYEFIQN 181
           T VAVK +  +   EK+    ++ +       +H N++ LLG C    GP Y++ E+   
Sbjct: 61  TKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYASK 118
Query: 182 GSLDHWIFPTSRRSEG--------HYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLH 233
           G+L  ++   +R   G        H     LS       A  VA+ + YL      + +H
Sbjct: 119 GNLREYL--QAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIH 173
Query: 234 LDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIRGTRGYLAPEWILEQGVSEKC 292
            D+   N+L+ E+    ++DFGL++ +   D  +  T  R    ++APE + ++  + + 
Sbjct: 174 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 233
Query: 293 DIYSYGMVLLEL 304
           D++S+G++L E+
Sbjct: 234 DVWSFGVLLWEI 245

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 107/231 (46%), Gaps = 47/231 (20%)
Query: 97  ELEEATDNFQALLGHGSSASVFKG-ILSDGTSVAVKRINGEENG-EKEFRSEVAAIASAQ 154
           E +E  D  + +LG G+   V+ G  LS+   +A+K I   ++   +    E+A     +
Sbjct: 20  EYDENGD--RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLK 77
Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYR--- 211
           H N+V+ LG              F +NG +  ++            GG LS  LR +   
Sbjct: 78  HKNIVQYLG-------------SFSENGFIKIFM--------EQVPGGSLSALLRSKWGP 116
Query: 212 ----------VAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV--VSDFGLSKL 259
                         + + L YLH++   +++H D+K +N+L++  Y  V  +SDFG SK 
Sbjct: 117 LKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLIN-TYSGVLKISDFGTSKR 172
Query: 260 MSRDQSRCITTIRGTRGYLAPEWILE--QGVSEKCDIYSYGMVLLELTGGR 308
           ++   + C  T  GT  Y+APE I +  +G  +  DI+S G  ++E+  G+
Sbjct: 173 LA-GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 97/227 (42%), Gaps = 37/227 (16%)
Query: 98  LEEATDNFQAL--LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQH 155
           +E   D+F+ +  LG G+   VFK            + +G     K    E+      Q 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK---------VSHKPSGLVMARKLIHLEIKPAIRNQI 51
Query: 156 VNLVRLLGYCVVP-----------GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCL 204
           +  +++L  C  P            G   +  E +  GSLD  +    R  E        
Sbjct: 52  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-------- 103
Query: 205 SWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ 264
              +  +V+I V K L+YL    + +++H DVKP NIL++      + DFG+S  +    
Sbjct: 104 --QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159
Query: 265 SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNV 311
           +    +  GTR Y++PE +     S + DI+S G+ L+E+  GR  +
Sbjct: 160 A---NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 97/227 (42%), Gaps = 37/227 (16%)
Query: 98  LEEATDNFQAL--LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQH 155
           +E   D+F+ +  LG G+   VFK            + +G     K    E+      Q 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK---------VSHKPSGLVMARKLIHLEIKPAIRNQI 51
Query: 156 VNLVRLLGYCVVP-----------GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCL 204
           +  +++L  C  P            G   +  E +  GSLD  +    R  E        
Sbjct: 52  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-------- 103
Query: 205 SWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ 264
              +  +V+I V K L+YL    + +++H DVKP NIL++      + DFG+S  +    
Sbjct: 104 --QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159
Query: 265 SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNV 311
           +    +  GTR Y++PE +     S + DI+S G+ L+E+  GR  +
Sbjct: 160 A---NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 80/171 (46%), Gaps = 21/171 (12%)
Query: 140 EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           E + R EV   +  +H N++RL GY        YL+ E+   G++   +   S+  E   
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGY-FHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRT 110
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS-- 257
           +              ++A ALSY H+    +V+H D+KPEN+LL       ++DFG S  
Sbjct: 111 AT----------YITELANALSYCHS---KKVIHRDIKPENLLLGSAGELKIADFGWSVH 157
Query: 258 KLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
              SR  + C     GT  YL PE I  +   EK D++S G++  E   G+
Sbjct: 158 APSSRRAALC-----GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 68/139 (48%), Gaps = 15/139 (10%)
Query: 174 LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLH 233
           +  E +  GSLD  +    R  E          ++  +V+I V + L+YL    + +++H
Sbjct: 91  ICMEHMDGGSLDQVLKEAKRIPE----------EILGKVSIAVLRGLAYLRE--KHQIMH 138
Query: 234 LDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCD 293
            DVKP NIL++      + DFG+S  +    +       GTR Y+APE +     S + D
Sbjct: 139 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMAPERLQGTHYSVQSD 195
Query: 294 IYSYGMVLLELTGGRRNVS 312
           I+S G+ L+EL  GR  + 
Sbjct: 196 IWSMGLSLVELAVGRYPIP 214

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 97/194 (50%), Gaps = 20/194 (10%)
Query: 124 DGTSVAVKRINGEENGEKEFRSEVAAIAS----AQHVNLVRLLGYCVVPGGPRYLVYEFI 179
           +  +VAVK +  ++  EK+    V+ +       +H N++ LLG C    GP Y++ E+ 
Sbjct: 66  EAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYA 123
Query: 180 QNGSLDHWIFPTSRRSEG-HYSGGC-------LSWDLRYRVAIDVAKALSYLHNDCRSRV 231
             G+L  ++   +RR  G  YS          +++         +A+ + YL      + 
Sbjct: 124 SKGNLREYL--RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKC 178
Query: 232 LHLDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIRGTRGYLAPEWILEQGVSE 290
           +H D+   N+L+ EN    ++DFGL++ ++  D  +  T  R    ++APE + ++  + 
Sbjct: 179 IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTH 238
Query: 291 KCDIYSYGMVLLEL 304
           + D++S+G+++ E+
Sbjct: 239 QSDVWSFGVLMWEI 252

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 107/231 (46%), Gaps = 47/231 (20%)
Query: 97  ELEEATDNFQALLGHGSSASVFKG-ILSDGTSVAVKRINGEEN-GEKEFRSEVAAIASAQ 154
           E +E  D  + +LG G+   V+ G  LS+   +A+K I   ++   +    E+A     +
Sbjct: 6   EYDENGD--RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLK 63
Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYR--- 211
           H N+V+ LG              F +NG +  ++            GG LS  LR +   
Sbjct: 64  HKNIVQYLG-------------SFSENGFIKIFM--------EQVPGGSLSALLRSKWGP 102
Query: 212 ----------VAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV--VSDFGLSKL 259
                         + + L YLH++   +++H D+K +N+L++  Y  V  +SDFG SK 
Sbjct: 103 LKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLIN-TYSGVLKISDFGTSKR 158
Query: 260 MSRDQSRCITTIRGTRGYLAPEWILE--QGVSEKCDIYSYGMVLLELTGGR 308
           ++   + C  T  GT  Y+APE I +  +G  +  DI+S G  ++E+  G+
Sbjct: 159 LA-GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 97/227 (42%), Gaps = 37/227 (16%)
Query: 98  LEEATDNFQAL--LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQH 155
           +E   D+F+ +  LG G+   VFK            + +G     K    E+      Q 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK---------VSHKPSGLVMARKLIHLEIKPAIRNQI 51
Query: 156 VNLVRLLGYCVVP-----------GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCL 204
           +  +++L  C  P            G   +  E +  GSLD  +    R  E        
Sbjct: 52  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-------- 103
Query: 205 SWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ 264
              +  +V+I V K L+YL    + +++H DVKP NIL++      + DFG+S  +    
Sbjct: 104 --QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159
Query: 265 SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNV 311
           +    +  GTR Y++PE +     S + DI+S G+ L+E+  GR  +
Sbjct: 160 A---NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 91/190 (47%), Gaps = 25/190 (13%)
Query: 125 GTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ 180
           G  VAVK +N ++    +   + + E+  +   +H ++++L      P    ++V E++ 
Sbjct: 36  GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD-FFMVMEYVS 94
Query: 181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPEN 240
            G L  +I    R  E          + R R+   +  A+ Y H   R  V+H D+KPEN
Sbjct: 95  GGELFDYICKHGRVEE---------MEAR-RLFQQILSAVDYCH---RHMVVHRDLKPEN 141
Query: 241 ILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWI---LEQGVSEKCDIYSY 297
           +LLD +  A ++DFGLS +MS      +    G+  Y APE I   L  G   + DI+S 
Sbjct: 142 VLLDAHMNAKIADFGLSNMMS--DGEFLRDSCGSPNYAAPEVISGRLYAG--PEVDIWSC 197
Query: 298 GMVLLELTGG 307
           G++L  L  G
Sbjct: 198 GVILYALLCG 207

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 97/194 (50%), Gaps = 20/194 (10%)
Query: 124 DGTSVAVKRINGEENGEKEFRSEVAAIAS----AQHVNLVRLLGYCVVPGGPRYLVYEFI 179
           +  +VAVK +  ++  EK+    V+ +       +H N++ LLG C    GP Y++ E+ 
Sbjct: 112 EAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYA 169
Query: 180 QNGSLDHWIFPTSRRSEG-HYSGGC-------LSWDLRYRVAIDVAKALSYLHNDCRSRV 231
             G+L  ++   +RR  G  YS          +++         +A+ + YL      + 
Sbjct: 170 SKGNLREYL--RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKC 224
Query: 232 LHLDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIRGTRGYLAPEWILEQGVSE 290
           +H D+   N+L+ EN    ++DFGL++ ++  D  +  T  R    ++APE + ++  + 
Sbjct: 225 IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 284
Query: 291 KCDIYSYGMVLLEL 304
           + D++S+G+++ E+
Sbjct: 285 QSDVWSFGVLMWEI 298

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 105/252 (41%), Gaps = 39/252 (15%)
Query: 98  LEEATDNFQAL--LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQH 155
           +E   D+F+ +  LG G+   VFK            + +G     K    E+      Q 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK---------VSHKPSGLVMARKLIHLEIKPAIRNQI 51
Query: 156 VNLVRLLGYCVVP-----------GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCL 204
           +  +++L  C  P            G   +  E +  GSLD  +    R  E        
Sbjct: 52  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-------- 103
Query: 205 SWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ 264
              +  +V+I V K L+YL    + +++H DVKP NIL++      + DFG+S  +    
Sbjct: 104 --QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159
Query: 265 SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNK 324
           +    +  GTR Y++PE +     S + DI+S G+ L+E+  GR  +   +   D     
Sbjct: 160 A---NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPM 216
Query: 325 --WQYFPKIVNE 334
             ++    IVNE
Sbjct: 217 AIFELLDYIVNE 228

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 97/227 (42%), Gaps = 37/227 (16%)
Query: 98  LEEATDNFQAL--LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQH 155
           +E   D+F+ +  LG G+   VFK            + +G     K    E+      Q 
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK---------VSHKPSGLVMARKLIHLEIKPAIRNQI 51
Query: 156 VNLVRLLGYCVVP-----------GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCL 204
           +  +++L  C  P            G   +  E +  GSLD  +    R  E        
Sbjct: 52  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-------- 103
Query: 205 SWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ 264
              +  +V+I V K L+YL    + +++H DVKP NIL++      + DFG+S  +    
Sbjct: 104 --QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159
Query: 265 SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNV 311
           +    +  GTR Y++PE +     S + DI+S G+ L+E+  GR  +
Sbjct: 160 A---NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/190 (24%), Positives = 89/190 (46%), Gaps = 30/190 (15%)
Query: 201 GGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM 260
           G  +  D+  ++A+ + KAL +LH+  +  V+H DVKP N+L++   +    DFG+S  +
Sbjct: 130 GQTIPEDILGKIAVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKXCDFGISGYL 187
Query: 261 SRDQSRCITTIRGTRGYLAPEWI----LEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEH 316
             D ++ I    G + Y APE I     ++G S K DI+S G+  +EL       +++  
Sbjct: 188 VDDVAKDIDA--GCKPYXAPERINPELNQKGYSVKSDIWSLGITXIEL-------AILRF 238
Query: 317 GNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERAR 376
             D     +Q   ++V E        ++   + + E           VD    C+++ ++
Sbjct: 239 PYDSWGTPFQQLKQVVEEPSP-----QLPADKFSAE----------FVDFTSQCLKKNSK 283
Query: 377 LRPSMARVVE 386
            RP+   + +
Sbjct: 284 ERPTYPELXQ 293

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 97/194 (50%), Gaps = 20/194 (10%)
Query: 124 DGTSVAVKRINGEENGEKEFRSEVAAIAS----AQHVNLVRLLGYCVVPGGPRYLVYEFI 179
           +  +VAVK +  ++  EK+    V+ +       +H N++ LLG C    GP Y++ E+ 
Sbjct: 66  EAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQ-DGPLYVIVEYA 123
Query: 180 QNGSLDHWIFPTSRRSEG-HYSGGC-------LSWDLRYRVAIDVAKALSYLHNDCRSRV 231
             G+L  ++   +RR  G  YS          +++         +A+ + YL      + 
Sbjct: 124 SKGNLREYL--RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKC 178
Query: 232 LHLDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIRGTRGYLAPEWILEQGVSE 290
           +H D+   N+L+ EN    ++DFGL++ ++  D  +  T  R    ++APE + ++  + 
Sbjct: 179 IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 238
Query: 291 KCDIYSYGMVLLEL 304
           + D++S+G+++ E+
Sbjct: 239 QSDVWSFGVLMWEI 252

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 96/198 (48%), Gaps = 28/198 (14%)
Query: 124 DGTSVAVKRINGEENGEKEFRSEVAAIAS----AQHVNLVRLLGYCVVPGGPRYLVYEFI 179
           +  +VAVK +  ++  EK+    V+ +       +H N++ LLG C    GP Y++ E+ 
Sbjct: 66  EAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYA 123
Query: 180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLR------------YRVAIDVAKALSYLHNDC 227
             G+L  ++   +RR  G       S+D+                   +A+ + YL    
Sbjct: 124 SKGNLREYL--RARRPPGMEX----SYDINRVPEEQMTFKDLVSCTYQLARGMEYL---A 174
Query: 228 RSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIRGTRGYLAPEWILEQ 286
             + +H D+   N+L+ EN    ++DFGL++ ++  D  +  T  R    ++APE + ++
Sbjct: 175 SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDR 234
Query: 287 GVSEKCDIYSYGMVLLEL 304
             + + D++S+G+++ E+
Sbjct: 235 VYTHQSDVWSFGVLMWEI 252

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/193 (24%), Positives = 96/193 (49%), Gaps = 18/193 (9%)
Query: 124 DGTSVAVKRINGEENGE--KEFRSEVAAIAS-AQHVNLVRLLGYCVVPGGPRYLVYEFIQ 180
           +  +VAVK +  +   E   +  SE+  +    +H N++ LLG C    GP Y++ E+  
Sbjct: 66  EAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYAS 124
Query: 181 NGSLDHWIFPTSRRSEG-HYSGGC-------LSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
            G+L  ++   +RR  G  YS          +++         +A+ + YL      + +
Sbjct: 125 KGNLREYL--RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCI 179
Query: 233 HLDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           H D+   N+L+ EN    ++DFGL++ ++  D  +  T  R    ++APE + ++  + +
Sbjct: 180 HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ 239
Query: 292 CDIYSYGMVLLEL 304
            D++S+G+++ E+
Sbjct: 240 SDVWSFGVLMWEI 252

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 94/224 (41%), Gaps = 39/224 (17%)
Query: 107 ALLGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLG-- 163
           A+LG G+   V K   + D    A+K+I   E       SEV  +AS  H  +VR     
Sbjct: 12  AVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVRYYAAW 71
Query: 164 ----------YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVA 213
                       V      ++  E+ +N +L   I         H        D  +R+ 
Sbjct: 72  LERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLI---------HSENLNQQRDEYWRLF 122
Query: 214 IDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD---------- 263
             + +ALSY+H+     ++H ++KP NI +DE+    + DFGL+K + R           
Sbjct: 123 RQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 264 ---QSRCITTIRGTRGYLAPEWILEQG-VSEKCDIYSYGMVLLE 303
               S  +T+  GT  Y+A E +   G  +EK D YS G++  E
Sbjct: 180 LPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 97/228 (42%), Gaps = 37/228 (16%)
Query: 94  RSKELEEATDNFQAL--LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIA 151
           + K  E   D+F+ +  LG G+   VFK            + +G     K    E+    
Sbjct: 16  KQKVGELKDDDFEKISELGAGNGGVVFK---------VSHKPSGLVMARKLIHLEIKPAI 66
Query: 152 SAQHVNLVRLLGYCVVP-----------GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYS 200
             Q +  +++L  C  P            G   +  E +  GSLD  +    R  E    
Sbjct: 67  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE---- 122
Query: 201 GGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM 260
                  +  +V+I V K L+YL    + +++H DVKP NIL++      + DFG+S  +
Sbjct: 123 ------QILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 174
Query: 261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
               +    +  GTR Y++PE +     S + DI+S G+ L+E+  GR
Sbjct: 175 IDSMA---NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 98/194 (50%), Gaps = 20/194 (10%)
Query: 124 DGTSVAVKRINGEENGEKEFRSEVAAIAS----AQHVNLVRLLGYCVVPGGPRYLVYEFI 179
           +  +VAVK +  ++  EK+    V+ +       +H N++ LLG C    GP Y++ E+ 
Sbjct: 53  EAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYA 110
Query: 180 QNGSLDHWIFPTSRRSEG-HYSGGC-------LSWDLRYRVAIDVAKALSYLHNDCRSRV 231
             G+L  ++   +RR  G  YS          +++         +A+ + YL +    + 
Sbjct: 111 SKGNLREYL--RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKC 165
Query: 232 LHLDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIRGTRGYLAPEWILEQGVSE 290
           +H D+   N+L+ EN    ++DFGL++ ++  D  +  T  R    ++APE + ++  + 
Sbjct: 166 IHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 225
Query: 291 KCDIYSYGMVLLEL 304
           + D++S+G+++ E+
Sbjct: 226 QSDVWSFGVLMWEI 239

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 68/139 (48%), Gaps = 15/139 (10%)
Query: 174 LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLH 233
           +  E +  GSLD  +    R  E           +  +V+I V K L+YL    + +++H
Sbjct: 108 ICMEHMDGGSLDQVLKKAGRIPE----------QILGKVSIAVIKGLTYLRE--KHKIMH 155
Query: 234 LDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCD 293
            DVKP NIL++      + DFG+S  +    +    +  GTR Y++PE +     S + D
Sbjct: 156 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPERLQGTHYSVQSD 212
Query: 294 IYSYGMVLLELTGGRRNVS 312
           I+S G+ L+E+  GR  + 
Sbjct: 213 IWSMGLSLVEMAVGRYPIP 231

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 72/242 (29%), Positives = 98/242 (40%), Gaps = 41/242 (16%)
Query: 103 DNFQAL--LGHGSSASVFKGILS--DGTSVAVKRINGEENGEKEFRSEVAAIAS----AQ 154
            +FQ L  LGHGS   VFK + S  DG   AVKR      G K+   ++A + S     Q
Sbjct: 57  QSFQRLSRLGHGSYGEVFK-VRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115
Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI 214
           H   VRL       GG  YL  E        H                C +W      A 
Sbjct: 116 HPCCVRL-EQAWEEGGILYLQTELCGPSLQQH----------------CEAWGASLPEAQ 158
Query: 215 ------DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI 268
                 D   AL++LH+     ++HLDVKP NI L    R  + DFGL  L+    +   
Sbjct: 159 VWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGL--LVELGTAGAG 213
Query: 269 TTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYF 328
               G   Y+APE +L+       D++S G+ +LE+     N+ L   G    + +  Y 
Sbjct: 214 EVQEGDPRYMAPE-LLQGSYGTAADVFSLGLTILEVAC---NMELPHGGEGWQQLRQGYL 269
Query: 329 PK 330
           P 
Sbjct: 270 PP 271

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 73/139 (52%), Gaps = 17/139 (12%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           +LV E +  G L   I     + + H+S    S+ +R  V+     A+S++H+     V+
Sbjct: 82  FLVMELLNGGELFERI-----KKKKHFSETEASYIMRKLVS-----AVSHMHD---VGVV 128
Query: 233 HLDVKPENILL---DENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVS 289
           H D+KPEN+L    ++N    + DFG ++L   D ++ + T   T  Y APE + + G  
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQPLKTPCFTLHYAAPELLNQNGYD 187
Query: 290 EKCDIYSYGMVLLELTGGR 308
           E CD++S G++L  +  G+
Sbjct: 188 ESCDLWSLGVILYTMLSGQ 206

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 97/194 (50%), Gaps = 20/194 (10%)
Query: 124 DGTSVAVKRINGEENGEKEFRSEVAAIAS----AQHVNLVRLLGYCVVPGGPRYLVYEFI 179
           +  +VAVK +  ++  EK+    V+ +       +H N++ LLG C    GP Y++ E+ 
Sbjct: 58  EAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYA 115
Query: 180 QNGSLDHWIFPTSRRSEG-HYSGGC-------LSWDLRYRVAIDVAKALSYLHNDCRSRV 231
             G+L  ++   +RR  G  YS          +++         +A+ + YL      + 
Sbjct: 116 SKGNLREYL--RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKC 170
Query: 232 LHLDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIRGTRGYLAPEWILEQGVSE 290
           +H D+   N+L+ EN    ++DFGL++ ++  D  +  T  R    ++APE + ++  + 
Sbjct: 171 IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 230
Query: 291 KCDIYSYGMVLLEL 304
           + D++S+G+++ E+
Sbjct: 231 QSDVWSFGVLMWEI 244

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 97/194 (50%), Gaps = 20/194 (10%)
Query: 124 DGTSVAVKRINGEENGEKEFRSEVAAIAS----AQHVNLVRLLGYCVVPGGPRYLVYEFI 179
           +  +VAVK +  ++  EK+    V+ +       +H N++ LLG C    GP Y++ E+ 
Sbjct: 66  EAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQ-DGPLYVIVEYA 123
Query: 180 QNGSLDHWIFPTSRRSEG-HYSGGC-------LSWDLRYRVAIDVAKALSYLHNDCRSRV 231
             G+L  ++   +RR  G  YS          +++         +A+ + YL      + 
Sbjct: 124 SKGNLREYL--RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKC 178
Query: 232 LHLDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIRGTRGYLAPEWILEQGVSE 290
           +H D+   N+L+ EN    ++DFGL++ ++  D  +  T  R    ++APE + ++  + 
Sbjct: 179 IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 238
Query: 291 KCDIYSYGMVLLEL 304
           + D++S+G+++ E+
Sbjct: 239 QSDVWSFGVLMWEI 252

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 88/204 (43%), Gaps = 19/204 (9%)
Query: 109 LGHGSSASV---FKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYC 165
           LG G+   V      +  +  +V +  +    +  +  + E+   A   H N+V+  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGH- 73
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
              G  +YL  E+   G L   I P     E              R    +   + YLH 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ----------RFFHQLMAGVVYLHG 123
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS-RDQSRCITTIRGTRGYLAPEWIL 284
                + H D+KPEN+LLDE     +SDFGL+ +    ++ R +  + GT  Y+APE + 
Sbjct: 124 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 285 EQGV-SEKCDIYSYGMVLLELTGG 307
            +   +E  D++S G+VL  +  G
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 97/194 (50%), Gaps = 20/194 (10%)
Query: 124 DGTSVAVKRINGEENGEKEFRSEVAAIAS----AQHVNLVRLLGYCVVPGGPRYLVYEFI 179
           +  +VAVK +  ++  EK+    V+ +       +H N++ LLG C    GP Y++ E+ 
Sbjct: 66  EAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYA 123
Query: 180 QNGSLDHWIFPTSRRSEG-HYSGGC-------LSWDLRYRVAIDVAKALSYLHNDCRSRV 231
             G+L  ++   +RR  G  YS          +++         +A+ + YL      + 
Sbjct: 124 SKGNLREYL--RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKC 178
Query: 232 LHLDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIRGTRGYLAPEWILEQGVSE 290
           +H D+   N+L+ EN    ++DFGL++ ++  D  +  T  R    ++APE + ++  + 
Sbjct: 179 IHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 238
Query: 291 KCDIYSYGMVLLEL 304
           + D++S+G+++ E+
Sbjct: 239 QSDVWSFGVLMWEI 252

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 67/139 (48%), Gaps = 15/139 (10%)
Query: 174 LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLH 233
           +  E +  GSLD  +    R  E           +  +V+I V K L+YL    + +++H
Sbjct: 143 ICMEHMDGGSLDQVLKKAGRIPE----------QILGKVSIAVIKGLTYLRE--KHKIMH 190
Query: 234 LDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCD 293
            DVKP NIL++      + DFG+S  +    +       GTR Y++PE +     S + D
Sbjct: 191 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSVQSD 247
Query: 294 IYSYGMVLLELTGGRRNVS 312
           I+S G+ L+E+  GR  + 
Sbjct: 248 IWSMGLSLVEMAVGRYPIP 266

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 97/194 (50%), Gaps = 20/194 (10%)
Query: 124 DGTSVAVKRINGEENGEKEFRSEVAAIAS----AQHVNLVRLLGYCVVPGGPRYLVYEFI 179
           +  +VAVK +  ++  EK+    V+ +       +H N++ LLG C    GP Y++ E+ 
Sbjct: 55  EAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVEYA 112
Query: 180 QNGSLDHWIFPTSRRSEG-HYSGGC-------LSWDLRYRVAIDVAKALSYLHNDCRSRV 231
             G+L  ++   +RR  G  YS          +++         +A+ + YL      + 
Sbjct: 113 SKGNLREYL--RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKC 167
Query: 232 LHLDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIRGTRGYLAPEWILEQGVSE 290
           +H D+   N+L+ EN    ++DFGL++ ++  D  +  T  R    ++APE + ++  + 
Sbjct: 168 IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 227
Query: 291 KCDIYSYGMVLLEL 304
           + D++S+G+++ E+
Sbjct: 228 QSDVWSFGVLMWEI 241

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 33/212 (15%)
Query: 112 GSSASVFKG-ILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGG 170
           G    V+K  +++D  +V +  +  +++ + E   E+ +    +H NL++ +        
Sbjct: 26  GRFGCVWKAQLMNDFVAVKIFPLQDKQSWQSE--REIFSTPGMKHENLLQFIAAEKRGSN 83
Query: 171 PR---YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHND- 226
                +L+  F   GSL  ++            G  ++W+    VA  +++ LSYLH D 
Sbjct: 84  LEVELWLITAFHDKGSLTDYL-----------KGNIITWNELCHVAETMSRGLSYLHEDV 132
Query: 227 --CRSR-----VLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR-GTRGYL 278
             CR       + H D K +N+LL  +  AV++DFGL+      +    T  + GTR Y+
Sbjct: 133 PWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYM 192
Query: 279 APEWILEQGVS------EKCDIYSYGMVLLEL 304
           APE +LE  ++       + D+Y+ G+VL EL
Sbjct: 193 APE-VLEGAINFQRDAFLRIDMYAMGLVLWEL 223

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 67/135 (49%), Gaps = 15/135 (11%)
Query: 174 LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLH 233
           +  E +  GSLD  +    R  E           +  +V+I V K L+YL    + +++H
Sbjct: 84  ICMEHMDGGSLDQVLKKAGRIPE----------QILGKVSIAVIKGLTYLRE--KHKIMH 131
Query: 234 LDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCD 293
            DVKP NIL++      + DFG+S  +  + +       GTR Y++PE +     S + D
Sbjct: 132 RDVKPSNILVNSRGEIKLCDFGVSGQLIDEMA---NEFVGTRSYMSPERLQGTHYSVQSD 188
Query: 294 IYSYGMVLLELTGGR 308
           I+S G+ L+E+  GR
Sbjct: 189 IWSMGLSLVEMAVGR 203

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 28/153 (18%)
Query: 168 PGGPRYLVY---EFIQNGSLDHWIFPTSRRS--EGHYSGGCLSWDLRYRVAIDVAKALSY 222
           P  P+  +Y   +  +  +L  W+   +RR   E    G CL       + I +A+A+ +
Sbjct: 129 PSSPKVYLYIQMQLCRKENLKDWM---NRRCSLEDREHGVCL------HIFIQIAEAVEF 179
Query: 223 LHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSR--CITTIR-------- 272
           LH+     ++H D+KP NI    +    V DFGL   M +D+     +T +         
Sbjct: 180 LHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQ 236
Query: 273 -GTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            GT+ Y++PE I     S K DI+S G++L EL
Sbjct: 237 VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFEL 269

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 68/136 (50%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E++  G +   +    R SE H          R+  A  +     YLH+     ++
Sbjct: 104 YMVMEYVAGGEMFSHLRRIGRFSEPH---------ARFYAA-QIVLTFEYLHS---LDLI 150
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+L+DE     V+DFG +K +  R    C     GT  YLAPE IL +G ++ 
Sbjct: 151 YRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA 205
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 206 VDWWALGVLIYEMAAG 221

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 70/135 (51%), Gaps = 17/135 (12%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E++  G +   +    R SE H          R+  A  +     YLH+     ++
Sbjct: 118 YMVMEYVPGGEMFSHLRRIGRFSEPH---------ARFYAA-QIVLTFEYLHS---LDLI 164
Query: 233 HLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKC 292
           + D+KPEN+L+D+     V+DFG +K   R + R   T+ GT  YLAPE IL +G ++  
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRT-WTLCGTPEYLAPEIILSKGYNKAV 220
Query: 293 DIYSYGMVLLELTGG 307
           D ++ G+++ E+  G
Sbjct: 221 DWWALGVLIYEMAAG 235

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 128/293 (43%), Gaps = 50/293 (17%)
Query: 109 LGHGSSASVF----KGILSDG--TSVAVKRINGEENGEK--EFRSEVAAIASAQHVNLVR 160
           LG GS   V+    KG++ D   T VA+K +N   +  +  EF +E + +      ++VR
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG  V  G P  ++ E +  G L  ++         +      S     ++A ++A  +
Sbjct: 83  LLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 141
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAP 280
           +YL+ +   + +H D+   N ++ E++   + DFG    M+RD        +G +G L  
Sbjct: 142 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPV 194
Query: 281 EWI----LEQGV-SEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEK 335
            W+    L+ GV +   D++S+G+VL E+       +L E          Q +  + NE+
Sbjct: 195 RWMSPESLKDGVFTTYSDVWSFGVVLWEIA------TLAE----------QPYQGLSNEQ 238
Query: 336 MKEGKLMEIVDQRLTDEGGI---DETQVRRLVDVAFWCIQERARLRPSMARVV 385
           +           R   EGG+    +     L ++   C Q   ++RPS   ++
Sbjct: 239 V----------LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 281

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 70/135 (51%), Gaps = 17/135 (12%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E++  G +   +    R SE H          R+  A  +     YLH+     ++
Sbjct: 103 YMVMEYVPGGEMFSHLRRIGRFSEPH---------ARFYAA-QIVLTFEYLHS---LDLI 149
Query: 233 HLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKC 292
           + D+KPEN+L+D+     V+DFG +K   R + R   T+ GT  YLAPE IL +G ++  
Sbjct: 150 YRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRT-WTLCGTPEYLAPEIILSKGYNKAV 205
Query: 293 DIYSYGMVLLELTGG 307
           D ++ G+++ E+  G
Sbjct: 206 DWWALGVLIYEMAAG 220

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 19/204 (9%)
Query: 109 LGHGSSASV---FKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYC 165
           LG G++  V      +  +  +V +  +    +  +  + E+       H N+V+  G+ 
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 72
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
              G  +YL  E+   G L   I P     E              R    +   + YLH 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ----------RFFHQLMAGVVYLHG 122
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS-RDQSRCITTIRGTRGYLAPEWIL 284
                + H D+KPEN+LLDE     +SDFGL+ +    ++ R +  + GT  Y+APE + 
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 285 EQGV-SEKCDIYSYGMVLLELTGG 307
            +   +E  D++S G+VL  +  G
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 74/157 (47%), Gaps = 21/157 (13%)
Query: 154 QHVNLVRL--LGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYR 211
           Q VN   L  L Y        Y+V E++  G +   +    R SE H          R+ 
Sbjct: 96  QAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH---------ARFY 146
Query: 212 VAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITT 270
            A  +     YLH+     +++ D+KPEN+L+D+     V+DFG +K +  R    C   
Sbjct: 147 AA-QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--- 199
Query: 271 IRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
             GT  YLAPE IL +G ++  D ++ G+++ E+  G
Sbjct: 200 --GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 74/157 (47%), Gaps = 21/157 (13%)
Query: 154 QHVNLVRL--LGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYR 211
           Q VN   L  L Y        Y+V E++  G +   +    R SE H          R+ 
Sbjct: 96  QAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH---------ARFY 146
Query: 212 VAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITT 270
            A  +     YLH+     +++ D+KPEN+L+D+     V+DFG +K +  R    C   
Sbjct: 147 AA-QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--- 199
Query: 271 IRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
             GT  YLAPE IL +G ++  D ++ G+++ E+  G
Sbjct: 200 --GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 88/181 (48%), Gaps = 8/181 (4%)
Query: 128 VAVKRINGEENG-EKE-FRSEVAAIAS-AQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL 184
           VAVK +    +  EKE   SE+  ++   QH N+V LLG C   GGP  ++ E+   G L
Sbjct: 71  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT-HGGPVLVITEYCCYGDL 129
Query: 185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD 244
            +++   +        G  L        +  VA+ +++L        +H DV   N+LL 
Sbjct: 130 LNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLT 186
Query: 245 ENYRAVVSDFGLSKLMSRDQSRCIT-TIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLE 303
             + A + DFGL++ +  D +  +    R    ++APE I +   + + D++SYG++L E
Sbjct: 187 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 246
Query: 304 L 304
           +
Sbjct: 247 I 247

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 96/207 (46%), Gaps = 26/207 (12%)
Query: 108 LLGHGSSASVFKGI-LSDGTSVAVK------RINGEENGEKEFRSEVAAIASAQHVNLVR 160
           +LG G+  +V+KG+ + +G  V +       R        KE   E   +AS  + ++ R
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG C+       L+ + +  G L  ++          Y    L+W       + +AK +
Sbjct: 85  LLGICLT--STVQLIMQLMPFGCLLDYVREHKDNIGSQY---LLNW------CVQIAKGM 133
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GY 277
           +YL +    R++H D+   N+L+       ++DFGL+KL+  ++        G +    +
Sbjct: 134 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE--YHAEGGKVPIKW 188
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +A E IL +  + + D++SYG+ + EL
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWEL 215

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 115/262 (43%), Gaps = 37/262 (14%)
Query: 53  IIRRRYHKRRLLLESKFVTEGRELRIEYSFLRKVAGVPIKFRSKELEEATDNFQALLGHG 112
           I+R+R   RRLL E + V            L      P +   + L+E       +LG G
Sbjct: 12  IVRKR-TLRRLLQERELVEP----------LTPSGEAPNQALLRILKETEFKKIKVLGSG 60
Query: 113 SSASVFKGI-LSDGTSVAVK------RINGEENGEKEFRSEVAAIASAQHVNLVRLLGYC 165
           +  +V+KG+ + +G  V +       R        KE   E   +AS  + ++ RLLG C
Sbjct: 61  AFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRLLGIC 120
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
           +       L+ + +  G L  ++          Y    L+W       + +AK ++YL +
Sbjct: 121 LT--STVQLITQLMPFGCLLDYVREHKDNIGSQY---LLNW------CVQIAKGMNYLED 169
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GYLAPEW 282
               R++H D+   N+L+       ++DFGL+KL+  ++        G +    ++A E 
Sbjct: 170 ---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE--YHAEGGKVPIKWMALES 224
Query: 283 ILEQGVSEKCDIYSYGMVLLEL 304
           IL +  + + D++SYG+ + EL
Sbjct: 225 ILHRIYTHQSDVWSYGVTVWEL 246

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 74/157 (47%), Gaps = 21/157 (13%)
Query: 154 QHVNLVRL--LGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYR 211
           Q VN   L  L Y        Y+V E++  G +   +    R SE H          R+ 
Sbjct: 96  QAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH---------ARFY 146
Query: 212 VAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITT 270
            A  +     YLH+     +++ D+KPEN+L+D+     V+DFG +K +  R    C   
Sbjct: 147 AA-QIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC--- 199
Query: 271 IRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
             GT  YLAPE IL +G ++  D ++ G+++ E+  G
Sbjct: 200 --GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 88/181 (48%), Gaps = 8/181 (4%)
Query: 128 VAVKRINGEENG-EKE-FRSEVAAIAS-AQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL 184
           VAVK +    +  EKE   SE+  ++   QH N+V LLG C   GGP  ++ E+   G L
Sbjct: 79  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT-HGGPVLVITEYCCYGDL 137
Query: 185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD 244
            +++   +        G  L        +  VA+ +++L        +H DV   N+LL 
Sbjct: 138 LNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLT 194
Query: 245 ENYRAVVSDFGLSKLMSRDQSRCIT-TIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLE 303
             + A + DFGL++ +  D +  +    R    ++APE I +   + + D++SYG++L E
Sbjct: 195 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 254
Query: 304 L 304
           +
Sbjct: 255 I 255

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 98/207 (47%), Gaps = 26/207 (12%)
Query: 108 LLGHGSSASVFKGI-LSDG----TSVAVKRIN--GEENGEKEFRSEVAAIASAQHVNLVR 160
           +LG G+  +V+KG+ + +G      VA+K +         KE   E   +AS  + ++ R
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG C+       L+ + +  G L  ++          Y    L+W       + +AK +
Sbjct: 82  LLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQY---LLNW------CVQIAKGM 130
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GY 277
           +YL +    R++H D+   N+L+       ++DFGL+KL+  ++        G +    +
Sbjct: 131 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE--YHAEGGKVPIKW 185
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +A E IL +  + + D++SYG+ + EL
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWEL 212

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 96/207 (46%), Gaps = 26/207 (12%)
Query: 108 LLGHGSSASVFKGI-LSDGTSVAVK------RINGEENGEKEFRSEVAAIASAQHVNLVR 160
           +LG G+  +V+KG+ + +G  V +       R        KE   E   +AS  + ++ R
Sbjct: 23  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 82
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG C+       L+ + +  G L  ++          Y    L+W       + +AK +
Sbjct: 83  LLGICLT--STVQLIMQLMPFGXLLDYVREHKDNIGSQY---LLNW------CVQIAKGM 131
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GY 277
           +YL +    R++H D+   N+L+       ++DFGL+KL+  ++        G +    +
Sbjct: 132 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE--YHAEGGKVPIKW 186
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +A E IL +  + + D++SYG+ + EL
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWEL 213

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 15/164 (9%)
Query: 144 RSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGC 203
           ++E   +   +H  +V L+ Y    GG  YL+ E++  G L    F    R       G 
Sbjct: 69  KAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGEL----FMQLERE------GI 117
Query: 204 LSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD 263
              D       +++ AL +LH   +  +++ D+KPENI+L+      ++DFGL K    D
Sbjct: 118 FMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD 174
Query: 264 QSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
            +    T  GT  Y+APE ++  G +   D +S G ++ ++  G
Sbjct: 175 GT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 96/207 (46%), Gaps = 26/207 (12%)
Query: 108 LLGHGSSASVFKGI-LSDGTSVAVK------RINGEENGEKEFRSEVAAIASAQHVNLVR 160
           +LG G+  +V+KG+ + +G  V +       R        KE   E   +AS  + ++ R
Sbjct: 23  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 82
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG C+       L+ + +  G L  ++          Y    L+W       + +AK +
Sbjct: 83  LLGICLT--STVQLIMQLMPFGCLLDYVREHKDNIGSQY---LLNW------CVQIAKGM 131
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GY 277
           +YL +    R++H D+   N+L+       ++DFGL+KL+  ++        G +    +
Sbjct: 132 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE--YHAEGGKVPIKW 186
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +A E IL +  + + D++SYG+ + EL
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWEL 213

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 128/293 (43%), Gaps = 50/293 (17%)
Query: 109 LGHGSSASVF----KGILSDG--TSVAVKRINGEENGEK--EFRSEVAAIASAQHVNLVR 160
           LG GS   V+    KG++ D   T VA+K +N   +  +  EF +E + +      ++VR
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG  V  G P  ++ E +  G L  ++         +      S     ++A ++A  +
Sbjct: 93  LLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAP 280
           +YL+ +   + +H D+   N ++ E++   + DFG    M+RD        +G +G L  
Sbjct: 152 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPV 204
Query: 281 EWI----LEQGV-SEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEK 335
            W+    L+ GV +   D++S+G+VL E+       +L E          Q +  + NE+
Sbjct: 205 RWMSPESLKDGVFTTYSDVWSFGVVLWEIA------TLAE----------QPYQGLSNEQ 248
Query: 336 MKEGKLMEIVDQRLTDEGGI---DETQVRRLVDVAFWCIQERARLRPSMARVV 385
           +           R   EGG+    +     L ++   C Q   ++RPS   ++
Sbjct: 249 V----------LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 291

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 96/207 (46%), Gaps = 26/207 (12%)
Query: 108 LLGHGSSASVFKGI-LSDGTSVAVK------RINGEENGEKEFRSEVAAIASAQHVNLVR 160
           +LG G+  +V+KG+ + +G  V +       R        KE   E   +AS  + ++ R
Sbjct: 32  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 91
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG C+       L+ + +  G L  ++          Y    L+W       + +AK +
Sbjct: 92  LLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQY---LLNW------CVQIAKGM 140
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GY 277
           +YL +    R++H D+   N+L+       ++DFGL+KL+  ++        G +    +
Sbjct: 141 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE--YHAEGGKVPIKW 195
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +A E IL +  + + D++SYG+ + EL
Sbjct: 196 MALESILHRIYTHQSDVWSYGVTVWEL 222

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 96/207 (46%), Gaps = 26/207 (12%)
Query: 108 LLGHGSSASVFKGI-LSDGTSVAVK------RINGEENGEKEFRSEVAAIASAQHVNLVR 160
           +LG G+  +V+KG+ + +G  V +       R        KE   E   +AS  + ++ R
Sbjct: 26  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 85
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG C+       L+ + +  G L  ++          Y    L+W       + +AK +
Sbjct: 86  LLGICLT--STVQLIMQLMPFGCLLDYVREHKDNIGSQY---LLNW------CVQIAKGM 134
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GY 277
           +YL +    R++H D+   N+L+       ++DFGL+KL+  ++        G +    +
Sbjct: 135 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE--YHAEGGKVPIKW 189
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +A E IL +  + + D++SYG+ + EL
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWEL 216

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 96/207 (46%), Gaps = 26/207 (12%)
Query: 108 LLGHGSSASVFKGI-LSDGTSVAVK------RINGEENGEKEFRSEVAAIASAQHVNLVR 160
           +LG G+  +V+KG+ + +G  V +       R        KE   E   +AS  + ++ R
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG C+       L+ + +  G L  ++          Y    L+W       + +AK +
Sbjct: 82  LLGICLT--STVQLIMQLMPFGCLLDYVREHKDNIGSQY---LLNW------CVQIAKGM 130
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GY 277
           +YL +    R++H D+   N+L+       ++DFGL+KL+  ++        G +    +
Sbjct: 131 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE--YHAEGGKVPIKW 185
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +A E IL +  + + D++SYG+ + EL
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWEL 212

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 96/207 (46%), Gaps = 26/207 (12%)
Query: 108 LLGHGSSASVFKGI-LSDGTSVAVK------RINGEENGEKEFRSEVAAIASAQHVNLVR 160
           +LG G+  +V+KG+ + +G  V +       R        KE   E   +AS  + ++ R
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG C+       L+ + +  G L  ++          Y    L+W       + +AK +
Sbjct: 84  LLGICLT--STVQLIMQLMPFGCLLDYVREHKDNIGSQY---LLNW------CVQIAKGM 132
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GY 277
           +YL +    R++H D+   N+L+       ++DFGL+KL+  ++        G +    +
Sbjct: 133 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE--YHAEGGKVPIKW 187
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +A E IL +  + + D++SYG+ + EL
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWEL 214

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 19/204 (9%)
Query: 109 LGHGSSASV---FKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYC 165
           LG G+   V      +  +  +V +  +    +  +  + E+       H N+V+  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 72
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
              G  +YL  E+   G L   I P     E              R    +   + YLH 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ----------RFFHQLMAGVVYLHG 122
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS-RDQSRCITTIRGTRGYLAPEWIL 284
                + H D+KPEN+LLDE     +SDFGL+ +    ++ R +  + GT  Y+APE + 
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 285 EQGV-SEKCDIYSYGMVLLELTGG 307
            +   +E  D++S G+VL  +  G
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 98/207 (47%), Gaps = 26/207 (12%)
Query: 108 LLGHGSSASVFKGI-LSDG----TSVAVKRIN--GEENGEKEFRSEVAAIASAQHVNLVR 160
           +LG G+  +V+KG+ + +G      VA+K +         KE   E   +AS  + ++ R
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG C+       L+ + +  G L  ++          Y    L+W       + +AK +
Sbjct: 85  LLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQY---LLNW------CVQIAKGM 133
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GY 277
           +YL +    R++H D+   N+L+       ++DFGL+KL+  ++        G +    +
Sbjct: 134 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE--YHAEGGKVPIKW 188
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +A E IL +  + + D++SYG+ + EL
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWEL 215

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 98/207 (47%), Gaps = 26/207 (12%)
Query: 108 LLGHGSSASVFKGI-LSDG----TSVAVKRIN--GEENGEKEFRSEVAAIASAQHVNLVR 160
           +LG G+  +V+KG+ + +G      VA+K +         KE   E   +AS  + ++ R
Sbjct: 29  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG C+       L+ + +  G L  ++          Y    L+W       + +AK +
Sbjct: 89  LLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQY---LLNW------CVQIAKGM 137
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GY 277
           +YL +    R++H D+   N+L+       ++DFGL+KL+  ++        G +    +
Sbjct: 138 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE--YHAEGGKVPIKW 192
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +A E IL +  + + D++SYG+ + EL
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWEL 219

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 98/207 (47%), Gaps = 26/207 (12%)
Query: 108 LLGHGSSASVFKGI-LSDG----TSVAVKRIN--GEENGEKEFRSEVAAIASAQHVNLVR 160
           +LG G+  +V+KG+ + +G      VA+K +         KE   E   +AS  + ++ R
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG C+       L+ + +  G L  ++          Y    L+W       + +AK +
Sbjct: 85  LLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQY---LLNW------CVQIAKGM 133
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GY 277
           +YL +    R++H D+   N+L+       ++DFGL+KL+  ++        G +    +
Sbjct: 134 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE--YHAEGGKVPIKW 188
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +A E IL +  + + D++SYG+ + EL
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWEL 215

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 98/207 (47%), Gaps = 26/207 (12%)
Query: 108 LLGHGSSASVFKGI-LSDG----TSVAVKRIN--GEENGEKEFRSEVAAIASAQHVNLVR 160
           +LG G+  +V+KG+ + +G      VA+K +         KE   E   +AS  + ++ R
Sbjct: 25  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 84
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG C+       L+ + +  G L  ++          Y    L+W       + +AK +
Sbjct: 85  LLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQY---LLNW------CVQIAKGM 133
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GY 277
           +YL +    R++H D+   N+L+       ++DFGL+KL+  ++        G +    +
Sbjct: 134 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE--YHAEGGKVPIKW 188
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +A E IL +  + + D++SYG+ + EL
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWEL 215

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 98/207 (47%), Gaps = 26/207 (12%)
Query: 108 LLGHGSSASVFKGI-LSDG----TSVAVKRIN--GEENGEKEFRSEVAAIASAQHVNLVR 160
           +LG G+  +V+KG+ + +G      VA+K +         KE   E   +AS  + ++ R
Sbjct: 16  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG C+       L+ + +  G L  ++          Y    L+W       + +AK +
Sbjct: 76  LLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQY---LLNW------CVQIAKGM 124
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GY 277
           +YL +    R++H D+   N+L+       ++DFGL+KL+  ++        G +    +
Sbjct: 125 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE--YHAEGGKVPIKW 179
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +A E IL +  + + D++SYG+ + EL
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWEL 206

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 96/207 (46%), Gaps = 26/207 (12%)
Query: 108 LLGHGSSASVFKGI-LSDGTSVAVK------RINGEENGEKEFRSEVAAIASAQHVNLVR 160
           +LG G+  +V+KG+ + +G  V +       R        KE   E   +AS  + ++ R
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG C+       L+ + +  G L  ++          Y    L+W       + +AK +
Sbjct: 82  LLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQY---LLNW------CVQIAKGM 130
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GY 277
           +YL +    R++H D+   N+L+       ++DFGL+KL+  ++        G +    +
Sbjct: 131 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE--YHAEGGKVPIKW 185
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +A E IL +  + + D++SYG+ + EL
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWEL 212

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 19/204 (9%)
Query: 109 LGHGSSASV---FKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYC 165
           LG G+   V      +  +  +V +  +    +  +  + E+       H N+V+  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 72
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
              G  +YL  E+   G L   I P     E              R    +   + YLH 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ----------RFFHQLMAGVVYLHG 122
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS-RDQSRCITTIRGTRGYLAPEWIL 284
                + H D+KPEN+LLDE     +SDFGL+ +    ++ R +  + GT  Y+APE + 
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 285 EQGV-SEKCDIYSYGMVLLELTGG 307
            +   +E  D++S G+VL  +  G
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 68/135 (50%), Gaps = 17/135 (12%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E++  G +   +    R SE H          R+  A  +     YLH+     ++
Sbjct: 138 YMVMEYVAGGEMFSHLRRIGRFSEPH---------ARFYAA-QIVLTFEYLHS---LDLI 184
Query: 233 HLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKC 292
           + D+KPEN+L+D+     V+DFG +K +         T+ GT  YLAPE IL +G ++  
Sbjct: 185 YRDLKPENLLIDQQGYIQVTDFGFAKRV----KGATWTLCGTPEYLAPEIILSKGYNKAV 240
Query: 293 DIYSYGMVLLELTGG 307
           D ++ G+++ E+  G
Sbjct: 241 DWWALGVLIYEMAAG 255

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 98/207 (47%), Gaps = 26/207 (12%)
Query: 108 LLGHGSSASVFKGI-LSDG----TSVAVKRIN--GEENGEKEFRSEVAAIASAQHVNLVR 160
           +LG G+  +V+KG+ + +G      VA+K +         KE   E   +AS  + ++ R
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG C+       L+ + +  G L  ++          Y    L+W       + +AK +
Sbjct: 82  LLGICLT--STVQLITQLMPFGXLLDYVREHKDNIGSQY---LLNW------CVQIAKGM 130
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GY 277
           +YL +    R++H D+   N+L+       ++DFGL+KL+  ++        G +    +
Sbjct: 131 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE--YHAEGGKVPIKW 185
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +A E IL +  + + D++SYG+ + EL
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWEL 212

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 91/185 (49%), Gaps = 12/185 (6%)
Query: 128 VAVKRINGEENG-EKE-FRSEVAAIAS-AQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL 184
           VAVK +    +  EKE   SE+  ++   QH N+V LLG C   GGP  ++ E+   G L
Sbjct: 79  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT-HGGPVLVITEYCCYGDL 137
Query: 185 DHWIFPTSRRSEGHYSGGCLSWDLRYR----VAIDVAKALSYLHNDCRSRVLHLDVKPEN 240
            +++   SR  E   +    +     R     +  VA+ +++L        +H DV   N
Sbjct: 138 LNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARN 194
Query: 241 ILLDENYRAVVSDFGLSKLMSRDQSRCIT-TIRGTRGYLAPEWILEQGVSEKCDIYSYGM 299
           +LL   + A + DFGL++ +  D +  +    R    ++APE I +   + + D++SYG+
Sbjct: 195 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 254
Query: 300 VLLEL 304
           +L E+
Sbjct: 255 LLWEI 259

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 19/207 (9%)
Query: 108 LLGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFRS-EVAAIASAQHVNLVRLLGYC 165
           ++G+GS   V++  L D G  VA+K++  +    K F++ E+  +    H N+VRL  + 
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRY--RVAIDVAKALSYL 223
              G  + +VY    N  LD ++  T  R   HYS    +  + Y       + ++L+Y+
Sbjct: 83  YSSGEKKDVVY---LNLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 224 HNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSRDQSRCITTIRGTRGYLAPEW 282
           H+     + H D+KP+N+LLD +   + + DFG +K + R +   ++ I  +R Y APE 
Sbjct: 139 HS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSXI-CSRYYRAPEL 193
Query: 283 IL-EQGVSEKCDIYSYGMVLLELTGGR 308
           I      +   D++S G VL EL  G+
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 96/207 (46%), Gaps = 26/207 (12%)
Query: 108 LLGHGSSASVFKGI-LSDGTSVAVK------RINGEENGEKEFRSEVAAIASAQHVNLVR 160
           +LG G+  +V+KG+ + +G  V +       R        KE   E   +AS  + ++ R
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG C+       L+ + +  G L  ++          Y    L+W       + +AK +
Sbjct: 84  LLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQY---LLNW------CVQIAKGM 132
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GY 277
           +YL +    R++H D+   N+L+       ++DFGL+KL+  ++        G +    +
Sbjct: 133 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE--YHAEGGKVPIKW 187
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +A E IL +  + + D++SYG+ + EL
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWEL 214

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 96/207 (46%), Gaps = 26/207 (12%)
Query: 108 LLGHGSSASVFKGI-LSDGTSVAVK------RINGEENGEKEFRSEVAAIASAQHVNLVR 160
           +LG G+  +V+KG+ + +G  V +       R        KE   E   +AS  + ++ R
Sbjct: 47  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 106
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG C+       L+ + +  G L  ++          Y    L+W       + +AK +
Sbjct: 107 LLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQY---LLNW------CVQIAKGM 155
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GY 277
           +YL +    R++H D+   N+L+       ++DFGL+KL+  ++        G +    +
Sbjct: 156 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE--YHAEGGKVPIKW 210
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +A E IL +  + + D++SYG+ + EL
Sbjct: 211 MALESILHRIYTHQSDVWSYGVTVWEL 237

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 34/96 (35%), Positives = 56/96 (58%), Gaps = 11/96 (11%)
Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGY 277
           +A+S+LH +    ++H D+KPENILLD+N +  +SDFG S  +   +   +  + GT GY
Sbjct: 211 EAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK--LRELCGTPGY 265
Query: 278 LAPEWI------LEQGVSEKCDIYSYGMVLLELTGG 307
           LAPE +         G  ++ D+++ G++L  L  G
Sbjct: 266 LAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 96/207 (46%), Gaps = 26/207 (12%)
Query: 108 LLGHGSSASVFKGI-LSDGTSVAVK------RINGEENGEKEFRSEVAAIASAQHVNLVR 160
           +LG G+  +V+KG+ + +G  V +       R        KE   E   +AS  + ++ R
Sbjct: 28  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 87
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG C+       L+ + +  G L  ++          Y    L+W       + +AK +
Sbjct: 88  LLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQY---LLNW------CVQIAKGM 136
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GY 277
           +YL +    R++H D+   N+L+       ++DFGL+KL+  ++        G +    +
Sbjct: 137 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE--YHAEGGKVPIKW 191
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +A E IL +  + + D++SYG+ + EL
Sbjct: 192 MALESILHRIYTHQSDVWSYGVTVWEL 218

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 21/225 (9%)
Query: 96  KELEEATDNFQALLGHGSSASVFKGIL------SDGTSVAVKRINGEENGE--KEFRSEV 147
           KE+  +   F   LG      V+KG L          +VA+K +  +  G   +EFR E 
Sbjct: 21  KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEA 80
Query: 148 AAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYS------- 200
              A  QH N+V LLG  V    P  +++ +  +G L  ++   S  S+   +       
Sbjct: 81  MLRARLQHPNVVCLLG-VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 139
Query: 201 GGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK-L 259
                 D  + VA  +A  + YL +     V+H D+   N+L+ +     +SD GL + +
Sbjct: 140 SALEPPDFVHLVA-QIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFREV 195
Query: 260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            + D  + +        ++APE I+    S   DI+SYG+VL E+
Sbjct: 196 YAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEV 240

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 19/204 (9%)
Query: 109 LGHGSSASV---FKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYC 165
           LG G+   V      +  +  +V +  +    +  +  + E+       H N+V+  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 72
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
              G  +YL  E+   G L   I P     E              R    +   + YLH 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ----------RFFHQLMAGVVYLHG 122
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS-RDQSRCITTIRGTRGYLAPEWIL 284
                + H D+KPEN+LLDE     +SDFGL+ +    ++ R +  + GT  Y+APE + 
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 285 EQGV-SEKCDIYSYGMVLLELTGG 307
            +   +E  D++S G+VL  +  G
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 69/135 (51%), Gaps = 17/135 (12%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E++  G +   +    R SE H          R+  A  +     YLH+     ++
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFSEPH---------ARFYAA-QIVLTFEYLHS---LDLI 163
Query: 233 HLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKC 292
           + D+KPEN+L+D+     V+DFG +K   R + R    + GT  YLAPE IL +G ++  
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRT-WXLXGTPEYLAPEIILSKGYNKAV 219
Query: 293 DIYSYGMVLLELTGG 307
           D ++ G+++ E+  G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 100/228 (43%), Gaps = 27/228 (11%)
Query: 96  KELEEATDNFQALLGHGSSASVFKGIL------SDGTSVAVKRINGEENGE--KEFRSEV 147
           KE+  +   F   LG      V+KG L          +VA+K +  +  G   +EFR E 
Sbjct: 4   KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEA 63
Query: 148 AAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWD 207
              A  QH N+V LLG  V    P  +++ +  +G L  ++   S  S+     G    D
Sbjct: 64  MLRARLQHPNVVCLLG-VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDV----GSTDDD 118
Query: 208 LRYRVAID----------VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS 257
              + A++          +A  + YL +     V+H D+   N+L+ +     +SD GL 
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLF 175
Query: 258 K-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           + + + D  + +        ++APE I+    S   DI+SYG+VL E+
Sbjct: 176 REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEV 223

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 19/204 (9%)
Query: 109 LGHGSSASV---FKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYC 165
           LG G+   V      +  +  +V +  +    +  +  + E+       H N+V+  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH- 72
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
              G  +YL  E+   G L   I P     E              R    +   + YLH 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ----------RFFHQLMAGVVYLHG 122
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS-RDQSRCITTIRGTRGYLAPEWIL 284
                + H D+KPEN+LLDE     +SDFGL+ +    ++ R +  + GT  Y+APE + 
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 285 EQGV-SEKCDIYSYGMVLLELTGG 307
            +   +E  D++S G+VL  +  G
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E++  G +   +    R SE H          R+  A  +     YLH+     ++
Sbjct: 138 YMVMEYVPGGEMFSHLRRIGRFSEPH---------ARFYAA-QIVLTFEYLHS---LDLI 184
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+L+D+     V+DFG +K +  R    C     GT  YLAPE IL +G ++ 
Sbjct: 185 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA 239
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 240 VDWWALGVLIYEMAAG 255

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E++  G +   +    R SE H          R+  A  +     YLH+     ++
Sbjct: 118 YMVMEYVAGGEMFSHLRRIGRFSEPH---------ARFYAA-QIVLTFEYLHS---LDLI 164
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+L+D+     V+DFG +K +  R    C     GT  YLAPE IL +G ++ 
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA 219
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 220 VDWWALGVLIYEMAAG 235

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E++  G +   +    R SE H          R+  A  +     YLH+     ++
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFSEPH---------ARFYAA-QIVLTFEYLHS---LDLI 163
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+L+D+     V+DFG +K +  R    C     GT  YLAPE IL +G ++ 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA 218
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E++  G +   +    R SE H          R+  A  +     YLH+     ++
Sbjct: 117 YMVMEYVPGGEMFSHLRRIGRFSEPH---------ARFYAA-QIVLTFEYLHS---LDLI 163
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+L+D+     V+DFG +K +  R    C     GT  YLAPE IL +G ++ 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA 218
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E++  G +   +    R SE H          R+  A  +     YLH+     ++
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFSEPH---------ARFYAA-QIVLTFEYLHS---LDLI 163
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+L+D+     V+DFG +K +  R    C     GT  YLAPE IL +G ++ 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA 218
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E++  G +   +    R SE H          R+  A  +     YLH+     ++
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFSEPH---------ARFYAA-QIVLTFEYLHS---LDLI 163
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+L+D+     V+DFG +K +  R    C     GT  YLAPE IL +G ++ 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA 218
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 93/210 (44%), Gaps = 18/210 (8%)
Query: 109 LGHGSSASVFKG------ILSDGTSVAVKRINGEE-NGEKEFRSEVAAIASAQHVNLVRL 161
           LG G+   VF           D   VAVK +        K+F+ E   + + QH ++V+ 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 162 LGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRS------EGHYSGGCLSWDLRYRVAID 215
            G C   G P  +V+E++++G L+ ++      +      +   + G L       +A  
Sbjct: 83  YGVC-GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGT 274
           +A  + YL        +H D+   N L+  N    + DFG+S+ + S D  R        
Sbjct: 142 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198
Query: 275 RGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
             ++ PE I+ +  + + D++S+G++L E+
Sbjct: 199 IRWMPPESIMYRKFTTESDVWSFGVILWEI 228

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 19/204 (9%)
Query: 109 LGHGSSASV---FKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYC 165
           LG G+   V      +  +  +V +  +    +  +  + E+       H N+V+  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH- 73
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
              G  +YL  E+   G L   I P     E              R    +   + YLH 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ----------RFFHQLMAGVVYLHG 123
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS-RDQSRCITTIRGTRGYLAPEWIL 284
                + H D+KPEN+LLDE     +SDFGL+ +    ++ R +  + GT  Y+APE + 
Sbjct: 124 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 180
Query: 285 EQGV-SEKCDIYSYGMVLLELTGG 307
            +   +E  D++S G+VL  +  G
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E++  G +   +    R SE H          R+  A  +     YLH+     ++
Sbjct: 118 YMVMEYVPGGEMFSHLRRIGRFSEPH---------ARFYAA-QIVLTFEYLHS---LDLI 164
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+L+D+     V+DFG +K +  R    C     GT  YLAPE IL +G ++ 
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA 219
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 220 VDWWALGVLIYEMAAG 235

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E++  G +   +    R SE H          R+  A  +     YLH+     ++
Sbjct: 117 YMVMEYVPGGEMFSHLRRIGRFSEPH---------ARFYAA-QIVLTFEYLHS---LDLI 163
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+L+D+     V+DFG +K +  R    C     GT  YLAPE IL +G ++ 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA 218
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 109 LGHGSSASVFKGILS------DGTSVAVKRIN--GEENGEKEFRSEVAAIASAQHVNLVR 160
           LGHG+   V++G +S          VAVK +     E  E +F  E   I+   H N+VR
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
            +G  +    PR+++ E +  G L  ++  T  R     S   L  DL + VA D+A   
Sbjct: 125 CIGVSLQ-SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML--DLLH-VARDIACGC 180
Query: 221 SYLHNDCRSRVLHLDVKPENILLD---ENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG- 276
            YL  +     +H D+   N LL        A + DFG    M+RD  R     +G    
Sbjct: 181 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG----MARDIYRASYYRKGGCAM 233
Query: 277 ----YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
               ++ PE  +E   + K D +S+G++L E+
Sbjct: 234 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 265

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E++  G +   +    R SE H          R+  A  +     YLH+     ++
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFSEPH---------ARFYAA-QIVLTFEYLHS---LDLI 163
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+L+D+     V+DFG +K +  R    C     GT  YLAPE IL +G ++ 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA 218
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E++  G +   +    R SE H          R+  A  +     YLH+     ++
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFSEPH---------ARFYAA-QIVLTFEYLHS---LDLI 163
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+L+D+     V+DFG +K +  R    C     GT  YLAPE IL +G ++ 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA 218
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E++  G +   +    R SE H          R+  A  +     YLH+     ++
Sbjct: 118 YMVMEYVPGGEMFSHLRRIGRFSEPH---------ARFYAA-QIVLTFEYLHS---LDLI 164
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+L+D+     V+DFG +K +  R    C     GT  YLAPE IL +G ++ 
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA 219
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 220 VDWWALGVLIYEMAAG 235

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E++  G +   +    R SE H          R+  A  +     YLH+     ++
Sbjct: 118 YMVMEYVPGGEMFSHLRRIGRFSEPH---------ARFYAA-QIVLTFEYLHS---LDLI 164
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+L+D+     V+DFG +K +  R    C     GT  YLAPE IL +G ++ 
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA 219
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 220 VDWWALGVLIYEMAAG 235

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E++  G +   +    R SE H          R+  A  +     YLH+     ++
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFSEPH---------ARFYAA-QIVLTFEYLHS---LDLI 163
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+L+D+     V+DFG +K +  R    C     GT  YLAPE IL +G ++ 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA 218
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 109 LGHGSSASVFKGILS------DGTSVAVKRIN--GEENGEKEFRSEVAAIASAQHVNLVR 160
           LGHG+   V++G +S          VAVK +     E  E +F  E   I+   H N+VR
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
            +G  +    PR+++ E +  G L  ++  T  R     S   L  DL + VA D+A   
Sbjct: 115 CIGVSLQ-SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML--DLLH-VARDIACGC 170
Query: 221 SYLHNDCRSRVLHLDVKPENILLD---ENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG- 276
            YL  +     +H D+   N LL        A + DFG    M+RD  R     +G    
Sbjct: 171 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG----MARDIYRASYYRKGGCAM 223
Query: 277 ----YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
               ++ PE  +E   + K D +S+G++L E+
Sbjct: 224 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 255

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E++  G +   +    R SE H          R+  A  +     YLH+     ++
Sbjct: 117 YMVMEYVPGGEMFSHLRRIGRFSEPH---------ARFYAA-QIVLTFEYLHS---LDLI 163
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+L+D+     V+DFG +K +  R    C     GT  YLAPE IL +G ++ 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA 218
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E++  G +   +    R SE H          R+  A  +     YLH+     ++
Sbjct: 118 YMVMEYVPGGEMFSHLRRIGRFSEPH---------ARFYAA-QIVLTFEYLHS---LDLI 164
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+L+D+     V+DFG +K +  R    C     GT  YLAPE IL +G ++ 
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA 219
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 220 VDWWALGVLIYEMAAG 235

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 80/166 (48%), Gaps = 22/166 (13%)
Query: 146 EVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLS 205
           E++ +   +H ++++L      P     +V E+   G L  +I    R +E         
Sbjct: 59  EISYLKLLRHPHIIKLYDVITTPTD-IVMVIEY-AGGELFDYIVEKKRMTE--------- 107
Query: 206 WDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQS 265
            D   R    +  A+ Y H   R +++H D+KPEN+LLD+N    ++DFGLS +M+    
Sbjct: 108 -DEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT--DG 161
Query: 266 RCITTIRGTRGYLAPEWI---LEQGVSEKCDIYSYGMVLLELTGGR 308
             + T  G+  Y APE I   L  G   + D++S G+VL  +  GR
Sbjct: 162 NFLKTSCGSPNYAAPEVINGKLYAG--PEVDVWSCGIVLYVMLVGR 205

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 69/135 (51%), Gaps = 17/135 (12%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E++  G +   +    R SE H          R+  A  +     YLH+     ++
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFSEPH---------ARFYAA-QIVLTFEYLHS---LDLI 163
Query: 233 HLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKC 292
           + D+KPEN+L+D+     V+DFG +K   R + R    + GT  YLAPE IL +G ++  
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRT-WXLAGTPEYLAPEIILSKGYNKAV 219
Query: 293 DIYSYGMVLLELTGG 307
           D ++ G+++ E+  G
Sbjct: 220 DWWALGVLIYEMAAG 234

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 101/204 (49%), Gaps = 23/204 (11%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEK--EFRSEVAAIASAQHVNLVRLLGYCV 166
           LG G+   V+K    + + +A  ++   ++ E+  ++  E+  +AS  H N+V+LL    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 167 VPGGPRYLVYEFIQNGSLDHWIFPTSRR-SEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
                 +++ EF   G++D  +    R  +E      C       +  +D   AL+YLH+
Sbjct: 105 YENN-LWILIEFCAGGAVDAVMLELERPLTESQIQVVC-------KQTLD---ALNYLHD 153
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWIL- 284
           +   +++H D+K  NIL   +    ++DFG+S   +R   R  + I GT  ++APE ++ 
Sbjct: 154 N---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMC 209
Query: 285 ----EQGVSEKCDIYSYGMVLLEL 304
               ++    K D++S G+ L+E+
Sbjct: 210 ETSKDRPYDYKADVWSLGITLIEM 233

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 109 LGHGSSASVFKGILS------DGTSVAVKRIN--GEENGEKEFRSEVAAIASAQHVNLVR 160
           LGHG+   V++G +S          VAVK +     E  E +F  E   I+   H N+VR
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
            +G  +    PR+++ E +  G L  ++  T  R     S   L  DL + VA D+A   
Sbjct: 105 CIGVSLQ-SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML--DLLH-VARDIACGC 160
Query: 221 SYLHNDCRSRVLHLDVKPENILLD---ENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG- 276
            YL  +     +H D+   N LL        A + DFG    M+RD  R     +G    
Sbjct: 161 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG----MARDIYRASYYRKGGCAM 213
Query: 277 ----YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
               ++ PE  +E   + K D +S+G++L E+
Sbjct: 214 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 245

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 109 LGHGSSASVFKGILS------DGTSVAVKRIN--GEENGEKEFRSEVAAIASAQHVNLVR 160
           LGHG+   V++G +S          VAVK +     E  E +F  E   I+   H N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
            +G  +    PR+++ E +  G L  ++  T  R     S   L  DL + VA D+A   
Sbjct: 99  CIGVSLQ-SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML--DLLH-VARDIACGC 154
Query: 221 SYLHNDCRSRVLHLDVKPENILLD---ENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG- 276
            YL  +     +H D+   N LL        A + DFG    M+RD  R     +G    
Sbjct: 155 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG----MARDIYRASYYRKGGCAM 207
Query: 277 ----YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
               ++ PE  +E   + K D +S+G++L E+
Sbjct: 208 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 96/201 (47%), Gaps = 24/201 (11%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+    +  T VAVK +       + F +E   + + QH  LV+L  + VV 
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKL--HAVVT 247
Query: 169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCR 228
             P Y++ EF+  GSL  ++    +  EG         D     +  +A+ ++++    +
Sbjct: 248 KEPIYIITEFMAKGSLLDFL----KSDEGSKQPLPKLIDF----SAQIAEGMAFIE---Q 296
Query: 229 SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGV 288
              +H D++  NIL+  +    ++DFGL+++ ++   +          + APE I     
Sbjct: 297 RNYIHRDLRAANILVSASLVCKIADFGLARVGAKFPIK----------WTAPEAINFGSF 346
Query: 289 SEKCDIYSYGMVLLEL-TGGR 308
           + K D++S+G++L+E+ T GR
Sbjct: 347 TIKSDVWSFGILLMEIVTYGR 367

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 101/204 (49%), Gaps = 23/204 (11%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEK--EFRSEVAAIASAQHVNLVRLLGYCV 166
           LG G+   V+K    + + +A  ++   ++ E+  ++  E+  +AS  H N+V+LL    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 167 VPGGPRYLVYEFIQNGSLDHWIFPTSRR-SEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
                 +++ EF   G++D  +    R  +E      C       +  +D   AL+YLH+
Sbjct: 105 YENN-LWILIEFCAGGAVDAVMLELERPLTESQIQVVC-------KQTLD---ALNYLHD 153
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWIL- 284
           +   +++H D+K  NIL   +    ++DFG+S   +R   R  + I GT  ++APE ++ 
Sbjct: 154 N---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFI-GTPYWMAPEVVMC 209
Query: 285 ----EQGVSEKCDIYSYGMVLLEL 304
               ++    K D++S G+ L+E+
Sbjct: 210 ETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E++  G +   +    R SE H          R+  A  +     YLH+     ++
Sbjct: 117 YMVMEYVPGGEMFSHLRRIGRFSEPH---------ARFYAA-QIVLTFEYLHS---LDLI 163
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+L+D+     V+DFG +K +  R    C     GT  YLAPE IL +G ++ 
Sbjct: 164 YRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA 218
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 109 LGHGSSASVFKGILS------DGTSVAVKRIN--GEENGEKEFRSEVAAIASAQHVNLVR 160
           LGHG+   V++G +S          VAVK +     E  E +F  E   I+   H N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
            +G  +    PR+++ E +  G L  ++  T  R     S   L  DL + VA D+A   
Sbjct: 99  CIGVSLQ-SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML--DLLH-VARDIACGC 154
Query: 221 SYLHNDCRSRVLHLDVKPENILLD---ENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG- 276
            YL  +     +H D+   N LL        A + DFG    M+RD  R     +G    
Sbjct: 155 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG----MARDIYRASYYRKGGCAM 207
Query: 277 ----YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
               ++ PE  +E   + K D +S+G++L E+
Sbjct: 208 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E++  G +   +    R SE H          R+  A  +     YLH+     ++
Sbjct: 110 YMVMEYVPGGEMFSHLRRIGRFSEPH---------ARFYAA-QIVLTFEYLHS---LDLI 156
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+L+D+     V+DFG +K +  R    C     GT  YLAPE IL +G ++ 
Sbjct: 157 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA 211
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 212 VDWWALGVLIYEMAAG 227

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 19/204 (9%)
Query: 109 LGHGSSASV---FKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYC 165
           LG G+   V      +  +  +V +  +    +  +  + E+       H N+V+  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
              G  +YL  E+   G L   I P     E              R    +   + YLH 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ----------RFFHQLMAGVVYLHG 123
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS-RDQSRCITTIRGTRGYLAPEWIL 284
                + H D+KPEN+LLDE     +SDFGL+ +    ++ R +  + GT  Y+APE + 
Sbjct: 124 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 285 EQGV-SEKCDIYSYGMVLLELTGG 307
            +   +E  D++S G+VL  +  G
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 109 LGHGSSASVFKGILS------DGTSVAVKRIN--GEENGEKEFRSEVAAIASAQHVNLVR 160
           LGHG+   V++G +S          VAVK +     E  E +F  E   I+   H N+VR
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
            +G  +    PR+++ E +  G L  ++  T  R     S   L  DL + VA D+A   
Sbjct: 98  CIGVSLQ-SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAML--DLLH-VARDIACGC 153
Query: 221 SYLHNDCRSRVLHLDVKPENILLD---ENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG- 276
            YL  +     +H D+   N LL        A + DFG    M+RD  R     +G    
Sbjct: 154 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG----MARDIYRASYYRKGGCAM 206
Query: 277 ----YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
               ++ PE  +E   + K D +S+G++L E+
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 109 LGHGSSASVFKGILS------DGTSVAVKRIN--GEENGEKEFRSEVAAIASAQHVNLVR 160
           LGHG+   V++G +S          VAVK +     E  E +F  E   I+   H N+VR
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
            +G  +    PR+++ E +  G L  ++  T  R     S   L  DL + VA D+A   
Sbjct: 98  CIGVSLQ-SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML--DLLH-VARDIACGC 153
Query: 221 SYLHNDCRSRVLHLDVKPENILLD---ENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG- 276
            YL  +     +H D+   N LL        A + DFG    M+RD  R     +G    
Sbjct: 154 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG----MARDIYRASYYRKGGCAM 206
Query: 277 ----YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
               ++ PE  +E   + K D +S+G++L E+
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 238

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 19/204 (9%)
Query: 109 LGHGSSASV---FKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYC 165
           LG G+   V      +  +  +V +  +    +  +  + E+       H N+V+  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
              G  +YL  E+   G L   I P     E              R    +   + YLH 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ----------RFFHQLMAGVVYLHG 123
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS-RDQSRCITTIRGTRGYLAPEWIL 284
                + H D+KPEN+LLDE     +SDFGL+ +    ++ R +  + GT  Y+APE + 
Sbjct: 124 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 285 EQGV-SEKCDIYSYGMVLLELTGG 307
            +   +E  D++S G+VL  +  G
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 19/204 (9%)
Query: 109 LGHGSSASV---FKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYC 165
           LG G+   V      +  +  +V +  +    +  +  + E+       H N+V+  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 72
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
              G  +YL  E+   G L   I P     E              R    +   + YLH 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ----------RFFHQLMAGVVYLHG 122
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS-RDQSRCITTIRGTRGYLAPEWIL 284
                + H D+KPEN+LLDE     +SDFGL+ +    ++ R +  + GT  Y+APE + 
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 285 EQGV-SEKCDIYSYGMVLLELTGG 307
            +   +E  D++S G+VL  +  G
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 19/204 (9%)
Query: 109 LGHGSSASV---FKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYC 165
           LG G+   V      +  +  +V +  +    +  +  + E+       H N+V+  G+ 
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 71
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
              G  +YL  E+   G L   I P     E              R    +   + YLH 
Sbjct: 72  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ----------RFFHQLMAGVVYLHG 121
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS-RDQSRCITTIRGTRGYLAPEWIL 284
                + H D+KPEN+LLDE     +SDFGL+ +    ++ R +  + GT  Y+APE + 
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 285 EQGV-SEKCDIYSYGMVLLELTGG 307
            +   +E  D++S G+VL  +  G
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAG 202

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 19/204 (9%)
Query: 109 LGHGSSASV---FKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYC 165
           LG G+   V      +  +  +V +  +    +  +  + E+       H N+V+  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 72
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
              G  +YL  E+   G L   I P     E              R    +   + YLH 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ----------RFFHQLMAGVVYLHG 122
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS-RDQSRCITTIRGTRGYLAPEWIL 284
                + H D+KPEN+LLDE     +SDFGL+ +    ++ R +  + GT  Y+APE + 
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 285 EQGV-SEKCDIYSYGMVLLELTGG 307
            +   +E  D++S G+VL  +  G
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 19/204 (9%)
Query: 109 LGHGSSASV---FKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYC 165
           LG G+   V      +  +  +V +  +    +  +  + E+       H N+V+  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 72
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
              G  +YL  E+   G L   I P     E              R    +   + YLH 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ----------RFFHQLMAGVVYLHG 122
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS-RDQSRCITTIRGTRGYLAPEWIL 284
                + H D+KPEN+LLDE     +SDFGL+ +    ++ R +  + GT  Y+APE + 
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 285 EQGV-SEKCDIYSYGMVLLELTGG 307
            +   +E  D++S G+VL  +  G
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 96/194 (49%), Gaps = 20/194 (10%)
Query: 124 DGTSVAVKRINGEENGEKEFRSEVAAIAS----AQHVNLVRLLGYCVVPGGPRYLVYEFI 179
           +  +VAVK +  ++  EK+    V+ +       +H N++ LLG C    GP Y++  + 
Sbjct: 66  EAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVAYA 123
Query: 180 QNGSLDHWIFPTSRRSEG-HYSGGC-------LSWDLRYRVAIDVAKALSYLHNDCRSRV 231
             G+L  ++   +RR  G  YS          +++         +A+ + YL      + 
Sbjct: 124 SKGNLREYL--RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKC 178
Query: 232 LHLDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIRGTRGYLAPEWILEQGVSE 290
           +H D+   N+L+ EN    ++DFGL++ ++  D  +  T  R    ++APE + ++  + 
Sbjct: 179 IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 238
Query: 291 KCDIYSYGMVLLEL 304
           + D++S+G+++ E+
Sbjct: 239 QSDVWSFGVLMWEI 252

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 19/204 (9%)
Query: 109 LGHGSSASV---FKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYC 165
           LG G+   V      +  +  +V +  +    +  +  + E+       H N+V+  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 72
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
              G  +YL  E+   G L   I P     E              R    +   + YLH 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ----------RFFHQLMAGVVYLHG 122
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS-RDQSRCITTIRGTRGYLAPEWIL 284
                + H D+KPEN+LLDE     +SDFGL+ +    ++ R +  + GT  Y+APE + 
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 285 EQGV-SEKCDIYSYGMVLLELTGG 307
            +   +E  D++S G+VL  +  G
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 19/204 (9%)
Query: 109 LGHGSSASV---FKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYC 165
           LG G+   V      +  +  +V +  +    +  +  + E+       H N+V+  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 72
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
              G  +YL  E+   G L   I P     E              R    +   + YLH 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ----------RFFHQLMAGVVYLHG 122
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS-RDQSRCITTIRGTRGYLAPEWIL 284
                + H D+KPEN+LLDE     +SDFGL+ +    ++ R +  + GT  Y+APE + 
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 285 EQGV-SEKCDIYSYGMVLLELTGG 307
            +   +E  D++S G+VL  +  G
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 109 LGHGSSASVFKG-ILSDGTSVAVKRINGEENGEKEFRS----EVAAIASAQHVNLVRLLG 163
           +G G  + V++   L DG  VA+K++   +  + + R+    E+  +    H N+++   
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWI--FPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALS 221
              +      +V E    G L   I  F   +R         +     ++  + +  AL 
Sbjct: 100 -SFIEDNELNIVLELADAGDLSRMIKHFKKQKR--------LIPERTVWKYFVQLCSALE 150
Query: 222 YLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPE 281
           ++H+    RV+H D+KP N+ +       + D GL +  S  ++    ++ GT  Y++PE
Sbjct: 151 HMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPE 206
Query: 282 WILEQGVSEKCDIYSYGMVLLELTG 306
            I E G + K DI+S G +L E+  
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAA 231

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 109 LGHGSSASVFKGILS------DGTSVAVKRIN--GEENGEKEFRSEVAAIASAQHVNLVR 160
           LGHG+   V++G +S          VAVK +     E  E +F  E   I+   H N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
            +G  +    PR+++ E +  G L  ++  T  R     S   L  DL + VA D+A   
Sbjct: 113 CIGVSLQ-SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML--DLLH-VARDIACGC 168
Query: 221 SYLHNDCRSRVLHLDVKPENILLD---ENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG- 276
            YL  +     +H D+   N LL        A + DFG    M+RD  R     +G    
Sbjct: 169 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG----MARDIYRASYYRKGGCAM 221
Query: 277 ----YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
               ++ PE  +E   + K D +S+G++L E+
Sbjct: 222 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 109 LGHGSSASVFKGILS------DGTSVAVKRIN--GEENGEKEFRSEVAAIASAQHVNLVR 160
           LGHG+   V++G +S          VAVK +     E  E +F  E   I+   H N+VR
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
            +G  +    PR+++ E +  G L  ++  T  R     S   L  DL + VA D+A   
Sbjct: 90  CIGVSLQ-SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML--DLLH-VARDIACGC 145
Query: 221 SYLHNDCRSRVLHLDVKPENILLD---ENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG- 276
            YL  +     +H D+   N LL        A + DFG    M+RD  R     +G    
Sbjct: 146 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG----MARDIYRASYYRKGGCAM 198
Query: 277 ----YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
               ++ PE  +E   + K D +S+G++L E+
Sbjct: 199 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 230

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 19/204 (9%)
Query: 109 LGHGSSASV---FKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYC 165
           LG G+   V      +  +  +V +  +    +  +  + E+       H N+V+  G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH- 72
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
              G  +YL  E+   G L   I P     E              R    +   + YLH 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ----------RFFHQLMAGVVYLHG 122
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS-RDQSRCITTIRGTRGYLAPEWIL 284
                + H D+KPEN+LLDE     +SDFGL+ +    ++ R +  + GT  Y+APE + 
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 285 EQGV-SEKCDIYSYGMVLLELTGG 307
            +   +E  D++S G+VL  +  G
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 109 LGHGSSASVFKGILS------DGTSVAVKRIN--GEENGEKEFRSEVAAIASAQHVNLVR 160
           LGHG+   V++G +S          VAVK +     E  E +F  E   I+   H N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
            +G  +    PR+++ E +  G L  ++  T  R     S   L  DL + VA D+A   
Sbjct: 113 CIGVSLQ-SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAML--DLLH-VARDIACGC 168
Query: 221 SYLHNDCRSRVLHLDVKPENILLD---ENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG- 276
            YL  +     +H D+   N LL        A + DFG    M+RD  R     +G    
Sbjct: 169 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG----MARDIYRASYYRKGGCAM 221
Query: 277 ----YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
               ++ PE  +E   + K D +S+G++L E+
Sbjct: 222 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E++  G +   +    R SE H          R+  A  +     YLH+     ++
Sbjct: 117 YMVMEYMPGGDMFSHLRRIGRFSEPH---------ARFYAA-QIVLTFEYLHS---LDLI 163
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+L+D+     V+DFG +K +  R    C     GT  YLAPE IL +G ++ 
Sbjct: 164 YRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA 218
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E++  G +   +    R SE H          R+  A  +     YLH+     ++
Sbjct: 117 YMVMEYMPGGDMFSHLRRIGRFSEPH---------ARFYAA-QIVLTFEYLHS---LDLI 163
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+L+D+     V+DFG +K +  R    C     GT  YLAPE IL +G ++ 
Sbjct: 164 YRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA 218
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 54/91 (59%), Gaps = 4/91 (4%)
Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGY 277
           + + YLHN+   RV+H D+K  N+ L+++    + DFGL+  +  D  R   T+ GT  Y
Sbjct: 153 QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKTLCGTPNY 208
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           +APE + ++G S + DI+S G +L  L  G+
Sbjct: 209 IAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 100/204 (49%), Gaps = 23/204 (11%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEK--EFRSEVAAIASAQHVNLVRLLGYCV 166
           LG G+   V+K    + + +A  ++   ++ E+  ++  E+  +AS  H N+V+LL    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 167 VPGGPRYLVYEFIQNGSLDHWIFPTSRR-SEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
                 +++ EF   G++D  +    R  +E      C       +  +D   AL+YLH+
Sbjct: 105 YENN-LWILIEFCAGGAVDAVMLELERPLTESQIQVVC-------KQTLD---ALNYLHD 153
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWIL- 284
           +   +++H D+K  NIL   +    ++DFG+S   +R   R    I GT  ++APE ++ 
Sbjct: 154 N---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFI-GTPYWMAPEVVMC 209
Query: 285 ----EQGVSEKCDIYSYGMVLLEL 304
               ++    K D++S G+ L+E+
Sbjct: 210 ETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 33/214 (15%)
Query: 108 LLGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFRS-EVAAIASAQHVNLVRLLGYC 165
           ++G+GS   V++  L D G  VA+K++  +    K F++ E+  +    H N+VRL    
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRL---- 78
Query: 166 VVPGGPRYLVY-------EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRY--RVAIDV 216
                 RY  Y       E   N  LD ++  T  R   HYS    +  + Y       +
Sbjct: 79  ------RYFFYSSGEKKDEVYLNLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSRDQSRCITTIRGTR 275
            ++L+Y+H+     + H D+KP+N+LLD +   + + DFG +K + R +   ++ I  +R
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSXI-CSR 186
Query: 276 GYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
            Y APE I      +   D++S G VL EL  G+
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 33/214 (15%)
Query: 108 LLGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFRS-EVAAIASAQHVNLVRLLGYC 165
           ++G+GS   V++  L D G  VA+K++  +    K F++ E+  +    H N+VRL    
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRL---- 78
Query: 166 VVPGGPRYLVY-------EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRY--RVAIDV 216
                 RY  Y       E   N  LD ++  T  R   HYS    +  + Y       +
Sbjct: 79  ------RYFFYSSGEKKDEVYLNLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSRDQSRCITTIRGTR 275
            ++L+Y+H+     + H D+KP+N+LLD +   + + DFG +K + R +   ++ I  +R
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSXI-CSR 186
Query: 276 GYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
            Y APE I      +   D++S G VL EL  G+
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 33/214 (15%)
Query: 108 LLGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFRS-EVAAIASAQHVNLVRLLGYC 165
           ++G+GS   V++  L D G  VA+K++  +    K F++ E+  +    H N+VRL    
Sbjct: 28  VIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRL---- 79
Query: 166 VVPGGPRYLVY-------EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRY--RVAIDV 216
                 RY  Y       E   N  LD ++  T  R   HYS    +  + Y       +
Sbjct: 80  ------RYFFYSSGEKKDEVYLNLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 132
Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSRDQSRCITTIRGTR 275
            ++L+Y+H+     + H D+KP+N+LLD +   + + DFG +K + R +   ++ I  +R
Sbjct: 133 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSXI-CSR 187
Query: 276 GYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
            Y APE I      +   D++S G VL EL  G+
Sbjct: 188 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 109 LGHGSSASVFKGILS------DGTSVAVKRING--EENGEKEFRSEVAAIASAQHVNLVR 160
           LGHG+   V++G +S          VAVK +     E  E +F  E   I+   H N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
            +G  +    PR+++ E +  G L  ++  T  R     S   L  DL + VA D+A   
Sbjct: 113 CIGVSLQ-SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML--DLLH-VARDIACGC 168
Query: 221 SYLHNDCRSRVLHLDVKPENILLD---ENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG- 276
            YL  +     +H D+   N LL        A + DFG    M+RD  R     +G    
Sbjct: 169 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG----MARDIYRASYYRKGGCAM 221
Query: 277 ----YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
               ++ PE  +E   + K D +S+G++L E+
Sbjct: 222 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 109 LGHGSSASVFKGILS------DGTSVAVKRIN--GEENGEKEFRSEVAAIASAQHVNLVR 160
           LGHG+   V++G +S          VAVK +     E  E +F  E   I+   H N+VR
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
            +G  +    PR+++ E +  G L  ++  T  R     S   L  DL + VA D+A   
Sbjct: 116 CIGVSLQ-SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML--DLLH-VARDIACGC 171
Query: 221 SYLHNDCRSRVLHLDVKPENILLD---ENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG- 276
            YL  +     +H D+   N LL        A + DFG    M+RD  R     +G    
Sbjct: 172 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG----MARDIYRAGYYRKGGCAM 224
Query: 277 ----YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
               ++ PE  +E   + K D +S+G++L E+
Sbjct: 225 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 256

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 68/136 (50%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E++  G +   +    R +E H          R+  A  +     YLH+     ++
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFAEPH---------ARFYAA-QIVLTFEYLHS---LDLI 163
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+L+D+     V+DFG +K +  R    C     GT  YLAPE IL +G ++ 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA 218
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 33/214 (15%)
Query: 108 LLGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFRS-EVAAIASAQHVNLVRLLGYC 165
           ++G+GS   V++  L D G  VA+K++  +    K F++ E+  +    H N+VRL    
Sbjct: 46  VIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRL---- 97
Query: 166 VVPGGPRYLVY-------EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRY--RVAIDV 216
                 RY  Y       E   N  LD ++  T  R   HYS    +  + Y       +
Sbjct: 98  ------RYFFYSSGEKKDEVYLNLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 150
Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSRDQSRCITTIRGTR 275
            ++L+Y+H+     + H D+KP+N+LLD +   + + DFG +K + R +   ++ I  +R
Sbjct: 151 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSXI-CSR 205
Query: 276 GYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
            Y APE I      +   D++S G VL EL  G+
Sbjct: 206 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 98/207 (47%), Gaps = 26/207 (12%)
Query: 108 LLGHGSSASVFKGI-LSDG----TSVAVKRIN--GEENGEKEFRSEVAAIASAQHVNLVR 160
           +LG G+  +V+KG+ + +G      VA+K +         KE   E   +AS  + ++ R
Sbjct: 19  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 78
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG C+       L+ + +  G L  ++          Y    L+W       + +A+ +
Sbjct: 79  LLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQY---LLNW------CVQIAEGM 127
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GY 277
           +YL +    R++H D+   N+L+       ++DFGL+KL+  ++        G +    +
Sbjct: 128 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE--YHAEGGKVPIKW 182
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +A E IL +  + + D++SYG+ + EL
Sbjct: 183 MALESILHRIYTHQSDVWSYGVTVWEL 209

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 19/204 (9%)
Query: 109 LGHGSSASV---FKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYC 165
           LG G+   V      +  +  +V +  +    +  +  + E+       H N+V+  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
              G  +YL  E+   G L   I P     E              R    +   + YLH 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ----------RFFHQLMAGVVYLHG 123
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS-RDQSRCITTIRGTRGYLAPEWIL 284
                + H D+KPEN+LLDE     +SDFGL+ +    ++ R +  + GT  Y+APE + 
Sbjct: 124 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 285 EQGV-SEKCDIYSYGMVLLELTGG 307
            +   +E  D++S G+VL  +  G
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 19/204 (9%)
Query: 109 LGHGSSASV---FKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYC 165
           LG G+   V      +  +  +V +  +    +  +  + E+       H N+V+  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
              G  +YL  E+   G L   I P     E              R    +   + YLH 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ----------RFFHQLMAGVVYLHG 123
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS-RDQSRCITTIRGTRGYLAPEWIL 284
                + H D+KPEN+LLDE     +SDFGL+ +    ++ R +  + GT  Y+APE + 
Sbjct: 124 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 285 EQGV-SEKCDIYSYGMVLLELTGG 307
            +   +E  D++S G+VL  +  G
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 19/204 (9%)
Query: 109 LGHGSSASV---FKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYC 165
           LG G+   V      +  +  +V +  +    +  +  + E+       H N+V+  G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
              G  +YL  E+   G L   I P     E              R    +   + YLH 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ----------RFFHQLMAGVVYLHG 123
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS-RDQSRCITTIRGTRGYLAPEWIL 284
                + H D+KPEN+LLDE     +SDFGL+ +    ++ R +  + GT  Y+APE + 
Sbjct: 124 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 285 EQGV-SEKCDIYSYGMVLLELTGG 307
            +   +E  D++S G+VL  +  G
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E+   G +   +    R SE H          R+  A  +     YLH+     ++
Sbjct: 117 YMVMEYAPGGEMFSHLRRIGRFSEPH---------ARFYAA-QIVLTFEYLHS---LDLI 163
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+++D+     V+DFGL+K +  R    C     GT  YLAPE IL +G ++ 
Sbjct: 164 YRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA 218
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 109 LGHGSSASVFKGILS------DGTSVAVKRIN--GEENGEKEFRSEVAAIASAQHVNLVR 160
           LGHG+   V++G +S          VAVK +     E  E +F  E   I+   H N+VR
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
            +G  +    PR+++ E +  G L  ++  T  R     S   L  DL + VA D+A   
Sbjct: 139 CIGVSLQ-SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML--DLLH-VARDIACGC 194
Query: 221 SYLHNDCRSRVLHLDVKPENILLD---ENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG- 276
            YL  +     +H D+   N LL        A + DFG    M+RD  R     +G    
Sbjct: 195 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG----MARDIYRAGYYRKGGCAM 247
Query: 277 ----YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
               ++ PE  +E   + K D +S+G++L E+
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 279

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/194 (23%), Positives = 96/194 (49%), Gaps = 20/194 (10%)
Query: 124 DGTSVAVKRINGEENGEKEFRSEVAAIAS----AQHVNLVRLLGYCVVPGGPRYLVYEFI 179
           +  +VAVK +  ++  EK+    V+ +       +H N++ LLG C    GP Y++  + 
Sbjct: 66  EAVTVAVKMLK-DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-DGPLYVIVGYA 123
Query: 180 QNGSLDHWIFPTSRRSEG-HYSGGC-------LSWDLRYRVAIDVAKALSYLHNDCRSRV 231
             G+L  ++   +RR  G  YS          +++         +A+ + YL      + 
Sbjct: 124 SKGNLREYL--RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKC 178
Query: 232 LHLDVKPENILLDENYRAVVSDFGLSKLMSR-DQSRCITTIRGTRGYLAPEWILEQGVSE 290
           +H D+   N+L+ EN    ++DFGL++ ++  D  +  T  R    ++APE + ++  + 
Sbjct: 179 IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 238
Query: 291 KCDIYSYGMVLLEL 304
           + D++S+G+++ E+
Sbjct: 239 QSDVWSFGVLMWEI 252

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 33/214 (15%)
Query: 108 LLGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFRS-EVAAIASAQHVNLVRLLGYC 165
           ++G+GS   V++  L D G  VA+K++  +    K F++ E+  +    H N+VRL    
Sbjct: 35  VIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRL---- 86
Query: 166 VVPGGPRYLVY-------EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRY--RVAIDV 216
                 RY  Y       E   N  LD ++  T  R   HYS    +  + Y       +
Sbjct: 87  ------RYFFYSSGEKKDEVYLNLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 139
Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSRDQSRCITTIRGTR 275
            ++L+Y+H+     + H D+KP+N+LLD +   + + DFG +K + R +   ++ I  +R
Sbjct: 140 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSXI-CSR 194
Query: 276 GYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
            Y APE I      +   D++S G VL EL  G+
Sbjct: 195 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 33/214 (15%)
Query: 108 LLGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFRS-EVAAIASAQHVNLVRLLGYC 165
           ++G+GS   V++  L D G  VA+K++  +    K F++ E+  +    H N+VRL    
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRL---- 78
Query: 166 VVPGGPRYLVY-------EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRY--RVAIDV 216
                 RY  Y       E   N  LD ++  T  R   HYS    +  + Y       +
Sbjct: 79  ------RYFFYSSGEKKDEVYLNLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSRDQSRCITTIRGTR 275
            ++L+Y+H+     + H D+KP+N+LLD +   + + DFG +K + R +     +   +R
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSR 186
Query: 276 GYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
            Y APE I      +   D++S G VL EL  G+
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC--ITTIRG 273
           + + L Y+H+   + VLH D+KP N+LL+      + DFGL+++   D      +T    
Sbjct: 133 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVA 189
Query: 274 TRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           TR Y APE +L  +G ++  DI+S G +L E+   R
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 68/136 (50%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E+   G +   +    R SE H          R+  A  +     YLH+     ++
Sbjct: 117 YMVMEYAPGGEMFSHLRRIGRFSEPH---------ARFYAA-QIVLTFEYLHS---LDLI 163
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+++D+     V+DFGL+K +  R    C     GT  YLAPE IL +G ++ 
Sbjct: 164 YRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA 218
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 33/214 (15%)
Query: 108 LLGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFRS-EVAAIASAQHVNLVRLLGYC 165
           ++G+GS   V++  L D G  VA+K++  +    K F++ E+  +    H N+VRL    
Sbjct: 39  VIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRL---- 90
Query: 166 VVPGGPRYLVY-------EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRY--RVAIDV 216
                 RY  Y       E   N  LD ++  T  R   HYS    +  + Y       +
Sbjct: 91  ------RYFFYSSGEKKDEVYLNLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 143
Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSRDQSRCITTIRGTR 275
            ++L+Y+H+     + H D+KP+N+LLD +   + + DFG +K + R +   ++ I  +R
Sbjct: 144 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSXI-CSR 198
Query: 276 GYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
            Y APE I      +   D++S G VL EL  G+
Sbjct: 199 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 68/136 (50%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E++  G +   +    R SE H          R+  A  +     YLH+     ++
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFSEPH---------ARFYAA-QIVLTFEYLHS---LDLI 163
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+L+D+     V+DFG +K +  R    C     GT  YLAPE IL +G ++ 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA 218
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ ++  G
Sbjct: 219 VDWWALGVLIYQMAAG 234

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC--ITTIRG 273
           + + L Y+H+   + VLH D+KP N+LL+      + DFGL+++   D      +T    
Sbjct: 133 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 274 TRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           TR Y APE +L  +G ++  DI+S G +L E+   R
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 33/214 (15%)
Query: 108 LLGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFRS-EVAAIASAQHVNLVRLLGYC 165
           ++G+GS   V++  L D G  VA+K++  +    K F++ E+  +    H N+VRL    
Sbjct: 31  VIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRL---- 82
Query: 166 VVPGGPRYLVY-------EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRY--RVAIDV 216
                 RY  Y       E   N  LD ++  T  R   HYS    +  + Y       +
Sbjct: 83  ------RYFFYSSGEKKDEVYLNLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 135
Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSRDQSRCITTIRGTR 275
            ++L+Y+H+     + H D+KP+N+LLD +   + + DFG +K + R +   ++ I  +R
Sbjct: 136 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSXI-CSR 190
Query: 276 GYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
            Y APE I      +   D++S G VL EL  G+
Sbjct: 191 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 102 TDNF--QALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRS---EVAAIASAQH 155
           +DN+  +  LG G+ + V + +  + G   A K IN ++   ++F+    E       QH
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
            N+VRL    +      YLV++ +  G L   I      SE   S  C+           
Sbjct: 64  PNIVRLHD-SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH-CIQ---------Q 112
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV---VSDFGLSKLMSRDQSRCITTIR 272
           + ++++Y H++    ++H ++KPEN+LL    +     ++DFGL+  +  + S       
Sbjct: 113 ILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFA 167
Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           GT GYL+PE + +   S+  DI++ G++L  L  G
Sbjct: 168 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 102 TDNF--QALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRS---EVAAIASAQH 155
           +DN+  +  LG G+ + V + +  + G   A K IN ++   ++F+    E       QH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
            N+VRL    +      YLV++ +  G L   I      SE   S  C+           
Sbjct: 65  PNIVRLHD-SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH-CIQ---------Q 113
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV---VSDFGLSKLMSRDQSRCITTIR 272
           + ++++Y H++    ++H ++KPEN+LL    +     ++DFGL+  +  + S       
Sbjct: 114 ILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFA 168
Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           GT GYL+PE + +   S+  DI++ G++L  L  G
Sbjct: 169 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC--ITTIRG 273
           + + L Y+H+   + VLH D+KP N+LL+      + DFGL+++   D      +T    
Sbjct: 133 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 274 TRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           TR Y APE +L  +G ++  DI+S G +L E+   R
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 33/214 (15%)
Query: 108 LLGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFRS-EVAAIASAQHVNLVRLLGYC 165
           ++G+GS   V++  L D G  VA+K++  +    K F++ E+  +    H N+VRL    
Sbjct: 40  VIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRL---- 91
Query: 166 VVPGGPRYLVY-------EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRY--RVAIDV 216
                 RY  Y       E   N  LD ++  T  R   HYS    +  + Y       +
Sbjct: 92  ------RYFFYSSGEKKDEVYLNLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 144
Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSRDQSRCITTIRGTR 275
            ++L+Y+H+     + H D+KP+N+LLD +   + + DFG +K + R +     +   +R
Sbjct: 145 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSR 199
Query: 276 GYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
            Y APE I      +   D++S G VL EL  G+
Sbjct: 200 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC--ITTIRG 273
           + + L Y+H+   + VLH D+KP N+LL+      + DFGL+++   D      +T    
Sbjct: 137 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 274 TRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           TR Y APE +L  +G ++  DI+S G +L E+   R
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 33/214 (15%)
Query: 108 LLGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFRS-EVAAIASAQHVNLVRLLGYC 165
           ++G+GS   V++  L D G  VA+K++  +    K F++ E+  +    H N+VRL    
Sbjct: 39  VIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRL---- 90
Query: 166 VVPGGPRYLVY-------EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRY--RVAIDV 216
                 RY  Y       E   N  LD ++  T  R   HYS    +  + Y       +
Sbjct: 91  ------RYFFYSSGEKKDEVYLNLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 143
Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSRDQSRCITTIRGTR 275
            ++L+Y+H+     + H D+KP+N+LLD +   + + DFG +K + R +   ++ I  +R
Sbjct: 144 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSXI-CSR 198
Query: 276 GYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
            Y APE I      +   D++S G VL EL  G+
Sbjct: 199 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 76/164 (46%), Gaps = 15/164 (9%)
Query: 144 RSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGC 203
           ++E   +   +H  +V L+ Y    GG  YL+ E++  G L    F    R       G 
Sbjct: 69  KAERNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGEL----FMQLERE------GI 117
Query: 204 LSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD 263
              D       +++ AL +LH   +  +++ D+KPENI+L+      ++DFGL K    D
Sbjct: 118 FMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD 174
Query: 264 QSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
            +       GT  Y+APE ++  G +   D +S G ++ ++  G
Sbjct: 175 GT-VTHXFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC--ITTIRG 273
           + + L Y+H+   + VLH D+KP N+LL+      + DFGL+++   D      +T    
Sbjct: 137 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 274 TRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           TR Y APE +L  +G ++  DI+S G +L E+   R
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC--ITTIRG 273
           + + L Y+H+   + VLH D+KP N+LL+      + DFGL+++   D      +T    
Sbjct: 153 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 274 TRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           TR Y APE +L  +G ++  DI+S G +L E+   R
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 102/219 (46%), Gaps = 20/219 (9%)
Query: 93  FRSKELEEATDNFQALLGHGSSASVFKGILSDGTSV-AVKRIN--GEENGEKEFRSEVAA 149
           F+S + EE     + + G GS   VFKGI +    V A+K I+    E+  ++ + E+  
Sbjct: 20  FQSMDPEELFTKLEKI-GKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITV 78
Query: 150 IASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR 209
           ++      + +  G   +     +++ E++  GS    + P           G L     
Sbjct: 79  LSQCDSPYVTKYYG-SYLKDTKLWIIMEYLGGGSALDLLEP-----------GPLDETQI 126
Query: 210 YRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT 269
             +  ++ K L YLH++ +   +H D+K  N+LL E+    ++DFG++  ++  Q +   
Sbjct: 127 ATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR-N 182
Query: 270 TIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           T  GT  ++APE I +     K DI+S G+  +EL  G 
Sbjct: 183 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 221

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 102 TDNF--QALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRS---EVAAIASAQH 155
           +DN+  +  LG G+ + V + +  + G   A K IN ++   ++F+    E       QH
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
            N+VRL    +      YLV++ +  G L   I      SE   S  C+           
Sbjct: 65  PNIVRLHD-SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH-CIQ---------Q 113
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV---VSDFGLSKLMSRDQSRCITTIR 272
           + ++++Y H++    ++H ++KPEN+LL    +     ++DFGL+  +  + S       
Sbjct: 114 ILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFA 168
Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           GT GYL+PE + +   S+  DI++ G++L  L  G
Sbjct: 169 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 100/219 (45%), Gaps = 35/219 (15%)
Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKE--FRSEVAAIASAQ-HVNLVRLLG 163
           LLG G+ A V   + L +G   AVK I  +    +   FR EV  +   Q + N++ L+ 
Sbjct: 20  LLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFR-EVETLYQCQGNKNILELIE 78
Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL 223
           +        YLV+E +Q GS+   I      +E   S          RV  DVA AL +L
Sbjct: 79  F-FEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREAS----------RVVRDVAAALDFL 127
Query: 224 HNDCRSRVLHLDVKPENILLDENYRAV---VSDFGLSKLMSRDQSRC-------ITTIRG 273
           H      + H D+KPENIL +   +     + DF L   M  + S C       +TT  G
Sbjct: 128 HT---KGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNS-CTPITTPELTTPCG 183
Query: 274 TRGYLAPEWI---LEQGV--SEKCDIYSYGMVLLELTGG 307
           +  Y+APE +    +Q     ++CD++S G+VL  +  G
Sbjct: 184 SAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 90/189 (47%), Gaps = 18/189 (9%)
Query: 128 VAVKRINGEENG-EKE-FRSEVAAIAS-AQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL 184
           VAVK +    +  EKE   SE+  ++   QH N+V LLG C   GGP  ++ E+   G L
Sbjct: 79  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH-GGPVLVITEYCCYGDL 137
Query: 185 DHWIFPTSRRSEG--------HYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDV 236
            +  F   +R  G        H     LS       +  VA+ +++L        +H DV
Sbjct: 138 LN--FLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFL---ASKNCIHRDV 192
Query: 237 KPENILLDENYRAVVSDFGLSKLMSRDQSRCIT-TIRGTRGYLAPEWILEQGVSEKCDIY 295
              N+LL   + A + DFGL++ +  D +  +    R    ++APE I +   + + D++
Sbjct: 193 AARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVW 252
Query: 296 SYGMVLLEL 304
           SYG++L E+
Sbjct: 253 SYGILLWEI 261

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 18/185 (9%)
Query: 127 SVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL 184
           +VAVK ++ +   +  +  + E+       H N+V+  G+    G  +YL  E+   G L
Sbjct: 34  AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH-RREGNIQYLFLEYCSGGEL 92
Query: 185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD 244
              I P     E              R    +   + YLH      + H D+KPEN+LLD
Sbjct: 93  FDRIEPDIGMPEPDAQ----------RFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 139
Query: 245 ENYRAVVSDFGLSKLMS-RDQSRCITTIRGTRGYLAPEWILEQGV-SEKCDIYSYGMVLL 302
           E     +SDFGL+ +    ++ R +  + GT  Y+APE +  +   +E  D++S G+VL 
Sbjct: 140 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 199
Query: 303 ELTGG 307
            +  G
Sbjct: 200 AMLAG 204

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/122 (31%), Positives = 64/122 (52%), Gaps = 19/122 (15%)
Query: 199 YSGGCLSWDLRYRVAID----------VAKALSYLHNDCRSRVLHLDVKPENILLDENYR 248
           Y GG L  ++ +R+  +          V   ++YLH   +  ++H D+KPEN+LL+   +
Sbjct: 118 YKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEK 174
Query: 249 AV---VSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELT 305
                + DFGLS +   +  + +    GT  Y+APE +L +   EKCD++S G++L  L 
Sbjct: 175 DALIKIVDFGLSAVF--ENQKKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILL 231
Query: 306 GG 307
            G
Sbjct: 232 AG 233

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 18/185 (9%)
Query: 127 SVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL 184
           +VAVK ++ +   +  +  + E+       H N+V+  G+    G  +YL  E+   G L
Sbjct: 33  AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH-RREGNIQYLFLEYCSGGEL 91
Query: 185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD 244
              I P     E              R    +   + YLH      + H D+KPEN+LLD
Sbjct: 92  FDRIEPDIGMPEPDAQ----------RFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 138
Query: 245 ENYRAVVSDFGLSKLMS-RDQSRCITTIRGTRGYLAPEWILEQGV-SEKCDIYSYGMVLL 302
           E     +SDFGL+ +    ++ R +  + GT  Y+APE +  +   +E  D++S G+VL 
Sbjct: 139 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 198
Query: 303 ELTGG 307
            +  G
Sbjct: 199 AMLAG 203

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC--ITTIRG 273
           + + L Y+H+   + VLH D+KP N+LL+      + DFGL+++   D      +T    
Sbjct: 135 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 274 TRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           TR Y APE +L  +G ++  DI+S G +L E+   R
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 67/136 (49%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E++  G +   +    R  E H          R+  A  +     YLH+     ++
Sbjct: 138 YMVMEYVAGGEMFSHLRRIGRFXEPH---------ARFYAA-QIVLTFEYLHS---LDLI 184
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+L+D+     V+DFG +K +  R    C     GT  YLAPE IL +G ++ 
Sbjct: 185 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA 239
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 240 VDWWALGVLIYEMAAG 255

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 67/136 (49%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E++  G +   +    R  E H          R+  A  +     YLH+     ++
Sbjct: 117 YMVMEYVPGGEMFSHLRRIGRFXEPH---------ARFYAA-QIVLTFEYLHS---LDLI 163
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+L+D+     V+DFG +K +  R    C     GT  YLAPE IL +G ++ 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA 218
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 108 LLGHGSSASVFKGI-LSDG----TSVAVKRIN--GEENGEKEFRSEVAAIASAQHVNLVR 160
           +L  G+  +V+KG+ + +G      VA+K +         KE   E   +AS  + ++ R
Sbjct: 29  VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG C+       L+ + +  G L  ++          Y    L+W       + +AK +
Sbjct: 89  LLGICLT--STVQLIMQLMPFGCLLDYVREHKDNIGSQY---LLNW------CVQIAKGM 137
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GY 277
           +YL +    R++H D+   N+L+       ++DFGL+KL+  ++        G +    +
Sbjct: 138 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE--YHAEGGKVPIKW 192
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +A E IL +  + + D++SYG+ + EL
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWEL 219

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 67/136 (49%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E++  G +   +    R  E H          R+  A  +     YLH+     ++
Sbjct: 118 YMVMEYVPGGEMFSHLRRIGRFXEPH---------ARFYAA-QIVLTFEYLHS---LDLI 164
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+L+D+     V+DFG +K +  R    C     GT  YLAPE IL +G ++ 
Sbjct: 165 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA 219
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 220 VDWWALGVLIYEMAAG 235

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 67/136 (49%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E++  G +   +    R  E H          R+  A  +     YLH+     ++
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFXEPH---------ARFYAA-QIVLTFEYLHS---LDLI 163
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+L+D+     V+DFG +K +  R    C     GT  YLAPE IL +G ++ 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA 218
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 31/213 (14%)
Query: 108 LLGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCV 166
           ++G+GS   V++  L D G  VA+K++     G+     E+  +    H N+VRL     
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKV---LQGKAFKNRELQIMRKLDHCNIVRL----- 78
Query: 167 VPGGPRYLVY-------EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRY--RVAIDVA 217
                RY  Y       E   N  LD ++  T  R   HYS    +  + Y       + 
Sbjct: 79  -----RYFFYSSGEKKDEVYLNLVLD-YVPATVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSRDQSRCITTIRGTRG 276
           ++L+Y+H+     + H D+KP+N+LLD +   + + DFG +K + R +   ++ I  +R 
Sbjct: 133 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSXI-CSRY 187
Query: 277 YLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
           Y APE I      +   D++S G VL EL  G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 67/136 (49%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E+   G +   +    R SE H          R+  A  +     YLH+     ++
Sbjct: 118 YMVLEYAPGGEMFSHLRRIGRFSEPH---------ARFYAA-QIVLTFEYLHS---LDLI 164
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+L+D+     V+DFG +K +  R    C     GT  YLAPE IL +G ++ 
Sbjct: 165 YRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA 219
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 220 VDWWALGVLIYEMAAG 235

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 67/136 (49%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E++  G +   +    R  E H          R+  A  +     YLH+     ++
Sbjct: 117 YMVMEYVPGGEMFSHLRRIGRFXEPH---------ARFYAA-QIVLTFEYLHS---LDLI 163
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+L+D+     V+DFG +K +  R    C     GT  YLAPE IL +G ++ 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA 218
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 67/136 (49%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E++  G +   +    R  E H          R+  A  +     YLH+     ++
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFXEPH---------ARFYAA-QIVLTFEYLHS---LDLI 163
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+L+D+     V+DFG +K +  R    C     GT  YLAPE IL +G ++ 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA 218
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 22/219 (10%)
Query: 104 NFQALLGHGS-----SASVFKGILSDGT-SVAVKRINGEEN-GEKE-FRSEVAAIAS-AQ 154
           +F   LG G+      A+ +  I SD   +VAVK +    +  E+E   SE+  ++    
Sbjct: 49  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 108
Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWI------FPTSRRSEG--HYSGGCLSW 206
           H+N+V LLG C + GGP  ++ E+   G L +++      F  S+ S          L  
Sbjct: 109 HMNIVNLLGACTI-GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 167
Query: 207 DLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSR 266
           +     +  VAK +++L        +H D+   NILL       + DFGL++ +  D + 
Sbjct: 168 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNY 224
Query: 267 CIT-TIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            +    R    ++APE I     + + D++SYG+ L EL
Sbjct: 225 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 263

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 67/136 (49%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E++  G +   +    R  E H          R+  A  +     YLH+     ++
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFXEPH---------ARFYAA-QIVLTFEYLHS---LDLI 163
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+L+D+     V+DFG +K +  R    C     GT  YLAPE IL +G ++ 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA 218
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC--ITTIRG 273
           + + L Y+H+   + VLH D+KP N+LL+      + DFGL+++   D      +T    
Sbjct: 131 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 274 TRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           TR Y APE +L  +G ++  DI+S G +L E+   R
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC--ITTIRG 273
           + + L Y+H+   + VLH D+KP N+LL+      + DFGL+++   D      +T    
Sbjct: 135 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 274 TRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           TR Y APE +L  +G ++  DI+S G +L E+   R
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 22/219 (10%)
Query: 104 NFQALLGHGS-----SASVFKGILSDGT-SVAVKRINGEEN-GEKE-FRSEVAAIAS-AQ 154
           +F   LG G+      A+ +  I SD   +VAVK +    +  E+E   SE+  ++    
Sbjct: 42  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 101
Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWI------FPTSRRSEG--HYSGGCLSW 206
           H+N+V LLG C + GGP  ++ E+   G L +++      F  S+ S          L  
Sbjct: 102 HMNIVNLLGACTI-GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 160
Query: 207 DLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSR 266
           +     +  VAK +++L +      +H D+   NILL       + DFGL++ +  D + 
Sbjct: 161 EDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 217
Query: 267 CIT-TIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            +    R    ++APE I     + + D++SYG+ L EL
Sbjct: 218 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 256

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC--ITTIRG 273
           + + L Y+H+   + VLH D+KP N+LL+      + DFGL+++   D      +T    
Sbjct: 133 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 274 TRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           TR Y APE +L  +G ++  DI+S G +L E+   R
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 68/136 (50%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E++  G +   +    R SE H          R+  A  +     YLH+     ++
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFSEPH---------ARFYAA-QIVLTFEYLHS---LDLI 163
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+++D+     V+DFG +K +  R    C     GT  YLAPE I+ +G ++ 
Sbjct: 164 YRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIIISKGYNKA 218
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 108 LLGHGSSASVFKGI-LSDGTSVAVK------RINGEENGEKEFRSEVAAIASAQHVNLVR 160
           +LG G+  +V+KG+ + +G  V +       R        KE   E   +AS  + ++ R
Sbjct: 26  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 85
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG C+       L+ + +  G L  ++          Y    L+W       + +AK +
Sbjct: 86  LLGICLT--STVQLIMQLMPFGCLLDYVREHKDNIGSQY---LLNW------CVQIAKGM 134
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GY 277
           +YL +    R++H D+   N+L+       ++DFG +KL+  ++        G +    +
Sbjct: 135 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE--YHAEGGKVPIKW 189
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +A E IL +  + + D++SYG+ + EL
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWEL 216

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC--ITTIRG 273
           + + L Y+H+   + VLH D+KP N+LL+      + DFGL+++   D      +T    
Sbjct: 137 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 274 TRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           TR Y APE +L  +G ++  DI+S G +L E+   R
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC--ITTIRG 273
           + + L Y+H+   + VLH D+KP N+LL+      + DFGL+++   D      +T    
Sbjct: 138 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 194
Query: 274 TRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           TR Y APE +L  +G ++  DI+S G +L E+   R
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC--ITTIRG 273
           + + L Y+H+   + VLH D+KP N+LL+      + DFGL+++   D      +T    
Sbjct: 139 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 195
Query: 274 TRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           TR Y APE +L  +G ++  DI+S G +L E+   R
Sbjct: 196 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC--ITTIRG 273
           + + L Y+H+   + VLH D+KP N+LL+      + DFGL+++   D      +T    
Sbjct: 130 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 186
Query: 274 TRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           TR Y APE +L  +G ++  DI+S G +L E+   R
Sbjct: 187 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC--ITTIRG 273
           + + L Y+H+   + VLH D+KP N+LL+      + DFGL+++   D      +T    
Sbjct: 137 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 274 TRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           TR Y APE +L  +G ++  DI+S G +L E+   R
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 109 LGHGSSASVFKGILS------DGTSVAVKRIN--GEENGEKEFRSEVAAIASAQHVNLVR 160
           LGHG+   V++G +S          VAVK +     E  E +F  E   I+   H N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
            +G  +    PR+++ E +  G L  ++  T  R     S   L  DL + VA D+A   
Sbjct: 99  CIGVSLQ-SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML--DLLH-VARDIACGC 154
Query: 221 SYLHNDCRSRVLHLDVKPENILLD---ENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG- 276
            YL  +     +H D+   N LL        A + DFG    M++D  R     +G    
Sbjct: 155 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG----MAQDIYRASYYRKGGCAM 207
Query: 277 ----YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
               ++ PE  +E   + K D +S+G++L E+
Sbjct: 208 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC--ITTIRG 273
           + + L Y+H+   + VLH D+KP N+LL+      + DFGL+++   D      +T    
Sbjct: 131 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 274 TRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           TR Y APE +L  +G ++  DI+S G +L E+   R
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC--ITTIRG 273
           + + L Y+H+   + VLH D+KP N+LL+      + DFGL+++   D      +T    
Sbjct: 137 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 274 TRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           TR Y APE +L  +G ++  DI+S G +L E+   R
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 56/102 (54%), Gaps = 8/102 (7%)
Query: 211 RVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITT 270
           ++ +   KAL++L  + +  ++H D+KP NILLD +    + DFG+S  +    ++  T 
Sbjct: 129 KITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK--TR 184
Query: 271 IRGTRGYLAPEWI----LEQGVSEKCDIYSYGMVLLELTGGR 308
             G R Y+APE I      QG   + D++S G+ L EL  GR
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 62/119 (52%), Gaps = 14/119 (11%)
Query: 199 YSGGCLSWDL-------RYRVAI---DVAKALSYLHNDCRSRVLHLDVKPENILLDENYR 248
           Y GG  + DL        +++A    ++ K L YLH++ +   +H D+K  N+LL E   
Sbjct: 102 YLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGD 158
Query: 249 AVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
             ++DFG++  ++  Q +   T  GT  ++APE I +     K DI+S G+  +EL  G
Sbjct: 159 VKLADFGVAGQLTDTQIKR-NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKG 216

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC--ITTIRG 273
           + + L Y+H+   + VLH D+KP N+LL+      + DFGL+++   D      +T    
Sbjct: 141 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 197
Query: 274 TRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           TR Y APE +L  +G ++  DI+S G +L E+   R
Sbjct: 198 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC--ITTIRG 273
           + + L Y+H+   + VLH D+KP N+LL+      + DFGL+++   D      +T    
Sbjct: 133 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 274 TRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           TR Y APE +L  +G ++  DI+S G +L E+   R
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC--ITTIRG 273
           + + L Y+H+   + VLH D+KP N+LL+      + DFGL+++   D      +T    
Sbjct: 135 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 274 TRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           TR Y APE +L  +G ++  DI+S G +L E+   R
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 22/219 (10%)
Query: 104 NFQALLGHGS-----SASVFKGILSDGT-SVAVKRINGEEN-GEKE-FRSEVAAIAS-AQ 154
           +F   LG G+      A+ +  I SD   +VAVK +    +  E+E   SE+  ++    
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWI------FPTSRRSEG--HYSGGCLSW 206
           H+N+V LLG C + GGP  ++ E+   G L +++      F  S+ S          L  
Sbjct: 86  HMNIVNLLGACTI-GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 207 DLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSR 266
           +     +  VAK +++L +      +H D+   NILL       + DFGL++ +  D + 
Sbjct: 145 EDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 267 CIT-TIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            +    R    ++APE I     + + D++SYG+ L EL
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC--ITTIRG 273
           + + L Y+H+   + VLH D+KP N+LL+      + DFGL+++   D      +T    
Sbjct: 153 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 274 TRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           TR Y APE +L  +G ++  DI+S G +L E+   R
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 67/136 (49%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E++  G +   +    R  E H          R+  A  +     YLH+     ++
Sbjct: 112 YMVMEYVAGGEMFSHLRRIGRFXEPH---------ARFYAA-QIVLTFEYLHS---LDLI 158
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+L+D+     V+DFG +K +  R    C     GT  YLAPE IL +G ++ 
Sbjct: 159 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA 213
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 214 VDWWALGVLIYEMAAG 229

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 31/213 (14%)
Query: 108 LLGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCV 166
           ++G+GS   V++  L D G  VA+K++     G+     E+  +    H N+VRL     
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKV---LQGKAFKNRELQIMRKLDHCNIVRL----- 78
Query: 167 VPGGPRYLVY-------EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRY--RVAIDVA 217
                RY  Y       E   N  LD ++  T  R   HYS    +  + Y       + 
Sbjct: 79  -----RYFFYSSGEKKDEVYLNLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSRDQSRCITTIRGTRG 276
           ++L+Y+H+     + H D+KP+N+LLD +   + + DFG +K + R +     +   +R 
Sbjct: 133 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRY 187
Query: 277 YLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
           Y APE I      +   D++S G VL EL  G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 33/214 (15%)
Query: 108 LLGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFRS-EVAAIASAQHVNLVRLLGYC 165
           ++G+GS   V++  L D G  VA+K++  +    K F++ E+  +    H N+VRL    
Sbjct: 61  VIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRL---- 112
Query: 166 VVPGGPRYLVY-------EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRY--RVAIDV 216
                 RY  Y       E   N  LD ++  T  R   HYS    +  + Y       +
Sbjct: 113 ------RYFFYSSGEKKDEVYLNLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSRDQSRCITTIRGTR 275
            ++L+Y+H+     + H D+KP+N+LLD +   + + DFG +K + R +   ++ I  +R
Sbjct: 166 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSXI-CSR 220
Query: 276 GYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
            Y APE I      +   D++S G VL EL  G+
Sbjct: 221 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 67/136 (49%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E++  G +   +    R  E H          R+  A  +     YLH+     ++
Sbjct: 110 YMVMEYVPGGEMFSHLRRIGRFXEPH---------ARFYAA-QIVLTFEYLHS---LDLI 156
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+L+D+     V+DFG +K +  R    C     GT  YLAPE IL +G ++ 
Sbjct: 157 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA 211
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 212 VDWWALGVLIYEMAAG 227

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 108 LLGHGSSASVFKGI-LSDGTSVAVK------RINGEENGEKEFRSEVAAIASAQHVNLVR 160
           +LG G+  +V+KG+ + +G  V +       R        KE   E   +AS  + ++ R
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG C+       L+ + +  G L  ++          Y    L+W       + +AK +
Sbjct: 84  LLGICLT--STVQLIMQLMPFGCLLDYVREHKDNIGSQY---LLNW------CVQIAKGM 132
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GY 277
           +YL +    R++H D+   N+L+       ++DFG +KL+  ++        G +    +
Sbjct: 133 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE--YHAEGGKVPIKW 187
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +A E IL +  + + D++SYG+ + EL
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWEL 214

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 108 LLGHGSSASVFKGI-LSDGTSVAVK------RINGEENGEKEFRSEVAAIASAQHVNLVR 160
           +LG G+  +V+KG+ + +G  V +       R        KE   E   +AS  + ++ R
Sbjct: 29  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG C+       L+ + +  G L  ++          Y    L+W       + +AK +
Sbjct: 89  LLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQY---LLNW------CVQIAKGM 137
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GY 277
           +YL +    R++H D+   N+L+       ++DFG +KL+  ++        G +    +
Sbjct: 138 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE--YHAEGGKVPIKW 192
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +A E IL +  + + D++SYG+ + EL
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWEL 219

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 108 LLGHGSSASVFKGI-LSDGTSVAVK------RINGEENGEKEFRSEVAAIASAQHVNLVR 160
           +L  G+  +V+KG+ + +G  V +       R        KE   E   +AS  + ++ R
Sbjct: 29  VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 88
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG C+       L+ + +  G L  ++          Y    L+W       + +AK +
Sbjct: 89  LLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQY---LLNW------CVQIAKGM 137
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GY 277
           +YL +    R++H D+   N+L+       ++DFGL+KL+  ++        G +    +
Sbjct: 138 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE--YHAEGGKVPIKW 192
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +A E IL +  + + D++SYG+ + EL
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWEL 219

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 88/191 (46%), Gaps = 30/191 (15%)
Query: 125 GTSVAVKRI-NGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRY-LVYEFIQNG 182
           G  VAVK++ +   + +++F+ E+  + +     +V+  G    PG     LV E++ +G
Sbjct: 39  GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG 98
Query: 183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRS-------RVLHLD 235
            L  ++                    R+R  +D ++ L Y    C+        R +H D
Sbjct: 99  CLRDFL-------------------QRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRD 139
Query: 236 VKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG--YLAPEWILEQGVSEKCD 293
           +   NIL++      ++DFGL+KL+  D+   +    G     + APE + +   S + D
Sbjct: 140 LAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSD 199
Query: 294 IYSYGMVLLEL 304
           ++S+G+VL EL
Sbjct: 200 VWSFGVVLYEL 210

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 33/214 (15%)
Query: 108 LLGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFRS-EVAAIASAQHVNLVRLLGYC 165
           ++G+GS   V++  L D G  VA+K++  +    K F++ E+  +    H N+VRL    
Sbjct: 55  VIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRL---- 106
Query: 166 VVPGGPRYLVY-------EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRY--RVAIDV 216
                 RY  Y       E   N  LD ++  T  R   HYS    +  + Y       +
Sbjct: 107 ------RYFFYSSGEKKDEVYLNLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 159
Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSRDQSRCITTIRGTR 275
            ++L+Y+H+     + H D+KP+N+LLD +   + + DFG +K + R +     +   +R
Sbjct: 160 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSR 214
Query: 276 GYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
            Y APE I      +   D++S G VL EL  G+
Sbjct: 215 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 108 LLGHGSSASVFKGI-LSDGTSVAVK------RINGEENGEKEFRSEVAAIASAQHVNLVR 160
           +LG G+  +V+KG+ + +G  V +       R        KE   E   +AS  + ++ R
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG C+       L+ + +  G L  ++          Y    L+W       + +AK +
Sbjct: 84  LLGICLT--STVQLIMQLMPFGCLLDYVREHKDNIGSQY---LLNW------CVQIAKGM 132
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GY 277
           +YL +    R++H D+   N+L+       ++DFG +KL+  ++        G +    +
Sbjct: 133 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE--YHAEGGKVPIKW 187
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +A E IL +  + + D++SYG+ + EL
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWEL 214

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 33/214 (15%)
Query: 108 LLGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFRS-EVAAIASAQHVNLVRLLGYC 165
           ++G+GS   V++  L D G  VA+K++  +    K F++ E+  +    H N+VRL    
Sbjct: 32  VIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRL---- 83
Query: 166 VVPGGPRYLVY-------EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRY--RVAIDV 216
                 RY  Y       E   N  LD ++  T  R   HYS    +  + Y       +
Sbjct: 84  ------RYFFYSSGEKKDEVYLNLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 136
Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSRDQSRCITTIRGTR 275
            ++L+Y+H+     + H D+KP+N+LLD +   + + DFG +K + R +     +   +R
Sbjct: 137 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSR 191
Query: 276 GYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
            Y APE I      +   D++S G VL EL  G+
Sbjct: 192 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 22/219 (10%)
Query: 104 NFQALLGHGS-----SASVFKGILSDGT-SVAVKRINGEEN-GEKE-FRSEVAAIAS-AQ 154
           +F   LG G+      A+ +  I SD   +VAVK +    +  E+E   SE+  ++    
Sbjct: 44  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 103
Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWI------FPTSRRSEG--HYSGGCLSW 206
           H+N+V LLG C + GGP  ++ E+   G L +++      F  S+ S          L  
Sbjct: 104 HMNIVNLLGACTI-GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 162
Query: 207 DLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSR 266
           +     +  VAK +++L +      +H D+   NILL       + DFGL++ +  D + 
Sbjct: 163 EDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 219
Query: 267 CIT-TIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            +    R    ++APE I     + + D++SYG+ L EL
Sbjct: 220 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 258

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 88/191 (46%), Gaps = 30/191 (15%)
Query: 125 GTSVAVKRI-NGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRY-LVYEFIQNG 182
           G  VAVK++ +   + +++F+ E+  + +     +V+  G    PG     LV E++ +G
Sbjct: 52  GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG 111
Query: 183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRS-------RVLHLD 235
            L  ++                    R+R  +D ++ L Y    C+        R +H D
Sbjct: 112 CLRDFL-------------------QRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRD 152
Query: 236 VKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG--YLAPEWILEQGVSEKCD 293
           +   NIL++      ++DFGL+KL+  D+   +    G     + APE + +   S + D
Sbjct: 153 LAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSD 212
Query: 294 IYSYGMVLLEL 304
           ++S+G+VL EL
Sbjct: 213 VWSFGVVLYEL 223

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 25/215 (11%)
Query: 102 TDNF--QALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRS---EVAAIASAQH 155
           +DN+  +  LG G+ + V + +  + G   A K IN ++   ++F+    E       QH
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
            N+VRL    +      YLV++ +  G L   I      SE   S  C+           
Sbjct: 88  PNIVRLHD-SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH-CIQ---------Q 136
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV---VSDFGLSKLMSRDQSRCITTIR 272
           + ++++Y H++    ++H ++KPEN+LL    +     ++DFGL+  +  + S       
Sbjct: 137 ILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFA 191
Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           GT GYL+PE + +   S+  DI++ G++L  L  G
Sbjct: 192 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 31/213 (14%)
Query: 108 LLGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCV 166
           ++G+GS   V++  L D G  VA+K++     G+     E+  +    H N+VRL     
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKV---LQGKAFKNRELQIMRKLDHCNIVRL----- 78
Query: 167 VPGGPRYLVY-------EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRY--RVAIDVA 217
                RY  Y       E   N  LD ++  T  R   HYS    +  + Y       + 
Sbjct: 79  -----RYFFYSSGEKKDEVYLNLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSRDQSRCITTIRGTRG 276
           ++L+Y+H+     + H D+KP+N+LLD +   + + DFG +K + R +     +   +R 
Sbjct: 133 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRY 187
Query: 277 YLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
           Y APE I      +   D++S G VL EL  G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 35/223 (15%)
Query: 98  LEEATDNFQALLGHGSSASV---FKGILSDGTS--VAVKRI-NGEENGEKEFRSEVAAIA 151
            EE    + + LG G+  SV       L D T   VAVK++ +   + +++F+ E+  + 
Sbjct: 8   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 67
Query: 152 SAQHVNLVRLLGYCVVPGGPRY-LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRY 210
           +     +V+  G    PG     LV E++ +G L  ++                    R+
Sbjct: 68  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-------------------QRH 108
Query: 211 RVAIDVAKALSYLHNDCRS-------RVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD 263
           R  +D ++ L Y    C+        R +H D+   NIL++      ++DFGL+KL+  D
Sbjct: 109 RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 168
Query: 264 QSRCITTIRGTRG--YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +   +    G     + APE + +   S + D++S+G+VL EL
Sbjct: 169 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 211

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 27/217 (12%)
Query: 101 ATDNFQAL--LGHGSSASVFKG-ILSDGTSVAVKRI---NGEENGEKEFRSEVAAI---A 151
           AT  ++ +  +G G+  +V+K      G  VA+K +   NGEE        EVA +    
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 152 SAQHVNLVRLLGYCVVPGGPR----YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWD 207
           + +H N+VRL+  C      R     LV+E +     D   +       G      L  +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ---DLRTYLDKAPPPG------LPAE 112
Query: 208 LRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC 267
               +     + L +LH +C   ++H D+KPENIL+       ++DFGL+++ S   +  
Sbjct: 113 TIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALA 169
Query: 268 ITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
              +  T  Y APE +L+   +   D++S G +  E+
Sbjct: 170 PVVV--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 108 LLGHGSSASVFKGI-LSDGTSVAVK------RINGEENGEKEFRSEVAAIASAQHVNLVR 160
           +LG G+  +V+KG+ + +G  V +       R        KE   E   +AS  + ++ R
Sbjct: 24  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 83
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG C+       L+ + +  G L  ++          Y    L+W       + +AK +
Sbjct: 84  LLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQY---LLNW------CVQIAKGM 132
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GY 277
           +YL +    R++H D+   N+L+       ++DFG +KL+  ++        G +    +
Sbjct: 133 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE--YHAEGGKVPIKW 187
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +A E IL +  + + D++SYG+ + EL
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWEL 214

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 108 LLGHGSSASVFKGI-LSDGTSVAVK------RINGEENGEKEFRSEVAAIASAQHVNLVR 160
           +L  G+  +V+KG+ + +G  V +       R        KE   E   +AS  + ++ R
Sbjct: 22  VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG C+       L+ + +  G L  ++          Y    L+W       + +AK +
Sbjct: 82  LLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQY---LLNW------CVQIAKGM 130
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GY 277
           +YL +    R++H D+   N+L+       ++DFGL+KL+  ++        G +    +
Sbjct: 131 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE--YHAEGGKVPIKW 185
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +A E IL +  + + D++SYG+ + EL
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWEL 212

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 27/207 (13%)
Query: 104 NFQAL--LGHGSSASV-FKGILSDGTSVAVKRIN----GEENGEKEFRSEVAAIASAQHV 156
           N+Q +  LG GS   V      + G  VA+K IN     + + +     E++ +   +H 
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 157 NLVRLLGYCVVPGGPRY-LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
           ++++L  Y V+       +V E+  N   D +I    + SE              R    
Sbjct: 65  HIIKL--YDVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEAR----------RFFQQ 111
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           +  A+ Y H   R +++H D+KPEN+LLDE+    ++DFGLS +M+      + T  G+ 
Sbjct: 112 IISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKTSCGSP 166
Query: 276 GYLAPEWILEQGVS-EKCDIYSYGMVL 301
            Y APE I  +  +  + D++S G++L
Sbjct: 167 NYAAPEVISGKLYAGPEVDVWSCGVIL 193

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 108 LLGHGSSASVFKGI-LSDGTSVAVK------RINGEENGEKEFRSEVAAIASAQHVNLVR 160
           +LG G+  +V+KG+ + +G  V +       R        KE   E   +AS  + ++ R
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG C+       L+ + +  G L  ++          Y    L+W       + +AK +
Sbjct: 82  LLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQY---LLNW------CVQIAKGM 130
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GY 277
           +YL +    R++H D+   N+L+       ++DFG +KL+  ++        G +    +
Sbjct: 131 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE--YHAEGGKVPIKW 185
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +A E IL +  + + D++SYG+ + EL
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWEL 212

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 67/136 (49%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E+   G +   +    R SE H          R+  A  +     YLH+     ++
Sbjct: 117 YMVMEYAPGGEMFSHLRRIGRFSEPH---------ARFYAA-QIVLTFEYLHS---LDLI 163
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+++D+     V+DFG +K +  R    C     GT  YLAPE IL +G ++ 
Sbjct: 164 YRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA 218
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 22/219 (10%)
Query: 104 NFQALLGHGS-----SASVFKGILSDGT-SVAVKRINGEEN-GEKE-FRSEVAAIAS-AQ 154
           +F   LG G+      A+ +  I SD   +VAVK +    +  E+E   SE+  ++    
Sbjct: 49  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 108
Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWI------FPTSRRSEG--HYSGGCLSW 206
           H+N+V LLG C + GGP  ++ E+   G L +++      F  S+ S          L  
Sbjct: 109 HMNIVNLLGACTI-GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 167
Query: 207 DLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSR 266
           +     +  VAK +++L +      +H D+   NILL       + DFGL++ +  D + 
Sbjct: 168 EDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 224
Query: 267 CIT-TIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
            +    R    ++APE I     + + D++SYG+ L EL
Sbjct: 225 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 263

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 67/136 (49%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E+   G +   +    R SE H          R+  A  +     YLH+     ++
Sbjct: 118 YMVMEYAPGGEMFSHLRRIGRFSEPH---------ARFYAA-QIVLTFEYLHS---LDLI 164
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+++D+     V+DFG +K +  R    C     GT  YLAPE IL +G ++ 
Sbjct: 165 YRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA 219
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 220 VDWWALGVLIYEMAAG 235

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 33/214 (15%)
Query: 108 LLGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFRS-EVAAIASAQHVNLVRLLGYC 165
           ++G+GS   V++  L D G  VA+K++  +    K F++ E+  +    H N+VRL    
Sbjct: 63  VIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRL---- 114
Query: 166 VVPGGPRYLVY-------EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRY--RVAIDV 216
                 RY  Y       E   N  LD ++  T  R   HYS    +  + Y       +
Sbjct: 115 ------RYFFYSSGEKKDEVYLNLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 167
Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSRDQSRCITTIRGTR 275
            ++L+Y+H+     + H D+KP+N+LLD +   + + DFG +K + R +     +   +R
Sbjct: 168 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSR 222
Query: 276 GYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
            Y APE I      +   D++S G VL EL  G+
Sbjct: 223 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 33/214 (15%)
Query: 108 LLGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFRS-EVAAIASAQHVNLVRLLGYC 165
           ++G+GS   V++  L D G  VA+K++  +    K F++ E+  +    H N+VRL    
Sbjct: 61  VIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRL---- 112
Query: 166 VVPGGPRYLVY-------EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRY--RVAIDV 216
                 RY  Y       E   N  LD ++  T  R   HYS    +  + Y       +
Sbjct: 113 ------RYFFYSSGEKKDEVYLNLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSRDQSRCITTIRGTR 275
            ++L+Y+H+     + H D+KP+N+LLD +   + + DFG +K + R +     +   +R
Sbjct: 166 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSR 220
Query: 276 GYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
            Y APE I      +   D++S G VL EL  G+
Sbjct: 221 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 67/136 (49%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E+   G +   +    R SE H          R+  A  +     YLH+     ++
Sbjct: 117 YMVMEYAPGGEMFSHLRRIGRFSEPH---------ARFYAA-QIVLTFEYLHS---LDLI 163
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+++D+     V+DFG +K +  R    C     GT  YLAPE IL +G ++ 
Sbjct: 164 YRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA 218
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 52/87 (59%), Gaps = 4/87 (4%)
Query: 222 YLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPE 281
           YLH   R+RV+H D+K  N+ L+E+    + DFGL+  +  D  R   T+ GT  Y+APE
Sbjct: 132 YLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-KKTLCGTPNYIAPE 187
Query: 282 WILEQGVSEKCDIYSYGMVLLELTGGR 308
            + ++G S + D++S G ++  L  G+
Sbjct: 188 VLSKKGHSFEVDVWSIGCIMYTLLVGK 214

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 52/87 (59%), Gaps = 4/87 (4%)
Query: 222 YLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPE 281
           YLH   R+RV+H D+K  N+ L+E+    + DFGL+  +  D  R   T+ GT  Y+APE
Sbjct: 136 YLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-KKTLCGTPNYIAPE 191
Query: 282 WILEQGVSEKCDIYSYGMVLLELTGGR 308
            + ++G S + D++S G ++  L  G+
Sbjct: 192 VLSKKGHSFEVDVWSIGCIMYTLLVGK 218

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/87 (36%), Positives = 52/87 (59%), Gaps = 4/87 (4%)
Query: 222 YLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPE 281
           YLH   R+RV+H D+K  N+ L+E+    + DFGL+  +  D  R   T+ GT  Y+APE
Sbjct: 132 YLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-KKTLCGTPNYIAPE 187
Query: 282 WILEQGVSEKCDIYSYGMVLLELTGGR 308
            + ++G S + D++S G ++  L  G+
Sbjct: 188 VLSKKGHSFEVDVWSIGCIMYTLLVGK 214

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 67/136 (49%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E+   G +   +    R SE H          R+  A  +     YLH+     ++
Sbjct: 118 YMVMEYAPGGEMFSHLRRIGRFSEPH---------ARFYAA-QIVLTFEYLHS---LDLI 164
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+++D+     V+DFG +K +  R    C     GT  YLAPE IL +G ++ 
Sbjct: 165 YRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA 219
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 220 VDWWALGVLIYEMAAG 235

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 67/136 (49%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E+   G +   +    R SE H          R+  A  +     YLH+     ++
Sbjct: 118 YMVMEYAPGGEMFSHLRRIGRFSEPH---------ARFYAA-QIVLTFEYLHS---LDLI 164
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+++D+     V+DFG +K +  R    C     GT  YLAPE IL +G ++ 
Sbjct: 165 YRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPEIILSKGYNKA 219
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 220 VDWWALGVLIYEMAAG 235

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 67/136 (49%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E++  G +   +    R SE H          R+  A  +     YLH+     ++
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFSEPH---------ARFYAA-QIVLTFEYLHS---LDLI 163
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+L+D+     V+DFG +K +  R    C     GT  YLAP  IL +G ++ 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPAIILSKGYNKA 218
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 99/228 (43%), Gaps = 33/228 (14%)
Query: 90  PIKFRSKELEEATDNFQALLGHGSSASVFKGILSD---GTSVAVKRINGEENGEKEFR-S 145
           P+ +  +E E      Q  LG GS   V +  + D   G   AVK++  E      FR  
Sbjct: 62  PVDYEYRE-EVHWMTHQPRLGRGSFGEVHR--MKDKQTGFQCAVKKVRLEV-----FRVE 113
Query: 146 EVAAIASAQHVNLVRLLGYCVVPGGPRYLVY-EFIQNGSLDHWIFPTSRRSEGHYSGGCL 204
           E+ A A      +V L G   V  GP   ++ E ++ GSL   I             GCL
Sbjct: 114 ELVACAGLSSPRIVPLYG--AVREGPWVNIFMELLEGGSLGQLIKQM----------GCL 161
Query: 205 SWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD-ENYRAVVSDFGLSKLMSRD 263
             D          + L YLH     R+LH DVK +N+LL  +  RA + DFG +  +  D
Sbjct: 162 PEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 218
Query: 264 Q-SRCITT---IRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
              + + T   I GT  ++APE ++ +    K DI+S   ++L +  G
Sbjct: 219 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 27/207 (13%)
Query: 104 NFQAL--LGHGSSASV-FKGILSDGTSVAVKRIN----GEENGEKEFRSEVAAIASAQHV 156
           N+Q +  LG GS   V      + G  VA+K IN     + + +     E++ +   +H 
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 157 NLVRLLGYCVVPGGPRY-LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
           ++++L  Y V+       +V E+  N   D +I    + SE              R    
Sbjct: 69  HIIKL--YDVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEAR----------RFFQQ 115
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           +  A+ Y H   R +++H D+KPEN+LLDE+    ++DFGLS +M+      + T  G+ 
Sbjct: 116 IISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKTSCGSP 170
Query: 276 GYLAPEWILEQGVS-EKCDIYSYGMVL 301
            Y APE I  +  +  + D++S G++L
Sbjct: 171 NYAAPEVISGKLYAGPEVDVWSCGVIL 197

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 27/207 (13%)
Query: 104 NFQAL--LGHGSSASV-FKGILSDGTSVAVKRIN----GEENGEKEFRSEVAAIASAQHV 156
           N+Q +  LG GS   V      + G  VA+K IN     + + +     E++ +   +H 
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 157 NLVRLLGYCVVPGGPRY-LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
           ++++L  Y V+       +V E+  N   D +I    + SE              R    
Sbjct: 75  HIIKL--YDVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEAR----------RFFQQ 121
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           +  A+ Y H   R +++H D+KPEN+LLDE+    ++DFGLS +M+      + T  G+ 
Sbjct: 122 IISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKTSCGSP 176
Query: 276 GYLAPEWILEQGVS-EKCDIYSYGMVL 301
            Y APE I  +  +  + D++S G++L
Sbjct: 177 NYAAPEVISGKLYAGPEVDVWSCGVIL 203

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 94/202 (46%), Gaps = 19/202 (9%)
Query: 109 LGHGSSASVFKGILSDGTSV-AVKRIN--GEENGEKEFRSEVAAIASAQHVNLVRLLGYC 165
           +G GS   V+KGI +    V A+K I+    E+  ++ + E+  ++      + R  G  
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFG-S 85
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
            +     +++ E++  GS    + P           G L       +  ++ K L YLH+
Sbjct: 86  YLKSTKLWIIMEYLGGGSALDLLKP-----------GPLEETYIATILREILKGLDYLHS 134
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILE 285
           +   R +H D+K  N+LL E     ++DFG++  ++  Q +    + GT  ++APE I +
Sbjct: 135 E---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQ 190
Query: 286 QGVSEKCDIYSYGMVLLELTGG 307
                K DI+S G+  +EL  G
Sbjct: 191 SAYDFKADIWSLGITAIELAKG 212

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 33/214 (15%)
Query: 108 LLGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFRS-EVAAIASAQHVNLVRLLGYC 165
           ++G+GS   V++  L D G  VA+K++  +    K F++ E+  +    H N+VRL    
Sbjct: 65  VIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRL---- 116
Query: 166 VVPGGPRYLVY-------EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRY--RVAIDV 216
                 RY  Y       E   N  LD ++  T  R   HYS    +  + Y       +
Sbjct: 117 ------RYFFYSSGEKKDEVYLNLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 169
Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSRDQSRCITTIRGTR 275
            ++L+Y+H+     + H D+KP+N+LLD +   + + DFG +K + R +     +   +R
Sbjct: 170 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSR 224
Query: 276 GYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
            Y APE I      +   D++S G VL EL  G+
Sbjct: 225 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 27/207 (13%)
Query: 104 NFQAL--LGHGSSASV-FKGILSDGTSVAVKRIN----GEENGEKEFRSEVAAIASAQHV 156
           N+Q +  LG GS   V      + G  VA+K IN     + + +     E++ +   +H 
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 157 NLVRLLGYCVVPGGPRY-LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
           ++++L  Y V+       +V E+  N   D +I    + SE              R    
Sbjct: 74  HIIKL--YDVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEAR----------RFFQQ 120
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           +  A+ Y H   R +++H D+KPEN+LLDE+    ++DFGLS +M+      + T  G+ 
Sbjct: 121 IISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKTSCGSP 175
Query: 276 GYLAPEWILEQGVS-EKCDIYSYGMVL 301
            Y APE I  +  +  + D++S G++L
Sbjct: 176 NYAAPEVISGKLYAGPEVDVWSCGVIL 202

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 102 TDNFQAL--LGHGSSASVFKGI-LSDGTSVAVKRINGEE---NGEKEFRSEVAAIASAQH 155
           TD +Q    +G G+ + V + + L  G   A K IN ++      ++   E       +H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
            N+VRL    +   G  YLV++ +  G L   I      SE   S  C+           
Sbjct: 63  SNIVRLHD-SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASH-CIQ---------Q 111
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV---VSDFGLSKLMSRDQSRCITTIR 272
           + +A+ + H   +  V+H D+KPEN+LL    +     ++DFGL+  +  DQ        
Sbjct: 112 ILEAVLHCH---QMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFG-FA 167
Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           GT GYL+PE + ++   +  DI++ G++L  L  G
Sbjct: 168 GTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 95/202 (47%), Gaps = 19/202 (9%)
Query: 109 LGHGSSASVFKGILSDGTSV-AVKRIN--GEENGEKEFRSEVAAIASAQHVNLVRLLGYC 165
           +G GS   VFKGI +    V A+K I+    E+  ++ + E+  ++      + +  G  
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG-S 73
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
            +     +++ E++  GS    + P           G L       +  ++ K L YLH+
Sbjct: 74  YLKDTKLWIIMEYLGGGSALDLLEP-----------GPLDETQIATILREILKGLDYLHS 122
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILE 285
           + +   +H D+K  N+LL E+    ++DFG++  ++  Q +   T  GT  ++APE I +
Sbjct: 123 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR-NTFVGTPFWMAPEVIKQ 178
Query: 286 QGVSEKCDIYSYGMVLLELTGG 307
                K DI+S G+  +EL  G
Sbjct: 179 SAYDSKADIWSLGITAIELARG 200

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 33/214 (15%)
Query: 108 LLGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFRS-EVAAIASAQHVNLVRLLGYC 165
           ++G+GS   V++  L D G  VA+K++  +    K F++ E+  +    H N+VRL    
Sbjct: 106 VIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRL---- 157
Query: 166 VVPGGPRYLVY-------EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRY--RVAIDV 216
                 RY  Y       E   N  LD ++  T  R   HYS    +  + Y       +
Sbjct: 158 ------RYFFYSSGEKKDEVYLNLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 210
Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSRDQSRCITTIRGTR 275
            ++L+Y+H+     + H D+KP+N+LLD +   + + DFG +K + R +     +   +R
Sbjct: 211 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSR 265
Query: 276 GYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
            Y APE I      +   D++S G VL EL  G+
Sbjct: 266 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 98/217 (45%), Gaps = 27/217 (12%)
Query: 101 ATDNFQAL--LGHGSSASVFKG-ILSDGTSVAVKRI---NGEENGEKEFRSEVAAI---A 151
           AT  ++ +  +G G+  +V+K      G  VA+K +   NGEE        EVA +    
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 152 SAQHVNLVRLLGYCVVPGGPR----YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWD 207
           + +H N+VRL+  C      R     LV+E +     D   +       G      L  +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ---DLRTYLDKAPPPG------LPAE 112
Query: 208 LRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC 267
               +     + L +LH +C   ++H D+KPENIL+       ++DFGL+++ S   +  
Sbjct: 113 TIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-- 167
Query: 268 ITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +  +  T  Y APE +L+   +   D++S G +  E+
Sbjct: 168 LDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 53/91 (58%), Gaps = 4/91 (4%)
Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGY 277
           + + YLHN+   RV+H D+K  N+ L+++    + DFGL+  +  D  R    + GT  Y
Sbjct: 153 QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKXLCGTPNY 208
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           +APE + ++G S + DI+S G +L  L  G+
Sbjct: 209 IAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 95/207 (45%), Gaps = 22/207 (10%)
Query: 107 ALLGHGSSASVFKGILSD-GTSVAVKRI---NGEENGEKEFRSEVAAIASAQHVNLVRLL 162
            L+G GS   V K    D G  VA+K+    + ++  +K    E+  +   +H NLV LL
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 163 GYCVVPGGPRYLVYEFIQNGSLDHW-IFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALS 221
             C       YLV+EF+ +  LD   +FP             L + +  +    +   + 
Sbjct: 91  EVCK-KKKRWYLVFEFVDHTILDDLELFPNG-----------LDYQVVQKYLFQIINGIG 138
Query: 222 YLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPE 281
           + H+     ++H D+KPENIL+ ++    + DFG ++ ++         +  TR Y APE
Sbjct: 139 FCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV-ATRWYRAPE 194
Query: 282 WIL-EQGVSEKCDIYSYGMVLLELTGG 307
            ++ +    +  D+++ G ++ E+  G
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMG 221

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 54/96 (56%), Gaps = 6/96 (6%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM--SRDQSRCITTIRG 273
           + + L Y+H+   + VLH D+KP N+L++      + DFGL+++     D +  +T    
Sbjct: 153 ILRGLKYIHS---ANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVA 209
Query: 274 TRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           TR Y APE +L  +G ++  DI+S G +L E+   R
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 27/217 (12%)
Query: 101 ATDNFQAL--LGHGSSASVFKG-ILSDGTSVAVKRI---NGEENGEKEFRSEVAAI---A 151
           AT  ++ +  +G G+  +V+K      G  VA+K +   NGEE        EVA +    
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 152 SAQHVNLVRLLGYCVVPGGPR----YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWD 207
           + +H N+VRL+  C      R     LV+E +     D   +       G      L  +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ---DLRTYLDKAPPPG------LPAE 112
Query: 208 LRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC 267
               +     + L +LH +C   ++H D+KPENIL+       ++DFGL+++ S   +  
Sbjct: 113 TIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALF 169
Query: 268 ITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
              +  T  Y APE +L+   +   D++S G +  E+
Sbjct: 170 PVVV--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 53/91 (58%), Gaps = 4/91 (4%)
Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGY 277
           + + YLHN+   RV+H D+K  N+ L+++    + DFGL+  +  D  R    + GT  Y
Sbjct: 153 QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKDLCGTPNY 208
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           +APE + ++G S + DI+S G +L  L  G+
Sbjct: 209 IAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 59/103 (57%), Gaps = 10/103 (9%)
Query: 207 DLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSR 266
           D+R+  A ++   L ++HN     V++ D+KP NILLDE+    +SD GL+   S+ +  
Sbjct: 293 DMRFYAA-EIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 348
Query: 267 CITTIRGTRGYLAPEWILEQGVS--EKCDIYSYGMVLLELTGG 307
                 GT GY+APE +L++GV+     D +S G +L +L  G
Sbjct: 349 ASV---GTHGYMAPE-VLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/103 (33%), Positives = 58/103 (56%), Gaps = 9/103 (8%)
Query: 211 RVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITT 270
           ++ + + KAL YL    +  V+H DVKP NILLDE  +  + DFG+S  +  D+++  + 
Sbjct: 128 KMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA 185
Query: 271 IRGTRGYLAPEWILEQGVSE-----KCDIYSYGMVLLELTGGR 308
             G   Y+APE I     ++     + D++S G+ L+EL  G+
Sbjct: 186 --GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 59/103 (57%), Gaps = 10/103 (9%)
Query: 207 DLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSR 266
           D+R+  A ++   L ++HN     V++ D+KP NILLDE+    +SD GL+   S+ +  
Sbjct: 293 DMRFYAA-EIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 348
Query: 267 CITTIRGTRGYLAPEWILEQGVS--EKCDIYSYGMVLLELTGG 307
                 GT GY+APE +L++GV+     D +S G +L +L  G
Sbjct: 349 ASV---GTHGYMAPE-VLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 59/103 (57%), Gaps = 10/103 (9%)
Query: 207 DLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSR 266
           D+R+  A ++   L ++HN     V++ D+KP NILLDE+    +SD GL+   S+ +  
Sbjct: 293 DMRFYAA-EIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 348
Query: 267 CITTIRGTRGYLAPEWILEQGVS--EKCDIYSYGMVLLELTGG 307
                 GT GY+APE +L++GV+     D +S G +L +L  G
Sbjct: 349 ASV---GTHGYMAPE-VLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 59/103 (57%), Gaps = 10/103 (9%)
Query: 207 DLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSR 266
           D+R+  A ++   L ++HN     V++ D+KP NILLDE+    +SD GL+   S+ +  
Sbjct: 292 DMRFYAA-EIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 347
Query: 267 CITTIRGTRGYLAPEWILEQGVS--EKCDIYSYGMVLLELTGG 307
                 GT GY+APE +L++GV+     D +S G +L +L  G
Sbjct: 348 ASV---GTHGYMAPE-VLQKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 53/91 (58%), Gaps = 4/91 (4%)
Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGY 277
           + + YLHN+   RV+H D+K  N+ L+++    + DFGL+  +  D  R    + GT  Y
Sbjct: 137 QGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKDLCGTPNY 192
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           +APE + ++G S + DI+S G +L  L  G+
Sbjct: 193 IAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 223

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 91/194 (46%), Gaps = 21/194 (10%)
Query: 128 VAVKRINGEENG-EKE-FRSEVAAIAS-AQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL 184
           VAVK +    +  EKE   SE+  ++   QH N+V LLG C   GGP  ++ E+   G L
Sbjct: 64  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH-GGPVLVITEYCCYGDL 122
Query: 185 DHWI-----------FPTSRRSEGHYSGGCLSWDLR--YRVAIDVAKALSYLHNDCRSRV 231
            +++               +  EG         +LR     +  VA+ +++L        
Sbjct: 123 LNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNC 179
Query: 232 LHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT-TIRGTRGYLAPEWILEQGVSE 290
           +H DV   N+LL   + A + DFGL++ +  D +  +    R    ++APE I +   + 
Sbjct: 180 IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTV 239
Query: 291 KCDIYSYGMVLLEL 304
           + D++SYG++L E+
Sbjct: 240 QSDVWSYGILLWEI 253

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 40/223 (17%)
Query: 108 LLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLL---GY 164
           L+G G   +V+KG L D   VAVK  +            +  +   +H N+ R +     
Sbjct: 20  LIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDER 78
Query: 165 CVVPGGPRYL-VYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL 223
               G   YL V E+  NGSL  ++           S     W    R+A  V + L+YL
Sbjct: 79  VTADGRMEYLLVMEYYPNGSLXKYL-----------SLHTSDWVSSCRLAHSVTRGLAYL 127
Query: 224 HNDC------RSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS--------RDQSRCIT 269
           H +       +  + H D+   N+L+  +   V+SDFGLS  ++         + +  I+
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAIS 187
Query: 270 TIRGTRGYLAPEWILEQGVS--------EKCDIYSYGMVLLEL 304
            + GT  Y+APE +LE  V+        ++ D+Y+ G++  E+
Sbjct: 188 EV-GTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 3/94 (3%)
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGT 274
           ++  AL YLH++    V++ D+K EN++LD++    ++DFGL K   +D +  + T  GT
Sbjct: 259 EIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKTFCGT 315
Query: 275 RGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
             YLAPE + +       D +  G+V+ E+  GR
Sbjct: 316 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 41/225 (18%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFR-SEVAAIASAQHVNLVRLLGYCVV 167
           +G G    V++G L  G SVAVK I    + +  FR +E+      +H N+   LG+   
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVK-IFSSRDEQSWFRETEIYNTVLLRHDNI---LGFIAS 70
Query: 168 PGGPR------YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALS 221
               R      +L+  + ++GSL  + F   +  E H         L  R+A+  A  L+
Sbjct: 71  DMTSRNSSTQLWLITHYHEHGSL--YDFLQRQTLEPH---------LALRLAVSAACGLA 119
Query: 222 YLH-----NDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR--DQSRCITTIR-G 273
           +LH        +  + H D K  N+L+  N +  ++D GL+ + S+  D        R G
Sbjct: 120 HLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVG 179
Query: 274 TRGYLAPEWILEQGVSEKC-------DIYSYGMVLLELTGGRRNV 311
           T+ Y+APE +L++ +   C       DI+++G+VL E+   RR +
Sbjct: 180 TKRYMAPE-VLDEQIRTDCFESYKWTDIWAFGLVLWEI--ARRTI 221

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 54/94 (57%), Gaps = 3/94 (3%)
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGT 274
           ++  AL YLH++    V++ D+K EN++LD++    ++DFGL K   +D +  + T  GT
Sbjct: 256 EIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKTFCGT 312
Query: 275 RGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
             YLAPE + +       D +  G+V+ E+  GR
Sbjct: 313 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 67/136 (49%), Gaps = 19/136 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E++  G +   +    R SE H          R+  A  +     YLH+     ++
Sbjct: 117 YMVMEYVAGGEMFSHLRRIGRFSEPH---------ARFYAA-QIVLTFEYLHS---LDLI 163
Query: 233 HLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           + D+KPEN+L+D+     V+DFG +K +  R    C     GT   LAPE IL +G ++ 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEALAPEIILSKGYNKA 218
Query: 292 CDIYSYGMVLLELTGG 307
            D ++ G+++ E+  G
Sbjct: 219 VDWWALGVLIYEMAAG 234

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 105/240 (43%), Gaps = 32/240 (13%)
Query: 81  SFLRKVAGVPIKFRSKELEEATDNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGE 140
           SF RK +   I  +  ++         L+G G    V+ G       VA++ I+ E + E
Sbjct: 13  SFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNE 70
Query: 141 ---KEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEG 197
              K F+ EV A    +H N+V  +G C+ P  P   +   +  G     ++   R ++ 
Sbjct: 71  DQLKAFKREVMAYRQTRHENVVLFMGACMSP--PHLAIITSLCKGRT---LYSVVRDAK- 124
Query: 198 HYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS 257
                 L  +   ++A ++ K + YLH      +LH D+K +N+  D N + V++DFGL 
Sbjct: 125 ----IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLF 176
Query: 258 KLMSRDQS-RCITTIRGTRGY---LAPEWILEQG---------VSEKCDIYSYGMVLLEL 304
            +    Q+ R    +R   G+   LAPE I +            S+  D+++ G +  EL
Sbjct: 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 94/220 (42%), Gaps = 29/220 (13%)
Query: 100 EATDNFQA--LLGHGSSASVFKG-ILSDGTSVAVKRINGEENGE----KEFRSEVAAIAS 152
           E  ++F+   LLG GS A V++   +  G  VA+K I+ +   +    +  ++EV     
Sbjct: 8   EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ 67
Query: 153 AQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHW----IFPTSRRSEGHYSGGCLSWDL 208
            +H +++ L  Y        YLV E   NG ++ +    + P S     H+         
Sbjct: 68  LKHPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH------- 119
Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI 268
                  +   + YLH+     +LH D+   N+LL  N    ++DFGL+  +     +  
Sbjct: 120 ------QIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY 170
Query: 269 TTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
            T+ GT  Y++PE         + D++S G +   L  GR
Sbjct: 171 -TLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 27/206 (13%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G+++ V++            ++  +   +K  R+E+  +    H N+++L      P
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETP 120
Query: 169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK----ALSYLH 224
                LV E +  G L   I       +G+YS          R A D  K    A++YLH
Sbjct: 121 TEIS-LVLELVTGGELFDRIV-----EKGYYSE---------RDAADAVKQILEAVAYLH 165
Query: 225 NDCRSRVLHLDVKPENILLD---ENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPE 281
            +    ++H D+KPEN+L      +    ++DFGLSK++  +    + T+ GT GY APE
Sbjct: 166 EN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKTVCGTPGYCAPE 220
Query: 282 WILEQGVSEKCDIYSYGMVLLELTGG 307
            +       + D++S G++   L  G
Sbjct: 221 ILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 99/228 (43%), Gaps = 33/228 (14%)
Query: 90  PIKFRSKELEEATDNFQALLGHGSSASVFKGILSD---GTSVAVKRINGEENGEKEFR-S 145
           P+ +  +E E      Q  +G GS   V +  + D   G   AVK++  E      FR  
Sbjct: 64  PVDYEYRE-EVHWMTHQPRVGRGSFGEVHR--MKDKQTGFQCAVKKVRLEV-----FRVE 115
Query: 146 EVAAIASAQHVNLVRLLGYCVVPGGPRYLVY-EFIQNGSLDHWIFPTSRRSEGHYSGGCL 204
           E+ A A      +V L G   V  GP   ++ E ++ GSL   I             GCL
Sbjct: 116 ELVACAGLSSPRIVPLYG--AVREGPWVNIFMELLEGGSLGQLIKQM----------GCL 163
Query: 205 SWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD-ENYRAVVSDFGLSKLMSRD 263
             D          + L YLH     R+LH DVK +N+LL  +  RA + DFG +  +  D
Sbjct: 164 PEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 220
Query: 264 Q-SRCITT---IRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
              + + T   I GT  ++APE ++ +    K DI+S   ++L +  G
Sbjct: 221 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 99/228 (43%), Gaps = 33/228 (14%)
Query: 90  PIKFRSKELEEATDNFQALLGHGSSASVFKGILSD---GTSVAVKRINGEENGEKEFR-S 145
           P+ +  +E E      Q  +G GS   V +  + D   G   AVK++  E      FR  
Sbjct: 48  PVDYEYRE-EVHWMTHQPRVGRGSFGEVHR--MKDKQTGFQCAVKKVRLEV-----FRVE 99
Query: 146 EVAAIASAQHVNLVRLLGYCVVPGGPRYLVY-EFIQNGSLDHWIFPTSRRSEGHYSGGCL 204
           E+ A A      +V L G   V  GP   ++ E ++ GSL   I             GCL
Sbjct: 100 ELVACAGLSSPRIVPLYG--AVREGPWVNIFMELLEGGSLGQLIKQM----------GCL 147
Query: 205 SWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD-ENYRAVVSDFGLSKLMSRD 263
             D          + L YLH     R+LH DVK +N+LL  +  RA + DFG +  +  D
Sbjct: 148 PEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204
Query: 264 Q-SRCITT---IRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
              + + T   I GT  ++APE ++ +    K DI+S   ++L +  G
Sbjct: 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 39/116 (33%), Positives = 58/116 (50%), Gaps = 26/116 (22%)
Query: 211 RVAIDVAKALSYLHNDCRSRVLHLDVKPENILL-DENY------------RAV------V 251
            +A  + +A+ +LH++   ++ H D+KPENIL  + +Y            R+V      V
Sbjct: 141 HMAFQLCQAVKFLHDN---KLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRV 197
Query: 252 SDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
            DFG +       S    TI  TR Y APE ILE G S+ CD++S G ++ E   G
Sbjct: 198 VDFGSATFDHEHHS----TIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVG 249

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 109/264 (41%), Gaps = 73/264 (27%)
Query: 109 LGHGSSASVFK----GILSDGT--SVAVKRIN-GEENGE-KEFRSEVAA-IASAQHVNLV 159
           LG G+   V +    GI    T  +VAVK +  G  + E +   SE+   I    H+N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 160 RLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSE-------------GHYSGGCLSW 206
            LLG C  PGGP  ++ EF + G+L  ++   S+R+E             G    G +  
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKTKGARFRQGKDYVGAIPV 154
Query: 207 DLRYRV---------------------------------------------AIDVAKALS 221
           DL+ R+                                             +  VAK + 
Sbjct: 155 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 214
Query: 222 YLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT-TIRGTRGYLAP 280
           +L +    + +H D+   NILL E     + DFGL++ + +D         R    ++AP
Sbjct: 215 FLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 271
Query: 281 EWILEQGVSEKCDIYSYGMVLLEL 304
           E I ++  + + D++S+G++L E+
Sbjct: 272 ETIFDRVYTIQSDVWSFGVLLWEI 295

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 109/264 (41%), Gaps = 73/264 (27%)
Query: 109 LGHGSSASVFK----GILSDGT--SVAVKRIN-GEENGE-KEFRSEVAA-IASAQHVNLV 159
           LG G+   V +    GI    T  +VAVK +  G  + E +   SE+   I    H+N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 160 RLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSE-------------GHYSGGCLSW 206
            LLG C  PGGP  ++ EF + G+L  ++   S+R+E             G    G +  
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKTKGARFRQGKDYVGAIPV 152
Query: 207 DLRYRV---------------------------------------------AIDVAKALS 221
           DL+ R+                                             +  VAK + 
Sbjct: 153 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 212
Query: 222 YLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT-TIRGTRGYLAP 280
           +L +    + +H D+   NILL E     + DFGL++ + +D         R    ++AP
Sbjct: 213 FLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 269
Query: 281 EWILEQGVSEKCDIYSYGMVLLEL 304
           E I ++  + + D++S+G++L E+
Sbjct: 270 ETIFDRVYTIQSDVWSFGVLLWEI 293

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 101/206 (49%), Gaps = 25/206 (12%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEK--EFRSEVAAIASAQHVNLVRLLGYCV 166
           LG G+   V+K    +  ++A  ++   ++ E+  ++  E+  +A+  H  +V+LLG   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLG-AY 77
Query: 167 VPGGPRYLVYEFIQNGSLDHWIFPTSR-RSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
              G  +++ EF   G++D  +    R  +E      C            + +AL++LH+
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQ----------MLEALNFLHS 127
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLS-KLMSRDQSRCITTIRGTRGYLAPEWIL 284
               R++H D+K  N+L+       ++DFG+S K +   Q R   +  GT  ++APE ++
Sbjct: 128 ---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR--DSFIGTPYWMAPEVVM 182
Query: 285 EQGVSE-----KCDIYSYGMVLLELT 305
            + + +     K DI+S G+ L+E+ 
Sbjct: 183 CETMKDTPYDYKADIWSLGITLIEMA 208

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 98/231 (42%), Gaps = 52/231 (22%)
Query: 103 DNFQAL--LGHGSSASVFKGILSDGTSVAVKRINGEENGE-------------------K 141
           +NF+ L  LG G+   VF           V++I+G + G+                   +
Sbjct: 54  ENFELLKVLGTGAYGKVF----------LVRKISGHDTGKLYAMKVLKKATIVQKAKTTE 103
Query: 142 EFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSG 201
             R+E   +   +    +  L Y        +L+ ++I  G L   +    R +E     
Sbjct: 104 HTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE----- 158
Query: 202 GCLSWDLRYRVAIDVAK---ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK 258
                   + V I V +   AL +LH   +  +++ D+K ENILLD N   V++DFGLSK
Sbjct: 159 --------HEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK 207
Query: 259 LMSRDQSRCITTIRGTRGYLAPEWIL--EQGVSEKCDIYSYGMVLLELTGG 307
               D++       GT  Y+AP+ +   + G  +  D +S G+++ EL  G
Sbjct: 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 52/96 (54%), Gaps = 6/96 (6%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC--ITTIRG 273
           + + L Y+H+   + VLH D+KP N+LL+      + DFGL+++   D      +     
Sbjct: 137 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 193
Query: 274 TRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           TR Y APE +L  +G ++  DI+S G +L E+   R
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 52/96 (54%), Gaps = 6/96 (6%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC--ITTIRG 273
           + + L Y+H+   + VLH D+KP N+LL+      + DFGL+++   D      +     
Sbjct: 138 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 194
Query: 274 TRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           TR Y APE +L  +G ++  DI+S G +L E+   R
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 109/264 (41%), Gaps = 73/264 (27%)
Query: 109 LGHGSSASVFK----GILSDGT--SVAVKRIN-GEENGE-KEFRSEVAA-IASAQHVNLV 159
           LG G+   V +    GI    T  +VAVK +  G  + E +   SE+   I    H+N+V
Sbjct: 28  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 87
Query: 160 RLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSE-------------GHYSGGCLSW 206
            LLG C  PGGP  ++ EF + G+L  ++   S+R+E             G    G +  
Sbjct: 88  NLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKTKGARFRQGKDYVGAIPV 145
Query: 207 DLRYRV---------------------------------------------AIDVAKALS 221
           DL+ R+                                             +  VAK + 
Sbjct: 146 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 205
Query: 222 YLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT-TIRGTRGYLAP 280
           +L +    + +H D+   NILL E     + DFGL++ + +D         R    ++AP
Sbjct: 206 FLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 262
Query: 281 EWILEQGVSEKCDIYSYGMVLLEL 304
           E I ++  + + D++S+G++L E+
Sbjct: 263 ETIFDRVYTIQSDVWSFGVLLWEI 286

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 9/96 (9%)
Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTI 271
           A  +     YLH+     +++ D+KPEN+++D+     V+DFG +K +  R    C    
Sbjct: 147 AAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---- 199
Query: 272 RGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
            GT  YLAPE IL +G ++  D ++ G+++ E+  G
Sbjct: 200 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/233 (22%), Positives = 102/233 (43%), Gaps = 19/233 (8%)
Query: 108 LLGHGSSASVFKGILSDGTSVAVKRINGEE--NGEKEF---RSEVAAIASAQHVNLVRLL 162
           ++G GS A V    L     +   R+  +E  N +++    ++E      A +   +  L
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 163 GYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY 222
             C       + V E++  G L   +    +  E H          R+  A +++ AL+Y
Sbjct: 119 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH---------ARFYSA-EISLALNY 168
Query: 223 LHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEW 282
           LH      +++ D+K +N+LLD      ++D+G+ K   R      +T  GT  Y+APE 
Sbjct: 169 LH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-PGDTTSTFCGTPNYIAPEI 224
Query: 283 ILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEK 335
           +  +      D ++ G+++ E+  GR    ++   ++  +N   Y  +++ EK
Sbjct: 225 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 277

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 101/206 (49%), Gaps = 25/206 (12%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEK--EFRSEVAAIASAQHVNLVRLLGYCV 166
           LG G+   V+K    +  ++A  ++   ++ E+  ++  E+  +A+  H  +V+LLG   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLG-AY 85
Query: 167 VPGGPRYLVYEFIQNGSLDHWIFPTSR-RSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
              G  +++ EF   G++D  +    R  +E      C            + +AL++LH+
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQ----------MLEALNFLHS 135
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLS-KLMSRDQSRCITTIRGTRGYLAPEWIL 284
               R++H D+K  N+L+       ++DFG+S K +   Q R   +  GT  ++APE ++
Sbjct: 136 ---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR--DSFIGTPYWMAPEVVM 190
Query: 285 EQGVSE-----KCDIYSYGMVLLELT 305
            + + +     K DI+S G+ L+E+ 
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMA 216

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 98/226 (43%), Gaps = 28/226 (12%)
Query: 94  RSKELEEATDNFQALLGHGSSASVFKGI-LSDGTSVAVKRIN-------GEENGEKEFRS 145
           + KE  E+      LLG G   SV+ GI +SD   VA+K +        GE         
Sbjct: 1   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 60
Query: 146 EVAAI--ASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGC 203
           EV  +   S+    ++RLL +   P     L+ E ++    D + F T R        G 
Sbjct: 61  EVVLLKKVSSGFSGVIRLLDWFERPDS-FVLILERMEPVQ-DLFDFITER--------GA 110
Query: 204 LSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSR 262
           L  +L       V +A+ + HN     VLH D+K ENIL+D N   + + DFG   L+  
Sbjct: 111 LQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL-- 165
Query: 263 DQSRCITTIRGTRGYLAPEWI-LEQGVSEKCDIYSYGMVLLELTGG 307
            +    T   GTR Y  PEWI   +       ++S G++L ++  G
Sbjct: 166 -KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 109/264 (41%), Gaps = 73/264 (27%)
Query: 109 LGHGSSASVFK----GILSDGT--SVAVKRIN-GEENGE-KEFRSEVAA-IASAQHVNLV 159
           LG G+   V +    GI    T  +VAVK +  G  + E +   SE+   I    H+N+V
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 160 RLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSE-------------GHYSGGCLSW 206
            LLG C  PGGP  ++ EF + G+L  ++   S+R+E             G    G +  
Sbjct: 90  NLLGACTKPGGPLMVIVEFCKFGNLSTYL--RSKRNEFVPYKTKGARFRQGKDYVGAIPV 147
Query: 207 DLRYRV---------------------------------------------AIDVAKALS 221
           DL+ R+                                             +  VAK + 
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207
Query: 222 YLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT-TIRGTRGYLAP 280
           +L +    + +H D+   NILL E     + DFGL++ + +D         R    ++AP
Sbjct: 208 FLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 264
Query: 281 EWILEQGVSEKCDIYSYGMVLLEL 304
           E I ++  + + D++S+G++L E+
Sbjct: 265 ETIFDRVYTIQSDVWSFGVLLWEI 288

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 9/96 (9%)
Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK-LMSRDQSRCITTI 271
           A  +     YLH+     +++ D+KPEN+++D+     V+DFG +K +  R    C    
Sbjct: 148 AAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC---- 200
Query: 272 RGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
            GT  YLAPE IL +G ++  D ++ G+++ E+  G
Sbjct: 201 -GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR 272
           A ++   L  LH   R R+++ D+KPENILLD++    +SD GL+  +   Q+  I    
Sbjct: 292 AAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV 346
Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           GT GY+APE +  +  +   D ++ G +L E+  G+
Sbjct: 347 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 110/254 (43%), Gaps = 59/254 (23%)
Query: 92  KFRSKELEEAT----DNFQALLGHGSSA-----SVFKGILSDGTSVAVKRIN----GEEN 138
           +F S ++ ++T      +Q L   GS A     + F  +L  G +VAVK+++     + +
Sbjct: 7   QFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTH 64
Query: 139 GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPR------YLVYEFIQ-------NGSLD 185
            ++ +R E+  +    H N++ LL     P          YLV E +        +  LD
Sbjct: 65  AKRAYR-ELVLLKCVNHKNIISLLN-VFTPQKTLEEFQDVYLVMELMDANLCQVIHMELD 122
Query: 186 HWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDE 245
           H      R S   Y   C                + +LH+   + ++H D+KP NI++  
Sbjct: 123 H-----ERMSYLLYQMLC---------------GIKHLHS---AGIIHRDLKPSNIVVKS 159
Query: 246 NYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELT 305
           +    + DFGL++  S +    +T    TR Y APE IL  G  E  DI+S G ++ EL 
Sbjct: 160 DCTLKILDFGLARTASTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELV 217
Query: 306 GGRRNVSLIEHGND 319
            G    S+I  G D
Sbjct: 218 KG----SVIFQGTD 227

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 92/201 (45%), Gaps = 29/201 (14%)
Query: 126 TSVAVKRI--NGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS 183
           T+VAVK +  N   +  ++  SE   +    H ++++L G C    GP  L+ E+ + GS
Sbjct: 54  TTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ-DGPLLLIVEYAKYGS 112
Query: 184 LDHWIFPTSRRSEG--------------HYSGGCLSWDLRYRVAIDVAKALSYLHNDCRS 229
           L  ++  + +   G              H     L+       A  +++ + YL      
Sbjct: 113 LRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEM 169
Query: 230 RVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEW-----IL 284
           +++H D+   NIL+ E  +  +SDFGL    SRD     + ++ ++G +  +W     + 
Sbjct: 170 KLVHRDLAARNILVAEGRKMKISDFGL----SRDVYEEDSXVKRSQGRIPVKWMAIESLF 225
Query: 285 EQGVSEKCDIYSYGMVLLELT 305
           +   + + D++S+G++L E+ 
Sbjct: 226 DHIYTTQSDVWSFGVLLWEIV 246

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 51/87 (58%), Gaps = 4/87 (4%)
Query: 222 YLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPE 281
           YLH   R+RV+H D+K  N+ L+E+    + DFGL+  +  D  R    + GT  Y+APE
Sbjct: 130 YLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-KKVLCGTPNYIAPE 185
Query: 282 WILEQGVSEKCDIYSYGMVLLELTGGR 308
            + ++G S + D++S G ++  L  G+
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVGK 212

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 51/87 (58%), Gaps = 4/87 (4%)
Query: 222 YLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPE 281
           YLH   R+RV+H D+K  N+ L+E+    + DFGL+  +  D  R    + GT  Y+APE
Sbjct: 156 YLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-KKVLCGTPNYIAPE 211
Query: 282 WILEQGVSEKCDIYSYGMVLLELTGGR 308
            + ++G S + D++S G ++  L  G+
Sbjct: 212 VLSKKGHSFEVDVWSIGCIMYTLLVGK 238

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR 272
           A ++   L  LH   R R+++ D+KPENILLD++    +SD GL+  +   Q+  I    
Sbjct: 292 AAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV 346
Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           GT GY+APE +  +  +   D ++ G +L E+  G+
Sbjct: 347 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 51/87 (58%), Gaps = 4/87 (4%)
Query: 222 YLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPE 281
           YLH   R+RV+H D+K  N+ L+E+    + DFGL+  +  D  R    + GT  Y+APE
Sbjct: 154 YLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-KKVLCGTPNYIAPE 209
Query: 282 WILEQGVSEKCDIYSYGMVLLELTGGR 308
            + ++G S + D++S G ++  L  G+
Sbjct: 210 VLSKKGHSFEVDVWSIGCIMYTLLVGK 236

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 105/225 (46%), Gaps = 39/225 (17%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           +G G    V++G    G +VAVK  +  +       +E+      +H N+   LG+    
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVMLRHENI---LGFIASD 71
Query: 169 GGPR------YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY 222
              R      +L+  + + GSL  ++  T+  +       CL      R+ + +A  L++
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVS-----CL------RIVLSIASGLAH 120
Query: 223 LH-----NDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR---GT 274
           LH        +  + H D+K +NIL+ +N +  ++D GL+ + S+  ++         GT
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
Query: 275 RGYLAPEWILEQGVSEKC-------DIYSYGMVLLELTGGRRNVS 312
           + Y+APE +L++ +   C       DI+++G+VL E+   RR VS
Sbjct: 181 KRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMVS 222

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 51/93 (54%), Gaps = 4/93 (4%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           +   L +LH   +  +++ D+KPEN+LLD++    +SD GL+  +   Q++      GT 
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTP 353
Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           G++APE +L +      D ++ G+ L E+   R
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 105/225 (46%), Gaps = 39/225 (17%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           +G G    V++G    G +VAVK  +  +       +E+      +H N+   LG+    
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVMLRHENI---LGFIASD 71
Query: 169 GGPR------YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY 222
              R      +L+  + + GSL  ++  T+  +       CL      R+ + +A  L++
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVS-----CL------RIVLSIASGLAH 120
Query: 223 LH-----NDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR---GT 274
           LH        +  + H D+K +NIL+ +N +  ++D GL+ + S+  ++         GT
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
Query: 275 RGYLAPEWILEQGVSEKC-------DIYSYGMVLLELTGGRRNVS 312
           + Y+APE +L++ +   C       DI+++G+VL E+   RR VS
Sbjct: 181 KRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMVS 222

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 51/93 (54%), Gaps = 4/93 (4%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           +   L +LH   +  +++ D+KPEN+LLD++    +SD GL+  +   Q++      GT 
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTP 353
Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           G++APE +L +      D ++ G+ L E+   R
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 51/93 (54%), Gaps = 4/93 (4%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           +   L +LH   +  +++ D+KPEN+LLD++    +SD GL+  +   Q++      GT 
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTP 353
Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           G++APE +L +      D ++ G+ L E+   R
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 50/87 (57%), Gaps = 5/87 (5%)
Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGY 277
           + L +LH +C   ++H D+KPENIL+       ++DFGL+++ S   +  +T +  T  Y
Sbjct: 131 RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LTPVVVTLWY 185
Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLEL 304
            APE +L+   +   D++S G +  E+
Sbjct: 186 RAPEVLLQSTYATPVDMWSVGCIFAEM 212

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 74/159 (46%), Gaps = 19/159 (11%)
Query: 153 AQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRV 212
            QH N++ L       G   YLV E ++ G L   I      SE   S           V
Sbjct: 78  GQHPNIITLKD-VYDDGKHVYLVTELMRGGELLDKILRQKFFSEREAS----------FV 126
Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENIL-LDENYRAV---VSDFGLSKLMSRDQSRCI 268
              + K + YLH+     V+H D+KP NIL +DE+       + DFG +K + R ++  +
Sbjct: 127 LHTIGKTVEYLHS---QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQL-RAENGLL 182
Query: 269 TTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
            T   T  ++APE +  QG  E CDI+S G++L  +  G
Sbjct: 183 MTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 78/168 (46%), Gaps = 26/168 (15%)
Query: 146 EVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLS 205
           EVA +    H N+++L  +        YLV E  + G L   I    + SE   +     
Sbjct: 54  EVAVLKQLDHPNIMKLYEF-FEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAA----- 107
Query: 206 WDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV---VSDFGLS---KL 259
                 +   V    +YLH   +  ++H D+KPEN+LL+   R     + DFGLS   ++
Sbjct: 108 -----VIMKQVLSGTTYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEV 159
Query: 260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
             + + R      GT  Y+APE +L +   EKCD++S G++L  L  G
Sbjct: 160 GGKMKERL-----GTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 201

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 19/202 (9%)
Query: 109 LGHGSSASVFKGILSDGTSV-AVKRIN--GEENGEKEFRSEVAAIASAQHVNLVRLLGYC 165
           +G GS   VFKGI +    V A+K I+    E+  ++ + E+  ++      + +  G  
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG-S 73
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
            +     +++ E++  GS    + P           G L       +  ++ K L YLH+
Sbjct: 74  YLKDTKLWIIMEYLGGGSALDLLEP-----------GPLDETQIATILREILKGLDYLHS 122
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILE 285
           + +   +H D+K  N+LL E+    ++DFG++  ++  Q +      GT  ++APE I +
Sbjct: 123 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR-NXFVGTPFWMAPEVIKQ 178
Query: 286 QGVSEKCDIYSYGMVLLELTGG 307
                K DI+S G+  +EL  G
Sbjct: 179 SAYDSKADIWSLGITAIELARG 200

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 51/93 (54%), Gaps = 4/93 (4%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           +   L +LH   +  +++ D+KPEN+LLD++    +SD GL+  +   Q++      GT 
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTP 353
Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           G++APE +L +      D ++ G+ L E+   R
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 92/201 (45%), Gaps = 29/201 (14%)
Query: 126 TSVAVKRI--NGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS 183
           T+VAVK +  N   +  ++  SE   +    H ++++L G C    GP  L+ E+ + GS
Sbjct: 54  TTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ-DGPLLLIVEYAKYGS 112
Query: 184 LDHWIFPTSRRSEG--------------HYSGGCLSWDLRYRVAIDVAKALSYLHNDCRS 229
           L  ++  + +   G              H     L+       A  +++ + YL      
Sbjct: 113 LRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEM 169
Query: 230 RVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEW-----IL 284
           +++H D+   NIL+ E  +  +SDFGL    SRD     + ++ ++G +  +W     + 
Sbjct: 170 KLVHRDLAARNILVAEGRKMKISDFGL----SRDVYEEDSYVKRSQGRIPVKWMAIESLF 225
Query: 285 EQGVSEKCDIYSYGMVLLELT 305
           +   + + D++S+G++L E+ 
Sbjct: 226 DHIYTTQSDVWSFGVLLWEIV 246

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 100/228 (43%), Gaps = 33/228 (14%)
Query: 90  PIKFRSKELEEATDNFQALLGHGSSASVFKGILSD---GTSVAVKRINGEENGEKEFRSE 146
           P+ +  +E E      Q  LG GS   V +  + D   G   AVK++  E      FR+E
Sbjct: 83  PVDYEYRE-EVHWATHQLRLGRGSFGEVHR--MEDKQTGFQCAVKKVRLEV-----FRAE 134
Query: 147 -VAAIASAQHVNLVRLLGYCVVPGGPRYLVY-EFIQNGSLDHWIFPTSRRSEGHYSGGCL 204
            + A A      +V L G   V  GP   ++ E ++ GSL   +             GCL
Sbjct: 135 ELMACAGLTSPRIVPLYG--AVREGPWVNIFMELLEGGSLGQLV----------KEQGCL 182
Query: 205 SWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD-ENYRAVVSDFGLSKLMSRD 263
             D          + L YLH+    R+LH DVK +N+LL  +   A + DFG +  +  D
Sbjct: 183 PEDRALYYLGQALEGLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPD 239
Query: 264 Q-SRCITT---IRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
              + + T   I GT  ++APE +L +    K D++S   ++L +  G
Sbjct: 240 GLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 74/159 (46%), Gaps = 19/159 (11%)
Query: 153 AQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRV 212
            QH N++ L       G   YLV E ++ G L   I      SE   S           V
Sbjct: 78  GQHPNIITLKD-VYDDGKHVYLVTELMRGGELLDKILRQKFFSEREAS----------FV 126
Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENIL-LDENYRAV---VSDFGLSKLMSRDQSRCI 268
              + K + YLH+     V+H D+KP NIL +DE+       + DFG +K + R ++  +
Sbjct: 127 LHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQL-RAENGLL 182
Query: 269 TTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
            T   T  ++APE +  QG  E CDI+S G++L  +  G
Sbjct: 183 MTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 108/220 (49%), Gaps = 25/220 (11%)
Query: 108 LLGHGSSASVFKGILSD----GTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVR 160
           +LG G    V++G+ ++      +VAVK    +   +N EK F SE   + +  H ++V+
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK-FMSEAVIMKNLDHPHIVK 73
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           L+G  ++   P +++ E    G L H++     R++   S   L+  L    ++ + KA+
Sbjct: 74  LIG--IIEEEPTWIIMELYPYGELGHYL----ERNKN--SLKVLTLVL---YSLQICKAM 122
Query: 221 SYLHN-DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLA 279
           +YL + +C    +H D+   NIL+       + DFGLS+ +  +     +  R    +++
Sbjct: 123 AYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMS 178
Query: 280 PEWILEQGVSEKCDIYSYGMVLLE-LTGGRRNVSLIEHGN 318
           PE I  +  +   D++ + + + E L+ G++    +E+ +
Sbjct: 179 PESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD 218

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 52/116 (44%), Gaps = 26/116 (22%)
Query: 211 RVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD-------------------ENYRAVV 251
            +A  +  AL +LH +   ++ H D+KPENIL                     +N    V
Sbjct: 136 HMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 192
Query: 252 SDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           +DFG +           TTI  TR Y  PE ILE G ++ CD++S G +L E   G
Sbjct: 193 ADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 244

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 105/225 (46%), Gaps = 39/225 (17%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           +G G    V++G    G +VAVK  +  +       +E+      +H N+   LG+    
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVMLRHENI---LGFIASD 100
Query: 169 GGPR------YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY 222
              R      +L+  + + GSL  ++  T+  +       CL      R+ + +A  L++
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVS-----CL------RIVLSIASGLAH 149
Query: 223 LH-----NDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR---GT 274
           LH        +  + H D+K +NIL+ +N +  ++D GL+ + S+  ++         GT
Sbjct: 150 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 209
Query: 275 RGYLAPEWILEQGVSEKC-------DIYSYGMVLLELTGGRRNVS 312
           + Y+APE +L++ +   C       DI+++G+VL E+   RR VS
Sbjct: 210 KRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMVS 251

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 19/202 (9%)
Query: 109 LGHGSSASVFKGILSDGTSV-AVKRIN--GEENGEKEFRSEVAAIASAQHVNLVRLLGYC 165
           +G GS   VFKGI +    V A+K I+    E+  ++ + E+  ++      + +  G  
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG-S 88
Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
            +     +++ E++  GS    + P           G L       +  ++ K L YLH+
Sbjct: 89  YLKDTKLWIIMEYLGGGSALDLLEP-----------GPLDETQIATILREILKGLDYLHS 137
Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILE 285
           + +   +H D+K  N+LL E+    ++DFG++  ++  Q +      GT  ++APE I +
Sbjct: 138 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR-NXFVGTPFWMAPEVIKQ 193
Query: 286 QGVSEKCDIYSYGMVLLELTGG 307
                K DI+S G+  +EL  G
Sbjct: 194 SAYDSKADIWSLGITAIELARG 215

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 52/116 (44%), Gaps = 26/116 (22%)
Query: 211 RVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD-------------------ENYRAVV 251
            +A  +  AL +LH +   ++ H D+KPENIL                     +N    V
Sbjct: 127 HMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183
Query: 252 SDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           +DFG +           TTI  TR Y  PE ILE G ++ CD++S G +L E   G
Sbjct: 184 ADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 52/116 (44%), Gaps = 26/116 (22%)
Query: 211 RVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD-------------------ENYRAVV 251
            +A  +  AL +LH +   ++ H D+KPENIL                     +N    V
Sbjct: 159 HMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 215
Query: 252 SDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           +DFG +           TTI  TR Y  PE ILE G ++ CD++S G +L E   G
Sbjct: 216 ADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 267

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 102 TDNFQAL--LGHGSSASVFKGILSDGTS-VAVKRINGEE---NGEKEFRSEVAAIASAQH 155
           TD++Q    LG G+ + V + +    T   A K IN ++      ++   E       +H
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKH 89
Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
            N+VRL    +   G  YLV++ +  G L   I      SE   S  C+           
Sbjct: 90  PNIVRLHD-SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASH-CIH---------Q 138
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV---VSDFGLSKLMSRDQSRCITTIR 272
           + ++++++H   +  ++H D+KPEN+LL    +     ++DFGL+  +  +Q        
Sbjct: 139 ILESVNHIH---QHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFG-FA 194
Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           GT GYL+PE + +    +  DI++ G++L  L  G
Sbjct: 195 GTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 102 TDNFQAL--LGHGSSASVFKGI-LSDGTSVAVKRINGEE---NGEKEFRSEVAAIASAQH 155
           TD +Q    LG G+ + V + + +  G   A K IN ++      ++   E       +H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
            N+VRL    +   G  YLV++ +  G L   I      SE   S  C+           
Sbjct: 63  PNIVRLHD-SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASH-CIQ---------Q 111
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV---VSDFGLSKLMSRDQSRCITTIR 272
           + +++++ H    + ++H D+KPEN+LL    +     ++DFGL+  +  DQ        
Sbjct: 112 ILESVNHCH---LNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG-FA 167
Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           GT GYL+PE + +    +  D+++ G++L  L  G
Sbjct: 168 GTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 96/226 (42%), Gaps = 28/226 (12%)
Query: 94  RSKELEEATDNFQALLGHGSSASVFKGI-LSDGTSVAVKRIN-------GEENGEKEFRS 145
           + KE  E+      LLG G   SV+ GI +SD   VA+K +        GE         
Sbjct: 2   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 61
Query: 146 EVAAI--ASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGC 203
           EV  +   S+    ++RLL +   P    +++         D + F T R        G 
Sbjct: 62  EVVLLKKVSSGFSGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITER--------GA 111
Query: 204 LSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSR 262
           L  +L       V +A+ + HN     VLH D+K ENIL+D N   + + DFG   L+  
Sbjct: 112 LQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL-- 166
Query: 263 DQSRCITTIRGTRGYLAPEWI-LEQGVSEKCDIYSYGMVLLELTGG 307
            +    T   GTR Y  PEWI   +       ++S G++L ++  G
Sbjct: 167 -KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 57/116 (49%), Gaps = 26/116 (22%)
Query: 211 RVAIDVAKALSYLHNDCRSRVLHLDVKPENILL---------------DE----NYRAVV 251
           ++A  + K++++LH++   ++ H D+KPENIL                DE    N    V
Sbjct: 122 KMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178
Query: 252 SDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
            DFG +       S    T+  TR Y APE IL  G S+ CD++S G +L+E   G
Sbjct: 179 VDFGSATYDDEHHS----TLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 97/226 (42%), Gaps = 28/226 (12%)
Query: 94  RSKELEEATDNFQALLGHGSSASVFKGI-LSDGTSVAVKRIN-------GEENGEKEFRS 145
           + KE  E+      LLG G   SV+ GI +SD   VA+K +        GE         
Sbjct: 1   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 60
Query: 146 EVAAI--ASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGC 203
           EV  +   S+    ++RLL +   P     L+ E  +    D + F T R        G 
Sbjct: 61  EVVLLKKVSSGFSGVIRLLDWFERPDS-FVLILERPEPVQ-DLFDFITER--------GA 110
Query: 204 LSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSR 262
           L  +L       V +A+ + HN     VLH D+K ENIL+D N   + + DFG   L+  
Sbjct: 111 LQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL-- 165
Query: 263 DQSRCITTIRGTRGYLAPEWI-LEQGVSEKCDIYSYGMVLLELTGG 307
            +    T   GTR Y  PEWI   +       ++S G++L ++  G
Sbjct: 166 -KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 108/220 (49%), Gaps = 25/220 (11%)
Query: 108 LLGHGSSASVFKGILSD----GTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVR 160
           +LG G    V++G+ ++      +VAVK    +   +N EK F SE   + +  H ++V+
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK-FMSEAVIMKNLDHPHIVK 89
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           L+G  ++   P +++ E    G L H++     R++   S   L+  L    ++ + KA+
Sbjct: 90  LIG--IIEEEPTWIIMELYPYGELGHYL----ERNKN--SLKVLTLVL---YSLQICKAM 138
Query: 221 SYLHN-DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLA 279
           +YL + +C    +H D+   NIL+       + DFGLS+ +  +     +  R    +++
Sbjct: 139 AYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMS 194
Query: 280 PEWILEQGVSEKCDIYSYGMVLLE-LTGGRRNVSLIEHGN 318
           PE I  +  +   D++ + + + E L+ G++    +E+ +
Sbjct: 195 PESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD 234

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 91/201 (45%), Gaps = 29/201 (14%)
Query: 126 TSVAVKRI--NGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS 183
           T+VAVK +  N   +  ++  SE   +    H ++++L G C    GP  L+ E+ + GS
Sbjct: 54  TTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ-DGPLLLIVEYAKYGS 112
Query: 184 LDHWIFPTSRRSEG--------------HYSGGCLSWDLRYRVAIDVAKALSYLHNDCRS 229
           L  ++  + +   G              H     L+       A  +++ + YL      
Sbjct: 113 LRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEM 169
Query: 230 RVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEW-----IL 284
            ++H D+   NIL+ E  +  +SDFGL    SRD     + ++ ++G +  +W     + 
Sbjct: 170 SLVHRDLAARNILVAEGRKMKISDFGL----SRDVYEEDSXVKRSQGRIPVKWMAIESLF 225
Query: 285 EQGVSEKCDIYSYGMVLLELT 305
           +   + + D++S+G++L E+ 
Sbjct: 226 DHIYTTQSDVWSFGVLLWEIV 246

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 102 TDNFQAL--LGHGSSASVFKGI-LSDGTSVAVKRINGEE---NGEKEFRSEVAAIASAQH 155
           TD +Q    LG G+ + V + + +  G   A K IN ++      ++   E       +H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
            N+VRL    +   G  YLV++ +  G L   I      SE   S  C+           
Sbjct: 63  PNIVRLHD-SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASH-CIQ---------Q 111
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV---VSDFGLSKLMSRDQSRCITTIR 272
           + +++++ H    + ++H D+KPEN+LL    +     ++DFGL+  +  DQ        
Sbjct: 112 ILESVNHCH---LNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG-FA 167
Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           GT GYL+PE + +    +  D+++ G++L  L  G
Sbjct: 168 GTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 108/220 (49%), Gaps = 25/220 (11%)
Query: 108 LLGHGSSASVFKGILSD----GTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVR 160
           +LG G    V++G+ ++      +VAVK    +   +N EK F SE   + +  H ++V+
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK-FMSEAVIMKNLDHPHIVK 77
Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           L+G  ++   P +++ E    G L H++     R++   S   L+  L    ++ + KA+
Sbjct: 78  LIG--IIEEEPTWIIMELYPYGELGHYL----ERNKN--SLKVLTLVL---YSLQICKAM 126
Query: 221 SYLHN-DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLA 279
           +YL + +C    +H D+   NIL+       + DFGLS+ +  +     +  R    +++
Sbjct: 127 AYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMS 182
Query: 280 PEWILEQGVSEKCDIYSYGMVLLE-LTGGRRNVSLIEHGN 318
           PE I  +  +   D++ + + + E L+ G++    +E+ +
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD 222

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 97/226 (42%), Gaps = 28/226 (12%)
Query: 94  RSKELEEATDNFQALLGHGSSASVFKGI-LSDGTSVAVKRIN-------GEENGEKEFRS 145
           + KE  E+      LLG G   SV+ GI +SD   VA+K +        GE         
Sbjct: 24  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 83
Query: 146 EVAAI--ASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGC 203
           EV  +   S+    ++RLL +   P     L+ E  +    D + F T R        G 
Sbjct: 84  EVVLLKKVSSGFSGVIRLLDWFERPDS-FVLILERPEPVQ-DLFDFITER--------GA 133
Query: 204 LSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSR 262
           L  +L       V +A+ + HN     VLH D+K ENIL+D N   + + DFG   L+  
Sbjct: 134 LQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL-- 188
Query: 263 DQSRCITTIRGTRGYLAPEWI-LEQGVSEKCDIYSYGMVLLELTGG 307
            +    T   GTR Y  PEWI   +       ++S G++L ++  G
Sbjct: 189 -KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 233

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 97/226 (42%), Gaps = 28/226 (12%)
Query: 94  RSKELEEATDNFQALLGHGSSASVFKGI-LSDGTSVAVKRIN-------GEENGEKEFRS 145
           + KE  E+      LLG G   SV+ GI +SD   VA+K +        GE         
Sbjct: 44  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 103
Query: 146 EVAAI--ASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGC 203
           EV  +   S+    ++RLL +   P     L+ E  +    D + F T R        G 
Sbjct: 104 EVVLLKKVSSGFSGVIRLLDWFERPDS-FVLILERPEPVQ-DLFDFITER--------GA 153
Query: 204 LSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSR 262
           L  +L       V +A+ + HN     VLH D+K ENIL+D N   + + DFG   L+  
Sbjct: 154 LQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL-- 208
Query: 263 DQSRCITTIRGTRGYLAPEWI-LEQGVSEKCDIYSYGMVLLELTGG 307
            +    T   GTR Y  PEWI   +       ++S G++L ++  G
Sbjct: 209 -KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 97/226 (42%), Gaps = 28/226 (12%)
Query: 94  RSKELEEATDNFQALLGHGSSASVFKGI-LSDGTSVAVKRIN-------GEENGEKEFRS 145
           + KE  E+      LLG G   SV+ GI +SD   VA+K +        GE         
Sbjct: 29  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 88
Query: 146 EVAAI--ASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGC 203
           EV  +   S+    ++RLL +   P     L+ E  +    D + F T R        G 
Sbjct: 89  EVVLLKKVSSGFSGVIRLLDWFERPDS-FVLILERPEPVQ-DLFDFITER--------GA 138
Query: 204 LSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSR 262
           L  +L       V +A+ + HN     VLH D+K ENIL+D N   + + DFG   L+  
Sbjct: 139 LQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL-- 193
Query: 263 DQSRCITTIRGTRGYLAPEWI-LEQGVSEKCDIYSYGMVLLELTGG 307
            +    T   GTR Y  PEWI   +       ++S G++L ++  G
Sbjct: 194 -KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 97/226 (42%), Gaps = 28/226 (12%)
Query: 94  RSKELEEATDNFQALLGHGSSASVFKGI-LSDGTSVAVKRIN-------GEENGEKEFRS 145
           + KE  E+      LLG G   SV+ GI +SD   VA+K +        GE         
Sbjct: 2   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 61
Query: 146 EVAAI--ASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGC 203
           EV  +   S+    ++RLL +   P     L+ E  +    D + F T R        G 
Sbjct: 62  EVVLLKKVSSGFSGVIRLLDWFERPDS-FVLILERPEPVQ-DLFDFITER--------GA 111
Query: 204 LSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSR 262
           L  +L       V +A+ + HN     VLH D+K ENIL+D N   + + DFG   L+  
Sbjct: 112 LQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL-- 166
Query: 263 DQSRCITTIRGTRGYLAPEWI-LEQGVSEKCDIYSYGMVLLELTGG 307
            +    T   GTR Y  PEWI   +       ++S G++L ++  G
Sbjct: 167 -KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 32/211 (15%)
Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAA---------IASAQHVNL 158
           +G G+  SV   I    G  VA+K+++      + F+SE+ A         +   QH N+
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLS------RPFQSEIFAKRAYRELLLLKHMQHENV 103
Query: 159 VRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK 218
           + LL     P       Y+F       + + P  +       G   S +    +   + K
Sbjct: 104 IGLLD-VFTPASSLRNFYDF-------YLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLK 155
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            L Y+H+   + V+H D+KP N+ ++E+    + DFGL++    + +  +     TR Y 
Sbjct: 156 GLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV----TRWYR 208
Query: 279 APEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           APE IL     ++  DI+S G ++ E+  G+
Sbjct: 209 APEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 100/228 (43%), Gaps = 33/228 (14%)
Query: 90  PIKFRSKELEEATDNFQALLGHGSSASVFKGILSD---GTSVAVKRINGEENGEKEFRSE 146
           P+ +  +E E      Q  LG GS   V +  + D   G   AVK++  E      FR+E
Sbjct: 64  PVDYEYRE-EVHWATHQLRLGRGSFGEVHR--MEDKQTGFQCAVKKVRLEV-----FRAE 115
Query: 147 -VAAIASAQHVNLVRLLGYCVVPGGPRYLVY-EFIQNGSLDHWIFPTSRRSEGHYSGGCL 204
            + A A      +V L G   V  GP   ++ E ++ GSL   +             GCL
Sbjct: 116 ELMACAGLTSPRIVPLYG--AVREGPWVNIFMELLEGGSLGQLV----------KEQGCL 163
Query: 205 SWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD-ENYRAVVSDFGLSKLMSRD 263
             D          + L YLH+    R+LH DVK +N+LL  +   A + DFG +  +  D
Sbjct: 164 PEDRALYYLGQALEGLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPD 220
Query: 264 Q-SRCITT---IRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
              + + T   I GT  ++APE +L +    K D++S   ++L +  G
Sbjct: 221 GLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 29/208 (13%)
Query: 109 LGHGSSASV--FKGILSDGTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLL 162
           +G G+ A V   + IL+ G  VA+K I+  +    + +K FR EV  +    H N+V+L 
Sbjct: 20  IGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLF 77
Query: 163 GYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY 222
              +      YL+ E+   G +  ++    R  E            ++R    +  A+ Y
Sbjct: 78  E-VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS-------KFR---QIVSAVQY 126
Query: 223 LHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEW 282
            H   + R++H D+K EN+LLD +    ++DFG S   +      + T  G+  Y APE 
Sbjct: 127 CH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK--LDTFCGSPPYAAPE- 180
Query: 283 ILEQGVS---EKCDIYSYGMVLLELTGG 307
            L QG      + D++S G++L  L  G
Sbjct: 181 -LFQGKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 97/226 (42%), Gaps = 28/226 (12%)
Query: 94  RSKELEEATDNFQALLGHGSSASVFKGI-LSDGTSVAVKRIN-------GEENGEKEFRS 145
           + KE  E+      LLG G   SV+ GI +SD   VA+K +        GE         
Sbjct: 16  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 75
Query: 146 EVAAI--ASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGC 203
           EV  +   S+    ++RLL +   P     L+ E  +    D + F T R        G 
Sbjct: 76  EVVLLKKVSSGFSGVIRLLDWFERPDS-FVLILERPEPVQ-DLFDFITER--------GA 125
Query: 204 LSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSR 262
           L  +L       V +A+ + HN     VLH D+K ENIL+D N   + + DFG   L+  
Sbjct: 126 LQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL-- 180
Query: 263 DQSRCITTIRGTRGYLAPEWI-LEQGVSEKCDIYSYGMVLLELTGG 307
            +    T   GTR Y  PEWI   +       ++S G++L ++  G
Sbjct: 181 -KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 97/226 (42%), Gaps = 28/226 (12%)
Query: 94  RSKELEEATDNFQALLGHGSSASVFKGI-LSDGTSVAVKRIN-------GEENGEKEFRS 145
           + KE  E+      LLG G   SV+ GI +SD   VA+K +        GE         
Sbjct: 16  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 75
Query: 146 EVAAI--ASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGC 203
           EV  +   S+    ++RLL +   P     L+ E  +    D + F T R        G 
Sbjct: 76  EVVLLKKVSSGFSGVIRLLDWFERPDS-FVLILERPEPVQ-DLFDFITER--------GA 125
Query: 204 LSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSR 262
           L  +L       V +A+ + HN     VLH D+K ENIL+D N   + + DFG   L+  
Sbjct: 126 LQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL-- 180
Query: 263 DQSRCITTIRGTRGYLAPEWI-LEQGVSEKCDIYSYGMVLLELTGG 307
            +    T   GTR Y  PEWI   +       ++S G++L ++  G
Sbjct: 181 -KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 29/212 (13%)
Query: 105 FQALLGHGSSASV--FKGILSDGTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNL 158
            Q  +G G+ A V   + +L+ G  VAVK I+  +    + +K FR EV  +    H N+
Sbjct: 19  LQKTIGKGNFAKVKLARHVLT-GREVAVKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNI 76
Query: 159 VRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK 218
           V+L    +      YLV E+   G +  ++    R  E            ++R    +  
Sbjct: 77  VKLFE-VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA-------KFR---QIVS 125
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
           A+ Y H   +  ++H D+K EN+LLD +    ++DFG S   +      + T  G+  Y 
Sbjct: 126 AVQYCH---QKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNK--LDTFCGSPPYA 180
Query: 279 APEWILEQGVS---EKCDIYSYGMVLLELTGG 307
           APE  L QG      + D++S G++L  L  G
Sbjct: 181 APE--LFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 97/226 (42%), Gaps = 28/226 (12%)
Query: 94  RSKELEEATDNFQALLGHGSSASVFKGI-LSDGTSVAVKRIN-------GEENGEKEFRS 145
           + KE  E+      LLG G   SV+ GI +SD   VA+K +        GE         
Sbjct: 36  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 95
Query: 146 EVAAI--ASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGC 203
           EV  +   S+    ++RLL +   P     L+ E  +    D + F T R        G 
Sbjct: 96  EVVLLKKVSSGFSGVIRLLDWFERPDS-FVLILERPEPVQ-DLFDFITER--------GA 145
Query: 204 LSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSR 262
           L  +L       V +A+ + HN     VLH D+K ENIL+D N   + + DFG   L+  
Sbjct: 146 LQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL-- 200
Query: 263 DQSRCITTIRGTRGYLAPEWI-LEQGVSEKCDIYSYGMVLLELTGG 307
            +    T   GTR Y  PEWI   +       ++S G++L ++  G
Sbjct: 201 -KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 97/226 (42%), Gaps = 28/226 (12%)
Query: 94  RSKELEEATDNFQALLGHGSSASVFKGI-LSDGTSVAVKRIN-------GEENGEKEFRS 145
           + KE  E+      LLG G   SV+ GI +SD   VA+K +        GE         
Sbjct: 17  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 76
Query: 146 EVAAI--ASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGC 203
           EV  +   S+    ++RLL +   P     L+ E  +    D + F T R        G 
Sbjct: 77  EVVLLKKVSSGFSGVIRLLDWFERPDS-FVLILERPEPVQ-DLFDFITER--------GA 126
Query: 204 LSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSR 262
           L  +L       V +A+ + HN     VLH D+K ENIL+D N   + + DFG   L+  
Sbjct: 127 LQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL-- 181
Query: 263 DQSRCITTIRGTRGYLAPEWI-LEQGVSEKCDIYSYGMVLLELTGG 307
            +    T   GTR Y  PEWI   +       ++S G++L ++  G
Sbjct: 182 -KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 97/226 (42%), Gaps = 28/226 (12%)
Query: 94  RSKELEEATDNFQALLGHGSSASVFKGI-LSDGTSVAVKRIN-------GEENGEKEFRS 145
           + KE  E+      LLG G   SV+ GI +SD   VA+K +        GE         
Sbjct: 30  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 89
Query: 146 EVAAI--ASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGC 203
           EV  +   S+    ++RLL +   P     L+ E  +    D + F T R        G 
Sbjct: 90  EVVLLKKVSSGFSGVIRLLDWFERPDS-FVLILERPEPVQ-DLFDFITER--------GA 139
Query: 204 LSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSR 262
           L  +L       V +A+ + HN     VLH D+K ENIL+D N   + + DFG   L+  
Sbjct: 140 LQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL-- 194
Query: 263 DQSRCITTIRGTRGYLAPEWI-LEQGVSEKCDIYSYGMVLLELTGG 307
            +    T   GTR Y  PEWI   +       ++S G++L ++  G
Sbjct: 195 -KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 97/226 (42%), Gaps = 28/226 (12%)
Query: 94  RSKELEEATDNFQALLGHGSSASVFKGI-LSDGTSVAVKRIN-------GEENGEKEFRS 145
           + KE  E+      LLG G   SV+ GI +SD   VA+K +        GE         
Sbjct: 29  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 88
Query: 146 EVAAI--ASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGC 203
           EV  +   S+    ++RLL +   P     L+ E  +    D + F T R        G 
Sbjct: 89  EVVLLKKVSSGFSGVIRLLDWFERPDS-FVLILERPEPVQ-DLFDFITER--------GA 138
Query: 204 LSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSR 262
           L  +L       V +A+ + HN     VLH D+K ENIL+D N   + + DFG   L+  
Sbjct: 139 LQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL-- 193
Query: 263 DQSRCITTIRGTRGYLAPEWI-LEQGVSEKCDIYSYGMVLLELTGG 307
            +    T   GTR Y  PEWI   +       ++S G++L ++  G
Sbjct: 194 -KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 97/226 (42%), Gaps = 28/226 (12%)
Query: 94  RSKELEEATDNFQALLGHGSSASVFKGI-LSDGTSVAVKRIN-------GEENGEKEFRS 145
           + KE  E+      LLG G   SV+ GI +SD   VA+K +        GE         
Sbjct: 17  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 76
Query: 146 EVAAI--ASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGC 203
           EV  +   S+    ++RLL +   P     L+ E  +    D + F T R        G 
Sbjct: 77  EVVLLKKVSSGFSGVIRLLDWFERPDS-FVLILERPEPVQ-DLFDFITER--------GA 126
Query: 204 LSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSR 262
           L  +L       V +A+ + HN     VLH D+K ENIL+D N   + + DFG   L+  
Sbjct: 127 LQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL-- 181
Query: 263 DQSRCITTIRGTRGYLAPEWI-LEQGVSEKCDIYSYGMVLLELTGG 307
            +    T   GTR Y  PEWI   +       ++S G++L ++  G
Sbjct: 182 -KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 78/168 (46%), Gaps = 26/168 (15%)
Query: 146 EVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLS 205
           EVA +    H N+++L  +        YLV E  + G L   I    + SE   +     
Sbjct: 71  EVAVLKQLDHPNIMKLYEF-FEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAA----- 124
Query: 206 WDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV---VSDFGLS---KL 259
                 +   V    +YLH   +  ++H D+KPEN+LL+   R     + DFGLS   ++
Sbjct: 125 -----VIMKQVLSGTTYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEV 176
Query: 260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
             + + R      GT  Y+APE +L +   EKCD++S G++L  L  G
Sbjct: 177 GGKMKERL-----GTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 218

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 32/211 (15%)
Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAA---------IASAQHVNL 158
           +G G+  SV   I    G  VA+K+++      + F+SE+ A         +   QH N+
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLS------RPFQSEIFAKRAYRELLLLKHMQHENV 85
Query: 159 VRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK 218
           + LL     P       Y+F       + + P  +       G   S +    +   + K
Sbjct: 86  IGLLD-VFTPASSLRNFYDF-------YLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLK 137
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            L Y+H+   + V+H D+KP N+ ++E+    + DFGL++    + +  +     TR Y 
Sbjct: 138 GLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV----TRWYR 190
Query: 279 APEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           APE IL     ++  DI+S G ++ E+  G+
Sbjct: 191 APEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 97/226 (42%), Gaps = 28/226 (12%)
Query: 94  RSKELEEATDNFQALLGHGSSASVFKGI-LSDGTSVAVKRIN-------GEENGEKEFRS 145
           + KE  E+      LLG G   SV+ GI +SD   VA+K +        GE         
Sbjct: 2   KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 61
Query: 146 EVAAI--ASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGC 203
           EV  +   S+    ++RLL +   P     L+ E  +    D + F T R        G 
Sbjct: 62  EVVLLKKVSSGFSGVIRLLDWFERPDS-FVLILERPEPVQ-DLFDFITER--------GA 111
Query: 204 LSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSR 262
           L  +L       V +A+ + HN     VLH D+K ENIL+D N   + + DFG   L+  
Sbjct: 112 LQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL-- 166
Query: 263 DQSRCITTIRGTRGYLAPEWI-LEQGVSEKCDIYSYGMVLLELTGG 307
            +    T   GTR Y  PEWI   +       ++S G++L ++  G
Sbjct: 167 -KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 97/226 (42%), Gaps = 28/226 (12%)
Query: 94  RSKELEEATDNFQALLGHGSSASVFKGI-LSDGTSVAVKRIN-------GEENGEKEFRS 145
           + KE  E+      LLG G   SV+ GI +SD   VA+K +        GE         
Sbjct: 29  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 88
Query: 146 EVAAI--ASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGC 203
           EV  +   S+    ++RLL +   P     L+ E  +    D + F T R        G 
Sbjct: 89  EVVLLKKVSSGFSGVIRLLDWFERPDS-FVLILERPEPVQ-DLFDFITER--------GA 138
Query: 204 LSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSR 262
           L  +L       V +A+ + HN     VLH D+K ENIL+D N   + + DFG   L+  
Sbjct: 139 LQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL-- 193
Query: 263 DQSRCITTIRGTRGYLAPEWI-LEQGVSEKCDIYSYGMVLLELTGG 307
            +    T   GTR Y  PEWI   +       ++S G++L ++  G
Sbjct: 194 -KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 97/226 (42%), Gaps = 28/226 (12%)
Query: 94  RSKELEEATDNFQALLGHGSSASVFKGI-LSDGTSVAVKRIN-------GEENGEKEFRS 145
           + KE  E+      LLG G   SV+ GI +SD   VA+K +        GE         
Sbjct: 30  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 89
Query: 146 EVAAI--ASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGC 203
           EV  +   S+    ++RLL +   P     L+ E  +    D + F T R        G 
Sbjct: 90  EVVLLKKVSSGFSGVIRLLDWFERPDS-FVLILERPEPVQ-DLFDFITER--------GA 139
Query: 204 LSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSR 262
           L  +L       V +A+ + HN     VLH D+K ENIL+D N   + + DFG   L+  
Sbjct: 140 LQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL-- 194
Query: 263 DQSRCITTIRGTRGYLAPEWI-LEQGVSEKCDIYSYGMVLLELTGG 307
            +    T   GTR Y  PEWI   +       ++S G++L ++  G
Sbjct: 195 -KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 97/226 (42%), Gaps = 28/226 (12%)
Query: 94  RSKELEEATDNFQALLGHGSSASVFKGI-LSDGTSVAVKRIN-------GEENGEKEFRS 145
           + KE  E+      LLG G   SV+ GI +SD   VA+K +        GE         
Sbjct: 29  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 88
Query: 146 EVAAI--ASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGC 203
           EV  +   S+    ++RLL +   P     L+ E  +    D + F T R        G 
Sbjct: 89  EVVLLKKVSSGFSGVIRLLDWFERPDS-FVLILERPEPVQ-DLFDFITER--------GA 138
Query: 204 LSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSR 262
           L  +L       V +A+ + HN     VLH D+K ENIL+D N   + + DFG   L+  
Sbjct: 139 LQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL-- 193
Query: 263 DQSRCITTIRGTRGYLAPEWI-LEQGVSEKCDIYSYGMVLLELTGG 307
            +    T   GTR Y  PEWI   +       ++S G++L ++  G
Sbjct: 194 -KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 97/226 (42%), Gaps = 28/226 (12%)
Query: 94  RSKELEEATDNFQALLGHGSSASVFKGI-LSDGTSVAVKRIN-------GEENGEKEFRS 145
           + KE  E+      LLG G   SV+ GI +SD   VA+K +        GE         
Sbjct: 17  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 76
Query: 146 EVAAI--ASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGC 203
           EV  +   S+    ++RLL +   P     L+ E  +    D + F T R        G 
Sbjct: 77  EVVLLKKVSSGFSGVIRLLDWFERPDS-FVLILERPEPVQ-DLFDFITER--------GA 126
Query: 204 LSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSR 262
           L  +L       V +A+ + HN     VLH D+K ENIL+D N   + + DFG   L+  
Sbjct: 127 LQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL-- 181
Query: 263 DQSRCITTIRGTRGYLAPEWI-LEQGVSEKCDIYSYGMVLLELTGG 307
            +    T   GTR Y  PEWI   +       ++S G++L ++  G
Sbjct: 182 -KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 53/94 (56%), Gaps = 3/94 (3%)
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGT 274
           ++  AL YLH++    V++ D+K EN++LD++    ++DFGL K   +D +  +    GT
Sbjct: 116 EIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKXFCGT 172
Query: 275 RGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
             YLAPE + +       D +  G+V+ E+  GR
Sbjct: 173 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 53/94 (56%), Gaps = 3/94 (3%)
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGT 274
           ++  AL YLH++    V++ D+K EN++LD++    ++DFGL K   +D +  +    GT
Sbjct: 117 EIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKXFCGT 173
Query: 275 RGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
             YLAPE + +       D +  G+V+ E+  GR
Sbjct: 174 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 53/94 (56%), Gaps = 3/94 (3%)
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGT 274
           ++  AL YLH++    V++ D+K EN++LD++    ++DFGL K   +D +  +    GT
Sbjct: 118 EIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKXFCGT 174
Query: 275 RGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
             YLAPE + +       D +  G+V+ E+  GR
Sbjct: 175 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 97/226 (42%), Gaps = 28/226 (12%)
Query: 94  RSKELEEATDNFQALLGHGSSASVFKGI-LSDGTSVAVKRIN-------GEENGEKEFRS 145
           + KE  E+      LLG G   SV+ GI +SD   VA+K +        GE         
Sbjct: 49  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 108
Query: 146 EVAAI--ASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGC 203
           EV  +   S+    ++RLL +   P     L+ E  +    D + F T R        G 
Sbjct: 109 EVVLLKKVSSGFSGVIRLLDWFERPDS-FVLILERPEPVQ-DLFDFITER--------GA 158
Query: 204 LSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSR 262
           L  +L       V +A+ + HN     VLH D+K ENIL+D N   + + DFG   L+  
Sbjct: 159 LQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL-- 213
Query: 263 DQSRCITTIRGTRGYLAPEWI-LEQGVSEKCDIYSYGMVLLELTGG 307
            +    T   GTR Y  PEWI   +       ++S G++L ++  G
Sbjct: 214 -KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 258

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 43/219 (19%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E ++ G L   +    R  E      C  +  +  +A+       YLH +    ++
Sbjct: 90  YIVLELMEGGELFDKVVGNKRLKEA----TCKLYFYQMLLAV------QYLHEN---GII 136
Query: 233 HLDVKPENILL---DENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVS 289
           H D+KPEN+LL   +E+    ++DFG SK++   ++  + T+ GT  YLAPE ++  G +
Sbjct: 137 HRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSVGTA 194
Query: 290 ---EKCDIYSYGMVLLELTGG-------RRNVSLIEHGNDKSKNKWQYFPKI---VNEK- 335
                 D +S G++L     G       R  VSL    +  +  K+ + P++   V+EK 
Sbjct: 195 GYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---KDQITSGKYNFIPEVWAEVSEKA 251
Query: 336 MKEGKLMEIVDQ--RLTDEGGI------DETQVRRLVDV 366
           +   K + +VD   R T E  +      DE   R+  D+
Sbjct: 252 LDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDL 290

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 97/226 (42%), Gaps = 28/226 (12%)
Query: 94  RSKELEEATDNFQALLGHGSSASVFKGI-LSDGTSVAVKRIN-------GEENGEKEFRS 145
           + KE  E+      LLG G   SV+ GI +SD   VA+K +        GE         
Sbjct: 30  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 89
Query: 146 EVAAI--ASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGC 203
           EV  +   S+    ++RLL +   P     L+ E  +    D + F T R        G 
Sbjct: 90  EVVLLKKVSSGFSGVIRLLDWFERPDS-FVLILERPEPVQ-DLFDFITER--------GA 139
Query: 204 LSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSR 262
           L  +L       V +A+ + HN     VLH D+K ENIL+D N   + + DFG   L+  
Sbjct: 140 LQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL-- 194
Query: 263 DQSRCITTIRGTRGYLAPEWI-LEQGVSEKCDIYSYGMVLLELTGG 307
            +    T   GTR Y  PEWI   +       ++S G++L ++  G
Sbjct: 195 -KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 97/226 (42%), Gaps = 28/226 (12%)
Query: 94  RSKELEEATDNFQALLGHGSSASVFKGI-LSDGTSVAVKRIN-------GEENGEKEFRS 145
           + KE  E+      LLG G   SV+ GI +SD   VA+K +        GE         
Sbjct: 30  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 89
Query: 146 EVAAI--ASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGC 203
           EV  +   S+    ++RLL +   P     L+ E  +    D + F T R        G 
Sbjct: 90  EVVLLKKVSSGFSGVIRLLDWFERPDS-FVLILERPEPVQ-DLFDFITER--------GA 139
Query: 204 LSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSR 262
           L  +L       V +A+ + HN     VLH D+K ENIL+D N   + + DFG   L+  
Sbjct: 140 LQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL-- 194
Query: 263 DQSRCITTIRGTRGYLAPEWI-LEQGVSEKCDIYSYGMVLLELTGG 307
            +    T   GTR Y  PEWI   +       ++S G++L ++  G
Sbjct: 195 -KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 43/219 (19%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E ++ G L   +    R  E      C  +  +  +A+       YLH +    ++
Sbjct: 89  YIVLELMEGGELFDKVVGNKRLKEA----TCKLYFYQMLLAV------QYLHEN---GII 135
Query: 233 HLDVKPENILL---DENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVS 289
           H D+KPEN+LL   +E+    ++DFG SK++   ++  + T+ GT  YLAPE ++  G +
Sbjct: 136 HRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSVGTA 193
Query: 290 ---EKCDIYSYGMVLLELTGG-------RRNVSLIEHGNDKSKNKWQYFPKI---VNEK- 335
                 D +S G++L     G       R  VSL    +  +  K+ + P++   V+EK 
Sbjct: 194 GYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---KDQITSGKYNFIPEVWAEVSEKA 250
Query: 336 MKEGKLMEIVDQ--RLTDEGGI------DETQVRRLVDV 366
           +   K + +VD   R T E  +      DE   R+  D+
Sbjct: 251 LDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDL 289

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 76/167 (45%), Gaps = 19/167 (11%)
Query: 146 EVAAIASAQHVNLVRLLGYCVVPGGPR-YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCL 204
           E+A +    H N+V+L+     P     Y+V+E +  G +     PT +          L
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME--VPTLKP---------L 134
Query: 205 SWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ 264
           S D       D+ K + YLH     +++H D+KP N+L+ E+    ++DFG+S       
Sbjct: 135 SEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 265 SRCITTIRGTRGYLAPEWILEQ---GVSEKCDIYSYGMVLLELTGGR 308
           +    T+ GT  ++APE + E       +  D+++ G+ L     G+
Sbjct: 192 ALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 43/219 (19%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E ++ G L   +    R  E      C  +  +  +A+       YLH +    ++
Sbjct: 90  YIVLELMEGGELFDKVVGNKRLKEA----TCKLYFYQMLLAV------QYLHEN---GII 136
Query: 233 HLDVKPENILL---DENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVS 289
           H D+KPEN+LL   +E+    ++DFG SK++   ++  + T+ GT  YLAPE ++  G +
Sbjct: 137 HRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSVGTA 194
Query: 290 ---EKCDIYSYGMVLLELTGG-------RRNVSLIEHGNDKSKNKWQYFPKI---VNEK- 335
                 D +S G++L     G       R  VSL    +  +  K+ + P++   V+EK 
Sbjct: 195 GYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---KDQITSGKYNFIPEVWAEVSEKA 251
Query: 336 MKEGKLMEIVDQ--RLTDEGGI------DETQVRRLVDV 366
           +   K + +VD   R T E  +      DE   R+  D+
Sbjct: 252 LDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDL 290

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 52/94 (55%), Gaps = 4/94 (4%)
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGT 274
           ++  AL YLH+     V++ D+K EN++LD++    ++DFGL K    D +  + T  GT
Sbjct: 113 EIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTFCGT 168
Query: 275 RGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
             YLAPE + +       D +  G+V+ E+  GR
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 93/227 (40%), Gaps = 42/227 (18%)
Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRI----NGEENGEKEFRSEVAAIASAQHVNLVRLLG 163
           LG G+   V+K I    G  VAVK+I        + ++ FR  +     + H N+V LL 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 164 YCVVPGG-PRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY 222
                     YLV+++++     H +   +     H          +  V   + K + Y
Sbjct: 77  VLRADNDRDVYLVFDYMETDL--HAVIRANILEPVH----------KQYVVYQLIKVIKY 124
Query: 223 LHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR-------------------- 262
           LH+     +LH D+KP NILL+      V+DFGLS+                        
Sbjct: 125 LHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 263 DQSRCITTIRGTRGYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
           D    +T    TR Y APE +L     ++  D++S G +L E+  G+
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 43/219 (19%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E ++ G L   +    R  E      C  +  +  +A+       YLH +    ++
Sbjct: 90  YIVLELMEGGELFDKVVGNKRLKEA----TCKLYFYQMLLAV------QYLHEN---GII 136
Query: 233 HLDVKPENILL---DENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVS 289
           H D+KPEN+LL   +E+    ++DFG SK++   ++  + T+ GT  YLAPE ++  G +
Sbjct: 137 HRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSVGTA 194
Query: 290 ---EKCDIYSYGMVLLELTGG-------RRNVSLIEHGNDKSKNKWQYFPKI---VNEK- 335
                 D +S G++L     G       R  VSL    +  +  K+ + P++   V+EK 
Sbjct: 195 GYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---KDQITSGKYNFIPEVWAEVSEKA 251
Query: 336 MKEGKLMEIVDQ--RLTDEGGI------DETQVRRLVDV 366
           +   K + +VD   R T E  +      DE   R+  D+
Sbjct: 252 LDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDL 290

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 97/226 (42%), Gaps = 28/226 (12%)
Query: 94  RSKELEEATDNFQALLGHGSSASVFKGI-LSDGTSVAVKRIN-------GEENGEKEFRS 145
           + KE  E+      LLG G   SV+ GI +SD   VA+K +        GE         
Sbjct: 44  KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 103
Query: 146 EVAAI--ASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGC 203
           EV  +   S+    ++RLL +   P     L+ E  +    D + F T R        G 
Sbjct: 104 EVVLLKKVSSGFSGVIRLLDWFERPDS-FVLILERPEPVQ-DLFDFITER--------GA 153
Query: 204 LSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSR 262
           L  +L       V +A+ + HN     VLH D+K ENIL+D N   + + DFG   L+  
Sbjct: 154 LQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL-- 208
Query: 263 DQSRCITTIRGTRGYLAPEWI-LEQGVSEKCDIYSYGMVLLELTGG 307
            +    T   GTR Y  PEWI   +       ++S G++L ++  G
Sbjct: 209 -KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 43/219 (19%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+V E ++ G L   +    R  E      C  +  +  +A+       YLH +    ++
Sbjct: 96  YIVLELMEGGELFDKVVGNKRLKEA----TCKLYFYQMLLAV------QYLHEN---GII 142
Query: 233 HLDVKPENILL---DENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVS 289
           H D+KPEN+LL   +E+    ++DFG SK++   ++  + T+ GT  YLAPE ++  G +
Sbjct: 143 HRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSVGTA 200
Query: 290 ---EKCDIYSYGMVLLELTGG-------RRNVSLIEHGNDKSKNKWQYFPKI---VNEK- 335
                 D +S G++L     G       R  VSL    +  +  K+ + P++   V+EK 
Sbjct: 201 GYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---KDQITSGKYNFIPEVWAEVSEKA 257
Query: 336 MKEGKLMEIVDQ--RLTDEGGI------DETQVRRLVDV 366
           +   K + +VD   R T E  +      DE   R+  D+
Sbjct: 258 LDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDL 296

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 95/224 (42%), Gaps = 28/224 (12%)
Query: 96  KELEEATDNFQALLGHGSSASVFKGI-LSDGTSVAVKRIN-------GEENGEKEFRSEV 147
           KE  E+      LLG G   SV+ GI +SD   VA+K +        GE         EV
Sbjct: 2   KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 61
Query: 148 AAI--ASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLS 205
             +   S+    ++RLL +   P    +++         D + F T R        G L 
Sbjct: 62  VLLKKVSSGFSGVIRLLDWFERPDS--FVLILERPEPVQDLFDFITER--------GALQ 111
Query: 206 WDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSRDQ 264
            +L       V +A+ + HN     VLH D+K ENIL+D N   + + DFG   L+   +
Sbjct: 112 EELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---K 165
Query: 265 SRCITTIRGTRGYLAPEWI-LEQGVSEKCDIYSYGMVLLELTGG 307
               T   GTR Y  PEWI   +       ++S G++L ++  G
Sbjct: 166 DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 209

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 52/94 (55%), Gaps = 4/94 (4%)
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGT 274
           ++  AL YLH+     V++ D+K EN++LD++    ++DFGL K    D +  + T  GT
Sbjct: 113 EIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTFCGT 168
Query: 275 RGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
             YLAPE + +       D +  G+V+ E+  GR
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 52/94 (55%), Gaps = 4/94 (4%)
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGT 274
           ++  AL YLH+     V++ D+K EN++LD++    ++DFGL K    D +  + T  GT
Sbjct: 116 EIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKTFCGT 171
Query: 275 RGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
             YLAPE + +       D +  G+V+ E+  GR
Sbjct: 172 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/261 (23%), Positives = 113/261 (43%), Gaps = 36/261 (13%)
Query: 65  LESKFVTEGRELR-IEYSFLRKVAGVPIKFRSKELEEATDNFQALLGHGSSASVFKGILS 123
           L+  F++EG  L+ + Y      +G  +    +     T   Q  +G G    V++G   
Sbjct: 5   LDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR 64
Query: 124 DGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPR---YLVYEFIQ 180
            G  VAVK  +  E       +E+      +H N++  +       G     +LV ++ +
Sbjct: 65  -GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 123
Query: 181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDC-----RSRVLHLD 235
           +GSL  ++   +   EG             ++A+  A  L++LH +      +  + H D
Sbjct: 124 HGSLFDYLNRYTVTVEG-----------MIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 172
Query: 236 VKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR-----GTRGYLAPEWILEQGVSE 290
           +K +NIL+ +N    ++D GL+  +  D +     I      GT+ Y+APE +L+  ++ 
Sbjct: 173 LKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTKRYMAPE-VLDDSINM 229
Query: 291 K-------CDIYSYGMVLLEL 304
           K        DIY+ G+V  E+
Sbjct: 230 KHFESFKRADIYAMGLVFWEI 250

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 29/208 (13%)
Query: 109 LGHGSSASV--FKGILSDGTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLL 162
           +G G+ A V   + IL+ G  VAVK I+  +    + +K FR EV  +    H N+V+L 
Sbjct: 22  IGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLF 79
Query: 163 GYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY 222
              +      YLV E+   G +  ++    R  E            ++R    +  A+ Y
Sbjct: 80  E-VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA-------KFR---QIVSAVQY 128
Query: 223 LHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEW 282
            H   +  ++H D+K EN+LLD +    ++DFG S   +      + T  G+  Y APE 
Sbjct: 129 CH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LDTFCGSPPYAAPE- 182
Query: 283 ILEQGVS---EKCDIYSYGMVLLELTGG 307
            L QG      + D++S G++L  L  G
Sbjct: 183 -LFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 24/213 (11%)
Query: 122 LSDGTSVAVKRINGEENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPR---YLVYE 177
           L DG   A+KRI   E  ++E     A +     H N++RL+ YC+   G +   +L+  
Sbjct: 51  LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLP 110
Query: 178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVK 237
           F + G+L  W      + +G++    L+ D    + + + + L  +H    +   H D+K
Sbjct: 111 FFKRGTL--WNEIERLKDKGNF----LTEDQILWLLLGICRGLEAIHAKGYA---HRDLK 161
Query: 238 PENILLDENYRAVVSDFGL--SKLMSRDQSRCITTI------RGTRGYLAPEWILEQG-- 287
           P NILL +  + V+ D G      +  + SR   T+      R T  Y APE    Q   
Sbjct: 162 PTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHC 221
Query: 288 -VSEKCDIYSYGMVLLELTGGRRNVSLIEHGND 319
            + E+ D++S G VL  +  G     ++    D
Sbjct: 222 VIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 102/248 (41%), Gaps = 26/248 (10%)
Query: 136 EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRS 195
           +E  E + R E+   +  +H N++R+  Y        YL+ EF   G L   +    R  
Sbjct: 54  KEGVEHQLRREIEIQSHLRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKELQKHGRFD 112
Query: 196 EGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFG 255
           E   +              ++A AL Y H     +V+H D+KPEN+L+       ++DFG
Sbjct: 113 EQRSAT----------FMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFG 159
Query: 256 LSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIE 315
            S      + R +    GT  YL PE I  +   EK D++  G++  E   G        
Sbjct: 160 WSVHAPSLRRRXMC---GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 216
Query: 316 HGNDKSK--NKWQYFPKIVNEKMKE--GKLMEI-VDQRLTDEGGIDETQV----RRLVDV 366
           H     +  N    FP  +++  K+   KL+     QRL  +G ++   V    RR++  
Sbjct: 217 HTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPP 276
Query: 367 AFWCIQER 374
            +   Q +
Sbjct: 277 VYQSTQSK 284

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/184 (23%), Positives = 83/184 (45%), Gaps = 15/184 (8%)
Query: 152 SAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYR 211
           ++ H  LV L   C       + V E++  G L   +    +  E H          R+ 
Sbjct: 77  ASNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH---------ARFY 126
Query: 212 VAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTI 271
            A +++ AL+YLH      +++ D+K +N+LLD      ++D+G+ K   R      +  
Sbjct: 127 SA-EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-PGDTTSXF 181
Query: 272 RGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKI 331
            GT  Y+APE +  +      D ++ G+++ E+  GR    ++   ++  +N   Y  ++
Sbjct: 182 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 241
Query: 332 VNEK 335
           + EK
Sbjct: 242 ILEK 245

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 29/208 (13%)
Query: 109 LGHGSSASV--FKGILSDGTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLL 162
           +G G+ A V   + IL+ G  VAVK I+  +    + +K FR EV  +    H N+V+L 
Sbjct: 22  IGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLF 79
Query: 163 GYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY 222
              +      YLV E+   G +  ++    R  E            ++R    +  A+ Y
Sbjct: 80  E-VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA-------KFR---QIVSAVQY 128
Query: 223 LHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEW 282
            H   +  ++H D+K EN+LLD +    ++DFG S   +      + T  G+  Y APE 
Sbjct: 129 CH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LDTFCGSPPYAAPE- 182
Query: 283 ILEQGVS---EKCDIYSYGMVLLELTGG 307
            L QG      + D++S G++L  L  G
Sbjct: 183 -LFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 27/218 (12%)
Query: 101 ATDNFQAL--LGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRS---EVAAIASAQ 154
           + +NFQ +  +G G+   V+K      G  VA+K+I  +   E    +   E++ +    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI 214
           H N+V+LL   +      YLV+EF+   S+D   F  +    G      +   L      
Sbjct: 62  HPNIVKLLD-VIHTENKLYLVFEFL---SMDLKKFMDASALTG------IPLPLIKSYLF 111
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS---RDQSRCITTI 271
            + + L++ H+    RVLH D+KPEN+L++      ++DFGL++      R     + T+
Sbjct: 112 QLLQGLAFCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL 168
Query: 272 RGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
                Y APE +L  +  S   DI+S G +  E+   R
Sbjct: 169 ----WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 79/176 (44%), Gaps = 25/176 (14%)
Query: 136 EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRS 195
           +E  E + R E+   A   H N++RL  Y        YL+ E+   G L   +       
Sbjct: 63  KEGVEHQLRREIEIQAHLHHPNILRLYNY-FYDRRRIYLILEYAPRGELYKEL------- 114
Query: 196 EGHYSGGCLSWDLRYRVAI--DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSD 253
                  C ++D +    I  ++A AL Y H     +V+H D+KPEN+LL       ++D
Sbjct: 115 ----QKSC-TFDEQRTATIMEELADALMYCHG---KKVIHRDIKPENLLLGLKGELKIAD 166
Query: 254 FGLSKLMS--RDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           FG S      R ++ C     GT  YL PE I  +  +EK D++  G++  EL  G
Sbjct: 167 FGWSVHAPSLRRKTMC-----GTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 55/106 (51%), Gaps = 9/106 (8%)
Query: 204 LSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVS--DFGLSKLMS 261
            S  L  + A  + + L  LH   ++R++H D+KPENILL +  R+ +   DFG S    
Sbjct: 197 FSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---C 250
Query: 262 RDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
            +  R  T I+ +R Y APE IL        D++S G +L EL  G
Sbjct: 251 YEHQRVYTXIQ-SRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 55/106 (51%), Gaps = 9/106 (8%)
Query: 204 LSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVS--DFGLSKLMS 261
            S  L  + A  + + L  LH   ++R++H D+KPENILL +  R+ +   DFG S    
Sbjct: 197 FSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---C 250
Query: 262 RDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
            +  R  T I+ +R Y APE IL        D++S G +L EL  G
Sbjct: 251 YEHQRVYTXIQ-SRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/123 (24%), Positives = 63/123 (51%), Gaps = 4/123 (3%)
Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR 272
           + +++ AL+YLH      +++ D+K +N+LLD      ++D+G+ K   R      +   
Sbjct: 116 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-PGDTTSXFC 171
Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIV 332
           GT  Y+APE +  +      D ++ G+++ E+  GR    ++   ++  +N   Y  +++
Sbjct: 172 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 231
Query: 333 NEK 335
            EK
Sbjct: 232 LEK 234

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 74/159 (46%), Gaps = 19/159 (11%)
Query: 153 AQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRV 212
            QH N++ L       G   Y+V E ++ G L   I      SE   S           V
Sbjct: 73  GQHPNIITLKD-VYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASA----------V 121
Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENIL-LDE--NYRAV-VSDFGLSKLMSRDQSRCI 268
              + K + YLH      V+H D+KP NIL +DE  N  ++ + DFG +K + R ++  +
Sbjct: 122 LFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL-RAENGLL 177
Query: 269 TTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
            T   T  ++APE +  QG    CDI+S G++L  +  G
Sbjct: 178 MTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 74/172 (43%), Gaps = 17/172 (9%)
Query: 136 EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRS 195
           +E  E + R E+   +  +H N++R+  Y        YL+ EF   G L   +    R  
Sbjct: 55  KEGVEHQLRREIEIQSHLRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKELQKHGRFD 113
Query: 196 EGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFG 255
           E   +              ++A AL Y H     +V+H D+KPEN+L+       ++DFG
Sbjct: 114 EQRSAT----------FMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFG 160
Query: 256 LSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
            S      + R +    GT  YL PE I  +   EK D++  G++  E   G
Sbjct: 161 WSVHAPSLRRRXMC---GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/123 (24%), Positives = 63/123 (51%), Gaps = 4/123 (3%)
Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR 272
           + +++ AL+YLH      +++ D+K +N+LLD      ++D+G+ K   R      +   
Sbjct: 112 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-PGDTTSXFC 167
Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIV 332
           GT  Y+APE +  +      D ++ G+++ E+  GR    ++   ++  +N   Y  +++
Sbjct: 168 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 227
Query: 333 NEK 335
            EK
Sbjct: 228 LEK 230

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 27/218 (12%)
Query: 101 ATDNFQAL--LGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRS---EVAAIASAQ 154
           + +NFQ +  +G G+   V+K      G  VA+K+I  +   E    +   E++ +    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI 214
           H N+V+LL   +      YLV+EF+   S+D   F  +    G      +   L      
Sbjct: 64  HPNIVKLLD-VIHTENKLYLVFEFL---SMDLKKFMDASALTG------IPLPLIKSYLF 113
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS---RDQSRCITTI 271
            + + L++ H+    RVLH D+KPEN+L++      ++DFGL++      R     + T+
Sbjct: 114 QLLQGLAFCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL 170
Query: 272 RGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
                Y APE +L  +  S   DI+S G +  E+   R
Sbjct: 171 ----WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/81 (37%), Positives = 48/81 (59%), Gaps = 6/81 (7%)
Query: 232 LHLDVKPENILLDENYRAVVSDFGLSKLMSRD-QSRCITTIRGTRGYLAPEWILEQG--- 287
           +H DVKP+N+LLD++    ++DFG    M+++   RC T + GT  Y++PE +  QG   
Sbjct: 190 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDG 248
Query: 288 -VSEKCDIYSYGMVLLELTGG 307
               +CD +S G+ L E+  G
Sbjct: 249 YYGRECDWWSVGVFLYEMLVG 269

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 100/206 (48%), Gaps = 18/206 (8%)
Query: 108 LLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRS-EVAAIASAQHVNLVRLLGYCV 166
           ++G+GS   VF+  L +   VA+K++  +    K F++ E+  +   +H N+V L  +  
Sbjct: 47  VIGNGSFGVVFQAKLVESDEVAIKKVLQD----KRFKNRELQIMRIVKHPNVVDLKAFFY 102
Query: 167 VPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSG--GCLSWDLRYRVAIDVAKALSYLH 224
             G  +  V+    N  L+ ++  T  R+  HY+     +   L       + ++L+Y+H
Sbjct: 103 SNGDKKDEVF---LNLVLE-YVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH 158
Query: 225 NDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWI 283
           +     + H D+KP+N+LLD     + + DFG +K++   +     +   +R Y APE I
Sbjct: 159 S---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN--VSXICSRYYRAPELI 213
Query: 284 L-EQGVSEKCDIYSYGMVLLELTGGR 308
                 +   DI+S G V+ EL  G+
Sbjct: 214 FGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 27/208 (12%)
Query: 109 LGHGSSASVFKGI--LSDGTSVAVK--RINGEENGEKEFRSEVAAIASAQHVNLVRLLGY 164
           LG G+ A+V+KG   L+D   VA+K  R+  EE        EV+ +   +H N+V L   
Sbjct: 10  LGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL--- 65
Query: 165 CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI---DVAKALS 221
                      ++ I        +F    +    Y   C +    + V +    + + L+
Sbjct: 66  -----------HDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLA 114
Query: 222 YLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPE 281
           Y H   R +VLH D+KP+N+L++E     ++DFGL++  S   ++       T  Y  P+
Sbjct: 115 YCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYDNEVVTLWYRPPD 170
Query: 282 WIL-EQGVSEKCDIYSYGMVLLELTGGR 308
            +L     S + D++  G +  E+  GR
Sbjct: 171 ILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 21/213 (9%)
Query: 103 DNFQAL--LGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRS---EVAAIASAQHV 156
           +NFQ +  +G G+   V+K      G  VA+K+I  +   E    +   E++ +    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 157 NLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDV 216
           N+V+LL   +      YLV+EF+     D   F  +    G      +   L       +
Sbjct: 63  NIVKLLD-VIHTENKLYLVFEFLHQ---DLKKFMDASALTG------IPLPLIKSYLFQL 112
Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG 276
            + LS+ H+    RVLH D+KP+N+L++      ++DFGL++       R  T    T  
Sbjct: 113 LQGLSFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLW 168
Query: 277 YLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           Y APE +L  +  S   DI+S G +  E+   R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/81 (37%), Positives = 48/81 (59%), Gaps = 6/81 (7%)
Query: 232 LHLDVKPENILLDENYRAVVSDFGLSKLMSRD-QSRCITTIRGTRGYLAPEWILEQG--- 287
           +H DVKP+N+LLD++    ++DFG    M+++   RC T + GT  Y++PE +  QG   
Sbjct: 195 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDG 253
Query: 288 -VSEKCDIYSYGMVLLELTGG 307
               +CD +S G+ L E+  G
Sbjct: 254 YYGRECDWWSVGVFLYEMLVG 274

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 21/216 (9%)
Query: 100 EATDNFQAL--LGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRS---EVAAIASA 153
           E  +NFQ +  +G G+   V+K      G  VA+K+I  +   E    +   E++ +   
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 154 QHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVA 213
            H N+V+LL   +      YLV+EF+     D   F  +    G      +   L     
Sbjct: 67  NHPNIVKLLD-VIHTENKLYLVFEFLHQ---DLKKFMDASALTG------IPLPLIKSYL 116
Query: 214 IDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRG 273
             + + L++ H+    RVLH D+KP+N+L++      ++DFGL++       R  T    
Sbjct: 117 FQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV 172
Query: 274 TRGYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
           T  Y APE +L  +  S   DI+S G +  E+   R
Sbjct: 173 TLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 55/103 (53%), Gaps = 14/103 (13%)
Query: 211 RVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITT 270
           R  ++V  AL  L+      ++H D+KPENILLD++    ++DFG S  +  D    + +
Sbjct: 131 RALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLRS 182
Query: 271 IRGTRGYLAPEWIL------EQGVSEKCDIYSYGMVLLELTGG 307
           + GT  YLAPE I         G  ++ D++S G+++  L  G
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 55/98 (56%), Gaps = 9/98 (9%)
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD-QSRCITTIRG 273
           +V  AL  +H+      +H DVKP+N+LLD++    ++DFG    M+++   RC T + G
Sbjct: 181 EVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-G 236
Query: 274 TRGYLAPEWILEQG----VSEKCDIYSYGMVLLELTGG 307
           T  Y++PE +  QG       +CD +S G+ L E+  G
Sbjct: 237 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 86/173 (49%), Gaps = 33/173 (19%)
Query: 219 ALSYLHNDCRSRVLHLDVKPENILL---DENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           A+ YLH +    ++H D+KPEN+LL   +E+    ++DFG SK++   ++  + T+ GT 
Sbjct: 265 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTP 319
Query: 276 GYLAPEWILE---QGVSEKCDIYSYGMVLLELTGG-------RRNVSLIEHGNDKSKNKW 325
            YLAPE ++     G +   D +S G++L     G       R  VSL    +  +  K+
Sbjct: 320 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---KDQITSGKY 376
Query: 326 QYFPKI---VNEK-MKEGKLMEIVDQ--RLTDEGGI------DETQVRRLVDV 366
            + P++   V+EK +   K + +VD   R T E  +      DE   R+  D+
Sbjct: 377 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDL 429

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 84/173 (48%), Gaps = 20/173 (11%)
Query: 141 KEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGH-- 198
           ++ + E +     +H ++V LL       G  Y+V+EF+    L    F   +R++    
Sbjct: 71  EDLKREASICHMLKHPHIVELLE-TYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFV 126
Query: 199 YSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILL--DENYRAV-VSDFG 255
           YS    S  +R      + +AL Y H++    ++H DVKPEN+LL   EN   V + DFG
Sbjct: 127 YSEAVASHYMR-----QILEALRYCHDN---NIIHRDVKPENVLLASKENSAPVKLGDFG 178
Query: 256 LSKLMSRDQSRCITTIR-GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           ++  +   +S  +   R GT  ++APE +  +   +  D++  G++L  L  G
Sbjct: 179 VA--IQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 104/228 (45%), Gaps = 29/228 (12%)
Query: 108 LLGHGSSASVFKGILS--DGT--SVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVR 160
           +LG G   SV +  L   DG+   VAVK +  +    +  +EF  E A +    H ++ +
Sbjct: 30  MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 161 LLGYCV---------VPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYR 211
           L+G  +         +P     ++  F+++G L H     SR  E  ++   L      R
Sbjct: 90  LVGVSLRSRAKGRLPIP----MVILPFMKHGDL-HAFLLASRIGENPFN---LPLQTLVR 141
Query: 212 VAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS-KLMSRDQSRCITT 270
             +D+A  + YL +      +H D+   N +L E+    V+DFGLS K+ S D  R    
Sbjct: 142 FMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCA 198
Query: 271 IRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLE-LTGGRRNVSLIEHG 317
            +    +LA E + +   +   D++++G+ + E +T G+   + IE+ 
Sbjct: 199 SKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA 246

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 86/173 (49%), Gaps = 33/173 (19%)
Query: 219 ALSYLHNDCRSRVLHLDVKPENILL---DENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           A+ YLH +    ++H D+KPEN+LL   +E+    ++DFG SK++   ++  + T+ GT 
Sbjct: 251 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTP 305
Query: 276 GYLAPEWILE---QGVSEKCDIYSYGMVLLELTGG-------RRNVSLIEHGNDKSKNKW 325
            YLAPE ++     G +   D +S G++L     G       R  VSL    +  +  K+
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---KDQITSGKY 362
Query: 326 QYFPKI---VNEK-MKEGKLMEIVDQ--RLTDEGGI------DETQVRRLVDV 366
            + P++   V+EK +   K + +VD   R T E  +      DE   R+  D+
Sbjct: 363 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDL 415

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 72/152 (47%), Gaps = 22/152 (14%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRV--AIDVAKALSYLHNDCRSR 230
           + V E++  G L + I              C  +DL      A ++   L +LH+     
Sbjct: 94  FFVMEYLNGGDLMYHI------------QSCHKFDLSRATFYAAEIILGLQFLHS---KG 138
Query: 231 VLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSE 290
           +++ D+K +NILLD++    ++DFG+ K      ++      GT  Y+APE +L Q  + 
Sbjct: 139 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT-NXFCGTPDYIAPEILLGQKYNH 197
Query: 291 KCDIYSYGMVLLELTGGRRNVSLIEHGNDKSK 322
             D +S+G++L E+  G+       HG D+ +
Sbjct: 198 SVDWWSFGVLLYEMLIGQSPF----HGQDEEE 225

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 72/152 (47%), Gaps = 22/152 (14%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRV--AIDVAKALSYLHNDCRSR 230
           + V E++  G L + I              C  +DL      A ++   L +LH+     
Sbjct: 95  FFVMEYLNGGDLMYHI------------QSCHKFDLSRATFYAAEIILGLQFLHS---KG 139
Query: 231 VLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSE 290
           +++ D+K +NILLD++    ++DFG+ K      ++      GT  Y+APE +L Q  + 
Sbjct: 140 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT-NEFCGTPDYIAPEILLGQKYNH 198
Query: 291 KCDIYSYGMVLLELTGGRRNVSLIEHGNDKSK 322
             D +S+G++L E+  G+       HG D+ +
Sbjct: 199 SVDWWSFGVLLYEMLIGQSPF----HGQDEEE 226

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/138 (29%), Positives = 68/138 (49%), Gaps = 18/138 (13%)
Query: 212 VAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTI 271
           +AID    L Y+H D         +KP+N+LLD N    ++DFG    M+ D +   +  
Sbjct: 202 LAIDSIHQLHYVHRD---------IKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVA 252
Query: 272 RGTRGYLAPEWI--LEQGVSE---KCDIYSYGMVLLELTGGRRNV---SLIE-HGNDKSK 322
            GT  Y++PE +  +E G+ +   +CD +S G+ + E+  G       SL+E +G   + 
Sbjct: 253 VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 312
Query: 323 NKWQYFPKIVNEKMKEGK 340
            +   FP  V +  +E K
Sbjct: 313 EERFQFPSHVTDVSEEAK 330

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/138 (29%), Positives = 68/138 (49%), Gaps = 18/138 (13%)
Query: 212 VAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTI 271
           +AID    L Y+H D         +KP+N+LLD N    ++DFG    M+ D +   +  
Sbjct: 186 LAIDSIHQLHYVHRD---------IKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVA 236
Query: 272 RGTRGYLAPEWI--LEQGVSE---KCDIYSYGMVLLELTGGRRNV---SLIE-HGNDKSK 322
            GT  Y++PE +  +E G+ +   +CD +S G+ + E+  G       SL+E +G   + 
Sbjct: 237 VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 296
Query: 323 NKWQYFPKIVNEKMKEGK 340
            +   FP  V +  +E K
Sbjct: 297 EERFQFPSHVTDVSEEAK 314

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 21/216 (9%)
Query: 100 EATDNFQAL--LGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRS---EVAAIASA 153
           E  +NFQ +  +G G+   V+K      G  VA+K+I  +   E    +   E++ +   
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 66
Query: 154 QHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVA 213
            H N+V+LL   +      YLV+EF+     D   F  +    G      +   L     
Sbjct: 67  NHPNIVKLLD-VIHTENKLYLVFEFLHQ---DLKKFMDASALTG------IPLPLIKSYL 116
Query: 214 IDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRG 273
             + + L++ H+    RVLH D+KP+N+L++      ++DFGL++       R  T    
Sbjct: 117 FQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV 172
Query: 274 TRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           T  Y APE +L  +  S   DI+S G +  E+   R
Sbjct: 173 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 27/218 (12%)
Query: 101 ATDNFQAL--LGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRS---EVAAIASAQ 154
           + +NFQ +  +G G+   V+K      G  VA+K+I  +   E    +   E++ +    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI 214
           H N+V+LL   +      YLV+EF+     D   F  +    G      +   L      
Sbjct: 61  HPNIVKLLD-VIHTENKLYLVFEFLHQDLKD---FMDASALTG------IPLPLIKSYLF 110
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS---RDQSRCITTI 271
            + + L++ H+    RVLH D+KPEN+L++      ++DFGL++      R     + T+
Sbjct: 111 QLLQGLAFCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL 167
Query: 272 RGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
                Y APE +L  +  S   DI+S G +  E+   R
Sbjct: 168 ----WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 21/213 (9%)
Query: 103 DNFQAL--LGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRS---EVAAIASAQHV 156
           +NFQ +  +G G+   V+K      G  VA+K+I  +   E    +   E++ +    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 157 NLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDV 216
           N+V+LL   +      YLV+EF+     D   F  +    G      +   L       +
Sbjct: 63  NIVKLLD-VIHTENKLYLVFEFLHQ---DLKKFMDASALTG------IPLPLIKSYLFQL 112
Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG 276
            + L++ H+    RVLH D+KP+N+L++      ++DFGL++       R  T    T  
Sbjct: 113 LQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLW 168
Query: 277 YLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
           Y APE +L  +  S   DI+S G +  E+   R
Sbjct: 169 YRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 95/222 (42%), Gaps = 34/222 (15%)
Query: 102 TDNFQ--ALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRS--EVAAIASAQHV 156
           + +FQ  +LLG G+   V        G  VA+K+I   +      R+  E+  +   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 157 NLVRLLGY----CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRV 212
           N++ +               Y++ E +Q     H +  T   S+ H         ++Y +
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDL--HRVISTQMLSDDH---------IQYFI 118
Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD--------- 263
                +A+  LH    S V+H D+KP N+L++ N    V DFGL++++            
Sbjct: 119 -YQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 264 QSRCITTIRGTRGYLAPEWILEQG-VSEKCDIYSYGMVLLEL 304
           Q   +T    TR Y APE +L     S   D++S G +L EL
Sbjct: 175 QQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 104/242 (42%), Gaps = 55/242 (22%)
Query: 92  KFRSKELEEAT----DNFQALLGHGSSA-----SVFKGILSDGTSVAVKRIN----GEEN 138
           +F S E+ ++T      +Q L   GS A     + F  +L  G +VAVK+++     + +
Sbjct: 9   QFYSVEVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTH 66
Query: 139 GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPR------YLVYEFIQ-------NGSLD 185
            ++ +R E+  +    H N++ LL     P          YLV E +        +  LD
Sbjct: 67  AKRAYR-ELVLLKCVNHKNIISLLN-VFTPQKTLEEFQDVYLVMELMDANLCQVIHMELD 124
Query: 186 HWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDE 245
           H      R S   Y   C                + +LH+   + ++H D+KP NI++  
Sbjct: 125 H-----ERMSYLLYQMLC---------------GIKHLHS---AGIIHRDLKPSNIVVKS 161
Query: 246 NYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELT 305
           +    + DFGL++    +    +T    TR Y APE IL  G +   DI+S G ++ EL 
Sbjct: 162 DCTLKILDFGLARTACTN--FMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELV 219
Query: 306 GG 307
            G
Sbjct: 220 KG 221

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            + +LH+   + ++H D+KP NI++  +    + DFGL++  +   S  +T    TR Y 
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYR 192
Query: 279 APEWILEQGVSEKCDIYSYGMVLLELTGG 307
           APE IL  G  E  DI+S G+++ E+  G
Sbjct: 193 APEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 95/222 (42%), Gaps = 34/222 (15%)
Query: 102 TDNFQ--ALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRS--EVAAIASAQHV 156
           + +FQ  +LLG G+   V        G  VA+K+I   +      R+  E+  +   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 157 NLVRLLGY----CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRV 212
           N++ +               Y++ E +Q     H +  T   S+ H         ++Y +
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDL--HRVISTQMLSDDH---------IQYFI 118
Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD--------- 263
                +A+  LH    S V+H D+KP N+L++ N    V DFGL++++            
Sbjct: 119 -YQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 264 QSRCITTIRGTRGYLAPEWILEQG-VSEKCDIYSYGMVLLEL 304
           Q   +T    TR Y APE +L     S   D++S G +L EL
Sbjct: 175 QQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            + +LH+   + ++H D+KP NI++  +    + DFGL++  +   S  +T    TR Y 
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYR 192
Query: 279 APEWILEQGVSEKCDIYSYGMVLLELTGG 307
           APE IL  G  E  DI+S G+++ E+  G
Sbjct: 193 APEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 92/213 (43%), Gaps = 28/213 (13%)
Query: 107 ALLGHGSSASVFKGI-LSDGTSVAVKRIN-------GEENGEKEFRSEVAAI--ASAQHV 156
            LLG G   SV+ GI +SD   VA+K +        GE         EV  +   S+   
Sbjct: 10  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 157 NLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDV 216
            ++RLL +   P     L+ E  +    D + F T R        G L  +L       V
Sbjct: 70  GVIRLLDWFERPDS-FVLILERPEPVQ-DLFDFITER--------GALQEELARSFFWQV 119
Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSRDQSRCITTIRGTR 275
            +A+ + HN     VLH D+K ENIL+D N   + + DFG   L+   +    T   GTR
Sbjct: 120 LEAVRHCHN---XGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTR 173
Query: 276 GYLAPEWI-LEQGVSEKCDIYSYGMVLLELTGG 307
            Y  PEWI   +       ++S G++L ++  G
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 14/103 (13%)
Query: 211 RVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITT 270
           R  ++V  AL  L+      ++H D+KPENILLD++    ++DFG S  +  D    +  
Sbjct: 131 RALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLRE 182
Query: 271 IRGTRGYLAPEWIL------EQGVSEKCDIYSYGMVLLELTGG 307
           + GT  YLAPE I         G  ++ D++S G+++  L  G
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 29/208 (13%)
Query: 109 LGHGSSASV--FKGILSDGTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLL 162
           +G G+ A V   + IL+ G  VA+K I+  +    + +K FR EV  +    H N+V+L 
Sbjct: 23  IGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLF 80
Query: 163 GYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY 222
              +      YL+ E+   G +  ++    R  E            ++R    +  A+ Y
Sbjct: 81  E-VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS-------KFR---QIVSAVQY 129
Query: 223 LHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEW 282
            H   + R++H D+K EN+LLD +    ++DFG S   +      +    G   Y APE 
Sbjct: 130 CH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK--LDAFCGAPPYAAPE- 183
Query: 283 ILEQGVS---EKCDIYSYGMVLLELTGG 307
            L QG      + D++S G++L  L  G
Sbjct: 184 -LFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 29/208 (13%)
Query: 109 LGHGSSASV--FKGILSDGTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLL 162
           +G G+ A V   + IL+ G  VAV+ I+  +    + +K FR EV  +    H N+V+L 
Sbjct: 22  IGKGNFAKVKLARHILT-GKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLF 79
Query: 163 GYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY 222
              +      YLV E+   G +  ++    R  E            ++R    +  A+ Y
Sbjct: 80  E-VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA-------KFR---QIVSAVQY 128
Query: 223 LHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEW 282
            H   +  ++H D+K EN+LLD +    ++DFG S   +      + T  G+  Y APE 
Sbjct: 129 CH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LDTFCGSPPYAAPE- 182
Query: 283 ILEQGVS---EKCDIYSYGMVLLELTGG 307
            L QG      + D++S G++L  L  G
Sbjct: 183 -LFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 93/209 (44%), Gaps = 22/209 (10%)
Query: 109 LGHGSSASVFKGIL---SDGTSVAVKRI-NGEENGE-KEFRSEVAAIASAQHVNLVRLLG 163
           LG G+  SV +G+         VA+K +  G E  + +E   E   +    +  +VRL+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL 223
            C        LV E    G L    F   +R E   S      +L ++V++     + YL
Sbjct: 78  VCQAEA--LMLVMEMAGGGPLHK--FLVGKREEIPVSNVA---ELLHQVSM----GMKYL 126
Query: 224 HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRG--TRGYLAPE 281
                   +H D+   N+LL   + A +SDFGLSK +  D S       G     + APE
Sbjct: 127 EE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 183
Query: 282 WILEQGVSEKCDIYSYGMVLLE-LTGGRR 309
            I  +  S + D++SYG+ + E L+ G++
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALSYGQK 212

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 14/103 (13%)
Query: 211 RVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITT 270
           R  ++V  AL  L+      ++H D+KPENILLD++    ++DFG S  +  D    +  
Sbjct: 118 RALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLRE 169
Query: 271 IRGTRGYLAPEWIL------EQGVSEKCDIYSYGMVLLELTGG 307
           + GT  YLAPE I         G  ++ D++S G+++  L  G
Sbjct: 170 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 21/215 (9%)
Query: 101 ATDNFQAL--LGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRS---EVAAIASAQ 154
           + +NFQ +  +G G+   V+K      G  VA+K+I  +   E    +   E++ +    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI 214
           H N+V+LL   +      YLV+EF+     D   F  +    G      +   L      
Sbjct: 62  HPNIVKLLD-VIHTENKLYLVFEFLHQ---DLKKFMDASALTG------IPLPLIKSYLF 111
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGT 274
            + + L++ H+    RVLH D+KP+N+L++      ++DFGL++       R  T    T
Sbjct: 112 QLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVT 167
Query: 275 RGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
             Y APE +L  +  S   DI+S G +  E+   R
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 21/213 (9%)
Query: 103 DNFQAL--LGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRS---EVAAIASAQHV 156
           +NFQ +  +G G+   V+K      G  VA+K+I  +   E    +   E++ +    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 157 NLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDV 216
           N+V+LL   +      YLV+EF+     D   F  +    G      +   L       +
Sbjct: 63  NIVKLLD-VIHTENKLYLVFEFLHQ---DLKKFMDASALTG------IPLPLIKSYLFQL 112
Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG 276
            + L++ H+    RVLH D+KP+N+L++      ++DFGL++       R  T    T  
Sbjct: 113 LQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLW 168
Query: 277 YLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           Y APE +L  +  S   DI+S G +  E+   R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 92/213 (43%), Gaps = 28/213 (13%)
Query: 107 ALLGHGSSASVFKGI-LSDGTSVAVKRIN-------GEENGEKEFRSEVAAI--ASAQHV 156
            LLG G   SV+ GI +SD   VA+K +        GE         EV  +   S+   
Sbjct: 10  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 157 NLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDV 216
            ++RLL +   P     L+ E  +    D + F T R        G L  +L       V
Sbjct: 70  GVIRLLDWFERPDS-FVLILERPEPVQ-DLFDFITER--------GALQEELARSFFWQV 119
Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSRDQSRCITTIRGTR 275
            +A+ + HN     VLH D+K ENIL+D N   + + DFG   L+   +    T   GTR
Sbjct: 120 LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTR 173
Query: 276 GYLAPEWI-LEQGVSEKCDIYSYGMVLLELTGG 307
            Y  PEWI   +       ++S G++L ++  G
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 21/213 (9%)
Query: 103 DNFQAL--LGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRS---EVAAIASAQHV 156
           +NFQ +  +G G+   V+K      G  VA+K+I  +   E    +   E++ +    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 157 NLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDV 216
           N+V+LL   +      YLV+EF+     D   F  +    G      +   L       +
Sbjct: 62  NIVKLLD-VIHTENKLYLVFEFLHQ---DLKKFMDASALTG------IPLPLIKSYLFQL 111
Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG 276
            + L++ H+    RVLH D+KP+N+L++      ++DFGL++       R  T    T  
Sbjct: 112 LQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLW 167
Query: 277 YLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           Y APE +L  +  S   DI+S G +  E+   R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 97/222 (43%), Gaps = 33/222 (14%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           +G G    V+ G    G  VAVK     E       +E+      +H N++  +   +  
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKG 103
Query: 169 GGP---RYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
            G     YL+ ++ +NGSL  ++  T+  ++              ++A      L +LH 
Sbjct: 104 TGSWTQLYLITDYHENGSLYDYLKSTTLDAKS-----------MLKLAYSSVSGLCHLHT 152
Query: 226 DC-----RSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC---ITTIRGTRGY 277
           +      +  + H D+K +NIL+ +N    ++D GL+     D +       T  GT+ Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 278 LAPEWILEQGVSEK-------CDIYSYGMVLLELTGGRRNVS 312
           + PE +L++ ++          D+YS+G++L E+   RR VS
Sbjct: 213 MPPE-VLDESLNRNHFQSYIMADMYSFGLILWEV--ARRCVS 251

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 56/116 (48%), Gaps = 26/116 (22%)
Query: 211 RVAIDVAKALSYLHNDCRSRVLHLDVKPENILL---------------DE----NYRAVV 251
           ++A  + K++++LH++   ++ H D+KPENIL                DE    N    V
Sbjct: 122 KMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178
Query: 252 SDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
            DFG +       S    T+   R Y APE IL  G S+ CD++S G +L+E   G
Sbjct: 179 VDFGSATYDDEHHS----TLVXXRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 92/213 (43%), Gaps = 28/213 (13%)
Query: 107 ALLGHGSSASVFKGI-LSDGTSVAVKRIN-------GEENGEKEFRSEVAAI--ASAQHV 156
            LLG G   SV+ GI +SD   VA+K +        GE         EV  +   S+   
Sbjct: 10  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 157 NLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDV 216
            ++RLL +   P     L+ E  +    D + F T R        G L  +L       V
Sbjct: 70  GVIRLLDWFERPDS-FVLILERPEPVQ-DLFDFITER--------GALQEELARSFFWQV 119
Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSRDQSRCITTIRGTR 275
            +A+ + HN     VLH D+K ENIL+D N   + + DFG   L+   +    T   GTR
Sbjct: 120 LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTR 173
Query: 276 GYLAPEWI-LEQGVSEKCDIYSYGMVLLELTGG 307
            Y  PEWI   +       ++S G++L ++  G
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 21/213 (9%)
Query: 103 DNFQAL--LGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRS---EVAAIASAQHV 156
           +NFQ +  +G G+   V+K      G  VA+K+I  +   E    +   E++ +    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 157 NLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDV 216
           N+V+LL   +      YLV+EF+     D   F  +    G      +   L       +
Sbjct: 62  NIVKLLD-VIHTENKLYLVFEFLHQ---DLKKFMDASALTG------IPLPLIKSYLFQL 111
Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG 276
            + L++ H+    RVLH D+KP+N+L++      ++DFGL++       R  T    T  
Sbjct: 112 LQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLW 167
Query: 277 YLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           Y APE +L  +  S   DI+S G +  E+   R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 21/213 (9%)
Query: 103 DNFQAL--LGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRS---EVAAIASAQHV 156
           +NFQ +  +G G+   V+K      G  VA+K+I  +   E    +   E++ +    H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 157 NLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDV 216
           N+V+LL   +      YLV+EF+     D   F  +    G      +   L       +
Sbjct: 67  NIVKLLD-VIHTENKLYLVFEFLHQ---DLKKFMDASALTG------IPLPLIKSYLFQL 116
Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG 276
            + L++ H+    RVLH D+KP+N+L++      ++DFGL++       R  T    T  
Sbjct: 117 LQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLW 172
Query: 277 YLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           Y APE +L  +  S   DI+S G +  E+   R
Sbjct: 173 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 21/213 (9%)
Query: 103 DNFQAL--LGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRS---EVAAIASAQHV 156
           +NFQ +  +G G+   V+K      G  VA+K+I  +   E    +   E++ +    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 157 NLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDV 216
           N+V+LL   +      YLV+EF+     D   F  +    G      +   L       +
Sbjct: 63  NIVKLLD-VIHTENKLYLVFEFLHQ---DLKKFMDASALTG------IPLPLIKSYLFQL 112
Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG 276
            + L++ H+    RVLH D+KP+N+L++      ++DFGL++       R  T    T  
Sbjct: 113 LQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLW 168
Query: 277 YLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           Y APE +L  +  S   DI+S G +  E+   R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 27/218 (12%)
Query: 101 ATDNFQAL--LGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRS---EVAAIASAQ 154
           + +NFQ +  +G G+   V+K      G  VA+K+I  +   E    +   E++ +    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI 214
           H N+V+LL   +      YLV+EF+   S+D   F  +    G      +   L      
Sbjct: 63  HPNIVKLLD-VIHTENKLYLVFEFL---SMDLKDFMDASALTG------IPLPLIKSYLF 112
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS---RDQSRCITTI 271
            + + L++ H+    RVLH D+KP+N+L++      ++DFGL++      R     + T+
Sbjct: 113 QLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL 169
Query: 272 RGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
                Y APE +L  +  S   DI+S G +  E+   R
Sbjct: 170 ----WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 51/99 (51%), Gaps = 10/99 (10%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDEN--YRAVVSDFGLSK---LMSRDQSRCITT 270
           +  AL YLHN     + H D+KPEN L   N  +   + DFGLSK    ++  +   +TT
Sbjct: 177 IFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT 233
Query: 271 IRGTRGYLAPEWI--LEQGVSEKCDIYSYGMVLLELTGG 307
             GT  ++APE +    +    KCD +S G++L  L  G
Sbjct: 234 KAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMG 272

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/100 (37%), Positives = 56/100 (56%), Gaps = 9/100 (9%)
Query: 212 VAIDVAKALSYLHNDCRSRVLHLDVKPENIL-LDE--NYRAV-VSDFGLSKLMSRDQSRC 267
           V   + K + YLH      V+H D+KP NIL +DE  N  ++ + DFG +K + R ++  
Sbjct: 121 VLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL-RAENGL 176
Query: 268 ITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLE-LTG 306
           + T   T  ++APE +  QG    CDI+S G++L   LTG
Sbjct: 177 LXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 51/94 (54%), Gaps = 4/94 (4%)
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGT 274
           ++  AL YLH+     V++ D+K EN++LD++    ++DFGL K    D +  +    GT
Sbjct: 113 EIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKXFCGT 168
Query: 275 RGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
             YLAPE + +       D +  G+V+ E+  GR
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 51/94 (54%), Gaps = 4/94 (4%)
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGT 274
           ++  AL YLH+     V++ D+K EN++LD++    ++DFGL K    D +  +    GT
Sbjct: 118 EIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKXFCGT 173
Query: 275 RGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
             YLAPE + +       D +  G+V+ E+  GR
Sbjct: 174 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 27/218 (12%)
Query: 101 ATDNFQAL--LGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRS---EVAAIASAQ 154
           + +NFQ +  +G G+   V+K      G  VA+K+I  +   E    +   E++ +    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI 214
           H N+V+LL   +      YLV+EF+   S+D   F  +    G      +   L      
Sbjct: 64  HPNIVKLLD-VIHTENKLYLVFEFL---SMDLKDFMDASALTG------IPLPLIKSYLF 113
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS---RDQSRCITTI 271
            + + L++ H+    RVLH D+KP+N+L++      ++DFGL++      R     + T+
Sbjct: 114 QLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL 170
Query: 272 RGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
                Y APE +L  +  S   DI+S G +  E+   R
Sbjct: 171 ----WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 58/129 (44%), Gaps = 32/129 (24%)
Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENY--RAVVS------------------ 252
            I++ KAL+YL    +  + H D+KPENILLD+ Y  +++++                  
Sbjct: 143 CIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199
Query: 253 -----DFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
                DFG +   S        +I  TR Y APE IL  G     D++S+G VL EL  G
Sbjct: 200 GIKLIDFGCATFKSDYHG----SIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255
Query: 308 RRNVSLIEH 316
                  EH
Sbjct: 256 SLLFRTHEH 264

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 65/138 (47%), Gaps = 18/138 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y V E++  G L + I    +  E                A +++  L +LH   +  ++
Sbjct: 96  YFVMEYVNGGDLMYHIQQVGKFKEPQ----------AVFYAAEISIGLFFLH---KRGII 142
Query: 233 HLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITT--IRGTRGYLAPEWILEQGVSE 290
           + D+K +N++LD      ++DFG+ K    D    +TT    GT  Y+APE I  Q   +
Sbjct: 143 YRDLKLDNVMLDSEGHIKIADFGMCKEHMMDG---VTTREFCGTPDYIAPEIIAYQPYGK 199
Query: 291 KCDIYSYGMVLLELTGGR 308
             D ++YG++L E+  G+
Sbjct: 200 SVDWWAYGVLLYEMLAGQ 217

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 101/230 (43%), Gaps = 25/230 (10%)
Query: 83  LRKVAGVPIKFRSKELEEATDNFQALLGHGSSASVF-KGILSDGTS--VAVKRINGEENG 139
           L +  G P  F  + L++  D  +   GH    S++     +DGT   VAVK +  +   
Sbjct: 18  LFQGPGDPTVFHKRYLKKIRDLGE---GHFGKVSLYCYDPTNDGTGEMVAVKALKADAGP 74
Query: 140 EKE--FRSEVAAIASAQHVNLVRLLGYCVVPGGPRY-LVYEFIQNGSLDHWIFPTSRRSE 196
           +    ++ E+  + +  H ++++  G C   G     LV E++  GSL  ++    R S 
Sbjct: 75  QHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSI 131
Query: 197 GHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL 256
           G      L+  L +  A  + + ++YLH       +H D+   N+LLD +    + DFGL
Sbjct: 132 G------LAQLLLF--AQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGL 180
Query: 257 SKLMSRDQSRCITTIRGTRG--YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +K +            G     + APE + E       D++S+G+ L EL
Sbjct: 181 AKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 230

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/318 (22%), Positives = 129/318 (40%), Gaps = 71/318 (22%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEK---EFRSEVAAIASAQHVN--LVRLLG 163
           +G G S+ VF+ +       A+K +N EE   +    +R+E+A +   Q  +  ++RL  
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY- 222
           Y +        +Y  ++ G++D                   SW L+ + +ID  +  SY 
Sbjct: 96  YEIT----DQYIYMVMECGNID-----------------LNSW-LKKKKSIDPWERKSYW 133
Query: 223 ------LHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR-GTR 275
                 +H   +  ++H D+KP N L+ +    ++ DFG++  M  D +  +   + GT 
Sbjct: 134 KNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTV 192
Query: 276 GYLAPEWILEQGVSEK-----------CDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNK 324
            Y+ PE I +   S +            D++S G +L  +T G+                
Sbjct: 193 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-------------- 238
Query: 325 WQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARV 384
              F +I+N+     KL  I+D     E    +   + L DV   C++   + R S+  +
Sbjct: 239 ---FQQIINQI---SKLHAIIDP--NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290
Query: 385 VEMLEGRVAVDDPPDTQM 402
             +    V +   P  QM
Sbjct: 291 --LAHPYVQIQTHPVNQM 306

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 51/94 (54%), Gaps = 4/94 (4%)
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGT 274
           ++  AL YLH+     V++ D+K EN++LD++    ++DFGL K    D +  +    GT
Sbjct: 113 EIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKXFCGT 168
Query: 275 RGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
             YLAPE + +       D +  G+V+ E+  GR
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 51/94 (54%), Gaps = 4/94 (4%)
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGT 274
           ++  AL YLH+     V++ D+K EN++LD++    ++DFGL K    D +  +    GT
Sbjct: 113 EIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKXFCGT 168
Query: 275 RGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
             YLAPE + +       D +  G+V+ E+  GR
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 106/246 (43%), Gaps = 39/246 (15%)
Query: 103 DNFQAL--LGHGSSASVFKG-ILSDGTSVAVKRING----EENGEKEFRSEVAAIASAQH 155
           DNF+ +  LG GS   V    +   G   AVK +      +++  +   +E   ++ A++
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRV-AI 214
              +  L  C       + V EF+  G L   I  + R  E            R R  A 
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA-----------RARFYAA 131
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC----ITT 270
           ++  AL +LH+     +++ D+K +N+LLD      ++DFG+ K     +  C      T
Sbjct: 132 EIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK-----EGICNGVTTAT 183
Query: 271 IRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPK 330
             GT  Y+APE + E       D ++ G++L E+  G        H   +++N+   F  
Sbjct: 184 FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG--------HAPFEAENEDDLFEA 235
Query: 331 IVNEKM 336
           I+N+++
Sbjct: 236 ILNDEV 241

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 50/97 (51%), Gaps = 7/97 (7%)
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGT 274
           +V  AL  +H+     ++H DVKP+N+LLD++    ++DFG    M         T  GT
Sbjct: 182 EVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGT 238
Query: 275 RGYLAPEWILEQG----VSEKCDIYSYGMVLLELTGG 307
             Y++PE +  QG       +CD +S G+ L E+  G
Sbjct: 239 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 27/218 (12%)
Query: 101 ATDNFQAL--LGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRS---EVAAIASAQ 154
           + +NFQ +  +G G+   V+K      G  VA+K+I  +   E    +   E++ +    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI 214
           H N+V+LL   +      YLV+EF+     D   F  +    G      +   L      
Sbjct: 62  HPNIVKLLD-VIHTENKLYLVFEFLHQ---DLKKFMDASALTG------IPLPLIKSYLF 111
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS---RDQSRCITTI 271
            + + L++ H+    RVLH D+KPEN+L++      ++DFGL++      R     + T+
Sbjct: 112 QLLQGLAFCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL 168
Query: 272 RGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
                Y APE +L  +  S   DI+S G +  E+   R
Sbjct: 169 ----WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 92/209 (44%), Gaps = 34/209 (16%)
Query: 109 LGHGSSASVFKGIL----SDGTSVAVKRING--EENGEKEFRSEVAAIASAQHVNLVRLL 162
           +G G    V +GI     +   +VA+K       ++  ++F  E   +    H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 163 GYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRV--AIDVAKAL 220
           G  V+   P +++ E    G L    F   R+          S DL   +  A  ++ AL
Sbjct: 78  G--VITENPVWIIMELCTLGELRS--FLQVRK---------FSLDLASLILYAYQLSTAL 124
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAP 280
           +YL +    R +H D+   N+L+  N    + DFGLS+ M        T  + ++G L  
Sbjct: 125 AYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-----TXXKASKGKLPI 176
Query: 281 EWILEQGV-----SEKCDIYSYGMVLLEL 304
           +W+  + +     +   D++ +G+ + E+
Sbjct: 177 KWMAPESINFRRFTSASDVWMFGVCMWEI 205

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 90/188 (47%), Gaps = 37/188 (19%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI-DVAKALSYLHNDCRSRV 231
           YLV+E ++ GS+   I    RR   H++      +L   V + DVA AL +LHN     +
Sbjct: 87  YLVFEKMRGGSILSHIH--KRR---HFN------ELEASVVVQDVASALDFLHN---KGI 132
Query: 232 LHLDVKPENILLDENYRAV---VSDFGLSK--LMSRDQSRCIT----TIRGTRGYLAPEW 282
            H D+KPENIL +   +     + DFGL     ++ D S   T    T  G+  Y+APE 
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192
Query: 283 ILEQGVSE-------KCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVN-- 333
           +  +  SE       +CD++S G++L  L  G     +   G+D   ++ +  P   N  
Sbjct: 193 V--EAFSEEASIYDKRCDLWSLGVILYILLSGYPPF-VGRCGSDCGWDRGEACPACQNML 249
Query: 334 -EKMKEGK 340
            E ++EGK
Sbjct: 250 FESIQEGK 257

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/318 (22%), Positives = 129/318 (40%), Gaps = 71/318 (22%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEK---EFRSEVAAIASAQHVN--LVRLLG 163
           +G G S+ VF+ +       A+K +N EE   +    +R+E+A +   Q  +  ++RL  
Sbjct: 17  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY- 222
           Y +        +Y  ++ G++D                   SW L+ + +ID  +  SY 
Sbjct: 77  YEIT----DQYIYMVMECGNID-----------------LNSW-LKKKKSIDPWERKSYW 114
Query: 223 ------LHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR-GTR 275
                 +H   +  ++H D+KP N L+ +    ++ DFG++  M  D +  +   + GT 
Sbjct: 115 KNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTV 173
Query: 276 GYLAPEWILEQGVSEK-----------CDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNK 324
            Y+ PE I +   S +            D++S G +L  +T G+                
Sbjct: 174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-------------- 219
Query: 325 WQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARV 384
              F +I+N+     KL  I+D     E    +   + L DV   C++   + R S+  +
Sbjct: 220 ---FQQIINQI---SKLHAIIDP--NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271
Query: 385 VEMLEGRVAVDDPPDTQM 402
             +    V +   P  QM
Sbjct: 272 --LAHPYVQIQTHPVNQM 287

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 5/89 (5%)
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            + +LH+   + ++H D+KP NI++  +    + DFGL++  +   S  +T    TR Y 
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYR 192
Query: 279 APEWILEQGVSEKCDIYSYGMVLLELTGG 307
           APE IL  G  E  DI+S G ++ E+  G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 5/89 (5%)
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            + +LH+   + ++H D+KP NI++  +    + DFGL++  +   S  +T    TR Y 
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYR 192
Query: 279 APEWILEQGVSEKCDIYSYGMVLLELTGG 307
           APE IL  G  E  DI+S G ++ E+  G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 53/96 (55%), Gaps = 7/96 (7%)
Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM---SRDQSRCITTIRGT 274
           + L Y+H+   ++V+H D+KP N+L++EN    + DFG+++ +     +    +T    T
Sbjct: 170 RGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 226
Query: 275 RGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRR 309
           R Y APE +L     ++  D++S G +  E+   R+
Sbjct: 227 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 5/89 (5%)
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            + +LH+   + ++H D+KP NI++  +    + DFGL++  +   S  +T    TR Y 
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYR 192
Query: 279 APEWILEQGVSEKCDIYSYGMVLLELTGG 307
           APE IL  G  E  DI+S G ++ E+  G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 27/218 (12%)
Query: 101 ATDNFQAL--LGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRS---EVAAIASAQ 154
           + +NFQ +  +G G+   V+K      G  VA+K+I  +   E    +   E++ +    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI 214
           H N+V+LL   +      YLV+EF+     D   F  +    G      +   L      
Sbjct: 63  HPNIVKLLD-VIHTENKLYLVFEFLHQ---DLKKFMDASALTG------IPLPLIKSYLF 112
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS---RDQSRCITTI 271
            + + L++ H+    RVLH D+KPEN+L++      ++DFGL++      R     + T+
Sbjct: 113 QLLQGLAFCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL 169
Query: 272 RGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
                Y APE +L  +  S   DI+S G +  E+   R
Sbjct: 170 ----WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/318 (22%), Positives = 129/318 (40%), Gaps = 71/318 (22%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEK---EFRSEVAAIASAQHVN--LVRLLG 163
           +G G S+ VF+ +       A+K +N EE   +    +R+E+A +   Q  +  ++RL  
Sbjct: 20  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 79
Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY- 222
           Y +        +Y  ++ G++D                   SW L+ + +ID  +  SY 
Sbjct: 80  YEIT----DQYIYMVMECGNID-----------------LNSW-LKKKKSIDPWERKSYW 117
Query: 223 ------LHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR-GTR 275
                 +H   +  ++H D+KP N L+ +    ++ DFG++  M  D +  +   + GT 
Sbjct: 118 KNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTV 176
Query: 276 GYLAPEWILEQGVSEK-----------CDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNK 324
            Y+ PE I +   S +            D++S G +L  +T G+                
Sbjct: 177 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-------------- 222
Query: 325 WQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARV 384
              F +I+N+     KL  I+D     E    +   + L DV   C++   + R S+  +
Sbjct: 223 ---FQQIINQI---SKLHAIIDP--NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 274
Query: 385 VEMLEGRVAVDDPPDTQM 402
             +    V +   P  QM
Sbjct: 275 --LAHPYVQIQTHPVNQM 290

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 52/98 (53%), Gaps = 13/98 (13%)
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVV---SDFGLSKLMSRD--QSRCIT 269
           D+  A+ +LH+     + H DVKPEN+L     +  V   +DFG +K  +++  Q+ C T
Sbjct: 136 DIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYT 192
Query: 270 TIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
                  Y+APE +  +   + CD++S G+++  L  G
Sbjct: 193 PY-----YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 53/96 (55%), Gaps = 7/96 (7%)
Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM---SRDQSRCITTIRGT 274
           + L Y+H+   ++V+H D+KP N+L++EN    + DFG+++ +     +    +T    T
Sbjct: 169 RGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 225
Query: 275 RGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRR 309
           R Y APE +L     ++  D++S G +  E+   R+
Sbjct: 226 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 52/98 (53%), Gaps = 13/98 (13%)
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVV---SDFGLSKLMSRD--QSRCIT 269
           D+  A+ +LH+     + H DVKPEN+L     +  V   +DFG +K  +++  Q+ C T
Sbjct: 117 DIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYT 173
Query: 270 TIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
                  Y+APE +  +   + CD++S G+++  L  G
Sbjct: 174 PY-----YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 206

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 54/106 (50%), Gaps = 9/106 (8%)
Query: 204 LSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVS--DFGLSKLMS 261
            S  L  + A  + + L  LH   ++R++H D+KPENILL +  R+ +   DFG S    
Sbjct: 197 FSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---C 250
Query: 262 RDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
            +  R    I+ +R Y APE IL        D++S G +L EL  G
Sbjct: 251 YEHQRVYXXIQ-SRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 65/138 (47%), Gaps = 18/138 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y V E++  G L + I    R  E H              A ++A  L +L +     ++
Sbjct: 97  YFVMEYVNGGDLMYHIQQVGRFKEPH----------AVFYAAEIAIGLFFLQS---KGII 143
Query: 233 HLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITT--IRGTRGYLAPEWILEQGVSE 290
           + D+K +N++LD      ++DFG+ K    D    +TT    GT  Y+APE I  Q   +
Sbjct: 144 YRDLKLDNVMLDSEGHIKIADFGMCKENIWDG---VTTKXFCGTPDYIAPEIIAYQPYGK 200
Query: 291 KCDIYSYGMVLLELTGGR 308
             D +++G++L E+  G+
Sbjct: 201 SVDWWAFGVLLYEMLAGQ 218

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 94/222 (42%), Gaps = 34/222 (15%)
Query: 102 TDNFQ--ALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRS--EVAAIASAQHV 156
           + +FQ  +LLG G+   V        G  VA+K+I   +      R+  E+  +   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69
Query: 157 NLVRLLGY----CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRV 212
           N++ +               Y++ E +Q     H +  T   S+ H         ++Y +
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDL--HRVISTQMLSDDH---------IQYFI 118
Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD--------- 263
                +A+  LH    S V+H D+KP N+L++ N    V DFGL++++            
Sbjct: 119 -YQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 264 QSRCITTIRGTRGYLAPEWILEQG-VSEKCDIYSYGMVLLEL 304
           Q   +     TR Y APE +L     S   D++S G +L EL
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 71/319 (22%), Positives = 130/319 (40%), Gaps = 71/319 (22%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEK---EFRSEVAAIAS-AQHVN-LVRLLG 163
           +G G S+ VF+ +       A+K +N EE   +    +R+E+A +    QH + ++RL  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY- 222
           Y +        +Y  ++ G++D                   SW L+ + +ID  +  SY 
Sbjct: 124 YEIT----DQYIYMVMECGNID-----------------LNSW-LKKKKSIDPWERKSYW 161
Query: 223 ------LHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR-GTR 275
                 +H   +  ++H D+KP N L+ +    ++ DFG++  M  D +  +   + GT 
Sbjct: 162 KNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTV 220
Query: 276 GYLAPEWILEQGVSEK-----------CDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNK 324
            Y+ PE I +   S +            D++S G +L  +T G+                
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-------------- 266
Query: 325 WQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARV 384
              F +I+N+     KL  I+D     E    +   + L DV   C++   + R S+  +
Sbjct: 267 ---FQQIINQI---SKLHAIIDP--NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318
Query: 385 VEMLEGRVAVDDPPDTQMV 403
             +    V +   P  QM 
Sbjct: 319 --LAHPYVQIQTHPVNQMA 335

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 29/208 (13%)
Query: 109 LGHGSSASV--FKGILSDGTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLL 162
           +G G+ A V   + IL+ G  VAVK I+  +    + +K FR EV  +    H N+V+L 
Sbjct: 22  IGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLF 79
Query: 163 GYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY 222
              +      YLV E+   G +  ++    R  E            ++R    +  A+ Y
Sbjct: 80  E-VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA-------KFR---QIVSAVQY 128
Query: 223 LHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEW 282
            H   +  ++H D+K EN+LLD +    ++DFG S   +      +    G   Y APE 
Sbjct: 129 CH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LDAFCGAPPYAAPE- 182
Query: 283 ILEQGVS---EKCDIYSYGMVLLELTGG 307
            L QG      + D++S G++L  L  G
Sbjct: 183 -LFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/318 (22%), Positives = 129/318 (40%), Gaps = 71/318 (22%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEK---EFRSEVAAIASAQHVN--LVRLLG 163
           +G G S+ VF+ +       A+K +N EE   +    +R+E+A +   Q  +  ++RL  
Sbjct: 16  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 75
Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY- 222
           Y +        +Y  ++ G++D                   SW L+ + +ID  +  SY 
Sbjct: 76  YEIT----DQYIYMVMECGNID-----------------LNSW-LKKKKSIDPWERKSYW 113
Query: 223 ------LHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR-GTR 275
                 +H   +  ++H D+KP N L+ +    ++ DFG++  M  D +  +   + GT 
Sbjct: 114 KNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTV 172
Query: 276 GYLAPEWILEQGVSEK-----------CDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNK 324
            Y+ PE I +   S +            D++S G +L  +T G+                
Sbjct: 173 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-------------- 218
Query: 325 WQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARV 384
              F +I+N+     KL  I+D     E    +   + L DV   C++   + R S+  +
Sbjct: 219 ---FQQIINQI---SKLHAIIDP--NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 270
Query: 385 VEMLEGRVAVDDPPDTQM 402
             +    V +   P  QM
Sbjct: 271 --LAHPYVQIQTHPVNQM 286

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 99/224 (44%), Gaps = 47/224 (20%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEK---EFRSEVAAIAS-AQHVN-LVRLLG 163
           +G G S+ VF+ +       A+K +N EE   +    +R+E+A +    QH + ++RL  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY- 222
           Y +        +Y  ++ G++D                   SW L+ + +ID  +  SY 
Sbjct: 124 YEIT----DQYIYMVMECGNID-----------------LNSW-LKKKKSIDPWERKSYW 161
Query: 223 ------LHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR-GTR 275
                 +H   +  ++H D+KP N L+ +    ++ DFG++  M  D +  +   + GT 
Sbjct: 162 KNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTV 220
Query: 276 GYLAPEWILEQGVSEK-----------CDIYSYGMVLLELTGGR 308
            Y+ PE I +   S +            D++S G +L  +T G+
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 27/218 (12%)
Query: 101 ATDNFQAL--LGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRS---EVAAIASAQ 154
           + +NFQ +  +G G+   V+K      G  VA+K+I  +   E    +   E++ +    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI 214
           H N+V+LL   +      YLV+EF+     D   F  +    G      +   L      
Sbjct: 64  HPNIVKLLD-VIHTENKLYLVFEFLHQ---DLKTFMDASALTG------IPLPLIKSYLF 113
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS---RDQSRCITTI 271
            + + L++ H+    RVLH D+KP+N+L++      ++DFGL++      R     + T+
Sbjct: 114 QLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL 170
Query: 272 RGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
                Y APE +L  +  S   DI+S G +  E+   R
Sbjct: 171 ----WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 65/138 (47%), Gaps = 18/138 (13%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y V E++  G L + I    R  E H              A ++A  L +L +     ++
Sbjct: 418 YFVMEYVNGGDLMYHIQQVGRFKEPH----------AVFYAAEIAIGLFFLQS---KGII 464
Query: 233 HLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITT--IRGTRGYLAPEWILEQGVSE 290
           + D+K +N++LD      ++DFG+ K    D    +TT    GT  Y+APE I  Q   +
Sbjct: 465 YRDLKLDNVMLDSEGHIKIADFGMCKENIWDG---VTTKXFCGTPDYIAPEIIAYQPYGK 521
Query: 291 KCDIYSYGMVLLELTGGR 308
             D +++G++L E+  G+
Sbjct: 522 SVDWWAFGVLLYEMLAGQ 539

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 22/205 (10%)
Query: 109 LGHGSSASVFKGILSD-GTSVAVKRINGEENG---EKEFRSEVAAIASAQHVNLVRLLGY 164
           +G GS   VFK    D G  VA+K+    E+    +K    E+  +   +H NLV LL  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE- 69
Query: 165 CVVPGGPR-YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL 223
            V     R +LV+E+      DH +     R    Y  G +   L   +     +A+++ 
Sbjct: 70  -VFRRKRRLHLVFEYC-----DHTVLHELDR----YQRG-VPEHLVKSITWQTLQAVNFC 118
Query: 224 HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWI 283
           H   +   +H DVKPENIL+ ++    + DFG ++L++         +  TR Y +PE +
Sbjct: 119 H---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV-ATRWYRSPELL 174
Query: 284 L-EQGVSEKCDIYSYGMVLLELTGG 307
           + +       D+++ G V  EL  G
Sbjct: 175 VGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 5/89 (5%)
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            + +LH+   + ++H D+KP NI++  +    + DFGL++  +   S  +T    TR Y 
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 192
Query: 279 APEWILEQGVSEKCDIYSYGMVLLELTGG 307
           APE IL  G  E  DI+S G ++ E+  G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 5/89 (5%)
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            + +LH+   + ++H D+KP NI++  +    + DFGL++  +   S  +T    TR Y 
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 192
Query: 279 APEWILEQGVSEKCDIYSYGMVLLELTGG 307
           APE IL  G  E  DI+S G ++ E+  G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 5/89 (5%)
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            + +LH+   + ++H D+KP NI++  +    + DFGL++  +   S  +T    TR Y 
Sbjct: 139 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 193
Query: 279 APEWILEQGVSEKCDIYSYGMVLLELTGG 307
           APE IL  G  E  DI+S G ++ E+  G
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGL----ARHTDDEMTGYVATR 186
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 139 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGL----ARHTDDEMTGYVATR 191
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 192 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 29/208 (13%)
Query: 109 LGHGSSASV--FKGILSDGTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLL 162
           +G G+ A V   + IL+ G  VAVK I+  +    + +K FR EV  +    H N+V+L 
Sbjct: 15  IGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLF 72
Query: 163 GYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY 222
              +      YLV E+   G +  ++       E            ++R    +  A+ Y
Sbjct: 73  E-VIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARA-------KFR---QIVSAVQY 121
Query: 223 LHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEW 282
            H   +  ++H D+K EN+LLD +    ++DFG S   +      + T  G+  Y APE 
Sbjct: 122 CH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LDTFCGSPPYAAPE- 175
Query: 283 ILEQGVS---EKCDIYSYGMVLLELTGG 307
            L QG      + D++S G++L  L  G
Sbjct: 176 -LFQGKKYDGPEVDVWSLGVILYTLVSG 202

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 145 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGL----ARHTDDEMTGYVATR 197
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 198 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R  +  +T    TR
Sbjct: 141 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTADEMTGYVATR 193
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 5/89 (5%)
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            + +LH+   + ++H D+KP NI++  +    + DFGL++  +   S  +T    TR Y 
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 192
Query: 279 APEWILEQGVSEKCDIYSYGMVLLELTGG 307
           APE IL  G  E  DI+S G ++ E+  G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 139 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGL----ARHTDDEMTGYVATR 191
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 192 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 96/222 (43%), Gaps = 30/222 (13%)
Query: 94  RSKELEEATDNFQALLGHGSSASVFKGIL----SDGTSVAVKRING--EENGEKEFRSEV 147
           R  E++         +G G    V +GI     +   +VA+K       ++  ++F  E 
Sbjct: 3   RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 62
Query: 148 AAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWD 207
             +    H ++V+L+G  V+   P +++ E    G L    F   R+    YS    S  
Sbjct: 63  LTMRQFDHPHIVKLIG--VITENPVWIIMELCTLGELRS--FLQVRK----YSLDLASLI 114
Query: 208 LRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC 267
           L    A  ++ AL+YL +    R +H D+   N+L+  N    + DFGLS+ M       
Sbjct: 115 L---YAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS---- 164
Query: 268 ITTIRGTRGYLAPEWILEQGV-----SEKCDIYSYGMVLLEL 304
            T  + ++G L  +W+  + +     +   D++ +G+ + E+
Sbjct: 165 -TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 205

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R  +  +T    TR
Sbjct: 141 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTADEMTGYVATR 193
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 96/217 (44%), Gaps = 25/217 (11%)
Query: 109 LGHGSSASVFKGILSDGTS-VAVKRINGEENGEKEFRS---EVAAIASAQHVNLVRLLGY 164
           +G G+  +VFK    +    VA+KR+  +++ E    S   E+  +   +H N+VRL  +
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL--H 67
Query: 165 CVVPGGPRY-LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL 223
            V+    +  LV+EF       ++              G L  ++       + K L + 
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYF----------DSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 224 HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWI 283
           H+     VLH D+KP+N+L++ N    ++DFGL++       RC +    T  Y  P+ +
Sbjct: 118 HS---RNVLHRDLKPQNLLINRNGELKLADFGLARAFGI-PVRCYSAEVVTLWYRPPDVL 173
Query: 284 LEQGV-SEKCDIYSYGMVLLELTGGRRNVSLIEHGND 319
               + S   D++S G +  EL    R +     GND
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAARPLF---PGND 207

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R  +  +T    TR
Sbjct: 141 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTADEMTGYVATR 193
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 27/205 (13%)
Query: 109 LGHGSSASV-FKGILSDGTSVAVKRIN--GEENGEK--EFRSEVAAIASAQHVNLVRLLG 163
           +GHGS  +V F   + +   VA+K+++  G+++ EK  +   EV  +   +H N ++  G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL 223
            C +     +LV E+    + D          E   +           V     + L+YL
Sbjct: 83  -CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA----------VTHGALQGLAYL 131
Query: 224 HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWI 283
           H+     ++H DVK  NILL E     + DFG + +M+           GT  ++APE I
Sbjct: 132 HS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANXFVGTPYWMAPEVI 183
Query: 284 L---EQGVSEKCDIYSYGMVLLELT 305
           L   E     K D++S G+  +EL 
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELA 208

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 140 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGL----ARHTDDEMTGYVATR 192
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 193 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 80/186 (43%), Gaps = 18/186 (9%)
Query: 125 GTSVAVKRINGEENGEKE-FRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS 183
           G + A K +      +KE  R E+  ++  +H  LV L            ++YEF+  G 
Sbjct: 76  GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHD-AFEDDNEMVMIYEFMSGGE 134
Query: 184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILL 243
           L        + ++ H     +S D        V K L ++H    +  +HLD+KPENI+ 
Sbjct: 135 L------FEKVADEH---NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMF 182
Query: 244 DENYRAVVS--DFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVL 301
                  +   DFGL+  +   QS  +TT  GT  + APE    + V    D++S G++ 
Sbjct: 183 TTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGYYTDMWSVGVLS 240
Query: 302 LELTGG 307
             L  G
Sbjct: 241 YILLSG 246

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 111/249 (44%), Gaps = 53/249 (21%)
Query: 85  KVAGVPIKFRSKELEEATDNF---QALLGHGSSASV-FKGILSDGTSVAVKR--INGEEN 138
           ++A +P        E++  N    + +LG+GSS +V F+G    G  VAVKR  I+  + 
Sbjct: 2   RIANIP------NFEQSLKNLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDI 54
Query: 139 GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGH 198
              E +       S  H N++R   YC      R+L Y  ++  +L+      S+    +
Sbjct: 55  ALMEIK---LLTESDDHPNVIRY--YCSETTD-RFL-YIALELCNLNLQDLVESK----N 103
Query: 199 YSGGCLSWDLRYR---VAIDVAKALSYLHNDCRSRVLHLDVKPENILLD----------- 244
            S   L     Y    +   +A  +++LH+    +++H D+KP+NIL+            
Sbjct: 104 VSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQT 160
Query: 245 --ENYRAVVSDFGLSKLMSRDQSRCITTIR---GTRGYLAPEWILEQG-------VSEKC 292
             EN R ++SDFGL K +   QS   T +    GT G+ APE + E         ++   
Sbjct: 161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSI 220
Query: 293 DIYSYGMVL 301
           DI+S G V 
Sbjct: 221 DIFSMGCVF 229

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 96/222 (43%), Gaps = 30/222 (13%)
Query: 94  RSKELEEATDNFQALLGHGSSASVFKGIL----SDGTSVAVKRING--EENGEKEFRSEV 147
           R  E++         +G G    V +GI     +   +VA+K       ++  ++F  E 
Sbjct: 3   RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 62
Query: 148 AAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWD 207
             +    H ++V+L+G  V+   P +++ E    G L    F   R+    YS    S  
Sbjct: 63  LTMRQFDHPHIVKLIG--VITENPVWIIMELCTLGELRS--FLQVRK----YSLDLASLI 114
Query: 208 LRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC 267
           L    A  ++ AL+YL +    R +H D+   N+L+  N    + DFGLS+ M       
Sbjct: 115 L---YAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS---- 164
Query: 268 ITTIRGTRGYLAPEWILEQGV-----SEKCDIYSYGMVLLEL 304
            T  + ++G L  +W+  + +     +   D++ +G+ + E+
Sbjct: 165 -TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 205

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 136 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGL----ARHTDDEMTGYVATR 188
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 189 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 27/205 (13%)
Query: 109 LGHGSSASV-FKGILSDGTSVAVKRIN--GEENGEK--EFRSEVAAIASAQHVNLVRLLG 163
           +GHGS  +V F   + +   VA+K+++  G+++ EK  +   EV  +   +H N ++  G
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL 223
            C +     +LV E+    + D          E   +           V     + L+YL
Sbjct: 122 -CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA----------VTHGALQGLAYL 170
Query: 224 HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWI 283
           H+     ++H DVK  NILL E     + DFG + +M+           GT  ++APE I
Sbjct: 171 HS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANXFVGTPYWMAPEVI 222
Query: 284 L---EQGVSEKCDIYSYGMVLLELT 305
           L   E     K D++S G+  +EL 
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELA 247

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 97/221 (43%), Gaps = 35/221 (15%)
Query: 105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGY 164
            Q  +G G    V++G    G  VAVK  +  E       +E+      +H N++  +  
Sbjct: 7   LQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 165 CVVPGGPR---YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALS 221
                G     +LV ++ ++GSL  ++   +   EG             ++A+  A  L+
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEG-----------MIKLALSTASGLA 114
Query: 222 YLHNDC-----RSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR---- 272
           +LH +      +  + H D+K +NIL+ +N    ++D GL+  +  D +     I     
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHR 172
Query: 273 -GTRGYLAPEWILEQGVSEK-------CDIYSYGMVLLELT 305
            GT+ Y+APE +L+  ++ K        DIY+ G+V  E+ 
Sbjct: 173 VGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIA 212

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 27/218 (12%)
Query: 101 ATDNFQAL--LGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRS---EVAAIASAQ 154
           + +NFQ +  +G G+   V+K      G  VA+K+I  +   E    +   E++ +    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI 214
           H N+V+LL   +      YLV+EF+     D   F  +    G      +   L      
Sbjct: 61  HPNIVKLLD-VIHTENKLYLVFEFLHQ---DLKKFMDASALTG------IPLPLIKSYLF 110
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS---RDQSRCITTI 271
            + + L++ H+    RVLH D+KP+N+L++      ++DFGL++      R     + T+
Sbjct: 111 QLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL 167
Query: 272 RGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
                Y APE +L  +  S   DI+S G +  E+   R
Sbjct: 168 ----WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 92/207 (44%), Gaps = 30/207 (14%)
Query: 109 LGHGSSASVFKGIL----SDGTSVAVKRING--EENGEKEFRSEVAAIASAQHVNLVRLL 162
           +G G    V +GI     +   +VA+K       ++  ++F  E   +    H ++V+L+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 163 GYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY 222
           G  V+   P +++ E    G L    F   R+    YS    S  L    A  ++ AL+Y
Sbjct: 75  G--VITENPVWIIMELCTLGELRS--FLQVRK----YSLDLASLIL---YAYQLSTALAY 123
Query: 223 LHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEW 282
           L +    R +H D+   N+L+  N    + DFGLS+ M        T  + ++G L  +W
Sbjct: 124 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-----TYYKASKGKLPIKW 175
Query: 283 ILEQGV-----SEKCDIYSYGMVLLEL 304
           +  + +     +   D++ +G+ + E+
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEI 202

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 70/318 (22%), Positives = 128/318 (40%), Gaps = 71/318 (22%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEK---EFRSEVAAIASAQHVN--LVRLLG 163
           +G G S+ VF+ +       A+K +N EE   +    +R+E+A +   Q  +  ++RL  
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY- 222
           Y +        +Y  ++ G++D                   SW L+ + +ID  +  SY 
Sbjct: 96  YEIT----DQYIYMVMECGNID-----------------LNSW-LKKKKSIDPWERKSYW 133
Query: 223 ------LHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR-GTR 275
                 +H   +  ++H D+KP N L+ +    ++ DFG++  M  D    +   + GT 
Sbjct: 134 KNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDXXXVVKDSQVGTV 192
Query: 276 GYLAPEWILEQGVSEK-----------CDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNK 324
            Y+ PE I +   S +            D++S G +L  +T G+                
Sbjct: 193 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-------------- 238
Query: 325 WQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARV 384
              F +I+N+     KL  I+D     E    +   + L DV   C++   + R S+  +
Sbjct: 239 ---FQQIINQI---SKLHAIIDP--NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290
Query: 385 VEMLEGRVAVDDPPDTQM 402
             +    V +   P  QM
Sbjct: 291 --LAHPYVQIQTHPVNQM 306

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 107/247 (43%), Gaps = 25/247 (10%)
Query: 74  RELRIEYSFLRKVAGVPIKFRSKELEEATDNF---QALLGHGSSASVFKGIL---SDGTS 127
           R + ++ S        P + + K+L    DN       LG G+  SV +G+         
Sbjct: 306 RPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQID 365
Query: 128 VAVKRI-NGEENGE-KEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLD 185
           VA+K +  G E  + +E   E   +    +  +VRL+G C        LV E    G L 
Sbjct: 366 VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA--LMLVMEMAGGGPLH 423
Query: 186 HWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDE 245
            ++    +R E   S      +L ++V++     + YL        +H ++   N+LL  
Sbjct: 424 KFL--VGKREEIPVSNVA---ELLHQVSM----GMKYLEE---KNFVHRNLAARNVLLVN 471
Query: 246 NYRAVVSDFGLSKLMSRDQSRCITTIRG--TRGYLAPEWILEQGVSEKCDIYSYGMVLLE 303
            + A +SDFGLSK +  D S       G     + APE I  +  S + D++SYG+ + E
Sbjct: 472 RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWE 531
Query: 304 -LTGGRR 309
            L+ G++
Sbjct: 532 ALSYGQK 538

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 27/218 (12%)
Query: 101 ATDNFQAL--LGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRS---EVAAIASAQ 154
           + +NFQ +  +G G+   V+K      G  VA+K+I  +   E    +   E++ +    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI 214
           H N+V+LL   +      YLV+EF+     D   F  +    G      +   L      
Sbjct: 61  HPNIVKLLD-VIHTENKLYLVFEFLHQ---DLKKFMDASALTG------IPLPLIKSYLF 110
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS---RDQSRCITTI 271
            + + L++ H+    RVLH D+KP+N+L++      ++DFGL++      R     + T+
Sbjct: 111 QLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL 167
Query: 272 RGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
                Y APE +L  +  S   DI+S G +  E+   R
Sbjct: 168 ----WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 96/207 (46%), Gaps = 27/207 (13%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRS---EVAAIASAQHVNLVRLLGYC 165
           +G G+   V+K   + G + A+K+I  E+  E    +   E++ +   +H N+V+L  Y 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL--YD 67
Query: 166 VVPGGPRY-LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH 224
           V+    R  LV+E +             ++      GG  S   +    + +   ++Y H
Sbjct: 68  VIHTKKRLVLVFEHLDQ---------DLKKLLDVCEGGLESVTAK-SFLLQLLNGIAYCH 117
Query: 225 NDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS---RDQSRCITTIRGTRGYLAPE 281
           +    RVLH D+KP+N+L++      ++DFGL++      R  +  I T+     Y AP+
Sbjct: 118 D---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL----WYRAPD 170
Query: 282 WIL-EQGVSEKCDIYSYGMVLLELTGG 307
            ++  +  S   DI+S G +  E+  G
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGXVATR 186
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATR 186
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 97/221 (43%), Gaps = 35/221 (15%)
Query: 105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGY 164
            Q  +G G    V++G    G  VAVK  +  E       +E+      +H N++  +  
Sbjct: 10  LQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 68
Query: 165 CVVPGGPR---YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALS 221
                G     +LV ++ ++GSL  ++   +   EG             ++A+  A  L+
Sbjct: 69  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEG-----------MIKLALSTASGLA 117
Query: 222 YLHNDC-----RSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR---- 272
           +LH +      +  + H D+K +NIL+ +N    ++D GL+  +  D +     I     
Sbjct: 118 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHR 175
Query: 273 -GTRGYLAPEWILEQGVSEK-------CDIYSYGMVLLELT 305
            GT+ Y+APE +L+  ++ K        DIY+ G+V  E+ 
Sbjct: 176 VGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIA 215

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 27/218 (12%)
Query: 101 ATDNFQAL--LGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRS---EVAAIASAQ 154
           + +NFQ +  +G G+   V+K      G  VA+K+I  +   E    +   E++ +    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI 214
           H N+V+LL   +      YLV+EF+     D   F  +    G      +   L      
Sbjct: 61  HPNIVKLLD-VIHTENKLYLVFEFLHQ---DLKKFMDASALTG------IPLPLIKSYLF 110
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS---RDQSRCITTI 271
            + + L++ H+    RVLH D+KP+N+L++      ++DFGL++      R     + T+
Sbjct: 111 QLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL 167
Query: 272 RGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
                Y APE +L  +  S   DI+S G +  E+   R
Sbjct: 168 ----WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 92/207 (44%), Gaps = 30/207 (14%)
Query: 109 LGHGSSASVFKGIL----SDGTSVAVKRING--EENGEKEFRSEVAAIASAQHVNLVRLL 162
           +G G    V +GI     +   +VA+K       ++  ++F  E   +    H ++V+L+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 163 GYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY 222
           G  V+   P +++ E    G L    F   R+    YS    S  L    A  ++ AL+Y
Sbjct: 80  G--VITENPVWIIMELCTLGELRS--FLQVRK----YSLDLASLIL---YAYQLSTALAY 128
Query: 223 LHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEW 282
           L +    R +H D+   N+L+  N    + DFGLS+ M        T  + ++G L  +W
Sbjct: 129 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-----TYYKASKGKLPIKW 180
Query: 283 ILEQGV-----SEKCDIYSYGMVLLEL 304
           +  + +     +   D++ +G+ + E+
Sbjct: 181 MAPESINFRRFTSASDVWMFGVCMWEI 207

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 21/213 (9%)
Query: 103 DNFQAL--LGHGSSASVFKG---ILSDGTSVAVKRINGEENGEKEFR-SEVAAIASAQHV 156
           +NFQ +  +G G+   V+K    +  +  ++   R++ E  G       E++ +    H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 157 NLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDV 216
           N+V+LL   +      YLV+EF+     D   F  +    G      +   L       +
Sbjct: 63  NIVKLLD-VIHTENKLYLVFEFLHQ---DLKKFMDASALTG------IPLPLIKSYLFQL 112
Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG 276
            + L++ H+    RVLH D+KP+N+L++      ++DFGL++       R  T    T  
Sbjct: 113 LQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLW 168
Query: 277 YLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           Y APE +L  +  S   DI+S G +  E+   R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 21/213 (9%)
Query: 103 DNFQAL--LGHGSSASVFKG---ILSDGTSVAVKRINGEENGEKEFR-SEVAAIASAQHV 156
           +NFQ +  +G G+   V+K    +  +  ++   R++ E  G       E++ +    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 157 NLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDV 216
           N+V+LL   +      YLV+EF+     D   F  +    G      +   L       +
Sbjct: 62  NIVKLLD-VIHTENKLYLVFEFLHQ---DLKKFMDASALTG------IPLPLIKSYLFQL 111
Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG 276
            + L++ H+    RVLH D+KP+N+L++      ++DFGL++       R  T    T  
Sbjct: 112 LQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLW 167
Query: 277 YLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           Y APE +L  +  S   DI+S G +  E+   R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 97/221 (43%), Gaps = 35/221 (15%)
Query: 105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGY 164
            Q  +G G    V++G    G  VAVK  +  E       +E+      +H N++  +  
Sbjct: 13  LQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 71
Query: 165 CVVPGGPR---YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALS 221
                G     +LV ++ ++GSL  ++   +   EG             ++A+  A  L+
Sbjct: 72  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEG-----------MIKLALSTASGLA 120
Query: 222 YLHNDC-----RSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR---- 272
           +LH +      +  + H D+K +NIL+ +N    ++D GL+  +  D +     I     
Sbjct: 121 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHR 178
Query: 273 -GTRGYLAPEWILEQGVSEK-------CDIYSYGMVLLELT 305
            GT+ Y+APE +L+  ++ K        DIY+ G+V  E+ 
Sbjct: 179 VGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIA 218

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATR 186
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATR 186
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 27/218 (12%)
Query: 101 ATDNFQAL--LGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRS---EVAAIASAQ 154
           + +NFQ +  +G G+   V+K      G  VA+K+I  +   E    +   E++ +    
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI 214
           H N+V+LL   +      YLV+EF+     D   F  +    G      +   L      
Sbjct: 62  HPNIVKLLD-VIHTENKLYLVFEFLHQ---DLKKFMDASALTG------IPLPLIKSYLF 111
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS---RDQSRCITTI 271
            + + L++ H+    RVLH D+KP+N+L++      ++DFGL++      R     + T+
Sbjct: 112 QLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL 168
Query: 272 RGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
                Y APE +L  +  S   DI+S G +  E+   R
Sbjct: 169 ----WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 141 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATR 193
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATR 186
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 139 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATR 191
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 192 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATR 186
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 133 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATR 185
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 186 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 157 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATR 209
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 210 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 136 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATR 188
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 189 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATR 186
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 21/213 (9%)
Query: 103 DNFQAL--LGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRS---EVAAIASAQHV 156
           +NFQ +  +G G+   V+K      G  VA+K+I  +   E    +   E++ +    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 157 NLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDV 216
           N+V+LL   +      YLV+E +     D   F  +    G      +   L       +
Sbjct: 62  NIVKLLD-VIHTENKLYLVFEHVHQ---DLKTFMDASALTG------IPLPLIKSYLFQL 111
Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG 276
            + L++ H+    RVLH D+KP+N+L++      ++DFGL++       R  T    T  
Sbjct: 112 LQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLW 167
Query: 277 YLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           Y APE +L  +  S   DI+S G +  E+   R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATR 186
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 145 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATR 197
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 198 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 27/218 (12%)
Query: 101 ATDNFQAL--LGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRS---EVAAIASAQ 154
           + +NFQ +  +G G+   V+K      G  VA+K+I  +   E    +   E++ +    
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI 214
           H N+V+LL   +      YLV+EF+     D   F  +    G      +   L      
Sbjct: 61  HPNIVKLLD-VIHTENKLYLVFEFLHQ---DLKKFMDASALTG------IPLPLIKSYLF 110
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS---RDQSRCITTI 271
            + + L++ H+    RVLH D+KP+N+L++      ++DFGL++      R     + T+
Sbjct: 111 QLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL 167
Query: 272 RGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
                Y APE +L  +  S   DI+S G +  E+   R
Sbjct: 168 ----WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 27/216 (12%)
Query: 103 DNFQAL--LGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRS---EVAAIASAQHV 156
           +NFQ +  +G G+   V+K      G  VA+K+I  +   E    +   E++ +    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 157 NLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDV 216
           N+V+LL   +      YLV+EF+     D   F  +    G      +   L       +
Sbjct: 62  NIVKLLD-VIHTENKLYLVFEFLHQ---DLKKFMDASALTG------IPLPLIKSYLFQL 111
Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS---RDQSRCITTIRG 273
            + L++ H+    RVLH D+KP+N+L++      ++DFGL++      R     + T+  
Sbjct: 112 LQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL-- 166
Query: 274 TRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
              Y APE +L  +  S   DI+S G +  E+   R
Sbjct: 167 --WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 136 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATR 188
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 189 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/209 (22%), Positives = 93/209 (44%), Gaps = 34/209 (16%)
Query: 109 LGHGSSASVFKGIL----SDGTSVAVKRING--EENGEKEFRSEVAAIASAQHVNLVRLL 162
           +G G    V +GI     +   +VA+K       ++  ++F  E   +    H ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 163 GYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRV--AIDVAKAL 220
           G  V+   P +++ E    G L  ++    R+          S DL   +  A  ++ AL
Sbjct: 458 G--VITENPVWIIMELCTLGELRSFL--QVRK---------FSLDLASLILYAYQLSTAL 504
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAP 280
           +YL +    R +H D+   N+L+  N    + DFGLS+ M        T  + ++G L  
Sbjct: 505 AYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-----TYYKASKGKLPI 556
Query: 281 EWILEQGV-----SEKCDIYSYGMVLLEL 304
           +W+  + +     +   D++ +G+ + E+
Sbjct: 557 KWMAPESINFRRFTSASDVWMFGVCMWEI 585

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 136 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATR 188
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 189 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATR 186
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 131 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATR 183
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 184 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 146 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATR 198
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 199 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 144 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATR 196
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 197 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 130 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATR 182
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 140 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATR 192
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 193 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 146 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATR 198
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 199 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 27/218 (12%)
Query: 101 ATDNFQAL--LGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRS---EVAAIASAQ 154
           + +NFQ +  +G G+   V+K      G  VA+K+I  +   E    +   E++ +    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI 214
           H N+V+LL   +      YLV+EF+     D   F  +    G      +   L      
Sbjct: 63  HPNIVKLLD-VIHTENKLYLVFEFLHQ---DLKKFMDASALTG------IPLPLIKSYLF 112
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS---RDQSRCITTI 271
            + + L++ H+    RVLH D+KP+N+L++      ++DFGL++      R     + T+
Sbjct: 113 QLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL 169
Query: 272 RGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
                Y APE +L  +  S   DI+S G +  E+   R
Sbjct: 170 ----WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 146 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATR 198
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 199 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATR 186
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 154 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATR 206
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 207 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 75/157 (47%), Gaps = 18/157 (11%)
Query: 154 QHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVA 213
           +H N+VRL    +   G  YL+++ +  G L   I      SE   S  C+         
Sbjct: 79  KHPNIVRLHD-SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASH-CIQ-------- 128
Query: 214 IDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV---VSDFGLSKLMSRDQSRCITT 270
             + +A+ + H   +  V+H D+KPEN+LL    +     ++DFGL+  +  +Q +    
Sbjct: 129 -QILEAVLHCH---QMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFG 183
Query: 271 IRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
             GT GYL+PE + +    +  D+++ G++L  L  G
Sbjct: 184 FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 220

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 139 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATR 191
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 192 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 153 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATR 205
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 206 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 27/218 (12%)
Query: 101 ATDNFQAL--LGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRS---EVAAIASAQ 154
           + +NFQ +  +G G+   V+K      G  VA+K+I  +   E    +   E++ +    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI 214
           H N+V+LL   +      YLV+EF+     D   F  +    G      +   L      
Sbjct: 64  HPNIVKLLD-VIHTENKLYLVFEFLHQ---DLKKFMDASALTG------IPLPLIKSYLF 113
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS---RDQSRCITTI 271
            + + L++ H+    RVLH D+KP+N+L++      ++DFGL++      R     + T+
Sbjct: 114 QLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL 170
Query: 272 RGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
                Y APE +L  +  S   DI+S G +  E+   R
Sbjct: 171 ----WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 27/218 (12%)
Query: 101 ATDNFQAL--LGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRS---EVAAIASAQ 154
           + +NFQ +  +G G+   V+K      G  VA+K+I  +   E    +   E++ +    
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI 214
           H N+V+LL   +      YLV+EF+     D   F  +    G      +   L      
Sbjct: 63  HPNIVKLLD-VIHTENKLYLVFEFLHQ---DLKKFMDASALTG------IPLPLIKSYLF 112
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS---RDQSRCITTI 271
            + + L++ H+    RVLH D+KP+N+L++      ++DFGL++      R     + T+
Sbjct: 113 QLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL 169
Query: 272 RGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
                Y APE +L  +  S   DI+S G +  E+   R
Sbjct: 170 ----WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 140 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATR 192
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 193 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 140 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATR 192
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 193 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 130 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATR 182
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 97/221 (43%), Gaps = 35/221 (15%)
Query: 105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGY 164
            Q  +G G    V++G    G  VAVK  +  E       +E+      +H N++  +  
Sbjct: 8   LQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 66
Query: 165 CVVPGGPR---YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALS 221
                G     +LV ++ ++GSL  ++   +   EG             ++A+  A  L+
Sbjct: 67  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEG-----------MIKLALSTASGLA 115
Query: 222 YLHNDC-----RSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR---- 272
           +LH +      +  + H D+K +NIL+ +N    ++D GL+  +  D +     I     
Sbjct: 116 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHR 173
Query: 273 -GTRGYLAPEWILEQGVSEK-------CDIYSYGMVLLELT 305
            GT+ Y+APE +L+  ++ K        DIY+ G+V  E+ 
Sbjct: 174 VGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIA 213

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 131 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATR 183
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 184 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 27/218 (12%)
Query: 101 ATDNFQAL--LGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRS---EVAAIASAQ 154
           + +NFQ +  +G G+   V+K      G  VA+K+I  +   E    +   E++ +    
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI 214
           H N+V+LL   +      YLV+EF+     D   F  +    G      +   L      
Sbjct: 65  HPNIVKLLD-VIHTENKLYLVFEFLHQ---DLKKFMDASALTG------IPLPLIKSYLF 114
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS---RDQSRCITTI 271
            + + L++ H+    RVLH D+KP+N+L++      ++DFGL++      R     + T+
Sbjct: 115 QLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL 171
Query: 272 RGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
                Y APE +L  +  S   DI+S G +  E+   R
Sbjct: 172 ----WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATR 186
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 187 WYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 132 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATR 184
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 185 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 153 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATR 205
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 206 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 96/222 (43%), Gaps = 30/222 (13%)
Query: 94  RSKELEEATDNFQALLGHGSSASVFKGIL----SDGTSVAVKRING--EENGEKEFRSEV 147
           R  E++         +G G    V +GI     +   +VA+K       ++  ++F  E 
Sbjct: 8   RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 67
Query: 148 AAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWD 207
             +    H ++V+L+G  V+   P +++ E    G L    F   R+    YS    S  
Sbjct: 68  LTMRQFDHPHIVKLIG--VITENPVWIIMELCTLGELRS--FLQVRK----YSLDLASLI 119
Query: 208 LRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC 267
           L    A  ++ AL+YL +    R +H D+   N+L+  N    + DFGLS+ M       
Sbjct: 120 L---YAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS---- 169
Query: 268 ITTIRGTRGYLAPEWILEQGV-----SEKCDIYSYGMVLLEL 304
            T  + ++G L  +W+  + +     +   D++ +G+ + E+
Sbjct: 170 -TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 210

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 154 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATR 206
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 207 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 80/186 (43%), Gaps = 18/186 (9%)
Query: 125 GTSVAVKRINGEENGEKE-FRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS 183
           G + A K +      +KE  R E+  ++  +H  LV L            ++YEF+  G 
Sbjct: 182 GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHD-AFEDDNEMVMIYEFMSGGE 240
Query: 184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILL 243
           L        + ++ H     +S D        V K L ++H +     +HLD+KPENI+ 
Sbjct: 241 L------FEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMF 288
Query: 244 DENYRAVVS--DFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVL 301
                  +   DFGL+  +   QS  +TT  GT  + APE    + V    D++S G++ 
Sbjct: 289 TTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
Query: 302 LELTGG 307
             L  G
Sbjct: 347 YILLSG 352

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 27/216 (12%)
Query: 103 DNFQAL--LGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRS---EVAAIASAQHV 156
           +NFQ +  +G G+   V+K      G  VA+K+I  +   E    +   E++ +    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 157 NLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDV 216
           N+V+LL   +      YLV+EF+     D   F  +    G      +   L       +
Sbjct: 62  NIVKLLD-VIHTENKLYLVFEFLHQ---DLKKFMDASALTG------IPLPLIKSYLFQL 111
Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS---RDQSRCITTIRG 273
            + L++ H+    RVLH D+KP+N+L++      ++DFGL++      R     + T+  
Sbjct: 112 LQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL-- 166
Query: 274 TRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
              Y APE +L  +  S   DI+S G +  E+   R
Sbjct: 167 --WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 97/220 (44%), Gaps = 35/220 (15%)
Query: 105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGY 164
            Q  +G G    V++G    G  VAVK  +  E       +E+      +H N++  +  
Sbjct: 33  LQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 91
Query: 165 CVVPGGPR---YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALS 221
                G     +LV ++ ++GSL  ++   +   EG             ++A+  A  L+
Sbjct: 92  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEG-----------MIKLALSTASGLA 140
Query: 222 YLHNDC-----RSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR---- 272
           +LH +      +  + H D+K +NIL+ +N    ++D GL+  +  D +     I     
Sbjct: 141 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHR 198
Query: 273 -GTRGYLAPEWILEQGVSEK-------CDIYSYGMVLLEL 304
            GT+ Y+APE +L+  ++ K        DIY+ G+V  E+
Sbjct: 199 VGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 27/218 (12%)
Query: 101 ATDNFQAL--LGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRS---EVAAIASAQ 154
           + +NFQ +  +G G+   V+K      G  VA+K+I  +   E    +   E++ +    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI 214
           H N+V+LL   +      YLV+EF+     D   F  +    G      +   L      
Sbjct: 64  HPNIVKLLD-VIHTENKLYLVFEFLHQ---DLKKFMDASALTG------IPLPLIKSYLF 113
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS---RDQSRCITTI 271
            + + L++ H+    RVLH D+KP+N+L++      ++DFGL++      R     + T+
Sbjct: 114 QLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL 170
Query: 272 RGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
                Y APE +L  +  S   DI+S G +  E+   R
Sbjct: 171 ----WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 130 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATR 182
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 5/89 (5%)
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            + +LH+   + ++H D+KP NI++  +    + DFGL++  +   S  +T    TR Y 
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPEVVTRYYR 192
Query: 279 APEWILEQGVSEKCDIYSYGMVLLELTGG 307
           APE IL  G  E  DI+S G ++ E+  G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 27/216 (12%)
Query: 103 DNFQAL--LGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRS---EVAAIASAQHV 156
           +NFQ +  +G G+   V+K      G  VA+K+I  +   E    +   E++ +    H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 157 NLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDV 216
           N+V+LL   +      YLV+EF+     D   F  +    G      +   L       +
Sbjct: 64  NIVKLLD-VIHTENKLYLVFEFLHQ---DLKKFMDASALTG------IPLPLIKSYLFQL 113
Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS---RDQSRCITTIRG 273
            + L++ H+    RVLH D+KP+N+L++      ++DFGL++      R     + T+  
Sbjct: 114 LQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL-- 168
Query: 274 TRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
              Y APE +L  +  S   DI+S G +  E+   R
Sbjct: 169 --WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 92/207 (44%), Gaps = 30/207 (14%)
Query: 109 LGHGSSASVFKGIL----SDGTSVAVKRING--EENGEKEFRSEVAAIASAQHVNLVRLL 162
           +G G    V +GI     +   +VA+K       ++  ++F  E   +    H ++V+L+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 163 GYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY 222
           G  V+   P +++ E    G L    F   R+    YS    S  L    A  ++ AL+Y
Sbjct: 81  G--VITENPVWIIMELCTLGELRS--FLQVRK----YSLDLASLIL---YAYQLSTALAY 129
Query: 223 LHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEW 282
           L +    R +H D+   N+L+  N    + DFGLS+ M        T  + ++G L  +W
Sbjct: 130 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-----TYYKASKGKLPIKW 181
Query: 283 ILEQGV-----SEKCDIYSYGMVLLEL 304
           +  + +     +   D++ +G+ + E+
Sbjct: 182 MAPESINFRRFTSASDVWMFGVCMWEI 208

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 92/207 (44%), Gaps = 30/207 (14%)
Query: 109 LGHGSSASVFKGIL----SDGTSVAVKRING--EENGEKEFRSEVAAIASAQHVNLVRLL 162
           +G G    V +GI     +   +VA+K       ++  ++F  E   +    H ++V+L+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 163 GYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY 222
           G  V+   P +++ E    G L    F   R+    YS    S  L    A  ++ AL+Y
Sbjct: 106 G--VITENPVWIIMELCTLGELRS--FLQVRK----YSLDLASLIL---YAYQLSTALAY 154
Query: 223 LHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEW 282
           L +    R +H D+   N+L+  N    + DFGLS+ M        T  + ++G L  +W
Sbjct: 155 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-----TYYKASKGKLPIKW 206
Query: 283 ILEQGV-----SEKCDIYSYGMVLLEL 304
           +  + +     +   D++ +G+ + E+
Sbjct: 207 MAPESINFRRFTSASDVWMFGVCMWEI 233

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 29/208 (13%)
Query: 109 LGHGSSASV--FKGILSDGTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLL 162
           +G G+ A V   + IL+ G  VAV+ I+  +    + +K FR EV  +    H N+V+L 
Sbjct: 22  IGKGNFAKVKLARHILT-GKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLF 79
Query: 163 GYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY 222
              +      YLV E+   G +  ++    R  E            ++R    +  A+ Y
Sbjct: 80  E-VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA-------KFR---QIVSAVQY 128
Query: 223 LHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEW 282
            H   +  ++H D+K EN+LLD +    ++DFG S   +      +    G+  Y APE 
Sbjct: 129 CH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LDEFCGSPPYAAPE- 182
Query: 283 ILEQGVS---EKCDIYSYGMVLLELTGG 307
            L QG      + D++S G++L  L  G
Sbjct: 183 -LFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/75 (38%), Positives = 41/75 (54%), Gaps = 1/75 (1%)
Query: 233 HLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKC 292
           H DVKPENIL+  +  A + DFG++   + ++   +    GT  Y APE   E   + + 
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRA 216
Query: 293 DIYSYGMVLLE-LTG 306
           DIY+   VL E LTG
Sbjct: 217 DIYALTCVLYECLTG 231

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 8/95 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLD---ENYRAVVSDFGLSKLMSRDQSRCITTIR 272
           + +A+ YLH+     + H DVKPEN+L      N    ++DFG +K  +   S  +TT  
Sbjct: 132 IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPC 186
Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
            T  Y+APE +  +   + CD++S G+++  L  G
Sbjct: 187 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 221

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 8/95 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLD---ENYRAVVSDFGLSKLMSRDQSRCITTIR 272
           + +A+ YLH+     + H DVKPEN+L      N    ++DFG +K  +   S  +TT  
Sbjct: 131 IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPC 185
Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
            T  Y+APE +  +   + CD++S G+++  L  G
Sbjct: 186 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 220

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 8/95 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDE---NYRAVVSDFGLSKLMSRDQSRCITTIR 272
           + +A+ YLH+     + H DVKPEN+L      N    ++DFG +K  +   S  +TT  
Sbjct: 125 IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPC 179
Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
            T  Y+APE +  +   + CD++S G+++  L  G
Sbjct: 180 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 214

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 8/95 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLD---ENYRAVVSDFGLSKLMSRDQSRCITTIR 272
           + +A+ YLH+     + H DVKPEN+L      N    ++DFG +K  +   S  +TT  
Sbjct: 130 IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPC 184
Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
            T  Y+APE +  +   + CD++S G+++  L  G
Sbjct: 185 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 219

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 8/95 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDE---NYRAVVSDFGLSKLMSRDQSRCITTIR 272
           + +A+ YLH+     + H DVKPEN+L      N    ++DFG +K  +   S  +TT  
Sbjct: 140 IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPC 194
Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
            T  Y+APE +  +   + CD++S G+++  L  G
Sbjct: 195 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 229

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 8/95 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDE---NYRAVVSDFGLSKLMSRDQSRCITTIR 272
           + +A+ YLH+     + H DVKPEN+L      N    ++DFG +K  +   S  +TT  
Sbjct: 126 IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPC 180
Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
            T  Y+APE +  +   + CD++S G+++  L  G
Sbjct: 181 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 215

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 8/95 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDE---NYRAVVSDFGLSKLMSRDQSRCITTIR 272
           + +A+ YLH+     + H DVKPEN+L      N    ++DFG +K  +   S  +TT  
Sbjct: 124 IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPC 178
Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
            T  Y+APE +  +   + CD++S G+++  L  G
Sbjct: 179 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 213

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 96/207 (46%), Gaps = 27/207 (13%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRS---EVAAIASAQHVNLVRLLGYC 165
           +G G+   V+K   + G + A+K+I  E+  E    +   E++ +   +H N+V+L  Y 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL--YD 67
Query: 166 VVPGGPRY-LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH 224
           V+    R  LV+E +             ++      GG  S   +    + +   ++Y H
Sbjct: 68  VIHTKKRLVLVFEHLDQ---------DLKKLLDVCEGGLESVTAK-SFLLQLLNGIAYCH 117
Query: 225 NDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS---RDQSRCITTIRGTRGYLAPE 281
           +    RVLH D+KP+N+L++      ++DFGL++      R  +  + T+     Y AP+
Sbjct: 118 D---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTL----WYRAPD 170
Query: 282 WIL-EQGVSEKCDIYSYGMVLLELTGG 307
            ++  +  S   DI+S G +  E+  G
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            + +LH+   + ++H D+KP NI++  +    + DFGL++  +   S  +     TR Y 
Sbjct: 140 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMVPFVVTRYYR 194
Query: 279 APEWILEQGVSEKCDIYSYGMVLLELTGG 307
           APE IL  G  E  DI+S G ++ E+  G
Sbjct: 195 APEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 108 LLGHGSSASVFKGILSDGTS----VAVKRIN--GEENGEKEFRSEVAAIASAQHVNLVRL 161
           ++G G    V+ G   D        A+K ++   E    + F  E   +    H N++ L
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 162 LGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALS 221
           +G  + P G  +++  ++ +G L  +I    R          +S+ L+      VA+ + 
Sbjct: 88  IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPT---VKDLISFGLQ------VARGME 138
Query: 222 YLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GYL 278
           YL      + +H D+   N +LDE++   V+DFGL++ +   +   +   R  R    + 
Sbjct: 139 YL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT 195
Query: 279 APEWILEQGVSEKCDIYSYGMVLLEL 304
           A E +     + K D++S+G++L EL
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWEL 221

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 92/208 (44%), Gaps = 29/208 (13%)
Query: 109 LGHGSSASV--FKGILSDGTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLL 162
           +G G+ A V   + IL+ G  VAVK I+  +    + +K FR EV       H N+V+L 
Sbjct: 22  IGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFR-EVRIXKVLNHPNIVKLF 79
Query: 163 GYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY 222
              +      YLV E+   G +  ++    R  E            ++R    +  A+ Y
Sbjct: 80  E-VIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARA-------KFR---QIVSAVQY 128
Query: 223 LHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEW 282
            H   +  ++H D+K EN+LLD +    ++DFG S   +      +    G   Y APE 
Sbjct: 129 CH---QKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNK--LDAFCGAPPYAAPE- 182
Query: 283 ILEQGVS---EKCDIYSYGMVLLELTGG 307
            L QG      + D++S G++L  L  G
Sbjct: 183 -LFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 96/207 (46%), Gaps = 27/207 (13%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRS---EVAAIASAQHVNLVRLLGYC 165
           +G G+   V+K   + G + A+K+I  E+  E    +   E++ +   +H N+V+L  Y 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL--YD 67
Query: 166 VVPGGPRY-LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH 224
           V+    R  LV+E +             ++      GG  S   +    + +   ++Y H
Sbjct: 68  VIHTKKRLVLVFEHLDQ---------DLKKLLDVCEGGLESVTAK-SFLLQLLNGIAYCH 117
Query: 225 NDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS---RDQSRCITTIRGTRGYLAPE 281
           +    RVLH D+KP+N+L++      ++DFGL++      R  +  + T+     Y AP+
Sbjct: 118 D---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTL----WYRAPD 170
Query: 282 WIL-EQGVSEKCDIYSYGMVLLELTGG 307
            ++  +  S   DI+S G +  E+  G
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 8/95 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDE---NYRAVVSDFGLSKLMSRDQSRCITTIR 272
           + +A+ YLH+     + H DVKPEN+L      N    ++DFG +K  +   S  +TT  
Sbjct: 126 IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPC 180
Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
            T  Y+APE +  +   + CD++S G+++  L  G
Sbjct: 181 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 215

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 48/86 (55%), Gaps = 5/86 (5%)
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            + +LH+   + ++H D+KP NI++  +    + DFGL++  +   S  +T    TR Y 
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 192
Query: 279 APEWILEQGVSEKCDIYSYGMVLLEL 304
           APE IL  G  E  DI+S G ++ E+
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL++    + +  +     TR
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFV----ATR 186
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 8/95 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDE---NYRAVVSDFGLSKLMSRDQSRCITTIR 272
           + +A+ YLH+     + H DVKPEN+L      N    ++DFG +K  +   S  +TT  
Sbjct: 170 IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPC 224
Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
            T  Y+APE +  +   + CD++S G+++  L  G
Sbjct: 225 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 8/95 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDE---NYRAVVSDFGLSKLMSRDQSRCITTIR 272
           + +A+ YLH+     + H DVKPEN+L      N    ++DFG +K  +   S  +TT  
Sbjct: 176 IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPC 230
Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
            T  Y+APE +  +   + CD++S G+++  L  G
Sbjct: 231 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 265

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL++    + +  +     TR
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFV----ATR 186
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 48/86 (55%), Gaps = 5/86 (5%)
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            + +LH+   + ++H D+KP NI++  +    + DFGL++  +   S  +T    TR Y 
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 192
Query: 279 APEWILEQGVSEKCDIYSYGMVLLEL 304
           APE IL  G  E  DI+S G ++ E+
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL     R     +T    TR
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGL----CRHTDDEMTGYVATR 186
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL++    + +  +     TR
Sbjct: 130 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFV----ATR 182
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 48/86 (55%), Gaps = 5/86 (5%)
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            + +LH+   + ++H D+KP NI++  +    + DFGL++  +   S  +T    TR Y 
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 192
Query: 279 APEWILEQGVSEKCDIYSYGMVLLEL 304
           APE IL  G  E  DI+S G ++ E+
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 48/86 (55%), Gaps = 5/86 (5%)
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            + +LH+   + ++H D+KP NI++  +    + DFGL++  +   S  +T    TR Y 
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 192
Query: 279 APEWILEQGVSEKCDIYSYGMVLLEL 304
           APE IL  G  E  DI+S G ++ E+
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 48/86 (55%), Gaps = 5/86 (5%)
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            + +LH+   + ++H D+KP NI++  +    + DFGL++  +   S  +T    TR Y 
Sbjct: 131 GIKHLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 185
Query: 279 APEWILEQGVSEKCDIYSYGMVLLEL 304
           APE IL  G  E  DI+S G ++ E+
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEM 211

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 101/217 (46%), Gaps = 31/217 (14%)
Query: 103 DNFQAL--LGHGSSASVFKGILSDGTSVAVKRI--NGEENG-EKEFRSEVAAIASAQHVN 157
           + +Q L  +G G+   V+K   S G  VA+KRI  + E+ G       E++ +    H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 158 LVRLLGY-----CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRV 212
           +V L+       C+       LV+EF++            +  + + +G   S     ++
Sbjct: 81  IVSLIDVIHSERCLT------LVFEFMEKD--------LKKVLDENKTGLQDS-----QI 121
Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR 272
            I + + L  + +  + R+LH D+KP+N+L++ +    ++DFGL++       R  T   
Sbjct: 122 KIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEV 180
Query: 273 GTRGYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
            T  Y AP+ ++  +  S   DI+S G +  E+  G+
Sbjct: 181 VTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 8/104 (7%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR
Sbjct: 163 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----ARHTDDEMTGYVATR 215
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGN 318
            Y APE +L     +   DI+S G ++ EL  GR      +H N
Sbjct: 216 WYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHIN 259

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 101/217 (46%), Gaps = 31/217 (14%)
Query: 103 DNFQAL--LGHGSSASVFKGILSDGTSVAVKRI--NGEENG-EKEFRSEVAAIASAQHVN 157
           + +Q L  +G G+   V+K   S G  VA+KRI  + E+ G       E++ +    H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 158 LVRLLGY-----CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRV 212
           +V L+       C+       LV+EF++            +  + + +G   S     ++
Sbjct: 81  IVSLIDVIHSERCLT------LVFEFMEKD--------LKKVLDENKTGLQDS-----QI 121
Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR 272
            I + + L  + +  + R+LH D+KP+N+L++ +    ++DFGL++       R  T   
Sbjct: 122 KIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI-PVRSYTHEV 180
Query: 273 GTRGYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
            T  Y AP+ ++  +  S   DI+S G +  E+  G+
Sbjct: 181 VTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGY 277
           + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR Y
Sbjct: 142 RGLKYIHS---AGIIHRDLKPSNVAVNEDSELRILDFGL----ARQADEEMTGYVATRWY 194
Query: 278 LAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            APE +L     ++  DI+S G ++ EL  G+
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 70/319 (21%), Positives = 129/319 (40%), Gaps = 71/319 (22%)
Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEK---EFRSEVAAIAS-AQHVN-LVRLLG 163
           +G G S+ VF+ +       A+K +N EE   +    +R+E+A +    QH + ++RL  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY- 222
           Y +        +Y  ++ G++D                   SW L+ + +ID  +  SY 
Sbjct: 124 YEIT----DQYIYMVMECGNID-----------------LNSW-LKKKKSIDPWERKSYW 161
Query: 223 ------LHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR-GTR 275
                 +H   +  ++H D+KP N L+ +    ++ DFG++  M  D +  +   + G  
Sbjct: 162 KNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGAV 220
Query: 276 GYLAPEWILEQGVSEK-----------CDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNK 324
            Y+ PE I +   S +            D++S G +L  +T G+                
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-------------- 266
Query: 325 WQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARV 384
              F +I+N+     KL  I+D     E    +   + L DV   C++   + R S+  +
Sbjct: 267 ---FQQIINQI---SKLHAIIDP--NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318
Query: 385 VEMLEGRVAVDDPPDTQMV 403
             +    V +   P  QM 
Sbjct: 319 --LAHPYVQIQTHPVNQMA 335

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGY 277
           + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR Y
Sbjct: 142 RGLKYIHS---AGIIHRDLKPSNVAVNEDSELRILDFGL----ARQADEEMTGYVATRWY 194
Query: 278 LAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            APE +L     ++  DI+S G ++ EL  G+
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 48/86 (55%), Gaps = 5/86 (5%)
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            + +LH+   + ++H D+KP NI++  +    + DFGL++  +   S  +T    TR Y 
Sbjct: 139 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 193
Query: 279 APEWILEQGVSEKCDIYSYGMVLLEL 304
           APE IL  G  E  DI+S G ++ E+
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEM 219

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 48/86 (55%), Gaps = 5/86 (5%)
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            + +LH+   + ++H D+KP NI++  +    + DFGL++  +   S  +T    TR Y 
Sbjct: 176 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 230
Query: 279 APEWILEQGVSEKCDIYSYGMVLLEL 304
           APE IL  G  E  DI+S G ++ E+
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEM 256

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 48/86 (55%), Gaps = 5/86 (5%)
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            + +LH+   + ++H D+KP NI++  +    + DFGL++  +   S  +T    TR Y 
Sbjct: 176 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 230
Query: 279 APEWILEQGVSEKCDIYSYGMVLLEL 304
           APE IL  G  E  DI+S G ++ E+
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEM 256

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/85 (34%), Positives = 48/85 (56%), Gaps = 5/85 (5%)
Query: 220 LSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLA 279
           + +LH+   + ++H D+KP NI++  +    + DFGL++  +   S  +T    TR Y A
Sbjct: 140 IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRA 194
Query: 280 PEWILEQGVSEKCDIYSYGMVLLEL 304
           PE IL  G  E  DI+S G ++ E+
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEM 219

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/85 (34%), Positives = 48/85 (56%), Gaps = 5/85 (5%)
Query: 220 LSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLA 279
           + +LH+   + ++H D+KP NI++  +    + DFGL++  +   S  +T    TR Y A
Sbjct: 139 IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRA 193
Query: 280 PEWILEQGVSEKCDIYSYGMVLLEL 304
           PE IL  G  E  DI+S G ++ E+
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 48/86 (55%), Gaps = 5/86 (5%)
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            + +LH+   + ++H D+KP NI++  +    + DFGL++  +   S  +T    TR Y 
Sbjct: 137 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 191
Query: 279 APEWILEQGVSEKCDIYSYGMVLLEL 304
           APE IL  G  E  DI+S G ++ E+
Sbjct: 192 APEVILGMGYKENVDIWSVGCIMGEM 217

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 48/86 (55%), Gaps = 5/86 (5%)
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            + +LH+   + ++H D+KP NI++  +    + DFGL++  +   S  +T    TR Y 
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 192
Query: 279 APEWILEQGVSEKCDIYSYGMVLLEL 304
           APE IL  G  E  DI+S G ++ E+
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEM 218

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/85 (34%), Positives = 48/85 (56%), Gaps = 5/85 (5%)
Query: 220 LSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLA 279
           + +LH+   + ++H D+KP NI++  +    + DFGL++  +   S  +T    TR Y A
Sbjct: 133 IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRA 187
Query: 280 PEWILEQGVSEKCDIYSYGMVLLEL 304
           PE IL  G  E  DI+S G ++ E+
Sbjct: 188 PEVILGMGYKENVDIWSVGCIMGEM 212

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 48/86 (55%), Gaps = 5/86 (5%)
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            + +LH+   + ++H D+KP NI++  +    + DFGL++  +   S  +T    TR Y 
Sbjct: 131 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 185
Query: 279 APEWILEQGVSEKCDIYSYGMVLLEL 304
           APE IL  G  E  DI+S G ++ E+
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEM 211

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/86 (33%), Positives = 48/86 (55%), Gaps = 5/86 (5%)
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            + +LH+   + ++H D+KP NI++  +    + DFGL++  +   S  +T    TR Y 
Sbjct: 132 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 186
Query: 279 APEWILEQGVSEKCDIYSYGMVLLEL 304
           APE IL  G  E  DI+S G ++ E+
Sbjct: 187 APEVILGMGYKENVDIWSVGCIMGEM 212

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL++    +    +     TR
Sbjct: 154 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGXV----ATR 206
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 207 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + D+GL    +R     +T    TR
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDYGL----ARHTDDEMTGYVATR 186
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGY 277
           + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +R     +T    TR Y
Sbjct: 134 RGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGL----ARQADEEMTGYVATRWY 186
Query: 278 LAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            APE +L     ++  DI+S G ++ EL  G+
Sbjct: 187 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 5/111 (4%)
Query: 195 SEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDF 254
           S+G Y       DL    +  VA+ + +L +    + +H D+   NILL EN    + DF
Sbjct: 188 SDGFYKEPITMEDL-ISYSFQVARGMEFLSS---RKCIHRDLAARNILLSENNVVKICDF 243
Query: 255 GLSKLMSRDQSRCIT-TIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           GL++ + ++         R    ++APE I ++  S K D++SYG++L E+
Sbjct: 244 GLARDIYKNPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEI 294

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 113/244 (46%), Gaps = 44/244 (18%)
Query: 105 FQALLGHGSSASVFKGILSD--------GTSVAVKRIN-GEENGEKEFRSEVAAIASAQH 155
           F   LG G+   +FKG+  +         T V +K ++    N  + F    + ++   H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
            +LV   G CV  G    LV EF++ GSLD ++           +  C++   +  VA  
Sbjct: 72  KHLVLNYGVCVC-GDENILVQEFVKFGSLDTYL---------KKNKNCINILWKLEVAKQ 121
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILL--DENYRA------VVSDFGLS-KLMSRDQSR 266
           +A A+ +L     + ++H +V  +NILL  +E+ +        +SD G+S  ++ +D   
Sbjct: 122 LAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD--- 175
Query: 267 CITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLEL-TGGRRNVSLIEHGNDKSKNK 324
               ++    ++ PE I   + ++   D +S+G  L E+ +GG + +S ++     S+ K
Sbjct: 176 ---ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-----SQRK 227
Query: 325 WQYF 328
            Q++
Sbjct: 228 LQFY 231

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/224 (21%), Positives = 95/224 (42%), Gaps = 34/224 (15%)
Query: 94  RSKELEEATDNFQALLGHGSSASVFKGIL----SDGTSVAVKRING--EENGEKEFRSEV 147
           R  E++         +G G    V +GI     +   +VA+K       ++  ++F  E 
Sbjct: 3   RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 62
Query: 148 AAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWD 207
             +    H ++V+L+G  V+   P +++ E    G L    F   R+          S D
Sbjct: 63  LTMRQFDHPHIVKLIG--VITENPVWIIMELCTLGELRS--FLQVRK---------FSLD 109
Query: 208 LRYRV--AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQS 265
           L   +  A  ++ AL+YL +    R +H D+   N+L+       + DFGLS+ M     
Sbjct: 110 LASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDS-- 164
Query: 266 RCITTIRGTRGYLAPEWILEQGV-----SEKCDIYSYGMVLLEL 304
              T  + ++G L  +W+  + +     +   D++ +G+ + E+
Sbjct: 165 ---TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 205

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 89/188 (47%), Gaps = 37/188 (19%)
Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI-DVAKALSYLHNDCRSRV 231
           YLV+E ++ GS+   I    RR   H++      +L   V + DVA AL +LHN     +
Sbjct: 87  YLVFEKMRGGSILSHIH--KRR---HFN------ELEASVVVQDVASALDFLHN---KGI 132
Query: 232 LHLDVKPENILLDENYRAV---VSDFGLSK--LMSRDQSRCIT----TIRGTRGYLAPEW 282
            H D+KPENIL +   +     + DF L     ++ D S   T    T  G+  Y+APE 
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192
Query: 283 ILEQGVSE-------KCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVN-- 333
           +  +  SE       +CD++S G++L  L  G     +   G+D   ++ +  P   N  
Sbjct: 193 V--EAFSEEASIYDKRCDLWSLGVILYILLSGYPPF-VGRCGSDCGWDRGEACPACQNML 249
Query: 334 -EKMKEGK 340
            E ++EGK
Sbjct: 250 FESIQEGK 257

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL++    +    +     TR
Sbjct: 157 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYV----ATR 209
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 210 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 83/186 (44%), Gaps = 25/186 (13%)
Query: 128 VAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHW 187
           VAVK I   E  ++  + E+    S +H N+VR     + P     +V E+   G L   
Sbjct: 47  VAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGELFER 105
Query: 188 IFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD--E 245
           I    R SE          + R+     +   +SY H     +V H D+K EN LLD   
Sbjct: 106 ICNAGRFSED---------EARFFFQ-QLISGVSYAH---AMQVAHRDLKLENTLLDGSP 152
Query: 246 NYRAVVSDFGLSK---LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK-CDIYSYGMVL 301
             R  ++DFG SK   L S+ +S       GT  Y+APE +L++    K  D++S G+ L
Sbjct: 153 APRLKIADFGYSKASVLHSQPKSAV-----GTPAYIAPEVLLKKEYDGKVADVWSCGVTL 207
Query: 302 LELTGG 307
             +  G
Sbjct: 208 YVMLVG 213

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 64/138 (46%), Gaps = 18/138 (13%)
Query: 212 VAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTI 271
           +AID    L Y+H D         +KP+NIL+D N    ++DFG    +  D +   +  
Sbjct: 186 IAIDSVHQLHYVHRD---------IKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 236
Query: 272 RGTRGYLAPEWI--LEQG---VSEKCDIYSYGMVLLELTGGRRNV---SLIEHGNDKSKN 323
            GT  Y++PE +  +E G      +CD +S G+ + E+  G       SL+E       +
Sbjct: 237 VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 296
Query: 324 KWQY-FPKIVNEKMKEGK 340
           K ++ FP  V +  +  K
Sbjct: 297 KERFQFPTQVTDVSENAK 314

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 74/157 (47%), Gaps = 18/157 (11%)
Query: 154 QHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVA 213
           +H N+VRL    +   G  YL+++ +  G L   I      SE   S  C+         
Sbjct: 68  KHPNIVRLHD-SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASH-CIQ-------- 117
Query: 214 IDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV---VSDFGLSKLMSRDQSRCITT 270
             + +A+ + H   +  V+H ++KPEN+LL    +     ++DFGL+  +  +Q      
Sbjct: 118 -QILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG- 172
Query: 271 IRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
             GT GYL+PE + +    +  D+++ G++L  L  G
Sbjct: 173 FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 24/165 (14%)
Query: 141 KEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYS 200
           ++F +EV   +  Q  N V        P G  Y+V E++   SL        +RS+G   
Sbjct: 130 RQFLAEVVHPSIVQIFNFVEHTDRHGDPVG--YIVMEYVGGQSL--------KRSKGQK- 178
Query: 201 GGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM 260
              L         +++  ALSYLH+     +++ D+KPENI+L E    ++    +S++ 
Sbjct: 179 ---LPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEEQLKLIDLGAVSRIN 232
Query: 261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELT 305
           S         + GT G+ APE I+  G +   DIY+ G  L  LT
Sbjct: 233 S------FGYLYGTPGFQAPE-IVRTGPTVATDIYTVGRTLAALT 270

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 96/217 (44%), Gaps = 25/217 (11%)
Query: 109 LGHGSSASVFKGILSDGTS-VAVKRINGEENGEKEFRS---EVAAIASAQHVNLVRLLGY 164
           +G G+  +VFK    +    VA+KR+  +++ E    S   E+  +   +H N+VRL  +
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL--H 67
Query: 165 CVVPGGPRY-LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL 223
            V+    +  LV+EF       ++              G L  ++       + K L + 
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYF----------DSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 224 HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWI 283
           H+     VLH D+KP+N+L++ N    +++FGL++       RC +    T  Y  P+ +
Sbjct: 118 HS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVVTLWYRPPDVL 173
Query: 284 LEQGV-SEKCDIYSYGMVLLELTGGRRNVSLIEHGND 319
               + S   D++S G +  EL    R +     GND
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLF---PGND 207

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 83/183 (45%), Gaps = 19/183 (10%)
Query: 128 VAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHW 187
           VAVK I   E  ++  + E+    S +H N+VR     + P     +V E+   G L   
Sbjct: 46  VAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGELFER 104
Query: 188 IFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD--E 245
           I    R SE          + R+     +   +SY H     +V H D+K EN LLD   
Sbjct: 105 ICNAGRFSED---------EARFFFQ-QLISGVSYCH---AMQVCHRDLKLENTLLDGSP 151
Query: 246 NYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK-CDIYSYGMVLLEL 304
             R  + DFG SK  S   S+  +T+ GT  Y+APE +L++    K  D++S G+ L  +
Sbjct: 152 APRLKICDFGYSK-SSVLHSQPKSTV-GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVM 209
Query: 305 TGG 307
             G
Sbjct: 210 LVG 212

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 109/245 (44%), Gaps = 49/245 (20%)
Query: 85  KVAGVPIKFRSKELEEATDNF---QALLGHGSSASV-FKGILSDGTSVAVKR--INGEEN 138
           ++A +P        E++  N    + +LG+GSS +V F+G    G  VAVKR  I+  + 
Sbjct: 20  RIANIP------NFEQSLKNLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDI 72
Query: 139 GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGH 198
              E +       S  H N++R   YC      R+L Y  ++  +L+      S+    +
Sbjct: 73  ALMEIK---LLTESDDHPNVIRY--YCSETTD-RFL-YIALELCNLNLQDLVESK----N 121
Query: 199 YSGGCLSWDLRYR---VAIDVAKALSYLHNDCRSRVLHLDVKPENILLD----------- 244
            S   L     Y    +   +A  +++LH+    +++H D+KP+NIL+            
Sbjct: 122 VSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQT 178
Query: 245 --ENYRAVVSDFGLSKLMSRDQSRC---ITTIRGTRGYLAPEWILEQG---VSEKCDIYS 296
             EN R ++SDFGL K +   Q      +    GT G+ APE + E     ++   DI+S
Sbjct: 179 GAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFS 238
Query: 297 YGMVL 301
            G V 
Sbjct: 239 MGCVF 243

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 109/245 (44%), Gaps = 49/245 (20%)
Query: 85  KVAGVPIKFRSKELEEATDNF---QALLGHGSSASV-FKGILSDGTSVAVKR--INGEEN 138
           ++A +P        E++  N    + +LG+GSS +V F+G    G  VAVKR  I+  + 
Sbjct: 20  RIANIP------NFEQSLKNLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDI 72
Query: 139 GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGH 198
              E +       S  H N++R   YC      R+L Y  ++  +L+      S+    +
Sbjct: 73  ALMEIK---LLTESDDHPNVIRY--YCSETTD-RFL-YIALELCNLNLQDLVESK----N 121
Query: 199 YSGGCLSWDLRYR---VAIDVAKALSYLHNDCRSRVLHLDVKPENILLD----------- 244
            S   L     Y    +   +A  +++LH+    +++H D+KP+NIL+            
Sbjct: 122 VSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQT 178
Query: 245 --ENYRAVVSDFGLSKLMSRDQSRC---ITTIRGTRGYLAPEWILEQG---VSEKCDIYS 296
             EN R ++SDFGL K +   Q      +    GT G+ APE + E     ++   DI+S
Sbjct: 179 GAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFS 238
Query: 297 YGMVL 301
            G V 
Sbjct: 239 MGCVF 243

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 48/90 (53%), Gaps = 9/90 (10%)
Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGY 277
           + L YLH   +  +LH D+KP N+LLDEN    ++DFGL+K      +R       TR Y
Sbjct: 123 QGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYXHQVVTRWY 178
Query: 278 LAPEWILEQ---GVSEKCDIYSYGMVLLEL 304
            APE +      GV    D+++ G +L EL
Sbjct: 179 RAPELLFGARMYGVG--VDMWAVGCILAEL 206

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 90/215 (41%), Gaps = 32/215 (14%)
Query: 107 ALLGHGSSASVFKG-ILSDGTSVAVKRI---NGEENGEKEFRSEVAAIASAQHVNLVRLL 162
           A +G G+   VFK      G  VA+K++   N +E        E+  +   +H N+V L+
Sbjct: 23  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 82
Query: 163 GYCVVPGGPR-------YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR--YRVA 213
             C     P        YLV++F ++               G  S   + + L    RV 
Sbjct: 83  EICRTKASPYNRCKGSIYLVFDFCEHDL------------AGLLSNVLVKFTLSEIKRVM 130
Query: 214 IDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK---LMSRDQSRCITT 270
             +   L Y+H   R+++LH D+K  N+L+  +    ++DFGL++   L    Q      
Sbjct: 131 QMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 187
Query: 271 IRGTRGYLAPEWIL-EQGVSEKCDIYSYGMVLLEL 304
              T  Y  PE +L E+      D++  G ++ E+
Sbjct: 188 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 222

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 92/207 (44%), Gaps = 14/207 (6%)
Query: 106 QALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYC 165
           Q  +  GS  +V  G+ S+G  VA+KR+    +  +       +    + +  +RLL + 
Sbjct: 27  QRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF 86
Query: 166 VVPG--GPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY- 222
             P   G R +   F +      ++     R++       +  D R  ++    +   Y 
Sbjct: 87  HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDL----AQVIHDQRIVISPQHIQYFMYH 142
Query: 223 ----LHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
               LH    + V+H D+ P NILL +N    + DF L++  + D ++  T     R Y 
Sbjct: 143 ILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK--THYVTHRWYR 200
Query: 279 APEWILE-QGVSEKCDIYSYGMVLLEL 304
           APE +++ +G ++  D++S G V+ E+
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEM 227

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 52/94 (55%), Gaps = 10/94 (10%)
Query: 211 RVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYR---AVVSDFGLSKLMSRDQSRC 267
           R+   + + + YLH   ++ ++HLD+KP+NILL   Y      + DFG+S+ +      C
Sbjct: 135 RLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH---AC 188
Query: 268 -ITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMV 300
            +  I GT  YLAPE +    ++   D+++ G++
Sbjct: 189 ELREIMGTPEYLAPEILNYDPITTATDMWNIGII 222

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 5/87 (5%)
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            + +LH+   + ++H D+KP NI++  +    + DFGL++  +   S  +T    TR Y 
Sbjct: 143 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 197
Query: 279 APEWILEQGVSEKCDIYSYGMVLLELT 305
           APE IL  G  E  D++S G ++ E+ 
Sbjct: 198 APEVILGMGYKENVDLWSVGCIMGEMV 224

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 92/207 (44%), Gaps = 14/207 (6%)
Query: 106 QALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYC 165
           Q  +  GS  +V  G+ S+G  VA+KR+    +  +       +    + +  +RLL + 
Sbjct: 27  QRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF 86
Query: 166 VVPG--GPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY- 222
             P   G R +   F +      ++     R++       +  D R  ++    +   Y 
Sbjct: 87  HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDL----AQVIHDQRIVISPQHIQYFMYH 142
Query: 223 ----LHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
               LH    + V+H D+ P NILL +N    + DF L++  + D ++  T     R Y 
Sbjct: 143 ILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK--THYVTHRWYR 200
Query: 279 APEWILE-QGVSEKCDIYSYGMVLLEL 304
           APE +++ +G ++  D++S G V+ E+
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEM 227

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 90/215 (41%), Gaps = 32/215 (14%)
Query: 107 ALLGHGSSASVFKG-ILSDGTSVAVKRI---NGEENGEKEFRSEVAAIASAQHVNLVRLL 162
           A +G G+   VFK      G  VA+K++   N +E        E+  +   +H N+V L+
Sbjct: 24  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 83
Query: 163 GYCVVPGGPR-------YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR--YRVA 213
             C     P        YLV++F ++               G  S   + + L    RV 
Sbjct: 84  EICRTKASPYNRCKGSIYLVFDFCEHDL------------AGLLSNVLVKFTLSEIKRVM 131
Query: 214 IDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK---LMSRDQSRCITT 270
             +   L Y+H   R+++LH D+K  N+L+  +    ++DFGL++   L    Q      
Sbjct: 132 QMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 271 IRGTRGYLAPEWIL-EQGVSEKCDIYSYGMVLLEL 304
              T  Y  PE +L E+      D++  G ++ E+
Sbjct: 189 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 90/215 (41%), Gaps = 32/215 (14%)
Query: 107 ALLGHGSSASVFKG-ILSDGTSVAVKRI---NGEENGEKEFRSEVAAIASAQHVNLVRLL 162
           A +G G+   VFK      G  VA+K++   N +E        E+  +   +H N+V L+
Sbjct: 24  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 83
Query: 163 GYCVVPGGPR-------YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR--YRVA 213
             C     P        YLV++F ++               G  S   + + L    RV 
Sbjct: 84  EICRTKASPYNRCKASIYLVFDFCEHDL------------AGLLSNVLVKFTLSEIKRVM 131
Query: 214 IDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK---LMSRDQSRCITT 270
             +   L Y+H   R+++LH D+K  N+L+  +    ++DFGL++   L    Q      
Sbjct: 132 QMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 271 IRGTRGYLAPEWIL-EQGVSEKCDIYSYGMVLLEL 304
              T  Y  PE +L E+      D++  G ++ E+
Sbjct: 189 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 5/87 (5%)
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            + +LH+   + ++H D+KP NI++  +    + DFGL++  +   S  +T    TR Y 
Sbjct: 132 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 186
Query: 279 APEWILEQGVSEKCDIYSYGMVLLELT 305
           APE IL  G  E  D++S G ++ E+ 
Sbjct: 187 APEVILGMGYKENVDLWSVGCIMGEMV 213

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 90/215 (41%), Gaps = 32/215 (14%)
Query: 107 ALLGHGSSASVFKG-ILSDGTSVAVKRI---NGEENGEKEFRSEVAAIASAQHVNLVRLL 162
           A +G G+   VFK      G  VA+K++   N +E        E+  +   +H N+V L+
Sbjct: 24  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 83
Query: 163 GYCVVPGGPR-------YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR--YRVA 213
             C     P        YLV++F ++               G  S   + + L    RV 
Sbjct: 84  EICRTKASPYNRCKGSIYLVFDFCEHDL------------AGLLSNVLVKFTLSEIKRVM 131
Query: 214 IDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK---LMSRDQSRCITT 270
             +   L Y+H   R+++LH D+K  N+L+  +    ++DFGL++   L    Q      
Sbjct: 132 QMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXN 188
Query: 271 IRGTRGYLAPEWIL-EQGVSEKCDIYSYGMVLLEL 304
              T  Y  PE +L E+      D++  G ++ E+
Sbjct: 189 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 5/90 (5%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQS--RCITTIRG 273
           V+  + YL     S  +H D+   N+LL   + A +SDFGLSK +  D++  +  T  + 
Sbjct: 478 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 534
Query: 274 TRGYLAPEWILEQGVSEKCDIYSYGMVLLE 303
              + APE I     S K D++S+G+++ E
Sbjct: 535 PVKWYAPECINYYKFSSKSDVWSFGVLMWE 564

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 5/90 (5%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           V+  + YL     S  +H D+   N+LL   + A +SDFGLSK +  D++       G  
Sbjct: 120 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKW 176
Query: 276 G--YLAPEWILEQGVSEKCDIYSYGMVLLE 303
              + APE I     S K D++S+G+++ E
Sbjct: 177 PVKWYAPECINYYKFSSKSDVWSFGVLMWE 206

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 100/226 (44%), Gaps = 25/226 (11%)
Query: 87  AGVPIKFRSKELEEATDNFQALLGHGSSASVF-KGILSDGTS--VAVKRINGEENGEKE- 142
           A  P  F  + L++  D  +   GH    S++     +DGT   VAVK +  +   +   
Sbjct: 5   ASDPTVFHKRYLKKIRDLGE---GHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRS 61
Query: 143 -FRSEVAAIASAQHVNLVRLLGYCVVPGGPRY-LVYEFIQNGSLDHWIFPTSRRSEGHYS 200
            ++ E+  + +  H ++++  G C   G     LV E++  GSL  ++    R S G   
Sbjct: 62  GWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHSIG--- 115
Query: 201 GGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM 260
              L+  L +  A  + + ++YLH+      +H ++   N+LLD +    + DFGL+K +
Sbjct: 116 ---LAQLLLF--AQQICEGMAYLHS---QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAV 167
Query: 261 SRDQSRCITTIRGTRG--YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
                       G     + APE + E       D++S+G+ L EL
Sbjct: 168 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 213

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 5/90 (5%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQS--RCITTIRG 273
           V+  + YL     S  +H D+   N+LL   + A +SDFGLSK +  D++  +  T  + 
Sbjct: 479 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 535
Query: 274 TRGYLAPEWILEQGVSEKCDIYSYGMVLLE 303
              + APE I     S K D++S+G+++ E
Sbjct: 536 PVKWYAPECINYYKFSSKSDVWSFGVLMWE 565

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 5/90 (5%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           V+  + YL     S  +H D+   N+LL   + A +SDFGLSK +  D++       G  
Sbjct: 116 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 172
Query: 276 G--YLAPEWILEQGVSEKCDIYSYGMVLLE 303
              + APE I     S K D++S+G+++ E
Sbjct: 173 PVKWYAPECINYYKFSSKSDVWSFGVLMWE 202

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/209 (22%), Positives = 92/209 (44%), Gaps = 34/209 (16%)
Query: 109 LGHGSSASVFKGIL----SDGTSVAVKRING--EENGEKEFRSEVAAIASAQHVNLVRLL 162
           +G G    V +GI     +   +VA+K       ++  ++F  E   +    H ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 163 GYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRV--AIDVAKAL 220
           G  V+   P +++ E    G L  ++    R+          S DL   +  A  ++ AL
Sbjct: 458 G--VITENPVWIIMELCTLGELRSFL--QVRK---------FSLDLASLILYAYQLSTAL 504
Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAP 280
           +YL +    R +H D+   N+L+       + DFGLS+ M        T  + ++G L  
Sbjct: 505 AYLES---KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDS-----TYYKASKGKLPI 556
Query: 281 EWILEQGV-----SEKCDIYSYGMVLLEL 304
           +W+  + +     +   D++ +G+ + E+
Sbjct: 557 KWMAPESINFRRFTSASDVWMFGVCMWEI 585

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 5/90 (5%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           V+  + YL     S  +H D+   N+LL   + A +SDFGLSK +  D++       G  
Sbjct: 114 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 170
Query: 276 G--YLAPEWILEQGVSEKCDIYSYGMVLLE 303
              + APE I     S K D++S+G+++ E
Sbjct: 171 PVKWYAPECINYYKFSSKSDVWSFGVLMWE 200

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 5/90 (5%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           V+  + YL     S  +H D+   N+LL   + A +SDFGLSK +  D++       G  
Sbjct: 126 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 182
Query: 276 G--YLAPEWILEQGVSEKCDIYSYGMVLLE 303
              + APE I     S K D++S+G+++ E
Sbjct: 183 PVKWYAPECINYYKFSSKSDVWSFGVLMWE 212

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 5/90 (5%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           V+  + YL     S  +H D+   N+LL   + A +SDFGLSK +  D++       G  
Sbjct: 120 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 176
Query: 276 G--YLAPEWILEQGVSEKCDIYSYGMVLLE 303
              + APE I     S K D++S+G+++ E
Sbjct: 177 PVKWYAPECINYYKFSSKSDVWSFGVLMWE 206

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 5/90 (5%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           V+  + YL     S  +H D+   N+LL   + A +SDFGLSK +  D++       G  
Sbjct: 134 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 190
Query: 276 G--YLAPEWILEQGVSEKCDIYSYGMVLLE 303
              + APE I     S K D++S+G+++ E
Sbjct: 191 PVKWYAPECINYYKFSSKSDVWSFGVLMWE 220

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 5/90 (5%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           V+  + YL     S  +H D+   N+LL   + A +SDFGLSK +  D++       G  
Sbjct: 136 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 192
Query: 276 G--YLAPEWILEQGVSEKCDIYSYGMVLLE 303
              + APE I     S K D++S+G+++ E
Sbjct: 193 PVKWYAPECINYYKFSSKSDVWSFGVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 46/90 (51%), Gaps = 5/90 (5%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           V+  + YL     S  +H D+   N+LL   + A +SDFGLSK +  D++       G  
Sbjct: 136 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 192
Query: 276 G--YLAPEWILEQGVSEKCDIYSYGMVLLE 303
              + APE I     S K D++S+G+++ E
Sbjct: 193 PVKWYAPECINYYKFSSKSDVWSFGVLMWE 222

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 8/95 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDE---NYRAVVSDFGLSKLMSRDQSRCITTIR 272
           + +A+ YLH+     + H DVKPEN+L      N    ++DFG +K  +   S  +T   
Sbjct: 124 IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTEPC 178
Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
            T  Y+APE +  +   + CD++S G+++  L  G
Sbjct: 179 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 213

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 49/95 (51%), Gaps = 8/95 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDE---NYRAVVSDFGLSKLMSRDQSRCITTIR 272
           + +A+ YLH+     + H DVKPEN+L      N    ++DFG +K  +   S  +TT  
Sbjct: 170 IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPC 224
Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
            T  Y+APE +  +   + CD +S G++   L  G
Sbjct: 225 YTPYYVAPEVLGPEKYDKSCDXWSLGVIXYILLCG 259

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    +  FGL    +R     +T    TR
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILGFGL----ARHTDDEMTGYVATR 186
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 27/218 (12%)
Query: 101 ATDNFQAL--LGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRS---EVAAIASAQ 154
           + +NFQ +  +G G+   V+K      G  VA+K+I  +   E    +   E++ +    
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI 214
           H N+V+LL   +      YLV+E +     D   F  +    G      +   L      
Sbjct: 64  HPNIVKLLD-VIHTENKLYLVFEHVDQ---DLKKFMDASALTG------IPLPLIKSYLF 113
Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS---RDQSRCITTI 271
            + + L++ H+    RVLH D+KP+N+L++      ++DFGL++      R     + T+
Sbjct: 114 QLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL 170
Query: 272 RGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
                Y APE +L  +  S   DI+S G +  E+   R
Sbjct: 171 ----WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 104/249 (41%), Gaps = 53/249 (21%)
Query: 85  KVAGVPIKFRSKELEEATDNF---QALLGHGSSASV-FKGILSDGTSVAVKR--INGEEN 138
           ++A +P        E++  N    + +LG+GSS +V F+G    G  VAVKR  I+  + 
Sbjct: 2   RIANIP------NFEQSLKNLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDI 54
Query: 139 GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGH 198
              E +       S  H N++R   YC         +   + N +L   +         +
Sbjct: 55  ALMEIK---LLTESDDHPNVIRY--YCSETTDRFLYIALELCNLNLQDLV------ESKN 103
Query: 199 YSGGCLSWDLRYR---VAIDVAKALSYLHNDCRSRVLHLDVKPENILLD----------- 244
            S   L     Y    +   +A  +++LH+    +++H D+KP+NIL+            
Sbjct: 104 VSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQT 160
Query: 245 --ENYRAVVSDFGLSKLMSRDQSRC---ITTIRGTRGYLAPEWILEQG-------VSEKC 292
             EN R ++SDFGL K +   Q      +    GT G+ APE + E         ++   
Sbjct: 161 GAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSI 220
Query: 293 DIYSYGMVL 301
           DI+S G V 
Sbjct: 221 DIFSMGCVF 229

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 81/183 (44%), Gaps = 19/183 (10%)
Query: 128 VAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHW 187
           VAVK I   E      + E+    S +H N+VR     + P     +V E+   G L   
Sbjct: 47  VAVKYIERGEKIAANVKREIINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGELFER 105
Query: 188 IFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD--E 245
           I    R SE          + R+     +   +SY H     +V H D+K EN LLD   
Sbjct: 106 ICNAGRFSED---------EARFFFQ-QLISGVSYCH---AMQVCHRDLKLENTLLDGSP 152
Query: 246 NYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK-CDIYSYGMVLLEL 304
             R  + DFG SK  S   S+  +T+ GT  Y+APE +L++    K  D++S G+ L  +
Sbjct: 153 APRLKICDFGYSK-SSVLHSQPKSTV-GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVM 210
Query: 305 TGG 307
             G
Sbjct: 211 LVG 213

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + DF L    +R     +T    TR
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFYL----ARHTDDEMTGYVATR 186
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 25/226 (11%)
Query: 87  AGVPIKFRSKELEEATDNFQALLGHGSSASVF-KGILSDGTS--VAVKRINGEENGEKE- 142
           A  P  F  + L++  D  +   GH    S++     +DGT   VAVK +  +   +   
Sbjct: 5   ASDPTVFHKRYLKKIRDLGE---GHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRS 61
Query: 143 -FRSEVAAIASAQHVNLVRLLGYCVVPGGPRY-LVYEFIQNGSLDHWIFPTSRRSEGHYS 200
            ++ E+  + +  H ++++  G C   G     LV E++  GSL  ++    R S G   
Sbjct: 62  GWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHSIG--- 115
Query: 201 GGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM 260
              L+  L +  A  + + ++YLH       +H ++   N+LLD +    + DFGL+K +
Sbjct: 116 ---LAQLLLF--AQQICEGMAYLHA---QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAV 167
Query: 261 SRDQSRCITTIRGTRG--YLAPEWILEQGVSEKCDIYSYGMVLLEL 304
                       G     + APE + E       D++S+G+ L EL
Sbjct: 168 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 213

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 31/207 (14%)
Query: 108 LLGHGSSAS-VFKGILSDGTSVAVKRINGEENGEKEFRSEVAAI-ASAQHVNLVRLLGYC 165
           +LGHG+  + V++G+  D   VAVKRI  E     +   EV  +  S +H N++R   +C
Sbjct: 31  VLGHGAEGTIVYRGMF-DNRDVAVKRILPECFSFAD--REVQLLRESDEHPNVIRY--FC 85
Query: 166 VVPGGP-RYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH 224
                  +Y+  E     +L  ++    ++   H     ++      +       L++LH
Sbjct: 86  TEKDRQFQYIAIELCA-ATLQEYV---EQKDFAHLGLEPIT------LLQQTTSGLAHLH 135
Query: 225 NDCRSRVLHLDVKPENILLDE-----NYRAVVSDFGLSKLMS--RDQSRCITTIRGTRGY 277
           +     ++H D+KP NIL+         +A++SDFGL K ++  R      + + GT G+
Sbjct: 136 S---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 278 LAPEWILE---QGVSEKCDIYSYGMVL 301
           +APE + E   +  +   DI+S G V 
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVF 219

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 82/183 (44%), Gaps = 19/183 (10%)
Query: 128 VAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHW 187
           VAVK I      ++  + E+    S +H N+VR     + P     ++ E+   G L   
Sbjct: 48  VAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTH-LAIIMEYASGGELYER 106
Query: 188 IFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD--E 245
           I    R SE          + R+     +   +SY H+    ++ H D+K EN LLD   
Sbjct: 107 ICNAGRFSED---------EARFFFQ-QLLSGVSYCHS---MQICHRDLKLENTLLDGSP 153
Query: 246 NYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK-CDIYSYGMVLLEL 304
             R  + DFG SK  S   S+  +T+ GT  Y+APE +L Q    K  D++S G+ L  +
Sbjct: 154 APRLKICDFGYSK-SSVLHSQPKSTV-GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVM 211
Query: 305 TGG 307
             G
Sbjct: 212 LVG 214

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 83/171 (48%), Gaps = 19/171 (11%)
Query: 140 EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           ++E ++E++ +    H NL++L            LV E++  G L   I   S      Y
Sbjct: 130 KEEVKNEISVMNQLDHANLIQLYD-AFESKNDIVLVMEYVDGGELFDRIIDES------Y 182
Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENIL-LDENYRAV-VSDFGLS 257
           +   L   L  +    + + + ++H   +  +LHLD+KPENIL ++ + + + + DFGL+
Sbjct: 183 NLTELDTILFMK---QICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLA 236
Query: 258 KLMSRDQSRCITTIR-GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
           +   R + R    +  GT  +LAPE +    VS   D++S G++   L  G
Sbjct: 237 R---RYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + D GL    +R     +T    TR
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDAGL----ARHTDDEMTGYVATR 186
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/123 (29%), Positives = 58/123 (47%), Gaps = 28/123 (22%)
Query: 229 SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI-------------------- 268
           S ++H D+KP N LL+++    V DFGL++ ++ ++   I                    
Sbjct: 148 SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQ 207
Query: 269 -TTIRGTRGYLAPEWI-LEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQ 326
            T+   TR Y APE I L++  ++  DI+S G +  EL        L  H ND + N++ 
Sbjct: 208 LTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN-----MLQSHINDPT-NRFP 261
Query: 327 YFP 329
            FP
Sbjct: 262 LFP 264

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 49/92 (53%), Gaps = 8/92 (8%)
Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGY 277
           K L Y+H    + ++H D+KP N+ ++E+    + DFGL++    +    +     TR Y
Sbjct: 139 KGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVV----TRWY 191
Query: 278 LAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            APE IL     ++  DI+S G ++ E+  G+
Sbjct: 192 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + D GL    +R     +T    TR
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDRGL----ARHTDDEMTGYVATR 186
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 8/94 (8%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           + + L Y+H+   + ++H D+KP N+ ++E+    + D GL    +R     +T    TR
Sbjct: 134 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDGGL----ARHTDDEMTGYVATR 186
Query: 276 GYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
            Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 50/96 (52%), Gaps = 9/96 (9%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENI-LLDENY---RAVVSDFGLSKLMSRDQSRCITTI 271
           +   + YLH+    ++ H D+KPENI LLD N    R  + DFGL+  +  D       I
Sbjct: 123 ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNI 177
Query: 272 RGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
            GT  ++APE +  + +  + D++S G++   L  G
Sbjct: 178 FGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 58/244 (23%), Positives = 112/244 (45%), Gaps = 44/244 (18%)
Query: 105 FQALLGHGSSASVFKGILSD--------GTSVAVKRIN-GEENGEKEFRSEVAAIASAQH 155
           F   LG G+   +FKG+  +         T V +K ++    N  + F    + ++   H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
            +LV   G C   G    LV EF++ GSLD ++           +  C++   +  VA  
Sbjct: 72  KHLVLNYGVCFC-GDENILVQEFVKFGSLDTYL---------KKNKNCINILWKLEVAKQ 121
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILL--DENYRA------VVSDFGLS-KLMSRDQSR 266
           +A A+ +L     + ++H +V  +NILL  +E+ +        +SD G+S  ++ +D   
Sbjct: 122 LAWAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD--- 175
Query: 267 CITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLEL-TGGRRNVSLIEHGNDKSKNK 324
               ++    ++ PE I   + ++   D +S+G  L E+ +GG + +S ++     S+ K
Sbjct: 176 ---ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-----SQRK 227
Query: 325 WQYF 328
            Q++
Sbjct: 228 LQFY 231

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 51/96 (53%), Gaps = 9/96 (9%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENI-LLDENY---RAVVSDFGLSKLMSRDQSRCITTI 271
           +   + YLH+    R+ H D+KPENI LLD+N    R  + DFG++  +  +       I
Sbjct: 117 ILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKNI 171
Query: 272 RGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
            GT  ++APE +  + +  + D++S G++   L  G
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 51/96 (53%), Gaps = 9/96 (9%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENI-LLDENY---RAVVSDFGLSKLMSRDQSRCITTI 271
           +   + YLH+    R+ H D+KPENI LLD+N    R  + DFG++  +  +       I
Sbjct: 124 ILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKNI 178
Query: 272 RGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
            GT  ++APE +  + +  + D++S G++   L  G
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 51/96 (53%), Gaps = 9/96 (9%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENI-LLDENY---RAVVSDFGLSKLMSRDQSRCITTI 271
           +   + YLH+    R+ H D+KPENI LLD+N    R  + DFG++  +  +       I
Sbjct: 138 ILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKNI 192
Query: 272 RGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
            GT  ++APE +  + +  + D++S G++   L  G
Sbjct: 193 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 47/87 (54%), Gaps = 5/87 (5%)
Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            + +LH+   + ++H D+KP NI++  +    + DFGL++  +   S  +     TR Y 
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMEPEVVTRYYR 192
Query: 279 APEWILEQGVSEKCDIYSYGMVLLELT 305
           APE IL  G  E  DI+S G ++ E+ 
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 71/168 (42%), Gaps = 20/168 (11%)
Query: 143 FRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGG 202
           F+ E+  + S  H N++RL           YLV E    G L   +       E   +  
Sbjct: 53  FKQEIEIMKSLDHPNIIRLYE-TFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA-- 109
Query: 203 CLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILL---DENYRAVVSDFGLSKL 259
                   R+  DV  A++Y H   +  V H D+KPEN L      +    + DFGL+  
Sbjct: 110 --------RIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158
Query: 260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
                 + + T  GT  Y++P+ +LE     +CD +S G+++  L  G
Sbjct: 159 FK--PGKMMRTKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 59/126 (46%), Gaps = 31/126 (24%)
Query: 229 SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ------------------------ 264
           S ++H D+KP N LL+++    + DFGL++ ++ D+                        
Sbjct: 150 SGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHNKNL 209
Query: 265 SRCITTIRGTRGYLAPEWI-LEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKN 323
            + +T+   TR Y APE I L++  +   DI+S G +  EL    ++     H N+ + N
Sbjct: 210 KKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKS-----HINNPT-N 263
Query: 324 KWQYFP 329
           ++  FP
Sbjct: 264 RFPLFP 269

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 71/168 (42%), Gaps = 20/168 (11%)
Query: 143 FRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGG 202
           F+ E+  + S  H N++RL           YLV E    G L   +       E   +  
Sbjct: 70  FKQEIEIMKSLDHPNIIRLYE-TFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA-- 126
Query: 203 CLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILL---DENYRAVVSDFGLSKL 259
                   R+  DV  A++Y H   +  V H D+KPEN L      +    + DFGL+  
Sbjct: 127 --------RIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 175
Query: 260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
                 + + T  GT  Y++P+ +LE     +CD +S G+++  L  G
Sbjct: 176 FK--PGKMMRTKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 220

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 50/96 (52%), Gaps = 9/96 (9%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENI-LLDENY---RAVVSDFGLSKLMSRDQSRCITTI 271
           +   + YLH+    ++ H D+KPENI LLD N    R  + DFGL+  +  D       I
Sbjct: 123 ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNI 177
Query: 272 RGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
            GT  ++APE +  + +  + D++S G++   L  G
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 50/96 (52%), Gaps = 9/96 (9%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENI-LLDENY---RAVVSDFGLSKLMSRDQSRCITTI 271
           +   + YLH+    ++ H D+KPENI LLD N    R  + DFGL+  +  D       I
Sbjct: 123 ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNI 177
Query: 272 RGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
            GT  ++APE +  + +  + D++S G++   L  G
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 50/96 (52%), Gaps = 9/96 (9%)
Query: 216 VAKALSYLHNDCRSRVLHLDVKPENI-LLDENY---RAVVSDFGLSKLMSRDQSRCITTI 271
           +   + YLH+    ++ H D+KPENI LLD N    R  + DFGL+  +  D       I
Sbjct: 123 ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNI 177
Query: 272 RGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG 307
            GT  ++APE +  + +  + D++S G++   L  G
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	453
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-113
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-97
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	9e-95
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-66
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-55
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	7e-55
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-53
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-52
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-49
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-49
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	7e-49
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-48
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	6e-48
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	8e-46
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-45
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-45
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	6e-45
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-44
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-35
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-33
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-32
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-32
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-32
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	9e-32
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-31
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-31
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-31
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	8e-31
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-29
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-29
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-29
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	7e-29
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-28
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-28
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	6e-28
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	7e-28
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-27
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-27
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-27
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-27
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	5e-27
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-27
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	7e-27
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-26
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-26
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-26
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-26
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-26
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-26
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-26
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-26
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	6e-26
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	7e-26
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	7e-26
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	9e-26
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-25
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-25
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-25
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-25
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-25
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-25
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-25
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-25
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-25
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-25
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-25
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-25
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-25
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	8e-25
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	8e-25
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	9e-25
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	9e-25
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-24
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-24
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-24
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-24
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-24
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-24
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-24
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-24
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-24
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-24
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-24
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-24
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	8e-24
4aoj_A	329	High affinity nerve growth factor receptor; transf	9e-24
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	9e-24
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-23
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-23
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-23
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-23
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-23
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-23
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-23
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-23
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-23
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-23
3an0_A	340	Dual specificity mitogen-activated protein kinase;	5e-23
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	5e-23
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-23
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	6e-23
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-23
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	8e-23
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	8e-23
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	8e-23
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	8e-23
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	9e-23
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-22
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-22
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-22
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-22
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-22
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-22
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-22
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-22
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-22
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-22
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-22
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-22
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-22
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-22
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-22
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-22
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-22
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	8e-22
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	9e-22
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	9e-22
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	9e-22
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-21
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-21
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-21
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-21
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-21
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-21
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-21
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-21
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-21
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-21
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-21
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	6e-21
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	8e-21
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-20
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-20
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-20
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-20
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-20
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-20
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	7e-20
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	8e-20
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	8e-20
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-19
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-19
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-19
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	9e-19
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-18
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-18
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-18
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	8e-18
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-17
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-17
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-17
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-17
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	7e-17
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-16
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-16
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	5e-16
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-16
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	7e-16
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-15
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-15
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-15
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-15
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-15
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-15
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-15
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-15
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	7e-15
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	8e-15
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	9e-15
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-14
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-14
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-14
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-14
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-14
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	6e-14
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	7e-14
3o0g_A	292	Cell division protein kinase 5; kinase activator c	7e-14
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	8e-14
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	8e-14
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	9e-14
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-13
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-13
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-13
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-13
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-13
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-13
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-13
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-13
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-13
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-13
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-13
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-13
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-13
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-13
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-13
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	6e-13
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	7e-13
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	9e-13
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-12
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-12
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-12
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-12
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	7e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-11
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-11
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-11
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-11
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-11
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-11
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	5e-11
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	5e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-11
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-10
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-10
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-10
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-08
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-08
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-08
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-07
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-05
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	1e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  334 bits (858), Expect = e-113
 Identities = 126/315 (40%), Positives = 175/315 (55%), Gaps = 21/315 (6%)

Query: 88  GVPIKFRSKELEEATDNFQA--LLGHGSSASVFKGILSDGTSVAVKRINGEEN--GEKEF 143
           G   +F  +EL+ A+DNF    +LG G    V+KG L+DGT VAVKR+  E    GE +F
Sbjct: 15  GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQF 74

Query: 144 RSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGC 203
           ++EV  I+ A H NL+RL G+C+     R LVY ++ NGS+   +       E   S   
Sbjct: 75  QTEVEMISMAVHRNLLRLRGFCM-TPTERLLVYPYMANGSVASCLR------ERPESQPP 127

Query: 204 LSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD 263
           L W  R R+A+  A+ L+YLH+ C  +++H DVK  NILLDE + AVV DFGL+KLM   
Sbjct: 128 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 187

Query: 264 QSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKN 323
            +   T +RGT G++APE++     SEK D++ YG++LLEL  G+R   L    ND    
Sbjct: 188 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 247

Query: 324 --KWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSM 381
              W      V   +KE KL  +VD  L  +G   + +V +L+ VA  C Q     RP M
Sbjct: 248 LLDW------VKGLLKEKKLEALVDVDL--QGNYKDEEVEQLIQVALLCTQSSPMERPKM 299

Query: 382 ARVVEMLEGRVAVDD 396
           + VV MLEG    + 
Sbjct: 300 SEVVRMLEGDGLAER 314

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  293 bits (753), Expect = 4e-97
 Identities = 100/310 (32%), Positives = 163/310 (52%), Gaps = 22/310 (7%)

Query: 92  KFRSKELEEATDNF--QALLGHGSSASVFKGILSDGTSVAVKRIN-GEENGEKEFRSEVA 148
           +    +LEEAT+NF  + L+GHG    V+KG+L DG  VA+KR       G +EF +E+ 
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87

Query: 149 AIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL 208
            ++  +H +LV L+G+C        L+Y++++NG+L   ++ +   +        +SW+ 
Sbjct: 88  TLSFCRHPHLVSLIGFCD-ERNEMILIYKYMENGNLKRHLYGSDLPTM------SMSWEQ 140

Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM-SRDQSRC 267
           R  + I  A+ L YLH      ++H DVK  NILLDEN+   ++DFG+SK     DQ+  
Sbjct: 141 RLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197

Query: 268 ITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQY 327
            T ++GT GY+ PE+ ++  ++EK D+YS+G+VL E+   R  +         +  +W  
Sbjct: 198 STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW-- 255

Query: 328 FPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM 387
                 E    G+L +IVD  L     I    +R+  D A  C+   +  RPSM  V+  
Sbjct: 256 ----AVESHNNGQLEQIVDPNL--ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309

Query: 388 LEGRVAVDDP 397
           LE  + + + 
Sbjct: 310 LEYALRLQES 319

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  287 bits (736), Expect = 9e-95
 Identities = 95/343 (27%), Positives = 159/343 (46%), Gaps = 58/343 (16%)

Query: 72  EGRELRIEYSFLRKVAGVPIKFRSKELEEATDNF--------QALLGHGSSASVFKGILS 123
           E + L +  +           F   EL+  T+NF           +G G    V+KG + 
Sbjct: 1   ENKSLEVSDTRFHS-------FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV- 52

Query: 124 DGTSVAVKRINGEEN-----GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEF 178
           + T+VAVK++    +      +++F  E+  +A  QH NLV LLG+    G    LVY +
Sbjct: 53  NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSS-DGDDLCLVYVY 111

Query: 179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKP 238
           + NGSL   +               LSW +R ++A   A  +++LH +     +H D+K 
Sbjct: 112 MPNGSLLDRLSCLDGTPP-------LSWHMRCKIAQGAANGINFLHENH---HIHRDIKS 161

Query: 239 ENILLDENYRAVVSDFGLSKLMSRDQSRCITT-IRGTRGYLAPEWILEQGVSEKCDIYSY 297
            NILLDE + A +SDFGL++   +     +T+ I GT  Y+APE +  + ++ K DIYS+
Sbjct: 162 ANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSF 220

Query: 298 GMVLLELTGGRRNVSLIEHGNDKSKNK-------WQYFPKIVNEKMKEGKLMEIVDQRLT 350
           G+VLLE+  G   V       D+ +          +          +E  + + +D+++ 
Sbjct: 221 GVVLLEIITGLPAV-------DEHREPQLLLDIKEEIED-------EEKTIEDYIDKKM- 265

Query: 351 DEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA 393
                D T V  +  VA  C+ E+   RP + +V ++L+   A
Sbjct: 266 --NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  213 bits (545), Expect = 5e-66
 Identities = 69/316 (21%), Positives = 121/316 (38%), Gaps = 42/316 (13%)

Query: 97  ELEEATDNFQ--ALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQ 154
            L   +   Q   +   G    V+K  L     VAVK    ++    +   EV ++   +
Sbjct: 18  NLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMK 76

Query: 155 HVNLVRLLGYCVVPGGP---RYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYR 211
           H N+++ +G            +L+  F + GSL  ++               +SW+    
Sbjct: 77  HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-----------KANVVSWNELCH 125

Query: 212 VAIDVAKALSYLHND-------CRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ 264
           +A  +A+ L+YLH D        +  + H D+K +N+LL  N  A ++DFGL+      +
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185

Query: 265 SRCITTIR-GTRGYLAPEWILEQGV------SEKCDIYSYGMVLLELTGGRRNVSLIEHG 317
           S   T  + GTR Y+APE +LE  +        + D+Y+ G+VL EL             
Sbjct: 186 SAGDTHGQVGTRRYMAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA------ 238

Query: 318 NDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTD----EGGIDETQVRRLVDVAFWCIQE 373
           +         F + + +      + E+V  +       +       +  L +    C   
Sbjct: 239 DGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDH 298

Query: 374 RARLRPSMARVVEMLE 389
            A  R S   V E + 
Sbjct: 299 DAEARLSAGCVGERIT 314

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  185 bits (472), Expect = 2e-55
 Identities = 65/288 (22%), Positives = 120/288 (41%), Gaps = 43/288 (14%)

Query: 105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGY 164
            + ++G G+   V K        VA+K+I  E    K F  E+  ++   H N+V+L G 
Sbjct: 12  VEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE-RKAFIVELRQLSRVNHPNIVKLYGA 69

Query: 165 CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH 224
           C+    P  LV E+ + GSL + +                +        +  ++ ++YLH
Sbjct: 70  CL---NPVCLVMEYAEGGSLYNVLHGAEPLPY-------YTAAHAMSWCLQCSQGVAYLH 119

Query: 225 NDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWI 283
           +     ++H D+KP N+LL      + + DFG     + D    +T  +G+  ++APE  
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT----ACDIQTHMTNNKGSAAWMAPEVF 175

Query: 284 LEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLME 343
                SEKCD++S+G++L E+   R                 + F +I        ++M 
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRR-----------------KPFDEIGGPAF---RIMW 215

Query: 344 IVDQ--RLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE 389
            V    R      + +   + +  +   C  +    RPSM  +V+++ 
Sbjct: 216 AVHNGTRPP----LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMT 259

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  184 bits (469), Expect = 7e-55
 Identities = 74/288 (25%), Positives = 130/288 (45%), Gaps = 37/288 (12%)

Query: 105 FQALLGHGSSASVFKGILSDGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRL 161
            +  +G GS  +V +     G+ VAVK +  +        EF  EVA +   +H N+V  
Sbjct: 41  IKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99

Query: 162 LGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALS 221
           +G    P     +V E++  GSL   +  +  R +       L    R  +A DVAK ++
Sbjct: 100 MGAVTQPP-NLSIVTEYLSRGSLYRLLHKSGAREQ-------LDERRRLSMAYDVAKGMN 151

Query: 222 YLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPE 281
           YLHN     ++H ++K  N+L+D+ Y   V DFGLS+L +        +  GT  ++APE
Sbjct: 152 YLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS-SKSAAGTPEWMAPE 209

Query: 282 WILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKL 341
            + ++  +EK D+YS+G++L EL   +                 Q +  +   ++     
Sbjct: 210 VLRDEPSNEKSDVYSFGVILWELATLQ-----------------QPWGNLNPAQVVAAVG 252

Query: 342 MEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE 389
            +   +RL     ++  QV  +++    C       RPS A ++++L 
Sbjct: 253 FK--CKRLEIPRNLNP-QVAAIIE---GCWTNEPWKRPSFATIMDLLR 294

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  181 bits (460), Expect = 2e-53
 Identities = 70/332 (21%), Positives = 130/332 (39%), Gaps = 51/332 (15%)

Query: 91  IKFRSKELEEATDNFQ--ALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSE-- 146
           ++  + E     DN +   L+G G   +V+KG L D   VAVK  +      + F +E  
Sbjct: 1   MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN--RQNFINEKN 57

Query: 147 VAAIASAQHVNLVRLLGYCVVPGGP----RYLVYEFIQNGSLDHWIFPTSRRSEGHYSGG 202
           +  +   +H N+ R +               LV E+  NGSL  ++   +          
Sbjct: 58  IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---------- 107

Query: 203 CLSWDLRYRVAIDVAKALSYLHND------CRSRVLHLDVKPENILLDENYRAVVSDFGL 256
              W    R+A  V + L+YLH +       +  + H D+   N+L+  +   V+SDFGL
Sbjct: 108 -SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL 166

Query: 257 SKLMSRD-------QSRCITTIRGTRGYLAPEWILEQGVS--------EKCDIYSYGMVL 301
           S  ++ +       +     +  GT  Y+APE +LE  V+        ++ D+Y+ G++ 
Sbjct: 167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIY 225

Query: 302 LELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLT----DEGGIDE 357
            E+    R   L    +     +  +  ++ N    E   + +  ++      +    + 
Sbjct: 226 WEIF--MRCTDLFPGESVPE-YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENS 282

Query: 358 TQVRRLVDVAFWCIQERARLRPSMARVVEMLE 389
             VR L +    C  + A  R +     E + 
Sbjct: 283 LAVRSLKETIEDCWDQDAEARLTAQXAEERMA 314

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  176 bits (448), Expect = 4e-52
 Identities = 71/301 (23%), Positives = 123/301 (40%), Gaps = 54/301 (17%)

Query: 105 FQALLGHGSSASVFKGI-LSDGTSVAVKRINGEENGE--------KEFRSEVAAIASAQH 155
           ++  +G G    V KG  + D + VA+K +   ++          +EF+ EV  +++  H
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82

Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
            N+V+L G       P  +V EF+  G L H +               + W ++ R+ +D
Sbjct: 83  PNIVKLYGLMH---NPPRMVMEFVPCGDLYHRL---------LDKAHPIKWSVKLRLMLD 130

Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDE-----NYRAVVSDFGLSKLMSRDQSRCITT 270
           +A  + Y+ N     ++H D++  NI L          A V+DFGL    S+     ++ 
Sbjct: 131 IALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL----SQQSVHSVSG 185

Query: 271 IRGTRGYLAPEWILEQG--VSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYF 328
           + G   ++APE I  +    +EK D YS+ M+L  +  G                    F
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE-----------------GPF 228

Query: 329 PKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEML 388
            +    K+K   ++     R T    I E    RL +V   C     + RP  + +V+ L
Sbjct: 229 DEYSYGKIKFINMIREEGLRPT----IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

Query: 389 E 389
            
Sbjct: 285 S 285

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  168 bits (428), Expect = 2e-49
 Identities = 55/293 (18%), Positives = 108/293 (36%), Gaps = 46/293 (15%)

Query: 104 NFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGE---KEFRSEVAAIASAQHVNLVR 160
           NF   L    S  ++KG    G  + VK +   +      ++F  E   +    H N++ 
Sbjct: 13  NFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71

Query: 161 LLGYCVVPGGPRY-LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKA 219
           +LG C  P  P   L+  ++  GSL + +   +           +      + A+D+A+ 
Sbjct: 72  VLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV--------VDQSQAVKFALDMARG 123

Query: 220 LSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLA 279
           +++LH      +    +   ++++DE+  A +S   +                    ++A
Sbjct: 124 MAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS------PGRMYAPAWVA 176

Query: 280 PEWILEQG---VSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKM 336
           PE + ++         D++S+ ++L EL                       F  + N ++
Sbjct: 177 PEALQKKPEDTNRRSADMWSFAVLLWELVTRE-----------------VPFADLSNMEI 219

Query: 337 KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE 389
                +E    R T   GI    V +L+     C+ E    RP    +V +LE
Sbjct: 220 GMKVALE--GLRPTIPPGISP-HVSKLMK---ICMNEDPAKRPKFDMIVPILE 266

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  169 bits (430), Expect = 3e-49
 Identities = 61/314 (19%), Positives = 107/314 (34%), Gaps = 56/314 (17%)

Query: 94  RSKELEEATDNFQALLGHGSSASVFKGIL-SDGTSVAVKRI-NGEENGEKEFRSEVAAIA 151
             +    +      +LG G      K      G  + +K +   +E  ++ F  EV  + 
Sbjct: 3   PHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMR 62

Query: 152 SAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYR 211
             +H N+++ +G           + E+I+ G+L   I                 W  R  
Sbjct: 63  CLEHPNVLKFIGVLYKDK-RLNFITEYIKGGTLRGII---------KSMDSQYPWSQRVS 112

Query: 212 VAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD-------- 263
            A D+A  ++YLH      ++H D+   N L+ EN   VV+DFGL++LM  +        
Sbjct: 113 FAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169

Query: 264 -----QSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGN 318
                  +   T+ G   ++APE I  +   EK D++S+G+VL E+ G            
Sbjct: 170 SLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN--------- 220

Query: 319 DKSKNKWQYFP---KIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERA 375
                    +          ++                            +   C     
Sbjct: 221 -----ADPDYLPRTMDFGLNVRGFLDRYCPP-------NCPP----SFFPITVRCCDLDP 264

Query: 376 RLRPSMARVVEMLE 389
             RPS  ++   LE
Sbjct: 265 EKRPSFVKLEHWLE 278

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  167 bits (424), Expect = 7e-49
 Identities = 65/298 (21%), Positives = 112/298 (37%), Gaps = 52/298 (17%)

Query: 105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGE-----KEFRSEVAAIASAQHVNLV 159
            + ++G G    V++     G  VAVK    + + +     +  R E    A  +H N++
Sbjct: 11  LEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 160 RLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKA 219
            L G C+       LV EF + G L+  +               +  D+    A+ +A+ 
Sbjct: 70  ALRGVCLKEP-NLCLVMEFARGGPLNRVL----SGKR-------IPPDILVNWAVQIARG 117

Query: 220 LSYLHNDCRSRVLHLDVKPENILLDENYRAV--------VSDFGLSKLMSRDQSRCITTI 271
           ++YLH++    ++H D+K  NIL+ +             ++DFGL++   R       + 
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSA 174

Query: 272 RGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKI 331
            G   ++APE I     S+  D++SYG++L EL  G                    F  I
Sbjct: 175 AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE-----------------VPFRGI 217

Query: 332 VNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE 389
               +  G  M      L     I  T       +   C       RPS   +++ L 
Sbjct: 218 DGLAVAYGVAMN--KLALP----IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  167 bits (425), Expect = 3e-48
 Identities = 62/304 (20%), Positives = 117/304 (38%), Gaps = 36/304 (11%)

Query: 105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGY 164
               +G G    V+ G    G  VAVK     E       +E+      +H N++  +  
Sbjct: 41  MVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99

Query: 165 CVVPGGPR---YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALS 221
            +   G     YL+ ++ +NGSL  ++      +        L      ++A      L 
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYL---KSTT--------LDAKSMLKLAYSSVSGLC 148

Query: 222 YLHNDCRSR-----VLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSR---CITTIRG 273
           +LH +  S      + H D+K +NIL+ +N    ++D GL+     D +       T  G
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208

Query: 274 TRGYLAPEWILEQGV-------SEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQ 326
           T+ Y+ PE +L++ +           D+YS+G++L E+     +  ++E       +   
Sbjct: 209 TKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267

Query: 327 YFPKIVNEKMKEGKLMEIVDQRLT-DEGGIDETQVRRLVDVAFWCIQERARLRPSMARVV 385
             P    E M+E   ++    R +       +  +R++  +   C       R +  RV 
Sbjct: 268 SDPSY--EDMREIVCIK--KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323

Query: 386 EMLE 389
           + L 
Sbjct: 324 KTLA 327

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  165 bits (419), Expect = 6e-48
 Identities = 72/296 (24%), Positives = 120/296 (40%), Gaps = 58/296 (19%)

Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYC 165
           +G GS  +V+KG       VAVK +N         + F++EV  +   +HVN++  +GY 
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89

Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
             P     +V ++ +  SL H +         H S           +A   A+ + YLH 
Sbjct: 90  TAP--QLAIVTQWCEGSSLYHHL---------HASETKFEMKKLIDIARQTARGMDYLH- 137

Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ-SRCITTIRGTRGYLAPEWIL 284
                ++H D+K  NI L E+    + DFGL+   SR   S     + G+  ++APE I 
Sbjct: 138 --AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195

Query: 285 EQG---VSEKCDIYSYGMVLLELTGGR---RNVSLIEH-----GNDKSKNKWQYFPKIVN 333
            Q     S + D+Y++G+VL EL  G+    N++  +      G                
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCP 255

Query: 334 EKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE 389
           ++MK   LM                           C++++   RPS  R++  +E
Sbjct: 256 KRMKR--LMA-------------------------ECLKKKRDERPSFPRILAEIE 284

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  160 bits (407), Expect = 8e-46
 Identities = 61/304 (20%), Positives = 114/304 (37%), Gaps = 61/304 (20%)

Query: 105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGE---KEFRSEVAAIASAQHVNLVRL 161
              L+G G    V+ G    G  VA++ I+ E + E   K F+ EV A    +H N+V  
Sbjct: 37  IGELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94

Query: 162 LGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALS 221
           +G C+ P     ++    +  +L   +           +   L  +   ++A ++ K + 
Sbjct: 95  MGACMSP-PHLAIITSLCKGRTLYSVV---------RDAKIVLDVNKTRQIAQEIVKGMG 144

Query: 222 YLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR----DQSRCITTIRGTRGY 277
           YLH      +LH D+K +N+  D   + V++DFGL  +        +   +    G   +
Sbjct: 145 YLHA---KGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200

Query: 278 LAPEWI---------LEQGVSEKCDIYSYGMVLLELTGGR---RNVSLIEHGNDKSKNKW 325
           LAPE I          +   S+  D+++ G +  EL       +                
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA---------- 250

Query: 326 QYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVV 385
                 +  +M  G    +    +  E          + D+  +C       RP+  +++
Sbjct: 251 ------IIWQMGTGMKPNLSQIGMGKE----------ISDILLFCWAFEQEERPTFTKLM 294

Query: 386 EMLE 389
           +MLE
Sbjct: 295 DMLE 298

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  159 bits (403), Expect = 2e-45
 Identities = 61/317 (19%), Positives = 128/317 (40%), Gaps = 47/317 (14%)

Query: 95  SKELEEATDNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQ 154
           ++++          +G G    V++G    G +VAVK  +  +       +E+      +
Sbjct: 7   ARDIT-----LLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVMLR 60

Query: 155 HVNLVRLLGYCVVPGGPR---YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYR 211
           H N++  +   +         +L+  + + GSL  ++               L      R
Sbjct: 61  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-----------QLTTLDTVSCLR 109

Query: 212 VAIDVAKALSYLHNDCRSR-----VLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSR 266
           + + +A  L++LH +         + H D+K +NIL+ +N +  ++D GL+ + S+  ++
Sbjct: 110 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 169

Query: 267 ---CITTIRGTRGYLAPEWILEQGV-------SEKCDIYSYGMVLLELTGGRRNVSLIEH 316
                    GT+ Y+APE +L++ +        ++ DI+++G+VL E+   RR VS    
Sbjct: 170 LDVGNNPRVGTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVA--RRMVSNGIV 226

Query: 317 GNDKSKNKWQYFPKIVNEKMKEGKLMEIV---DQRLT-DEGGIDETQVRRLVDVAFWCIQ 372
            + K       F  +V        + ++V    QR         +  +  L  +   C  
Sbjct: 227 EDYK-----PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWY 281

Query: 373 ERARLRPSMARVVEMLE 389
           +    R +  R+ + L 
Sbjct: 282 QNPSARLTALRIKKTLT 298

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  157 bits (398), Expect = 3e-44
 Identities = 59/307 (19%), Positives = 118/307 (38%), Gaps = 42/307 (13%)

Query: 105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGY 164
            Q  +G G    V++G    G  VAVK  +  E       +E+      +H N++  +  
Sbjct: 46  LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104

Query: 165 CVVPGGPR---YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALS 221
                G     +LV ++ ++GSL  ++   +R +        ++ +   ++A+  A  L+
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYT--------VTVEGMIKLALSTASGLA 153

Query: 222 YLHNDCRSR-----VLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC---ITTIRG 273
           +LH +         + H D+K +NIL+ +N    ++D GL+                  G
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 213

Query: 274 TRGYLAPEWILEQGV-------SEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQ 326
           T+ Y+APE +L+  +        ++ DIY+ G+V  E+            G      +  
Sbjct: 214 TKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEI------ARRCSIGGIHEDYQLP 266

Query: 327 YFPKIVNEKMKEGKLMEIV---DQRLT-DEGGIDETQVRRLVDVAFWCIQERARLRPSMA 382
           Y+  +V       ++ ++V     R            +R +  +   C       R +  
Sbjct: 267 YY-DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 325

Query: 383 RVVEMLE 389
           R+ + L 
Sbjct: 326 RIKKTLS 332

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  132 bits (333), Expect = 2e-35
 Identities = 76/285 (26%), Positives = 108/285 (37%), Gaps = 50/285 (17%)

Query: 103 DNFQAL--LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKE---FRSEVAAIAS-AQH 155
            +FQ L  LGHGS   VFK     DG   AVKR      G K+     +EV +     QH
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116

Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
              VRL       GG  YL  E     SL                G  L     +    D
Sbjct: 117 PCCVRLEQ-AWEEGGILYLQTELCG-PSLQQHC---EAW------GASLPEAQVWGYLRD 165

Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
              AL++LH+     ++HLDVKP NI L    R  + DFGL   +    +       G  
Sbjct: 166 TLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG--EVQEGDP 220

Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEK 335
            Y+APE +L+       D++S G+ +LE+        L   G       WQ        +
Sbjct: 221 RYMAPE-LLQGSYGTAADVFSLGLTILEVACNM---ELPHGGEG-----WQ--------Q 263

Query: 336 MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPS 380
           +++G L       L+ E        R ++      ++   +LR +
Sbjct: 264 LRQGYLPPEFTAGLSSEL-------RSVLV---MMLEPDPKLRAT 298

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  125 bits (317), Expect = 4e-33
 Identities = 60/284 (21%), Positives = 116/284 (40%), Gaps = 45/284 (15%)

Query: 105 FQALLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKE---FRSEVAAIASAQHVNLVR 160
           F   +G GS  +V+KG+       VA   +   +  + E   F+ E   +   QH N+VR
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89

Query: 161 LLGYCVVPGGPR---YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
                      +    LV E + +G+L  ++    +R         +   +       + 
Sbjct: 90  FYDSWESTVKGKKCIVLVTELMTSGTLKTYL----KR------FKVMKIKVLRSWCRQIL 139

Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSRDQSRCITTIRGTRG 276
           K L +LH      ++H D+K +NI +     +V + D GL+ L     ++    + GT  
Sbjct: 140 KGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPE 195

Query: 277 YLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKM 336
           ++APE + E+   E  D+Y++GM +LE+          E+   + +N  Q + + V   +
Sbjct: 196 FMAPE-MYEEKYDESVDVYAFGMCMLEMATS-------EYPYSECQNAAQIY-RRVTSGV 246

Query: 337 KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPS 380
           K     ++              +V+ +++    CI++    R S
Sbjct: 247 KPASFDKVAIP-----------EVKEIIE---GCIRQNKDERYS 276

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  124 bits (313), Expect = 1e-32
 Identities = 57/213 (26%), Positives = 92/213 (43%), Gaps = 32/213 (15%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGY-- 164
           L+G G    VFK     DG +  +KR+       ++   EV A+A   HVN+V   G   
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWD 74

Query: 165 -------------CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYR 211
                                ++  EF   G+L+ WI            G  L   L   
Sbjct: 75  GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI--------EKRRGEKLDKVLALE 126

Query: 212 VAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTI 271
           +   + K + Y+H+    ++++ D+KP NI L +  +  + DFGL   +  D  R  T  
Sbjct: 127 LFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--TRS 181

Query: 272 RGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
           +GT  Y++PE I  Q   ++ D+Y+ G++L EL
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 214

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  124 bits (312), Expect = 2e-32
 Identities = 56/222 (25%), Positives = 90/222 (40%), Gaps = 35/222 (15%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKRIN--GEENGEKEFRSEVAAIASAQHVNLVRLLGY 164
            LG G    VF+     D  + A+KRI     E   ++   EV A+A  +H  +VR    
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71

Query: 165 C-----------VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVA 213
                         P    Y+  +  +  +L  W+   + R         +   +     
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM---NGRCTIEERERSVCLHI----F 124

Query: 214 IDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC------ 267
           + +A+A+ +LH+     ++H D+KP NI    +    V DFGL   M +D+         
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 268 -----ITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL 304
                 T   GT+ Y++PE I     S K DI+S G++L EL
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  124 bits (314), Expect = 3e-32
 Identities = 53/213 (24%), Positives = 90/213 (42%), Gaps = 19/213 (8%)

Query: 103 DNFQAL--LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRS---EVAAIASAQHV 156
           + +  L  +G GS           DG    +K IN      KE      EVA +A+ +H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 157 NLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDV 216
           N+V+         G  Y+V ++ + G L   I       +G         D      + +
Sbjct: 84  NIVQYRE-SFEENGSLYIVMDYCEGGDLFKRI----NAQKGVL----FQEDQILDWFVQI 134

Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG 276
             AL ++H     ++LH D+K +NI L ++    + DFG++++++           GT  
Sbjct: 135 CLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA-RACIGTPY 190

Query: 277 YLAPEWILEQGVSEKCDIYSYGMVLLELTGGRR 309
           YL+PE    +  + K DI++ G VL EL   + 
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLKH 223

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  122 bits (308), Expect = 9e-32
 Identities = 61/227 (26%), Positives = 94/227 (41%), Gaps = 39/227 (17%)

Query: 105 FQALLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLG 163
             A+LG G+   V K     D    A+K+I   E       SEV  +AS  H  +VR   
Sbjct: 10  EIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYA 69

Query: 164 YCVVPGGPR------------YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYR 211
             +                  ++  E+ +NG+L   I      SE         W    R
Sbjct: 70  AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI-----HSENLNQQRDEYW----R 120

Query: 212 VAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI--- 268
           +   + +ALSY+H+     ++H D+KP NI +DE+    + DFGL+K + R         
Sbjct: 121 LFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177

Query: 269 ----------TTIRGTRGYLAPEWILEQGV-SEKCDIYSYGMVLLEL 304
                     T+  GT  Y+A E +   G  +EK D+YS G++  E+
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  121 bits (306), Expect = 2e-31
 Identities = 61/292 (20%), Positives = 113/292 (38%), Gaps = 39/292 (13%)

Query: 103 DNFQAL--LGHGSSASVFKGI-LSDGTSVAVKRIN-GEENGEKE---FRSEVAAIASAQH 155
            NF+    +G G  + V++   L DG  VA+K++   +    K       E+  +    H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
            N+++      +      +V E    G L   I     + +       +     ++  + 
Sbjct: 92  PNVIKYYA-SFIEDNELNIVLELADAGDLSRMI--KHFKKQKRL----IPERTVWKYFVQ 144

Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           +  AL ++H+    RV+H D+KP N+ +       + D GL +  S   +    ++ GT 
Sbjct: 145 LCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA-HSLVGTP 200

Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEK 335
            Y++PE I E G + K DI+S G +L E+   +              N +    KI    
Sbjct: 201 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF------YGDKMNLYSLCKKIEQ-- 252

Query: 336 MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM 387
                   +     ++E       +R+LV+    CI      RP +  V ++
Sbjct: 253 ---CDYPPLPSDHYSEE-------LRQLVN---MCINPDPEKRPDVTYVYDV 291

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  120 bits (303), Expect = 3e-31
 Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 16/216 (7%)

Query: 103 DNFQAL--LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKE---FRSEVAAIASAQHV 156
           ++++ L  +G GS     K    SDG  +  K ++     E E     SEV  +   +H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 157 NLVRLLGYCVVPGGPR-YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
           N+VR     +       Y+V E+ + G L   I  T    E  Y    L  +   RV   
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI--TKGTKERQY----LDEEFVLRVMTQ 119

Query: 216 VAKALSYLH--NDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRG 273
           +  AL   H  +D    VLH D+KP N+ LD      + DFGL+++++ D S   T + G
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-G 178

Query: 274 TRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRR 309
           T  Y++PE +     +EK DI+S G +L EL     
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 214

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  122 bits (309), Expect = 4e-31
 Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 28/217 (12%)

Query: 104 NFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAA-IASAQHVNLVRLL 162
             + +LGHG+  ++    + D   VAVKRI  E         EV     S +H N++R  
Sbjct: 27  CPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYF 84

Query: 163 GYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY 222
                    +Y+  E     +L  ++     + +  + G          +       L++
Sbjct: 85  CTEKDRQF-QYIAIELCA-ATLQEYV----EQKDFAHLG-----LEPITLLQQTTSGLAH 133

Query: 223 LHNDCRSRVLHLDVKPENILLDE-----NYRAVVSDFGLSKLMSRDQS--RCITTIRGTR 275
           LH+     ++H D+KP NIL+         +A++SDFGL K ++  +      + + GT 
Sbjct: 134 LHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190

Query: 276 GYLAPEWILE---QGVSEKCDIYSYGMVLLE-LTGGR 308
           G++APE + E   +  +   DI+S G V    ++ G 
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS 227

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  119 bits (300), Expect = 8e-31
 Identities = 52/234 (22%), Positives = 82/234 (35%), Gaps = 42/234 (17%)

Query: 102 TDNFQ--ALLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRS---EVAAIAS-AQ 154
           T  F     +G G   SVFK +   DG   A+KR      G  + ++   EV A A   Q
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI 214
           H ++VR             +  E+   GSL   I      SE +             + +
Sbjct: 70  HSHVVRYFS-AWAEDDHMLIQNEYCNGGSLADAI------SENYRIMSYFKEAELKDLLL 122

Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVS-------------------DFG 255
            V + L Y+H+     ++H+D+KP NI +        +                   D G
Sbjct: 123 QVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179

Query: 256 LSKLMSRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
               +S  Q        G   +LA E + E      K DI++  + ++   G  
Sbjct: 180 HVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  116 bits (292), Expect = 2e-29
 Identities = 56/210 (26%), Positives = 83/210 (39%), Gaps = 24/210 (11%)

Query: 106 QALLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGY 164
           Q  +G GS   V +      G   AVK++  E    +E    + A A      +V L G 
Sbjct: 63  QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEE----LVACAGLSSPRIVPLYG- 117

Query: 165 CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH 224
            V  G    +  E ++ GSL   I             GCL  D          + L YLH
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLI----------KQMGCLPEDRALYYLGQALEGLEYLH 167

Query: 225 NDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSRDQSRCIT----TIRGTRGYLA 279
                R+LH DVK +N+LL  +     + DFG +  +  D           I GT  ++A
Sbjct: 168 T---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMA 224

Query: 280 PEWILEQGVSEKCDIYSYGMVLLELTGGRR 309
           PE ++ +    K DI+S   ++L +  G  
Sbjct: 225 PEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  119 bits (300), Expect = 2e-29
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 14/206 (6%)

Query: 105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGY 164
            +  LG G    V+ G  +  T VA+K +       + F  E   +   +H  LV+L   
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA- 329

Query: 165 CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH 224
            VV   P Y+V E++  GSL  ++    +   G Y    L       +A  +A  ++Y+ 
Sbjct: 330 -VVSEEPIYIVTEYMSKGSLLDFL----KGETGKY----LRLPQLVDMAAQIASGMAYVE 380

Query: 225 NDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWIL 284
              R   +H D++  NIL+ EN    V+DFGL++L+  ++       +    + APE  L
Sbjct: 381 ---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 437

Query: 285 EQGVSEKCDIYSYGMVLLEL-TGGRR 309
               + K D++S+G++L EL T GR 
Sbjct: 438 YGRFTIKSDVWSFGILLTELTTKGRV 463

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  117 bits (294), Expect = 6e-29
 Identities = 59/246 (23%), Positives = 99/246 (40%), Gaps = 41/246 (16%)

Query: 94  RSKELEEATDNFQAL------LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEV 147
           R   +     + + L      LG+GSS +V       G  VAVKR+  +         E+
Sbjct: 2   RIANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF--CDIALMEI 59

Query: 148 AA-IASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSW 206
                S  H N++R            Y+  E   N +L   +     ++    +      
Sbjct: 60  KLLTESDDHPNVIRYYCSETTDRF-LYIALELC-NLNLQDLV---ESKNVSDENLKLQKE 114

Query: 207 DLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD-------------ENYRAVVSD 253
                +   +A  +++LH+    +++H D+KP+NIL+              EN R ++SD
Sbjct: 115 YNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171

Query: 254 FGLSKLMSRDQSRCITTIR---GTRGYLAPEWILE-------QGVSEKCDIYSYGMVLLE 303
           FGL K +   QS   T +    GT G+ APE + E       + ++   DI+S G V   
Sbjct: 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYY 231

Query: 304 -LTGGR 308
            L+ G+
Sbjct: 232 ILSKGK 237

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  117 bits (294), Expect = 7e-29
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 14/206 (6%)

Query: 105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGY 164
            +  LG G    V+ G  +  T VA+K +       + F  E   +   +H  LV+L   
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA- 246

Query: 165 CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH 224
            VV   P Y+V E++  GSL  ++    +   G Y    L       +A  +A  ++Y+ 
Sbjct: 247 -VVSEEPIYIVTEYMSKGSLLDFL----KGETGKY----LRLPQLVDMAAQIASGMAYVE 297

Query: 225 NDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWIL 284
              R   +H D++  NIL+ EN    V+DFGL++L+  ++       +    + APE  L
Sbjct: 298 ---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 354

Query: 285 EQGVSEKCDIYSYGMVLLEL-TGGRR 309
               + K D++S+G++L EL T GR 
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRV 380

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  115 bits (289), Expect = 1e-28
 Identities = 58/236 (24%), Positives = 93/236 (39%), Gaps = 26/236 (11%)

Query: 83  LRKVAGVPIKFRSKELEEATDNFQALLGHGSSASVFKGIL-SDGTSVAVKRINGE--ENG 139
              V    +      L          +G G+   VF G L +D T VAVK        + 
Sbjct: 96  SGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDL 155

Query: 140 EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHY 199
           + +F  E   +    H N+VRL+G C     P Y+V E +Q G    ++     R+EG  
Sbjct: 156 KAKFLQEARILKQYSHPNIVRLIGVCTQ-KQPIYIVMELVQGGDFLTFL-----RTEGAR 209

Query: 200 SGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL 259
               L      ++  D A  + YL        +H D+   N L+ E     +SDFG+S+ 
Sbjct: 210 ----LRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSRE 262

Query: 260 MSRDQSRCITTIRGTRGYL-----APEWILEQGVSEKCDIYSYGMVLLEL-TGGRR 309
            +      +    G    +     APE +     S + D++S+G++L E  + G  
Sbjct: 263 EADG----VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGAS 314

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  112 bits (282), Expect = 6e-28
 Identities = 51/218 (23%), Positives = 94/218 (43%), Gaps = 33/218 (15%)

Query: 108 LLGHGSSASVFKGILSDGTSVAVKRINGEENGEKE---FRSEVAAIASAQHVNL--VRLL 162
            +G G S+ VF+ +       A+K +N EE   +    +R+E+A +   Q  +   +RL 
Sbjct: 16  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75

Query: 163 GYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY 222
            Y +      Y+V E   N  L+ W+               +    R     ++ +A+  
Sbjct: 76  DYEITDQY-IYMVMEC-GNIDLNSWL----------KKKKSIDPWERKSYWKNMLEAVHT 123

Query: 223 LHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI-TTIRGTRGYLAPE 281
           +H   +  ++H D+KP N L+ +     + DFG++  M  D +  +  +  GT  Y+ PE
Sbjct: 124 IH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179

Query: 282 WILEQG-----------VSEKCDIYSYGMVLLELTGGR 308
            I +             +S K D++S G +L  +T G+
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  112 bits (281), Expect = 6e-28
 Identities = 49/218 (22%), Positives = 92/218 (42%), Gaps = 33/218 (15%)

Query: 108 LLGHGSSASVFKGILSDGTSVAVKRIN---GEENGEKEFRSEVAAIASAQHVNL--VRLL 162
            +G G S+ VF+ +       A+K +N    +      +R+E+A +   Q  +   +RL 
Sbjct: 35  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94

Query: 163 GYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY 222
            Y +      Y+V E   N  L+ W+               +    R     ++ +A+  
Sbjct: 95  DYEITDQY-IYMVMEC-GNIDLNSWL----------KKKKSIDPWERKSYWKNMLEAVHT 142

Query: 223 LHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI-TTIRGTRGYLAPE 281
           +H   +  ++H D+KP N L+ +     + DFG++  M  D +  +  +  GT  Y+ PE
Sbjct: 143 IH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 198

Query: 282 WILEQG-----------VSEKCDIYSYGMVLLELTGGR 308
            I +             +S K D++S G +L  +T G+
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  113 bits (284), Expect = 7e-28
 Identities = 50/218 (22%), Positives = 93/218 (42%), Gaps = 33/218 (15%)

Query: 108 LLGHGSSASVFKGILSDGTSVAVKRINGEENGEKE---FRSEVAAIASAQHVNL--VRLL 162
            +G G S+ VF+ +       A+K +N EE   +    +R+E+A +   Q  +   +RL 
Sbjct: 63  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122

Query: 163 GYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY 222
            Y +      Y+V E   N  L+ W+               +    R     ++ +A+  
Sbjct: 123 DYEITDQY-IYMVMEC-GNIDLNSWL----------KKKKSIDPWERKSYWKNMLEAVHT 170

Query: 223 LHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI-TTIRGTRGYLAPE 281
           +H   +  ++H D+KP N L+ +     + DFG++  M  D +  +  +  G   Y+ PE
Sbjct: 171 IH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226

Query: 282 WILEQG-----------VSEKCDIYSYGMVLLELTGGR 308
            I +             +S K D++S G +L  +T G+
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  112 bits (281), Expect = 1e-27
 Identities = 38/243 (15%), Positives = 77/243 (31%), Gaps = 34/243 (13%)

Query: 89  VPIKFRSKELEEATDNFQ--ALLGHGSSASVFKGILSD------GTSVAVKRINGEENGE 140
           +P      E +  +       LLG G+ A V++    D           +K    +    
Sbjct: 51  LPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ--KPANP 108

Query: 141 KEF---RSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEG 197
            EF      +  +  +     ++     +   G   LV E    G+L + I         
Sbjct: 109 WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG-SVLVGELYSYGTLLNAI-----NLYK 162

Query: 198 HYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRA-------- 249
           +     +   L    A+ +   +  +H+     ++H D+KP+N +L   +          
Sbjct: 163 NTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLS 219

Query: 250 ---VVSDFGLSKLMSR-DQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELT 305
               + D G S  M    +    T    T G+   E +  +  + + D +     +  + 
Sbjct: 220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCML 279

Query: 306 GGR 308
            G 
Sbjct: 280 FGT 282

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  114 bits (286), Expect = 1e-27
 Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 14/207 (6%)

Query: 105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLG 163
            +  LG G    V++G+      +VAVK +  +    +EF  E A +   +H NLV+LLG
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283

Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL 223
            C     P Y++ EF+  G+L  ++    R          +S  +   +A  ++ A+ YL
Sbjct: 284 VCTR-EPPFYIITEFMTYGNLLDYL----RECNRQE----VSAVVLLYMATQISSAMEYL 334

Query: 224 HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWI 283
               +   +H ++   N L+ EN+   V+DFGLS+LM+ D        +    + APE +
Sbjct: 335 E---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 391

Query: 284 LEQGVSEKCDIYSYGMVLLEL-TGGRR 309
                S K D++++G++L E+ T G  
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIATYGMS 418

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  111 bits (279), Expect = 2e-27
 Identities = 60/223 (26%), Positives = 96/223 (43%), Gaps = 21/223 (9%)

Query: 91  IKFRSKELEEATDNFQAL--LGHGSSASVFKGIL-SDGTSVAVKRINGEENGE--KEFRS 145
           +  + K  E   D+F+ +  LG G+   VFK      G  +A K I+ E       +   
Sbjct: 21  LTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR 80

Query: 146 EVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLS 205
           E+  +       +V   G      G   +  E +  GSLD  +    R  E         
Sbjct: 81  ELQVLHECNSPYIVGFYG-AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG----- 134

Query: 206 WDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQS 265
                +V+I V K L+YL      +++H DVKP NIL++      + DFG+S  +    +
Sbjct: 135 -----KVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 187

Query: 266 RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
               +  GTR Y++PE +     S + DI+S G+ L+E+  GR
Sbjct: 188 N---SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  110 bits (277), Expect = 3e-27
 Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 29/213 (13%)

Query: 109 LGHGSSASVFKGILSDG-----TSVAVK--RINGEENGEKEFRSEVAAIASAQHVNLVRL 161
           LG G+  +V+KG+           VA+K  R        KE   E   +AS  + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 162 LGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCL-SWDLRYRVAIDVAKAL 220
           LG  +       L+ + +  G L  ++    R  + +     L +W       + +AK +
Sbjct: 83  LG--ICLTSTVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNW------CVQIAKGM 130

Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GY 277
           +YL      R++H D+   N+L+       ++DFGL+KL+  ++        G +    +
Sbjct: 131 NYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--EYHAEGGKVPIKW 185

Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLEL-TGGRR 309
           +A E IL +  + + D++SYG+ + EL T G +
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  113 bits (283), Expect = 5e-27
 Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 23/212 (10%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKE--FRSEVAAIASAQHVNLVRLL--- 162
           LG G    V + I    G  VA+K+   E + +    +  E+  +    H N+V      
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81

Query: 163 --GYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
                + P     L  E+ + G L  ++         +  G  L       +  D++ AL
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYL-----NQFENCCG--LKEGPIRTLLSDISSAL 134

Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAV---VSDFGLSKLMSRDQSRCITTIRGTRGY 277
            YLH    +R++H D+KPENI+L    + +   + D G +K +  DQ    T   GT  Y
Sbjct: 135 RYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQY 189

Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLELTGGRR 309
           LAPE + ++  +   D +S+G +  E   G R
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  108 bits (273), Expect = 5e-27
 Identities = 64/235 (27%), Positives = 98/235 (41%), Gaps = 33/235 (14%)

Query: 90  PIKFRSKELEEATDNFQALLGHGSSASVFKGIL----SDGTSVAVKRIN----GEENGEK 141
           P++  +  + E        LG GS   V +G          SVAVK +      +     
Sbjct: 7   PLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD 66

Query: 142 EFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSG 201
           +F  EV A+ S  H NL+RL G  VV   P  +V E    GSL   +    R+ +GH+  
Sbjct: 67  DFIREVNAMHSLDHRNLIRLYG--VVLTPPMKMVTELAPLGSLLDRL----RKHQGHFLL 120

Query: 202 GCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS 261
           G L    RY  A+ VA+ + YL      R +H D+   N+LL       + DFGL + + 
Sbjct: 121 GTL---SRY--AVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172

Query: 262 RDQSRCITT------IRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL-TGGRR 309
           ++    +                APE +  +  S   D + +G+ L E+ T G+ 
Sbjct: 173 QNDDHYVMQEHRKVPFAWC----APESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  108 bits (271), Expect = 7e-27
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 20/209 (9%)

Query: 105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGY 164
           F   +G G    V  G   +   VA+K I      E++F  E   +    H  LV+L G 
Sbjct: 12  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 165 CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH 224
           C+    P  LV EF+++G L  ++    R   G ++   L       + +DV + ++YL 
Sbjct: 72  CLE-QAPICLVTEFMEHGCLSDYL----RTQRGLFAAETL-----LGMCLDVCEGMAYL- 120

Query: 225 NDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GYLAPE 281
               + V+H D+   N L+ EN    VSDFG+++ +  DQ    T+  GT+    + +PE
Sbjct: 121 --EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY---TSSTGTKFPVKWASPE 175

Query: 282 WILEQGVSEKCDIYSYGMVLLEL-TGGRR 309
                  S K D++S+G+++ E+ + G+ 
Sbjct: 176 VFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  108 bits (272), Expect = 1e-26
 Identities = 56/234 (23%), Positives = 98/234 (41%), Gaps = 33/234 (14%)

Query: 90  PIKFRSKELEEATDNFQALLGHGSSASVFKGILSDG-----TSVAVK--RINGEENGEKE 142
            +K  ++  +E       +LG G   +V KG+           V +K           + 
Sbjct: 2   AMKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQA 61

Query: 143 FRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGG 202
               + AI S  H ++VRLLG  + PG    LV +++  GSL   +    R+  G     
Sbjct: 62  VTDHMLAIGSLDHAHIVRLLG--LCPGSSLQLVTQYLPLGSLLDHV----RQHRGALGPQ 115

Query: 203 CL-SWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS 261
            L +W       + +AK + YL       ++H ++   N+LL    +  V+DFG++ L+ 
Sbjct: 116 LLLNW------GVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166

Query: 262 RDQSRCITT-----IRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL-TGGRR 309
            D  + + +     I+      A E I     + + D++SYG+ + EL T G  
Sbjct: 167 PDDKQLLYSEAKTPIKWM----ALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  108 bits (272), Expect = 1e-26
 Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 25/213 (11%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKRIN-GEENGEKEFRSEVAAIASAQHVNLVRLLGYC 165
            LG G  + V     L DG   A+KRI   E+   +E + E        H N++RL+ YC
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 166 VVPGGPRYLVY---EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY 222
           +   G ++  +    F + G+L + I     + +G++    L+ D    + + + + L  
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEI--ERLKDKGNF----LTEDQILWLLLGICRGLEA 149

Query: 223 LHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD---QSRCIT-----TIRGT 274
           +H        H D+KP NILL +  + V+ D G             + +T       R T
Sbjct: 150 IH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 275 RGYLAPEWILEQG---VSEKCDIYSYGMVLLEL 304
             Y APE    Q    + E+ D++S G VL  +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAM 239

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  106 bits (268), Expect = 2e-26
 Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 24/207 (11%)

Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           LG G    V+ G  +  T VAVK +         F +E   +   QH  LVRL    VV 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA--VVT 78

Query: 169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCR 228
             P Y++ E+++NGSL  ++    +   G      L+ +    +A  +A+ ++++     
Sbjct: 79  QEPIYIITEYMENGSLVDFL----KTPSGIK----LTINKLLDMAAQIAEGMAFIE---E 127

Query: 229 SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL-----APEWI 283
              +H D++  NIL+ +     ++DFGL++L+  ++    T   G +        APE I
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAK--FPIKWTAPEAI 182

Query: 284 LEQGVSEKCDIYSYGMVLLEL-TGGRR 309
                + K D++S+G++L E+ T GR 
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRI 209

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  110 bits (276), Expect = 2e-26
 Identities = 54/237 (22%), Positives = 107/237 (45%), Gaps = 20/237 (8%)

Query: 77  RIEYSFLRKVAGVPIKFRSKELEEATDNFQALLGHGSSASVFKGILSDGTSVAVKRINGE 136
           ++    +      P +  + E+   +   +  LG G    V+    +  T VAVK +   
Sbjct: 164 KLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG 223

Query: 137 ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSE 196
               + F +E   + + QH  LV+L    VV   P Y++ EF+  GSL  ++    +  E
Sbjct: 224 SMSVEAFLAEANVMKTLQHDKLVKLHA--VVTKEPIYIITEFMAKGSLLDFL----KSDE 277

Query: 197 GHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL 256
           G               +  +A+ ++++    +   +H D++  NIL+  +    ++DFGL
Sbjct: 278 GSK----QPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGL 330

Query: 257 SKLMSRDQSRCITTIRGTRG---YLAPEWILEQGVSEKCDIYSYGMVLLEL-TGGRR 309
           ++++  ++    T   G +    + APE I     + K D++S+G++L+E+ T GR 
Sbjct: 331 ARVIEDNEY---TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRI 384

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  106 bits (268), Expect = 2e-26
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 20/209 (9%)

Query: 105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGY 164
           F   LG G    V  G       VA+K I      E EF  E   + +  H  LV+L G 
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87

Query: 165 CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH 224
           C     P +++ E++ NG L +++    R     +    L       +  DV +A+ YL 
Sbjct: 88  CTK-QRPIFIITEYMANGCLLNYL----REMRHRFQTQQL-----LEMCKDVCEAMEYLE 137

Query: 225 NDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GYLAPE 281
                + LH D+   N L+++     VSDFGLS+ +  D+    T+  G++    +  PE
Sbjct: 138 ---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPE 191

Query: 282 WILEQGVSEKCDIYSYGMVLLEL-TGGRR 309
            ++    S K DI+++G+++ E+ + G+ 
Sbjct: 192 VLMYSKFSSKSDIWAFGVLMWEIYSLGKM 220

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  107 bits (269), Expect = 3e-26
 Identities = 46/217 (21%), Positives = 81/217 (37%), Gaps = 28/217 (12%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKE--FRSEVAAIASAQHVNLVRLLGY 164
           +LG G++A+VF+G     G   A+K  N             E   +    H N+V+L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 165 CVVPGGPR-YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL 223
                     L+ EF   GSL   +       E   +   L       V  DV   +++L
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVL-------EEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 224 HNDCRSRVLHLDVKPENILL----DENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLA 279
                + ++H ++KP NI+     D      ++DFG ++ +  +      ++ GT  YL 
Sbjct: 129 R---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSLYGTEEYLH 183

Query: 280 PE--------WILEQGVSEKCDIYSYGMVLLELTGGR 308
           P+           ++      D++S G+       G 
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  107 bits (269), Expect = 3e-26
 Identities = 60/262 (22%), Positives = 111/262 (42%), Gaps = 29/262 (11%)

Query: 96  KELEEATDNFQALLGHGSSASVFKGIL-----SDGTSVAVKRI-NGEENGEKEFRSEVAA 149
              EE    + + LG G+  SV          + G  VAVK++ +   + +++F+ E+  
Sbjct: 18  TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQI 77

Query: 150 IASAQHVNLVRLLGYCVVPGG-PRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL 208
           + +     +V+  G    PG     LV E++ +G L  ++    +R         L   L
Sbjct: 78  LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL----QRHRARLDASRL---L 130

Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI 268
            Y  +  + K + YL      R +H D+   NIL++      ++DFGL+KL+  D+    
Sbjct: 131 LY--SSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD--- 182

Query: 269 TTIRGTRGYL-----APEWILEQGVSEKCDIYSYGMVLLEL-TGGRRNVSLIEHGNDKSK 322
             +    G       APE + +   S + D++S+G+VL EL T   ++ S          
Sbjct: 183 YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG 242

Query: 323 NKWQYFP-KIVNEKMKEGKLME 343
            +        + E ++EG+ + 
Sbjct: 243 CERDVPALSRLLELLEEGQRLP 264

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  105 bits (265), Expect = 4e-26
 Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 20/209 (9%)

Query: 105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGY 164
               LG G    V  G       VAVK I      E EF  E   +    H  LV+  G 
Sbjct: 12  LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71

Query: 165 CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH 224
           C     P Y+V E+I NG L +++     RS G      L       +  DV + +++L 
Sbjct: 72  CSK-EYPIYIVTEYISNGCLLNYL-----RSHGKG----LEPSQLLEMCYDVCEGMAFLE 121

Query: 225 NDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GYLAPE 281
                + +H D+   N L+D +    VSDFG+++ +  DQ     +  GT+    + APE
Sbjct: 122 ---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY---VSSVGTKFPVKWSAPE 175

Query: 282 WILEQGVSEKCDIYSYGMVLLEL-TGGRR 309
                  S K D++++G+++ E+ + G+ 
Sbjct: 176 VFHYFKYSSKSDVWAFGILMWEVFSLGKM 204

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  106 bits (267), Expect = 6e-26
 Identities = 51/211 (24%), Positives = 87/211 (41%), Gaps = 30/211 (14%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKRIN----GEENGEKEFRSEVAAIASAQHVNLVRLL 162
            LG G  A  F+          A K +      + +  ++   E++   S  H ++V   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 163 GY-----CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
           G+      V      ++V E  +  SL        RR         L+          + 
Sbjct: 108 GFFEDNDFV------FVVLELCRRRSLLELH---KRR-------KALTEPEARYYLRQIV 151

Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGY 277
               YLH   R+RV+H D+K  N+ L+E+    + DFGL+  +  D  R    + GT  Y
Sbjct: 152 LGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-KKVLCGTPNY 207

Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           +APE + ++G S + D++S G ++  L  G+
Sbjct: 208 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  105 bits (264), Expect = 7e-26
 Identities = 52/210 (24%), Positives = 86/210 (40%), Gaps = 24/210 (11%)

Query: 109 LGHGSSASVFKGILSDG---TSVAVK--RINGEENGEKEFRSEVAAIASAQHVNLVRLLG 163
           LG G+  SV +G+         VA+K  +   E+   +E   E   +    +  +VRL+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL 223
             V       LV E    G L  ++               +       +   V+  + YL
Sbjct: 78  --VCQAEALMLVMEMAGGGPLHKFL----VGKREEIPVSNV-----AELLHQVSMGMKYL 126

Query: 224 HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GYLAP 280
                   +H D+   N+LL   + A +SDFGLSK +  D S   T     +    + AP
Sbjct: 127 ---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTARSAGKWPLKWYAP 182

Query: 281 EWILEQGVSEKCDIYSYGMVLLEL-TGGRR 309
           E I  +  S + D++SYG+ + E  + G++
Sbjct: 183 ECINFRKFSSRSDVWSYGVTMWEALSYGQK 212

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  105 bits (265), Expect = 7e-26
 Identities = 51/211 (24%), Positives = 87/211 (41%), Gaps = 30/211 (14%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKRIN----GEENGEKEFRSEVAAIASAQHVNLVRLL 162
            LG G  A  F+          A K +      + +  ++   E++   S  H ++V   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 163 GY-----CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
           G+      V      ++V E  +  SL        RR         L+          + 
Sbjct: 82  GFFEDNDFV------FVVLELCRRRSLLELH---KRR-------KALTEPEARYYLRQIV 125

Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGY 277
               YLH   R+RV+H D+K  N+ L+E+    + DFGL+  +  D  R    + GT  Y
Sbjct: 126 LGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER-KKVLCGTPNY 181

Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           +APE + ++G S + D++S G ++  L  G+
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  108 bits (271), Expect = 9e-26
 Identities = 66/206 (32%), Positives = 102/206 (49%), Gaps = 18/206 (8%)

Query: 105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGY 164
               +G G    V  G    G  VAVK I   +   + F +E + +   +H NLV+LLG 
Sbjct: 197 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIK-NDATAQAFLAEASVMTQLRHSNLVQLLGV 254

Query: 165 CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH 224
            V   G  Y+V E++  GSL  ++     RS G      L  D   + ++DV +A+ YL 
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYL-----RSRG---RSVLGGDCLLKFSLDVCEAMEYLE 306

Query: 225 NDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWIL 284
               +  +H D+   N+L+ E+  A VSDFGL+K  S  Q      ++ T    APE + 
Sbjct: 307 ---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALR 359

Query: 285 EQGVSEKCDIYSYGMVLLEL-TGGRR 309
           E+  S K D++S+G++L E+ + GR 
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGRV 385

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  105 bits (264), Expect = 1e-25
 Identities = 57/263 (21%), Positives = 105/263 (39%), Gaps = 32/263 (12%)

Query: 97  ELEEATDNFQALLGHGSSASVFKGIL-----SDGTSVAVK--RINGEENGEKEFRSEVAA 149
             E+        LG G    V          + G  VAVK  +     N   + + E+  
Sbjct: 17  HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEI 76

Query: 150 IASAQHVNLVRLLGYCVVPGG-PRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL 208
           + +  H N+V+  G C   GG    L+ EF+ +GSL  ++     +++   +       L
Sbjct: 77  LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL----PKNKNKINLKQQ---L 129

Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI 268
           +Y  A+ + K + YL      + +H D+   N+L++  ++  + DFGL+K +  D+    
Sbjct: 130 KY--AVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE--- 181

Query: 269 TTIRGTRG------YLAPEWILEQGVSEKCDIYSYGMVLLEL-TGGRRNVSLIEHGNDKS 321
                         + APE +++       D++S+G+ L EL T    + S +       
Sbjct: 182 -YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMI 240

Query: 322 KNK-WQYFPKIVNEKMKEGKLME 343
                Q     +   +KEGK + 
Sbjct: 241 GPTHGQMTVTRLVNTLKEGKRLP 263

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  104 bits (262), Expect = 1e-25
 Identities = 51/211 (24%), Positives = 86/211 (40%), Gaps = 29/211 (13%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLL 162
           LLG GS A V++   +  G  VA+K I+ +        +  ++EV      +H +++ L 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77

Query: 163 GY-----CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
            Y      V      YLV E   NG ++ ++                S +        + 
Sbjct: 78  NYFEDSNYV------YLVLEMCHNGEMNRYL---------KNRVKPFSENEARHFMHQII 122

Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGY 277
             + YLH      +LH D+   N+LL  N    ++DFGL+  +     +   T+ GT  Y
Sbjct: 123 TGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK-HYTLCGTPNY 178

Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           ++PE         + D++S G +   L  GR
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  106 bits (267), Expect = 2e-25
 Identities = 46/217 (21%), Positives = 81/217 (37%), Gaps = 28/217 (12%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKE--FRSEVAAIASAQHVNLVRLLGY 164
           +LG G++A+VF+G     G   A+K  N             E   +    H N+V+L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 165 CVVPGGPR-YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL 223
                     L+ EF   GSL   +       E   +   L       V  DV   +++L
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVL-------EEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 224 HNDCRSRVLHLDVKPENILL----DENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLA 279
                + ++H ++KP NI+     D      ++DFG ++ +  +      ++ GT  YL 
Sbjct: 129 R---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSLYGTEEYLH 183

Query: 280 PE--------WILEQGVSEKCDIYSYGMVLLELTGGR 308
           P+           ++      D++S G+       G 
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  105 bits (264), Expect = 2e-25
 Identities = 65/227 (28%), Positives = 105/227 (46%), Gaps = 30/227 (13%)

Query: 96  KELEEATDNFQALLGHGSSASVFKGIL----SDGTSVAVK--RINGEENGEKEFRSEVAA 149
           +E+E +  + + ++G G S  V  G L         VA+K  +    E   ++F SE + 
Sbjct: 44  REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASI 103

Query: 150 IASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR 209
           +    H N++RL G     G    +V E+++NGSLD ++    R  +G ++   L     
Sbjct: 104 MGQFDHPNIIRLEGVVTR-GRLAMIVTEYMENGSLDTFL----RTHDGQFTIMQL----- 153

Query: 210 YRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT 269
             +   V   + YL        +H D+   N+L+D N    VSDFGLS+++  D     T
Sbjct: 154 VGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT 210

Query: 270 T------IRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL-TGGRR 309
           T      IR T    APE I  +  S   D++S+G+V+ E+   G R
Sbjct: 211 TTGGKIPIRWT----APEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  104 bits (262), Expect = 2e-25
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 14/208 (6%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEK--EFRSEVAAIASAQHVNLVRLLGYC 165
           +G G++A V           VA+KRIN E+      E   E+ A++   H N+V      
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT-S 81

Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
            V     +LV + +  GS+   I      ++G +  G L       +  +V + L YLH 
Sbjct: 82  FVVKDELWLVMKLLSGGSVLDII--KHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK 139

Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR----GTRGYLAPE 281
           +     +H DVK  NILL E+    ++DFG+S  ++         +R    GT  ++APE
Sbjct: 140 N---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 196

Query: 282 WILE-QGVSEKCDIYSYGMVLLELTGGR 308
            + + +G   K DI+S+G+  +EL  G 
Sbjct: 197 VMEQVRGYDFKADIWSFGITAIELATGA 224

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  104 bits (262), Expect = 2e-25
 Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 19/202 (9%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEK--EFRSEVAAIASAQHVNLVRLLGYC 165
           +G GS   VFKGI       VA+K I+ EE  ++  + + E+  ++      + +  G  
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG-S 88

Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
            +     +++ E++  GS    +       E   +              ++ K L YLH+
Sbjct: 89  YLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILR----------EILKGLDYLHS 137

Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILE 285
           +   + +H D+K  N+LL E+    ++DFG++  ++  Q +  T + GT  ++APE I +
Sbjct: 138 E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQ 193

Query: 286 QGVSEKCDIYSYGMVLLELTGG 307
                K DI+S G+  +EL  G
Sbjct: 194 SAYDSKADIWSLGITAIELARG 215

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  104 bits (262), Expect = 2e-25
 Identities = 66/260 (25%), Positives = 110/260 (42%), Gaps = 26/260 (10%)

Query: 97  ELEEATDNFQALLGHGSSASVFKGIL-----SDGTSVAVKRI-NGEENGEKEFRSEVAAI 150
           + EE    F   LG G+  SV          + G  VAVK++ +  E   ++F  E+  +
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65

Query: 151 ASAQHVNLVRLLGYCVVPGG-PRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR 209
            S QH N+V+  G C   G     L+ E++  GSL  ++    ++ +       L   L+
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKL---LQ 118

Query: 210 YRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT 269
           Y     + K + YL      R +H D+   NIL++   R  + DFGL+K++ +D+     
Sbjct: 119 Y--TSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE-FFK 172

Query: 270 TIRGTRG---YLAPEWILEQGVSEKCDIYSYGMVLLEL-TGGRRNVSLIEHGNDKSKNK- 324
                     + APE + E   S   D++S+G+VL EL T   ++ S          N  
Sbjct: 173 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 232

Query: 325 -WQYFPKIVNEKMKEGKLME 343
             Q     + E +K    + 
Sbjct: 233 QGQMIVFHLIELLKNNGRLP 252

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  105 bits (263), Expect = 2e-25
 Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 33/215 (15%)

Query: 109 LGHGSSASVFKGILSDG-----TSVAVK--RINGEENGEKEFRSEVAAIASAQHVNLVRL 161
           LG G+  +V+KG+           VA+K  R        KE   E   +AS  + ++ RL
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 162 LGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCL-SWDLRYRVAIDVAKAL 220
           LG  +       L+ + +  G L  ++    R  + +     L +W       + +AK +
Sbjct: 83  LG--ICLTSTVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNW------CVQIAKGM 130

Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL-- 278
           +YL +    R++H D+   N+L+       ++DFGL+KL+  ++           G +  
Sbjct: 131 NYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK----EYHAEGGKVPI 183

Query: 279 ---APEWILEQGVSEKCDIYSYGMVLLEL-TGGRR 309
              A E IL +  + + D++SYG+ + EL T G +
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  105 bits (263), Expect = 2e-25
 Identities = 67/262 (25%), Positives = 110/262 (41%), Gaps = 30/262 (11%)

Query: 97  ELEEATDNFQALLGHGSSASVFKGIL-----SDGTSVAVKRI-NGEENGEKEFRSEVAAI 150
           + EE    F   LG G+  SV          + G  VAVK++ +  E   ++F  E+  +
Sbjct: 37  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 96

Query: 151 ASAQHVNLVRLLGYCVVPGG-PRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR 209
            S QH N+V+  G C   G     L+ E++  GSL  ++    ++ +       L   L+
Sbjct: 97  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKL---LQ 149

Query: 210 YRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT 269
           Y     + K + YL      R +H D+   NIL++   R  + DFGL+K++ +D+     
Sbjct: 150 Y--TSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE---Y 201

Query: 270 TIRGTRGYL-----APEWILEQGVSEKCDIYSYGMVLLEL-TGGRRNVSLIEHGNDKSKN 323
                 G       APE + E   S   D++S+G+VL EL T   ++ S          N
Sbjct: 202 YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 261

Query: 324 K--WQYFPKIVNEKMKEGKLME 343
               Q     + E +K    + 
Sbjct: 262 DKQGQMIVFHLIELLKNNGRLP 283

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  103 bits (260), Expect = 3e-25
 Identities = 65/216 (30%), Positives = 102/216 (47%), Gaps = 38/216 (17%)

Query: 105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGY 164
               +G G    V  G    G  VAVK I   +   + F +E + +   +H NLV+LLG 
Sbjct: 25  LLQTIGKGEFGDVMLGDY-RGNKVAVKCIK-NDATAQAFLAEASVMTQLRHSNLVQLLGV 82

Query: 165 CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL- 223
            V   G  Y+V E++  GSL  ++     RS G      L  D   + ++DV +A+ YL 
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYL-----RSRG---RSVLGGDCLLKFSLDVCEAMEYLE 134

Query: 224 -----HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITT----IRGT 274
                H D  +R         N+L+ E+  A VSDFG    ++++ S    T    ++ T
Sbjct: 135 GNNFVHRDLAAR---------NVLVSEDNVAKVSDFG----LTKEASSTQDTGKLPVKWT 181

Query: 275 RGYLAPEWILEQGVSEKCDIYSYGMVLLEL-TGGRR 309
               APE + E+  S K D++S+G++L E+ + GR 
Sbjct: 182 ----APEALREKKFSTKSDVWSFGILLWEIYSFGRV 213

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  105 bits (262), Expect = 4e-25
 Identities = 25/255 (9%), Positives = 58/255 (22%), Gaps = 46/255 (18%)

Query: 88  GVPIKFRSKELEEATDNFQ--ALLGHGSSASVFKGI-LSDGTSVAVKRIN----GEENGE 140
                  S  L +     +    L  G  + VF    +      A+K          +  
Sbjct: 48  NAETTVDS-LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSEL 106

Query: 141 KEFRSEVAAIASAQHVNLVRLLGYC---------VVPGGPR----------------YLV 175
           +       A A     +                  V   P                  L+
Sbjct: 107 ERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLL 166

Query: 176 YEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLD 235
                   L+                G       + +   + +  + L       ++H  
Sbjct: 167 MPAAS-VDLELLFSTLDFVYVFR---GDEGILALHILTAQLIRLAANLQ---SKGLVHGH 219

Query: 236 VKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWIL--EQGVSEKCD 293
             P+N+ +  + R ++ D        +  +R          Y   E++       +   +
Sbjct: 220 FTPDNLFIMPDGRLMLGDVSALW---KVGTRG-PASSVPVTYAPREFLNASTATFTHALN 275

Query: 294 IYSYGMVLLELTGGR 308
            +  G+ +  +    
Sbjct: 276 AWQLGLSIYRVWCLF 290

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  103 bits (259), Expect = 4e-25
 Identities = 54/201 (26%), Positives = 107/201 (53%), Gaps = 18/201 (8%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKE-FRSEVAAIASAQHVNLVRLLGYCV 166
           +G G+S +V+  + ++ G  VA++++N ++  +KE   +E+  +   ++ N+V  L    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD-SY 86

Query: 167 VPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHND 226
           + G   ++V E++  GSL   +  T    EG  +           V  +  +AL +LH++
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIA----------AVCRECLQALEFLHSN 135

Query: 227 CRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQ 286
              +V+H D+K +NILL  +    ++DFG    ++ +QS+  T + GT  ++APE +  +
Sbjct: 136 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRK 191

Query: 287 GVSEKCDIYSYGMVLLELTGG 307
               K DI+S G++ +E+  G
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEG 212

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  103 bits (259), Expect = 5e-25
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 19/208 (9%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKRINGEENGE-KEFRSEVAAIASAQHVNLVRLLGYC 165
           +LG G+   V+ G  LS+   +A+K I   ++   +    E+A     +H N+V+ LG  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG-S 87

Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
               G   +  E +  GSL   +          +     +          + + L YLH+
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALL-------RSKWGPLKDNEQTIGFYTKQILEGLKYLHD 140

Query: 226 DCRSRVLHLDVKPENILLDENYRAVV--SDFGLSKLMSRDQSRCITTIRGTRGYLAPEWI 283
              ++++H D+K +N+L++  Y  V+  SDFG SK ++   + C  T  GT  Y+APE I
Sbjct: 141 ---NQIVHRDIKGDNVLIN-TYSGVLKISDFGTSKRLA-GINPCTETFTGTLQYMAPEII 195

Query: 284 L--EQGVSEKCDIYSYGMVLLELTGGRR 309
               +G  +  DI+S G  ++E+  G+ 
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKP 223

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  104 bits (261), Expect = 8e-25
 Identities = 60/256 (23%), Positives = 107/256 (41%), Gaps = 26/256 (10%)

Query: 66  ESKFVTEGRELRIEYSFLRKVAGVPIKFRSKELEEATDNFQALLGHGSSASVFKGILSDG 125
           E+ +      + I+ S L       ++           +F  ++G G    V+ G L D 
Sbjct: 54  ENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDN 113

Query: 126 ----TSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI 179
                  AVK +N         +F +E   +    H N++ LLG C+   G   +V  ++
Sbjct: 114 DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 173

Query: 180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPE 239
           ++G L ++I    R    + +   L         + VAK + +L +    + +H D+   
Sbjct: 174 KHGDLRNFI----RNETHNPTVKDL-----IGFGLQVAKGMKFLAS---KKFVHRDLAAR 221

Query: 240 NILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL-----APEWILEQGVSEKCDI 294
           N +LDE +   V+DFGL++ M   +   +     T   L     A E +  Q  + K D+
Sbjct: 222 NCMLDEKFTVKVADFGLARDMYDKEFDSVHN--KTGAKLPVKWMALESLQTQKFTTKSDV 279

Query: 295 YSYGMVLLEL-TGGRR 309
           +S+G++L EL T G  
Sbjct: 280 WSFGVLLWELMTRGAP 295

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  103 bits (258), Expect = 8e-25
 Identities = 57/201 (28%), Positives = 99/201 (49%), Gaps = 18/201 (8%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKE-FRSEVAAIASAQHVNLVRLLGYCV 166
           +G GS+  V        G  VAVK ++  +   +E   +EV  +   QH N+V +     
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYK-SY 111

Query: 167 VPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHND 226
           + G   +++ EF+Q G+L   +    R +E   +  C            V +AL+YLH  
Sbjct: 112 LVGEELWVLMEFLQGGALTDIVSQV-RLNEEQIATVCE----------AVLQALAYLHAQ 160

Query: 227 CRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQ 286
               V+H D+K ++ILL  + R  +SDFG    +S+D  +  + + GT  ++APE I   
Sbjct: 161 ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRS 216

Query: 287 GVSEKCDIYSYGMVLLELTGG 307
             + + DI+S G++++E+  G
Sbjct: 217 LYATEVDIWSLGIMVIEMVDG 237

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  106 bits (266), Expect = 9e-25
 Identities = 48/212 (22%), Positives = 84/212 (39%), Gaps = 30/212 (14%)

Query: 106 QALLGHGSSASVFKG--ILSDGTSVAVK--RINGEENGEKEFRSEVAAIASAQHVNLVRL 161
           +  + HG    ++       +G  V +K    +G+   +    +E   +A   H ++V++
Sbjct: 85  KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144

Query: 162 LGYCVVPGGPR----YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
             +            Y+V E++   SL                G  L         +++ 
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK------------GQKLPVAEAIAYLLEIL 192

Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGY 277
            ALSYLH      +++ D+KPENI+L E  +  + D G    ++         + GT G+
Sbjct: 193 PALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY-----LYGTPGF 243

Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLELTGGRR 309
            APE I+  G +   DIY+ G  L  LT    
Sbjct: 244 QAPE-IVRTGPTVATDIYTVGRTLAALTLDLP 274

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  102 bits (257), Expect = 9e-25
 Identities = 50/211 (23%), Positives = 91/211 (43%), Gaps = 26/211 (12%)

Query: 109 LGHGSSASVFKGIL---SDGTSVAVKRI---NGEENGEKEFRSEVAAIASAQHVNLVRLL 162
           LG G+  +V KG         +VAVK +     +   + E  +E   +    +  +VR++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 163 GYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY 222
           G  +       LV E  + G L+ ++     +   H     +       +   V+  + Y
Sbjct: 85  G--ICEAESWMLVMEMAELGPLNKYL-----QQNRHVKDKNI-----IELVHQVSMGMKY 132

Query: 223 LHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GYLA 279
           L     S  +H D+   N+LL   + A +SDFGLSK +  D++         +    + A
Sbjct: 133 LE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN-YYKAQTHGKWPVKWYA 188

Query: 280 PEWILEQGVSEKCDIYSYGMVLLEL-TGGRR 309
           PE I     S K D++S+G+++ E  + G++
Sbjct: 189 PECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  101 bits (255), Expect = 1e-24
 Identities = 61/213 (28%), Positives = 92/213 (43%), Gaps = 36/213 (16%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLL 162
            LG G   +V+          +A+K +   +      E + R EV   +  +H N++RL 
Sbjct: 16  PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75

Query: 163 GY-----CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
           GY      V      YL+ E+   G++   +   S+  E   +         Y    ++A
Sbjct: 76  GYFHDATRV------YLILEYAPLGTVYRELQKLSKFDEQRTA--------TY--ITELA 119

Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM--SRDQSRCITTIRGTR 275
            ALSY H     RV+H D+KPEN+LL       ++DFG S     SR    C     GT 
Sbjct: 120 NALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC-----GTL 171

Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
            YL PE I  +   EK D++S G++  E   G+
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  105 bits (264), Expect = 1e-24
 Identities = 51/210 (24%), Positives = 86/210 (40%), Gaps = 24/210 (11%)

Query: 109 LGHGSSASVFKGILSDG---TSVAVK--RINGEENGEKEFRSEVAAIASAQHVNLVRLLG 163
           LG G+  SV +G+         VA+K  +   E+   +E   E   +    +  +VRL+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL 223
             V       LV E    G L  ++               +       +   V+  + YL
Sbjct: 404 --VCQAEALMLVMEMAGGGPLHKFL----VGKREEIPVSNV-----AELLHQVSMGMKYL 452

Query: 224 HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR---GYLAP 280
                   +H ++   N+LL   + A +SDFGLSK +  D S   T     +    + AP
Sbjct: 453 ---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTARSAGKWPLKWYAP 508

Query: 281 EWILEQGVSEKCDIYSYGMVLLEL-TGGRR 309
           E I  +  S + D++SYG+ + E  + G++
Sbjct: 509 ECINFRKFSSRSDVWSYGVTMWEALSYGQK 538

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  103 bits (259), Expect = 1e-24
 Identities = 33/243 (13%), Positives = 68/243 (27%), Gaps = 54/243 (22%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKRING--------------EENGEKEFRSEVAAIAS 152
           +LG     +  +      G S  V                   E    +  R       +
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 153 AQHVNLVRLLGYCVVPGGP----------------RYLVYEFIQNGSLDHWIFPTSRRSE 196
             H+  +        P                   R+ +Y  +Q+          S  S 
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 197 GHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL 256
                  L    R ++ + V + L+ LH      ++H  ++P +I+LD+     ++ F  
Sbjct: 200 H----KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEH 252

Query: 257 SKLMSRDQSRCITTIRGTRGYLAPEWILEQG-----------VSEKCDIYSYGMVLLELT 305
                            +RG+  PE    +            ++   D ++ G+V+  + 
Sbjct: 253 LVRDGARVVSS-----VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307

Query: 306 GGR 308
              
Sbjct: 308 CAD 310

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  101 bits (255), Expect = 1e-24
 Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 22/211 (10%)

Query: 105 FQALLGHGSSASVFKGILSDG-TSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLG 163
            +  LG G    V++G+      +VAVK +  +    +EF  E A +   +H NLV+LLG
Sbjct: 17  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76

Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL 223
            C     P Y++ EF+  G+L  ++    R          +S  +   +A  ++ A+ YL
Sbjct: 77  VCTR-EPPFYIITEFMTYGNLLDYL----RECNRQE----VSAVVLLYMATQISSAMEYL 127

Query: 224 HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITT----IRGTRGYLA 279
               +   +H D+   N L+ EN+   V+DFGLS+LM+ D           I+ T    A
Sbjct: 128 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----A 180

Query: 280 PEWILEQGVSEKCDIYSYGMVLLEL-TGGRR 309
           PE +     S K D++++G++L E+ T G  
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMS 211

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  102 bits (256), Expect = 2e-24
 Identities = 64/234 (27%), Positives = 104/234 (44%), Gaps = 43/234 (18%)

Query: 96  KELEEATDNFQALLGHGSSASVFKGILSDGT-----SVAVK--RINGEENGEKEFRSEVA 148
            E+  +    Q ++G G    V+KG+L   +      VA+K  +    E    +F  E  
Sbjct: 39  TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAG 98

Query: 149 AIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL 208
            +    H N++RL G       P  ++ E+++NG+LD ++    R  +G +S   L    
Sbjct: 99  IMGQFSHHNIIRLEGVISK-YKPMMIITEYMENGALDKFL----REKDGEFSVLQL---- 149

Query: 209 RYRVAIDVAKALSYL------HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR 262
              +   +A  + YL      H D  +R         NIL++ N    VSDFGLS+++  
Sbjct: 150 -VGMLRGIAAGMKYLANMNYVHRDLAAR---------NILVNSNLVCKVSDFGLSRVLED 199

Query: 263 DQSRCITT------IRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL-TGGRR 309
           D     TT      IR T    APE I  +  +   D++S+G+V+ E+ T G R
Sbjct: 200 DPEATYTTSGGKIPIRWT----APEAISYRKFTSASDVWSFGIVMWEVMTYGER 249

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  101 bits (253), Expect = 2e-24
 Identities = 44/213 (20%), Positives = 95/213 (44%), Gaps = 31/213 (14%)

Query: 109 LGHGSSASVFKGIL----SDGTSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLL 162
           LG G    V++G+      +  +VAVK    +   + +++F SE   + +  H ++V+L+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79

Query: 163 GYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY 222
           G  ++   P +++ E    G L H++     R++       L        ++ + KA++Y
Sbjct: 80  G--IIEEEPTWIIMELYPYGELGHYL----ERNKNSLKVLTL-----VLYSLQICKAMAY 128

Query: 223 LHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL---- 278
           L        +H D+   NIL+       + DFGLS+ +  +        + +   L    
Sbjct: 129 LE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED-----YYKASVTRLPIKW 180

Query: 279 -APEWILEQGVSEKCDIYSYGMVLLEL-TGGRR 309
            +PE I  +  +   D++ + + + E+ + G++
Sbjct: 181 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  103 bits (258), Expect = 2e-24
 Identities = 64/233 (27%), Positives = 104/233 (44%), Gaps = 42/233 (18%)

Query: 96  KELEEATDNFQALLGHGSSASVFKGIL----SDGTSVAVK--RINGEENGEKEFRSEVAA 149
           KEL+    +   ++G G    V  G L        SVA+K  ++   E   ++F  E + 
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99

Query: 150 IASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR 209
           +    H N++RL G       P  +V E+++NGSLD ++    R+ +  ++   L     
Sbjct: 100 MGQFDHPNIIRLEGVVTK-SKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQL----- 149

Query: 210 YRVAIDVAKALSYL------HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD 263
             +   +A  + YL      H D  +R         NIL++ N    VSDFGL +++  D
Sbjct: 150 VGMLRGIASGMKYLSDMGYVHRDLAAR---------NILINSNLVCKVSDFGLGRVLEDD 200

Query: 264 QSRCITT------IRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL-TGGRR 309
                TT      IR T    +PE I  +  +   D++SYG+VL E+ + G R
Sbjct: 201 PEAAYTTRGGKIPIRWT----SPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  102 bits (255), Expect = 2e-24
 Identities = 54/223 (24%), Positives = 99/223 (44%), Gaps = 21/223 (9%)

Query: 96  KELEEATDNFQAL--LGHGSSASVFKGI-LSDGTSVAVKRINGEENGE--KEFRSEVAAI 150
           +  +   ++ + L  +G G+  SV K +    G  +AVKRI    + +  K+   ++  +
Sbjct: 15  QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74

Query: 151 ASA-QHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR 209
             +     +V+  G      G  ++  E + + S D +        +       L     
Sbjct: 75  MRSSDCPYIVQFYGALFR-EGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILG---- 128

Query: 210 YRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT 269
            ++ +   KAL++L  +   +++H D+KP NILLD +    + DFG+S  +    ++   
Sbjct: 129 -KITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD 185

Query: 270 TIRGTRGYLAPEWI----LEQGVSEKCDIYSYGMVLLELTGGR 308
              G R Y+APE I      QG   + D++S G+ L EL  GR
Sbjct: 186 A--GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  101 bits (253), Expect = 3e-24
 Identities = 56/227 (24%), Positives = 97/227 (42%), Gaps = 28/227 (12%)

Query: 96  KELEEATDNFQALLGHGSSASVFKGILSDG----TSVAVKRINGE--ENGEKEFRSEVAA 149
                   +F  ++G G    V+ G L D        AVK +N         +F +E   
Sbjct: 20  IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGII 79

Query: 150 IASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR 209
           +    H N++ LLG C+   G   +V  ++++G L ++I    R    + +   L     
Sbjct: 80  MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI----RNETHNPTVKDL----- 130

Query: 210 YRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT 269
               + VAK + YL +    + +H D+   N +LDE +   V+DFGL++ M   +     
Sbjct: 131 IGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY---Y 184

Query: 270 TIRGTRGYL------APEWILEQGVSEKCDIYSYGMVLLEL-TGGRR 309
           ++    G        A E +  Q  + K D++S+G++L EL T G  
Sbjct: 185 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  100 bits (252), Expect = 3e-24
 Identities = 53/211 (25%), Positives = 86/211 (40%), Gaps = 32/211 (15%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLL 162
            LG G   +V+      +   +A+K +   +      E + R E+   +  +H N++R+ 
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 163 GY-----CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
            Y      +      YL+ EF   G L   +    R  E   +         +    ++A
Sbjct: 81  NYFHDRKRI------YLMLEFAPRGELYKELQKHGRFDEQRSA--------TF--MEELA 124

Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGY 277
            AL Y H     +V+H D+KPEN+L+       ++DFG S        R  T   GT  Y
Sbjct: 125 DALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHA--PSLRRRTMC-GTLDY 178

Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           L PE I  +   EK D++  G++  E   G 
Sbjct: 179 LPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  100 bits (252), Expect = 4e-24
 Identities = 61/209 (29%), Positives = 91/209 (43%), Gaps = 24/209 (11%)

Query: 106 QALLGHGSSASVFKG---ILSDGTSVAVKRINGEENGEKE----FRSEVAAIASAQHVNL 158
              LG G  ++V+     IL     VA+K I      ++E    F  EV   +   H N+
Sbjct: 16  VDKLGGGGMSTVYLAEDTIL--NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNI 73

Query: 159 VRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK 218
           V ++          YLV E+I+  +L  +I      S G      LS D        +  
Sbjct: 74  VSMIDVDEEDDCY-YLVMEYIEGPTLSEYI-----ESHGP-----LSVDTAINFTNQILD 122

Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            + + H     R++H D+KP+NIL+D N    + DFG++K +S         + GT  Y 
Sbjct: 123 GIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYF 179

Query: 279 APEWILEQGVSEKCDIYSYGMVLLE-LTG 306
           +PE    +   E  DIYS G+VL E L G
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVG 208

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  100 bits (251), Expect = 4e-24
 Identities = 48/213 (22%), Positives = 91/213 (42%), Gaps = 31/213 (14%)

Query: 109 LGHGSSASVFKGILSDG----TSVAVK--RINGEENGEKEFRSEVAAIASAQHVNLVRLL 162
           +G G    V +GI         +VA+K  +    ++  ++F  E   +    H ++V+L+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82

Query: 163 GYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY 222
           G  V+   P +++ E    G L  ++    +  +       L        A  ++ AL+Y
Sbjct: 83  G--VITENPVWIIMELCTLGELRSFL----QVRKYSLDLASL-----ILYAYQLSTALAY 131

Query: 223 LHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL---- 278
           L      R +H D+   N+L+  N    + DFGLS+ M        T  + ++G L    
Sbjct: 132 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-----TYYKASKGKLPIKW 183

Query: 279 -APEWILEQGVSEKCDIYSYGMVLLEL-TGGRR 309
            APE I  +  +   D++ +G+ + E+   G +
Sbjct: 184 MAPESINFRRFTSASDVWMFGVCMWEILMHGVK 216

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  102 bits (254), Expect = 8e-24
 Identities = 30/238 (12%), Positives = 67/238 (28%), Gaps = 43/238 (18%)

Query: 107 ALLGHGSSASVFKGI-LSDGTSVAVK--------------RINGEENGEKEFRSEVAAIA 151
            +LG     +  +      G S  V               ++  E    +  R       
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 152 SAQHVNLVRLLGYCVVPGGPR----------------YLVYEFIQNGSLDHWIFPTSRRS 195
           +  H+  +        P   +                + +Y  +Q  +L  +       S
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHS 202

Query: 196 EGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFG 255
             H     L    R ++ + V + L+ LH      ++H  ++P +I+LD+     ++ F 
Sbjct: 203 STH---KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFE 256

Query: 256 LSKLMSRDQSRCITTIRGTRGYLAPEWILEQG-----VSEKCDIYSYGMVLLELTGGR 308
                       I          A   +         ++   D ++ G+ +  +    
Sbjct: 257 HLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  100 bits (251), Expect = 9e-24
 Identities = 57/223 (25%), Positives = 89/223 (39%), Gaps = 37/223 (16%)

Query: 105 FQALLGHGSSASVFKGILSDG------TSVAVKRIN-GEENGEKEFRSEVAAIASAQHVN 157
            +  LG G+   VF     +         VAVK +    E+  ++F+ E   +   QH +
Sbjct: 45  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104

Query: 158 LVRLLGYCVVPGGPRYLVYEFIQNGSLD-----HWIFPTSRRSEGHYSGGCLSWDLRYRV 212
           +VR  G     G P  +V+E++++G L+     H             + G L       V
Sbjct: 105 IVRFFG-VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163

Query: 213 AIDVAKALSYL------HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSR 266
           A  VA  + YL      H D  +R         N L+ +     + DFG    MSRD   
Sbjct: 164 ASQVAAGMVYLAGLHFVHRDLATR---------NCLVGQGLVVKIGDFG----MSRDIYS 210

Query: 267 CITTIRGTRGYL-----APEWILEQGVSEKCDIYSYGMVLLEL 304
                 G R  L      PE IL +  + + D++S+G+VL E+
Sbjct: 211 TDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEI 253

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  100 bits (252), Expect = 9e-24
 Identities = 49/225 (21%), Positives = 88/225 (39%), Gaps = 39/225 (17%)

Query: 109 LGHGSSASVFKGILSDGTSVAVKRIN------------------GEENGEKEFRSEVAAI 150
           L  G    +      D    A+K+                      ++   +F++E+  I
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 151 ASAQHVNLVRLLGYC-----VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLS 205
              ++   +   G       V      Y++YE+++N S+  +        + +     + 
Sbjct: 98  TDIKNEYCLTCEGIITNYDEV------YIIYEYMENDSILKFDEYFFVLDKNY--TCFIP 149

Query: 206 WDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQS 265
             +   +   V  + SY+HN     + H DVKP NIL+D+N R  +SDFG S+ M   + 
Sbjct: 150 IQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK- 206

Query: 266 RCITTIRGTRGYLAPEWILEQGV--SEKCDIYSYGMVLLELTGGR 308
             I   RGT  ++ PE+   +      K DI+S G+ L  +    
Sbjct: 207 --IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 99.2 bits (248), Expect = 1e-23
 Identities = 56/209 (26%), Positives = 84/209 (40%), Gaps = 32/209 (15%)

Query: 104 NFQALLGHGSSASVFKGI-LSDGTSVAVKRIN---GEENGEKEFRSEVAAIASAQHVNLV 159
           N   +LG GS   V K          AVK IN    +         EV  +    H N++
Sbjct: 25  NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84

Query: 160 RLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK- 218
           +L           Y+V E    G L   I          +S            A  + K 
Sbjct: 85  KLFEILEDSSS-FYIVGELYTGGELFDEI-----IKRKRFS---------EHDAARIIKQ 129

Query: 219 ---ALSYLHNDCRSRVLHLDVKPENILL---DENYRAVVSDFGLSKLMSRDQSRCITTIR 272
               ++Y+H      ++H D+KPENILL   +++    + DFGLS    ++    +    
Sbjct: 130 VFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--MKDRI 184

Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVL 301
           GT  Y+APE +L     EKCD++S G++L
Sbjct: 185 GTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 99.7 bits (249), Expect = 1e-23
 Identities = 53/262 (20%), Positives = 93/262 (35%), Gaps = 32/262 (12%)

Query: 97  ELEEATDNFQALLGHGSSASVFKGIL-----SDGTSVAVK--RINGEENGEKEFRSEVAA 149
              +        LG G    V            G  VAVK  + +        ++ E+  
Sbjct: 27  VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDI 86

Query: 150 IASAQHVNLVRLLGYCVVPGG-PRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL 208
           + +  H ++++  G C   G     LV E++  GSL  ++     R     +       L
Sbjct: 87  LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLA------QL 136

Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI 268
               A  + + ++YLH       +H D+   N+LLD +    + DFGL+K +        
Sbjct: 137 LL-FAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE--- 189

Query: 269 TTIRGTRGYL-----APEWILEQGVSEKCDIYSYGMVLLEL-TGGRRNVSLIEHGNDKSK 322
                  G       APE + E       D++S+G+ L EL T    + S      +   
Sbjct: 190 YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIG 249

Query: 323 NK-WQYFPKIVNEKMKEGKLME 343
               Q     + E ++ G+ + 
Sbjct: 250 IAQGQMTVLRLTELLERGERLP 271

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 98.8 bits (247), Expect = 2e-23
 Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 37/208 (17%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRIN--GEENGEKEFRSEVAAIASAQHVNLVRLLGY- 164
           LG G+   V      S G    +K IN    +   ++  +E+  + S  H N++++    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89

Query: 165 ----CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK-- 218
                +      Y+V E  + G L   I     R     S              ++ K  
Sbjct: 90  EDYHNM------YIVMETCEGGELLERIVSAQAR-GKALS---------EGYVAELMKQM 133

Query: 219 --ALSYLHNDCRSRVLHLDVKPENILL---DENYRAVVSDFGLSKLMSRDQSRCITTIRG 273
             AL+Y H+     V+H D+KPENIL      +    + DFGL++L   D+    T   G
Sbjct: 134 MNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--STNAAG 188

Query: 274 TRGYLAPEWILEQGVSEKCDIYSYGMVL 301
           T  Y+APE + ++ V+ KCDI+S G+V+
Sbjct: 189 TALYMAPE-VFKRDVTFKCDIWSAGVVM 215

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 99.7 bits (249), Expect = 2e-23
 Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 21/209 (10%)

Query: 109 LGHGSSASVFKGILSDG------TSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVR 160
           LG GS   V++G+          T VA+K +N         EF +E + +      ++VR
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92

Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG  V  G P  ++ E +  G L  ++         +      S     ++A ++A  +
Sbjct: 93  LLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151

Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL-- 278
           +YL+    ++ +H D+   N ++ E++   + DFG    M+RD        +G +G L  
Sbjct: 152 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFG----MTRDIYETDYYRKGGKGLLPV 204

Query: 279 ---APEWILEQGVSEKCDIYSYGMVLLEL 304
              +PE + +   +   D++S+G+VL E+
Sbjct: 205 RWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 98.9 bits (247), Expect = 2e-23
 Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 22/221 (9%)

Query: 98  LEEATDNFQAL--LGHGSSASVFKGI-LSDGTSVAVKRINGEENGE--KEFRSEVAAI-A 151
           +E   D+ + +  LG G+   V K   +  G  +AVKRI    N +  K    ++     
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61

Query: 152 SAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYR 211
           +      V   G  +   G  ++  E + + SLD +      +      G  +  D+  +
Sbjct: 62  TVDCPFTVTFYG-ALFREGDVWICMELM-DTSLDKFYKQVIDK------GQTIPEDILGK 113

Query: 212 VAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTI 271
           +A+ + KAL +LH+     V+H DVKP N+L++   +  + DFG+S  +  D ++     
Sbjct: 114 IAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK--DID 169

Query: 272 RGTRGYLAPEWIL----EQGVSEKCDIYSYGMVLLELTGGR 308
            G + Y+APE I     ++G S K DI+S G+ ++EL   R
Sbjct: 170 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 98.9 bits (247), Expect = 2e-23
 Identities = 53/217 (24%), Positives = 89/217 (41%), Gaps = 29/217 (13%)

Query: 106 QALLGHGSSASVFKG---ILSDGTSVAVK----RINGEENGEKEFRSEVAAIASAQHVNL 158
             +LG G  + V             VAVK     +  + +    FR E    A+  H  +
Sbjct: 17  GEILGFGGMSEVHLARDLRD--HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 74

Query: 159 VRLLGYCVVPGGPR---YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
           V +              Y+V E++   +L   +      +EG      ++      V  D
Sbjct: 75  VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-----HTEGP-----MTPKRAIEVIAD 124

Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT---TIR 272
             +AL++ H   ++ ++H DVKP NI++       V DFG+++ ++ D    +T    + 
Sbjct: 125 ACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIA-DSGNSVTQTAAVI 180

Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRR 309
           GT  YL+PE      V  + D+YS G VL E+  G  
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 98.5 bits (246), Expect = 3e-23
 Identities = 52/220 (23%), Positives = 87/220 (39%), Gaps = 38/220 (17%)

Query: 109 LGHGSSASVFKGIL------SDGTSVAVKRIN-GEENGEKEFRSEVAAIASAQHVNLVRL 161
           LG G+   VF           D   VAVK +        K+F+ E   + + QH ++V+ 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 162 LGYCVVPGGPRYLVYEFIQNGSLDHW------IFPTSRRSEGHYSGGCLSWDLRYRVAID 215
            G     G P  +V+E++++G L+ +              +   + G L       +A  
Sbjct: 83  YG-VCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141

Query: 216 VAKALSYL------HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT 269
           +A  + YL      H D  +R         N L+  N    + DFG    MSRD      
Sbjct: 142 IASGMVYLASQHFVHRDLATR---------NCLVGANLLVKIGDFG----MSRDVYSTDY 188

Query: 270 TIRGTRGYL-----APEWILEQGVSEKCDIYSYGMVLLEL 304
              G    L      PE I+ +  + + D++S+G++L E+
Sbjct: 189 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEI 228

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 98.5 bits (246), Expect = 3e-23
 Identities = 49/220 (22%), Positives = 90/220 (40%), Gaps = 40/220 (18%)

Query: 109 LGHGSSASVFKGILSDG----TSVAVK--RINGEENGEKEFRSEVAAIASAQHVNLVRLL 162
           +G G    V+ G   D        A+K      E    + F  E   +    H N++ L+
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88

Query: 163 GYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY 222
           G  + P G  +++  ++ +G L  +I    R  + + +   L         + VA+ + Y
Sbjct: 89  GIMLPPEGLPHVLLPYMCHGDLLQFI----RSPQRNPTVKDL-----ISFGLQVARGMEY 139

Query: 223 L------HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG 276
           L      H D  +R         N +LDE++   V+DFGL++ +   +     +++  R 
Sbjct: 140 LAEQKFVHRDLAAR---------NCMLDESFTVKVADFGLARDILDRE---YYSVQQHRH 187

Query: 277 YL------APEWILEQGVSEKCDIYSYGMVLLEL-TGGRR 309
                   A E +     + K D++S+G++L EL T G  
Sbjct: 188 ARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 98.6 bits (246), Expect = 3e-23
 Identities = 51/224 (22%), Positives = 93/224 (41%), Gaps = 26/224 (11%)

Query: 96  KELEEATDNFQAL--LGHGSSASVFKGI-LSDGTSVAVKRINGEENGE--KEFRSEVAAI 150
           +  +   ++ + L  +G G+   V+K      G  +AVK++    N E  K    ++  +
Sbjct: 18  QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77

Query: 151 ASA-QHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR 209
             +     +V+  G   +     ++  E +   +            E             
Sbjct: 78  LKSHDCPYIVQCFG-TFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG--------- 127

Query: 210 YRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT 269
            ++ + + KAL YL       V+H DVKP NILLDE  +  + DFG+S  +  D+++   
Sbjct: 128 -KMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK--D 182

Query: 270 TIRGTRGYLAPEWI-----LEQGVSEKCDIYSYGMVLLELTGGR 308
              G   Y+APE I      +     + D++S G+ L+EL  G+
Sbjct: 183 RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  100 bits (251), Expect = 4e-23
 Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 25/206 (12%)

Query: 104 NFQALLGHGSSASVFKGI-LSDGTSVAVKRIN----GEENGEKEFRSEVAAIASAQHVNL 158
             Q +LG GS   V        G   AVK I+     ++  ++    EV  +    H N+
Sbjct: 29  KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88

Query: 159 VRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK 218
           ++L  +    G   YLV E    G L   I      S   +S    +     R+   V  
Sbjct: 89  MKLYEFFEDKGY-FYLVGEVYTGGELFDEI-----ISRKRFSEVDAA-----RIIRQVLS 137

Query: 219 ALSYLHNDCRSRVLHLDVKPENILL---DENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
            ++Y+H    ++++H D+KPEN+LL    ++    + DFGLS      +   +    GT 
Sbjct: 138 GITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK--MKDKIGTA 192

Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVL 301
            Y+APE +L     EKCD++S G++L
Sbjct: 193 YYIAPE-VLHGTYDEKCDVWSTGVIL 217

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  100 bits (250), Expect = 5e-23
 Identities = 53/212 (25%), Positives = 85/212 (40%), Gaps = 24/212 (11%)

Query: 105 FQALLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKE---FRSEVAAIASAQHVNLVR 160
               LG G+   V            A+K I               EVA +    H N+++
Sbjct: 41  RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMK 100

Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           L  +        YLV E  + G L   I          ++    +      +   V   +
Sbjct: 101 LYDFFEDKRN-YYLVMECYKGGELFDEI-----IHRMKFNEVDAA-----VIIKQVLSGV 149

Query: 221 SYLHNDCRSRVLHLDVKPENILL---DENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGY 277
           +YLH      ++H D+KPEN+LL   +++    + DFGLS +    +   +    GT  Y
Sbjct: 150 TYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK--MKERLGTAYY 204

Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLELTGGRR 309
           +APE +L +   EKCD++S G++L  L  G  
Sbjct: 205 IAPE-VLRKKYDEKCDVWSIGVILFILLAGYP 235

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  100 bits (251), Expect = 5e-23
 Identities = 56/219 (25%), Positives = 91/219 (41%), Gaps = 43/219 (19%)

Query: 105 FQALLGHGSSASVFKGI-LSDGTSVAVKRIN--------------GEENGEKEFRSEVAA 149
               LG G+   V      +  +  A+K I                 E   +E  +E++ 
Sbjct: 40  KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99

Query: 150 IASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR 209
           + S  H N+++L           YLV EF + G L   I      +   +          
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKY-FYLVTEFYEGGELFEQI-----INRHKFD--------- 144

Query: 210 YRVAIDVAK----ALSYLHNDCRSRVLHLDVKPENILL---DENYRAVVSDFGLSKLMSR 262
              A ++ K     + YLH      ++H D+KPENILL   +      + DFGLS   S+
Sbjct: 145 ECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK 201

Query: 263 DQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVL 301
           D    +    GT  Y+APE +L++  +EKCD++S G+++
Sbjct: 202 DYK--LRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIM 237

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 97.8 bits (244), Expect = 6e-23
 Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 18/201 (8%)

Query: 106 QALLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGY 164
              LG GS  SV+K I    G  VA+K++  E +  +E   E++ +      ++V+  G 
Sbjct: 34  LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-LQEIIKEISIMQQCDSPHVVKYYG- 91

Query: 165 CVVPGGPRYLVYEFIQNGSLDHWIFPTSRR-SEGHYSGGCLSWDLRYRVAIDVAKALSYL 223
                   ++V E+   GS+   I   ++  +E   +                 K L YL
Sbjct: 92  SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQ----------STLKGLEYL 141

Query: 224 HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWI 283
           H     R +H D+K  NILL+    A ++DFG++  ++   ++  T I GT  ++APE I
Sbjct: 142 HFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVI 197

Query: 284 LEQGVSEKCDIYSYGMVLLEL 304
            E G +   DI+S G+  +E+
Sbjct: 198 QEIGYNCVADIWSLGITAIEM 218

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  100 bits (251), Expect = 6e-23
 Identities = 49/217 (22%), Positives = 91/217 (41%), Gaps = 31/217 (14%)

Query: 105 FQALLGHGSSASVFKGILSDG----TSVAVK--RINGEENGEKEFRSEVAAIASAQHVNL 158
               +G G    V +GI         +VA+K  +    ++  ++F  E   +    H ++
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453

Query: 159 VRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK 218
           V+L+G  V+   P +++ E    G L  ++    +  +       L        A  ++ 
Sbjct: 454 VKLIG--VITENPVWIIMELCTLGELRSFL----QVRKFSLDLASL-----ILYAYQLST 502

Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
           AL+YL      R +H D+   N+L+  N    + DFGLS+ M        T  + ++G L
Sbjct: 503 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-----TYYKASKGKL 554

Query: 279 -----APEWILEQGVSEKCDIYSYGMVLLE-LTGGRR 309
                APE I  +  +   D++ +G+ + E L  G +
Sbjct: 555 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 591

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 97.7 bits (244), Expect = 8e-23
 Identities = 48/209 (22%), Positives = 78/209 (37%), Gaps = 36/209 (17%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRIN------GEENGEKE-FRSEVAAIASAQHVNLVR 160
           LG G  A V K    S G   A K I             +E    EV+ +    H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK-- 218
           L            L+ E +  G L  ++       +   S            A    K  
Sbjct: 80  LHDVYENRTD-VVLILELVSGGELFDFL-----AQKESLS---------EEEATSFIKQI 124

Query: 219 --ALSYLHNDCRSRVLHLDVKPENILL----DENYRAVVSDFGLSKLMSRDQSRCITTIR 272
              ++YLH     ++ H D+KPENI+L           + DFGL+  +  +       I 
Sbjct: 125 LDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIF 179

Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVL 301
           GT  ++APE +  + +  + D++S G++ 
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 96.9 bits (242), Expect = 8e-23
 Identities = 53/225 (23%), Positives = 81/225 (36%), Gaps = 39/225 (17%)

Query: 105 FQALLGHGSSASVFKGILSDG------TSVAVKRINGE--ENGEKEFRSEVAAIASAQHV 156
           F   LG      V+KG L          +VA+K +  +      +EFR E    A  QH 
Sbjct: 13  FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72

Query: 157 NLVRLLGYCVVPGGPRYLVYEFIQNGSLDHW------IFPTSRRSEGHYSGGCLSWDLRY 210
           N+V LLG  V    P  +++ +  +G L  +              +       L      
Sbjct: 73  NVVCLLG-VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131

Query: 211 RVAIDVAKALSYL------HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ 264
            +   +A  + YL      H D  +R         N+L+ +     +SD G    + R+ 
Sbjct: 132 HLVAQIAAGMEYLSSHHVVHKDLATR---------NVLVYDKLNVKISDLG----LFREV 178

Query: 265 SRCITTIRGTRGYL-----APEWILEQGVSEKCDIYSYGMVLLEL 304
                        L     APE I+    S   DI+SYG+VL E+
Sbjct: 179 YAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEV 223

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 97.9 bits (244), Expect = 8e-23
 Identities = 51/220 (23%), Positives = 85/220 (38%), Gaps = 31/220 (14%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKRING-EENGEKEFRSEVAAIAS-AQHVNLVRLLGY 164
           +L  G  A V++   +  G   A+KR+   EE   +    EV  +   + H N+V+    
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 165 CVVP------GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK 218
             +       G   +L+   +  G L    F     S G      LS D   ++     +
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQL--VEFLKKMESRGP-----LSCDTVLKIFYQTCR 147

Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT--------- 269
           A+ ++H   +  ++H D+K EN+LL       + DFG +  +S       +         
Sbjct: 148 AVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206

Query: 270 --TIRGTRGYLAPEWI---LEQGVSEKCDIYSYGMVLLEL 304
             T   T  Y  PE I       + EK DI++ G +L  L
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL 246

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 98.8 bits (246), Expect = 8e-23
 Identities = 49/219 (22%), Positives = 75/219 (34%), Gaps = 36/219 (16%)

Query: 109 LGHGSS--ASVFKGI-LSDGTSVAVKRINGEENGEKEF---RSEVAAIASAQHVNLVRLL 162
           +G G     +V        G  V V+RIN E    +     + E+       H N+V   
Sbjct: 33  IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92

Query: 163 GYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRR--SEGHYSGGCLSWDLRYRVAI---DVA 217
               +     ++V  F+  GS    I        +E               +A     V 
Sbjct: 93  A-TFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-------------IAYILQGVL 138

Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR----- 272
           KAL Y+H       +H  VK  +IL+  + +  +S    +  M     R           
Sbjct: 139 KALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195

Query: 273 -GTRGYLAPEWILE--QGVSEKCDIYSYGMVLLELTGGR 308
                +L+PE + +  QG   K DIYS G+   EL  G 
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 99.4 bits (248), Expect = 9e-23
 Identities = 57/205 (27%), Positives = 86/205 (41%), Gaps = 24/205 (11%)

Query: 104 NFQALLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKE---FRSEVAAIASAQHVNLV 159
           N   +LG GS   V K          AVK IN      K+      EV  +    H N++
Sbjct: 25  NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84

Query: 160 RLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKA 219
           +L           Y+V E    G L   I          +S    +     R+   V   
Sbjct: 85  KLFEILEDSSS-FYIVGELYTGGELFDEI-----IKRKRFSEHDAA-----RIIKQVFSG 133

Query: 220 LSYLHNDCRSRVLHLDVKPENILL---DENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG 276
           ++Y+H      ++H D+KPENILL   +++    + DFGLS    ++    +    GT  
Sbjct: 134 ITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--MKDRIGTAY 188

Query: 277 YLAPEWILEQGVSEKCDIYSYGMVL 301
           Y+APE +L     EKCD++S G++L
Sbjct: 189 YIAPE-VLRGTYDEKCDVWSAGVIL 212

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 96.9 bits (242), Expect = 1e-22
 Identities = 51/235 (21%), Positives = 99/235 (42%), Gaps = 35/235 (14%)

Query: 85  KVAGVPIKFRSKELEEATDNFQALLGHGSSASVFKGI-LSDGTSVAVKRIN--------- 134
           + A +P    +    E  +  + +LG G S+ V + I        AVK I+         
Sbjct: 2   RDAALPGSHSTHGFYENYE-PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSA 60

Query: 135 -GEENGEKEFRSEVAAIAS-AQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTS 192
              +   +    EV  +   + H N+++L           +LV++ ++ G L  ++    
Sbjct: 61  EEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF-FFLVFDLMKKGELFDYLT--- 116

Query: 193 RRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVS 252
              +   S      + R ++   + + +  LH      ++H D+KPENILLD++    ++
Sbjct: 117 --EKVTLS----EKETR-KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLT 166

Query: 253 DFGLSKLMSRDQSRCITTIRGTRGYLAPE------WILEQGVSEKCDIYSYGMVL 301
           DFG S  +   +   +  + GT  YLAPE           G  ++ D++S G+++
Sbjct: 167 DFGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 97.3 bits (243), Expect = 1e-22
 Identities = 59/230 (25%), Positives = 97/230 (42%), Gaps = 43/230 (18%)

Query: 105 FQALLGHGSSASVFKGILSDG---TSVAVKRINGE--ENGEKEFRSEVAAIAS--AQHVN 157
           FQ ++G G+   V K  +         A+KR+     ++  ++F  E   +      H N
Sbjct: 29  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGE-LEVLCKLGHHPN 87

Query: 158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHW------IFPTSRRSEGHYSGGCLSWDLRYR 211
           ++ LLG C    G  YL  E+  +G+L  +      +      +  + +   LS      
Sbjct: 88  IINLLGACEH-RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146

Query: 212 VAIDVAKALSYL------HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQS 265
            A DVA+ + YL      H D  +R         NIL+ ENY A ++DFG    +SR Q 
Sbjct: 147 FAADVARGMDYLSQKQFIHRDLAAR---------NILVGENYVAKIADFG----LSRGQE 193

Query: 266 RCITTIRGTRGYL-----APEWILEQGVSEKCDIYSYGMVLLEL-TGGRR 309
                ++ T G L     A E +     +   D++SYG++L E+ + G  
Sbjct: 194 ---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT 240

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 98.2 bits (245), Expect = 1e-22
 Identities = 47/214 (21%), Positives = 79/214 (36%), Gaps = 36/214 (16%)

Query: 104 NFQALLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKE-------FRSEVAAIASAQH 155
           +    LG G  A V K    S G   A K I   ++              EV+ +    H
Sbjct: 15  DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74

Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
            N++ L            L+ E +  G L  ++       +   S            A  
Sbjct: 75  PNIITLHDVYENRTD-VVLILELVSGGELFDFL-----AQKESLS---------EEEATS 119

Query: 216 VAK----ALSYLHNDCRSRVLHLDVKPENILL----DENYRAVVSDFGLSKLMSRDQSRC 267
             K     ++YLH     ++ H D+KPENI+L           + DFGL+  +  +    
Sbjct: 120 FIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVE 174

Query: 268 ITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVL 301
              I GT  ++APE +  + +  + D++S G++ 
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 96.6 bits (241), Expect = 1e-22
 Identities = 48/222 (21%), Positives = 90/222 (40%), Gaps = 39/222 (17%)

Query: 105 FQALLGHGSSASVFKGILSDG----TSVAVKRINGEENGEKE---FRSEVAAIASAQHVN 157
              +LG G   SV +G L         VAVK +  + + ++E   F SE A +    H N
Sbjct: 38  LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97

Query: 158 LVRLLGYCV----VPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVA 213
           ++RLLG C+           ++  F++ G L  ++      S        +      +  
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL----LYSRLETGPKHIPLQTLLKFM 153

Query: 214 IDVAKALSYL------HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC 267
           +D+A  + YL      H D  +R         N +L ++    V+DFG    +S+     
Sbjct: 154 VDIALGMEYLSNRNFLHRDLAAR---------NCMLRDDMTVCVADFG----LSKKIYSG 200

Query: 268 ITTIRGTRGYL-----APEWILEQGVSEKCDIYSYGMVLLEL 304
               +G    +     A E + ++  + K D++++G+ + E+
Sbjct: 201 DYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEI 242

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 96.6 bits (241), Expect = 2e-22
 Identities = 51/209 (24%), Positives = 87/209 (41%), Gaps = 24/209 (11%)

Query: 106 QALLGHGSSASVFKG---ILSDGTSVAVKRINGEENGEKEFRS----EVAAIASAQHVNL 158
           + L+G G    V++    +      VA+K ++   + +  FR+    E       Q  ++
Sbjct: 39  RRLVGRGGMGDVYEAEDTVR--ERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHV 96

Query: 159 VRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK 218
           V +  +  + G   Y+    I    L   +     R +G      L+      +   +  
Sbjct: 97  VPIHDFGEIDGQL-YVDMRLINGVDLAAML-----RRQGP-----LAPPRAVAIVRQIGS 145

Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
           AL   H    +   H DVKPENIL+  +  A + DFG++   + ++   +    GT  Y+
Sbjct: 146 ALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYM 202

Query: 279 APEWILEQGVSEKCDIYSYGMVLLE-LTG 306
           APE   E   + + DIY+   VL E LTG
Sbjct: 203 APERFSESHATYRADIYALTCVLYECLTG 231

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 97.0 bits (242), Expect = 2e-22
 Identities = 66/248 (26%), Positives = 95/248 (38%), Gaps = 42/248 (16%)

Query: 79  EYSFLRKVAGVPIKFRSKELEEATDNFQALLGHGSSASVFKGILSDG------TSVAVKR 132
            Y F  K + +      KE+          LGHG+   V++G +S          VAVK 
Sbjct: 11  NYCFAGKTSSISDL---KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT 67

Query: 133 INGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFP 190
           +     E  E +F  E   I+   H N+VR +G   +   PR+++ E +  G L    F 
Sbjct: 68  LPEVCSEQDELDFLMEALIISKFNHQNIVRCIG-VSLQSLPRFILMELMAGGDLKS--FL 124

Query: 191 TSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL------HNDCRSRVLHLDVKPENILLD 244
              R            DL   VA D+A    YL      H D  +R         N LL 
Sbjct: 125 RETRPRPSQPSSLAMLDL-LHVARDIACGCQYLEENHFIHRDIAAR---------NCLLT 174

Query: 245 ---ENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL-----APEWILEQGVSEKCDIYS 296
                  A + DFG    M+RD  R     +G    L      PE  +E   + K D +S
Sbjct: 175 CPGPGRVAKIGDFG----MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWS 230

Query: 297 YGMVLLEL 304
           +G++L E+
Sbjct: 231 FGVLLWEI 238

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 96.5 bits (241), Expect = 2e-22
 Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 30/207 (14%)

Query: 104 NFQALLGHGSSASVFKGI-LSDGTSVAVKRIN-GEENGEKEFRSEVAAIASAQHVNLVRL 161
            F  +LG G+ + VF       G   A+K I       +    +E+A +   +H N+V L
Sbjct: 12  IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71

Query: 162 LGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK--- 218
                      YLV + +  G L   I        G Y+          + A  V +   
Sbjct: 72  EDIYESTTH-YYLVMQLVSGGELFDRIL-----ERGVYT---------EKDASLVIQQVL 116

Query: 219 -ALSYLHNDCRSRVLHLDVKPENILL---DENYRAVVSDFGLSKLMSRDQSRCITTIRGT 274
            A+ YLH    + ++H D+KPEN+L    +EN + +++DFGLSK+        ++T  GT
Sbjct: 117 SAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI---MSTACGT 170

Query: 275 RGYLAPEWILEQGVSEKCDIYSYGMVL 301
            GY+APE + ++  S+  D +S G++ 
Sbjct: 171 PGYVAPEVLAQKPYSKAVDCWSIGVIT 197

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 97.5 bits (243), Expect = 2e-22
 Identities = 47/227 (20%), Positives = 90/227 (39%), Gaps = 30/227 (13%)

Query: 84  RKVAGVPIKFRSKELEEATDNFQALLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKE 142
           +K    P++ +   + +  D     LG G+   V + +  + G     K IN     +K 
Sbjct: 35  KKYVPQPVEVKQGSVYDYYD-ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY 93

Query: 143 -FRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL-DHWIFPTSRRSEGHYS 200
             ++E++ +    H  L+ L            L+ EF+  G L D       + SE    
Sbjct: 94  TVKNEISIMNQLHHPKLINLHDAFEDKYE-MVLILEFLSGGELFDRIAAEDYKMSE---- 148

Query: 201 GGCLSWDLRYRVAIDVAK----ALSYLHNDCRSRVLHLDVKPENILL--DENYRAVVSDF 254
                        I+  +     L ++H      ++HLD+KPENI+    +     + DF
Sbjct: 149 ----------AEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDF 195

Query: 255 GLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVL 301
           GL+  ++ D+   +     T  + APE +  + V    D+++ G++ 
Sbjct: 196 GLATKLNPDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 96.5 bits (241), Expect = 2e-22
 Identities = 38/197 (19%), Positives = 73/197 (37%), Gaps = 26/197 (13%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVV 167
           LG G    V + +  S   +   K +  +   +   + E++ +  A+H N++ L      
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72

Query: 168 PGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK----ALSYL 223
                 +++EFI    +   I      S    +          R  +        AL +L
Sbjct: 73  MEE-LVMIFEFISGLDIFERIN----TSAFELN---------EREIVSYVHQVCEALQFL 118

Query: 224 HNDCRSRVLHLDVKPENILL--DENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPE 281
           H+     + H D++PENI+     +    + +FG ++ +    +     +     Y APE
Sbjct: 119 HS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPE 173

Query: 282 WILEQGVSEKCDIYSYG 298
                 VS   D++S G
Sbjct: 174 VHQHDVVSTATDMWSLG 190

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 97.8 bits (244), Expect = 2e-22
 Identities = 47/210 (22%), Positives = 86/210 (40%), Gaps = 35/210 (16%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRIN---------GEENGEKEFRSEVAAIASAQHVNL 158
           LG G+   V           VA++ I+          E +      +E+  +    H  +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202

Query: 159 VRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK 218
           +++  +        Y+V E ++ G L   +                           +  
Sbjct: 203 IKIKNFFDAED--YYIVLELMEGGELFDKV-----VGNKRLKE-----ATCKLYFYQMLL 250

Query: 219 ALSYLHNDCRSRVLHLDVKPENILL---DENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           A+ YLH    + ++H D+KPEN+LL   +E+    ++DFG SK++   ++  + T+ GT 
Sbjct: 251 AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTP 305

Query: 276 GYLAPEWILEQ----GVSEKCDIYSYGMVL 301
            YLAPE +L      G +   D +S G++L
Sbjct: 306 TYLAPE-VLVSVGTAGYNRAVDCWSLGVIL 334

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 95.4 bits (238), Expect = 3e-22
 Identities = 52/220 (23%), Positives = 88/220 (40%), Gaps = 37/220 (16%)

Query: 109 LGHGSSASVFKGIL--------SDGTSVAVKRIN-GEENGEKEFRSEVAAIASAQHVNLV 159
           LG G+   +FKG+            T V +K ++    N  + F    + ++   H +LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 160 RLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKA 219
              G CV  G    LV EF++ GSLD ++    ++++   +           VA  +A A
Sbjct: 76  LNYGVCVC-GDENILVQEFVKFGSLDTYL----KKNKNCINILWK-----LEVAKQLAAA 125

Query: 220 LSYLHNDCRSRVLHLDVKPENILLDENYRAV--------VSDFGLSKLMSRDQSRCITTI 271
           + +L     + ++H +V  +NILL               +SD G+S  +          I
Sbjct: 126 MHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQE-RI 181

Query: 272 RGTRGYLAPEWILEQGV-SEKCDIYSYGMVLLE-LTGGRR 309
                   PE I      +   D +S+G  L E  +GG +
Sbjct: 182 PWV----PPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 95.0 bits (237), Expect = 3e-22
 Identities = 48/202 (23%), Positives = 77/202 (38%), Gaps = 30/202 (14%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEE-NGEKEFRSEVAAIASAQHVNLVRLLGYCV 166
           +G GS   V   +        A K+I          F+ E+  + S  H N++RL     
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76

Query: 167 VPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK----ALSY 222
                 YLV E    G L   +       +  +             A  + K    A++Y
Sbjct: 77  DNTD-IYLVMELCTGGELFERVV-----HKRVFR---------ESDAARIMKDVLSAVAY 121

Query: 223 LHNDCRSRVLHLDVKPENILL---DENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLA 279
            H      V H D+KPEN L      +    + DFGL+      +   + T  GT  Y++
Sbjct: 122 CHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM--MRTKVGTPYYVS 176

Query: 280 PEWILEQGVSEKCDIYSYGMVL 301
           P+ +LE     +CD +S G+++
Sbjct: 177 PQ-VLEGLYGPECDEWSAGVMM 197

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 94.9 bits (237), Expect = 3e-22
 Identities = 49/209 (23%), Positives = 79/209 (37%), Gaps = 36/209 (17%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRIN-----GEENGE--KEFRSEVAAIASAQHVNLVR 160
           LG G  A V K      G   A K I          G   +E   EV  +   +H N++ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK-- 218
           L            L+ E +  G L  ++       +   +            A    K  
Sbjct: 73  LHDIFENKTD-VVLILELVSGGELFDFLA-----EKESLT---------EDEATQFLKQI 117

Query: 219 --ALSYLHNDCRSRVLHLDVKPENILL----DENYRAVVSDFGLSKLMSRDQSRCITTIR 272
              + YLH     R+ H D+KPENI+L      N R  + DFG++  +  +       I 
Sbjct: 118 LDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKNIF 172

Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVL 301
           GT  ++APE +  + +  + D++S G++ 
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 201

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 96.7 bits (241), Expect = 3e-22
 Identities = 52/210 (24%), Positives = 96/210 (45%), Gaps = 33/210 (15%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRIN---------GEENGEKEFRSEVAAIAS-AQHVN 157
           +G G S+ V + +  + G   AVK +            E   +  R E   +   A H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161

Query: 158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
           ++ L+          +LV++ ++ G L  ++       +   S      + R  +   + 
Sbjct: 162 IITLIDSYESSSF-MFLVFDLMRKGELFDYLT-----EKVALS----EKETR-SIMRSLL 210

Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGY 277
           +A+S+LH    + ++H D+KPENILLD+N +  +SDFG S  +   +   +  + GT GY
Sbjct: 211 EAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK--LRELCGTPGY 265

Query: 278 LAPE------WILEQGVSEKCDIYSYGMVL 301
           LAPE           G  ++ D+++ G++L
Sbjct: 266 LAPEILKCSMDETHPGYGKEVDLWACGVIL 295

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 94.5 bits (236), Expect = 5e-22
 Identities = 50/206 (24%), Positives = 90/206 (43%), Gaps = 35/206 (16%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRIN-----GEENGEKEFRSEVAAIASAQHVNLVRLL 162
           LG G+ + V + +  + G   A K IN       +   ++   E       QH N+VRL 
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD--FQKLEREARICRKLQHPNIVRLH 71

Query: 163 GYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK---- 218
                     YLV++ +  G L   I      +   YS            A    +    
Sbjct: 72  DSIQEESF-HYLVFDLVTGGELFEDIV-----AREFYS---------EADASHCIQQILE 116

Query: 219 ALSYLHNDCRSRVLHLDVKPENILL---DENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           +++Y H+   + ++H ++KPEN+LL    +     ++DFGL+  ++  ++       GT 
Sbjct: 117 SIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGFAGTP 171

Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVL 301
           GYL+PE + +   S+  DI++ G++L
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVIL 197

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 95.3 bits (237), Expect = 5e-22
 Identities = 39/143 (27%), Positives = 64/143 (44%), Gaps = 21/143 (14%)

Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
           Y+  +  +  +L  W+   +RR         +   +     I +A+A+ +LH+     ++
Sbjct: 137 YIQMQLCRKENLKDWM---NRRCSLEDREHGVCLHI----FIQIAEAVEFLHS---KGLM 186

Query: 233 HLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC-----------ITTIRGTRGYLAPE 281
           H D+KP NI    +    V DFGL   M +D+               T   GT+ Y++PE
Sbjct: 187 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246

Query: 282 WILEQGVSEKCDIYSYGMVLLEL 304
            I     S K DI+S G++L EL
Sbjct: 247 QIHGNNYSHKVDIFSLGLILFEL 269

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 94.7 bits (236), Expect = 7e-22
 Identities = 53/204 (25%), Positives = 96/204 (47%), Gaps = 23/204 (11%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKE-FRSEVAAIASAQHVNLVRLLGYCV 166
           LG G+   V+K      G   A K I  +   E E +  E+  +A+  H  +V+LLG   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLG-AY 85

Query: 167 VPGGPRYLVYEFIQNGSLDHWIFPTSRR-SEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
              G  +++ EF   G++D  +    R  +E      C            + +AL++LH+
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCR----------QMLEALNFLHS 135

Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILE 285
               R++H D+K  N+L+       ++DFG+S    +   +  + I GT  ++APE ++ 
Sbjct: 136 K---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMC 191

Query: 286 QGVSE-----KCDIYSYGMVLLEL 304
           + + +     K DI+S G+ L+E+
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEM 215

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 94.6 bits (236), Expect = 8e-22
 Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 39/222 (17%)

Query: 109 LGHGSSASVFKGIL------SDGTSVAVKRINGE--ENGEKEFRSEVAAIAS-AQHVNLV 159
           LG G+   V +         +   +VAVK +      +  +   SE+  +     H+N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94

Query: 160 RLLGYCVVPGGPRYLVYEFIQNGSLDHWI------FPTSRRSEGHYSGGCLSWDLRYRVA 213
            LLG C  PGGP  ++ EF + G+L  ++      F   + +        L+ +     +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154

Query: 214 IDVAKALSYL------HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC 267
             VAK + +L      H D  +R         NILL E     + DFGL++ + +D    
Sbjct: 155 FQVAKGMEFLASRKCIHRDLAAR---------NILLSEKNVVKICDFGLARDIYKDPDY- 204

Query: 268 ITTIRGTRGYL-----APEWILEQGVSEKCDIYSYGMVLLEL 304
              +R     L     APE I ++  + + D++S+G++L E+
Sbjct: 205 ---VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 95.5 bits (238), Expect = 9e-22
 Identities = 61/218 (27%), Positives = 87/218 (39%), Gaps = 39/218 (17%)

Query: 109 LGHGSSASVFKGILSDG------TSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVR 160
           LGHG+   V++G +S          VAVK +     E  E +F  E   I+   H N+VR
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138

Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
            +G   +   PR+++ E +  G L    F    R            DL   VA D+A   
Sbjct: 139 CIG-VSLQSLPRFILLELMAGGDLKS--FLRETRPRPSQPSSLAMLDL-LHVARDIACGC 194

Query: 221 SYL------HNDCRSRVLHLDVKPENILLD---ENYRAVVSDFGLSKLMSRDQSRCITTI 271
            YL      H D  +R         N LL        A + DFG    M+RD  R     
Sbjct: 195 QYLEENHFIHRDIAAR---------NCLLTCPGPGRVAKIGDFG----MARDIYRAGYYR 241

Query: 272 RGTRGYL-----APEWILEQGVSEKCDIYSYGMVLLEL 304
           +G    L      PE  +E   + K D +S+G++L E+
Sbjct: 242 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEI 279

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 97.2 bits (242), Expect = 9e-22
 Identities = 49/220 (22%), Positives = 88/220 (40%), Gaps = 28/220 (12%)

Query: 90  PIKFRSKELEEATDNFQALLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKE-FRSEV 147
           P++ +   + +  D     LG G+   V +    + G + A K +      +KE  R E+
Sbjct: 147 PVEIKHDHVLDHYD-IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEI 205

Query: 148 AAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWD 207
             ++  +H  LV L            ++YEF+  G L   +           S       
Sbjct: 206 QTMSVLRHPTLVNLHDAFEDDNE-MVMIYEFMSGGELFEKVA----DEHNKMS------- 253

Query: 208 LRYRVAIDVAK----ALSYLHNDCRSRVLHLDVKPENILL--DENYRAVVSDFGLSKLMS 261
                A++  +     L ++H    +  +HLD+KPENI+     +    + DFGL+  + 
Sbjct: 254 --EDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308

Query: 262 RDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVL 301
             QS  +    GT  + APE    + V    D++S G++ 
Sbjct: 309 PKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 94.7 bits (236), Expect = 9e-22
 Identities = 45/223 (20%), Positives = 82/223 (36%), Gaps = 40/223 (17%)

Query: 105 FQALLGHGSSASVFKGILSDG----TSVAVKRINGEENGEKE---FRSEVAAIASAQHVN 157
              +LG G   SV +  L         VAVK +  +     +   F  E A +    H +
Sbjct: 27  LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86

Query: 158 LVRLLGYC-----VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRV 212
           + +L+G               ++  F+++G L  ++      S    +   L      R 
Sbjct: 87  VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL----LASRIGENPFNLPLQTLVRF 142

Query: 213 AIDVAKALSYL------HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSR 266
            +D+A  + YL      H D  +R         N +L E+    V+DFG    +SR    
Sbjct: 143 MVDIACGMEYLSSRNFIHRDLAAR---------NCMLAEDMTVCVADFG----LSRKIYS 189

Query: 267 CITTIRGTRGYL-----APEWILEQGVSEKCDIYSYGMVLLEL 304
                +G    L     A E + +   +   D++++G+ + E+
Sbjct: 190 GDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEI 232

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 96.2 bits (240), Expect = 1e-21
 Identities = 48/204 (23%), Positives = 85/204 (41%), Gaps = 30/204 (14%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRIN---GEENGEKEFRSEVAAIASAQHVNLVRLLGY 164
           LG G+ + V + + +  G   A   IN         ++   E       +H N+VRL   
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78

Query: 165 CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK----AL 220
               G   YL+++ +  G L   I      +  +YS            A    +    A+
Sbjct: 79  ISEEGH-HYLIFDLVTGGELFEDIV-----AREYYS---------EADASHCIQQILEAV 123

Query: 221 SYLHNDCRSRVLHLDVKPENILL---DENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGY 277
            + H      V+H ++KPEN+LL    +     ++DFGL+  +  +Q        GT GY
Sbjct: 124 LHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA-WFGFAGTPGY 179

Query: 278 LAPEWILEQGVSEKCDIYSYGMVL 301
           L+PE + +    +  D+++ G++L
Sbjct: 180 LSPEVLRKDPYGKPVDLWACGVIL 203

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 94.6 bits (236), Expect = 1e-21
 Identities = 48/206 (23%), Positives = 81/206 (39%), Gaps = 31/206 (15%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRIN---GEENGEKEFRSEVAAIASAQHV-NLVRLLG 163
           LG G  A V + I  S G   A K +      ++   E   E+A +  A+    ++ L  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK----A 219
                     L+ E+   G +     P         S             I + K     
Sbjct: 97  VYENTSE-IILILEYAAGGEIFSLCLP---ELAEMVS---------ENDVIRLIKQILEG 143

Query: 220 LSYLHNDCRSRVLHLDVKPENILL---DENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG 276
           + YLH    + ++HLD+KP+NILL          + DFG+S+ +    +  +  I GT  
Sbjct: 144 VYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--GHACELREIMGTPE 198

Query: 277 YLAPEWILEQGVSEKCDIYSYGMVLL 302
           YLAPE +    ++   D+++ G ++ 
Sbjct: 199 YLAPEILNYDPITTATDMWNIG-IIA 223

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 94.4 bits (235), Expect = 1e-21
 Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 28/210 (13%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAAIASA-QHVNLVRLLGYCV 166
           +G+G+   V+KG  +  G   A+K ++   + E+E + E+  +     H N+    G  +
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91

Query: 167 VPGGPRY-----LVYEFIQNGSLDHWIFPTSRR--SEGHYSGGCLSWDLRYRVAIDVAKA 219
               P       LV EF   GS+   I  T      E   +  C           ++ + 
Sbjct: 92  KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR----------EILRG 141

Query: 220 LSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLA 279
           LS+LH     +V+H D+K +N+LL EN    + DFG+S  + R   R  T I GT  ++A
Sbjct: 142 LSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMA 197

Query: 280 PEWILEQGVSE-----KCDIYSYGMVLLEL 304
           PE I      +     K D++S G+  +E+
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEM 227

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 94.7 bits (236), Expect = 1e-21
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 29/205 (14%)

Query: 105 FQALLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLG 163
            ++ LG G+++ V++          A+K +    + +K  R+E+  +    H N+++L  
Sbjct: 57  VESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-KKIVRTEIGVLLRLSHPNIIKLKE 115

Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK----A 219
               P     LV E +  G L   I       +G+YS          R A D  K    A
Sbjct: 116 IFETPTE-ISLVLELVTGGELFDRIV-----EKGYYS---------ERDAADAVKQILEA 160

Query: 220 LSYLHNDCRSRVLHLDVKPENILL---DENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG 276
           ++YLH    + ++H D+KPEN+L      +    ++DFGLSK++       + T+ GT G
Sbjct: 161 VAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL--MKTVCGTPG 215

Query: 277 YLAPEWILEQGVSEKCDIYSYGMVL 301
           Y APE +       + D++S G++ 
Sbjct: 216 YCAPEILRGCAYGPEVDMWSVGIIT 240

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 94.7 bits (236), Expect = 1e-21
 Identities = 54/230 (23%), Positives = 98/230 (42%), Gaps = 33/230 (14%)

Query: 85  KVAGVPIKFRSKELEEATDNFQ--ALLGHGSSASVFKGI-LSDGTSVAVKRIN---GEEN 138
           +  G   +F      + +DN+     LG G+ + V + +  + G   A K IN       
Sbjct: 11  QQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR 70

Query: 139 GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGH 198
             ++   E       QH N+VRL           YLV++ +  G L   I      +   
Sbjct: 71  DFQKLEREARICRKLQHPNIVRLHDSIQEESF-HYLVFDLVTGGELFEDIV-----AREF 124

Query: 199 YSGGCLSWDLRYRVAIDVAK----ALSYLHNDCRSRVLHLDVKPENILL---DENYRAVV 251
           YS            A    +    +++Y H+   + ++H ++KPEN+LL    +     +
Sbjct: 125 YS---------EADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKL 172

Query: 252 SDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVL 301
           +DFGL+  ++  ++       GT GYL+PE + +   S+  DI++ G++L
Sbjct: 173 ADFGLAIEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 93.5 bits (233), Expect = 3e-21
 Identities = 46/209 (22%), Positives = 82/209 (39%), Gaps = 33/209 (15%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRIN------GEENGEKEFRSEVAAIASAQHVNLVRL 161
           +G G  + V + I    G   AVK ++            ++ + E +     +H ++V L
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91

Query: 162 LGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRY--RVAIDVAK- 218
           L      G   Y+V+EF+    L   I    R   G            Y   VA    + 
Sbjct: 92  LETYSSDGM-LYMVFEFMDGADLCFEI--VKRADAGFV----------YSEAVASHYMRQ 138

Query: 219 ---ALSYLHNDCRSRVLHLDVKPENILL---DENYRAVVSDFGLSKLMSRDQSRCITTIR 272
              AL Y H+   + ++H DVKP  +LL   + +    +  FG++  +            
Sbjct: 139 ILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV-AGGRV 194

Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVL 301
           GT  ++APE +  +   +  D++  G++L
Sbjct: 195 GTPHFMAPEVVKREPYGKPVDVWGCGVIL 223

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 93.1 bits (232), Expect = 3e-21
 Identities = 54/209 (25%), Positives = 90/209 (43%), Gaps = 34/209 (16%)

Query: 104 NFQALLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAAIA-SAQHVNLVRL 161
             +  +G GS +   + I  +     AVK I+     +++   E+  +    QH N++ L
Sbjct: 25  EVKEDIGVGSYSVCKRCIHKATNMEFAVKIID---KSKRDPTEEIEILLRYGQHPNIITL 81

Query: 162 LGY-----CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDV 216
                    V      Y+V E ++ G L   I       +  +S    S      V   +
Sbjct: 82  KDVYDDGKYV------YVVTELMKGGELLDKI-----LRQKFFSEREAS-----AVLFTI 125

Query: 217 AKALSYLHNDCRSRVLHLDVKPENILL---DENYRAV-VSDFGLSKLMSRDQSRCITTIR 272
            K + YLH      V+H D+KP NIL      N  ++ + DFG +K + R ++  + T  
Sbjct: 126 TKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL-RAENGLLMTPC 181

Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVL 301
            T  ++APE +  QG    CDI+S G++L
Sbjct: 182 YTANFVAPEVLERQGYDAACDIWSLGVLL 210

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 92.7 bits (231), Expect = 4e-21
 Identities = 48/210 (22%), Positives = 84/210 (40%), Gaps = 35/210 (16%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRIN---------GEENGEKEFRSEVAAIASAQHVNL 158
           LG G+   V           VA+K I+          E +      +E+  +    H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 159 VRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK 218
           +++  +        Y+V E ++ G L   +                           +  
Sbjct: 78  IKIKNFFDAED--YYIVLELMEGGELFDKV-----VGNKRLKEATCK-----LYFYQMLL 125

Query: 219 ALSYLHNDCRSRVLHLDVKPENILL---DENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           A+ YLH    + ++H D+KPEN+LL   +E+    ++DFG SK++       + T+ GT 
Sbjct: 126 AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL--MRTLCGTP 180

Query: 276 GYLAPEWILE----QGVSEKCDIYSYGMVL 301
            YLAPE +L      G +   D +S G++L
Sbjct: 181 TYLAPE-VLVSVGTAGYNRAVDCWSLGVIL 209

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 92.7 bits (231), Expect = 4e-21
 Identities = 50/209 (23%), Positives = 81/209 (38%), Gaps = 36/209 (17%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRIN------GEENGEKE-FRSEVAAIASAQHVNLVR 160
           LG G  A V K    S G   A K I             +E    EV+ +   QH N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK-- 218
           L            L+ E +  G L  ++       +   +            A +  K  
Sbjct: 79  LHEVYENKTD-VILILELVAGGELFDFLA-----EKESLT---------EEEATEFLKQI 123

Query: 219 --ALSYLHNDCRSRVLHLDVKPENILL----DENYRAVVSDFGLSKLMSRDQSRCITTIR 272
              + YLH+    ++ H D+KPENI+L        R  + DFGL+  +  D       I 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF 178

Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVL 301
           GT  ++APE +  + +  + D++S G++ 
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 92.8 bits (231), Expect = 5e-21
 Identities = 57/236 (24%), Positives = 93/236 (39%), Gaps = 53/236 (22%)

Query: 105 FQALLGHGSSASVFKGILSDG------TSVAVK--RINGEENGEKEFRSEVAAIASAQHV 156
           +   +G G+   VF+            T VAVK  +     + + +F+ E A +A   + 
Sbjct: 51  YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110

Query: 157 NLVRLLGYCVVPGGPRYLVYEFIQNGSL--------------DHWIFPTSRRSEGHYSGG 202
           N+V+LLG C V G P  L++E++  G L                    ++R         
Sbjct: 111 NIVKLLGVCAV-GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169

Query: 203 CLSWDLRYRVAIDVAKALSYL------HND--CRSRVLHLDVKPENILLDENYRAVVSDF 254
            LS   +  +A  VA  ++YL      H D   R           N L+ EN    ++DF
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR-----------NCLVGENMVVKIADF 218

Query: 255 GLS-KLMSRDQSRCITTIRGTRGYL-----APEWILEQGVSEKCDIYSYGMVLLEL 304
           GLS  + S D  +           +      PE I     + + D+++YG+VL E+
Sbjct: 219 GLSRNIYSADYYK-----ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 269

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 93.2 bits (232), Expect = 5e-21
 Identities = 53/238 (22%), Positives = 87/238 (36%), Gaps = 39/238 (16%)

Query: 79  EYSFLRKVAGVPIKFRSKELEEATDNFQAL--------LGHGSSASVFKGI-LSDGTSVA 129
             +    +   P  F  + +        +         LG G    V K    + G  +A
Sbjct: 59  TSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLA 118

Query: 130 VKRINGEENGEKE-FRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWI 188
            K I      +KE  ++E++ +    H NL++L            LV E++  G L   I
Sbjct: 119 AKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKND-IVLVMEYVDGGELFDRI 177

Query: 189 FPTSRRSEGHYSGGCLSWDLRY--RVAIDVAK----ALSYLHNDCRSRVLHLDVKPENIL 242
                  E +                 I   K     + ++H      +LHLD+KPENIL
Sbjct: 178 I-----DESY----------NLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENIL 219

Query: 243 L--DENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYG 298
               +  +  + DFGL++     +   +    GT  +LAPE +    VS   D++S G
Sbjct: 220 CVNRDAKQIKIIDFGLARRYKPREK--LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVG 275

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 91.9 bits (229), Expect = 6e-21
 Identities = 54/222 (24%), Positives = 89/222 (40%), Gaps = 30/222 (13%)

Query: 105 FQALLGHGSSASVFKGILSD------GTSVAVKRINGEENGE--KEFRSEVAAIAS-AQH 155
           F   LG G+   V +             +VAVK +    +    +   SE+  ++    H
Sbjct: 27  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86

Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSL--------DHWIFPTSRRSEGHYSGGCLSWD 207
           +N+V LLG C + GGP  ++ E+   G L        D +I   +  +        L  +
Sbjct: 87  MNIVNLLGACTI-GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145

Query: 208 LRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC 267
                +  VAK +++L        +H D+   NILL       + DFGL++ +  D    
Sbjct: 146 DLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS--- 199

Query: 268 ITTIRGTRGYL-----APEWILEQGVSEKCDIYSYGMVLLEL 304
              +      L     APE I     + + D++SYG+ L EL
Sbjct: 200 -NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 92.2 bits (229), Expect = 8e-21
 Identities = 56/243 (23%), Positives = 85/243 (34%), Gaps = 60/243 (24%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRIN------GEENGEKEFRSEVAAIASAQHVNLVRL 161
           +G GS   V   I        A+K +N            +  ++EV  +    H N+ RL
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 162 LGY-----CVVPGGPRYLVYEFIQNGSLDHWI------------------------FPTS 192
                    +       LV E    G L   +                            
Sbjct: 94  YEVYEDEQYI------CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNE 147

Query: 193 RRSEGHYSGGCLSWDLRY------RVAIDVAKALSYLHNDCRSRVLHLDVKPENILL--D 244
               G   G   S D          +   +  AL YLHN     + H D+KPEN L   +
Sbjct: 148 EAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTN 204

Query: 245 ENYRAVVSDFGLSKLMSR---DQSRCITTIRGTRGYLAPEWILE---QGVSEKCDIYSYG 298
           +++   + DFGLSK   +    +   +TT  GT  ++APE +L    +    KCD +S G
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE-VLNTTNESYGPKCDAWSAG 263

Query: 299 MVL 301
           ++L
Sbjct: 264 VLL 266

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 91.6 bits (228), Expect = 1e-20
 Identities = 57/219 (26%), Positives = 92/219 (42%), Gaps = 28/219 (12%)

Query: 105 FQALLGHGSSASVFKGILSD------GTSVAVKRINGE--ENGEKEFRSEVAAIAS--AQ 154
           F   LG G+   V +              VAVK +      + ++   SE   I S   Q
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE-LKIMSHLGQ 108

Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYR--- 211
           H N+V LLG     GGP  ++ E+   G L +++   SR  E   +    +     R   
Sbjct: 109 HENIVNLLG-ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167

Query: 212 -VAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITT 270
             +  VA+ +++L        +H DV   N+LL   + A + DFGL++ +  D       
Sbjct: 168 HFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS----NY 220

Query: 271 IRGTRGYL-----APEWILEQGVSEKCDIYSYGMVLLEL 304
           I      L     APE I +   + + D++SYG++L E+
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 90.6 bits (225), Expect = 3e-20
 Identities = 52/204 (25%), Positives = 91/204 (44%), Gaps = 27/204 (13%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRIN--GEENGE--KEFRSEVAAIASAQHVNLVRLLG 163
           +GHGS  +V+    + +   VA+K+++  G+++ E  ++   EV  +   +H N ++  G
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121

Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL 223
            C +     +LV E+    + D          E   +                 + L+YL
Sbjct: 122 -CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTH----------GALQGLAYL 170

Query: 224 HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWI 283
           H+     ++H DVK  NILL E     + DFG + +M+        +  GT  ++APE I
Sbjct: 171 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---A--NSFVGTPYWMAPEVI 222

Query: 284 L---EQGVSEKCDIYSYGMVLLEL 304
           L   E     K D++S G+  +EL
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIEL 246

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 89.7 bits (223), Expect = 5e-20
 Identities = 47/224 (20%), Positives = 90/224 (40%), Gaps = 42/224 (18%)

Query: 109 LGHGSSASVFKGILSD--------GTSVAVKRINGE--ENGEKEFRSEVAAIAS-AQHVN 157
           LG G+   V                 +VAVK +  +  E    +  SE+  +    +H N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102

Query: 158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHW------IFPTSRRSEGHYSGGCLSWDLRYR 211
           ++ LLG C    GP Y++ E+   G+L  +                      +++     
Sbjct: 103 IINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161

Query: 212 VAIDVAKALSYL------HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQS 265
               +A+ + YL      H D  +R         N+L+ EN    ++DFGL++ ++    
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAAR---------NVLVTENNVMKIADFGLARDINNID- 211

Query: 266 RCITTIRGTRGYL-----APEWILEQGVSEKCDIYSYGMVLLEL 304
                 + T G L     APE + ++  + + D++S+G+++ E+
Sbjct: 212 ---YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 90.1 bits (224), Expect = 5e-20
 Identities = 64/314 (20%), Positives = 116/314 (36%), Gaps = 75/314 (23%)

Query: 109 LGHGSSASVFKGILSD--------GTSVAVKRINGE--ENGEKEFRSEVAAIAS-AQHVN 157
           LG G    V                 +VAVK +  +  E    +  SE+  +    +H N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148

Query: 158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHW------IFPTSRRSEGHYSGGCLSWDLRYR 211
           ++ LLG      GP Y++ E+   G+L  +                      +++     
Sbjct: 149 IINLLG-ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207

Query: 212 VAIDVAKALSYL------HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQS 265
               +A+ + YL      H D  +R         N+L+ EN    ++DFGL++ ++    
Sbjct: 208 CTYQLARGMEYLASQKCIHRDLAAR---------NVLVTENNVMKIADFGLARDINNID- 257

Query: 266 RCITTIRGTRGYL-----APEWILEQGVSEKCDIYSYGMVLLEL-TGGRRNVSLIEHGND 319
                 + T G L     APE + ++  + + D++S+G+++ E+ T G            
Sbjct: 258 ---YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG----------- 303

Query: 320 KSKNKWQYFPKIVNEKM----KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERA 375
                   +P I  E++    KEG  M+      T+E          L  +   C     
Sbjct: 304 ------SPYPGIPVEELFKLLKEGHRMDKPAN-CTNE----------LYMMMRDCWHAVP 346

Query: 376 RLRPSMARVVEMLE 389
             RP+  ++VE L+
Sbjct: 347 SQRPTFKQLVEDLD 360

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 89.2 bits (222), Expect = 6e-20
 Identities = 49/229 (21%), Positives = 91/229 (39%), Gaps = 47/229 (20%)

Query: 109 LGHGSSASVFKGILSDG------TSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVR 160
           LG G    V K            T+VAVK +      +  ++  SE   +    H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90

Query: 161 LLGYCVVPGGPRYLVYEFIQNGSL--------------DHWIFPTSRRSEGHYSGGCLSW 206
           L G      GP  L+ E+ + GSL                     +  S  H     L+ 
Sbjct: 91  LYG-ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149

Query: 207 DLRYRVAIDVAKALSYL------HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM 260
                 A  +++ + YL      H D  +R         NIL+ E  +  +SDFGLS+ +
Sbjct: 150 GDLISFAWQISQGMQYLAEMKLVHRDLAAR---------NILVAEGRKMKISDFGLSRDV 200

Query: 261 SRDQSRCITTIRGTRGYL-----APEWILEQGVSEKCDIYSYGMVLLEL 304
             +     + ++ ++G +     A E + +   + + D++S+G++L E+
Sbjct: 201 YEED----SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 89.3 bits (222), Expect = 6e-20
 Identities = 60/208 (28%), Positives = 86/208 (41%), Gaps = 32/208 (15%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKRIN--------GEENGEKEFRSEVAAIASAQHV-- 156
           LLG G   SV+ GI +SD   VA+K +            NG +    EV  +        
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKVSSGFS 108

Query: 157 NLVRLLGYCVVPGGPRYLVYEFIQN-GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
            ++RLL +   P     L+ E  +    L  +I  T R        G L  +L       
Sbjct: 109 GVIRLLDWFERPDS-FVLILERPEPVQDLFDFI--TER--------GALQEELARSFFWQ 157

Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSRDQSRCITTIRGT 274
           V +A+ + H      VLH D+K ENIL+D N   + + DFG   L+   +    T   GT
Sbjct: 158 VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGT 211

Query: 275 RGYLAPEWILEQG-VSEKCDIYSYGMVL 301
           R Y  PEWI           ++S G++L
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILL 239

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 89.3 bits (222), Expect = 7e-20
 Identities = 55/227 (24%), Positives = 91/227 (40%), Gaps = 35/227 (15%)

Query: 105 FQALLGHGSSASVFKGILSDG------TSVAVKRINGE--ENGEKEFRSEVAAIAS-AQH 155
           F  +LG G+   V                VAVK +  +   +  +   SE+  +     H
Sbjct: 49  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108

Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSL-------------DHWIFPTSRRSEGHYSGG 202
            N+V LLG C +  GP YL++E+   G L             D   +   +R E      
Sbjct: 109 ENIVNLLGACTL-SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167

Query: 203 CLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR 262
            L+++     A  VAK + +L        +H D+   N+L+       + DFGL++ +  
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224

Query: 263 DQSRCITTIRGTRGYL-----APEWILEQGVSEKCDIYSYGMVLLEL 304
           D       +      L     APE + E   + K D++SYG++L E+
Sbjct: 225 DS----NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 89.3 bits (222), Expect = 8e-20
 Identities = 42/203 (20%), Positives = 87/203 (42%), Gaps = 28/203 (13%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAAI-ASAQHVNLVRLLGYC 165
           +LG G +  V +      G   A+K +        + R EV     ++   ++V +L   
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVY 91

Query: 166 ---VVPGGPRYLVYEFIQNGSL-DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALS 221
                      ++ E ++ G L          R +  ++    +      +  D+  A+ 
Sbjct: 92  ENMHHGKRCLLIIMECMEGGELFSRIQ----ERGDQAFTEREAA-----EIMRDIGTAIQ 142

Query: 222 YLHNDCRSRVLHLDVKPENILL---DENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
           +LH+     + H DVKPEN+L    +++    ++DFG +K  +++    + T   T  Y+
Sbjct: 143 FLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPCYTPYYV 196

Query: 279 APEWILEQGVSEKCDIYSYGMVL 301
           APE +  +   + CD++S G+++
Sbjct: 197 APEVLGPEKYDKSCDMWSLGVIM 219

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 89.7 bits (223), Expect = 8e-20
 Identities = 55/231 (23%), Positives = 97/231 (41%), Gaps = 47/231 (20%)

Query: 109 LGHGSSASVFKGIL--------SDGTSVAVKRINGE--ENGEKEFRSEVAAIAS-AQHVN 157
           LG G+   V             +  T VAVK +  +  E    +  SE+  +    +H N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136

Query: 158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRV----- 212
           ++ LLG      GP Y++ E+   G+L    +  +RR  G       S +   ++     
Sbjct: 137 IINLLG-ACTQDGPLYVIVEYASKGNLRE--YLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 213 ---AIDVAKALSYL------HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD 263
              A  VA+ + YL      H D  +R         N+L+ E+    ++DFGL++ +   
Sbjct: 194 VSCAYQVARGMEYLASKKCIHRDLAAR---------NVLVTEDNVMKIADFGLARDIHHI 244

Query: 264 QSRCITTIRGTRGYL-----APEWILEQGVSEKCDIYSYGMVLLEL-TGGR 308
                   + T G L     APE + ++  + + D++S+G++L E+ T G 
Sbjct: 245 D----YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 291

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 32/203 (15%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAAIASAQ-HVNLVRLLGY-- 164
           LG GS +   K +      + AVK I+  +  E   + E+ A+   + H N+V+L     
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIIS--KRMEANTQKEITALKLCEGHPNIVKLHEVFH 76

Query: 165 ---CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALS 221
                      +LV E +  G L   I     + + H+S    S      +   +  A+S
Sbjct: 77  DQLHT------FLVMELLNGGELFERI-----KKKKHFSETEAS-----YIMRKLVSAVS 120

Query: 222 YLHNDCRSRVLHLDVKPENILL---DENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
           ++H+     V+H D+KPEN+L    ++N    + DFG ++L     ++ + T   T  Y 
Sbjct: 121 HMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK-PPDNQPLKTPCFTLHYA 176

Query: 279 APEWILEQGVSEKCDIYSYGMVL 301
           APE + + G  E CD++S G++L
Sbjct: 177 APELLNQNGYDESCDLWSLGVIL 199

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 87.0 bits (216), Expect = 3e-19
 Identities = 58/209 (27%), Positives = 79/209 (37%), Gaps = 32/209 (15%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKRIN-------GEENGEKEFRSEVA----AIASAQH 155
           LLG G   +VF G  L+D   VA+K I           +       EVA      A   H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGS-LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI 214
             ++RLL +     G   LV E       L  +I  T +        G L          
Sbjct: 98  PGVIRLLDWFETQEG-FMLVLERPLPAQDLFDYI--TEK--------GPLGEGPSRCFFG 146

Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSRDQSRCITTIRG 273
            V  A+ + H      V+H D+K ENIL+D       + DFG   L+        T   G
Sbjct: 147 QVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTDFDG 200

Query: 274 TRGYLAPEWILEQG-VSEKCDIYSYGMVL 301
           TR Y  PEWI      +    ++S G++L
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILL 229

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 86.5 bits (215), Expect = 3e-19
 Identities = 56/216 (25%), Positives = 88/216 (40%), Gaps = 39/216 (18%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLG 163
            LG G+   V   +      +VAVK ++ +   +  E   + E+       H N+V+   
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-EICINKMLNHENVVKF-- 70

Query: 164 YCVVPGGPR-YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK---- 218
           Y     G   YL  E+   G L   I P     E                    A+    
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE------------------PDAQRFFH 112

Query: 219 ----ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM-SRDQSRCITTIRG 273
                + YLH      + H D+KPEN+LLDE     +SDFGL+ +    ++ R +  + G
Sbjct: 113 QLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169

Query: 274 TRGYLAPEWILEQG-VSEKCDIYSYGMVLLELTGGR 308
           T  Y+APE +  +   +E  D++S G+VL  +  G 
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 85.8 bits (213), Expect = 9e-19
 Identities = 56/216 (25%), Positives = 88/216 (40%), Gaps = 39/216 (18%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLG 163
            LG G+   V   +      +VAVK ++ +   +  E   + E+       H N+V+   
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-EICINKMLNHENVVKF-- 70

Query: 164 YCVVPGGPR-YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK---- 218
           Y     G   YL  E+   G L   I P     E                    A+    
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE------------------PDAQRFFH 112

Query: 219 ----ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM-SRDQSRCITTIRG 273
                + YLH      + H D+KPEN+LLDE     +SDFGL+ +    ++ R +  + G
Sbjct: 113 QLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169

Query: 274 TRGYLAPEWILEQG-VSEKCDIYSYGMVLLELTGGR 308
           T  Y+APE +  +   +E  D++S G+VL  +  G 
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 86.3 bits (214), Expect = 1e-18
 Identities = 48/202 (23%), Positives = 84/202 (41%), Gaps = 27/202 (13%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAAI-ASAQHVNLVRLLGYCV 166
           LG G +  V +          A+K +          R EV     ++Q  ++VR++    
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVELHWRASQCPHIVRIVDVYE 125

Query: 167 VPGGPR---YLVYEFIQNGSL-DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY 222
                R    +V E +  G L          R +  ++    S      +   + +A+ Y
Sbjct: 126 NLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQAFTEREAS-----EIMKSIGEAIQY 176

Query: 223 LHNDCRSRVLHLDVKPENILL---DENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLA 279
           LH+     + H DVKPEN+L      N    ++DFG +K  +   S  +TT   T  Y+A
Sbjct: 177 LHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPCYTPYYVA 231

Query: 280 PEWILEQGVSEKCDIYSYGMVL 301
           PE +  +   + CD++S G+++
Sbjct: 232 PEVLGPEKYDKSCDMWSLGVIM 253

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 45/218 (20%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKE-FRSEVAAIASAQ-HVNLVRLLGY 164
           +LG G+ A V   I L      AVK I  +    +     EV  +   Q H N++ L+ +
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 165 -----CVVPGGPRYLVYEFIQNGSL-DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK 218
                        YLV+E ++ GS+  H I         H++    S      V  DVA 
Sbjct: 80  FEEEDRF------YLVFEKMRGGSILSH-I-----HKRRHFNELEAS-----VVVQDVAS 122

Query: 219 ALSYLHNDCRSRVLHLDVKPENILL---DENYRAVVSDFGLSKLMSRDQSRC------IT 269
           AL +LHN     + H D+KPENIL    ++     + DF L   +  +          + 
Sbjct: 123 ALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179

Query: 270 TIRGTRGYLAPEWILEQGVS------EKCDIYSYGMVL 301
           T  G+  Y+APE ++E          ++CD++S G++L
Sbjct: 180 TPCGSAEYMAPE-VVEAFSEEASIYDKRCDLWSLGVIL 216

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 84.7 bits (210), Expect = 3e-18
 Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 27/208 (12%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRIN----GEENGEKEFRSEVAAIASAQHVNLVRLLG 163
           +G G+ A V     +  G  VA+K I+       + +K FR EV  +    H N+V+L  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKL-- 79

Query: 164 YCVVPGGPR-YLVYEFIQNGSL-DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALS 221
           + V+      YL+ E+   G + D+ +           + G +           +  A+ 
Sbjct: 80  FEVIETEKTLYLIMEYASGGEVFDYLV-----------AHGRMKEKEARSKFRQIVSAVQ 128

Query: 222 YLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPE 281
           Y H   + R++H D+K EN+LLD +    ++DFG S   +      +    G   Y APE
Sbjct: 129 YCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--KLDAFCGAPPYAAPE 183

Query: 282 WILEQG-VSEKCDIYSYGMVLLELTGGR 308
               +     + D++S G++L  L  G 
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGS 211

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 83.6 bits (207), Expect = 8e-18
 Identities = 53/211 (25%), Positives = 79/211 (37%), Gaps = 46/211 (21%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCV 166
            +G G+               VAVK I      ++  + E+    S +H N+VR     V
Sbjct: 27  DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRF--KEV 84

Query: 167 VPGGPR--YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK------ 218
           +   P    ++ E+   G L   I    R SE                  D A+      
Sbjct: 85  I-LTPTHLAIIMEYASGGELYERICNAGRFSE------------------DEARFFFQQL 125

Query: 219 --ALSYLHNDCRSRVLHLDVKPENILLDENYRAV--VSDFGLSKLMSRD---QSRCITTI 271
              +SY H     ++ H D+K EN LLD +      + DFG SK        +S      
Sbjct: 126 LSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV---- 178

Query: 272 RGTRGYLAPEWILEQG-VSEKCDIYSYGMVL 301
            GT  Y+APE +L Q    +  D++S G+ L
Sbjct: 179 -GTPAYIAPEVLLRQEYDGKIADVWSCGVTL 208

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 82.7 bits (205), Expect = 1e-17
 Identities = 50/223 (22%), Positives = 84/223 (37%), Gaps = 46/223 (20%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVK-----RINGEENGEKEFRSEVAAIASAQHVNLVRL 161
           LLG GS   V + +        AVK     ++    NGE   + E+  +   +H N+++L
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 162 LGYCVVPGGPR---YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK 218
               V+    +   Y+V E+   G  +  +       E              R  +  A 
Sbjct: 72  --VDVLYNEEKQKMYMVMEYCVCGMQE--ML--DSVPEK-------------RFPVCQAH 112

Query: 219 --------ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM-SRDQSRCIT 269
                    L YLH      ++H D+KP N+LL       +S  G+++ +          
Sbjct: 113 GYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR 169

Query: 270 TIRGTRGYLAPEWILEQGVSE----KCDIYSYGMVLLELTGGR 308
           T +G+  +  PE     G+      K DI+S G+ L  +T G 
Sbjct: 170 TSQGSPAFQPPEIA--NGLDTFSGFKVDIWSAGVTLYNITTGL 210

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 82.3 bits (204), Expect = 1e-17
 Identities = 44/170 (25%), Positives = 80/170 (47%), Gaps = 30/170 (17%)

Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL-RYRVAIDVAKALSYLHNDCRSRV 231
           Y    + +NG L  +I    R+       G       R+  A ++  AL YLH      +
Sbjct: 106 YFGLSYAKNGELLKYI----RKI------GSFDETCTRFYTA-EIVSALEYLHG---KGI 151

Query: 232 LHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT-TIRGTRGYLAPEWILEQGVSE 290
           +H D+KPENILL+E+    ++DFG +K++S +  +    +  GT  Y++PE + E+   +
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 211

Query: 291 KCDIYSYGMVLLELTGGR---RNVSLIEHGNDKSKNKWQYFPKIVNEKMK 337
             D+++ G ++ +L  G    R           + N++  F KI+  +  
Sbjct: 212 SSDLWALGCIIYQLVAGLPPFR-----------AGNEYLIFQKIIKLEYD 250

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 81.1 bits (201), Expect = 2e-17
 Identities = 62/217 (28%), Positives = 95/217 (43%), Gaps = 42/217 (19%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVK-----RINGEENGEKEFRSEVAAIASAQHVNLVRL 161
            LG G+   V  G     G  VAVK     +I   +   K  R E+  +   +H ++++L
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR-EIQNLKLFRHPHIIKL 76

Query: 162 LGYCVVPGGPR-YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK-- 218
             Y V+      ++V E++  G L  +I    R  E                    A+  
Sbjct: 77  --YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEE------------------MEARRL 116

Query: 219 ------ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR 272
                 A+ Y H   R  V+H D+KPEN+LLD +  A ++DFGLS +MS  +   + T  
Sbjct: 117 FQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRTSC 171

Query: 273 GTRGYLAPEWILEQG-VSEKCDIYSYGMVLLELTGGR 308
           G+  Y APE I  +     + DI+S G++L  L  G 
Sbjct: 172 GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT 208

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 80.8 bits (200), Expect = 3e-17
 Identities = 49/235 (20%), Positives = 89/235 (37%), Gaps = 51/235 (21%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKRIN---------------------------GEENG 139
            +G GS   V      +D T  A+K ++                                
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 140 EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPR---YLVYEFIQNGSLDHWIFPTSRRSE 196
            ++   E+A +    H N+V+L    V+        Y+V+E +  G +            
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPV----MEVPTL-- 131

Query: 197 GHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL 256
                  LS D       D+ K + YLH     +++H D+KP N+L+ E+    ++DFG+
Sbjct: 132 -----KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGV 183

Query: 257 SKLMSRDQSRCITTIRGTRGYLAPEWI--LEQGVS-EKCDIYSYGMVLLELTGGR 308
           S       +    T+ GT  ++APE +    +  S +  D+++ G+ L     G+
Sbjct: 184 SNEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 80.5 bits (199), Expect = 7e-17
 Identities = 45/215 (20%), Positives = 83/215 (38%), Gaps = 48/215 (22%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRIN---------GEENGEKEFRSEVAAIASAQHVNL 158
           LG G+   V+  +       V VK I           E+    +   E+A ++  +H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 159 VRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWD---LRYRVAID 215
           +++               +  +N     +        E H SG  L +       R+   
Sbjct: 92  IKV--------------LDIFEN---QGFFQLVM---EKHGSGLDL-FAFIDRHPRLDEP 130

Query: 216 VAK--------ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC 267
           +A         A+ YL       ++H D+K ENI++ E++   + DFG +  + R +   
Sbjct: 131 LASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK--L 185

Query: 268 ITTIRGTRGYLAPEWILEQG-VSEKCDIYSYGMVL 301
             T  GT  Y APE ++       + +++S G+ L
Sbjct: 186 FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTL 220

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 80.6 bits (199), Expect = 2e-16
 Identities = 60/217 (27%), Positives = 94/217 (43%), Gaps = 42/217 (19%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVK-----RINGEENGEKEFRSEVAAIASAQHVNLVRL 161
            LG G+   V  G     G  VAVK     +I   +   K  R E+  +   +H ++++L
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR-EIQNLKLFRHPHIIKL 81

Query: 162 LGYCVVPGGPR-YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK-- 218
             Y V+      ++V E++  G L  +I    R  E                    ++  
Sbjct: 82  --YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDE------------------KESRRL 121

Query: 219 ------ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR 272
                  + Y H   R  V+H D+KPEN+LLD +  A ++DFGLS +MS  +   + T  
Sbjct: 122 FQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--FLRTSC 176

Query: 273 GTRGYLAPEWILEQG-VSEKCDIYSYGMVLLELTGGR 308
           G+  Y APE I  +     + DI+S G++L  L  G 
Sbjct: 177 GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 79.4 bits (196), Expect = 3e-16
 Identities = 55/218 (25%), Positives = 88/218 (40%), Gaps = 43/218 (19%)

Query: 107 ALLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAAI-------ASAQHVNL 158
            ++G GS   V K         VA+K +  E+   ++   E+  +             N+
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTM-NV 161

Query: 159 VRLLGY-------CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYR 211
           + +L         C+        +YE I+                  + G   S  L  +
Sbjct: 162 IHMLENFTFRNHICMTFELLSMNLYELIKKN---------------KFQG--FSLPLVRK 204

Query: 212 VAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV--VSDFGLSKLMSRDQSRCIT 269
            A  + + L  LH   ++R++H D+KPENILL +  R+   V DFG S      + + + 
Sbjct: 205 FAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC----YEHQRVY 257

Query: 270 TIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL-TG 306
           T   +R Y APE IL        D++S G +L EL TG
Sbjct: 258 TYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 79.5 bits (196), Expect = 5e-16
 Identities = 47/214 (21%), Positives = 86/214 (40%), Gaps = 34/214 (15%)

Query: 130 VKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIF 189
           +K   GE     E R  ++ +++     +V +  Y          + + +  G L + + 
Sbjct: 227 IKMKQGETLALNE-RIMLSLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLS 284

Query: 190 PTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRA 249
                SE           +R+  A ++   L ++H      V++ D+KP NILLDE+   
Sbjct: 285 QHGVFSEAD---------MRFYAA-EIILGLEHMH---NRFVVYRDLKPANILLDEHGHV 331

Query: 250 VVSDFGLSKLMSRDQ--SRCITTIRGTRGYLAPEWIL-EQGVSEKCDIYSYGMVLLELTG 306
            +SD GL+   S+ +  +       GT GY+APE +          D +S G +L +L  
Sbjct: 332 RISDLGLACDFSKKKPHASV-----GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 386

Query: 307 GR---RNVSLIEHGNDKSKNKWQYFPKIVNEKMK 337
           G    R          K+K+K +     +   ++
Sbjct: 387 GHSPFR--------QHKTKDKHEIDRMTLTMAVE 412

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 78.1 bits (193), Expect = 6e-16
 Identities = 36/97 (37%), Positives = 55/97 (56%), Gaps = 8/97 (8%)

Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           +  AL YL      R++H D+KP+NILLDE+    ++DF ++ ++ R+    ITT+ GT+
Sbjct: 124 LVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ--ITTMAGTK 178

Query: 276 GYLAPEWILEQGV---SEKCDIYSYGMVLLELTGGRR 309
            Y+APE    +     S   D +S G+   EL  GRR
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 78.7 bits (194), Expect = 7e-16
 Identities = 35/175 (20%), Positives = 70/175 (40%), Gaps = 34/175 (19%)

Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEG-------HYSGGCLSWDLRYRVAIDVAKALSYLHN 225
            LV   +  G + + I+     + G        Y                +   L +LH 
Sbjct: 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY-------------TAQIVSGLEHLH- 306

Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILE 285
             +  +++ D+KPEN+LLD++    +SD GL+  +   Q++      GT G++APE +L 
Sbjct: 307 --QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELLLG 363

Query: 286 QGVSEKCDIYSYGMVLLELTGGR---RNVSLIEHGNDKSKNKWQYFPKIVNEKMK 337
           +      D ++ G+ L E+   R   R          +     +   +++ + + 
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAARGPFR-------ARGEKVENKELKQRVLEQAVT 411

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 77.9 bits (192), Expect = 1e-15
 Identities = 32/93 (34%), Positives = 52/93 (55%), Gaps = 5/93 (5%)

Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           +   L  LH   R R+++ D+KPENILLD++    +SD GL+  +   Q+  I    GT 
Sbjct: 295 ICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTV 349

Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           GY+APE +  +  +   D ++ G +L E+  G+
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 77.0 bits (190), Expect = 2e-15
 Identities = 58/239 (24%), Positives = 102/239 (42%), Gaps = 56/239 (23%)

Query: 95  SKELEEATDNFQAL--LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIAS 152
            K  E+    +     +G+GS   VF+  L +   VA+K++  ++    + R E+  +  
Sbjct: 32  GKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK--RFKNR-ELQIMRI 88

Query: 153 AQHVNLVRLLGYCVVPGGPR------YLVYEFIQNGSLDHWIFPTS-RRSEGHYSGGCLS 205
            +H N+V L        G +       LV E++          P +  R+  HY      
Sbjct: 89  VKHPNVVDLK-AFFYSNGDKKDEVFLNLVLEYV----------PETVYRASRHY------ 131

Query: 206 WDLRYRVAIDVAK--------ALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGL 256
             L+  + + + K        +L+Y+H+     + H D+KP+N+LLD     + + DFG 
Sbjct: 132 AKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGS 188

Query: 257 SKLMSRDQSR----CITTIRGTRGYLAPEWILEQGVSE---KCDIYSYGMVLLELTGGR 308
           +K++   +      C      +R Y APE I   G +      DI+S G V+ EL  G+
Sbjct: 189 AKILIAGEPNVSYIC------SRYYRAPELIF--GATNYTTNIDIWSTGCVMAELMQGQ 239

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 74.8 bits (184), Expect = 4e-15
 Identities = 30/210 (14%), Positives = 55/210 (26%), Gaps = 53/210 (25%)

Query: 107 ALLGHGSSASVFKGILSD---GTSVAVK----RINGEENGEKEFRSEVAAIASAQHVNLV 159
              G       ++ +  D      VA+     +    ++  +E  S    ++      + 
Sbjct: 37  IFHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94

Query: 160 RLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKA 219
           R+L       G   +V E+I+ GSL                    S     R    +A A
Sbjct: 95  RVLDVVHTRAGG-LVVAEWIRGGSLQEVA------------DTSPSPVGAIRAMQSLAAA 141

Query: 220 LSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLA 279
               H   R+ V      P  + +  +   V++                         + 
Sbjct: 142 ADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYP---------------------ATMP 177

Query: 280 PEWILEQGVSEKCDIYSYGMVLLELTGGRR 309
                    + + DI   G  L  L   R 
Sbjct: 178 D-------ANPQDDIRGIGASLYALLVNRW 200

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 75.0 bits (185), Expect = 4e-15
 Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 29/210 (13%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVK-----RINGEENGEKEFRSEVAAIASAQHVNLVRL 161
            LG GS   V           VA+K      +   +   +  R E++ +   +H ++++L
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER-EISYLKLLRHPHIIKL 74

Query: 162 LGYCVVPGGPR-YLVYEFIQNGSL-DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKA 219
             Y V+       +V E+   G L D+ +               ++ D   R    +  A
Sbjct: 75  --YDVITTPTDIVMVIEYA-GGELFDYIV-----------EKKRMTEDEGRRFFQQIICA 120

Query: 220 LSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLA 279
           + Y H   R +++H D+KPEN+LLD+N    ++DFGLS +M+      + T  G+  Y A
Sbjct: 121 IEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--FLKTSCGSPNYAA 175

Query: 280 PEWILEQG-VSEKCDIYSYGMVLLELTGGR 308
           PE I  +     + D++S G+VL  +  GR
Sbjct: 176 PEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 74.9 bits (185), Expect = 5e-15
 Identities = 38/138 (27%), Positives = 63/138 (45%), Gaps = 21/138 (15%)

Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGH---YSGGCLSWDLRYRVAIDVAKALSYLHNDCRS 229
           YL+ E++  G L   +       E     Y               +++ AL +LH     
Sbjct: 97  YLILEYLSGGELFMQLEREGIFMEDTACFYLA-------------EISMALGHLHQ---K 140

Query: 230 RVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVS 289
            +++ D+KPENI+L+      ++DFGL K    D +    T  GT  Y+APE ++  G +
Sbjct: 141 GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT-HTFCGTIEYMAPEILMRSGHN 199

Query: 290 EKCDIYSYGMVLLE-LTG 306
              D +S G ++ + LTG
Sbjct: 200 RAVDWWSLGALMYDMLTG 217

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 75.5 bits (186), Expect = 5e-15
 Identities = 55/219 (25%), Positives = 96/219 (43%), Gaps = 45/219 (20%)

Query: 109 LGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVV 167
           +G+GS   V++  L D G  VA+K++  ++    + R E+  +    H N+VRL  Y   
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFKNR-ELQIMRKLDHCNIVRLR-YFFY 117

Query: 168 PGGPR------YLVYEFIQ---NGSLDHWIFPTSRRSEGH---YSGGCLSWDLRYRVAID 215
             G +       LV +++         H+          +   Y          Y++   
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM---------YQLF-- 166

Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSRDQSR----CITT 270
             ++L+Y+H+     + H D+KP+N+LLD +   + + DFG +K + R +      C   
Sbjct: 167 --RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--- 218

Query: 271 IRGTRGYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
              +R Y APE I      +   D++S G VL EL  G+
Sbjct: 219 ---SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 75.1 bits (185), Expect = 6e-15
 Identities = 52/221 (23%), Positives = 86/221 (38%), Gaps = 47/221 (21%)

Query: 107 ALLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVN-------- 157
           +L+G GS   V K     +   VA+K I    N +         +   + +N        
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIK---NKKAFLNQAQIEVRLLELMNKHDTEMKY 116

Query: 158 -LVRLLGY-------CVVPGGPRYLVYEFI-QNGSLDHWIFPTSRRSEGHYSGGCLSWDL 208
            +V L  +       C+V     Y +Y+ +                    + G  +S +L
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTN----------------FRG--VSLNL 158

Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV--VSDFGLSKLMSRDQSR 266
             + A  +  AL +L       ++H D+KPENILL    R+   + DFG     S    +
Sbjct: 159 TRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG----SSCQLGQ 213

Query: 267 CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL-TG 306
            I     +R Y +PE +L        D++S G +L+E+ TG
Sbjct: 214 RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG 254

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 75.2 bits (185), Expect = 7e-15
 Identities = 34/148 (22%), Positives = 59/148 (39%), Gaps = 34/148 (22%)

Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK--------ALSYLH 224
           YLV ++   G L   +     + E                  ++A+        A+  +H
Sbjct: 150 YLVMDYYVGGDLLTLL----SKFEDRLP-------------EEMARFYLAEMVIAIDSVH 192

Query: 225 NDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWIL 284
                  +H D+KP+NIL+D N    ++DFG    +  D +   +   GT  Y++PE + 
Sbjct: 193 Q---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249

Query: 285 EQGVSEK-----CDIYSYGMVLLE-LTG 306
                +      CD +S G+ + E L G
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYG 277

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 74.2 bits (183), Expect = 8e-15
 Identities = 39/176 (22%), Positives = 74/176 (42%), Gaps = 37/176 (21%)

Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK--------ALSYLH 224
           +L+ ++I  G L   +          ++                 +        AL +LH
Sbjct: 135 HLILDYINGGELFTHL-----SQRERFT-------------EHEVQIYVGEIVLALEHLH 176

Query: 225 NDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWIL 284
                 +++ D+K ENILLD N   V++DFGLSK    D++       GT  Y+AP+ + 
Sbjct: 177 K---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 233

Query: 285 --EQGVSEKCDIYSYGMVLLE-LTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMK 337
             + G  +  D +S G+++ E LTG     +     + +  ++ +   +I+  +  
Sbjct: 234 GGDSGHDKAVDWWSLGVLMYELLTG-----ASPFTVDGEKNSQAEISRRILKSEPP 284

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 74.1 bits (183), Expect = 9e-15
 Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 31/217 (14%)

Query: 103 DNFQAL--LGHGSSASVF----KGILSDGTSVAVKRINGE---ENGEKEFRSEVAAIASA 153
             F+ L  LG GS   VF              A+K +             + E   +   
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83

Query: 154 QHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGH---YSGGCLSWDLRY 210
            H  +V+L  Y     G  YL+ +F++ G L   +      +E     Y           
Sbjct: 84  NHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA--------- 133

Query: 211 RVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITT 270
               ++A AL +LH+     +++ D+KPENILLDE     ++DFGLSK     + +   +
Sbjct: 134 ----ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA-YS 185

Query: 271 IRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLE-LTG 306
             GT  Y+APE +  +G ++  D +S+G+++ E LTG
Sbjct: 186 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 67/304 (22%), Positives = 117/304 (38%), Gaps = 47/304 (15%)

Query: 81  SFLRKVAGVPIKFRSKELEEATDNFQAL--LGHGSSASVF----KGILSDGTSVAVKRIN 134
            FL+     PI  R KE+    D+F+ L  +G G+ + V     K     G   A+K +N
Sbjct: 41  DFLQWAE--PIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMN 95

Query: 135 GEENGEKE----FRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFP 190
             +  ++     FR E   + +     + +L  +        YLV E+   G L   +  
Sbjct: 96  KWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLL-- 152

Query: 191 TSRRSEGHYSGGCLSWDL-RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRA 249
            S+       G  +  ++ R+ +A ++  A+  +H       +H D+KP+NILLD     
Sbjct: 153 -SKF------GERIPAEMARFYLA-EIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHI 201

Query: 250 VVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK-------CDIYSYGMVLL 302
            ++DFG    +  D +       GT  YL+PE +   G           CD ++ G+   
Sbjct: 202 RLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAY 261

Query: 303 E-LTG-----GRRNVSLIEH-GNDKSKNKWQYFPKIVNEKMKE--GKLMEIVDQRLTDEG 353
           E   G                 + K         + V E+ ++   +L+   + RL   G
Sbjct: 262 EMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCPPETRLG-RG 320

Query: 354 GIDE 357
           G  +
Sbjct: 321 GAGD 324

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 39/135 (28%), Positives = 63/135 (46%), Gaps = 14/135 (10%)

Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL 232
             V E+   G L   +      SE            R+  A ++  AL YLH++    V+
Sbjct: 224 CFVMEYANGGELFFHLSRERVFSEDR---------ARFYGA-EIVSALDYLHSE--KNVV 271

Query: 233 HLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKC 292
           + D+K EN++LD++    ++DFGL K   +D +    T  GT  YLAPE + +       
Sbjct: 272 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM-KTFCGTPEYLAPEVLEDNDYGRAV 330

Query: 293 DIYSYGMVLLE-LTG 306
           D +  G+V+ E + G
Sbjct: 331 DWWGLGVVMYEMMCG 345

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 73.0 bits (180), Expect = 2e-14
 Identities = 37/169 (21%), Positives = 73/169 (43%), Gaps = 21/169 (12%)

Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGH---YSGGCLSWDLRYRVAIDVAKALSYLHNDCRS 229
           + V E++  G L   +    +  E H   YS              +++ AL+YLH     
Sbjct: 86  FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-------------EISLALNYLHE---R 129

Query: 230 RVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVS 289
            +++ D+K +N+LLD      ++D+G+ K   R      +T  GT  Y+APE +  +   
Sbjct: 130 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-STFCGTPNYIAPEILRGEDYG 188

Query: 290 EKCDIYSYGMVLLE-LTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMK 337
              D ++ G+++ E + G      +    N     +   F  I+ ++++
Sbjct: 189 FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 237

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 72.8 bits (179), Expect = 3e-14
 Identities = 38/122 (31%), Positives = 57/122 (46%), Gaps = 17/122 (13%)

Query: 199 YSGGCLSWDLR-YRVAIDVAK--------ALSYLHNDCRSRVLHLDVKPENILLDENYRA 249
             GG L   +  Y V    A+        AL  +H+      +H DVKP+N+LLD++   
Sbjct: 151 MPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHL 207

Query: 250 VVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK----CDIYSYGMVLLE-L 304
            ++DFG    M+++      T  GT  Y++PE +  QG        CD +S G+ L E L
Sbjct: 208 KLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 267

Query: 305 TG 306
            G
Sbjct: 268 VG 269

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 71.8 bits (177), Expect = 4e-14
 Identities = 54/231 (23%), Positives = 98/231 (42%), Gaps = 59/231 (25%)

Query: 103 DNFQAL--LGHGSSASVFKGILSDGTSVAVKRINGEENGEKE------FRSEVAAIASAQ 154
           + +Q L  +G G+   V+K   S G  VA+KRI  +   E E       R E++ +    
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA--EDEGIPSTAIR-EISLLKELH 77

Query: 155 HVNLVRLLGYCVVPGGPR-YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR---- 209
           H N+V L+   V+       LV+EF     ++                     DL+    
Sbjct: 78  HPNIVSLI--DVIHSERCLTLVFEF-----MEK--------------------DLKKVLD 110

Query: 210 -YRVAIDVA----------KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK 258
             +  +  +          + +++ H   + R+LH D+KP+N+L++ +    ++DFGL++
Sbjct: 111 ENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLAR 167

Query: 259 LMSRDQSRCITTIRGTRGYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
                  R  T    T  Y AP+ ++  +  S   DI+S G +  E+  G+
Sbjct: 168 AFG-IPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 71.0 bits (175), Expect = 6e-14
 Identities = 56/231 (24%), Positives = 95/231 (41%), Gaps = 59/231 (25%)

Query: 103 DNFQAL--LGHGSSASVFKGILSDGTSVAVKRINGEENGEKE------FRSEVAAIASAQ 154
           + +  L  +G G+   V+K   + G + A+K+I  E+  E E       R E++ +   +
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEK--EDEGIPSTTIR-EISILKELK 58

Query: 155 HVNLVRLLGYCVVPGGPR-YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR---- 209
           H N+V+L  Y V+    R  LV+E      LD                     DL+    
Sbjct: 59  HSNIVKL--YDVIHTKKRLVLVFEH-----LDQ--------------------DLKKLLD 91

Query: 210 -YRVAIDVA----------KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK 258
                ++              ++Y H     RVLH D+KP+N+L++      ++DFGL++
Sbjct: 92  VCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLAR 148

Query: 259 LMSRDQSRCITTIRGTRGYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
                  R  T    T  Y AP+ ++  +  S   DI+S G +  E+  G 
Sbjct: 149 AFG-IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 72.6 bits (178), Expect = 7e-14
 Identities = 48/226 (21%), Positives = 87/226 (38%), Gaps = 41/226 (18%)

Query: 100 EATDNFQAL--LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAA------- 149
                +Q L  +G G+   V          +VA+K+++      + F+++  A       
Sbjct: 59  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS------RPFQNQTHAKRAYREL 112

Query: 150 --IASAQHVNLVRLLGYCVVPGGPR-----YLVYEFIQNGSLDHWIFPTSRRSEGHYSGG 202
             +    H N++ LL               YLV E +     +                 
Sbjct: 113 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA---NLCQVIQMELDHERM--- 166

Query: 203 CLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR 262
                  Y +   +   + +LH+   + ++H D+KP NI++  +    + DFGL++  + 
Sbjct: 167 ------SYLL-YQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TA 214

Query: 263 DQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
             S  +T    TR Y APE IL  G  E  DI+S G ++ E+   +
Sbjct: 215 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 71.0 bits (175), Expect = 7e-14
 Identities = 54/233 (23%), Positives = 91/233 (39%), Gaps = 60/233 (25%)

Query: 103 DNFQAL--LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKE------FRSEVAAIASA 153
             ++ L  +G G+  +VFK         VA+KR+  ++  + E       R E+  +   
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALR-EICLLKEL 58

Query: 154 QHVNLVRLLGYCVVPGGPR-YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR--- 209
           +H N+VRL    V+    +  LV+EF      D                     DL+   
Sbjct: 59  KHKNIVRLH--DVLHSDKKLTLVFEF-----CDQ--------------------DLKKYF 91

Query: 210 --YRVAIDVA----------KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS 257
                 +D            K L + H      VLH D+KP+N+L++ N    +++FGL+
Sbjct: 92  DSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLA 148

Query: 258 KLMSRDQSRCITTIRGTRGYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGRR 309
           +       RC +    T  Y  P+ +   +  S   D++S G +  EL    R
Sbjct: 149 RAFG-IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 72.0 bits (177), Expect = 8e-14
 Identities = 37/169 (21%), Positives = 73/169 (43%), Gaps = 21/169 (12%)

Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGH---YSGGCLSWDLRYRVAIDVAKALSYLHNDCRS 229
           + V E++  G L   +    +  E H   YS              +++ AL+YLH     
Sbjct: 129 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-------------EISLALNYLHE---R 172

Query: 230 RVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVS 289
            +++ D+K +N+LLD      ++D+G+ K   R      +T  GT  Y+APE +  +   
Sbjct: 173 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-STFCGTPNYIAPEILRGEDYG 231

Query: 290 EKCDIYSYGMVLLE-LTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMK 337
              D ++ G+++ E + G      +    N     +   F  I+ ++++
Sbjct: 232 FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 280

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 71.1 bits (175), Expect = 8e-14
 Identities = 51/230 (22%), Positives = 90/230 (39%), Gaps = 56/230 (24%)

Query: 103 DNFQAL--LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRS----EVAAIASAQH 155
           + ++ L  +G GS   V K      G  VA+K+   E + +K  +     E+  +   +H
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL-ESDDDKMVKKIAMREIKLLKQLRH 83

Query: 156 VNLVRLLGYCVVPGGPR-YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL-----R 209
            NLV LL   V     R YLV+EF     +DH                     +      
Sbjct: 84  ENLVNLL--EVCKKKKRWYLVFEF-----VDH--------------------TILDDLEL 116

Query: 210 YRVAIDVA----------KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL 259
           +   +D              + + H      ++H D+KPENIL+ ++    + DFG ++ 
Sbjct: 117 FPNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFART 173

Query: 260 MSRDQSRCITTIRGTRGYLAPEWILEQGV-SEKCDIYSYGMVLLELTGGR 308
           ++            TR Y APE ++      +  D+++ G ++ E+  G 
Sbjct: 174 LA-APGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 71.6 bits (176), Expect = 9e-14
 Identities = 50/226 (22%), Positives = 90/226 (39%), Gaps = 41/226 (18%)

Query: 100 EATDNFQAL--LGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFRSEVAA------- 149
                +Q L  +G G+   V     +    +VA+K+++      + F+++  A       
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS------RPFQNQTHAKRAYREL 75

Query: 150 --IASAQHVNLVRLLGYCVVPGGPR-----YLVYEFIQNGSLDHWIFPTSRRSEGHYSGG 202
             +    H N++ LL               Y+V E +   +L   I              
Sbjct: 76  VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI--QMELDHERM--- 129

Query: 203 CLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR 262
                  Y +   +   + +LH+   + ++H D+KP NI++  +    + DFGL++  + 
Sbjct: 130 ------SYLL-YQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TA 177

Query: 263 DQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
             S  +T    TR Y APE IL  G  E  DI+S G ++ E+  G 
Sbjct: 178 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 72.4 bits (177), Expect = 1e-13
 Identities = 55/219 (25%), Positives = 86/219 (39%), Gaps = 40/219 (18%)

Query: 104 NFQALLGHGSSASVF----KGILSDGTSVAVKRINGEENGEKEF---RSEVAAI------ 150
           NF  +LG GS   V     KG        AVK +       K+      +V         
Sbjct: 344 NFLMVLGKGSFGKVMLSERKG---TDELYAVKILK------KDVVIQDDDVECTMVEKRV 394

Query: 151 --ASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL 208
                +   L +L   C       Y V E++  G L + I    R  E H          
Sbjct: 395 LALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH---------A 444

Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI 268
            +  A ++A  L +L +     +++ D+K +N++LD      ++DFG+ K    D     
Sbjct: 445 VFYAA-EIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT- 499

Query: 269 TTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLE-LTG 306
            T  GT  Y+APE I  Q   +  D +++G++L E L G
Sbjct: 500 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 538

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 71.1 bits (175), Expect = 1e-13
 Identities = 37/138 (26%), Positives = 60/138 (43%), Gaps = 21/138 (15%)

Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGH---YSGGCLSWDLRYRVAIDVAKALSYLHNDCRS 229
           + V EF+  G L   I  + R  E     Y+              ++  AL +LH     
Sbjct: 100 FFVMEFVNGGDLMFHIQKSRRFDEARARFYAA-------------EIISALMFLH---DK 143

Query: 230 RVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVS 289
            +++ D+K +N+LLD      ++DFG+ K    +      T  GT  Y+APE + E    
Sbjct: 144 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT-ATFCGTPDYIAPEILQEMLYG 202

Query: 290 EKCDIYSYGMVLLE-LTG 306
              D ++ G++L E L G
Sbjct: 203 PAVDWWAMGVLLYEMLCG 220

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 71.3 bits (175), Expect = 1e-13
 Identities = 45/222 (20%), Positives = 87/222 (39%), Gaps = 37/222 (16%)

Query: 107 ALLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEV-----------AAIASAQ 154
             LG G  ++V+    + + T VA+K + G++   +    E+               S  
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 155 HVNLVRLLGYCVVPGGPRY---LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYR 211
             ++++LL +    G       +V+E      L   +    ++    + G  +      +
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKKY--EHRG--IPLIYVKQ 135

Query: 212 VAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV------VSDFGLSKLMSRDQS 265
           ++  +   L Y+H  C   ++H D+KPEN+L++            ++D G     +    
Sbjct: 136 ISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLG----NACWYD 189

Query: 266 RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL-TG 306
              T    TR Y +PE +L        DI+S   ++ EL TG
Sbjct: 190 EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG 231

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 70.7 bits (174), Expect = 1e-13
 Identities = 36/138 (26%), Positives = 65/138 (47%), Gaps = 21/138 (15%)

Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGH---YSGGCLSWDLRYRVAIDVAKALSYLHNDCRS 229
           + V E++  G L + I    +        Y+              ++   L +LH+    
Sbjct: 94  FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA-------------EIILGLQFLHS---K 137

Query: 230 RVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVS 289
            +++ D+K +NILLD++    ++DFG+ K      ++   T  GT  Y+APE +L Q  +
Sbjct: 138 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT-NTFCGTPDYIAPEILLGQKYN 196

Query: 290 EKCDIYSYGMVLLE-LTG 306
              D +S+G++L E L G
Sbjct: 197 HSVDWWSFGVLLYEMLIG 214

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 69.9 bits (172), Expect = 2e-13
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 28/216 (12%)

Query: 103 DNFQAL--LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKE-FRS----EVAAIASAQ 154
           + ++ +  +G GS   VFK      G  VA+K+    E  +    +     E+  +   +
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE--DDPVIKKIALREIRMLKQLK 60

Query: 155 HVNLVRLLGYCVVPGGPR-YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVA 213
           H NLV LL   V     R +LV+E+  + ++ H +    R   G      +   L   + 
Sbjct: 61  HPNLVNLL--EVFRRKRRLHLVFEYCDH-TVLHEL---DRYQRG------VPEHLVKSIT 108

Query: 214 IDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRG 273
               +A+++ H   +   +H DVKPENIL+ ++    + DFG ++L++   S        
Sbjct: 109 WQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLT-GPSDYYDDEVA 164

Query: 274 TRGYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
           TR Y +PE ++ +       D+++ G V  EL  G 
Sbjct: 165 TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 69.9 bits (172), Expect = 2e-13
 Identities = 56/220 (25%), Positives = 106/220 (48%), Gaps = 28/220 (12%)

Query: 101 ATDNFQAL--LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRS----EVAAIASA 153
           ++  F+ L  LG+G+ A+V+KG+  + G  VA+K +  +   E+   S    E++ +   
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKEL 60

Query: 154 QHVNLVRLLGYCVVPGGPR-YLVYEFIQN---GSLDHWIFPTSRRSEGHYSGGCLSWDLR 209
           +H N+VRL    V+    +  LV+EF+ N     +D      + R           W L 
Sbjct: 61  KHENIVRLY--DVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL- 117

Query: 210 YRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT 269
                   + L++ H    +++LH D+KP+N+L+++  +  + DFGL++          +
Sbjct: 118 -------LQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG-IPVNTFS 166

Query: 270 TIRGTRGYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
           +   T  Y AP+ ++  +  S   DI+S G +L E+  G+
Sbjct: 167 SEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 46/138 (33%), Positives = 63/138 (45%), Gaps = 21/138 (15%)

Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGH---YSGGCLSWDLRYRVAIDVAKALSYLHNDCRS 229
           Y V ++I  G L + +       E     Y             A ++A AL YLH+    
Sbjct: 115 YFVLDYINGGELFYHLQRERCFLEPRARFY-------------AAEIASALGYLHS---L 158

Query: 230 RVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVS 289
            +++ D+KPENILLD     V++DFGL K      S   +T  GT  YLAPE + +Q   
Sbjct: 159 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT-STFCGTPEYLAPEVLHKQPYD 217

Query: 290 EKCDIYSYGMVLLE-LTG 306
              D +  G VL E L G
Sbjct: 218 RTVDWWCLGAVLYEMLYG 235

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 52/220 (23%), Positives = 89/220 (40%), Gaps = 38/220 (17%)

Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKE---FRSEVAA---------IASAQHV 156
           +  GS  +V  G+ S+G  VA+KR+    +  +                    +    H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89

Query: 157 NLVRLLGYCVVPGGPR----YLVYEFIQNGSLD-HWIFPTSRR--SEGHYSGGCLSWDLR 209
           N++ L    V    P     YLV E ++    D   +    R   S  H          +
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMRT---DLAQVIHDQRIVISPQHI---------Q 137

Query: 210 YRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT 269
           Y +   +   L  LH    + V+H D+ P NILL +N    + DF L++  + D +   T
Sbjct: 138 YFM-YHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN--KT 191

Query: 270 TIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
                R Y APE +++ +G ++  D++S G V+ E+   +
Sbjct: 192 HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 50/234 (21%), Positives = 89/234 (38%), Gaps = 47/234 (20%)

Query: 99  EEATDNFQAL--LGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFR--SEVAAIASA 153
            +  D FQ     G G+  +V  G     G SVA+K++   ++     R    +  +A  
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV--IQDPRFRNRELQIMQDLAVL 76

Query: 154 QHVNLVRLLGYCVVPGGPR-------YLVYEFIQ---NGSLDHWIFPTSRRSEGH---YS 200
            H N+V+L        G R        +V E++    +    ++              + 
Sbjct: 77  HHPNIVQLQ-SYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFL 135

Query: 201 GGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD-ENYRAVVSDFGLSKL 259
                    +++     +++  LH      V H D+KP N+L++  +    + DFG +K 
Sbjct: 136 ---------FQLI----RSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKK 181

Query: 260 MSRDQSR----CITTIRGTRGYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
           +S  +      C      +R Y APE I   Q  +   DI+S G +  E+  G 
Sbjct: 182 LSPSEPNVAYIC------SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 69.6 bits (171), Expect = 3e-13
 Identities = 40/137 (29%), Positives = 69/137 (50%), Gaps = 19/137 (13%)

Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRV-AIDVAKALSYLHNDCRSRV 231
           Y+V E++  G +   +     R  G +S      +   R  A  +     YLH+     +
Sbjct: 117 YMVMEYVAGGEMFSHL-----RRIGRFS------EPHARFYAAQIVLTFEYLHS---LDL 162

Query: 232 LHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEK 291
           ++ D+KPEN+L+D+     V+DFG +K   R + R   T+ GT   LAPE IL +G ++ 
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRT-WTLCGTPEALAPEIILSKGYNKA 218

Query: 292 CDIYSYGMVLLELTGGR 308
            D ++ G+++ E+  G 
Sbjct: 219 VDWWALGVLIYEMAAGY 235

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 70.0 bits (172), Expect = 3e-13
 Identities = 55/228 (24%), Positives = 94/228 (41%), Gaps = 40/228 (17%)

Query: 103 DNFQAL--LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKE-FRS----EVAAIASAQ 154
             ++ L  +G G+   VFK      G  VA+K++  E   EKE F      E+  +   +
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN--EKEGFPITALREIKILQLLK 74

Query: 155 HVNLVRLLGYCVVPGGPR-------YLVYEFIQN---GSLDHWIFPTSRRSEGHYSGGCL 204
           H N+V L+  C     P        YLV++F ++   G L +      + +        +
Sbjct: 75  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIK--RV 129

Query: 205 SWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS--- 261
              L           L Y+H   R+++LH D+K  N+L+  +    ++DFGL++  S   
Sbjct: 130 MQML--------LNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178

Query: 262 RDQSRCITTIRGTRGYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
             Q    T    T  Y  PE +L E+      D++  G ++ E+    
Sbjct: 179 NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 69.1 bits (170), Expect = 3e-13
 Identities = 55/227 (24%), Positives = 93/227 (40%), Gaps = 36/227 (15%)

Query: 101 ATDNFQAL--LGHGSSASVFKGI-LSDGTSVAVKRI--NGEENGEKEFRS----EVAA-- 149
           AT  ++ +  +G G+  +V+K      G  VA+K +       G          EVA   
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66

Query: 150 -IASAQHVNLVRLLGYCVVPGGPR----YLVYEFIQN---GSLDHWIFPTSRRSEGHYSG 201
            + + +H N+VRL+  C      R     LV+E +       LD    P           
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDK--APPPGLPAETIK- 123

Query: 202 GCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS 261
             L             + L +LH    + ++H D+KPENIL+       ++DFGL+++ S
Sbjct: 124 -DLMRQF--------LRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYS 171

Query: 262 RDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
                 +T +  T  Y APE +L+   +   D++S G +  E+   +
Sbjct: 172 YQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 69.6 bits (171), Expect = 3e-13
 Identities = 38/138 (27%), Positives = 63/138 (45%), Gaps = 21/138 (15%)

Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGH---YSGGCLSWDLRYRVAIDVAKALSYLHNDCRS 229
           Y V E++  G L + I    R  E H   Y+              ++A  L +L +    
Sbjct: 97  YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA-------------EIAIGLFFLQS---K 140

Query: 230 RVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVS 289
            +++ D+K +N++LD      ++DFG+ K    D      T  GT  Y+APE I  Q   
Sbjct: 141 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT-KTFCGTPDYIAPEIIAYQPYG 199

Query: 290 EKCDIYSYGMVLLE-LTG 306
           +  D +++G++L E L G
Sbjct: 200 KSVDWWAFGVLLYEMLAG 217

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 69.2 bits (170), Expect = 4e-13
 Identities = 56/222 (25%), Positives = 93/222 (41%), Gaps = 36/222 (16%)

Query: 103 DNFQAL--LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKE------FRSEVAAIASA 153
           D ++ +  LG G+   V+K I      +VA+KRI  E   E+E       R EV+ +   
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH--EEEGVPGTAIR-EVSLLKEL 90

Query: 154 QHVNLVRLLGYCVVPGGPR-YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRV 212
           QH N++ L    V+    R +L++E+ +N  L  ++      S          + L    
Sbjct: 91  QHRNIIELK--SVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIK--SFLYQL---- 141

Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-----VSDFGLSKLMSRDQSRC 267
                  +++ H     R LH D+KP+N+LL  +  +      + DFGL++       R 
Sbjct: 142 ----INGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG-IPIRQ 193

Query: 268 ITTIRGTRGYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
            T    T  Y  PE +L  +  S   DI+S   +  E+    
Sbjct: 194 FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 68.8 bits (169), Expect = 6e-13
 Identities = 37/138 (26%), Positives = 59/138 (42%), Gaps = 21/138 (15%)

Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGH---YSGGCLSWDLRYRVAIDVAKALSYLHNDCRS 229
             V E+   G L   +      +E     Y               ++  AL YLH+    
Sbjct: 81  CFVMEYANGGELFFHLSRERVFTEERARFYGA-------------EIVSALEYLHS---R 124

Query: 230 RVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVS 289
            V++ D+K EN++LD++    ++DFGL K    D +    T  GT  YLAPE + +    
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM-KTFCGTPEYLAPEVLEDNDYG 183

Query: 290 EKCDIYSYGMVLLE-LTG 306
              D +  G+V+ E + G
Sbjct: 184 RAVDWWGLGVVMYEMMCG 201

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 68.9 bits (169), Expect = 7e-13
 Identities = 54/228 (23%), Positives = 95/228 (41%), Gaps = 45/228 (19%)

Query: 100 EATDNFQAL--LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAA------- 149
           E    ++ L  +G G+  +V   +    G  VA+K++       + F+SE+ A       
Sbjct: 22  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY------RPFQSELFAKRAYREL 75

Query: 150 --IASAQHVNLVRLLGYCVVPGGPR-----YLVYEFIQNGSLD-HWIFPTSRRSEGHYSG 201
             +   +H N++ LL               YLV  F+     D   +    +  E     
Sbjct: 76  RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT---DLGKLMKHEKLGEDRI-- 130

Query: 202 GCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS 261
                  ++ V   + K L Y+H    + ++H D+KP N+ ++E+    + DFGL    +
Sbjct: 131 -------QFLV-YQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL----A 175

Query: 262 RDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           R     +T    TR Y APE IL     ++  DI+S G ++ E+  G+
Sbjct: 176 RQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 68.0 bits (167), Expect = 9e-13
 Identities = 57/234 (24%), Positives = 90/234 (38%), Gaps = 61/234 (26%)

Query: 103 DNFQAL--LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKE--FRS----EVAAIASA 153
             ++ L  LG G  A+V+K    +    VA+K+I      E +         E+  +   
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69

Query: 154 QHVNLVRLLGYCVVPGGPR-YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR--- 209
            H N++ LL            LV++F     ++                     DL    
Sbjct: 70  SHPNIIGLLD--AFGHKSNISLVFDF-----MET--------------------DLEVII 102

Query: 210 --YRVAIDVA----------KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS 257
               + +  +          + L YLH   +  +LH D+KP N+LLDEN    ++DFGL+
Sbjct: 103 KDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLA 159

Query: 258 KLMSRDQSRCITTIRGTRGYLAPEWIL---EQGVSEKCDIYSYGMVLLELTGGR 308
           K      +R  T    TR Y APE +      GV    D+++ G +L EL    
Sbjct: 160 KSFG-SPNRAYTHQVVTRWYRAPELLFGARMYGVG--VDMWAVGCILAELLLRV 210

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 67.2 bits (165), Expect = 2e-12
 Identities = 56/230 (24%), Positives = 95/230 (41%), Gaps = 57/230 (24%)

Query: 103 DNFQAL--LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRS----EVAAIASAQH 155
           + +  L  LG G+ A+V+KG        VA+K I  E   E+        EV+ +   +H
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLKH 59

Query: 156 VNLVRLLGYCVVPGGPR-YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR----- 209
            N+V L    ++       LV+E+     LD                     DL+     
Sbjct: 60  ANIVTLH--DIIHTEKSLTLVFEY-----LDK--------------------DLKQYLDD 92

Query: 210 YRVAIDVA----------KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL 259
               I++           + L+Y H   R +VLH D+KP+N+L++E     ++DFGL++ 
Sbjct: 93  CGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARA 149

Query: 260 MSRDQSRCITTIRGTRGYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
            S   ++       T  Y  P+ +L     S + D++  G +  E+  GR
Sbjct: 150 KS-IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 61/227 (26%), Positives = 99/227 (43%), Gaps = 44/227 (19%)

Query: 100 EATDNFQAL--LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAA------- 149
           E    + +   +G G+  SV   I    G  VA+K+++      + F+SE+ A       
Sbjct: 21  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS------RPFQSEIFAKRAYREL 74

Query: 150 --IASAQHVNLVRLLGYCVVPGGPR-----YLVYEFIQNGSLDHWIFPTSRRSEGHYSGG 202
             +   QH N++ LL         R     YLV  F+Q   L   +    + SE      
Sbjct: 75  LLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIM--GLKFSEEKI--- 128

Query: 203 CLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR 262
                 +Y V   + K L Y+H+   + V+H D+KP N+ ++E+    + DFGL    +R
Sbjct: 129 ------QYLV-YQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGL----AR 174

Query: 263 DQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
                +T    TR Y APE IL     ++  DI+S G ++ E+  G+
Sbjct: 175 HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 66.8 bits (164), Expect = 2e-12
 Identities = 39/143 (27%), Positives = 67/143 (46%), Gaps = 34/143 (23%)

Query: 173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK--------ALSYLH 224
           +++ ++I+ G L   +     R    +                VAK        AL YLH
Sbjct: 82  FMIMDYIEGGELFSLL-----RKSQRFP-------------NPVAKFYAAEVCLALEYLH 123

Query: 225 NDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWIL 284
           +     +++ D+KPENILLD+N    ++DFG +K           T+ GT  Y+APE + 
Sbjct: 124 S---KDIIYRDLKPENILLDKNGHIKITDFGFAK---YVPDVT-YTLCGTPDYIAPEVVS 176

Query: 285 EQGVSEKCDIYSYGMVLLE-LTG 306
            +  ++  D +S+G+++ E L G
Sbjct: 177 TKPYNKSIDWWSFGILIYEMLAG 199

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 53/224 (23%), Positives = 98/224 (43%), Gaps = 33/224 (14%)

Query: 100 EATDNFQAL--LGHGSSASVFKGI-LSDGTSVAVKRINGEEN---GEKEFRSEVAAIASA 153
           +    +  L  +G G+   V       +   VA+K+I+  E+    ++  R E+  +   
Sbjct: 24  DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRF 82

Query: 154 QHVNLVRLLGYCVVPGGPR-----YLVYEFIQNGSLD-HWIFPTSRRSEGHYSGGCLSWD 207
           +H N++ +    +           Y+V + ++    D + +  T   S  H         
Sbjct: 83  RHENIIGIND-IIRAPTIEQMKDVYIVQDLMET---DLYKLLKTQHLSNDHI-------- 130

Query: 208 LRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC 267
             Y +   + + L Y+H+   + VLH D+KP N+LL+      + DFGL+++   D    
Sbjct: 131 -CYFL-YQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185

Query: 268 --ITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
             +T    TR Y APE +L  +G ++  DI+S G +L E+   R
Sbjct: 186 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 65.4 bits (160), Expect = 7e-12
 Identities = 55/228 (24%), Positives = 100/228 (43%), Gaps = 45/228 (19%)

Query: 100 EATDNFQAL--LGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFRSEVAA------- 149
           E  + +Q L  +G G+  SV     +  G  VAVK+++      + F+S + A       
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYREL 79

Query: 150 --IASAQHVNLVRLLGYCVVPGGPR-----YLVYEFIQNGSLD-HWIFPTSRRSEGHYSG 201
             +   +H N++ LL               YLV   +     D + I    + ++ H   
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA---DLNNIVKCQKLTDDHV-- 134

Query: 202 GCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS 261
                  ++ +   + + L Y+H+   + ++H D+KP N+ ++E+    + DFGL    +
Sbjct: 135 -------QFLI-YQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL----A 179

Query: 262 RDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
           R  +  +T    TR Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 180 RHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 64.9 bits (157), Expect = 1e-11
 Identities = 40/259 (15%), Positives = 66/259 (25%), Gaps = 57/259 (22%)

Query: 90  PIKFRSKELEEATDNFQAL--LGHGSSASVFKGILSDGTSVAVKRI---------NGEEN 138
           P+ F        T+  Q    +G G    VF+ I  D T VA+K I            + 
Sbjct: 10  PVPFSHCL---PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQK 65

Query: 139 GEKEFRSEVA---------AIASAQHVNLVRLLGYCVVPG-GPRYLVYEFIQ----NGSL 184
             +E   E+               +    + L     V G  P  L+  +       GS 
Sbjct: 66  TFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSA 125

Query: 185 DH-------------WIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRV 231
           +                F               S      +   +  +L+        R 
Sbjct: 126 NDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRF 183

Query: 232 LHLDVKPENILLDENYRAVVSDFGLSKLMS----------RDQSRCITTIRGTRGYL--- 278
            H D+   N+LL +     +      K  +           D +       G   +    
Sbjct: 184 EHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVS 243

Query: 279 APEWILEQGVSEKCDIYSY 297
             E +       + DIY  
Sbjct: 244 MDEDLFTGDGDYQFDIYRL 262

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 34/112 (30%), Positives = 51/112 (45%), Gaps = 19/112 (16%)

Query: 211 RVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI-- 268
            +A  +  AL +LH    +++ H D+KPENIL   +    + +   S      ++  I  
Sbjct: 127 HMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183

Query: 269 -------------TTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL-TG 306
                        TTI  TR Y  PE ILE G ++ CD++S G +L E   G
Sbjct: 184 ADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 64.1 bits (157), Expect = 2e-11
 Identities = 58/226 (25%), Positives = 102/226 (45%), Gaps = 40/226 (17%)

Query: 103 DNFQAL--LGHGSSASVFKG--ILSDGTSVAVKRINGEENGEKE------FRSEVAA--- 149
             ++ +  +G G+   VFK   + + G  VA+KR+  +    +E       R EVA    
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT--GEEGMPLSTIR-EVAVLRH 67

Query: 150 IASAQHVNLVRLLGYCVVPGGPR----YLVYEFIQN---GSLDHWIFPTSRRSEGHYSGG 202
           + + +H N+VRL   C V    R     LV+E +       LD    P            
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIK-- 123

Query: 203 CLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR 262
            + + L         + L +LH     RV+H D+KP+NIL+  + +  ++DFGL+++ S 
Sbjct: 124 DMMFQL--------LRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF 172

Query: 263 DQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
             +  +T++  T  Y APE +L+   +   D++S G +  E+   +
Sbjct: 173 QMA--LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 50/221 (22%), Positives = 102/221 (46%), Gaps = 35/221 (15%)

Query: 100 EATDNFQAL--LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAAIAS-AQH 155
              D++Q +  LG G  + VF+ I +++   V VK +   +  +K+ + E+  + +    
Sbjct: 33  GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGG 90

Query: 156 VNLVRLLGYCVVP---GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLS-WDLRYR 211
            N++ L    +V         LV+E + N      ++ T            L+ +D+R+ 
Sbjct: 91  PNIITLA--DIVKDPVSRTPALVFEHVNNTDF-KQLYQT------------LTDYDIRFY 135

Query: 212 VAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV-VSDFGLSKLMSRDQSRCITT 270
           +  ++ KAL Y H      ++H DVKP N+++D  +R + + D+GL++     Q      
Sbjct: 136 M-YEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---N 188

Query: 271 IR-GTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRR 309
           +R  +R +  PE +++ Q      D++S G +L  +   + 
Sbjct: 189 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 63.4 bits (155), Expect = 3e-11
 Identities = 31/112 (27%), Positives = 55/112 (49%), Gaps = 19/112 (16%)

Query: 211 RVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI-- 268
           ++A  + K++++LH    +++ H D+KPENIL  ++      +  + +      +  I  
Sbjct: 122 KMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178

Query: 269 -------------TTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL-TG 306
                        +T+  TR Y APE IL  G S+ CD++S G +L+E   G
Sbjct: 179 VDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 63.5 bits (155), Expect = 3e-11
 Identities = 36/118 (30%), Positives = 48/118 (40%), Gaps = 25/118 (21%)

Query: 211 RVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC--- 267
              I++ KAL+YL    +  + H D+KPENILLD+ Y              +        
Sbjct: 141 LYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197

Query: 268 ------------------ITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLEL-TG 306
                               +I  TR Y APE IL  G     D++S+G VL EL TG
Sbjct: 198 STGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 63.3 bits (154), Expect = 5e-11
 Identities = 54/233 (23%), Positives = 97/233 (41%), Gaps = 28/233 (12%)

Query: 94  RSKELEEATDNFQAL---LGHGSSASVFKGI---LSDGTSVAVKRINGEENGEKEFRSEV 147
            S E E   D F+     +G G+   V+K       D    A+K+I G        R E+
Sbjct: 11  LSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR-EI 69

Query: 148 AAIASAQHVNLVRLLGYCVVPGGPR-YLVYEFIQNGSLDH---WIFPTSRRSEGHYSGGC 203
           A +   +H N++ L    +     + +L++++      +H    I    R S+ +     
Sbjct: 70  ALLRELKHPNVISLQKVFLSHADRKVWLLFDY-----AEHDLWHIIKFHRASKANKKPVQ 124

Query: 204 LSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILL--DENYRAVV--SDFGLSKL 259
           L   +   +   +   + YLH    + VLH D+KP NIL+  +   R  V  +D G ++L
Sbjct: 125 LPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181

Query: 260 MSRDQSRCITTIRG---TRGYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGR 308
            +    + +  +     T  Y APE +L  +  ++  DI++ G +  EL    
Sbjct: 182 FN-SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 62.3 bits (152), Expect = 5e-11
 Identities = 42/220 (19%), Positives = 80/220 (36%), Gaps = 46/220 (20%)

Query: 90  PIKFRSKELEEATDNFQALLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVA 148
            ++ +   + +       +LG G +  V +          A+K +          R EV 
Sbjct: 7   GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK----ARREVE 62

Query: 149 A-IASAQHVNLVRLLGYCVVPGGPR---YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCL 204
               ++Q  ++VR++         R    +V E +  G L   I     R +  ++    
Sbjct: 63  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREA 119

Query: 205 SWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILL---DENYRAVVSDFGLSKLMS 261
           S  ++      + +A+ YLH+     + H DVKPEN+L      N    ++DFG      
Sbjct: 120 SEIMK-----SIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFG------ 165

Query: 262 RDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVL 301
                            A E    +   + CD++S G+++
Sbjct: 166 ----------------FAKE-TTGEKYDKSCDMWSLGVIM 188

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 62.6 bits (152), Expect = 6e-11
 Identities = 55/263 (20%), Positives = 97/263 (36%), Gaps = 71/263 (26%)

Query: 109 LGHGSSASVFKGIL------SDGTSVAVKRINGE--ENGEKEFRSEVA-AIASAQHVNLV 159
           LG G+   V +         +   +VAVK +      +  +   SE+   I    H+N+V
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89

Query: 160 RLLGYCVVPGGPRYLVYEFIQNGSLDHWI-----------FPTSRRSEGHYSGGCLSWDL 208
            LLG C  PGGP  ++ EF + G+L  ++              +R  +G    G +  DL
Sbjct: 90  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL 149

Query: 209 RYRVAIDV------------AKALSYLHNDCRSRVLHLDVKPENILL------------- 243
           + R+                 K+LS +  +     L+ D      L+             
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209

Query: 244 -----------------DENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL-----APE 281
                             E     + DFGL++ + +D       +R     L     APE
Sbjct: 210 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP----DYVRKGDARLPLKWMAPE 265

Query: 282 WILEQGVSEKCDIYSYGMVLLEL 304
            I ++  + + D++S+G++L E+
Sbjct: 266 TIFDRVYTIQSDVWSFGVLLWEI 288

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 45/251 (17%), Positives = 90/251 (35%), Gaps = 53/251 (21%)

Query: 98  LEEATDNFQAL--LGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFRSEVAAIASAQ 154
           LE ++  +     LG GS   V +    + G   A+K++   ++   + R E+  +    
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV--LQDPRYKNR-ELDIMKVLD 58

Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR----- 209
           HVN+++L+       G          +             +         S +       
Sbjct: 59  HVNIIKLV-DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117

Query: 210 -------YRVAIDVAK-------------------ALSYLHNDCRSRVLHLDVKPENILL 243
                  ++V     +                   A+ ++H+     + H D+KP+N+L+
Sbjct: 118 EYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLV 174

Query: 244 D-ENYRAVVSDFGLSKLMSRDQSR----CITTIRGTRGYLAPEWILE-QGVSEKCDIYSY 297
           + ++    + DFG +K +   +      C      +R Y APE +L     +   D++S 
Sbjct: 175 NSKDNTLKLCDFGSAKKLIPSEPSVAYIC------SRFYRAPELMLGATEYTPSIDLWSI 228

Query: 298 GMVLLELTGGR 308
           G V  EL  G+
Sbjct: 229 GCVFGELILGK 239

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 61.5 bits (150), Expect = 1e-10
 Identities = 55/220 (25%), Positives = 89/220 (40%), Gaps = 38/220 (17%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEEN---GEKEFRSEVAAIASAQHVNLVRLLGY 164
           LG G+   V        G  VA+K+I   +      +  R E+  +   +H N++ +   
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHENIITIF-N 76

Query: 165 CVVPGGPR-----YLVYEFIQNGSLD-HWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK 218
              P         Y++ E +Q    D H +  T   S+ H          +Y +     +
Sbjct: 77  IQRPDSFENFNEVYIIQELMQT---DLHRVISTQMLSDDHI---------QYFI-YQTLR 123

Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRG----- 273
           A+  LH    S V+H D+KP N+L++ N    V DFGL++++    +             
Sbjct: 124 AVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180

Query: 274 ----TRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
               TR Y APE +L     S   D++S G +L EL   R
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 51/262 (19%), Positives = 91/262 (34%), Gaps = 76/262 (29%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVA---AIASAQ-----HVNLV 159
           LG G  ++V+    +     VA+K +   E+  +    E+    ++ ++         +V
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVV 104

Query: 160 RLLGYCVV--PGGPRY-LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDV 216
           +LL    +    G    +V+E + +  L  WI     +S        L      ++   V
Sbjct: 105 QLLDDFKISGVNGTHICMVFEVLGH-HLLKWI----IKSNYQ----GLPLPCVKKIIQQV 155

Query: 217 AKALSYLHNDCRSRVLHLDVKPENILL--------------------------------- 243
            + L YLH  CR  ++H D+KPENILL                                 
Sbjct: 156 LQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213

Query: 244 ----------------DENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQG 287
                            E  +  ++D G +  + +  +  I T    R Y + E ++  G
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQT----RQYRSLEVLIGSG 269

Query: 288 VSEKCDIYSYGMVLLELTGGRR 309
            +   DI+S   +  EL  G  
Sbjct: 270 YNTPADIWSTACMAFELATGDY 291

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 48/229 (20%), Positives = 91/229 (39%), Gaps = 54/229 (23%)

Query: 109 LGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFRSEVAA---------IASAQHVNL 158
           LG G +  VF  + +D    VA+K+I              +          I    H N+
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIV--------LTDPQSVKHALREIKIIRRLDHDNI 70

Query: 159 VRLLGYCVVPGGPR--------------YLVYEFIQNGSLD-HWIFPTSRRSEGHYSGGC 203
           V++    + P G +              Y+V E+++    D   +       E H     
Sbjct: 71  VKVFE-ILGPSGSQLTDDVGSLTELNSVYIVQEYMET---DLANVLEQGPLLEEHA---- 122

Query: 204 LSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD-ENYRAVVSDFGLSKLMSR 262
                R      + + L Y+H+   + VLH D+KP N+ ++ E+    + DFGL+++M  
Sbjct: 123 -----RL-FMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDP 173

Query: 263 DQSRC--ITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
             S    ++    T+ Y +P  +L     ++  D+++ G +  E+  G+
Sbjct: 174 HYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 55.2 bits (132), Expect = 3e-08
 Identities = 63/429 (14%), Positives = 128/429 (29%), Gaps = 97/429 (22%)

Query: 61  RRLL--LESK-------FVTEGRELRIEYSFLRKVAGVPIKFRSKELEEATDNFQALLGH 111
            RL   L SK       FV E   LRI Y FL      PIK   ++    T  +      
Sbjct: 65  LRLFWTLLSKQEEMVQKFVEEV--LRINYKFLMS----PIKTEQRQPSMMTRMYI----- 113

Query: 112 GSSASVFKGILSDGTSVA---VKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
                    + +D    A   V R        + +     A+   +    V + G   V 
Sbjct: 114 ----EQRDRLYNDNQVFAKYNVSR-------LQPYLKLRQALLELRPAKNVLIDG---VL 159

Query: 169 G-GPRYLVYEFIQNGSLD-------HWI-FPTSRRSEG---HYSGGCLSWDLRYRVAIDV 216
           G G  ++  +   +  +         W+        E             D  +    D 
Sbjct: 160 GSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDH 219

Query: 217 AKALSYLHNDCRSRVLHLDVKPEN-----ILLDENYRAVVSDFGLS-KLM--SRDQSRCI 268
           +  +    +  ++ +  L           +LL+       + F LS K++  +R +   +
Sbjct: 220 SSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQ--V 277

Query: 269 TTIRGTRGYLAPEWILEQGV---SEKCDIYS--YGMVLLEL-----TGGRRNVSLIEHGN 318
           T                       E   +          +L     T   R +S+I    
Sbjct: 278 TDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESI 337

Query: 319 DKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRL-VDVA-FWCIQERAR 376
                 W  +  +  +K+       I++  L     ++  + R++   ++ F      A 
Sbjct: 338 RDGLATWDNWKHVNCDKLT-----TIIESSLNV---LEPAEYRKMFDRLSVF---PPSAH 386

Query: 377 LRPSMARVVEMLEGRVAVDDPPDTQMVIVDWLS----IDQDDDAGGDIGRRRLAALASDL 432
           + P++  ++ ++      D      MV+V+ L     +++            + ++  +L
Sbjct: 387 I-PTI--LLSLIWF----DVIKSDVMVVVNKLHKYSLVEKQPKE----STISIPSIYLEL 435

Query: 433 GRNLATDSA 441
              L  + A
Sbjct: 436 KVKLENEYA 444

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 53.9 bits (130), Expect = 4e-08
 Identities = 61/239 (25%), Positives = 93/239 (38%), Gaps = 66/239 (27%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAAIASAQ------------- 154
           LG G+   V+K I    G  VAVK+I         F++       AQ             
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIF------DAFQNST----DAQRTFREIMILTELS 66

Query: 155 -HVNLVRLLGYCVVPGGPR--YLVYEFIQNGSLD-HWIFPTSRRSEGHYSGGCLSWDLRY 210
            H N+V LL   +     R  YLV+++++    D H +   +     H          +Y
Sbjct: 67  GHENIVNLLN-VLRADNDRDVYLVFDYMET---DLHAVIRANILEPVHK---------QY 113

Query: 211 RVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITT 270
            V   + K + YLH+     +LH D+KP NILL+      V+DFGLS+     +      
Sbjct: 114 -VVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169

Query: 271 IRG--------------------TRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGR 308
                                  TR Y APE +L     ++  D++S G +L E+  G+
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 54.0 bits (130), Expect = 4e-08
 Identities = 46/247 (18%), Positives = 94/247 (38%), Gaps = 60/247 (24%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAA---------IASAQHVNL 158
           +G GS   V+     +   +VA+K++N      + F   +           +   +   +
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVN------RMFEDLIDCKRILREITILNRLKSDYI 87

Query: 159 VRLLGYCVVPGGPR----YLVYEFIQNGSLD-HWIFPTSRRSEGHYSGGCLSWDLRYRVA 213
           +RL    +     +    Y+V E   +   D   +F          +   L+ +   +  
Sbjct: 88  IRLYDLIIPDDLLKFDELYIVLEIADS---DLKKLF---------KTPIFLT-EEHIKTI 134

Query: 214 I-DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR 272
           + ++    +++H    S ++H D+KP N LL+++    V DFGL++ ++ ++   I    
Sbjct: 135 LYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191

Query: 273 G---------------------TRGYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGRRN 310
                                 TR Y APE IL ++  ++  DI+S G +  EL    ++
Sbjct: 192 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251

Query: 311 VSLIEHG 317
                  
Sbjct: 252 HINDPTN 258

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 47/249 (18%), Positives = 92/249 (36%), Gaps = 65/249 (26%)

Query: 100 EATDNFQAL--LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAA------- 149
           +  D ++    +G GS   V +     +   VA+K+I       + F   +         
Sbjct: 50  QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL------RVFEDLIDCKRILREI 103

Query: 150 --IASAQHVNLVRLLGYCVVPGGPR----YLVYEFIQNGSLD-HWIFPTSRRSEGHYSGG 202
             +    H ++V++L   +     +    Y+V E       D   +F          +  
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD---SDFKKLF---------RTPV 151

Query: 203 CLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR 262
            L+      +  ++   + Y+H+   + +LH D+KP N L++++    V DFGL++ +  
Sbjct: 152 YLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208

Query: 263 DQSRCITTIRG--------------------------TRGYLAPEWIL-EQGVSEKCDIY 295
            ++                                  TR Y APE IL ++  +E  D++
Sbjct: 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVW 268

Query: 296 SYGMVLLEL 304
           S G +  EL
Sbjct: 269 SIGCIFAEL 277

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 44.7 bits (106), Expect = 3e-05
 Identities = 27/175 (15%), Positives = 49/175 (28%), Gaps = 41/175 (23%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVA---AIASAQHVNLVRLLG 163
            +G G    ++     +     A   +  E        SE+     +A    +       
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYS-------GGCLSWDLR------- 209
                G P +            +     +      Y        G  L   +        
Sbjct: 104 QLDYLGIPLF------------YG-SGLTEFKGRSYRFMVMERLGIDL-QKISGQNGTFK 149

Query: 210 ----YRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVV--SDFGLSK 258
                ++ I +   L Y+H    +  +H D+K  N+LL       V  +D+GLS 
Sbjct: 150 KSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 41.3 bits (97), Expect = 5e-04
 Identities = 14/50 (28%), Positives = 26/50 (52%), Gaps = 5/50 (10%)

Query: 211 RVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVV--SDFGLSK 258
           +VA  +  AL +LH    +  +H +V  ENI +D   ++ V  + +G + 
Sbjct: 163 QVACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	453
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.81
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.69
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.26
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.21
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.13
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.97
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.64
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.6
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.55
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.4
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.29
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.29
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.08
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.08
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.7
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.63
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.56
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.47
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.34
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.24
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.23
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.12
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.04
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.03
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.83
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.74
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.16
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	94.81
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	94.74
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.21
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	91.71
2klu_A	70	T-cell surface glycoprotein CD4; cell membrane, di	89.52
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	87.82
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	82.78
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	82.69
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	81.25

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.2e-59  Score=451.09  Aligned_cols=268  Identities=23%  Similarity=0.325  Sum_probs=213.9

Q ss_pred             HHHHHHHHHhcccCcCCceEEEEEEeC------CCcEEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEec
Q 047276           97 ELEEATDNFQALLGHGSSASVFKGILS------DGTSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP  168 (453)
Q Consensus        97 el~~~~~~~~~~lG~G~fG~Vy~~~~~------~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~  168 (453)
                      ||..++..|.++||+|+||+||+|++.      +++.||||+++..  ....++|.+|+.++++++|||||+++|+|. .
T Consensus        22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~  100 (308)
T 4gt4_A           22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT-K  100 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred             cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEE-E
Confidence            344444567789999999999999963      4678999999753  334578999999999999999999999986 5


Q ss_pred             CCCeEEEEEecCCCChhhhhccCCCCCCC------CCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEE
Q 047276          169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEG------HYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENIL  242 (453)
Q Consensus       169 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiL  242 (453)
                      +++.++|||||++|+|.++|.........      ......++|..+++|+.|||.||+|||+   .+|+||||||+|||
T Consensus       101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NIL  177 (308)
T 4gt4_A          101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVL  177 (308)
T ss_dssp             SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceE
Confidence            66889999999999999999765432111      1123459999999999999999999999   89999999999999


Q ss_pred             ECCCCcEEEeeccccccccCCC-CceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCC
Q 047276          243 LDENYRAVVSDFGLSKLMSRDQ-SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDK  320 (453)
Q Consensus       243 l~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~  320 (453)
                      |++++.+||+|||+++...... ....+...||+.|||||++.++.|+.++|||||||++|||+| |+.||.....    
T Consensus       178 l~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~----  253 (308)
T 4gt4_A          178 VYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN----  253 (308)
T ss_dssp             ECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH----
T ss_pred             ECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH----
Confidence            9999999999999998765433 233455689999999999999999999999999999999998 8999953211    


Q ss_pred             CcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          321 SKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                               ..+...+..+...           +.+.+++..+.+++.+||+.||++||||+||++.|+...
T Consensus       254 ---------~~~~~~i~~~~~~-----------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          254 ---------QDVVEMIRNRQVL-----------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             ---------HHHHHHHHTTCCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             ---------HHHHHHHHcCCCC-----------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence                     1122233333211           123344566899999999999999999999999998643

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.4e-57  Score=440.89  Aligned_cols=261  Identities=23%  Similarity=0.376  Sum_probs=202.0

Q ss_pred             HhcccCcCCceEEEEEEeC------CCcEEEEEEecCCC-ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          105 FQALLGHGSSASVFKGILS------DGTSVAVKRINGEE-NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      +.++||+|+||+||+|++.      +++.||||+++... ...++|.+|+++|++++|||||+++|+|. .++..++|||
T Consensus        45 l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~-~~~~~~lV~E  123 (329)
T 4aoj_A           45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCT-EGRPLLMVFE  123 (329)
T ss_dssp             EEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSSEEEEEE
T ss_pred             EEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-ECCEEEEEEE
Confidence            3578999999999999864      47889999997643 34567999999999999999999999986 5668999999


Q ss_pred             ecCCCChhhhhccCCCCCC-----CCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEe
Q 047276          178 FIQNGSLDHWIFPTSRRSE-----GHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVS  252 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~-----~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~  252 (453)
                      ||++|+|.++++.......     .......++|..+++|+.||+.||+|||+   ++|+||||||+||||++++.+||+
T Consensus       124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~Ki~  200 (329)
T 4aoj_A          124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIG  200 (329)
T ss_dssp             CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEEC
T ss_pred             cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcEEEc
Confidence            9999999999976543211     11123569999999999999999999999   899999999999999999999999


Q ss_pred             eccccccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhH
Q 047276          253 DFGLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPK  330 (453)
Q Consensus       253 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  330 (453)
                      |||+++....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||.....             .
T Consensus       201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-------------~  267 (329)
T 4aoj_A          201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-------------T  267 (329)
T ss_dssp             CCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-------------H
T ss_pred             ccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-------------H
Confidence            9999987654332 23345679999999999999999999999999999999999 8999953211             1


Q ss_pred             HHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          331 IVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       331 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                      .+...+..+..       +    ..+..++..+.+++.+||+.||++||||+||++.|+.+..
T Consensus       268 ~~~~~i~~g~~-------~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          268 EAIDCITQGRE-------L----ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             HHHHHHHHTCC-------C----CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCC-------C----CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence            12222222221       1    1223344568999999999999999999999999998754

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.3e-57  Score=436.92  Aligned_cols=260  Identities=23%  Similarity=0.402  Sum_probs=206.7

Q ss_pred             HhcccCcCCceEEEEEEeC------CCcEEEEEEecCC-CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          105 FQALLGHGSSASVFKGILS------DGTSVAVKRINGE-ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      +.+.||+|+||+||+|++.      ++..||||+++.. ....++|.+|+++|++++|||||+++|+|. .++..++|||
T Consensus        17 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~-~~~~~~lV~E   95 (299)
T 4asz_A           17 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-EGDPLIMVFE   95 (299)
T ss_dssp             EEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSSEEEEEE
T ss_pred             EeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEe-eCCEEEEEEE
Confidence            4678999999999999864      4778999999764 334567999999999999999999999987 5668999999


Q ss_pred             ecCCCChhhhhccCCCCC---CCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeec
Q 047276          178 FIQNGSLDHWIFPTSRRS---EGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDF  254 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~---~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~Df  254 (453)
                      ||++|+|.++|+......   ........++|..+++|+.||+.||+|||+   ++|+||||||+||||++++.+||+||
T Consensus        96 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki~DF  172 (299)
T 4asz_A           96 YMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDF  172 (299)
T ss_dssp             CCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             cCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEECCc
Confidence            999999999997543100   000123459999999999999999999999   89999999999999999999999999


Q ss_pred             cccccccCCCCc-eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHH
Q 047276          255 GLSKLMSRDQSR-CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIV  332 (453)
Q Consensus       255 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  332 (453)
                      |+++........ ......||+.|||||++.++.|+.++|||||||++|||+| |+.||.....             ..+
T Consensus       173 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-------------~~~  239 (299)
T 4asz_A          173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-------------NEV  239 (299)
T ss_dssp             SCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------------HHH
T ss_pred             ccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-------------HHH
Confidence            999876543322 2233568999999999999999999999999999999999 8999953211             112


Q ss_pred             HHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          333 NEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       333 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      ...+..+...           ..+..++..+.+++.+||+.||++|||+++|++.|++..
T Consensus       240 ~~~i~~~~~~-----------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~  288 (299)
T 4asz_A          240 IECITQGRVL-----------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA  288 (299)
T ss_dssp             HHHHHHTCCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHcCCCC-----------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            2233333211           122334456899999999999999999999999998754

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-56  Score=430.74  Aligned_cols=255  Identities=26%  Similarity=0.387  Sum_probs=199.5

Q ss_pred             HHhcccCcCCceEEEEEEeCCCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          104 NFQALLGHGSSASVFKGILSDGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      .+.++||+|+||+||+|++.+  .||||+++...   ...+.|.+|+.+|++++|||||+++|+|.  .+..++|||||+
T Consensus        39 ~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~--~~~~~iVmEy~~  114 (307)
T 3omv_A           39 MLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT--KDNLAIVTQWCE  114 (307)
T ss_dssp             CEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSCEEEEECCS
T ss_pred             EEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE--CCeEEEEEEcCC
Confidence            356889999999999999763  59999987532   33467999999999999999999999974  357899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|.++|+...         ..++|..+++|+.|||.||+|||+   ++|+||||||+||||++++.+||+|||+|+..
T Consensus       115 gGsL~~~l~~~~---------~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  182 (307)
T 3omv_A          115 GSSLYKHLHVQE---------TKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVK  182 (307)
T ss_dssp             SCBHHHHHHTSC---------CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred             CCCHHHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceec
Confidence            999999996442         249999999999999999999999   89999999999999999999999999999876


Q ss_pred             cCCC-CceeeeccCCccccchhhhhc---CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhh
Q 047276          261 SRDQ-SRCITTIRGTRGYLAPEWILE---QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKM  336 (453)
Q Consensus       261 ~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (453)
                      .... ........||+.|||||++..   +.|+.++|||||||++|||+||+.||......            ..+...+
T Consensus       183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~------------~~~~~~~  250 (307)
T 3omv_A          183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR------------DQIIFMV  250 (307)
T ss_dssp             -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------------HHHHHHH
T ss_pred             ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH------------HHHHHHH
Confidence            5432 233456789999999999964   46899999999999999999999999532110            1112222


Q ss_pred             hcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          337 KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       337 ~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                      ..+.    ..+.+.   ..+.+++..+.+++.+||+.||++||||.+|++.|+....
T Consensus       251 ~~~~----~~p~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          251 GRGY----ASPDLS---KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             HTTC----CCCCST---TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             hcCC----CCCCcc---cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            2221    111111   1233445668999999999999999999999999986543

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.3e-55  Score=422.40  Aligned_cols=271  Identities=20%  Similarity=0.273  Sum_probs=200.2

Q ss_pred             HhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCC---CeEEEEEecCC
Q 047276          105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGG---PRYLVYEFIQN  181 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~---~~~lv~e~~~~  181 (453)
                      +.++||+|+||+||+|++ +|+.||||+++........+..|+..+.+++|||||+++|+|...+.   ..++|||||++
T Consensus         7 L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~   85 (303)
T 3hmm_A            7 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH   85 (303)
T ss_dssp             EEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred             EEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCC
Confidence            357899999999999998 58999999997544333334456666678999999999999986543   46899999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccC-----CCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDC-----RSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~-----~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      |+|.++|+..           .++|..+.+++.|++.||+|||+.+     .++|+||||||+|||||.++.+||+|||+
T Consensus        86 gsL~~~l~~~-----------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl  154 (303)
T 3hmm_A           86 GSLFDYLNRY-----------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             CBHHHHHHHC-----------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             CcHHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence            9999999532           3899999999999999999999832     24899999999999999999999999999


Q ss_pred             cccccCCCCc---eeeeccCCccccchhhhhcC------CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCccc--c
Q 047276          257 SKLMSRDQSR---CITTIRGTRGYLAPEWILEQ------GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNK--W  325 (453)
Q Consensus       257 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~--~  325 (453)
                      ++........   ......||+.|||||++.+.      .++.++|||||||++|||+||+.|+.........-...  .
T Consensus       155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~  234 (303)
T 3hmm_A          155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  234 (303)
T ss_dssp             CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred             CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccc
Confidence            9877543322   22346799999999998754      36789999999999999999998875433221110000  0


Q ss_pred             cchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          326 QYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      ..........+..+.    .++.+... ..+.+....+.+++.+||+.||++||||.||++.|+++.
T Consensus       235 ~~~~~~~~~~~~~~~----~rp~~p~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~  296 (303)
T 3hmm_A          235 DPSVEEMRKVVCEQK----LRPNIPNR-WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             SCCHHHHHHHHTTSC----CCCCCCGG-GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cchHHHHHHHHhccc----CCCCCCcc-ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            001111122221111    22222211 112356678999999999999999999999999998754

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.6e-56  Score=435.36  Aligned_cols=273  Identities=23%  Similarity=0.382  Sum_probs=215.2

Q ss_pred             cHHHHHHHHHHHhcccCcCCceEEEEEEeCC------CcEEEEEEecCCC--ccHHHHHHHHHHHHhcCC-CceeeEeeE
Q 047276           94 RSKELEEATDNFQALLGHGSSASVFKGILSD------GTSVAVKRINGEE--NGEKEFRSEVAAIASAQH-VNLVRLLGY  164 (453)
Q Consensus        94 ~~~el~~~~~~~~~~lG~G~fG~Vy~~~~~~------g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h-~niv~l~g~  164 (453)
                      +.+||....+.+.+.||+|+||+||+|.+..      ++.||||+++...  ...+.|.+|+.+|.+++| ||||+++|+
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~  136 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA  136 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence            3445555555567899999999999998532      3579999997643  234679999999999965 899999999


Q ss_pred             EEecCCCeEEEEEecCCCChhhhhccCCCCC------CCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCC
Q 047276          165 CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRS------EGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKP  238 (453)
Q Consensus       165 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~  238 (453)
                      |...++..++|||||++|+|.++|+......      ........++|..++.++.|||+||+|||+   ++||||||||
T Consensus       137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~  213 (353)
T 4ase_A          137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAA  213 (353)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSG
T ss_pred             EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCc
Confidence            9766678899999999999999997643211      011123458999999999999999999999   8999999999


Q ss_pred             CcEEECCCCcEEEeeccccccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCccccc
Q 047276          239 ENILLDENYRAVVSDFGLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEH  316 (453)
Q Consensus       239 ~NiLl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~  316 (453)
                      +|||+++++.+||+|||+|+....+.. .......||+.|||||++.++.|+.++|||||||++|||+| |+.||.....
T Consensus       214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~  293 (353)
T 4ase_A          214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  293 (353)
T ss_dssp             GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999997755433 23445678999999999999999999999999999999998 9999953221


Q ss_pred             CCCCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          317 GNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      .            ..+...+..+...           ..+..++.++.+++.+||+.||++|||+++|++.|+...
T Consensus       294 ~------------~~~~~~i~~g~~~-----------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll  346 (353)
T 4ase_A          294 D------------EEFCRRLKEGTRM-----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  346 (353)
T ss_dssp             S------------HHHHHHHHHTCCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H------------HHHHHHHHcCCCC-----------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            1            1122333333211           122233456889999999999999999999999998764

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.2e-53  Score=406.87  Aligned_cols=243  Identities=22%  Similarity=0.375  Sum_probs=193.0

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEec---CCCeEEEEE
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP---GGPRYLVYE  177 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~---~~~~~lv~e  177 (453)
                      |.++||+|+||+||+|.. .++..||+|++...   ....+.|.+|+.+|++++|||||+++++|...   ++..++|||
T Consensus        30 ~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmE  109 (290)
T 3fpq_A           30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE  109 (290)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred             eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEe
Confidence            456899999999999996 46889999999653   23345799999999999999999999988642   235789999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCc--eeccCCCCCcEEEC-CCCcEEEeec
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSR--VLHLDVKPENILLD-ENYRAVVSDF  254 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~--ivH~Dlk~~NiLl~-~~~~~kl~Df  254 (453)
                      ||++|+|.+++...          ..+++..+..++.||+.||+|||+   ++  |+||||||+||||+ .++.+||+||
T Consensus       110 y~~gg~L~~~l~~~----------~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DF  176 (290)
T 3fpq_A          110 LMTSGTLKTYLKRF----------KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDL  176 (290)
T ss_dssp             CCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCT
T ss_pred             CCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeC
Confidence            99999999999643          238999999999999999999998   55  99999999999998 4899999999


Q ss_pred             cccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHH
Q 047276          255 GLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNE  334 (453)
Q Consensus       255 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  334 (453)
                      |+|+.....   .....+||+.|||||.+. +.|+.++|||||||++|||+||+.||.....            ...+..
T Consensus       177 Gla~~~~~~---~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~------------~~~~~~  240 (290)
T 3fpq_A          177 GLATLKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN------------AAQIYR  240 (290)
T ss_dssp             TGGGGCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------------HHHHHH
T ss_pred             cCCEeCCCC---ccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCc------------HHHHHH
Confidence            999864332   235678999999999876 4699999999999999999999999953211            011122


Q ss_pred             hhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          335 KMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       335 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      .+..+......+          ...+..+.+++.+||+.||++|||++|+++
T Consensus       241 ~i~~~~~~~~~~----------~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          241 RVTSGVKPASFD----------KVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HHTTTCCCGGGG----------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHcCCCCCCCC----------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            222221111111          112235889999999999999999999875

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2e-54  Score=421.09  Aligned_cols=245  Identities=24%  Similarity=0.336  Sum_probs=193.8

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.+.||+|+||+||+|+. .+|+.||||+++...   ...+.|.+|+.+|++++|||||++++++. +++..|+|||||+
T Consensus        28 ~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~-~~~~~yiVmEy~~  106 (350)
T 4b9d_A           28 RLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE-ENGSLYIVMDYCE  106 (350)
T ss_dssp             EEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-ETTEEEEEEECCT
T ss_pred             EeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEE-ECCEEEEEEeCCC
Confidence            357899999999999996 569999999997543   23457899999999999999999999986 5668899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|.+++...+        ...+++...+.|+.||+.||+|||+   ++|+||||||+||||+.++.+||+|||+++..
T Consensus       107 gg~L~~~i~~~~--------~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  175 (350)
T 4b9d_A          107 GGDLFKRINAQK--------GVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVL  175 (350)
T ss_dssp             TCBHHHHHHHTT--------TCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCC
T ss_pred             CCcHHHHHHHcC--------CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceee
Confidence            999999996442        2347899999999999999999999   89999999999999999999999999999876


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      .... ......+||+.|||||.+.+..|+.++|||||||++|||++|+.||.....            .. +...+..+.
T Consensus       176 ~~~~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------------~~-~~~~i~~~~  241 (350)
T 4b9d_A          176 NSTV-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM------------KN-LVLKIISGS  241 (350)
T ss_dssp             CHHH-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------------HH-HHHHHHHTC
T ss_pred             cCCc-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------------HH-HHHHHHcCC
Confidence            4321 123456799999999999999999999999999999999999999953210            11 111222222


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ..           ..+...+..+.+++.+||+.||++|||++|+++
T Consensus       242 ~~-----------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          242 FP-----------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             CC-----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CC-----------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11           112233456889999999999999999999985

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.8e-53  Score=413.64  Aligned_cols=242  Identities=24%  Similarity=0.340  Sum_probs=198.7

Q ss_pred             cccCcCCceEEEEEEe-CCCcEEEEEEecCC-CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCCh
Q 047276          107 ALLGHGSSASVFKGIL-SDGTSVAVKRINGE-ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL  184 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL  184 (453)
                      ++||+|+||+||+|+. .+|+.||||+++.. ....+.+.+|+.+|++++|||||++++++. .++..|+|||||++|+|
T Consensus        80 ~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~-~~~~~~ivmEy~~gg~L  158 (346)
T 4fih_A           80 IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-VGDELWVVMEFLEGGAL  158 (346)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEE-ETTEEEEEECCCTTEEH
T ss_pred             EEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-ECCEEEEEEeCCCCCcH
Confidence            5799999999999996 46999999999652 334456889999999999999999999987 55689999999999999


Q ss_pred             hhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCCC
Q 047276          185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ  264 (453)
Q Consensus       185 ~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~  264 (453)
                      .+++..           ..+++..+..++.||+.||+|||+   ++|+||||||+||||+.++.+||+|||+++.+....
T Consensus       159 ~~~l~~-----------~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  224 (346)
T 4fih_A          159 TDIVTH-----------TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  224 (346)
T ss_dssp             HHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred             HHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence            999853           238999999999999999999999   899999999999999999999999999998775433


Q ss_pred             CceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCccccc
Q 047276          265 SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEI  344 (453)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (453)
                      . .....+||+.|||||.+.+..|+.++|||||||++|||++|+.||.....             ......+..+.    
T Consensus       225 ~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-------------~~~~~~i~~~~----  286 (346)
T 4fih_A          225 P-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-------------LKAMKMIRDNL----  286 (346)
T ss_dssp             C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------------HHHHHHHHHSS----
T ss_pred             C-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------------HHHHHHHHcCC----
Confidence            2 24567899999999999999999999999999999999999999953211             00111222111    


Q ss_pred             ccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          345 VDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       345 ~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                       .+.+    ......+..+.+++.+||+.||++|||++|+++
T Consensus       287 -~~~~----~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          287 -PPRL----KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             -CCCC----SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -CCCC----CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             1111    112233456889999999999999999999875

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=5.4e-53  Score=409.13  Aligned_cols=247  Identities=25%  Similarity=0.286  Sum_probs=197.2

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCCh
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL  184 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL  184 (453)
                      .++||+|+||+||+|+. .+|+.||||+++....    +.+|+.+|++++|||||++++++. +++..++|||||++|+|
T Consensus        63 ~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~-~~~~~~ivmEy~~gg~L  137 (336)
T 4g3f_A           63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVR-EGPWVNIFMELLEGGSL  137 (336)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEE-ETTEEEEEECCCTTCBH
T ss_pred             CcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEE-ECCEEEEEEeccCCCcH
Confidence            46899999999999996 4689999999976433    246999999999999999999986 55688999999999999


Q ss_pred             hhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCC-cEEEeeccccccccCC
Q 047276          185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENY-RAVVSDFGLSKLMSRD  263 (453)
Q Consensus       185 ~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~-~~kl~DfGla~~~~~~  263 (453)
                      .+++...          +.+++..+..++.||+.||+|||+   ++|+||||||+||||+.++ .+||+|||+|+.+...
T Consensus       138 ~~~l~~~----------~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~  204 (336)
T 4g3f_A          138 GQLIKQM----------GCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD  204 (336)
T ss_dssp             HHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred             HHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence            9999643          249999999999999999999999   8999999999999999987 6999999999977543


Q ss_pred             CCc----eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          264 QSR----CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       264 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      ...    .....+||+.|||||.+.+..|+.++|||||||++|||++|+.||.......        .    .. .+..+
T Consensus       205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~--------~----~~-~i~~~  271 (336)
T 4g3f_A          205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP--------L----CL-KIASE  271 (336)
T ss_dssp             ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC--------C----HH-HHHHS
T ss_pred             CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--------H----HH-HHHcC
Confidence            211    1234679999999999999999999999999999999999999996322111        0    11 11111


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      ..      .+   ...++..+..+.+++.+||+.||++|||+.|+++.|....
T Consensus       272 ~~------~~---~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l  315 (336)
T 4g3f_A          272 PP------PI---REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL  315 (336)
T ss_dssp             CC------GG---GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CC------Cc---hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence            10      00   0122334456889999999999999999999998886543

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.1e-53  Score=409.32  Aligned_cols=244  Identities=23%  Similarity=0.333  Sum_probs=202.2

Q ss_pred             HHHhcccCcCCceEEEEEEe-CCCcEEEEEEecC----CCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          103 DNFQALLGHGSSASVFKGIL-SDGTSVAVKRING----EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      +.+.++||+|+||+||+|+. .+|+.||||+++.    .....+.+.+|+++|++++|||||++++++. +++..|+|||
T Consensus        34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-~~~~~yivmE  112 (311)
T 4aw0_A           34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-DDEKLYFGLS  112 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-CSSEEEEEEC
T ss_pred             cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-eCCEEEEEEe
Confidence            34568999999999999996 5689999999964    2344577999999999999999999999876 5668899999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |+++|+|.+++...          +.+++.....++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||+|
T Consensus       113 y~~gG~L~~~i~~~----------~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla  179 (311)
T 4aw0_A          113 YAKNGELLKYIRKI----------GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTA  179 (311)
T ss_dssp             CCTTEEHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             cCCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCc
Confidence            99999999999643          239999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhh
Q 047276          258 KLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKM  336 (453)
Q Consensus       258 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (453)
                      +.+..... ......+||+.|||||.+.+..|+.++||||+||++|||++|+.||.....             ......+
T Consensus       180 ~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-------------~~~~~~i  246 (311)
T 4aw0_A          180 KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-------------GLIFAKI  246 (311)
T ss_dssp             EECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------------HHHHHHH
T ss_pred             eecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-------------HHHHHHH
Confidence            98764432 334567899999999999999999999999999999999999999953211             0111222


Q ss_pred             hcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 047276          337 KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVV  385 (453)
Q Consensus       337 ~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~  385 (453)
                      ..+..            .++...+..+.+++.+||+.||++|||++|+.
T Consensus       247 ~~~~~------------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          247 IKLEY------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             HHTCC------------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             HcCCC------------CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence            22221            12223345688999999999999999999864

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2e-52  Score=394.97  Aligned_cols=241  Identities=23%  Similarity=0.337  Sum_probs=184.6

Q ss_pred             HHhcccCcCCceEEEEEEe-CCCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEe
Q 047276          104 NFQALLGHGSSASVFKGIL-SDGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      .+.+.||+|+||+||+|+. .+|+.||||+++..    ....+.+.+|+.+|++++|||||++++++. ..+..++||||
T Consensus        16 ~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-~~~~~~ivmEy   94 (275)
T 3hyh_A           16 QIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK-SKDEIIMVIEY   94 (275)
T ss_dssp             EEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE-CSSEEEEEEEC
T ss_pred             EEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-ECCEEEEEEeC
Confidence            3457999999999999995 56999999999753    233567999999999999999999999876 56688999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      + +|+|.+++..+.          .+++.....++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+|+
T Consensus        95 ~-~g~L~~~l~~~~----------~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~  160 (275)
T 3hyh_A           95 A-GNELFDYIVQRD----------KMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSN  160 (275)
T ss_dssp             C-CEEHHHHHHHSC----------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-
T ss_pred             C-CCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCe
Confidence            9 689999986432          39999999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCceeeeccCCccccchhhhhcCCC-CccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhh
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWILEQGV-SEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMK  337 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (453)
                      ......  .....+||+.|||||.+.+..+ +.++||||+||++|||++|+.||....            ... ....+.
T Consensus       161 ~~~~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~------------~~~-~~~~i~  225 (275)
T 3hyh_A          161 IMTDGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES------------IPV-LFKNIS  225 (275)
T ss_dssp             ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------------HHH-HHHHHH
T ss_pred             ecCCCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC------------HHH-HHHHHH
Confidence            764332  2345789999999999988776 579999999999999999999995311            011 112222


Q ss_pred             cCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          338 EGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       338 ~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      .+..            .++...+..+.+++.+||+.||++|||++|+++
T Consensus       226 ~~~~------------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          226 NGVY------------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             HTCC------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cCCC------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            2211            112223455889999999999999999999986

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.8e-52  Score=414.15  Aligned_cols=242  Identities=24%  Similarity=0.342  Sum_probs=198.8

Q ss_pred             cccCcCCceEEEEEEe-CCCcEEEEEEecCC-CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCCh
Q 047276          107 ALLGHGSSASVFKGIL-SDGTSVAVKRINGE-ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL  184 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL  184 (453)
                      ++||+|+||+||+|+. .+|+.||||+++.. ....+.+.+|+.+|+.++|||||++++++. .++..|+|||||++|+|
T Consensus       157 ~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~-~~~~~~iVmEy~~gG~L  235 (423)
T 4fie_A          157 IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-VGDELWVVMEFLEGGAL  235 (423)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEE-ETTEEEEEEECCTTEEH
T ss_pred             eEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEE-ECCEEEEEEeCCCCCcH
Confidence            6799999999999996 46899999999753 334456899999999999999999999987 55689999999999999


Q ss_pred             hhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCCC
Q 047276          185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ  264 (453)
Q Consensus       185 ~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~  264 (453)
                      .+++..           ..+++..+..|+.||+.||+|||+   ++|+||||||+||||+.+|.+||+|||+++.+....
T Consensus       236 ~~~i~~-----------~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~  301 (423)
T 4fie_A          236 TDIVTH-----------TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  301 (423)
T ss_dssp             HHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred             HHHHhc-----------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence            999843           238999999999999999999999   899999999999999999999999999998775443


Q ss_pred             CceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCccccc
Q 047276          265 SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEI  344 (453)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (453)
                      . .....+||+.|||||.+.+..|+.++|||||||++|||++|+.||.....             ......+..+.    
T Consensus       302 ~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-------------~~~~~~i~~~~----  363 (423)
T 4fie_A          302 P-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-------------LKAMKMIRDNL----  363 (423)
T ss_dssp             C-CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------------HHHHHHHHHSC----
T ss_pred             c-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------------HHHHHHHHcCC----
Confidence            2 24567899999999999999999999999999999999999999953211             00112222111    


Q ss_pred             ccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          345 VDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       345 ~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                       .+.+.    .....+..+.+++.+||+.||++|||+.|+++
T Consensus       364 -~~~~~----~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          364 -PPRLK----NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             -CCCCS----CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -CCCCc----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             11111    11223445889999999999999999999875

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=8.5e-53  Score=402.93  Aligned_cols=238  Identities=23%  Similarity=0.293  Sum_probs=186.7

Q ss_pred             HHhcccCcCCceEEEEEEeC----CCcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEE
Q 047276          104 NFQALLGHGSSASVFKGILS----DGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVY  176 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~----~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~  176 (453)
                      .+.+.||+|+||+||+|+..    +++.||||+++..   ......+.+|+.+|++++|||||++++++. .++..++||
T Consensus        27 ~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-~~~~~~ivm  105 (304)
T 3ubd_A           27 ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQ-TEGKLYLIL  105 (304)
T ss_dssp             EEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEE-ETTEEEEEE
T ss_pred             EEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-ECCEEEEEE
Confidence            34689999999999999852    4789999999752   222346888999999999999999999986 556889999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      |||++|+|.+++....          .+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+
T Consensus       106 Ey~~gg~L~~~l~~~~----------~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGl  172 (304)
T 3ubd_A          106 DFLRGGDLFTRLSKEV----------MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGL  172 (304)
T ss_dssp             CCCTTCEEHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEE
T ss_pred             EcCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEeccccc
Confidence            9999999999996432          39999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhh
Q 047276          257 SKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKM  336 (453)
Q Consensus       257 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (453)
                      |+....... .....+||+.|||||.+.+..|+.++|||||||++|||+||+.||.....            .. ....+
T Consensus       173 a~~~~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------------~~-~~~~i  238 (304)
T 3ubd_A          173 SKESIDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR------------KE-TMTMI  238 (304)
T ss_dssp             EEC-----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HH-HHHHH
T ss_pred             ceeccCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH------------HH-HHHHH
Confidence            986543322 23457899999999999999999999999999999999999999953211            01 11122


Q ss_pred             hcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCH
Q 047276          337 KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSM  381 (453)
Q Consensus       337 ~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  381 (453)
                      ..+..            .++...+..+.+++.+||+.||++|||+
T Consensus       239 ~~~~~------------~~p~~~s~~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          239 LKAKL------------GMPQFLSPEAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             HHCCC------------CCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred             HcCCC------------CCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence            22211            1222334568899999999999999985

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.9e-50  Score=387.61  Aligned_cols=245  Identities=24%  Similarity=0.320  Sum_probs=182.7

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCC-----------C
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGG-----------P  171 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-----------~  171 (453)
                      .+.||+|+||+||+|+. .+|+.||||+++...  ...+.+.+|+.+|++++|||||++++++...+.           .
T Consensus        10 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~   89 (299)
T 4g31_A           10 IQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVY   89 (299)
T ss_dssp             EEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEE
T ss_pred             eeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcE
Confidence            47899999999999996 468999999986532  234578999999999999999999998865432           2


Q ss_pred             eEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEE
Q 047276          172 RYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVV  251 (453)
Q Consensus       172 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl  251 (453)
                      .++|||||++|+|.+++.....       ....++..++.|+.|++.||+|||+   ++|+||||||+|||++.++.+||
T Consensus        90 l~ivmE~~~gg~L~~~l~~~~~-------~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl  159 (299)
T 4g31_A           90 LYIQMQLCRKENLKDWMNGRCT-------IEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKV  159 (299)
T ss_dssp             EEEEEECCCSCCHHHHHHTCCS-------GGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEE
T ss_pred             EEEEEecCCCCcHHHHHHhcCC-------CChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEE
Confidence            6899999999999999965432       1236778889999999999999999   89999999999999999999999


Q ss_pred             eeccccccccCCCCc-----------eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCC
Q 047276          252 SDFGLSKLMSRDQSR-----------CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDK  320 (453)
Q Consensus       252 ~DfGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~  320 (453)
                      +|||+|+........           .....+||+.|||||.+.+..|+.++|||||||++|||++   ||....+    
T Consensus       160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~----  232 (299)
T 4g31_A          160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME----  232 (299)
T ss_dssp             CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH----
T ss_pred             ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH----
Confidence            999999877543211           1234579999999999999999999999999999999996   6632100    


Q ss_pred             CcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          321 SKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                             ... ...........           .........+.+++.+||+.||++|||+.|+++
T Consensus       233 -------~~~-~~~~~~~~~~p-----------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          233 -------RVR-TLTDVRNLKFP-----------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             -------HHH-HHHHHHTTCCC-----------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------HHH-HHHHHhcCCCC-----------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                   000 01111111110           011233345678999999999999999999875

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.5e-48  Score=377.54  Aligned_cols=290  Identities=42%  Similarity=0.707  Sum_probs=237.9

Q ss_pred             CceecHHHHHHHHHHHh--cccCcCCceEEEEEEeCCCcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEE
Q 047276           90 PIKFRSKELEEATDNFQ--ALLGHGSSASVFKGILSDGTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYC  165 (453)
Q Consensus        90 ~~~~~~~el~~~~~~~~--~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~  165 (453)
                      ...|+..++...+.+|.  +.||+|+||+||+|...+|+.||||++....  .....+.+|+.+++.++||||++++++|
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            45688888888777775  7899999999999998889999999987532  2233689999999999999999999998


Q ss_pred             EecCCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECC
Q 047276          166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDE  245 (453)
Q Consensus       166 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~  245 (453)
                      . ..+..++||||+++|+|.+++.....      ....++|..+..++.|++.||+|||+.+..+++||||||+|||++.
T Consensus        97 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~  169 (326)
T 3uim_A           97 M-TPTERLLVYPYMANGSVASCLRERPE------SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDE  169 (326)
T ss_dssp             C-CSSCCEEEEECCTTCBHHHHHHCCST------TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECT
T ss_pred             e-cCCceEEEEEeccCCCHHHHHHhccc------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECC
Confidence            6 55678999999999999999975543      2345999999999999999999999933339999999999999999


Q ss_pred             CCcEEEeeccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccc
Q 047276          246 NYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKW  325 (453)
Q Consensus       246 ~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~  325 (453)
                      ++.+||+|||++...............||+.|+|||.+.+..++.++||||||+++|||++|+.||..........    
T Consensus       170 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----  245 (326)
T 3uim_A          170 EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD----  245 (326)
T ss_dssp             TCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSC----
T ss_pred             CCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccc----
Confidence            9999999999998876555555556679999999999999899999999999999999999999996433222111    


Q ss_pred             cchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          326 QYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      .....+..............+..+.  ...+.+....+.+++.+||+.+|++|||+.+|+++|++..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          246 VMLLDWVKGLLKEKKLEALVDVDLQ--GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             SBHHHHHTTTTSSCCSTTSSCTTCT--TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             hhHHHHHHHHhhchhhhhhcChhhc--cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence            1233444455555566666666654  3467888999999999999999999999999999998743

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=5.9e-47  Score=368.21  Aligned_cols=282  Identities=35%  Similarity=0.624  Sum_probs=228.4

Q ss_pred             HHHHHHHHHH--hcccCcCCceEEEEEEeCCCcEEEEEEecCC-CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCe
Q 047276           96 KELEEATDNF--QALLGHGSSASVFKGILSDGTSVAVKRINGE-ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPR  172 (453)
Q Consensus        96 ~el~~~~~~~--~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  172 (453)
                      .++...+++|  .+.||+|+||+||+|...+|+.||||++... ....+.+.+|+.+++.++||||++++++|. ..+..
T Consensus        32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~  110 (321)
T 2qkw_B           32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD-ERNEM  110 (321)
T ss_dssp             SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC-CTTCC
T ss_pred             HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-CCCeE
Confidence            3344444444  4689999999999999888999999998764 344567999999999999999999999976 56688


Q ss_pred             EEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEe
Q 047276          173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVS  252 (453)
Q Consensus       173 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~  252 (453)
                      ++||||+++|+|.+++.....      ....++|..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+
T Consensus       111 ~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~  181 (321)
T 2qkw_B          111 ILIYKYMENGNLKRHLYGSDL------PTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKIT  181 (321)
T ss_dssp             EEEEECCTTCBTGGGSSSSCC------CSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEEC
T ss_pred             EEEEEcCCCCcHHHHHhccCC------CccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEe
Confidence            999999999999999965432      22348999999999999999999999   899999999999999999999999


Q ss_pred             eccccccccCCC-CceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHH
Q 047276          253 DFGLSKLMSRDQ-SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKI  331 (453)
Q Consensus       253 DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~  331 (453)
                      |||++....... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||....+.....      ...+
T Consensus       182 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~------~~~~  255 (321)
T 2qkw_B          182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN------LAEW  255 (321)
T ss_dssp             CCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCC------HHHH
T ss_pred             ecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHH------HHHH
Confidence            999998754322 222334568999999999999999999999999999999999999996443322221      2223


Q ss_pred             HHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccCCC
Q 047276          332 VNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVD  395 (453)
Q Consensus       332 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~~~  395 (453)
                      .......+.+...+++.+..  ....+....+.+++.+||+.||++|||+.+|++.|+.....+
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~  317 (321)
T 2qkw_B          256 AVESHNNGQLEQIVDPNLAD--KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ  317 (321)
T ss_dssp             THHHHTTTCCCSSSSSSCTT--CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             hhhccccccHHHhcChhhcc--ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence            33444455666666666543  356788899999999999999999999999999999876543

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.8e-48  Score=383.30  Aligned_cols=259  Identities=20%  Similarity=0.283  Sum_probs=192.8

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEec-----CCCeEEE
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVP-----GGPRYLV  175 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~~lv  175 (453)
                      +.+.||+|+||+||+|+. .+|+.||||+++...   ...+.+.+|+.+|+.++|||||++++++...     .+..|+|
T Consensus        58 ~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~iv  137 (398)
T 4b99_A           58 IIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVV  137 (398)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEE
T ss_pred             EEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEE
Confidence            347899999999999996 579999999997543   2335688999999999999999999986532     3567999


Q ss_pred             EEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecc
Q 047276          176 YEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFG  255 (453)
Q Consensus       176 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfG  255 (453)
                      ||||+ |+|.+++...          +.+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||
T Consensus       138 mE~~~-g~L~~~i~~~----------~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFG  203 (398)
T 4b99_A          138 LDLME-SDLHQIIHSS----------QPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFG  203 (398)
T ss_dssp             EECCS-EEHHHHHTSS----------SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred             EeCCC-CCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecc
Confidence            99995 6899999643          349999999999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCC---CceeeeccCCccccchhhhhcC-CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHH
Q 047276          256 LSKLMSRDQ---SRCITTIRGTRGYLAPEWILEQ-GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKI  331 (453)
Q Consensus       256 la~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~  331 (453)
                      +++.+....   .......+||+.|||||.+.+. .++.++||||+||++|||++|+.||.......        .+...
T Consensus       204 la~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~--------~l~~I  275 (398)
T 4b99_A          204 MARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH--------QLQLI  275 (398)
T ss_dssp             TCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--------HHHHH
T ss_pred             eeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH--------HHHHH
Confidence            998764322   2234567899999999998865 56999999999999999999999995322110        00000


Q ss_pred             HHHh----------hhcCcccccccccccCCCCCc-----HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          332 VNEK----------MKEGKLMEIVDQRLTDEGGID-----ETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       332 ~~~~----------~~~~~~~~~~d~~l~~~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ....          .........+ ..+......+     +.....+.+|+.+||+.||++|||+.|+++
T Consensus       276 ~~~~g~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          276 MMVLGTPSPAVIQAVGAERVRAYI-QSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             HHHHCCCCGGGTC-----CHHHHH-HSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHhcCCCChHHhhhhhhhhhhhhh-hcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0000          0000000000 0000000000     112345889999999999999999999875

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.7e-46  Score=369.65  Aligned_cols=192  Identities=21%  Similarity=0.326  Sum_probs=162.5

Q ss_pred             HHhcccCcCCceEEEEEEeC----CCcEEEEEEecCCCccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEEEEEe
Q 047276          104 NFQALLGHGSSASVFKGILS----DGTSVAVKRINGEENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      .+.++||+|+||+||+|+.+    +++.||||++.... ....+.+|+++|..+ +|||||++++++. ..+..++||||
T Consensus        24 ~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~-~~~~~~lvmE~  101 (361)
T 4f9c_A           24 KIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFR-KNDHVVIAMPY  101 (361)
T ss_dssp             EEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEE-ETTEEEEEEEC
T ss_pred             EEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEE-ECCEEEEEEeC
Confidence            34578999999999999852    46789999987543 356788999999998 6999999999876 56789999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCC-CcEEEeecccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDEN-YRAVVSDFGLS  257 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~-~~~kl~DfGla  257 (453)
                      +++|+|.+++.             .+++.....++.|++.||+|||+   .+|+||||||+|||++.+ +.+||+|||+|
T Consensus       102 ~~g~~L~~~~~-------------~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla  165 (361)
T 4f9c_A          102 LEHESFLDILN-------------SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLA  165 (361)
T ss_dssp             CCCCCHHHHHT-------------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             CCcccHHHHHc-------------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence            99999999982             28999999999999999999999   899999999999999876 89999999999


Q ss_pred             ccccCCCC---------------------------ceeeeccCCccccchhhhhcC-CCCccccchhHHHHHHHHHcCCC
Q 047276          258 KLMSRDQS---------------------------RCITTIRGTRGYLAPEWILEQ-GVSEKCDIYSYGMVLLELTGGRR  309 (453)
Q Consensus       258 ~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvil~elltG~~  309 (453)
                      +.......                           ......+||+.|+|||.+.+. .++.++||||+||++|||++|+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~  245 (361)
T 4f9c_A          166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY  245 (361)
T ss_dssp             EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred             cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence            86532211                           112345799999999999875 58999999999999999999999


Q ss_pred             CCcc
Q 047276          310 NVSL  313 (453)
Q Consensus       310 p~~~  313 (453)
                      ||..
T Consensus       246 Pf~~  249 (361)
T 4f9c_A          246 PFYK  249 (361)
T ss_dssp             SSSC
T ss_pred             CCCC
Confidence            9953

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.1e-46  Score=387.96  Aligned_cols=240  Identities=21%  Similarity=0.263  Sum_probs=190.2

Q ss_pred             cccCcCCceEEEEEEe-CCCcEEEEEEecCC----CccHHHHHHH---HHHHHhcCCCceeeEeeEEEecCCCeEEEEEe
Q 047276          107 ALLGHGSSASVFKGIL-SDGTSVAVKRINGE----ENGEKEFRSE---VAAIASAQHVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~----~~~~~~~~~E---~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      ++||+|+||+||+++. .+|+.||||+++..    ......+.+|   +.+++.++|||||++++++. +.+..|+||||
T Consensus       195 k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~-~~~~lylVmEy  273 (689)
T 3v5w_A          195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-TPDKLSFILDL  273 (689)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE-CSSEEEEEECC
T ss_pred             EEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE-ECCEEEEEEec
Confidence            6899999999999996 46899999999642    2233344444   55666778999999999876 56789999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      |++|+|.++|...          +.+++..+..++.||+.||+|||+   .+|+||||||+||||+.+|++||+|||+|+
T Consensus       274 ~~GGdL~~~l~~~----------~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~  340 (689)
T 3v5w_A          274 MNGGDLHYHLSQH----------GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC  340 (689)
T ss_dssp             CCSCBHHHHHHHH----------CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceee
Confidence            9999999999643          239999999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhh
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMK  337 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (453)
                      .+....   ....+||+.|||||.+.. ..|+.++|+||+||++|||++|+.||.......         ... ......
T Consensus       341 ~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~---------~~~-i~~~i~  407 (689)
T 3v5w_A          341 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---------KHE-IDRMTL  407 (689)
T ss_dssp             ECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC---------HHH-HHHHHH
T ss_pred             ecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---------HHH-HHHhhc
Confidence            765433   345689999999999975 579999999999999999999999996422111         000 111111


Q ss_pred             cCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCC-----HHHHH
Q 047276          338 EGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPS-----MARVV  385 (453)
Q Consensus       338 ~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~~v~  385 (453)
                      ...            ..++...+..+.+++.+||+.||++|++     ++||.
T Consensus       408 ~~~------------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~  448 (689)
T 3v5w_A          408 TMA------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK  448 (689)
T ss_dssp             HCC------------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred             CCC------------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence            111            1123334456899999999999999998     57766

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.5e-46  Score=388.78  Aligned_cols=247  Identities=21%  Similarity=0.269  Sum_probs=199.7

Q ss_pred             HHhcccCcCCceEEEEEEe-CCCcEEEEEEecCCC-ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          104 NFQALLGHGSSASVFKGIL-SDGTSVAVKRINGEE-NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      .+.+.||+|+||+||+|.. .+|+.||+|++.... ...+.+.+|+.+|+.++|||||++++++. ..+..++|||||++
T Consensus       160 ~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-~~~~~~iv~E~~~g  238 (573)
T 3uto_A          160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE-DDNEMVMIYEFMSG  238 (573)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE-CSSEEEEEEECCCC
T ss_pred             EEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEE-ECCEEEEEEeecCC
Confidence            3457899999999999996 468999999987643 34467889999999999999999999876 56789999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCC--CcEEEeecccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDEN--YRAVVSDFGLSKL  259 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~--~~~kl~DfGla~~  259 (453)
                      |+|.+++....         +.+++..+..++.||+.||+|||+   ++|+||||||+|||++.+  +.+||+|||+++.
T Consensus       239 g~L~~~i~~~~---------~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~  306 (573)
T 3uto_A          239 GELFEKVADEH---------NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH  306 (573)
T ss_dssp             CBHHHHHTCTT---------SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred             CcHHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence            99999985332         348999999999999999999999   899999999999999854  8999999999998


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      +....  .....+||+.|||||.+.+..|+.++||||+||++|||++|+.||......             .....+..+
T Consensus       307 ~~~~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~-------------~~~~~i~~~  371 (573)
T 3uto_A          307 LDPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-------------ETLRNVKSC  371 (573)
T ss_dssp             CCTTS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------------HHHHHHHTT
T ss_pred             ccCCC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-------------HHHHHHHhC
Confidence            75433  345678999999999999999999999999999999999999999532110             011122211


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ... .-++       .....+..+.+|+.+||+.||++|||+.|+++
T Consensus       372 ~~~-~~~~-------~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          372 DWN-MDDS-------AFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             CCC-CCSG-------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCC-CCcc-------cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            110 0000       11122345889999999999999999999987

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.6e-45  Score=356.99  Aligned_cols=268  Identities=23%  Similarity=0.289  Sum_probs=203.9

Q ss_pred             HhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCC---CeEEEEEecCC
Q 047276          105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGG---PRYLVYEFIQN  181 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~---~~~lv~e~~~~  181 (453)
                      +.++||+|+||+||+|+.. ++.||||++.........+..|+.++.+++||||+++++++.....   ..++||||+++
T Consensus        28 ~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~  106 (322)
T 3soc_A           28 LLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEK  106 (322)
T ss_dssp             EEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred             hhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCC
Confidence            3578999999999999986 7899999997655555667779999999999999999999875432   36999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCC----------ceeccCCCCCcEEECCCCcEEE
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRS----------RVLHLDVKPENILLDENYRAVV  251 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~----------~ivH~Dlk~~NiLl~~~~~~kl  251 (453)
                      |+|.+++...           .++|..++.++.|++.||+|||+   .          +|+||||||+|||++.++.+||
T Consensus       107 g~L~~~l~~~-----------~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL  172 (322)
T 3soc_A          107 GSLSDFLKAN-----------VVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI  172 (322)
T ss_dssp             CBHHHHHHHC-----------CBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred             CCHHHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence            9999999532           38999999999999999999998   6          9999999999999999999999


Q ss_pred             eeccccccccCCCC-ceeeeccCCccccchhhhhcC-----CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccc
Q 047276          252 SDFGLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQ-----GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKW  325 (453)
Q Consensus       252 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~  325 (453)
                      +|||+++....... .......||+.|+|||.+.+.     .++.++|||||||++|||++|+.||..............
T Consensus       173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~  252 (322)
T 3soc_A          173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE  252 (322)
T ss_dssp             CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred             ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence            99999987654332 223345789999999998763     456789999999999999999999964332211110000


Q ss_pred             -c--chhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          326 -Q--YFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       326 -~--~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                       .  ......................+     ........+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~  317 (322)
T 3soc_A          253 IGQHPSLEDMQEVVVHKKKRPVLRDYW-----QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ  317 (322)
T ss_dssp             HCSSCCHHHHHHHHTTSCCCCCCCGGG-----GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hccCCchhhhhhhhhcccCCCCccccc-----cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence             0  00011111111111111111111     12245677999999999999999999999999998754

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4e-44  Score=345.77  Aligned_cols=278  Identities=33%  Similarity=0.555  Sum_probs=222.6

Q ss_pred             ceecHHHHHHHHHHHh--------cccCcCCceEEEEEEeCCCcEEEEEEecCC-----CccHHHHHHHHHHHHhcCCCc
Q 047276           91 IKFRSKELEEATDNFQ--------ALLGHGSSASVFKGILSDGTSVAVKRINGE-----ENGEKEFRSEVAAIASAQHVN  157 (453)
Q Consensus        91 ~~~~~~el~~~~~~~~--------~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~h~n  157 (453)
                      ..|++.++..++.+|.        +.||+|+||+||+|.. +++.||||++...     ....+.+.+|+.++++++|||
T Consensus        13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   91 (307)
T 2nru_A           13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN   91 (307)
T ss_dssp             EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred             CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence            4689999999999986        4699999999999987 5889999998642     233567999999999999999


Q ss_pred             eeeEeeEEEecCCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCC
Q 047276          158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVK  237 (453)
Q Consensus       158 iv~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk  237 (453)
                      |+++++++. ..+..++||||+++|+|.+++.....       ...+++..++.++.|++.||+|||+   .+++|||||
T Consensus        92 i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlk  160 (307)
T 2nru_A           92 LVELLGFSS-DGDDLCLVYVYMPNGSLLDRLSCLDG-------TPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIK  160 (307)
T ss_dssp             BCCEEEEEC-SSSSCEEEEECCTTCBHHHHHHTGGG-------CCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCC
T ss_pred             eEEEEEEEe-cCCceEEEEEecCCCcHHHHHHhccC-------CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCC
Confidence            999999976 56688999999999999999864321       2348999999999999999999999   899999999


Q ss_pred             CCcEEECCCCcEEEeeccccccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCccccc
Q 047276          238 PENILLDENYRAVVSDFGLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEH  316 (453)
Q Consensus       238 ~~NiLl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~  316 (453)
                      |+||+++.++.+||+|||++........ .......||+.|+|||.+.+ .++.++||||||+++|||++|+.||.....
T Consensus       161 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~  239 (307)
T 2nru_A          161 SANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE  239 (307)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred             HHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence            9999999999999999999987654332 22334578999999998764 589999999999999999999999964332


Q ss_pred             CCCCCcccccchhHHHHHhh-hcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          317 GNDKSKNKWQYFPKIVNEKM-KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      ...        ...+..... ....+.+.+++.+.   ..+......+.+++.+||+.+|++|||+.+|++.|+++.
T Consensus       240 ~~~--------~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          240 PQL--------LLDIKEEIEDEEKTIEDYIDKKMN---DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             SSB--------TTHHHHHHHTTSCCHHHHSCSSCS---CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             hHH--------HHHHHHHhhhhhhhhhhhcccccc---ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            211        111111111 11223334444442   346677888999999999999999999999999998764

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.4e-45  Score=373.87  Aligned_cols=254  Identities=22%  Similarity=0.368  Sum_probs=208.1

Q ss_pred             HHHhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCC
Q 047276          103 DNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      +.+.+.||+|+||+||+|.+.++..||||+++......+.|.+|+.+|++++||||+++++++.  .+..++||||+++|
T Consensus       190 ~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~--~~~~~lv~e~~~~g  267 (454)
T 1qcf_A          190 LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT--KEPIYIITEFMAKG  267 (454)
T ss_dssp             EEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSCEEEECCCTTC
T ss_pred             eEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe--CCccEEEEeecCCC
Confidence            3446799999999999999988899999999877677889999999999999999999999874  55789999999999


Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccC
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR  262 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~  262 (453)
                      +|.+++.....        ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       268 ~L~~~l~~~~~--------~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~  336 (454)
T 1qcf_A          268 SLLDFLKSDEG--------SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIED  336 (454)
T ss_dssp             BHHHHHHSHHH--------HTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred             cHHHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence            99999964321        238899999999999999999999   8999999999999999999999999999987643


Q ss_pred             CCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcCcc
Q 047276          263 DQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKL  341 (453)
Q Consensus       263 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (453)
                      ..........+|+.|+|||.+..+.++.++|||||||++|||++ |+.||.....             ..+...+..+. 
T Consensus       337 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~-------------~~~~~~i~~~~-  402 (454)
T 1qcf_A          337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-------------PEVIRALERGY-  402 (454)
T ss_dssp             HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------------HHHHHHHHHTC-
T ss_pred             CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH-------------HHHHHHHHcCC-
Confidence            32222233456789999999999999999999999999999999 9999953211             01112222221 


Q ss_pred             cccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          342 MEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       342 ~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                            ++    ..+..++..+.+++.+||+.||++|||+++|++.|+....
T Consensus       403 ------~~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          403 ------RM----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             ------CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             ------CC----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence                  11    1122334568999999999999999999999999998654

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=7e-45  Score=351.75  Aligned_cols=253  Identities=25%  Similarity=0.399  Sum_probs=201.7

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecC-CCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCC
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRING-EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      +.++||+|+||+||++... +++.||+|.+.. .....+.|.+|+.++++++||||+++++++. .++..++||||+++|
T Consensus        14 ~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~~lv~e~~~~~   92 (310)
T 3s95_A           14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY-KDKRLNFITEYIKGG   92 (310)
T ss_dssp             EEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-ETTEEEEEEECCTTC
T ss_pred             ccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEe-cCCeeEEEEEecCCC
Confidence            3578999999999999964 689999998865 3345567999999999999999999999987 456789999999999


Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccC
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR  262 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~  262 (453)
                      +|.+++....         ..+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++.....
T Consensus        93 ~L~~~l~~~~---------~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  160 (310)
T 3s95_A           93 TLRGIIKSMD---------SQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD  160 (310)
T ss_dssp             BHHHHHHHCC---------TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred             cHHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence            9999996532         238999999999999999999999   8999999999999999999999999999987643


Q ss_pred             CCCce-------------eeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchh
Q 047276          263 DQSRC-------------ITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFP  329 (453)
Q Consensus       263 ~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~  329 (453)
                      .....             .....||+.|+|||.+.+..++.++||||||+++|||++|..|+.............   . 
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~---~-  236 (310)
T 3s95_A          161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN---V-  236 (310)
T ss_dssp             -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC---H-
T ss_pred             ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh---h-
Confidence            32211             114579999999999999999999999999999999999999985432221111000   0 


Q ss_pred             HHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          330 KIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       330 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                         ..         ..+...      +...+..+.+++.+||+.||++|||+.++++.|+...
T Consensus       237 ---~~---------~~~~~~------~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~  281 (310)
T 3s95_A          237 ---RG---------FLDRYC------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR  281 (310)
T ss_dssp             ---HH---------HHHHTC------CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---hc---------cccccC------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence               00         001101      1122234889999999999999999999999998764

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.9e-44  Score=341.13  Aligned_cols=252  Identities=24%  Similarity=0.374  Sum_probs=208.1

Q ss_pred             HhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCCh
Q 047276          105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL  184 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL  184 (453)
                      +.+.||+|+||+||+|...++..||+|+++......+++.+|+.++.+++||||+++++++. ..+..++||||+++|+|
T Consensus        12 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L   90 (268)
T 3sxs_A           12 LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS-KEYPIYIVTEYISNGCL   90 (268)
T ss_dssp             EEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSSEEEEEECCTTCBH
T ss_pred             eeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEc-cCCceEEEEEccCCCcH
Confidence            45789999999999999988889999999887777788999999999999999999999975 56688999999999999


Q ss_pred             hhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCCC
Q 047276          185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ  264 (453)
Q Consensus       185 ~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~  264 (453)
                      .+++....         ..+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.......
T Consensus        91 ~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           91 LNYLRSHG---------KGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             HHHHHHHG---------GGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             HHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            99996432         238999999999999999999999   899999999999999999999999999998775544


Q ss_pred             CceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcCcccc
Q 047276          265 SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLME  343 (453)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (453)
                      ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......            . .......+..  
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------------~-~~~~~~~~~~--  223 (268)
T 3sxs_A          159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS------------E-VVLKVSQGHR--  223 (268)
T ss_dssp             EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH------------H-HHHHHHTTCC--
T ss_pred             hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH------------H-HHHHHHcCCC--
Confidence            333344566778999999998889999999999999999999 99998532111            0 1111111110  


Q ss_pred             cccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          344 IVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       344 ~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                      .         ..+......+.+++.+||+.+|++|||+.++++.|+....
T Consensus       224 ~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          224 L---------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             C---------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             C---------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence            0         0111223458899999999999999999999999998654

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.1e-44  Score=343.12  Aligned_cols=251  Identities=25%  Similarity=0.412  Sum_probs=206.8

Q ss_pred             HhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCCh
Q 047276          105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL  184 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL  184 (453)
                      +.+.||+|+||+||+|...+++.||+|++.......+.+.+|+.++++++||||+++++++. .++..++||||+++|+|
T Consensus        14 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L   92 (269)
T 4hcu_A           14 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL-EQAPICLVFEFMEHGCL   92 (269)
T ss_dssp             EEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSSEEEEEECCTTCBH
T ss_pred             eeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCceEEEEEeCCCCcH
Confidence            35789999999999999988999999999887777788999999999999999999999976 56688999999999999


Q ss_pred             hhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCCC
Q 047276          185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ  264 (453)
Q Consensus       185 ~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~  264 (453)
                      .+++....         ..+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.......
T Consensus        93 ~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  160 (269)
T 4hcu_A           93 SDYLRTQR---------GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  160 (269)
T ss_dssp             HHHHHTTT---------TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             HHHHHhcC---------cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence            99995432         248999999999999999999999   899999999999999999999999999998765433


Q ss_pred             CceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcCcccc
Q 047276          265 SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLME  343 (453)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (453)
                      ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....             ......+..+..  
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~-------------~~~~~~~~~~~~--  225 (269)
T 4hcu_A          161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-------------SEVVEDISTGFR--  225 (269)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------------HHHHHHHHTTCC--
T ss_pred             cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH-------------HHHHHHHhcCcc--
Confidence            222334556788999999999999999999999999999999 9999853211             011111111110  


Q ss_pred             cccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          344 IVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       344 ~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                         .      ..+......+.+++.+|++.+|++|||+.++++.|++..
T Consensus       226 ---~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~  265 (269)
T 4hcu_A          226 ---L------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  265 (269)
T ss_dssp             ---C------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---C------CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence               0      011122445889999999999999999999999998754

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.9e-45  Score=378.36  Aligned_cols=260  Identities=27%  Similarity=0.414  Sum_probs=211.4

Q ss_pred             HHHHHHHHHhcccCcCCceEEEEEEeCC-CcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEE
Q 047276           97 ELEEATDNFQALLGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLV  175 (453)
Q Consensus        97 el~~~~~~~~~~lG~G~fG~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv  175 (453)
                      ++....+.+.+.||+|+||.||+|.+.. +..||||.++......++|.+|+.+|++++||||++++|+|. ..+..++|
T Consensus       216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~~lv  294 (495)
T 1opk_A          216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-REPPFYII  294 (495)
T ss_dssp             BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSSCEEE
T ss_pred             ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEe-cCCcEEEE
Confidence            3333334456899999999999999764 889999999877667788999999999999999999999986 55688999


Q ss_pred             EEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecc
Q 047276          176 YEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFG  255 (453)
Q Consensus       176 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfG  255 (453)
                      |||+++|+|.+++.....        ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||
T Consensus       295 ~E~~~~g~L~~~l~~~~~--------~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG  363 (495)
T 1opk_A          295 TEFMTYGNLLDYLRECNR--------QEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFG  363 (495)
T ss_dssp             EECCTTCBHHHHHHHSCT--------TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTT
T ss_pred             EEccCCCCHHHHHHhcCc--------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecc
Confidence            999999999999965432        348999999999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHH
Q 047276          256 LSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNE  334 (453)
Q Consensus       256 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  334 (453)
                      +++..............+++.|+|||.+....++.++|||||||++|||++ |+.||......             .+.+
T Consensus       364 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~-------------~~~~  430 (495)
T 1opk_A          364 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------------QVYE  430 (495)
T ss_dssp             CEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-------------GHHH
T ss_pred             cceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH-------------HHHH
Confidence            998765443322334456789999999999999999999999999999999 99998532211             0112


Q ss_pred             hhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          335 KMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       335 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      .+..+.       ++    ..+..+...+.+++.+||+.+|++|||+.+|++.|+...
T Consensus       431 ~~~~~~-------~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          431 LLEKDY-------RM----ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             HHHTTC-------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             HHHcCC-------CC----CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            221111       01    122234456889999999999999999999999999764

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.8e-44  Score=349.01  Aligned_cols=259  Identities=28%  Similarity=0.423  Sum_probs=194.8

Q ss_pred             HhcccCcCCceEEEEEEeCCCcEEEEEEecCCCc---cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEEN---GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      +.+.||+|+||+||+|+. +|+.||||++.....   ..+.|.+|+.++++++||||+++++++. ..+..++||||+++
T Consensus        41 i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~~lv~e~~~~  118 (309)
T 3p86_A           41 IKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT-QPPNLSIVTEYLSR  118 (309)
T ss_dssp             EEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-STTCCEEEEECCTT
T ss_pred             eeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-ECCceEEEEecCCC
Confidence            457899999999999987 588999999976432   2356889999999999999999999976 55678999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCc--eeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSR--VLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~--ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      |+|.+++.....       ...+++..++.++.|++.||+|||+   .+  |+||||||+|||++.++.+||+|||+++.
T Consensus       119 ~~L~~~l~~~~~-------~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  188 (309)
T 3p86_A          119 GSLYRLLHKSGA-------REQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL  188 (309)
T ss_dssp             CBHHHHHHSTTH-------HHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred             CcHHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence            999999964321       1238999999999999999999999   67  99999999999999999999999999976


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      ..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......            . ........
T Consensus       189 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~------------~-~~~~~~~~  254 (309)
T 3p86_A          189 KASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA------------Q-VVAAVGFK  254 (309)
T ss_dssp             --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH------------H-HHHHHHHS
T ss_pred             ccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------------H-HHHHHHhc
Confidence            53322 2234467899999999999999999999999999999999999999532110            0 11111000


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccCCCCCCC
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVDDPPD  399 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~~~~~~~  399 (453)
                      .      ..    ...+......+.+++.+||+.+|++|||+.++++.|+.......||.
T Consensus       255 ~------~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~  304 (309)
T 3p86_A          255 C------KR----LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP  304 (309)
T ss_dssp             C------CC----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC------
T ss_pred             C------CC----CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCC
Confidence            0      00    11222334568999999999999999999999999998776554443

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.1e-44  Score=368.81  Aligned_cols=256  Identities=25%  Similarity=0.394  Sum_probs=203.3

Q ss_pred             HHhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCC
Q 047276          104 NFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS  183 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gs  183 (453)
                      .+.+.||+|+||+||+|.+.++..||||+++......+.|.+|+.+|++++||||+++++++.  .+..++||||+++|+
T Consensus       187 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~iv~e~~~~gs  264 (452)
T 1fmk_A          187 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS--EEPIYIVTEYMSKGS  264 (452)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSCEEEECCCTTCB
T ss_pred             eeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEc--CCceEEEehhhcCCC
Confidence            345789999999999999988888999999876666788999999999999999999999975  367899999999999


Q ss_pred             hhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCC
Q 047276          184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD  263 (453)
Q Consensus       184 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~  263 (453)
                      |.+++....        ...+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++.....
T Consensus       265 L~~~l~~~~--------~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  333 (452)
T 1fmk_A          265 LLDFLKGET--------GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  333 (452)
T ss_dssp             HHHHHSHHH--------HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             HHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence            999996421        1238999999999999999999999   89999999999999999999999999999876543


Q ss_pred             CCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcCccc
Q 047276          264 QSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLM  342 (453)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (453)
                      .........+++.|+|||.+..+.++.++||||||+++|||++ |+.||.....             ..+...+..+.. 
T Consensus       334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-------------~~~~~~i~~~~~-  399 (452)
T 1fmk_A          334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------------REVLDQVERGYR-  399 (452)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------------HHHHHHHHTTCC-
T ss_pred             ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH-------------HHHHHHHHcCCC-
Confidence            3333344557889999999999999999999999999999999 9999853211             111222222210 


Q ss_pred             ccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccCCCC
Q 047276          343 EIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVDD  396 (453)
Q Consensus       343 ~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~~~~  396 (453)
                            +    ..+..++..+.+++.+||+.+|++|||++++++.|+.......
T Consensus       400 ------~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~  443 (452)
T 1fmk_A          400 ------M----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  443 (452)
T ss_dssp             ------C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             ------C----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence                  1    1222344568999999999999999999999999998765433

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.1e-44  Score=357.29  Aligned_cols=261  Identities=22%  Similarity=0.382  Sum_probs=204.8

Q ss_pred             HhcccCcCCceEEEEEEe--------CCCcEEEEEEecCCCc--cHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeE
Q 047276          105 FQALLGHGSSASVFKGIL--------SDGTSVAVKRINGEEN--GEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRY  173 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~--------~~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~  173 (453)
                      +.+.||+|+||+||+|+.        .++..||||+++....  ..+.+.+|+.+++++ +||||++++++|. ..+..+
T Consensus        85 ~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-~~~~~~  163 (370)
T 2psq_A           85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT-QDGPLY  163 (370)
T ss_dssp             EEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC-SSSSCE
T ss_pred             eeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc-cCCCEE
Confidence            357899999999999985        2356799999976432  345789999999999 8999999999986 566889


Q ss_pred             EEEEecCCCChhhhhccCCCCCC------CCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCC
Q 047276          174 LVYEFIQNGSLDHWIFPTSRRSE------GHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENY  247 (453)
Q Consensus       174 lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~  247 (453)
                      +||||+++|+|.+++........      .......+++..++.++.|++.||+|||+   .+|+||||||+|||++.++
T Consensus       164 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~  240 (370)
T 2psq_A          164 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENN  240 (370)
T ss_dssp             EEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTC
T ss_pred             EEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEECCCC
Confidence            99999999999999976542110      01123458999999999999999999999   8999999999999999999


Q ss_pred             cEEEeeccccccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccc
Q 047276          248 RAVVSDFGLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKW  325 (453)
Q Consensus       248 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~  325 (453)
                      .+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......        
T Consensus       241 ~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~--------  312 (370)
T 2psq_A          241 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--------  312 (370)
T ss_dssp             CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--------
T ss_pred             CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH--------
Confidence            999999999987654322 22234567889999999999999999999999999999999 99998532110        


Q ss_pred             cchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          326 QYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                          . ....+..+...           ..+..+...+.+++.+||+.+|++||++.++++.|+.+..
T Consensus       313 ----~-~~~~~~~~~~~-----------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~  364 (370)
T 2psq_A          313 ----E-LFKLLKEGHRM-----------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  364 (370)
T ss_dssp             ----G-HHHHHHTTCCC-----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----H-HHHHHhcCCCC-----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                0 11122222110           1122334568999999999999999999999999987653

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.3e-44  Score=349.08  Aligned_cols=259  Identities=23%  Similarity=0.315  Sum_probs=208.3

Q ss_pred             ceecHHHHHHHHHHH------------hcccCcCCceEEEEEEeC-CCcEEEEEEecCC-CccHHHHHHHHHHHHhcCCC
Q 047276           91 IKFRSKELEEATDNF------------QALLGHGSSASVFKGILS-DGTSVAVKRINGE-ENGEKEFRSEVAAIASAQHV  156 (453)
Q Consensus        91 ~~~~~~el~~~~~~~------------~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~  156 (453)
                      ..++.+++..++...            .+.||+|+||.||+|+.. +|+.||||++... ....+.+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            457888888888642            257999999999999975 7999999999753 44567799999999999999


Q ss_pred             ceeeEeeEEEecCCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCC
Q 047276          157 NLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDV  236 (453)
Q Consensus       157 niv~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dl  236 (453)
                      ||+++++++. ..+..++||||+++|+|.+++..           ..+++..+..++.|++.||+|||+   .+++||||
T Consensus       103 niv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~-----------~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dl  167 (321)
T 2c30_A          103 NVVEMYKSYL-VGEELWVLMEFLQGGALTDIVSQ-----------VRLNEEQIATVCEAVLQALAYLHA---QGVIHRDI  167 (321)
T ss_dssp             TBCCEEEEEE-ETTEEEEEECCCCSCBHHHHHTT-----------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCC
T ss_pred             CcceEEEEEE-ECCEEEEEEecCCCCCHHHHHHh-----------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCC
Confidence            9999999987 45688999999999999999842           238999999999999999999999   89999999


Q ss_pred             CCCcEEECCCCcEEEeeccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCccccc
Q 047276          237 KPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEH  316 (453)
Q Consensus       237 k~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~  316 (453)
                      ||+|||++.++.+||+|||++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus       168 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~  246 (321)
T 2c30_A          168 KSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP  246 (321)
T ss_dssp             SGGGEEECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred             CHHHEEECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            99999999999999999999987654322 23456799999999999999999999999999999999999999953211


Q ss_pred             CCCCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          317 GNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                                   ......+....     .+.+.    ........+.+++.+||+.||++|||+.++++.
T Consensus       247 -------------~~~~~~~~~~~-----~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          247 -------------VQAMKRLRDSP-----PPKLK----NSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             -------------HHHHHHHHHSS-----CCCCT----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             -------------HHHHHHHhcCC-----CCCcC----ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                         00111111111     11111    112233458899999999999999999999863

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.9e-44  Score=351.30  Aligned_cols=253  Identities=26%  Similarity=0.402  Sum_probs=201.2

Q ss_pred             HhcccCcCCceEEEEEEeC----CCcEEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEe
Q 047276          105 FQALLGHGSSASVFKGILS----DGTSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~----~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      +.+.||+|+||+||+|...    .+..||||+++..  ....+.|.+|+.++++++||||+++++++. .++..++||||
T Consensus        53 i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~  131 (325)
T 3kul_A           53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVT-RGRLAMIVTEY  131 (325)
T ss_dssp             EEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-GGGCCEEEEEC
T ss_pred             EeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-eCCccEEEeeC
Confidence            3578999999999999974    3556999999763  233467999999999999999999999985 56688999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +++|+|.+++....         ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       132 ~~~~~L~~~l~~~~---------~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  199 (325)
T 3kul_A          132 MENGSLDTFLRTHD---------GQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSR  199 (325)
T ss_dssp             CTTCBHHHHHHTTT---------TCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             CCCCcHHHHHHhcc---------cCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccc
Confidence            99999999995432         248999999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCC--ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHh
Q 047276          259 LMSRDQS--RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEK  335 (453)
Q Consensus       259 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  335 (453)
                      .......  .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....             ......
T Consensus       200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-------------~~~~~~  266 (325)
T 3kul_A          200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-------------RDVISS  266 (325)
T ss_dssp             ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH-------------HHHHHH
T ss_pred             ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH-------------HHHHHH
Confidence            7754332  12233456788999999999999999999999999999999 9999853211             111112


Q ss_pred             hhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccCC
Q 047276          336 MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAV  394 (453)
Q Consensus       336 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~~  394 (453)
                      +..+..           ...+......+.+++.+||+.+|++|||+.+|++.|+.....
T Consensus       267 ~~~~~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~  314 (325)
T 3kul_A          267 VEEGYR-----------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS  314 (325)
T ss_dssp             HHTTCC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHcCCC-----------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence            221110           011223345689999999999999999999999999987654

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=4.7e-44  Score=341.21  Aligned_cols=251  Identities=24%  Similarity=0.376  Sum_probs=203.7

Q ss_pred             HhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCCh
Q 047276          105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL  184 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL  184 (453)
                      +.+.||+|+||+||++...++..||+|++.......+++.+|+.++.+++||||+++++++. ..+..++||||+++|+|
T Consensus        28 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L  106 (283)
T 3gen_A           28 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT-KQRPIFIITEYMANGCL  106 (283)
T ss_dssp             EEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSSEEEEECCCTTCBH
T ss_pred             hHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEe-cCCCeEEEEeccCCCcH
Confidence            45789999999999999988889999999887777788999999999999999999999975 56688999999999999


Q ss_pred             hhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCCC
Q 047276          185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ  264 (453)
Q Consensus       185 ~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~  264 (453)
                      .+++....         ..+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.......
T Consensus       107 ~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  174 (283)
T 3gen_A          107 LNYLREMR---------HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  174 (283)
T ss_dssp             HHHHHCGG---------GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred             HHHHHHhc---------cCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence            99996432         238999999999999999999999   899999999999999999999999999998764432


Q ss_pred             CceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcCcccc
Q 047276          265 SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLME  343 (453)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (453)
                      ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......             .....+..+..  
T Consensus       175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~-------------~~~~~~~~~~~--  239 (283)
T 3gen_A          175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-------------ETAEHIAQGLR--  239 (283)
T ss_dssp             HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-------------HHHHHHHTTCC--
T ss_pred             cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh-------------HHHHHHhcccC--
Confidence            222334456788999999999999999999999999999998 99998532210             11111211110  


Q ss_pred             cccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          344 IVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       344 ~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                         .      ..+......+.+++.+||+.+|++|||+.++++.|++..
T Consensus       240 ---~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~  279 (283)
T 3gen_A          240 ---L------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM  279 (283)
T ss_dssp             ---C------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---C------CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence               0      011122345889999999999999999999999998754

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.6e-44  Score=350.71  Aligned_cols=241  Identities=22%  Similarity=0.327  Sum_probs=197.4

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.+.||+|+||.||+|.. .+|+.||||++....   ...+.+.+|+.+++.++||||+++++++. ..+..++||||++
T Consensus        19 ~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-~~~~~~lv~e~~~   97 (328)
T 3fe3_A           19 LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE-TEKTLYLIMEYAS   97 (328)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-CSSEEEEEECCCT
T ss_pred             EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-ECCEEEEEEECCC
Confidence            357899999999999996 679999999996532   33456889999999999999999999976 5668899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++...
T Consensus        98 ~~~L~~~l~~~~----------~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  164 (328)
T 3fe3_A           98 GGEVFDYLVAHG----------RMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEF  164 (328)
T ss_dssp             TCBHHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred             CCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence            999999996442          38999999999999999999999   89999999999999999999999999999876


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCC-ccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVS-EKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      ....  ......||+.|+|||.+.+..+. .++|||||||++|||++|+.||....            . ......+..+
T Consensus       165 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------------~-~~~~~~i~~~  229 (328)
T 3fe3_A          165 TVGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------------L-KELRERVLRG  229 (328)
T ss_dssp             SSSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS------------H-HHHHHHHHHC
T ss_pred             CCCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC------------H-HHHHHHHHhC
Confidence            5432  23456799999999999887765 79999999999999999999995321            0 1112222222


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ..            ..+...+..+.+++.+||+.||++|||++++++
T Consensus       230 ~~------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          230 KY------------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             CC------------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             CC------------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            11            112223445889999999999999999999875

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=5.5e-44  Score=343.53  Aligned_cols=257  Identities=21%  Similarity=0.349  Sum_probs=196.8

Q ss_pred             HhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHh--cCCCceeeEeeEEEec---CCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIAS--AQHVNLVRLLGYCVVP---GGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~---~~~~~lv~e~~  179 (453)
                      +.+.||+|+||+||+|+. +|+.||||++...  ....+..|.+++..  ++||||+++++++...   ....++||||+
T Consensus        12 ~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~   88 (301)
T 3q4u_A           12 LLECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYH   88 (301)
T ss_dssp             EEEEEEECSSEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred             EEEeeccCCCcEEEEEEE-CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhc
Confidence            357899999999999998 5899999998643  44566778877777  7999999999987643   23478999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhcccc--------ccCCCceeccCCCCCcEEECCCCcEEE
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH--------NDCRSRVLHLDVKPENILLDENYRAVV  251 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh--------~~~~~~ivH~Dlk~~NiLl~~~~~~kl  251 (453)
                      ++|+|.+++..           ..+++..+++++.|++.||+|||        +   .+|+||||||+|||++.++.+||
T Consensus        89 ~~g~L~~~l~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl  154 (301)
T 3q4u_A           89 EMGSLYDYLQL-----------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCI  154 (301)
T ss_dssp             TTCBHHHHHTT-----------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEE
T ss_pred             cCCCHHHHHhh-----------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEE
Confidence            99999999942           23899999999999999999999        6   89999999999999999999999


Q ss_pred             eeccccccccCCCCce---eeeccCCccccchhhhhcC------CCCccccchhHHHHHHHHHcC----------CCCCc
Q 047276          252 SDFGLSKLMSRDQSRC---ITTIRGTRGYLAPEWILEQ------GVSEKCDIYSYGMVLLELTGG----------RRNVS  312 (453)
Q Consensus       252 ~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~sDV~S~Gvil~elltG----------~~p~~  312 (453)
                      +|||+++.........   .....||+.|+|||.+.+.      .++.++||||||+++|||++|          +.||.
T Consensus       155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~  234 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY  234 (301)
T ss_dssp             CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence            9999998765443321   2334799999999999876      455799999999999999999          66664


Q ss_pred             ccccCCCCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 047276          313 LIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR  391 (453)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~  391 (453)
                      ........       . ............    .+.+.. ...+......+.+++.+||+.||++|||+.+|++.|+++
T Consensus       235 ~~~~~~~~-------~-~~~~~~~~~~~~----~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          235 DVVPNDPS-------F-EDMRKVVCVDQQ----RPNIPN-RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TTSCSSCC-------H-HHHHHHHTTSCC----CCCCCG-GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccCCCCcc-------h-hhhhHHHhccCC----CCCCCh-hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            22211110       0 011111111110    111110 112345678899999999999999999999999999863

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=7.4e-44  Score=362.43  Aligned_cols=247  Identities=31%  Similarity=0.453  Sum_probs=201.8

Q ss_pred             HhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCCh
Q 047276          105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL  184 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL  184 (453)
                      +.+.||+|+||.||+|.+. |+.||||+++... ..+.|.+|+.+|++++||||++++++|.......++||||+++|+|
T Consensus       197 ~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L  274 (450)
T 1k9a_A          197 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL  274 (450)
T ss_dssp             EEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBH
T ss_pred             EEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcH
Confidence            3478999999999999986 7899999998654 4567999999999999999999999988666688999999999999


Q ss_pred             hhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCCC
Q 047276          185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ  264 (453)
Q Consensus       185 ~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~  264 (453)
                      .+++.....        ..+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++......
T Consensus       275 ~~~l~~~~~--------~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  343 (450)
T 1k9a_A          275 VDYLRSRGR--------SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  343 (450)
T ss_dssp             HHHHHHHCT--------TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             HHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence            999975422        237999999999999999999999   899999999999999999999999999998543221


Q ss_pred             CceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcCcccc
Q 047276          265 SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLME  343 (453)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (453)
                          ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......             +...+..+..  
T Consensus       344 ----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-------------~~~~i~~~~~--  404 (450)
T 1k9a_A          344 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------------VVPRVEKGYK--  404 (450)
T ss_dssp             -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-------------HHHHHHTTCC--
T ss_pred             ----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------------HHHHHHcCCC--
Confidence                22357889999999999999999999999999999998 999995322110             1122222211  


Q ss_pred             cccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          344 IVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       344 ~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                           +    ..+..++..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       405 -----~----~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~  444 (450)
T 1k9a_A          405 -----M----DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR  444 (450)
T ss_dssp             -----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----C----CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                 1    122234456899999999999999999999999998754

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2e-44  Score=346.67  Aligned_cols=243  Identities=23%  Similarity=0.377  Sum_probs=198.3

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecC-CCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCC
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRING-EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS  183 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gs  183 (453)
                      .+.||+|+||+||+|.. .+|+.||||++.. .....+.+.+|+.+++.++||||+++++++. .++..++||||+++|+
T Consensus        25 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~~lv~e~~~~~~  103 (297)
T 3fxz_A           25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-VGDELWVVMEYLAGGS  103 (297)
T ss_dssp             CEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-ETTEEEEEEECCTTCB
T ss_pred             eeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEE-ECCEEEEEEECCCCCC
Confidence            47899999999999995 5789999999865 3345667899999999999999999999987 4568899999999999


Q ss_pred             hhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCC
Q 047276          184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD  263 (453)
Q Consensus       184 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~  263 (453)
                      |.+++...           .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++......
T Consensus       104 L~~~~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (297)
T 3fxz_A          104 LTDVVTET-----------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (297)
T ss_dssp             HHHHHHHS-----------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             HHHHHhhc-----------CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence            99999532           38999999999999999999999   89999999999999999999999999999876543


Q ss_pred             CCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcccc
Q 047276          264 QSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLME  343 (453)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (453)
                      .. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......            .........+.   
T Consensus       170 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------------~~~~~~~~~~~---  233 (297)
T 3fxz_A          170 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------------RALYLIATNGT---  233 (297)
T ss_dssp             TC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------------HHHHHHHHHCS---
T ss_pred             cc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------------HHHHHHHhCCC---
Confidence            32 234567999999999999999999999999999999999999999532110            00111111111   


Q ss_pred             cccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          344 IVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       344 ~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                         +.    ...+......+.+++.+||+.||++|||+.++++
T Consensus       234 ---~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          234 ---PE----LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             ---CC----CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---CC----CCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence               00    1122334456889999999999999999999875

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1e-44  Score=360.51  Aligned_cols=251  Identities=24%  Similarity=0.338  Sum_probs=200.8

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCCc--cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEEN--GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      +.+.||+|+||+||+|.+. +++.||||.++....  ..+.|.+|+.++++++||||++++|+|. ..+..++||||+++
T Consensus       118 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~~~lv~e~~~~  196 (377)
T 3cbl_A          118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-QKQPIYIVMELVQG  196 (377)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC-SSSSCEEEEECCTT
T ss_pred             EeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-cCCCcEEEEEcCCC
Confidence            4578999999999999975 789999999875432  2346889999999999999999999986 55688999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      |+|.+++....         ..+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++...
T Consensus       197 g~L~~~l~~~~---------~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~  264 (377)
T 3cbl_A          197 GDFLTFLRTEG---------ARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEA  264 (377)
T ss_dssp             CBHHHHHHHHG---------GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred             CCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence            99999996432         238999999999999999999999   899999999999999999999999999998654


Q ss_pred             CCCCce-eeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          262 RDQSRC-ITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       262 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      ...... .....+++.|+|||.+..+.++.++||||||+++|||++ |+.||.....             ......+..+
T Consensus       265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~-------------~~~~~~~~~~  331 (377)
T 3cbl_A          265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-------------QQTREFVEKG  331 (377)
T ss_dssp             TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH-------------HHHHHHHHTT
T ss_pred             CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------------HHHHHHHHcC
Confidence            321111 112235678999999999999999999999999999998 9999853211             1122222222


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      ..       +    ..+..++..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       332 ~~-------~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~  373 (377)
T 3cbl_A          332 GR-------L----PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR  373 (377)
T ss_dssp             CC-------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CC-------C----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            11       1    112233456889999999999999999999999998753

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.8e-44  Score=358.17  Aligned_cols=253  Identities=25%  Similarity=0.398  Sum_probs=191.2

Q ss_pred             HHhcccCcCCceEEEEEEeC----CCcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          104 NFQALLGHGSSASVFKGILS----DGTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~----~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      .+.+.||+|+||.||+|+..    ++..||||.++...  ...+.|.+|+.++++++||||++++|+|. ..+..++|||
T Consensus        48 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e  126 (373)
T 2qol_A           48 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT-KSKPVMIVTE  126 (373)
T ss_dssp             CCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSSCEEEEE
T ss_pred             eeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-eCCceEEEEe
Confidence            34579999999999999864    57789999997532  33457999999999999999999999986 5668899999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |+++|+|.+++....         ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus       127 ~~~~~sL~~~l~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  194 (373)
T 2qol_A          127 YMENGSLDSFLRKHD---------AQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLG  194 (373)
T ss_dssp             CCTTCBHHHHHHTTT---------TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred             CCCCCcHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccc
Confidence            999999999996432         248999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCc--eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHH
Q 047276          258 KLMSRDQSR--CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNE  334 (453)
Q Consensus       258 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  334 (453)
                      +........  ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....             .....
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-------------~~~~~  261 (373)
T 2qol_A          195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-------------QDVIK  261 (373)
T ss_dssp             -------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-------------HHHHH
T ss_pred             cccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-------------HHHHH
Confidence            876543221  1222345778999999999999999999999999999998 9999853211             11111


Q ss_pred             hhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          335 KMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       335 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                      .+..+.       ..    ..+......+.+++.+||+.+|++||++.+|++.|+....
T Consensus       262 ~i~~~~-------~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  309 (373)
T 2qol_A          262 AVDEGY-------RL----PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR  309 (373)
T ss_dssp             HHHTTE-------EC----CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHcCC-------CC----CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence            222111       01    1122334568999999999999999999999999987654

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=8.2e-45  Score=358.33  Aligned_cols=264  Identities=24%  Similarity=0.398  Sum_probs=205.8

Q ss_pred             HHHhcccCcCCceEEEEEEe------CCCcEEEEEEecCCCc--cHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeE
Q 047276          103 DNFQALLGHGSSASVFKGIL------SDGTSVAVKRINGEEN--GEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRY  173 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~------~~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~  173 (453)
                      +.+.+.||+|+||.||+|.+      .+++.||||+++....  ..+.+.+|+.++.++ +||||++++++|...+...+
T Consensus        24 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~  103 (359)
T 3vhe_A           24 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM  103 (359)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCE
T ss_pred             eeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceE
Confidence            34468999999999999973      3467899999976432  335699999999999 79999999999886666789


Q ss_pred             EEEEecCCCChhhhhccCCCCCC--------------------------------------------------------C
Q 047276          174 LVYEFIQNGSLDHWIFPTSRRSE--------------------------------------------------------G  197 (453)
Q Consensus       174 lv~e~~~~gsL~~~l~~~~~~~~--------------------------------------------------------~  197 (453)
                      +||||+++|+|.+++........                                                        .
T Consensus       104 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  183 (359)
T 3vhe_A          104 VIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPE  183 (359)
T ss_dssp             EEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccccc
Confidence            99999999999999976542100                                                        0


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCCCC-ceeeeccCCcc
Q 047276          198 HYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQS-RCITTIRGTRG  276 (453)
Q Consensus       198 ~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~  276 (453)
                      ......+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++........ .......||+.
T Consensus       184 ~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~  260 (359)
T 3vhe_A          184 DLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK  260 (359)
T ss_dssp             CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGG
T ss_pred             chhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCce
Confidence            0012238999999999999999999999   8999999999999999999999999999987644332 23345668899


Q ss_pred             ccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcCcccccccccccCCCCC
Q 047276          277 YLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGI  355 (453)
Q Consensus       277 y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  355 (453)
                      |+|||.+.+..++.++||||||+++|||++ |+.||......            .........+...           ..
T Consensus       261 y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------------~~~~~~~~~~~~~-----------~~  317 (359)
T 3vhe_A          261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------------EEFCRRLKEGTRM-----------RA  317 (359)
T ss_dssp             GCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS------------HHHHHHHHHTCCC-----------CC
T ss_pred             eEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh------------HHHHHHHHcCCCC-----------CC
Confidence            999999999999999999999999999998 99999532211            1122222222111           11


Q ss_pred             cHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          356 DETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       356 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      +......+.+++..||+.+|++|||+.++++.|+...
T Consensus       318 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  354 (359)
T 3vhe_A          318 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  354 (359)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            1223345889999999999999999999999998754

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.7e-43  Score=339.70  Aligned_cols=259  Identities=24%  Similarity=0.333  Sum_probs=199.2

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCCC----ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      +.+.||+|+||.||++.. .+++.||+|.+....    ...+.|.+|+.++.+++||||+++++++. .++..++||||+
T Consensus        15 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-~~~~~~lv~e~~   93 (294)
T 4eqm_A           15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDE-EDDCYYLVMEYI   93 (294)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEE-CSSEEEEEEECC
T ss_pred             EEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeee-eCCeEEEEEeCC
Confidence            357899999999999995 468899999985422    22357889999999999999999999976 566889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ++|+|.+++...          +.+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++..
T Consensus        94 ~g~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~  160 (294)
T 4eqm_A           94 EGPTLSEYIESH----------GPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKA  160 (294)
T ss_dssp             CSCBHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTT
T ss_pred             CCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccc
Confidence            999999999643          238999999999999999999999   8999999999999999999999999999987


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      .............||+.|+|||.+.+..++.++||||||+++|||++|+.||......            ......... 
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------------~~~~~~~~~-  227 (294)
T 4eqm_A          161 LSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------------SIAIKHIQD-  227 (294)
T ss_dssp             C-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------------HHHHHHHSS-
T ss_pred             cccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------------HHHHHHhhc-
Confidence            6544433344567999999999999999999999999999999999999999532110            001111111 


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHhccccCCCCC
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRP-SMARVVEMLEGRVAVDDP  397 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-s~~~v~~~L~~~~~~~~~  397 (453)
                      ..... ...      ...+.+..+.+++.+|++.+|++|| ++.++.+.|+........
T Consensus       228 ~~~~~-~~~------~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~  279 (294)
T 4eqm_A          228 SVPNV-TTD------VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA  279 (294)
T ss_dssp             CCCCH-HHH------SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred             cCCCc-chh------cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence            11000 000      1112345688999999999999998 999999999886654433

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-43  Score=342.00  Aligned_cols=269  Identities=19%  Similarity=0.238  Sum_probs=209.4

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCC-CeEEEEEecCC
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGG-PRYLVYEFIQN  181 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-~~~lv~e~~~~  181 (453)
                      .++||+|+||+||+|... +|+.||||+++..  ....+.+.+|+.++++++||||+++++++..... ..++||||+++
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~   93 (319)
T 4euu_A           14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC   93 (319)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTT
T ss_pred             EEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCC
Confidence            578999999999999975 5899999999752  2345778899999999999999999999875433 67999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEE----CCCCcEEEeecccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILL----DENYRAVVSDFGLS  257 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl----~~~~~~kl~DfGla  257 (453)
                      |+|.+++.....       ...+++..++.++.|++.||+|||+   .+|+||||||+|||+    +.++.+||+|||++
T Consensus        94 ~~L~~~l~~~~~-------~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           94 GSLYTVLEEPSN-------AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             CBHHHHHHSGGG-------TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             CCHHHHHHHhcc-------ccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            999999965432       2238999999999999999999999   899999999999999    88889999999999


Q ss_pred             ccccCCCCceeeeccCCccccchhhhh--------cCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchh
Q 047276          258 KLMSRDQSRCITTIRGTRGYLAPEWIL--------EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFP  329 (453)
Q Consensus       258 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~  329 (453)
                      +.......  .....||+.|+|||.+.        +..++.++|||||||++|||++|+.||.........        .
T Consensus       164 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--------~  233 (319)
T 4euu_A          164 RELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--------K  233 (319)
T ss_dssp             EECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--------H
T ss_pred             eecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--------H
Confidence            87654332  23457999999999986        467899999999999999999999999643221111        0


Q ss_pred             HHHHHhhhc---Cccc---------ccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccCC
Q 047276          330 KIVNEKMKE---GKLM---------EIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAV  394 (453)
Q Consensus       330 ~~~~~~~~~---~~~~---------~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~~  394 (453)
                      .........   ....         -.....+.............+.+++.+||+.||++|||++|+++..++....
T Consensus       234 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~  310 (319)
T 4euu_A          234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (319)
T ss_dssp             HHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred             HHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence            111111110   0000         0011122222345678888899999999999999999999999999876543

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=6e-44  Score=370.53  Aligned_cols=255  Identities=25%  Similarity=0.392  Sum_probs=207.7

Q ss_pred             HHhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCC
Q 047276          104 NFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS  183 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gs  183 (453)
                      .+.++||+|+||+||+|.+.++..||||+++......+.|.+|+.+|++++||||++++++|.  .+..++||||+++|+
T Consensus       270 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~lv~e~~~~gs  347 (535)
T 2h8h_A          270 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS--EEPIYIVTEYMSKGS  347 (535)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSCEEEECCCTTEE
T ss_pred             hhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEe--eccceEeeehhcCCc
Confidence            345789999999999999988888999999876666788999999999999999999999975  367899999999999


Q ss_pred             hhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCC
Q 047276          184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD  263 (453)
Q Consensus       184 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~  263 (453)
                      |.+++....        ...+++..++.++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++.....
T Consensus       348 L~~~l~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  416 (535)
T 2h8h_A          348 LLDFLKGET--------GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  416 (535)
T ss_dssp             HHHHHSHHH--------HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred             HHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence            999996431        1238999999999999999999999   89999999999999999999999999999876432


Q ss_pred             CCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcCccc
Q 047276          264 QSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLM  342 (453)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (453)
                      .........++..|+|||.+..+.++.++|||||||++|||++ |+.||.....             ..+...+..+.. 
T Consensus       417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-------------~~~~~~i~~~~~-  482 (535)
T 2h8h_A          417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------------REVLDQVERGYR-  482 (535)
T ss_dssp             HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-------------HHHHHHHHTTCC-
T ss_pred             ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------------HHHHHHHHcCCC-
Confidence            2122233456789999999999999999999999999999999 9999853211             111222222211 


Q ss_pred             ccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccCCC
Q 047276          343 EIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVD  395 (453)
Q Consensus       343 ~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~~~  395 (453)
                            +    ..+..+...+.+++.+||+.||++|||+.+|++.|+......
T Consensus       483 ------~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          483 ------M----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             ------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             ------C----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence                  1    112233456889999999999999999999999999876443

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.2e-44  Score=343.05  Aligned_cols=253  Identities=27%  Similarity=0.401  Sum_probs=208.4

Q ss_pred             HHhcccCcCCceEEEEEEeC-CCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCC
Q 047276          104 NFQALLGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      .+.+.||+|+||+||+|... ++..||+|.+.......+.+.+|+.++++++||||+++++++. ..+..++||||+++|
T Consensus        16 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~~v~e~~~~~   94 (288)
T 3kfa_A           16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-REPPFYIITEFMTYG   94 (288)
T ss_dssp             EEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSSEEEEEECCTTE
T ss_pred             eEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-cCCCEEEEEEcCCCC
Confidence            34678999999999999975 4789999999877777788999999999999999999999975 566889999999999


Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccC
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR  262 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~  262 (453)
                      +|.+++.....        ..+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.....
T Consensus        95 ~L~~~~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  163 (288)
T 3kfa_A           95 NLLDYLRECNR--------QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  163 (288)
T ss_dssp             EHHHHHHHCCT--------TTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred             cHHHHHHhccc--------CCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence            99999965432        348999999999999999999999   7999999999999999999999999999987765


Q ss_pred             CCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcCcc
Q 047276          263 DQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKL  341 (453)
Q Consensus       263 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (453)
                      ..........+|+.|+|||.+.+..++.++||||||+++|||++ |..||.......             .......+..
T Consensus       164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~-------------~~~~~~~~~~  230 (288)
T 3kfa_A          164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------------VYELLEKDYR  230 (288)
T ss_dssp             SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-------------HHHHHHTTCC
T ss_pred             CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------------HHHHHhccCC
Confidence            54444445567889999999999999999999999999999999 999985322110             1111111100


Q ss_pred             cccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          342 MEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       342 ~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                                 ...+...+..+.+++.+|++.||++|||+.++++.|+...
T Consensus       231 -----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~  270 (288)
T 3kfa_A          231 -----------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  270 (288)
T ss_dssp             -----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----------CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence                       0112233456899999999999999999999999998754

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.1e-43  Score=346.10  Aligned_cols=251  Identities=22%  Similarity=0.373  Sum_probs=195.7

Q ss_pred             HhcccCcCCceEEEEEEeC-CCc----EEEEEEecC--CCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          105 FQALLGHGSSASVFKGILS-DGT----SVAVKRING--EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~----~vavK~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      +.++||+|+||+||+|+.. +++    .||+|.+..  .....+.|.+|+.++++++||||++++++|..  +..++++|
T Consensus        19 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e   96 (327)
T 3poz_A           19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--STVQLITQ   96 (327)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES--SSEEEEEE
T ss_pred             cceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeEEEEE
Confidence            3578999999999999953 444    368888764  23456789999999999999999999999873  35789999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |+++|+|.+++....         ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus        97 ~~~~g~L~~~l~~~~---------~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a  164 (327)
T 3poz_A           97 LMPFGCLLDYVREHK---------DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLA  164 (327)
T ss_dssp             CCTTCBHHHHHHHST---------TSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred             ecCCCcHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcce
Confidence            999999999996543         238999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHh
Q 047276          258 KLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEK  335 (453)
Q Consensus       258 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  335 (453)
                      +....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......             ....
T Consensus       165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------------~~~~  231 (327)
T 3poz_A          165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------------ISSI  231 (327)
T ss_dssp             HHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------------HHHH
T ss_pred             eEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH-------------HHHH
Confidence            87754332 22334567889999999999999999999999999999999 999995322110             1112


Q ss_pred             hhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          336 MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       336 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                      +..+..           ...+......+.+++.+||+.+|++||++.++++.|+....
T Consensus       232 ~~~~~~-----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          232 LEKGER-----------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             HHTTCC-----------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             HHcCCC-----------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            221110           01122334568899999999999999999999999987643

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.5e-43  Score=336.92  Aligned_cols=252  Identities=25%  Similarity=0.408  Sum_probs=205.8

Q ss_pred             HhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCCh
Q 047276          105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL  184 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL  184 (453)
                      +.+.||+|+||.||+|...++..||||.+.......+.+.+|+.++++++||||+++++++.  .+..++||||+++++|
T Consensus        17 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~v~e~~~~~~L   94 (279)
T 1qpc_A           17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT--QEPIYIITEYMENGSL   94 (279)
T ss_dssp             EEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSCEEEEECCTTCBH
T ss_pred             heeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc--CCCcEEEEecCCCCCH
Confidence            45789999999999999988889999999877667788999999999999999999999874  4568999999999999


Q ss_pred             hhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCCC
Q 047276          185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ  264 (453)
Q Consensus       185 ~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~  264 (453)
                      .+++....        ...+++..++.++.|++.||+|||+   .+++||||||+||++++++.+||+|||++.......
T Consensus        95 ~~~l~~~~--------~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T 1qpc_A           95 VDFLKTPS--------GIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (279)
T ss_dssp             HHHTTSHH--------HHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             HHHHhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence            99995321        1248999999999999999999999   899999999999999999999999999998775443


Q ss_pred             CceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcCcccc
Q 047276          265 SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLME  343 (453)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (453)
                      ........+++.|+|||.+.++.++.++||||||+++|||++ |+.||.....            .. ....+..+..  
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------------~~-~~~~~~~~~~--  228 (279)
T 1qpc_A          164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN------------PE-VIQNLERGYR--  228 (279)
T ss_dssp             EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH------------HH-HHHHHHTTCC--
T ss_pred             cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH------------HH-HHHHHhcccC--
Confidence            332334456789999999998889999999999999999999 9999853211            01 1111221110  


Q ss_pred             cccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          344 IVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       344 ~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                         .      ..+......+.+++.+|++.+|++|||++++++.|++...
T Consensus       229 ---~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  269 (279)
T 1qpc_A          229 ---M------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (279)
T ss_dssp             ---C------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---C------CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence               0      0112233568899999999999999999999999987643

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=6.1e-44  Score=342.59  Aligned_cols=265  Identities=23%  Similarity=0.314  Sum_probs=199.3

Q ss_pred             HhcccCcCCceEEEEEEe-----CCCcEEEEEEecCCC-ccHHHHHHHHHHHHhcCCCceeeEeeEEEec-CCCeEEEEE
Q 047276          105 FQALLGHGSSASVFKGIL-----SDGTSVAVKRINGEE-NGEKEFRSEVAAIASAQHVNLVRLLGYCVVP-GGPRYLVYE  177 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~~lv~e  177 (453)
                      +.+.||+|+||+||++++     .+++.||||++.... ...+.+.+|+.++++++||||++++++|... ....++|||
T Consensus        14 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   93 (295)
T 3ugc_A           14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME   93 (295)
T ss_dssp             EEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEE
T ss_pred             hhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEE
Confidence            457899999999999984     358899999997643 3346789999999999999999999998643 245799999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |+++|+|.+++....         ..+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++
T Consensus        94 ~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           94 YLPYGSLRDYLQKHK---------ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             CCTTCBHHHHHHHCG---------GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             eCCCCCHHHHHHhcc---------cccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence            999999999996542         238999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCC--ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCC---CCcccccchhHHH
Q 047276          258 KLMSRDQS--RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGND---KSKNKWQYFPKIV  332 (453)
Q Consensus       258 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~---~~~~~~~~~~~~~  332 (453)
                      ........  .......++..|+|||.+.+..++.++||||||+++|||++|..|+........   .............
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (295)
T 3ugc_A          162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  241 (295)
T ss_dssp             C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence            87654322  222334577789999999999999999999999999999999998853211100   0000000000011


Q ss_pred             HHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          333 NEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       333 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      ......+.       +    ...+...+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       242 ~~~~~~~~-------~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~  290 (295)
T 3ugc_A          242 IELLKNNG-------R----LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  290 (295)
T ss_dssp             HHHHHTTC-------C----CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHhccC-------c----CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            11111111       0    1122334556899999999999999999999999998754

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-43  Score=352.49  Aligned_cols=255  Identities=25%  Similarity=0.410  Sum_probs=192.5

Q ss_pred             HhcccCcCCceEEEEEEeC--CC--cEEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEe
Q 047276          105 FQALLGHGSSASVFKGILS--DG--TSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~--~g--~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      +.+.||+|+||+||+|.+.  ++  ..||||.++..  ....+.|.+|+.++++++||||++++++|...++..++||||
T Consensus        93 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~  172 (373)
T 3c1x_A           93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY  172 (373)
T ss_dssp             EEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEEC
T ss_pred             cCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEEC
Confidence            3578999999999999863  22  36899998753  334567999999999999999999999987666688999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +++|+|.+++....         ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       173 ~~~g~L~~~l~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~  240 (373)
T 3c1x_A          173 MKHGDLRNFIRNET---------HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR  240 (373)
T ss_dssp             CTTCBHHHHHHCTT---------CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             CCCCCHHHHHhhcc---------cCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccc
Confidence            99999999996432         238899999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCC---ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHH
Q 047276          259 LMSRDQS---RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNE  334 (453)
Q Consensus       259 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  334 (453)
                      .......   .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||.......             ...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~-------------~~~  307 (373)
T 3c1x_A          241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------------ITV  307 (373)
T ss_dssp             -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC-------------HHH
T ss_pred             cccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH-------------HHH
Confidence            6643321   12234567889999999999999999999999999999999 666774321110             111


Q ss_pred             hhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccCCC
Q 047276          335 KMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVD  395 (453)
Q Consensus       335 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~~~  395 (453)
                      ....+..       ..    .+......+.+++.+||+.+|++|||+.++++.|+......
T Consensus       308 ~~~~~~~-------~~----~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~  357 (373)
T 3c1x_A          308 YLLQGRR-------LL----QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  357 (373)
T ss_dssp             HHHTTCC-------CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             HHHcCCC-------CC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            1111211       00    11223345889999999999999999999999999876443

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2e-43  Score=333.64  Aligned_cols=251  Identities=25%  Similarity=0.409  Sum_probs=205.8

Q ss_pred             HhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCCh
Q 047276          105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL  184 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL  184 (453)
                      +.+.||+|+||.||++...+++.||+|.+.......+.+.+|+.++++++||||+++++++. ..+..++||||+++++|
T Consensus        12 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L   90 (267)
T 3t9t_A           12 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL-EQAPICLVTEFMEHGCL   90 (267)
T ss_dssp             EEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSSCEEEECCCTTCBH
T ss_pred             eeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEc-cCCCeEEEEeCCCCCcH
Confidence            35789999999999999988899999999887767788999999999999999999999986 55688999999999999


Q ss_pred             hhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCCC
Q 047276          185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ  264 (453)
Q Consensus       185 ~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~  264 (453)
                      .+++....         ..+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.......
T Consensus        91 ~~~~~~~~---------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  158 (267)
T 3t9t_A           91 SDYLRTQR---------GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  158 (267)
T ss_dssp             HHHHHHTT---------TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             HHHHhhCc---------ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence            99996432         238999999999999999999999   899999999999999999999999999998764332


Q ss_pred             CceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcCcccc
Q 047276          265 SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLME  343 (453)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (453)
                      ........+++.|+|||.+....++.++||||||+++|||++ |+.||.....            .. ....+..+..  
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------------~~-~~~~i~~~~~--  223 (267)
T 3t9t_A          159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------------SE-VVEDISTGFR--  223 (267)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------------HH-HHHHHHTTCC--
T ss_pred             ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH------------HH-HHHHHhcCCc--
Confidence            222233457788999999998999999999999999999999 8999853211            01 1112222110  


Q ss_pred             cccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          344 IVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       344 ~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                         .      ..+......+.+++.+|++.+|++||++.++++.|++..
T Consensus       224 ---~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (267)
T 3t9t_A          224 ---L------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  263 (267)
T ss_dssp             ---C------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---C------CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence               0      011123345889999999999999999999999998764

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.8e-43  Score=349.83  Aligned_cols=268  Identities=24%  Similarity=0.362  Sum_probs=209.0

Q ss_pred             HHHHhcccCcCCceEEEEEEeC--------CCcEEEEEEecCCCc--cHHHHHHHHHHHHhc-CCCceeeEeeEEEecCC
Q 047276          102 TDNFQALLGHGSSASVFKGILS--------DGTSVAVKRINGEEN--GEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGG  170 (453)
Q Consensus       102 ~~~~~~~lG~G~fG~Vy~~~~~--------~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~  170 (453)
                      .+.+.+.||+|+||+||+|+..        ++..||||+++....  ....+.+|+++++++ +||||++++++|. .++
T Consensus        70 ~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-~~~  148 (382)
T 3tt0_A           70 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT-QDG  148 (382)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred             heEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec-cCC
Confidence            3344688999999999999852        235799999976432  336789999999999 8999999999986 566


Q ss_pred             CeEEEEEecCCCChhhhhccCCCCC------CCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEEC
Q 047276          171 PRYLVYEFIQNGSLDHWIFPTSRRS------EGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD  244 (453)
Q Consensus       171 ~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~  244 (453)
                      ..++||||+++|+|.+++.......      ........+++..++.++.|++.||+|||+   .+|+||||||+|||++
T Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~  225 (382)
T 3tt0_A          149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT  225 (382)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEC
T ss_pred             ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEEc
Confidence            8899999999999999997654211      011123459999999999999999999999   8999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCc
Q 047276          245 ENYRAVVSDFGLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSK  322 (453)
Q Consensus       245 ~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~  322 (453)
                      .++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....      
T Consensus       226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~------  299 (382)
T 3tt0_A          226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------  299 (382)
T ss_dssp             TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------
T ss_pred             CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH------
Confidence            999999999999987654322 22334567889999999999999999999999999999999 9999853211      


Q ss_pred             ccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccCCCCC
Q 047276          323 NKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVDDP  397 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~~~~~  397 (453)
                             ......+..+...           ..+......+.+++.+||+.+|++|||+.+|++.|+.+......
T Consensus       300 -------~~~~~~~~~~~~~-----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~  356 (382)
T 3tt0_A          300 -------EELFKLLKEGHRM-----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN  356 (382)
T ss_dssp             -------HHHHHHHHTTCCC-----------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred             -------HHHHHHHHcCCCC-----------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence                   1122222222111           11122344589999999999999999999999999987654433

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=7.3e-44  Score=353.05  Aligned_cols=259  Identities=26%  Similarity=0.348  Sum_probs=203.6

Q ss_pred             HHhcccCcCCceEEEEEEeC------CCcEEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEE
Q 047276          104 NFQALLGHGSSASVFKGILS------DGTSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLV  175 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~------~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv  175 (453)
                      .+.+.||+|+||+||+|++.      +++.||||+++..  ......+.+|+.++++++||||+++++++. .....++|
T Consensus        74 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~~~~~lv  152 (367)
T 3l9p_A           74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL-QSLPRFIL  152 (367)
T ss_dssp             EEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSSCEEE
T ss_pred             EEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCCCCEEE
Confidence            34578999999999999953      4668999999753  334457899999999999999999999976 56678999


Q ss_pred             EEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCC---cEEEe
Q 047276          176 YEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENY---RAVVS  252 (453)
Q Consensus       176 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~---~~kl~  252 (453)
                      |||+++|+|.+++........   ....+++..++.++.|++.||+|||+   .+|+||||||+|||++.++   .+||+
T Consensus       153 ~e~~~~g~L~~~l~~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          153 LELMAGGDLKSFLRETRPRPS---QPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EECCTTEEHHHHHHHHSCCSS---SCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEeCCCCCHHHHHHhhccccC---ccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEEC
Confidence            999999999999975543211   22458999999999999999999999   8999999999999999554   59999


Q ss_pred             eccccccccCCC-CceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhH
Q 047276          253 DFGLSKLMSRDQ-SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPK  330 (453)
Q Consensus       253 DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  330 (453)
                      |||+++...... ........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.....             .
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~-------------~  293 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-------------Q  293 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------------H
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-------------H
Confidence            999998653222 222344568999999999999999999999999999999998 9999853211             1


Q ss_pred             HHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          331 IVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       331 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                      .....+..+...           ..+......+.+++.+||+.+|++|||+.+|++.|+....
T Consensus       294 ~~~~~i~~~~~~-----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          294 EVLEFVTSGGRM-----------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             HHHHHHHTTCCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCC-----------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence            111222222110           1122334458899999999999999999999999987653

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-43  Score=342.86  Aligned_cols=246  Identities=17%  Similarity=0.236  Sum_probs=199.3

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCC
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS  183 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gs  183 (453)
                      +.+.||+|+||+||++... +++.+|+|.+.........+.+|+.+++.++||||+++++++. ..+..++||||+++|+
T Consensus         9 ~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~~~~~lv~e~~~g~~   87 (321)
T 1tki_A            9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE-SMEELVMIFEFISGLD   87 (321)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEE-ETTEEEEEECCCCCCB
T ss_pred             eeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEe-cCCEEEEEEEeCCCCC
Confidence            3578999999999999964 5889999999876666677899999999999999999999986 5568899999999999


Q ss_pred             hhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECC--CCcEEEeecccccccc
Q 047276          184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDE--NYRAVVSDFGLSKLMS  261 (453)
Q Consensus       184 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~--~~~~kl~DfGla~~~~  261 (453)
                      |.+++....         ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.  ++.+||+|||++....
T Consensus        88 L~~~l~~~~---------~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~  155 (321)
T 1tki_A           88 IFERINTSA---------FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             HHHHHTSSS---------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             HHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence            999995432         248999999999999999999999   89999999999999997  7899999999998765


Q ss_pred             CCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcc
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKL  341 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (453)
                      ...  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......            . ....+..+..
T Consensus       156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------------~-~~~~i~~~~~  220 (321)
T 1tki_A          156 PGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------------Q-IIENIMNAEY  220 (321)
T ss_dssp             TTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------------H-HHHHHHHTCC
T ss_pred             CCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH------------H-HHHHHHcCCC
Confidence            432  234567899999999999888899999999999999999999999532110            1 1111111111


Q ss_pred             cccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          342 MEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       342 ~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      .  .+..      .....+..+.+++.+||+.||++|||+.|+++
T Consensus       221 ~--~~~~------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          221 T--FDEE------AFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             C--CCHH------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             C--CChh------hhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0  0000      00122456889999999999999999999986

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.7e-43  Score=337.12  Aligned_cols=250  Identities=20%  Similarity=0.335  Sum_probs=189.4

Q ss_pred             HhcccCcCCceEEEEEEeCC----CcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEe
Q 047276          105 FQALLGHGSSASVFKGILSD----GTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~----g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      +.+.||+|+||.||+|....    +..||+|.+....  ...+.+.+|+.++++++||||+++++++.  ++..++||||
T Consensus        19 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~lv~e~   96 (281)
T 1mp8_A           19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT--ENPVWIIMEL   96 (281)
T ss_dssp             EEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSCEEEEEC
T ss_pred             EEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc--cCccEEEEec
Confidence            46789999999999999643    4579999987532  23457899999999999999999999873  4578999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +++|+|.+++....         ..+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++
T Consensus        97 ~~~~~L~~~l~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           97 CTLGELRSFLQVRK---------YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSR  164 (281)
T ss_dssp             CTTEEHHHHHHHTT---------TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             CCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECcccccc
Confidence            99999999996432         238999999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhh
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMK  337 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (453)
                      ..............+|+.|+|||.+....++.++||||||+++|||++ |+.||.......             ....+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~-------------~~~~i~  231 (281)
T 1mp8_A          165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------------VIGRIE  231 (281)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------------HHHHHH
T ss_pred             ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH-------------HHHHHH
Confidence            765443333344567889999999999999999999999999999996 999985322110             111111


Q ss_pred             cCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          338 EGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       338 ~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      .+...           ..+...+..+.+++.+||+.+|++|||+.++++.|+...
T Consensus       232 ~~~~~-----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  275 (281)
T 1mp8_A          232 NGERL-----------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  275 (281)
T ss_dssp             TTCCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCCCC-----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            11110           112233456889999999999999999999999998753

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.9e-43  Score=344.40  Aligned_cols=242  Identities=22%  Similarity=0.265  Sum_probs=197.2

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecC----CCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRING----EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      .+.||+|+||+||+++.. +|+.||+|+++.    .......+.+|+.+++.++||||+++++++. ..+..++||||++
T Consensus        10 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-~~~~~~lv~E~~~   88 (337)
T 1o6l_A           10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-THDRLCFVMEYAN   88 (337)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-CSSEEEEEEECCT
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE-eCCEEEEEEeCCC
Confidence            478999999999999964 689999999964    2344567899999999999999999999876 5568899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|.+++...          ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        89 gg~L~~~l~~~----------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  155 (337)
T 1o6l_A           89 GGELFFHLSRE----------RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEG  155 (337)
T ss_dssp             TCBHHHHHHHH----------SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             CCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence            99999998643          238999999999999999999999   89999999999999999999999999999864


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      .... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....            .. ....+..+.
T Consensus       156 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------------~~-~~~~i~~~~  221 (337)
T 1o6l_A          156 ISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------------ER-LFELILMEE  221 (337)
T ss_dssp             CCTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------------HH-HHHHHHHCC
T ss_pred             ccCC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH------------HH-HHHHHHcCC
Confidence            3322 223456799999999999999999999999999999999999999953210            01 111111111


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRP-----SMARVVEM  387 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~~v~~~  387 (453)
                                  ..++......+.+++.+||+.||++||     ++.++++.
T Consensus       222 ------------~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          222 ------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             ------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ------------CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence                        112223345688999999999999999     89998753

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=6e-43  Score=340.47  Aligned_cols=246  Identities=24%  Similarity=0.330  Sum_probs=193.8

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCC
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      .+.||+|+||+||+|... +++.||||++....  ...+.+.+|+.+++.++||||+++++++. .++..++||||+++|
T Consensus        12 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~~~~~lv~e~~~~~   90 (323)
T 3tki_A           12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-EGNIQYLFLEYCSGG   90 (323)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEE-CSSEEEEEEECCTTE
T ss_pred             eeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCCeEEEEEEcCCCC
Confidence            578999999999999965 78999999986532  23356889999999999999999999986 566889999999999


Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccC
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR  262 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~  262 (453)
                      +|.+++...          ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++.....
T Consensus        91 ~L~~~l~~~----------~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  157 (323)
T 3tki_A           91 ELFDRIEPD----------IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (323)
T ss_dssp             EGGGGSBTT----------TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             cHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence            999998533          238999999999999999999999   8999999999999999999999999999987643


Q ss_pred             CCC-ceeeeccCCccccchhhhhcCCC-CccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          263 DQS-RCITTIRGTRGYLAPEWILEQGV-SEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       263 ~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      ... .......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.......       .     ....+....
T Consensus       158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~-----~~~~~~~~~  225 (323)
T 3tki_A          158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-------Q-----EYSDWKEKK  225 (323)
T ss_dssp             TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS-------H-----HHHHHHTTC
T ss_pred             CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH-------H-----HHHHHhccc
Confidence            322 22345679999999999987765 778999999999999999999996322110       0     001111110


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      ..  .        .........+.+++.+||+.||++|||+.|+++.
T Consensus       226 ~~--~--------~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          226 TY--L--------NPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             TT--S--------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             cc--C--------CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            00  0        0111233457899999999999999999998753

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-43  Score=344.71  Aligned_cols=261  Identities=25%  Similarity=0.394  Sum_probs=203.9

Q ss_pred             HhcccCcCCceEEEEEEeC------CCcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEE
Q 047276          105 FQALLGHGSSASVFKGILS------DGTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVY  176 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~------~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~  176 (453)
                      +.+.||+|+||.||+|...      +++.||||+++...  ...+.|.+|+.++++++||||++++++|. .++..++||
T Consensus        51 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~~lv~  129 (343)
T 1luf_A           51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA-VGKPMCLLF  129 (343)
T ss_dssp             EEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSSCEEEE
T ss_pred             eeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc-cCCceEEEE
Confidence            3478999999999999974      34789999997643  23467999999999999999999999986 566889999


Q ss_pred             EecCCCChhhhhccCCCCCC--------------CCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEE
Q 047276          177 EFIQNGSLDHWIFPTSRRSE--------------GHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENIL  242 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~--------------~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiL  242 (453)
                      ||+++|+|.+++........              .......+++..++.++.|++.||+|||+   .+++||||||+|||
T Consensus       130 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl  206 (343)
T 1luf_A          130 EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCL  206 (343)
T ss_dssp             ECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred             ecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEE
Confidence            99999999999976432100              00012459999999999999999999999   89999999999999


Q ss_pred             ECCCCcEEEeeccccccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCC
Q 047276          243 LDENYRAVVSDFGLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDK  320 (453)
Q Consensus       243 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~  320 (453)
                      ++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....    
T Consensus       207 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~----  282 (343)
T 1luf_A          207 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH----  282 (343)
T ss_dssp             ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH----
T ss_pred             ECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh----
Confidence            99999999999999986643221 22344567899999999999999999999999999999999 9999853211    


Q ss_pred             CcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          321 SKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                               ......+..+...           ..+......+.+++.+||+.+|++||++.++++.|++...
T Consensus       283 ---------~~~~~~~~~~~~~-----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          283 ---------EEVIYYVRDGNIL-----------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             ---------HHHHHHHHTTCCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ---------HHHHHHHhCCCcC-----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence                     1112222222211           1122334568999999999999999999999999998654

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-43  Score=341.97  Aligned_cols=275  Identities=22%  Similarity=0.287  Sum_probs=197.5

Q ss_pred             HHHHHhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHh--cCCCceeeEeeEEEecC---CCeEEE
Q 047276          101 ATDNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIAS--AQHVNLVRLLGYCVVPG---GPRYLV  175 (453)
Q Consensus       101 ~~~~~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~~---~~~~lv  175 (453)
                      ..+.+.+.||+|+||.||+|+.. |+.||||++....  ...+..|.+++..  ++||||+++++++....   ...++|
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv  113 (337)
T 3mdy_A           37 KQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLI  113 (337)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEE
T ss_pred             cceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEE
Confidence            34445689999999999999986 8999999986433  3445556666554  48999999999987543   467999


Q ss_pred             EEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccC-----CCceeccCCCCCcEEECCCCcEE
Q 047276          176 YEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDC-----RSRVLHLDVKPENILLDENYRAV  250 (453)
Q Consensus       176 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~-----~~~ivH~Dlk~~NiLl~~~~~~k  250 (453)
                      |||+++|+|.+++...           .+++..++.++.|++.||+|||+.+     ..+++||||||+|||++.++.+|
T Consensus       114 ~e~~~~g~L~~~l~~~-----------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  182 (337)
T 3mdy_A          114 TDYHENGSLYDYLKST-----------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC  182 (337)
T ss_dssp             ECCCTTCBHHHHHHHC-----------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             EeccCCCcHHHHhhcc-----------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence            9999999999999432           3899999999999999999999821     12999999999999999999999


Q ss_pred             EeeccccccccCCCCc---eeeeccCCccccchhhhhcCCCCcc------ccchhHHHHHHHHHcCCCCCcccccCCCCC
Q 047276          251 VSDFGLSKLMSRDQSR---CITTIRGTRGYLAPEWILEQGVSEK------CDIYSYGMVLLELTGGRRNVSLIEHGNDKS  321 (453)
Q Consensus       251 l~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~------sDV~S~Gvil~elltG~~p~~~~~~~~~~~  321 (453)
                      |+|||++.........   ......||+.|+|||.+.+...+.+      +|||||||++|||++|..|+.........-
T Consensus       183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~  262 (337)
T 3mdy_A          183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY  262 (337)
T ss_dssp             ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence            9999999876543221   1234579999999999987766665      999999999999999955442211100000


Q ss_pred             ccc--ccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccCC
Q 047276          322 KNK--WQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAV  394 (453)
Q Consensus       322 ~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~~  394 (453)
                      ...  .........................     ...++...+.+++.+||+.||++|||+.+|++.|+.....
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  332 (337)
T 3mdy_A          263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRW-----SSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES  332 (337)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCCGGG-----GGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             hhhcCCCCchhhhHHHHhhhccCccccccc-----hhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence            000  0000011111111111111111111     1236778899999999999999999999999999986543

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.9e-43  Score=338.63  Aligned_cols=255  Identities=24%  Similarity=0.399  Sum_probs=195.8

Q ss_pred             HhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCCh
Q 047276          105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL  184 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL  184 (453)
                      +.+.||+|+||+||+|+.. ++.||||.+... ...+.|.+|+.++++++||||++++|++.   +..++||||+++|+|
T Consensus        12 ~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~---~~~~lv~e~~~~~~L   86 (307)
T 2eva_A           12 VEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACL---NPVCLVMEYAEGGSL   86 (307)
T ss_dssp             EEEEEECCSSSEEEEEEET-TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCT---TTTEEEEECCTTCBH
T ss_pred             eeeEeecCCCceEEEEEEC-CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEc---CCcEEEEEcCCCCCH
Confidence            3578999999999999985 788999998753 34567999999999999999999999864   357999999999999


Q ss_pred             hhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCc-EEEeeccccccccCC
Q 047276          185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYR-AVVSDFGLSKLMSRD  263 (453)
Q Consensus       185 ~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~-~kl~DfGla~~~~~~  263 (453)
                      .+++.....       ...+++..++.++.|+++||+|||+....+++||||||+|||++.++. +||+|||++......
T Consensus        87 ~~~l~~~~~-------~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~  159 (307)
T 2eva_A           87 YNVLHGAEP-------LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH  159 (307)
T ss_dssp             HHHHHCSSS-------EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred             HHHHhccCC-------CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence            999965432       123789999999999999999999854468999999999999998886 799999999755332


Q ss_pred             CCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcccc
Q 047276          264 QSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLME  343 (453)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (453)
                          .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......      .    .. .......+... 
T Consensus       160 ----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~----~~-~~~~~~~~~~~-  223 (307)
T 2eva_A          160 ----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP------A----FR-IMWAVHNGTRP-  223 (307)
T ss_dssp             ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS------H----HH-HHHHHHTTCCC-
T ss_pred             ----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc------H----HH-HHHHHhcCCCC-
Confidence                23346899999999999989999999999999999999999999532110      0    00 11111111110 


Q ss_pred             cccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccCCCCC
Q 047276          344 IVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVDDP  397 (453)
Q Consensus       344 ~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~~~~~  397 (453)
                                .........+.+++.+||+.+|++|||++++++.|+........
T Consensus       224 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  267 (307)
T 2eva_A          224 ----------PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG  267 (307)
T ss_dssp             ----------CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred             ----------CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence                      11122334588999999999999999999999999887654433

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=9.1e-43  Score=344.01  Aligned_cols=245  Identities=21%  Similarity=0.271  Sum_probs=196.8

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC-------ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEE
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEE-------NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVY  176 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~  176 (453)
                      +.+.||+|+||+||++... +|+.||+|.++...       ...+.+.+|+.++.+++||||+++++++. ..+..++||
T Consensus        16 ~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~~lv~   94 (361)
T 2yab_A           16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE-NRTDVVLIL   94 (361)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE-CSSEEEEEE
T ss_pred             EeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE-eCCEEEEEE
Confidence            4578999999999999964 68999999987532       13577999999999999999999999976 566889999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCC----cEEEe
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENY----RAVVS  252 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~----~~kl~  252 (453)
                      ||+++|+|.+++...          ..+++..+..++.|++.||+|||+   .+|+||||||+|||+++++    .+||+
T Consensus        95 e~~~gg~L~~~l~~~----------~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~  161 (361)
T 2yab_A           95 ELVSGGELFDFLAQK----------ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLI  161 (361)
T ss_dssp             ECCCSCBHHHHHTTC----------SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred             EcCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEE
Confidence            999999999999532          348999999999999999999999   8999999999999998877    79999


Q ss_pred             eccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHH
Q 047276          253 DFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIV  332 (453)
Q Consensus       253 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  332 (453)
                      |||++.......  ......||+.|+|||.+.+..++.++|||||||++|||++|..||......            . .
T Consensus       162 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~------------~-~  226 (361)
T 2yab_A          162 DFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------------E-T  226 (361)
T ss_dssp             CCSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------------H-H
T ss_pred             ecCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------------H-H
Confidence            999998765432  234567999999999999889999999999999999999999999532110            0 1


Q ss_pred             HHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          333 NEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       333 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ...+..+...  +++..      .......+.+++.+||+.||++|||+.++++
T Consensus       227 ~~~i~~~~~~--~~~~~------~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          227 LANITAVSYD--FDEEF------FSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HHHHHTTCCC--CCHHH------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHhcCCC--CCchh------ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1111111110  00000      0122345889999999999999999999874

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=5e-44  Score=342.37  Aligned_cols=257  Identities=27%  Similarity=0.429  Sum_probs=192.1

Q ss_pred             HHHHHhcccCcCCceEEEEEEeCCCcEEEEEEecCCCc---cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          101 ATDNFQALLGHGSSASVFKGILSDGTSVAVKRINGEEN---GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       101 ~~~~~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      ..+.+.++||+|+||+||+|+..+  .||+|+++....   ..+.|.+|+.++++++||||+++++++  .....++|||
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~lv~e   99 (289)
T 3og7_A           24 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS--TAPQLAIVTQ   99 (289)
T ss_dssp             TSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE--CSSSCEEEEE
T ss_pred             cceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec--cCCccEEEEE
Confidence            334456899999999999998753  599999975432   335689999999999999999999975  4557899999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |+++++|.+++....         ..+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++
T Consensus       100 ~~~~~~L~~~l~~~~---------~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  167 (289)
T 3og7_A          100 WCEGSSLYHHLHASE---------TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLA  167 (289)
T ss_dssp             CCCEEEHHHHHTTC------------CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC--
T ss_pred             ecCCCcHHHHHhhcc---------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceec
Confidence            999999999995432         348999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCC-CceeeeccCCccccchhhhh---cCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHH
Q 047276          258 KLMSRDQ-SRCITTIRGTRGYLAPEWIL---EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVN  333 (453)
Q Consensus       258 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  333 (453)
                      ....... ........||+.|+|||.+.   ...++.++||||||+++|||++|+.||......            ....
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------------~~~~  235 (289)
T 3og7_A          168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------------DQII  235 (289)
T ss_dssp             ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH------------HHHH
T ss_pred             cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH------------HHHH
Confidence            8654322 22334567899999999986   567889999999999999999999999532111            1122


Q ss_pred             HhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          334 EKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       334 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      .....+.....    +   .......+..+.+++.+||+.+|++|||+.++++.|++..
T Consensus       236 ~~~~~~~~~~~----~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          236 EMVGRGSLSPD----L---SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             HHHHHTSCCCC----T---TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             HHhcccccCcc----h---hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            22222221111    1   0112233456899999999999999999999999998764

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.1e-42  Score=336.82  Aligned_cols=245  Identities=24%  Similarity=0.321  Sum_probs=193.3

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCC------------
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGG------------  170 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------------  170 (453)
                      .+.||+|+||.||+|+.. +|+.||||+++..  ....+.+.+|+.++++++||||++++++|.....            
T Consensus        11 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~   90 (332)
T 3qd2_B           11 IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWL   90 (332)
T ss_dssp             EEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC---
T ss_pred             eeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhh
Confidence            478999999999999975 7899999998743  3345779999999999999999999999864432            


Q ss_pred             --------------------------------------------CeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCH
Q 047276          171 --------------------------------------------PRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSW  206 (453)
Q Consensus       171 --------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~  206 (453)
                                                                  ..++||||+++|+|.+++.....       ....++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------~~~~~~  163 (332)
T 3qd2_B           91 KDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-------LEDREH  163 (332)
T ss_dssp             -----------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-------GGGSCH
T ss_pred             ccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-------ccchhh
Confidence                                                        26899999999999999975442       233678


Q ss_pred             HHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCCCC-----------ceeeeccCCc
Q 047276          207 DLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQS-----------RCITTIRGTR  275 (453)
Q Consensus       207 ~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~-----------~~~~~~~gt~  275 (453)
                      ..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.......           .......||+
T Consensus       164 ~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            8899999999999999999   8999999999999999999999999999987754321           1123457999


Q ss_pred             cccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcccccccccccCCCCC
Q 047276          276 GYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGI  355 (453)
Q Consensus       276 ~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  355 (453)
                      .|+|||.+.+..++.++||||||+++|||++|..|+...               .............           ..
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~---------------~~~~~~~~~~~~~-----------~~  294 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER---------------VRIITDVRNLKFP-----------LL  294 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH---------------HHHHHHHHTTCCC-----------HH
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH---------------HHHHHHhhccCCC-----------cc
Confidence            999999999999999999999999999999997765210               0011111111110           01


Q ss_pred             cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          356 DETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       356 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      .......+.+++.+||+.||++|||+.++++
T Consensus       295 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          295 FTQKYPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             cccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence            2234456789999999999999999999985

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.5e-43  Score=357.57  Aligned_cols=249  Identities=19%  Similarity=0.226  Sum_probs=195.6

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      .++||+|+||+||+|+.. +++.||+|+++..    ......+.+|..++..++||||++++++|. ..+..++||||++
T Consensus        79 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~-~~~~~~lV~Ey~~  157 (437)
T 4aw2_A           79 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ-DDNNLYLVMDYYV  157 (437)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE-CSSEEEEEECCCT
T ss_pred             EEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-eCCEEEEEEecCC
Confidence            378999999999999975 4789999998642    122234889999999999999999999886 5668899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|.+++....         ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       158 gg~L~~~l~~~~---------~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla~~~  225 (437)
T 4aw2_A          158 GGDLLTLLSKFE---------DRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKL  225 (437)
T ss_dssp             TCBHHHHHHTTT---------TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCcHHHHHHHcc---------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhhhhc
Confidence            999999996432         338999999999999999999999   89999999999999999999999999999877


Q ss_pred             cCCCCceeeeccCCccccchhhhh-----cCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHh
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWIL-----EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEK  335 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  335 (453)
                      ............||+.|+|||++.     .+.++.++|||||||++|||++|+.||......            ......
T Consensus       226 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~------------~~~~~i  293 (437)
T 4aw2_A          226 MEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------------ETYGKI  293 (437)
T ss_dssp             CTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH------------HHHHHH
T ss_pred             ccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh------------HHHHhh
Confidence            655444445578999999999987     456899999999999999999999999532110            001111


Q ss_pred             hhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 047276          336 MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARL--RPSMARVVEM  387 (453)
Q Consensus       336 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPs~~~v~~~  387 (453)
                      .....  .   ..+..   ........+.+++.+|++.+|++  ||+++|+++.
T Consensus       294 ~~~~~--~---~~~p~---~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          294 MNHKE--R---FQFPT---QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             HTHHH--H---CCCCS---SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             hhccc--c---ccCCc---ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            11000  0   00100   00113345889999999888888  9999999853

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=7e-43  Score=330.82  Aligned_cols=244  Identities=27%  Similarity=0.411  Sum_probs=187.6

Q ss_pred             HhcccCcCCceEEEEEEeCCCcEEEEEEecCCC-----ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEE-----NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      +.+.||+|+||+||+|... |+.||||+++...     ...+.+.+|+.+++.++||||+++++++. .++..++||||+
T Consensus        11 ~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~   88 (271)
T 3dtc_A           11 LEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL-KEPNLCLVMEFA   88 (271)
T ss_dssp             EEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-CC--CEEEEECC
T ss_pred             eeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-cCCceEEEEEcC
Confidence            3578999999999999985 8899999986532     23467899999999999999999999986 556789999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCc---eeccCCCCCcEEECC--------CCc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSR---VLHLDVKPENILLDE--------NYR  248 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~---ivH~Dlk~~NiLl~~--------~~~  248 (453)
                      ++++|.+++..           ..+++..++.++.|++.||+|||+   .+   ++||||||+|||++.        ++.
T Consensus        89 ~~~~L~~~~~~-----------~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~  154 (271)
T 3dtc_A           89 RGGPLNRVLSG-----------KRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKI  154 (271)
T ss_dssp             TTEEHHHHHTS-----------SCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCC
T ss_pred             CCCCHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcc
Confidence            99999999842           348999999999999999999999   56   999999999999986        778


Q ss_pred             EEEeeccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccch
Q 047276          249 AVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYF  328 (453)
Q Consensus       249 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~  328 (453)
                      +||+|||++.......   .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......           
T Consensus       155 ~kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----------  220 (271)
T 3dtc_A          155 LKITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL-----------  220 (271)
T ss_dssp             EEECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH-----------
T ss_pred             eEEccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----------
Confidence            9999999998654332   22456899999999999999999999999999999999999999532110           


Q ss_pred             hHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 047276          329 PKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEG  390 (453)
Q Consensus       329 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~  390 (453)
                       . .......+...          ...+......+.+++.+||+.+|++|||+.++++.|+.
T Consensus       221 -~-~~~~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          221 -A-VAYGVAMNKLA----------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             -H-HHHHHHTSCCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             -H-HHHhhhcCCCC----------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence             0 11111111110          01122334568999999999999999999999999975

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2e-43  Score=349.46  Aligned_cols=278  Identities=12%  Similarity=0.153  Sum_probs=202.4

Q ss_pred             HhcccCcCCceEEEEEEeCC------CcEEEEEEecCCCcc------------HHHHHHHHHHHHhcCCCceeeEeeEEE
Q 047276          105 FQALLGHGSSASVFKGILSD------GTSVAVKRINGEENG------------EKEFRSEVAAIASAQHVNLVRLLGYCV  166 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~------g~~vavK~~~~~~~~------------~~~~~~E~~~l~~l~h~niv~l~g~~~  166 (453)
                      +.++||+|+||+||+|.+.+      ++.||||++......            ...+..|+..+..++||||+++++++.
T Consensus        39 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~  118 (364)
T 3op5_A           39 VGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGL  118 (364)
T ss_dssp             EEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEE
T ss_pred             EEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeee
Confidence            35789999999999999754      478999998754321            012334555666778999999999987


Q ss_pred             ecC---CCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEE
Q 047276          167 VPG---GPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILL  243 (453)
Q Consensus       167 ~~~---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl  243 (453)
                      ...   ...++||||+ +++|.+++....         ..+++..++.++.|++.||+|||+   .+|+||||||+|||+
T Consensus       119 ~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---------~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill  185 (364)
T 3op5_A          119 HDKNGKSYRFMIMDRF-GSDLQKIYEANA---------KRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLL  185 (364)
T ss_dssp             EEETTEEEEEEEEECE-EEEHHHHHHHTT---------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEE
T ss_pred             eccCCcceEEEEEeCC-CCCHHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEE
Confidence            542   3479999999 999999996432         349999999999999999999999   899999999999999


Q ss_pred             C--CCCcEEEeeccccccccCCCCc------eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccc
Q 047276          244 D--ENYRAVVSDFGLSKLMSRDQSR------CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIE  315 (453)
Q Consensus       244 ~--~~~~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~  315 (453)
                      +  .++.+||+|||+++.+......      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus       186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~  265 (364)
T 3op5_A          186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL  265 (364)
T ss_dssp             ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence            9  8899999999999876533211      1134559999999999999899999999999999999999999996322


Q ss_pred             cCCCCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccCCC
Q 047276          316 HGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVD  395 (453)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~~~  395 (453)
                      ...     .   ......... ...+.+++++.+.. .    ..+..+.+++..||+.+|++||++.+|++.|++.....
T Consensus       266 ~~~-----~---~~~~~~~~~-~~~~~~~~~~~~~~-~----~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  331 (364)
T 3op5_A          266 KDP-----K---YVRDSKIRY-RENIASLMDKCFPA-A----NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI  331 (364)
T ss_dssp             TCH-----H---HHHHHHHHH-HHCHHHHHHHHSCT-T----CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             cCH-----H---HHHHHHHHh-hhhHHHHHHHhccc-c----cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence            110     0   011111111 12233344444321 1    22345889999999999999999999999998766443


Q ss_pred             CCCCCccccccccccc
Q 047276          396 DPPDTQMVIVDWLSID  411 (453)
Q Consensus       396 ~~~~~~~~~~~~~~~~  411 (453)
                      .....  ...+|...+
T Consensus       332 ~~~~~--~~~dw~~~~  345 (364)
T 3op5_A          332 GSKDD--GKLDLSVVE  345 (364)
T ss_dssp             TCCCC--CCCCC----
T ss_pred             CCCcC--CccceEecc
Confidence            33322  234565444

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.1e-42  Score=337.02  Aligned_cols=247  Identities=21%  Similarity=0.266  Sum_probs=197.3

Q ss_pred             HHHhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC-------ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEE
Q 047276          103 DNFQALLGHGSSASVFKGILS-DGTSVAVKRINGEE-------NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYL  174 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~l  174 (453)
                      +.+.+.||+|+||.||++... +|+.||+|.+....       ...+.+.+|+.++++++||||+++++++. ..+..++
T Consensus        13 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~~l   91 (326)
T 2y0a_A           13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE-NKTDVIL   91 (326)
T ss_dssp             EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-CSSEEEE
T ss_pred             eEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-eCCEEEE
Confidence            344689999999999999964 68999999986532       23577999999999999999999999986 5668899


Q ss_pred             EEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCC----cEE
Q 047276          175 VYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENY----RAV  250 (453)
Q Consensus       175 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~----~~k  250 (453)
                      ||||+++|+|.+++...          ..+++..++.++.|++.||+|||+   .+++||||||+|||++.++    .+|
T Consensus        92 v~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~k  158 (326)
T 2y0a_A           92 ILELVAGGELFDFLAEK----------ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIK  158 (326)
T ss_dssp             EEECCCSCBHHHHHTTS----------SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEE
T ss_pred             EEEcCCCCCHHHHHHhc----------CCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEE
Confidence            99999999999999533          238999999999999999999999   8999999999999999887    899


Q ss_pred             EeeccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhH
Q 047276          251 VSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPK  330 (453)
Q Consensus       251 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~  330 (453)
                      |+|||++.......  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......            .
T Consensus       159 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------------~  224 (326)
T 2y0a_A          159 IIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------------E  224 (326)
T ss_dssp             ECCCTTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------------H
T ss_pred             EEECCCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH------------H
Confidence            99999998765332  224457999999999999889999999999999999999999999532110            0


Q ss_pred             HHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          331 IVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       331 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                       ....+..... ...+.       ........+.+++.+||+.||++|||+.++++
T Consensus       225 -~~~~~~~~~~-~~~~~-------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          225 -TLANVSAVNY-EFEDE-------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             -HHHHHHHTCC-CCCHH-------HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -HHHHHHhcCC-CcCcc-------ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             1111111110 00000       00122345889999999999999999999986

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.2e-43  Score=345.02  Aligned_cols=240  Identities=23%  Similarity=0.298  Sum_probs=193.7

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      +.+.||+|+||+||+|.. .+|+.||||++...    ......+.+|+.+++.++||||+++++++. ..+..++||||+
T Consensus        13 i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-~~~~~~lv~E~~   91 (336)
T 3h4j_B           13 IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT-TPTDIVMVIEYA   91 (336)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE-CSSEEEEEECCC
T ss_pred             EEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE-eCCEEEEEEECC
Confidence            357899999999999996 57899999998642    223357889999999999999999999986 556789999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                       +|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||++..
T Consensus        92 -~g~l~~~l~~~~----------~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~  157 (336)
T 3h4j_B           92 -GGELFDYIVEKK----------RMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNI  157 (336)
T ss_dssp             -CEEHHHHHHHHC----------SCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBT
T ss_pred             -CCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEecccee
Confidence             789999886432          38999999999999999999999   7999999999999999999999999999987


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcCCC-CccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQGV-SEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      .....  ......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||..........             ....
T Consensus       158 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~-------------~i~~  222 (336)
T 3h4j_B          158 MTDGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK-------------KVNS  222 (336)
T ss_dssp             TTTSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC-------------CCCS
T ss_pred             ccCCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH-------------HHHc
Confidence            64432  2345579999999999987765 789999999999999999999996322111000             0000


Q ss_pred             CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      +            ....+...+..+.+++.+||+.||.+|||+.|+++
T Consensus       223 ~------------~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          223 C------------VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             S------------CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             C------------CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            0            01122233455889999999999999999999875

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.2e-42  Score=334.04  Aligned_cols=253  Identities=25%  Similarity=0.403  Sum_probs=197.7

Q ss_pred             HhcccCcCCceEEEEEEeCC----CcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEe
Q 047276          105 FQALLGHGSSASVFKGILSD----GTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~----g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      +.++||+|+||+||+|...+    +..+|+|.++...  ...+.+.+|+.++++++||||++++++|...++..++||||
T Consensus        29 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~  108 (298)
T 3f66_A           29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY  108 (298)
T ss_dssp             EEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEEC
T ss_pred             hcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeC
Confidence            35789999999999999643    2358999987533  23467899999999999999999999987777788999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +++|+|.+++....         ..+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.
T Consensus       109 ~~~~~L~~~l~~~~---------~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~  176 (298)
T 3f66_A          109 MKHGDLRNFIRNET---------HNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR  176 (298)
T ss_dssp             CTTCBHHHHHHCTT---------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred             CCCCCHHHHHHhcc---------cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccc
Confidence            99999999996432         238999999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCC---ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcC-CCCCcccccCCCCCcccccchhHHHHH
Q 047276          259 LMSRDQS---RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGG-RRNVSLIEHGNDKSKNKWQYFPKIVNE  334 (453)
Q Consensus       259 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~  334 (453)
                      .......   .......+|+.|+|||.+.+..++.++||||||+++|||++| ..||.......             ...
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-------------~~~  243 (298)
T 3f66_A          177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------------ITV  243 (298)
T ss_dssp             CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT-------------HHH
T ss_pred             cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH-------------HHH
Confidence            7643321   123345678899999999999999999999999999999995 55553211100             111


Q ss_pred             hhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          335 KMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       335 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                      ....+..       .    ..+......+.+++.+||+.+|++|||+.++++.|+....
T Consensus       244 ~~~~~~~-------~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  291 (298)
T 3f66_A          244 YLLQGRR-------L----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  291 (298)
T ss_dssp             HHHTTCC-------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHhcCCC-------C----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            1111110       0    0111223458999999999999999999999999988654

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.8e-43  Score=367.42  Aligned_cols=247  Identities=23%  Similarity=0.323  Sum_probs=197.4

Q ss_pred             ccCcCCceEEEEEEeC---CCcEEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCC
Q 047276          108 LLGHGSSASVFKGILS---DGTSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       108 ~lG~G~fG~Vy~~~~~---~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      .||+|+||.||+|.+.   ++..||||+++..  ....++|.+|+.+|++++||||++++|+|..  +..++||||+++|
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~~lv~E~~~~g  420 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALMLVMEMAGGG  420 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES--SSEEEEEECCTTC
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc--CCeEEEEEeCCCC
Confidence            6999999999999863   4667999999763  3456789999999999999999999999863  5789999999999


Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccC
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR  262 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~  262 (453)
                      +|.+++....         ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       421 ~L~~~l~~~~---------~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~  488 (613)
T 2ozo_A          421 PLHKFLVGKR---------EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA  488 (613)
T ss_dssp             BHHHHHTTCT---------TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred             cHHHHHhhcc---------CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence            9999995432         348999999999999999999999   8999999999999999999999999999987654


Q ss_pred             CCCc--eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          263 DQSR--CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       263 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      ....  ......+|+.|+|||++..+.++.++|||||||++|||++ |+.||......             .+...+..+
T Consensus       489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-------------~~~~~i~~~  555 (613)
T 2ozo_A          489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------------EVMAFIEQG  555 (613)
T ss_dssp             -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH-------------HHHHHHHTT
T ss_pred             CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH-------------HHHHHHHcC
Confidence            3221  1223346789999999999999999999999999999998 99999532211             122222222


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      ..       +    ..+..+...+.+++..||+.+|++||++.+|++.|+...
T Consensus       556 ~~-------~----~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  597 (613)
T 2ozo_A          556 KR-------M----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  597 (613)
T ss_dssp             CC-------C----CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CC-------C----CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            21       1    122334456899999999999999999999999998753

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.4e-43  Score=334.90  Aligned_cols=244  Identities=23%  Similarity=0.316  Sum_probs=189.4

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCCCc---------------------------cHHHHHHHHHHHHhcCCC
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGEEN---------------------------GEKEFRSEVAAIASAQHV  156 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~---------------------------~~~~~~~E~~~l~~l~h~  156 (453)
                      +.+.||+|+||.||+|.. .+|+.||||++.....                           ..+.+.+|+.++++++||
T Consensus        17 ~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   96 (298)
T 2zv2_A           17 LKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHP   96 (298)
T ss_dssp             EEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCT
T ss_pred             EEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCC
Confidence            357899999999999996 4688999999865321                           124688999999999999


Q ss_pred             ceeeEeeEEEec-CCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccC
Q 047276          157 NLVRLLGYCVVP-GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLD  235 (453)
Q Consensus       157 niv~l~g~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~D  235 (453)
                      ||+++++++... .+..++||||+++|+|.+++.           ...+++..++.++.|++.||+|||+   .+++|||
T Consensus        97 ~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----------~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~D  162 (298)
T 2zv2_A           97 NVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----------LKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRD  162 (298)
T ss_dssp             TBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----------SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCC
T ss_pred             CCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----------cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccC
Confidence            999999998753 456799999999999988752           2348999999999999999999999   8999999


Q ss_pred             CCCCcEEECCCCcEEEeeccccccccCCCCceeeeccCCccccchhhhhcCC---CCccccchhHHHHHHHHHcCCCCCc
Q 047276          236 VKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQG---VSEKCDIYSYGMVLLELTGGRRNVS  312 (453)
Q Consensus       236 lk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDV~S~Gvil~elltG~~p~~  312 (453)
                      |||+|||++.++.+||+|||++........ ......||+.|+|||.+.+..   ++.++||||||+++|||++|+.||.
T Consensus       163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  241 (298)
T 2zv2_A          163 IKPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM  241 (298)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence            999999999999999999999987654322 234567999999999987654   3788999999999999999999995


Q ss_pred             ccccCCCCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          313 LIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ....             ......+......      .....    .....+.+++.+||+.||++|||+.++++
T Consensus       242 ~~~~-------------~~~~~~~~~~~~~------~~~~~----~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          242 DERI-------------MCLHSKIKSQALE------FPDQP----DIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             CSSH-------------HHHHHHHHHCCCC------CCSSS----CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CccH-------------HHHHHHHhcccCC------CCCcc----ccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            3110             0011111111110      01011    22345889999999999999999999864

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.4e-43  Score=344.00  Aligned_cols=265  Identities=20%  Similarity=0.294  Sum_probs=202.3

Q ss_pred             HhcccCcCCceEEEEEEeC-----CCcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecC-CCeEEEE
Q 047276          105 FQALLGHGSSASVFKGILS-----DGTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG-GPRYLVY  176 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-----~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~~lv~  176 (453)
                      +.+.||+|+||+||++.+.     +|+.||||+++...  ...+.+.+|+.++++++||||+++++++...+ ...++||
T Consensus        35 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~  114 (318)
T 3lxp_A           35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVM  114 (318)
T ss_dssp             EEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEE
T ss_pred             hhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEE
Confidence            3578999999999998753     57899999998643  33456899999999999999999999987653 4678999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||+++|+|.+++...           .+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+
T Consensus       115 e~~~~~~L~~~l~~~-----------~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~  180 (318)
T 3lxp_A          115 EYVPLGSLRDYLPRH-----------SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGL  180 (318)
T ss_dssp             CCCTTCBHHHHGGGS-----------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred             ecccCCcHHHHHhhC-----------CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccc
Confidence            999999999999432           38999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCC--ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHH
Q 047276          257 SKLMSRDQS--RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNE  334 (453)
Q Consensus       257 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  334 (453)
                      +........  .......+|+.|+|||.+.+..++.++||||||+++|||++|+.||......... ...+..      .
T Consensus       181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~------~  253 (318)
T 3lxp_A          181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE-LIGIAQ------G  253 (318)
T ss_dssp             CEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HHCSCC------H
T ss_pred             cccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh-hhcccc------c
Confidence            987754432  1223456788899999999989999999999999999999999998532111000 000000      0


Q ss_pred             hhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          335 KMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       335 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      ......+.+.++....  ...+...+..+.+++.+||+.||++|||+.++++.|+...
T Consensus       254 ~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  309 (318)
T 3lxp_A          254 QMTVLRLTELLERGER--LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH  309 (318)
T ss_dssp             HHHHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             chhHHHHHHHHhcccC--CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            0000001111111111  1122344556999999999999999999999999998764

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=7.3e-43  Score=337.70  Aligned_cols=260  Identities=23%  Similarity=0.373  Sum_probs=203.7

Q ss_pred             HhcccCcCCceEEEEEEe------CCCcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEE
Q 047276          105 FQALLGHGSSASVFKGIL------SDGTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVY  176 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~------~~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~  176 (453)
                      +.+.||+|+||.||++..      .+++.||||++....  ...+.+.+|+.++++++||||+++++++. ..+..++||
T Consensus        27 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~~lv~  105 (314)
T 2ivs_A           27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS-QDGPLLLIV  105 (314)
T ss_dssp             EEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSSCEEEE
T ss_pred             eeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe-cCCceEEEE
Confidence            357899999999999985      345789999997533  33467899999999999999999999976 566889999


Q ss_pred             EecCCCChhhhhccCCCCCC--------------CCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEE
Q 047276          177 EFIQNGSLDHWIFPTSRRSE--------------GHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENIL  242 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~--------------~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiL  242 (453)
                      ||+++|+|.+++........              .......+++..++.++.|++.||+|||+   .+++||||||+|||
T Consensus       106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp~NIl  182 (314)
T 2ivs_A          106 EYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNIL  182 (314)
T ss_dssp             ECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEE
T ss_pred             eecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccchheEE
Confidence            99999999999976532100              00012348999999999999999999999   89999999999999


Q ss_pred             ECCCCcEEEeeccccccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCC
Q 047276          243 LDENYRAVVSDFGLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDK  320 (453)
Q Consensus       243 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~  320 (453)
                      ++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......   
T Consensus       183 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---  259 (314)
T 2ivs_A          183 VAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE---  259 (314)
T ss_dssp             EETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---
Confidence            99999999999999987654332 12234457889999999999889999999999999999999 99998532211   


Q ss_pred             CcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          321 SKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                                .....+..+...           ..+......+.+++.+||+.||++||++.++++.|++..
T Consensus       260 ----------~~~~~~~~~~~~-----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~  310 (314)
T 2ivs_A          260 ----------RLFNLLKTGHRM-----------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM  310 (314)
T ss_dssp             ----------GHHHHHHTTCCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----------HHHHHhhcCCcC-----------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                      011222222110           112233456899999999999999999999999998754

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.7e-43  Score=342.17  Aligned_cols=250  Identities=24%  Similarity=0.392  Sum_probs=196.1

Q ss_pred             hcccCcCCceEEEEEEeC-CCcE----EEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEe
Q 047276          106 QALLGHGSSASVFKGILS-DGTS----VAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~----vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      .++||+|+||+||+|... +++.    ||+|.+...  ......+.+|+.++++++||||++++++|.  ++..++|+||
T Consensus        18 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~v~e~   95 (325)
T 3kex_A           18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP--GSSLQLVTQY   95 (325)
T ss_dssp             EEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC--BSSEEEEEEC
T ss_pred             eeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCccEEEEEe
Confidence            578999999999999964 4443    888887543  223346788999999999999999999874  4578999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +++|+|.+++....         ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        96 ~~~~~L~~~l~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  163 (325)
T 3kex_A           96 LPLGSLLDHVRQHR---------GALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVAD  163 (325)
T ss_dssp             CTTCBSHHHHHSSG---------GGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred             CCCCCHHHHHHHcc---------ccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCccc
Confidence            99999999996432         248889999999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhh
Q 047276          259 LMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKM  336 (453)
Q Consensus       259 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (453)
                      ....... .......+|+.|+|||.+.++.++.++||||||+++|||++ |+.||......             .....+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------------~~~~~~  230 (325)
T 3kex_A          164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA-------------EVPDLL  230 (325)
T ss_dssp             GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT-------------HHHHHH
T ss_pred             ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH-------------HHHHHH
Confidence            8754432 22345567889999999999999999999999999999999 99999632211             011222


Q ss_pred             hcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          337 KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       337 ~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                      ..+....           .+......+.+++.+||+.+|++||++.++++.|+....
T Consensus       231 ~~~~~~~-----------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          231 EKGERLA-----------QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             HTTCBCC-----------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             HcCCCCC-----------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            2221100           111122347889999999999999999999999987643

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=5.2e-43  Score=339.05  Aligned_cols=241  Identities=27%  Similarity=0.312  Sum_probs=186.5

Q ss_pred             HHHhcccCcCCceEEEEEEeC-CCcEEEEEEecCCCcc---HHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEEEEE
Q 047276          103 DNFQALLGHGSSASVFKGILS-DGTSVAVKRINGEENG---EKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      +.+.++||+|+||+||+|... +|+.||||++......   ...+..|+..+.++ +||||++++++|. .++..++|||
T Consensus        59 y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-~~~~~~lv~e  137 (311)
T 3p1a_A           59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-EGGILYLQTE  137 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-ETTEEEEEEE
T ss_pred             eeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-eCCEEEEEEe
Confidence            334578999999999999975 7899999998653322   23455666666555 8999999999986 5668899999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |+ +++|.+++....         ..++|..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus       138 ~~-~~~L~~~~~~~~---------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a  204 (311)
T 3p1a_A          138 LC-GPSLQQHCEAWG---------ASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLL  204 (311)
T ss_dssp             CC-CCBHHHHHHHHC---------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTC
T ss_pred             cc-CCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceee
Confidence            99 679999886432         239999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhh
Q 047276          258 KLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMK  337 (453)
Q Consensus       258 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (453)
                      .......  ......||++|+|||.+.+ .++.++|||||||++|||++|..|+....                ....+.
T Consensus       205 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----------------~~~~~~  265 (311)
T 3p1a_A          205 VELGTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----------------GWQQLR  265 (311)
T ss_dssp             EECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----------------HHHHHT
T ss_pred             eecccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----------------HHHHHh
Confidence            8764332  2344569999999998775 79999999999999999999977653211                111111


Q ss_pred             cCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          338 EGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       338 ~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      .+...    +.+      +......+.+++.+||+.||++|||+.++++
T Consensus       266 ~~~~~----~~~------~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          266 QGYLP----PEF------TAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             TTCCC----HHH------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccCCC----ccc------ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            11111    111      1122356899999999999999999999885

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.3e-42  Score=333.07  Aligned_cols=261  Identities=20%  Similarity=0.259  Sum_probs=204.5

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCCh
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL  184 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL  184 (453)
                      .+.||+|+||.||+|+. .+|+.||||++..... ...+.+|+.++..++|+|+++.++++...++..++||||+ +++|
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L   91 (296)
T 3uzp_A           14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSL   91 (296)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred             EEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCH
Confidence            57899999999999996 6789999999875433 3468899999999999998888888877777889999999 8999


Q ss_pred             hhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEE---CCCCcEEEeecccccccc
Q 047276          185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILL---DENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       185 ~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl---~~~~~~kl~DfGla~~~~  261 (453)
                      .+++....         ..+++..++.++.|++.||+|||+   .+++||||||+|||+   ++++.+||+|||++....
T Consensus        92 ~~~~~~~~---------~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           92 EDLFNFCS---------RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             HHHHHHTT---------TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             HHHHHhhc---------cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            99996332         238999999999999999999999   899999999999999   488999999999998765


Q ss_pred             CCCCc------eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHh
Q 047276          262 RDQSR------CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEK  335 (453)
Q Consensus       262 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  335 (453)
                      .....      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..........     .+.......
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-----~~~~~~~~~  234 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-----KYERISEKK  234 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS-----HHHHHHHHH
T ss_pred             ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhh-----hhhhhcccc
Confidence            43321      1245679999999999999999999999999999999999999996433222111     011111111


Q ss_pred             hhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccCCCCC
Q 047276          336 MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVDDP  397 (453)
Q Consensus       336 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~~~~~  397 (453)
                      ...     .. +.+      ....+..+.+++.+||+.+|++|||+++|++.|+........
T Consensus       235 ~~~-----~~-~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  284 (296)
T 3uzp_A          235 MST-----PI-EVL------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             HHS-----CH-HHH------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             cCC-----ch-HHH------HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence            000     00 000      012234589999999999999999999999999987654433

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3e-42  Score=334.61  Aligned_cols=238  Identities=24%  Similarity=0.318  Sum_probs=195.7

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      .+.||+|+||+||+++.. +|+.||+|+++..    ....+.+.+|..+++.++||||+++++++. ..+..++||||++
T Consensus        11 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-~~~~~~lv~e~~~   89 (318)
T 1fot_A           11 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-DAQQIFMIMDYIE   89 (318)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-CSSEEEEEECCCC
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE-eCCEEEEEEeCCC
Confidence            578999999999999964 6899999998642    234567889999999999999999999876 5668899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        90 gg~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~  156 (318)
T 1fot_A           90 GGELFSLLRKSQ----------RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYV  156 (318)
T ss_dssp             SCBHHHHHHHTS----------SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred             CCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceec
Confidence            999999996432          38999999999999999999999   89999999999999999999999999999865


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      ...    .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....            .. ....+..+.
T Consensus       157 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------------~~-~~~~i~~~~  219 (318)
T 1fot_A          157 PDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------------MK-TYEKILNAE  219 (318)
T ss_dssp             SSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------------HH-HHHHHHHCC
T ss_pred             CCc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------------HH-HHHHHHhCC
Confidence            432    2346799999999999999999999999999999999999999953210            01 111111111


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRP-----SMARVVE  386 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~~v~~  386 (453)
                              +    .++......+.+++.+|++.+|++||     +++++++
T Consensus       220 --------~----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          220 --------L----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             --------C----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             --------C----CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence                    1    11222345688999999999999999     8888873

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-42  Score=331.20  Aligned_cols=249  Identities=23%  Similarity=0.316  Sum_probs=201.3

Q ss_pred             cccCcCCceEEEEEEeC---CCcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          107 ALLGHGSSASVFKGILS---DGTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~---~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      +.||+|+||.||+|...   ++..||||+++...  ...+.+.+|+.++++++||||+++++++.  .+..++||||+++
T Consensus        16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~lv~e~~~~   93 (287)
T 1u59_A           16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ--AEALMLVMEMAGG   93 (287)
T ss_dssp             EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--SSSEEEEEECCTT
T ss_pred             ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec--CCCcEEEEEeCCC
Confidence            48999999999999853   57889999998632  34567999999999999999999999983  4578999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      ++|.+++....         ..+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++....
T Consensus        94 ~~L~~~l~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           94 GPLHKFLVGKR---------EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             EEHHHHHTTCT---------TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             CCHHHHHHhCC---------ccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence            99999995332         348999999999999999999999   899999999999999999999999999998775


Q ss_pred             CCCCc--eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          262 RDQSR--CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       262 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      .....  ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......            . ....+..
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------------~-~~~~i~~  228 (287)
T 1u59_A          162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP------------E-VMAFIEQ  228 (287)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH------------H-HHHHHHT
T ss_pred             cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH------------H-HHHHHhc
Confidence            43321  1233456889999999998889999999999999999998 99999532110            0 1122222


Q ss_pred             CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                      +..           ...+...+..+.+++..||+.+|++||++.++++.|+....
T Consensus       229 ~~~-----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  272 (287)
T 1u59_A          229 GKR-----------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  272 (287)
T ss_dssp             TCC-----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCc-----------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            211           01222334568999999999999999999999999987653

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-42  Score=341.08  Aligned_cols=264  Identities=23%  Similarity=0.354  Sum_probs=203.3

Q ss_pred             HHHhcccCcCCceEEEEEEe------CCCcEEEEEEecCC--CccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeE
Q 047276          103 DNFQALLGHGSSASVFKGIL------SDGTSVAVKRINGE--ENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRY  173 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~------~~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~  173 (453)
                      +.+.+.||+|+||+||+|..      .++..||||.+...  ....+.+.+|+.++.++ +||||+++++++. ..+..+
T Consensus        47 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-~~~~~~  125 (344)
T 1rjb_A           47 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT-LSGPIY  125 (344)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSSCE
T ss_pred             ceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe-eCCccE
Confidence            34468999999999999995      24568999999753  23346789999999999 8999999999986 566889


Q ss_pred             EEEEecCCCChhhhhccCCCCCC-------------CCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCc
Q 047276          174 LVYEFIQNGSLDHWIFPTSRRSE-------------GHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPEN  240 (453)
Q Consensus       174 lv~e~~~~gsL~~~l~~~~~~~~-------------~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~N  240 (453)
                      +||||+++|+|.+++........             .......+++..++.++.|++.||+|||+   .+|+||||||+|
T Consensus       126 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~N  202 (344)
T 1rjb_A          126 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARN  202 (344)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGGG
T ss_pred             EEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhh
Confidence            99999999999999976532100             00012348999999999999999999999   899999999999


Q ss_pred             EEECCCCcEEEeeccccccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCC
Q 047276          241 ILLDENYRAVVSDFGLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGN  318 (453)
Q Consensus       241 iLl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~  318 (453)
                      ||++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...... 
T Consensus       203 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-  281 (344)
T 1rjb_A          203 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD-  281 (344)
T ss_dssp             EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-
T ss_pred             EEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH-
Confidence            9999999999999999987654332 22334567889999999999999999999999999999998 99999532211 


Q ss_pred             CCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          319 DKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                                 .........+..     .      ..+......+.+++.+||+.||.+|||+.++++.|+....
T Consensus       282 -----------~~~~~~~~~~~~-----~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  334 (344)
T 1rjb_A          282 -----------ANFYKLIQNGFK-----M------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA  334 (344)
T ss_dssp             -----------HHHHHHHHTTCC-----C------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             -----------HHHHHHHhcCCC-----C------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence                       011122222110     0      1112234568999999999999999999999999998654

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=7.4e-43  Score=368.64  Aligned_cols=246  Identities=26%  Similarity=0.366  Sum_probs=196.8

Q ss_pred             cccCcCCceEEEEEEe---CCCcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          107 ALLGHGSSASVFKGIL---SDGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~---~~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.||+|+||+||+|.+   .+++.||||+++..   ....++|.+|+.+|.+++|||||+++++|.  .+..++||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~~lv~E~~~  452 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE--AESWMLVMEMAE  452 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE--SSSEEEEEECCT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe--cCCEEEEEEccC
Confidence            4799999999999975   34678999999753   234578999999999999999999999985  346899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|.+++...          ..+++..++.|+.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       453 ~g~L~~~l~~~----------~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~  519 (635)
T 4fl3_A          453 LGPLNKYLQQN----------RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKAL  519 (635)
T ss_dssp             TEEHHHHHHHC----------TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHT
T ss_pred             CCCHHHHHhhC----------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCcccc
Confidence            99999999643          238999999999999999999999   89999999999999999999999999999877


Q ss_pred             cCCCC--ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhh
Q 047276          261 SRDQS--RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMK  337 (453)
Q Consensus       261 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (453)
                      .....  .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.....             ..+...+.
T Consensus       520 ~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-------------~~~~~~i~  586 (635)
T 4fl3_A          520 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------------SEVTAMLE  586 (635)
T ss_dssp             TC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------------HHHHHHHH
T ss_pred             ccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-------------HHHHHHHH
Confidence            54332  22333457889999999999999999999999999999998 9999953221             11222222


Q ss_pred             cCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 047276          338 EGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR  391 (453)
Q Consensus       338 ~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~  391 (453)
                      .+...           ..+..++..+.+++..||+.||++||++.+|++.|++.
T Consensus       587 ~~~~~-----------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          587 KGERM-----------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             TTCCC-----------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             cCCCC-----------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            22211           12233445689999999999999999999999999864

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.1e-43  Score=346.39  Aligned_cols=242  Identities=21%  Similarity=0.273  Sum_probs=191.8

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEEEEEe
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      +.++||+|+||+||+++.. +|+.||||+++..    ....+.+..|..++..+ +||||+++++++. ..+..++||||
T Consensus        27 ~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~-~~~~~~lv~E~  105 (353)
T 3txo_A           27 FIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ-TPDRLFFVMEF  105 (353)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE-CSSEEEEEEEC
T ss_pred             EEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEE-eCCEEEEEEeC
Confidence            3578999999999999964 5899999999742    23456688999999988 6999999999876 56688999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       106 ~~gg~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~  172 (353)
T 3txo_A          106 VNGGDLMFHIQKSR----------RFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK  172 (353)
T ss_dssp             CCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             CCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEcccccee
Confidence            99999999996432          38999999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      ...... ......+||+.|+|||.+.+..++.++|||||||++|||++|+.||......            . ....+..
T Consensus       173 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------------~-~~~~i~~  238 (353)
T 3txo_A          173 EGICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED------------D-LFEAILN  238 (353)
T ss_dssp             CSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH------------H-HHHHHHH
T ss_pred             ecccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH------------H-HHHHHHc
Confidence            543222 2234568999999999999888999999999999999999999999532110            1 1111111


Q ss_pred             CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCH------HHHHH
Q 047276          339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSM------ARVVE  386 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~------~~v~~  386 (453)
                      +.            ..++......+.+++.+||+.||++||++      .++++
T Consensus       239 ~~------------~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          239 DE------------VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             CC------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             CC------------CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            11            11222234558899999999999999998      66663

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.4e-42  Score=330.84  Aligned_cols=250  Identities=21%  Similarity=0.366  Sum_probs=196.5

Q ss_pred             HhcccCcCCceEEEEEEeCC----CcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEe
Q 047276          105 FQALLGHGSSASVFKGILSD----GTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~----g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      +.+.||+|+||+||+|...+    +..||+|.+....  ...+.+.+|+.++++++||||+++++++.  .+..++||||
T Consensus        16 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~v~e~   93 (281)
T 3cc6_A           16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE--EEPTWIIMEL   93 (281)
T ss_dssp             EEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC--SSSCEEEEEC
T ss_pred             EEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc--CCCCEEEEec
Confidence            35789999999999998542    3469999987642  34567999999999999999999999864  3467999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +++++|.+++....         ..+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.
T Consensus        94 ~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  161 (281)
T 3cc6_A           94 YPYGELGHYLERNK---------NSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSR  161 (281)
T ss_dssp             CTTCBHHHHHHHHT---------TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred             CCCCCHHHHHHhcc---------ccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCc
Confidence            99999999996432         238999999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhh
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMK  337 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (453)
                      ..............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......             ......
T Consensus       162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~-------------~~~~~~  228 (281)
T 3cc6_A          162 YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-------------VIGVLE  228 (281)
T ss_dssp             CC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG-------------HHHHHH
T ss_pred             ccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH-------------HHHHHh
Confidence            765443333344567889999999998999999999999999999998 999985322110             111111


Q ss_pred             cCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          338 EGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       338 ~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      .+..       .    ..+......+.+++.+||+.+|++||++.++++.|+...
T Consensus       229 ~~~~-------~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~  272 (281)
T 3cc6_A          229 KGDR-------L----PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY  272 (281)
T ss_dssp             HTCC-------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCCC-------C----CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence            1111       0    011123345889999999999999999999999998754

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.7e-42  Score=334.03  Aligned_cols=261  Identities=21%  Similarity=0.281  Sum_probs=192.9

Q ss_pred             hcccCcCCceEEEEEEeCCCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCC
Q 047276          106 QALLGHGSSASVFKGILSDGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      .++||+|+||+||+|+..+|+.||+|++....   .....+.+|+.++++++||||+++++++. .++..++||||+++ 
T Consensus        26 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~~lv~e~~~~-  103 (311)
T 3niz_A           26 LEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH-SERCLTLVFEFMEK-  103 (311)
T ss_dssp             EEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC-CSSCEEEEEECCSE-
T ss_pred             hhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc-cCCEEEEEEcCCCC-
Confidence            57899999999999999889999999997532   22367889999999999999999999976 56688999999975 


Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccC
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR  262 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~  262 (453)
                      +|.+++....         ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++.....
T Consensus       104 ~l~~~~~~~~---------~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A          104 DLKKVLDENK---------TGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGI  171 (311)
T ss_dssp             EHHHHHHTCT---------TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred             CHHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence            8888875432         238999999999999999999999   8999999999999999999999999999987643


Q ss_pred             CCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCC----------CcccccchhHH
Q 047276          263 DQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDK----------SKNKWQYFPKI  331 (453)
Q Consensus       263 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~----------~~~~~~~~~~~  331 (453)
                      .. .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.........          ....|......
T Consensus       172 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  250 (311)
T 3niz_A          172 PV-RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL  250 (311)
T ss_dssp             CC-C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred             Cc-ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence            32 22344578999999999876 56899999999999999999999999643222110          00000000000


Q ss_pred             HHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          332 VNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       332 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                        ..+..... ...+....  ....+.....+.+++.+||+.||++|||++|+++
T Consensus       251 --~~~~~~~~-~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          251 --PLWKQRTF-QVFEKKPW--SSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             --HHHHSCCC-CCCCCCCH--HHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             --chhhhccc-ccccCCcH--HHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence              00000000 00000000  0001122346889999999999999999999885

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.1e-42  Score=346.98  Aligned_cols=246  Identities=20%  Similarity=0.286  Sum_probs=192.4

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC----ccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEEEEEe
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEE----NGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      +.++||+|+||+||+++.. +++.||+|+++...    ...+.+..|..++.++ +||||+++++++. ..+..++||||
T Consensus        56 ~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~-~~~~~~lV~E~  134 (396)
T 4dc2_A           56 LLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-TESRLFFVIEY  134 (396)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEE-CSSEEEEEEEC
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE-ECCEEEEEEEc
Confidence            3478999999999999965 57899999997532    2224578899999887 8999999999876 56688999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +++|+|.+++....          .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       135 ~~gg~L~~~l~~~~----------~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~  201 (396)
T 4dc2_A          135 VNGGDLMFHMQRQR----------KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK  201 (396)
T ss_dssp             CTTCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             CCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceee
Confidence            99999999986432          38999999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      ...... ......+||+.|+|||.+.+..++.++|||||||++|||++|+.||...........    .......+....
T Consensus       202 ~~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~----~~~~~~~~~i~~  276 (396)
T 4dc2_A          202 EGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ----NTEDYLFQVILE  276 (396)
T ss_dssp             CCCCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC----------CCHHHHHHHHHH
T ss_pred             ecccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch----hhHHHHHHHHhc
Confidence            643222 224557899999999999999999999999999999999999999964322211110    001111111111


Q ss_pred             CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCH
Q 047276          339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSM  381 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  381 (453)
                      +.            ..++......+.+++.+||+.||++||++
T Consensus       277 ~~------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          277 KQ------------IRIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             CC------------CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             cc------------cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            11            11233344568899999999999999995

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2e-42  Score=340.70  Aligned_cols=252  Identities=20%  Similarity=0.293  Sum_probs=198.3

Q ss_pred             HHHHhcccCcCCceEEEEEEe-CCCcEEEEEEecC------CCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEE
Q 047276          102 TDNFQALLGHGSSASVFKGIL-SDGTSVAVKRING------EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYL  174 (453)
Q Consensus       102 ~~~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~------~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~l  174 (453)
                      .+.+.+.||+|+||+||+|.. .+|+.||||++..      .....+.+.+|+.+++.++||||+++++++. ..+..++
T Consensus        25 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~~~~~l  103 (351)
T 3c0i_A           25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS-SDGMLYM  103 (351)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEE-ETTEEEE
T ss_pred             ceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEE-eCCEEEE
Confidence            345568999999999999996 4689999999853      1224678999999999999999999999986 4568899


Q ss_pred             EEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCc---EEE
Q 047276          175 VYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYR---AVV  251 (453)
Q Consensus       175 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~---~kl  251 (453)
                      ||||+++|+|.+++.....      ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.   +||
T Consensus       104 v~e~~~g~~L~~~l~~~~~------~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl  174 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRAD------AGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKL  174 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHH------TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEE
T ss_pred             EEeCCCCCCHHHHHHHhcc------cCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEE
Confidence            9999999999888854321      12348999999999999999999999   89999999999999986654   999


Q ss_pred             eeccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHH
Q 047276          252 SDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKI  331 (453)
Q Consensus       252 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~  331 (453)
                      +|||++....... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....             . 
T Consensus       175 ~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------------~-  239 (351)
T 3c0i_A          175 GGFGVAIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-------------R-  239 (351)
T ss_dssp             CCCTTCEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-------------H-
T ss_pred             ecCcceeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-------------H-
Confidence            9999998765432 223456799999999999998999999999999999999999999953210             0 


Q ss_pred             HHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          332 VNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       332 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ....+..+...  .++..      .......+.+++.+||+.||++|||+.++++
T Consensus       240 ~~~~i~~~~~~--~~~~~------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          240 LFEGIIKGKYK--MNPRQ------WSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HHHHHHHTCCC--CCHHH------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHcCCCC--CCccc------cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            11111111110  00000      0112346889999999999999999999985

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=4.5e-42  Score=336.37  Aligned_cols=266  Identities=21%  Similarity=0.302  Sum_probs=203.3

Q ss_pred             HHHHHHHHHhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHh--cCCCceeeEeeEEEecCC---C
Q 047276           97 ELEEATDNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIAS--AQHVNLVRLLGYCVVPGG---P  171 (453)
Q Consensus        97 el~~~~~~~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~~~---~  171 (453)
                      +.....+.+.+.||+|+||+||+|+. +|+.||||++...  ....+..|.+++..  ++||||+++++++.....   .
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~  114 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ  114 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence            33344455568999999999999998 4899999999643  45678889999888  789999999999875442   6


Q ss_pred             eEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhcccc--------ccCCCceeccCCCCCcEEE
Q 047276          172 RYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH--------NDCRSRVLHLDVKPENILL  243 (453)
Q Consensus       172 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh--------~~~~~~ivH~Dlk~~NiLl  243 (453)
                      .++||||+++|+|.+++...           .+++..++.++.|++.||+|||        +   .+++||||||+|||+
T Consensus       115 ~~lv~e~~~~g~L~~~l~~~-----------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll  180 (342)
T 1b6c_B          115 LWLVSDYHEHGSLFDYLNRY-----------TVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILV  180 (342)
T ss_dssp             EEEEECCCTTCBHHHHHHHC-----------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEE
T ss_pred             eEEEEeecCCCcHHHHHhcc-----------CccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEE
Confidence            89999999999999999532           3899999999999999999999        6   899999999999999


Q ss_pred             CCCCcEEEeeccccccccCCCCc---eeeeccCCccccchhhhhcCC------CCccccchhHHHHHHHHHcC-------
Q 047276          244 DENYRAVVSDFGLSKLMSRDQSR---CITTIRGTRGYLAPEWILEQG------VSEKCDIYSYGMVLLELTGG-------  307 (453)
Q Consensus       244 ~~~~~~kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~sDV~S~Gvil~elltG-------  307 (453)
                      +.++.+||+|||++.........   ......||+.|+|||.+.+..      ++.++||||||+++|||++|       
T Consensus       181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~  260 (342)
T 1b6c_B          181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH  260 (342)
T ss_dssp             CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence            99999999999999876544322   123457899999999987652      33689999999999999999       


Q ss_pred             ---CCCCcccccCCCCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 047276          308 ---RRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARV  384 (453)
Q Consensus       308 ---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v  384 (453)
                         +.||.........        .......+........+....     ...+....+.+++.+||+.||++|||+.+|
T Consensus       261 ~~~~~p~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~Rps~~~i  327 (342)
T 1b6c_B          261 EDYQLPYYDLVPSDPS--------VEEMRKVVCEQKLRPNIPNRW-----QSCEALRVMAKIMRECWYANGAARLTALRI  327 (342)
T ss_dssp             CCCCCTTTTTSCSSCC--------HHHHHHHHTTSCCCCCCCGGG-----GTSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             cccccCccccCcCccc--------HHHHHHHHHHHHhCCCCcccc-----cchhHHHHHHHHHHHHhccChhhCCCHHHH
Confidence               5566422111100        011112221111111111111     123667789999999999999999999999


Q ss_pred             HHHhcccc
Q 047276          385 VEMLEGRV  392 (453)
Q Consensus       385 ~~~L~~~~  392 (453)
                      ++.|+.+.
T Consensus       328 ~~~L~~i~  335 (342)
T 1b6c_B          328 KKTLSQLS  335 (342)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            99998764

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=7.1e-43  Score=339.56  Aligned_cols=260  Identities=22%  Similarity=0.357  Sum_probs=191.7

Q ss_pred             HHHhcccCcCCceEEEEEEeCCC----cEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCC----
Q 047276          103 DNFQALLGHGSSASVFKGILSDG----TSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGP----  171 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~~g----~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~----  171 (453)
                      +.+.+.||+|+||+||+|.....    ..||||+++..   ....+.+.+|+.++++++||||+++++++......    
T Consensus        25 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (323)
T 3qup_A           25 FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLP  104 (323)
T ss_dssp             CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------
T ss_pred             eEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCC
Confidence            34468999999999999996543    27999998753   33456799999999999999999999998743321    


Q ss_pred             -eEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEE
Q 047276          172 -RYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV  250 (453)
Q Consensus       172 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~k  250 (453)
                       .++|+||+++|+|.+++.......    ....+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+|
T Consensus       105 ~~~~v~e~~~~~~L~~~l~~~~~~~----~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          105 IPMVILPFMKHGDLHAFLLASRIGE----NPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHHC-------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEE
T ss_pred             ccEEEEEeccCCcHHHHHHhhhccc----cccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEE
Confidence             289999999999999986433211    12248999999999999999999999   8999999999999999999999


Q ss_pred             EeeccccccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccch
Q 047276          251 VSDFGLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYF  328 (453)
Q Consensus       251 l~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~  328 (453)
                      |+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......           
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-----------  246 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA-----------  246 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-----------
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH-----------
Confidence            999999987644322 22234457889999999999999999999999999999999 99998532211           


Q ss_pred             hHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          329 PKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       329 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                       . .......+..       .    ..+......+.+++.+||+.||++|||+.++++.|++...
T Consensus       247 -~-~~~~~~~~~~-------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~  298 (323)
T 3qup_A          247 -E-IYNYLIGGNR-------L----KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG  298 (323)
T ss_dssp             -G-HHHHHHTTCC-------C----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -H-HHHHHhcCCC-------C----CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence             0 1111111111       0    1122334568999999999999999999999999998764

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.8e-43  Score=343.21  Aligned_cols=274  Identities=23%  Similarity=0.310  Sum_probs=196.0

Q ss_pred             HhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHH--HHhcCCCceeeEeeEEEec----CCCeEEEEEe
Q 047276          105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAA--IASAQHVNLVRLLGYCVVP----GGPRYLVYEF  178 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~g~~~~~----~~~~~lv~e~  178 (453)
                      +.+.||+|+||+||+|+. +++.||||++....  ...+..|.++  +..++||||+++++++...    ....++||||
T Consensus        17 ~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~   93 (336)
T 3g2f_A           17 LLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN--RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEY   93 (336)
T ss_dssp             EEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECC
T ss_pred             eeeecccCCCeEEEEEEE-CCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEec
Confidence            357899999999999987 58999999997533  3444445444  4458999999999865421    2245899999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccC------CCceeccCCCCCcEEECCCCcEEEe
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDC------RSRVLHLDVKPENILLDENYRAVVS  252 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~------~~~ivH~Dlk~~NiLl~~~~~~kl~  252 (453)
                      +++|+|.+++...           ..++..+++++.|++.||+|||+.+      ..+|+||||||+|||++.++.+||+
T Consensus        94 ~~~g~L~~~l~~~-----------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~  162 (336)
T 3g2f_A           94 YPNGSLXKYLSLH-----------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS  162 (336)
T ss_dssp             CTTCBHHHHHHHC-----------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred             CCCCcHHHHHhhc-----------ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence            9999999999533           2689999999999999999999821      1199999999999999999999999


Q ss_pred             eccccccccCCC-------CceeeeccCCccccchhhhhc-------CCCCccccchhHHHHHHHHHcCCCCCcccccCC
Q 047276          253 DFGLSKLMSRDQ-------SRCITTIRGTRGYLAPEWILE-------QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGN  318 (453)
Q Consensus       253 DfGla~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~  318 (453)
                      |||++.......       ........||+.|+|||.+.+       ..++.++||||||+++|||++|+.|+.......
T Consensus       163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~  242 (336)
T 3g2f_A          163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP  242 (336)
T ss_dssp             CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred             eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence            999998765322       112234579999999999876       456678999999999999999988874332221


Q ss_pred             CCCcccc---cc--hhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          319 DKSKNKW---QY--FPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       319 ~~~~~~~---~~--~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                      .......   ..  ..............    .+.+.............+.+++.+||+.||++|||+.++++.|+++..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~  318 (336)
T 3g2f_A          243 EYQMAFQTEVGNHPTFEDMQVLVSREKQ----RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM  318 (336)
T ss_dssp             CCCCTTHHHHCSSCCHHHHHHHHTTSCC----CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHhhhcccCCCchHHHHHhhhccccc----CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence            1110000   00  00001111111111    111221122233567789999999999999999999999999998765


Q ss_pred             CCC
Q 047276          394 VDD  396 (453)
Q Consensus       394 ~~~  396 (453)
                      ...
T Consensus       319 ~~~  321 (336)
T 3g2f_A          319 IWE  321 (336)
T ss_dssp             CCC
T ss_pred             HHH
Confidence            443

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.8e-42  Score=338.00  Aligned_cols=255  Identities=16%  Similarity=0.171  Sum_probs=199.5

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCCccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEEEEEecCCCC
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYLVYEFIQNGS  183 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~lv~e~~~~gs  183 (453)
                      .+.||+|+||+||+|+. .+|+.||||++..... ...+.+|+.+++++ +||||+++++++. .++..++||||+ +++
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~h~~i~~~~~~~~-~~~~~~lv~e~~-~~~   90 (330)
T 2izr_A           14 GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-APQLHLEYRFYKQLGSGDGIPQVYYFGP-CGKYNAMVLELL-GPS   90 (330)
T ss_dssp             EEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-SCCHHHHHHHHHHHCSCTTSCCEEEEEE-ETTEEEEEEECC-CCB
T ss_pred             EEEeeccCCceEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHhhCCCCCCEEEEEEe-cCCccEEEEEeC-CCC
Confidence            57899999999999995 5789999999875432 34588999999999 9999999999976 456789999999 999


Q ss_pred             hhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCc-----EEEeeccccc
Q 047276          184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYR-----AVVSDFGLSK  258 (453)
Q Consensus       184 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~-----~kl~DfGla~  258 (453)
                      |.+++....         ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.     +||+|||+++
T Consensus        91 L~~~~~~~~---------~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~  158 (330)
T 2izr_A           91 LEDLFDLCD---------RTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK  158 (330)
T ss_dssp             HHHHHHHTT---------TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred             HHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence            999996432         249999999999999999999999   89999999999999999887     9999999998


Q ss_pred             cccCCCCc------eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHH
Q 047276          259 LMSRDQSR------CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIV  332 (453)
Q Consensus       259 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  332 (453)
                      ........      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........         ....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~---------~~~~  229 (330)
T 2izr_A          159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL---------KERY  229 (330)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH---------HHHH
T ss_pred             eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH---------HHHH
Confidence            76543221      12456799999999999999999999999999999999999999964321110         0000


Q ss_pred             HHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          333 NEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       333 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                       ..+......... ..+.  .    ..+ .+.+++..|++.+|.+||++++|.+.|++...
T Consensus       230 -~~i~~~~~~~~~-~~~~--~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~  281 (330)
T 2izr_A          230 -QKIGDTKRATPI-EVLC--E----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD  281 (330)
T ss_dssp             -HHHHHHHHHSCH-HHHT--T----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             -HHHHhhhccCCH-HHHh--c----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence             111000000000 0000  0    112 69999999999999999999999999986543

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.4e-42  Score=341.48  Aligned_cols=248  Identities=22%  Similarity=0.293  Sum_probs=197.2

Q ss_pred             HHHhcccCcCCceEEEEEEeC-CCcEEEEEEecCCCc---cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEe
Q 047276          103 DNFQALLGHGSSASVFKGILS-DGTSVAVKRINGEEN---GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      +.+.+.||+|+||.||++... +|+.||+|++.....   ..+.+.+|+.+++.++||||+++++++. ..+..++||||
T Consensus        31 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-~~~~~~lv~e~  109 (362)
T 2bdw_A           31 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-EESFHYLVFDL  109 (362)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-CSSEEEEEECC
T ss_pred             eEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-eCCEEEEEEec
Confidence            344588999999999999964 689999999976432   3356889999999999999999999986 56688999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCC---CcEEEeecc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDEN---YRAVVSDFG  255 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~---~~~kl~DfG  255 (453)
                      +++|+|.+++...          ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.+   +.+||+|||
T Consensus       110 ~~gg~L~~~l~~~----------~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG  176 (362)
T 2bdw_A          110 VTGGELFEDIVAR----------EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFG  176 (362)
T ss_dssp             CCSCBHHHHHTTC----------SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecC
Confidence            9999999998533          238999999999999999999999   899999999999999865   459999999


Q ss_pred             ccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHh
Q 047276          256 LSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEK  335 (453)
Q Consensus       256 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  335 (453)
                      ++.......  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....             ......
T Consensus       177 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-------------~~~~~~  241 (362)
T 2bdw_A          177 LAIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-------------HRLYAQ  241 (362)
T ss_dssp             TCBCCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------------HHHHHH
T ss_pred             cceEecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------------HHHHHH
Confidence            998765332  23456799999999999988999999999999999999999999953211             011122


Q ss_pred             hhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          336 MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       336 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      +..+... ...+       ........+.+++.+||+.||++||++.++++.
T Consensus       242 i~~~~~~-~~~~-------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          242 IKAGAYD-YPSP-------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             HHHTCCC-CCTT-------GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             HHhCCCC-CCcc-------cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            2222111 0000       011234458899999999999999999998853

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=8.5e-43  Score=346.00  Aligned_cols=244  Identities=23%  Similarity=0.294  Sum_probs=190.9

Q ss_pred             cccCcCCceEEEEEEe-CCCcEEEEEEecCCC-ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCCh
Q 047276          107 ALLGHGSSASVFKGIL-SDGTSVAVKRINGEE-NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL  184 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL  184 (453)
                      +.||+|+||.||+|.. .+|+.||+|+++... ...+.+.+|+.++++++||||+++++++. ..+..++||||+++|+|
T Consensus        95 ~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE-SKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-CSSEEEEEEECCTTCEE
T ss_pred             eEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEE-ECCEEEEEEeCCCCCcH
Confidence            5799999999999996 568999999998643 34567999999999999999999999986 55688999999999999


Q ss_pred             hhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEE--CCCCcEEEeeccccccccC
Q 047276          185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILL--DENYRAVVSDFGLSKLMSR  262 (453)
Q Consensus       185 ~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl--~~~~~~kl~DfGla~~~~~  262 (453)
                      .+++....         ..+++..++.++.|++.||+|||+   .+|+||||||+|||+  ++++.+||+|||+++....
T Consensus       174 ~~~l~~~~---------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~  241 (373)
T 2x4f_A          174 FDRIIDES---------YNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP  241 (373)
T ss_dssp             HHHHHHTG---------GGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred             HHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence            99885432         238999999999999999999999   899999999999999  6778999999999987654


Q ss_pred             CCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCccc
Q 047276          263 DQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLM  342 (453)
Q Consensus       263 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (453)
                      ...  .....||+.|+|||.+....++.++|||||||++|||++|+.||......            ....... .... 
T Consensus       242 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------------~~~~~i~-~~~~-  305 (373)
T 2x4f_A          242 REK--LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA------------ETLNNIL-ACRW-  305 (373)
T ss_dssp             TCB--CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH------------HHHHHHH-HTCC-
T ss_pred             ccc--cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------------HHHHHHH-hccC-
Confidence            332  23456999999999999888999999999999999999999999532110            1111111 1110 


Q ss_pred             ccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          343 EIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       343 ~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ...+..       .......+.+++.+||+.||++|||+.++++
T Consensus       306 ~~~~~~-------~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          306 DLEDEE-------FQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             CSCSGG-------GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCChhh-------hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            000000       1122345899999999999999999999986

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=5.3e-43  Score=336.92  Aligned_cols=264  Identities=22%  Similarity=0.302  Sum_probs=201.6

Q ss_pred             HhcccCcCCceEEEEEEe-----CCCcEEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEecC-CCeEEEE
Q 047276          105 FQALLGHGSSASVFKGIL-----SDGTSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG-GPRYLVY  176 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-----~~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~~lv~  176 (453)
                      +.+.||+|+||.||++++     .+++.||+|++...  ....+.+.+|+.+++.++||||+++++++...+ +..++||
T Consensus        25 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~  104 (302)
T 4e5w_A           25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIM  104 (302)
T ss_dssp             EEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEE
T ss_pred             hhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEE
Confidence            357899999999999984     46889999999753  344578999999999999999999999987543 4578999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||+++|+|.+++....         ..+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+
T Consensus       105 e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~  172 (302)
T 4e5w_A          105 EFLPSGSLKEYLPKNK---------NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGL  172 (302)
T ss_dssp             ECCTTCBHHHHHHHHT---------TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             EeCCCCcHHHHHHhcc---------ccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccc
Confidence            9999999999995432         238999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCC--ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCC--CcccccchhHHH
Q 047276          257 SKLMSRDQS--RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDK--SKNKWQYFPKIV  332 (453)
Q Consensus       257 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~--~~~~~~~~~~~~  332 (453)
                      +........  .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+.........  ............
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  252 (302)
T 4e5w_A          173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL  252 (302)
T ss_dssp             CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred             cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence            987754432  2233456888899999999999999999999999999999999986421100000  000000000011


Q ss_pred             HHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 047276          333 NEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR  391 (453)
Q Consensus       333 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~  391 (453)
                      ......+..           ...+...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus       253 ~~~~~~~~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          253 VNTLKEGKR-----------LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             HHHHHTTCC-----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHhccCC-----------CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            111111110           112233445689999999999999999999999999864

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.7e-42  Score=348.46  Aligned_cols=248  Identities=22%  Similarity=0.278  Sum_probs=196.8

Q ss_pred             HHhcccCcCCceEEEEEEe-CCCcEEEEEEecCCCc---cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          104 NFQALLGHGSSASVFKGIL-SDGTSVAVKRINGEEN---GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      .+.+.||+|+||+||++.. .+|+.+|+|++.....   ..+.+.+|+.+++.++||||+++++++. .++..++||||+
T Consensus        14 ~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~~lv~E~~   92 (444)
T 3soa_A           14 QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS-EEGHHYLIFDLV   92 (444)
T ss_dssp             EEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE-CSSEEEEEECCC
T ss_pred             EEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE-ECCEEEEEEEeC
Confidence            3457999999999999985 5689999999976432   3356889999999999999999999976 566889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEEC---CCCcEEEeeccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD---ENYRAVVSDFGL  256 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~---~~~~~kl~DfGl  256 (453)
                      ++|+|.+++...          ..+++..+..++.|++.||+|||+   .+|+||||||+|||++   .++.+||+|||+
T Consensus        93 ~gg~L~~~i~~~----------~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~  159 (444)
T 3soa_A           93 TGGELFEDIVAR----------EYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGL  159 (444)
T ss_dssp             BCCBHHHHHHHC----------SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred             CCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCce
Confidence            999999998643          238999999999999999999999   8999999999999998   568899999999


Q ss_pred             cccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhh
Q 047276          257 SKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKM  336 (453)
Q Consensus       257 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (453)
                      +........ ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....             ......+
T Consensus       160 a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~-------------~~~~~~i  225 (444)
T 3soa_A          160 AIEVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-------------HRLYQQI  225 (444)
T ss_dssp             CBCCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------------HHHHHHH
T ss_pred             eEEecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH-------------HHHHHHH
Confidence            987654332 23456799999999999988999999999999999999999999953211             1112222


Q ss_pred             hcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          337 KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       337 ~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      ..+... ...+       ........+.+++.+||+.||++|||+.++++.
T Consensus       226 ~~~~~~-~~~~-------~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          226 KAGAYD-FPSP-------EWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             HHTCCC-CCTT-------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HhCCCC-CCcc-------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            222211 0001       011234458899999999999999999999863

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.6e-42  Score=335.09  Aligned_cols=262  Identities=24%  Similarity=0.367  Sum_probs=204.7

Q ss_pred             HHhcccCcCCceEEEEEEe------CCCcEEEEEEecCCC--ccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEE
Q 047276          104 NFQALLGHGSSASVFKGIL------SDGTSVAVKRINGEE--NGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYL  174 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~------~~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~l  174 (453)
                      .+.+.||+|+||.||+|+.      .+++.||||.++...  ...+.+.+|+.++.++ +||||+++++++. .++..++
T Consensus        26 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~-~~~~~~l  104 (313)
T 1t46_A           26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT-IGGPTLV  104 (313)
T ss_dssp             EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSSCEE
T ss_pred             hHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe-cCCCcEE
Confidence            3468999999999999984      346789999997643  2346789999999999 9999999999986 5668899


Q ss_pred             EEEecCCCChhhhhccCCCCCC--------CCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCC
Q 047276          175 VYEFIQNGSLDHWIFPTSRRSE--------GHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDEN  246 (453)
Q Consensus       175 v~e~~~~gsL~~~l~~~~~~~~--------~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~  246 (453)
                      ||||+++|+|.+++........        .......+++..++.++.|++.||+|||+   .+++||||||+||+++.+
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~  181 (313)
T 1t46_A          105 ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHG  181 (313)
T ss_dssp             EEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEETT
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEcCC
Confidence            9999999999999975532100        00012348999999999999999999999   899999999999999999


Q ss_pred             CcEEEeeccccccccCCCCc-eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCccc
Q 047276          247 YRAVVSDFGLSKLMSRDQSR-CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNK  324 (453)
Q Consensus       247 ~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~  324 (453)
                      +.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......       
T Consensus       182 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------  254 (313)
T 1t46_A          182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-------  254 (313)
T ss_dssp             TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-------
T ss_pred             CCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch-------
Confidence            99999999999876544332 2234557889999999999999999999999999999999 99998532211       


Q ss_pred             ccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          325 WQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                           .........+..     .      ..+......+.+++.+||+.||++|||+.++++.|++..
T Consensus       255 -----~~~~~~~~~~~~-----~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  306 (313)
T 1t46_A          255 -----SKFYKMIKEGFR-----M------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (313)
T ss_dssp             -----HHHHHHHHHTCC-----C------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----hHHHHHhccCCC-----C------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence                 011111111110     0      011223456899999999999999999999999998764

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=3.1e-43  Score=340.67  Aligned_cols=264  Identities=24%  Similarity=0.400  Sum_probs=205.7

Q ss_pred             HHHhcccCcCCceEEEEEEe------CCCcEEEEEEecCCCc--cHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeE
Q 047276          103 DNFQALLGHGSSASVFKGIL------SDGTSVAVKRINGEEN--GEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRY  173 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~------~~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~  173 (453)
                      +.+.+.||+|+||+||+|..      .+++.||||++.....  ..+.+.+|+.++.++ +||||++++++|...+...+
T Consensus        29 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~  108 (316)
T 2xir_A           29 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM  108 (316)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCE
T ss_pred             eeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceE
Confidence            33458999999999999984      3468899999976432  345789999999999 79999999999876666789


Q ss_pred             EEEEecCCCChhhhhccCCCCCC------CCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCC
Q 047276          174 LVYEFIQNGSLDHWIFPTSRRSE------GHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENY  247 (453)
Q Consensus       174 lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~  247 (453)
                      +||||+++|+|.+++........      .......+++..++.++.|++.||+|||+   .+++||||||+||+++.++
T Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~  185 (316)
T 2xir_A          109 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKN  185 (316)
T ss_dssp             EEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCC
Confidence            99999999999999975532100      00012338899999999999999999999   8999999999999999999


Q ss_pred             cEEEeeccccccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccc
Q 047276          248 RAVVSDFGLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKW  325 (453)
Q Consensus       248 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~  325 (453)
                      .+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......        
T Consensus       186 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--------  257 (316)
T 2xir_A          186 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------  257 (316)
T ss_dssp             CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--------
T ss_pred             CEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh--------
Confidence            999999999987654332 22334567889999999999999999999999999999998 99998532211        


Q ss_pred             cchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          326 QYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                          .........+....           .+......+.+++.+||+.+|++|||+.++++.|+...
T Consensus       258 ----~~~~~~~~~~~~~~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  309 (316)
T 2xir_A          258 ----EEFCRRLKEGTRMR-----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  309 (316)
T ss_dssp             ----HHHHHHHHHTCCCC-----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----HHHHHHhccCccCC-----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                11122222221110           11123345889999999999999999999999998754

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1e-42  Score=339.41  Aligned_cols=251  Identities=22%  Similarity=0.369  Sum_probs=193.8

Q ss_pred             HhcccCcCCceEEEEEEeC-CCc----EEEEEEecC--CCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          105 FQALLGHGSSASVFKGILS-DGT----SVAVKRING--EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~----~vavK~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      +.++||+|+||+||+|... +++    .||+|.+..  .....+.+.+|+.++++++||||++++++|..  ...++++|
T Consensus        19 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~v~~   96 (327)
T 3lzb_A           19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--STVQLITQ   96 (327)
T ss_dssp             EEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES--SSEEEEEC
T ss_pred             EEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec--CCceEEEE
Confidence            3578999999999999953 444    357887754  34456789999999999999999999999863  35889999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |+++|+|.+++....         ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus        97 ~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a  164 (327)
T 3lzb_A           97 LMPFGCLLDYVREHK---------DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLA  164 (327)
T ss_dssp             CCSSCBHHHHHHHTT---------TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred             ecCCCcHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence            999999999996542         238999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHh
Q 047276          258 KLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEK  335 (453)
Q Consensus       258 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  335 (453)
                      +....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......             ....
T Consensus       165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------------~~~~  231 (327)
T 3lzb_A          165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------------ISSI  231 (327)
T ss_dssp             ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------------HHHH
T ss_pred             eEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------------HHHH
Confidence            87654322 22334457889999999999999999999999999999999 999995322110             1111


Q ss_pred             hhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          336 MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       336 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                      +..+..           ...+......+.+++.+||+.+|++||++.++++.|+....
T Consensus       232 ~~~~~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          232 LEKGER-----------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             HHTTCC-----------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             HHcCCC-----------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            111110           01122334458899999999999999999999999998654

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.5e-42  Score=336.71  Aligned_cols=242  Identities=24%  Similarity=0.327  Sum_probs=186.4

Q ss_pred             HhcccCcCCceEEEEEEe----CCCcEEEEEEecCCC-----ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEE
Q 047276          105 FQALLGHGSSASVFKGIL----SDGTSVAVKRINGEE-----NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLV  175 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~----~~g~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv  175 (453)
                      +.+.||+|+||.||+++.    .+|+.||+|+++...     .....+.+|+.+++.++||||+++++++. .++..++|
T Consensus        21 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~~lv   99 (327)
T 3a62_A           21 LLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ-TGGKLYLI   99 (327)
T ss_dssp             EEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE-CSSCEEEE
T ss_pred             EEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE-cCCEEEEE
Confidence            457899999999999996    478999999997532     23356788999999999999999999986 56788999


Q ss_pred             EEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecc
Q 047276          176 YEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFG  255 (453)
Q Consensus       176 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfG  255 (453)
                      |||+++|+|.+++...          ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||
T Consensus       100 ~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg  166 (327)
T 3a62_A          100 LEYLSGGELFMQLERE----------GIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFG  166 (327)
T ss_dssp             EECCTTEEHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCS
T ss_pred             EeCCCCCcHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCC
Confidence            9999999999999643          238899999999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHh
Q 047276          256 LSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEK  335 (453)
Q Consensus       256 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  335 (453)
                      +++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....            .. ....
T Consensus       167 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------------~~-~~~~  232 (327)
T 3a62_A          167 LCKESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR------------KK-TIDK  232 (327)
T ss_dssp             CC-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------------HH-HHHH
T ss_pred             cccccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH------------HH-HHHH
Confidence            997543222 123446799999999999998999999999999999999999999953211            01 1111


Q ss_pred             hhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 047276          336 MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRP-----SMARVVE  386 (453)
Q Consensus       336 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~~v~~  386 (453)
                      +..+.            ...+......+.+++.+||+.||++||     ++.++++
T Consensus       233 i~~~~------------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          233 ILKCK------------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             HHHTC------------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             HHhCC------------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            11111            112223345688999999999999999     6677764

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1e-42  Score=343.95  Aligned_cols=248  Identities=23%  Similarity=0.246  Sum_probs=188.1

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCC
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS  183 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gs  183 (453)
                      +.+.||+|+||+||+++.. +++.||||++.......+.+.+|+.+++.++||||+++++++. ..+..++||||+++|+
T Consensus        24 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~~~lv~e~~~~~~  102 (361)
T 3uc3_A           24 FVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVIL-TPTHLAIIMEYASGGE  102 (361)
T ss_dssp             EEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEE-CSSEEEEEEECCCSCB
T ss_pred             EEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEe-eCCEEEEEEEeCCCCC
Confidence            4578999999999999975 7899999999876555677899999999999999999999986 5568899999999999


Q ss_pred             hhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCc--EEEeecccccccc
Q 047276          184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYR--AVVSDFGLSKLMS  261 (453)
Q Consensus       184 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~--~kl~DfGla~~~~  261 (453)
                      |.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.  +||+|||+++...
T Consensus       103 L~~~l~~~~----------~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~  169 (361)
T 3uc3_A          103 LYERICNAG----------RFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  169 (361)
T ss_dssp             HHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred             HHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence            999985432          38999999999999999999999   89999999999999987765  9999999997543


Q ss_pred             CCCCceeeeccCCccccchhhhhcCCCCcc-ccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILEQGVSEK-CDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      ...  ......||+.|+|||.+.+..++.+ +|||||||++|||++|+.||........        +......... ..
T Consensus       170 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--------~~~~~~~~~~-~~  238 (361)
T 3uc3_A          170 LHS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--------YRKTIQRILS-VK  238 (361)
T ss_dssp             -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--------HHHHHHHHHT-TC
T ss_pred             ccC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--------HHHHHHHHhc-CC
Confidence            222  2234579999999999988877665 8999999999999999999964322111        1111111111 10


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      .      .+....    .....+.+++.+||+.+|++|||+.++++.
T Consensus       239 ~------~~~~~~----~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          239 Y------SIPDDI----RISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             C------CCCTTS----CCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             C------CCCCcC----CCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            0      111111    123458899999999999999999999854

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=8.2e-43  Score=342.21  Aligned_cols=241  Identities=20%  Similarity=0.279  Sum_probs=195.3

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEEEEEe
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      +.+.||+|+||.||+|+.. +|+.||+|+++..    ......+..|..++..+ +||||+++++++. ..+..++||||
T Consensus        21 ~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~-~~~~~~lv~E~   99 (345)
T 1xjd_A           21 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ-TKENLFFVMEY   99 (345)
T ss_dssp             EEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE-CSSEEEEEEEC
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE-eCCEEEEEEeC
Confidence            3578999999999999974 6889999999752    33456788899999887 8999999999876 56688999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       100 ~~gg~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~  166 (345)
T 1xjd_A          100 LNGGDLMYHIQSCH----------KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK  166 (345)
T ss_dssp             CTTCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             CCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence            99999999996432          38999999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      ...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....             ......+..
T Consensus       167 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------------~~~~~~i~~  232 (345)
T 1xjd_A          167 ENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-------------EELFHSIRM  232 (345)
T ss_dssp             CCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------------HHHHHHHHH
T ss_pred             hcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH-------------HHHHHHHHh
Confidence            643222 223556899999999999999999999999999999999999999953211             001111111


Q ss_pred             CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHH-HHH
Q 047276          339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMA-RVV  385 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~-~v~  385 (453)
                      +.      +      .++......+.+++.+||+.||++||++. ++.
T Consensus       233 ~~------~------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          233 DN------P------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             CC------C------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             CC------C------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence            11      1      11222345688999999999999999997 654

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=4.7e-43  Score=341.62  Aligned_cols=266  Identities=21%  Similarity=0.287  Sum_probs=203.7

Q ss_pred             HhcccCcCCceEEEEEEe-----CCCcEEEEEEecCCC-ccHHHHHHHHHHHHhcCCCceeeEeeEEEec-CCCeEEEEE
Q 047276          105 FQALLGHGSSASVFKGIL-----SDGTSVAVKRINGEE-NGEKEFRSEVAAIASAQHVNLVRLLGYCVVP-GGPRYLVYE  177 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~~lv~e  177 (453)
                      +.+.||+|+||.||++++     .+++.||||++.... ...+.+.+|+.++++++||||+++++++... ....++|||
T Consensus        27 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e  106 (327)
T 3lxl_A           27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVME  106 (327)
T ss_dssp             EEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEE
T ss_pred             hhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEe
Confidence            357899999999999984     467899999997643 3345689999999999999999999988743 345789999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |+++|+|.+++....         ..+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++
T Consensus       107 ~~~~~~L~~~l~~~~---------~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  174 (327)
T 3lxl_A          107 YLPSGCLRDFLQRHR---------ARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLA  174 (327)
T ss_dssp             CCTTCBHHHHHHHHG---------GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred             ecCCCCHHHHHHhcc---------cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccc
Confidence            999999999996432         238999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCc--eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCC---CcccccchhHHH
Q 047276          258 KLMSRDQSR--CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDK---SKNKWQYFPKIV  332 (453)
Q Consensus       258 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~---~~~~~~~~~~~~  332 (453)
                      .........  ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||.........   ........ ...
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~  253 (327)
T 3lxl_A          175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL-SRL  253 (327)
T ss_dssp             EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHH-HHH
T ss_pred             eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccH-HHH
Confidence            877543321  223356788899999999988999999999999999999999998532211000   00000000 001


Q ss_pred             HHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccCC
Q 047276          333 NEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAV  394 (453)
Q Consensus       333 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~~  394 (453)
                      ......+.         .  ...+......+.+++.+||+.||++|||+.++++.|+.....
T Consensus       254 ~~~~~~~~---------~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  304 (327)
T 3lxl_A          254 LELLEEGQ---------R--LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG  304 (327)
T ss_dssp             HHHHHTTC---------C--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred             HHHhhccc---------C--CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            11111111         0  112334455689999999999999999999999999987543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3.6e-43  Score=340.06  Aligned_cols=253  Identities=23%  Similarity=0.318  Sum_probs=188.4

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCCCc----cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCC---eEEEE
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGEEN----GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGP---RYLVY  176 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~---~~lv~  176 (453)
                      +.+.||+|+||+||+++. .+++.||||+++....    ....+.+|+.++.+++||||+++++++......   .++||
T Consensus        16 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~   95 (311)
T 3ork_A           16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVM   95 (311)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEE
Confidence            357899999999999995 6789999999976322    234688999999999999999999988654322   38999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||+++|+|.+++...          +.+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+
T Consensus        96 e~~~g~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  162 (311)
T 3ork_A           96 EYVDGVTLRDIVHTE----------GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGI  162 (311)
T ss_dssp             ECCCEEEHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred             ecCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccC
Confidence            999999999999643          238999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCC--ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHH
Q 047276          257 SKLMSRDQS--RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNE  334 (453)
Q Consensus       257 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  334 (453)
                      +........  .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....            ......
T Consensus       163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------------~~~~~~  230 (311)
T 3ork_A          163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------------VSVAYQ  230 (311)
T ss_dssp             C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------------HHHHHH
T ss_pred             cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------------HHHHHH
Confidence            987654322  223345689999999999999999999999999999999999999953211            011111


Q ss_pred             hhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHH-HHhccc
Q 047276          335 KMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVV-EMLEGR  391 (453)
Q Consensus       335 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~-~~L~~~  391 (453)
                      ........    +..     .....+..+.+++.+||+.||++||+..+++ ..+...
T Consensus       231 ~~~~~~~~----~~~-----~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          231 HVREDPIP----PSA-----RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             HHHCCCCC----HHH-----HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             HhcCCCCC----ccc-----ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            11111100    000     0011234588999999999999999776655 444443

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.6e-42  Score=328.78  Aligned_cols=246  Identities=29%  Similarity=0.490  Sum_probs=194.0

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCCCc--cH------HHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEE
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGEEN--GE------KEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLV  175 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~--~~------~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv  175 (453)
                      +.+.||+|+||+||+|+. .+++.||+|++.....  ..      +.+.+|+.++++++||||+++++++..   ..++|
T Consensus        23 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~lv   99 (287)
T 4f0f_A           23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN---PPRMV   99 (287)
T ss_dssp             EEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT---TTEEE
T ss_pred             ehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC---CCeEE
Confidence            357899999999999996 5789999999864221  11      678999999999999999999998742   33799


Q ss_pred             EEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCc--eeccCCCCCcEEECCCCc-----
Q 047276          176 YEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSR--VLHLDVKPENILLDENYR-----  248 (453)
Q Consensus       176 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~--ivH~Dlk~~NiLl~~~~~-----  248 (453)
                      |||+++|+|.+++....         ..+++..++.++.|++.||+|||+   .+  ++||||||+|||++.++.     
T Consensus       100 ~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~  167 (287)
T 4f0f_A          100 MEFVPCGDLYHRLLDKA---------HPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVC  167 (287)
T ss_dssp             EECCTTCBHHHHHHCTT---------SCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred             EEecCCCCHHHHHhccc---------CCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCcee
Confidence            99999999999885432         248999999999999999999999   67  999999999999988776     


Q ss_pred             EEEeeccccccccCCCCceeeeccCCccccchhhhh--cCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCccccc
Q 047276          249 AVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWIL--EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQ  326 (453)
Q Consensus       249 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~  326 (453)
                      +||+|||+++....    ......||+.|+|||.+.  ...++.++||||||+++|||++|+.||.......        
T Consensus       168 ~kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--------  235 (287)
T 4f0f_A          168 AKVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK--------  235 (287)
T ss_dssp             EEECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH--------
T ss_pred             EEeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH--------
Confidence            99999999975432    234567999999999984  4567899999999999999999999995322110        


Q ss_pred             chhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 047276          327 YFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEG  390 (453)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~  390 (453)
                        .. ...........    +      ..+......+.+++.+||+.||++|||++++++.|++
T Consensus       236 --~~-~~~~~~~~~~~----~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          236 --IK-FINMIREEGLR----P------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             --HH-HHHHHHHSCCC----C------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             --HH-HHHHHhccCCC----C------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence              00 01111111111    1      1222334568999999999999999999999999975

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.4e-42  Score=341.61  Aligned_cols=245  Identities=22%  Similarity=0.305  Sum_probs=180.9

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCC
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS  183 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gs  183 (453)
                      +.+.||+|+||+||+|+.. +++.||||+++... ..+.+.+|+.++.+++||||+++++++. ..+..++||||+++|+
T Consensus        57 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~~~~  134 (349)
T 2w4o_A           57 VESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFE-TPTEISLVLELVTGGE  134 (349)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEE-CSSEEEEEECCCCSCB
T ss_pred             EeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEe-cCCeEEEEEEeCCCCC
Confidence            3578999999999999975 57899999997543 3456889999999999999999999986 5567899999999999


Q ss_pred             hhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECC---CCcEEEeeccccccc
Q 047276          184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDE---NYRAVVSDFGLSKLM  260 (453)
Q Consensus       184 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~---~~~~kl~DfGla~~~  260 (453)
                      |.+++...          ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.   ++.+||+|||+++..
T Consensus       135 L~~~l~~~----------~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          135 LFDRIVEK----------GYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             HHHHHTTC----------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             HHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            99998533          238999999999999999999999   89999999999999975   899999999999865


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      ....  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......            ......+..+.
T Consensus       202 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------------~~~~~~i~~~~  267 (349)
T 2w4o_A          202 EHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD------------QFMFRRILNCE  267 (349)
T ss_dssp             -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH------------HHHHHHHHTTC
T ss_pred             Cccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc------------HHHHHHHHhCC
Confidence            4322  234467899999999999989999999999999999999999999532110            00111111111


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      .. ...       .........+.+++.+||+.||++|||+.++++
T Consensus       268 ~~-~~~-------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          268 YY-FIS-------PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             CC-CCT-------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             Cc-cCC-------chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            10 000       111233456889999999999999999999886

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.6e-42  Score=343.03  Aligned_cols=244  Identities=24%  Similarity=0.326  Sum_probs=195.7

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecC----CCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRING----EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      +.+.||+|+||.||++... +++.||+|++..    .....+.+.+|+.++..++||||+++++++. ..+..++||||+
T Consensus        19 i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-~~~~~~lv~e~~   97 (384)
T 4fr4_A           19 ILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ-DEEDMFMVVDLL   97 (384)
T ss_dssp             EEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-CSSEEEEEECCC
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-eCCEEEEEEecC
Confidence            3578999999999999964 588999999864    2344567899999999999999999999886 556889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ++|+|.+++...          ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++..
T Consensus        98 ~gg~L~~~l~~~----------~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~  164 (384)
T 4fr4_A           98 LGGDLRYHLQQN----------VHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAM  164 (384)
T ss_dssp             TTEEHHHHHHTT----------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeee
Confidence            999999999643          238999999999999999999999   8999999999999999999999999999987


Q ss_pred             ccCCCCceeeeccCCccccchhhhhc---CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhh
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILE---QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKM  336 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (453)
                      .....  ......||+.|+|||.+..   ..++.++|||||||++|||++|+.||.......         ... .....
T Consensus       165 ~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~---------~~~-~~~~~  232 (384)
T 4fr4_A          165 LPRET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS---------SKE-IVHTF  232 (384)
T ss_dssp             CCTTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC---------HHH-HHHHH
T ss_pred             ccCCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc---------HHH-HHHHH
Confidence            65332  2355689999999999874   458999999999999999999999996322111         000 11111


Q ss_pred             hcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCC-HHHHHH
Q 047276          337 KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPS-MARVVE  386 (453)
Q Consensus       337 ~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-~~~v~~  386 (453)
                      ....            ..++......+.+++.+||+.||++||+ ++++.+
T Consensus       233 ~~~~------------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          233 ETTV------------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             HHCC------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             hhcc------------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            1110            1122334456899999999999999998 666653

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.3e-42  Score=329.17  Aligned_cols=253  Identities=21%  Similarity=0.305  Sum_probs=198.8

Q ss_pred             hcccCcCCceEEEEEEeC-CC---cEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          106 QALLGHGSSASVFKGILS-DG---TSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g---~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      .++||+|+||+||+|... ++   ..||+|.+....  ...+.+.+|+.++++++||||+++++++...+...++++||+
T Consensus        26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~  105 (298)
T 3pls_A           26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM  105 (298)
T ss_dssp             EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred             CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence            478999999999999853 22   379999997533  234678999999999999999999999875555569999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      .+|+|.+++....         ..+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++.
T Consensus       106 ~~~~L~~~~~~~~---------~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  173 (298)
T 3pls_A          106 CHGDLLQFIRSPQ---------RNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARD  173 (298)
T ss_dssp             TTCBHHHHHHCTT---------CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred             cCCCHHHHHhccc---------cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence            9999999996432         338999999999999999999999   8999999999999999999999999999986


Q ss_pred             ccCCC---CceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhh
Q 047276          260 MSRDQ---SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKM  336 (453)
Q Consensus       260 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (453)
                      .....   ........+|+.|+|||.+.+..++.++||||||+++|||++|..|+......            .......
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~------------~~~~~~~  241 (298)
T 3pls_A          174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP------------FDLTHFL  241 (298)
T ss_dssp             TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG------------GGHHHHH
T ss_pred             ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH------------HHHHHHh
Confidence            54322   12233456788999999999999999999999999999999966654311110            0011111


Q ss_pred             hcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          337 KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       337 ~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                      ..+..       .    ..+......+.+++.+|++.+|++|||+.++++.|++...
T Consensus       242 ~~~~~-------~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  287 (298)
T 3pls_A          242 AQGRR-------L----PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS  287 (298)
T ss_dssp             HTTCC-------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hcCCC-------C----CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            11110       0    1112233468899999999999999999999999988654

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=5.4e-42  Score=324.21  Aligned_cols=247  Identities=19%  Similarity=0.317  Sum_probs=196.5

Q ss_pred             HhcccCcCCceEEEEEEeCCCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEec-CCCeEEEEEecC
Q 047276          105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVP-GGPRYLVYEFIQ  180 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~~lv~e~~~  180 (453)
                      +.+.||+|+||+||+|+.. |+.||||+++...   ...+.|.+|+.++++++||||+++++++... .+..++||||++
T Consensus        14 ~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~   92 (271)
T 3kmu_A           14 FLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMP   92 (271)
T ss_dssp             EEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCT
T ss_pred             HHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccC
Confidence            4578999999999999985 8899999997643   2345699999999999999999999998644 257799999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCc--eeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSR--VLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~--ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +|+|.+++.....        ..+++..++.++.|++.||+|||+   .+  ++||||||+||+++.++.++|+|||++.
T Consensus        93 ~~~L~~~l~~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~  161 (271)
T 3kmu_A           93 YGSLYNVLHEGTN--------FVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKF  161 (271)
T ss_dssp             TCBHHHHHHSCSS--------CCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred             CCcHHHHHhhccc--------CCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEecccee
Confidence            9999999965422        248999999999999999999998   67  9999999999999999999999999875


Q ss_pred             cccCCCCceeeeccCCccccchhhhhcCCCCc---cccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHh
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWILEQGVSE---KCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEK  335 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  335 (453)
                      ....      ....||+.|+|||.+.+..++.   ++||||||+++|||++|+.||.....            .......
T Consensus       162 ~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------------~~~~~~~  223 (271)
T 3kmu_A          162 SFQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN------------MEIGMKV  223 (271)
T ss_dssp             TTSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH------------HHHHHHH
T ss_pred             eecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh------------HHHHHHH
Confidence            4322      2346799999999998755444   79999999999999999999953211            0111111


Q ss_pred             hhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          336 MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       336 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      ...+..     +      ..+......+.+++..||+.||++|||++++++.|+...
T Consensus       224 ~~~~~~-----~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          224 ALEGLR-----P------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             HHSCCC-----C------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             HhcCCC-----C------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            111110     1      112233455899999999999999999999999998754

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=6.6e-42  Score=334.55  Aligned_cols=263  Identities=22%  Similarity=0.378  Sum_probs=204.0

Q ss_pred             HHhcccCcCCceEEEEEEeC--------CCcEEEEEEecCCC--ccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCe
Q 047276          104 NFQALLGHGSSASVFKGILS--------DGTSVAVKRINGEE--NGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPR  172 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~--------~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~  172 (453)
                      .+.+.||+|+||+||+|...        ++..||||+++...  ...+.+.+|+.++.++ +||||++++++|. ..+..
T Consensus        38 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-~~~~~  116 (334)
T 2pvf_A           38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT-QDGPL  116 (334)
T ss_dssp             EEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCC
T ss_pred             EEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc-cCCce
Confidence            34689999999999999863        46789999997643  2345789999999999 8999999999986 56688


Q ss_pred             EEEEEecCCCChhhhhccCCCCCCC------CCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCC
Q 047276          173 YLVYEFIQNGSLDHWIFPTSRRSEG------HYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDEN  246 (453)
Q Consensus       173 ~lv~e~~~~gsL~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~  246 (453)
                      ++||||+++|+|.+++.........      ......+++..++.++.|++.||+|||+   .+++||||||+|||++.+
T Consensus       117 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~  193 (334)
T 2pvf_A          117 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTEN  193 (334)
T ss_dssp             EEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTT
T ss_pred             EEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEEcCC
Confidence            9999999999999999755421100      0112348999999999999999999999   899999999999999999


Q ss_pred             CcEEEeeccccccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCccc
Q 047276          247 YRAVVSDFGLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNK  324 (453)
Q Consensus       247 ~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~  324 (453)
                      +.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....        
T Consensus       194 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------  265 (334)
T 2pvf_A          194 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--------  265 (334)
T ss_dssp             CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------
T ss_pred             CCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH--------
Confidence            9999999999987654332 12233457889999999998889999999999999999999 9999853210        


Q ss_pred             ccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccCC
Q 047276          325 WQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAV  394 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~~  394 (453)
                           ......+..+...           ..+......+.+++.+||+.+|++|||+.++++.|+.+...
T Consensus       266 -----~~~~~~~~~~~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~  319 (334)
T 2pvf_A          266 -----EELFKLLKEGHRM-----------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  319 (334)
T ss_dssp             -----HHHHHHHHHTCCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----HHHHHHHhcCCCC-----------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence                 0111222222110           11122345688999999999999999999999999987543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.4e-42  Score=338.16  Aligned_cols=248  Identities=25%  Similarity=0.317  Sum_probs=176.9

Q ss_pred             cccCcCCceEEEEEEeC-CCcEEEEEEecCCCccHHHHHHHHHHHHhcC-CCceeeEeeEEEecCCCeEEEEEecCCCCh
Q 047276          107 ALLGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRSEVAAIASAQ-HVNLVRLLGYCVVPGGPRYLVYEFIQNGSL  184 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~~lv~e~~~~gsL  184 (453)
                      +.||+|+||+||++... +|+.||||++...  ....+.+|+.++..+. ||||+++++++. .+...++||||+++|+|
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~-~~~~~~lv~e~~~~~~L   93 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFH-DQLHTFLVMELLNGGEL   93 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEE-CSSEEEEEECCCCSCBH
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEE-cCCEEEEEEEccCCCcH
Confidence            67999999999999974 6899999999643  4567889999999997 999999999986 56688999999999999


Q ss_pred             hhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCC---cEEEeecccccccc
Q 047276          185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENY---RAVVSDFGLSKLMS  261 (453)
Q Consensus       185 ~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~---~~kl~DfGla~~~~  261 (453)
                      .+++...          ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++   .+||+|||+++...
T Consensus        94 ~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~  160 (325)
T 3kn6_A           94 FERIKKK----------KHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP  160 (325)
T ss_dssp             HHHHHHC----------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred             HHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence            9999643          238999999999999999999999   8999999999999997665   89999999998664


Q ss_pred             CCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcc
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKL  341 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (453)
                      ... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..........      ........+..+..
T Consensus       161 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~------~~~~~~~~i~~~~~  233 (325)
T 3kn6_A          161 PDN-QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCT------SAVEIMKKIKKGDF  233 (325)
T ss_dssp             C-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CC------CHHHHHHHHTTTCC
T ss_pred             CCC-CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccc------cHHHHHHHHHcCCC
Confidence            332 22345578999999999999999999999999999999999999996433211110      01111222222221


Q ss_pred             cccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 047276          342 MEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVV  385 (453)
Q Consensus       342 ~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~  385 (453)
                      .-        ...........+.+++.+||+.||++|||+++++
T Consensus       234 ~~--------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell  269 (325)
T 3kn6_A          234 SF--------EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR  269 (325)
T ss_dssp             CC--------CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred             CC--------CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence            00        0000112345689999999999999999999986

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.4e-43  Score=338.04  Aligned_cols=257  Identities=19%  Similarity=0.238  Sum_probs=191.9

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCCc----cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEEN----GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      +.+.||+|+||.||++... +++.||+|++.....    ..+.+.+|+.++.+++||||+++++++. .++..++|+||+
T Consensus        38 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-~~~~~~lv~e~~  116 (309)
T 2h34_A           38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGE-IDGQLYVDMRLI  116 (309)
T ss_dssp             EEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-ETTEEEEEEECC
T ss_pred             EEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe-eCCeEEEEEEec
Confidence            3578999999999999964 688999999875322    2367889999999999999999999986 456889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ++++|.+++...          ..+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++..
T Consensus       117 ~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~  183 (309)
T 2h34_A          117 NGVDLAAMLRRQ----------GPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASA  183 (309)
T ss_dssp             CCEEHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC---
T ss_pred             CCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcc
Confidence            999999999643          238999999999999999999999   8999999999999999999999999999987


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      .............|++.|+|||.+.+..++.++||||||+++|||++|+.||.....             ..........
T Consensus       184 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------------~~~~~~~~~~  250 (309)
T 2h34_A          184 TTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-------------SVMGAHINQA  250 (309)
T ss_dssp             -------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-------------HHHHHHHHSC
T ss_pred             ccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-------------HHHHHHhccC
Confidence            654433334456789999999999988999999999999999999999999953211             0111111111


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHhccccCCCCC
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRP-SMARVVEMLEGRVAVDDP  397 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-s~~~v~~~L~~~~~~~~~  397 (453)
                      .. .   +     ...+...+..+.+++.+||+.||++|| +++++++.|+........
T Consensus       251 ~~-~---~-----~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~  300 (309)
T 2h34_A          251 IP-R---P-----STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ  300 (309)
T ss_dssp             CC-C---G-----GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred             CC-C---c-----cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence            10 0   0     001122334588999999999999999 999999999987654433

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.1e-42  Score=340.13  Aligned_cols=238  Identities=23%  Similarity=0.274  Sum_probs=196.2

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      .+.||+|+||.||+++.. +|+.||+|++...    ....+.+.+|+.++..++||||+++++++. ..+..++||||++
T Consensus        46 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~~lv~e~~~  124 (350)
T 1rdq_E           46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-DNSNLYMVMEYVA  124 (350)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-CSSEEEEEEECCT
T ss_pred             EEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-cCCEEEEEEcCCC
Confidence            478999999999999964 6899999998642    234567889999999999999999999876 5668899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       125 gg~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~  191 (350)
T 1rdq_E          125 GGEMFSHLRRIG----------RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV  191 (350)
T ss_dssp             TCBHHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceec
Confidence            999999996432          38999999999999999999999   89999999999999999999999999999876


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      ...    .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.....             ......+..+.
T Consensus       192 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------------~~~~~~i~~~~  254 (350)
T 1rdq_E          192 KGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-------------IQIYEKIVSGK  254 (350)
T ss_dssp             SSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------------HHHHHHHHHCC
T ss_pred             cCC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH-------------HHHHHHHHcCC
Confidence            432    2345789999999999999999999999999999999999999953211             11112222221


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPS-----MARVVE  386 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~~v~~  386 (453)
                      .            .++......+.+++.+||+.||++||+     ++++.+
T Consensus       255 ~------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          255 V------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             C------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             C------------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            1            112233455889999999999999998     888774

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=5.5e-42  Score=335.35  Aligned_cols=235  Identities=23%  Similarity=0.301  Sum_probs=193.1

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCCc---------cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEE
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEEN---------GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLV  175 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv  175 (453)
                      .+.||+|+||+||+|.. .+++.||||+++....         ....+.+|+.++++++||||+++++++. ..+..++|
T Consensus        29 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~-~~~~~~lv  107 (335)
T 3dls_A           29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE-NQGFFQLV  107 (335)
T ss_dssp             EEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE-CSSEEEEE
T ss_pred             EeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-eCCEEEEE
Confidence            47899999999999995 5688999999975321         2235778999999999999999999986 56688999


Q ss_pred             EEecCCC-ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeec
Q 047276          176 YEFIQNG-SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDF  254 (453)
Q Consensus       176 ~e~~~~g-sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~Df  254 (453)
                      |||+.+| +|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+||
T Consensus       108 ~e~~~~g~~l~~~~~~~~----------~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Df  174 (335)
T 3dls_A          108 MEKHGSGLDLFAFIDRHP----------RLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDF  174 (335)
T ss_dssp             EECCTTSCBHHHHHHTCC----------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCC
T ss_pred             EEeCCCCccHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeec
Confidence            9999877 9999986432          38999999999999999999999   89999999999999999999999999


Q ss_pred             cccccccCCCCceeeeccCCccccchhhhhcCCC-CccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHH
Q 047276          255 GLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGV-SEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVN  333 (453)
Q Consensus       255 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  333 (453)
                      |++........  .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.......               
T Consensus       175 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---------------  237 (335)
T 3dls_A          175 GSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV---------------  237 (335)
T ss_dssp             TTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT---------------
T ss_pred             ccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH---------------
Confidence            99987654332  345679999999999988776 789999999999999999999995321100               


Q ss_pred             HhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          334 EKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       334 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                                  .....    .+......+.+++.+||+.||++|||+.++++.
T Consensus       238 ------------~~~~~----~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          238 ------------EAAIH----PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ------------TTCCC----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ------------hhccC----CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                        00000    011123458899999999999999999999864

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.4e-42  Score=337.29  Aligned_cols=245  Identities=21%  Similarity=0.286  Sum_probs=192.4

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCCC----ccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEEEEEec
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGEE----NGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      .+.||+|+||.||+++.. +|+.||+|+++...    ...+.+.+|..++.++ +||||+++++++. ..+..++||||+
T Consensus        14 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~-~~~~~~lv~e~~   92 (345)
T 3a8x_A           14 LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-TESRLFFVIEYV   92 (345)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-CSSEEEEEECCC
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE-eCCEEEEEEeCC
Confidence            578999999999999975 58899999997532    2235688899999988 8999999999876 566889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~gg~L~~~l~~~~----------~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~  159 (345)
T 3a8x_A           93 NGGDLMFHMQRQR----------KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  159 (345)
T ss_dssp             CSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred             CCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEecccccc
Confidence            9999999996432          38999999999999999999999   8999999999999999999999999999986


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      ..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..........    .............+
T Consensus       160 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~----~~~~~~~~~~i~~~  234 (345)
T 3a8x_A          160 GLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD----QNTEDYLFQVILEK  234 (345)
T ss_dssp             SCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-----------CHHHHHHHHHHC
T ss_pred             ccCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccc----cccHHHHHHHHHcC
Confidence            43222 22345689999999999999999999999999999999999999996432111110    00011111111111


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCH
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSM  381 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  381 (453)
                      .            ..++......+.+++.+||+.||++||++
T Consensus       235 ~------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          235 Q------------IRIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             C------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             C------------CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence            1            11222334568899999999999999995

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.8e-42  Score=331.91  Aligned_cols=259  Identities=20%  Similarity=0.277  Sum_probs=202.2

Q ss_pred             HHhcccCcCCceEEEEEEe-CCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCC
Q 047276          104 NFQALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      .+.+.||+|+||+||+|+. .+++.||||++..... ...+..|+.++..++|+|++..+++|...++..++||||+ ++
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~   89 (296)
T 4hgt_A           12 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GP   89 (296)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred             EEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CC
Confidence            3458999999999999995 6789999998764322 2357889999999999998888888877777889999999 99


Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEE---CCCCcEEEeecccccc
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILL---DENYRAVVSDFGLSKL  259 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl---~~~~~~kl~DfGla~~  259 (453)
                      +|.+++....         ..+++..++.++.|++.||+|||+   .+++||||||+|||+   ++++.+||+|||++..
T Consensus        90 ~L~~~~~~~~---------~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~  157 (296)
T 4hgt_A           90 SLEDLFNFCS---------RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             BHHHHHHHTT---------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             CHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence            9999986432         238999999999999999999999   899999999999999   7899999999999987


Q ss_pred             ccCCCC------ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHH
Q 047276          260 MSRDQS------RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVN  333 (453)
Q Consensus       260 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  333 (453)
                      ......      .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..........     .......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-----~~~~~~~  232 (296)
T 4hgt_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-----KYERISE  232 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS-----HHHHHHH
T ss_pred             ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhh-----hhhhhhc
Confidence            654332      12235678999999999999999999999999999999999999996433222111     0111111


Q ss_pred             HhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          334 EKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       334 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                      ..... ..     +.+      ....+..+.+++.+||+.+|++|||+++|++.|++...
T Consensus       233 ~~~~~-~~-----~~~------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~  280 (296)
T 4hgt_A          233 KKMST-PI-----EVL------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  280 (296)
T ss_dssp             HHHHS-CH-----HHH------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred             ccccc-hh-----hhh------hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence            11000 00     000      01123468999999999999999999999999987654

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.1e-42  Score=329.29  Aligned_cols=246  Identities=26%  Similarity=0.362  Sum_probs=196.9

Q ss_pred             ccCcCCceEEEEEEe---CCCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          108 LLGHGSSASVFKGIL---SDGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       108 ~lG~G~fG~Vy~~~~---~~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      .||+|+||+||+|..   .+++.||||+++...   ...+.+.+|+.+++.++||||+++++++  ..+..++||||+++
T Consensus        24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~lv~e~~~~  101 (291)
T 1xbb_A           24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC--EAESWMLVMEMAEL  101 (291)
T ss_dssp             EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE--ESSSEEEEEECCTT
T ss_pred             ccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE--CCCCcEEEEEeCCC
Confidence            899999999999964   346789999997532   2246799999999999999999999998  34578999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      ++|.+++....          .+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++....
T Consensus       102 ~~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A          102 GPLNKYLQQNR----------HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             EEHHHHHHHCT----------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             CCHHHHHHhCc----------CCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence            99999996432          38999999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCce--eeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          262 RDQSRC--ITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       262 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      ......  .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....             ......+..
T Consensus       169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------------~~~~~~~~~  235 (291)
T 1xbb_A          169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------------SEVTAMLEK  235 (291)
T ss_dssp             TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------------HHHHHHHHT
T ss_pred             cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH-------------HHHHHHHHc
Confidence            443321  223456789999999998889999999999999999999 9999853211             111222222


Q ss_pred             CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      +...           ..+......+.+++.+||+.||++||++.++++.|++..
T Consensus       236 ~~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  278 (291)
T 1xbb_A          236 GERM-----------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  278 (291)
T ss_dssp             TCCC-----------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCC-----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            2111           112233456899999999999999999999999998754

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.4e-42  Score=331.62  Aligned_cols=257  Identities=18%  Similarity=0.224  Sum_probs=201.0

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCCCccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEEEEEecCCC
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      +.+.||+|+||+||+|.. .+|+.||||++.... ..+.+.+|+.++..+ +|+|++++++++. .+...++||||+ ++
T Consensus        14 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-~~~~~~lv~e~~-~~   90 (298)
T 1csn_A           14 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-EGLHNVLVIDLL-GP   90 (298)
T ss_dssp             EEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEE-ETTEEEEEEECC-CC
T ss_pred             EEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecC-CCceeEEEEEec-CC
Confidence            357899999999999995 578999999986533 234578899999999 7999999999876 566889999999 99


Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCc-----EEEeecccc
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYR-----AVVSDFGLS  257 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~-----~kl~DfGla  257 (453)
                      +|.+++....         ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.     +||+|||++
T Consensus        91 ~L~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~  158 (298)
T 1csn_A           91 SLEDLLDLCG---------RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  158 (298)
T ss_dssp             BHHHHHHHTT---------TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             CHHHHHHHhc---------cCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence            9999996432         238999999999999999999999   89999999999999987776     999999999


Q ss_pred             ccccCCCC------ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHH
Q 047276          258 KLMSRDQS------RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKI  331 (453)
Q Consensus       258 ~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~  331 (453)
                      ........      .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........     ..+.. 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-----~~~~~-  232 (298)
T 1csn_A          159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK-----QKYER-  232 (298)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH-----HHHHH-
T ss_pred             cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccH-----HHHHH-
Confidence            87654322      1234567999999999999989999999999999999999999999643211100     00000 


Q ss_pred             HHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          332 VNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       332 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                      ...........     .+      ....+..+.+++.+||+.+|++||++++|++.|++...
T Consensus       233 ~~~~~~~~~~~-----~~------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~  283 (298)
T 1csn_A          233 IGEKKQSTPLR-----EL------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  283 (298)
T ss_dssp             HHHHHHHSCHH-----HH------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHhhccCccHH-----HH------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence            00000000000     00      01223468999999999999999999999999988754

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=341.40  Aligned_cols=262  Identities=14%  Similarity=0.165  Sum_probs=193.1

Q ss_pred             HHhcccCcCCceEEEEEEeC----CCcEEEEEEecCCCcc------------HHHHHHHHHHHHhcCCCceeeEeeEEEe
Q 047276          104 NFQALLGHGSSASVFKGILS----DGTSVAVKRINGEENG------------EKEFRSEVAAIASAQHVNLVRLLGYCVV  167 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~----~g~~vavK~~~~~~~~------------~~~~~~E~~~l~~l~h~niv~l~g~~~~  167 (453)
                      .+.+.||+|+||+||+|...    ++..+|||++......            ...+.+|+..+..++||||+++++++..
T Consensus        40 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~  119 (345)
T 2v62_A           40 VLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLT  119 (345)
T ss_dssp             EEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEE
T ss_pred             EEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccccc
Confidence            34679999999999999975    5778999998754321            1236678888999999999999999875


Q ss_pred             c---CCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEEC
Q 047276          168 P---GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD  244 (453)
Q Consensus       168 ~---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~  244 (453)
                      .   ....++||||+ +++|.+++....          .+++..++.++.|++.||+|||+   .+|+||||||+|||++
T Consensus       120 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~  185 (345)
T 2v62_A          120 EFKGRSYRFMVMERL-GIDLQKISGQNG----------TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLG  185 (345)
T ss_dssp             ESSSCEEEEEEEECE-EEEHHHHCBGGG----------BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEE
T ss_pred             ccCCCcEEEEEEecc-CCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEc
Confidence            3   45789999999 999999996432          48999999999999999999999   8999999999999999


Q ss_pred             CCC--cEEEeeccccccccCCCC------ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCccccc
Q 047276          245 ENY--RAVVSDFGLSKLMSRDQS------RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEH  316 (453)
Q Consensus       245 ~~~--~~kl~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~  316 (453)
                      .++  .+||+|||+++.......      .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus       186 ~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~  265 (345)
T 2v62_A          186 YKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK  265 (345)
T ss_dssp             SSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT
T ss_pred             cCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence            887  999999999987643221      112445799999999999998999999999999999999999999953211


Q ss_pred             CCCCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          317 GNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                      ...       .. ......... .....+..... ..    ..+..+.+++..||+.+|++||++.+|++.|++...
T Consensus       266 ~~~-------~~-~~~~~~~~~-~~~~~~~~~~~-~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          266 DPV-------AV-QTAKTNLLD-ELPQSVLKWAP-SG----SSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             CHH-------HH-HHHHHHHHH-TTTHHHHHHSC-TT----SCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             ccH-------HH-HHHHHhhcc-cccHHHHhhcc-cc----ccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            100       00 000011100 00010101000 00    223458999999999999999999999999997544

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=7.1e-43  Score=333.91  Aligned_cols=247  Identities=24%  Similarity=0.396  Sum_probs=193.6

Q ss_pred             HhcccCcCCceEEEEEEeCC-C-------cEEEEEEecCC-CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEE
Q 047276          105 FQALLGHGSSASVFKGILSD-G-------TSVAVKRINGE-ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLV  175 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~-g-------~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv  175 (453)
                      +.+.||+|+||+||+|.... +       ..||+|.+... ....+.+.+|+.++++++||||+++++++. .++..++|
T Consensus        12 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv   90 (289)
T 4fvq_A           12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCV-CGDENILV   90 (289)
T ss_dssp             EEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC-CTTCCEEE
T ss_pred             eeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-eCCCCEEE
Confidence            45789999999999998542 3       47999998653 345577999999999999999999999986 55678999


Q ss_pred             EEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCc-------
Q 047276          176 YEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYR-------  248 (453)
Q Consensus       176 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~-------  248 (453)
                      |||+++|+|.+++....         ..+++..++.++.|++.||+|||+   .+++||||||+|||++.++.       
T Consensus        91 ~e~~~~~~L~~~l~~~~---------~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~  158 (289)
T 4fvq_A           91 QEFVKFGSLDTYLKKNK---------NCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPP  158 (289)
T ss_dssp             EECCTTCBHHHHHHHTG---------GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred             EECCCCCCHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccc
Confidence            99999999999996432         238999999999999999999999   89999999999999998887       


Q ss_pred             -EEEeeccccccccCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCccccc
Q 047276          249 -AVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQ  326 (453)
Q Consensus       249 -~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~  326 (453)
                       +||+|||++......     ....+|+.|+|||.+.+ ..++.++||||||+++|||++|..|+......         
T Consensus       159 ~~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~---------  224 (289)
T 4fvq_A          159 FIKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS---------  224 (289)
T ss_dssp             EEEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---------
T ss_pred             eeeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch---------
Confidence             999999998754322     23457889999999987 67899999999999999999965544211000         


Q ss_pred             chhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccCC
Q 047276          327 YFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAV  394 (453)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~~  394 (453)
                        .. ........       ..      .+......+.+++.+||+.||++|||+.++++.|++....
T Consensus       225 --~~-~~~~~~~~-------~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          225 --QR-KLQFYEDR-------HQ------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             --HH-HHHHHHTT-------CC------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             --HH-HHHHhhcc-------CC------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence              00 01111110       00      1111123478999999999999999999999999987653

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-42  Score=335.31  Aligned_cols=251  Identities=25%  Similarity=0.412  Sum_probs=194.1

Q ss_pred             hcccCcCCceEEEEEEeCC-----CcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEe
Q 047276          106 QALLGHGSSASVFKGILSD-----GTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~~-----g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      .+.||+|+||+||+|....     +..||||.++...  .....+.+|+.++++++||||+++++++. ..+..++||||
T Consensus        49 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~  127 (333)
T 1mqb_A           49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-KYKPMMIITEY  127 (333)
T ss_dssp             EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSSEEEEEEC
T ss_pred             ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe-cCCCcEEEEeC
Confidence            4689999999999998642     2469999997643  23456899999999999999999999975 56788999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +++|+|.+++....         ..+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++.
T Consensus       128 ~~~~~L~~~l~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          128 MENGALDKFLREKD---------GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSR  195 (333)
T ss_dssp             CTTEEHHHHHHHTT---------TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             CCCCcHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcch
Confidence            99999999996432         248999999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCc--eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHh
Q 047276          259 LMSRDQSR--CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEK  335 (453)
Q Consensus       259 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  335 (453)
                      ........  ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....             ......
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-------------~~~~~~  262 (333)
T 1mqb_A          196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-------------HEVMKA  262 (333)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------------HHHHHH
T ss_pred             hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-------------HHHHHH
Confidence            76543221  1223456789999999998999999999999999999999 9999853211             111122


Q ss_pred             hhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          336 MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       336 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                      +..+..       .    ..+......+.+++.+||+.+|++||++.++++.|+....
T Consensus       263 ~~~~~~-------~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  309 (333)
T 1mqb_A          263 INDGFR-------L----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  309 (333)
T ss_dssp             HHTTCC-------C----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHCCCc-------C----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            222210       1    1112334568999999999999999999999999987654

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-42  Score=341.46  Aligned_cols=248  Identities=20%  Similarity=0.249  Sum_probs=197.9

Q ss_pred             HHhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC-ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          104 NFQALLGHGSSASVFKGILS-DGTSVAVKRINGEE-NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      .+.+.||+|+||+||+|... +|+.||+|.+.... .....+.+|+.++..++||||+++++++. .....++||||+++
T Consensus        54 ~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-~~~~~~lv~E~~~g  132 (387)
T 1kob_A           54 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-DKYEMVLILEFLSG  132 (387)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-CSSEEEEEEECCCC
T ss_pred             EEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEE-eCCEEEEEEEcCCC
Confidence            34578999999999999964 68899999997643 33457899999999999999999999986 56688999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECC--CCcEEEeecccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDE--NYRAVVSDFGLSKL  259 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~--~~~~kl~DfGla~~  259 (453)
                      |+|.+++....         ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.  ++.+||+|||++..
T Consensus       133 g~L~~~l~~~~---------~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~  200 (387)
T 1kob_A          133 GELFDRIAAED---------YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATK  200 (387)
T ss_dssp             CBHHHHTTCTT---------CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             CcHHHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEeccccee
Confidence            99999985432         238999999999999999999999   89999999999999974  57899999999987


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      .....  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......            . ....+...
T Consensus       201 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------------~-~~~~i~~~  265 (387)
T 1kob_A          201 LNPDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------------E-TLQNVKRC  265 (387)
T ss_dssp             CCTTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------------H-HHHHHHHC
T ss_pred             cCCCc--ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH------------H-HHHHHHhC
Confidence            65433  234457999999999999989999999999999999999999999532110            0 11111111


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      ...  .++      .........+.+++.+||+.||++|||+.++++.
T Consensus       266 ~~~--~~~------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          266 DWE--FDE------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             CCC--CCS------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCC--CCc------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            110  000      0111234458899999999999999999999864

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.2e-42  Score=345.93  Aligned_cols=268  Identities=19%  Similarity=0.240  Sum_probs=208.5

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCC-CeEEEEEecC
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGG-PRYLVYEFIQ  180 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-~~~lv~e~~~  180 (453)
                      +.++||+|+||+||+|... +|+.||||++...  ....+.+.+|+.++++++||||+++++++..... ..++||||++
T Consensus        13 i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~   92 (396)
T 4eut_A           13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCP   92 (396)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCT
T ss_pred             EEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCC
Confidence            3578999999999999975 5899999999752  2345778899999999999999999999875433 6799999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEE----CCCCcEEEeeccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILL----DENYRAVVSDFGL  256 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl----~~~~~~kl~DfGl  256 (453)
                      +|+|.+++.....       ...+++..++.++.|++.||+|||+   .+|+||||||+|||+    +.++.+||+|||+
T Consensus        93 ~g~L~~~l~~~~~-------~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           93 CGSLYTVLEEPSN-------AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             TEEHHHHTTSGGG-------TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             CCCHHHHHHhhhc-------ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            9999999964432       2238999999999999999999999   899999999999999    7888899999999


Q ss_pred             cccccCCCCceeeeccCCccccchhhhhc--------CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccch
Q 047276          257 SKLMSRDQSRCITTIRGTRGYLAPEWILE--------QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYF  328 (453)
Q Consensus       257 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~  328 (453)
                      ++......  ......||+.|+|||.+..        ..++.++|||||||++|||++|+.||.........        
T Consensus       163 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--------  232 (396)
T 4eut_A          163 ARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--------  232 (396)
T ss_dssp             CEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--------
T ss_pred             ceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--------
Confidence            98764432  2234579999999999875        56788999999999999999999999643221111        


Q ss_pred             hHHHHHhhhcCcccc-------------cccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          329 PKIVNEKMKEGKLME-------------IVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       329 ~~~~~~~~~~~~~~~-------------~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                      ........ .+....             .....+.............+.+++..||+.||++||++.++++.++.+..
T Consensus       233 ~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          233 KEVMYKII-TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             HHHHHHHH-HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             HHHHHHHh-cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            01111111 111000             01112222234567888889999999999999999999999999887654

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.1e-42  Score=325.66  Aligned_cols=242  Identities=24%  Similarity=0.338  Sum_probs=175.0

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      .+.||+|+||.||+|+. .+|+.||||.+...    ....+.+.+|+.++++++||||+++++++. ..+..++||||++
T Consensus        16 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~   94 (278)
T 3cok_A           16 GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE-DSNYVYLVLEMCH   94 (278)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE-CSSEEEEEEECCT
T ss_pred             eeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc-cCCeEEEEEecCC
Confidence            57899999999999996 57899999998642    223467899999999999999999999986 5667899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +++|.+++....         ..+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++...
T Consensus        95 ~~~L~~~l~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~  162 (278)
T 3cok_A           95 NGEMNRYLKNRV---------KPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQL  162 (278)
T ss_dssp             TEEHHHHHHTCS---------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCcHHHHHhhcc---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence            999999996432         348999999999999999999999   89999999999999999999999999999876


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      ..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........            ...      
T Consensus       163 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------------~~~------  223 (278)
T 3cok_A          163 KMPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT------------LNK------  223 (278)
T ss_dssp             C-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------------------
T ss_pred             cCCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH------------HHH------
Confidence            43222 12345689999999999988899999999999999999999999963221110            000      


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                         .....    ...+......+.+++.+||+.||++|||++++++
T Consensus       224 ---~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          224 ---VVLAD----YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             ---CCSSC----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ---Hhhcc----cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence               00000    0112223446889999999999999999999874

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=6e-42  Score=341.94  Aligned_cols=271  Identities=20%  Similarity=0.236  Sum_probs=195.1

Q ss_pred             HhcccCcC--CceEEEEEEeC-CCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEe
Q 047276          105 FQALLGHG--SSASVFKGILS-DGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       105 ~~~~lG~G--~fG~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      +.++||+|  +||+||+++.. +|+.||||+++...   ...+.+.+|+.+++.++||||+++++++. .++..++||||
T Consensus        29 ~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~  107 (389)
T 3gni_B           29 LLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFI-ADNELWVVTSF  107 (389)
T ss_dssp             EEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-ETTEEEEEEEC
T ss_pred             EEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE-ECCEEEEEEEc
Confidence            35789999  99999999975 68999999997533   23356888999999999999999999987 55688999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +++|+|.+++.....        ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++.
T Consensus       108 ~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~  176 (389)
T 3gni_B          108 MAYGSAKDLICTHFM--------DGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNL  176 (389)
T ss_dssp             CTTCBHHHHHHHTCT--------TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             cCCCCHHHHHhhhcc--------cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccce
Confidence            999999999965421        338999999999999999999999   899999999999999999999999999986


Q ss_pred             cccCCCC------ceeeeccCCccccchhhhhc--CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhH
Q 047276          259 LMSRDQS------RCITTIRGTRGYLAPEWILE--QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPK  330 (453)
Q Consensus       259 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~  330 (453)
                      .......      .......||+.|+|||.+.+  ..++.++|||||||++|||++|+.||.................+.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  256 (389)
T 3gni_B          177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC  256 (389)
T ss_dssp             ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------
T ss_pred             eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCc
Confidence            5432211      11223478999999999987  679999999999999999999999996432211000000000000


Q ss_pred             HHH--------------HhhhcCccccccc---ccc----cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          331 IVN--------------EKMKEGKLMEIVD---QRL----TDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       331 ~~~--------------~~~~~~~~~~~~d---~~l----~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      ...              .........+...   +..    ......+......+.+++.+||+.||++|||+.++++.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence            000              0000000000000   000    00001223345679999999999999999999999853

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=9.6e-43  Score=349.03  Aligned_cols=246  Identities=22%  Similarity=0.263  Sum_probs=195.2

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      .++||+|+||+||+++.. +++.||+|+++..    ....+.+.+|..+++.++||||+++++++. ..+..++||||++
T Consensus        74 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-~~~~~~lV~E~~~  152 (410)
T 3v8s_A           74 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ-DDRYLYMVMEYMP  152 (410)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE-CSSEEEEEECCCT
T ss_pred             EEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-ECCEEEEEEeCCC
Confidence            478999999999999975 5889999998641    223345889999999999999999999986 5668899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|.+++...           .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       153 gg~L~~~l~~~-----------~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~~~  218 (410)
T 3v8s_A          153 GGDLVNLMSNY-----------DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  218 (410)
T ss_dssp             TEEHHHHHHHC-----------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCcHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeEee
Confidence            99999998532           28999999999999999999999   89999999999999999999999999999876


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCC----CCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhh
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQG----VSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKM  336 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (453)
                      ............||+.|+|||.+....    ++.++|||||||++|||++|+.||.....            ........
T Consensus       219 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------------~~~~~~i~  286 (410)
T 3v8s_A          219 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------------VGTYSKIM  286 (410)
T ss_dssp             CTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH------------HHHHHHHH
T ss_pred             ccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh------------hhHHHHHH
Confidence            554433344678999999999998655    78999999999999999999999953211            01111111


Q ss_pred             hcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCC--CCCHHHHHHH
Q 047276          337 KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARL--RPSMARVVEM  387 (453)
Q Consensus       337 ~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPs~~~v~~~  387 (453)
                      . +..    ......    .......+.+++.+||+.+|.+  ||++++|.+.
T Consensus       287 ~-~~~----~~~~p~----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          287 N-HKN----SLTFPD----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             T-HHH----HCCCCT----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             h-ccc----cccCCC----cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            1 000    000110    1122345889999999999988  9999999864

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-42  Score=340.07  Aligned_cols=245  Identities=24%  Similarity=0.360  Sum_probs=187.8

Q ss_pred             HhcccCcCCceEEEEEEeCCCcEEEEEEecCCCc---cHHHHHHHHHHHHhcCC--CceeeEeeEEEecCCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEEN---GEKEFRSEVAAIASAQH--VNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      +.+.||+|+||+||++...+++.||||++.....   ..+.+.+|+.++.+++|  +||+++++++. .++..++||| +
T Consensus        13 i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-~~~~~~lv~e-~   90 (343)
T 3dbq_A           13 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-TDQYIYMVME-C   90 (343)
T ss_dssp             EEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-CSSEEEEEEC-C
T ss_pred             EEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe-eCCEEEEEEe-C
Confidence            3578999999999999998899999999875432   23578999999999986  99999999986 5668899999 4


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      .+|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+|||++ ++.+||+|||+++.
T Consensus        91 ~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~  156 (343)
T 3dbq_A           91 GNIDLNSWLKKKK----------SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQ  156 (343)
T ss_dssp             CSEEHHHHHHHSC----------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred             CCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccc
Confidence            5789999996432          38999999999999999999999   8999999999999997 67899999999987


Q ss_pred             ccCCCC-ceeeeccCCccccchhhhhc-----------CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccc
Q 047276          260 MSRDQS-RCITTIRGTRGYLAPEWILE-----------QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQY  327 (453)
Q Consensus       260 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~  327 (453)
                      ...... .......||+.|+|||.+.+           ..++.++|||||||++|||++|+.||......          
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----------  226 (343)
T 3dbq_A          157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----------  226 (343)
T ss_dssp             C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH----------
T ss_pred             cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH----------
Confidence            654332 12345679999999999875           67899999999999999999999999521100          


Q ss_pred             hhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          328 FPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                       .......         +++...  ...+......+.+++.+||+.||++|||+.++++.
T Consensus       227 -~~~~~~~---------~~~~~~--~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          227 -ISKLHAI---------IDPNHE--IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             -HHHHHHH---------HCTTSC--CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -HHHHHHH---------hcCCcc--cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence             0001111         111110  01111223458899999999999999999999864

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.4e-42  Score=351.16  Aligned_cols=241  Identities=26%  Similarity=0.378  Sum_probs=196.9

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      +.+.||+|+||.||+|+.. +|+.||||+++..    ......+.+|+.+++.++||||+++++++. ..+..++||||+
T Consensus        20 l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~-~~~~~~lv~E~~   98 (476)
T 2y94_A           20 LGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS-TPSDIFMVMEYV   98 (476)
T ss_dssp             EEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE-CSSEEEEEEECC
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-ECCEEEEEEeCC
Confidence            3578999999999999975 7899999999642    233467899999999999999999999986 556889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ++|+|.+++...          +.+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++..
T Consensus        99 ~gg~L~~~l~~~----------~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~  165 (476)
T 2y94_A           99 SGGELFDYICKN----------GRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNM  165 (476)
T ss_dssp             SSEEHHHHTTSS----------SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             CCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhh
Confidence            999999999533          338999999999999999999999   8999999999999999999999999999987


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcCCC-CccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQGV-SEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      .....  ......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||.....            .. ....+..
T Consensus       166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~------------~~-~~~~i~~  230 (476)
T 2y94_A          166 MSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV------------PT-LFKKICD  230 (476)
T ss_dssp             CCTTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS------------HH-HHHHHHT
T ss_pred             ccccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH------------HH-HHHHHhc
Confidence            65432  2345679999999999988765 6899999999999999999999953210            11 1122222


Q ss_pred             CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      +..            ..+......+.+++.+||+.||++|||+.++++
T Consensus       231 ~~~------------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          231 GIF------------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             TCC------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCc------------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence            211            011122345889999999999999999999996

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.8e-42  Score=335.13  Aligned_cols=257  Identities=23%  Similarity=0.393  Sum_probs=191.3

Q ss_pred             HhcccCcCCceEEEEEEeC----CCcEEEEEEecCCCc---cHHHHHHHHHHHHhcCCCceeeEeeEEEecCC----CeE
Q 047276          105 FQALLGHGSSASVFKGILS----DGTSVAVKRINGEEN---GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGG----PRY  173 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~----~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~----~~~  173 (453)
                      +.+.||+|+||+||+|...    ++..||+|.++....   ..+.+.+|+.++++++||||+++++++.....    ..+
T Consensus        38 ~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~  117 (313)
T 3brb_A           38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPM  117 (313)
T ss_dssp             EEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEE
T ss_pred             eccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccE
Confidence            4578999999999999853    345899999875432   23568999999999999999999999875432    358


Q ss_pred             EEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEee
Q 047276          174 LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSD  253 (453)
Q Consensus       174 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~D  253 (453)
                      +|+||+++|+|.+++.......    ....+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|
T Consensus       118 ~v~e~~~~~~L~~~l~~~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kl~D  190 (313)
T 3brb_A          118 VILPFMKYGDLHTYLLYSRLET----GPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVAD  190 (313)
T ss_dssp             EEEECCTTCBHHHHHHHTTBTT----SCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEEECS
T ss_pred             EEEecccCCCHHHHHHHhhhhc----CCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEEee
Confidence            9999999999999985433211    23459999999999999999999999   8999999999999999999999999


Q ss_pred             ccccccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHH
Q 047276          254 FGLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKI  331 (453)
Q Consensus       254 fGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  331 (453)
                      ||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......            . 
T Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------------~-  257 (313)
T 3brb_A          191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH------------E-  257 (313)
T ss_dssp             CSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG------------G-
T ss_pred             cCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH------------H-
Confidence            999987644322 22234567889999999999999999999999999999999 88888532111            0 


Q ss_pred             HHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          332 VNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       332 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      .......+..           ...+......+.+++.+||+.+|++|||+.++++.|+...
T Consensus       258 ~~~~~~~~~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~  307 (313)
T 3brb_A          258 MYDYLLHGHR-----------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL  307 (313)
T ss_dssp             HHHHHHTTCC-----------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHcCCC-----------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1111111111           0112233456899999999999999999999999998764

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.3e-42  Score=337.34  Aligned_cols=262  Identities=21%  Similarity=0.364  Sum_probs=203.2

Q ss_pred             HHhcccCcCCceEEEEEEeC------CCcEEEEEEecCCCc--cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEE
Q 047276          104 NFQALLGHGSSASVFKGILS------DGTSVAVKRINGEEN--GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLV  175 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~------~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv  175 (453)
                      .+.+.||+|+||.||+|...      +++.||||.+.....  ....+.+|+.+++.++||||+++++++. .++..++|
T Consensus        28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv  106 (322)
T 1p4o_A           28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS-QGQPTLVI  106 (322)
T ss_dssp             EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC-SSSSCEEE
T ss_pred             eeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc-cCCccEEE
Confidence            34689999999999999854      367899999975432  3356889999999999999999999975 56688999


Q ss_pred             EEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecc
Q 047276          176 YEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFG  255 (453)
Q Consensus       176 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfG  255 (453)
                      |||+++|+|.+++...............+++..+++++.|++.||+|||+   .+++||||||+||+++.++.+||+|||
T Consensus       107 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~~kl~Dfg  183 (322)
T 1p4o_A          107 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFG  183 (322)
T ss_dssp             EECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred             EEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCeEEECcCc
Confidence            99999999999986432100000012347999999999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHH
Q 047276          256 LSKLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVN  333 (453)
Q Consensus       256 la~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  333 (453)
                      ++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....             ....
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------------~~~~  250 (322)
T 1p4o_A          184 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-------------EQVL  250 (322)
T ss_dssp             CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-------------HHHH
T ss_pred             cccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH-------------HHHH
Confidence            9986643322 11223456889999999999999999999999999999999 8888853211             1111


Q ss_pred             HhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          334 EKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       334 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                      .....+....           .+......+.+++.+||+.+|++|||+.++++.|++...
T Consensus       251 ~~~~~~~~~~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          251 RFVMEGGLLD-----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHHHTTCCCC-----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHcCCcCC-----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            2222221111           112334458899999999999999999999999998654

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.7e-42  Score=335.91  Aligned_cols=258  Identities=24%  Similarity=0.310  Sum_probs=197.9

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCC-CccHHHHHHHHHHHHhcCCCceeeEeeEEEec---CCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGE-ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP---GGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~---~~~~~lv~e~~  179 (453)
                      +.+.||+|+||.||++.. .+|+.||||++... ....+.+.+|+.+++.++||||+++++++...   ....++|+||+
T Consensus        33 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~  112 (317)
T 2buj_A           33 FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFF  112 (317)
T ss_dssp             EEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECC
T ss_pred             EEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeC
Confidence            457899999999999996 67899999988653 33456789999999999999999999998632   23678999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ++|+|.+++.....      ....+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++..
T Consensus       113 ~~~~L~~~l~~~~~------~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          113 KRGTLWNEIERLKD------KGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             TTCBHHHHHHHHHT------TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             CCCcHHHHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            99999999865321      12348999999999999999999999   8999999999999999999999999999876


Q ss_pred             ccCCCCc--------eeeeccCCccccchhhhhcCC---CCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccch
Q 047276          260 MSRDQSR--------CITTIRGTRGYLAPEWILEQG---VSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYF  328 (453)
Q Consensus       260 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~  328 (453)
                      .......        ......||+.|+|||.+....   ++.++||||||+++|||++|+.||.........        
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--------  255 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS--------  255 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC--------
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch--------
Confidence            5321110        012345799999999987543   689999999999999999999998532211110        


Q ss_pred             hHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          329 PKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       329 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                         ........ .      .+.    ........+.+++.+||+.||.+|||+.++++.|+....
T Consensus       256 ---~~~~~~~~-~------~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          256 ---VALAVQNQ-L------SIP----QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             ---HHHHHHCC---------CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             ---hhHHhhcc-C------CCC----ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence               00111110 0      010    111233468999999999999999999999999997654

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.7e-42  Score=328.29  Aligned_cols=247  Identities=31%  Similarity=0.450  Sum_probs=193.1

Q ss_pred             HhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCCh
Q 047276          105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL  184 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL  184 (453)
                      +.+.||+|+||+||++... |+.||||.++... ..+.+.+|+.++++++||||+++++++....+..++||||+++|+|
T Consensus        25 ~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L  102 (278)
T 1byg_A           25 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL  102 (278)
T ss_dssp             EEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEH
T ss_pred             EEeEEecCCCceEEEEEEc-CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCH
Confidence            4578999999999999885 8899999997543 4567999999999999999999999987666678999999999999


Q ss_pred             hhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCCC
Q 047276          185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ  264 (453)
Q Consensus       185 ~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~  264 (453)
                      .+++.....        ..+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++.......
T Consensus       103 ~~~l~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  171 (278)
T 1byg_A          103 VDYLRSRGR--------SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  171 (278)
T ss_dssp             HHHHHHHHH--------HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             HHHHHhccc--------ccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence            999954321        227899999999999999999999   899999999999999999999999999987554322


Q ss_pred             CceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcCcccc
Q 047276          265 SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLME  343 (453)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (453)
                          ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......            . .......+..  
T Consensus       172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~------------~-~~~~~~~~~~--  232 (278)
T 1byg_A          172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------------D-VVPRVEKGYK--  232 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG------------G-HHHHHTTTCC--
T ss_pred             ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH------------H-HHHHHhcCCC--
Confidence                23357889999999999999999999999999999998 99998532110            0 1111111110  


Q ss_pred             cccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          344 IVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       344 ~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                         .      ..+...+..+.+++.+||+.||++|||+.++++.|+...
T Consensus       233 ---~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~  272 (278)
T 1byg_A          233 ---M------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  272 (278)
T ss_dssp             ---C------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---C------CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence               0      112233456889999999999999999999999998753

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=8.8e-42  Score=341.86  Aligned_cols=247  Identities=20%  Similarity=0.237  Sum_probs=186.2

Q ss_pred             cccCcCCceEEEEEEeC-CCcEEEEEEecCCCccHHHHHHHHHHHHh-cCCCceeeEeeEEEe---cCCCeEEEEEecCC
Q 047276          107 ALLGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRSEVAAIAS-AQHVNLVRLLGYCVV---PGGPRYLVYEFIQN  181 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~---~~~~~~lv~e~~~~  181 (453)
                      ++||+|+||+||++... +|+.||||+++..    ..+.+|+.++.+ .+||||+++++++..   .....++||||+++
T Consensus        68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~g  143 (400)
T 1nxk_A           68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG  143 (400)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred             ceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCC
Confidence            57999999999999964 6889999999642    457788888754 589999999998753   23467999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECC---CCcEEEeeccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDE---NYRAVVSDFGLSK  258 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~---~~~~kl~DfGla~  258 (453)
                      |+|.+++....        ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.   ++.+||+|||+++
T Consensus       144 g~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~  212 (400)
T 1nxk_A          144 GELFSRIQDRG--------DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  212 (400)
T ss_dssp             EEHHHHHHCC-----------CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             CcHHHHHHHhC--------CCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence            99999996532        1348999999999999999999999   89999999999999997   7899999999998


Q ss_pred             cccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      ......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........     .    ....+..
T Consensus       213 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-----~----~~~~i~~  281 (400)
T 1nxk_A          213 ETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-----G----MKTRIRM  281 (400)
T ss_dssp             ECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC-----S----HHHHHHH
T ss_pred             ccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH-----H----HHHHHHc
Confidence            654322  2345678999999999998999999999999999999999999996432211100     0    1111111


Q ss_pred             CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      +... .-.+       ........+.+++.+||+.||++|||+.++++.
T Consensus       282 ~~~~-~~~~-------~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          282 GQYE-FPNP-------EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             TCCC-CCTT-------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             Cccc-CCCc-------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            1110 0000       011234558899999999999999999999974

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=5.3e-42  Score=337.47  Aligned_cols=242  Identities=21%  Similarity=0.263  Sum_probs=194.9

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEEEEEe
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      +.+.||+|+||+||+++.. +|+.||+|+++..    ....+.+..|..++..+ +||||+++++++. ..+..++||||
T Consensus        24 ~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~-~~~~~~lv~E~  102 (353)
T 2i0e_A           24 FLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-TMDRLYFVMEY  102 (353)
T ss_dssp             EEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE-CSSEEEEEEEC
T ss_pred             EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE-cCCEEEEEEeC
Confidence            3578999999999999975 4789999999742    33456788999999887 7999999999876 56688999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       103 ~~gg~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~  169 (353)
T 2i0e_A          103 VNGGDLMYHIQQVG----------RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK  169 (353)
T ss_dssp             CCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             CCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence            99999999996432          38999999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      ...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....            .. ....+..
T Consensus       170 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------------~~-~~~~i~~  235 (353)
T 2i0e_A          170 ENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------------DE-LFQSIME  235 (353)
T ss_dssp             CCCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HH-HHHHHHH
T ss_pred             ccccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH------------HH-HHHHHHh
Confidence            643222 223456899999999999999999999999999999999999999953211            01 1111111


Q ss_pred             CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 047276          339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPS-----MARVVE  386 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~~v~~  386 (453)
                      +.            ..++......+.+++.+||+.+|++||+     +.++.+
T Consensus       236 ~~------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          236 HN------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             CC------------CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             CC------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            11            1122233456899999999999999996     466653

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.2e-41  Score=323.84  Aligned_cols=258  Identities=21%  Similarity=0.275  Sum_probs=191.4

Q ss_pred             HhcccCcCCceEEEEEEeCCCcEEEEEEecCCCc---cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEEN---GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      +.+.||+|+||+||+|...+|+.||+|++.....   ....+.+|+.++++++||||+++++++. ..+..++||||+++
T Consensus         6 ~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~   84 (288)
T 1ob3_A            6 GLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-TKKRLVLVFEHLDQ   84 (288)
T ss_dssp             EEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-CSSCEEEEEECCSE
T ss_pred             hhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEc-cCCeEEEEEEecCC
Confidence            3578999999999999998899999999865332   2367889999999999999999999986 55688999999975


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                       +|.+++....         ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++....
T Consensus        85 -~l~~~~~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  151 (288)
T 1ob3_A           85 -DLKKLLDVCE---------GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFG  151 (288)
T ss_dssp             -EHHHHHHTST---------TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred             -CHHHHHHhcc---------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccC
Confidence             9999886432         338999999999999999999999   899999999999999999999999999998664


Q ss_pred             CCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      .... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.......        .+.... .......
T Consensus       152 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--------~~~~~~-~~~~~~~  221 (288)
T 1ob3_A          152 IPVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--------QLMRIF-RILGTPN  221 (288)
T ss_dssp             C----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHH-HHHCCCC
T ss_pred             cccc-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHH-HHHCCCC
Confidence            3221 2234568999999999875 458999999999999999999999995322110        000000 0000000


Q ss_pred             ------c--cccccccccCCC-----CCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          341 ------L--MEIVDQRLTDEG-----GIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       341 ------~--~~~~d~~l~~~~-----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                            .  ....++.+....     .........+.+++.+||+.||++|||+.++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          222 SKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                  0  000011110000     011123456889999999999999999999874

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.3e-41  Score=324.05  Aligned_cols=246  Identities=25%  Similarity=0.400  Sum_probs=198.7

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEe---------------c
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVV---------------P  168 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~---------------~  168 (453)
                      +.+.||+|+||.||+|... +|+.||+|.+....   ..+.+|+.++.+++||||+++++++..               .
T Consensus        15 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~   91 (284)
T 2a19_B           15 EIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSK   91 (284)
T ss_dssp             EEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCE
T ss_pred             eeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccC
Confidence            3578999999999999975 78999999997543   356789999999999999999998753               1


Q ss_pred             CCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCc
Q 047276          169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYR  248 (453)
Q Consensus       169 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~  248 (453)
                      ....++||||+++|+|.+++....        ...+++..++.++.|++.||.|||+   .+++|+||||+|||++.++.
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           92 TKCLFIQMEFCDKGTLEQWIEKRR--------GEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             EEEEEEEECCCCSCBHHHHHHHGG--------GSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTE
T ss_pred             cceEEEEEeccCCCCHHHHHhhcc--------CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCC
Confidence            234689999999999999996432        1348999999999999999999999   89999999999999999999


Q ss_pred             EEEeeccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccch
Q 047276          249 AVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYF  328 (453)
Q Consensus       249 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~  328 (453)
                      +||+|||++........  .....||+.|+|||.+.+..++.++||||||+++|||++|..|+....             
T Consensus       161 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-------------  225 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-------------  225 (284)
T ss_dssp             EEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-------------
T ss_pred             EEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-------------
Confidence            99999999987654322  234568999999999999999999999999999999999998873110             


Q ss_pred             hHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccCCC
Q 047276          329 PKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVD  395 (453)
Q Consensus       329 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~~~  395 (453)
                       . .......+..              +......+.+++.+||+.||++|||+.++++.|+......
T Consensus       226 -~-~~~~~~~~~~--------------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~  276 (284)
T 2a19_B          226 -K-FFTDLRDGII--------------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP  276 (284)
T ss_dssp             -H-HHHHHHTTCC--------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred             -H-HHHHhhcccc--------------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence             0 1111111111              1112334789999999999999999999999998765443

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.9e-42  Score=351.73  Aligned_cols=242  Identities=23%  Similarity=0.275  Sum_probs=186.2

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecC----CCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRING----EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      .++||+|+||.||++.. .+|+.||||++..    .......+.+|+.+++.++||||++++++|. ..+..++||||++
T Consensus       153 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~-~~~~~~lv~e~~~  231 (446)
T 4ejn_A          153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ-THDRLCFVMEYAN  231 (446)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE-ETTEEEEEECCCS
T ss_pred             eEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe-eCCEEEEEEeeCC
Confidence            47899999999999995 4689999999864    2233456788999999999999999999987 4567899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|.+++....          .+++..+..++.|++.||+|||+.  .+|+||||||+|||++.++.+||+|||+++..
T Consensus       232 ~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~  299 (446)
T 4ejn_A          232 GGELFFHLSRER----------VFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEG  299 (446)
T ss_dssp             SCBHHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred             CCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence            999999986432          389999999999999999999963  68999999999999999999999999999864


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      .... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....            .. ....+..+.
T Consensus       300 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------------~~-~~~~i~~~~  365 (446)
T 4ejn_A          300 IKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------------EK-LFELILMEE  365 (446)
T ss_dssp             CC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HH-HHHHHHHCC
T ss_pred             cCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH------------HH-HHHHHHhCC
Confidence            3322 223457899999999999999999999999999999999999999953211            01 111111111


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRP-----SMARVVE  386 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~~v~~  386 (453)
                                  ..++......+.+++.+||+.||++||     +++++++
T Consensus       366 ------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          366 ------------IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             ------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ------------CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                        112223345688999999999999999     9999875

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.6e-42  Score=344.56  Aligned_cols=245  Identities=24%  Similarity=0.356  Sum_probs=188.4

Q ss_pred             HhcccCcCCceEEEEEEeCCCcEEEEEEecCCC---ccHHHHHHHHHHHHhcC--CCceeeEeeEEEecCCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEE---NGEKEFRSEVAAIASAQ--HVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      +.+.||+|+||+||++...+++.||||++....   ...+.+.+|+.++.+++  ||||+++++++. ..+..++||| +
T Consensus        60 ~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~-~~~~~~lv~E-~  137 (390)
T 2zmd_A           60 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-TDQYIYMVME-C  137 (390)
T ss_dssp             EEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-CSSEEEEEEE-C
T ss_pred             EEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe-cCCEEEEEEe-c
Confidence            357899999999999998889999999997533   23467899999999996  599999999987 4567899999 5


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      .+++|.+++....          .+++..+..++.||+.||+|||+   .+|+||||||+|||++ ++.+||+|||+++.
T Consensus       138 ~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~  203 (390)
T 2zmd_A          138 GNIDLNSWLKKKK----------SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQ  203 (390)
T ss_dssp             CSEEHHHHHHHCS----------SCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCC
T ss_pred             CCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCcccc
Confidence            6889999996432          38899999999999999999999   8999999999999996 58999999999987


Q ss_pred             ccCCCC-ceeeeccCCccccchhhhhc-----------CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccc
Q 047276          260 MSRDQS-RCITTIRGTRGYLAPEWILE-----------QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQY  327 (453)
Q Consensus       260 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~  327 (453)
                      ...... .......||+.|+|||++.+           ..++.++|||||||++|||++|+.||......          
T Consensus       204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~----------  273 (390)
T 2zmd_A          204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----------  273 (390)
T ss_dssp             C---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH----------
T ss_pred             ccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH----------
Confidence            654332 22345679999999999875           46889999999999999999999999522100          


Q ss_pred             hhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          328 FPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                       ........         ++...  ...+......+.+++.+||+.||++|||+.++++.
T Consensus       274 -~~~~~~~~---------~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          274 -ISKLHAII---------DPNHE--IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             -HHHHHHHH---------CTTSC--CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -HHHHHHHh---------Ccccc--CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence             00111111         11110  00111123458899999999999999999999854

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.6e-41  Score=328.44  Aligned_cols=247  Identities=21%  Similarity=0.272  Sum_probs=197.6

Q ss_pred             HHHhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC-------ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEE
Q 047276          103 DNFQALLGHGSSASVFKGILS-DGTSVAVKRINGEE-------NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYL  174 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~l  174 (453)
                      +.+.+.||+|+||.||++... +|+.||+|.+....       ...+.+.+|+.++.+++||||+++++++. ..+..++
T Consensus        14 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~l   92 (321)
T 2a2a_A           14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE-NRTDVVL   92 (321)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-CSSEEEE
T ss_pred             EEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe-cCCEEEE
Confidence            345689999999999999964 68999999986532       13577999999999999999999999986 5668899


Q ss_pred             EEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCC----cEE
Q 047276          175 VYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENY----RAV  250 (453)
Q Consensus       175 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~----~~k  250 (453)
                      ||||+++++|.+++...          ..+++..++.++.|++.||+|||+   .+++||||||+||+++.++    .+|
T Consensus        93 v~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~k  159 (321)
T 2a2a_A           93 ILELVSGGELFDFLAQK----------ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIK  159 (321)
T ss_dssp             EECCCCSCBHHHHHHTC----------SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEE
T ss_pred             EEEcCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEE
Confidence            99999999999999643          238999999999999999999999   8999999999999999888    799


Q ss_pred             EeeccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhH
Q 047276          251 VSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPK  330 (453)
Q Consensus       251 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~  330 (453)
                      |+|||++........  .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......            .
T Consensus       160 l~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------------~  225 (321)
T 2a2a_A          160 LIDFGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------------E  225 (321)
T ss_dssp             ECCCTTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------------H
T ss_pred             EccCccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH------------H
Confidence            999999987654322  24456899999999999889999999999999999999999999532110            0


Q ss_pred             HHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          331 IVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       331 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                       ....+.....  ..++..      .......+.+++.+||+.||++|||+.++++
T Consensus       226 -~~~~i~~~~~--~~~~~~------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          226 -TLANITSVSY--DFDEEF------FSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             -HHHHHHTTCC--CCCHHH------HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             -HHHHHHhccc--ccChhh------hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence             1111111110  000100      0112345889999999999999999999986

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=347.78  Aligned_cols=248  Identities=19%  Similarity=0.226  Sum_probs=193.5

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCCC----ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      .++||+|+||+||+++.. +|+.||+|+++...    ...+.+.+|..++..++||||+++++++. ..+..++||||++
T Consensus        66 ~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~-~~~~~~lVmE~~~  144 (412)
T 2vd5_A           66 LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ-DENYLYLVMEYYV  144 (412)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE-CSSEEEEEECCCC
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe-eCCEEEEEEcCCC
Confidence            378999999999999974 68999999996421    22234889999999999999999999876 5668899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|.+++....         ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++++||+|||+++..
T Consensus       145 gg~L~~~l~~~~---------~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla~~~  212 (412)
T 2vd5_A          145 GGDLLTLLSKFG---------ERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKL  212 (412)
T ss_dssp             SCBHHHHHHHHS---------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCcHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhheec
Confidence            999999996432         238999999999999999999999   89999999999999999999999999999877


Q ss_pred             cCCCCceeeeccCCccccchhhhh-------cCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHH
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWIL-------EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVN  333 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  333 (453)
                      ............||+.|+|||.+.       ...++.++|||||||++|||++|+.||......            ....
T Consensus       213 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------------~~~~  280 (412)
T 2vd5_A          213 RADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA------------ETYG  280 (412)
T ss_dssp             CTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH------------HHHH
T ss_pred             cCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH------------HHHH
Confidence            554433334568999999999987       356899999999999999999999999532110            0011


Q ss_pred             HhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCC---CCHHHHHHH
Q 047276          334 EKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLR---PSMARVVEM  387 (453)
Q Consensus       334 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~R---Ps~~~v~~~  387 (453)
                      ........  .   .+.   ..+...+..+.+++.+||+ +|++|   |+++++.+.
T Consensus       281 ~i~~~~~~--~---~~p---~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          281 KIVHYKEH--L---SLP---LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             HHHTHHHH--C---CCC-------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             HHHhcccC--c---CCC---ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            11110000  0   000   0112234568999999999 99998   689998743

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.5e-41  Score=336.06  Aligned_cols=248  Identities=16%  Similarity=0.170  Sum_probs=197.6

Q ss_pred             HhcccCcCCceEEEEEE------eCCCcEEEEEEecCCCccHHHHHHHHHHHHhcC---CCceeeEeeEEEecCCCeEEE
Q 047276          105 FQALLGHGSSASVFKGI------LSDGTSVAVKRINGEENGEKEFRSEVAAIASAQ---HVNLVRLLGYCVVPGGPRYLV  175 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~------~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~~lv  175 (453)
                      +.++||+|+||+||+|.      ..+++.||||+++..  ...++..|+.++..++   |+|++++++++. ..+..++|
T Consensus        69 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~-~~~~~~lv  145 (365)
T 3e7e_A           69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL-FQNGSVLV  145 (365)
T ss_dssp             EEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE-CSSCEEEE
T ss_pred             EEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeee-cCCCcEEE
Confidence            34789999999999994      456889999999753  4567888999999887   999999999986 56688999


Q ss_pred             EEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECC----------
Q 047276          176 YEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDE----------  245 (453)
Q Consensus       176 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~----------  245 (453)
                      |||+++|+|.+++......     ....++|..++.|+.|++.||+|||+   .+|+||||||+|||++.          
T Consensus       146 ~e~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~  217 (365)
T 3e7e_A          146 GELYSYGTLLNAINLYKNT-----PEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDD  217 (365)
T ss_dssp             ECCCCSCBHHHHHHHHHTS-----TTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC-----
T ss_pred             EeccCCCcHHHHHHHhhcc-----cccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCcccccc
Confidence            9999999999999643221     12449999999999999999999999   89999999999999998          


Q ss_pred             -CCcEEEeeccccccccCC-CCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcc
Q 047276          246 -NYRAVVSDFGLSKLMSRD-QSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKN  323 (453)
Q Consensus       246 -~~~~kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~  323 (453)
                       ++.+||+|||+++.+... .........||++|+|||++.+..++.++|||||||++|||++|+.||.....+.     
T Consensus       218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-----  292 (365)
T 3e7e_A          218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-----  292 (365)
T ss_dssp             -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-----
T ss_pred             ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-----
Confidence             899999999999765422 2334456789999999999999999999999999999999999999985322110     


Q ss_pred             cccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCC-CCHHHHHHHhcccc
Q 047276          324 KWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLR-PSMARVVEMLEGRV  392 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~R-Ps~~~v~~~L~~~~  392 (453)
                       +.                  .+..+.   ..  .....+.+++..|++.+|.+| |++.++.+.|++..
T Consensus       293 -~~------------------~~~~~~---~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l  338 (365)
T 3e7e_A          293 -CK------------------PEGLFR---RL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF  338 (365)
T ss_dssp             -EE------------------ECSCCT---TC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred             -ee------------------echhcc---cc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence             00                  000010   01  113346788889999999998 67888888887654

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.8e-41  Score=328.53  Aligned_cols=254  Identities=26%  Similarity=0.315  Sum_probs=190.7

Q ss_pred             cccCcCCceEEEEEEe-CCCcEEEEEEecCC-CccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEEEEEecCCCC
Q 047276          107 ALLGHGSSASVFKGIL-SDGTSVAVKRINGE-ENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYLVYEFIQNGS  183 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~lv~e~~~~gs  183 (453)
                      +.||+|+||+||+|.. .+++.||||++... ......+.+|+.++.++ +||||+++++++. .++..++||||+++|+
T Consensus        19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~   97 (316)
T 2ac3_A           19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE-EEDRFYLVFEKMRGGS   97 (316)
T ss_dssp             CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE-ETTEEEEEEECCTTCB
T ss_pred             ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe-eCCEEEEEEEcCCCCc
Confidence            5799999999999995 57899999999764 34467799999999985 7999999999986 4568899999999999


Q ss_pred             hhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCc---EEEeeccccccc
Q 047276          184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYR---AVVSDFGLSKLM  260 (453)
Q Consensus       184 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~---~kl~DfGla~~~  260 (453)
                      |.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.   +||+|||++...
T Consensus        98 L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           98 ILSHIHKRR----------HFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             HHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             HHHHHhccC----------CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            999996432          38999999999999999999999   89999999999999998776   999999998765


Q ss_pred             cCCCC------ceeeeccCCccccchhhhhc-----CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcc--cccc
Q 047276          261 SRDQS------RCITTIRGTRGYLAPEWILE-----QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKN--KWQY  327 (453)
Q Consensus       261 ~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~--~~~~  327 (453)
                      .....      .......||+.|+|||.+..     ..++.++||||||+++|||++|+.||............  ....
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  244 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA  244 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence            42211      11234569999999999875     55889999999999999999999999643322111000  0000


Q ss_pred             hhHHHHHhhhcCcccccccccccCCCCCcH----HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          328 FPKIVNEKMKEGKLMEIVDQRLTDEGGIDE----TQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~----~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ........+..+..            ..+.    .....+.+++.+||+.||++|||+.++++
T Consensus       245 ~~~~~~~~i~~~~~------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          245 CQNMLFESIQEGKY------------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHHHHCCC------------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHhccCc------------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            00111122222211            1111    12356899999999999999999999986

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.6e-41  Score=333.69  Aligned_cols=240  Identities=23%  Similarity=0.309  Sum_probs=191.2

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCCc----cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEEN----GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      .+.||+|+||+||+|.. .+|+.||||++.....    ..+.+.+|+.++++++||||+++++++. .++..++||||+.
T Consensus        59 ~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~~~lv~e~~~  137 (348)
T 1u5q_A           59 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-REHTAWLVMEYCL  137 (348)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-ETTEEEEEEECCS
T ss_pred             eeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-ECCeEEEEEecCC
Confidence            46899999999999995 5789999999975322    2246889999999999999999999986 4568899999997


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                       |+|.+++....         ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++...
T Consensus       138 -g~l~~~l~~~~---------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~  204 (348)
T 1u5q_A          138 -GSASDLLEVHK---------KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM  204 (348)
T ss_dssp             -EEHHHHHHHHT---------SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred             -CCHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceec
Confidence             68888875332         248999999999999999999999   89999999999999999999999999999865


Q ss_pred             cCCCCceeeeccCCccccchhhhh---cCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhh
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWIL---EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMK  337 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (453)
                      ...     ....||+.|+|||.+.   .+.++.++|||||||++|||++|+.||.....            .........
T Consensus       205 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------------~~~~~~~~~  267 (348)
T 1u5q_A          205 APA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------------MSALYHIAQ  267 (348)
T ss_dssp             SSB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------------HHHHHHHHH
T ss_pred             CCC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------------HHHHHHHHh
Confidence            432     3457899999999985   56789999999999999999999999853211            011111111


Q ss_pred             cCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          338 EGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       338 ~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                       +..     +.+.     +......+.+++.+||+.+|++|||++++++.
T Consensus       268 -~~~-----~~~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          268 -NES-----PALQ-----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             -SCC-----CCCC-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             -cCC-----CCCC-----CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence             111     1111     11223458899999999999999999998854

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-42  Score=341.19  Aligned_cols=260  Identities=17%  Similarity=0.150  Sum_probs=200.0

Q ss_pred             HhcccCcCCceEEEEEEeCC---------CcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceee---------------
Q 047276          105 FQALLGHGSSASVFKGILSD---------GTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVR---------------  160 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------------  160 (453)
                      +.+.||+|+||.||+|....         ++.||+|.+...    +.+.+|+.++.+++||||++               
T Consensus        46 ~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~  121 (352)
T 2jii_A           46 LKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPT  121 (352)
T ss_dssp             EEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCC
T ss_pred             EEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCccCccc
Confidence            35789999999999999753         789999998754    35789999999999999987               


Q ss_pred             EeeEEEecCCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCc
Q 047276          161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPEN  240 (453)
Q Consensus       161 l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~N  240 (453)
                      +++++...+...++||||+ +++|.+++....        ...+++..++.++.|++.||+|||+   .+|+||||||+|
T Consensus       122 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~N  189 (352)
T 2jii_A          122 CMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--------KHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAEN  189 (352)
T ss_dssp             CCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--------GGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGG
T ss_pred             hhhccccCCcEEEEEecCC-CcCHHHHHHhCC--------cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHH
Confidence            6778776567889999999 999999996541        1349999999999999999999999   899999999999


Q ss_pred             EEECCCC--cEEEeeccccccccCCCCc------eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCc
Q 047276          241 ILLDENY--RAVVSDFGLSKLMSRDQSR------CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVS  312 (453)
Q Consensus       241 iLl~~~~--~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~  312 (453)
                      ||++.++  .+||+|||+++........      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.
T Consensus       190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  269 (352)
T 2jii_A          190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT  269 (352)
T ss_dssp             EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            9999998  9999999999876532211      1234579999999999999899999999999999999999999996


Q ss_pred             ccccCCCCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          313 LIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      .......       ...... .... .....+.+....     .......+.+++.+||+.||++||+++++++.|++..
T Consensus       270 ~~~~~~~-------~~~~~~-~~~~-~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  335 (352)
T 2jii_A          270 NCLPNTE-------DIMKQK-QKFV-DKPGPFVGPCGH-----WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL  335 (352)
T ss_dssp             GGTTCHH-------HHHHHH-HHHH-HSCCCEECTTSC-----EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             cCCcCHH-------HHHHHH-Hhcc-CChhhhhhhccc-----cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence            4321110       000000 1011 111111111110     0112345899999999999999999999999998875


Q ss_pred             CC
Q 047276          393 AV  394 (453)
Q Consensus       393 ~~  394 (453)
                      ..
T Consensus       336 ~~  337 (352)
T 2jii_A          336 QD  337 (352)
T ss_dssp             HH
T ss_pred             Hh
Confidence            43

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.8e-42  Score=335.61  Aligned_cols=264  Identities=23%  Similarity=0.264  Sum_probs=194.2

Q ss_pred             HHHHHHHH--hcccCcCCceEEEEEEe-CCCcEEEEEEecC------CCccHHHHHHHHHHHHhcCCCceeeEeeEEEec
Q 047276           98 LEEATDNF--QALLGHGSSASVFKGIL-SDGTSVAVKRING------EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP  168 (453)
Q Consensus        98 l~~~~~~~--~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~------~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~  168 (453)
                      +.....+|  .+.||+|+||+||+|.. .++..||+|++..      .....+.+.+|+.++++++||||+++++++. .
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~   99 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE-D   99 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE-C
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc-c
Confidence            33334444  58999999999999996 4688999999853      2344567999999999999999999999986 5


Q ss_pred             CCCeEEEEEecCCCChhhhhccCCCCCCC------------------------------CCCCCCCCHHHHHHHHHHHHH
Q 047276          169 GGPRYLVYEFIQNGSLDHWIFPTSRRSEG------------------------------HYSGGCLSWDLRYRVAIDVAK  218 (453)
Q Consensus       169 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------------------------------~~~~~~l~~~~~~~i~~~ia~  218 (453)
                      .+..++||||+++|+|.+++.........                              ......+++..++.++.|++.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            66889999999999999998532110000                              000112467788899999999


Q ss_pred             HhccccccCCCceeccCCCCCcEEECCCC--cEEEeeccccccccCCC---CceeeeccCCccccchhhhhc--CCCCcc
Q 047276          219 ALSYLHNDCRSRVLHLDVKPENILLDENY--RAVVSDFGLSKLMSRDQ---SRCITTIRGTRGYLAPEWILE--QGVSEK  291 (453)
Q Consensus       219 ~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~--~~kl~DfGla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~  291 (453)
                      ||+|||+   .+|+||||||+|||++.++  .+||+|||++.......   ........||+.|+|||.+..  ..++.+
T Consensus       180 ~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          180 ALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            9999999   8999999999999998776  89999999998764322   122345679999999999875  678999


Q ss_pred             ccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhcc
Q 047276          292 CDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCI  371 (453)
Q Consensus       292 sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl  371 (453)
                      +||||||+++|||++|+.||......            ............  ...+       ........+.+++.+||
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~~------------~~~~~~~~~~~~--~~~~-------~~~~~~~~~~~li~~~l  315 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVNDA------------DTISQVLNKKLC--FENP-------NYNVLSPLARDLLSNLL  315 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHH------------HHHHHHHHCCCC--TTSG-------GGGGSCHHHHHHHHHHS
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCChH------------HHHHHHHhcccc--cCCc-------ccccCCHHHHHHHHHHc
Confidence            99999999999999999999532211            111111111100  0000       11123456889999999


Q ss_pred             ccCCCCCCCHHHHHH
Q 047276          372 QERARLRPSMARVVE  386 (453)
Q Consensus       372 ~~~p~~RPs~~~v~~  386 (453)
                      +.+|++||++.++++
T Consensus       316 ~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          316 NRNVDERFDAMRALQ  330 (345)
T ss_dssp             CSCTTTSCCHHHHHH
T ss_pred             CCChhHCCCHHHHhc
Confidence            999999999999986

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.7e-41  Score=322.41  Aligned_cols=241  Identities=24%  Similarity=0.317  Sum_probs=195.3

Q ss_pred             HHhcccCcCCceEEEEEEeC-CCcEEEEEEecCC-CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          104 NFQALLGHGSSASVFKGILS-DGTSVAVKRINGE-ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      .+.+.||+|+||+||+|... ++..+|+|++... ....+.+.+|+.++++++||||+++++++. .++..++||||+++
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~   90 (277)
T 3f3z_A           12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE-DNTDIYLVMELCTG   90 (277)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-CSSEEEEEEECCCS
T ss_pred             EeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCeEEEEEeccCC
Confidence            34578999999999999965 4778999998753 445678999999999999999999999986 56678999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEE---CCCCcEEEeeccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILL---DENYRAVVSDFGLSK  258 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl---~~~~~~kl~DfGla~  258 (453)
                      ++|.+++....          .+++..++.++.|++.||+|||+   .+++||||||+||++   +.++.+||+|||++.
T Consensus        91 ~~L~~~~~~~~----------~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~  157 (277)
T 3f3z_A           91 GELFERVVHKR----------VFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA  157 (277)
T ss_dssp             CBHHHHHHHHC----------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             CcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence            99999986432          38999999999999999999999   899999999999999   788999999999998


Q ss_pred             cccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      ......  ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||......             .....+..
T Consensus       158 ~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------------~~~~~~~~  221 (277)
T 3f3z_A          158 RFKPGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS-------------EVMLKIRE  221 (277)
T ss_dssp             ECCTTS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------------HHHHHHHH
T ss_pred             eccCcc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH-------------HHHHHHHh
Confidence            765432  2344578999999998765 4899999999999999999999999532110             11111222


Q ss_pred             CcccccccccccCCCCCcH----HHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          339 GKLMEIVDQRLTDEGGIDE----TQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~----~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      +..            ..+.    .....+.+++.+|++.+|++|||+.++++
T Consensus       222 ~~~------------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          222 GTF------------TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             CCC------------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCC------------CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            111            0111    22456889999999999999999999874

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3e-42  Score=333.12  Aligned_cols=260  Identities=20%  Similarity=0.349  Sum_probs=192.5

Q ss_pred             HHhcccCcCCceEEEEEEe-CCCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEe
Q 047276          104 NFQALLGHGSSASVFKGIL-SDGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      .+.+.||+|+||.||+|.. .+|+.||||++...    ......+.+|+.++++++||||+++++++. ..+..++||||
T Consensus        35 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~  113 (310)
T 2wqm_A           35 RIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-EDNELNIVLEL  113 (310)
T ss_dssp             EEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-ETTEEEEEEEC
T ss_pred             EEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-cCCcEEEEEec
Confidence            3457899999999999996 57899999999752    223456889999999999999999999987 45688999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +++|+|.+++.....      ....+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.
T Consensus       114 ~~~~~L~~~l~~~~~------~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~  184 (310)
T 2wqm_A          114 ADAGDLSRMIKHFKK------QKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGR  184 (310)
T ss_dssp             CCSCBHHHHHHHHHH------TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC----
T ss_pred             CCCCCHHHHHHHhcc------cccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEecccee
Confidence            999999999854221      12348999999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      ....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......          ... ....+..
T Consensus       185 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----------~~~-~~~~~~~  252 (310)
T 2wqm_A          185 FFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----------LYS-LCKKIEQ  252 (310)
T ss_dssp             ---------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----------HHH-HHHHHHT
T ss_pred             eecCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----------HHH-HHHHhhc
Confidence            6643322 223456899999999999999999999999999999999999998532110          000 1111222


Q ss_pred             CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccCCC
Q 047276          339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVD  395 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~~~  395 (453)
                      +.....     .     .......+.+++.+||+.||++|||+.+|++.|++..+..
T Consensus       253 ~~~~~~-----~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~  299 (310)
T 2wqm_A          253 CDYPPL-----P-----SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT  299 (310)
T ss_dssp             TCSCCC-----C-----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ccCCCC-----c-----ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence            211111     0     1123345889999999999999999999999998875443

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.1e-41  Score=330.65  Aligned_cols=267  Identities=22%  Similarity=0.360  Sum_probs=186.4

Q ss_pred             HHhcccCcCCceEEEEEEe-CCCcEEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          104 NFQALLGHGSSASVFKGIL-SDGTSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      .+.+.||+|+||+||+|.. .+|+.||+|+++..  ......+.+|+.++++++||||+++++++. .++..++||||++
T Consensus         8 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~~lv~e~~~   86 (317)
T 2pmi_A            8 KQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIH-TENKLTLVFEFMD   86 (317)
T ss_dssp             -----------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEEC-CTTEEEEEEECCC
T ss_pred             eEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEE-ECCeEEEEEEecC
Confidence            3457899999999999996 46899999998753  233467889999999999999999999976 5568899999998


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                       |+|.+++.......    ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++...
T Consensus        87 -~~L~~~l~~~~~~~----~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           87 -NDLKKYMDSRTVGN----TPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             -CBHHHHHHHHHSSS----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             -CCHHHHHHhccccc----cccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence             59999986432211    12348999999999999999999999   89999999999999999999999999999876


Q ss_pred             cCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCC----------CCcccccchh
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGND----------KSKNKWQYFP  329 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~----------~~~~~~~~~~  329 (453)
                      ..... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||........          .....|....
T Consensus       159 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          159 GIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             TSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             CCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            43221 2334578999999999876 4689999999999999999999999964321100          0000000000


Q ss_pred             HHHH--Hhh---hcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          330 KIVN--EKM---KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       330 ~~~~--~~~---~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ....  ...   ....+.+.+.+..      .......+.+++.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHT------KEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGC------SSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhcccccccccchhHHHhhcccc------cccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            0000  000   0000000001100      0122346899999999999999999999874

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=7.9e-42  Score=325.19  Aligned_cols=240  Identities=25%  Similarity=0.341  Sum_probs=191.8

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      .+.||+|+||+||+|... ++..||+|++...    ......+.+|+.++++++||||+++++++. ..+..++||||++
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~   92 (279)
T 3fdn_A           14 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-DATRVYLILEYAP   92 (279)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-CSSEEEEEECCCT
T ss_pred             eeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe-cCCEEEEEEecCC
Confidence            578999999999999864 5779999998642    233567899999999999999999999986 5567899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|.+++....          .+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++...
T Consensus        93 ~~~l~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~  159 (279)
T 3fdn_A           93 LGTVYRELQKLS----------KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA  159 (279)
T ss_dssp             TEEHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred             CCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccC
Confidence            999999986432          38999999999999999999999   89999999999999999999999999998654


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      ....   .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.....            .. .........
T Consensus       160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------------~~-~~~~~~~~~  223 (279)
T 3fdn_A          160 PSSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------------QE-TYKRISRVE  223 (279)
T ss_dssp             -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------------HH-HHHHHHHTC
T ss_pred             Cccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH------------HH-HHHHHHhCC
Confidence            3322   2345789999999999998999999999999999999999999953210            00 111111111


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                                  ...+......+.+++.+||+.+|++|||+.++++.
T Consensus       224 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          224 ------------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             ------------CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             ------------CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                        11122234458899999999999999999999953

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=7.8e-42  Score=327.53  Aligned_cols=258  Identities=21%  Similarity=0.292  Sum_probs=192.0

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      .+.||+|+||+||+|... +|+.||||++....   .....+.+|+.++++++||||+++++++. .++..++||||+++
T Consensus         7 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~   85 (292)
T 3o0g_A            7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-SDKKLTLVFEFCDQ   85 (292)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-ETTEEEEEEECCSE
T ss_pred             eeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEE-eCCEEEEEEecCCC
Confidence            578999999999999964 68999999997532   23467889999999999999999999986 55688999999976


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                       +|.+++....         +.+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++....
T Consensus        86 -~l~~~~~~~~---------~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~  152 (292)
T 3o0g_A           86 -DLKKYFDSCN---------GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFG  152 (292)
T ss_dssp             -EHHHHHHHTT---------TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             -CHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecC
Confidence             6666654322         348999999999999999999999   899999999999999999999999999998764


Q ss_pred             CCCCceeeeccCCccccchhhhhcCC-CCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhc--
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILEQG-VSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE--  338 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  338 (453)
                      ... .......||+.|+|||.+.+.. ++.++|||||||++|||++|..|+........       .+.. .......  
T Consensus       153 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~-------~~~~-i~~~~~~~~  223 (292)
T 3o0g_A          153 IPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-------QLKR-IFRLLGTPT  223 (292)
T ss_dssp             SCC-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-------HHHH-HHHHHCCCC
T ss_pred             Ccc-ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH-------HHHH-HHHHhCCCC
Confidence            332 2234567899999999998765 89999999999999999999888632211100       0000 0000000  


Q ss_pred             -Cc---cccccc-------ccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          339 -GK---LMEIVD-------QRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       339 -~~---~~~~~d-------~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                       ..   ..+..+       +...............+.+++.+||+.||++|||++|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          224 EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence             00   000000       0000001122234556889999999999999999999885

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-42  Score=340.45  Aligned_cols=249  Identities=24%  Similarity=0.276  Sum_probs=195.6

Q ss_pred             HhcccCcCCceEEEEEEe----CCCcEEEEEEecCC-----CccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEE
Q 047276          105 FQALLGHGSSASVFKGIL----SDGTSVAVKRINGE-----ENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYL  174 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~----~~g~~vavK~~~~~-----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~l  174 (453)
                      +.+.||+|+||+||+++.    .+|+.||||+++..     ....+.+.+|+.++..+ +||||+++++++. ..+..++
T Consensus        58 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-~~~~~~l  136 (355)
T 1vzo_A           58 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ-TETKLHL  136 (355)
T ss_dssp             EEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE-ETTEEEE
T ss_pred             EEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe-eCceEEE
Confidence            457899999999999997    46899999998642     22345677899999999 6999999999876 4567899


Q ss_pred             EEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeec
Q 047276          175 VYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDF  254 (453)
Q Consensus       175 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~Df  254 (453)
                      ||||+++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+||
T Consensus       137 v~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Df  203 (355)
T 1vzo_A          137 ILDYINGGELFTHLSQRE----------RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDF  203 (355)
T ss_dssp             EECCCCSCBHHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCS
T ss_pred             EeecCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeC
Confidence            999999999999996432          38999999999999999999999   89999999999999999999999999


Q ss_pred             cccccccCCCCceeeeccCCccccchhhhhc--CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHH
Q 047276          255 GLSKLMSRDQSRCITTIRGTRGYLAPEWILE--QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIV  332 (453)
Q Consensus       255 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  332 (453)
                      |+++..............||+.|+|||.+.+  ..++.++|||||||++|||++|+.||........        .....
T Consensus       204 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--------~~~~~  275 (355)
T 1vzo_A          204 GLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--------QAEIS  275 (355)
T ss_dssp             SEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--------HHHHH
T ss_pred             CCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--------HHHHH
Confidence            9998765443333445679999999999985  3478999999999999999999999963221110        01111


Q ss_pred             HHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHHHh
Q 047276          333 NEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRP-----SMARVVEML  388 (453)
Q Consensus       333 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~~v~~~L  388 (453)
                      ..... .            ....+......+.+++.+||+.||++||     +++++++..
T Consensus       276 ~~~~~-~------------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          276 RRILK-S------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             HHHHH-C------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             HHHhc-c------------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            11111 0            0112233445688999999999999999     899988654

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4e-41  Score=325.11  Aligned_cols=260  Identities=22%  Similarity=0.275  Sum_probs=192.9

Q ss_pred             HHhcccCcCCceEEEEEEe-CCCcEEEEEEecCC------CccHHHHHHHHHHHHhc---CCCceeeEeeEEEecCC---
Q 047276          104 NFQALLGHGSSASVFKGIL-SDGTSVAVKRINGE------ENGEKEFRSEVAAIASA---QHVNLVRLLGYCVVPGG---  170 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~------~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~~---  170 (453)
                      .+.+.||+|+||+||+|+. .+|+.||||++...      ......+.+|+.+++.+   +||||++++++|.....   
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~   91 (308)
T 3g33_A           12 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDRE   91 (308)
T ss_dssp             EEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSE
T ss_pred             EEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCc
Confidence            3457899999999999995 56899999998632      12234677788877766   49999999999875443   


Q ss_pred             -CeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcE
Q 047276          171 -PRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRA  249 (453)
Q Consensus       171 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~  249 (453)
                       ..++||||+. |+|.+++.....        ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+
T Consensus        92 ~~~~lv~e~~~-~~L~~~~~~~~~--------~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~  159 (308)
T 3g33_A           92 IKVTLVFEHVD-QDLRTYLDKAPP--------PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTV  159 (308)
T ss_dssp             EEEEEEEECCC-CBHHHHHHTCCT--------TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCE
T ss_pred             eeEEEEehhhh-cCHHHHHhhccC--------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCE
Confidence             3689999997 599999965432        238999999999999999999999   899999999999999999999


Q ss_pred             EEeeccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchh
Q 047276          250 VVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFP  329 (453)
Q Consensus       250 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~  329 (453)
                      ||+|||+++......  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......        ...
T Consensus       160 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--------~~~  229 (308)
T 3g33_A          160 KLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--------QLG  229 (308)
T ss_dssp             EECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH--------HHH
T ss_pred             EEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--------HHH
Confidence            999999998664332  2345678999999999999999999999999999999999999995322110        000


Q ss_pred             HHHHHhhh---cCccc---ccccccccCCCCC-----cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          330 KIVNEKMK---EGKLM---EIVDQRLTDEGGI-----DETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       330 ~~~~~~~~---~~~~~---~~~d~~l~~~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      . ......   .....   ......+......     .++....+.+++.+||+.||++|||+.|+++
T Consensus       230 ~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          230 K-IFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             H-HHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             H-HHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            0 000000   00000   0000000000000     1123456889999999999999999999874

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.9e-41  Score=323.89  Aligned_cols=249  Identities=28%  Similarity=0.362  Sum_probs=190.6

Q ss_pred             HHHhcccCcCCceEEEEEEe-CCCcEEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          103 DNFQALLGHGSSASVFKGIL-SDGTSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      +.+.+.||+|+||+||++.. .++..+|+|++...  ....+.+.+|+.++++++||||+++++++. ..+..++||||+
T Consensus        24 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~~~lv~e~~  102 (285)
T 3is5_A           24 FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE-DYHNMYIVMETC  102 (285)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-CSSEEEEEECCC
T ss_pred             eeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhee-cCCeEEEEEEeC
Confidence            34468999999999999996 46889999998753  345678999999999999999999999986 566789999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEE---CCCCcEEEeeccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILL---DENYRAVVSDFGL  256 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl---~~~~~~kl~DfGl  256 (453)
                      ++|+|.+++.....      ....+++..++.++.|++.||+|||+   .+++||||||+|||+   +.++.+||+|||+
T Consensus       103 ~~~~L~~~l~~~~~------~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~  173 (285)
T 3is5_A          103 EGGELLERIVSAQA------RGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGL  173 (285)
T ss_dssp             SCCBHHHHHHHHHH------HTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCC
T ss_pred             CCCcHHHHHHhhhh------cccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeec
Confidence            99999999854321      12348999999999999999999999   899999999999999   4568899999999


Q ss_pred             cccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhh
Q 047276          257 SKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKM  336 (453)
Q Consensus       257 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (453)
                      +.......  ......||+.|+|||.+. +.++.++||||||+++|||++|+.||.....            .. .....
T Consensus       174 a~~~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~------------~~-~~~~~  237 (285)
T 3is5_A          174 AELFKSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL------------EE-VQQKA  237 (285)
T ss_dssp             CCC------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------------HH-HHHHH
T ss_pred             ceecCCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH------------HH-HHhhh
Confidence            98664332  234557899999999875 5689999999999999999999999953211            00 11111


Q ss_pred             hcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          337 KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       337 ~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ..........     ...    ....+.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~-----~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          238 TYKEPNYAVE-----CRP----LTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             HHCCCCCCC-------CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ccCCcccccc-----cCc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1111000000     011    2345789999999999999999999884

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3e-41  Score=333.19  Aligned_cols=193  Identities=28%  Similarity=0.336  Sum_probs=168.9

Q ss_pred             HHhcccCcCCceEEEEEEe-CCCcEEEEEEecCCCccHHHHHHHHHHHHhcC-----CCceeeEeeEEEecCCCeEEEEE
Q 047276          104 NFQALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRSEVAAIASAQ-----HVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      .+.++||+|+||+||+|+. .+++.||||+++........+..|+.++..++     ||||+++++++. ..+..++|||
T Consensus        38 ~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~-~~~~~~lv~e  116 (360)
T 3llt_A           38 LVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM-YYDHMCLIFE  116 (360)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE-ETTEEEEEEC
T ss_pred             EEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceee-ECCeeEEEEc
Confidence            3458999999999999996 56889999999865555677888999999986     999999999987 4568899999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECC------------
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDE------------  245 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~------------  245 (453)
                      |+ +++|.+++.....        ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.            
T Consensus       117 ~~-~~~L~~~~~~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~~~~~~  184 (360)
T 3llt_A          117 PL-GPSLYEIITRNNY--------NGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRR  184 (360)
T ss_dssp             CC-CCBHHHHHHHTTT--------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred             CC-CCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccccccchhc
Confidence            99 8899999965432        238999999999999999999999   89999999999999986            


Q ss_pred             -------------CCcEEEeeccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCc
Q 047276          246 -------------NYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVS  312 (453)
Q Consensus       246 -------------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~  312 (453)
                                   ++.+||+|||++.......    ....||+.|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus       185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~  260 (360)
T 3llt_A          185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR  260 (360)
T ss_dssp             TTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred             ccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence                         7899999999998654322    34578999999999999999999999999999999999999996


Q ss_pred             c
Q 047276          313 L  313 (453)
Q Consensus       313 ~  313 (453)
                      .
T Consensus       261 ~  261 (360)
T 3llt_A          261 T  261 (360)
T ss_dssp             C
T ss_pred             C
Confidence            4

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=7.8e-42  Score=333.63  Aligned_cols=262  Identities=24%  Similarity=0.369  Sum_probs=201.8

Q ss_pred             HHhcccCcCCceEEEEEEeCC-C-----cEEEEEEecCCC--ccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEE
Q 047276          104 NFQALLGHGSSASVFKGILSD-G-----TSVAVKRINGEE--NGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYL  174 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~~-g-----~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~l  174 (453)
                      .+.+.||+|+||.||+|.... +     ..||+|.+....  ...+.+.+|+.++..+ +||||++++++|. .++..++
T Consensus        49 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-~~~~~~l  127 (333)
T 2i1m_A           49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT-HGGPVLV  127 (333)
T ss_dssp             EEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSSCEE
T ss_pred             eeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe-cCCceEE
Confidence            345899999999999999642 2     479999997643  2346789999999999 8999999999986 5668899


Q ss_pred             EEEecCCCChhhhhccCCCCCC----CCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEE
Q 047276          175 VYEFIQNGSLDHWIFPTSRRSE----GHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAV  250 (453)
Q Consensus       175 v~e~~~~gsL~~~l~~~~~~~~----~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~k  250 (453)
                      ||||+++|+|.+++........    .......+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+|
T Consensus       128 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~k  204 (333)
T 2i1m_A          128 ITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAK  204 (333)
T ss_dssp             EEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGGGEEE
T ss_pred             EEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCCCeEE
Confidence            9999999999999864321000    00012348999999999999999999999   8999999999999999999999


Q ss_pred             EeeccccccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccch
Q 047276          251 VSDFGLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYF  328 (453)
Q Consensus       251 l~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~  328 (453)
                      |+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||......           
T Consensus       205 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-----------  273 (333)
T 2i1m_A          205 IGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN-----------  273 (333)
T ss_dssp             BCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS-----------
T ss_pred             ECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh-----------
Confidence            999999987654332 22234557889999999999999999999999999999998 99998532111           


Q ss_pred             hHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          329 PKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       329 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                       .........+..     .      ..+......+.+++.+||+.+|.+|||+.+|++.|+...
T Consensus       274 -~~~~~~~~~~~~-----~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  325 (333)
T 2i1m_A          274 -SKFYKLVKDGYQ-----M------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA  325 (333)
T ss_dssp             -HHHHHHHHHTCC-----C------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HHHHHHHhcCCC-----C------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence             011111111110     0      011122345889999999999999999999999998653

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-41  Score=331.19  Aligned_cols=265  Identities=24%  Similarity=0.332  Sum_probs=201.6

Q ss_pred             HhcccCcCCceEEEEEEe-----CCCcEEEEEEecCC-CccHHHHHHHHHHHHhcCCCceeeEeeEEEecC-CCeEEEEE
Q 047276          105 FQALLGHGSSASVFKGIL-----SDGTSVAVKRINGE-ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG-GPRYLVYE  177 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-----~~g~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~~lv~e  177 (453)
                      +.+.||+|+||.||++++     .+|+.||||++... ....+.+.+|+.++++++||||+++++++...+ ...++|||
T Consensus        45 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e  124 (326)
T 2w1i_A           45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME  124 (326)
T ss_dssp             EEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEEC
T ss_pred             eeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEE
Confidence            457899999999999984     36889999999764 334467999999999999999999999876443 36799999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |+++|+|.+++....         ..+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++
T Consensus       125 ~~~~~~L~~~l~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~  192 (326)
T 2w1i_A          125 YLPYGSLRDYLQKHK---------ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLT  192 (326)
T ss_dssp             CCTTCBHHHHHHHST---------TSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             CCCCCCHHHHHHhcc---------cCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcch
Confidence            999999999996542         238999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCce--eeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCC---CCcccccchhHHH
Q 047276          258 KLMSRDQSRC--ITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGND---KSKNKWQYFPKIV  332 (453)
Q Consensus       258 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~---~~~~~~~~~~~~~  332 (453)
                      ..........  .....++..|+|||.+.+..++.++||||||+++|||++|+.|+........   .............
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (326)
T 2w1i_A          193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  272 (326)
T ss_dssp             EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence            8775443211  2234567789999999988899999999999999999999998753210000   0000000000011


Q ss_pred             HHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          333 NEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       333 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      .+.+..+.       ..    ..+...+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       273 ~~~~~~~~-------~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~  321 (326)
T 2w1i_A          273 IELLKNNG-------RL----PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  321 (326)
T ss_dssp             HHHHHTTC-------CC----CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHhhcCC-------CC----CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            11111111       00    112234456899999999999999999999999998753

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.8e-41  Score=323.27  Aligned_cols=243  Identities=22%  Similarity=0.373  Sum_probs=191.5

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEec---CCCeEEEEE
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP---GGPRYLVYE  177 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~---~~~~~lv~e  177 (453)
                      +.+.||+|+||+||+|.. .++..||+|.+...   ....+.+.+|+.++++++||||+++++++...   +...++|||
T Consensus        30 ~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e  109 (290)
T 1t4h_A           30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE  109 (290)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred             eeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEE
Confidence            356899999999999996 46789999998753   23345689999999999999999999987643   345789999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCc--eeccCCCCCcEEEC-CCCcEEEeec
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSR--VLHLDVKPENILLD-ENYRAVVSDF  254 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~--ivH~Dlk~~NiLl~-~~~~~kl~Df  254 (453)
                      |+++|+|.+++...          ..+++..++.++.|++.||+|||+   .+  ++||||||+|||++ +++.+||+||
T Consensus       110 ~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Df  176 (290)
T 1t4h_A          110 LMTSGTLKTYLKRF----------KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDL  176 (290)
T ss_dssp             CCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred             ecCCCCHHHHHHHc----------cCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeC
Confidence            99999999999643          238999999999999999999999   67  99999999999998 8899999999


Q ss_pred             cccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHH
Q 047276          255 GLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNE  334 (453)
Q Consensus       255 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  334 (453)
                      |++.......   .....||+.|+|||.+. +.++.++||||||+++|||++|+.||......            .....
T Consensus       177 g~~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------------~~~~~  240 (290)
T 1t4h_A          177 GLATLKRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA------------AQIYR  240 (290)
T ss_dssp             TGGGGCCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------------HHHHH
T ss_pred             CCcccccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH------------HHHHH
Confidence            9997544332   34557899999999776 56899999999999999999999999532110            01111


Q ss_pred             hhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          335 KMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       335 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ....+......          +......+.+++.+||+.+|++|||+.++++
T Consensus       241 ~~~~~~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          241 RVTSGVKPASF----------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HHTTTCCCGGG----------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhccCCcccc----------CCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            11111111111          1112235889999999999999999999885

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.4e-41  Score=331.25  Aligned_cols=259  Identities=25%  Similarity=0.352  Sum_probs=199.1

Q ss_pred             HHhcccCcCCceEEEEEEe------CCCcEEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEE
Q 047276          104 NFQALLGHGSSASVFKGIL------SDGTSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLV  175 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~------~~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv  175 (453)
                      .+.+.||+|+||.||+|+.      .+++.||||.+...  ......+.+|+.++++++||||+++++++. .....++|
T Consensus        33 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv  111 (327)
T 2yfx_A           33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL-QSLPRFIL  111 (327)
T ss_dssp             EEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSSCEEE
T ss_pred             EEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc-CCCCcEEE
Confidence            4468999999999999984      34678999999653  334467899999999999999999999976 55678999


Q ss_pred             EEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECC---CCcEEEe
Q 047276          176 YEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDE---NYRAVVS  252 (453)
Q Consensus       176 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~---~~~~kl~  252 (453)
                      |||+++|+|.+++........   ....+++..++.++.|++.||.|||+   .+++||||||+|||++.   +..+||+
T Consensus       112 ~e~~~~~~L~~~l~~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          112 MELMAGGDLKSFLRETRPRPS---QPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EECCTTEEHHHHHHHTSCCSS---STTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EecCCCCcHHHHHHhhccccc---ccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999976543211   22448999999999999999999999   89999999999999994   4569999


Q ss_pred             eccccccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhH
Q 047276          253 DFGLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPK  330 (453)
Q Consensus       253 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  330 (453)
                      |||++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....             .
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-------------~  252 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-------------Q  252 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------------H
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH-------------H
Confidence            9999986543322 22334567899999999999999999999999999999998 9999853210             0


Q ss_pred             HHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          331 IVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       331 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                      .....+..+...           ..+......+.+++.+||+.+|++||++.++++.|+....
T Consensus       253 ~~~~~~~~~~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          253 EVLEFVTSGGRM-----------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             HHHHHHHTTCCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHhcCCCC-----------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence            111222222110           0112233468899999999999999999999999987643

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=5.1e-42  Score=326.24  Aligned_cols=251  Identities=27%  Similarity=0.364  Sum_probs=197.8

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEe-cCCCeEEEEEecC
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVV-PGGPRYLVYEFIQ  180 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~~lv~e~~~  180 (453)
                      .+.||+|+||+||++... +|+.||+|.+....   ...+.+.+|+.++++++||||+++++++.. .+...++||||++
T Consensus        11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~   90 (279)
T 2w5a_A           11 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE   90 (279)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCT
T ss_pred             ehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCC
Confidence            578999999999999974 68999999997533   234568999999999999999999998764 3456799999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCc-----eeccCCCCCcEEECCCCcEEEeecc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSR-----VLHLDVKPENILLDENYRAVVSDFG  255 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~-----ivH~Dlk~~NiLl~~~~~~kl~DfG  255 (453)
                      +|+|.+++.....      ....+++..++.++.|++.||+|||+   .+     ++||||||+||+++.++.+||+|||
T Consensus        91 ~~~L~~~l~~~~~------~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           91 GGDLASVITKGTK------ERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             TEEHHHHHHHHHH------TTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             CCCHHHHHHhhcc------cCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            9999999964322      12348999999999999999999999   56     9999999999999999999999999


Q ss_pred             ccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHh
Q 047276          256 LSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEK  335 (453)
Q Consensus       256 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  335 (453)
                      ++........ ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.....             ......
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------------~~~~~~  227 (279)
T 2w5a_A          162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-------------KELAGK  227 (279)
T ss_dssp             HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------------HHHHHH
T ss_pred             hheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-------------HHHHHH
Confidence            9987643321 12345689999999999988999999999999999999999999853211             111222


Q ss_pred             hhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 047276          336 MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEG  390 (453)
Q Consensus       336 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~  390 (453)
                      +..+....           .+......+.+++.+||+.+|++||++.++++.+..
T Consensus       228 i~~~~~~~-----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          228 IREGKFRR-----------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             HHHTCCCC-----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             Hhhccccc-----------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence            22222211           122234568999999999999999999999987654

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.6e-41  Score=319.72  Aligned_cols=246  Identities=25%  Similarity=0.337  Sum_probs=195.3

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      +.+.||+|+||.||+|... +++.||||++...  ....+.+.+|+.+++.++||||+++++++. .++..++|+||+++
T Consensus        11 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~   89 (276)
T 2yex_A           11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-EGNIQYLFLEYCSG   89 (276)
T ss_dssp             EEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEE-ETTEEEEEEECCTT
T ss_pred             EEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEE-cCCEEEEEEEecCC
Confidence            3578999999999999975 6899999998642  334567899999999999999999999986 55678999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      ++|.+++...          ..+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++....
T Consensus        90 ~~L~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  156 (276)
T 2yex_A           90 GELFDRIEPD----------IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFR  156 (276)
T ss_dssp             EEGGGGSBTT----------TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred             CcHHHHHhhc----------cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence            9999998533          238999999999999999999999   899999999999999999999999999998664


Q ss_pred             CCCC-ceeeeccCCccccchhhhhcCCC-CccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          262 RDQS-RCITTIRGTRGYLAPEWILEQGV-SEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       262 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      .... .......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.......       .     ....+...
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~-----~~~~~~~~  224 (276)
T 2yex_A          157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-------Q-----EYSDWKEK  224 (276)
T ss_dssp             ETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-------H-----HHHHHHTT
T ss_pred             CCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-------H-----HHHHhhhc
Confidence            3321 22344678999999999987665 779999999999999999999996422110       0     00111111


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ...      .    .........+.+++.+||+.||++|||+.++++
T Consensus       225 ~~~------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          225 KTY------L----NPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             CTT------S----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccc------c----CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            100      0    011123345889999999999999999999875

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.4e-41  Score=323.91  Aligned_cols=247  Identities=22%  Similarity=0.296  Sum_probs=194.2

Q ss_pred             HHHhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC-------ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEE
Q 047276          103 DNFQALLGHGSSASVFKGILS-DGTSVAVKRINGEE-------NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYL  174 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~l  174 (453)
                      +.+.+.||+|+||.||++... +|+.||+|.++...       ...+.+.+|+.++++++||||+++++++. ..+..++
T Consensus         7 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~l   85 (283)
T 3bhy_A            7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE-NKTDVVL   85 (283)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-CSSEEEE
T ss_pred             hhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec-CCCeEEE
Confidence            344689999999999999975 68999999986432       23678999999999999999999999986 5567899


Q ss_pred             EEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCC----cEE
Q 047276          175 VYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENY----RAV  250 (453)
Q Consensus       175 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~----~~k  250 (453)
                      ||||+++++|.+++...          ..+++..++.++.|++.||+|||+   .+++||||||+||+++.++    .+|
T Consensus        86 v~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~k  152 (283)
T 3bhy_A           86 ILELVSGGELFDFLAEK----------ESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIK  152 (283)
T ss_dssp             EEECCCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEE
T ss_pred             EEeecCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceE
Confidence            99999999999999543          238999999999999999999999   8999999999999999877    899


Q ss_pred             EeeccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhH
Q 047276          251 VSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPK  330 (453)
Q Consensus       251 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~  330 (453)
                      |+|||++........  .....|++.|+|||.+.+..++.++||||||+++|||++|+.||......            .
T Consensus       153 l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------------~  218 (283)
T 3bhy_A          153 LIDFGIAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ------------E  218 (283)
T ss_dssp             ECCCTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------------H
T ss_pred             EEecccceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH------------H
Confidence            999999987643322  23456899999999999889999999999999999999999999532110            0


Q ss_pred             HHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          331 IVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       331 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                       ....+......  .+...      .......+.+++.+|++.||++|||+.++++
T Consensus       219 -~~~~~~~~~~~--~~~~~------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          219 -TLTNISAVNYD--FDEEY------FSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             -HHHHHHTTCCC--CCHHH------HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -HHHHhHhcccC--Ccchh------cccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence             11111111100  00000      0112345889999999999999999999986

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.1e-41  Score=321.97  Aligned_cols=240  Identities=23%  Similarity=0.299  Sum_probs=195.8

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      +.+.||+|+||.||+|... +++.||+|++...    ......+.+|+.+++.++||||+++++++. ..+..++||||+
T Consensus        18 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~   96 (284)
T 2vgo_A           18 IGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH-DRKRIYLMLEFA   96 (284)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-CSSEEEEEECCC
T ss_pred             eeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE-cCCEEEEEEEeC
Confidence            3578999999999999965 5788999998642    234567899999999999999999999986 556889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ++|+|.+++....          .+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++..
T Consensus        97 ~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~  163 (284)
T 2vgo_A           97 PRGELYKELQKHG----------RFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVH  163 (284)
T ss_dssp             TTEEHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             CCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEeccccccc
Confidence            9999999996432          38999999999999999999999   8999999999999999999999999999876


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      .....   .....|++.|+|||.+.+..++.++||||||+++|||++|+.||......            . ........
T Consensus       164 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------------~-~~~~~~~~  227 (284)
T 2vgo_A          164 APSLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT------------E-THRRIVNV  227 (284)
T ss_dssp             CSSSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------------H-HHHHHHTT
T ss_pred             Ccccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh------------H-HHHHHhcc
Confidence            54322   23457899999999999989999999999999999999999999532110            0 11111111


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      .            ...+......+.+++.+|++.+|++||++.++++
T Consensus       228 ~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          228 D------------LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             C------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             c------------cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            1            0112223445889999999999999999999985

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.7e-41  Score=322.06  Aligned_cols=244  Identities=22%  Similarity=0.306  Sum_probs=194.7

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      .+.||+|+||.||+|... +|+.||+|++....   ...+.+.+|+.++++++||||+++++++. .++..++||||+++
T Consensus        11 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~~v~e~~~~   89 (284)
T 3kk8_A           11 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-EESFHYLVFDLVTG   89 (284)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-CSSEEEEEECCCCS
T ss_pred             hhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE-cCCEEEEEEecCCC
Confidence            578999999999999964 58999999987533   23356889999999999999999999986 56678999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCc---EEEeeccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYR---AVVSDFGLSK  258 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~---~kl~DfGla~  258 (453)
                      |+|.+++...          ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.   +||+|||++.
T Consensus        90 ~~l~~~~~~~----------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~  156 (284)
T 3kk8_A           90 GELFEDIVAR----------EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAI  156 (284)
T ss_dssp             CBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             CCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence            9999888543          238999999999999999999999   89999999999999986655   9999999997


Q ss_pred             cccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      .......  .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.....             .........
T Consensus       157 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-------------~~~~~~~~~  221 (284)
T 3kk8_A          157 EVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-------------HRLYAQIKA  221 (284)
T ss_dssp             ECCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------------HHHHHHHHH
T ss_pred             EcccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch-------------hHHHHHHHh
Confidence            6654322  2446789999999999999999999999999999999999999953211             011112222


Q ss_pred             CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      +... ...+       ........+.+++.+||+.+|++|||+.++++
T Consensus       222 ~~~~-~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          222 GAYD-YPSP-------EWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             TCCC-CCTT-------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cccc-CCch-------hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            2111 0000       01122345889999999999999999999986

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4.8e-42  Score=340.17  Aligned_cols=240  Identities=26%  Similarity=0.311  Sum_probs=184.6

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC----ccHHHHHHHHHH-HHhcCCCceeeEeeEEEecCCCeEEEEEe
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEE----NGEKEFRSEVAA-IASAQHVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~E~~~-l~~l~h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      +.+.||+|+||.||+++.. +++.||+|+++...    .....+..|..+ ++.++||||+++++++. ..+..++||||
T Consensus        42 ~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~-~~~~~~lv~E~  120 (373)
T 2r5t_A           42 FLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-TADKLYFVLDY  120 (373)
T ss_dssp             EEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEE-CSSEEEEEEEC
T ss_pred             EEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE-eCCEEEEEEeC
Confidence            4589999999999999975 58899999997532    233456667776 56789999999999876 56688999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +++|+|.+++....          .+++.....++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       121 ~~gg~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~  187 (373)
T 2r5t_A          121 INGGELFYHLQRER----------CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK  187 (373)
T ss_dssp             CCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCG
T ss_pred             CCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCcccc
Confidence            99999999996432          38899999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      ...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....            .. ....+..
T Consensus       188 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------------~~-~~~~i~~  253 (373)
T 2r5t_A          188 ENIEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------------AE-MYDNILN  253 (373)
T ss_dssp             GGBCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH------------HH-HHHHHHH
T ss_pred             ccccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------------HH-HHHHHHh
Confidence            643322 223556899999999999999999999999999999999999999953211            01 1111111


Q ss_pred             CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 047276          339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARV  384 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v  384 (453)
                      +.        +    .++......+.+++.+||+.||++||++.+.
T Consensus       254 ~~--------~----~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~  287 (373)
T 2r5t_A          254 KP--------L----QLKPNITNSARHLLEGLLQKDRTKRLGAKDD  287 (373)
T ss_dssp             SC--------C----CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred             cc--------c----CCCCCCCHHHHHHHHHHcccCHHhCCCCCCC
Confidence            11        1    1122233458899999999999999998543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.8e-41  Score=328.26  Aligned_cols=245  Identities=20%  Similarity=0.281  Sum_probs=192.0

Q ss_pred             cccCcCCceEEEEEEeC-CCcEEEEEEecC---CCccHHHHHHHHHHHHhcC-CCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          107 ALLGHGSSASVFKGILS-DGTSVAVKRING---EENGEKEFRSEVAAIASAQ-HVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      +.||+|+||+||+|... +|+.||+|++..   .......+.+|+.++..+. ||||+++++++. ..+..++||||+++
T Consensus        35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~-~~~~~~lv~e~~~~  113 (327)
T 3lm5_A           35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE-NTSEIILILEYAAG  113 (327)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE-CSSEEEEEEECCTT
T ss_pred             ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE-eCCeEEEEEEecCC
Confidence            78999999999999965 689999999875   2344678999999999995 699999999986 56678999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECC---CCcEEEeeccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDE---NYRAVVSDFGLSK  258 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~---~~~~kl~DfGla~  258 (453)
                      |+|.+++....        ...+++..++.++.|++.||+|||+   .+++||||||+|||++.   ++.+||+|||++.
T Consensus       114 ~~L~~~~~~~~--------~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~  182 (327)
T 3lm5_A          114 GEIFSLCLPEL--------AEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR  182 (327)
T ss_dssp             EEGGGGGSSCC---------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEECCGGGCE
T ss_pred             CcHHHHHHHhc--------ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEeeCcccc
Confidence            99999985432        2348999999999999999999999   89999999999999998   7899999999998


Q ss_pred             cccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      .......  .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......            . .......
T Consensus       183 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------------~-~~~~i~~  247 (327)
T 3lm5_A          183 KIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ------------E-TYLNISQ  247 (327)
T ss_dssp             EC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------------H-HHHHHHH
T ss_pred             ccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch------------H-HHHHHHh
Confidence            7643322  23457999999999999999999999999999999999999999532110            0 0111111


Q ss_pred             CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ...      ..  ...........+.+++.+||+.||++|||++++++
T Consensus       248 ~~~------~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          248 VNV------DY--SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             TCC------CC--CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccc------cc--CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            100      00  00111233455889999999999999999999874

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.9e-41  Score=348.47  Aligned_cols=243  Identities=21%  Similarity=0.279  Sum_probs=195.0

Q ss_pred             cccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          107 ALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      ++||+|+||.||+++.. +|+.||+|++...    ......+..|+.++++++||||+++++++. ..+..++||||+++
T Consensus       191 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-~~~~l~lVmE~~~g  269 (543)
T 3c4z_A          191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE-TKTDLCLVMTIMNG  269 (543)
T ss_dssp             EEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-CSSEEEEEECCCTT
T ss_pred             EEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-eCCEEEEEEEeccC
Confidence            56999999999999974 6899999999642    234567899999999999999999999876 56688999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      |+|.+++.....      ....+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       270 g~L~~~l~~~~~------~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          270 GDIRYHIYNVDE------DNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             CBHHHHHHTSST------TSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CCHHHHHHHhhc------ccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            999999865432      12348999999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcc
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKL  341 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (453)
                      .... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........         ..........+. 
T Consensus       341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~---------~~~~~~~i~~~~-  409 (543)
T 3c4z_A          341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE---------NKELKQRVLEQA-  409 (543)
T ss_dssp             TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC---------HHHHHHHHHHCC-
T ss_pred             CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh---------HHHHHHHHhhcc-
Confidence            4332 23445899999999999999999999999999999999999999964321100         001111111111 


Q ss_pred             cccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCH
Q 047276          342 MEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSM  381 (453)
Q Consensus       342 ~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  381 (453)
                                 ..++......+.+++.+||+.||++||++
T Consensus       410 -----------~~~p~~~s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          410 -----------VTYPDKFSPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             -----------CCCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred             -----------cCCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence                       11223344568899999999999999976

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.2e-41  Score=327.18  Aligned_cols=264  Identities=20%  Similarity=0.247  Sum_probs=189.7

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCCCcc---HHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGEENG---EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      .+.||+|+||+||+|... +|+.||+|++......   .+.+.+|+.++++++||||+++++++. ..+..++||||+++
T Consensus         8 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~   86 (311)
T 4agu_A            8 IGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR-RKRRLHLVFEYCDH   86 (311)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-ETTEEEEEEECCSE
T ss_pred             eeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee-cCCeEEEEEEeCCC
Confidence            578999999999999975 5899999998654332   356889999999999999999999986 55678999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      ++|.+++...          ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++....
T Consensus        87 ~~l~~~~~~~----------~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  153 (311)
T 4agu_A           87 TVLHELDRYQ----------RGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLT  153 (311)
T ss_dssp             EHHHHHHHTS----------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             chHHHHHhhh----------cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence            9999987533          238999999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCccc--ccchhHHHHHhhhc
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNK--WQYFPKIVNEKMKE  338 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  338 (453)
                      .... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.............  ...........+..
T Consensus       154 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (311)
T 4agu_A          154 GPSD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST  232 (311)
T ss_dssp             -------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred             Cccc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence            3322 2244578999999999876 678999999999999999999999995322111000000  00000000000000


Q ss_pred             CcccccccccccCCCCC------cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          339 GKLMEIVDQRLTDEGGI------DETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~------~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ......  ..+......      .+.....+.+++.+||+.||++|||++++++
T Consensus       233 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          233 NQYFSG--VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             CGGGTT--CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cccccc--CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            000000  000000000      0123455889999999999999999999985

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.2e-41  Score=333.66  Aligned_cols=246  Identities=25%  Similarity=0.346  Sum_probs=193.0

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCCccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEEEEEecCCC
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      +.+.||+|+||+||++... +|+.||||++......   +.+|++++.++ +||||+++++++. .++..++||||+++|
T Consensus        26 ~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~---~~~E~~~l~~~~~hp~iv~~~~~~~-~~~~~~lv~E~~~gg  101 (342)
T 2qr7_A           26 VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD---PTEEIEILLRYGQHPNIITLKDVYD-DGKYVYVVTELMKGG  101 (342)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC---CHHHHHHHHHHTTSTTBCCEEEEEE-CSSEEEEEECCCCSC
T ss_pred             EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC---hHHHHHHHHHhcCCCCcCeEEEEEE-cCCEEEEEEeCCCCC
Confidence            3578999999999999964 6889999999764332   35688888888 7999999999976 566889999999999


Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCC----CcEEEeeccccc
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDEN----YRAVVSDFGLSK  258 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~----~~~kl~DfGla~  258 (453)
                      +|.+++...          ..+++..+..++.|++.||+|||+   .+|+||||||+|||+.++    +.+||+|||++.
T Consensus       102 ~L~~~i~~~----------~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~  168 (342)
T 2qr7_A          102 ELLDKILRQ----------KFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAK  168 (342)
T ss_dssp             BHHHHHHTC----------TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred             cHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence            999998643          238999999999999999999999   899999999999998543    359999999998


Q ss_pred             cccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      ....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......          ........+..
T Consensus       169 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----------~~~~~~~~i~~  237 (342)
T 2qr7_A          169 QLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD----------TPEEILARIGS  237 (342)
T ss_dssp             ECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS----------CHHHHHHHHHH
T ss_pred             cCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC----------CHHHHHHHHcc
Confidence            7654332 234567899999999998888899999999999999999999999632111          01112222222


Q ss_pred             CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      +...      +  ...........+.+++.+||+.||++||++.++++
T Consensus       238 ~~~~------~--~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          238 GKFS------L--SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             CCCC------C--CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCcc------c--CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            2211      0  01111233456889999999999999999999885

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.3e-41  Score=350.15  Aligned_cols=245  Identities=23%  Similarity=0.277  Sum_probs=197.9

Q ss_pred             cccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          107 ALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      ++||+|+||.||+++.. +|+.||+|++...    ......+.+|+.+|..++||||+++++++. ..+..++||||+++
T Consensus       190 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-~~~~l~lVmEy~~g  268 (576)
T 2acx_A          190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-TKDALCLVLTLMNG  268 (576)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-CSSEEEEEECCCCS
T ss_pred             EEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe-eCCEEEEEEEcCCC
Confidence            68999999999999974 6899999998642    344567899999999999999999999876 56688999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      |+|.+++.....        ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       269 g~L~~~l~~~~~--------~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          269 GDLKFHIYHMGQ--------AGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             CBHHHHHHSSSS--------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CcHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence            999999964422        238999999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcc
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKL  341 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (453)
                      ...  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........         ...+........ 
T Consensus       338 ~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~---------~~~i~~~i~~~~-  405 (576)
T 2acx_A          338 EGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK---------REEVERLVKEVP-  405 (576)
T ss_dssp             TTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC---------HHHHHHHHHHCC-
T ss_pred             cCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh---------HHHHHHHhhccc-
Confidence            432  23456899999999999988899999999999999999999999964221110         011111111110 


Q ss_pred             cccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 047276          342 MEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRP-----SMARVVE  386 (453)
Q Consensus       342 ~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~~v~~  386 (453)
                                 ..++......+.+++.+||+.||++||     +++++++
T Consensus       406 -----------~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          406 -----------EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             -----------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             -----------ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence                       112223345689999999999999999     6788874

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=7.3e-42  Score=339.96  Aligned_cols=240  Identities=15%  Similarity=0.175  Sum_probs=184.5

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecC----CCccHHHHHHHH---HHHHhcCCCceeeEe-------eEEEecCC
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRING----EENGEKEFRSEV---AAIASAQHVNLVRLL-------GYCVVPGG  170 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~----~~~~~~~~~~E~---~~l~~l~h~niv~l~-------g~~~~~~~  170 (453)
                      .+.||+|+||+||+|+. .+|+.||||++..    .....+.+.+|+   .++++++||||++++       +++...+.
T Consensus        78 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  157 (377)
T 3byv_A           78 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK  157 (377)
T ss_dssp             EEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTS
T ss_pred             cceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCC
Confidence            47899999999999995 5699999999863    233457789999   455566899999998       66543321


Q ss_pred             ----------------CeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceecc
Q 047276          171 ----------------PRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHL  234 (453)
Q Consensus       171 ----------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~  234 (453)
                                      ..++||||+ +|+|.+++.......+   ....+++..++.|+.|++.||+|||+   .+|+||
T Consensus       158 ~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHr  230 (377)
T 3byv_A          158 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSS---THKSLVHHARLQLTLQVIRLLASLHH---YGLVHT  230 (377)
T ss_dssp             CSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTT---TTHHHHHHHHHHHHHHHHHHHHHHHH---TTEECS
T ss_pred             ccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcccccc---ccccccHHHHHHHHHHHHHHHHHHHh---CCeecC
Confidence                            378999999 6899999975432111   11236678999999999999999999   899999


Q ss_pred             CCCCCcEEECCCCcEEEeeccccccccCCCCceeeeccCCccccchhhhhcC-----------CCCccccchhHHHHHHH
Q 047276          235 DVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQ-----------GVSEKCDIYSYGMVLLE  303 (453)
Q Consensus       235 Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDV~S~Gvil~e  303 (453)
                      ||||+|||++.++.+||+|||+++....    ......| +.|+|||.+.+.           .++.++|||||||++||
T Consensus       231 Dikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e  305 (377)
T 3byv_A          231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW  305 (377)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence            9999999999999999999999985322    2345567 999999999887           89999999999999999


Q ss_pred             HHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHH
Q 047276          304 LTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMAR  383 (453)
Q Consensus       304 lltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~  383 (453)
                      |++|+.||.........                     .... ..   ...+    ...+.+++.+||+.||++|||+.+
T Consensus       306 lltg~~Pf~~~~~~~~~---------------------~~~~-~~---~~~~----~~~~~~li~~~L~~dp~~Rpt~~e  356 (377)
T 3byv_A          306 IWCADLPITKDAALGGS---------------------EWIF-RS---CKNI----PQPVRALLEGFLRYPKEDRLLPLQ  356 (377)
T ss_dssp             HHHSSCCC------CCS---------------------GGGG-SS---CCCC----CHHHHHHHHHHTCSSGGGCCCHHH
T ss_pred             HHHCCCCCcccccccch---------------------hhhh-hh---ccCC----CHHHHHHHHHHcCCCchhCCCHHH
Confidence            99999999532211100                     0000 00   0112    245889999999999999999999


Q ss_pred             HHH
Q 047276          384 VVE  386 (453)
Q Consensus       384 v~~  386 (453)
                      +++
T Consensus       357 ~l~  359 (377)
T 3byv_A          357 AME  359 (377)
T ss_dssp             HHT
T ss_pred             Hhh
Confidence            985

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.7e-41  Score=341.86  Aligned_cols=246  Identities=21%  Similarity=0.326  Sum_probs=184.4

Q ss_pred             HHhcccCcCCceEEEEEEe-CCCcEEEEEEecCCC---------ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeE
Q 047276          104 NFQALLGHGSSASVFKGIL-SDGTSVAVKRINGEE---------NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRY  173 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~  173 (453)
                      .+.+.||+|+||+||+|.. .+++.||||++....         .....+.+|+.+|++++||||+++++++.  .+..+
T Consensus       138 ~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--~~~~~  215 (419)
T 3i6u_A          138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD--AEDYY  215 (419)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE--SSEEE
T ss_pred             EEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe--cCceE
Confidence            3457899999999999996 458899999986421         11224889999999999999999999874  34679


Q ss_pred             EEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCC---CcEE
Q 047276          174 LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDEN---YRAV  250 (453)
Q Consensus       174 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~---~~~k  250 (453)
                      +||||+++|+|.+++...          ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.+   +.+|
T Consensus       216 lv~e~~~~g~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~k  282 (419)
T 3i6u_A          216 IVLELMEGGELFDKVVGN----------KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIK  282 (419)
T ss_dssp             EEEECCTTCBGGGGTSSS----------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEE
T ss_pred             EEEEcCCCCcHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEE
Confidence            999999999999998543          238999999999999999999999   899999999999999754   4599


Q ss_pred             EeeccccccccCCCCceeeeccCCccccchhhhh---cCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccc
Q 047276          251 VSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWIL---EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQY  327 (453)
Q Consensus       251 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~  327 (453)
                      |+|||+++......  ......||+.|+|||++.   ...++.++|||||||++|||++|+.||........        
T Consensus       283 l~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--------  352 (419)
T 3i6u_A          283 ITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--------  352 (419)
T ss_dssp             ECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--------
T ss_pred             EeecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--------
Confidence            99999998764322  234567999999999985   35688899999999999999999999963221110        


Q ss_pred             hhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          328 FPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                          ....+..+.... ... .      .......+.+++.+||+.||++|||+.++++
T Consensus       353 ----~~~~i~~~~~~~-~~~-~------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          353 ----LKDQITSGKYNF-IPE-V------WAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             ----HHHHHHTTCCCC-CHH-H------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ----HHHHHhcCCCCC-Cch-h------hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence                111122221100 000 0      0112456889999999999999999999885

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=8.6e-41  Score=321.88  Aligned_cols=242  Identities=24%  Similarity=0.390  Sum_probs=197.3

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCC
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      .+.||+|+||.||+|.. .+++.||||++...  ....+.+.+|+.+++.++||||+++++++. .....++||||++++
T Consensus        27 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~  105 (303)
T 3a7i_A           27 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-KDTKLWIIMEYLGGG  105 (303)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEE-ETTEEEEEEECCTTE
T ss_pred             hhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEe-cCCeEEEEEEeCCCC
Confidence            57899999999999985 46899999999753  344578999999999999999999999987 456789999999999


Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccC
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR  262 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~  262 (453)
                      +|.+++..           ..+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++.....
T Consensus       106 ~L~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  171 (303)
T 3a7i_A          106 SALDLLEP-----------GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  171 (303)
T ss_dssp             EHHHHHTT-----------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred             cHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCc
Confidence            99999842           348999999999999999999999   8999999999999999999999999999987654


Q ss_pred             CCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCccc
Q 047276          263 DQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLM  342 (453)
Q Consensus       263 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (453)
                      ... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....             .........+.. 
T Consensus       172 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------------~~~~~~~~~~~~-  236 (303)
T 3a7i_A          172 TQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP-------------MKVLFLIPKNNP-  236 (303)
T ss_dssp             TBC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------------HHHHHHHHHSCC-
T ss_pred             ccc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH-------------HHHHHHhhcCCC-
Confidence            321 23445789999999999999999999999999999999999999853211             001111111111 


Q ss_pred             ccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          343 EIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       343 ~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                          +.      .+......+.+++..||+.+|++|||+.++++.
T Consensus       237 ----~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          237 ----PT------LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             ----CC------CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             ----CC------CccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                11      111223458899999999999999999999864

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.3e-41  Score=329.68  Aligned_cols=262  Identities=27%  Similarity=0.406  Sum_probs=199.0

Q ss_pred             HHhcccCcCCceEEEEEEeC-CCcE--EEEEEecCC--CccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEEEEE
Q 047276          104 NFQALLGHGSSASVFKGILS-DGTS--VAVKRINGE--ENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~-~g~~--vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      .+.+.||+|+||.||+|+.. +|..  +|+|.+...  ....+.+.+|+.++.++ +||||+++++++. ..+..++|||
T Consensus        28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-~~~~~~lv~e  106 (327)
T 1fvr_A           28 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-HRGYLYLAIE  106 (327)
T ss_dssp             EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE-ETTEEEEEEC
T ss_pred             cceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeee-eCCceEEEEe
Confidence            34689999999999999964 5654  499988752  33445789999999999 8999999999986 5567899999


Q ss_pred             ecCCCChhhhhccCCCCCCC------CCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEE
Q 047276          178 FIQNGSLDHWIFPTSRRSEG------HYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVV  251 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~------~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl  251 (453)
                      |+++|+|.+++.........      ......+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||
T Consensus       107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kL  183 (327)
T 1fvr_A          107 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKI  183 (327)
T ss_dssp             CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEE
T ss_pred             cCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeEEE
Confidence            99999999999654310000      0012358999999999999999999999   89999999999999999999999


Q ss_pred             eeccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhH
Q 047276          252 SDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPK  330 (453)
Q Consensus       252 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  330 (453)
                      +|||+++......  ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....             .
T Consensus       184 ~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-------------~  248 (327)
T 1fvr_A          184 ADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------------A  248 (327)
T ss_dssp             CCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------------H
T ss_pred             cccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-------------H
Confidence            9999987433211  1233456889999999998889999999999999999998 9999853211             0


Q ss_pred             HHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccCCC
Q 047276          331 IVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVD  395 (453)
Q Consensus       331 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~~~  395 (453)
                      .....+..+..       .    ..+......+.+++.+||+.+|++|||+.++++.|+......
T Consensus       249 ~~~~~~~~~~~-------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  302 (327)
T 1fvr_A          249 ELYEKLPQGYR-------L----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  302 (327)
T ss_dssp             HHHHHGGGTCC-------C----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             HHHHHhhcCCC-------C----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence            11122222110       0    111223456899999999999999999999999998766543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.2e-41  Score=323.51  Aligned_cols=242  Identities=21%  Similarity=0.283  Sum_probs=195.9

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      .+.||+|+||.||++... +++.||+|.+...    ....+.+.+|+.+++.++||||+++++++. .++..++||||++
T Consensus        20 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~   98 (294)
T 2rku_A           20 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-DNDFVFVVLELCR   98 (294)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-CSSEEEEEEECCT
T ss_pred             EEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec-cCCEEEEEEecCC
Confidence            578999999999999975 5789999998643    223456889999999999999999999986 5567899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +++|.+++...          ..+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++...
T Consensus        99 ~~~L~~~~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  165 (294)
T 2rku_A           99 RRSLLELHKRR----------KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV  165 (294)
T ss_dssp             TCBHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceec
Confidence            99999988543          238999999999999999999999   89999999999999999999999999999876


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      ..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....            .. .......+.
T Consensus       166 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------------~~-~~~~~~~~~  231 (294)
T 2rku_A          166 EYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------------KE-TYLRIKKNE  231 (294)
T ss_dssp             CSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------------HH-HHHHHHTTC
T ss_pred             ccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------------HH-HHHHHhhcc
Confidence            43322 23345789999999999988899999999999999999999999953211            00 111111111


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      .            ..+......+.+++.+|++.||++|||++++++.
T Consensus       232 ~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          232 Y------------SIPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             C------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             C------------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            0            1112233458899999999999999999998863

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.9e-41  Score=321.86  Aligned_cols=240  Identities=24%  Similarity=0.322  Sum_probs=191.2

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCC---CccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGE---ENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      +.+.||+|+||+||+|... +++.||+|++...   ......+.+|+..+..+ +||||+++++++. ..+..++||||+
T Consensus        15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~-~~~~~~lv~e~~   93 (289)
T 1x8b_A           15 ELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA-EDDHMLIQNEYC   93 (289)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEE-ETTEEEEEEECC
T ss_pred             hhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeee-cCCeEEEEEEec
Confidence            3578999999999999975 7899999998753   33456788999999999 8999999999986 556889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECC--------------
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDE--------------  245 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~--------------  245 (453)
                      ++|+|.+++.....      ....+++..++.++.|++.||+|||+   .+|+||||||+|||++.              
T Consensus        94 ~~~~L~~~l~~~~~------~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~  164 (289)
T 1x8b_A           94 NGGSLADAISENYR------IMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDED  164 (289)
T ss_dssp             TTCBHHHHHHHHHH------HTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC---------------
T ss_pred             CCCcHHHHHHhhcc------cccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence            99999999964321      11348999999999999999999999   89999999999999984              


Q ss_pred             -----CCcEEEeeccccccccCCCCceeeeccCCccccchhhhhcC-CCCccccchhHHHHHHHHHcCCCCCcccccCCC
Q 047276          246 -----NYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQ-GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGND  319 (453)
Q Consensus       246 -----~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~  319 (453)
                           +..+||+|||++.......     ...||+.|+|||.+.+. .++.++||||||+++|||++|..|+....    
T Consensus       165 ~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----  235 (289)
T 1x8b_A          165 DWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----  235 (289)
T ss_dssp             -----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----
T ss_pred             cccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh----
Confidence                 4479999999998765432     23589999999998765 56789999999999999999987753110    


Q ss_pred             CCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          320 KSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                                  ....+..+...     .      .+......+.+++.+||+.||++|||+.++++
T Consensus       236 ------------~~~~~~~~~~~-----~------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          236 ------------QWHEIRQGRLP-----R------IPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             ------------HHHHHHTTCCC-----C------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------------HHHHHHcCCCC-----C------CCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                        11112222211     1      11223345889999999999999999999874

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3e-41  Score=330.14  Aligned_cols=241  Identities=21%  Similarity=0.288  Sum_probs=195.6

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      .+.||+|+||.||++... +++.||+|++...    ....+.+.+|+.+++.++||||+++++++. ..+..++||||++
T Consensus        46 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~  124 (335)
T 2owb_A           46 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-DNDFVFVVLELCR  124 (335)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-CSSEEEEEECCCT
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCCeEEEEEecCC
Confidence            578999999999999965 5789999998642    233456889999999999999999999986 5567899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +++|.+++...          ..+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++...
T Consensus       125 ~~~L~~~~~~~----------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  191 (335)
T 2owb_A          125 RRSLLELHKRR----------KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV  191 (335)
T ss_dssp             TCBHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCCHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence            99999998543          238999999999999999999999   89999999999999999999999999999876


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      ..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....            .. ....+..+.
T Consensus       192 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------------~~-~~~~~~~~~  257 (335)
T 2owb_A          192 EYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------------KE-TYLRIKKNE  257 (335)
T ss_dssp             CSTTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------------HH-HHHHHHHTC
T ss_pred             ccCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH------------HH-HHHHHhcCC
Confidence            43322 23445789999999999998999999999999999999999999953210            01 111111111


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      .            ..+......+.+++.+||+.||++|||+.++++
T Consensus       258 ~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          258 Y------------SIPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             C------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             C------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0            111122345889999999999999999999985

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.6e-41  Score=346.88  Aligned_cols=257  Identities=21%  Similarity=0.277  Sum_probs=197.6

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCC
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS  183 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gs  183 (453)
                      +.++||+|+||.||+|+. .+++.||||++..... ..++..|+.++..++|++.+..+.++....+..++||||+ +++
T Consensus        11 i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~s   88 (483)
T 3sv0_A           11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPS   88 (483)
T ss_dssp             CCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred             EEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCC
Confidence            357899999999999995 5689999998875332 2357899999999988655555555555677889999999 899


Q ss_pred             hhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEE---CCCCcEEEeeccccccc
Q 047276          184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILL---DENYRAVVSDFGLSKLM  260 (453)
Q Consensus       184 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl---~~~~~~kl~DfGla~~~  260 (453)
                      |.+++....         ..+++..++.|+.||+.||+|||+   .+|+||||||+||||   +.++.+||+|||+++..
T Consensus        89 L~~ll~~~~---------~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~  156 (483)
T 3sv0_A           89 LEDLFNFCS---------RKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY  156 (483)
T ss_dssp             HHHHHHHTT---------TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             HHHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence            999996432         239999999999999999999999   899999999999999   68899999999999877


Q ss_pred             cCCCCc------eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHH
Q 047276          261 SRDQSR------CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNE  334 (453)
Q Consensus       261 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  334 (453)
                      ......      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.........     ..+     .
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~-----~~~-----~  226 (483)
T 3sv0_A          157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-----QKY-----E  226 (483)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHH-----HHH-----H
T ss_pred             cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHH-----HHH-----H
Confidence            543321      123567999999999999999999999999999999999999999643221110     000     0


Q ss_pred             hhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          335 KMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       335 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      .+........++. +      .......+.+++..||+.+|++||++.+|++.|++..
T Consensus       227 ~i~~~~~~~~~~~-l------~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~  277 (483)
T 3sv0_A          227 KISEKKVATSIEA-L------CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF  277 (483)
T ss_dssp             HHHHHHHHSCHHH-H------HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             HHhhccccccHHH-H------hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence            1111111111110 0      0122346899999999999999999999999998763

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.8e-40  Score=328.45  Aligned_cols=243  Identities=23%  Similarity=0.399  Sum_probs=193.2

Q ss_pred             cccCcCCceEEEEEEeC-CCcEEEEEEecCCCc---------cHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEEE
Q 047276          107 ALLGHGSSASVFKGILS-DGTSVAVKRINGEEN---------GEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYLV  175 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~---------~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~lv  175 (453)
                      +.||+|+||.||+|... +|+.||||+++....         ..+.+.+|+.++.++ +||||+++++++. .....++|
T Consensus       100 ~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-~~~~~~lv  178 (365)
T 2y7j_A          100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE-SSSFMFLV  178 (365)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE-BSSEEEEE
T ss_pred             eEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe-eCCEEEEE
Confidence            78999999999999975 799999999875321         134578899999999 7999999999976 56688999


Q ss_pred             EEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecc
Q 047276          176 YEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFG  255 (453)
Q Consensus       176 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfG  255 (453)
                      |||+++|+|.+++...          ..+++..+..++.|++.||.|||+   .+++|+||||+|||++.++.+||+|||
T Consensus       179 ~e~~~g~~L~~~l~~~----------~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~DfG  245 (365)
T 2y7j_A          179 FDLMRKGELFDYLTEK----------VALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFG  245 (365)
T ss_dssp             ECCCTTCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             EEeCCCCcHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEecC
Confidence            9999999999999633          238999999999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCceeeeccCCccccchhhhhc------CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchh
Q 047276          256 LSKLMSRDQSRCITTIRGTRGYLAPEWILE------QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFP  329 (453)
Q Consensus       256 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~  329 (453)
                      ++........  .....||+.|+|||++.+      ..++.++|||||||++|||++|+.||.....             
T Consensus       246 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-------------  310 (365)
T 2y7j_A          246 FSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ-------------  310 (365)
T ss_dssp             TCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------------
T ss_pred             cccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH-------------
Confidence            9987654322  345679999999999864      3588999999999999999999999953210             


Q ss_pred             HHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          330 KIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       330 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ......+..+... ...+..       ......+.+++.+||+.||++|||+.++++
T Consensus       311 ~~~~~~i~~~~~~-~~~~~~-------~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          311 ILMLRMIMEGQYQ-FSSPEW-------DDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHHHHHHHHTCCC-CCHHHH-------SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHhCCCC-CCCccc-------ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0011111111110 000000       012345889999999999999999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.3e-41  Score=331.96  Aligned_cols=252  Identities=24%  Similarity=0.285  Sum_probs=181.5

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCC-CccHHHHHHHHHHHHhcC-CCceeeEeeEEEe-------cCCCeEE
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGE-ENGEKEFRSEVAAIASAQ-HVNLVRLLGYCVV-------PGGPRYL  174 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~-------~~~~~~l  174 (453)
                      +.++||+|+||.||+|+. .+|+.||||++... ....+.+.+|+.++.++. ||||+++++++..       .....++
T Consensus        32 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~l  111 (337)
T 3ll6_A           32 VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLL  111 (337)
T ss_dssp             EEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEE
T ss_pred             EEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEE
Confidence            457999999999999996 46899999988653 334567899999999996 9999999999852       2334689


Q ss_pred             EEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCc--eeccCCCCCcEEECCCCcEEEe
Q 047276          175 VYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSR--VLHLDVKPENILLDENYRAVVS  252 (453)
Q Consensus       175 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~--ivH~Dlk~~NiLl~~~~~~kl~  252 (453)
                      ++||+. |+|.+++.....       ...+++..++.++.|++.||+|||+   .+  ++||||||+|||++.++.+||+
T Consensus       112 v~e~~~-g~L~~~l~~~~~-------~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~  180 (337)
T 3ll6_A          112 LTELCK-GQLVEFLKKMES-------RGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLC  180 (337)
T ss_dssp             EEECCS-EEHHHHHHHHHT-------TCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred             EEEecC-CCHHHHHHHhhc-------cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEe
Confidence            999996 799998854221       2349999999999999999999999   67  9999999999999999999999


Q ss_pred             eccccccccCCCCc-----------eeeeccCCccccchhhh---hcCCCCccccchhHHHHHHHHHcCCCCCcccccCC
Q 047276          253 DFGLSKLMSRDQSR-----------CITTIRGTRGYLAPEWI---LEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGN  318 (453)
Q Consensus       253 DfGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~  318 (453)
                      |||++.........           ......||+.|+|||.+   .+..++.++||||||+++|||++|+.||.......
T Consensus       181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~  260 (337)
T 3ll6_A          181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR  260 (337)
T ss_dssp             CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence            99999876543221           11234689999999998   56678999999999999999999999995321110


Q ss_pred             CCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccCC
Q 047276          319 DKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAV  394 (453)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~~  394 (453)
                      .            .     .+...      ..    ........+.+++.+||+.+|++|||+.++++.|+.....
T Consensus       261 ~------------~-----~~~~~------~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~  309 (337)
T 3ll6_A          261 I------------V-----NGKYS------IP----PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA  309 (337)
T ss_dssp             ----------------------CC------CC----TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             h------------h-----cCccc------CC----cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            0            0     00000      00    0011122378899999999999999999999999877543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=9.9e-41  Score=340.31  Aligned_cols=192  Identities=26%  Similarity=0.372  Sum_probs=149.4

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecC----CCeEEEE
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG----GPRYLVY  176 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~~lv~  176 (453)
                      +.++||+|+||+||+|... +|+.||||++....   ...+.+.+|+.+|+.++||||+++++++....    ...++||
T Consensus        57 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  136 (458)
T 3rp9_A           57 IRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVL  136 (458)
T ss_dssp             ECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEE
T ss_pred             EeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEE
Confidence            4578999999999999854 68999999986532   23467889999999999999999999975332    4679999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||+ +|+|.+++...          ..+++..+..++.||+.||+|||+   .+|+||||||+||||+.++.+||+|||+
T Consensus       137 e~~-~~~L~~~~~~~----------~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGl  202 (458)
T 3rp9_A          137 EIA-DSDFKKLFRTP----------VYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGL  202 (458)
T ss_dssp             CCC-SEEHHHHHHSS----------CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ecc-ccchhhhcccC----------CCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeeccccc
Confidence            998 56999998543          238999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCC--------------------------ceeeeccCCccccchhhhh-cCCCCccccchhHHHHHHHHHcCCC
Q 047276          257 SKLMSRDQS--------------------------RCITTIRGTRGYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGRR  309 (453)
Q Consensus       257 a~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~sDV~S~Gvil~elltG~~  309 (453)
                      ++.......                          .......||+.|+|||.+. ...++.++|||||||++|||++|..
T Consensus       203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~  282 (458)
T 3rp9_A          203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK  282 (458)
T ss_dssp             CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred             chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence            987643211                          1234457899999999864 5679999999999999999999543


Q ss_pred             C
Q 047276          310 N  310 (453)
Q Consensus       310 p  310 (453)
                      |
T Consensus       283 ~  283 (458)
T 3rp9_A          283 E  283 (458)
T ss_dssp             T
T ss_pred             c
Confidence            3

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=5.3e-41  Score=355.75  Aligned_cols=252  Identities=20%  Similarity=0.316  Sum_probs=197.9

Q ss_pred             HHHhcccCcCCceEEEEEEeCC----CcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEE
Q 047276          103 DNFQALLGHGSSASVFKGILSD----GTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVY  176 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~~----g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~  176 (453)
                      +.+.+.||+|+||+||+|.+..    +..||||.++...  ...+.|.+|+.++++++||||++++|++.  ++..++||
T Consensus       392 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~--~~~~~lv~  469 (656)
T 2j0j_A          392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT--ENPVWIIM  469 (656)
T ss_dssp             EEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSCEEEE
T ss_pred             EEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe--cCceEEEE
Confidence            3445789999999999999642    4579999987533  23367999999999999999999999873  45789999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||+++|+|.+++....         ..+++..++.++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus       470 E~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~  537 (656)
T 2j0j_A          470 ELCTLGELRSFLQVRK---------FSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGL  537 (656)
T ss_dssp             ECCTTCBHHHHHHHTT---------TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred             EcCCCCcHHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCC
Confidence            9999999999996432         238999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHh
Q 047276          257 SKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEK  335 (453)
Q Consensus       257 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  335 (453)
                      ++..............+|+.|+|||.+.+..++.++||||||+++|||++ |..||......            . ....
T Consensus       538 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~------------~-~~~~  604 (656)
T 2j0j_A          538 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN------------D-VIGR  604 (656)
T ss_dssp             CCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------------H-HHHH
T ss_pred             CeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH------------H-HHHH
Confidence            98775443333344567889999999999999999999999999999997 99998532110            0 1111


Q ss_pred             hhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          336 MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       336 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      +..+..           ...+...+..+.+++.+||+.||++|||+.++++.|+...
T Consensus       605 i~~~~~-----------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il  650 (656)
T 2j0j_A          605 IENGER-----------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  650 (656)
T ss_dssp             HHHTCC-----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHcCCC-----------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            211111           0122233456889999999999999999999999998753

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.9e-41  Score=336.90  Aligned_cols=194  Identities=30%  Similarity=0.423  Sum_probs=155.5

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCC---CccHHHHHHHHHHHHhcC-CCceeeEeeEEEecC-CCeEEEEEe
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGE---ENGEKEFRSEVAAIASAQ-HVNLVRLLGYCVVPG-GPRYLVYEF  178 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~-~~~~lv~e~  178 (453)
                      +.+.||+|+||.||+|.. .+|+.||||++...   ......+.+|+.++..+. ||||+++++++...+ ...++||||
T Consensus        13 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~   92 (388)
T 3oz6_A           13 LVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDY   92 (388)
T ss_dssp             EEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEEC
T ss_pred             EEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecc
Confidence            357899999999999995 56899999998653   233456789999999997 999999999987443 367999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      |+ |+|.+++..           ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        93 ~~-~~L~~~~~~-----------~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           93 ME-TDLHAVIRA-----------NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             CS-EEHHHHHHH-----------TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             cC-cCHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            97 599999853           238999999999999999999999   899999999999999999999999999998


Q ss_pred             cccCC--------------------CCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcc
Q 047276          259 LMSRD--------------------QSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSL  313 (453)
Q Consensus       259 ~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~  313 (453)
                      .....                    .........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  233 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG  233 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence            65321                    1112344679999999999876 6789999999999999999999999953

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.7e-41  Score=325.65  Aligned_cols=245  Identities=27%  Similarity=0.377  Sum_probs=194.7

Q ss_pred             HHhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC-ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          104 NFQALLGHGSSASVFKGILS-DGTSVAVKRINGEE-NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      .+.+.||+|+||+||+++.. +|+.||+|.+.... .....+.+|+.++.+++||||+++++++. ..+..++||||+++
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~   90 (304)
T 2jam_A           12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE-STTHYYLVMQLVSG   90 (304)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE-CSSEEEEEECCCCS
T ss_pred             eeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc-cCCEEEEEEEcCCC
Confidence            34589999999999999964 68999999997643 33456889999999999999999999976 56688999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEE---CCCCcEEEeeccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILL---DENYRAVVSDFGLSK  258 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl---~~~~~~kl~DfGla~  258 (453)
                      |+|.+++...          +.+++..+..++.|++.||+|||+   .+++||||||+||++   ++++.+||+|||++.
T Consensus        91 ~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~  157 (304)
T 2jam_A           91 GELFDRILER----------GVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSK  157 (304)
T ss_dssp             CBHHHHHHHH----------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred             ccHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence            9999998543          238999999999999999999999   899999999999999   788999999999987


Q ss_pred             cccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      ......   .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.....             ......+..
T Consensus       158 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------------~~~~~~i~~  221 (304)
T 2jam_A          158 MEQNGI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-------------SKLFEKIKE  221 (304)
T ss_dssp             CCCCBT---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH-------------HHHHHHHHH
T ss_pred             ecCCCc---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------------HHHHHHHHc
Confidence            543221   2345689999999999988999999999999999999999999853211             001122222


Q ss_pred             CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      +... . .      ..........+.+++.+|++.||++|||+.++++
T Consensus       222 ~~~~-~-~------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          222 GYYE-F-E------SPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             CCCC-C-C------TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCCC-C-C------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            2110 0 0      1111233456899999999999999999999985

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=7.7e-41  Score=341.11  Aligned_cols=264  Identities=20%  Similarity=0.248  Sum_probs=188.3

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEecC-----CCeEEEE
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG-----GPRYLVY  176 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~~lv~  176 (453)
                      .+.||+|+||+||+|.. .+|+.||||++...   ....+.+.+|+.+++.++||||+++++++....     ...++||
T Consensus        67 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~  146 (464)
T 3ttj_A           67 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM  146 (464)
T ss_dssp             EEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred             EEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEE
Confidence            47899999999999985 46889999999753   233467889999999999999999999986432     3469999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||+++ +|.+.+..            .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus       147 E~~~~-~l~~~~~~------------~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~  210 (464)
T 3ttj_A          147 ELMDA-NLCQVIQM------------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (464)
T ss_dssp             ECCSE-EHHHHHTS------------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred             eCCCC-CHHHHHhh------------cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEe
Confidence            99976 57666631            28999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCC----------CCccccc
Q 047276          257 SKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGND----------KSKNKWQ  326 (453)
Q Consensus       257 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~----------~~~~~~~  326 (453)
                      ++......  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........          .....+.
T Consensus       211 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~  288 (464)
T 3ttj_A          211 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  288 (464)
T ss_dssp             C-----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             eeecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            98664322  23456799999999999999999999999999999999999999964221100          0000000


Q ss_pred             chhHHHHHhhhcC------cccccccccc-cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          327 YFPKIVNEKMKEG------KLMEIVDQRL-TDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       327 ~~~~~~~~~~~~~------~~~~~~d~~l-~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      .............      .+.+.+...+ .............+.+++.+||+.||++|||++|+++.
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000000000000      0000000000 00000112235678999999999999999999999864

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.2e-41  Score=337.52  Aligned_cols=249  Identities=12%  Similarity=0.059  Sum_probs=176.0

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCCc----cHHHHHHHHHHHHhc--CCCceeeEe-------eEEEecC-
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEEN----GEKEFRSEVAAIASA--QHVNLVRLL-------GYCVVPG-  169 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l--~h~niv~l~-------g~~~~~~-  169 (453)
                      +.+.||+|+||+||+|... +|+.||||++.....    ..+.+.+|+.++..+  +|||+++++       +++...+ 
T Consensus        66 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~  145 (371)
T 3q60_A           66 LVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQ  145 (371)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTS
T ss_pred             eeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCC
Confidence            3578999999999999964 789999999987432    335677886555555  699987754       4443322 


Q ss_pred             ---------------CCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHH------HHHHHHHHHHhccccccCC
Q 047276          170 ---------------GPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLR------YRVAIDVAKALSYLHNDCR  228 (453)
Q Consensus       170 ---------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~------~~i~~~ia~~L~~Lh~~~~  228 (453)
                                     ...++||||++ |+|.+++.....         .+.+..+      +.++.|++.||+|||+   
T Consensus       146 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---------~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---  212 (371)
T 3q60_A          146 PPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---------VYVFRGDEGILALHILTAQLIRLAANLQS---  212 (371)
T ss_dssp             CSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---------SCCCCHHHHHHHHHHHHHHHHHHHHHHHH---
T ss_pred             CCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---------ccchhhhhhhhhHHHHHHHHHHHHHHHHH---
Confidence                           23699999998 899999965421         1444555      7888999999999999   


Q ss_pred             CceeccCCCCCcEEECCCCcEEEeeccccccccCCCCceeeeccCCccccchhhhhc--CCCCccccchhHHHHHHHHHc
Q 047276          229 SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILE--QGVSEKCDIYSYGMVLLELTG  306 (453)
Q Consensus       229 ~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDV~S~Gvil~ellt  306 (453)
                      .+|+||||||+|||++.++.+||+|||+++.....    .....+|+.|+|||.+.+  ..++.++|||||||++|||++
T Consensus       213 ~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt  288 (371)
T 3q60_A          213 KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC  288 (371)
T ss_dssp             TTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCCccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence            89999999999999999999999999999865321    224567799999999987  679999999999999999999


Q ss_pred             CCCCCcccccCCCCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          307 GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       307 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      |+.||..........   +.           ...........+.  ..........+.+++.+||+.||++|||+.++++
T Consensus       289 g~~Pf~~~~~~~~~~---~~-----------~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          289 LFLPFGLVTPGIKGS---WK-----------RPSLRVPGTDSLA--FGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             SSCSTTBCCTTCTTC---CC-----------BCCTTSCCCCSCC--CTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCCCCcCcccccc---hh-----------hhhhhhccccccc--hhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            999996543221111   10           0000000000110  0011123456889999999999999999999873

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=6.6e-41  Score=321.07  Aligned_cols=246  Identities=23%  Similarity=0.310  Sum_probs=191.6

Q ss_pred             cccCcCCceEEEEEEe-CCCcEEEEEEecCC-CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCCh
Q 047276          107 ALLGHGSSASVFKGIL-SDGTSVAVKRINGE-ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL  184 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL  184 (453)
                      .+||+|+||.||+|.. .+++.||||.+... ....+.+.+|+.+++.++||||+++++++. ..+..++||||+++++|
T Consensus        28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~~~L  106 (295)
T 2clq_A           28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS-ENGFIKIFMEQVPGGSL  106 (295)
T ss_dssp             CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEE-ETTEEEEEEECCSEEEH
T ss_pred             EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEE-eCCcEEEEEEeCCCCCH
Confidence            4899999999999995 56889999998764 334567999999999999999999999986 45678999999999999


Q ss_pred             hhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECC-CCcEEEeeccccccccCC
Q 047276          185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDE-NYRAVVSDFGLSKLMSRD  263 (453)
Q Consensus       185 ~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~-~~~~kl~DfGla~~~~~~  263 (453)
                      .+++.....       ...+++..+..++.|++.||+|||+   .+++|+||||+||+++. ++.+||+|||++......
T Consensus       107 ~~~l~~~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~  176 (295)
T 2clq_A          107 SALLRSKWG-------PLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI  176 (295)
T ss_dssp             HHHHHHTTC-------CCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred             HHHHHhhcc-------CCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence            999965421       2236789999999999999999999   89999999999999987 899999999999876432


Q ss_pred             CCceeeeccCCccccchhhhhcCC--CCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcc
Q 047276          264 QSRCITTIRGTRGYLAPEWILEQG--VSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKL  341 (453)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (453)
                      .. ......||+.|+|||.+.+..  ++.++||||||+++|||++|+.||.......           ..........  
T Consensus       177 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----------~~~~~~~~~~--  242 (295)
T 2clq_A          177 NP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ-----------AAMFKVGMFK--  242 (295)
T ss_dssp             -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH-----------HHHHHHHHHC--
T ss_pred             CC-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh-----------HHHHhhcccc--
Confidence            21 233457899999999987653  7899999999999999999999995321100           0000000000  


Q ss_pred             cccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          342 MEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       342 ~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                         ..+      ..+......+.+++.+||+.||++||++.++++
T Consensus       243 ---~~~------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          243 ---VHP------EIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             ---CCC------CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ---ccc------cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence               011      122233456889999999999999999999874

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=5.9e-41  Score=318.42  Aligned_cols=242  Identities=26%  Similarity=0.376  Sum_probs=187.8

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      +.+.||+|+||.||+|... +|+.||||.+...    ....+.+.+|+.+++.++||||+++++++. ..+..++||||+
T Consensus        15 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~   93 (276)
T 2h6d_A           15 LGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS-TPTDFFMVMEYV   93 (276)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-CSSEEEEEEECC
T ss_pred             EEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe-cCCeEEEEEecc
Confidence            3578999999999999975 7899999998642    234567899999999999999999999976 556889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ++++|.+++....          .+++..+..++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++..
T Consensus        94 ~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~  160 (276)
T 2h6d_A           94 SGGELFDYICKHG----------RVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNM  160 (276)
T ss_dssp             CSCBHHHHHHHHC----------SCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGC
T ss_pred             CCCcHHHHHhccC----------CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccc
Confidence            9999999996432          38999999999999999999999   7999999999999999999999999999987


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcCCC-CccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQGV-SEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      .....  ......+++.|+|||.+.+..+ +.++||||||+++|||++|+.||.....            .. .......
T Consensus       161 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------------~~-~~~~~~~  225 (276)
T 2h6d_A          161 MSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV------------PT-LFKKIRG  225 (276)
T ss_dssp             CCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH------------HH-HHHHHHH
T ss_pred             cCCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH------------HH-HHHHhhc
Confidence            64432  1234568999999999987765 6899999999999999999999853110            01 1111221


Q ss_pred             CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      +..            ..+......+.+++.+|++.||++|||+.++++.
T Consensus       226 ~~~------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          226 GVF------------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             CCC------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             Ccc------------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            110            0112223458899999999999999999999863

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-40  Score=322.92  Aligned_cols=246  Identities=24%  Similarity=0.391  Sum_probs=190.0

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCCccHHHHHHHHHHHHhc-CCCceeeEeeEEEec-----CCCeEEEEEe
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVP-----GGPRYLVYEF  178 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-----~~~~~lv~e~  178 (453)
                      .+.||+|+||.||+|.. .+|+.||||++.........+.+|+.++.++ +||||+++++++...     .+..++||||
T Consensus        29 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~  108 (326)
T 2x7f_A           29 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF  108 (326)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEEC
T ss_pred             EEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEc
Confidence            57899999999999996 5789999999987666677899999999999 799999999998753     3567999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +++|+|.+++....        ...+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||++.
T Consensus       109 ~~~~~L~~~l~~~~--------~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  177 (326)
T 2x7f_A          109 CGAGSVTDLIKNTK--------GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA  177 (326)
T ss_dssp             CTTEEHHHHHHHSG--------GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred             CCCCcHHHHHHhcc--------cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence            99999999996542        1348999999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCceeeeccCCccccchhhhh-----cCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHH
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWIL-----EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVN  333 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  333 (453)
                      ....... ......||+.|+|||.+.     ...++.++||||||+++|||++|+.||......            ... 
T Consensus       178 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------------~~~-  243 (326)
T 2x7f_A          178 QLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------------RAL-  243 (326)
T ss_dssp             --------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------------HHH-
T ss_pred             ecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------------HHH-
Confidence            6543221 223457899999999987     567899999999999999999999998532110            001 


Q ss_pred             HhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          334 EKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       334 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ..........     +.     .......+.+++.+||+.||++||++.++++
T Consensus       244 ~~~~~~~~~~-----~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          244 FLIPRNPAPR-----LK-----SKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHHHHSCCCC-----CS-----CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHhhcCcccc-----CC-----ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            1111111111     10     1122345889999999999999999999986

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=7.5e-41  Score=343.71  Aligned_cols=248  Identities=26%  Similarity=0.329  Sum_probs=196.0

Q ss_pred             HHHHhcccCcCCceEEEEEEeC-CCcEEEEEEecC---CCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          102 TDNFQALLGHGSSASVFKGILS-DGTSVAVKRING---EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       102 ~~~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      .+.+.++||+|+||+||++... +|+.||||++..   .......+.+|+.++++++||||+++++++. ..+..++|||
T Consensus        23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~~~lv~e  101 (486)
T 3mwu_A           23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-DSSSFYIVGE  101 (486)
T ss_dssp             HEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-CSSEEEEEEC
T ss_pred             ceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE-cCCEEEEEEE
Confidence            3445689999999999999964 689999999854   2345678999999999999999999999986 5668899999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEEC---CCCcEEEeec
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD---ENYRAVVSDF  254 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~---~~~~~kl~Df  254 (453)
                      |+++|+|.+++....          .+++..+..++.|++.||.|||+   .+|+||||||+|||++   .++.+||+||
T Consensus       102 ~~~~~~L~~~~~~~~----------~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  168 (486)
T 3mwu_A          102 LYTGGELFDEIIKRK----------RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDF  168 (486)
T ss_dssp             CCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSC
T ss_pred             cCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEEC
Confidence            999999999886432          38999999999999999999999   8999999999999995   5668999999


Q ss_pred             cccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHH
Q 047276          255 GLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNE  334 (453)
Q Consensus       255 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  334 (453)
                      |++.......  ......||+.|+|||.+.+ .++.++|||||||++|+|++|+.||.....             .....
T Consensus       169 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------------~~~~~  232 (486)
T 3mwu_A          169 GLSTCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-------------YDILK  232 (486)
T ss_dssp             SCTTTBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------------HHHHH
T ss_pred             CcCeECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------------HHHHH
Confidence            9998664332  2345679999999998865 599999999999999999999999953211             01112


Q ss_pred             hhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          335 KMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       335 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      .+..+...... +       .....+..+.+++.+||+.+|++|||+.++++.
T Consensus       233 ~i~~~~~~~~~-~-------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          233 RVETGKYAFDL-P-------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             HHHHTCCCSCS-G-------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             HHHhCCCCCCC-c-------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            22222111000 0       011234458899999999999999999999863

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-40  Score=329.49  Aligned_cols=260  Identities=22%  Similarity=0.292  Sum_probs=187.1

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCCc---cHHHHHHHHHHHHhcCCCceeeEeeEEEecC-----CCeEEEE
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEEN---GEKEFRSEVAAIASAQHVNLVRLLGYCVVPG-----GPRYLVY  176 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~~lv~  176 (453)
                      .+.||+|+||.||+|.. .+|+.||||++.....   ..+.+.+|+.+++.++||||+++++++....     ...++||
T Consensus        30 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~  109 (367)
T 1cm8_A           30 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM  109 (367)
T ss_dssp             EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred             eEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEE
Confidence            57899999999999996 5689999999865322   2456889999999999999999999986432     2459999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||+ +++|.+++..           ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus       110 e~~-~~~L~~~~~~-----------~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  174 (367)
T 1cm8_A          110 PFM-GTDLGKLMKH-----------EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL  174 (367)
T ss_dssp             ECC-SEEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ecC-CCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeec
Confidence            999 7899999853           238999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcc-c-ccchhHHHH
Q 047276          257 SKLMSRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKN-K-WQYFPKIVN  333 (453)
Q Consensus       257 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~-~-~~~~~~~~~  333 (453)
                      ++.....    .....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||............ . ....+....
T Consensus       175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~  250 (367)
T 1cm8_A          175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  250 (367)
T ss_dssp             CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            9875432    234578999999999887 67999999999999999999999999632211000000 0 000000000


Q ss_pred             HhhhcCc-------ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          334 EKMKEGK-------LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       334 ~~~~~~~-------~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      ..+....       +.+.....+.   .........+.+++.+||+.||++|||+.++++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          251 QRLQSDEAKNYMKGLPELEKKDFA---SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGG---GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHhhhHHHHHHHHhCCCCCCCCHH---HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            0000000       0000000010   0112234568899999999999999999999873

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.5e-40  Score=336.45  Aligned_cols=193  Identities=24%  Similarity=0.373  Sum_probs=160.8

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecC----CCeEEEEE
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG----GPRYLVYE  177 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~~lv~e  177 (453)
                      .+.||+|+||+||+|.. .+|+.||||++....   ...+.+.+|+.+|+.++||||+++++++....    ...++|||
T Consensus        31 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e  110 (432)
T 3n9x_A           31 KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLE  110 (432)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEE
T ss_pred             EEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEe
Confidence            57899999999999996 458899999997532   23467899999999999999999999876443    46899999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |+. |+|.+++...          ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus       111 ~~~-~~L~~~~~~~----------~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla  176 (432)
T 3n9x_A          111 IAD-SDLKKLFKTP----------IFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLA  176 (432)
T ss_dssp             CCS-EEHHHHHHSS----------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             cCC-cCHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence            996 5999999643          238999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCC---------------------ceeeeccCCccccchhhh-hcCCCCccccchhHHHHHHHHHcCCCCCc
Q 047276          258 KLMSRDQS---------------------RCITTIRGTRGYLAPEWI-LEQGVSEKCDIYSYGMVLLELTGGRRNVS  312 (453)
Q Consensus       258 ~~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDV~S~Gvil~elltG~~p~~  312 (453)
                      +.......                     .......||+.|+|||.+ ....++.++|||||||++|||++|..||.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            87643321                     123556899999999986 45679999999999999999999776664

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=334.70  Aligned_cols=203  Identities=23%  Similarity=0.336  Sum_probs=153.0

Q ss_pred             hcccCcCCceEEEEEEeC---CCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEe-cCCCeEEEEEecCC
Q 047276          106 QALLGHGSSASVFKGILS---DGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVV-PGGPRYLVYEFIQN  181 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~~lv~e~~~~  181 (453)
                      .++||+|+||+||+|+..   +++.||||++..... ...+.+|+.+|++++||||+++++++.. .+...++||||+. 
T Consensus        26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-  103 (405)
T 3rgf_A           26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-  103 (405)
T ss_dssp             SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-
T ss_pred             CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-
Confidence            358999999999999965   578899999976433 3468899999999999999999999864 3456799999996 


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEE----CCCCcEEEeecccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILL----DENYRAVVSDFGLS  257 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl----~~~~~~kl~DfGla  257 (453)
                      |+|.+++........ ......+++..++.++.|++.||+|||+   .+|+||||||+|||+    +.++.+||+|||++
T Consensus       104 ~~l~~~~~~~~~~~~-~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  179 (405)
T 3rgf_A          104 HDLWHIIKFHRASKA-NKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA  179 (405)
T ss_dssp             EEHHHHHHHHHHHC--------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred             CCHHHHHHHhccccc-cccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence            488888753221000 0012348999999999999999999999   899999999999999    77899999999999


Q ss_pred             ccccCCCC--ceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCccc
Q 047276          258 KLMSRDQS--RCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLI  314 (453)
Q Consensus       258 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~  314 (453)
                      +.......  .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  239 (405)
T 3rgf_A          180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  239 (405)
T ss_dssp             C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred             eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence            87653221  22345678999999999987 45899999999999999999999999644

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.5e-41  Score=320.96  Aligned_cols=252  Identities=27%  Similarity=0.391  Sum_probs=190.4

Q ss_pred             HhcccCcCCceEEEEEEeC--CCc--EEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEE
Q 047276          105 FQALLGHGSSASVFKGILS--DGT--SVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVY  176 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~--~g~--~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~  176 (453)
                      +.+.||+|+||+||+|.+.  +++  .||||+++..    ....+.+.+|+.++.+++||||+++++++..  ...++|+
T Consensus        22 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~v~   99 (291)
T 1u46_A           22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT--PPMKMVT   99 (291)
T ss_dssp             EEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEE
T ss_pred             eeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc--CCceeeE
Confidence            4578999999999999853  333  6899998753    2334678999999999999999999999753  3589999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||+++|+|.+++....         ..+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|||+
T Consensus       100 e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~  167 (291)
T 1u46_A          100 ELAPLGSLLDRLRKHQ---------GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGL  167 (291)
T ss_dssp             ECCTTCBHHHHHHHHG---------GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             ecccCCCHHHHHHhcc---------CCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccc
Confidence            9999999999996432         238999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCc--eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHH
Q 047276          257 SKLMSRDQSR--CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVN  333 (453)
Q Consensus       257 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  333 (453)
                      +.........  ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....            .....
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------------~~~~~  235 (291)
T 1u46_A          168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------------SQILH  235 (291)
T ss_dssp             CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------------HHHHH
T ss_pred             cccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH------------HHHHH
Confidence            9877544322  1233467889999999998889999999999999999999 9999853211            01111


Q ss_pred             HhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          334 EKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       334 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                      .....+.       ..    ..+...+..+.+++.+||+.+|++|||+.++++.|++...
T Consensus       236 ~~~~~~~-------~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          236 KIDKEGE-------RL----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             HHHTSCC-------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             HHHccCC-------CC----CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence            1111110       01    1112334568999999999999999999999999987643

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=4.4e-41  Score=345.26  Aligned_cols=247  Identities=26%  Similarity=0.320  Sum_probs=198.1

Q ss_pred             HHHHhcccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEE
Q 047276          102 TDNFQALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVY  176 (453)
Q Consensus       102 ~~~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~  176 (453)
                      .+.+.++||+|+||+||++... +|+.||||++...    ......+.+|+.++++++||||+++++++. ..+..++|+
T Consensus        27 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~~~lv~  105 (484)
T 3nyv_A           27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE-DKGYFYLVG  105 (484)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEE-CSSEEEEEE
T ss_pred             ceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEE-eCCEEEEEE
Confidence            3445689999999999999965 7899999998642    345678999999999999999999999986 566889999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEE---CCCCcEEEee
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILL---DENYRAVVSD  253 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl---~~~~~~kl~D  253 (453)
                      ||+.+|+|.+++...          ..+++..+..++.|++.||+|||+   .+|+||||||+|||+   +.++.+||+|
T Consensus       106 e~~~~~~L~~~~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~D  172 (484)
T 3nyv_A          106 EVYTGGELFDEIISR----------KRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIID  172 (484)
T ss_dssp             CCCCSCBHHHHHHTC----------SCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred             ecCCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEe
Confidence            999999999998643          238999999999999999999999   899999999999999   5678999999


Q ss_pred             ccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHH
Q 047276          254 FGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVN  333 (453)
Q Consensus       254 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  333 (453)
                      ||++........  .....||+.|+|||.+.+ .++.++|||||||++|||++|+.||.....             ....
T Consensus       173 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------------~~~~  236 (484)
T 3nyv_A          173 FGLSTHFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE-------------YDIL  236 (484)
T ss_dssp             TTHHHHBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------------HHHH
T ss_pred             eeeeEEcccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH-------------HHHH
Confidence            999987654332  344579999999998865 699999999999999999999999953211             0111


Q ss_pred             HhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          334 EKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       334 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ..+..+...-. .+       .....+..+.+++.+||+.+|++|||+.++++
T Consensus       237 ~~i~~~~~~~~-~~-------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          237 KKVEKGKYTFE-LP-------QWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             HHHHHCCCCCC-SG-------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHcCCCCCC-Cc-------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            22222221100 00       11123456889999999999999999999985

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.6e-40  Score=320.04  Aligned_cols=246  Identities=22%  Similarity=0.262  Sum_probs=192.7

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCC-----CccHHHHHHHHHHHHhcCCCceeeEeeEEEe-cCCCeEEEEE
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGE-----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVV-PGGPRYLVYE  177 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~~lv~e  177 (453)
                      +.+.||+|+||.||++.. .+++.||+|+++..     ......+.+|+.++++++||||+++++++.. .....++|||
T Consensus         9 i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e   88 (305)
T 2wtk_C            9 MGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVME   88 (305)
T ss_dssp             CCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEE
T ss_pred             EeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEeh
Confidence            357899999999999996 46889999998642     2345679999999999999999999999753 3457899999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |++++ |.+++....        ...+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++
T Consensus        89 ~~~~~-l~~~~~~~~--------~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~  156 (305)
T 2wtk_C           89 YCVCG-MQEMLDSVP--------EKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVA  156 (305)
T ss_dssp             CCSEE-HHHHHHHST--------TCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             hccCC-HHHHHHhCc--------ccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeeccccc
Confidence            99876 777775432        2348999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCC-CceeeeccCCccccchhhhhcCC--CCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHH
Q 047276          258 KLMSRDQ-SRCITTIRGTRGYLAPEWILEQG--VSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNE  334 (453)
Q Consensus       258 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  334 (453)
                      ....... ........||+.|+|||.+.+..  ++.++||||||+++|||++|+.||.....            .. ...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------------~~-~~~  223 (305)
T 2wtk_C          157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI------------YK-LFE  223 (305)
T ss_dssp             EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH------------HH-HHH
T ss_pred             cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH------------HH-HHH
Confidence            8765332 22334567899999999987643  37899999999999999999999953210            01 111


Q ss_pred             hhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          335 KMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       335 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      .+..+..            ..+......+.+++.+||+.||++|||+.++++.
T Consensus       224 ~i~~~~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          224 NIGKGSY------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             HHHHCCC------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             HHhcCCC------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            2222211            1112233458899999999999999999999963

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=5.1e-41  Score=322.61  Aligned_cols=247  Identities=26%  Similarity=0.360  Sum_probs=187.5

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEec------------CCC
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP------------GGP  171 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------------~~~  171 (453)
                      +.+.||+|+||.||+|+. .+|+.||||.+.......+.+.+|+.++++++||||+++++++...            ...
T Consensus        10 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~   89 (303)
T 1zy4_A           10 EIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKST   89 (303)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEE
T ss_pred             hhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCc
Confidence            347899999999999996 4789999999976555567799999999999999999999987643            245


Q ss_pred             eEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEE
Q 047276          172 RYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVV  251 (453)
Q Consensus       172 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl  251 (453)
                      .++||||+++|+|.+++....         ..+++..++.++.|++.||+|||+   .+++||||||+|||++.++.+||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl  157 (303)
T 1zy4_A           90 LFIQMEYCENGTLYDLIHSEN---------LNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKI  157 (303)
T ss_dssp             EEEEEECCCSCBHHHHHHHSC---------GGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEE
T ss_pred             eEEEEecCCCCCHHHhhhccc---------cccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEE
Confidence            689999999999999996432         237889999999999999999999   89999999999999999999999


Q ss_pred             eeccccccccCCC-------------CceeeeccCCccccchhhhhcC-CCCccccchhHHHHHHHHHcCCCCCcccccC
Q 047276          252 SDFGLSKLMSRDQ-------------SRCITTIRGTRGYLAPEWILEQ-GVSEKCDIYSYGMVLLELTGGRRNVSLIEHG  317 (453)
Q Consensus       252 ~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvil~elltG~~p~~~~~~~  317 (453)
                      +|||++.......             ........||+.|+|||.+.+. .++.++||||||+++|||++   ||..... 
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~-  233 (303)
T 1zy4_A          158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME-  233 (303)
T ss_dssp             CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH-
T ss_pred             eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh-
Confidence            9999998664321             1122345689999999998754 78999999999999999998   4421100 


Q ss_pred             CCCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          318 NDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                                 .......+....      ..+.  ...+......+.+++.+||+.||++|||+.++++
T Consensus       234 -----------~~~~~~~~~~~~------~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          234 -----------RVNILKKLRSVS------IEFP--PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             -----------HHHHHHHHHSTT------CCCC--TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----------HHHHHHhccccc------cccC--ccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence                       000111111111      0111  1123344456889999999999999999999986

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=323.93  Aligned_cols=261  Identities=23%  Similarity=0.298  Sum_probs=185.3

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCCCccH--HHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCC
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGEENGE--KEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      .+.||+|+||+||+|... +++.||+|++.......  ..+.+|+.++++++||||+++++++. .++..++||||++ |
T Consensus         7 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~-~   84 (324)
T 3mtl_A            7 LDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-TEKSLTLVFEYLD-K   84 (324)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEE-CSSCEEEEEECCS-E
T ss_pred             EEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEe-eCCEEEEEecccc-c
Confidence            478999999999999975 68999999987533221  24567999999999999999999986 5668899999997 5


Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccC
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR  262 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~  262 (453)
                      +|.+++....         ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++.....
T Consensus        85 ~l~~~~~~~~---------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  152 (324)
T 3mtl_A           85 DLKQYLDDCG---------NIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSI  152 (324)
T ss_dssp             EHHHHHHHTT---------TCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred             CHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence            9999886442         238999999999999999999999   8999999999999999999999999999986543


Q ss_pred             CCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCC----------CCcccccchhHH
Q 047276          263 DQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGND----------KSKNKWQYFPKI  331 (453)
Q Consensus       263 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~----------~~~~~~~~~~~~  331 (453)
                      .. .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........          .....|..... 
T Consensus       153 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-  230 (324)
T 3mtl_A          153 PT-KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS-  230 (324)
T ss_dssp             -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG-
T ss_pred             Cc-cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhc-
Confidence            22 22334568999999999876 5689999999999999999999999954221100          00000000000 


Q ss_pred             HHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          332 VNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       332 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                       ................+.   .........+.+++.+||+.||++|||++|+++
T Consensus       231 -~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          231 -NEEFKTYNYPKYRAEALL---SHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             -CHHHHHTCCCCCCCCCHH---HHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             -chhhcccccccccchhhh---hhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence             000000000000000000   001122345889999999999999999999985

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=8.5e-41  Score=324.93  Aligned_cols=247  Identities=21%  Similarity=0.311  Sum_probs=189.9

Q ss_pred             HHHhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC---------ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCe
Q 047276          103 DNFQALLGHGSSASVFKGILS-DGTSVAVKRINGEE---------NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPR  172 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~  172 (453)
                      +.+.+.||+|+||.||+|... +++.||||.+....         .....+.+|+.++++++||||+++++++..  +..
T Consensus        12 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~   89 (322)
T 2ycf_A           12 YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA--EDY   89 (322)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--SSE
T ss_pred             eeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--Cce
Confidence            344689999999999999964 57899999986432         112358899999999999999999998753  358


Q ss_pred             EEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCc---E
Q 047276          173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYR---A  249 (453)
Q Consensus       173 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~---~  249 (453)
                      ++||||+++|+|.+++...          ..+++..++.++.|++.||+|||+   .+++||||||+|||++.++.   +
T Consensus        90 ~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~  156 (322)
T 2ycf_A           90 YIVLELMEGGELFDKVVGN----------KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLI  156 (322)
T ss_dssp             EEEEECCTTEETHHHHSTT----------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCE
T ss_pred             EEEEecCCCCcHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeE
Confidence            9999999999999998543          238999999999999999999999   89999999999999987654   9


Q ss_pred             EEeeccccccccCCCCceeeeccCCccccchhhhh---cCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCccccc
Q 047276          250 VVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWIL---EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQ  326 (453)
Q Consensus       250 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~  326 (453)
                      ||+|||++.......  ......||+.|+|||.+.   ...++.++||||||+++|||++|+.||........       
T Consensus       157 kl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------  227 (322)
T 2ycf_A          157 KITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-------  227 (322)
T ss_dssp             EECCCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-------
T ss_pred             EEccCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-------
Confidence            999999998764321  223456899999999874   46788999999999999999999999963221110       


Q ss_pred             chhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          327 YFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                           ....+..+....  .+..      .......+.+++.+||+.||++||++.++++
T Consensus       228 -----~~~~~~~~~~~~--~~~~------~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          228 -----LKDQITSGKYNF--IPEV------WAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             -----HHHHHHHTCCCC--CHHH------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -----HHHHHHhCcccc--Cchh------hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence                 111111111100  0000      0122356889999999999999999999884

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.3e-41  Score=329.82  Aligned_cols=252  Identities=24%  Similarity=0.375  Sum_probs=190.8

Q ss_pred             HhcccCcCCceEEEEEEeCCCcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          105 FQALLGHGSSASVFKGILSDGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      +.+.||+|+||.||+|...+  .+|+|+++..   ....+.+.+|+.++++++||||+++++++. ..+..++|+||+++
T Consensus        37 ~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~iv~e~~~~  113 (319)
T 2y4i_B           37 IGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM-SPPHLAIITSLCKG  113 (319)
T ss_dssp             CCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE-CSSCEEEECBCCCS
T ss_pred             EeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe-cCCceEEEeecccC
Confidence            46799999999999999854  4999998653   223345788999999999999999999987 55678999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      ++|.+++....         ..+++..++.++.|++.||+|||+   .+++||||||+|||++ ++.+||+|||++....
T Consensus       114 ~~L~~~l~~~~---------~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~  180 (319)
T 2y4i_B          114 RTLYSVVRDAK---------IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISG  180 (319)
T ss_dssp             EEHHHHTTSSC---------CCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred             CcHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence            99999995432         248999999999999999999999   8999999999999998 6799999999987653


Q ss_pred             CCC----CceeeeccCCccccchhhhhc---------CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccch
Q 047276          262 RDQ----SRCITTIRGTRGYLAPEWILE---------QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYF  328 (453)
Q Consensus       262 ~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~  328 (453)
                      ...    ........|++.|+|||.+..         ..++.++||||||+++|||++|+.||.....            
T Consensus       181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------------  248 (319)
T 2y4i_B          181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA------------  248 (319)
T ss_dssp             -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH------------
T ss_pred             cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------------
Confidence            211    122234568999999999874         3578899999999999999999999953211            


Q ss_pred             hHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccCCC
Q 047276          329 PKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVD  395 (453)
Q Consensus       329 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~~~  395 (453)
                       .........+........          .....+.+++.+||+.+|++|||+.++++.|+......
T Consensus       249 -~~~~~~~~~~~~~~~~~~----------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          249 -EAIIWQMGTGMKPNLSQI----------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             -HHHHHHHHTTCCCCCCCS----------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             -HHHHHHhccCCCCCCCcC----------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence             011112222211111111          12234889999999999999999999999999876543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.7e-40  Score=331.50  Aligned_cols=268  Identities=22%  Similarity=0.297  Sum_probs=198.8

Q ss_pred             HHHhcccCcCCceEEEEEEe-CCCcEEEEEEecCCCccHHHHHHHHHHHHhcC--------CCceeeEeeEEEe---cCC
Q 047276          103 DNFQALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRSEVAAIASAQ--------HVNLVRLLGYCVV---PGG  170 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~g~~~~---~~~  170 (453)
                      +.+.++||+|+||+||+|+. .+++.||||+++......+.+.+|+.+++.++        |+||+++++++..   .+.
T Consensus        39 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~  118 (397)
T 1wak_A           39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGT  118 (397)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEE
T ss_pred             EEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCc
Confidence            34457899999999999985 56889999999876555678899999999985        7889999998763   334


Q ss_pred             CeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCC-ceeccCCCCCcEEECCCC--
Q 047276          171 PRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRS-RVLHLDVKPENILLDENY--  247 (453)
Q Consensus       171 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~-~ivH~Dlk~~NiLl~~~~--  247 (453)
                      ..++||||+ +++|.+++....        ...+++..++.++.|++.||+|||+   . +|+||||||+|||++.++  
T Consensus       119 ~~~lv~e~~-~~~l~~~~~~~~--------~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~  186 (397)
T 1wak_A          119 HICMVFEVL-GHHLLKWIIKSN--------YQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQY  186 (397)
T ss_dssp             EEEEEECCC-CCBHHHHHHHTT--------TSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHH
T ss_pred             eEEEEEecc-CccHHHHHHhcc--------cCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchh
Confidence            679999999 567777665432        1348999999999999999999999   7 999999999999999775  


Q ss_pred             -----------------------------------------------cEEEeeccccccccCCCCceeeeccCCccccch
Q 047276          248 -----------------------------------------------RAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAP  280 (453)
Q Consensus       248 -----------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aP  280 (453)
                                                                     .+||+|||++......    .....||+.|+||
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aP  262 (397)
T 1wak_A          187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSL  262 (397)
T ss_dssp             HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCH
T ss_pred             hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCC
Confidence                                                           7999999999876432    2345789999999


Q ss_pred             hhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCccc-ccchhHHH----HHhhhcCc-----------cccc
Q 047276          281 EWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNK-WQYFPKIV----NEKMKEGK-----------LMEI  344 (453)
Q Consensus       281 E~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~-----------~~~~  344 (453)
                      |.+.+..++.++|||||||++|||++|+.||............. ........    ...+..+.           ....
T Consensus       263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  342 (397)
T 1wak_A          263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI  342 (397)
T ss_dssp             HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred             hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence            99999999999999999999999999999996433221110000 00000000    00000000           0000


Q ss_pred             cc-------ccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          345 VD-------QRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       345 ~d-------~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      .+       ..+......+......+.+++.+||+.||++|||+.|+++
T Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          343 TKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            00       0001112345677888999999999999999999999885

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2e-40  Score=341.18  Aligned_cols=246  Identities=24%  Similarity=0.318  Sum_probs=191.9

Q ss_pred             HHHhcccCcCCceEEEEEEeC-CCcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEe
Q 047276          103 DNFQALLGHGSSASVFKGILS-DGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      +.+.+.||+|+||+||+|+.. ++..||+|++...   ......+.+|+.+++.++||||++++++|. .....++||||
T Consensus        39 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~~~~~lv~e~  117 (494)
T 3lij_A           39 YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE-DKRNYYLVMEC  117 (494)
T ss_dssp             EEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE-CSSEEEEEEEC
T ss_pred             eEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE-eCCEEEEEEec
Confidence            444689999999999999964 6889999998753   334567899999999999999999999986 56688999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECC---CCcEEEeecc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDE---NYRAVVSDFG  255 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~---~~~~kl~DfG  255 (453)
                      +++|+|.+++...          ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.   ++.+||+|||
T Consensus       118 ~~~g~L~~~~~~~----------~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG  184 (494)
T 3lij_A          118 YKGGELFDEIIHR----------MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFG  184 (494)
T ss_dssp             CCSCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CCCCcHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECC
Confidence            9999999988543          238999999999999999999999   89999999999999976   4559999999


Q ss_pred             ccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHh
Q 047276          256 LSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEK  335 (453)
Q Consensus       256 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  335 (453)
                      ++.......  ......||+.|+|||.+. +.++.++|||||||++|||++|+.||.....             ......
T Consensus       185 ~a~~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------------~~~~~~  248 (494)
T 3lij_A          185 LSAVFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD-------------QEILRK  248 (494)
T ss_dssp             TCEECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------------HHHHHH
T ss_pred             CCeECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-------------HHHHHH
Confidence            998765432  234567999999999876 5699999999999999999999999953211             111122


Q ss_pred             hhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          336 MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       336 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      +..+... ...+.+       ...+..+.+++.+||+.+|++|||+.++++
T Consensus       249 i~~~~~~-~~~~~~-------~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          249 VEKGKYT-FDSPEW-------KNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             HHHTCCC-CCSGGG-------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHhCCCC-CCchhc-------ccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            2222111 001111       122345889999999999999999999884

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.8e-40  Score=324.21  Aligned_cols=269  Identities=20%  Similarity=0.233  Sum_probs=192.4

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEec-------CCCeE
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP-------GGPRY  173 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-------~~~~~  173 (453)
                      +.+.||+|+||+||+|+. .+|+.||||++...   ......+.+|+.+++.++||||+++++++...       ++..+
T Consensus        21 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~  100 (351)
T 3mi9_A           21 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY  100 (351)
T ss_dssp             EEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEE
T ss_pred             EEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEE
Confidence            357899999999999997 57899999998643   22345788999999999999999999998754       23578


Q ss_pred             EEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEee
Q 047276          174 LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSD  253 (453)
Q Consensus       174 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~D  253 (453)
                      +||||+++ +|.+.+....         ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|
T Consensus       101 lv~e~~~~-~l~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~D  167 (351)
T 3mi9_A          101 LVFDFCEH-DLAGLLSNVL---------VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLAD  167 (351)
T ss_dssp             EEEECCSE-EHHHHHHCTT---------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECC
T ss_pred             EEEeccCC-CHHHHHhhcc---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEcc
Confidence            99999975 7877775432         238999999999999999999999   8999999999999999999999999


Q ss_pred             ccccccccCCC---CceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCccc--ccc
Q 047276          254 FGLSKLMSRDQ---SRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNK--WQY  327 (453)
Q Consensus       254 fGla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~--~~~  327 (453)
                      ||+++......   ........||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.............  ...
T Consensus       168 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  247 (351)
T 3mi9_A          168 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS  247 (351)
T ss_dssp             CTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             chhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            99998765322   122344678999999998876 458999999999999999999999996422110000000  000


Q ss_pred             hhHHHHHhhhcCcccccccccccCCCCCcHH------HHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          328 FPKIVNEKMKEGKLMEIVDQRLTDEGGIDET------QVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~------~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      .+...+.........+.... .........+      ....+.+++.+||+.||++|||++|+++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          248 ITPEVWPNVDNYELYEKLEL-VKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             CCTTTSTTGGGCGGGTSSCC-CSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CChhhccccccchhhccccc-ccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            00000000000000000000 0000000011      13458899999999999999999998853

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=6.8e-41  Score=326.93  Aligned_cols=266  Identities=21%  Similarity=0.315  Sum_probs=190.5

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCCCcc---HHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGEENG---EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      .+.||+|+||.||+|... +|+.||||++......   .+.+.+|+.++++++||||++++++|. ..+..++||||+++
T Consensus        30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~  108 (331)
T 4aaa_A           30 LGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-KKKRWYLVFEFVDH  108 (331)
T ss_dssp             EEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-ETTEEEEEEECCSE
T ss_pred             eeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee-cCCEEEEEEecCCc
Confidence            478999999999999975 5899999998654332   355789999999999999999999986 55678999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      ++|.+++...          ..+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++....
T Consensus       109 ~~l~~~~~~~----------~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  175 (331)
T 4aaa_A          109 TILDDLELFP----------NGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLA  175 (331)
T ss_dssp             EHHHHHHHST----------TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             chHHHHHhhc----------cCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence            9998886432          238999999999999999999999   899999999999999999999999999998664


Q ss_pred             CCCCceeeeccCCccccchhhhhcC-CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcc--cccchhHHHHHhhhc
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILEQ-GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKN--KWQYFPKIVNEKMKE  338 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  338 (453)
                      .... ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||............  ............+..
T Consensus       176 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (331)
T 4aaa_A          176 APGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK  254 (331)
T ss_dssp             ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred             CCcc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence            3322 23445689999999998865 7899999999999999999999999543211000000  000000000000110


Q ss_pred             C-cccccccccccCCCC---CcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          339 G-KLMEIVDQRLTDEGG---IDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       339 ~-~~~~~~d~~l~~~~~---~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      . .......+.+.....   ..+.....+.+++.+||+.||++|||+.|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0 000111111110000   01123456899999999999999999999874

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=7.8e-41  Score=330.26  Aligned_cols=192  Identities=28%  Similarity=0.420  Sum_probs=166.1

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCC
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      .+.||+|+||+||++... +|+.||+|++....  ...+.+.+|+.+++.++||||+++++++. .++..++||||+++|
T Consensus        38 ~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~~  116 (360)
T 3eqc_A           38 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-SDGEISICMEHMDGG  116 (360)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE-ETTEEEEEECCCTTC
T ss_pred             eeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEE-ECCEEEEEEECCCCC
Confidence            478999999999999975 68999999997642  33467899999999999999999999987 456789999999999


Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccC
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR  262 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~  262 (453)
                      +|.+++....          .+++..+..++.|++.||+|||+.  .+|+||||||+|||++.++.+||+|||++.....
T Consensus       117 ~L~~~l~~~~----------~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          117 SLDQVLKKAG----------RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  184 (360)
T ss_dssp             BHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             CHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence            9999996432          389999999999999999999982  2899999999999999999999999999976532


Q ss_pred             CCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcc
Q 047276          263 DQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSL  313 (453)
Q Consensus       263 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~  313 (453)
                      ..   .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus       185 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  232 (360)
T 3eqc_A          185 SM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP  232 (360)
T ss_dssp             HC-------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred             cc---ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            21   2345789999999999999999999999999999999999999964

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2e-40  Score=320.90  Aligned_cols=245  Identities=25%  Similarity=0.347  Sum_probs=192.8

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCC
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS  183 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gs  183 (453)
                      +.+.||+|+||.||+|... +|+.||+|.+.... ..+.+.+|+.++..++||||+++++++. ..+..++||||+++|+
T Consensus        33 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~  110 (314)
T 3com_A           33 VLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYF-KNTDLWIVMEYCGAGS  110 (314)
T ss_dssp             EEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEE-ETTEEEEEEECCTTEE
T ss_pred             hheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEE-eCCEEEEEeecCCCCC
Confidence            3478999999999999975 58999999997643 3467899999999999999999999987 4567899999999999


Q ss_pred             hhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCC
Q 047276          184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD  263 (453)
Q Consensus       184 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~  263 (453)
                      |.+++...         ...+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++......
T Consensus       111 L~~~~~~~---------~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          111 VSDIIRLR---------NKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             HHHHHHHH---------TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             HHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            99998532         1348999999999999999999999   89999999999999999999999999999876433


Q ss_pred             CCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcccc
Q 047276          264 QSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLME  343 (453)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (453)
                      .. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......            . ..........  
T Consensus       179 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------------~-~~~~~~~~~~--  242 (314)
T 3com_A          179 MA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM------------R-AIFMIPTNPP--  242 (314)
T ss_dssp             BS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------------H-HHHHHHHSCC--
T ss_pred             cc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH------------H-HHHHHhcCCC--
Confidence            22 234457899999999999889999999999999999999999998532110            0 0001111110  


Q ss_pred             cccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          344 IVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       344 ~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                         +.+    ..+......+.+++.+||+.||++|||+.++++
T Consensus       243 ---~~~----~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          243 ---PTF----RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             ---CCC----SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ---ccc----CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence               001    112223456889999999999999999999975

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=5e-40  Score=339.03  Aligned_cols=244  Identities=24%  Similarity=0.325  Sum_probs=192.4

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC--------------ccHHHHHHHHHHHHhcCCCceeeEeeEEEecC
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEE--------------NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG  169 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~  169 (453)
                      +.++||+|+||+||+|... +++.||+|++....              ...+.+.+|+.++++++||||+++++++. ..
T Consensus        40 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-~~  118 (504)
T 3q5i_A           40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFE-DK  118 (504)
T ss_dssp             EEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEE-CS
T ss_pred             EEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-cC
Confidence            3579999999999999964 57899999987532              23467899999999999999999999986 56


Q ss_pred             CCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCC--
Q 047276          170 GPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENY--  247 (453)
Q Consensus       170 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~--  247 (453)
                      ...++||||+++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++  
T Consensus       119 ~~~~lv~e~~~gg~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~  185 (504)
T 3q5i_A          119 KYFYLVTEFYEGGELFEQIINRH----------KFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSL  185 (504)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCC
T ss_pred             CEEEEEEecCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCC
Confidence            68899999999999999986432          38999999999999999999999   8999999999999999776  


Q ss_pred             -cEEEeeccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCccccc
Q 047276          248 -RAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQ  326 (453)
Q Consensus       248 -~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~  326 (453)
                       .+||+|||++.......  ......||+.|+|||.+. +.++.++|||||||++|+|++|+.||.....          
T Consensus       186 ~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----------  252 (504)
T 3q5i_A          186 LNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND----------  252 (504)
T ss_dssp             SSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------
T ss_pred             ccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH----------
Confidence             69999999998765432  234567999999999876 5699999999999999999999999953211          


Q ss_pred             chhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          327 YFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                         ......+..+...-.. +.+       ...+..+.+++.+||+.||++|||+.++++
T Consensus       253 ---~~~~~~i~~~~~~~~~-~~~-------~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          253 ---QDIIKKVEKGKYYFDF-NDW-------KNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             ---HHHHHHHHHCCCCCCH-HHH-------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ---HHHHHHHHcCCCCCCc-ccc-------CCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence               1112222222211000 000       112355899999999999999999999984

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=9.9e-41  Score=354.69  Aligned_cols=241  Identities=21%  Similarity=0.256  Sum_probs=195.3

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEEEEEec
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      .++||+|+||.||+|+.. +++.||||+++..    ....+.+..|..++..+ +||||+++++++. ..+..++||||+
T Consensus       346 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~-~~~~~~lV~E~~  424 (674)
T 3pfq_A          346 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-TMDRLYFVMEYV  424 (674)
T ss_dssp             EEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECB-CSSEEEEEEECC
T ss_pred             EEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEE-eCCEEEEEEeCc
Confidence            368999999999999964 5889999998742    23446678899999887 7999999998765 566889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ++|+|.+++....          .+++..+..++.||+.||+|||+   .+|+||||||+||||+.++.+||+|||+++.
T Consensus       425 ~gg~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~  491 (674)
T 3pfq_A          425 NGGDLMYHIQQVG----------RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  491 (674)
T ss_dssp             CSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred             CCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeec
Confidence            9999999996432          38999999999999999999999   8999999999999999999999999999986


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      ..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....            .. ....+..+
T Consensus       492 ~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~------------~~-~~~~i~~~  557 (674)
T 3pfq_A          492 NIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------------DE-LFQSIMEH  557 (674)
T ss_dssp             CCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------------HH-HHHHHHSS
T ss_pred             cccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH------------HH-HHHHHHhC
Confidence            43322 224567899999999999999999999999999999999999999953211            01 11112111


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCH-----HHHHH
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSM-----ARVVE  386 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~-----~~v~~  386 (453)
                      .            ..++......+.+++..||+.||++||++     ++|.+
T Consensus       558 ~------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          558 N------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             C------------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             C------------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence            1            11233445568999999999999999998     66653

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.2e-40  Score=320.80  Aligned_cols=260  Identities=18%  Similarity=0.237  Sum_probs=193.7

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCCCccHHHHHHHHHHHHhcC-CCceeeEeeEEEec-CCCeEEEEEecCC
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRSEVAAIASAQ-HVNLVRLLGYCVVP-GGPRYLVYEFIQN  181 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~-~~~~~lv~e~~~~  181 (453)
                      +.+.||+|+||+||+|.. .+++.||||+++.  ...+.+.+|+.++.+++ ||||+++++++... ....++||||+++
T Consensus        40 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~  117 (330)
T 3nsz_A           40 LVRKLGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN  117 (330)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEECS--CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCC
T ss_pred             EEEEecccCCeEEEEEEECCCCcEEEEEEecc--cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCc
Confidence            357899999999999985 5789999999974  34577999999999997 99999999998753 4567999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCC-cEEEeeccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENY-RAVVSDFGLSKLM  260 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~-~~kl~DfGla~~~  260 (453)
                      ++|.+++.             .+++..+..++.|++.||+|||+   .+++||||||+|||++.++ .+||+|||+++..
T Consensus       118 ~~l~~~~~-------------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~  181 (330)
T 3nsz_A          118 TDFKQLYQ-------------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  181 (330)
T ss_dssp             CCHHHHGG-------------GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             hhHHHHHH-------------hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence            99999882             28899999999999999999999   8999999999999999776 8999999999876


Q ss_pred             cCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccch-hHHHHHhhhc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYF-PKIVNEKMKE  338 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  338 (453)
                      .....  .....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||................. .......+..
T Consensus       182 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  259 (330)
T 3nsz_A          182 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  259 (330)
T ss_dssp             CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             CCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence            54332  244578999999999877 6789999999999999999999999943211100000000000 0000000000


Q ss_pred             Cc--------------ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          339 GK--------------LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       339 ~~--------------~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ..              .....+....  ..........+.+++.+||+.||++|||++++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          260 YNIELDPRFNDILGRHSRKRWERFVH--SENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             TTCCCCTHHHHHHCCCCCCCGGGGCC--TTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hccccccchhhhhhhccccchhhhcc--ccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00              0000000000  0112224566899999999999999999999985

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3e-40  Score=333.73  Aligned_cols=192  Identities=27%  Similarity=0.337  Sum_probs=166.5

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCCccHHHHHHHHHHHHhc------CCCceeeEeeEEEecCCCeEEEEE
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRSEVAAIASA------QHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      +.++||+|+||+||+|... +++.||||+++........+.+|+.++..+      +|+||+++++++. ..+..++|||
T Consensus       101 ~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~-~~~~~~lv~e  179 (429)
T 3kvw_A          101 VLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT-FRNHICMTFE  179 (429)
T ss_dssp             EEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE-ETTEEEEEEC
T ss_pred             EEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc-cCCeEEEEEe
Confidence            3578999999999999864 588999999987655567788899998887      5779999999986 4568899999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCc--EEEeecc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYR--AVVSDFG  255 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~--~kl~DfG  255 (453)
                      |+. ++|.+++.....        ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.  +||+|||
T Consensus       180 ~~~-~~L~~~l~~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          180 LLS-MNLYELIKKNKF--------QGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             CCC-CBHHHHHHHTTT--------CCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             ccC-CCHHHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecc
Confidence            996 699999865432        238999999999999999999999   79999999999999999987  9999999


Q ss_pred             ccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcc
Q 047276          256 LSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSL  313 (453)
Q Consensus       256 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~  313 (453)
                      ++......    .....||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       248 ~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~  301 (429)
T 3kvw_A          248 SSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG  301 (429)
T ss_dssp             TCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence            99764332    2345789999999999999999999999999999999999999964

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=9.8e-41  Score=329.72  Aligned_cols=267  Identities=23%  Similarity=0.280  Sum_probs=189.0

Q ss_pred             HHHHHHHHHH--hcccCcCCceEEEEEEeCCCcEEEEEEecCCCc------------cHHHHHHHHHHHHhcCCCceeeE
Q 047276           96 KELEEATDNF--QALLGHGSSASVFKGILSDGTSVAVKRINGEEN------------GEKEFRSEVAAIASAQHVNLVRL  161 (453)
Q Consensus        96 ~el~~~~~~~--~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~------------~~~~~~~E~~~l~~l~h~niv~l  161 (453)
                      .++.....+|  .+.||+|+||.||+|...+|+.||||++.....            ..+.+.+|+.++++++||||+++
T Consensus        15 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   94 (362)
T 3pg1_A           15 AELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGL   94 (362)
T ss_dssp             HHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred             HHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccce
Confidence            3444433333  478999999999999988899999999854211            12678999999999999999999


Q ss_pred             eeEEEecC----CCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCC
Q 047276          162 LGYCVVPG----GPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVK  237 (453)
Q Consensus       162 ~g~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk  237 (453)
                      ++++....    ...++||||++ |+|.+++....         ..+++..+..++.|++.||+|||+   .+++|||||
T Consensus        95 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlk  161 (362)
T 3pg1_A           95 RDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---------IVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLH  161 (362)
T ss_dssp             SEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCC
T ss_pred             eeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---------cCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCC
Confidence            99986433    24699999997 68888886432         248999999999999999999999   899999999


Q ss_pred             CCcEEECCCCcEEEeeccccccccCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCccccc
Q 047276          238 PENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEH  316 (453)
Q Consensus       238 ~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~  316 (453)
                      |+|||++.++.+||+|||++.......  ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.....
T Consensus       162 p~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~  239 (362)
T 3pg1_A          162 PGNILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF  239 (362)
T ss_dssp             GGGEEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             hHHEEEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            999999999999999999997544332  2244578999999999876 6789999999999999999999999963221


Q ss_pred             CCCCCcccccchhHHHHHhhhc-----------CcccccccccccCCC-----CCcHHHHHHHHHHHHhccccCCCCCCC
Q 047276          317 GNDKSKNKWQYFPKIVNEKMKE-----------GKLMEIVDQRLTDEG-----GIDETQVRRLVDVAFWCIQERARLRPS  380 (453)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~d~~l~~~~-----~~~~~~~~~l~~l~~~Cl~~~p~~RPs  380 (453)
                      ..        .... .......           ....+.+...+....     .........+.+++.+||+.||++|||
T Consensus       240 ~~--------~~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  310 (362)
T 3pg1_A          240 YN--------QLNK-IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIS  310 (362)
T ss_dssp             HH--------HHHH-HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred             HH--------HHHH-HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCC
Confidence            10        0000 0000000           000000000000000     001122455889999999999999999


Q ss_pred             HHHHHH
Q 047276          381 MARVVE  386 (453)
Q Consensus       381 ~~~v~~  386 (453)
                      +.++++
T Consensus       311 ~~ell~  316 (362)
T 3pg1_A          311 TEQALR  316 (362)
T ss_dssp             HHHHHT
T ss_pred             HHHHHc
Confidence            999885

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.3e-40  Score=316.01  Aligned_cols=244  Identities=22%  Similarity=0.325  Sum_probs=193.8

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCCC----------ccHHHHHHHHHHHHhcC-CCceeeEeeEEEecCCCeE
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGEE----------NGEKEFRSEVAAIASAQ-HVNLVRLLGYCVVPGGPRY  173 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~----------~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~~  173 (453)
                      .+.||+|+||.||+|... +|+.||||.+....          ...+.+.+|+.++.++. ||||+++++++. .++..+
T Consensus        22 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~-~~~~~~  100 (298)
T 1phk_A           22 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE-TNTFFF  100 (298)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE-CSSEEE
T ss_pred             eeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec-cCCeEE
Confidence            478999999999999974 68899999997532          11346789999999996 999999999986 566889


Q ss_pred             EEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEee
Q 047276          174 LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSD  253 (453)
Q Consensus       174 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~D  253 (453)
                      +||||+++++|.+++...          ..+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.+||+|
T Consensus       101 lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~d  167 (298)
T 1phk_A          101 LVFDLMKKGELFDYLTEK----------VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTD  167 (298)
T ss_dssp             EEEECCTTCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECC
T ss_pred             EEEeccCCCcHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEec
Confidence            999999999999999643          238999999999999999999999   8999999999999999999999999


Q ss_pred             ccccccccCCCCceeeeccCCccccchhhhh------cCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccc
Q 047276          254 FGLSKLMSRDQSRCITTIRGTRGYLAPEWIL------EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQY  327 (453)
Q Consensus       254 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~  327 (453)
                      ||++.......  ......|++.|+|||.+.      ...++.++||||||+++|||++|+.||.....           
T Consensus       168 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----------  234 (298)
T 1phk_A          168 FGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-----------  234 (298)
T ss_dssp             CTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----------
T ss_pred             ccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH-----------
Confidence            99998765432  234457899999999885      45688999999999999999999999853211           


Q ss_pred             hhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          328 FPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                        .........+... ..       ..........+.+++.+||+.||++|||+.++++
T Consensus       235 --~~~~~~~~~~~~~-~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          235 --MLMLRMIMSGNYQ-FG-------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             --HHHHHHHHHTCCC-CC-------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             --HHHHHHHhcCCcc-cC-------cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence              0011111111110 00       0111233456899999999999999999999874

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=5.7e-40  Score=324.75  Aligned_cols=265  Identities=21%  Similarity=0.265  Sum_probs=192.0

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecC----CCeEEEEEe
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG----GPRYLVYEF  178 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~~lv~e~  178 (453)
                      .+.||+|+||.||++... +++.||||++....  ...+.+.+|+.++.+++||||+++++++....    ...++|+||
T Consensus        32 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~  111 (364)
T 3qyz_A           32 LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL  111 (364)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEEC
T ss_pred             EEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcc
Confidence            578999999999999964 68899999997533  23367899999999999999999999986433    367999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +. |+|.+++..           ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||++.
T Consensus       112 ~~-~~L~~~l~~-----------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  176 (364)
T 3qyz_A          112 ME-TDLYKLLKT-----------QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLAR  176 (364)
T ss_dssp             CS-EEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             cC-cCHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceE
Confidence            97 599999843           238999999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCc--eeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCccc-c-cchhHHHH
Q 047276          259 LMSRDQSR--CITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNK-W-QYFPKIVN  333 (453)
Q Consensus       259 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~-~-~~~~~~~~  333 (453)
                      ........  ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||............. . ...+....
T Consensus       177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  256 (364)
T 3qyz_A          177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  256 (364)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred             ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            76543221  1244579999999998765 458999999999999999999999995432111000000 0 00000000


Q ss_pred             HhhhcCcccccccccccCCCCC-----cHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          334 EKMKEGKLMEIVDQRLTDEGGI-----DETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       334 ~~~~~~~~~~~~d~~l~~~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ..+......... ..+......     .......+.+++.+||+.||++|||+.++++
T Consensus       257 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          257 NCIINLKARNYL-LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HTCCCHHHHHHH-HTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHhhhhhHHHHH-HhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            000000000000 000000000     0122356889999999999999999999985

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.2e-40  Score=317.51  Aligned_cols=246  Identities=23%  Similarity=0.339  Sum_probs=190.1

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecC-CCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCC
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRING-EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      +.+.||+|+||.||+|... +|+.||+|++.. .....+.+.+|+.+++.++||||+++++++. ..+..++||||++++
T Consensus        23 i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~  101 (302)
T 2j7t_A           23 IVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY-HDGKLWIMIEFCPGG  101 (302)
T ss_dssp             EEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEE-CC-CEEEEEECCTTE
T ss_pred             ecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeee-eCCeEEEEEEeCCCC
Confidence            3578999999999999975 588999999875 3445678999999999999999999999987 556889999999999


Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccC
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR  262 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~  262 (453)
                      +|.+++....         ..+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.....
T Consensus       102 ~l~~~~~~~~---------~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (302)
T 2j7t_A          102 AVDAIMLELD---------RGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK  169 (302)
T ss_dssp             EHHHHHHHHT---------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred             cHHHHHHhhc---------cCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence            9999985432         238999999999999999999999   8999999999999999999999999998764321


Q ss_pred             CCCceeeeccCCccccchhhhh-----cCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhh
Q 047276          263 DQSRCITTIRGTRGYLAPEWIL-----EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMK  337 (453)
Q Consensus       263 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (453)
                      .. .......||+.|+|||.+.     ...++.++||||||+++|||++|+.||......            ...... .
T Consensus       170 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------------~~~~~~-~  235 (302)
T 2j7t_A          170 TL-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------------RVLLKI-A  235 (302)
T ss_dssp             HH-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH------------HHHHHH-H
T ss_pred             cc-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH------------HHHHHH-h
Confidence            11 1123356899999999984     567889999999999999999999998532110            011111 1


Q ss_pred             cCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          338 EGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       338 ~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      .+.....         ..+......+.+++.+||+.||++|||+.++++
T Consensus       236 ~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          236 KSDPPTL---------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             HSCCCCC---------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             ccCCccc---------CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            1111100         012233456889999999999999999999874

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-40  Score=323.60  Aligned_cols=261  Identities=24%  Similarity=0.276  Sum_probs=191.5

Q ss_pred             HHHhcccCcCCceEEEEEEeC-CCcEEEEEEecCCCcc------HHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEE
Q 047276          103 DNFQALLGHGSSASVFKGILS-DGTSVAVKRINGEENG------EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLV  175 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv  175 (453)
                      +.+.+.||+|+||.||+|... +|+.||||++......      .+.+.+|+.+++.++||||+++++++. ..+..++|
T Consensus        12 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv   90 (346)
T 1ua2_A           12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG-HKSNISLV   90 (346)
T ss_dssp             -CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC-CTTCCEEE
T ss_pred             cEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEe-eCCceEEE
Confidence            334589999999999999964 6899999998742211      236889999999999999999999975 56688999


Q ss_pred             EEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecc
Q 047276          176 YEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFG  255 (453)
Q Consensus       176 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfG  255 (453)
                      |||+++ +|.+++....         ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||
T Consensus        91 ~e~~~~-~l~~~~~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg  157 (346)
T 1ua2_A           91 FDFMET-DLEVIIKDNS---------LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFG  157 (346)
T ss_dssp             EECCSE-EHHHHHTTCC---------SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCG
T ss_pred             EEcCCC-CHHHHHHhcC---------cCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecc
Confidence            999986 8988885432         238888999999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCceeeeccCCccccchhhhhcC-CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHH
Q 047276          256 LSKLMSRDQSRCITTIRGTRGYLAPEWILEQ-GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNE  334 (453)
Q Consensus       256 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  334 (453)
                      +++...... .......||+.|+|||.+.+. .++.++|||||||++|||++|..||......        ..+..... 
T Consensus       158 ~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~--------~~~~~i~~-  227 (346)
T 1ua2_A          158 LAKSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--------DQLTRIFE-  227 (346)
T ss_dssp             GGSTTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHH-
T ss_pred             cceeccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHH-
Confidence            998764332 223456789999999998754 5899999999999999999999998532211        00000000 


Q ss_pred             hhhcC---cc---ccccccc-ccCCCCCc-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          335 KMKEG---KL---MEIVDQR-LTDEGGID-----ETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       335 ~~~~~---~~---~~~~d~~-l~~~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      .....   ..   ....+.. .......+     ......+.+++.+||+.||++|||+.|+++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          228 TLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             HHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             HcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            00000   00   0000000 00000001     1223568999999999999999999999864

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=7e-40  Score=324.94  Aligned_cols=263  Identities=21%  Similarity=0.257  Sum_probs=185.1

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecC-----CCeEEEE
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG-----GPRYLVY  176 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~~lv~  176 (453)
                      .+.||+|+||.||+|.. .+|+.||||++....   ...+.+.+|+.+++.++||||+++++++...+     ...++||
T Consensus        30 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~  109 (371)
T 2xrw_A           30 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM  109 (371)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEE
T ss_pred             eeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEE
Confidence            57899999999999985 468899999997532   23356889999999999999999999986433     2569999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||+++ +|.+++..            .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus       110 e~~~~-~l~~~~~~------------~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  173 (371)
T 2xrw_A          110 ELMDA-NLCQVIQM------------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL  173 (371)
T ss_dssp             ECCSE-EHHHHHHS------------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             EcCCC-CHHHHHhh------------ccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeec
Confidence            99975 88888741            28899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCC----------CCccccc
Q 047276          257 SKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGND----------KSKNKWQ  326 (453)
Q Consensus       257 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~----------~~~~~~~  326 (453)
                      ++......  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........          .....+.
T Consensus       174 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  251 (371)
T 2xrw_A          174 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK  251 (371)
T ss_dssp             ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred             cccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            98654322  23446789999999999998999999999999999999999999964321100          0000000


Q ss_pred             chhHHHHHhhhcC------cccccccccc-cCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          327 YFPKIVNEKMKEG------KLMEIVDQRL-TDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       327 ~~~~~~~~~~~~~------~~~~~~d~~l-~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      .+...........      .+.+...... .............+.+++.+||+.||++|||++++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence            0000000000000      0000000000 0000112234667999999999999999999999986

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.2e-40  Score=320.44  Aligned_cols=261  Identities=25%  Similarity=0.386  Sum_probs=178.4

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      +.+.||+|+||.||+|.. .+++.||||.+...  ....+.+.+|+.++.+++||||+++++++. ..+..++||||+++
T Consensus        19 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~   97 (303)
T 2vwi_A           19 LQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFV-VKDELWLVMKLLSG   97 (303)
T ss_dssp             EEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEE-SSSCEEEEEECCTT
T ss_pred             hhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEe-ecCCcEEEehhccC
Confidence            457899999999999995 46889999998653  233467889999999999999999999986 55688999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      |+|.+++.......  ......+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++....
T Consensus        98 ~~L~~~l~~~~~~~--~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  172 (303)
T 2vwi_A           98 GSVLDIIKHIVAKG--EHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLA  172 (303)
T ss_dssp             CBHHHHHHHHHHTT--TTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC
T ss_pred             CchHHHHHHHhhcc--ccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchheec
Confidence            99999986321100  0023458999999999999999999999   899999999999999999999999999998664


Q ss_pred             CCCC----ceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhh
Q 047276          262 RDQS----RCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKM  336 (453)
Q Consensus       262 ~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (453)
                      ....    .......||+.|+|||.+.. ..++.++||||||+++|||++|+.||.......            ......
T Consensus       173 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------------~~~~~~  240 (303)
T 2vwi_A          173 TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK------------VLMLTL  240 (303)
T ss_dssp             ---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG------------HHHHHH
T ss_pred             cCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh------------HHHHHh
Confidence            3221    12234578999999999876 568999999999999999999999996422110            000111


Q ss_pred             hcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          337 KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       337 ~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      . +..... ...... ..........+.+++.+||+.||++|||+.++++
T Consensus       241 ~-~~~~~~-~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          241 Q-NDPPSL-ETGVQD-KEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             T-SSCCCT-TC------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             c-cCCCcc-cccccc-chhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            1 100000 000000 0011122345889999999999999999999885

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.9e-40  Score=325.75  Aligned_cols=261  Identities=20%  Similarity=0.240  Sum_probs=195.4

Q ss_pred             HhcccCcCCceEEEEEEeCCCcEEEEEEecCCCc----c--------------HHHHHHHHHHHHhcCCCceeeEeeEEE
Q 047276          105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEEN----G--------------EKEFRSEVAAIASAQHVNLVRLLGYCV  166 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~----~--------------~~~~~~E~~~l~~l~h~niv~l~g~~~  166 (453)
                      +.+.||+|+||.||+|.. +|+.||||.+.....    .              .+.+.+|+.++.+++||||+++++++.
T Consensus        35 ~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~  113 (348)
T 2pml_X           35 IIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIIT  113 (348)
T ss_dssp             EEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEE
T ss_pred             EEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            357899999999999999 899999999864211    1              178999999999999999999999986


Q ss_pred             ecCCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCC
Q 047276          167 VPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDEN  246 (453)
Q Consensus       167 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~  246 (453)
                       ..+..++||||+++|+|.+++.......  ......+++..++.++.|++.||+|||+.  .+++||||||+||+++.+
T Consensus       114 -~~~~~~lv~e~~~~~~L~~~~~~~~~l~--~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dl~p~Nil~~~~  188 (348)
T 2pml_X          114 -NYDEVYIIYEYMENDSILKFDEYFFVLD--KNYTCFIPIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKN  188 (348)
T ss_dssp             -SSSEEEEEEECCTTCBSSEESSSEESSC--SSSCCCCCHHHHHHHHHHHHHHHHHHHHT--SCEECCCCCGGGEEECTT
T ss_pred             -eCCeEEEEEeccCCCcHHHHHHHhhhhh--hccccCCCHHHHHHHHHHHHHHHHHHhcc--CCEeecCCChHhEEEcCC
Confidence             5568899999999999999932110000  00134599999999999999999999973  699999999999999999


Q ss_pred             CcEEEeeccccccccCCCCceeeeccCCccccchhhhhcC-CCCc-cccchhHHHHHHHHHcCCCCCcccccCCCCCccc
Q 047276          247 YRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQ-GVSE-KCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNK  324 (453)
Q Consensus       247 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~  324 (453)
                      +.+||+|||++......   ......||+.|+|||.+.+. .++. ++||||||+++|||++|+.||......       
T Consensus       189 ~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------  258 (348)
T 2pml_X          189 GRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-------  258 (348)
T ss_dssp             SCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-------
T ss_pred             CcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-------
Confidence            99999999999876433   33456789999999999876 6666 999999999999999999999643211       


Q ss_pred             ccchhHHHHHhhhcCcccccc------cccccCC-CCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          325 WQYFPKIVNEKMKEGKLMEIV------DQRLTDE-GGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~------d~~l~~~-~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                           ......+..+...-..      .+..... ..........+.+++.+||+.||++|||+.++++
T Consensus       259 -----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          259 -----VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             -----HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             -----HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                 0011111111110000      0000000 0001233456899999999999999999999985

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.4e-40  Score=316.40  Aligned_cols=247  Identities=26%  Similarity=0.364  Sum_probs=177.8

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCCCcc--HH-HHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGEENG--EK-EFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~--~~-~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.+.||+|+||+||++.. .+|+.||+|+++.....  .. .+.++...++.++||||+++++++. .++..++||||++
T Consensus        11 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-~~~~~~lv~e~~~   89 (290)
T 3fme_A           11 PIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF-REGDVWICMELMD   89 (290)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-CSSSEEEEEECCS
T ss_pred             hHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee-ccCCEEEEEehhc
Confidence            357899999999999996 57899999999764222  22 3444555577889999999999987 5668899999997


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCC-ceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRS-RVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~-~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                       |+|.+++.....      ....+++..++.++.|++.||+|||+   . +++||||||+||+++.++.+||+|||++..
T Consensus        90 -~~l~~~l~~~~~------~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T 3fme_A           90 -TSLDKFYKQVID------KGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGY  159 (290)
T ss_dssp             -EEHHHHHHHHHH------TTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred             -cchHHHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence             588887753211      12349999999999999999999999   6 999999999999999999999999999987


Q ss_pred             ccCCCCceeeeccCCccccchhhh----hcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHh
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWI----LEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEK  335 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  335 (453)
                      ......  .....||+.|+|||.+    ....++.++||||||+++|||++|+.||.....           ........
T Consensus       160 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----------~~~~~~~~  226 (290)
T 3fme_A          160 LVDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT-----------PFQQLKQV  226 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC-----------HHHHHHHH
T ss_pred             cccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc-----------hHHHHHHH
Confidence            644322  2334689999999996    456789999999999999999999999953111           00111111


Q ss_pred             hhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          336 MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       336 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      .....      +..     ........+.+++.+|++.+|++|||+.++++
T Consensus       227 ~~~~~------~~~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          227 VEEPS------PQL-----PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             HHSCC------CCC-----CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             hccCC------CCc-----ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            11111      001     11123445899999999999999999999875

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.7e-39  Score=319.53  Aligned_cols=261  Identities=24%  Similarity=0.279  Sum_probs=190.0

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEec----CCCeEEEEEe
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVP----GGPRYLVYEF  178 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~----~~~~~lv~e~  178 (453)
                      .+.||+|+||.||+|... +|+.||||++....  .....+.+|+.++++++||||+++++++...    ....++|+||
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~   95 (353)
T 2b9h_A           16 KSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQEL   95 (353)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECC
T ss_pred             eeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEec
Confidence            578999999999999964 68999999997533  2345688999999999999999999987543    2567999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +. |+|.+++..           ..+++..+..++.|++.||+|||+   .+++||||||+|||++.++.+||+|||++.
T Consensus        96 ~~-~~L~~~~~~-----------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           96 MQ-TDLHRVIST-----------QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLAR  160 (353)
T ss_dssp             CS-EEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             cC-ccHHHHHhh-----------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence            97 599999853           238999999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCc---------eeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCC---------
Q 047276          259 LMSRDQSR---------CITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGND---------  319 (453)
Q Consensus       259 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~---------  319 (453)
                      ........         ......||+.|+|||.+.. ..++.++||||||+++|||++|+.||........         
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  240 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG  240 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence            76532211         1223578999999998765 6789999999999999999999999964321000         


Q ss_pred             --CCcccccch-hHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          320 --KSKNKWQYF-PKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       320 --~~~~~~~~~-~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                        .....+... .....+....  +.......+.   .........+.+++.+||+.||++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          241 TPHSDNDLRCIESPRAREYIKS--LPMYPAAPLE---KMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             CCCSTTTTTTCCCHHHHHHHHT--SCCCCCCCHH---HHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCchhccccccccchhhHHhhc--ccCCCCcchh---hhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence              000000000 0000000000  0000000000   000123456889999999999999999999986

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.5e-40  Score=321.76  Aligned_cols=258  Identities=22%  Similarity=0.223  Sum_probs=183.3

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCCCc---cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGEEN---GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      +.++||+|+||+||+|.. .+|+.||||+++....   ..+.+.+|+.++++++||||+++++++. .++..++||||++
T Consensus        38 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~  116 (329)
T 3gbz_A           38 RITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH-HNHRLHLIFEYAE  116 (329)
T ss_dssp             EEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE-ETTEEEEEEECCS
T ss_pred             EEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe-cCCEEEEEEecCC
Confidence            357899999999999995 4689999999975332   2346789999999999999999999986 5668899999997


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEE-----CCCCcEEEeecc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILL-----DENYRAVVSDFG  255 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl-----~~~~~~kl~DfG  255 (453)
                       |+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+|||+     +.++.+||+|||
T Consensus       117 -~~L~~~~~~~~----------~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg  182 (329)
T 3gbz_A          117 -NDLKKYMDKNP----------DVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFG  182 (329)
T ss_dssp             -EEHHHHHHHCT----------TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred             -CCHHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence             49999986442          38999999999999999999999   899999999999999     455669999999


Q ss_pred             ccccccCCCCceeeeccCCccccchhhhhcC-CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHH
Q 047276          256 LSKLMSRDQSRCITTIRGTRGYLAPEWILEQ-GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNE  334 (453)
Q Consensus       256 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  334 (453)
                      ++........ ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.......        .+......
T Consensus       183 ~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--------~~~~~~~~  253 (329)
T 3gbz_A          183 LARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID--------QLFKIFEV  253 (329)
T ss_dssp             HHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHH
T ss_pred             CccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH--------HHHHHHHH
Confidence            9987643322 23445689999999999874 58999999999999999999999995322110        00000000


Q ss_pred             hh--hcCcc---cc--cccccccCCCC------CcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          335 KM--KEGKL---ME--IVDQRLTDEGG------IDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       335 ~~--~~~~~---~~--~~d~~l~~~~~------~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ..  .....   ..  .....+.....      ........+.+++.+||+.||++|||+.|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          254 LGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             HCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            00  00000   00  00000000000      00112356889999999999999999999885

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.8e-40  Score=325.03  Aligned_cols=269  Identities=20%  Similarity=0.228  Sum_probs=181.1

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCC------CeEEEEEe
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGG------PRYLVYEF  178 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------~~~lv~e~  178 (453)
                      .+.||+|+||+||+|+. .+|+.||||++.........+.+|+..+..++||||+++++++...+.      ..++||||
T Consensus        28 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~  107 (360)
T 3e3p_A           28 ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEY  107 (360)
T ss_dssp             C----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEEC
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeec
Confidence            47899999999999997 468999999987655445567788899999999999999999875432      16899999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhcccc--ccCCCceeccCCCCCcEEECC-CCcEEEeecc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH--NDCRSRVLHLDVKPENILLDE-NYRAVVSDFG  255 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh--~~~~~~ivH~Dlk~~NiLl~~-~~~~kl~DfG  255 (453)
                      +++ +|.+.+.....      ....+++..+..++.|++.||.|||  +   .+|+||||||+|||++. ++.+||+|||
T Consensus       108 ~~~-~l~~~~~~~~~------~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~kl~Dfg  177 (360)
T 3e3p_A          108 VPD-TLHRCCRNYYR------RQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTLKLCDFG  177 (360)
T ss_dssp             CSC-BHHHHHHHHHT------TTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred             ccc-cHHHHHHHHhh------cccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence            986 55544432111      1234899999999999999999999  7   89999999999999996 8999999999


Q ss_pred             ccccccCCCCceeeeccCCccccchhhhhcC-CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcc-c-ccchhHHH
Q 047276          256 LSKLMSRDQSRCITTIRGTRGYLAPEWILEQ-GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKN-K-WQYFPKIV  332 (453)
Q Consensus       256 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~-~-~~~~~~~~  332 (453)
                      ++........  .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||............ . ....+...
T Consensus       178 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  255 (360)
T 3e3p_A          178 SAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREV  255 (360)
T ss_dssp             TCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             CceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHH
Confidence            9987654332  2345789999999998754 4899999999999999999999999642211000000 0 00000000


Q ss_pred             HHhhhcC-cccccccc-ccc--C-CCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          333 NEKMKEG-KLMEIVDQ-RLT--D-EGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       333 ~~~~~~~-~~~~~~d~-~l~--~-~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ...+... ......+. ...  . ...........+.+++.+||+.||++|||+.|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          256 LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            0000000 00000000 000  0 00111224567999999999999999999999885

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.6e-40  Score=321.80  Aligned_cols=265  Identities=25%  Similarity=0.323  Sum_probs=196.7

Q ss_pred             HhcccCcCCceEEEEEEe--CCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCc------eeeEeeEEEecCCCeEEEE
Q 047276          105 FQALLGHGSSASVFKGIL--SDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVN------LVRLLGYCVVPGGPRYLVY  176 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~g~~~~~~~~~~lv~  176 (453)
                      +.+.||+|+||+||+|..  .+|+.||||+++......+.+.+|+.++..++|+|      ++++++++. ..+..++||
T Consensus        18 ~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~-~~~~~~lv~   96 (339)
T 1z57_A           18 IVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE-HHGHICIVF   96 (339)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE-ETTEEEEEE
T ss_pred             EEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc-cCCcEEEEE
Confidence            457899999999999986  36889999999866555677899999999987654      999999876 456889999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECC-----------
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDE-----------  245 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~-----------  245 (453)
                      ||+ +++|.+++.....        ..+++..+..++.|++.||+|||+   .+++||||||+|||++.           
T Consensus        97 e~~-~~~l~~~l~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~  164 (339)
T 1z57_A           97 ELL-GLSTYDFIKENGF--------LPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKI  164 (339)
T ss_dssp             ECC-CCBHHHHHHHTTT--------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC---
T ss_pred             cCC-CCCHHHHHHhcCC--------CCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCcc
Confidence            999 8899999965432        248999999999999999999999   89999999999999987           


Q ss_pred             --------CCcEEEeeccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccC
Q 047276          246 --------NYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHG  317 (453)
Q Consensus       246 --------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~  317 (453)
                              ++.+||+|||++......    .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus       165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  240 (339)
T 1z57_A          165 KRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK  240 (339)
T ss_dssp             -CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred             ccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence                    678999999999865432    23457899999999999989999999999999999999999999642211


Q ss_pred             CCCCcc--cccchhHHHHHhhhcCcccc-----------------cccccccCCCCCcHHHHHHHHHHHHhccccCCCCC
Q 047276          318 NDKSKN--KWQYFPKIVNEKMKEGKLME-----------------IVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLR  378 (453)
Q Consensus       318 ~~~~~~--~~~~~~~~~~~~~~~~~~~~-----------------~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~R  378 (453)
                      ......  .....+..............                 .....+.............+.+++.+||+.||++|
T Consensus       241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  320 (339)
T 1z57_A          241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR  320 (339)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence            000000  00000000000000000000                 00000000111233566789999999999999999


Q ss_pred             CCHHHHHH
Q 047276          379 PSMARVVE  386 (453)
Q Consensus       379 Ps~~~v~~  386 (453)
                      ||+.|+++
T Consensus       321 pt~~ell~  328 (339)
T 1z57_A          321 ITLREALK  328 (339)
T ss_dssp             CCHHHHTT
T ss_pred             cCHHHHhc
Confidence            99999874

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1e-39  Score=323.42  Aligned_cols=267  Identities=19%  Similarity=0.265  Sum_probs=197.6

Q ss_pred             HHhcccCcCCceEEEEEEe-CCCcEEEEEEecCCCccHHHHHHHHHHHHhcC-----------CCceeeEeeEEEecC--
Q 047276          104 NFQALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRSEVAAIASAQ-----------HVNLVRLLGYCVVPG--  169 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~g~~~~~~--  169 (453)
                      .+.+.||+|+||+||+|+. .+++.||||++.......+.+.+|+.++.+++           |+||+++++++...+  
T Consensus        22 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  101 (373)
T 1q8y_A           22 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPN  101 (373)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETT
T ss_pred             EEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCC
Confidence            3467999999999999996 56899999999876555677889999999886           899999999987433  


Q ss_pred             -CCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCC-ceeccCCCCCcEEEC---
Q 047276          170 -GPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRS-RVLHLDVKPENILLD---  244 (453)
Q Consensus       170 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~-~ivH~Dlk~~NiLl~---  244 (453)
                       ...++||||+ +++|.+++.....        ..+++..+..++.|++.||+|||+   . +|+||||||+|||++   
T Consensus       102 ~~~~~lv~e~~-~~~L~~~~~~~~~--------~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~  169 (373)
T 1q8y_A          102 GVHVVMVFEVL-GENLLALIKKYEH--------RGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVD  169 (373)
T ss_dssp             EEEEEEEECCC-CEEHHHHHHHTTT--------SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEE
T ss_pred             CceEEEEEecC-CCCHHHHHHHhhc--------cCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccC
Confidence             2578999999 8899999965422        338999999999999999999999   7 999999999999994   


Q ss_pred             ---CCCcEEEeeccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCC
Q 047276          245 ---ENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKS  321 (453)
Q Consensus       245 ---~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~  321 (453)
                         .++.+||+|||++......    .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..........
T Consensus       170 ~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  245 (373)
T 1q8y_A          170 SPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK  245 (373)
T ss_dssp             TTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred             CCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence               4558999999999876432    234578999999999999999999999999999999999999996433211100


Q ss_pred             ccc-cc-------chhHHHHHh-------hhcCcccccc--------cccccCCCCCcHHHHHHHHHHHHhccccCCCCC
Q 047276          322 KNK-WQ-------YFPKIVNEK-------MKEGKLMEIV--------DQRLTDEGGIDETQVRRLVDVAFWCIQERARLR  378 (453)
Q Consensus       322 ~~~-~~-------~~~~~~~~~-------~~~~~~~~~~--------d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~R  378 (453)
                      ... ..       ..+......       .........+        ...+......+......+.+++.+||+.||++|
T Consensus       246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  325 (373)
T 1q8y_A          246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR  325 (373)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred             hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence            000 00       000000000       0000000000        000111223567788899999999999999999


Q ss_pred             CCHHHHHH
Q 047276          379 PSMARVVE  386 (453)
Q Consensus       379 Ps~~~v~~  386 (453)
                      ||+.++++
T Consensus       326 pt~~ell~  333 (373)
T 1q8y_A          326 ADAGGLVN  333 (373)
T ss_dssp             BCHHHHHT
T ss_pred             CCHHHHhh
Confidence            99999986

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.3e-40  Score=328.66  Aligned_cols=259  Identities=21%  Similarity=0.291  Sum_probs=187.8

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCC-------------
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGG-------------  170 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-------------  170 (453)
                      +.+.||+|+||+||+|.. .+|+.||||++..+..   ...+|+.+++.++||||+++++++...+.             
T Consensus        11 ~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~   87 (383)
T 3eb0_A           11 LGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHN   87 (383)
T ss_dssp             EEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHTTCCCTTBCCEEEEEEEC---------------
T ss_pred             EEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHHcCCCCccchhheeeecCcccccccccccccc
Confidence            357899999999999995 5789999999875432   22469999999999999999999864322             


Q ss_pred             ------------------------CeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhcccccc
Q 047276          171 ------------------------PRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHND  226 (453)
Q Consensus       171 ------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~  226 (453)
                                              ..++||||++ |+|.+.+.....      ....+++..+..++.|++.||+|||+ 
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~------~~~~l~~~~~~~i~~qi~~aL~~LH~-  159 (383)
T 3eb0_A           88 KLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR------SGRSIPMNLISIYIYQLFRAVGFIHS-  159 (383)
T ss_dssp             ----------------------CCEEEEEECCCS-EEHHHHHHHHHH------TTCCCCHHHHHHHHHHHHHHHHHHHT-
T ss_pred             cccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHH-
Confidence                                    2689999998 588777753211      12349999999999999999999999 


Q ss_pred             CCCceeccCCCCCcEEEC-CCCcEEEeeccccccccCCCCceeeeccCCccccchhhhhcC-CCCccccchhHHHHHHHH
Q 047276          227 CRSRVLHLDVKPENILLD-ENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQ-GVSEKCDIYSYGMVLLEL  304 (453)
Q Consensus       227 ~~~~ivH~Dlk~~NiLl~-~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvil~el  304 (453)
                        .+|+||||||+|||++ .++.+||+|||+++.......  .....+|+.|+|||.+.+. .++.++|||||||++|||
T Consensus       160 --~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el  235 (383)
T 3eb0_A          160 --LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL  235 (383)
T ss_dssp             --TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred             --CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence              8999999999999998 689999999999987644332  2345689999999998764 589999999999999999


Q ss_pred             HcCCCCCcccccCCCCCcccccchhHHHHH-------hhh--cCcccccccccccCC---CCCcHHHHHHHHHHHHhccc
Q 047276          305 TGGRRNVSLIEHGNDKSKNKWQYFPKIVNE-------KMK--EGKLMEIVDQRLTDE---GGIDETQVRRLVDVAFWCIQ  372 (453)
Q Consensus       305 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-------~~~--~~~~~~~~d~~l~~~---~~~~~~~~~~l~~l~~~Cl~  372 (453)
                      ++|+.||.......        .+......       .+.  .....+..-+.+...   ...+......+.+++.+||+
T Consensus       236 l~g~~pf~~~~~~~--------~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  307 (383)
T 3eb0_A          236 ILGKPLFSGETSID--------QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR  307 (383)
T ss_dssp             HHSSCSSCCSSHHH--------HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred             HhCCCCCCCCChHH--------HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHcc
Confidence            99999996322110        00000000       000  000000000000000   00122234568999999999


Q ss_pred             cCCCCCCCHHHHHH
Q 047276          373 ERARLRPSMARVVE  386 (453)
Q Consensus       373 ~~p~~RPs~~~v~~  386 (453)
                      .||++|||+.|+++
T Consensus       308 ~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          308 YEPDLRINPYEAMA  321 (383)
T ss_dssp             SSGGGSCCHHHHHT
T ss_pred             CChhhCCCHHHHhc
Confidence            99999999999984

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.2e-39  Score=311.48  Aligned_cols=247  Identities=26%  Similarity=0.340  Sum_probs=194.5

Q ss_pred             HHHHhcccCcCCceEEEEEEeC-CCcEEEEEEecC---CCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          102 TDNFQALLGHGSSASVFKGILS-DGTSVAVKRING---EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       102 ~~~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      .+.+.+.||+|+||+||+|+.. +++.||+|++..   .......+.+|+.++++++||||+++++++. ..+..++|+|
T Consensus        23 ~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e  101 (287)
T 2wei_A           23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-DSSSFYIVGE  101 (287)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-CSSEEEEEEC
T ss_pred             cceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe-CCCeEEEEEE
Confidence            3444689999999999999975 689999999864   2345678999999999999999999999986 5668899999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCC---CcEEEeec
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDEN---YRAVVSDF  254 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~---~~~kl~Df  254 (453)
                      |+++++|.+++....          .+++..++.++.|++.||+|||+   .+++|+||||+||+++.+   +.+||+||
T Consensus       102 ~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Df  168 (287)
T 2wei_A          102 LYTGGELFDEIIKRK----------RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDF  168 (287)
T ss_dssp             CCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECST
T ss_pred             ccCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEecc
Confidence            999999999885432          38999999999999999999999   899999999999999754   47999999


Q ss_pred             cccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHH
Q 047276          255 GLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNE  334 (453)
Q Consensus       255 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  334 (453)
                      |++........  .....+|+.|+|||.+.+ .++.++||||||+++|||++|+.||.....             .....
T Consensus       169 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------------~~~~~  232 (287)
T 2wei_A          169 GLSTCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-------------YDILK  232 (287)
T ss_dssp             TGGGTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------------HHHHH
T ss_pred             CcceeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH-------------HHHHH
Confidence            99986643322  233457889999998765 589999999999999999999999853211             00112


Q ss_pred             hhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          335 KMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       335 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      .+..+.....    +..    .......+.+++.+|++.+|++|||+.++++
T Consensus       233 ~~~~~~~~~~----~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          233 RVETGKYAFD----LPQ----WRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             HHHHCCCCCC----SGG----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHcCCCCCC----chh----hhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            2222221100    000    0122345889999999999999999999986

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.1e-39  Score=328.75  Aligned_cols=258  Identities=21%  Similarity=0.285  Sum_probs=187.4

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCC-----CeEEEEEec
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGG-----PRYLVYEFI  179 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-----~~~lv~e~~  179 (453)
                      .+.||+|+||+||+|+.. +|+.||||++.....   .+.+|+++++.++||||+++++++...+.     ..++||||+
T Consensus        59 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~  135 (420)
T 1j1b_A           59 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV  135 (420)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECC
T ss_pred             eeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcc
Confidence            578999999999999974 589999999865332   23469999999999999999998864322     257899999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCC-CcEEEeeccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDEN-YRAVVSDFGLSK  258 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~-~~~kl~DfGla~  258 (453)
                      ++ +|.+.+.....      ....+++..+..++.|+++||+|||+   .+|+||||||+|||++.+ +.+||+|||+++
T Consensus       136 ~~-~l~~~~~~~~~------~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          136 PE-TVYRVARHYSR------AKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             CE-EHHHHHHHHHH------TTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             cc-cHHHHHHHHhh------ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            76 67666532111      12348999999999999999999999   899999999999999955 678999999998


Q ss_pred             cccCCCCceeeeccCCccccchhhhhcC-CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHH----
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWILEQ-GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVN----  333 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~----  333 (453)
                      .......  .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......        ..+.....    
T Consensus       206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~--------~~l~~i~~~lg~  275 (420)
T 1j1b_A          206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--------DQLVEIIKVLGT  275 (420)
T ss_dssp             ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHHHCS
T ss_pred             hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHHHhCC
Confidence            7644322  2345789999999998764 7899999999999999999999999632211        00111010    


Q ss_pred             ---Hhhh--cCcccccccccccCCC---CCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          334 ---EKMK--EGKLMEIVDQRLTDEG---GIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       334 ---~~~~--~~~~~~~~d~~l~~~~---~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                         +.+.  .....+..-+.+....   .++......+.+|+.+||+.||++||++.|+++
T Consensus       276 p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          276 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             CCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence               0000  0011111111110000   011123456899999999999999999999985

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.5e-39  Score=321.94  Aligned_cols=262  Identities=22%  Similarity=0.274  Sum_probs=174.8

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEec-----CCCeEEEE
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVP-----GGPRYLVY  176 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~~lv~  176 (453)
                      .+.||+|+||.||+|.. .+|+.||||++....   ...+.+.+|+.+++.++||||+++++++...     ....++|+
T Consensus        34 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~  113 (367)
T 2fst_X           34 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT  113 (367)
T ss_dssp             EEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred             eeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEe
Confidence            57899999999999995 568999999996532   2345788999999999999999999997632     24579999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||+ +++|.+++..           ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus       114 e~~-~~~L~~~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~  178 (367)
T 2fst_X          114 HLM-GADLNNIVKC-----------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL  178 (367)
T ss_dssp             ECC-CEECC----------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred             ccc-CCCHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence            999 6799988842           238999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcc-cc-cchhHHHH
Q 047276          257 SKLMSRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKN-KW-QYFPKIVN  333 (453)
Q Consensus       257 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~-~~-~~~~~~~~  333 (453)
                      ++.....    .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||............ .. ........
T Consensus       179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  254 (367)
T 2fst_X          179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  254 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            9865432    244578999999999886 67899999999999999999999999532211000000 00 00000000


Q ss_pred             HhhhcCcccccccccccCCCCCc-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          334 EKMKEGKLMEIVDQRLTDEGGID-----ETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       334 ~~~~~~~~~~~~d~~l~~~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      ..+........+. .+......+     ......+.+++.+||+.||++|||+.++++.
T Consensus       255 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          255 KKISSESARNYIQ-SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             TTCCCHHHHHHHH-TSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHhhhHHHHHHHh-ccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            0000000000000 000000000     1123458899999999999999999999853

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.9e-39  Score=314.31  Aligned_cols=265  Identities=19%  Similarity=0.260  Sum_probs=184.6

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCCC-ccHHHHHHHHHHHHhcCCCceeeEeeEEEe-------------cCC
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGEE-NGEKEFRSEVAAIASAQHVNLVRLLGYCVV-------------PGG  170 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-------------~~~  170 (453)
                      .+.||+|+||.||+|... +|+.||+|++.... ...+.+.+|+.++++++||||+++++++..             ...
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~   95 (320)
T 2i6l_A           16 LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELN   95 (320)
T ss_dssp             EEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCS
T ss_pred             EEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccC
Confidence            478999999999999975 48999999987543 344678999999999999999999998742             234


Q ss_pred             CeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEEC-CCCcE
Q 047276          171 PRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD-ENYRA  249 (453)
Q Consensus       171 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~-~~~~~  249 (453)
                      ..++||||++ |+|.+++..           +.+++..++.++.|++.||+|||+   .+++||||||+|||++ +++.+
T Consensus        96 ~~~lv~e~~~-~~L~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~  160 (320)
T 2i6l_A           96 SVYIVQEYME-TDLANVLEQ-----------GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVL  160 (320)
T ss_dssp             EEEEEEECCS-EEHHHHHTT-----------CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEE
T ss_pred             ceeEEeeccC-CCHHHHhhc-----------CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeE
Confidence            6789999997 699999842           348999999999999999999999   8999999999999997 67799


Q ss_pred             EEeeccccccccCCCC--ceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcc--c
Q 047276          250 VVSDFGLSKLMSRDQS--RCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKN--K  324 (453)
Q Consensus       250 kl~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~--~  324 (453)
                      ||+|||++........  .......+|..|+|||.+.. ..++.++||||||+++|||++|+.||............  .
T Consensus       161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  240 (320)
T 2i6l_A          161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES  240 (320)
T ss_dssp             EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            9999999987643221  12234567899999998875 67899999999999999999999999643211000000  0


Q ss_pred             ccchhHHHHHhhhcCcccccccccccCCCC----CcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          325 WQYFPKIVNEKMKEGKLMEIVDQRLTDEGG----IDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ............. ......+.........    ........+.+++.+||+.||++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          241 IPVVHEEDRQELL-SVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             SCCCCHHHHHHHH-TTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cCCCchhhhhhhh-hcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            0000000000000 0000000000000000    01123456899999999999999999999985

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3e-40  Score=319.67  Aligned_cols=245  Identities=24%  Similarity=0.353  Sum_probs=185.7

Q ss_pred             HhcccCcCCceEEEEEEeCCCcEEEEEEecCCC---ccHHHHHHHHHHHHhcC--CCceeeEeeEEEecCCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEE---NGEKEFRSEVAAIASAQ--HVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      +.+.||+|+||.||++...+++.||||++....   .....+.+|+.++.+++  |+||+++++++. ..+..++||| +
T Consensus        32 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-~~~~~~lv~e-~  109 (313)
T 3cek_A           32 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-TDQYIYMVME-C  109 (313)
T ss_dssp             EEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE-CSSEEEEEEC-C
T ss_pred             EEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee-cCCEEEEEEe-c
Confidence            357899999999999998889999999997533   23467899999999997  599999999986 4567899999 5


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      .+++|.+++....          .+++..++.++.|++.||+|||+   .+++||||||+|||+++ +.+||+|||++..
T Consensus       110 ~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~  175 (313)
T 3cek_A          110 GNIDLNSWLKKKK----------SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQ  175 (313)
T ss_dssp             CSEEHHHHHHHCS----------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred             CCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeecccccc
Confidence            6789999996432          38999999999999999999999   89999999999999965 8999999999987


Q ss_pred             ccCCCC-ceeeeccCCccccchhhhhc-----------CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccc
Q 047276          260 MSRDQS-RCITTIRGTRGYLAPEWILE-----------QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQY  327 (453)
Q Consensus       260 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~  327 (453)
                      ...... .......||+.|+|||.+.+           ..++.++||||||+++|||++|+.||......          
T Consensus       176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~----------  245 (313)
T 3cek_A          176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----------  245 (313)
T ss_dssp             --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH----------
T ss_pred             ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH----------
Confidence            654322 12234578999999999875           46888999999999999999999998532110          


Q ss_pred             hhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          328 FPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                       .........         +...  ...+......+.+++.+||+.||++||++.++++.
T Consensus       246 -~~~~~~~~~---------~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          246 -ISKLHAIID---------PNHE--IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             -HHHHHHHHC---------TTSC--CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -HHHHHHHHh---------cccc--cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence             000111111         1100  01111223458899999999999999999999853

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=8.3e-40  Score=320.03  Aligned_cols=251  Identities=17%  Similarity=0.237  Sum_probs=169.0

Q ss_pred             cccCcCCceEEEEEEeC-CCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEec---CCCeEEEEEecCCC
Q 047276          107 ALLGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP---GGPRYLVYEFIQNG  182 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~---~~~~~lv~e~~~~g  182 (453)
                      ++||+|+||+||+|... +|+.||||++.....   ...+....+..++||||+++++++...   +...++||||+++|
T Consensus        35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg  111 (336)
T 3fhr_A           35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGG  111 (336)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEESSHH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTE
T ss_pred             eeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCC
Confidence            46999999999999975 689999999975322   222233346677999999999987642   23478999999999


Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECC---CCcEEEeecccccc
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDE---NYRAVVSDFGLSKL  259 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~---~~~~kl~DfGla~~  259 (453)
                      +|.+++....        ...+++..++.++.|++.||+|||+   .+++||||||+|||++.   ++.+||+|||++..
T Consensus       112 ~L~~~l~~~~--------~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~  180 (336)
T 3fhr_A          112 ELFSRIQERG--------DQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE  180 (336)
T ss_dssp             EHHHHHHTC---------CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             CHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence            9999996542        1348999999999999999999999   89999999999999986   45699999999986


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      .....   .....||+.|+|||.+....++.++||||||+++|||++|+.||...........         .......+
T Consensus       181 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---------~~~~~~~~  248 (336)
T 3fhr_A          181 TTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG---------MKRRIRLG  248 (336)
T ss_dssp             C-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------
T ss_pred             ccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh---------HHHhhhcc
Confidence            54322   2345689999999999888899999999999999999999999954322111000         00000000


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH--Hhccc
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE--MLEGR  391 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~--~L~~~  391 (453)
                      ..      .+.  ..........+.+++.+||+.||++|||+.++++  .+.+.
T Consensus       249 ~~------~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  294 (336)
T 3fhr_A          249 QY------GFP--NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS  294 (336)
T ss_dssp             --------CCC--TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred             cc------ccC--chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence            00      000  0011123456889999999999999999999997  44443

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=5.5e-40  Score=319.31  Aligned_cols=260  Identities=23%  Similarity=0.314  Sum_probs=191.2

Q ss_pred             HhcccCcCCceEEEEEEe--CCCcEEEEEEecCC---CccHHHHHHHHHHHHhc---CCCceeeEeeEEEe----cCCCe
Q 047276          105 FQALLGHGSSASVFKGIL--SDGTSVAVKRINGE---ENGEKEFRSEVAAIASA---QHVNLVRLLGYCVV----PGGPR  172 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~--~~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~----~~~~~  172 (453)
                      +.+.||+|+||.||+|..  .+|+.||+|++...   ......+.+|+.+++.+   +||||++++++|..    .....
T Consensus        15 ~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~   94 (326)
T 1blx_A           15 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL   94 (326)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEE
T ss_pred             eeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceE
Confidence            357899999999999997  46889999998642   22223566788777766   89999999999862    33467


Q ss_pred             EEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEe
Q 047276          173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVS  252 (453)
Q Consensus       173 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~  252 (453)
                      ++||||+. |+|.+++.....        ..+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+
T Consensus        95 ~lv~e~~~-~~L~~~l~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           95 TLVFEHVD-QDLTTYLDKVPE--------PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             EEEEECCS-CBHHHHHHHSCT--------TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             EEEEecCC-CCHHHHHHhccc--------CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEe
Confidence            89999997 699999865432        238999999999999999999999   899999999999999999999999


Q ss_pred             eccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHH
Q 047276          253 DFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIV  332 (453)
Q Consensus       253 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  332 (453)
                      |||++.......  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......        .+....
T Consensus       163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~i~  232 (326)
T 1blx_A          163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--------QLGKIL  232 (326)
T ss_dssp             SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHH
T ss_pred             cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHH
Confidence            999998654322  2344578999999999999899999999999999999999999996322110        000000


Q ss_pred             HH-------hhhcC-cc-cccccc-cccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          333 NE-------KMKEG-KL-MEIVDQ-RLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       333 ~~-------~~~~~-~~-~~~~d~-~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ..       .+... .. ...+.. ...............+.+++.+||+.||++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          233 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             HHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00       00000 00 000000 000000011223456889999999999999999999984

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=6.2e-40  Score=327.89  Aligned_cols=258  Identities=21%  Similarity=0.263  Sum_probs=186.9

Q ss_pred             HhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCC-----CeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGG-----PRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-----~~~lv~e~~  179 (453)
                      +.++||+|+||+||+|+..++..+|+|++......   ..+|+.+++.++||||+++++++...+.     ..++||||+
T Consensus        44 ~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~  120 (394)
T 4e7w_A           44 NCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV  120 (394)
T ss_dssp             EEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECC
T ss_pred             EeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeecc
Confidence            35789999999999999877777999988653221   2369999999999999999999875443     268999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEEC-CCCcEEEeeccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD-ENYRAVVSDFGLSK  258 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~-~~~~~kl~DfGla~  258 (453)
                      +++.+........       ....+++..+..++.|++.||+|||+   .+|+||||||+|||++ .++.+||+|||+++
T Consensus       121 ~~~l~~~~~~~~~-------~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~  190 (394)
T 4e7w_A          121 PETVYRASRHYAK-------LKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAK  190 (394)
T ss_dssp             SEEHHHHHHHHHH-------TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             CccHHHHHHHHHh-------hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence            8754333321111       12348999999999999999999999   8999999999999999 89999999999998


Q ss_pred             cccCCCCceeeeccCCccccchhhhhcC-CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHH----
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWILEQ-GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVN----  333 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~----  333 (453)
                      .......  .....+|+.|+|||.+.+. .++.++|||||||++|||++|+.||.......        .+.....    
T Consensus       191 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--------~l~~i~~~~g~  260 (394)
T 4e7w_A          191 ILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID--------QLVEIIKVLGT  260 (394)
T ss_dssp             ECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHHHCC
T ss_pred             cccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHHHhCC
Confidence            7644332  2345789999999998764 58999999999999999999999996422110        0000000    


Q ss_pred             ------Hh----hhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          334 ------EK----MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       334 ------~~----~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                            ..    .....+.......+.  ..+.......+.+++.+||+.||++|||+.++++.
T Consensus       261 p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          261 PSREQIKTMNPNYMEHKFPQIRPHPFS--KVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             CCHHHHHHHCGGGSSSCCCCCCCCCHH--HHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CCHHHHHhhChhhhhhccccccCCcHH--HhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence                  00    000000000000000  00111234568999999999999999999999863

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.9e-39  Score=320.50  Aligned_cols=261  Identities=23%  Similarity=0.279  Sum_probs=186.7

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCCcc---HHHHHHHHHHHHhcCCCceeeEeeEEEecCC-----CeEEEE
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEENG---EKEFRSEVAAIASAQHVNLVRLLGYCVVPGG-----PRYLVY  176 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-----~~~lv~  176 (453)
                      .+.||+|+||+||+|.. .+|+.||||++......   .+.+.+|+.+++.++||||+++++++...+.     ..++||
T Consensus        47 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~  126 (371)
T 4exu_A           47 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM  126 (371)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEE
T ss_pred             EeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEE
Confidence            57899999999999996 46899999999764322   4678899999999999999999999864332     139999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||+. ++|.+++.            ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus       127 e~~~-~~l~~~~~------------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~  190 (371)
T 4exu_A          127 PFMQ-TDLQKIMG------------MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGL  190 (371)
T ss_dssp             ECCC-EEHHHHTT------------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred             cccc-ccHHHHhh------------cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence            9997 58988872            228999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcc-c-ccchhHHHH
Q 047276          257 SKLMSRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKN-K-WQYFPKIVN  333 (453)
Q Consensus       257 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~-~-~~~~~~~~~  333 (453)
                      ++.....    .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||............ . ....+....
T Consensus       191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  266 (371)
T 4exu_A          191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV  266 (371)
T ss_dssp             C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHH
Confidence            9865332    234578999999999887 68899999999999999999999999632211000000 0 000000000


Q ss_pred             HhhhcCcccccccccccCCCC-----CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          334 EKMKEGKLMEIVDQRLTDEGG-----IDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       334 ~~~~~~~~~~~~d~~l~~~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      ..+.......... .+.....     ........+.+++.+||+.||++|||+.++++.
T Consensus       267 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          267 QKLNDKAAKSYIQ-SLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             TTCSCHHHHHHHH-HSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHhhhhhhhhhhh-ccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            0000000000000 0000000     011224568999999999999999999998853

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.6e-39  Score=323.55  Aligned_cols=194  Identities=27%  Similarity=0.320  Sum_probs=164.5

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCCccHHHHHHHHHHHHhcC-CC-----ceeeEeeEEEecCCCeEEEEE
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRSEVAAIASAQ-HV-----NLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~g~~~~~~~~~~lv~e  177 (453)
                      +.+.||+|+||+||+|... +++.||||+++.......++..|+.++..++ |+     +++++++++. ..+..++|||
T Consensus        58 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~-~~~~~~lv~e  136 (382)
T 2vx3_A           58 IDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM-FRNHLCLVFE  136 (382)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE-ETTEEEEEEE
T ss_pred             EEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec-cCCceEEEEe
Confidence            3578999999999999964 6889999999865555567888999998885 44     4999999876 4568899999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEEC--CCCcEEEeecc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD--ENYRAVVSDFG  255 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~--~~~~~kl~DfG  255 (453)
                      |+. |+|.+++.....        ..+++..+..++.|++.||.|||+. ..+|+||||||+|||++  .++.+||+|||
T Consensus       137 ~~~-~~L~~~l~~~~~--------~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG  206 (382)
T 2vx3_A          137 MLS-YNLYDLLRNTNF--------RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG  206 (382)
T ss_dssp             CCC-CBHHHHHHHTTT--------SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred             cCC-CCHHHHHhhcCc--------CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence            996 599999965432        2389999999999999999999952 27899999999999994  57889999999


Q ss_pred             ccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcc
Q 047276          256 LSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSL  313 (453)
Q Consensus       256 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~  313 (453)
                      +++.....    .....||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       207 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~  260 (382)
T 2vx3_A          207 SSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG  260 (382)
T ss_dssp             TCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             Cceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            99876432    2345789999999999999999999999999999999999999964

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5.5e-40  Score=319.08  Aligned_cols=234  Identities=27%  Similarity=0.420  Sum_probs=189.5

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCCCc-------cHHHHHHHHHHHHhcC--CCceeeEeeEEEecCCCeEE
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGEEN-------GEKEFRSEVAAIASAQ--HVNLVRLLGYCVVPGGPRYL  174 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~-------~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~~l  174 (453)
                      +.+.||+|+||.||+|.. .+++.||||.+.....       ....+.+|+.++.+++  |+|++++++++. ..+..++
T Consensus        47 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~-~~~~~~l  125 (320)
T 3a99_A           47 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE-RPDSFVL  125 (320)
T ss_dssp             EEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE-CSSEEEE
T ss_pred             EEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe-cCCcEEE
Confidence            457899999999999985 5689999999865321       2245778999999996  599999999986 5567899


Q ss_pred             EEEecCC-CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEEC-CCCcEEEe
Q 047276          175 VYEFIQN-GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD-ENYRAVVS  252 (453)
Q Consensus       175 v~e~~~~-gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~-~~~~~kl~  252 (453)
                      |+||+.+ ++|.+++...          ..+++..++.++.|++.||+|||+   .+|+||||||+|||++ +++.+||+
T Consensus       126 v~e~~~~~~~L~~~l~~~----------~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          126 ILERPEPVQDLFDFITER----------GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             EEECCSSEEEHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             EEEcCCCCccHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEe
Confidence            9999976 8999998643          238999999999999999999999   8999999999999999 78999999


Q ss_pred             eccccccccCCCCceeeeccCCccccchhhhhcCCC-CccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHH
Q 047276          253 DFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGV-SEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKI  331 (453)
Q Consensus       253 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~  331 (453)
                      |||++.......   .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....                
T Consensus       193 Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----------------  253 (320)
T 3a99_A          193 DFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------------  253 (320)
T ss_dssp             CCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------------
T ss_pred             eCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh----------------
Confidence            999998765332   234568999999999987766 688999999999999999999985311                


Q ss_pred             HHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          332 VNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       332 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                        ... .+..        .    .+......+.+++.+||+.||++|||++++++
T Consensus       254 --~~~-~~~~--------~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          254 --EII-RGQV--------F----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             --HHH-HCCC--------C----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --hhh-cccc--------c----ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              000 0100        0    11112345889999999999999999999986

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.6e-39  Score=328.99  Aligned_cols=251  Identities=24%  Similarity=0.310  Sum_probs=181.9

Q ss_pred             hcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEEEEEecCCCCh
Q 047276          106 QALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL  184 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL  184 (453)
                      .+.||+|+||+||.+...+|+.||||++...  ..+.+.+|+.++.++ +||||+++++++. .++..++||||+. |+|
T Consensus        20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~-~~~~~~lv~E~~~-gsL   95 (434)
T 2rio_A           20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSET-TDRFLYIALELCN-LNL   95 (434)
T ss_dssp             EEEEEECSTTCEEEEEESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEE-CSSEEEEEECCCS-EEH
T ss_pred             cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEe-cCCeEEEEEecCC-CCH
Confidence            3689999999998766667999999998653  245678999999886 8999999999875 5667899999995 699


Q ss_pred             hhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCC-------------CcEEE
Q 047276          185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDEN-------------YRAVV  251 (453)
Q Consensus       185 ~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~-------------~~~kl  251 (453)
                      .+++........   .....++..++.++.|++.||+|||+   .+|+||||||+|||++.+             +.+||
T Consensus        96 ~~~l~~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL  169 (434)
T 2rio_A           96 QDLVESKNVSDE---NLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI  169 (434)
T ss_dssp             HHHHHTC---------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred             HHHHhccCCCch---hhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence            999975432110   00112344567899999999999999   899999999999999754             58999


Q ss_pred             eeccccccccCCCCc---eeeeccCCccccchhhhhc-------CCCCccccchhHHHHHHHHHc-CCCCCcccccCCCC
Q 047276          252 SDFGLSKLMSRDQSR---CITTIRGTRGYLAPEWILE-------QGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDK  320 (453)
Q Consensus       252 ~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~  320 (453)
                      +|||+++........   ......||+.|+|||.+.+       ..++.++|||||||++|||++ |+.||......   
T Consensus       170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---  246 (434)
T 2rio_A          170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR---  246 (434)
T ss_dssp             CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH---
T ss_pred             cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh---
Confidence            999999877543221   2234579999999999865       568999999999999999999 99998521100   


Q ss_pred             CcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          321 SKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                                 . ..+..+... .  +.+.  ...+......+.+++.+||+.||++|||+.+|++
T Consensus       247 -----------~-~~i~~~~~~-~--~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          247 -----------E-SNIIRGIFS-L--DEMK--CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             -----------H-HHHHHTCCC-C--CCCT--TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----------H-HHHhcCCCC-c--cccc--ccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence                       0 001111100 0  0000  1123466778999999999999999999999985

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.3e-40  Score=319.18  Aligned_cols=239  Identities=26%  Similarity=0.342  Sum_probs=188.3

Q ss_pred             HHHHHhcccCcCCceEEEEEEe-CCCcEEEEEEecCCCc-------cHHHHHHHHHHHHhc----CCCceeeEeeEEEec
Q 047276          101 ATDNFQALLGHGSSASVFKGIL-SDGTSVAVKRINGEEN-------GEKEFRSEVAAIASA----QHVNLVRLLGYCVVP  168 (453)
Q Consensus       101 ~~~~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~-------~~~~~~~E~~~l~~l----~h~niv~l~g~~~~~  168 (453)
                      ..+.+.+.||+|+||.||+|.. .+++.||||++.....       ....+.+|+.++.++    +||||+++++++. .
T Consensus        31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~-~  109 (312)
T 2iwi_A           31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE-T  109 (312)
T ss_dssp             --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred             hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe-c
Confidence            3445568999999999999985 5688999999965322       223466799999998    8999999999876 4


Q ss_pred             CCCeEEEEEe-cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEEC-CC
Q 047276          169 GGPRYLVYEF-IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD-EN  246 (453)
Q Consensus       169 ~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~-~~  246 (453)
                      .+..++|+|| +.+++|.+++....          .+++..++.++.|++.||+|||+   .+++||||||+||+++ .+
T Consensus       110 ~~~~~~v~e~~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~  176 (312)
T 2iwi_A          110 QEGFMLVLERPLPAQDLFDYITEKG----------PLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRR  176 (312)
T ss_dssp             ---CEEEEECCSSEEEHHHHHHHHC----------SCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTT
T ss_pred             CCeEEEEEEecCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCC
Confidence            5678999999 78999999996432          38999999999999999999999   7999999999999999 89


Q ss_pred             CcEEEeeccccccccCCCCceeeeccCCccccchhhhhcCCCC-ccccchhHHHHHHHHHcCCCCCcccccCCCCCcccc
Q 047276          247 YRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVS-EKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKW  325 (453)
Q Consensus       247 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~  325 (453)
                      +.+||+|||++.......   .....|++.|+|||.+.+..+. .++||||||+++|||++|+.||....          
T Consensus       177 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----------  243 (312)
T 2iwi_A          177 GCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----------  243 (312)
T ss_dssp             TEEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------
T ss_pred             CeEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH----------
Confidence            999999999998765432   2345689999999999877764 58999999999999999999985211          


Q ss_pred             cchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          326 QYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                              +.. ..        ..    ..+......+.+++.+||+.+|++|||+.++++.
T Consensus       244 --------~~~-~~--------~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          244 --------EIL-EA--------EL----HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             --------HHH-HT--------CC----CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             --------HHh-hh--------cc----CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                    000 00        00    1112233458899999999999999999999863

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.5e-39  Score=318.00  Aligned_cols=265  Identities=23%  Similarity=0.278  Sum_probs=193.6

Q ss_pred             HhcccCcCCceEEEEEEeC-CC-cEEEEEEecCCCccHHHHHHHHHHHHhcCCCc------eeeEeeEEEecCCCeEEEE
Q 047276          105 FQALLGHGSSASVFKGILS-DG-TSVAVKRINGEENGEKEFRSEVAAIASAQHVN------LVRLLGYCVVPGGPRYLVY  176 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g-~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~g~~~~~~~~~~lv~  176 (453)
                      +.+.||+|+||+||+|... ++ +.||+|+++......+.+.+|+.+++.++|+|      ++.+.+++. ..+..++||
T Consensus        23 ~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~-~~~~~~lv~  101 (355)
T 2eu9_A           23 IVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN-FHGHMCIAF  101 (355)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE-ETTEEEEEE
T ss_pred             EEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee-eCCeEEEEE
Confidence            4578999999999999964 34 68999999876555677889999999997766      899999876 456889999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEE-------------
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILL-------------  243 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl-------------  243 (453)
                      ||+ +++|.+++....        ...+++..++.++.|++.||+|||+   .+|+||||||+|||+             
T Consensus       102 e~~-~~~l~~~l~~~~--------~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~  169 (355)
T 2eu9_A          102 ELL-GKNTFEFLKENN--------FQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHK  169 (355)
T ss_dssp             ECC-CCBHHHHHHHTT--------TCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred             ecc-CCChHHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccccc
Confidence            999 667777775432        1348999999999999999999999   899999999999999             


Q ss_pred             ------CCCCcEEEeeccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccC
Q 047276          244 ------DENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHG  317 (453)
Q Consensus       244 ------~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~  317 (453)
                            +.++.+||+|||++......    .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus       170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (355)
T 2eu9_A          170 SCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR  245 (355)
T ss_dssp             CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence                  56889999999999864432    23457899999999999999999999999999999999999999642211


Q ss_pred             CCCCcc--cccchhHHHHHhhhcCcccc----cc-------------cccccCCCCCcHHHHHHHHHHHHhccccCCCCC
Q 047276          318 NDKSKN--KWQYFPKIVNEKMKEGKLME----IV-------------DQRLTDEGGIDETQVRRLVDVAFWCIQERARLR  378 (453)
Q Consensus       318 ~~~~~~--~~~~~~~~~~~~~~~~~~~~----~~-------------d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~R  378 (453)
                      ......  .....+..............    ..             .+.+.............+.+++.+||+.||++|
T Consensus       246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  325 (355)
T 2eu9_A          246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR  325 (355)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence            000000  00000111110000000000    00             000000011223446679999999999999999


Q ss_pred             CCHHHHHH
Q 047276          379 PSMARVVE  386 (453)
Q Consensus       379 Ps~~~v~~  386 (453)
                      ||+.++++
T Consensus       326 pt~~e~l~  333 (355)
T 2eu9_A          326 ITLAEALL  333 (355)
T ss_dssp             CCHHHHTT
T ss_pred             cCHHHHhc
Confidence            99999873

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.1e-38  Score=314.15  Aligned_cols=261  Identities=23%  Similarity=0.267  Sum_probs=187.2

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCCc---cHHHHHHHHHHHHhcCCCceeeEeeEEEecCC-----CeEEEE
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEEN---GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGG-----PRYLVY  176 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-----~~~lv~  176 (453)
                      .+.||+|+||.||+|.. .+|+.||||++.....   ..+.+.+|+.+++.++||||+++++++.....     ..++||
T Consensus        29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~  108 (353)
T 3coi_A           29 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM  108 (353)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred             eeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEe
Confidence            57899999999999996 4689999999975332   23568899999999999999999999864332     349999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||+. |+|.+++.            ..+++..+..++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+
T Consensus       109 e~~~-~~l~~~~~------------~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~  172 (353)
T 3coi_A          109 PFMQ-TDLQKIMG------------LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGL  172 (353)
T ss_dssp             ECCS-EEGGGTTT------------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred             cccc-CCHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeeccc
Confidence            9997 59988872            128999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcc-c-ccchhHHHH
Q 047276          257 SKLMSRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKN-K-WQYFPKIVN  333 (453)
Q Consensus       257 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~-~-~~~~~~~~~  333 (453)
                      +......    .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||............ . ....+....
T Consensus       173 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  248 (353)
T 3coi_A          173 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV  248 (353)
T ss_dssp             TTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHH
T ss_pred             ccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            9865322    234578999999999876 67899999999999999999999999642211000000 0 000000000


Q ss_pred             HhhhcCcccccc---ccccc-CCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          334 EKMKEGKLMEIV---DQRLT-DEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       334 ~~~~~~~~~~~~---d~~l~-~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ..+........+   ..... ............+.+++.+||+.||++|||+.++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            000000000000   00000 001112234566899999999999999999999885

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.3e-39  Score=315.37  Aligned_cols=250  Identities=24%  Similarity=0.398  Sum_probs=170.0

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCCC--ccHHHHHHHHH-HHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGEE--NGEKEFRSEVA-AIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      .+.||+|+||.||+|... +|+.||||++....  ....++..|+. +++.++||||+++++++. ..+..++||||+++
T Consensus        27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~-~~~~~~lv~e~~~~  105 (327)
T 3aln_A           27 LGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF-REGDCWICMELMST  105 (327)
T ss_dssp             -CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE-CSSEEEEEECCCSE
T ss_pred             hheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE-eCCceEEEEeecCC
Confidence            578999999999999974 68999999997643  23345666666 667789999999999987 45678999999985


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCC-ceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRS-RVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~-~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                       +|.+++......     ....+++..+..++.|++.||.|||+   . +++||||||+|||++.++.+||+|||++...
T Consensus       106 -~l~~~~~~~~~~-----~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          106 -SFDKFYKYVYSV-----LDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             -EHHHHHHHHHHT-----TCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             -ChHHHHHHHHhh-----hcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence             888777421110     12348999999999999999999999   6 9999999999999999999999999999876


Q ss_pred             cCCCCceeeeccCCccccchhhh----hcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhh
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWI----LEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKM  336 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (453)
                      .....  .....||+.|+|||.+    .+..++.++||||||+++|||++|+.||.........           . ...
T Consensus       177 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----------~-~~~  242 (327)
T 3aln_A          177 VDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-----------L-TQV  242 (327)
T ss_dssp             -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------------CCC
T ss_pred             ccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH-----------H-HHH
Confidence            43322  2334689999999998    4567899999999999999999999999632211000           0 000


Q ss_pred             hcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          337 KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       337 ~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ..+..     +.+..  .........+.+++.+||+.||++|||+.++++
T Consensus       243 ~~~~~-----~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          243 VKGDP-----PQLSN--SEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCSCC-----CCCCC--CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             hcCCC-----CCCCC--cccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            01111     11110  011123345899999999999999999999974

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-38  Score=322.39  Aligned_cols=243  Identities=23%  Similarity=0.303  Sum_probs=178.1

Q ss_pred             hcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEEEEEecCCCCh
Q 047276          106 QALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL  184 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL  184 (453)
                      .++||+|+||+||.....+|+.||||++.....  ..+.+|+.+++.+ +||||+++++++. .....++||||+. |+|
T Consensus        29 ~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~-~~~~~~lv~E~~~-g~L  104 (432)
T 3p23_A           29 KDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEK-DRQFQYIAIELCA-ATL  104 (432)
T ss_dssp             EEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEE-ETTEEEEEEECCS-EEH
T ss_pred             CCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEe-cCCEEEEEEECCC-CCH
Confidence            478999999996655556789999999975332  2356799999999 7999999999876 5567899999996 599


Q ss_pred             hhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECC-----CCcEEEeecccccc
Q 047276          185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDE-----NYRAVVSDFGLSKL  259 (453)
Q Consensus       185 ~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~-----~~~~kl~DfGla~~  259 (453)
                      .+++.....         .+.+...+.++.|++.||+|||+   .+|+||||||+|||++.     +..+||+|||+++.
T Consensus       105 ~~~l~~~~~---------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~  172 (432)
T 3p23_A          105 QEYVEQKDF---------AHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK  172 (432)
T ss_dssp             HHHHHSSSC---------CCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred             HHHHHhcCC---------CccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence            999965432         13334467899999999999999   89999999999999953     34688999999987


Q ss_pred             ccCCCC--ceeeeccCCccccchhhhh---cCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHH
Q 047276          260 MSRDQS--RCITTIRGTRGYLAPEWIL---EQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVN  333 (453)
Q Consensus       260 ~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  333 (453)
                      ......  .......||+.|+|||.+.   ...++.++|||||||++|||++ |..||.....             ....
T Consensus       173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-------------~~~~  239 (432)
T 3p23_A          173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-------------RQAN  239 (432)
T ss_dssp             C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-------------HHHH
T ss_pred             ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-------------HHHH
Confidence            653321  2234567999999999987   4567889999999999999999 8888842110             0011


Q ss_pred             HhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          334 EKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       334 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ........ ..        ..........+.+++.+||+.||++|||+.+|++
T Consensus       240 ~~~~~~~~-~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          240 ILLGACSL-DC--------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             HHTTCCCC-TT--------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhccCCc-cc--------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            11111000 00        0112234556889999999999999999999983

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=6.2e-38  Score=303.64  Aligned_cols=244  Identities=23%  Similarity=0.357  Sum_probs=169.9

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCCCccH---HHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGEENGE---KEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      .+.||+|+||.||+|... +|+.||||++.......   +.+.++..+++.++||||+++++++. ..+..++||||+ +
T Consensus        30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~-~~~~~~lv~e~~-~  107 (318)
T 2dyl_A           30 LGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI-TNTDVFIAMELM-G  107 (318)
T ss_dssp             EEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-CSSEEEEEECCC-S
T ss_pred             cceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe-cCCcEEEEEecc-C
Confidence            478999999999999974 68999999997643222   23444555678889999999999986 556889999999 4


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCC-ceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRS-RVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~-~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +.+..+....         ...+++..++.++.|++.||+|||+   . +++|+||||+||+++.++.+||+|||++...
T Consensus       108 ~~~~~l~~~~---------~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A          108 TCAEKLKKRM---------QGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRL  175 (318)
T ss_dssp             EEHHHHHHHH---------TSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             CcHHHHHHHh---------ccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence            4555554321         1348999999999999999999998   4 8999999999999999999999999999765


Q ss_pred             cCCCCceeeeccCCccccchhhhh-----cCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHh
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWIL-----EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEK  335 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  335 (453)
                      .....  .....||+.|+|||.+.     ...++.++||||||+++|||++|+.||......           .......
T Consensus       176 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----------~~~~~~~  242 (318)
T 2dyl_A          176 VDDKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----------FEVLTKV  242 (318)
T ss_dssp             -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----------HHHHHHH
T ss_pred             cCCcc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----------HHHHHHH
Confidence            43322  23456899999999984     456889999999999999999999999532110           0111111


Q ss_pred             hhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          336 MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       336 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      .. +..     +.+....    .....+.+++.+||+.||.+||++.++++
T Consensus       243 ~~-~~~-----~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          243 LQ-EEP-----PLLPGHM----GFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             HH-SCC-----CCCCSSS----CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             hc-cCC-----CCCCccC----CCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            11 111     1111111    12345889999999999999999999885

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.4e-38  Score=337.86  Aligned_cols=235  Identities=21%  Similarity=0.249  Sum_probs=185.7

Q ss_pred             HHHhcccCcCCceEEEEEEeC--CCcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCC----eEE
Q 047276          103 DNFQALLGHGSSASVFKGILS--DGTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGP----RYL  174 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~--~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~----~~l  174 (453)
                      +.+.+.||+|+||+||+|...  +|+.||||++....  .....+.+|+.++.+++||||++++++|...+..    .++
T Consensus        82 y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~l  161 (681)
T 2pzi_A           82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYI  161 (681)
T ss_dssp             EEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEE
Confidence            344678999999999999974  68999999986532  3345688999999999999999999998755432    699


Q ss_pred             EEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeec
Q 047276          175 VYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDF  254 (453)
Q Consensus       175 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~Df  254 (453)
                      ||||+++++|.+++..            .++|..++.++.|++.||+|||+   .+|+||||||+|||++.+ .+||+||
T Consensus       162 v~E~~~g~~L~~~~~~------------~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DF  225 (681)
T 2pzi_A          162 VMEYVGGQSLKRSKGQ------------KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDL  225 (681)
T ss_dssp             EEECCCCEECC----C------------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCC
T ss_pred             EEEeCCCCcHHHHHhC------------CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEec
Confidence            9999999999887632            38999999999999999999999   899999999999999986 8999999


Q ss_pred             cccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHH
Q 047276          255 GLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNE  334 (453)
Q Consensus       255 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  334 (453)
                      |+++.....     ....||++|+|||++.++ .+.++|||||||++|||++|..|+........               
T Consensus       226 G~a~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~---------------  284 (681)
T 2pzi_A          226 GAVSRINSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL---------------  284 (681)
T ss_dssp             TTCEETTCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC---------------
T ss_pred             ccchhcccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc---------------
Confidence            999876433     345699999999998765 48999999999999999999988752110000               


Q ss_pred             hhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCC-HHHHHHHhcc
Q 047276          335 KMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPS-MARVVEMLEG  390 (453)
Q Consensus       335 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-~~~v~~~L~~  390 (453)
                                     .. ..........+.+++.+||+.||++||+ ++++...|..
T Consensus       285 ---------------~~-~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          285 ---------------PE-DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             ---------------CT-TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ---------------cc-cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence                           00 0011123356889999999999999995 5556555544

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=6.3e-39  Score=335.44  Aligned_cols=264  Identities=23%  Similarity=0.291  Sum_probs=195.1

Q ss_pred             HHHhcccCcCCceEEEEEEe-CCCcEEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEe-----cCCCeEE
Q 047276          103 DNFQALLGHGSSASVFKGIL-SDGTSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVV-----PGGPRYL  174 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----~~~~~~l  174 (453)
                      +.+.+.||+|+||+||+|.. .+|+.||||+++..  ....+.+.+|+.++.+++||||+++++++..     .++..++
T Consensus        16 Y~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~L   95 (676)
T 3qa8_A           16 WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLL   95 (676)
T ss_dssp             -CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCC
T ss_pred             eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEE
Confidence            44568999999999999996 46899999998753  2334568999999999999999999998643     2456799


Q ss_pred             EEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCc---EEE
Q 047276          175 VYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYR---AVV  251 (453)
Q Consensus       175 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~---~kl  251 (453)
                      ||||+++|+|.+++.....       ...+++..++.++.|++.||+|||+   .+|+||||||+||+++.++.   +||
T Consensus        96 VmEy~~ggsL~~~L~~~~~-------~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL  165 (676)
T 3qa8_A           96 AMEYCEGGDLRKYLNQFEN-------CCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKI  165 (676)
T ss_dssp             EEECCSSCBHHHHHHSSSC-------TTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEE
T ss_pred             EEEeCCCCCHHHHHHhccc-------CCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEE
Confidence            9999999999999965432       2248888999999999999999999   89999999999999997664   999


Q ss_pred             eeccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccc-hhH
Q 047276          252 SDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQY-FPK  330 (453)
Q Consensus       252 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~-~~~  330 (453)
                      +|||++........  .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......     ..|.. ...
T Consensus       166 ~DFG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~  238 (676)
T 3qa8_A          166 IDLGYAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVRE  238 (676)
T ss_dssp             CSCCCCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC-
T ss_pred             cccccccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhc
Confidence            99999987654322  24467899999999999999999999999999999999999999532110     00000 000


Q ss_pred             HHHH-hhhcCcccc--cccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHH
Q 047276          331 IVNE-KMKEGKLME--IVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMAR  383 (453)
Q Consensus       331 ~~~~-~~~~~~~~~--~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~  383 (453)
                      .... .........  .+...+.............+.+++..||+.||++|||+.+
T Consensus       239 ~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e  294 (676)
T 3qa8_A          239 KSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ  294 (676)
T ss_dssp             -----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred             ccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence            0000 000000000  0111111122344556788999999999999999999977

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3.1e-38  Score=301.82  Aligned_cols=229  Identities=16%  Similarity=0.133  Sum_probs=175.6

Q ss_pred             HHhcccCcCCceEEEEEEeC-CCcEEEEEEecCCCcc----HHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEe
Q 047276          104 NFQALLGHGSSASVFKGILS-DGTSVAVKRINGEENG----EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      .+.+.||+|+||.||+|... +|+.||||++......    .+.|.+|+.++.+++||||+++++++. .++..++||||
T Consensus        34 ~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-~~~~~~lv~e~  112 (286)
T 3uqc_A           34 RLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH-TRAGGLVVAEW  112 (286)
T ss_dssp             EEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-ETTEEEEEEEC
T ss_pred             EEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE-ECCcEEEEEEe
Confidence            34579999999999999975 4899999999764322    367899999999999999999999986 45678999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +++++|.+++...            .......+++.|++.||+|||+   .+|+||||||+|||++.++.+||+++|   
T Consensus       113 ~~g~~L~~~l~~~------------~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~---  174 (286)
T 3uqc_A          113 IRGGSLQEVADTS------------PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA---  174 (286)
T ss_dssp             CCEEEHHHHHTTC------------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC---
T ss_pred             cCCCCHHHHHhcC------------CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc---
Confidence            9999999998321            3455678899999999999999   899999999999999999999997443   


Q ss_pred             cccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                                        |++|       ++.++||||||+++|||++|+.||........... ...        .. .
T Consensus       175 ------------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~-~~~--------~~-~  219 (286)
T 3uqc_A          175 ------------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP-AER--------DT-A  219 (286)
T ss_dssp             ------------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE-CCB--------CT-T
T ss_pred             ------------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH-HHH--------Hh-c
Confidence                              4443       68999999999999999999999964332211100 000        00 0


Q ss_pred             CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccCCC
Q 047276          339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVD  395 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~~~  395 (453)
                      +...   .+.     .........+.+++.+||+.||++| |+.++++.|+......
T Consensus       220 ~~~~---~~~-----~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          220 GQPI---EPA-----DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             SCBC---CHH-----HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             cCCC---Chh-----hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence            0000   000     0011223458899999999999999 9999999999866543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.7e-37  Score=312.19  Aligned_cols=239  Identities=15%  Similarity=0.139  Sum_probs=173.0

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCC----CccHHHHHHHHHHHHhcCC-Cce---------------eeE---
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGE----ENGEKEFRSEVAAIASAQH-VNL---------------VRL---  161 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h-~ni---------------v~l---  161 (453)
                      .++||+|+||+||+|+. .+|+.||||++...    ....+.|.+|+.++..++| +|.               +.+   
T Consensus        83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (413)
T 3dzo_A           83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK  162 (413)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred             ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence            46899999999999994 57999999998742    2224679999999999987 221               111   


Q ss_pred             ---eeEEEec----CCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceecc
Q 047276          162 ---LGYCVVP----GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHL  234 (453)
Q Consensus       162 ---~g~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~  234 (453)
                         ..++...    ....+++|+++ +++|.+++........   ....+++..++.++.|++.||+|||+   .+|+||
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~---~~iiHr  235 (413)
T 3dzo_A          163 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSS---THKSLVHHARLQLTLQVIRLLASLHH---YGLVHT  235 (413)
T ss_dssp             --------------CCSEEEEEECC-SEEHHHHHHHHHHHTT---TSHHHHHHHHHHHHHHHHHHHHHHHH---TTEECS
T ss_pred             CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccc---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccC
Confidence               1111100    12346677765 6799998842110000   12348899999999999999999999   899999


Q ss_pred             CCCCCcEEECCCCcEEEeeccccccccCCCCceeeeccCCccccchhhh----------hcCCCCccccchhHHHHHHHH
Q 047276          235 DVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWI----------LEQGVSEKCDIYSYGMVLLEL  304 (453)
Q Consensus       235 Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDV~S~Gvil~el  304 (453)
                      ||||+|||++.++.+||+|||+++.....    .....| +.|+|||.+          ....++.++|||||||++|||
T Consensus       236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el  310 (413)
T 3dzo_A          236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI  310 (413)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred             CcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence            99999999999999999999998764332    344567 999999999          444578899999999999999


Q ss_pred             HcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHH
Q 047276          305 TGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARV  384 (453)
Q Consensus       305 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v  384 (453)
                      ++|+.||........                         .+..+.....++    ..+.+++.+||+.||++||++.++
T Consensus       311 ltg~~Pf~~~~~~~~-------------------------~~~~~~~~~~~~----~~~~~li~~~l~~dP~~Rpt~~~~  361 (413)
T 3dzo_A          311 WCADLPNTDDAALGG-------------------------SEWIFRSCKNIP----QPVRALLEGFLRYPKEDRLLPLQA  361 (413)
T ss_dssp             HHSSCCCCTTGGGSC-------------------------SGGGGSSCCCCC----HHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHCCCCCCCcchhhh-------------------------HHHHHhhcccCC----HHHHHHHHHHccCChhhCcCHHHH
Confidence            999999953221110                         001111111223    458899999999999999998776


Q ss_pred             H
Q 047276          385 V  385 (453)
Q Consensus       385 ~  385 (453)
                      +
T Consensus       362 l  362 (413)
T 3dzo_A          362 M  362 (413)
T ss_dssp             T
T ss_pred             H
Confidence            5

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=6.2e-37  Score=294.56  Aligned_cols=221  Identities=19%  Similarity=0.239  Sum_probs=171.6

Q ss_pred             cccCcCCceEEEEEEe-CCCcEEEEEEecCCCccHHHHHHHHHHH-HhcCCCceeeEeeEEEe---cCCCeEEEEEecCC
Q 047276          107 ALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRSEVAAI-ASAQHVNLVRLLGYCVV---PGGPRYLVYEFIQN  181 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~g~~~~---~~~~~~lv~e~~~~  181 (453)
                      ++||+|+||.||++.. .+++.||+|+++.    ...+.+|+.++ +.++||||+++++++..   .+...++||||+++
T Consensus        24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~   99 (299)
T 3m2w_A           24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG   99 (299)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCS
T ss_pred             cccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCC
Confidence            6799999999999996 5689999999964    24577888887 55689999999998764   14567999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECC---CCcEEEeeccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDE---NYRAVVSDFGLSK  258 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~---~~~~kl~DfGla~  258 (453)
                      |+|.+++....        ...+++..++.++.|++.||+|||+   .+++||||||+|||++.   ++.+||+|||++.
T Consensus       100 ~~L~~~l~~~~--------~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~  168 (299)
T 3m2w_A          100 GELFSRIQDRG--------DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  168 (299)
T ss_dssp             CBHHHHHHHCT--------TCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             CcHHHHHHhcc--------CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence            99999996542        2348999999999999999999999   89999999999999998   7899999999986


Q ss_pred             cccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      ...                       +..++.++||||||+++|||++|+.||..........                 
T Consensus       169 ~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-----------------  208 (299)
T 3m2w_A          169 ETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-----------------  208 (299)
T ss_dssp             ECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C-----------------
T ss_pred             ccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH-----------------
Confidence            432                       1346789999999999999999999995332111000                 


Q ss_pred             CcccccccccccCCCCCc----HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          339 GKLMEIVDQRLTDEGGID----ETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~----~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ..........    ...+    ......+.+++.+||+.||++|||+.++++
T Consensus       209 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          209 GMKTRIRMGQ----YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             CSCCSSCTTC----CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHhhcc----ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            0000000000    0011    123456899999999999999999999986

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.4e-36  Score=295.34  Aligned_cols=242  Identities=17%  Similarity=0.156  Sum_probs=181.9

Q ss_pred             HHHHHHhcccCcCCceEEEEEEeCCCcEEEEEEecCCC---------ccHHHHHHHHHHHHhcC---------CCceeeE
Q 047276          100 EATDNFQALLGHGSSASVFKGILSDGTSVAVKRINGEE---------NGEKEFRSEVAAIASAQ---------HVNLVRL  161 (453)
Q Consensus       100 ~~~~~~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~---------h~niv~l  161 (453)
                      ...+.+.+.||+|+||+||+|+. +|+.||||++....         ...+.+.+|+.+++.++         |||++++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            34456678999999999999998 68999999997432         22377899999999886         8888887


Q ss_pred             eeEEEe-----------------------------cCCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHH
Q 047276          162 LGYCVV-----------------------------PGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRV  212 (453)
Q Consensus       162 ~g~~~~-----------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i  212 (453)
                      .+.+..                             ..+..++||||+++|++.+.+..           ..+++..+..+
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----------~~~~~~~~~~i  166 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----------KLSSLATAKSI  166 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----------TCCCHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----------cCCCHHHHHHH
Confidence            776431                             15688999999999977666632           23899999999


Q ss_pred             HHHHHHHhcccc-ccCCCceeccCCCCCcEEECCCC--------------------cEEEeeccccccccCCCCceeeec
Q 047276          213 AIDVAKALSYLH-NDCRSRVLHLDVKPENILLDENY--------------------RAVVSDFGLSKLMSRDQSRCITTI  271 (453)
Q Consensus       213 ~~~ia~~L~~Lh-~~~~~~ivH~Dlk~~NiLl~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~  271 (453)
                      +.|++.||+||| +   .+|+||||||+|||++.++                    .+||+|||+++.....      ..
T Consensus       167 ~~qi~~aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~  237 (336)
T 2vuw_A          167 LHQLTASLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IV  237 (336)
T ss_dssp             HHHHHHHHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EE
T ss_pred             HHHHHHHHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cE
Confidence            999999999999 8   7999999999999999887                    9999999999876432      34


Q ss_pred             cCCccccchhhhhcCCCCccccchhHHHH-HHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCccccccccccc
Q 047276          272 RGTRGYLAPEWILEQGVSEKCDIYSYGMV-LLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLT  350 (453)
Q Consensus       272 ~gt~~y~aPE~~~~~~~~~~sDV~S~Gvi-l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  350 (453)
                      .||+.|+|||.+.+.. +.++||||+|++ .+++++|..||...         .|  ...............    ..  
T Consensus       238 ~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~--~~~~~~~~~~~~~~~----~~--  299 (336)
T 2vuw_A          238 VFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LW--LHYLTDKMLKQMTFK----TK--  299 (336)
T ss_dssp             ECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HH--HHHHHHHHHHTCCCS----SC--
T ss_pred             EEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch---------hh--hhHHHHhhhhhhccC----cc--
Confidence            7899999999988655 899999998777 77789999998421         00  000001111000000    00  


Q ss_pred             CCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHH
Q 047276          351 DEGGIDETQVRRLVDVAFWCIQERARLRPSMARVV  385 (453)
Q Consensus       351 ~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~  385 (453)
                      ............+.+++.+||+.+     |++|++
T Consensus       300 ~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          300 CNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             CCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             cchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence            001123466788999999999976     888877

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=4.3e-31  Score=275.02  Aligned_cols=185  Identities=17%  Similarity=0.115  Sum_probs=128.6

Q ss_pred             ccCcCCceEEEEEE-eCCCcEEEEEEecCCC-----------ccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEE
Q 047276          108 LLGHGSSASVFKGI-LSDGTSVAVKRINGEE-----------NGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYL  174 (453)
Q Consensus       108 ~lG~G~fG~Vy~~~-~~~g~~vavK~~~~~~-----------~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~l  174 (453)
                      ..+.|++|.+..++ ...|+.+++|.+..+.           ...++|.+|+++|+++ .|+||+++++++. +++..||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~e-d~~~~yL  319 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGE-NAQSGWL  319 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEE-CSSEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE-ECCEEEE
Confidence            46677777666554 3347889999996531           2235699999999999 6999999999976 6678999


Q ss_pred             EEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeec
Q 047276          175 VYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDF  254 (453)
Q Consensus       175 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~Df  254 (453)
                      ||||++||+|.++|....          .++..   +|+.||+.||+|+|+   ++||||||||+||||+++|.+||+||
T Consensus       320 VMEyv~G~~L~d~i~~~~----------~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DF  383 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAAGE----------EIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDF  383 (569)
T ss_dssp             EEECCCSEEHHHHHHTTC----------CCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCC
T ss_pred             EEecCCCCcHHHHHHhCC----------CCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeec
Confidence            999999999999996432          36554   588999999999999   89999999999999999999999999


Q ss_pred             cccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCC
Q 047276          255 GLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNV  311 (453)
Q Consensus       255 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~  311 (453)
                      |+++....... .....+||++|||||++.+ .+..++|+||+|++++++.++..++
T Consensus       384 GlAr~~~~~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          384 GSIVTTPQDCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             TTEESCC---C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             ccCeeCCCCCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence            99987654332 2355689999999998865 4678899999999999888775443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=5.5e-28  Score=250.23  Aligned_cols=181  Identities=17%  Similarity=0.225  Sum_probs=143.7

Q ss_pred             hcccCcCCceEEEEEEeCCCcEEEEEEecCCCc---------cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEE
Q 047276          106 QALLGHGSSASVFKGILSDGTSVAVKRINGEEN---------GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVY  176 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~  176 (453)
                      .++||+|+||+||+|.. .++.+++|+......         ..+.|.+|++++++++||||+++..++. ..+..++||
T Consensus       341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~-~~~~~~lVm  418 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDV-DLDNKRIMM  418 (540)
T ss_dssp             -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEE-ETTTTEEEE
T ss_pred             CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEE-eCCccEEEE
Confidence            46899999999999965 478899998654221         1245899999999999999996666655 445679999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||+++|+|.+++..                  +..++.|+++||+|||+   .+|+||||||+|||+++  .+||+|||+
T Consensus       419 E~~~ggsL~~~l~~------------------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGl  475 (540)
T 3en9_A          419 SYINGKLAKDVIED------------------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGL  475 (540)
T ss_dssp             ECCCSEEHHHHSTT------------------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTT
T ss_pred             ECCCCCCHHHHHHH------------------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECcc
Confidence            99999999999842                  45799999999999999   89999999999999999  999999999


Q ss_pred             cccccCCCCce------eeeccCCccccchhhhhc--CCCCccccchhHHHHHHHHHcCCCCC
Q 047276          257 SKLMSRDQSRC------ITTIRGTRGYLAPEWILE--QGVSEKCDIYSYGMVLLELTGGRRNV  311 (453)
Q Consensus       257 a~~~~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~sDV~S~Gvil~elltG~~p~  311 (453)
                      ++.........      .....||+.|||||.+..  ..|+..+|+|+...-.++-+.++.+|
T Consensus       476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            99875432211      235679999999999986  56888999999999999988887766

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=1.8e-24  Score=205.72  Aligned_cols=150  Identities=17%  Similarity=0.116  Sum_probs=119.7

Q ss_pred             cccCcCCceEEEEEEeCCCcEEEEEEecCCCc-------------------cHHHHHHHHHHHHhcCCCceeeEeeEEEe
Q 047276          107 ALLGHGSSASVFKGILSDGTSVAVKRINGEEN-------------------GEKEFRSEVAAIASAQHVNLVRLLGYCVV  167 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~-------------------~~~~~~~E~~~l~~l~h~niv~l~g~~~~  167 (453)
                      +.||+|+||.||+|...+|+.||+|.++....                   ....+.+|+.++++++  | +++.+++. 
T Consensus        96 ~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~-  171 (282)
T 1zar_A           96 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYA-  171 (282)
T ss_dssp             EEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEE-
T ss_pred             CEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEe-
Confidence            78999999999999997799999999964221                   2356889999999999  5 67776543 


Q ss_pred             cCCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCC
Q 047276          168 PGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENY  247 (453)
Q Consensus       168 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~  247 (453)
                      . +..++||||+++|+|.+ +..              .  ....++.|++.||+|||+   .+|+||||||+|||++ ++
T Consensus       172 ~-~~~~lvmE~~~g~~L~~-l~~--------------~--~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~  229 (282)
T 1zar_A          172 W-EGNAVLMELIDAKELYR-VRV--------------E--NPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EE  229 (282)
T ss_dssp             E-ETTEEEEECCCCEEGGG-CCC--------------S--CHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TT
T ss_pred             c-cceEEEEEecCCCcHHH-cch--------------h--hHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CC
Confidence            2 46699999999999988 421              1  134699999999999999   8999999999999999 99


Q ss_pred             cEEEeeccccccccCCCCceeeeccCCccccchhhhhc----------CCCCccccchh
Q 047276          248 RAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILE----------QGVSEKCDIYS  296 (453)
Q Consensus       248 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~sDV~S  296 (453)
                      .+||+|||+++.              +..|+|||++..          .++...+|+|.
T Consensus       230 ~vkl~DFG~a~~--------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          230 GIWIIDFPQSVE--------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             EEEECCCTTCEE--------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             cEEEEECCCCeE--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence            999999999863              334789998753          34455566654

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.81  E-value=2.9e-20  Score=174.36  Aligned_cols=132  Identities=21%  Similarity=0.190  Sum_probs=102.7

Q ss_pred             hcccCcCCceEEEEEEe-CCCcE--EEEEEecCCCcc-------------------------HHHHHHHHHHHHhcCCCc
Q 047276          106 QALLGHGSSASVFKGIL-SDGTS--VAVKRINGEENG-------------------------EKEFRSEVAAIASAQHVN  157 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~--vavK~~~~~~~~-------------------------~~~~~~E~~~l~~l~h~n  157 (453)
                      .+.||+|+||.||+|.. .+|+.  ||||+++.....                         ...+.+|+..|.+++|++
T Consensus        52 ~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~  131 (258)
T 1zth_A           52 GGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAG  131 (258)
T ss_dssp             EEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCC
Confidence            46899999999999997 68988  999987543111                         135788999999998876


Q ss_pred             e--eeEeeEEEecCCCeEEEEEecCC-C----ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhcccc-ccCCC
Q 047276          158 L--VRLLGYCVVPGGPRYLVYEFIQN-G----SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH-NDCRS  229 (453)
Q Consensus       158 i--v~l~g~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh-~~~~~  229 (453)
                      +  ..++++     +..++||||+.+ |    +|.++...             .++.....++.|++.||.||| +   .
T Consensus       132 i~~p~~~~~-----~~~~lVmE~~g~~g~~~~~L~~~~~~-------------~~~~~~~~i~~qi~~~l~~lH~~---~  190 (258)
T 1zth_A          132 VSVPQPYTY-----MKNVLLMEFIGEDELPAPTLVELGRE-------------LKELDVEGIFNDVVENVKRLYQE---A  190 (258)
T ss_dssp             CCCCCEEEE-----ETTEEEEECCEETTEECCBHHHHGGG-------------GGGSCHHHHHHHHHHHHHHHHHT---S
T ss_pred             CCCCeEEEc-----CCCEEEEEecCCCCCccccHHHHhhc-------------cChHHHHHHHHHHHHHHHHHHHH---C
Confidence            4  333332     256899999942 4    66665421             123456789999999999999 7   8


Q ss_pred             ceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          230 RVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       230 ~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+||||||+|||+++  .++|+|||++...
T Consensus       191 givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          191 ELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            9999999999999998  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.69  E-value=5.2e-18  Score=166.00  Aligned_cols=130  Identities=12%  Similarity=0.112  Sum_probs=94.5

Q ss_pred             hcccCcCCceEEEEEEeCCCcEEEEEEecCCC---------------ccHHHH--------HHHHHHHHhcCCCcee--e
Q 047276          106 QALLGHGSSASVFKGILSDGTSVAVKRINGEE---------------NGEKEF--------RSEVAAIASAQHVNLV--R  160 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~---------------~~~~~~--------~~E~~~l~~l~h~niv--~  160 (453)
                      ...||+|+||.||+|...+|+.||||+++...               ......        .+|...|.++.+.++.  .
T Consensus       100 ~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~  179 (397)
T 4gyi_A          100 GSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPE  179 (397)
T ss_dssp             EEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCC
T ss_pred             cCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCe
Confidence            46899999999999999899999999875321               011112        2455566666444332  2


Q ss_pred             EeeEEEecCCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCc
Q 047276          161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPEN  240 (453)
Q Consensus       161 l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~N  240 (453)
                      .+++     ...++||||+++++|..+..              .  .....++.|++.+|.|||+   .+||||||||.|
T Consensus       180 p~~~-----~~~~LVME~i~G~~L~~l~~--------------~--~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~N  235 (397)
T 4gyi_A          180 PIAQ-----SRHTIVMSLVDALPMRQVSS--------------V--PDPASLYADLIALILRLAK---HGLIHGDFNEFN  235 (397)
T ss_dssp             EEEE-----ETTEEEEECCSCEEGGGCCC--------------C--SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTS
T ss_pred             eeec-----cCceEEEEecCCccHhhhcc--------------c--HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHH
Confidence            2221     13379999999988876542              1  1134678999999999999   899999999999


Q ss_pred             EEECCCC----------cEEEeecccccc
Q 047276          241 ILLDENY----------RAVVSDFGLSKL  259 (453)
Q Consensus       241 iLl~~~~----------~~kl~DfGla~~  259 (453)
                      ||+++++          .+.|+||+-+-.
T Consensus       236 ILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          236 ILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             EEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             EEEeCCCCcccccccccceEEEEeCCccc
Confidence            9998876          389999997654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.26  E-value=1.2e-11  Score=115.54  Aligned_cols=136  Identities=13%  Similarity=0.038  Sum_probs=103.6

Q ss_pred             hcccCcCCceEEEEEEeCCCcEEEEEEecCCC-ccHHHHHHHHHHHHhcC-CCceeeEeeEEEecCCCeEEEEEecCCCC
Q 047276          106 QALLGHGSSASVFKGILSDGTSVAVKRINGEE-NGEKEFRSEVAAIASAQ-HVNLVRLLGYCVVPGGPRYLVYEFIQNGS  183 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~~lv~e~~~~gs  183 (453)
                      ...++.|+.+.||+.... ++.+++|...... .....+.+|+.+++.+. +.++.++++++. ..+..++||||++|.+
T Consensus        19 ~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-~~~~~~lv~e~i~G~~   96 (263)
T 3tm0_A           19 VKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-HDGWSNLLMSEADGVL   96 (263)
T ss_dssp             EECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-ETTEEEEEEECCSSEE
T ss_pred             EeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-cCCceEEEEEecCCee
Confidence            456788888999999864 6789999986421 22345889999999985 677888998876 4557799999999999


Q ss_pred             hhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhcccccc-------------------------------------
Q 047276          184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHND-------------------------------------  226 (453)
Q Consensus       184 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~-------------------------------------  226 (453)
                      |.+.+.               +......++.+++++|+.||+.                                     
T Consensus        97 l~~~~~---------------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (263)
T 3tm0_A           97 CSEEYE---------------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED  161 (263)
T ss_dssp             HHHHCC---------------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred             hhhccC---------------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence            987641               1112346778888999999971                                     


Q ss_pred             -------------------CCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          227 -------------------CRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       227 -------------------~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                                         ....++|+|+++.|||++++..+.|+||+.+.
T Consensus       162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                               01459999999999999876666799999875

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.21  E-value=3e-11  Score=112.38  Aligned_cols=129  Identities=19%  Similarity=0.110  Sum_probs=92.9

Q ss_pred             CcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCc--eeeEeeEEEecCCCeEEEEEecCCCChhhh
Q 047276          110 GHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVN--LVRLLGYCVVPGGPRYLVYEFIQNGSLDHW  187 (453)
Q Consensus       110 G~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~~~~~~lv~e~~~~gsL~~~  187 (453)
                      +.|..+.||+....+|..+++|.....  ....+..|+.+++.+.+.+  +.++++++. .++..++||||+++.+|.  
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~-~~~~~~~v~e~i~G~~l~--  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVT-EAGRDWLLLGEVPGQDLL--  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-CSSCEEEEEECCSSEETT--
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEecc-CCCCCEEEEEecCCcccC--
Confidence            456669999998877888999987653  2245788999999986545  445777754 445689999999998884  


Q ss_pred             hccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccC----------------------------------------
Q 047276          188 IFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDC----------------------------------------  227 (453)
Q Consensus       188 l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~----------------------------------------  227 (453)
                      ...             .+   ...++.++++.|+.||+..                                        
T Consensus       104 ~~~-------------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (264)
T 1nd4_A          104 SSH-------------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP  167 (264)
T ss_dssp             TSC-------------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred             cCc-------------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence            210             11   1245566666666666521                                        


Q ss_pred             ---------------CCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          228 ---------------RSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       228 ---------------~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                                     ...++|+|++|.||++++++.+.|+|||.+..
T Consensus       168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                           12399999999999998876677999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.13  E-value=2.2e-10  Score=112.13  Aligned_cols=141  Identities=16%  Similarity=0.224  Sum_probs=104.5

Q ss_pred             cccCcCCceEEEEEEeCCCcEEEEEEec--CCC--ccHHHHHHHHHHHHhcC--CCceeeEeeEEEecC--CCeEEEEEe
Q 047276          107 ALLGHGSSASVFKGILSDGTSVAVKRIN--GEE--NGEKEFRSEVAAIASAQ--HVNLVRLLGYCVVPG--GPRYLVYEF  178 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~g~~vavK~~~--~~~--~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~--~~~~lv~e~  178 (453)
                      +.|+.|.++.||+....+ ..+++|+..  ...  .....+.+|+.+++.+.  +.++.++++++....  +..++||||
T Consensus        44 ~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~  122 (359)
T 3dxp_A           44 EQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF  122 (359)
T ss_dssp             EECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred             EEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence            468999999999998764 578888776  322  22356888999999997  456788888875331  347899999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccC-------------------------------
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDC-------------------------------  227 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~-------------------------------  227 (453)
                      +++..+.+..            ...++...+..++.++++.|+.||+..                               
T Consensus       123 v~G~~l~~~~------------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (359)
T 3dxp_A          123 VSGRVLWDQS------------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSE  190 (359)
T ss_dssp             CCCBCCCCTT------------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHC
T ss_pred             cCCeecCCCc------------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcC
Confidence            9998775422            122678888899999999999999721                               


Q ss_pred             ------------------------CCceeccCCCCCcEEECCCCc--EEEeeccccccc
Q 047276          228 ------------------------RSRVLHLDVKPENILLDENYR--AVVSDFGLSKLM  260 (453)
Q Consensus       228 ------------------------~~~ivH~Dlk~~NiLl~~~~~--~kl~DfGla~~~  260 (453)
                                              ...++|+|+++.|||++.++.  +.|.||+.+...
T Consensus       191 ~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          191 TESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             CSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             CcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                    257999999999999997753  689999988653

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.97  E-value=2e-10  Score=109.74  Aligned_cols=183  Identities=16%  Similarity=0.184  Sum_probs=115.0

Q ss_pred             cccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcC-CCc--eeeEeeEEEecC--CCeEEEEEecCC
Q 047276          107 ALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQ-HVN--LVRLLGYCVVPG--GPRYLVYEFIQN  181 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~g~~~~~~--~~~~lv~e~~~~  181 (453)
                      +.++.|.+..||+..    ..+++|..... .....+.+|..+|+.+. +..  +.++++++....  ...++||++++|
T Consensus        26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G  100 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG  100 (304)
T ss_dssp             CEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred             EecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence            358899999999863    45888886532 23467889999999884 322  334444322111  134789999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhcccccc-----------------------------------
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHND-----------------------------------  226 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~-----------------------------------  226 (453)
                      .+|.+...            ..++...+..++.++++.|+.||+.                                   
T Consensus       101 ~~l~~~~~------------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (304)
T 3sg8_A          101 VPLTPLLL------------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGP  168 (304)
T ss_dssp             EECCHHHH------------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHH
T ss_pred             eECCcccc------------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcc
Confidence            88865321            1145555666666666666666641                                   


Q ss_pred             --------------------CCCceeccCCCCCcEEECC--CCcEEEeeccccccccCCCCceeeeccCCccc---cchh
Q 047276          227 --------------------CRSRVLHLDVKPENILLDE--NYRAVVSDFGLSKLMSRDQSRCITTIRGTRGY---LAPE  281 (453)
Q Consensus       227 --------------------~~~~ivH~Dlk~~NiLl~~--~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y---~aPE  281 (453)
                                          ....++|+|+++.||++++  +..+.|+||+.+.........  .   ....+   ..|+
T Consensus       169 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl--~---~~~~~~~~~~~~  243 (304)
T 3sg8_A          169 QMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF--I---SLMEDDEEYGME  243 (304)
T ss_dssp             HHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH--H---TTCCTTTSCCHH
T ss_pred             cHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH--H---HHHhhccccCHH
Confidence                                1246899999999999998  556789999998754321100  0   00011   2222


Q ss_pred             hhh-----cCCC---------CccccchhHHHHHHHHHcCCCCC
Q 047276          282 WIL-----EQGV---------SEKCDIYSYGMVLLELTGGRRNV  311 (453)
Q Consensus       282 ~~~-----~~~~---------~~~sDV~S~Gvil~elltG~~p~  311 (453)
                      ...     .+..         ..-.+.|++|.++|++.+|..+|
T Consensus       244 ~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          244 FVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            211     0111         12268999999999999998776

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.55  E-value=3.2e-07  Score=87.51  Aligned_cols=136  Identities=18%  Similarity=0.235  Sum_probs=89.2

Q ss_pred             cccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCC---ceeeEeeEEEecCCCeEEEEEecCCCC
Q 047276          107 ALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHV---NLVRLLGYCVVPGGPRYLVYEFIQNGS  183 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~g~~~~~~~~~~lv~e~~~~gs  183 (453)
                      +.++.|....||+.    |..+++|+-.. ......+..|..+|..+.+.   .+.+.+.++....+..+++|||++|.+
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~   99 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI   99 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred             eecCCCcceeEEEE----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence            35788888999987    56688887532 22345788999999999753   355666666434556789999999988


Q ss_pred             hhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhcccccc-------------------------------------
Q 047276          184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHND-------------------------------------  226 (453)
Q Consensus       184 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~-------------------------------------  226 (453)
                      |.+....            .++...+..++.++++.|+.||+.                                     
T Consensus       100 l~~~~~~------------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~  167 (306)
T 3tdw_A          100 LGEDGMA------------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDES  167 (306)
T ss_dssp             CHHHHHT------------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHH
T ss_pred             Cchhhhh------------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchh
Confidence            8653210            022222333333333333333321                                     


Q ss_pred             --------------------CCCceeccCCCCCcEEECC---CCc-EEEeecccccc
Q 047276          227 --------------------CRSRVLHLDVKPENILLDE---NYR-AVVSDFGLSKL  259 (453)
Q Consensus       227 --------------------~~~~ivH~Dlk~~NiLl~~---~~~-~kl~DfGla~~  259 (453)
                                          ....++|+|+++.||+++.   ++. +.|+||+.+..
T Consensus       168 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          168 LRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                2256899999999999997   455 48999998764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.29  E-value=2.1e-06  Score=79.98  Aligned_cols=77  Identities=10%  Similarity=0.104  Sum_probs=54.4

Q ss_pred             ccCcCCce-EEEEEEeC-CCcEEEEEEecCCCccHHHHHHHHHHHHhcC-CCceeeEeeEEEecCCCeEEEEEecCCCCh
Q 047276          108 LLGHGSSA-SVFKGILS-DGTSVAVKRINGEENGEKEFRSEVAAIASAQ-HVNLVRLLGYCVVPGGPRYLVYEFIQNGSL  184 (453)
Q Consensus       108 ~lG~G~fG-~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~~lv~e~~~~gsL  184 (453)
                      .+..|..| .||+.... ++..+++|+-...  ....+..|...|+.+. +-.+.++++++. ..+..++|||++++.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~-~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIR-TPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEE-ETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEE-ECCeEEEEEEeeCCccc
Confidence            34455555 68988754 4667899986532  3456888999999885 334667788776 44577999999999877


Q ss_pred             hhh
Q 047276          185 DHW  187 (453)
Q Consensus       185 ~~~  187 (453)
                      .+.
T Consensus       108 ~~~  110 (272)
T 4gkh_A          108 FQV  110 (272)
T ss_dssp             HHH
T ss_pred             ccc
Confidence            654

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.29  E-value=1.1e-06  Score=85.38  Aligned_cols=80  Identities=9%  Similarity=0.073  Sum_probs=54.5

Q ss_pred             ccc-CcCCceEEEEEEeC-------CCcEEEEEEecCCC---c-cHHHHHHHHHHHHhcCC---CceeeEeeEEEecC--
Q 047276          107 ALL-GHGSSASVFKGILS-------DGTSVAVKRINGEE---N-GEKEFRSEVAAIASAQH---VNLVRLLGYCVVPG--  169 (453)
Q Consensus       107 ~~l-G~G~fG~Vy~~~~~-------~g~~vavK~~~~~~---~-~~~~~~~E~~~l~~l~h---~niv~l~g~~~~~~--  169 (453)
                      +.| +.|....+|+....       +++.+++|......   . ....+..|+.+++.+..   -.+.++++++....  
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            356 88889999998764       26678888765422   1 12457788888888742   35667777764321  


Q ss_pred             CCeEEEEEecCCCChhh
Q 047276          170 GPRYLVYEFIQNGSLDH  186 (453)
Q Consensus       170 ~~~~lv~e~~~~gsL~~  186 (453)
                      +..++||||+++.++.+
T Consensus       106 g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSCEEEEECCCCBCCCB
T ss_pred             CCceEEEEecCCCChhh
Confidence            34689999999877754

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.08  E-value=4.1e-06  Score=82.77  Aligned_cols=73  Identities=15%  Similarity=0.061  Sum_probs=48.3

Q ss_pred             cccCcCCceEEEEEEeC-CCcEEEEEEecCCC--------ccHHHHHHHHHHHHhcCC--Cc-eeeEeeEEEecCCCeEE
Q 047276          107 ALLGHGSSASVFKGILS-DGTSVAVKRINGEE--------NGEKEFRSEVAAIASAQH--VN-LVRLLGYCVVPGGPRYL  174 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~~~E~~~l~~l~h--~n-iv~l~g~~~~~~~~~~l  174 (453)
                      +.||.|.++.||++... +++.++||......        .....+..|.+++..+..  +. +.+++.+   ..+..++
T Consensus        36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~---d~~~~~l  112 (397)
T 2olc_A           36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS---DTEMAVT  112 (397)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE---ETTTTEE
T ss_pred             EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE---cCCccEE
Confidence            46999999999999754 46889999764321        123456789999888742  33 3345543   2345689


Q ss_pred             EEEecCCC
Q 047276          175 VYEFIQNG  182 (453)
Q Consensus       175 v~e~~~~g  182 (453)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.08  E-value=1.6e-05  Score=76.36  Aligned_cols=147  Identities=21%  Similarity=0.201  Sum_probs=80.0

Q ss_pred             ccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcC-----CCceeeEe-e-EEEecCCCeEEEEEecC
Q 047276          108 LLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQ-----HVNLVRLL-G-YCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       108 ~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~-g-~~~~~~~~~~lv~e~~~  180 (453)
                      .|+.|..+.||+....+| .+++|+....   ...+..|..++..|.     .|.++... | ++...++..+++++|++
T Consensus        39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~  114 (346)
T 2q83_A           39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIE  114 (346)
T ss_dssp             ECC----CEEEEEEETTE-EEEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCC
T ss_pred             eccccccCcEEEEEeCCC-CEEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeec
Confidence            466677899999987655 4889988752   234445566655543     23333311 1 11112445789999999


Q ss_pred             CCChhh--------------hhccCCCCC--C-CC-CCCCCCCHHHHH-------------------------------H
Q 047276          181 NGSLDH--------------WIFPTSRRS--E-GH-YSGGCLSWDLRY-------------------------------R  211 (453)
Q Consensus       181 ~gsL~~--------------~l~~~~~~~--~-~~-~~~~~l~~~~~~-------------------------------~  211 (453)
                      +.++..              .+|......  . .. .....-.|...+                               .
T Consensus       115 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  194 (346)
T 2q83_A          115 GRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDG  194 (346)
T ss_dssp             CBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHH
T ss_pred             CccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHH
Confidence            865530              111111000  0 00 000112343211                               1


Q ss_pred             HHHHHHHHhccccc----------cCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          212 VAIDVAKALSYLHN----------DCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       212 i~~~ia~~L~~Lh~----------~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +...+..++++|++          .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus       195 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          195 FIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            11223345666652          123789999999999999888899999999875

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.70  E-value=0.00027  Score=66.29  Aligned_cols=73  Identities=22%  Similarity=0.317  Sum_probs=53.8

Q ss_pred             cccCcCCceEEEEEEeCCCcEEEEEEecCC-CccHHHHHHHHHHHHhcCCC---ceeeEeeEEEecCCCeEEEEEecCCC
Q 047276          107 ALLGHGSSASVFKGILSDGTSVAVKRINGE-ENGEKEFRSEVAAIASAQHV---NLVRLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~---niv~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      +.+|.|..+.||+.++.||+.+++|+-... ......|..|+..|+.|.-.   .+.+++++.     ..++||||++.+
T Consensus        21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~-----~~~lv~e~l~~~   95 (288)
T 3f7w_A           21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD-----DRTLAMEWVDER   95 (288)
T ss_dssp             EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE-----TTEEEEECCCCC
T ss_pred             EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc-----CceEEEEeeccc
Confidence            468999999999999999999999987543 23335688999999988522   344455432     347899999876


Q ss_pred             Ch
Q 047276          183 SL  184 (453)
Q Consensus       183 sL  184 (453)
                      ..
T Consensus        96 ~~   97 (288)
T 3f7w_A           96 PP   97 (288)
T ss_dssp             CC
T ss_pred             CC
Confidence            54

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.63  E-value=0.00052  Score=65.22  Aligned_cols=144  Identities=17%  Similarity=0.186  Sum_probs=90.2

Q ss_pred             cccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcC---CCceeeEeeEEEecCCCeEEEEEecCCCC
Q 047276          107 ALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQ---HVNLVRLLGYCVVPGGPRYLVYEFIQNGS  183 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~~lv~e~~~~gs  183 (453)
                      +.|+.|.+..+|+... ++..+++|+....  ....|..|...|+.|.   ...+.++++++.. .+..++||||+++..
T Consensus        42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-~g~~~lvme~l~G~~  117 (312)
T 3jr1_A           42 EKLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNS-QGHSFLLLEALNKSK  117 (312)
T ss_dssp             EEECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-SSEEEEEEECCCCCC
T ss_pred             EEeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-CCceEEEEEeccCCC
Confidence            3588999999999886 4678889987532  3567889999998884   3567788887753 457899999999876


Q ss_pred             hhh-----------hhccCCC-CCCCC-----------CCCCCCCHHHHH---HHHH--H--------------HHHHh-
Q 047276          184 LDH-----------WIFPTSR-RSEGH-----------YSGGCLSWDLRY---RVAI--D--------------VAKAL-  220 (453)
Q Consensus       184 L~~-----------~l~~~~~-~~~~~-----------~~~~~l~~~~~~---~i~~--~--------------ia~~L-  220 (453)
                      +..           .|+.... .....           .+.-.-+|....   ++..  +              +.+.+ 
T Consensus       118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~  197 (312)
T 3jr1_A          118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA  197 (312)
T ss_dssp             CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred             CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence            521           1222211 00000           001113565332   1111  1              11111 


Q ss_pred             ccccc-cCCCceeccCCCCCcEEECCCCcEEEeecc
Q 047276          221 SYLHN-DCRSRVLHLDVKPENILLDENYRAVVSDFG  255 (453)
Q Consensus       221 ~~Lh~-~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfG  255 (453)
                      ..|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus       198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            12321 1237899999999999999887 8899974

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.56  E-value=0.0003  Score=69.88  Aligned_cols=77  Identities=16%  Similarity=0.036  Sum_probs=48.2

Q ss_pred             CceeccCCCCCcEEECCCCcEEEeeccccccccCCCCceeeecc--CCccccchhhhhcC---CCCccccchhHHHHHHH
Q 047276          229 SRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR--GTRGYLAPEWILEQ---GVSEKCDIYSYGMVLLE  303 (453)
Q Consensus       229 ~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~---~~~~~sDV~S~Gvil~e  303 (453)
                      ..++|+|+++.|||++.++ ++|+||+.+........  .....  -...|.+|+.....   .-....++.+....+|+
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D--la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD--IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH--HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH--HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            7899999999999999876 99999998875432110  00000  01245566544311   11123555678888888


Q ss_pred             HHcCC
Q 047276          304 LTGGR  308 (453)
Q Consensus       304 lltG~  308 (453)
                      .+++.
T Consensus       309 ~y~~~  313 (420)
T 2pyw_A          309 LFNKR  313 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77664

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.47  E-value=0.00021  Score=67.54  Aligned_cols=143  Identities=16%  Similarity=0.074  Sum_probs=75.0

Q ss_pred             cccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCce-eeEeeEEEecCCCeEEEEEec-CCCCh
Q 047276          107 ALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNL-VRLLGYCVVPGGPRYLVYEFI-QNGSL  184 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~~lv~e~~-~~gsL  184 (453)
                      +.|+.|....+|+.     ..+++|+........-....|..++..+...++ .+++++   ..+.-++++||+ ++.+|
T Consensus        24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~---~~~~~~~v~e~i~~g~~l   95 (301)
T 3dxq_A           24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV---DPATGVMVTRYIAGAQTM   95 (301)
T ss_dssp             EEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE---CTTTCCEEEECCTTCEEC
T ss_pred             eEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE---ECCCCEEEEeecCCCccC
Confidence            46888999999998     458888876432111123467777777642222 345543   233457899999 55444


Q ss_pred             hhh------------------hccCCCCCCCCC-----------------CCCCCCHHHHHHHHHHHHHHhccccccCCC
Q 047276          185 DHW------------------IFPTSRRSEGHY-----------------SGGCLSWDLRYRVAIDVAKALSYLHNDCRS  229 (453)
Q Consensus       185 ~~~------------------l~~~~~~~~~~~-----------------~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~  229 (453)
                      ...                  +|..........                 ...........+.+..+...+.-..  ...
T Consensus        96 ~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~--~~~  173 (301)
T 3dxq_A           96 SPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP--LPL  173 (301)
T ss_dssp             CHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC--CCC
T ss_pred             CHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC--CCc
Confidence            321                  111110000000                 0000011111111222222221111  236


Q ss_pred             ceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          230 RVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       230 ~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      .++|+|+.+.||+ ..++.+.++||..+...
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence            7999999999999 56667899999987643

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.34  E-value=0.0018  Score=61.71  Aligned_cols=163  Identities=13%  Similarity=0.115  Sum_probs=89.6

Q ss_pred             ecHHHHHHHHHHHh-------cccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCC--ceeeEee
Q 047276           93 FRSKELEEATDNFQ-------ALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHV--NLVRLLG  163 (453)
Q Consensus        93 ~~~~el~~~~~~~~-------~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~g  163 (453)
                      .+.+++......+.       ..++ |....||+....+|+.+++|...........+..|..++..+...  .+.+++.
T Consensus        11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~   89 (328)
T 1zyl_A           11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVA   89 (328)
T ss_dssp             CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCC
T ss_pred             CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceee
Confidence            44555555544442       2355 778899998877787899999875444566778888888877422  2344443


Q ss_pred             E----EEecCCCeEEEEEecCCCChhh-----h---------hccCCCCCCCCCCCCCCCHHHH----------------
Q 047276          164 Y----CVVPGGPRYLVYEFIQNGSLDH-----W---------IFPTSRRSEGHYSGGCLSWDLR----------------  209 (453)
Q Consensus       164 ~----~~~~~~~~~lv~e~~~~gsL~~-----~---------l~~~~~~~~~~~~~~~l~~~~~----------------  209 (453)
                      .    ....++..+++++|+++..+..     +         ++....... .......++...                
T Consensus        90 ~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~~~~  168 (328)
T 1zyl_A           90 FNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQL-FIHRPTIGLNEYLIEPRKLFEDATLIPS  168 (328)
T ss_dssp             BTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSC-CSSSCBCSHHHHTHHHHHHHHTCSSSCT
T ss_pred             cCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCC-CccCCCCCHHHHHhhHHHHHhhcCcCCH
Confidence            2    0011234578999998754421     0         111000000 000111222111                


Q ss_pred             ------HHHHHHHHHHhccc-cccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          210 ------YRVAIDVAKALSYL-HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       210 ------~~i~~~ia~~L~~L-h~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                            ...+..+...+.-+ .......++|+|+++.|||++ + .+.|+||+.+..
T Consensus       169 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          169 GLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             TTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                  11111222222211 111236789999999999999 4 899999988754

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.24  E-value=0.0004  Score=66.13  Aligned_cols=149  Identities=13%  Similarity=0.106  Sum_probs=77.6

Q ss_pred             ccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCc--eeeEeeE-----EEecCCCeEEEEEecC
Q 047276          108 LLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVN--LVRLLGY-----CVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       108 ~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~-----~~~~~~~~~lv~e~~~  180 (453)
                      .|+.|....+|+....+| .+++|..... .....+..|+.++..+...+  +.+++..     +....+..+++++|++
T Consensus        29 ~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~  106 (322)
T 2ppq_A           29 GIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE  106 (322)
T ss_dssp             EECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred             ccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCC
Confidence            467788899999987666 5788988752 12234566787777664222  2233321     0011234688999998


Q ss_pred             CCChhhh--------------hccCCCCCC-CC-CCCCCCCHHHHHHH------------HHHHHHHhccccc----cCC
Q 047276          181 NGSLDHW--------------IFPTSRRSE-GH-YSGGCLSWDLRYRV------------AIDVAKALSYLHN----DCR  228 (453)
Q Consensus       181 ~gsL~~~--------------l~~~~~~~~-~~-~~~~~l~~~~~~~i------------~~~ia~~L~~Lh~----~~~  228 (453)
                      +..+...              ++....... .. .......|...+.-            ...+.+.++++.+    ...
T Consensus       107 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~  186 (322)
T 2ppq_A          107 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP  186 (322)
T ss_dssp             CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred             CcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCC
Confidence            8654210              111110000 00 00011123321110            0012233333331    123


Q ss_pred             CceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          229 SRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       229 ~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      ..++|+|+.+.|||++++..+.|+||+.+.
T Consensus       187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            679999999999999987666899998775

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.23  E-value=0.0013  Score=62.86  Aligned_cols=32  Identities=31%  Similarity=0.297  Sum_probs=28.2

Q ss_pred             CceeccCCCCCcEEECCC----CcEEEeeccccccc
Q 047276          229 SRVLHLDVKPENILLDEN----YRAVVSDFGLSKLM  260 (453)
Q Consensus       229 ~~ivH~Dlk~~NiLl~~~----~~~kl~DfGla~~~  260 (453)
                      ..++|+|+.+.||+++.+    +.+.|+||+.+...
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            689999999999999875    68999999988754

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.12  E-value=0.0013  Score=65.46  Aligned_cols=72  Identities=21%  Similarity=0.241  Sum_probs=49.0

Q ss_pred             cccCcCCceEEEEEEeCC--------CcEEEEEEecCCCccHHHHHHHHHHHHhcCCCce-eeEeeEEEecCCCeEEEEE
Q 047276          107 ALLGHGSSASVFKGILSD--------GTSVAVKRINGEENGEKEFRSEVAAIASAQHVNL-VRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~~lv~e  177 (453)
                      +.|+.|....+|+....+        +..+++|+.... .....+..|..++..+...++ .++++.+  .+   .+|+|
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~--~~---g~v~e  152 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIF--SG---GRLEE  152 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEE--TT---EEEEC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEe--CC---CEEEE
Confidence            357888889999998753        478999988432 222456689999888853333 4566653  22   38999


Q ss_pred             ecCCCCh
Q 047276          178 FIQNGSL  184 (453)
Q Consensus       178 ~~~~gsL  184 (453)
                      |+++.+|
T Consensus       153 ~l~G~~l  159 (429)
T 1nw1_A          153 YIPSRPL  159 (429)
T ss_dssp             CCCEEEC
T ss_pred             EeCCccc
Confidence            9986454

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.04  E-value=0.002  Score=64.57  Aligned_cols=72  Identities=10%  Similarity=0.072  Sum_probs=46.4

Q ss_pred             ccCcCCceEEEEEEeCC-CcEEEEEEecCCCccHHHHHHHHHHHHhcCCCce-eeEeeEEEecCCCeEEEEEecCCCCh
Q 047276          108 LLGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFRSEVAAIASAQHVNL-VRLLGYCVVPGGPRYLVYEFIQNGSL  184 (453)
Q Consensus       108 ~lG~G~fG~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~~lv~e~~~~gsL  184 (453)
                      .|+.|-...+|+....+ +..+++|+........-....|..++..|...++ .++++++  .+   .+|+||+++.+|
T Consensus       115 ~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~---G~v~e~I~G~~l  188 (458)
T 2qg7_A          115 IINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF--TN---GRIEEFMDGYAL  188 (458)
T ss_dssp             EECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE--TT---EEEEECCCSEEC
T ss_pred             EcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe--CC---eEEEEeeCCccC
Confidence            57788889999998865 4778888875422111112578999998875555 4566654  22   359999987555

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.03  E-value=0.00093  Score=65.00  Aligned_cols=73  Identities=15%  Similarity=0.115  Sum_probs=43.5

Q ss_pred             cccCcCCceEEEEEEeCC---------CcEEEEEEecCCCccHHHHHHHHHHHHhcCCCce-eeEeeEEEecCCCeEEEE
Q 047276          107 ALLGHGSSASVFKGILSD---------GTSVAVKRINGEENGEKEFRSEVAAIASAQHVNL-VRLLGYCVVPGGPRYLVY  176 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~~lv~  176 (453)
                      ..|+.|....+|+....+         +..+++|+.............|..++..+...++ .++++..  .   -++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~---~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N---GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T---TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C---CcEEE
Confidence            357788889999998754         2678888875432211123578888887753333 3555432  2   37899


Q ss_pred             EecCCCCh
Q 047276          177 EFIQNGSL  184 (453)
Q Consensus       177 e~~~~gsL  184 (453)
                      ||+++.++
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99987544

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.83  E-value=0.0031  Score=61.51  Aligned_cols=144  Identities=17%  Similarity=0.160  Sum_probs=82.2

Q ss_pred             cccCcCCceEEEEEEeCC--------CcEEEEEEecCCCccHHHHHHHHHHHHhcCCCc-eeeEeeEEEecCCCeEEEEE
Q 047276          107 ALLGHGSSASVFKGILSD--------GTSVAVKRINGEENGEKEFRSEVAAIASAQHVN-LVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~~lv~e  177 (453)
                      +.|..|-...+|+....+        ++.+++|+..........+.+|..+++.+.-.+ ..++++++  .+   .+|+|
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~--~~---g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF--PE---GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE--TT---EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc--CC---ccEEE
Confidence            357778888999998752        478999986443334556778999988875222 24566554  22   38999


Q ss_pred             ecCCCChhhh-----------------hccCCCCCCCCCCCCCC-CHHHHHHHHHHHHHH-------------------h
Q 047276          178 FIQNGSLDHW-----------------IFPTSRRSEGHYSGGCL-SWDLRYRVAIDVAKA-------------------L  220 (453)
Q Consensus       178 ~~~~gsL~~~-----------------l~~~~~~~~~~~~~~~l-~~~~~~~i~~~ia~~-------------------L  220 (453)
                      |+++.+|..-                 ||....    ....... -|.+..++..++...                   +
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~----~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~  206 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEM----PFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM  206 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCC----SSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCC----CCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence            9998665321                 111110    0011111 244455454443221                   1


Q ss_pred             ccc----cc-cCCCceeccCCCCCcEEECCC----CcEEEeecccccc
Q 047276          221 SYL----HN-DCRSRVLHLDVKPENILLDEN----YRAVVSDFGLSKL  259 (453)
Q Consensus       221 ~~L----h~-~~~~~ivH~Dlk~~NiLl~~~----~~~kl~DfGla~~  259 (453)
                      .+|    .. .....++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            222    11 123579999999999999876    7899999998753

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.74  E-value=0.0044  Score=59.50  Aligned_cols=31  Identities=19%  Similarity=0.302  Sum_probs=27.9

Q ss_pred             CceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          229 SRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       229 ~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ..++|+|+.+.||++++++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            6899999999999999888899999987754

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=94.81  E-value=0.047  Score=48.34  Aligned_cols=98  Identities=12%  Similarity=0.053  Sum_probs=62.7

Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccC
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR  262 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~  262 (453)
                      ||.+.|...         +.+|+++++|.++.|.+.+|.-+-..  ..-..+=+.|..|++..+|.+...+ +.+.    
T Consensus        34 SL~eIL~~~---------~~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----   97 (229)
T 2yle_A           34 SLEEILRLY---------NQPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD----   97 (229)
T ss_dssp             EHHHHHHHH---------TSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C-------
T ss_pred             cHHHHHHHc---------CCCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc----
Confidence            788888644         34699999999999999998766210  0111233457899999999987653 1110    


Q ss_pred             CCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc
Q 047276          263 DQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG  306 (453)
Q Consensus       263 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt  306 (453)
                               .....+.+||... ...+.+.=|||+|+++|.-+-
T Consensus        98 ---------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 ---------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             ------------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred             ---------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence                     0122356787653 344678899999999999885

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=94.74  E-value=0.038  Score=35.08  Aligned_cols=28  Identities=36%  Similarity=0.508  Sum_probs=11.7

Q ss_pred             hHHHHHHHHHHHHHHHHHHHHHHHhhhc
Q 047276           33 AFFLIVGADIAVVLAVFACVIIRRRYHK   60 (453)
Q Consensus        33 ~~~~i~~~~~~~~l~~~~~~~~~~~~~~   60 (453)
                      +...++|+.+++++++.+.++++||+.+
T Consensus        14 Ia~~vVGvll~vi~~l~~~~~~RRR~~~   41 (44)
T 2jwa_A           14 IISAVVGILLVVVLGVVFGILIKRRQQK   41 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHCSC
T ss_pred             hHHHHHHHHHHHHHHHHHHhheehhhhh
Confidence            3344445333333333344444444433

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.21  E-value=0.12  Score=50.97  Aligned_cols=73  Identities=12%  Similarity=0.150  Sum_probs=46.6

Q ss_pred             cccCcCCceEEEEEEeCC--------CcEEEEEEecCCCccHHHHHHHHHHHHhcCCCc-eeeEeeEEEecCCCeEEEEE
Q 047276          107 ALLGHGSSASVFKGILSD--------GTSVAVKRINGEENGEKEFRSEVAAIASAQHVN-LVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~~lv~e  177 (453)
                      +.+..|-...+|+....+        ++.+++|+........-...+|..+++.+.-.+ ..++++.+  .   -++|+|
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~---~~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P---EGRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T---TEEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C---CCEEEE
Confidence            357778889999998753        578999886542211112356888887775322 34455432  2   278999


Q ss_pred             ecCCCCh
Q 047276          178 FIQNGSL  184 (453)
Q Consensus       178 ~~~~gsL  184 (453)
                      |+++.+|
T Consensus       151 fI~G~~l  157 (424)
T 3mes_A          151 FIDGEPL  157 (424)
T ss_dssp             CCCSEEC
T ss_pred             EeCCccC
Confidence            9998664

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=91.71  E-value=0.29  Score=47.81  Aligned_cols=30  Identities=33%  Similarity=0.443  Sum_probs=25.4

Q ss_pred             ceeccCCCCCcEEE------CCCCcEEEeecccccc
Q 047276          230 RVLHLDVKPENILL------DENYRAVVSDFGLSKL  259 (453)
Q Consensus       230 ~ivH~Dlk~~NiLl------~~~~~~kl~DfGla~~  259 (453)
                      .++|+|+.+.|||+      +++..+.++||..+..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            46799999999999      4567899999998753

>2klu_A T-cell surface glycoprotein CD4; cell membrane, disulfide bond, HOST- virus interaction, immune response, immunoglobulin domain, lipoprotein; NMR {Homo sapiens}

Probab=89.52  E-value=0.45  Score=32.66  Aligned_cols=23  Identities=17%  Similarity=0.241  Sum_probs=12.7

Q ss_pred             cchhHHHHHHHHHHHHHHHHHHHH
Q 047276           30 LSKAFFLIVGADIAVVLAVFACVI   53 (453)
Q Consensus        30 ~~~~~~~i~~~~~~~~l~~~~~~~   53 (453)
                      +.+.+ +++|.++.+++++.++++
T Consensus         7 ~p~~L-ivlGg~~~lll~~glcI~   29 (70)
T 2klu_A            7 GSMAL-IVLGGVAGLLLFIGLGIF   29 (70)
T ss_dssp             CSSHH-HHHHHHHHHHHHHHHHHH
T ss_pred             hHHHH-HHHhHHHHHHHHHHHHHH
Confidence            33444 566666666655555544

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=87.82  E-value=0.05  Score=54.48  Aligned_cols=57  Identities=7%  Similarity=0.032  Sum_probs=16.9

Q ss_pred             cccCcCCceEEEEEEeCC-CcEEEE------EEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEE
Q 047276          107 ALLGHGSSASVFKGILSD-GTSVAV------KRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCV  166 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~-g~~vav------K~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~  166 (453)
                      +.||   ||.||+|.+.. ..+|||      |..+...   .....|.+|..++..++|||+++.+++..
T Consensus       148 ~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          148 EHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             TTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             ccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            4666   99999999854 367888      7665422   22346888999999999999999998754

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=82.78  E-value=2.8  Score=36.83  Aligned_cols=117  Identities=9%  Similarity=0.131  Sum_probs=77.3

Q ss_pred             cCCCceeeEeeEEEecCCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCcee
Q 047276          153 AQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVL  232 (453)
Q Consensus       153 l~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~iv  232 (453)
                      ..||+.++.- + ....+...+.|+.  ..+..+|-.           -..++...+++++.+|+..-.+++.     -+
T Consensus        42 ~~~~~Fl~~~-I-~e~eD~v~~~y~~--~~~~~~f~~-----------ik~~~~~eKlr~l~ni~~l~~~~~~-----r~  101 (215)
T 4ann_A           42 QHSPYFIDAE-L-TELRDSFQIHYDI--NDNHTPFDN-----------IKSFTKNEKLRYLLNIKNLEEVNRT-----RY  101 (215)
T ss_dssp             SCCTTBCCEE-E-EECSSEEEEEECC--CTTSEEGGG-----------GGGSCHHHHHHHHHHGGGGGGGGGS-----SE
T ss_pred             ccCCcccceE-E-EEcccEEEEEEEc--CcccCCHHH-----------HHhcCHHHHHHHHHHHHHHHHHhcC-----ce
Confidence            3588887652 2 2344444444443  333433321           1227888999999999998877764     37


Q ss_pred             ccCCCCCcEEECCCCcEEEeeccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCc
Q 047276          233 HLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVS  312 (453)
Q Consensus       233 H~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~  312 (453)
                      |--++|+|+++|.++.+++.-.|+...+.                  |.     ..+...=.-.+=+++..+++++..|.
T Consensus       102 tf~L~P~NL~f~~~~~p~i~~RGik~~l~------------------P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          102 TFVLAPDELFFTRDGLPIAKTRGLQNVVD------------------PL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             ECCCSGGGEEECTTSCEEESCCEETTTBS------------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EEEEecceEEEcCCCCEEEEEccCccCCC------------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            88899999999999999998877654332                  21     11222223356788999999998874

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=82.69  E-value=1.3  Score=27.22  Aligned_cols=22  Identities=23%  Similarity=0.185  Sum_probs=10.3

Q ss_pred             HHHHHHHHHHHHHHHHHHHHHH
Q 047276           35 FLIVGADIAVVLAVFACVIIRR   56 (453)
Q Consensus        35 ~~i~~~~~~~~l~~~~~~~~~~   56 (453)
                      .+++|+.+++++++.++++++|
T Consensus        15 GiVvG~v~gv~li~~l~~~~~r   36 (38)
T 2k1k_A           15 AVIFGLLLGAALLLGILVFRSR   36 (38)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHC
T ss_pred             eeehHHHHHHHHHHHHHHHHee
Confidence            3444555555544444444443

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=81.25  E-value=2.2  Score=37.59  Aligned_cols=115  Identities=17%  Similarity=0.134  Sum_probs=75.5

Q ss_pred             cCCCceeeEeeEEEecCCCeEEEEEecCCC-ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhc-cccccCCCc
Q 047276          153 AQHVNLVRLLGYCVVPGGPRYLVYEFIQNG-SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALS-YLHNDCRSR  230 (453)
Q Consensus       153 l~h~niv~l~g~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~-~Lh~~~~~~  230 (453)
                      ..||++ +.- . ...++...+.|+.-+++ +.. .+             ..++...+++++.+++.... +++.     
T Consensus        47 ~~~~~f-~~~-I-~~~eD~~~i~y~~~~~~~~f~-~i-------------~~~~~~eKlrll~nl~~L~~~~~~~-----  104 (219)
T 4ano_A           47 EVDPCI-VRD-I-DVSEDEVKVVIKPPSSFLTFA-AI-------------RKTTLLSRIRAAIHLVSKVKHHSAR-----  104 (219)
T ss_dssp             GSCSSS-EEE-E-EECSSEEEEEEECCTTCEEHH-HH-------------HTSCHHHHHHHHHHHHHHHSSCCSS-----
T ss_pred             ccCCCC-CeE-E-EEeCCEEEEEEEcCcccCcHH-HH-------------HhcCHHHHHHHHHHHHHHHHHhhhC-----
Confidence            357777 322 2 23455655666654333 233 22             12788899999999999988 7765     


Q ss_pred             eeccCCCCCcEEECCCCcEEEeeccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCC
Q 047276          231 VLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRN  310 (453)
Q Consensus       231 ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p  310 (453)
                      -+|--++|+|+++|.++.++|.-.|+-..+++..             +.+|-+          .-++=+++..++.++..
T Consensus       105 r~tf~l~P~NL~f~~~~~p~i~hRGi~~~lpP~e-------------~~ee~f----------l~qyKali~all~~K~~  161 (219)
T 4ano_A          105 RLIFIVCPENLMFNRALEPFFLHVGVKESLPPDE-------------WDDERL----------LREVKATVLALTEGEYR  161 (219)
T ss_dssp             SEECCCCGGGEEECTTCCEEESCCEETTTBSSCS-------------CCHHHH----------HHHHHHHHHHHTTCSSC
T ss_pred             ceeEEEeCceEEEeCCCcEEEEEcCCcccCCCCC-------------CCHHHH----------HHHHHHHHHHHHcCCCC
Confidence            4788899999999999999998888754332111             122222          23466788889989877


Q ss_pred             Cc
Q 047276          311 VS  312 (453)
Q Consensus       311 ~~  312 (453)
                      |.
T Consensus       162 Fe  163 (219)
T 4ano_A          162 FD  163 (219)
T ss_dssp             HH
T ss_pred             HH
Confidence            74

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	453
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-58
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-58
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-57
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-57
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-56
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-55
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-55
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-53
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-53
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-53
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-53
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	8e-53
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-52
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-52
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-50
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	7e-50
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-49
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-49
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-49
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	9e-49
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-47
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-47
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-47
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-47
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-45
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-45
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-45
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-45
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-44
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	5e-43
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-42
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-42
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-42
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-39
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	6e-39
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-38
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	6e-38
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-37
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-37
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-36
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-36
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	9e-36
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-35
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-35
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-35
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-35
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-35
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-34
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-33
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-33
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-32
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	8e-32
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	6e-31
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	6e-31
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-30
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-29
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	6e-29
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	7e-29
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-28
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-26
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-26
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-25
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	8e-15

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 1e-58
 Identities = 63/286 (22%), Positives = 113/286 (39%), Gaps = 38/286 (13%)

Query: 105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGY 164
               LG G    V+ G  +  T VAVK +         F +E   +   QH  LVRL   
Sbjct: 17  LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76

Query: 165 CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH 224
                 P Y++ E+++NGSL  ++           SG  L+ +    +A  +A+ ++++ 
Sbjct: 77  VT--QEPIYIITEYMENGSLVDFLK--------TPSGIKLTINKLLDMAAQIAEGMAFIE 126

Query: 225 NDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWIL 284
                  +H D++  NIL+ +     ++DFGL++L+  ++       +    + APE I 
Sbjct: 127 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183

Query: 285 EQGVSEKCDIYSYGMVLLE-LTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLME 343
               + K D++S+G++L E +T GR                 +    +            
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRI--------PYPGMTNPEVIQNLER---------- 225

Query: 344 IVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE 389
               R+       E     L  +   C +ER   RP+   +  +LE
Sbjct: 226 --GYRMVRPDNCPE----ELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (485), Expect = 3e-58
 Identities = 66/292 (22%), Positives = 118/292 (40%), Gaps = 42/292 (14%)

Query: 105 FQALLGHGSSASVFKGILSDGTSVAVKRIN---GEENGEKEFRSEVAAIASAQHVNLVRL 161
               +G GS  +V+KG       VAVK +N         + F++EV  +   +HVN++  
Sbjct: 12  VGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69

Query: 162 LGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALS 221
           +GY         +V ++ +  SL H +         H             +A   A+ + 
Sbjct: 70  MGYST--APQLAIVTQWCEGSSLYHHL---------HIIETKFEMIKLIDIARQTAQGMD 118

Query: 222 YLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ-SRCITTIRGTRGYLAP 280
           YLH      ++H D+K  NI L E+    + DFGL+ + SR   S     + G+  ++AP
Sbjct: 119 YLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175

Query: 281 EWILEQG---VSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMK 337
           E I  Q     S + D+Y++G+VL EL  G+   S        + N       +V     
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS--------NINNRDQIIFMVGRGYL 227

Query: 338 EGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE 389
              L +           +     + +  +   C++++   RP   +++  +E
Sbjct: 228 SPDLSK-----------VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 2e-57
 Identities = 66/295 (22%), Positives = 118/295 (40%), Gaps = 38/295 (12%)

Query: 105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGY 164
            +  LG G    V+ G  +  T VA+K +       + F  E   +   +H  LV+L   
Sbjct: 21  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80

Query: 165 CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH 224
                 P Y+V E++  GSL  ++           +G  L       +A  +A  ++Y+ 
Sbjct: 81  VSE--EPIYIVTEYMSKGSLLDFLK--------GETGKYLRLPQLVDMAAQIASGMAYVE 130

Query: 225 NDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWIL 284
                  +H D++  NIL+ EN    V+DFGL++L+  ++       +    + APE  L
Sbjct: 131 RMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 187

Query: 285 EQGVSEKCDIYSYGMVLLEL-TGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLME 343
               + K D++S+G++L EL T GR                   +P +VN      ++++
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRV-----------------PYPGMVNR-----EVLD 225

Query: 344 IVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVDDPP 398
            V++               L D+   C ++    RP+   +   LE      +P 
Sbjct: 226 QVERGYRMP--CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 3e-57
 Identities = 61/287 (21%), Positives = 109/287 (37%), Gaps = 38/287 (13%)

Query: 104 NFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLG 163
            F   LG G    V  G       VA+K I      E EF  E   + +  H  LV+L G
Sbjct: 7   TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66

Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL 223
            C     P +++ E++ NG L +++                       +  DV +A+ YL
Sbjct: 67  VCTKQR-PIFIITEYMANGCLLNYL---------REMRHRFQTQQLLEMCKDVCEAMEYL 116

Query: 224 HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWI 283
            +      LH D+   N L+++     VSDFGLS+ +  D+       +    +  PE +
Sbjct: 117 ESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173

Query: 284 LEQGVSEKCDIYSYGMVLLEL-TGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLM 342
           +    S K DI+++G+++ E+ + G+                         E+    +  
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMPY----------------------ERFTNSETA 211

Query: 343 EIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE 389
           E + Q L            ++  + + C  E+A  RP+   ++  + 
Sbjct: 212 EHIAQGLRLY--RPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 2e-56
 Identities = 65/287 (22%), Positives = 116/287 (40%), Gaps = 38/287 (13%)

Query: 104 NFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLG 163
            F   +G G    V  G   +   VA+K I      E++F  E   +    H  LV+L G
Sbjct: 8   TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 67

Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL 223
            C+    P  LV+EF+++G L  ++             G  + +    + +DV + ++YL
Sbjct: 68  VCLE-QAPICLVFEFMEHGCLSDYL---------RTQRGLFAAETLLGMCLDVCEGMAYL 117

Query: 224 HNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWI 283
              C   V+H D+   N L+ EN    VSDFG+++ +  DQ    T  +    + +PE  
Sbjct: 118 EEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174

Query: 284 LEQGVSEKCDIYSYGMVLLE-LTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLM 342
                S K D++S+G+++ E  + G+           ++++  +    I           
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGKI--------PYENRSNSEVVEDIST--------- 217

Query: 343 EIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE 389
                RL             +  +   C +ER   RP+ +R++  L 
Sbjct: 218 ---GFRLYKPRLAST----HVYQIMNHCWKERPEDRPAFSRLLRQLA 257

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 1e-55
 Identities = 56/298 (18%), Positives = 117/298 (39%), Gaps = 32/298 (10%)

Query: 109 LGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP 168
           +G G    V++G    G  VAVK  +  E       +E+      +H N++  +      
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 69

Query: 169 GGPR---YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
            G     +LV ++ ++GSL  ++           +   ++ +   ++A+  A  L++LH 
Sbjct: 70  NGTWTQLWLVSDYHEHGSLFDYL-----------NRYTVTVEGMIKLALSTASGLAHLHM 118

Query: 226 DC-----RSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ---SRCITTIRGTRGY 277
           +      +  + H D+K +NIL+ +N    ++D GL+                  GT+ Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178

Query: 278 LAPEWILEQ------GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKI 331
           +APE + +          ++ DIY+ G+V  E+        + E       +     P +
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238

Query: 332 VNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE 389
             E+M++    + +   + +     E  +R +  +   C       R +  R+ + L 
Sbjct: 239 --EEMRKVVCEQKLRPNIPNRWQSCE-ALRVMAKIMRECWYANGAARLTALRIKKTLS 293

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (464), Expect = 2e-55
 Identities = 78/286 (27%), Positives = 124/286 (43%), Gaps = 42/286 (14%)

Query: 105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGY 164
               +G G    V  G    G  VAVK I  +    + F +E + +   +H NLV+LLG 
Sbjct: 11  LLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT-AQAFLAEASVMTQLRHSNLVQLLGV 68

Query: 165 CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH 224
            V   G  Y+V E++  GSL  ++    R          L  D   + ++DV +A+ YL 
Sbjct: 69  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--------LGGDCLLKFSLDVCEAMEYLE 120

Query: 225 NDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWIL 284
               +  +H D+   N+L+ E+  A VSDFGL+K  S  Q     T +    + APE + 
Sbjct: 121 ---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALR 173

Query: 285 EQGVSEKCDIYSYGMVLLE-LTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLME 343
           E+  S K D++S+G++L E  + GR                 +   K V  ++++G  M+
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRV-------------PYPRIPLKDVVPRVEKGYKMD 220

Query: 344 IVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE 389
             D                + +V   C    A +RPS  ++ E LE
Sbjct: 221 APDGCPPA-----------VYEVMKNCWHLDAAMRPSFLQLREQLE 255

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  179 bits (455), Expect = 1e-53
 Identities = 69/319 (21%), Positives = 119/319 (37%), Gaps = 59/319 (18%)

Query: 93  FRSKELEEATDNF-----------QALLGHGSSASVFKGIL----SDGTSVAVKRINGE- 136
           F  ++  EA   F           + ++G G    V  G L         VA+K +    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 137 -ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRS 195
            E   ++F SE + +    H N++ L G       P  ++ EF++NGSLD ++       
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVT-KSTPVMIITEFMENGSLDSFL------- 118

Query: 196 EGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFG 255
               + G  +      +   +A  + YL +      +H D+   NIL++ N    VSDFG
Sbjct: 119 --RQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFG 173

Query: 256 LSKLMSRDQSRCITT----IRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLE-LTGGRRN 310
           LS+ +  D S    T     +    + APE I  +  +   D++SYG+V+ E ++ G R 
Sbjct: 174 LSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 233

Query: 311 VSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWC 370
                                    M    ++  ++Q               L  +   C
Sbjct: 234 Y----------------------WDMTNQDVINAIEQDYRLP--PPMDCPSALHQLMLDC 269

Query: 371 IQERARLRPSMARVVEMLE 389
            Q+    RP   ++V  L+
Sbjct: 270 WQKDRNHRPKFGQIVNTLD 288

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 1e-53
 Identities = 67/305 (21%), Positives = 112/305 (36%), Gaps = 49/305 (16%)

Query: 96  KELEEATDNFQAL---LGHGSSASVFKGIL---SDGTSVAVKRIN--GEENGEKEFRSEV 147
           K+L    DN       LG G+  SV +G+         VA+K +    E+   +E   E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 148 AAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWD 207
             +    +  +VRL+G C        LV E    G L  ++               +   
Sbjct: 61  QIMHQLDNPYIVRLIGVC--QAEALMLVMEMAGGGPLHKFL---------VGKREEIPVS 109

Query: 208 LRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC 267
               +   V+  + YL        +H D+   N+LL   + A +SDFGLSK +  D S  
Sbjct: 110 NVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166

Query: 268 I--TTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLE-LTGGRRNVSLIEHGNDKSKNK 324
              +  +    + APE I  +  S + D++SYG+ + E L+ G++               
Sbjct: 167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY------------- 213

Query: 325 WQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARV 384
            +     V   +++GK ME   +    E          L  +   C   +   RP    V
Sbjct: 214 KKMKGPEVMAFIEQGKRMECPPE-CPPE----------LYALMSDCWIYKWEDRPDFLTV 262

Query: 385 VEMLE 389
            + + 
Sbjct: 263 EQRMR 267

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  178 bits (453), Expect = 2e-53
 Identities = 70/303 (23%), Positives = 128/303 (42%), Gaps = 38/303 (12%)

Query: 90  PIKFRSKELEEATDNFQAL--LGHGSSASVFKGILSD-GTSVAVKRINGEENGEKEFRSE 146
           P      + E    +      LG G    V++G+      +VAVK +  +    +EF  E
Sbjct: 4   PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE 63

Query: 147 VAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSW 206
            A +   +H NLV+LLG C     P Y++ EF+  G+L  ++   +R+         +S 
Sbjct: 64  AAVMKEIKHPNLVQLLGVCT-REPPFYIITEFMTYGNLLDYLRECNRQE--------VSA 114

Query: 207 DLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSR 266
            +   +A  ++ A+ YL    +   +H D+   N L+ EN+   V+DFGLS+LM+ D   
Sbjct: 115 VVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 171

Query: 267 CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQ 326
                +    + APE +     S K D++++G++L E+                      
Sbjct: 172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG----------------MS 215

Query: 327 YFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE 386
            +P      +   ++ E++++    E    E    ++ ++   C Q     RPS A + +
Sbjct: 216 PYP-----GIDLSQVYELLEKDYRME--RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268

Query: 387 MLE 389
             E
Sbjct: 269 AFE 271

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 2e-53
 Identities = 68/288 (23%), Positives = 113/288 (39%), Gaps = 26/288 (9%)

Query: 98  LEEATDNFQAL--LGHGSSASVFKGI-LSDGTSVAVKRINGE--ENGEKEFRSEVAAIAS 152
           +E   D+F+ +  LG G+   VFK      G  +A K I+ E       +   E+  +  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 153 AQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRV 212
                +V   G     G    +  E +  GSLD  +             G +   +  +V
Sbjct: 61  CNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVL----------KKAGRIPEQILGKV 109

Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR 272
           +I V K L+YL    +  ++H DVKP NIL++      + DFG+S  +    +    +  
Sbjct: 110 SIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFV 164

Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIV 332
           GTR Y++PE +     S + DI+S G+ L+E+  GR  +         +K     F   V
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP-----PPDAKELELMFGCQV 219

Query: 333 NEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPS 380
                E         R     G+D      + ++  + + E     PS
Sbjct: 220 EGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPS 267

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 8e-53
 Identities = 74/293 (25%), Positives = 120/293 (40%), Gaps = 40/293 (13%)

Query: 103 DNFQAL--LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKE---FRSEVAAIASAQHV 156
           ++++ L  +G GS     K    SDG  +  K ++     E E     SEV  +   +H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 157 NLVRLLGYCVVPGGPR-YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
           N+VR     +       Y+V E+ + G L   I   ++          L  +   RV   
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKE------RQYLDEEFVLRVMTQ 117

Query: 216 VAKALSYLH--NDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRG 273
           +  AL   H  +D    VLH D+KP N+ LD      + DFGL+++++ D S       G
Sbjct: 118 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA-KAFVG 176

Query: 274 TRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVN 333
           T  Y++PE +     +EK DI+S G +L EL       +                 K + 
Sbjct: 177 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-------------QKELA 223

Query: 334 EKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE 386
            K++EGK   I   R +DE          L ++    +  +   RPS+  ++E
Sbjct: 224 GKIREGKFRRI-PYRYSDE----------LNEIITRMLNLKDYHRPSVEEILE 265

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  176 bits (448), Expect = 2e-52
 Identities = 70/324 (21%), Positives = 131/324 (40%), Gaps = 52/324 (16%)

Query: 91  IKFRSKELEEATDNFQAL--LGHGSSASVFKGIL------SDGTSVAVKRINGE--ENGE 140
           +  +   LE   +N + +  +G G+   VF+            T VAVK +  E   + +
Sbjct: 1   LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60

Query: 141 KEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYS 200
            +F+ E A +A   + N+V+LLG C V G P  L++E++  G L+ ++   S  +    S
Sbjct: 61  ADFQREAALMAEFDNPNIVKLLGVCAV-GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 119

Query: 201 GGC--------------LSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDEN 246
                            LS   +  +A  VA  ++YL      + +H D+   N L+ EN
Sbjct: 120 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGEN 176

Query: 247 YRAVVSDFGLSKLM-SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELT 305
               ++DFGLS+ + S D  +          ++ PE I     + + D+++YG+VL E+ 
Sbjct: 177 MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 236

Query: 306 GGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVD 365
                                 +  + +E++    +  + D  +       E     L +
Sbjct: 237 SYGLQ----------------PYYGMAHEEV----IYYVRDGNILA---CPENCPLELYN 273

Query: 366 VAFWCIQERARLRPSMARVVEMLE 389
           +   C  +    RPS   +  +L+
Sbjct: 274 LMRLCWSKLPADRPSFCSIHRILQ 297

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 3e-52
 Identities = 62/309 (20%), Positives = 117/309 (37%), Gaps = 46/309 (14%)

Query: 91  IKFRSKELEEATDNFQALLGHGSSASVFKGILSDGTS----VAVKRIN--GEENGEKEFR 144
           ++           +F  ++G G    V+ G L D        AVK +N   +     +F 
Sbjct: 17  VQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL 76

Query: 145 SEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCL 204
           +E   +    H N++ LLG C+   G   +V  ++++G L ++I                
Sbjct: 77  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---------RNETHNP 127

Query: 205 SWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ 264
           +        + VAK    +      + +H D+   N +LDE +   V+DFGL++ M   +
Sbjct: 128 TVKDLIGFGLQVAKG---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184

Query: 265 ---SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLE-LTGGRRNVSLIEHGNDK 320
                  T  +    ++A E +  Q  + K D++S+G++L E +T G             
Sbjct: 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP--------PYP 236

Query: 321 SKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPS 380
             N +     ++  +            RL       +     L +V   C   +A +RPS
Sbjct: 237 DVNTFDITVYLLQGR------------RLLQPEYCPD----PLYEVMLKCWHPKAEMRPS 280

Query: 381 MARVVEMLE 389
            + +V  + 
Sbjct: 281 FSELVSRIS 289

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 1e-50
 Identities = 64/309 (20%), Positives = 114/309 (36%), Gaps = 51/309 (16%)

Query: 105 FQALLGHGSSASVFKGILSD------GTSVAVKRIN--GEENGEKEFRSEVAAIAS-AQH 155
           F  +LG G+   V                VAVK +    + +  +   SE+  +     H
Sbjct: 41  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100

Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWI-------------FPTSRRSEGHYSGG 202
            N+V LLG C + G P YL++E+   G L +++             +   +R E      
Sbjct: 101 ENIVNLLGACTLSG-PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 159

Query: 203 CLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK-LMS 261
            L+++     A  VAK + +L        +H D+   N+L+       + DFGL++ +MS
Sbjct: 160 VLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 216

Query: 262 RDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLE-LTGGRRNVSLIEHGNDK 320
                     R    ++APE + E   + K D++SYG++L E  + G             
Sbjct: 217 DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN----------- 265

Query: 321 SKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPS 380
                  +P I  +        +++      +          +  +   C    +R RPS
Sbjct: 266 ------PYPGIPVDAN----FYKLIQNGFKMD--QPFYATEEIYIIMQSCWAFDSRKRPS 313

Query: 381 MARVVEMLE 389
              +   L 
Sbjct: 314 FPNLTSFLG 322

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 7e-50
 Identities = 63/290 (21%), Positives = 108/290 (37%), Gaps = 48/290 (16%)

Query: 109 LGHGSSASVFKGILSD---GTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLL 162
           LG G+  +V KG         +VAVK +  E      + E  +E   +    +  +VR++
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74

Query: 163 GYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSY 222
           G C        LV E  + G L+ ++               +       +   V+  + Y
Sbjct: 75  GICEAE--SWMLVMEMAELGPLNKYL----------QQNRHVKDKNIIELVHQVSMGMKY 122

Query: 223 LHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQS--RCITTIRGTRGYLAP 280
           L     S  +H D+   N+LL   + A +SDFGLSK +  D++  +  T  +    + AP
Sbjct: 123 LEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 179

Query: 281 EWILEQGVSEKCDIYSYGMVLLE-LTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG 339
           E I     S K D++S+G+++ E  + G++                      V   +++G
Sbjct: 180 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY-------------RGMKGSEVTAMLEKG 226

Query: 340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE 389
           + M                  R + D+   C       RP  A V   L 
Sbjct: 227 ERMG-----------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 1e-49
 Identities = 60/307 (19%), Positives = 118/307 (38%), Gaps = 44/307 (14%)

Query: 105 FQALLGHGSSASVFKGIL------SDGTSVAVKRINGEEN--GEKEFRSEVAAIAS-AQH 155
           F   LG G+   V +             +VAVK +    +    +   SE+  ++    H
Sbjct: 27  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86

Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIF--------PTSRRSEGHYSGGCLSWD 207
           +N+V LLG C + GGP  ++ E+   G L +++           +  +        L  +
Sbjct: 87  MNIVNLLGACTI-GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145

Query: 208 LRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC 267
                +  VAK +++L +      +H D+   NILL       + DFGL++ +  D +  
Sbjct: 146 DLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202

Query: 268 ITT-IRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQ 326
           +    R    ++APE I     + + D++SYG+ L EL     +       +        
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS------- 255

Query: 327 YFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE 386
                        K  +++ +         E     + D+   C       RP+  ++V+
Sbjct: 256 -------------KFYKMIKEGFRML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

Query: 387 MLEGRVA 393
           ++E +++
Sbjct: 301 LIEKQIS 307

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 2e-49
 Identities = 55/290 (18%), Positives = 107/290 (36%), Gaps = 45/290 (15%)

Query: 105 FQALLGHGSSASVFKGILSD-GTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVR 160
           F   +G GS  +V+KG+ ++    VA   +      ++  + F+ E   +   QH N+VR
Sbjct: 13  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72

Query: 161 LLGYCVVP---GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
                           LV E + +G+L  ++               +   +       + 
Sbjct: 73  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----------RFKVMKIKVLRSWCRQIL 122

Query: 218 KALSYLHNDCRSRVLHLDVKPENILL-DENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG 276
           K L +LH      ++H D+K +NI +        + D GL+ L     +     + GT  
Sbjct: 123 KGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPE 178

Query: 277 YLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKM 336
           ++APE + E+   E  D+Y++GM +LE+       S                   +  ++
Sbjct: 179 FMAPE-MYEEKYDESVDVYAFGMCMLEMATSEYPYS------------ECQNAAQIYRRV 225

Query: 337 KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE 386
             G      D+    E          + ++   CI++    R S+  ++ 
Sbjct: 226 TSGVKPASFDKVAIPE----------VKEIIEGCIRQNKDERYSIKDLLN 265

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 3e-49
 Identities = 69/316 (21%), Positives = 125/316 (39%), Gaps = 47/316 (14%)

Query: 95  SKELEEATDNFQALLGHGSSASVFKGILSDGTS-----VAVKRINGE--ENGEKEFRSEV 147
           + E+  +    Q ++G G    V+KG+L   +      VA+K +     E    +F  E 
Sbjct: 1   TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60

Query: 148 AAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWD 207
             +    H N++RL G       P  ++ E+++NG+LD ++             G  S  
Sbjct: 61  GIMGQFSHHNIIRLEGVIS-KYKPMMIITEYMENGALDKFL---------REKDGEFSVL 110

Query: 208 LRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC 267
               +   +A  + YL N      +H D+   NIL++ N    VSDFGLS+++  D    
Sbjct: 111 QLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT 167

Query: 268 ITT--IRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLE-LTGGRRNVSLIEHGNDKSKNK 324
            TT   +    + APE I  +  +   D++S+G+V+ E +T G R               
Sbjct: 168 YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP-------------- 213

Query: 325 WQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARV 384
                     ++   ++M+ ++                +  +   C Q+    RP  A +
Sbjct: 214 --------YWELSNHEVMKAINDGFRLP--TPMDCPSAIYQLMMQCWQQERARRPKFADI 263

Query: 385 VEMLEGRVAVDDPPDT 400
           V +L+  +   D   T
Sbjct: 264 VSILDKLIRAPDSLKT 279

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 9e-49
 Identities = 67/298 (22%), Positives = 120/298 (40%), Gaps = 41/298 (13%)

Query: 104 NFQALLGHGSSASVFKGILSDG---TSVAVKRIN--GEENGEKEFRSEVAAIAS-AQHVN 157
            FQ ++G G+   V K  +         A+KR+     ++  ++F  E+  +     H N
Sbjct: 13  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 72

Query: 158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIF------PTSRRSEGHYSGGCLSWDLRYR 211
           ++ LLG C   G   YL  E+  +G+L  ++            +  + +   LS      
Sbjct: 73  IINLLGACEHRG-YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131

Query: 212 VAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTI 271
            A DVA+ + YL    + + +H D+   NIL+ ENY A ++DFGLS+       +  T  
Sbjct: 132 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TMG 186

Query: 272 RGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKI 331
           R    ++A E +     +   D++SYG++L E+                     + + K+
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY-------CGMTCAELYEKL 239

Query: 332 VNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE 389
                           RL      D+     + D+   C +E+   RPS A+++  L 
Sbjct: 240 PQ------------GYRLEKPLNCDD----EVYDLMRQCWREKPYERPSFAQILVSLN 281

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 1e-47
 Identities = 59/295 (20%), Positives = 119/295 (40%), Gaps = 36/295 (12%)

Query: 105 FQALLGHGSSASVFKGIL------SDGTSVAVKRIN--GEENGEKEFRSEVAAIASAQHV 156
               LG GS   V++G+          T VA+K +N         EF +E + +      
Sbjct: 24  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83

Query: 157 NLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDV 216
           ++VRLLG     G P  ++ E +  G L  ++         +      S     ++A ++
Sbjct: 84  HVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 142

Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM-SRDQSRCITTIRGTR 275
           A  ++YL+    ++ +H D+   N ++ E++   + DFG+++ +   D  R         
Sbjct: 143 ADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 199

Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEK 335
            +++PE + +   +   D++S+G+VL E+       +L E       N+           
Sbjct: 200 RWMSPESLKDGVFTTYSDVWSFGVVLWEI------ATLAEQPYQGLSNEQVL------RF 247

Query: 336 MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEG 390
           + EG L++  D                L ++   C Q   ++RPS   ++  ++ 
Sbjct: 248 VMEGGLLDKPDNCPDM-----------LFELMRMCWQYNPKMRPSFLEIISSIKE 291

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  163 bits (414), Expect = 2e-47
 Identities = 57/298 (19%), Positives = 109/298 (36%), Gaps = 52/298 (17%)

Query: 99  EEATDNFQAL--LGHGSSASVFKGI-LSDGTSVAVKRIN----GEENGEKEFRSEVAAIA 151
           ++    F  L  +GHGS  +V+    + +   VA+K+++          ++   EV  + 
Sbjct: 11  DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70

Query: 152 SAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYR 211
             +H N ++  G  +      +LV E+    + D                  L       
Sbjct: 71  KLRHPNTIQYRGCYLREH-TAWLVMEYCLGSASDLLE----------VHKKPLQEVEIAA 119

Query: 212 VAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTI 271
           V     + L+YLH      ++H DVK  NILL E     + DFG + +M+   S      
Sbjct: 120 VTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV---- 172

Query: 272 RGTRGYLAPEWIL---EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYF 328
            GT  ++APE IL   E     K D++S G+  +EL   +  +             +   
Sbjct: 173 -GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL-------------FNMN 218

Query: 329 PKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE 386
                  + + +   +     ++             +    C+Q+  + RP+   +++
Sbjct: 219 AMSALYHIAQNESPALQSGHWSEY----------FRNFVDSCLQKIPQDRPTSEVLLK 266

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 3e-47
 Identities = 67/300 (22%), Positives = 107/300 (35%), Gaps = 50/300 (16%)

Query: 103 DNFQAL--LGHGSSASVFKGIL----SDGTSVAVKRIN----GEENGEKEFRSEVAAIAS 152
            + + L  LG GS   V +G          SVAVK +      +     +F  EV A+ S
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 153 AQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRV 212
             H NL+RL G  +    P  +V E    GSL   +             G        R 
Sbjct: 68  LDHRNLIRLYGVVL--TPPMKMVTELAPLGSLLDRL---------RKHQGHFLLGTLSRY 116

Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI--TT 270
           A+ VA+ + YL +      +H D+   N+LL       + DFGL + + ++    +    
Sbjct: 117 AVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 173

Query: 271 IRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLE-LTGGRRNVSLIEHGNDKSKNKWQYFP 329
            +    + APE +  +  S   D + +G+ L E  T G+              N  Q   
Sbjct: 174 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE--------PWIGLNGSQILH 225

Query: 330 KIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE 389
           KI  E            +RL       +     + +V   C   +   RP+   + + L 
Sbjct: 226 KIDKE-----------GERLPRPEDCPQ----DIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 4e-47
 Identities = 63/291 (21%), Positives = 105/291 (36%), Gaps = 49/291 (16%)

Query: 103 DNFQ--ALLGHGSSASVFKGIL-SDGTSVAVKRIN----GEENGEKEFRSEVAAIASAQH 155
           ++F+    LG G   +V+          +A+K +      +   E + R EV   +  +H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
            N++RL GY        YL+ E+   G++   +                          +
Sbjct: 66  PNILRLYGYFHDATRV-YLILEYAPLGTVYRELQKL----------SKFDEQRTATYITE 114

Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           +A ALSY H     RV+H D+KPEN+LL       ++DFG S      +     T+ GT 
Sbjct: 115 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTL 168

Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEK 335
            YL PE I  +   EK D++S G++  E   G+                           
Sbjct: 169 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP-------------------------P 203

Query: 336 MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE 386
            +     E   +    E    +       D+    ++     RP +  V+E
Sbjct: 204 FEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 1e-45
 Identities = 60/291 (20%), Positives = 112/291 (38%), Gaps = 43/291 (14%)

Query: 103 DNFQAL--LGHGSSASVFKGI-LSDGTSVAVKRINGE--ENGEKEFRSEVAAIASAQHVN 157
           +++  +  LG G+   V   +      +VAVK ++ +   +  +  + E+       H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
           +V+  G+    G  +YL  E+   G L   I P             +      R    + 
Sbjct: 65  VVKFYGHRR-EGNIQYLFLEYCSGGELFDRIEP----------DIGMPEPDAQRFFHQLM 113

Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD-QSRCITTIRGTRG 276
             + YLH      + H D+KPEN+LLDE     +SDFGL+ +   + + R +  + GT  
Sbjct: 114 AGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 170

Query: 277 YLAPEWILEQGV-SEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEK 335
           Y+APE +  +   +E  D++S G+VL  +  G           D+  +  Q +     +K
Sbjct: 171 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP-------WDQPSDSCQEYSDWKEKK 223

Query: 336 MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE 386
                  +I                   + +    + E    R ++  + +
Sbjct: 224 TYLNPWKKIDSA---------------PLALLHKILVENPSARITIPDIKK 259

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (399), Expect = 2e-45
 Identities = 58/294 (19%), Positives = 113/294 (38%), Gaps = 45/294 (15%)

Query: 102 TDNFQAL--LGHGSSASVFKGI-LSDGTSVAVKRINGE-ENGEKEFRSEVAAIASAQHVN 157
            D ++ +  LG G+   V+K          A K I+ + E   +++  E+  +AS  H N
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70

Query: 158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
           +V+LL          +++ EF   G++D  +               L+      V     
Sbjct: 71  IVKLLDAFYYEN-NLWILIEFCAGGAVDAVM---------LELERPLTESQIQVVCKQTL 120

Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGY 277
            AL+YLH    ++++H D+K  NIL   +    ++DFG+S   +R   R   +  GT  +
Sbjct: 121 DALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR-DSFIGTPYW 176

Query: 278 LAPEWIL-----EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIV 332
           +APE ++     ++    K D++S G+ L+E+                  N  +   KI 
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP--------PHHELNPMRVLLKIA 228

Query: 333 NEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE 386
             +                             D    C+++    R + +++++
Sbjct: 229 KSEPPTLAQPSRWSS--------------NFKDFLKKCLEKNVDARWTTSQLLQ 268

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 2e-45
 Identities = 55/291 (18%), Positives = 112/291 (38%), Gaps = 47/291 (16%)

Query: 108 LLGHGSSASVFKGI-LSDGTS----VAVKRIN--GEENGEKEFRSEVAAIASAQHVNLVR 160
           +LG G+  +V+KG+ + +G      VA+K +         KE   E   +AS  + ++ R
Sbjct: 16  VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75

Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LLG C+       L+ + +  G L  ++               +         + +AK +
Sbjct: 76  LLGICL--TSTVQLITQLMPFGCLLDYV---------REHKDNIGSQYLLNWCVQIAKGM 124

Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITT-IRGTRGYLA 279
           +YL      R++H D+   N+L+       ++DFGL+KL+  ++        +    ++A
Sbjct: 125 NYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181

Query: 280 PEWILEQGVSEKCDIYSYGMVLLEL-TGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE 338
            E IL +  + + D++SYG+ + EL T G +                        + +  
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPY----------------------DGIPA 219

Query: 339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE 389
            ++  I+++               +  +   C    A  RP    ++    
Sbjct: 220 SEISSILEKGERLP--QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 3e-45
 Identities = 52/204 (25%), Positives = 105/204 (51%), Gaps = 18/204 (8%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKE-FRSEVAAIASAQHVNLVRLLGYC 165
            +G G+S +V+  + ++ G  VA++++N ++  +KE   +E+  +   ++ N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHN 225
           +V     ++V E++  GSL   +              C+       V  +  +AL +LH 
Sbjct: 87  LVGDEL-WVVMEYLAGGSLTDVVT-----------ETCMDEGQIAAVCRECLQALEFLH- 133

Query: 226 DCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILE 285
              ++V+H D+K +NILL  +    ++DFG    ++ +QS+  +T+ GT  ++APE +  
Sbjct: 134 --SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTR 190

Query: 286 QGVSEKCDIYSYGMVLLELTGGRR 309
           +    K DI+S G++ +E+  G  
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEP 214

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (394), Expect = 1e-44
 Identities = 65/301 (21%), Positives = 118/301 (39%), Gaps = 41/301 (13%)

Query: 105 FQALLGHGSSASVFKGI------LSDGTSVAVKRIN--GEENGEKEFRSEVAAIAS-AQH 155
               LG G+   V +         +   +VAVK +      +  +   SE+  +     H
Sbjct: 17  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76

Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWI------FPTSRRSEGHYSGGCLSWDLR 209
           +N+V LLG C  PGGP  ++ EF + G+L  ++      F   + +        L+ +  
Sbjct: 77  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136

Query: 210 YRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCIT 269
              +  VAK + +L +    + +H D+   NILL E     + DFGL++ + +D      
Sbjct: 137 ICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193

Query: 270 T-IRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYF 328
              R    ++APE I ++  + + D++S+G++L E+                S       
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-----------SPYPGVKI 242

Query: 329 PKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEML 388
            +    ++KEG  M   D    +           +      C       RP+ + +VE L
Sbjct: 243 DEEFCRRLKEGTRMRAPDYTTPE-----------MYQTMLDCWHGEPSQRPTFSELVEHL 291

Query: 389 E 389
            
Sbjct: 292 G 292

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 5e-43
 Identities = 54/292 (18%), Positives = 98/292 (33%), Gaps = 45/292 (15%)

Query: 105 FQALLGHGSSASVFKGILSD----GTSVAVKRIN--GEENGEKEFRSEVAAIASAQHVNL 158
               +G G    V +GI         +VA+K       ++  ++F  E   +    H ++
Sbjct: 11  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70

Query: 159 VRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK 218
           V+L+G       P +++ E    G L  ++               L        A  ++ 
Sbjct: 71  VKLIGVIT--ENPVWIIMELCTLGELRSFL---------QVRKYSLDLASLILYAYQLST 119

Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
           AL+YL      R +H D+   N+L+  N    + DFGLS+ M        +  +    ++
Sbjct: 120 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 176

Query: 279 APEWILEQGVSEKCDIYSYGMVLLE-LTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMK 337
           APE I  +  +   D++ +G+ + E L  G +          +         +I N    
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGVK--------PFQGVKNNDVIGRIEN---- 224

Query: 338 EGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE 389
                    +RL             L  +   C       RP    +   L 
Sbjct: 225 --------GERLPMPPNCPP----TLYSLMTKCWAYDPSRRPRFTELKAQLS 264

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  151 bits (383), Expect = 2e-42
 Identities = 55/290 (18%), Positives = 106/290 (36%), Gaps = 42/290 (14%)

Query: 103 DNFQ--ALLGHGSSASVFKGI-LSDGTSVAVKRIN-GEENGEKEFRSEVAAIASAQHVNL 158
           D++     LG G+   V +    + G + A K +    E+ ++  R E+  ++  +H  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 159 VRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK 218
           V L            ++YEF+  G L   +               +S D        V K
Sbjct: 86  VNLHDAFEDDNEM-VMIYEFMSGGELFEKV---------ADEHNKMSEDEAVEYMRQVCK 135

Query: 219 ALSYLHNDCRSRVLHLDVKPENILL--DENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG 276
            L ++H    +  +HLD+KPENI+     +    + DFGL+  +   QS       GT  
Sbjct: 136 GLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK--VTTGTAE 190

Query: 277 YLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKM 336
           + APE    + V    D++S G++   L  G              +N  +    + +   
Sbjct: 191 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF--------GGENDDETLRNVKS--- 239

Query: 337 KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE 386
            +  + +     ++++            D     +      R ++ + +E
Sbjct: 240 CDWNMDDSAFSGISED----------GKDFIRKLLLADPNTRMTIHQALE 279

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (378), Expect = 2e-42
 Identities = 51/215 (23%), Positives = 93/215 (43%), Gaps = 22/215 (10%)

Query: 103 DNFQ--ALLGHGSSASVFKGI-LSDGTSVAVKRIN----GEENGEKEFRSEVAAIASAQH 155
           ++F+   +LG GS ++V     L+     A+K +      +EN       E   ++   H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
              V+L           Y    + +NG L  +I             G            +
Sbjct: 68  PFFVKLYFTFQDDEKL-YFGLSYAKNGELLKYIRKI----------GSFDETCTRFYTAE 116

Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI-TTIRGT 274
           +  AL YLH      ++H D+KPENILL+E+    ++DFG +K++S +  +    +  GT
Sbjct: 117 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 173

Query: 275 RGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRR 309
             Y++PE + E+   +  D+++ G ++ +L  G  
Sbjct: 174 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 208

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (378), Expect = 2e-42
 Identities = 64/309 (20%), Positives = 120/309 (38%), Gaps = 47/309 (15%)

Query: 105 FQALLGHGSSASVFKGIL--------SDGTSVAVKRINGE--ENGEKEFRSEVAAIAS-A 153
               LG G+   V             +  T VAVK +  +  E    +  SE+  +    
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76

Query: 154 QHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRS------EGHYSGGCLSWD 207
           +H N++ LLG C    GP Y++ E+   G+L  ++               H     LS  
Sbjct: 77  KHKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 135

Query: 208 LRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC 267
                A  VA+ + YL +    + +H D+   N+L+ E+    ++DFGL++ +       
Sbjct: 136 DLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192

Query: 268 IT-TIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLE-LTGGRRNVSLIEHGNDKSKNKW 325
            T   R    ++APE + ++  + + D++S+G++L E  T G                  
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS---------------- 236

Query: 326 QYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVV 385
             +P      +   +L +++ +    +          L  +   C       RP+  ++V
Sbjct: 237 -PYP-----GVPVEELFKLLKEGHRMD--KPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288

Query: 386 EMLEGRVAV 394
           E L+  VA+
Sbjct: 289 EDLDRIVAL 297

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  142 bits (358), Expect = 1e-39
 Identities = 49/292 (16%), Positives = 96/292 (32%), Gaps = 41/292 (14%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCV 166
            +G GS   ++ G  ++ G  VA+K     +    +   E       Q    +  + +C 
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLEC-VKTKHPQLHIESKIYKMMQGGVGIPTIRWCG 72

Query: 167 VPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHND 226
             G    +V E +     D +          ++     S      +A  +   + Y+H  
Sbjct: 73  AEGDYNVMVMELLGPSLEDLF----------NFCSRKFSLKTVLLLADQMISRIEYIH-- 120

Query: 227 CRSRVLHLDVKPENIL---LDENYRAVVSDFGLSKLMSRDQSRCI------TTIRGTRGY 277
                +H DVKP+N L     +     + DFGL+K     ++           + GT  Y
Sbjct: 121 -SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179

Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMK 337
            +    L    S + D+ S G VL+    G      ++    + K +     K+      
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--- 236

Query: 338 EGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE 389
               +E++ +    E                +C   R   +P  + + ++  
Sbjct: 237 ----IEVLCKGYPSE----------FATYLNFCRSLRFDDKPDYSYLRQLFR 274

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  140 bits (354), Expect = 6e-39
 Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 18/219 (8%)

Query: 96  KELEEATDNFQ--ALLGHGSSASVFKGI-LSDGTSVAVKRINGE--ENGEKEFRSEVAAI 150
           K+ E+  D +    +LG G+ + V           VA+K I  +  E  E    +E+A +
Sbjct: 2   KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61

Query: 151 ASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRY 210
              +H N+V L       GG  YL+ + +  G L   I             G  +     
Sbjct: 62  HKIKHPNIVALDDIYE-SGGHLYLIMQLVSGGELFDRI----------VEKGFYTERDAS 110

Query: 211 RVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITT 270
           R+   V  A+ YLH+                 LDE+ + ++SDFGLSK+   D    ++T
Sbjct: 111 RLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLST 168

Query: 271 IRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRR 309
             GT GY+APE + ++  S+  D +S G++   L  G  
Sbjct: 169 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP 207

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  140 bits (354), Expect = 2e-38
 Identities = 47/213 (22%), Positives = 85/213 (39%), Gaps = 21/213 (9%)

Query: 103 DNFQAL--LGHGSSASVFKGI-LSDGTSVAVKRIN-GEENGEKEFRSEVAAIASAQHVNL 158
           D +  L  LG G+   V + +  + G     K IN      +   ++E++ +    H  L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 159 VRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK 218
           + L            L+ EF+  G L   I               +S            +
Sbjct: 89  INLHDAFEDKYEM-VLILEFLSGGELFDRI---------AAEDYKMSEAEVINYMRQACE 138

Query: 219 ALSYLHNDCRSRVLHLDVKPENILLD--ENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG 276
            L ++H      ++HLD+KPENI+ +  +     + DFGL+  ++ D+   +TT   T  
Sbjct: 139 GLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAE 193

Query: 277 YLAPEWILEQGVSEKCDIYSYGMVLLELTGGRR 309
           + APE +  + V    D+++ G++   L  G  
Sbjct: 194 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLS 226

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 6e-38
 Identities = 49/293 (16%), Positives = 104/293 (35%), Gaps = 41/293 (13%)

Query: 99  EEATDNFQAL--LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAAIASAQH 155
           +E  + +     LG G    V + +  S   +   K +  +   +   + E++ +  A+H
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH 60

Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
            N++ L            +++EFI    +   I         + S   L+          
Sbjct: 61  RNILHLHESFESME-ELVMIFEFISGLDIFERI---------NTSAFELNEREIVSYVHQ 110

Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLD--ENYRAVVSDFGLSKLMSRDQSRCITTIRG 273
           V +AL +LH      + H D++PENI+     +    + +FG ++ +    +     +  
Sbjct: 111 VCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFT 165

Query: 274 TRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVN 333
              Y APE      VS   D++S G ++  L  G             ++   Q    I+N
Sbjct: 166 APEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPF--------LAETNQQIIENIMN 217

Query: 334 EKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE 386
            +       E   + ++ E           +D     + +  + R + +  ++
Sbjct: 218 AE---YTFDEEAFKEISIE----------AMDFVDRLLVKERKSRMTASEALQ 257

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 2e-37
 Identities = 48/215 (22%), Positives = 88/215 (40%), Gaps = 23/215 (10%)

Query: 103 DNFQ--ALLGHGSSASVFKGI-LSDGTSVAVKRIN----GEENGEKEFRSEVAAIASA-Q 154
           ++F    +LG GS   VF           A+K +       ++  +    E   ++ A +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI 214
           H  L  +           + V E++  G L + I           S            A 
Sbjct: 62  HPFLTHMFCTFQTKE-NLFFVMEYLNGGDLMYHIQ----------SCHKFDLSRATFYAA 110

Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGT 274
           ++   L +L       +++ D+K +NILLD++    ++DFG+ K      ++   T  GT
Sbjct: 111 EIILGLQFL---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT-NTFCGT 166

Query: 275 RGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRR 309
             Y+APE +L Q  +   D +S+G++L E+  G+ 
Sbjct: 167 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 201

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  135 bits (341), Expect = 3e-37
 Identities = 52/220 (23%), Positives = 92/220 (41%), Gaps = 25/220 (11%)

Query: 102 TDNFQ--ALLGHGSSASVFKGI-LSDGTSVAVKRIN----GEENGEKEFRSEVAAIASAQ 154
           +D ++   +LG G  + V     L     VAVK +      + +    FR E    A+  
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 155 HVNLVRLLGYCVVP---GGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYR 211
           H  +V +          G   Y+V E++   +L   +          ++ G ++      
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----------HTEGPMTPKRAIE 115

Query: 212 VAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI--T 269
           V  D  +AL++     ++ ++H DVKP NI++       V DFG+++ ++   +      
Sbjct: 116 VIADACQALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 172

Query: 270 TIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRR 309
            + GT  YL+PE      V  + D+YS G VL E+  G  
Sbjct: 173 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 212

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 2e-36
 Identities = 54/318 (16%), Positives = 109/318 (34%), Gaps = 43/318 (13%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYC- 165
           +LG G +  V +          A+K +       +E         ++Q  ++VR++    
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYE 75

Query: 166 --VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL 223
                     +V E +  G L   I                +      +   + +A+ YL
Sbjct: 76  NLYAGRKCLLIVMECLDGGELFSRIQ--------DRGDQAFTEREASEIMKSIGEAIQYL 127

Query: 224 HNDCRSRVLHLDVKPENILLD---ENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAP 280
           H      + H DVKPEN+L      N    ++DFG +K  +   S    T   T  Y+AP
Sbjct: 128 H---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT--TPCYTPYYVAP 182

Query: 281 EWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK 340
           E +  +   + CD++S G+++  L  G        + N           +I   +M + +
Sbjct: 183 EVLGPEKYDKSCDMWSLGVIMYILLCGYP----PFYSNHGLAISPGMKTRI---RMGQYE 235

Query: 341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE---MLEGRVAVDDP 397
                   +++E          +  +    ++     R ++   +    +++       P
Sbjct: 236 FPNPEWSEVSEE----------VKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 285

Query: 398 PDTQMVIVDWLSIDQDDD 415
             T  V+ +     +D  
Sbjct: 286 LHTSRVLKEDKERWEDVK 303

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 3e-36
 Identities = 55/223 (24%), Positives = 100/223 (44%), Gaps = 28/223 (12%)

Query: 101 ATDNFQAL--LGHGSSASVFKG--ILSDGTSVAVKRIN---GEENGEKEFRSEVA---AI 150
           A   ++ +  +G G+   VFK   + + G  VA+KR+    GEE        EVA    +
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 151 ASAQHVNLVRLLGYCVVPGGPR----YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSW 206
            + +H N+VRL   C V    R     LV+E +      +                 +  
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLD---------KVPEPGVPT 115

Query: 207 DLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSR 266
           +    +   + + L +LH+     V+H D+KP+NIL+  + +  ++DFGL+++ S     
Sbjct: 116 ETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM-- 170

Query: 267 CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRR 309
            +T++  T  Y APE +L+   +   D++S G +  E+   + 
Sbjct: 171 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 213

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  133 bits (336), Expect = 9e-36
 Identities = 55/275 (20%), Positives = 106/275 (38%), Gaps = 37/275 (13%)

Query: 103 DNFQ--ALLGHGSSASVFKGILSD-GTSVAVKRIN----GEENGEKEFRSEVAAIA---S 152
           ++F    ++G G    V+    +D G   A+K ++      + GE    +E   ++   +
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 153 AQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRV 212
                +V +      P      + + +  G L + +             G  S       
Sbjct: 64  GDCPFIVCMSYAFHTPDKL-SFILDLMNGGDLHYHLS----------QHGVFSEADMRFY 112

Query: 213 AIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIR 272
           A ++   L ++H      V++ D+KP NILLDE+    +SD GL+   S+ +        
Sbjct: 113 AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA---SV 166

Query: 273 GTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQY---- 327
           GT GY+APE + +        D +S G +L +L  G       +  +    ++       
Sbjct: 167 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 226

Query: 328 -FPKIVNEKMKE--GKLMEI-VDQRLT-DEGGIDE 357
             P   + +++     L++  V++RL     G  E
Sbjct: 227 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQE 261

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (329), Expect = 1e-35
 Identities = 70/294 (23%), Positives = 108/294 (36%), Gaps = 59/294 (20%)

Query: 105 FQALLGHGSSASVFKGI-LSDGTSVAVKRIN-------GEENGEKEFRSEVAAIA--SAQ 154
              LLG G   SV+ GI +SD   VA+K +        GE         EV  +   S+ 
Sbjct: 8   VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67

Query: 155 HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAI 214
              ++RLL +   P     L+ E  +                     G L  +L      
Sbjct: 68  FSGVIRLLDWFERPDS-FVLILERPEPVQDLFDFI---------TERGALQEELARSFFW 117

Query: 215 DVAKALSYLHNDCRSRVLHLDVKPENILLDEN-YRAVVSDFGLSKLMSRDQSRCITTIRG 273
            V +A+ + HN     VLH D+K ENIL+D N     + DFG   L+   +    T   G
Sbjct: 118 QVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDG 171

Query: 274 TRGYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIV 332
           TR Y  PEWI   +       ++S G++L ++  G                     P   
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD-------------------IPFEH 212

Query: 333 NEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE 386
           +E++  G++     QR++ E             +  WC+  R   RP+   +  
Sbjct: 213 DEEIIRGQV--FFRQRVSSE----------CQHLIRWCLALRPSDRPTFEEIQN 254

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  131 bits (331), Expect = 2e-35
 Identities = 47/214 (21%), Positives = 87/214 (40%), Gaps = 25/214 (11%)

Query: 103 DNFQAL--LGHGSSASVFKGI-LSDGTSVAVKRIN----GEENGEKEFRSEVAAIASAQH 155
            +FQ L  LG GS   V       +G   A+K +           +    E   ++   H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
             ++R+ G         +++ ++I+ G L   +  + R                      
Sbjct: 64  PFIIRMWGTFQDAQQI-FMIMDYIEGGELFSLLRKSQRFPN-------------PVAKFY 109

Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
            A+    L       +++ D+KPENILLD+N    ++DFG +K +         T+ GT 
Sbjct: 110 AAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTP 165

Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRR 309
            Y+APE +  +  ++  D +S+G+++ E+  G  
Sbjct: 166 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 199

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  130 bits (328), Expect = 2e-35
 Identities = 56/304 (18%), Positives = 112/304 (36%), Gaps = 57/304 (18%)

Query: 103 DNFQ--ALLGHGSSASVFKGI-LSDGTSVAVKRINGE----------ENGEKEFRSEVAA 149
           +N++   +LG G S+ V + I        AVK I+            +   +    EV  
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 150 IASAQ-HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDL 208
           +     H N+++L           +LV++ ++ G L  ++               LS   
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFF-FLVFDLMKKGELFDYL----------TEKVTLSEKE 111

Query: 209 RYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCI 268
             ++   + + +  LH   +  ++H D+KPENILLD++    ++DFG S  +   +    
Sbjct: 112 TRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL-- 166

Query: 269 TTIRGTRGYLAPEWIL------EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSK 322
             + GT  YLAPE I         G  ++ D++S G+++  L  G              +
Sbjct: 167 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF--------WHR 218

Query: 323 NKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMA 382
            +      I++      +         +D           + D+    +  + + R +  
Sbjct: 219 KQMLMLRMIMSGNY---QFGSPEWDDYSDT----------VKDLVSRFLVVQPQKRYTAE 265

Query: 383 RVVE 386
             + 
Sbjct: 266 EALA 269

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 6e-35
 Identities = 56/291 (19%), Positives = 101/291 (34%), Gaps = 26/291 (8%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKRIN------GEENGEKEFRSEVAAIASAQHVNLVR 160
            LG G  A+V+K    +    VA+K+I        ++   +    E+  +    H N++ 
Sbjct: 5   FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64

Query: 161 LLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKAL 220
           LL           LV++F++                   +   L+        +   + L
Sbjct: 65  LLDAFGHKSNI-SLVFDFMETDLEVII----------KDNSLVLTPSHIKAYMLMTLQGL 113

Query: 221 SYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAP 280
            YLH      +LH D+KP N+LLDEN    ++DFGL+K            +  TR Y AP
Sbjct: 114 EYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAP 169

Query: 281 EWILE-QGVSEKCDIYSYGMVLLELTGGR---RNVSLIEHGNDKSKNKWQYFPKIVNEKM 336
           E +   +      D+++ G +L EL          S ++      +       +   +  
Sbjct: 170 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229

Query: 337 KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM 387
                +            I       L+D+           R +  + ++M
Sbjct: 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  129 bits (324), Expect = 8e-35
 Identities = 48/297 (16%), Positives = 87/297 (29%), Gaps = 43/297 (14%)

Query: 105 FQALLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLG 163
               +G GS   +F+G  L +   VA+K      +   + R E            +  + 
Sbjct: 9   VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-RRSDAPQLRDEYRTYKLLAGCTGIPNVY 67

Query: 164 YCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYL 223
           Y    G    LV + +     D               G   S       A  +   +  +
Sbjct: 68  YFGQEGLHNVLVIDLLGPSLEDLL----------DLCGRKFSVKTVAMAAKQMLARVQSI 117

Query: 224 HNDCRSRVLHLDVKPENILLDENYRAV-----VSDFGLSKLMSRDQSR------CITTIR 272
           H      +++ D+KP+N L+            V DFG+ K      ++          + 
Sbjct: 118 H---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174

Query: 273 GTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIV 332
           GT  Y++    L +  S + D+ + G V +    G            K+    Q + +I 
Sbjct: 175 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP-----WQGLKAATNKQKYERIG 229

Query: 333 NEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE 389
            +K     L E+         G  E           +         P    +  +  
Sbjct: 230 EKKQS-TPLRELCA-------GFPE----EFYKYMHYARNLAFDATPDYDYLQGLFS 274

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 2e-34
 Identities = 49/210 (23%), Positives = 88/210 (41%), Gaps = 23/210 (10%)

Query: 108 LLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCV 166
           ++G+GS   V++  L   G  VA+K++      ++    E+  +    H N+VRL  +  
Sbjct: 27  VIGNGSFGVVYQAKLCDSGELVAIKKVL---QDKRFKNRELQIMRKLDHCNIVRLRYFFY 83

Query: 167 VPGGPR-----YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALS 221
             G  +      LV +++                    +   L           + ++L+
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVAR-------HYSRAKQTLPVIYVKLYMYQLFRSLA 136

Query: 222 YLHNDCRSRVLHLDVKPENILLD-ENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAP 280
           Y+H      + H D+KP+N+LLD +     + DFG +K + R +     +   +R Y AP
Sbjct: 137 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRYYRAP 191

Query: 281 EWIL-EQGVSEKCDIYSYGMVLLELTGGRR 309
           E I      +   D++S G VL EL  G+ 
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 1e-33
 Identities = 55/300 (18%), Positives = 107/300 (35%), Gaps = 35/300 (11%)

Query: 109 LGHGSSASVFKGI-LSDGTSVAVKRI---NGEENGEKEFRSEVAAIASAQHVNLVRLLGY 164
           +G G+   VFK      G  VA+K++   N +E        E+  +   +H N+V L+  
Sbjct: 18  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77

Query: 165 CVVPGGPR-------YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
           C     P        YLV++F ++                       +     RV   + 
Sbjct: 78  CRTKASPYNRCKGSIYLVFDFCEHDLAGLL----------SNVLVKFTLSEIKRVMQML- 126

Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQS---RCITTIRGT 274
             L+ L+   R+++LH D+K  N+L+  +    ++DFGL++  S  ++      T    T
Sbjct: 127 --LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184

Query: 275 RGYLAPEWIL-EQGVSEKCDIYSYGMVLLELTGGRR-------NVSLIEHGNDKSKNKWQ 326
             Y  PE +L E+      D++  G ++ E+               L            +
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244

Query: 327 YFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE 386
            +P + N ++ E   +    +R   +      +    +D+    +      R      + 
Sbjct: 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 5e-33
 Identities = 53/291 (18%), Positives = 107/291 (36%), Gaps = 23/291 (7%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKRINGEENGE--KEFRSEVAAIASAQHVNLVRLLGY 164
            +G G+   V       +   VA+K+I+  E+    +    E+  +   +H N++ +   
Sbjct: 15  YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74

Query: 165 CVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLH 224
              P     +   ++    +   ++              LS D        + + L Y+H
Sbjct: 75  IRAPTI-EQMKDVYLVTHLMGADLY-------KLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 225 NDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRC--ITTIRGTRGYLAPEW 282
               + VLH D+KP N+LL+      + DFGL+++   D      +T    TR Y APE 
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 283 IL-EQGVSEKCDIYSYGMVLLELTGGRR------NVSLIEHGNDKSKNKWQYFPKIVNEK 335
           +L  +G ++  DI+S G +L E+   R        +  + H      +  Q     +   
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243

Query: 336 MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE 386
                L+ +  +       +      + +D+    +      R  + + + 
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  122 bits (307), Expect = 2e-32
 Identities = 44/211 (20%), Positives = 80/211 (37%), Gaps = 19/211 (9%)

Query: 103 DNFQAL--LGHGSSASVFKGILSDGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVN 157
           + +  L  +G G+   V+K   + G + A+K+I  E   E        E++ +   +H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 158 LVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
           +V+L            LV+E +                      G L         + + 
Sbjct: 62  IVKLYDVIHTKK-RLVLVFEHLDQDLKKLLD----------VCEGGLESVTAKSFLLQLL 110

Query: 218 KALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGY 277
             ++Y H     RVLH D+KP+N+L++      ++DFGL++       +    I      
Sbjct: 111 NGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYR 167

Query: 278 LAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
                +  +  S   DI+S G +  E+  G 
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 8e-32
 Identities = 54/214 (25%), Positives = 89/214 (41%), Gaps = 21/214 (9%)

Query: 103 DNFQAL--LGHGSSASVFKGI-LSDGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHV 156
           +NFQ +  +G G+   V+K      G  VA+K+I  +   E        E++ +    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 157 NLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDV 216
           N+V+LL          YLV+EF+                    +   +   L       +
Sbjct: 62  NIVKLLDVIH-TENKLYLVFEFLHQDLKKFMD---------ASALTGIPLPLIKSYLFQL 111

Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG 276
            + L++ H+     VLH D+KP+N+L++      ++DFGL++       R  T    T  
Sbjct: 112 LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTLW 167

Query: 277 YLAPEWILEQG-VSEKCDIYSYGMVLLELTGGRR 309
           Y APE +L     S   DI+S G +  E+   R 
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 201

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 6e-31
 Identities = 52/230 (22%), Positives = 87/230 (37%), Gaps = 33/230 (14%)

Query: 93  FRSKELEEATDNFQ--ALLGHGSSASVFKGI-LSDGTSVAVKRIN-------GEENGEKE 142
           FR + ++   D +     LG G  A V K    S G   A K I              ++
Sbjct: 3   FRQENVD---DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 59

Query: 143 FRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGG 202
              EV+ +   QH N++ L            L+ E +  G L  +               
Sbjct: 60  IEREVSILKEIQHPNVITLHEVYENKTDV-ILILELVAGGELFDF----------LAEKE 108

Query: 203 CLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDEN----YRAVVSDFGLSK 258
            L+ +        +   + YLH+     + H D+KPENI+L +      R  + DFGL+ 
Sbjct: 109 SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165

Query: 259 LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR 308
            +          I GT  ++APE +  + +  + D++S G++   L  G 
Sbjct: 166 KIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 213

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 6e-31
 Identities = 50/214 (23%), Positives = 83/214 (38%), Gaps = 22/214 (10%)

Query: 103 DNFQ--ALLGHGSSASVFKGI-LSDGTSVAVKRINGE----ENGEKEFRSEVAAIASAQH 155
           ++F    LLG G+   V      + G   A+K +  E    ++      +E   + + +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
             L  L             V E+   G L   +      +E              R    
Sbjct: 65  PFLTALKYAFQTHD-RLCFVMEYANGGELFFHLSRERVFTE-------------ERARFY 110

Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
            A+ +S L       V++ D+K EN++LD++    ++DFGL K    D +    T  GT 
Sbjct: 111 GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK-TFCGTP 169

Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRR 309
            YLAPE + +       D +  G+V+ E+  GR 
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  117 bits (293), Expect = 6e-30
 Identities = 49/214 (22%), Positives = 84/214 (39%), Gaps = 25/214 (11%)

Query: 103 DNFQAL--LGHGSSASVFKGI-LSDGTSVAVKRIN----GEENGEKEFRSEVAAIASAQH 155
           D F  +  LG GS   V        G   A+K ++     +    +   +E   + +   
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAID 215
             LV+L             V E++  G +   +             G  S       A  
Sbjct: 101 PFLVKLEFSFKDNSNLYM-VMEYVAGGEMFSHL----------RRIGRFSEPHARFYAAQ 149

Query: 216 VAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTR 275
           +     YLH      +++ D+KPEN+L+D+     V+DFG +K +         T+ GT 
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT----WTLCGTP 202

Query: 276 GYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRR 309
             LAPE IL +G ++  D ++ G+++ E+  G  
Sbjct: 203 EALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 3e-29
 Identities = 51/295 (17%), Positives = 101/295 (34%), Gaps = 25/295 (8%)

Query: 103 DNFQAL--LGHGSSASVFKGI-LSDGTSVAVKRINGEENGE---KEFRSEVAAIASAQHV 156
             ++ L  +G G+  +VFK         VA+KR+  +++ E        E+  +   +H 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 157 NLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDV 216
           N+VRL            LV+EF       ++              G L  ++       +
Sbjct: 62  NIVRLHDVLH-SDKKLTLVFEFCDQDLKKYF----------DSCNGDLDPEIVKSFLFQL 110

Query: 217 AKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG 276
            K L + H+     VLH D+KP+N+L++ N    +++FGL++            +     
Sbjct: 111 LKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWY 167

Query: 277 YLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKM 336
                    +  S   D++S G +  EL    R +      +D+ K  ++       E+ 
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227

Query: 337 KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAF-----WCIQERARLRPSMARVVE 386
                +                 V   ++          ++     R S    ++
Sbjct: 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 6e-29
 Identities = 58/316 (18%), Positives = 111/316 (35%), Gaps = 41/316 (12%)

Query: 93  FRSKELEEATDNFQA------LLGHGSSASVFKGI-LSDGTSVAVKRINGEENGE---KE 142
           F  +E+ +     +A       +G G+  +V   +    G  VA+K++      E   K 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 143 FRSEVAAIASAQHVNLVRLLGYCVVPGGPR-----YLVYEFIQNGSLDHWIFPTSRRSEG 197
              E+  +   +H N++ LL               YLV  F+                  
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM---------- 113

Query: 198 HYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS 257
                 L  D    +   + K L Y+H        H D+KP N+ ++E+    + DFGL+
Sbjct: 114 --KHEKLGEDRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLA 168

Query: 258 KLMSRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRR------N 310
           +    +    +T    TR Y APE IL     ++  DI+S G ++ E+  G+       +
Sbjct: 169 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 224

Query: 311 VSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWC 370
           +  ++     +      F + +     +  +  + +    D   I        V++    
Sbjct: 225 LDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKM 284

Query: 371 IQERARLRPSMARVVE 386
           +   A  R +    + 
Sbjct: 285 LVLDAEQRVTAGEALA 300

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 7e-29
 Identities = 53/220 (24%), Positives = 92/220 (41%), Gaps = 26/220 (11%)

Query: 103 DNFQ--ALLGHGSSASVFKGIL----SDGTSVAVKRIN-----GEENGEKEFRSEVAAIA 151
           +NF+   +LG G+   VF          G   A+K +       +    +  R+E   + 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 152 SAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYR 211
             +    +  L Y        +L+ ++I  G L   +    R +E               
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE------------- 130

Query: 212 VAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTI 271
           V I V + +  L +  +  +++ D+K ENILLD N   V++DFGLSK    D++      
Sbjct: 131 VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF 190

Query: 272 RGTRGYLAPEWIL--EQGVSEKCDIYSYGMVLLELTGGRR 309
            GT  Y+AP+ +   + G  +  D +S G+++ EL  G  
Sbjct: 191 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  111 bits (277), Expect = 5e-28
 Identities = 46/214 (21%), Positives = 88/214 (41%), Gaps = 27/214 (12%)

Query: 103 DNFQAL--LGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAAIAS-AQHVNL 158
           D++Q +  LG G  + VF+ I +++   V VK +   +  +K+ + E+  + +     N+
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNI 92

Query: 159 VRLLGYCVVPGGPR-YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVA 217
           + L      P      LV+E + N                      L+         ++ 
Sbjct: 93  ITLADIVKDPVSRTPALVFEHVNNTDFKQLY-------------QTLTDYDIRFYMYEIL 139

Query: 218 KALSYLHNDCRSRVLHLDVKPENILLD-ENYRAVVSDFGLSKLMSRDQSRCITTIRGTRG 276
           KAL Y H      ++H DVKP N+++D E+ +  + D+GL++     Q         +R 
Sbjct: 140 KALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRY 194

Query: 277 YLAPE-WILEQGVSEKCDIYSYGMVLLELTGGRR 309
           +  PE  +  Q      D++S G +L  +   + 
Sbjct: 195 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 1e-26
 Identities = 53/232 (22%), Positives = 91/232 (39%), Gaps = 33/232 (14%)

Query: 92  KFRSKELE----EATDNFQAL--LGHGSSASVFKGI-LSDGTSVAVKRINGEENGE---K 141
            F  +EL     E  + +Q L  +G G+  SV        G  VAVK+++         K
Sbjct: 3   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 62

Query: 142 EFRSEVAAIASAQHVNLVRLLGYCVVPG----GPRYLVYEFIQNGSLDHWIFPTSRRSEG 197
               E+  +   +H N++ LL                +   +    L++           
Sbjct: 63  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI---------- 112

Query: 198 HYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS 257
                 L+ D    +   + + L Y+H+       H D+KP N+ ++E+    + DFGL+
Sbjct: 113 -VKCQKLTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLA 168

Query: 258 KLMSRDQSRCITTIRGTRGYLAPEWILEQG-VSEKCDIYSYGMVLLELTGGR 308
           +         +T    TR Y APE +L     ++  DI+S G ++ EL  GR
Sbjct: 169 RHT----DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 2e-26
 Identities = 45/210 (21%), Positives = 77/210 (36%), Gaps = 27/210 (12%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLG 163
            +G G+   V          +VA+K+++     +   K    E+  +    H N++ LL 
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 164 YCVVPG-----GPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAK 218
                         YLV E +                        L  +    +   +  
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQ-------------MELDHERMSYLLYQMLC 130

Query: 219 ALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYL 278
            + +LH+      +H D+KP NI++  +    + DFGL++          T    TR Y 
Sbjct: 131 GIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYYR 185

Query: 279 APEWILEQGVSEKCDIYSYGMVLLELTGGR 308
           APE IL  G  E  DI+S G ++ E+   +
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  103 bits (258), Expect = 3e-25
 Identities = 43/272 (15%), Positives = 91/272 (33%), Gaps = 15/272 (5%)

Query: 108 LLGHGSSASVFKGI-LSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCV 166
            LG G  ++V+    + + T VA+K + G++   +    E+  +      +  +      
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79

Query: 167 VPGGPRYLVYEFIQNGSLDHWIFP-----TSRRSEGHYSGGCLSWDLRYRVAIDVAKALS 221
                    +       +   +               Y    +      +++  +   L 
Sbjct: 80  NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139

Query: 222 YLHNDCRSRVLHLDVKPENILLD-ENYRAVVSDFGLSKL-MSRDQSRCITTIRGTRGYLA 279
           Y+H  C   ++H D+KPEN+L++  +    +    ++ L  +       T    TR Y +
Sbjct: 140 YMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197

Query: 280 PEWILEQGVSEKCDIYSYGMVLLELTGGR-----RNVSLIEHGNDKSKNKWQYFPKIVNE 334
           PE +L        DI+S   ++ EL  G               +D      +   ++ + 
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSY 257

Query: 335 KMKEGKLMEIVDQRLTDEGGIDETQVRRLVDV 366
            ++ GK              I + +   L DV
Sbjct: 258 LLRNGKYTRTFFNSRGLLRNISKLKFWPLEDV 289

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 70.6 bits (172), Expect = 8e-15
 Identities = 27/173 (15%), Positives = 50/173 (28%), Gaps = 35/173 (20%)

Query: 108 LLGHGSSASVFKGILSDGTSVAVKRI-----------NGEENGEKEFRSEVAAIASAQHV 156
           L+G G  ++VF           VK                + G+  F       A  +  
Sbjct: 7   LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66

Query: 157 NLVRLLGYCVVPG---GPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVA 213
            L +L G  V          ++ E I    L                           V 
Sbjct: 67  ALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPD-----------------EVL 109

Query: 214 IDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQSR 266
             + + ++  ++     ++H D+   N+L+ E     + DF  S  +  +  R
Sbjct: 110 DMILEEVAKFYHRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWR 158

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	453
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.22
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.98
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.64
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.33
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.25
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.03

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-55  Score=411.95  Aligned_cols=251  Identities=25%  Similarity=0.405  Sum_probs=196.6

Q ss_pred             HhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCCh
Q 047276          105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL  184 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL  184 (453)
                      +.+.||+|+||+||+|.+.+++.||||+++......++|.+|+.++++++|||||+++|+|. .++..++||||+++|+|
T Consensus         9 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~~lv~E~~~~g~L   87 (263)
T d1sm2a_           9 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL-EQAPICLVFEFMEHGCL   87 (263)
T ss_dssp             EEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSSCEEEEECCTTCBH
T ss_pred             EEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceec-cCCceEEEEEecCCCcH
Confidence            45789999999999999988999999999887777889999999999999999999999986 55688999999999999


Q ss_pred             hhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCCC
Q 047276          185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ  264 (453)
Q Consensus       185 ~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~  264 (453)
                      .+++....         ..++|..+++++.|++.||+|||+   .+|+||||||+|||+|+++.+||+|||+++......
T Consensus        88 ~~~l~~~~---------~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  155 (263)
T d1sm2a_          88 SDYLRTQR---------GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  155 (263)
T ss_dssp             HHHHHTTT---------TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred             HHHhhccc---------cCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCC
Confidence            99986442         348999999999999999999999   899999999999999999999999999998776554


Q ss_pred             CceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCC-CcccccCCCCCcccccchhHHHHHhhhcCcccc
Q 047276          265 SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRN-VSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLME  343 (453)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (453)
                      ........||+.|+|||.+.+..++.++|||||||++|||+|+..| +....             .......+..+..  
T Consensus       156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-------------~~~~~~~i~~~~~--  220 (263)
T d1sm2a_         156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-------------NSEVVEDISTGFR--  220 (263)
T ss_dssp             ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-------------HHHHHHHHHHTCC--
T ss_pred             ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-------------HHHHHHHHHhcCC--
Confidence            4444556789999999999999999999999999999999995444 42110             0111122222211  


Q ss_pred             cccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          344 IVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       344 ~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      .         ..+..++.++.+++.+||+.||++||||++|++.|+++.
T Consensus       221 ~---------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~  260 (263)
T d1sm2a_         221 L---------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA  260 (263)
T ss_dssp             C---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C---------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence            0         112233456899999999999999999999999998754

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-55  Score=416.11  Aligned_cols=252  Identities=24%  Similarity=0.365  Sum_probs=206.8

Q ss_pred             HHhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCC
Q 047276          104 NFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS  183 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gs  183 (453)
                      .+.+.||+|+||+||+|.+++++.||||+++......+.|.+|+.++++++|||||+++|+|.  ++..++||||+++|+
T Consensus        16 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~--~~~~~iv~Ey~~~g~   93 (272)
T d1qpca_          16 KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT--QEPIYIITEYMENGS   93 (272)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSCEEEEECCTTCB
T ss_pred             EEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeec--cCCeEEEEEeCCCCc
Confidence            346789999999999999988899999999887777888999999999999999999999874  356799999999999


Q ss_pred             hhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCC
Q 047276          184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD  263 (453)
Q Consensus       184 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~  263 (453)
                      |.+++....        ...++|..+++|+.||++||+|||+   ++|+||||||+||||++++.+||+|||+++.....
T Consensus        94 L~~~~~~~~--------~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~  162 (272)
T d1qpca_          94 LVDFLKTPS--------GIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (272)
T ss_dssp             HHHHTTSHH--------HHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             HHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCC
Confidence            999875432        1238999999999999999999999   89999999999999999999999999999987655


Q ss_pred             CCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcccc
Q 047276          264 QSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLME  343 (453)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (453)
                      .........||+.|+|||.+.++.++.++|||||||++|||+||..|+.....            .......+..+..  
T Consensus       163 ~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~------------~~~~~~~i~~~~~--  228 (272)
T d1qpca_         163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT------------NPEVIQNLERGYR--  228 (272)
T ss_dssp             CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC------------HHHHHHHHHTTCC--
T ss_pred             ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC------------HHHHHHHHHhcCC--
Confidence            44444556789999999999999999999999999999999997665431110            0111222222210  


Q ss_pred             cccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 047276          344 IVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR  391 (453)
Q Consensus       344 ~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~  391 (453)
                         +      ..+...+..+.+++.+||+.||++||||++|++.|+..
T Consensus       229 ---~------~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         229 ---M------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             ---C------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---C------CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence               0      11223344689999999999999999999999999863

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.2e-55  Score=416.97  Aligned_cols=255  Identities=26%  Similarity=0.350  Sum_probs=210.4

Q ss_pred             HHHhcccCcCCceEEEEEEeC-CCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          103 DNFQALLGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      +.+.+.||+|+||+||+|++. +|+.||||+++.+....++|.+|+.+|++++|||||+++|+|. .++..++||||+++
T Consensus        19 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-~~~~~~iv~E~~~~   97 (287)
T d1opja_          19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-REPPFYIITEFMTY   97 (287)
T ss_dssp             EEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSSCEEEEECCTT
T ss_pred             eEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEe-eCCeeEEEeecccC
Confidence            345689999999999999975 5889999999887777888999999999999999999999986 56788999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      |+|.+++....        ...++|..++.|+.|++.||+|||+   ++|+||||||+||||++++.+||+|||+++...
T Consensus        98 g~l~~~l~~~~--------~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~  166 (287)
T d1opja_          98 GNLLDYLRECN--------RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT  166 (287)
T ss_dssp             CBHHHHHHHSC--------TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred             cchHHHhhhcc--------ccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecC
Confidence            99999996543        2348999999999999999999999   899999999999999999999999999999876


Q ss_pred             CCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcc
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKL  341 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (453)
                      ...........|++.|+|||++.++.++.++|||||||++|||++|..|+.....            .....+.+..+..
T Consensus       167 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~------------~~~~~~~i~~~~~  234 (287)
T d1opja_         167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID------------LSQVYELLEKDYR  234 (287)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC------------HHHHHHHHHTTCC
T ss_pred             CCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch------------HHHHHHHHhcCCC
Confidence            6554444555688999999999999999999999999999999998777632110            0111222222211


Q ss_pred             cccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          342 MEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       342 ~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                                 ...+...+..+.+++.+||+.||++|||+++|++.|+...
T Consensus       235 -----------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         235 -----------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             -----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             -----------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                       1122234456899999999999999999999999998754

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-55  Score=414.42  Aligned_cols=254  Identities=26%  Similarity=0.405  Sum_probs=197.9

Q ss_pred             HhcccCcCCceEEEEEEeCCCcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          105 FQALLGHGSSASVFKGILSDGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      +.+.||+|+||+||+|++++  .||||+++..   ....+.|.+|+.+|++++|||||+++|++.  .+..++||||+++
T Consensus        12 ~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~--~~~~~lv~Ey~~~   87 (276)
T d1uwha_          12 VGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST--APQLAIVTQWCEG   87 (276)
T ss_dssp             CCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSCEEEEECCCE
T ss_pred             EEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe--ccEEEEEEecCCC
Confidence            46789999999999998753  5999998752   344578999999999999999999999874  4578999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      |+|.+++....         ..++|..+.+|+.||++||+|||+   ++|+||||||+||||+.++.+||+|||+++...
T Consensus        88 g~L~~~l~~~~---------~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~  155 (276)
T d1uwha_          88 SSLYHHLHIIE---------TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS  155 (276)
T ss_dssp             EEHHHHHHTSC---------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred             CCHHHHHhhcc---------CCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence            99999996442         239999999999999999999999   899999999999999999999999999998765


Q ss_pred             CCC-CceeeeccCCccccchhhhhc---CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhh
Q 047276          262 RDQ-SRCITTIRGTRGYLAPEWILE---QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMK  337 (453)
Q Consensus       262 ~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (453)
                      ... ........||+.|||||++.+   +.++.++|||||||++|||+||+.||......            ........
T Consensus       156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~------------~~~~~~~~  223 (276)
T d1uwha_         156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------------DQIIFMVG  223 (276)
T ss_dssp             ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------------HHHHHHHH
T ss_pred             ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH------------HHHHHHHh
Confidence            432 233456689999999999864   35899999999999999999999999532111            11122222


Q ss_pred             cCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          338 EGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       338 ~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                      .+..    .+.+.   ..+.+++..+.+++.+||+.||++|||+++|++.|+.+..
T Consensus       224 ~~~~----~p~~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         224 RGYL----SPDLS---KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             HTSC----CCCGG---GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCC----CCcch---hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            2211    11111   1122334568999999999999999999999999987653

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.1e-54  Score=412.55  Aligned_cols=264  Identities=27%  Similarity=0.413  Sum_probs=199.6

Q ss_pred             ecHHHHHHHHHHHh-----------cccCcCCceEEEEEEeCC-C---cEEEEEEecCC--CccHHHHHHHHHHHHhcCC
Q 047276           93 FRSKELEEATDNFQ-----------ALLGHGSSASVFKGILSD-G---TSVAVKRINGE--ENGEKEFRSEVAAIASAQH  155 (453)
Q Consensus        93 ~~~~el~~~~~~~~-----------~~lG~G~fG~Vy~~~~~~-g---~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h  155 (453)
                      ++++++..++.+|.           ++||+|+||+||+|.+.. |   ..||||.+...  ....+.|.+|+.+|++++|
T Consensus         7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H   86 (299)
T d1jpaa_           7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH   86 (299)
T ss_dssp             GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred             CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence            34556666666663           579999999999999742 3   36899988653  2334679999999999999


Q ss_pred             CceeeEeeEEEecCCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccC
Q 047276          156 VNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLD  235 (453)
Q Consensus       156 ~niv~l~g~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~D  235 (453)
                      ||||+++|+|. .++..++|||||++|+|.+++....         +.++|..+++++.||++||+|||+   ++|+|||
T Consensus        87 pnIv~l~g~~~-~~~~~~iv~Ey~~~g~L~~~~~~~~---------~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrD  153 (299)
T d1jpaa_          87 PNVIHLEGVVT-KSTPVMIITEFMENGSLDSFLRQND---------GQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRD  153 (299)
T ss_dssp             TTBCCEEEEEC-SSSSCEEEEECCTTEEHHHHHHTTT---------TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred             CCCccEEEEEe-eCCEEEEEEEecCCCcceeeecccc---------CCCCHHHHHHHHHHHHHHHHHHhh---CCCccCc
Confidence            99999999986 5678899999999999999886432         349999999999999999999999   8999999


Q ss_pred             CCCCcEEECCCCcEEEeeccccccccCCCCc----eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCC
Q 047276          236 VKPENILLDENYRAVVSDFGLSKLMSRDQSR----CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRN  310 (453)
Q Consensus       236 lk~~NiLl~~~~~~kl~DfGla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p  310 (453)
                      |||+||||+.++.+||+|||+++........    ......||+.|||||.+.++.++.++|||||||++|||+| |+.|
T Consensus       154 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~P  233 (299)
T d1jpaa_         154 LAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP  233 (299)
T ss_dssp             CCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             cccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCC
Confidence            9999999999999999999999877543221    1223467899999999999999999999999999999998 8999


Q ss_pred             CcccccCCCCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 047276          311 VSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEG  390 (453)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~  390 (453)
                      |.....             ..+...+..+.       ++    ..+.+.+..+.+++.+||+.||++|||+.+|++.|+.
T Consensus       234 f~~~~~-------------~~~~~~i~~~~-------~~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~  289 (299)
T d1jpaa_         234 YWDMTN-------------QDVINAIEQDY-------RL----PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK  289 (299)
T ss_dssp             TTTCCH-------------HHHHHHHHTTC-------CC----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCCCH-------------HHHHHHHHcCC-------CC----CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            853211             11112222221       11    1223345568999999999999999999999999987


Q ss_pred             ccC
Q 047276          391 RVA  393 (453)
Q Consensus       391 ~~~  393 (453)
                      +..
T Consensus       290 ~l~  292 (299)
T d1jpaa_         290 MIR  292 (299)
T ss_dssp             HHH
T ss_pred             Hhc
Confidence            654

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-53  Score=398.42  Aligned_cols=249  Identities=24%  Similarity=0.387  Sum_probs=210.2

Q ss_pred             HhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCCh
Q 047276          105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL  184 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL  184 (453)
                      |.++||+|+||+||+|++++++.||||+++......++|.+|+.++++++||||++++|+|. .++..++||||+++|+|
T Consensus         8 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~-~~~~~~iv~Ey~~~g~l   86 (258)
T d1k2pa_           8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT-KQRPIFIITEYMANGCL   86 (258)
T ss_dssp             CCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEC-CSSSEEEEEECCTTEEH
T ss_pred             EeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEe-eCCceEEEEEccCCCcH
Confidence            46789999999999999988899999999987777889999999999999999999999986 55789999999999999


Q ss_pred             hhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCCC
Q 047276          185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ  264 (453)
Q Consensus       185 ~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~  264 (453)
                      .+++....         ..+++..+++++.|+++||+|||+   .+|+||||||+|||+++++.+||+|||+++......
T Consensus        87 ~~~~~~~~---------~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  154 (258)
T d1k2pa_          87 LNYLREMR---------HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  154 (258)
T ss_dssp             HHHHHSGG---------GCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred             HHhhhccc---------cCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence            99975442         248999999999999999999999   899999999999999999999999999998776554


Q ss_pred             CceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcCcccc
Q 047276          265 SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLME  343 (453)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (453)
                      ........||+.|+|||.+.+..++.++|||||||++|||+| |+.||.....             ..+...+..+..  
T Consensus       155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~-------------~~~~~~i~~~~~--  219 (258)
T d1k2pa_         155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-------------SETAEHIAQGLR--  219 (258)
T ss_dssp             CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH-------------HHHHHHHHTTCC--
T ss_pred             ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH-------------HHHHHHHHhCCC--
Confidence            444455679999999999999999999999999999999998 8999853221             112222332211  


Q ss_pred             cccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 047276          344 IVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEG  390 (453)
Q Consensus       344 ~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~  390 (453)
                           +    ..+...+..+.+++.+||+.||++|||++++++.|.+
T Consensus       220 -----~----~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         220 -----L----YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             -----C----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             -----C----CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence                 1    1122334568999999999999999999999999865

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-54  Score=407.62  Aligned_cols=258  Identities=24%  Similarity=0.351  Sum_probs=204.0

Q ss_pred             HHHhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCC
Q 047276          103 DNFQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      +.+.+.||+|+||+||+|.+++++.||||+++......+.|.+|+.++++++|||||+++|+|.  .+..++||||+++|
T Consensus        19 ~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~--~~~~~lv~Ey~~~g   96 (285)
T d1fmka3          19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS--EEPIYIVTEYMSKG   96 (285)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSCEEEECCCTTC
T ss_pred             EEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe--cCCeEEEEEecCCC
Confidence            3456899999999999999988889999999887777889999999999999999999999974  35689999999999


Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccC
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR  262 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~  262 (453)
                      +|.+++....        ...++|..++.|+.||+.||+|||+   .+|+||||||+|||||+++.+||+|||+++....
T Consensus        97 ~l~~~~~~~~--------~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~  165 (285)
T d1fmka3          97 SLLDFLKGET--------GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED  165 (285)
T ss_dssp             BHHHHHSHHH--------HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             chhhhhhhcc--------cccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccC
Confidence            9999986432        1349999999999999999999999   8999999999999999999999999999987755


Q ss_pred             CCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCccc
Q 047276          263 DQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLM  342 (453)
Q Consensus       263 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (453)
                      ..........||+.|+|||++..+.++.++||||||+++|||++|..|+.....            .......+..+.. 
T Consensus       166 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~------------~~~~~~~i~~~~~-  232 (285)
T d1fmka3         166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV------------NREVLDQVERGYR-  232 (285)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC------------HHHHHHHHHTTCC-
T ss_pred             CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC------------HHHHHHHHHhcCC-
Confidence            444444556799999999999999999999999999999999997766532110            0111122222211 


Q ss_pred             ccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccCCCC
Q 047276          343 EIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAVDD  396 (453)
Q Consensus       343 ~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~~~~  396 (453)
                                .+.+...+.++.+++.+||+.||++|||+++|+++|+.......
T Consensus       233 ----------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         233 ----------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             ----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             ----------CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence                      11223344568999999999999999999999999998654433

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-53  Score=401.84  Aligned_cols=246  Identities=24%  Similarity=0.332  Sum_probs=201.0

Q ss_pred             ccCcCCceEEEEEEeC---CCcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCC
Q 047276          108 LLGHGSSASVFKGILS---DGTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       108 ~lG~G~fG~Vy~~~~~---~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      +||+|+||+||+|.+.   ++..||||+++...  ...++|.+|+++|++++|||||+++|+|.  .+..++||||+++|
T Consensus        16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~~lvmE~~~~g   93 (285)
T d1u59a_          16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ--AEALMLVMEMAGGG   93 (285)
T ss_dssp             EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--SSSEEEEEECCTTE
T ss_pred             EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeec--cCeEEEEEEeCCCC
Confidence            4999999999999863   35579999997532  33467999999999999999999999985  34789999999999


Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccC
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR  262 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~  262 (453)
                      +|.+++...+         ..+++..+.+++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++....
T Consensus        94 ~L~~~l~~~~---------~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          94 PLHKFLVGKR---------EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EHHHHHTTCT---------TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             cHHHHhhccc---------cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence            9999985432         349999999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCCc--eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          263 DQSR--CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       263 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      ....  ......||+.|+|||.+.++.++.++|||||||++|||+| |+.||.....             ..+...+..+
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~-------------~~~~~~i~~~  228 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-------------PEVMAFIEQG  228 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-------------HHHHHHHHTT
T ss_pred             cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH-------------HHHHHHHHcC
Confidence            4322  2234568999999999999999999999999999999998 9999953211             0122233333


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR  391 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~  391 (453)
                      ...           ..+...+..+.+++.+||+.||++|||+.+|++.|+..
T Consensus       229 ~~~-----------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         229 KRM-----------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             CCC-----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCC-----------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            211           12233445689999999999999999999999999754

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-53  Score=400.39  Aligned_cols=245  Identities=26%  Similarity=0.363  Sum_probs=197.9

Q ss_pred             cccCcCCceEEEEEEeCC---CcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          107 ALLGHGSSASVFKGILSD---GTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~---g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      ++||+|+||+||+|.+.+   ++.||||+++..   ....++|.+|+.+|++++|||||+++|+|.  .+..++||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~--~~~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE--AESWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE--SSSEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec--cCCEEEEEEcCC
Confidence            479999999999998643   468999999653   223467999999999999999999999985  346799999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|.+++....          .++|..+++++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        91 ~g~L~~~l~~~~----------~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~  157 (277)
T d1xbba_          91 LGPLNKYLQQNR----------HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKAL  157 (277)
T ss_dssp             TEEHHHHHHHCT----------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CCcHHHHHhhcc----------CCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhc
Confidence            999999986432          39999999999999999999999   89999999999999999999999999999877


Q ss_pred             cCCCCc--eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhh
Q 047276          261 SRDQSR--CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMK  337 (453)
Q Consensus       261 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (453)
                      ......  ......||+.|||||.+.++.++.++|||||||++|||+| |+.||.....             ..+...+.
T Consensus       158 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-------------~~~~~~i~  224 (277)
T d1xbba_         158 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------------SEVTAMLE  224 (277)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------------HHHHHHHH
T ss_pred             cccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH-------------HHHHHHHH
Confidence            554332  2234578999999999999999999999999999999998 8999953211             11222233


Q ss_pred             cCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcc
Q 047276          338 EGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEG  390 (453)
Q Consensus       338 ~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~  390 (453)
                      .+..       +    ..+...+..+.+++.+||+.||++|||+++|++.|+.
T Consensus       225 ~~~~-------~----~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         225 KGER-------M----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             TTCC-------C----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             cCCC-------C----CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence            3221       1    1222344568899999999999999999999998875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-53  Score=401.48  Aligned_cols=253  Identities=24%  Similarity=0.363  Sum_probs=195.3

Q ss_pred             HhcccCcCCceEEEEEEeCCC-----cEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          105 FQALLGHGSSASVFKGILSDG-----TSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g-----~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      +.++||+|+||+||+|.+++.     ..||||+++...  ....+|.+|+.++++++|||||+++|+|. ..+..++|||
T Consensus        11 ~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~-~~~~~~~v~e   89 (283)
T d1mqba_          11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-KYKPMMIITE   89 (283)
T ss_dssp             EEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSSEEEEEE
T ss_pred             eeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe-cCCceEEEEE
Confidence            367899999999999997532     379999997533  33457999999999999999999999986 5568899999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |+.+|+|.+++....         ..++|..+++++.|++.||+|||+   .+|+||||||+||||+.++.+||+|||++
T Consensus        90 ~~~~~~l~~~~~~~~---------~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla  157 (283)
T d1mqba_          90 YMENGALDKFLREKD---------GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLS  157 (283)
T ss_dssp             CCTTEEHHHHHHHTT---------TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             ecccCcchhhhhccc---------ccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchh
Confidence            999999998875432         349999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCC--ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHh
Q 047276          258 KLMSRDQS--RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEK  335 (453)
Q Consensus       258 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  335 (453)
                      +.......  .......||+.|||||++.++.++.++|||||||++|||++|..|+.....            ...+...
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~------------~~~~~~~  225 (283)
T d1mqba_         158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS------------NHEVMKA  225 (283)
T ss_dssp             ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC------------HHHHHHH
T ss_pred             hcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC------------HHHHHHH
Confidence            87654332  223345689999999999999999999999999999999997666532110            0112222


Q ss_pred             hhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          336 MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       336 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                      +..+..           ...+.+.+..+.+++.+||+.||++||||.+|++.|+.+..
T Consensus       226 i~~~~~-----------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         226 INDGFR-----------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             HHTTCC-----------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HhccCC-----------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence            222211           11223344568999999999999999999999999987654

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=393.22  Aligned_cols=240  Identities=26%  Similarity=0.347  Sum_probs=199.3

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecC----CCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRING----EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      +.+.||+|+||+||+|+.. +|+.||+|++..    .....+.+.+|+.++++++|||||++++++. +++..++||||+
T Consensus        10 i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-~~~~~~ivmEy~   88 (263)
T d2j4za1          10 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-DATRVYLILEYA   88 (263)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-CSSEEEEEEECC
T ss_pred             EEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE-ECCEEEEEEeec
Confidence            4578999999999999974 689999999863    2344677999999999999999999999986 566889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ++|+|.+++....          .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++..
T Consensus        89 ~~g~L~~~l~~~~----------~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~  155 (263)
T d2j4za1          89 PLGTVYRELQKLS----------KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVH  155 (263)
T ss_dssp             TTCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSC
T ss_pred             CCCcHHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeee
Confidence            9999999996432          38999999999999999999999   8999999999999999999999999999986


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      .....   .....||+.|||||.+.+..++.++|||||||++|||++|+.||.....             ......+..+
T Consensus       156 ~~~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------------~~~~~~i~~~  219 (263)
T d2j4za1         156 APSSR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-------------QETYKRISRV  219 (263)
T ss_dssp             CCCCC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------------HHHHHHHHTT
T ss_pred             cCCCc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH-------------HHHHHHHHcC
Confidence            54332   3456799999999999999999999999999999999999999953211             1111222222


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      .            ...+...+..+.+++.+||+.||++|||++|+++
T Consensus       220 ~------------~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         220 E------------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             C------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             C------------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            1            1122233456889999999999999999999985

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-52  Score=392.89  Aligned_cols=246  Identities=24%  Similarity=0.326  Sum_probs=195.1

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      +.+.||+|+||+||+|+. .+|+.||||+++...  ...+.+.+|+.+|++++|||||++++++. .++..++||||+++
T Consensus         9 ~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~-~~~~~~ivmEy~~g   87 (271)
T d1nvra_           9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-EGNIQYLFLEYCSG   87 (271)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEE-ETTEEEEEEECCTT
T ss_pred             EEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeec-cCceeEEEEeccCC
Confidence            357899999999999996 468999999987532  23456899999999999999999999986 55688999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      |+|.+++...          ..+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++...
T Consensus        88 g~L~~~l~~~----------~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~  154 (271)
T d1nvra_          88 GELFDRIEPD----------IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFR  154 (271)
T ss_dssp             EEGGGGSBTT----------TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECE
T ss_pred             CcHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeec
Confidence            9999999533          349999999999999999999999   899999999999999999999999999999775


Q ss_pred             CCCC-ceeeeccCCccccchhhhhcCCC-CccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          262 RDQS-RCITTIRGTRGYLAPEWILEQGV-SEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       262 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      .... .......||+.|||||.+.+..+ +.++|||||||++|||++|+.||.......           .... .....
T Consensus       155 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~-----------~~~~-~~~~~  222 (271)
T d1nvra_         155 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-----------QEYS-DWKEK  222 (271)
T ss_dssp             ETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS-----------HHHH-HHHTT
T ss_pred             cCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH-----------HHHH-HHhcC
Confidence            4332 23455789999999999988776 578999999999999999999995322110           0001 11111


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ...          .......+..+.+++.+||+.||++|||++|+++
T Consensus       223 ~~~----------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         223 KTY----------LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             CTT----------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCC----------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            100          0011123345789999999999999999999853

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-53  Score=395.89  Aligned_cols=251  Identities=27%  Similarity=0.374  Sum_probs=188.4

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCCCc---cHHHHHHHHHHHHhcCCCceeeEeeEEEec-CCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGEEN---GEKEFRSEVAAIASAQHVNLVRLLGYCVVP-GGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~~lv~e~~  179 (453)
                      +.+.||+|+||+||+|+. .+|+.||||.++....   ..+.+.+|++++++++|||||++++++.+. ++..++||||+
T Consensus         8 ~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~   87 (269)
T d2java1           8 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC   87 (269)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECC
T ss_pred             EeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecC
Confidence            357899999999999996 5689999999976432   235688999999999999999999988643 44679999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccC--CCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDC--RSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~--~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      ++|+|.+++.....      ....+++..++.++.|++.||+|||+..  ..+|+||||||+|||++.++.+||+|||++
T Consensus        88 ~~g~L~~~i~~~~~------~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a  161 (269)
T d2java1          88 EGGDLASVITKGTK------ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  161 (269)
T ss_dssp             TTEEHHHHHHHHHH------HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred             CCCcHHHHHHhccc------cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence            99999999864322      1234999999999999999999999832  135999999999999999999999999999


Q ss_pred             ccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhh
Q 047276          258 KLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMK  337 (453)
Q Consensus       258 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (453)
                      +....... ......||+.|||||.+.+..++.++|||||||++|||+||+.||.....             ......+.
T Consensus       162 ~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-------------~~~~~~i~  227 (269)
T d2java1         162 RILNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-------------KELAGKIR  227 (269)
T ss_dssp             HHC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------------HHHHHHHH
T ss_pred             eecccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH-------------HHHHHHHH
Confidence            88754332 23457899999999999999999999999999999999999999953211             11222223


Q ss_pred             cCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          338 EGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       338 ~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      .+....           .+...+..+.+++.+||+.||++|||++|+++
T Consensus       228 ~~~~~~-----------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         228 EGKFRR-----------IPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             HTCCCC-----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cCCCCC-----------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            332211           12233446899999999999999999999874

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-52  Score=402.95  Aligned_cols=260  Identities=23%  Similarity=0.367  Sum_probs=201.9

Q ss_pred             HHHhcccCcCCceEEEEEEeCC-C-----cEEEEEEecCC--CccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeE
Q 047276          103 DNFQALLGHGSSASVFKGILSD-G-----TSVAVKRINGE--ENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRY  173 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~~-g-----~~vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~  173 (453)
                      ..+.++||+|+||+||+|++.. +     ..||||.+...  ......|.+|+.+|.++ +|||||+++|+|. ..+..+
T Consensus        39 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~-~~~~~~  117 (325)
T d1rjba_          39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT-LSGPIY  117 (325)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSSCE
T ss_pred             eEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe-eCCeEE
Confidence            3456899999999999998642 2     36999998653  33345789999999998 8999999999986 566889


Q ss_pred             EEEEecCCCChhhhhccCCCCCC-------------CCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCc
Q 047276          174 LVYEFIQNGSLDHWIFPTSRRSE-------------GHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPEN  240 (453)
Q Consensus       174 lv~e~~~~gsL~~~l~~~~~~~~-------------~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~N  240 (453)
                      +||||+++|+|.++|+.......             .......++|..++.++.|++.||+|||+   ++|+||||||+|
T Consensus       118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~N  194 (325)
T d1rjba_         118 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARN  194 (325)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGGG
T ss_pred             EEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCchhc
Confidence            99999999999999976543210             01123458999999999999999999999   899999999999


Q ss_pred             EEECCCCcEEEeeccccccccCCCCc-eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCC
Q 047276          241 ILLDENYRAVVSDFGLSKLMSRDQSR-CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGN  318 (453)
Q Consensus       241 iLl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~  318 (453)
                      ||++.++.+||+|||+++........ ......||+.|||||.+.++.++.++|||||||++|||+| |+.||...... 
T Consensus       195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~-  273 (325)
T d1rjba_         195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD-  273 (325)
T ss_dssp             EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-
T ss_pred             cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH-
Confidence            99999999999999999876554432 3345668999999999999999999999999999999998 89999532211 


Q ss_pred             CCCcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhc
Q 047276          319 DKSKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLE  389 (453)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~  389 (453)
                                 ......+..+.       ++    +.+...+..+.+++.+||+.||++|||++||+++|.
T Consensus       274 -----------~~~~~~~~~~~-------~~----~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         274 -----------ANFYKLIQNGF-------KM----DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             -----------HHHHHHHHTTC-------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -----------HHHHHHHhcCC-------CC----CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence                       11122222221       11    122233456899999999999999999999999985

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-51  Score=387.40  Aligned_cols=243  Identities=22%  Similarity=0.381  Sum_probs=192.3

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEec---CCCeEEEEE
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVP---GGPRYLVYE  177 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~---~~~~~lv~e  177 (453)
                      |.++||+|+||+||+|... +++.||+|.+....   ...+.|.+|+++|++++|||||++++++...   +...++|||
T Consensus        13 ~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE   92 (270)
T d1t4ha_          13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE   92 (270)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred             eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEe
Confidence            4568999999999999964 68899999986532   2345689999999999999999999998642   335689999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCc--eeccCCCCCcEEEC-CCCcEEEeec
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSR--VLHLDVKPENILLD-ENYRAVVSDF  254 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~--ivH~Dlk~~NiLl~-~~~~~kl~Df  254 (453)
                      |+++|+|.+++....          .+++..+..++.||+.||+|||+   .+  |+||||||+|||++ +++.+||+||
T Consensus        93 ~~~~g~L~~~l~~~~----------~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DF  159 (270)
T d1t4ha_          93 LMTSGTLKTYLKRFK----------VMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDL  159 (270)
T ss_dssp             CCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred             CCCCCcHHHHHhccc----------cccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeec
Confidence            999999999996432          38999999999999999999998   56  99999999999997 5899999999


Q ss_pred             cccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHH
Q 047276          255 GLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNE  334 (453)
Q Consensus       255 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  334 (453)
                      |+++.....   ......||+.|||||.+.+ .++.++|||||||++|||++|+.||.....            ......
T Consensus       160 Gla~~~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~------------~~~~~~  223 (270)
T d1t4ha_         160 GLATLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN------------AAQIYR  223 (270)
T ss_dssp             TGGGGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------------HHHHHH
T ss_pred             CcceeccCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc------------HHHHHH
Confidence            999864332   2345689999999998764 699999999999999999999999952211            011122


Q ss_pred             hhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          335 KMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       335 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      .+..+.....+          +......+.+++.+||+.||++|||++|+++
T Consensus       224 ~i~~~~~~~~~----------~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         224 RVTSGVKPASF----------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             HHTTTCCCGGG----------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHcCCCCccc----------CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            22222111111          1112334889999999999999999999875

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-51  Score=389.50  Aligned_cols=243  Identities=23%  Similarity=0.379  Sum_probs=199.0

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecC-CCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCC
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRING-EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS  183 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gs  183 (453)
                      .+.||+|+||+||+|.. .+|+.||||+++. .....+.+.+|+.++++++|||||++++++. .++..++||||+++|+
T Consensus        25 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-~~~~~~ivmEy~~gg~  103 (293)
T d1yhwa1          25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-VGDELWVVMEYLAGGS  103 (293)
T ss_dssp             CEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-ETTEEEEEEECCTTCB
T ss_pred             EEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEE-ECCEEEEEEEecCCCc
Confidence            47899999999999995 5799999999875 3345677999999999999999999999987 4568899999999999


Q ss_pred             hhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCC
Q 047276          184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD  263 (453)
Q Consensus       184 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~  263 (453)
                      |.+++..           ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       104 L~~~~~~-----------~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~  169 (293)
T d1yhwa1         104 LTDVVTE-----------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (293)
T ss_dssp             HHHHHHH-----------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             HHHHhhc-----------cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence            9998743           238999999999999999999999   89999999999999999999999999999877543


Q ss_pred             CCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcccc
Q 047276          264 QSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLME  343 (453)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (453)
                      .. ......||+.|+|||.+.++.++.++|||||||++|||++|+.||......            .........+..  
T Consensus       170 ~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------------~~~~~~~~~~~~--  234 (293)
T d1yhwa1         170 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------------RALYLIATNGTP--  234 (293)
T ss_dssp             TC-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------------HHHHHHHHHCSC--
T ss_pred             cc-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH------------HHHHHHHhCCCC--
Confidence            32 235567999999999999999999999999999999999999999532110            111111111110  


Q ss_pred             cccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          344 IVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       344 ~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                          .+    ..+...+..+.+++.+||+.||++|||++|+++
T Consensus       235 ----~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         235 ----EL----QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             ----CC----SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ----CC----CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                11    122334456889999999999999999999864

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-51  Score=392.29  Aligned_cols=256  Identities=25%  Similarity=0.390  Sum_probs=203.9

Q ss_pred             HHhcccCcCCceEEEEEEeCCC----cEEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          104 NFQALLGHGSSASVFKGILSDG----TSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~~g----~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      +|+++||+|+||+||+|.+.++    ..||||+++..  ....++|.+|+++|++++||||++++|+|...++..++|||
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence            4567899999999999997432    36899999752  33346799999999999999999999998866678899999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      ||++|+|.+++....         ..+++..+++++.|++.||.|||+   .+|+||||||+|||+++++.+||+|||++
T Consensus       110 ~~~~g~l~~~~~~~~---------~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~  177 (311)
T d1r0pa_         110 YMKHGDLRNFIRNET---------HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLA  177 (311)
T ss_dssp             CCTTCBHHHHHHCTT---------CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGG
T ss_pred             EeecCchhhhhcccc---------ccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccch
Confidence            999999999986443         237899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCC---ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHH
Q 047276          258 KLMSRDQS---RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNE  334 (453)
Q Consensus       258 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  334 (453)
                      +.......   .......||+.|+|||.+..+.++.++||||||+++|||+||+.||.......+            ...
T Consensus       178 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~------------~~~  245 (311)
T d1r0pa_         178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD------------ITV  245 (311)
T ss_dssp             CCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------------------CHH
T ss_pred             hhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH------------HHH
Confidence            87754322   222345789999999999999999999999999999999998888743211100            111


Q ss_pred             hhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccCC
Q 047276          335 KMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVAV  394 (453)
Q Consensus       335 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~~  394 (453)
                      .+..+..       ..    .+......+.+++.+||+.||++||+|.||++.|+++...
T Consensus       246 ~i~~g~~-------~~----~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         246 YLLQGRR-------LL----QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             HHHTTCC-------CC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHHcCCC-------CC----CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            1222221       10    1122334588999999999999999999999999987643

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-51  Score=385.48  Aligned_cols=246  Identities=30%  Similarity=0.450  Sum_probs=193.9

Q ss_pred             HhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCCh
Q 047276          105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGSL  184 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gsL  184 (453)
                      |.++||+|+||.||+|.++ |..||||+++.+. ..+.|.+|++++++++||||++++|+|....+..++||||+++|+|
T Consensus        11 ~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L   88 (262)
T d1byga_          11 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL   88 (262)
T ss_dssp             EEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEH
T ss_pred             EeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCH
Confidence            4578999999999999985 7899999997643 4567999999999999999999999987656678999999999999


Q ss_pred             hhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCCC
Q 047276          185 DHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRDQ  264 (453)
Q Consensus       185 ~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~~  264 (453)
                      .+++.....        ..++|..+++|+.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++..... 
T Consensus        89 ~~~l~~~~~--------~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-  156 (262)
T d1byga_          89 VDYLRSRGR--------SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  156 (262)
T ss_dssp             HHHHHHHHH--------HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             HHHHHhcCC--------CCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCC-
Confidence            999964321        238999999999999999999999   89999999999999999999999999999865432 


Q ss_pred             CceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhhhcCcccc
Q 047276          265 SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKLME  343 (453)
Q Consensus       265 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (453)
                         .....+|+.|+|||++.++.++.++||||||+++|||+| |+.||.......             +...+..+..  
T Consensus       157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~-------------~~~~i~~~~~--  218 (262)
T d1byga_         157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------------VVPRVEKGYK--  218 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-------------HHHHHTTTCC--
T ss_pred             ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH-------------HHHHHHcCCC--
Confidence               233467889999999999999999999999999999998 677774321110             1122222211  


Q ss_pred             cccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 047276          344 IVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR  391 (453)
Q Consensus       344 ~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~  391 (453)
                         +      +.+.....++.+++.+||+.||++|||+.+++++|+++
T Consensus       219 ---~------~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         219 ---M------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             ---C------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---C------CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence               1      12233345688999999999999999999999999865

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-51  Score=390.89  Aligned_cols=244  Identities=23%  Similarity=0.339  Sum_probs=197.2

Q ss_pred             HHhcccCcCCceEEEEEEe-CCCcEEEEEEecC----CCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEe
Q 047276          104 NFQALLGHGSSASVFKGIL-SDGTSVAVKRING----EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      .+.+.||+|+||+||+|+. .+|+.||||+++.    .....+.+.+|+.+|++++||||+++++++. +++..++||||
T Consensus        11 ~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-~~~~~~ivmEy   89 (288)
T d1uu3a_          11 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-DDEKLYFGLSY   89 (288)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE-CSSEEEEEECC
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE-ECCEEEEEEEc
Confidence            3468999999999999996 5689999999864    2344567999999999999999999999976 56688999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +++|+|.+++...          +.+++..+..++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++
T Consensus        90 ~~gg~L~~~~~~~----------~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~  156 (288)
T d1uu3a_          90 AKNGELLKYIRKI----------GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAK  156 (288)
T ss_dssp             CTTEEHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCCCHHHhhhcc----------CCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccce
Confidence            9999999998643          239999999999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhh
Q 047276          259 LMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMK  337 (453)
Q Consensus       259 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (453)
                      ....... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....             ......+.
T Consensus       157 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------------~~~~~~i~  223 (288)
T d1uu3a_         157 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-------------YLIFQKII  223 (288)
T ss_dssp             ECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------------HHHHHHHH
T ss_pred             ecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH-------------HHHHHHHH
Confidence            8754332 234456799999999999999999999999999999999999999953210             01112222


Q ss_pred             cCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          338 EGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       338 ~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      .+..            .++......+.+++.+||+.||++|||++|+++
T Consensus       224 ~~~~------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         224 KLEY------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             TTCC------------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             cCCC------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence            2211            122233455889999999999999999999753

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=389.64  Aligned_cols=251  Identities=20%  Similarity=0.327  Sum_probs=191.2

Q ss_pred             HHhcccCcCCceEEEEEEeCC----CcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          104 NFQALLGHGSSASVFKGILSD----GTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~~----g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      .+.+.||+|+||+||+|++..    +..||||.++...  ...+.|.+|+.++++++|||||+++|+|.  .+..++|||
T Consensus        10 ~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~--~~~~~iv~E   87 (273)
T d1mp8a_          10 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT--ENPVWIIME   87 (273)
T ss_dssp             EEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSCEEEEE
T ss_pred             EEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe--cCeEEEEEE
Confidence            346899999999999998642    3568999987532  23457999999999999999999999974  457899999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |+++|+|.+++....         ..+++..++.++.||+.||+|||+   .+++||||||+||+++.++.+||+|||++
T Consensus        88 ~~~~g~l~~~~~~~~---------~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a  155 (273)
T d1mp8a_          88 LCTLGELRSFLQVRK---------YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLS  155 (273)
T ss_dssp             CCTTEEHHHHHHHTT---------TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred             eccCCcHHhhhhccC---------CCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhh
Confidence            999999999875432         348999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHhh
Q 047276          258 KLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEKM  336 (453)
Q Consensus       258 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (453)
                      +..............||+.|+|||.+.++.++.++|||||||++|||++ |+.||......             .+...+
T Consensus       156 ~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~-------------~~~~~i  222 (273)
T d1mp8a_         156 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-------------DVIGRI  222 (273)
T ss_dssp             ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-------------GHHHHH
T ss_pred             eeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH-------------HHHHHH
Confidence            8776544444455678999999999999999999999999999999998 88888533211             012222


Q ss_pred             hcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          337 KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       337 ~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      ..+...           ..+...+..+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus       223 ~~~~~~-----------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         223 ENGERL-----------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  267 (273)
T ss_dssp             HTTCCC-----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HcCCCC-----------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            222211           122234456899999999999999999999999997653

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-50  Score=387.39  Aligned_cols=271  Identities=21%  Similarity=0.273  Sum_probs=200.2

Q ss_pred             HhcccCcCCceEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCC---CeEEEEEecCC
Q 047276          105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGG---PRYLVYEFIQN  181 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~---~~~lv~e~~~~  181 (453)
                      +.+.||+|+||+||+|++ +|+.||||+++........+..|+..+..++|||||+++|+|...+.   ..++|||||++
T Consensus         7 l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~   85 (303)
T d1vjya_           7 LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH   85 (303)
T ss_dssp             EEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred             EEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccC
Confidence            357899999999999997 58899999997543322223344555567899999999999986543   46899999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccC-----CCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDC-----RSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~-----~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      |+|.++++..           .++|..+++++.|++.||+|||+..     .++|+||||||+||||++++.+||+|||+
T Consensus        86 g~L~~~l~~~-----------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl  154 (303)
T d1vjya_          86 GSLFDYLNRY-----------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             CBHHHHHHHC-----------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             CCHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence            9999999542           3899999999999999999999731     26999999999999999999999999999


Q ss_pred             cccccCCCCc---eeeeccCCccccchhhhhcCC------CCccccchhHHHHHHHHHcCCCCCcccccCCCCCcc--cc
Q 047276          257 SKLMSRDQSR---CITTIRGTRGYLAPEWILEQG------VSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKN--KW  325 (453)
Q Consensus       257 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~--~~  325 (453)
                      ++........   ......||+.|+|||++....      ++.++|||||||++|||+||..|+............  ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~  234 (303)
T d1vjya_         155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  234 (303)
T ss_dssp             CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred             cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence            9877544322   234567999999999987542      567899999999999999999988644332221111  01


Q ss_pred             cchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          326 QYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      .............+..    ++.+... ..+.+....+.+++.+||+.||++|||+.||++.|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~----~p~~~~~-~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~  296 (303)
T d1vjya_         235 DPSVEEMRKVVCEQKL----RPNIPNR-WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             SCCHHHHHHHHTTSCC----CCCCCGG-GGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cchHHHHHHHHhcccc----CCCCCcc-cCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            1111222222222221    2222111 112356677999999999999999999999999998653

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-51  Score=387.92  Aligned_cols=245  Identities=23%  Similarity=0.331  Sum_probs=196.2

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCC-CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCC
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGE-ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS  183 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gs  183 (453)
                      .+.||+|+||+||+|+. .+|+.||||+++.. ....+.|.+|+++|++++|||||++++++. ..+..++||||+++|+
T Consensus        17 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-~~~~~~lvmEy~~~g~   95 (288)
T d2jfla1          17 IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-YENNLWILIEFCAGGA   95 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEE-ETTEEEEEEECCTTEE
T ss_pred             eEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-eCCeEEEEEecCCCCc
Confidence            57899999999999996 46899999999753 344567999999999999999999999987 4568899999999999


Q ss_pred             hhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccCC
Q 047276          184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSRD  263 (453)
Q Consensus       184 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~~  263 (453)
                      |.+++....         ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        96 L~~~~~~~~---------~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~  163 (288)
T d2jfla1          96 VDAVMLELE---------RPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  163 (288)
T ss_dssp             HHHHHHHHT---------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred             HHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence            999975432         249999999999999999999999   89999999999999999999999999999765332


Q ss_pred             CCceeeeccCCccccchhhhh-----cCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          264 QSRCITTIRGTRGYLAPEWIL-----EQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       264 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      . .......||+.|+|||++.     ...++.++|||||||++|||++|+.||.......             ....+..
T Consensus       164 ~-~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-------------~~~~i~~  229 (288)
T d2jfla1         164 I-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-------------VLLKIAK  229 (288)
T ss_dssp             H-HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-------------HHHHHHH
T ss_pred             c-ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-------------HHHHHHc
Confidence            1 1223467999999999984     4568899999999999999999999995322110             1111111


Q ss_pred             CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      +...     .+    ..+...+..+.+++.+||+.||++|||++|+++
T Consensus       230 ~~~~-----~~----~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         230 SEPP-----TL----AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             SCCC-----CC----SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCC-----CC----CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1111     11    112233456889999999999999999999864

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-50  Score=388.24  Aligned_cols=260  Identities=24%  Similarity=0.372  Sum_probs=203.8

Q ss_pred             HhcccCcCCceEEEEEEeC------CCcEEEEEEecCCCc--cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEE
Q 047276          105 FQALLGHGSSASVFKGILS------DGTSVAVKRINGEEN--GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVY  176 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~------~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~  176 (453)
                      +.+.||+|+||+||+|++.      +++.||||+++....  ..++|.+|+.+|++++||||++++++|. ..+..+++|
T Consensus        17 ~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-~~~~~~~v~   95 (301)
T d1lufa_          17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA-VGKPMCLLF   95 (301)
T ss_dssp             EEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSSCEEEE
T ss_pred             EeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec-cCCceEEEE
Confidence            3578999999999999863      457899999976432  3467999999999999999999999986 567889999


Q ss_pred             EecCCCChhhhhccCCCCCC--------------CCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEE
Q 047276          177 EFIQNGSLDHWIFPTSRRSE--------------GHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENIL  242 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~--------------~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiL  242 (453)
                      ||+++|+|.++++.......              .......++|..+++|+.|++.||+|||+   .+++||||||+|||
T Consensus        96 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlKp~NIL  172 (301)
T d1lufa_          96 EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCL  172 (301)
T ss_dssp             ECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred             EecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEcccceE
Confidence            99999999999975432110              00122348999999999999999999999   89999999999999


Q ss_pred             ECCCCcEEEeeccccccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCC-CCCcccccCCCC
Q 047276          243 LDENYRAVVSDFGLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR-RNVSLIEHGNDK  320 (453)
Q Consensus       243 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~-~p~~~~~~~~~~  320 (453)
                      +|.++.+||+|||+++....... ...+...||+.|+|||.+.+..++.++|||||||++|||++|. .||....     
T Consensus       173 ld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~-----  247 (301)
T d1lufa_         173 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA-----  247 (301)
T ss_dssp             ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-----
T ss_pred             ECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC-----
Confidence            99999999999999987644322 3334567899999999999999999999999999999999986 5664221     


Q ss_pred             CcccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          321 SKNKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                              .......+..+....           .+...+.++.+++.+||+.+|++||||.||+++|+++.
T Consensus       248 --------~~e~~~~v~~~~~~~-----------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         248 --------HEEVIYYVRDGNILA-----------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             --------HHHHHHHHHTTCCCC-----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             --------HHHHHHHHHcCCCCC-----------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence                    111223333333211           12233456899999999999999999999999998764

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=398.63  Aligned_cols=192  Identities=28%  Similarity=0.425  Sum_probs=168.5

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCC--CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCC
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGE--ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      .++||+|+||+||+|+. .+|+.||+|+++..  ......+.+|+.+|++++|||||+++++|. ..+..++||||+++|
T Consensus        11 ~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~~iVmEy~~gg   89 (322)
T d1s9ja_          11 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-SDGEISICMEHMDGG   89 (322)
T ss_dssp             EEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE-CSSEEEEEEECCTTE
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-ECCEEEEEEEcCCCC
Confidence            47899999999999996 56899999998753  333567999999999999999999999987 556889999999999


Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccC
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR  262 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~  262 (453)
                      +|.+++.+..          .+++..+..++.|++.||.|||+.  ++|+||||||+|||+++++.+||+|||+|+....
T Consensus        90 ~L~~~l~~~~----------~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          90 SLDQVLKKAG----------RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             EHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             cHHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence            9999996432          389999999999999999999972  4899999999999999999999999999987643


Q ss_pred             CCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcc
Q 047276          263 DQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSL  313 (453)
Q Consensus       263 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~  313 (453)
                      ..   .....||+.|+|||++.+..|+.++||||+||++|||++|+.||..
T Consensus       158 ~~---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~  205 (322)
T d1s9ja_         158 SM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP  205 (322)
T ss_dssp             HT---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred             Cc---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            32   2356899999999999999999999999999999999999999964

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-50  Score=387.51  Aligned_cols=250  Identities=22%  Similarity=0.385  Sum_probs=197.6

Q ss_pred             HhcccCcCCceEEEEEEeC-CCc----EEEEEEecC--CCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEE
Q 047276          105 FQALLGHGSSASVFKGILS-DGT----SVAVKRING--EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~----~vavK~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e  177 (453)
                      +.++||+|+||+||+|.+. +|+    .||+|+++.  .....++|.+|+.++++++|||||+++|+|..  +..++++|
T Consensus        13 ~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~v~e   90 (317)
T d1xkka_          13 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--STVQLITQ   90 (317)
T ss_dssp             EEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEEEEEE
T ss_pred             EeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCeeEEEE
Confidence            3579999999999999964 444    589998864  34456789999999999999999999999863  46789999


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |+.+|+|.+++....         ..+++..+++++.||+.||+|||+   ++|+||||||+|||++.++.+||+|||++
T Consensus        91 ~~~~~~l~~~~~~~~---------~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla  158 (317)
T d1xkka_          91 LMPFGCLLDYVREHK---------DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLA  158 (317)
T ss_dssp             CCTTCBHHHHHHHTS---------SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHH
T ss_pred             eccCCcccccccccc---------cCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccc
Confidence            999999999886442         348999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCc-eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHHHh
Q 047276          258 KLMSRDQSR-CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVNEK  335 (453)
Q Consensus       258 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  335 (453)
                      +........ ......||+.|+|||.+.++.++.++|||||||++|||+| |+.||......             .+...
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~-------------~~~~~  225 (317)
T d1xkka_         159 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-------------EISSI  225 (317)
T ss_dssp             HHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG-------------GHHHH
T ss_pred             eecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH-------------HHHHH
Confidence            987554332 2344568999999999999999999999999999999998 78888532111             01222


Q ss_pred             hhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          336 MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       336 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      +..+..       +    ..+..++..+.+++.+||+.||++|||+.+|++.|+...
T Consensus       226 i~~~~~-------~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         226 LEKGER-------L----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             HHHTCC-------C----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHcCCC-------C----CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence            222211       1    122334456899999999999999999999999987653

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-51  Score=392.05  Aligned_cols=264  Identities=23%  Similarity=0.380  Sum_probs=197.1

Q ss_pred             HHHhcccCcCCceEEEEEEeC------CCcEEEEEEecCCC--ccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeE
Q 047276          103 DNFQALLGHGSSASVFKGILS------DGTSVAVKRINGEE--NGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRY  173 (453)
Q Consensus       103 ~~~~~~lG~G~fG~Vy~~~~~------~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~  173 (453)
                      +.+.++||+|+||+||+|...      +++.||||+++...  ...+.+..|...+.++ +|+||+.+++++...+...+
T Consensus        15 y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~   94 (299)
T d1ywna1          15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM   94 (299)
T ss_dssp             EEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCE
T ss_pred             EEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEE
Confidence            345689999999999999853      34689999997532  3345688888888877 68999999999877777889


Q ss_pred             EEEEecCCCChhhhhccCCCCCC------CCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCC
Q 047276          174 LVYEFIQNGSLDHWIFPTSRRSE------GHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENY  247 (453)
Q Consensus       174 lv~e~~~~gsL~~~l~~~~~~~~------~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~  247 (453)
                      +|||||++|+|.++++.......      .......++|..+..++.||+.||+|||+   ++|+||||||+||||++++
T Consensus        95 iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~~~~  171 (299)
T d1ywna1          95 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKN  171 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGG
T ss_pred             EEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeECCCC
Confidence            99999999999999975432110      01123458999999999999999999999   8999999999999999999


Q ss_pred             cEEEeeccccccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCC-CCCcccccCCCCCcccc
Q 047276          248 RAVVSDFGLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR-RNVSLIEHGNDKSKNKW  325 (453)
Q Consensus       248 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~-~p~~~~~~~~~~~~~~~  325 (453)
                      .+||+|||+++....... .......||+.|+|||.+.++.++.++|||||||++|||+||. .||.....         
T Consensus       172 ~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~---------  242 (299)
T d1ywna1         172 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI---------  242 (299)
T ss_dssp             CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC---------
T ss_pred             cEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH---------
Confidence            999999999987654433 2334567999999999999999999999999999999999975 56642211         


Q ss_pred             cchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          326 QYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                         .......+..+....           .+...+..+.+++.+||+.||++|||++||+++|+++.
T Consensus       243 ---~~~~~~~~~~~~~~~-----------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il  295 (299)
T d1ywna1         243 ---DEEFCRRLKEGTRMR-----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  295 (299)
T ss_dssp             ---SHHHHHHHHHTCCCC-----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---HHHHHHHHhcCCCCC-----------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence               111222233322111           12233456899999999999999999999999998753

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-50  Score=389.01  Aligned_cols=246  Identities=25%  Similarity=0.372  Sum_probs=183.4

Q ss_pred             HHhcccCcCCceEEEEEEeC-CCcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          104 NFQALLGHGSSASVFKGILS-DGTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      .+.+.||+|+||+||+|+.. +|+.||||++....  .....+.+|+.+|++++|||||++++++. .++..++|||||+
T Consensus        12 ~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~~lvmE~~~   90 (307)
T d1a06a_          12 DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYE-SGGHLYLIMQLVS   90 (307)
T ss_dssp             EEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEE-CSSEEEEEECCCC
T ss_pred             EEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-ECCEEEEEEeccC
Confidence            34689999999999999964 68999999997532  33456889999999999999999999976 5668899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEEC---CCCcEEEeecccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD---ENYRAVVSDFGLS  257 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~---~~~~~kl~DfGla  257 (453)
                      +|+|.+++...          +.+++..+..++.|++.||+|||+   .+|+||||||+|||++   +++.+||+|||++
T Consensus        91 gg~L~~~l~~~----------~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a  157 (307)
T d1a06a_          91 GGELFDRIVEK----------GFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLS  157 (307)
T ss_dssp             SCBHHHHHHTC----------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred             CCcHHHhhhcc----------cCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEecccee
Confidence            99999999643          349999999999999999999999   8999999999999994   5789999999999


Q ss_pred             ccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhh
Q 047276          258 KLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMK  337 (453)
Q Consensus       258 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (453)
                      +......  ......||+.|||||.+.+..++.++|||||||++|||++|+.||.....             ......+.
T Consensus       158 ~~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------------~~~~~~i~  222 (307)
T d1a06a_         158 KMEDPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND-------------AKLFEQIL  222 (307)
T ss_dssp             -----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------------HHHHHHHH
T ss_pred             EEccCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH-------------HHHHHHHh
Confidence            8664332  23456799999999999999999999999999999999999999953211             00111111


Q ss_pred             cCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          338 EGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       338 ~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      .+...      .  ........+..+.+++.+||+.||++|||++|+++
T Consensus       223 ~~~~~------~--~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         223 KAEYE------F--DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             TTCCC------C--CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccCCC------C--CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            11110      0  01112233456899999999999999999999987

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.2e-50  Score=382.95  Aligned_cols=239  Identities=23%  Similarity=0.303  Sum_probs=192.4

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCCc----cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEEN----GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      .+.||+|+||+||+|+. .+|+.||||+++....    ..+.+.+|+.+|++++|||||++++++. .++..++|||||+
T Consensus        20 l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-~~~~~~iv~E~~~   98 (309)
T d1u5ra_          20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-REHTAWLVMEYCL   98 (309)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-ETTEEEEEEECCS
T ss_pred             eEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE-ECCEEEEEEEecC
Confidence            47899999999999995 5688999999975432    2246889999999999999999999987 4568899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|..++...          ..+++..+..++.||+.||.|||+   ++|+||||||+|||+++++.+||+|||++...
T Consensus        99 ~g~l~~~~~~~----------~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~  165 (309)
T d1u5ra_          99 GSASDLLEVHK----------KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM  165 (309)
T ss_dssp             EEHHHHHHHHT----------SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred             CCchHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeeccccccc
Confidence            99998776432          349999999999999999999999   89999999999999999999999999999865


Q ss_pred             cCCCCceeeeccCCccccchhhhhc---CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhh
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILE---QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMK  337 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (453)
                      ...     ....||+.|||||++.+   +.|+.++|||||||++|||++|+.||.....            ...... ..
T Consensus       166 ~~~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~------------~~~~~~-i~  227 (309)
T d1u5ra_         166 APA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------------MSALYH-IA  227 (309)
T ss_dssp             SSB-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------------HHHHHH-HH
T ss_pred             CCC-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH------------HHHHHH-HH
Confidence            432     34579999999999863   4689999999999999999999999952210            011111 11


Q ss_pred             cCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          338 EGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       338 ~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      .+....     +.     +...+..+.+++.+||+.||++|||++|+++
T Consensus       228 ~~~~~~-----~~-----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         228 QNESPA-----LQ-----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             HSCCCC-----CS-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             hCCCCC-----CC-----CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            111111     11     1122345889999999999999999999975

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.4e-49  Score=387.75  Aligned_cols=248  Identities=21%  Similarity=0.275  Sum_probs=199.7

Q ss_pred             HHhcccCcCCceEEEEEEe-CCCcEEEEEEecCCC-ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          104 NFQALLGHGSSASVFKGIL-SDGTSVAVKRINGEE-NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      .+.+.||+|+||+||+|+. .+|+.||||++.... ...+.+.+|+.+|++++|||||++++++. .++..++|||||++
T Consensus        29 ~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-~~~~~~ivmE~~~g  107 (350)
T d1koaa2          29 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE-DDNEMVMIYEFMSG  107 (350)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE-ETTEEEEEECCCCS
T ss_pred             EEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-ECCEEEEEEEcCCC
Confidence            3468899999999999996 568999999997643 34467899999999999999999999986 56689999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEEC--CCCcEEEeecccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD--ENYRAVVSDFGLSKL  259 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~--~~~~~kl~DfGla~~  259 (453)
                      |+|.+++....         +.+++..+..|+.||+.||+|||+   .+|+||||||+|||++  .++.+||+|||+++.
T Consensus       108 g~L~~~l~~~~---------~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~  175 (350)
T d1koaa2         108 GELFEKVADEH---------NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH  175 (350)
T ss_dssp             CBHHHHHTCTT---------SCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             CCHHHHHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchhee
Confidence            99999985332         349999999999999999999999   8999999999999996  468899999999987


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      .....  ......||+.|||||.+.+..++.++|||||||++|||++|+.||.....            .. ....+..+
T Consensus       176 ~~~~~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------------~~-~~~~i~~~  240 (350)
T d1koaa2         176 LDPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND------------DE-TLRNVKSC  240 (350)
T ss_dssp             CCTTS--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------------HH-HHHHHHHT
T ss_pred             ccccc--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH------------HH-HHHHHHhC
Confidence            75433  23557899999999999999999999999999999999999999953211            01 11111111


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      ...  .+.      ......+..+.+++.+||+.||++|||++|+++.
T Consensus       241 ~~~--~~~------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         241 DWN--MDD------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             CCC--SCC------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             CCC--CCc------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            110  000      0111233458899999999999999999999874

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=375.66  Aligned_cols=250  Identities=26%  Similarity=0.385  Sum_probs=190.8

Q ss_pred             HhcccCcCCceEEEEEEeC--CC--cEEEEEEecCC----CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEE
Q 047276          105 FQALLGHGSSASVFKGILS--DG--TSVAVKRINGE----ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVY  176 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~--~g--~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~  176 (453)
                      +.+.||+|+||+||+|++.  ++  ..||||+++..    ....++|.+|+.+|++++|||||+++|+|.  .+..++||
T Consensus        12 ~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~--~~~~~lv~   89 (273)
T d1u46a_          12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL--TPPMKMVT   89 (273)
T ss_dssp             EEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSCEEEE
T ss_pred             EEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe--ecchheee
Confidence            3578999999999999853  23  37899998652    233467999999999999999999999985  34678999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||+++|+|.+++....         ..+++..+++++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+
T Consensus        90 e~~~~~~l~~~~~~~~---------~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl  157 (273)
T d1u46a_          90 ELAPLGSLLDRLRKHQ---------GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGL  157 (273)
T ss_dssp             ECCTTCBHHHHHHHHG---------GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             eeecCcchhhhhhccc---------CCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchh
Confidence            9999999999875432         349999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCce--eeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCcccccchhHHHH
Q 047276          257 SKLMSRDQSRC--ITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNKWQYFPKIVN  333 (453)
Q Consensus       257 a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  333 (453)
                      ++.........  .....||..|+|||.+.+..++.++|||||||++|||+| |+.||.....            .....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~------------~~~~~  225 (273)
T d1u46a_         158 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------------SQILH  225 (273)
T ss_dssp             CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------------HHHHH
T ss_pred             hhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH------------HHHHH
Confidence            99875543322  233567889999999999999999999999999999998 8999853211            11112


Q ss_pred             HhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 047276          334 EKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR  391 (453)
Q Consensus       334 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~  391 (453)
                      .....+..       +    +.+...+..+.+++.+||+.||++|||+++|++.|.+.
T Consensus       226 ~i~~~~~~-------~----~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         226 KIDKEGER-------L----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             HHHTSCCC-------C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhCCCC-------C----CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            22222111       1    11223345688999999999999999999999999764

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.3e-49  Score=385.31  Aligned_cols=248  Identities=20%  Similarity=0.245  Sum_probs=200.4

Q ss_pred             HHhcccCcCCceEEEEEEe-CCCcEEEEEEecCCC-ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          104 NFQALLGHGSSASVFKGIL-SDGTSVAVKRINGEE-NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      .+.+.||+|+||+||+|.. .+|+.||||+++... ...+.+.+|+.+|++++|||||++++++. .++..++|||||++
T Consensus        32 ~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-~~~~~~ivmE~~~g  110 (352)
T d1koba_          32 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-DKYEMVLILEFLSG  110 (352)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-CSSEEEEEEECCCC
T ss_pred             EEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-ECCEEEEEEEcCCC
Confidence            3457999999999999996 579999999997643 33456889999999999999999999976 56788999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEEC--CCCcEEEeecccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD--ENYRAVVSDFGLSKL  259 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~--~~~~~kl~DfGla~~  259 (453)
                      |+|.+++....         ..+++..+..|+.||+.||+|||+   .+|+||||||+||||+  .++.+||+|||++..
T Consensus       111 g~L~~~~~~~~---------~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~  178 (352)
T d1koba_         111 GELFDRIAAED---------YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATK  178 (352)
T ss_dssp             CBHHHHTTCTT---------CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             ChHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeeccccee
Confidence            99998875332         248999999999999999999999   8999999999999998  678999999999988


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      .....  ......||+.|+|||.+.+..++.++|||||||++|||+||+.||......            . ....+..+
T Consensus       179 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------------~-~~~~i~~~  243 (352)
T d1koba_         179 LNPDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------------E-TLQNVKRC  243 (352)
T ss_dssp             CCTTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------------H-HHHHHHHC
T ss_pred             cCCCC--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH------------H-HHHHHHhC
Confidence            75433  245567999999999999999999999999999999999999999532110            0 11112221


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      ...      +.  .......+..+.+++.+||+.||++|||+.|+++.
T Consensus       244 ~~~------~~--~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         244 DWE------FD--EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             CCC------CC--SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCC------CC--cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            110      00  11112334568899999999999999999999863

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-49  Score=377.89  Aligned_cols=246  Identities=21%  Similarity=0.260  Sum_probs=197.7

Q ss_pred             HHhcccCcCCceEEEEEEe-CCCcEEEEEEecCC-------CccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEE
Q 047276          104 NFQALLGHGSSASVFKGIL-SDGTSVAVKRINGE-------ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLV  175 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv  175 (453)
                      .+.+.||+|+||+||+|+. .+|+.||||+++..       ....+.|.+|+.+|++++|||||++++++. +.+..++|
T Consensus        13 ~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-~~~~~~iv   91 (293)
T d1jksa_          13 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE-NKTDVILI   91 (293)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-CSSEEEEE
T ss_pred             EEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-ECCEEEEE
Confidence            3457899999999999996 57899999998642       123578999999999999999999999986 56788999


Q ss_pred             EEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCC----cEEE
Q 047276          176 YEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENY----RAVV  251 (453)
Q Consensus       176 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~----~~kl  251 (453)
                      ||||++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++    .+||
T Consensus        92 ~E~~~gg~L~~~i~~~~----------~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl  158 (293)
T d1jksa_          92 LELVAGGELFDFLAEKE----------SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKI  158 (293)
T ss_dssp             EECCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEE
T ss_pred             EEcCCCccccchhcccc----------ccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEe
Confidence            99999999999996432          39999999999999999999999   8999999999999998776    5999


Q ss_pred             eeccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHH
Q 047276          252 SDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKI  331 (453)
Q Consensus       252 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~  331 (453)
                      +|||++.......  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......             .
T Consensus       159 ~DfG~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-------------~  223 (293)
T d1jksa_         159 IDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-------------E  223 (293)
T ss_dssp             CCCTTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------------H
T ss_pred             cchhhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH-------------H
Confidence            9999998765432  234567899999999999999999999999999999999999999532110             0


Q ss_pred             HHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          332 VNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       332 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ....+..+... . .+.      .+...+..+.+++.+||+.||++|||++|+++
T Consensus       224 ~~~~i~~~~~~-~-~~~------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         224 TLANVSAVNYE-F-EDE------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HHHHHHTTCCC-C-CHH------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhcCCC-C-Cch------hcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11111111110 0 000      01122345889999999999999999999875

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.3e-49  Score=378.64  Aligned_cols=239  Identities=23%  Similarity=0.296  Sum_probs=197.4

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecC----CCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRING----EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      +.+.||+|+||+||+|+. .+|+.||||+++.    .....+.+.+|+.++++++|||||++++++. ..+..++||||+
T Consensus         8 i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-~~~~~~ivmE~~   86 (316)
T d1fota_           8 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-DAQQIFMIMDYI   86 (316)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-CSSEEEEEECCC
T ss_pred             EEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe-eCCeeeeEeeec
Confidence            357899999999999996 5689999999864    2344577999999999999999999999976 566889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ++|+|..++....          .+++.....++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus        87 ~gg~l~~~~~~~~----------~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~  153 (316)
T d1fota_          87 EGGELFSLLRKSQ----------RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKY  153 (316)
T ss_dssp             CSCBHHHHHHHTS----------SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             CCccccccccccc----------cccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceE
Confidence            9999999886443          38889999999999999999999   8999999999999999999999999999987


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      ....    .....||+.|||||.+.+..++.++|||||||++|||++|+.||.....             ......+..+
T Consensus       154 ~~~~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-------------~~~~~~i~~~  216 (316)
T d1fota_         154 VPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-------------MKTYEKILNA  216 (316)
T ss_dssp             CSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------------HHHHHHHHHC
T ss_pred             eccc----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-------------HHHHHHHHcC
Confidence            6433    2456899999999999999999999999999999999999999953211             0111122121


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRP-----SMARVVE  386 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~~v~~  386 (453)
                      .            ...+...+..+.+++.+||+.||++||     |++++++
T Consensus       217 ~------------~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         217 E------------LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             C------------CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             C------------CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            1            112223345588999999999999996     8999875

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-50  Score=383.28  Aligned_cols=261  Identities=21%  Similarity=0.346  Sum_probs=204.4

Q ss_pred             HhcccCcCCceEEEEEEeC------CCcEEEEEEecCCCc--cHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEE
Q 047276          105 FQALLGHGSSASVFKGILS------DGTSVAVKRINGEEN--GEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVY  176 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~------~g~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~  176 (453)
                      +.+.||+|+||+||+|.+.      +++.||||+++....  ....|.+|+.++++++|||||+++|+|. ..+..++||
T Consensus        24 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~-~~~~~~lv~  102 (308)
T d1p4oa_          24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS-QGQPTLVIM  102 (308)
T ss_dssp             EEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC-SSSSCEEEE
T ss_pred             EeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe-cCCceeEEE
Confidence            4588999999999999863      357899999975332  2346899999999999999999999986 566889999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||+++|+|.+++...............+++..+.+++.|++.||.|||+   .+|+||||||+|||+|+++++||+|||+
T Consensus       103 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~DFGl  179 (308)
T d1p4oa_         103 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGM  179 (308)
T ss_dssp             ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred             eecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEeeccc
Confidence            9999999999986432111001122347999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCc-eeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCC-CCCcccccCCCCCcccccchhHHHHH
Q 047276          257 SKLMSRDQSR-CITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGR-RNVSLIEHGNDKSKNKWQYFPKIVNE  334 (453)
Q Consensus       257 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~  334 (453)
                      ++........ ......||+.|+|||.+.++.++.++||||||+++|||+||+ .||....            ... ...
T Consensus       180 a~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~------------~~~-~~~  246 (308)
T d1p4oa_         180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------------NEQ-VLR  246 (308)
T ss_dssp             CCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC------------HHH-HHH
T ss_pred             ceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC------------HHH-HHH
Confidence            9876544332 223346899999999999999999999999999999999985 5663211            111 122


Q ss_pred             hhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          335 KMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       335 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                      .+..+....           .+...+..+.+++.+||+.+|++||||++|+++|++..+
T Consensus       247 ~i~~~~~~~-----------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         247 FVMEGGLLD-----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HHHTTCCCC-----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHhCCCCC-----------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            222222111           122334569999999999999999999999999987643

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-49  Score=376.02  Aligned_cols=262  Identities=24%  Similarity=0.374  Sum_probs=201.4

Q ss_pred             HHhcccCcCCceEEEEEEeCC--------CcEEEEEEecCCCc--cHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCe
Q 047276          104 NFQALLGHGSSASVFKGILSD--------GTSVAVKRINGEEN--GEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPR  172 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~~~--------g~~vavK~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~  172 (453)
                      .+.+.||+|+||.||+|+...        +..||||+++.+..  ...++.+|...+.++ +|||||+++|+|. .++..
T Consensus        16 ~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~-~~~~~   94 (299)
T d1fgka_          16 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT-QDGPL   94 (299)
T ss_dssp             EEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSSC
T ss_pred             EEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc-cCCeE
Confidence            346889999999999998522        34799999976433  346788999999888 7999999999987 55688


Q ss_pred             EEEEEecCCCChhhhhccCCCCC------CCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCC
Q 047276          173 YLVYEFIQNGSLDHWIFPTSRRS------EGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDEN  246 (453)
Q Consensus       173 ~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~  246 (453)
                      ++||||+++|+|.+++.......      ........+++..+++++.|++.||+|||+   .+|+||||||+|||++.+
T Consensus        95 ~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~~~  171 (299)
T d1fgka_          95 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTED  171 (299)
T ss_dssp             EEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTT
T ss_pred             EEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeecCC
Confidence            99999999999999997654211      011123459999999999999999999999   899999999999999999


Q ss_pred             CcEEEeeccccccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHc-CCCCCcccccCCCCCccc
Q 047276          247 YRAVVSDFGLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTG-GRRNVSLIEHGNDKSKNK  324 (453)
Q Consensus       247 ~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~ellt-G~~p~~~~~~~~~~~~~~  324 (453)
                      +.+||+|||+++....... .......+|+.|+|||.+.++.++.++|||||||++|||++ |..||.....        
T Consensus       172 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~--------  243 (299)
T d1fgka_         172 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--------  243 (299)
T ss_dssp             CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------
T ss_pred             CCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH--------
Confidence            9999999999997765432 23345678999999999999999999999999999999998 6878742211        


Q ss_pred             ccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          325 WQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                           ..+...+..+...           ..+...+..+.+++.+||+.||++|||+.||++.|+++.+
T Consensus       244 -----~~~~~~i~~~~~~-----------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         244 -----EELFKLLKEGHRM-----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             -----HHHHHHHHTTCCC-----------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----HHHHHHHHcCCCC-----------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence                 1122333332211           1122234568999999999999999999999999987654

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-50  Score=385.05  Aligned_cols=264  Identities=24%  Similarity=0.353  Sum_probs=205.2

Q ss_pred             HHHHhcccCcCCceEEEEEEe------CCCcEEEEEEecCCC--ccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCe
Q 047276          102 TDNFQALLGHGSSASVFKGIL------SDGTSVAVKRINGEE--NGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPR  172 (453)
Q Consensus       102 ~~~~~~~lG~G~fG~Vy~~~~------~~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~  172 (453)
                      .+.+.++||+|+||.||+|++      .+++.||||+++...  ....+|.+|+.+++++ +|||||+++|+|. ..+..
T Consensus        24 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~-~~~~~  102 (311)
T d1t46a_          24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT-IGGPT  102 (311)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSSC
T ss_pred             HeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe-eCCEE
Confidence            344578999999999999985      345789999997643  3345689999999999 6999999999986 55678


Q ss_pred             EEEEEecCCCChhhhhccCCCCCC--------CCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEEC
Q 047276          173 YLVYEFIQNGSLDHWIFPTSRRSE--------GHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD  244 (453)
Q Consensus       173 ~lv~e~~~~gsL~~~l~~~~~~~~--------~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~  244 (453)
                      ++|||||++|+|.++++.......        .......+++..+.+++.||+.||+|||+   ++++||||||+|||++
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~~  179 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLT  179 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEE
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccccccccccc
Confidence            999999999999999976542110        00123358999999999999999999999   8999999999999999


Q ss_pred             CCCcEEEeeccccccccCCCC-ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCC-CcccccCCCCCc
Q 047276          245 ENYRAVVSDFGLSKLMSRDQS-RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRN-VSLIEHGNDKSK  322 (453)
Q Consensus       245 ~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p-~~~~~~~~~~~~  322 (453)
                      .++.+||+|||+++....... .......||+.|+|||.+.++.++.++|||||||++|||+|++.| +......     
T Consensus       180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-----  254 (311)
T d1t46a_         180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-----  254 (311)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-----
T ss_pred             ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH-----
Confidence            999999999999997765433 333456789999999999999999999999999999999995444 4321110     


Q ss_pred             ccccchhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          323 NKWQYFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                             ..+...+..+...           ..+...+..+.+|+.+||+.||++|||+++|+++|++..
T Consensus       255 -------~~~~~~i~~~~~~-----------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i  306 (311)
T d1t46a_         255 -------SKFYKMIKEGFRM-----------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (311)
T ss_dssp             -------HHHHHHHHHTCCC-----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------HHHHHHHhcCCCC-----------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence                   1122222222110           112223456899999999999999999999999998653

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-49  Score=381.69  Aligned_cols=242  Identities=22%  Similarity=0.279  Sum_probs=199.2

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecC----CCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRING----EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      +.+.||+|+||+||+|+. .+|+.||||+++.    .....+.+.+|+.+|++++||||+++++++. +.+..++|||||
T Consensus         9 ~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-~~~~~~iv~ey~   87 (337)
T d1o6la_           9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-THDRLCFVMEYA   87 (337)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-CSSEEEEEEECC
T ss_pred             EEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeec-cccccccceecc
Confidence            357899999999999996 5799999999964    2344577899999999999999999999876 566889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      ++|+|.+++....          .+++.....++.|++.||+|||+   ++|+||||||+|||++.+|.+||+|||+++.
T Consensus        88 ~gg~L~~~~~~~~----------~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~  154 (337)
T d1o6la_          88 NGGELFFHLSRER----------VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKE  154 (337)
T ss_dssp             TTCBHHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             CCCchhhhhhccc----------CCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccc
Confidence            9999999986543          38999999999999999999999   8999999999999999999999999999987


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcC
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEG  339 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                      ...... .....+||+.|+|||.+.+..|+.++||||+||++|||++|+.||.....            .. .......+
T Consensus       155 ~~~~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~------------~~-~~~~i~~~  220 (337)
T d1o6la_         155 GISDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------------ER-LFELILME  220 (337)
T ss_dssp             SCCTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------------HH-HHHHHHHC
T ss_pred             cccCCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH------------HH-HHHHHhcC
Confidence            643322 23557899999999999999999999999999999999999999963221            01 11222222


Q ss_pred             cccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 047276          340 KLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPS-----MARVVE  386 (453)
Q Consensus       340 ~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~~v~~  386 (453)
                      .            ..++...+..+.+++.+||+.||++||+     +.++++
T Consensus       221 ~------------~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         221 E------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             C------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             C------------CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            1            1122334456889999999999999995     677765

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-49  Score=376.45  Aligned_cols=259  Identities=26%  Similarity=0.386  Sum_probs=199.1

Q ss_pred             HhcccCcCCceEEEEEEeC-CCc--EEEEEEecCC--CccHHHHHHHHHHHHhc-CCCceeeEeeEEEecCCCeEEEEEe
Q 047276          105 FQALLGHGSSASVFKGILS-DGT--SVAVKRINGE--ENGEKEFRSEVAAIASA-QHVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~--~vavK~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      +.++||+|+||+||+|++. +|.  .||||+++..  ....+.|.+|+++|+++ +|||||+++|+|. .++..++||||
T Consensus        14 ~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~-~~~~~~iV~ey   92 (309)
T d1fvra_          14 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-HRGYLYLAIEY   92 (309)
T ss_dssp             EEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE-ETTEEEEEECC
T ss_pred             EEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEe-cCCeeEEEEEe
Confidence            4578999999999999975 343  5788887642  33445799999999998 7999999999987 55688999999


Q ss_pred             cCCCChhhhhccCCCCC------CCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEe
Q 047276          179 IQNGSLDHWIFPTSRRS------EGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVS  252 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~------~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~  252 (453)
                      +++|+|.++|+......      ........++|..+++++.||+.||.|||+   .+|+||||||+|||++.++.+||+
T Consensus        93 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~kl~  169 (309)
T d1fvra_          93 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIA  169 (309)
T ss_dssp             CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEEC
T ss_pred             cCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCceEEc
Confidence            99999999997542100      000123459999999999999999999999   899999999999999999999999


Q ss_pred             eccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCC-CCcccccCCCCCcccccchhHH
Q 047276          253 DFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRR-NVSLIEHGNDKSKNKWQYFPKI  331 (453)
Q Consensus       253 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~-p~~~~~~~~~~~~~~~~~~~~~  331 (453)
                      |||+++.......  .....||..|+|||.+.++.++.++|||||||++|||++|.. ||....             ...
T Consensus       170 DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~-------------~~~  234 (309)
T d1fvra_         170 DFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-------------CAE  234 (309)
T ss_dssp             CTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-------------HHH
T ss_pred             ccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC-------------HHH
Confidence            9999986543222  234568999999999999999999999999999999999765 553211             111


Q ss_pred             HHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccccC
Q 047276          332 VNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRVA  393 (453)
Q Consensus       332 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~~  393 (453)
                      +...+..+..           ...+...+..+.+++.+||+.||++||||++|++.|+++..
T Consensus       235 ~~~~i~~~~~-----------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~  285 (309)
T d1fvra_         235 LYEKLPQGYR-----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  285 (309)
T ss_dssp             HHHHGGGTCC-----------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHhcCC-----------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            1222222211           11222344568999999999999999999999999988764

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=7.5e-49  Score=371.47  Aligned_cols=253  Identities=22%  Similarity=0.299  Sum_probs=194.0

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCCC----ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCC---CeEEEE
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGEE----NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGG---PRYLVY  176 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~---~~~lv~  176 (453)
                      +.+.||+|+||+||+|+. .+|+.||||+++...    .....|.+|+.+++.++||||+++++++...+.   ..++||
T Consensus        11 i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvm   90 (277)
T d1o6ya_          11 LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVM   90 (277)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             EeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEE
Confidence            467899999999999995 579999999997532    223568999999999999999999999875443   368999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||+++|+|.+++....          .+++..+..++.|++.||+|||+   .+|+||||||+|||++.++..+|+|||.
T Consensus        91 E~~~g~~L~~~~~~~~----------~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~  157 (277)
T d1o6ya_          91 EYVDGVTLRDIVHTEG----------PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGI  157 (277)
T ss_dssp             ECCCEEEHHHHHHHHC----------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTT
T ss_pred             ECCCCCEehhhhcccC----------CCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhh
Confidence            9999999999886442          39999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCC--CceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHH
Q 047276          257 SKLMSRDQ--SRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNE  334 (453)
Q Consensus       257 a~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  334 (453)
                      +.......  ........||+.|+|||.+.+..++.++|||||||++|||+||+.||.....            ......
T Consensus       158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------------~~~~~~  225 (277)
T d1o6ya_         158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------------VSVAYQ  225 (277)
T ss_dssp             CEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------------HHHHHH
T ss_pred             hhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH------------HHHHHH
Confidence            87654332  2234456799999999999999999999999999999999999999953211            111122


Q ss_pred             hhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCC-CHHHHHHHhccc
Q 047276          335 KMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRP-SMARVVEMLEGR  391 (453)
Q Consensus       335 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-s~~~v~~~L~~~  391 (453)
                      ....+...    +.     ....+.+..+.+++.+||+.||++|| |++++...|...
T Consensus       226 ~~~~~~~~----~~-----~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         226 HVREDPIP----PS-----ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             HHHCCCCC----GG-----GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             HHhcCCCC----Cc-----hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence            22221110    00     01112334588999999999999999 899998888653

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.3e-47  Score=362.10  Aligned_cols=245  Identities=22%  Similarity=0.317  Sum_probs=196.4

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCCCc----------cHHHHHHHHHHHHhcC-CCceeeEeeEEEecCCCe
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGEEN----------GEKEFRSEVAAIASAQ-HVNLVRLLGYCVVPGGPR  172 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~----------~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~  172 (453)
                      +.+.||+|+||+||+|+. .+|+.||||+++....          ..+.+.+|+.++++++ ||||+++++++. +++..
T Consensus         7 ~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-~~~~~   85 (277)
T d1phka_           7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE-TNTFF   85 (277)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE-CSSEE
T ss_pred             EceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc-cCcce
Confidence            357899999999999996 5789999999865321          1235889999999997 999999999976 56788


Q ss_pred             EEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEe
Q 047276          173 YLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVS  252 (453)
Q Consensus       173 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~  252 (453)
                      ++|||||++|+|.+++..+          +.+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+
T Consensus        86 ~ivmE~~~~g~L~~~l~~~----------~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~  152 (277)
T d1phka_          86 FLVFDLMKKGELFDYLTEK----------VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLT  152 (277)
T ss_dssp             EEEEECCTTCBHHHHHHHH----------SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEEEEcCCCchHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEc
Confidence            9999999999999999643          239999999999999999999999   899999999999999999999999


Q ss_pred             eccccccccCCCCceeeeccCCccccchhhhhc------CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCccccc
Q 047276          253 DFGLSKLMSRDQSRCITTIRGTRGYLAPEWILE------QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQ  326 (453)
Q Consensus       253 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~  326 (453)
                      |||+++.......  .....||+.|+|||.+..      ..++.++||||+||++|||++|+.||.....          
T Consensus       153 DFG~a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~----------  220 (277)
T d1phka_         153 DFGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ----------  220 (277)
T ss_dssp             CCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----------
T ss_pred             cchheeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH----------
Confidence            9999987754332  345679999999999863      3468899999999999999999999963211          


Q ss_pred             chhHHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          327 YFPKIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                         ......+..+... ..       .......+..+.+++.+||+.||++|||++||++
T Consensus       221 ---~~~~~~i~~~~~~-~~-------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         221 ---MLMLRMIMSGNYQ-FG-------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             ---HHHHHHHHHTCCC-CC-------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ---HHHHHHHHhCCCC-CC-------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence               1112222222211 00       1112234456899999999999999999999864

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-48  Score=371.06  Aligned_cols=246  Identities=17%  Similarity=0.232  Sum_probs=198.9

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCC
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS  183 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gs  183 (453)
                      +.+.||+|+||+||+|... +|+.||||.++........+.+|+++|+.++|||||++++++. .++..++|||||++|+
T Consensus         9 i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-~~~~~~lvmE~~~gg~   87 (321)
T d1tkia_           9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE-SMEELVMIFEFISGLD   87 (321)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEE-ETTEEEEEECCCCCCB
T ss_pred             EEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEE-ECCEEEEEEecCCCCc
Confidence            4578999999999999964 6889999999876666677899999999999999999999876 5668999999999999


Q ss_pred             hhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECC--CCcEEEeecccccccc
Q 047276          184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDE--NYRAVVSDFGLSKLMS  261 (453)
Q Consensus       184 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~--~~~~kl~DfGla~~~~  261 (453)
                      |.+++....         ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.  +..+||+|||+++...
T Consensus        88 L~~~i~~~~---------~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~  155 (321)
T d1tkia_          88 IFERINTSA---------FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             HHHHHTSSS---------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             HHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccc
Confidence            999995432         248999999999999999999999   89999999999999985  4589999999998764


Q ss_pred             CCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCcc
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGKL  341 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  341 (453)
                      ...  ......+|+.|+|||.+.+..++.++||||+||++|||++|+.||......             .....+..+..
T Consensus       156 ~~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-------------~~~~~i~~~~~  220 (321)
T d1tkia_         156 PGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-------------QIIENIMNAEY  220 (321)
T ss_dssp             TTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------------HHHHHHHHTCC
T ss_pred             cCC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH-------------HHHHHHHhCCC
Confidence            332  345567899999999999999999999999999999999999999532110             01111111111


Q ss_pred             cccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          342 MEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       342 ~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      .  ++..      .....+..+.+++.+||+.||++|||++|+++
T Consensus       221 ~--~~~~------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         221 T--FDEE------AFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             C--CCHH------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             C--CChh------hccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0  0000      00112345889999999999999999999987

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=5.5e-48  Score=378.56  Aligned_cols=243  Identities=21%  Similarity=0.258  Sum_probs=190.3

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCC----CccHHHHHHH---HHHHHhcCCCceeeEeeEEEecCCCeEEEE
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGE----ENGEKEFRSE---VAAIASAQHVNLVRLLGYCVVPGGPRYLVY  176 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~----~~~~~~~~~E---~~~l~~l~h~niv~l~g~~~~~~~~~~lv~  176 (453)
                      +.++||+|+||+||+|+. .+|+.||||++...    ......+.+|   +.+++.++|||||++++++. ..+..++||
T Consensus         8 i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~-~~~~~~ivm   86 (364)
T d1omwa3           8 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-TPDKLSFIL   86 (364)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE-CSSEEEEEE
T ss_pred             eeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE-ECCEEEEEE
Confidence            357899999999999996 46999999998632    2233445555   55666778999999999976 556889999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||+++|+|.+++....          .+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus        87 E~~~gg~L~~~l~~~~----------~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGl  153 (364)
T d1omwa3          87 DLMNGGDLHYHLSQHG----------VFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGL  153 (364)
T ss_dssp             CCCCSCBHHHHHHHHC----------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTT
T ss_pred             EecCCCcHHHHHHhcc----------cccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeece
Confidence            9999999999996443          38899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHh
Q 047276          257 SKLMSRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEK  335 (453)
Q Consensus       257 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  335 (453)
                      ++......   .....||+.|+|||.+.. ..++.++|||||||++|||+||+.||.......         ... ....
T Consensus       154 a~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---------~~~-~~~~  220 (364)
T d1omwa3         154 ACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---------KHE-IDRM  220 (364)
T ss_dssp             CEECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC---------HHH-HHHH
T ss_pred             eeecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH---------HHH-HHHh
Confidence            98765432   345679999999999975 468999999999999999999999996322111         000 1111


Q ss_pred             hhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 047276          336 MKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPS-----MARVVE  386 (453)
Q Consensus       336 ~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~~v~~  386 (453)
                      ....            ....+...+..+.+++.+||+.||++|||     ++++++
T Consensus       221 ~~~~------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         221 TLTM------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             SSSC------------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             cccC------------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            0000            01122233455899999999999999999     577764

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-48  Score=373.43  Aligned_cols=242  Identities=20%  Similarity=0.279  Sum_probs=195.7

Q ss_pred             HhcccCcCCceEEEEEEeC-CCcEEEEEEecCC----CccHHHHHHHHHHHH-hcCCCceeeEeeEEEecCCCeEEEEEe
Q 047276          105 FQALLGHGSSASVFKGILS-DGTSVAVKRINGE----ENGEKEFRSEVAAIA-SAQHVNLVRLLGYCVVPGGPRYLVYEF  178 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~----~~~~~~~~~E~~~l~-~l~h~niv~l~g~~~~~~~~~~lv~e~  178 (453)
                      +.+.||+|+||+||+|+.. +|+.||||+++..    ....+.+..|..++. .++|||||++++++. .++..++||||
T Consensus         6 i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~-~~~~~yivmEy   84 (320)
T d1xjda_           6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ-TKENLFFVMEY   84 (320)
T ss_dssp             EEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE-CSSEEEEEEEC
T ss_pred             EeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEc-cCCceeEEEee
Confidence            4689999999999999964 6899999999642    334456677777765 689999999999976 56689999999


Q ss_pred             cCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          179 IQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       179 ~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +++|+|.+++....          .+++..+..++.||+.||+|||+   .+|+||||||+|||+++++.+||+|||+++
T Consensus        85 ~~~g~L~~~i~~~~----------~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~  151 (320)
T d1xjda_          85 LNGGDLMYHIQSCH----------KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK  151 (320)
T ss_dssp             CTTCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             cCCCcHHHHhhccC----------CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhh
Confidence            99999999996443          38899999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      ....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....             ..+......
T Consensus       152 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~-------------~~~~~~i~~  217 (320)
T d1xjda_         152 ENMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-------------EELFHSIRM  217 (320)
T ss_dssp             CCCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------------HHHHHHHHH
T ss_pred             hcccccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH-------------HHHHHHHHc
Confidence            6654332 23456899999999999999999999999999999999999999963211             112222222


Q ss_pred             CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHH-HHHH
Q 047276          339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMA-RVVE  386 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~-~v~~  386 (453)
                      +.      +      .++...+..+.+++.+||+.||++||++. ++++
T Consensus       218 ~~------~------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         218 DN------P------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             CC------C------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CC------C------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            21      1      12223345589999999999999999995 6653

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-47  Score=365.90  Aligned_cols=256  Identities=23%  Similarity=0.250  Sum_probs=188.9

Q ss_pred             cccCcCCceEEEEEEe-CCCcEEEEEEecCCCcc------HHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEec
Q 047276          107 ALLGHGSSASVFKGIL-SDGTSVAVKRINGEENG------EKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFI  179 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~------~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~  179 (453)
                      ++||+|+||+||+|+. .+|+.||||+++.....      .+.+.+|+.++++++|||||++++++. .++..++||||+
T Consensus         4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~-~~~~~~ivmE~~   82 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG-HKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC-CTTCCEEEEECC
T ss_pred             eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCceeehhhhh
Confidence            5799999999999996 56899999998653211      245889999999999999999999986 566889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      .++++..+....          ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus        83 ~~~~~~~~~~~~----------~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~  149 (299)
T d1ua2a_          83 ETDLEVIIKDNS----------LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKS  149 (299)
T ss_dssp             SEEHHHHHTTCC----------SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             cchHHhhhhhcc----------cCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccc
Confidence            988777665322          338888999999999999999999   8999999999999999999999999999987


Q ss_pred             ccCCCCceeeeccCCccccchhhhhcC-CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          260 MSRDQSRCITTIRGTRGYLAPEWILEQ-GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       260 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      ...... ......||+.|+|||.+... .++.++|||||||++|||++|+.||....+..        .+... .+....
T Consensus       150 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~--------~l~~i-~~~~~~  219 (299)
T d1ua2a_         150 FGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--------QLTRI-FETLGT  219 (299)
T ss_dssp             TTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHH-HHHHCC
T ss_pred             cCCCcc-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH--------HHHHH-HHhcCC
Confidence            654332 23446799999999998754 57999999999999999999999995322110        00000 000000


Q ss_pred             Cc---c---ccccc-ccccCCCCCc-----HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          339 GK---L---MEIVD-QRLTDEGGID-----ETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       339 ~~---~---~~~~d-~~l~~~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ..   .   ..... .........+     ......+.+++.+||+.||++|||++|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         220 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            00   0   00000 0000000001     122356899999999999999999999885

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-47  Score=370.36  Aligned_cols=246  Identities=21%  Similarity=0.246  Sum_probs=192.4

Q ss_pred             cccCcCCceEEEEEEe-CCCcEEEEEEecCCCccHHHHHHHHHHHHhc-CCCceeeEeeEEEe---cCCCeEEEEEecCC
Q 047276          107 ALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRSEVAAIASA-QHVNLVRLLGYCVV---PGGPRYLVYEFIQN  181 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~---~~~~~~lv~e~~~~  181 (453)
                      +.||+|+||+||+|+. .+|+.||||+++.    ...+.+|+.++.++ +|||||++++++..   .+...++|||||++
T Consensus        18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~g   93 (335)
T d2ozaa1          18 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG   93 (335)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred             EEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCC
Confidence            5699999999999996 5789999999964    34577899987655 89999999998753   23467999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECC---CCcEEEeeccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDE---NYRAVVSDFGLSK  258 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~---~~~~kl~DfGla~  258 (453)
                      |+|.+++....        ...+++..+..|+.|++.||+|||+   .+|+||||||+|||+++   ++.+||+|||+++
T Consensus        94 g~L~~~i~~~~--------~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~  162 (335)
T d2ozaa1          94 GELFSRIQDRG--------DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  162 (335)
T ss_dssp             EEHHHHHHSCS--------CCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             CcHHHHHHhcC--------CCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceee
Confidence            99999996432        2349999999999999999999999   89999999999999985   5679999999998


Q ss_pred             cccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhc
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKE  338 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (453)
                      .......  .....||+.|+|||.+.+..|+.++|||||||++|||+||+.||..........         ........
T Consensus       163 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---------~~~~~i~~  231 (335)
T d2ozaa1         163 ETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---------GMKTRIRM  231 (335)
T ss_dssp             ECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------------CCCS
T ss_pred             eccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH---------HHHHHHhc
Confidence            7654332  345679999999999999899999999999999999999999996432111000         00000000


Q ss_pred             CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          339 GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       339 ~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      +..      .+.  .......+..+.+++.+||+.||++|||+.|+++
T Consensus       232 ~~~------~~~--~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         232 GQY------EFP--NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             CSS------SCC--TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCC------CCC--CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            000      000  0111234567999999999999999999999987

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-47  Score=374.16  Aligned_cols=238  Identities=23%  Similarity=0.273  Sum_probs=196.4

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecC----CCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecC
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRING----EENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQ  180 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~  180 (453)
                      .+.||+|+||+||+|+. .+|+.||||++..    .....+.+.+|+.+|+.++|||||++++++. .....++|+||+.
T Consensus        46 ~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-~~~~~~~v~e~~~  124 (350)
T d1rdqe_          46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-DNSNLYMVMEYVA  124 (350)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-CSSEEEEEEECCT
T ss_pred             EEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc-ccccccccccccc
Confidence            47899999999999996 4799999999863    2344567899999999999999999999876 5667899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccc
Q 047276          181 NGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLM  260 (453)
Q Consensus       181 ~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~  260 (453)
                      +|+|.+++....          .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       125 ~g~l~~~l~~~~----------~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~  191 (350)
T d1rdqe_         125 GGEMFSHLRRIG----------RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV  191 (350)
T ss_dssp             TCBHHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             ccchhhhHhhcC----------CCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeec
Confidence            999999986443          38999999999999999999999   89999999999999999999999999999876


Q ss_pred             cCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhhcCc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMKEGK  340 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                      ...    .....||+.|||||.+.+..++.++|||||||++|||++|+.||.....             ......+..+.
T Consensus       192 ~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-------------~~~~~~i~~~~  254 (350)
T d1rdqe_         192 KGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-------------IQIYEKIVSGK  254 (350)
T ss_dssp             SSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------------HHHHHHHHHCC
T ss_pred             ccc----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH-------------HHHHHHHhcCC
Confidence            432    2346799999999999999999999999999999999999999953210             11112222221


Q ss_pred             ccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCC-----CHHHHHH
Q 047276          341 LMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRP-----SMARVVE  386 (453)
Q Consensus       341 ~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~~v~~  386 (453)
                      .            ..+...+..+.+++.+||+.||++|+     |++++++
T Consensus       255 ~------------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         255 V------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             C------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             C------------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            1            11223344588999999999999994     8999875

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-47  Score=357.44  Aligned_cols=234  Identities=27%  Similarity=0.413  Sum_probs=188.1

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCCC-------ccHHHHHHHHHHHHhcC--CCceeeEeeEEEecCCCeEE
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGEE-------NGEKEFRSEVAAIASAQ--HVNLVRLLGYCVVPGGPRYL  174 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~-------~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~~l  174 (453)
                      +.++||+|+||+||+|+. .+|+.||||+++...       .....+.+|+.++++++  |||||++++++. ..+..++
T Consensus         8 i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~-~~~~~~l   86 (273)
T d1xwsa_           8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE-RPDSFVL   86 (273)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE-CSSEEEE
T ss_pred             EeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEe-eCCeEEE
Confidence            457899999999999996 578999999986421       11234678999999997  899999999976 5668899


Q ss_pred             EEEecCC-CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECC-CCcEEEe
Q 047276          175 VYEFIQN-GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDE-NYRAVVS  252 (453)
Q Consensus       175 v~e~~~~-gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~-~~~~kl~  252 (453)
                      ||||+.+ +++.+++...          ..+++..+..++.|++.||+|||+   .+|+||||||+|||++. ++.+||+
T Consensus        87 v~e~~~~~~~l~~~~~~~----------~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~  153 (273)
T d1xwsa_          87 ILERPEPVQDLFDFITER----------GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLI  153 (273)
T ss_dssp             EEECCSSEEEHHHHHHHH----------CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEEC
T ss_pred             EEEeccCcchHHHHHhcc----------CCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEEC
Confidence            9999976 5788887543          238999999999999999999999   89999999999999985 5799999


Q ss_pred             eccccccccCCCCceeeeccCCccccchhhhhcCCC-CccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHH
Q 047276          253 DFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGV-SEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKI  331 (453)
Q Consensus       253 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~  331 (453)
                      |||+++......   .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||...+                
T Consensus       154 DFG~a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----------------  214 (273)
T d1xwsa_         154 DFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------------  214 (273)
T ss_dssp             CCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------------
T ss_pred             ccccceeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----------------
Confidence            999998754332   345679999999999987765 567899999999999999999995311                


Q ss_pred             HHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          332 VNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       332 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                        + ...+..            .++...+..+.+++.+||+.||++|||++|+++
T Consensus       215 --~-i~~~~~------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         215 --E-IIRGQV------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             --H-HHHCCC------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --H-Hhhccc------------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence              0 011110            011122345889999999999999999999875

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.7e-46  Score=353.86  Aligned_cols=259  Identities=20%  Similarity=0.249  Sum_probs=190.7

Q ss_pred             hcccCcCCceEEEEEEeCCCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCC
Q 047276          106 QALLGHGSSASVFKGILSDGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      .++||+|+||+||+|+.++|+.||||+++...   ...+.+.+|+.+|++++|||||++++++. ..+..++++||+.++
T Consensus         7 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-~~~~~~i~~e~~~~~   85 (286)
T d1ob3a_           7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-TKKRLVLVFEHLDQD   85 (286)
T ss_dssp             EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-CSSCEEEEEECCSEE
T ss_pred             ccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecc-cCCceeEEEEeehhh
Confidence            46899999999999999999999999997532   23467999999999999999999999986 567889999999887


Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccccccccC
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMSR  262 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~~  262 (453)
                      .+..+....          +.+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++.....
T Consensus        86 ~~~~~~~~~----------~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~  152 (286)
T d1ob3a_          86 LKKLLDVCE----------GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGI  152 (286)
T ss_dssp             HHHHHHTST----------TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred             hHHHHHhhc----------CCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceeccc
Confidence            776665422          349999999999999999999999   8999999999999999999999999999987654


Q ss_pred             CCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCC----------CCcccccchhHH
Q 047276          263 DQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGND----------KSKNKWQYFPKI  331 (453)
Q Consensus       263 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~----------~~~~~~~~~~~~  331 (453)
                      ... ......+++.|+|||.+.. ..++.++|||||||++|||++|+.||........          .....|....  
T Consensus       153 ~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--  229 (286)
T d1ob3a_         153 PVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT--  229 (286)
T ss_dssp             ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG--
T ss_pred             Ccc-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchh--
Confidence            322 2344568999999999875 4568999999999999999999999953221100          0000000000  


Q ss_pred             HHHhhhcCccccccccccc-CCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          332 VNEKMKEGKLMEIVDQRLT-DEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       332 ~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                           ............-. ............+.+++.+||+.||++|||++|+++
T Consensus       230 -----~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         230 -----ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             -----GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -----hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 00000000000000 000011123356889999999999999999999873

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-45  Score=350.18  Aligned_cols=260  Identities=22%  Similarity=0.268  Sum_probs=190.5

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      .+.||+|+||+||+|+. .+|+.||||+++...   ...+.+.+|+.+|++++|||||++++++. .++..++||||+.+
T Consensus         7 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~-~~~~~~iv~e~~~~   85 (298)
T d1gz8a_           7 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-TENKLYLVFEFLHQ   85 (298)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEE-ETTEEEEEEECCSE
T ss_pred             ccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccc-cccceeEEEeecCC
Confidence            47899999999999996 579999999996532   23467899999999999999999999986 56688999999975


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                       ++.+++....        ...+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        86 -~~~~~~~~~~--------~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~  153 (298)
T d1gz8a_          86 -DLKKFMDASA--------LTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFG  153 (298)
T ss_dssp             -EHHHHHHHTT--------TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHC
T ss_pred             -chhhhhhhhc--------ccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceecc
Confidence             5555543322        2349999999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCceeeeccCCccccchhhhhcCC-CCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHHhhh--c
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILEQG-VSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNEKMK--E  338 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~  338 (453)
                      ... .......||+.|+|||.+.... ++.++|||||||++|||++|+.||.......        .+.........  +
T Consensus       154 ~~~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~--------~~~~i~~~~~~~~~  224 (298)
T d1gz8a_         154 VPV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--------QLFRIFRTLGTPDE  224 (298)
T ss_dssp             CCS-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHHHCCCCT
T ss_pred             CCc-ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH--------HHHHHHHhcCCCch
Confidence            432 2234457999999999887655 5789999999999999999999996322110        00000000000  0


Q ss_pred             ---Cccccccc--ccccCCCC-----CcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          339 ---GKLMEIVD--QRLTDEGG-----IDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       339 ---~~~~~~~d--~~l~~~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                         .......+  ........     ........+.+++.+||+.||++|||++|+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         225 VVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             TTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence               00000000  00000000     001223568899999999999999999999864

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-45  Score=353.15  Aligned_cols=259  Identities=23%  Similarity=0.294  Sum_probs=187.5

Q ss_pred             hcccCcCCceEEEEEEe-CC-CcEEEEEEecCC---CccHHHHHHHHHHHHhc---CCCceeeEeeEEEec----CCCeE
Q 047276          106 QALLGHGSSASVFKGIL-SD-GTSVAVKRINGE---ENGEKEFRSEVAAIASA---QHVNLVRLLGYCVVP----GGPRY  173 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~-g~~vavK~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~----~~~~~  173 (453)
                      .+.||+|+||+||+|+. .+ ++.||||+++..   ......+.+|+.+|+.+   +||||++++++|...    ....+
T Consensus        12 ~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~   91 (305)
T d1blxa_          12 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT   91 (305)
T ss_dssp             EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred             EEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEE
Confidence            47899999999999996 34 667999998642   22223466788777665   799999999988532    23568


Q ss_pred             EEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEee
Q 047276          174 LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSD  253 (453)
Q Consensus       174 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~D  253 (453)
                      +++||+.+|++.......         ...+++.....++.|++.||+|||+   .+|+||||||+|||++.++.+||+|
T Consensus        92 ~~~e~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          92 LVFEHVDQDLTTYLDKVP---------EPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             EEEECCSCBHHHHHHHSC---------TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECS
T ss_pred             EEEEeccCCchhhhhhcc---------CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecc
Confidence            999999887775544322         2348999999999999999999999   8999999999999999999999999


Q ss_pred             ccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHH
Q 047276          254 FGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVN  333 (453)
Q Consensus       254 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  333 (453)
                      ||+++......  ......||+.|+|||.+.+..++.++||||+||++|||++|+.||.......        .+.....
T Consensus       160 fg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~--------~~~~i~~  229 (305)
T d1blxa_         160 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--------QLGKILD  229 (305)
T ss_dssp             CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHH
T ss_pred             hhhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH--------HHHHHHH
Confidence            99988654322  2355689999999999999999999999999999999999999996332110        0000000


Q ss_pred             H-------hhhcC-ccc-cccc-ccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          334 E-------KMKEG-KLM-EIVD-QRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       334 ~-------~~~~~-~~~-~~~d-~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      .       .+... ... .... ................+.+++.+||+.||++|||++|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         230 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0       00000 000 0000 0000000011123345789999999999999999999875

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.5e-45  Score=349.31  Aligned_cols=256  Identities=21%  Similarity=0.286  Sum_probs=194.6

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCCCC
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQNGS  183 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~gs  183 (453)
                      +.+.||+|+||+||+|+. .+|+.||||++..... ..++..|+++++.++|+|++..+++|...++..++||||+ +|+
T Consensus        11 l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~   88 (299)
T d1ckia_          11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPS   88 (299)
T ss_dssp             EEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred             EeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCc
Confidence            467899999999999996 5689999998875432 3457889999999998887777777777777889999999 557


Q ss_pred             hhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEEC---CCCcEEEeeccccccc
Q 047276          184 LDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLD---ENYRAVVSDFGLSKLM  260 (453)
Q Consensus       184 L~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~---~~~~~kl~DfGla~~~  260 (453)
                      |.+.+....         ..+++..+..++.|++.||+|||+   ++|+||||||+|||++   .+..+||+|||+++..
T Consensus        89 l~~~~~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          89 LEDLFNFCS---------RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             HHHHHHHTT---------TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             hhhhhhhcc---------CCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence            766664332         348999999999999999999999   8999999999999986   4567999999999987


Q ss_pred             cCCCC------ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHHHHH
Q 047276          261 SRDQS------RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKIVNE  334 (453)
Q Consensus       261 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  334 (453)
                      .....      .......||+.|||||.+.+..++.++|||||||++|||++|+.||...........     .......
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~-----~~~~~~~  231 (299)
T d1ckia_         157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK-----YERISEK  231 (299)
T ss_dssp             BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC------------HHHHHHH
T ss_pred             cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHH-----HHHhhcc
Confidence            54322      123456799999999999999999999999999999999999999964332221110     0000000


Q ss_pred             hhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhccc
Q 047276          335 KMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGR  391 (453)
Q Consensus       335 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~  391 (453)
                      ... ...     +.+      ....+.++.+++..|++.+|++||+++++.+.|+..
T Consensus       232 ~~~-~~~-----~~~------~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         232 KMS-TPI-----EVL------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             HHH-SCH-----HHH------TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             cCC-CCh-----hHh------ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            000 000     000      112234588999999999999999999998888764

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-43  Score=346.48  Aligned_cols=264  Identities=22%  Similarity=0.289  Sum_probs=187.1

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCCcc---HHHHHHHHHHHHhcCCCceeeEeeEEEecCC-----CeEEEE
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEENG---EKEFRSEVAAIASAQHVNLVRLLGYCVVPGG-----PRYLVY  176 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-----~~~lv~  176 (453)
                      .++||+|+||+||+|.. .+|+.||||+++.....   .+.+.+|+.+|+.++|||||+++++|...+.     ..++||
T Consensus        23 i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~  102 (346)
T d1cm8a_          23 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM  102 (346)
T ss_dssp             EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEE
Confidence            47899999999999996 56999999999753322   3568899999999999999999999864432     469999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||+ +++|..+...           ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+|++|||+
T Consensus       103 e~~-~~~l~~~~~~-----------~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_         103 PFM-GTDLGKLMKH-----------EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             ECC-SEEHHHHHHH-----------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ecc-cccHHHHHHh-----------ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccc
Confidence            999 5578777632           239999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCccc--ccchhHHHH
Q 047276          257 SKLMSRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNK--WQYFPKIVN  333 (453)
Q Consensus       257 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~--~~~~~~~~~  333 (453)
                      ++.....    .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.............  ....+....
T Consensus       168 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (346)
T d1cm8a_         168 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  243 (346)
T ss_dssp             CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             eeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence            9876433    245679999999999876 457899999999999999999999996432110000000  000000000


Q ss_pred             Hhhhc-------CcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH--hccc
Q 047276          334 EKMKE-------GKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM--LEGR  391 (453)
Q Consensus       334 ~~~~~-------~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~--L~~~  391 (453)
                      .....       ..+.+.....+.   .........+.+++.+||+.||++|||+.|+++.  ++..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         244 QRLQSDEAKNYMKGLPELEKKDFA---SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGG---GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             hhhcchhhhhhhccCCcccccchH---HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence            00000       000000000010   0111223457899999999999999999999974  5544

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-44  Score=345.83  Aligned_cols=195  Identities=25%  Similarity=0.333  Sum_probs=160.7

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCC---CccHHHHHHHHHHHHhcCCCceeeEeeEEEec-------CCCeEE
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGE---ENGEKEFRSEVAAIASAQHVNLVRLLGYCVVP-------GGPRYL  174 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-------~~~~~l  174 (453)
                      .+.||+|+||+||+|+. .+|+.||||++...   ......+.+|+.+|++++|||++++++++...       .+..++
T Consensus        15 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~i   94 (318)
T d3blha1          15 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYL   94 (318)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEE
T ss_pred             EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEE
Confidence            47899999999999996 57999999998642   23346788999999999999999999987542       235789


Q ss_pred             EEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeec
Q 047276          175 VYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDF  254 (453)
Q Consensus       175 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~Df  254 (453)
                      ||||+.++.+..+....          ..++......++.|++.||.|||+   .+|+||||||+|||++.++.+||+||
T Consensus        95 v~e~~~~~~~~~~~~~~----------~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~df  161 (318)
T d3blha1          95 VFDFCEHDLAGLLSNVL----------VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF  161 (318)
T ss_dssp             EEECCCEEHHHHHTCTT----------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCC
T ss_pred             EEeccCCCccchhhhcc----------cccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeec
Confidence            99999887776554322          238888999999999999999999   89999999999999999999999999


Q ss_pred             cccccccCCCC---ceeeeccCCccccchhhhhcC-CCCccccchhHHHHHHHHHcCCCCCcc
Q 047276          255 GLSKLMSRDQS---RCITTIRGTRGYLAPEWILEQ-GVSEKCDIYSYGMVLLELTGGRRNVSL  313 (453)
Q Consensus       255 Gla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvil~elltG~~p~~~  313 (453)
                      |+++.......   .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||..
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~  224 (318)
T d3blha1         162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG  224 (318)
T ss_dssp             TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCC
Confidence            99987654321   222345799999999998764 689999999999999999999999953

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-44  Score=351.02  Aligned_cols=264  Identities=21%  Similarity=0.233  Sum_probs=186.6

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCceeeEeeEEEecC-----CCeEEEEEec
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNLVRLLGYCVVPG-----GPRYLVYEFI  179 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~~lv~e~~  179 (453)
                      .++||+|+||+||+|+. .+|+.||||++..+...   +.+|+.+|++++||||+++++++....     ...++|||||
T Consensus        25 ~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~  101 (350)
T d1q5ka_          25 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV  101 (350)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECC
T ss_pred             eeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEecc
Confidence            56899999999999996 46899999999764322   347999999999999999999986432     2358999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCC-cEEEeeccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENY-RAVVSDFGLSK  258 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~-~~kl~DfGla~  258 (453)
                      +++.+..+.....       ....+++..+..++.|++.||+|||+   .+|+||||||+|||++.++ .+||+|||+++
T Consensus       102 ~~~~~~~l~~~~~-------~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~  171 (350)
T d1q5ka_         102 PETVYRVARHYSR-------AKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  171 (350)
T ss_dssp             SEEHHHHHHHHHH-------TTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred             CCccHHHHHhhhh-------ccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchh
Confidence            8764433332111       12349999999999999999999999   8999999999999999775 89999999998


Q ss_pred             cccCCCCceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCccc---ccchhHHHHH
Q 047276          259 LMSRDQSRCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNK---WQYFPKIVNE  334 (453)
Q Consensus       259 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~---~~~~~~~~~~  334 (453)
                      .......  .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.............   ..........
T Consensus       172 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         172 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             ECCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             hccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence            7654332  244679999999998775 578999999999999999999999995332110000000   0000000000


Q ss_pred             hh---hcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          335 KM---KEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       335 ~~---~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ..   ............+..  .........+.+++.+||+.||++|||+.|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTK--VFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGG--TSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccchhhccccccccCchhh--hcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00   000000000000000  011123445889999999999999999999985

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-43  Score=346.10  Aligned_cols=267  Identities=20%  Similarity=0.237  Sum_probs=188.1

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCC--ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCC---CeEEEEEec
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEE--NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGG---PRYLVYEFI  179 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~---~~~lv~e~~  179 (453)
                      .++||+|+||+||+|+. .+|+.||||+++...  ...+.+++|+.+|++++|||++++++++.....   ..+++++|+
T Consensus        13 ~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~   92 (345)
T d1pmea_          13 LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHL   92 (345)
T ss_dssp             EEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEEC
T ss_pred             EEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEee
Confidence            47899999999999985 579999999997533  234578899999999999999999999864321   235556677


Q ss_pred             CCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccc
Q 047276          180 QNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       180 ~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      .+|+|.+++...           .+++..+..++.|++.||+|||+   ++|+||||||+|||++.++.+||+|||++..
T Consensus        93 ~~g~L~~~l~~~-----------~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~  158 (345)
T d1pmea_          93 MGADLYKLLKTQ-----------HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV  158 (345)
T ss_dssp             CCEEHHHHHHHC-----------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             cCCchhhhhhcC-----------CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceee
Confidence            799999999532           38999999999999999999999   8999999999999999999999999999987


Q ss_pred             ccCCCC--ceeeeccCCccccchhhhhc-CCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCccc--ccchhHHHHH
Q 047276          260 MSRDQS--RCITTIRGTRGYLAPEWILE-QGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNK--WQYFPKIVNE  334 (453)
Q Consensus       260 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~--~~~~~~~~~~  334 (453)
                      ......  .......||+.|+|||.+.. ..++.++||||+||++|||++|+.||.............  ..........
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (345)
T d1pmea_         159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN  238 (345)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence            644322  12345679999999999854 467899999999999999999999995422110000000  0000000000


Q ss_pred             hhhcCcccccccccccCCCCCc-----HHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          335 KMKEGKLMEIVDQRLTDEGGID-----ETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       335 ~~~~~~~~~~~d~~l~~~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      ............ .+......+     ......+.+++.+||+.||++|||++|+++.
T Consensus       239 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         239 CIINLKARNYLL-SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             TCCCHHHHHHHH-TSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhcccc-cCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000000000000 000000000     1123458899999999999999999999864

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.1e-44  Score=342.20  Aligned_cols=256  Identities=18%  Similarity=0.244  Sum_probs=196.2

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCCCccHHHHHHHHHHHHhcCC-CceeeEeeEEEecCCCeEEEEEecCCC
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRSEVAAIASAQH-VNLVRLLGYCVVPGGPRYLVYEFIQNG  182 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~~lv~e~~~~g  182 (453)
                      +.++||+|+||+||+|+. .+|+.||||++.... ....+.+|++.+..++| +|++.+++++. .+...++||||+ +|
T Consensus         9 i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-~~~~~~~vme~~-~~   85 (293)
T d1csna_           9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-EGLHNVLVIDLL-GP   85 (293)
T ss_dssp             EEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEE-ETTEEEEEEECC-CC
T ss_pred             EEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEee-cCCccEEEEEec-CC
Confidence            467899999999999995 468999999886532 23457889999999976 89999998875 566889999999 68


Q ss_pred             ChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECC-----CCcEEEeecccc
Q 047276          183 SLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDE-----NYRAVVSDFGLS  257 (453)
Q Consensus       183 sL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~-----~~~~kl~DfGla  257 (453)
                      +|.+++....         ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.     ++.+||+|||++
T Consensus        86 ~l~~~~~~~~---------~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a  153 (293)
T d1csna_          86 SLEDLLDLCG---------RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  153 (293)
T ss_dssp             BHHHHHHHTT---------TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             CHHHHHHhhc---------cchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEccccee
Confidence            9999886443         238999999999999999999999   89999999999999974     578999999999


Q ss_pred             ccccCCCC------ceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHH
Q 047276          258 KLMSRDQS------RCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKI  331 (453)
Q Consensus       258 ~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~  331 (453)
                      +.......      .......||+.|||||.+.+..++.++|||||||++|||++|+.||..........     .... 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~-----~~~~-  227 (293)
T d1csna_         154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ-----KYER-  227 (293)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH-----HHHH-
T ss_pred             EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH-----HHHH-
Confidence            97754321      12345679999999999999999999999999999999999999996332211100     0000 


Q ss_pred             HHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHHhcccc
Q 047276          332 VNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEMLEGRV  392 (453)
Q Consensus       332 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~L~~~~  392 (453)
                      ....-......+     +.  ..+    +.++.+++..|++.+|++||+.+.+.+.|++..
T Consensus       228 i~~~~~~~~~~~-----l~--~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~  277 (293)
T d1csna_         228 IGEKKQSTPLRE-----LC--AGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  277 (293)
T ss_dssp             HHHHHHHSCHHH-----HT--TTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             HHhccCCCChHH-----hc--CCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            000000000000     10  112    345889999999999999999999988887653

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-44  Score=348.59  Aligned_cols=248  Identities=22%  Similarity=0.272  Sum_probs=194.3

Q ss_pred             HHhcccCcCCceEEEEEEe----CCCcEEEEEEecCC-----CccHHHHHHHHHHHHhcCC-CceeeEeeEEEecCCCeE
Q 047276          104 NFQALLGHGSSASVFKGIL----SDGTSVAVKRINGE-----ENGEKEFRSEVAAIASAQH-VNLVRLLGYCVVPGGPRY  173 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~----~~g~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~~  173 (453)
                      .+.+.||+|+||+||+|+.    .+|+.||||.++..     ....+.+.+|+.++++++| |||+++++++. .....+
T Consensus        27 ~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~-~~~~~~  105 (322)
T d1vzoa_          27 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ-TETKLH  105 (322)
T ss_dssp             EEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE-ETTEEE
T ss_pred             EEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec-cCCcee
Confidence            3458999999999999984    24789999998642     2234568899999999976 89999999876 556889


Q ss_pred             EEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEee
Q 047276          174 LVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSD  253 (453)
Q Consensus       174 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~D  253 (453)
                      +++||+.+|+|.+++....          .+.......++.|++.||+|||+   .+|+||||||+|||++.++.+||+|
T Consensus       106 ~v~e~~~~~~L~~~i~~~~----------~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~D  172 (322)
T d1vzoa_         106 LILDYINGGELFTHLSQRE----------RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTD  172 (322)
T ss_dssp             EEECCCCSCBHHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESC
T ss_pred             eeeecccccHHHHHHHhcc----------cccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEee
Confidence            9999999999999986543          27788899999999999999999   8999999999999999999999999


Q ss_pred             ccccccccCCCCceeeeccCCccccchhhhhcC--CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccchhHH
Q 047276          254 FGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQ--GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYFPKI  331 (453)
Q Consensus       254 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~  331 (453)
                      ||+++.+............|++.|++||.+...  .++.++|||||||+||||++|+.||........        ... 
T Consensus       173 FG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~--------~~~-  243 (322)
T d1vzoa_         173 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--------QAE-  243 (322)
T ss_dssp             SSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--------HHH-
T ss_pred             ccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--------HHH-
Confidence            999987755444444567899999999998754  468899999999999999999999964322110        011 


Q ss_pred             HHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCC-----HHHHHH
Q 047276          332 VNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPS-----MARVVE  386 (453)
Q Consensus       332 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~~v~~  386 (453)
                      .........            ...+...+..+.+++.+||+.||++|||     ++|+++
T Consensus       244 i~~~~~~~~------------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         244 ISRRILKSE------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             HHHHHHHCC------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             HHHhcccCC------------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            111111110            1122344567999999999999999995     677764

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-43  Score=336.17  Aligned_cols=260  Identities=21%  Similarity=0.276  Sum_probs=194.2

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCC---ccHHHHHHHHHHHHhcCCCceeeEeeEEEecCCCeEEEEEecCC
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEE---NGEKEFRSEVAAIASAQHVNLVRLLGYCVVPGGPRYLVYEFIQN  181 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~~lv~e~~~~  181 (453)
                      .+.||+|+||+||+|+. .+|+.||||+++...   .....+.+|+.+|+.++||||+++++++. .....+++++++.+
T Consensus         7 i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-~~~~~~iv~~~~~~   85 (292)
T d1unla_           7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-SDKKLTLVFEFCDQ   85 (292)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-CSSEEEEEEECCSE
T ss_pred             eeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccc-cccceeEEeeeccc
Confidence            47899999999999996 578999999986532   33567899999999999999999999986 56688999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLSKLMS  261 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~~~~  261 (453)
                      ++|..++...          +.+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||.++...
T Consensus        86 ~~l~~~~~~~----------~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~  152 (292)
T d1unla_          86 DLKKYFDSCN----------GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFG  152 (292)
T ss_dssp             EHHHHHHHTT----------TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             cccccccccc----------cccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhccc
Confidence            9998887543          238899999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCceeeeccCCccccchhhhhcCC-CCccccchhHHHHHHHHHcCCCCCcccccCCCC-----------Ccccccchh
Q 047276          262 RDQSRCITTIRGTRGYLAPEWILEQG-VSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDK-----------SKNKWQYFP  329 (453)
Q Consensus       262 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~-----------~~~~~~~~~  329 (453)
                      .... ......+++.|+|||.+.... ++.++|||||||++|||++|+.||.........           ....|....
T Consensus       153 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (292)
T d1unla_         153 IPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             SCCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             CCCc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence            4332 233445778899999887654 689999999999999999999997432111000           000000000


Q ss_pred             HHHHHhhhcCcccccccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          330 KIVNEKMKEGKLMEIVDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       330 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                          . ............ ..............+.+++.+||+.||++|||++|+++
T Consensus       232 ----~-~~~~~~~~~~~~-~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         232 ----K-LPDYKPYPMYPA-TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             ----G-STTCCCCCCCCT-TCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ----h-cccccccccccc-cchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                0 000000000000 00001122333456889999999999999999999875

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.2e-42  Score=336.77  Aligned_cols=261  Identities=18%  Similarity=0.262  Sum_probs=191.2

Q ss_pred             HhcccCcCCceEEEEEEe-CCCcEEEEEEecCCCccHHHHHHHHHHHHhcC-CCceeeEeeEEEec-CCCeEEEEEecCC
Q 047276          105 FQALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRSEVAAIASAQ-HVNLVRLLGYCVVP-GGPRYLVYEFIQN  181 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~-~~~~~lv~e~~~~  181 (453)
                      +.++||+|+||+||+|+. .+|+.||||+++..  ..+++.+|+.+|..++ ||||+++++++... ....++||||+.+
T Consensus        39 i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~  116 (328)
T d3bqca1          39 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN  116 (328)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCS
T ss_pred             EEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCC
Confidence            357899999999999996 57899999999753  3567899999999996 99999999987643 3468999999999


Q ss_pred             CChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCC-cEEEeeccccccc
Q 047276          182 GSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENY-RAVVSDFGLSKLM  260 (453)
Q Consensus       182 gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~-~~kl~DfGla~~~  260 (453)
                      |+|..+.             ..+++..+..++.||+.||+|||+   ++|+||||||+|||++.++ .+||+|||+++..
T Consensus       117 ~~L~~~~-------------~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~  180 (328)
T d3bqca1         117 TDFKQLY-------------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  180 (328)
T ss_dssp             CBGGGTT-------------TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred             CcHHHHh-------------cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceec
Confidence            9997764             238999999999999999999999   8999999999999998654 6999999999876


Q ss_pred             cCCCCceeeeccCCccccchhhhhcC-CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcccccch-hHHHHHhhhc
Q 047276          261 SRDQSRCITTIRGTRGYLAPEWILEQ-GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNKWQYF-PKIVNEKMKE  338 (453)
Q Consensus       261 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  338 (453)
                      .....  .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||................+ ..........
T Consensus       181 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  258 (328)
T d3bqca1         181 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  258 (328)
T ss_dssp             CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             cCCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence            54332  3456789999999998765 479999999999999999999999964322110000000000 0000000000


Q ss_pred             Ccc------ccccc-------ccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          339 GKL------MEIVD-------QRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       339 ~~~------~~~~d-------~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      ...      .....       ..... ..........+.+++.+||+.||++|||++|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         259 YNIELDPRFNDILGRHSRKRWERFVH-SENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TTCCCCGGGGGTCCCCCCCCGGGGCC-TTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccCcccchhcccccccchhhccc-ccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000      00000       00000 0111223456889999999999999999999875

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-43  Score=340.96  Aligned_cols=264  Identities=19%  Similarity=0.233  Sum_probs=184.1

Q ss_pred             hcccCcCCceEEEEEEeC-CCcEEEEEEecCCCc---cHHHHHHHHHHHHhcCCCceeeEeeEEEec-----CCCeEEEE
Q 047276          106 QALLGHGSSASVFKGILS-DGTSVAVKRINGEEN---GEKEFRSEVAAIASAQHVNLVRLLGYCVVP-----GGPRYLVY  176 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~~lv~  176 (453)
                      .++||+|+||+||+|... +|+.||||++.....   ....+.+|+.++++++||||+++++++...     ....|+||
T Consensus        22 ~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~  101 (355)
T d2b1pa1          22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM  101 (355)
T ss_dssp             EEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred             EEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEE
Confidence            468999999999999964 699999999975432   234688999999999999999999998643     24679999


Q ss_pred             EecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeeccc
Q 047276          177 EFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGL  256 (453)
Q Consensus       177 e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGl  256 (453)
                      ||+.++ +.+.+.            ..+++..+..++.|++.||+|||+   .+|+||||||+|||++.++.+|++|||+
T Consensus       102 Ey~~~~-l~~~~~------------~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~  165 (355)
T d2b1pa1         102 ELMDAN-LCQVIQ------------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_dssp             ECCSEE-HHHHHT------------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             eccchH-HHHhhh------------cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhh
Confidence            999765 444442            238999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCC----------CCccccc
Q 047276          257 SKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGND----------KSKNKWQ  326 (453)
Q Consensus       257 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~----------~~~~~~~  326 (453)
                      ++......  ......+|+.|+|||.+.+..++.++||||+||+++||++|+.||........          .....|.
T Consensus       166 ~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  243 (355)
T d2b1pa1         166 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  243 (355)
T ss_dssp             -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             hhcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence            88654332  23456789999999999999999999999999999999999999953221100          0000010


Q ss_pred             chhHHHHHhhhcCc------cccccccc-ccCCCCCcHHHHHHHHHHHHhccccCCCCCCCHHHHHHH
Q 047276          327 YFPKIVNEKMKEGK------LMEIVDQR-LTDEGGIDETQVRRLVDVAFWCIQERARLRPSMARVVEM  387 (453)
Q Consensus       327 ~~~~~~~~~~~~~~------~~~~~d~~-l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~~  387 (453)
                      ..............      ........ ..............+.+++.+||+.||++|||++|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            01111111111000      00011001 111111233456779999999999999999999999843

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-42  Score=334.72  Aligned_cols=262  Identities=21%  Similarity=0.242  Sum_probs=185.1

Q ss_pred             hcccCcCCceEEEEEEe-CCCcEEEEEEecCCCc---cHHHHHHHHHHHHhcCCCceeeEeeEEEec----CCCeEEEEE
Q 047276          106 QALLGHGSSASVFKGIL-SDGTSVAVKRINGEEN---GEKEFRSEVAAIASAQHVNLVRLLGYCVVP----GGPRYLVYE  177 (453)
Q Consensus       106 ~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~g~~~~~----~~~~~lv~e  177 (453)
                      .++||+|+||+||+|+. .+|+.||||+++....   ..+.+.+|+.+|++++|||+|++++++...    ....+++++
T Consensus        23 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~  102 (348)
T d2gfsa1          23 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT  102 (348)
T ss_dssp             EEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEE
Confidence            47899999999999995 5799999999975432   335688999999999999999999987532    223466778


Q ss_pred             ecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCCcEEEeecccc
Q 047276          178 FIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENYRAVVSDFGLS  257 (453)
Q Consensus       178 ~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla  257 (453)
                      |+.+|+|.+++..           ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+|++|||++
T Consensus       103 ~~~gg~L~~~~~~-----------~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1         103 HLMGADLNNIVKC-----------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             ECCSEEHHHHHTT-----------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             eecCCchhhhccc-----------ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchh
Confidence            8889999999842           239999999999999999999999   89999999999999999999999999998


Q ss_pred             ccccCCCCceeeeccCCccccchhhhhcC-CCCccccchhHHHHHHHHHcCCCCCcccccCCCCCcc--cccchhHHHHH
Q 047276          258 KLMSRDQSRCITTIRGTRGYLAPEWILEQ-GVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKN--KWQYFPKIVNE  334 (453)
Q Consensus       258 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~--~~~~~~~~~~~  334 (453)
                      ......    .....||+.|+|||...+. .++.++|||||||++|||++|+.||............  ...........
T Consensus       169 ~~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         169 RHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  244 (348)
T ss_dssp             -CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             cccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            754322    3445688999999987765 4689999999999999999999999532111000000  00000000000


Q ss_pred             hhhcCcccccccccccCCCCCc-----HHHHHHHHHHHHhccccCCCCCCCHHHHHH
Q 047276          335 KMKEGKLMEIVDQRLTDEGGID-----ETQVRRLVDVAFWCIQERARLRPSMARVVE  386 (453)
Q Consensus       335 ~~~~~~~~~~~d~~l~~~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~~v~~  386 (453)
                      .......... ...+.......     ......+.+++.+||+.||++|||++|+++
T Consensus       245 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         245 KISSESARNY-IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             TCCCHHHHHH-HTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccchhhhhh-hhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence            0000000000 00000000000     112345789999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.8e-39  Score=314.36  Aligned_cols=270  Identities=19%  Similarity=0.233  Sum_probs=189.3

Q ss_pred             HHhcccCcCCceEEEEEEe-CCCcEEEEEEecCCCccHHHHHHHHHHHHhcC-----------CCceeeEeeEEEecC-C
Q 047276          104 NFQALLGHGSSASVFKGIL-SDGTSVAVKRINGEENGEKEFRSEVAAIASAQ-----------HVNLVRLLGYCVVPG-G  170 (453)
Q Consensus       104 ~~~~~lG~G~fG~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~g~~~~~~-~  170 (453)
                      .+.++||+|+||+||+|+. .+|+.||||+++.+....+.+.+|+.+++.++           |+||+++++++.... .
T Consensus        16 ~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~   95 (362)
T d1q8ya_          16 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPN   95 (362)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETT
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecccc
Confidence            4468999999999999996 57999999999876655667888999988875           578999999875433 3


Q ss_pred             CeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECCCC---
Q 047276          171 PRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDENY---  247 (453)
Q Consensus       171 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~~~---  247 (453)
                      ..+++++++..+..........       ....+++..+..++.|++.||+|||+.  .+|+||||||+|||++.++   
T Consensus        96 ~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~  166 (362)
T d1q8ya_          96 GVHVVMVFEVLGENLLALIKKY-------EHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPE  166 (362)
T ss_dssp             EEEEEEEECCCCEEHHHHHHHT-------TTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTT
T ss_pred             ceeeeeeecccccccccccccc-------cccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCccc
Confidence            4566777766554333322111       123488999999999999999999974  6899999999999998665   


Q ss_pred             ---cEEEeeccccccccCCCCceeeeccCCccccchhhhhcCCCCccccchhHHHHHHHHHcCCCCCcccccCCCCCccc
Q 047276          248 ---RAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAPEWILEQGVSEKCDIYSYGMVLLELTGGRRNVSLIEHGNDKSKNK  324 (453)
Q Consensus       248 ---~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDV~S~Gvil~elltG~~p~~~~~~~~~~~~~~  324 (453)
                         .++++|||.+......    .....||+.|+|||.+....++.++|+||+||+++||++|+.||.............
T Consensus       167 ~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~  242 (362)
T d1q8ya_         167 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  242 (362)
T ss_dssp             TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             ccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence               3999999999865432    244679999999999999999999999999999999999999996432211111000


Q ss_pred             cc--------chhHHHHHh-------hhcCccccc--------ccccccCCCCCcHHHHHHHHHHHHhccccCCCCCCCH
Q 047276          325 WQ--------YFPKIVNEK-------MKEGKLMEI--------VDQRLTDEGGIDETQVRRLVDVAFWCIQERARLRPSM  381 (453)
Q Consensus       325 ~~--------~~~~~~~~~-------~~~~~~~~~--------~d~~l~~~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~  381 (453)
                      ..        ..+......       .........        ....+.............+.+++.+||+.||++|||+
T Consensus       243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta  322 (362)
T d1q8ya_         243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  322 (362)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence            00        000000000       000000000        0000111123456778899999999999999999999


Q ss_pred             HHHHH
Q 047276          382 ARVVE  386 (453)
Q Consensus       382 ~~v~~  386 (453)
                      +|+++
T Consensus       323 ~e~L~  327 (362)
T d1q8ya_         323 GGLVN  327 (362)
T ss_dssp             HHHHT
T ss_pred             HHHhc
Confidence            99985

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=6e-25  Score=194.69  Aligned_cols=162  Identities=18%  Similarity=0.186  Sum_probs=119.9

Q ss_pred             HhcccCcCCceEEEEEEeCCCcEEEEEEecCCCc-------------------cHHHHHHHHHHHHhcCCCceeeEeeEE
Q 047276          105 FQALLGHGSSASVFKGILSDGTSVAVKRINGEEN-------------------GEKEFRSEVAAIASAQHVNLVRLLGYC  165 (453)
Q Consensus       105 ~~~~lG~G~fG~Vy~~~~~~g~~vavK~~~~~~~-------------------~~~~~~~E~~~l~~l~h~niv~l~g~~  165 (453)
                      +.++||+|+||+||+|...+|+.||||+++....                   .......|...+.++.|.+++..+++.
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            4578999999999999998999999998753110                   012345688889999999999887652


Q ss_pred             EecCCCeEEEEEecCCCChhhhhccCCCCCCCCCCCCCCCHHHHHHHHHHHHHHhccccccCCCceeccCCCCCcEEECC
Q 047276          166 VVPGGPRYLVYEFIQNGSLDHWIFPTSRRSEGHYSGGCLSWDLRYRVAIDVAKALSYLHNDCRSRVLHLDVKPENILLDE  245 (453)
Q Consensus       166 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~L~~Lh~~~~~~ivH~Dlk~~NiLl~~  245 (453)
                           ..+++|||++++.+.++                 +.....+++.|++.+|+|||+   .+|+||||||+|||+++
T Consensus        84 -----~~~lvme~~~~~~~~~l-----------------~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~  138 (191)
T d1zara2          84 -----GNAVLMELIDAKELYRV-----------------RVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSE  138 (191)
T ss_dssp             -----TTEEEEECCCCEEGGGC-----------------CCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEET
T ss_pred             -----CCEEEEEeeccccccch-----------------hhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeC
Confidence                 23799999988655432                 223346789999999999999   89999999999999996


Q ss_pred             CCcEEEeeccccccccCCCCceeeeccCCccccch------hhhhcCCCCccccchhHHHHHH
Q 047276          246 NYRAVVSDFGLSKLMSRDQSRCITTIRGTRGYLAP------EWILEQGVSEKCDIYSYGMVLL  302 (453)
Q Consensus       246 ~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~sDV~S~Gvil~  302 (453)
                      + .++|+|||++.........         .|...      +. ..+.|+.++|+||..--++
T Consensus       139 ~-~~~liDFG~a~~~~~~~~~---------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         139 E-GIWIIDFPQSVEVGEEGWR---------EILERDVRNIITY-FSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             T-EEEECCCTTCEETTSTTHH---------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred             C-CEEEEECCCcccCCCCCcH---------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHHh
Confidence            5 5899999999765433211         11111      11 2356789999999765443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.22  E-value=2.1e-06  Score=77.31  Aligned_cols=74  Identities=12%  Similarity=0.069  Sum_probs=49.5

Q ss_pred             CCceEEEEEEeCCCcEEEEEEecCC-CccHHHHHHHHHHHHhcC-CCceeeEeeEEEecCCCeEEEEEecCCCChhhh
Q 047276          112 GSSASVFKGILSDGTSVAVKRINGE-ENGEKEFRSEVAAIASAQ-HVNLVRLLGYCVVPGGPRYLVYEFIQNGSLDHW  187 (453)
Q Consensus       112 G~fG~Vy~~~~~~g~~vavK~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~~lv~e~~~~gsL~~~  187 (453)
                      ++.+.||+.... ++.+++|+.... ......+.+|...+..+. +-.+.+++.++. .++..++||++.++.++.+.
T Consensus        25 ~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~-~~~~~~lv~~~l~G~~~~~~  100 (263)
T d1j7la_          25 MSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-HDGWSNLLMSEADGVLCSEE  100 (263)
T ss_dssp             CSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-ETTEEEEEEECCSSEEHHHH
T ss_pred             CCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEe-cCCceEEEEEeccccccccc
Confidence            334689998754 556788877542 223345678888888774 333556666654 45567899999999877554

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.98  E-value=1.6e-05  Score=70.93  Aligned_cols=75  Identities=20%  Similarity=0.174  Sum_probs=51.8

Q ss_pred             cCcCCc-eEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCC--CceeeEeeEEEecCCCeEEEEEecCCCChh
Q 047276          109 LGHGSS-ASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQH--VNLVRLLGYCVVPGGPRYLVYEFIQNGSLD  185 (453)
Q Consensus       109 lG~G~f-G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~~lv~e~~~~gsL~  185 (453)
                      +..|.. ..||+...+++..+++|......  ...+..|...++.+..  -.+.++++++. .++..++||+|+++.++.
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~-~~~~~~~v~~~i~G~~~~   94 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVT-EAGRDWLLLGEVPGQDLL   94 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEE-CSSCEEEEEECCSSEETT
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecc-cccceEEEEEeeeccccc
Confidence            444543 68999998888888999866433  2346778888877643  33556677654 556779999999886654


Q ss_pred             h
Q 047276          186 H  186 (453)
Q Consensus       186 ~  186 (453)
                      +
T Consensus        95 ~   95 (255)
T d1nd4a_          95 S   95 (255)
T ss_dssp             T
T ss_pred             c
Confidence            3

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.64  E-value=9.1e-05  Score=70.60  Aligned_cols=74  Identities=18%  Similarity=0.102  Sum_probs=47.1

Q ss_pred             cccCcCCceEEEEEEeCC-CcEEEEEEecC------C--CccHHHHHHHHHHHHhcC-C--CceeeEeeEEEecCCCeEE
Q 047276          107 ALLGHGSSASVFKGILSD-GTSVAVKRING------E--ENGEKEFRSEVAAIASAQ-H--VNLVRLLGYCVVPGGPRYL  174 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~-g~~vavK~~~~------~--~~~~~~~~~E~~~l~~l~-h--~niv~l~g~~~~~~~~~~l  174 (453)
                      +.||.|....||+....+ ++.++||.-..      .  .........|.+.|..+. +  ..+.+++.+   +....++
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~---d~~~~~l  108 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS---DTEMAVT  108 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE---ETTTTEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE---cCCCCEE
Confidence            468999999999998654 67899996432      1  112234456888887663 2  345556654   2345689


Q ss_pred             EEEecCCCC
Q 047276          175 VYEFIQNGS  183 (453)
Q Consensus       175 v~e~~~~gs  183 (453)
                      |||++.+..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.33  E-value=0.00036  Score=64.47  Aligned_cols=142  Identities=13%  Similarity=0.112  Sum_probs=80.3

Q ss_pred             eEEEEEEeCCCcEEEEEEecCCCccHHHHHHHHHHHHhcCCCce--eeEee----EEEecCCCeEEEEEecCCCChhh--
Q 047276          115 ASVFKGILSDGTSVAVKRINGEENGEKEFRSEVAAIASAQHVNL--VRLLG----YCVVPGGPRYLVYEFIQNGSLDH--  186 (453)
Q Consensus       115 G~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~g----~~~~~~~~~~lv~e~~~~gsL~~--  186 (453)
                      -.||+...++|+.+++|..+......+++..|...+..|....+  +..+.    .....++..+.++++++|..+..  
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~  115 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADN  115 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSC
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCC
Confidence            58999999999999999988776677889999999888753222  11111    01112334578899987643311  


Q ss_pred             ---h---------hccCCCCCCCCCCCCCCCHH----------------------HHHHHHHHHHHHhcc-ccccCCCce
Q 047276          187 ---W---------IFPTSRRSEGHYSGGCLSWD----------------------LRYRVAIDVAKALSY-LHNDCRSRV  231 (453)
Q Consensus       187 ---~---------l~~~~~~~~~~~~~~~l~~~----------------------~~~~i~~~ia~~L~~-Lh~~~~~~i  231 (453)
                         +         ++...... .......+++.                      .....+..+...+.- +.+....++
T Consensus       116 ~~~~~~lG~~LA~lH~~~~~~-~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         116 IDQMEAVGRYLGRMHQTGRKQ-LFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             HHHHHHHHHHHHHHHHHHTSS-CCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             HHHHHHHHHHHHHHHhhcccC-CccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence               1         01000000 00000111111                      112222333333221 222334689


Q ss_pred             eccCCCCCcEEECCCCcEEEeecccccc
Q 047276          232 LHLDVKPENILLDENYRAVVSDFGLSKL  259 (453)
Q Consensus       232 vH~Dlk~~NiLl~~~~~~kl~DfGla~~  259 (453)
                      +|+|+.+.|||++++  ..+.||+-+..
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999754  45899998764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.25  E-value=0.0072  Score=56.91  Aligned_cols=72  Identities=21%  Similarity=0.233  Sum_probs=48.7

Q ss_pred             cccCcCCceEEEEEEeCCC--------cEEEEEEecCCCccHHHHHHHHHHHHhcCCCce-eeEeeEEEecCCCeEEEEE
Q 047276          107 ALLGHGSSASVFKGILSDG--------TSVAVKRINGEENGEKEFRSEVAAIASAQHVNL-VRLLGYCVVPGGPRYLVYE  177 (453)
Q Consensus       107 ~~lG~G~fG~Vy~~~~~~g--------~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~~lv~e  177 (453)
                      +.|+.|-.-.+|+...+++        +.|.+++... ....-...+|..+++.+.-.++ .++++++  .+   ..|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~--~~---g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIF--SG---GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEE--TT---EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEc--CC---ceEEE
Confidence            4688888999999987543        4566666553 3334456689988888753344 4666664  22   68999


Q ss_pred             ecCCCCh
Q 047276          178 FIQNGSL  184 (453)
Q Consensus       178 ~~~~gsL  184 (453)
                      |+++.+|
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987554

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.03  E-value=0.0068  Score=55.05  Aligned_cols=31  Identities=19%  Similarity=0.271  Sum_probs=27.9

Q ss_pred             CCceeccCCCCCcEEECCCCcEEEeeccccc
Q 047276          228 RSRVLHLDVKPENILLDENYRAVVSDFGLSK  258 (453)
Q Consensus       228 ~~~ivH~Dlk~~NiLl~~~~~~kl~DfGla~  258 (453)
                      +.++||+|+.+.||+++.+...-|.||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            4789999999999999998877899999875